Citrus Sinensis ID: 016865

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-
Protein Sequence
MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENIIWKPTEGSSLLRTMSC
Secondary Structure (PSIPRED)
ccccccccEEEEEEEEEcccEEEEEEEEccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccEEEEccccccccccccccEEcccccccccccHHccccccccccccHHHHHHHHHHHHHcccccccccHHHHHHHHHcccccccccccHHHHHHHHHHccccccccccHHHHHccccccccccccccccccccccccccccccccHHHHHHHHccccccccccccHHHHHHHccccccccccccccccccccccEEccccHHHHHHHHHHHHHHcccEEEEEccEEEEEEccccccccEEEEEEEEEEEccEEEEEEEEccccHHHHHHHHHHHHHHcccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
HHHcccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHcccEEcccccHHHEEEcccccEEEccccccEEccccccEEEcccccHccccHHHHHcccccccHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHcccccccccccHHHHHHHHHHcccccccEEEHHHHHccHcHcccccccccccccccccccHHHcccccccccccccccccccccccccHHHEEEcccccccHHHHHHcccccEEEEEEEccccHHHHHHHHHHHHHHcccEEEEcccEEEEEEcccccccEEEEEEEEEEEcccEEEEEEEccccccHHHHHHHHHHcHHHHHHEEccccccHHcccccc
Coil and Loop (DISEMBL)
mkivrhpniVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHChskgvyhrdlkpenllldsygnlkvsdfglsalpqqgvellhttcgtpnyvapevlsnrgydgsaadvWSCGVILFVLMAgylpfgetdlptLYKKInaaefscpfwfstgatslihkildpnpktririegirkhpwfrknynpvkcseeeevnlddvhavfdDIEDQYVAEqsenkvggpllMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRNYKtrlegvsanktgQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENIiwkptegssllrtmsc
Flexible Loop (DISEMBL)
mkivrhpnivrlhevlasrTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATslihkildpnpktririegirkhpwfrknynPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRNYKTRlegvsanktgQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENiiwkptegssllrtmsc
Low Complexity Region (SEG)
MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENIIWKPTEGSSLLRTMSC
Disordered region (IsUnstruct)
****RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENIIWKP************
Disordered Region (DISOPRED)
MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVK*********DDVHAVF*********************MNAFEMITLSQGLNLA***********************VILSNIE**************************TGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENII***************
Disordered Region (DISEMBL)
MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENIIWKPTEGS********
Disordered Region (DISPRO)
MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVK*********************************GPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENIIWKPTEG*********
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENIIWKPTEGSSLLRTMSC
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	381	2.2.26 [Sep-21-2011]
Q9LDI3	446	CBL-interacting serine/th	yes	no	0.997	0.852	0.762	1e-178
Q69Q47	453	CBL-interacting protein k	yes	no	1.0	0.841	0.75	1e-176
Q9STV4	445	CBL-interacting serine/th	no	no	0.976	0.835	0.678	1e-155
Q5JLD8	446	CBL-interacting protein k	no	no	0.973	0.831	0.681	1e-154
Q6ZLP5	450	CBL-interacting protein k	no	no	0.958	0.811	0.612	1e-136
Q93VD3	482	CBL-interacting serine/th	no	no	0.963	0.761	0.599	1e-134
Q84VQ3	439	CBL-interacting serine/th	no	no	0.973	0.845	0.583	1e-131
Q2QY53	438	CBL-interacting protein k	no	no	0.952	0.828	0.591	1e-129
Q2V452	441	CBL-interacting serine/th	no	no	0.963	0.832	0.576	1e-129
Q6X4A2	449	CBL-interacting protein k	no	no	0.955	0.810	0.564	1e-126

>sp|Q9LDI3|CIPKO_ARATH CBL-interacting serine/threonine-protein kinase 24 OS=Arabidopsis thaliana GN=CIPK24 PE=1 SV=1

 Score =  625 bits (1611), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 292/383 (76%), Positives = 335/383 (87%), Gaps = 3/383 (0%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MKIVRHPNIVRL+EVLAS +K+YI+LEFVTGGELFD+IVH+GRL E++ R+YFQQL+DAV
Sbjct: 63  MKIVRHPNIVRLYEVLASPSKIYIVLEFVTGGELFDRIVHKGRLEESESRKYFQQLVDAV 122

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           AHCH KGVYHRDLKPENLLLD+ GNLKVSDFGLSALPQ+GVELL TTCGTPNYVAPEVLS
Sbjct: 123 AHCHCKGVYHRDLKPENLLLDTNGNLKVSDFGLSALPQEGVELLRTTCGTPNYVAPEVLS 182

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            +GYDGSAAD+WSCGVILFV++AGYLPF ETDLP LY+KINAAEFSCP WFS     LIH
Sbjct: 183 GQGYDGSAADIWSCGVILFVILAGYLPFSETDLPGLYRKINAAEFSCPPWFSAEVKFLIH 242

Query: 181 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSEN 240
           +ILDPNPKTRI+I+GI+K PWFR NY P++  EEEEVNLDD+ AVFD IE  YVAE  E 
Sbjct: 243 RILDPNPKTRIQIQGIKKDPWFRLNYVPIRAREEEEVNLDDIRAVFDGIEGSYVAENVER 302

Query: 241 KVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLS 300
              GPL+MNAFEMITLSQGLNL+ALFDRRQD+VKRQTRFVSR+    I++NIEAVA S+ 
Sbjct: 303 NDEGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMG 362

Query: 301 LKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCA 360
            K HTRN+KTRLEG+S+ K GQ AVV+E++EVAPSLFMVDVRKAAG+TLEYHKFYK  C+
Sbjct: 363 FKSHTRNFKTRLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCS 422

Query: 361 KLENIIWKPTEG---SSLLRTMS 380
           KLENIIW+ TEG   S +LRT++
Sbjct: 423 KLENIIWRATEGIPKSEILRTIT 445

Involved in the regulatory pathway for the control of intracellular Na(+) and K(+) homeostasis and salt tolerance. Activates the vacuolar H(+)/Ca(2+) antiporter CAX1 and operates in synergy with CBL4/SOS3 to activate the plasma membrane Na(+)/H(+) antiporter SOS1. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q69Q47|CIPKO_ORYSJ CBL-interacting protein kinase 24 OS=Oryza sativa subsp. japonica GN=CIPK24 PE=1 SV=1

 Score =  618 bits (1594), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 288/384 (75%), Positives = 334/384 (86%), Gaps = 3/384 (0%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MKIVRHPNIVRL+EVLA +TK+YIILE +TGGELFDKI  QG+L EN+ R+YFQQLIDA+
Sbjct: 70  MKIVRHPNIVRLNEVLAGKTKIYIILELITGGELFDKIARQGKLRENEARKYFQQLIDAI 129

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            +CHSKGVYHRDLKPENLLLDS GNLKVSDFGLS L Q+GV LLHTTCGTPNYVAPEVLS
Sbjct: 130 NYCHSKGVYHRDLKPENLLLDSRGNLKVSDFGLSTLAQKGVGLLHTTCGTPNYVAPEVLS 189

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           N GYDGSAADVWSCGVIL+VLMAGYLPF E DLPTLY KI A +FSCP+WFS GATSLIH
Sbjct: 190 NNGYDGSAADVWSCGVILYVLMAGYLPFEEDDLPTLYDKITAGQFSCPYWFSPGATSLIH 249

Query: 181 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSEN 240
           +ILDPNPKTRI IE IR+  WF+K Y  +K  E+E V+LDDV AVFD+IED+YV+EQ  +
Sbjct: 250 RILDPNPKTRITIEQIREDTWFKKTYVAIKRGEDENVDLDDVQAVFDNIEDKYVSEQVTH 309

Query: 241 KVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLS 300
             GGPL+MNAFEMITLSQGL+L+ALFDR+Q++VKRQTRFVSR+PA+ I++ IE VAE++ 
Sbjct: 310 NDGGPLVMNAFEMITLSQGLDLSALFDRQQEFVKRQTRFVSRKPAKTIVATIEVVAETMG 369

Query: 301 LKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCA 360
           LKVH++NYK RLEGVS+N+   FAVVL+VFEVAPSLFMVDVRK AGDTLEYH+FYKN C 
Sbjct: 370 LKVHSQNYKLRLEGVSSNRMSPFAVVLQVFEVAPSLFMVDVRKVAGDTLEYHRFYKNLCN 429

Query: 361 KLENIIWKPTE---GSSLLRTMSC 381
           K+E+IIW+P E    S+LLRT +C
Sbjct: 430 KMESIIWRPIEVSAKSALLRTATC 453

Involved in the regulatory pathway for the control of intracellular Na(+) and K(+) homeostasis and salt tolerance. Operates in synergy with CBL4 to activate the plasma membrane Na(+)/H(+) antiporter SOS1. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9STV4|CIPK8_ARATH CBL-interacting serine/threonine-protein kinase 8 OS=Arabidopsis thaliana GN=CIPK8 PE=1 SV=1

 Score =  547 bits (1410), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 253/373 (67%), Positives = 309/373 (82%), Gaps = 1/373 (0%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MK+VRHP +VRL+EVLASRTK+YIILE++TGGELFDKIV  GRL E++ R+YF QLID V
Sbjct: 61  MKLVRHPCVVRLYEVLASRTKIYIILEYITGGELFDKIVRNGRLSESEARKYFHQLIDGV 120

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            +CHSKGVYHRDLKPENLLLDS GNLK+SDFGLSALP+QGV +L TTCGTPNYVAPEVLS
Sbjct: 121 DYCHSKGVYHRDLKPENLLLDSQGNLKISDFGLSALPEQGVTILKTTCGTPNYVAPEVLS 180

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+G+ AD+WSCGVIL+VLMAGYLPF E DLPTLY KI+ AEFSCP +F+ GA SLI+
Sbjct: 181 HKGYNGAVADIWSCGVILYVLMAGYLPFDEMDLPTLYSKIDKAEFSCPSYFALGAKSLIN 240

Query: 181 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSEN 240
           +ILDPNP+TRI I  IRK  WF K+Y PV+  + E VNLDDV+A FDD E+Q  A Q   
Sbjct: 241 RILDPNPETRITIAEIRKDEWFLKDYTPVQLIDYEHVNLDDVYAAFDDPEEQTYA-QDGT 299

Query: 241 KVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLS 300
           +  GPL +NAF++I LSQGLNLA LFDR +D +K QTRF+S +PA V+LS++E V++S+ 
Sbjct: 300 RDTGPLTLNAFDLIILSQGLNLATLFDRGKDSMKHQTRFISHKPANVVLSSMEVVSQSMG 359

Query: 301 LKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCA 360
            K H RNYK R+EG+SANKT  F+V+LEVF+VAPS+ MVD++ AAGD  EY KFYK FC+
Sbjct: 360 FKTHIRNYKMRVEGLSANKTSHFSVILEVFKVAPSILMVDIQNAAGDAEEYLKFYKTFCS 419

Query: 361 KLENIIWKPTEGS 373
           KL++IIWKP + S
Sbjct: 420 KLDDIIWKPPDAS 432

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q5JLD8|CIPK8_ORYSJ CBL-interacting protein kinase 8 OS=Oryza sativa subsp. japonica GN=CIPK8 PE=2 SV=1

 Score =  543 bits (1400), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 255/374 (68%), Positives = 305/374 (81%), Gaps = 3/374 (0%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MK+VRHPN+VRLHEVLASR K++IILEF+TGGELFDKI+  GRL E D RRYFQQLID V
Sbjct: 65  MKLVRHPNVVRLHEVLASRKKIFIILEFITGGELFDKIIRHGRLNEADARRYFQQLIDGV 124

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
             CHSKGVYHRDLKPENLLLDS GNLK+SDFGLSA P QG  LL TTCGTPNYVAPEVLS
Sbjct: 125 DFCHSKGVYHRDLKPENLLLDSQGNLKISDFGLSAWPAQGGALLRTTCGTPNYVAPEVLS 184

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GYDG+ AD WSCGVIL+VL+AGYLPF E DL TLY KI +AE+S P WF  GA SLIH
Sbjct: 185 HKGYDGALADTWSCGVILYVLLAGYLPFDEVDLTTLYGKIESAEYSFPAWFPNGAKSLIH 244

Query: 181 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSEN 240
           +ILDPNP  RIRIE IR   WF+KNY P +  E EEVNLDDV+A FDD E+   A+ + +
Sbjct: 245 RILDPNPDKRIRIEEIRNDEWFKKNYEPTREIESEEVNLDDVNAAFDDPEED--ADHTLD 302

Query: 241 KVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLS 300
              GPL +NAF++I LSQGLNLAALFDRRQDY K Q RF+SR+PA+VI+S++E VA+S+ 
Sbjct: 303 DEAGPLTLNAFDLIILSQGLNLAALFDRRQDYDKLQNRFLSRKPAKVIMSSMEVVAQSMG 362

Query: 301 LKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCA 360
            K H RNYK R+EG++ANKT   AV+LE+FEVAPS+FM+++++AAGDT +Y+KF  N+C+
Sbjct: 363 YKTHIRNYKMRVEGLNANKTSHLAVMLEIFEVAPSIFMIELQRAAGDTSDYNKFINNYCS 422

Query: 361 KLENIIWK-PTEGS 373
           KL++IIW  P E S
Sbjct: 423 KLDDIIWNFPIEKS 436

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6ZLP5|CIPKN_ORYSJ CBL-interacting protein kinase 23 OS=Oryza sativa subsp. japonica GN=CIPK23 PE=2 SV=1

 Score =  484 bits (1246), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 229/374 (61%), Positives = 291/374 (77%), Gaps = 9/374 (2%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MK++RHPN++R+HEV+AS+TK+YI++E VTGGELFDKI  +GRL E+D R+YFQQLI+AV
Sbjct: 65  MKLIRHPNVIRMHEVMASKTKIYIVMELVTGGELFDKIASRGRLKEDDARKYFQQLINAV 124

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEV 118
            +CHS+GVYHRDLKPENLLLD+ G LKVSDFGLSAL QQ  E  LLHTTCGTPNYVAPEV
Sbjct: 125 DYCHSRGVYHRDLKPENLLLDASGTLKVSDFGLSALSQQVREDGLLHTTCGTPNYVAPEV 184

Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
           ++N+GYDG+ AD+WSCGVILFVLMAGYLPF +++L +LYKKI  A+FSCP WFST A  L
Sbjct: 185 INNKGYDGAKADLWSCGVILFVLMAGYLPFEDSNLMSLYKKIFKADFSCPSWFSTSAKKL 244

Query: 179 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIED--QYVAE 236
           I KILDPNP TRI I  +  + WF+K Y P +  E  +VNLDD++++F++  D  Q V E
Sbjct: 245 IKKILDPNPSTRITIAELINNEWFKKGYQPPRF-ETADVNLDDINSIFNESGDQTQLVVE 303

Query: 237 QSENKVGGPLLMNAFEMITLSQGLNLAALFDRR-QDYVKRQTRFVSRQPAQVILSNIEAV 295
           + E +   P +MNAFE+I+ SQGLNL  LF+++ Q  VKR+TRF SR PA  ILS IEA 
Sbjct: 304 RREER---PSVMNAFELISTSQGLNLGTLFEKQSQGSVKRETRFASRLPANEILSKIEAA 360

Query: 296 AESLSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFY 355
           A  +   V  RNYK +L+G +  + GQ A+  EVFEV PSL+MV++RK+ GDTLE+HKFY
Sbjct: 361 AGPMGFNVQKRNYKLKLQGENPGRKGQLAIATEVFEVTPSLYMVELRKSNGDTLEFHKFY 420

Query: 356 KNFCAKLENIIWKP 369
            N    L++++WKP
Sbjct: 421 HNISNGLKDVMWKP 434

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q93VD3|CIPKN_ARATH CBL-interacting serine/threonine-protein kinase 23 OS=Arabidopsis thaliana GN=CIPK23 PE=1 SV=1

 Score =  479 bits (1232), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 223/372 (59%), Positives = 285/372 (76%), Gaps = 5/372 (1%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MK+++HPN++R+ EV+AS+TK+Y +LEFVTGGELFDKI   GRL E++ R+YFQQLI+AV
Sbjct: 83  MKLIKHPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAV 142

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEV 118
            +CHS+GVYHRDLKPENLLLD+ G LKVSDFGLSALPQQ  E  LLHTTCGTPNYVAPEV
Sbjct: 143 DYCHSRGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEV 202

Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
           ++N+GYDG+ AD+WSCGVILFVLMAGYLPF +++L +LYKKI  AEF+CP WFS  A  L
Sbjct: 203 INNKGYDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKL 262

Query: 179 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIED--QYVAE 236
           I +ILDPNP TRI    + ++ WF+K Y   K  E  +V+LDDV A+FDD  +    V E
Sbjct: 263 IKRILDPNPATRITFAEVIENEWFKKGYKAPKF-ENADVSLDDVDAIFDDSGESKNLVVE 321

Query: 237 QSENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVA 296
           + E  +  P+ MNAFE+I+ SQGLNL +LF+++   VKR+TRF S+  A  I++ IEA A
Sbjct: 322 RREEGLKTPVTMNAFELISTSQGLNLGSLFEKQMGLVKRKTRFTSKSSANEIVTKIEAAA 381

Query: 297 ESLSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYK 356
             +   V T NYK +L G  + + GQ AV  EVF+VAPSL+MV++RK+ GDTLE+HKFYK
Sbjct: 382 APMGFDVKTNNYKMKLTGEKSGRKGQLAVATEVFQVAPSLYMVEMRKSGGDTLEFHKFYK 441

Query: 357 NFCAKLENIIWK 368
           N    L++I+WK
Sbjct: 442 NLTTGLKDIVWK 453

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein leads to activation of the kinase in a calcium-dependent manner. Downstream of CBL1, CBL2, CBL3 and CBL9, regulates by phosphorylation the K(+) conductance and uptake of AKT1 in low K(+) condition, in response to calcium signaling and during the stomatal opening regulation by monitoring the turgor pressure in guard cells. In response to low nitrate concentration, phosphorylates NRT1.1, switching it from a low-affinity nitrate transporter to a high-affinity transporter. Confers tolerance to low potassium conditions. Involved in drought sensitivity and leaf transpiration.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q84VQ3|CIPKQ_ARATH CBL-interacting serine/threonine-protein kinase 26 OS=Arabidopsis thaliana GN=CIPK26 PE=2 SV=2

 Score =  468 bits (1203), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 220/377 (58%), Positives = 281/377 (74%), Gaps = 6/377 (1%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MK++ HPN+VRL+EVLAS+TK+YI+LEF TGGELFDKIVH GRL E + R+YFQQLI+AV
Sbjct: 65  MKLINHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQLINAV 124

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEV 118
            +CHS+GVYHRDLKPENLLLD+ GNLKVSDFGLSAL +Q  G  LLHT CGTPNY APEV
Sbjct: 125 DYCHSRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYAAPEV 184

Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
           L+++GYDG+ AD+WSCGVILFVL+AGYLPF +++L TLYKKI A E+ CP W S GA +L
Sbjct: 185 LNDQGYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPGAKNL 244

Query: 179 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQS 238
           I +ILDPNP TRI I  +    WF+KNY P    E+EE NLDDV AVF D E+ +V E+ 
Sbjct: 245 IVRILDPNPMTRITIPEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSEEHHVTEKK 304

Query: 239 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 298
           E +   P  MNAFE+I++S+ L+L  LF+  + + KR+TRF ++  A  ++  IE  ++ 
Sbjct: 305 EEQ---PTSMNAFELISMSRALDLGNLFEEEEGF-KRETRFAAKGAANDLVQKIEEASKP 360

Query: 299 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 358
           L   +  +NYK RLE V+A + G   V  E+F+V+PSL M++VRK  GDTLE+HKFYK  
Sbjct: 361 LGFDIQKKNYKMRLENVTAGRKGNLRVATEIFQVSPSLHMIEVRKTKGDTLEFHKFYKKL 420

Query: 359 CAKLENIIWKPTEGSSL 375
              L +++WK  E S L
Sbjct: 421 STSLNDVVWKSGESSGL 437

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2QY53|CIPKW_ORYSJ CBL-interacting protein kinase 32 OS=Oryza sativa subsp. japonica GN=CIPK32 PE=2 SV=2

 Score =  461 bits (1186), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 219/370 (59%), Positives = 282/370 (76%), Gaps = 7/370 (1%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MK+++HPN+VR++EV+ S+TK+YI+LE+VTGGELFD IV+ GR+ E++ RRYFQQLI+AV
Sbjct: 65  MKLIKHPNVVRIYEVMGSKTKIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQLINAV 124

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEV 118
            +CHS+GVYHRDLKPENLLLDSYGNLKVSDFGLSAL QQ  +  LLHTTCGTPNYVAPEV
Sbjct: 125 DYCHSRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYVAPEV 184

Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
           L ++GYDG+ AD+WSCGVILFVL+AGYLPF +++L TLYKKI+ AEF+ P W S  A  L
Sbjct: 185 LEDQGYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLYKKISNAEFTFPPWTSFPAKRL 244

Query: 179 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQS 238
           + +ILDPNP TR+ I  I +  WF+K Y   +  E+ +  LDDV+AVF+D E+ +V E+ 
Sbjct: 245 LTRILDPNPMTRVTIPEILEDEWFKKGYKRPEFDEKYDTTLDDVYAVFNDSEEHHVTEKK 304

Query: 239 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 298
           E     P  +NAFE+I++S GLNL  LFD  Q++ KR+TRF S+ P + I+  IE  A+ 
Sbjct: 305 EE----PEALNAFELISMSAGLNLGNLFDSEQEF-KRETRFTSKCPPKEIVRKIEEAAKP 359

Query: 299 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 358
           L   V  +NYK RLE V A + G   V  E+ +VAPSL MV+VRKA GDTLE+HKFYKN 
Sbjct: 360 LGFDVQKKNYKLRLEKVKAGRKGNLNVATEILQVAPSLHMVEVRKAKGDTLEFHKFYKNL 419

Query: 359 CAKLENIIWK 368
              L++++WK
Sbjct: 420 SRTLKDVVWK 429

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2V452|CIPK3_ARATH CBL-interacting serine/threonine-protein kinase 3 OS=Arabidopsis thaliana GN=CIPK3 PE=1 SV=2

 Score =  460 bits (1184), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 215/373 (57%), Positives = 280/373 (75%), Gaps = 6/373 (1%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MK+++HPN+V+L+EV+AS+TK++IILE+VTGGELFDKIV+ GR+ E++ RRYFQQLI AV
Sbjct: 66  MKLIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAV 125

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEV 118
            +CHS+GVYHRDLKPENLLLDSYGNLK+SDFGLSAL QQ  +  LLHT+CGTPNYVAPEV
Sbjct: 126 DYCHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEV 185

Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
           L++RGYDG+ AD+WSCGV+L+VL+AGYLPF +++L  LYKKI++ EF+CP W S GA  L
Sbjct: 186 LNDRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAMKL 245

Query: 179 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQS 238
           I +ILDPNP TR+  + + +  WF+K+Y P    E ++ N+DD+ AVF D E+  V E+ 
Sbjct: 246 ITRILDPNPMTRVTPQEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSEEHLVTEKR 305

Query: 239 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 298
           E +   P  +NAFE+I++S+GLNL  LFD  Q++ KR+TR   R  A  I+  IE  A+ 
Sbjct: 306 EEQ---PAAINAFEIISMSRGLNLENLFDPEQEF-KRETRITLRGGANEIIEKIEEAAKP 361

Query: 299 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 358
           L   V  +NYK RLE V A + G   V  E+F+VAPSL MV V K+ GDTLE+HKFYK  
Sbjct: 362 LGFDVQKKNYKMRLENVKAGRKGNLNVATEIFQVAPSLHMVQVSKSKGDTLEFHKFYKKL 421

Query: 359 CAKLENIIWKPTE 371
              LE ++W   E
Sbjct: 422 SNSLEQVVWTNNE 434

Involved in the resistance to some abiotic stresses (e.g. high salt, hyperosmotic stress) in young seedlings, by regulating the expression of several stress-inducible genes (cold-and salt-induced genes but not drought-responsive genes). Required for the ABA response during germination. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6X4A2|CIPKV_ORYSJ CBL-interacting protein kinase 31 OS=Oryza sativa subsp. japonica GN=CIPK31 PE=1 SV=1

 Score =  451 bits (1161), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 209/370 (56%), Positives = 281/370 (75%), Gaps = 6/370 (1%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MK+V+HPN+VRL EV+ S+ +++I+LE+VTGGELF+ I   GRL E + R+YFQQLI+AV
Sbjct: 72  MKLVKHPNVVRLFEVMGSKARIFIVLEYVTGGELFEIIATNGRLKEEEARKYFQQLINAV 131

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEV 118
            +CHS+GVYHRDLK ENLLLD+ GNLKVSDFGLSAL +Q     LLHTTCGTPNYVAPEV
Sbjct: 132 DYCHSRGVYHRDLKLENLLLDASGNLKVSDFGLSALTEQVKADGLLHTTCGTPNYVAPEV 191

Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
           + +RGYDG+AAD+WSCGVIL+VL+AG+LPF + ++  LYKKI+ A+F+CP WFSTGA  L
Sbjct: 192 IEDRGYDGAAADIWSCGVILYVLLAGFLPFEDDNIIALYKKISEAQFTCPSWFSTGAKKL 251

Query: 179 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQS 238
           I +ILDPNP TRI I  I + PWF+K Y P    E+ E + DDV A F D ED++V E++
Sbjct: 252 ITRILDPNPTTRITISQILEDPWFKKGYKPPVFDEKYETSFDDVDAAFGDSEDRHVKEET 311

Query: 239 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 298
           E++   P  MNAFE+I+L+Q LNL  LF+ +++Y KR+TRF S+ P + I++ IE  A+ 
Sbjct: 312 EDQ---PTSMNAFELISLNQALNLDNLFEAKKEY-KRETRFTSQCPPKEIITKIEEAAKP 367

Query: 299 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 358
           L   +  +NYK R+E + A + G   V  EVF+VAPSL +V+++KA GDTLE+ KFY+  
Sbjct: 368 LGFDIQKKNYKMRMENLKAGRKGNLNVATEVFQVAPSLHVVELKKAKGDTLEFQKFYRTL 427

Query: 359 CAKLENIIWK 368
             +L++++WK
Sbjct: 428 STQLKDVVWK 437

Involved in cold stress tolerance. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	381
255567051	449	CBL-interacting serine/threonine-protein	1.0	0.848	0.851	0.0
147846506	446	hypothetical protein VITISV_043742 [Viti	1.0	0.854	0.846	0.0
225445529	446	PREDICTED: CBL-interacting serine/threon	1.0	0.854	0.846	0.0
224993594	444	CBL-interacting protein kinase 26 [Popul	0.984	0.844	0.853	0.0
229893775	446	serine/threonine protein kinase [Malus x	0.997	0.852	0.838	0.0
224142617	444	predicted protein [Populus trichocarpa]	0.984	0.844	0.848	0.0
310896475	445	salt overly sensitive protein 2b [Gossyp	0.997	0.853	0.828	0.0
350535735	446	calcineurin B-like interacting protein k	0.997	0.852	0.798	0.0
356563005	446	PREDICTED: CBL-interacting protein kinas	0.971	0.829	0.813	0.0
224087128	431	predicted protein [Populus trichocarpa]	0.963	0.851	0.825	0.0

>gi|255567051|ref|XP_002524508.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] gi|223536296|gb|EEF37948.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis]

 Score =  696 bits (1795), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 327/384 (85%), Positives = 358/384 (93%), Gaps = 3/384 (0%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MKIVRH NIVRLHEVLASRTK+YIILEFVTGGELFDKIVHQGRL EN+ RRYFQQLIDAV
Sbjct: 66  MKIVRHNNIVRLHEVLASRTKIYIILEFVTGGELFDKIVHQGRLSENEARRYFQQLIDAV 125

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           AHCHSKGVYHRDLKPENLLLDS+GNLKVSDFGLSALPQQGV LLHTTCGTPNYVAPEV+ 
Sbjct: 126 AHCHSKGVYHRDLKPENLLLDSFGNLKVSDFGLSALPQQGVGLLHTTCGTPNYVAPEVIG 185

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GYDG+AADVWSCGVIL+VLMAGYLPF E DLPTLY+KINAAE+S PFWFS GA SLI 
Sbjct: 186 HQGYDGAAADVWSCGVILYVLMAGYLPFDEVDLPTLYRKINAAEYSSPFWFSPGAKSLID 245

Query: 181 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSEN 240
           KILDPNPKTRI+IEGI+KH WFRKNY PVK SEEEEVNLDDVHAVF DIEDQYVAEQ+EN
Sbjct: 246 KILDPNPKTRIKIEGIKKHLWFRKNYMPVKQSEEEEVNLDDVHAVFGDIEDQYVAEQTEN 305

Query: 241 KVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLS 300
             GGPL+MNAFEMITLSQGLNL+ALFDR+QDY+KRQTRFVSR+PA+ I+S IEAVAES+S
Sbjct: 306 SEGGPLIMNAFEMITLSQGLNLSALFDRQQDYIKRQTRFVSRRPAKDIISTIEAVAESMS 365

Query: 301 LKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCA 360
           LKVHTRNYKTRLEG+SANK G FAVVLEVFEVAPSLFMVDVRKA+GDTLEYHKFYK+FC+
Sbjct: 366 LKVHTRNYKTRLEGISANKAGHFAVVLEVFEVAPSLFMVDVRKASGDTLEYHKFYKDFCS 425

Query: 361 KLENIIWKPTEG---SSLLRTMSC 381
           KLE+IIW+P +G    +LLR+M+C
Sbjct: 426 KLEDIIWRPADGVNACNLLRSMTC 449

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147846506|emb|CAN83760.1| hypothetical protein VITISV_043742 [Vitis vinifera] gi|229609819|gb|ACQ83525.1| CBL-interacting protein kinase 09 [Vitis vinifera]

 Score =  693 bits (1788), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 325/384 (84%), Positives = 355/384 (92%), Gaps = 3/384 (0%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MKIVRHPNIVRLHEVLAS+T +YIILEFVTGGEL+DKIVHQGRL EN+ RRYFQQLIDAV
Sbjct: 63  MKIVRHPNIVRLHEVLASQTTIYIILEFVTGGELYDKIVHQGRLSENESRRYFQQLIDAV 122

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           +HCHSKGVYHRDLKPENLLLDS GNLKVSDFGLSALP+QGV LLHTTCGTPNYVAPEVLS
Sbjct: 123 SHCHSKGVYHRDLKPENLLLDSNGNLKVSDFGLSALPKQGVGLLHTTCGTPNYVAPEVLS 182

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           N+GYDG+AADVWSCGVIL+VLMAGYLPF E DLP+LYKKINAAEFSCPFWFS+G+ S + 
Sbjct: 183 NQGYDGAAADVWSCGVILYVLMAGYLPFNEIDLPSLYKKINAAEFSCPFWFSSGSKSFLC 242

Query: 181 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSEN 240
           +ILDPNPKTRIRIEGI+  PWFRKNY   KC E+EEVNLDD+HAVFDDIE+ YV+EQS N
Sbjct: 243 RILDPNPKTRIRIEGIKNDPWFRKNYVSSKCREDEEVNLDDIHAVFDDIEENYVSEQSGN 302

Query: 241 KVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLS 300
              GPL+MNAFEMITLSQGLNL+ALFDRRQDYVKRQTRFVSR+PA+VI+S IEAVAES++
Sbjct: 303 NDTGPLIMNAFEMITLSQGLNLSALFDRRQDYVKRQTRFVSREPAKVIISTIEAVAESMN 362

Query: 301 LKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCA 360
            KVHTR+YKTRLEG+SANKT QFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCA
Sbjct: 363 FKVHTRHYKTRLEGISANKTAQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCA 422

Query: 361 KLENIIWKPTEG---SSLLRTMSC 381
           KLE+IIWKP E    SSLLRTM+C
Sbjct: 423 KLEHIIWKPKEAMTNSSLLRTMTC 446

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225445529|ref|XP_002285262.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 24 [Vitis vinifera] gi|297738965|emb|CBI28210.3| unnamed protein product [Vitis vinifera]

 Score =  692 bits (1786), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 325/384 (84%), Positives = 355/384 (92%), Gaps = 3/384 (0%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MKIVRHPNIVRLHEVLAS+T +YIILEFVTGGEL+DKIVHQGRL EN+ RRYFQQLIDAV
Sbjct: 63  MKIVRHPNIVRLHEVLASQTTIYIILEFVTGGELYDKIVHQGRLSENESRRYFQQLIDAV 122

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           +HCHSKGVYHRDLKPENLLLDS GNLKVSDFGLSALP+QGV LLHTTCGTPNYVAPEVLS
Sbjct: 123 SHCHSKGVYHRDLKPENLLLDSNGNLKVSDFGLSALPKQGVGLLHTTCGTPNYVAPEVLS 182

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           N+GYDG+AADVWSCGVIL+VLMAGYLPF E DLP+LYKKINAAEFSCPFWFS+G+ SL+ 
Sbjct: 183 NQGYDGAAADVWSCGVILYVLMAGYLPFNEIDLPSLYKKINAAEFSCPFWFSSGSKSLLC 242

Query: 181 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSEN 240
           +ILD NPKTRIRIEGI+  PWFRKNY   KC E+EEVNLDD+HAVFDDIE+ YV+EQS N
Sbjct: 243 RILDSNPKTRIRIEGIKNDPWFRKNYVSSKCREDEEVNLDDIHAVFDDIEENYVSEQSGN 302

Query: 241 KVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLS 300
              GPL+MNAFEMITLSQGLNL+ALFDRRQDYVKRQTRFVSR+PA+VI+S IEAVAES++
Sbjct: 303 NDTGPLIMNAFEMITLSQGLNLSALFDRRQDYVKRQTRFVSREPAKVIISTIEAVAESMN 362

Query: 301 LKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCA 360
            KVHTR+YKTRLEG+SANKT QFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCA
Sbjct: 363 FKVHTRHYKTRLEGISANKTAQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCA 422

Query: 361 KLENIIWKPTEG---SSLLRTMSC 381
           KLE+IIWKP E    SSLLRTM+C
Sbjct: 423 KLEHIIWKPKEAMTNSSLLRTMTC 446

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224993594|gb|ACN76476.1| CBL-interacting protein kinase 26 [Populus euphratica]

 Score =  683 bits (1763), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 320/375 (85%), Positives = 348/375 (92%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MK+VRHP IVRLHEVLASRTK+YIILEFVTGGELFDKIVHQGRL EN+ RRYFQQLIDAV
Sbjct: 64  MKLVRHPYIVRLHEVLASRTKIYIILEFVTGGELFDKIVHQGRLGENESRRYFQQLIDAV 123

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           AHCH KGVYHRDLKPENLLLD++GNLKVSDFGLSALPQ+GV LLHTTCGTPNYVAPEVL 
Sbjct: 124 AHCHCKGVYHRDLKPENLLLDAFGNLKVSDFGLSALPQKGVGLLHTTCGTPNYVAPEVLG 183

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           N+GYDG+AADVWSCGVILFVLMAGYLPF E DLPTLY+KINAAE+SCPFWFS GA +LI 
Sbjct: 184 NQGYDGAAADVWSCGVILFVLMAGYLPFEEADLPTLYRKINAAEYSCPFWFSPGAKALID 243

Query: 181 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSEN 240
           KIL+PNP+TRI IEGI+KHPWF+KNY PV   E+EEVNLDDVHAVFDDIEDQYVAEQ EN
Sbjct: 244 KILNPNPRTRIGIEGIKKHPWFQKNYEPVGHREDEEVNLDDVHAVFDDIEDQYVAEQLEN 303

Query: 241 KVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLS 300
            VGGPL+MNAFEMITLSQGLNL+ALFDRRQDY+KRQTRFVSR+PA+ I+S IEAVA S++
Sbjct: 304 SVGGPLVMNAFEMITLSQGLNLSALFDRRQDYIKRQTRFVSRKPAEDIISTIEAVAGSMN 363

Query: 301 LKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCA 360
           LKVHTRNYKTRLEGVS NK GQFAVVLEV+EVAPSLFMVD RKA+G+TLEYHKFYKNFC 
Sbjct: 364 LKVHTRNYKTRLEGVSENKAGQFAVVLEVYEVAPSLFMVDARKASGETLEYHKFYKNFCT 423

Query: 361 KLENIIWKPTEGSSL 375
           KLENIIWKP EG+ L
Sbjct: 424 KLENIIWKPPEGAKL 438

Source: Populus euphratica

Species: Populus euphratica

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|229893775|gb|ACQ90245.1| serine/threonine protein kinase [Malus x domestica]

 Score =  678 bits (1749), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 321/383 (83%), Positives = 352/383 (91%), Gaps = 3/383 (0%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MKIVRHPNIVRL EVLA RTK++IILEFVTGGELFDKIVHQG+L EN+ R+YFQQLIDAV
Sbjct: 63  MKIVRHPNIVRLLEVLAGRTKIFIILEFVTGGELFDKIVHQGKLPENESRKYFQQLIDAV 122

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           AHCHSKGVYHRDLKPENLLLD+YGNLKVSDFGLSALP QG  LLHTTCGTPNY+APEVL 
Sbjct: 123 AHCHSKGVYHRDLKPENLLLDAYGNLKVSDFGLSALPLQGDGLLHTTCGTPNYIAPEVLG 182

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GYDGSAAD+WSCGVILFVLMAGYLPF ET+L TLY+KIN A+FSCPFWFS  A  LIH
Sbjct: 183 DQGYDGSAADIWSCGVILFVLMAGYLPFDETNLSTLYRKINDADFSCPFWFSPEANKLIH 242

Query: 181 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSEN 240
           KILDPNPKTRIRI+GIRK PWF+KNY P+   E+EEV+LDDV AVF+DIEDQYVAE+SE 
Sbjct: 243 KILDPNPKTRIRIDGIRKDPWFKKNYAPLTYREDEEVSLDDVRAVFEDIEDQYVAERSEI 302

Query: 241 KVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLS 300
           K GGPLLMNAFEMITLSQGLNL+ALFDRRQDYV RQTRFVSR+PA VI+SN+EAVAES+ 
Sbjct: 303 KDGGPLLMNAFEMITLSQGLNLSALFDRRQDYVNRQTRFVSRKPAHVIISNVEAVAESMG 362

Query: 301 LKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCA 360
           LKVHTRNYKTRLEG+SAN+TGQFAVVLEV+EVAPSLFMVDVRKAAGDTLEYHKFYKNFCA
Sbjct: 363 LKVHTRNYKTRLEGISANRTGQFAVVLEVYEVAPSLFMVDVRKAAGDTLEYHKFYKNFCA 422

Query: 361 KLENIIWKPTEG---SSLLRTMS 380
           KLE IIWKP EG   S+LL+TM+
Sbjct: 423 KLEEIIWKPKEGMGHSNLLKTMT 445

Source: Malus x domestica

Species: Malus x domestica

Genus: Malus

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224142617|ref|XP_002324651.1| predicted protein [Populus trichocarpa] gi|116265968|gb|ABJ91232.1| CBL-interacting protein kinase 26 [Populus trichocarpa] gi|222866085|gb|EEF03216.1| predicted protein [Populus trichocarpa]

 Score =  674 bits (1740), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 318/375 (84%), Positives = 346/375 (92%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MK+VRHP IV LHEVLASRTK+YIILEFVTGGELFDKIVHQ RL EN+ RRYFQQLIDAV
Sbjct: 64  MKLVRHPYIVMLHEVLASRTKIYIILEFVTGGELFDKIVHQRRLEENESRRYFQQLIDAV 123

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           AHCH KGVYHRDLKPENLLLD++GNLKVSDFGLSALPQ+GV LLHTTCGTPNYVAPEVL 
Sbjct: 124 AHCHCKGVYHRDLKPENLLLDAFGNLKVSDFGLSALPQKGVGLLHTTCGTPNYVAPEVLG 183

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GYDG+AADVWSCGVILFVLMAGYLPF ETDLPTLY+KINAAE+SCPFWFS GA +LI 
Sbjct: 184 HQGYDGAAADVWSCGVILFVLMAGYLPFEETDLPTLYRKINAAEYSCPFWFSPGAKALID 243

Query: 181 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSEN 240
           KIL+PNPKTRI IEGI+KHPWF+KNY PV   E+EEVNLDDVHAVFDDIEDQYVAEQ EN
Sbjct: 244 KILNPNPKTRIGIEGIKKHPWFQKNYEPVGHREDEEVNLDDVHAVFDDIEDQYVAEQLEN 303

Query: 241 KVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLS 300
              GPL+MNAFEMITLSQGLNL+ALFDRRQDY+KRQTRFVSR+PA+ I+S IEAVAES++
Sbjct: 304 SEDGPLVMNAFEMITLSQGLNLSALFDRRQDYIKRQTRFVSRKPAKDIISAIEAVAESMN 363

Query: 301 LKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCA 360
           LKVHTRNYKTRLEGVS NK GQFAVVLEV+EVAPSLFMVD RKA+G+TLEYHKFYKNFC 
Sbjct: 364 LKVHTRNYKTRLEGVSENKAGQFAVVLEVYEVAPSLFMVDARKASGETLEYHKFYKNFCT 423

Query: 361 KLENIIWKPTEGSSL 375
           KLENIIWKP EG+ L
Sbjct: 424 KLENIIWKPPEGAKL 438

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|310896475|gb|ADP37983.1| salt overly sensitive protein 2b [Gossypium hirsutum]

 Score =  670 bits (1729), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 318/384 (82%), Positives = 351/384 (91%), Gaps = 4/384 (1%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MKIVRHPNIVRLHEVLASRTK+YIILEF++GGELFDKIVH GRL EN+CRRYFQQLIDAV
Sbjct: 63  MKIVRHPNIVRLHEVLASRTKIYIILEFISGGELFDKIVHCGRLPENECRRYFQQLIDAV 122

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           AHCHSKGVYHRDLKPENLLLDSYG+LKVSDFGLSAL QQGV LLHTTCGTPNYVAPEVL 
Sbjct: 123 AHCHSKGVYHRDLKPENLLLDSYGDLKVSDFGLSALLQQGVGLLHTTCGTPNYVAPEVLG 182

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           N+GYDG+AAD+WSCGVILF +MAGYLPF E D+PTLYKKI+A +FS PFWFS  A SLI 
Sbjct: 183 NQGYDGAAADIWSCGVILFFIMAGYLPFYEIDIPTLYKKISAGQFSSPFWFSPEANSLIK 242

Query: 181 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSEN 240
           KILDPNPKTRI+IEGI+KHPWF+KNY PVK S EEEVNLDDV AVFDDIEDQYV+EQS  
Sbjct: 243 KILDPNPKTRIQIEGIKKHPWFKKNYLPVKPS-EEEVNLDDVRAVFDDIEDQYVSEQSVA 301

Query: 241 KVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLS 300
           K GGPL+MNAFEMITLSQGLNL++LFDR+QDYVKRQTRFVSR+P + I+S++EAVAES+ 
Sbjct: 302 KEGGPLMMNAFEMITLSQGLNLSSLFDRQQDYVKRQTRFVSRKPPRDIISSVEAVAESMG 361

Query: 301 LKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCA 360
           LKVHTRNYKTRLE +SANK G+FAVVLEVFEVAPSLFM DVRKA+GDTLEYHKFYKNFC 
Sbjct: 362 LKVHTRNYKTRLERISANKVGEFAVVLEVFEVAPSLFMADVRKASGDTLEYHKFYKNFCT 421

Query: 361 KLENIIWKPTE---GSSLLRTMSC 381
           KLENIIWKPTE     S+LR+++C
Sbjct: 422 KLENIIWKPTEDVANPSVLRSLTC 445

Source: Gossypium hirsutum

Species: Gossypium hirsutum

Genus: Gossypium

Family: Malvaceae

Order: Malvales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|350535735|ref|NP_001234210.1| calcineurin B-like interacting protein kinase [Solanum lycopersicum] gi|66765941|emb|CAG30526.1| calcineurin B-like interacting protein kinase [Solanum lycopersicum] gi|149930452|gb|ABR37648.1| putative SOS2-like protein kinase [Solanum lycopersicum]

 Score =  663 bits (1711), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 306/383 (79%), Positives = 346/383 (90%), Gaps = 3/383 (0%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MKIVRHP IVRLHEVLAS+TK+YI+ EFVTGGELFDKIVH GRL E++ RRYFQ+LIDA+
Sbjct: 63  MKIVRHPCIVRLHEVLASQTKIYIVQEFVTGGELFDKIVHLGRLSEDEARRYFQELIDAI 122

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           AHCHSKGVYHRDLKPENLLLD  GNLK+SDFGLSALPQQGVELL+TTCGTPNYVAPEVL 
Sbjct: 123 AHCHSKGVYHRDLKPENLLLDFQGNLKISDFGLSALPQQGVELLYTTCGTPNYVAPEVLG 182

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           NRGYDG+AADVWSCG+IL+VLMAGYLPF ETDLPTLY KI AAEFSCPFWFS GATSLI 
Sbjct: 183 NRGYDGAAADVWSCGIILYVLMAGYLPFDETDLPTLYTKIKAAEFSCPFWFSPGATSLIQ 242

Query: 181 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSEN 240
           KI+DPNP+TRI+I+GI++ PWFRKNY  VK   +E VNLDD+HAVFDDIED +V+E+SE+
Sbjct: 243 KIIDPNPQTRIKIDGIKRDPWFRKNYRAVKAKADEVVNLDDIHAVFDDIEDAFVSEKSED 302

Query: 241 KVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLS 300
              GPL+MNAFEMITLSQGLNL+ALFDRRQDYVKRQTRF+SRQPA+V++  IEA AESL 
Sbjct: 303 SESGPLVMNAFEMITLSQGLNLSALFDRRQDYVKRQTRFISRQPAKVVIETIEAAAESLG 362

Query: 301 LKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCA 360
           LKVHTR+YKTR+EGV+AN+ GQFAVVLEVF+VAPSLFMVDVRKAAGDTLEYHKFYK FC 
Sbjct: 363 LKVHTRDYKTRIEGVTANRAGQFAVVLEVFQVAPSLFMVDVRKAAGDTLEYHKFYKTFCT 422

Query: 361 KLENIIWKPTEGSS---LLRTMS 380
           K++++IWKP EG S   LLRT +
Sbjct: 423 KIDDVIWKPKEGMSNAVLLRTRT 445

Source: Solanum lycopersicum

Species: Solanum lycopersicum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356563005|ref|XP_003549757.1| PREDICTED: CBL-interacting protein kinase 24-like isoform 1 [Glycine max]

 Score =  648 bits (1671), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 301/370 (81%), Positives = 331/370 (89%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MKIVRHPNIVRLHEVLAS+TK+YIILEFV GGEL+DKIV  G+L EN+ R YFQQLIDAV
Sbjct: 63  MKIVRHPNIVRLHEVLASQTKIYIILEFVMGGELYDKIVQLGKLSENESRHYFQQLIDAV 122

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            HCH KGVYHRDLKPENLLLD+YGNLKVSDFGLSAL +QG +LLHTTCGTPNYVAPEVLS
Sbjct: 123 DHCHRKGVYHRDLKPENLLLDAYGNLKVSDFGLSALTKQGADLLHTTCGTPNYVAPEVLS 182

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           NRGYDG+AADVWSCGVIL+VLMAGYLPF E DLPTLY++INAAEF CPFWFS    S I 
Sbjct: 183 NRGYDGAAADVWSCGVILYVLMAGYLPFEEADLPTLYRRINAAEFVCPFWFSADTKSFIQ 242

Query: 181 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSEN 240
           KILDPNPKTR++IE IRK PWF+KNY PVK  E+E+VNLDDV AVFDDIEDQYV+E+SE 
Sbjct: 243 KILDPNPKTRVKIEEIRKDPWFKKNYFPVKLGEDEQVNLDDVRAVFDDIEDQYVSERSEI 302

Query: 241 KVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLS 300
             GGPL+MNAFEMI LSQGLNL+ LFDR QDYVKRQTRFVSR+PA+VI+S+IEAVAES+ 
Sbjct: 303 TEGGPLIMNAFEMIALSQGLNLSPLFDRHQDYVKRQTRFVSRKPAKVIISSIEAVAESMG 362

Query: 301 LKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCA 360
           LKVH+RNYK RLEGVSAN+ GQFAVVLEVFEVAPSLFMVDVRKA GDT +YHKFYKNFC 
Sbjct: 363 LKVHSRNYKVRLEGVSANRVGQFAVVLEVFEVAPSLFMVDVRKATGDTFDYHKFYKNFCG 422

Query: 361 KLENIIWKPT 370
           KL NIIW+P 
Sbjct: 423 KLGNIIWRPA 432

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224087128|ref|XP_002308077.1| predicted protein [Populus trichocarpa] gi|116265970|gb|ABJ91233.1| CBL-interacting protein kinase 27 [Populus trichocarpa] gi|222854053|gb|EEE91600.1| predicted protein [Populus trichocarpa]

 Score =  647 bits (1669), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 307/372 (82%), Positives = 335/372 (90%), Gaps = 5/372 (1%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MKIVRHPNIVRLHEVL+SRTK+YIILEFVTGGELFDKIVHQGRL EN+ RRYFQQLIDAV
Sbjct: 64  MKIVRHPNIVRLHEVLSSRTKIYIILEFVTGGELFDKIVHQGRLSENESRRYFQQLIDAV 123

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           AHCH KGVYHRDLKPENLLLD++GNLKVSDFGLSAL Q+GV LLHTTCGTPNYVAPEVL 
Sbjct: 124 AHCHRKGVYHRDLKPENLLLDAFGNLKVSDFGLSALRQKGVGLLHTTCGTPNYVAPEVLG 183

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GYDG+AADVWSCGVILFVLMAGYLPF E DLPTL +K     +SCPFWFS  A +LI 
Sbjct: 184 HQGYDGAAADVWSCGVILFVLMAGYLPFEEIDLPTLCRK-----YSCPFWFSPVAKALID 238

Query: 181 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSEN 240
           KILDPNPKTRI IEGI+KHPWFRK+Y PV  SEEEEVNLDDVHAVFDDIED YVAEQ EN
Sbjct: 239 KILDPNPKTRIGIEGIKKHPWFRKSYEPVGHSEEEEVNLDDVHAVFDDIEDHYVAEQLEN 298

Query: 241 KVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLS 300
             GGPL+MNAFEMI LSQGLNL+ALFDRRQDYVK+QTRFVS +PA+VI+S  EAVAES++
Sbjct: 299 SEGGPLVMNAFEMIALSQGLNLSALFDRRQDYVKKQTRFVSHKPAKVIISAFEAVAESMN 358

Query: 301 LKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCA 360
           LK HT NYKTRLEG+S NK GQFAVVLEV+EV PSLFMVD RKA+G+TLEYH+FYKNFCA
Sbjct: 359 LKFHTHNYKTRLEGISENKAGQFAVVLEVYEVGPSLFMVDARKASGETLEYHEFYKNFCA 418

Query: 361 KLENIIWKPTEG 372
           +LENIIWKP EG
Sbjct: 419 QLENIIWKPPEG 430

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	381
TAIR|locus:2155233	446	SOS2 "SALT OVERLY SENSITIVE 2"	0.997	0.852	0.762	1.2e-159
TAIR|locus:2135962	445	CIPK8 "CBL-interacting protein	0.976	0.835	0.675	5.6e-139
TAIR|locus:2009812	482	CIPK23 "CBL-interacting protei	0.963	0.761	0.599	1.1e-119
TAIR|locus:1005716172	439	CIPK26 "calcineurin B-like pro	0.973	0.845	0.583	1.3e-118
TAIR|locus:2059279	451	CIPK3 "CBL-interacting protein	0.963	0.813	0.576	1.6e-116
TAIR|locus:2126749	441	SIP3 "SOS3-interacting protein	0.939	0.811	0.484	4.1e-88
TAIR|locus:2179260	488	CIPK25 "CBL-interacting protei	0.939	0.733	0.488	4.1e-88
TAIR|locus:2183720	445	CIPK5 "CBL-interacting protein	0.950	0.813	0.478	1.4e-87
TAIR|locus:2090537	444	CIPK1 "CBL-interacting protein	0.918	0.788	0.472	2.9e-87
TAIR|locus:2152380	439	CIPK20 "CBL-interacting protei	0.929	0.806	0.453	3.7e-87

TAIR|locus:2155233 SOS2 "SALT OVERLY SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1555 (552.4 bits), Expect = 1.2e-159, P = 1.2e-159
 Identities = 292/383 (76%), Positives = 335/383 (87%)

Query:     1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
             MKIVRHPNIVRL+EVLAS +K+YI+LEFVTGGELFD+IVH+GRL E++ R+YFQQL+DAV
Sbjct:    63 MKIVRHPNIVRLYEVLASPSKIYIVLEFVTGGELFDRIVHKGRLEESESRKYFQQLVDAV 122

Query:    61 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
             AHCH KGVYHRDLKPENLLLD+ GNLKVSDFGLSALPQ+GVELL TTCGTPNYVAPEVLS
Sbjct:   123 AHCHCKGVYHRDLKPENLLLDTNGNLKVSDFGLSALPQEGVELLRTTCGTPNYVAPEVLS 182

Query:   121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
              +GYDGSAAD+WSCGVILFV++AGYLPF ETDLP LY+KINAAEFSCP WFS     LIH
Sbjct:   183 GQGYDGSAADIWSCGVILFVILAGYLPFSETDLPGLYRKINAAEFSCPPWFSAEVKFLIH 242

Query:   181 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSEN 240
             +ILDPNPKTRI+I+GI+K PWFR NY P++  EEEEVNLDD+ AVFD IE  YVAE  E 
Sbjct:   243 RILDPNPKTRIQIQGIKKDPWFRLNYVPIRAREEEEVNLDDIRAVFDGIEGSYVAENVER 302

Query:   241 KVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLS 300
                GPL+MNAFEMITLSQGLNL+ALFDRRQD+VKRQTRFVSR+    I++NIEAVA S+ 
Sbjct:   303 NDEGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMG 362

Query:   301 LKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCA 360
              K HTRN+KTRLEG+S+ K GQ AVV+E++EVAPSLFMVDVRKAAG+TLEYHKFYK  C+
Sbjct:   363 FKSHTRNFKTRLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCS 422

Query:   361 KLENIIWKPTEG---SSLLRTMS 380
             KLENIIW+ TEG   S +LRT++
Sbjct:   423 KLENIIWRATEGIPKSEILRTIT 445

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0004672 "protein kinase activity" evidence=IDA

GO:0042802 "identical protein binding" evidence=IPI

GO:0009705 "plant-type vacuole membrane" evidence=IDA

GO:0009651 "response to salt stress" evidence=IMP

TAIR|locus:2135962 CIPK8 "CBL-interacting protein kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 1360 (483.8 bits), Expect = 5.6e-139, P = 5.6e-139
 Identities = 252/373 (67%), Positives = 308/373 (82%)

Query:     1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
             MK+VRHP +VRL+EVLASRTK+YIILE++TGGELFDKIV  GRL E++ R+YF QLID V
Sbjct:    61 MKLVRHPCVVRLYEVLASRTKIYIILEYITGGELFDKIVRNGRLSESEARKYFHQLIDGV 120

Query:    61 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
              +CHSKGVYHRDLKPENLLLDS GNLK+SDFGLSALP+QGV +L TTCGTPNYVAPEVLS
Sbjct:   121 DYCHSKGVYHRDLKPENLLLDSQGNLKISDFGLSALPEQGVTILKTTCGTPNYVAPEVLS 180

Query:   121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
             ++GY+G+ AD+WSCGVIL+VLMAGYLPF E DLPTLY KI+ AEFSCP +F+ GA SLI+
Sbjct:   181 HKGYNGAVADIWSCGVILYVLMAGYLPFDEMDLPTLYSKIDKAEFSCPSYFALGAKSLIN 240

Query:   181 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSEN 240
             +ILDPNP+TRI I  IRK  WF K+Y PV+  + E VNLDDV+A FDD E+Q  A+    
Sbjct:   241 RILDPNPETRITIAEIRKDEWFLKDYTPVQLIDYEHVNLDDVYAAFDDPEEQTYAQDGTR 300

Query:   241 KVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLS 300
               G PL +NAF++I LSQGLNLA LFDR +D +K QTRF+S +PA V+LS++E V++S+ 
Sbjct:   301 DTG-PLTLNAFDLIILSQGLNLATLFDRGKDSMKHQTRFISHKPANVVLSSMEVVSQSMG 359

Query:   301 LKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCA 360
              K H RNYK R+EG+SANKT  F+V+LEVF+VAPS+ MVD++ AAGD  EY KFYK FC+
Sbjct:   360 FKTHIRNYKMRVEGLSANKTSHFSVILEVFKVAPSILMVDIQNAAGDAEEYLKFYKTFCS 419

Query:   361 KLENIIWKPTEGS 373
             KL++IIWKP + S
Sbjct:   420 KLDDIIWKPPDAS 432

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009749 "response to glucose stimulus" evidence=TAS

GO:0010167 "response to nitrate" evidence=IEP;IMP

GO:0048364 "root development" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2009812 CIPK23 "CBL-interacting protein kinase 23" [Arabidopsis thaliana (taxid:3702)]

 Score = 1178 (419.7 bits), Expect = 1.1e-119, P = 1.1e-119
 Identities = 223/372 (59%), Positives = 285/372 (76%)

Query:     1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
             MK+++HPN++R+ EV+AS+TK+Y +LEFVTGGELFDKI   GRL E++ R+YFQQLI+AV
Sbjct:    83 MKLIKHPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAV 142

Query:    61 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEV 118
              +CHS+GVYHRDLKPENLLLD+ G LKVSDFGLSALPQQ  E  LLHTTCGTPNYVAPEV
Sbjct:   143 DYCHSRGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEV 202

Query:   119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
             ++N+GYDG+ AD+WSCGVILFVLMAGYLPF +++L +LYKKI  AEF+CP WFS  A  L
Sbjct:   203 INNKGYDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKL 262

Query:   179 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQ--YVAE 236
             I +ILDPNP TRI    + ++ WF+K Y   K  E  +V+LDDV A+FDD  +    V E
Sbjct:   263 IKRILDPNPATRITFAEVIENEWFKKGYKAPKF-ENADVSLDDVDAIFDDSGESKNLVVE 321

Query:   237 QSENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVA 296
             + E  +  P+ MNAFE+I+ SQGLNL +LF+++   VKR+TRF S+  A  I++ IEA A
Sbjct:   322 RREEGLKTPVTMNAFELISTSQGLNLGSLFEKQMGLVKRKTRFTSKSSANEIVTKIEAAA 381

Query:   297 ESLSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYK 356
               +   V T NYK +L G  + + GQ AV  EVF+VAPSL+MV++RK+ GDTLE+HKFYK
Sbjct:   382 APMGFDVKTNNYKMKLTGEKSGRKGQLAVATEVFQVAPSLYMVEMRKSGGDTLEFHKFYK 441

Query:   357 NFCAKLENIIWK 368
             N    L++I+WK
Sbjct:   442 NLTTGLKDIVWK 453

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IPI

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0010107 "potassium ion import" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0007584 "response to nutrient" evidence=IMP

GO:0009414 "response to water deprivation" evidence=IMP

GO:0010118 "stomatal movement" evidence=RCA;IMP

GO:0009536 "plastid" evidence=IDA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0016036 "cellular response to phosphate starvation" evidence=RCA

GO:0019375 "galactolipid biosynthetic process" evidence=RCA

GO:0019722 "calcium-mediated signaling" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042631 "cellular response to water deprivation" evidence=RCA

TAIR|locus:1005716172 CIPK26 "calcineurin B-like protein (CBL)-interacting protein kinase 26" [Arabidopsis thaliana (taxid:3702)]

 Score = 1168 (416.2 bits), Expect = 1.3e-118, P = 1.3e-118
 Identities = 220/377 (58%), Positives = 281/377 (74%)

Query:     1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
             MK++ HPN+VRL+EVLAS+TK+YI+LEF TGGELFDKIVH GRL E + R+YFQQLI+AV
Sbjct:    65 MKLINHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQLINAV 124

Query:    61 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEV 118
              +CHS+GVYHRDLKPENLLLD+ GNLKVSDFGLSAL +Q  G  LLHT CGTPNY APEV
Sbjct:   125 DYCHSRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYAAPEV 184

Query:   119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
             L+++GYDG+ AD+WSCGVILFVL+AGYLPF +++L TLYKKI A E+ CP W S GA +L
Sbjct:   185 LNDQGYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPGAKNL 244

Query:   179 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQS 238
             I +ILDPNP TRI I  +    WF+KNY P    E+EE NLDDV AVF D E+ +V E+ 
Sbjct:   245 IVRILDPNPMTRITIPEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSEEHHVTEKK 304

Query:   239 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 298
             E +   P  MNAFE+I++S+ L+L  LF+  + + KR+TRF ++  A  ++  IE  ++ 
Sbjct:   305 EEQ---PTSMNAFELISMSRALDLGNLFEEEEGF-KRETRFAAKGAANDLVQKIEEASKP 360

Query:   299 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 358
             L   +  +NYK RLE V+A + G   V  E+F+V+PSL M++VRK  GDTLE+HKFYK  
Sbjct:   361 LGFDIQKKNYKMRLENVTAGRKGNLRVATEIFQVSPSLHMIEVRKTKGDTLEFHKFYKKL 420

Query:   359 CAKLENIIWKPTEGSSL 375
                L +++WK  E S L
Sbjct:   421 STSLNDVVWKSGESSGL 437

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007165 "signal transduction" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

TAIR|locus:2059279 CIPK3 "CBL-interacting protein kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1148 (409.2 bits), Expect = 1.6e-116, P = 1.6e-116
 Identities = 215/373 (57%), Positives = 280/373 (75%)

Query:     1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
             MK+++HPN+V+L+EV+AS+TK++IILE+VTGGELFDKIV+ GR+ E++ RRYFQQLI AV
Sbjct:    76 MKLIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAV 135

Query:    61 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEV 118
              +CHS+GVYHRDLKPENLLLDSYGNLK+SDFGLSAL QQ  +  LLHT+CGTPNYVAPEV
Sbjct:   136 DYCHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEV 195

Query:   119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
             L++RGYDG+ AD+WSCGV+L+VL+AGYLPF +++L  LYKKI++ EF+CP W S GA  L
Sbjct:   196 LNDRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAMKL 255

Query:   179 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQS 238
             I +ILDPNP TR+  + + +  WF+K+Y P    E ++ N+DD+ AVF D E+  V E+ 
Sbjct:   256 ITRILDPNPMTRVTPQEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSEEHLVTEKR 315

Query:   239 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 298
             E +   P  +NAFE+I++S+GLNL  LFD  Q++ KR+TR   R  A  I+  IE  A+ 
Sbjct:   316 EEQ---PAAINAFEIISMSRGLNLENLFDPEQEF-KRETRITLRGGANEIIEKIEEAAKP 371

Query:   299 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 358
             L   V  +NYK RLE V A + G   V  E+F+VAPSL MV V K+ GDTLE+HKFYK  
Sbjct:   372 LGFDVQKKNYKMRLENVKAGRKGNLNVATEIFQVAPSLHMVQVSKSKGDTLEFHKFYKKL 431

Query:   359 CAKLENIIWKPTE 371
                LE ++W   E
Sbjct:   432 SNSLEQVVWTNNE 444

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0009735 "response to cytokinin stimulus" evidence=IEP

TAIR|locus:2126749 SIP3 "SOS3-interacting protein 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 880 (314.8 bits), Expect = 4.1e-88, P = 4.1e-88
 Identities = 182/376 (48%), Positives = 245/376 (65%)

Query:     1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
             M++V+HPNIV LHEV+AS++K+Y  +E V GGELF K+  +GRL E+  R YFQQLI AV
Sbjct:    76 MRMVKHPNIVELHEVMASKSKIYFAMELVRGGELFAKVA-KGRLREDVARVYFQQLISAV 134

Query:    61 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA----LPQQGVELLHTTCGTPNYVAP 116
               CHS+GVYHRDLKPENLLLD  GNLKV+DFGLSA    L Q G  LLHTTCGTP YVAP
Sbjct:   135 DFCHSRGVYHRDLKPENLLLDEEGNLKVTDFGLSAFTEHLKQDG--LLHTTCGTPAYVAP 192

Query:   117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGAT 176
             EV+  +GYDG+ AD+WSCGVILFVL+AGYLPF + +L  +Y+KI   +F CP W S+ A 
Sbjct:   193 EVILKKGYDGAKADLWSCGVILFVLLAGYLPFQDDNLVNMYRKIYRGDFKCPGWLSSDAR 252

Query:   177 SLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAE 236
              L+ K+LDPNP TRI IE +   PWF+K       S  E V    +    +D++  ++  
Sbjct:   253 RLVTKLLDPNPNTRITIEKVMDSPWFKKQATR---SRNEPVAAT-ITTTEEDVD--FLVH 306

Query:   237 QSENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVA 296
             +S+ +      +NAF +I LS+G +L+ LF+ ++   KR+ RF + +PA  ++S++E  A
Sbjct:   307 KSKEETE---TLNAFHIIALSEGFDLSPLFEEKKKEEKREMRFATSRPASSVISSLEEAA 363

Query:   297 E-SLSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFY 355
                    V     + R+EG    + G+ AV  E+F VAPS  +V+V+K  GDTLEY+ F 
Sbjct:   364 RVGNKFDVRKSESRVRIEGKQNGRKGKLAVEAEIFAVAPSFVVVEVKKDHGDTLEYNNFC 423

Query:   356 KNFCAK-LENIIWKPT 370
                    L++I W  T
Sbjct:   424 STALRPALKDIFWTST 439

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0007275 "multicellular organismal development" evidence=IMP

GO:0009414 "response to water deprivation" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0010540 "basipetal auxin transport" evidence=IMP

GO:0042538 "hyperosmotic salinity response" evidence=IDA

GO:0010118 "stomatal movement" evidence=RCA

GO:0019722 "calcium-mediated signaling" evidence=RCA

TAIR|locus:2179260 CIPK25 "CBL-interacting protein kinase 25" [Arabidopsis thaliana (taxid:3702)]

 Score = 880 (314.8 bits), Expect = 4.1e-88, P = 4.1e-88
 Identities = 183/375 (48%), Positives = 254/375 (67%)

Query:     1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
             M++VRHPNIV L EV+A++TK++ I+E+V GGELF KIV +G+L E+  R+YFQQLI AV
Sbjct:    95 MRLVRHPNIVELKEVMATKTKIFFIMEYVKGGELFSKIV-KGKLKEDSARKYFQQLISAV 153

Query:    61 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEV 118
               CHS+GV HRDLKPENLL+D  G+LKVSDFGLSALP+Q ++  LLHT CGTP YVAPEV
Sbjct:   154 DFCHSRGVSHRDLKPENLLVDENGDLKVSDFGLSALPEQILQDGLLHTQCGTPAYVAPEV 213

Query:   119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
             L  +GYDG+  D+WSCG+IL+VL+AG+LPF + +L  +Y+KI  +EF  P WFS  +  L
Sbjct:   214 LRKKGYDGAKGDIWSCGIILYVLLAGFLPFQDENLMKMYRKIFKSEFEYPPWFSPESKRL 273

Query:   179 IHKILDPNPKTRIRIEGIRKHPWFRKNYN-PV--KCSEEEEVNLDDVHAVFDDIEDQYVA 235
             I K+L  +P  RI I  I + PWFRKN N P+  K  E E  N++D             A
Sbjct:   274 ISKLLVVDPNKRISIPAIMRTPWFRKNINSPIEFKIDELEIQNVEDETPT----TTATTA 329

Query:   236 EQSENKVGGPLLMNAFEMIT-LSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEA 294
               +   V  P   NAFE I+ +S G +L++LF+ ++   K ++ F SR  A  I+  +E 
Sbjct:   330 TTTTTPVS-PKFFNAFEFISSMSSGFDLSSLFESKR---KLRSMFTSRWSASEIMGKLEG 385

Query:   295 VAESLSLKV-HTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHK 353
             + + +++KV  T+++K +L G +  + GQ AV  EVFEVAP + +V++ K+AGDTLEY++
Sbjct:   386 IGKEMNMKVKRTKDFKVKLFGKTEGRKGQIAVTAEVFEVAPEVAVVELCKSAGDTLEYNR 445

Query:   354 FYKNFCAK-LENIIW 367
              Y+      LE I+W
Sbjct:   446 LYEEHVRPALEEIVW 460

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0050832 "defense response to fungus" evidence=IEP

TAIR|locus:2183720 CIPK5 "CBL-interacting protein kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 875 (313.1 bits), Expect = 1.4e-87, P = 1.4e-87
 Identities = 178/372 (47%), Positives = 250/372 (67%)

Query:     1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
             MK+VRHPNIV L EV+A++TK++ ++EFV GGELF KI  +G+L E+  RRYFQQLI AV
Sbjct:    65 MKLVRHPNIVELKEVMATKTKIFFVMEFVKGGELFCKI-SKGKLHEDAARRYFQQLISAV 123

Query:    61 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEV 118
              +CHS+GV HRDLKPENLLLD  G+LK+SDFGLSALP+Q ++  LLHT CGTP YVAPEV
Sbjct:   124 DYCHSRGVSHRDLKPENLLLDENGDLKISDFGLSALPEQILQDGLLHTQCGTPAYVAPEV 183

Query:   119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
             L  +GYDG+ AD+WSCGV+L+VL+AG LPF + +L  +Y+KI  A+F  P WFS  A  L
Sbjct:   184 LKKKGYDGAKADIWSCGVVLYVLLAGCLPFQDENLMNMYRKIFRADFEFPPWFSPEARRL 243

Query:   179 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQS 238
             I K+L  +P  RI I  I + PW RKN+ P    + +E          ++ E+    E  
Sbjct:   244 ISKLLVVDPDRRISIPAIMRTPWLRKNFTPPLAFKIDEPICSQSSKNNEEEEEDGDCENQ 303

Query:   239 ENKVGGPLLMNAFEMIT-LSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAE 297
                +  P   NAFE I+ +S G +L++LF+ ++   K Q+ F SR  A  ++  IE V +
Sbjct:   304 TEPIS-PKFFNAFEFISSMSSGFDLSSLFESKR---KVQSVFTSRSSATEVMEKIETVTK 359

Query:   298 SLSLKV-HTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYK 356
              +++KV  T+++K ++EG +  + G+ ++  EVFEVAP + +V+  K+AGDTLEY + Y+
Sbjct:   360 EMNMKVKRTKDFKVKMEGKTEGRKGRLSMTAEVFEVAPEISVVEFCKSAGDTLEYDRLYE 419

Query:   357 NFCAK-LENIIW 367
                   L +I+W
Sbjct:   420 EEVRPALNDIVW 431

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2090537 CIPK1 "CBL-interacting protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 872 (312.0 bits), Expect = 2.9e-87, P = 2.9e-87
 Identities = 171/362 (47%), Positives = 248/362 (68%)

Query:     1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
             +K+++HP+IVRLHEVLAS+TK+ +++E VTGGELFD+IV  G+L E D R+ FQQLID +
Sbjct:    72 LKMLKHPHIVRLHEVLASKTKINMVMELVTGGELFDRIVSNGKLTETDGRKMFQQLIDGI 131

Query:    61 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEV 118
             ++CHSKGV+HRDLK EN+LLD+ G++K++DFGLSALPQ   +  LLHTTCG+PNYVAPEV
Sbjct:   132 SYCHSKGVFHRDLKLENVLLDAKGHIKITDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 191

Query:   119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
             L+NRGYDG+A+D+WSCGVIL+V++ G LPF + +L  LY+KI   +   P W S GA ++
Sbjct:   192 LANRGYDGAASDIWSCGVILYVILTGCLPFDDRNLAVLYQKICKGDPPIPRWLSPGARTM 251

Query:   179 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPV--KCSEEEEVNLDDVHAVFDDIEDQYVAE 236
             I ++LDPNP TRI + GI+   WF+  Y P      +EEEV+ DD     D    Q +  
Sbjct:   252 IKRMLDPNPVTRITVVGIKASEWFKLEYIPSIPDDDDEEEVDTDD-----DAFSIQELGS 306

Query:   237 QSENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVA 296
             +       P ++NAF++I +S  L+L+  F++ ++  +R+ RF S   A+ +L  IE   
Sbjct:   307 EEGKGSDSPTIINAFQLIGMSSFLDLSGFFEQ-ENVSERRIRFTSNSSAKDLLEKIETAV 365

Query:   297 ESLSLKVHTRNYKTRLEGVSANKTGQ--FAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKF 354
               +   V  ++ K R++    N+ GQ   +V  EVFE+ PSL +V++RK+ GD+  Y + 
Sbjct:   366 TEMGFSVQKKHAKLRVKQEERNQKGQVGLSVTAEVFEIKPSLNVVELRKSYGDSCLYRQL 425

Query:   355 YK 356
             Y+
Sbjct:   426 YE 427

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0006970 "response to osmotic stress" evidence=IMP

GO:0009651 "response to salt stress" evidence=IMP

GO:0009737 "response to abscisic acid stimulus" evidence=IMP

GO:0010118 "stomatal movement" evidence=RCA

GO:0019722 "calcium-mediated signaling" evidence=RCA

TAIR|locus:2152380 CIPK20 "CBL-interacting protein kinase 20" [Arabidopsis thaliana (taxid:3702)]

 Score = 871 (311.7 bits), Expect = 3.7e-87, P = 3.7e-87
 Identities = 169/373 (45%), Positives = 252/373 (67%)

Query:     1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
             M++VRHP++V LHEV+AS+TK+Y  +E+V GGELFDK V +G+L EN  R+YFQQLI A+
Sbjct:    64 MRLVRHPHVVFLHEVMASKTKIYFAMEYVKGGELFDK-VSKGKLKENIARKYFQQLIGAI 122

Query:    61 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEV 118
              +CHS+GVYHRDLKPENLLLD  G+LK+SDFGLSAL +   +  LLHTTCGTP YVAPEV
Sbjct:   123 DYCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAPEV 182

Query:   119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
             +  +GYDG+ ADVWSCGV+L+VL+AG+LPF E +L  +Y+KI   EF CP WF      L
Sbjct:   183 IGKKGYDGAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVKKL 242

Query:   179 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQS 238
             + +ILDPNP +RI+IE I ++ WF+K +  ++  +  E +   + ++  D+   +  +  
Sbjct:   243 LSRILDPNPNSRIKIEKIMENSWFQKGFKKIETPKSPESH--QIDSLISDVHAAFSVK-- 298

Query:   239 ENKVGGPLLMNAFEMIT-LSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAE 297
                   P+  NAF++I+ LSQG +L+ LF++ +   + +++F +++ A+ I+S  E +A 
Sbjct:   299 ------PMSYNAFDLISSLSQGFDLSGLFEKEE---RSESKFTTKKDAKEIVSKFEEIAT 349

Query:   298 SLS-LKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFY- 355
             S     +   +   ++E     + G  A+ +E+FEV  S  MV+ +K+ GDT+EY +F  
Sbjct:   350 SSERFNLTKSDVGVKMEDKREGRKGHLAIDVEIFEVTNSFHMVEFKKSGGDTMEYKQFCD 409

Query:   356 KNFCAKLENIIWK 368
             +     L++I+WK
Sbjct:   410 RELRPSLKDIVWK 422

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;TAS

GO:0005524 "ATP binding" evidence=IEA

GO:0005829 "cytosol" evidence=TAS

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009737 "response to abscisic acid stimulus" evidence=IMP

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q69Q47	CIPKO_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.75	1.0	0.8410	yes	no
Q9LDI3	CIPKO_ARATH	2, ., 7, ., 1, 1, ., 1	0.7624	0.9973	0.8520	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.991
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	381
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-83
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-72
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-62
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-55
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-54
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-53
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-52
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-49
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-48
cd12195	116	cd12195, CIPK_C, C-terminal regulatory domain of C	6e-47
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-46
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-45
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-45
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-43
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-42
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-41
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-41
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-39
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-39
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-39
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	8e-39
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-37
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-37
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	8e-37
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-37
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-36
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	9e-36
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-35
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-35
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-35
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-35
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-35
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-35
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	6e-35
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	8e-35
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	8e-35
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	9e-35
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-34
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-34
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-34
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-34
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-34
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-32
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-32
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-32
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-32
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	9e-32
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	9e-32
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-31
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-31
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-31
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-31
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	6e-31
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-30
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-30
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-30
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-30
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-30
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-30
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	6e-30
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-30
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	9e-30
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-29
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-29
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-29
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-29
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-29
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-28
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-28
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-28
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-28
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-28
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-28
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	7e-28
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-27
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-27
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-27
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-27
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-26
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-26
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-26
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-26
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-25
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-25
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-25
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-25
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-25
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	6e-25
pfam03822	58	pfam03822, NAF, NAF domain	6e-25
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	7e-25
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-24
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-24
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-24
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-24
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-24
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-24
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	6e-24
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	7e-24
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	7e-24
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	9e-24
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-23
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-23
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-23
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-23
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-23
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-23
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-23
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-23
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-23
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	9e-23
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-22
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-22
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-22
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-22
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-22
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-22
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-22
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-22
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	7e-22
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-22
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-22
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-21
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-21
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-21
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-21
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-21
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-21
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	5e-21
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	5e-21
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-21
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	6e-21
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	7e-21
cd12120	95	cd12120, AMPKA_C_like, C-terminal regulatory domai	8e-21
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-20
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-20
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-20
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-20
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-20
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-20
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-20
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	8e-20
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-19
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-19
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-19
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-19
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-19
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-19
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-19
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-18
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-18
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-18
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-18
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-18
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-18
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-18
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-18
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-17
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-17
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-17
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-17
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-17
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-17
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-17
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-17
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-17
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	9e-17
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-16
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-16
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-16
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-16
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-16
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-16
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-16
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-16
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-16
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-16
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-16
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-16
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	7e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-15
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-15
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-15
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-15
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-15
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-15
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-15
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-15
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-15
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-15
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-15
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-15
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	8e-15
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-14
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-14
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-14
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-14
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	7e-14
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	7e-14
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	7e-14
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-14
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	8e-14
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-13
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-13
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-13
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-13
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-13
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-13
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-13
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-13
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-13
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-13
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	5e-13
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	8e-13
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	9e-13
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	9e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-12
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-12
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-12
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-12
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	8e-12
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-11
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-11
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-11
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-11
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-11
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-10
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-10
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-10
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-09
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-09
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-09
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-09
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-09
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-09
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-09
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	6e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	7e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	8e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	9e-09
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-08
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-08
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-08
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-07
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-07
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	8e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	8e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-06
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	6e-06
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	7e-06
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-06
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	8e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	8e-06
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	8e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	2e-05
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-05
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	2e-04
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-04
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-04
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	6e-04
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	7e-04
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	8e-04
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	9e-04
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	0.001
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	0.001
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	0.001
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	0.002
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	0.002
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.002
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.002
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.002
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	0.003
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	0.003
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  254 bits (651), Expect = 2e-83
 Identities = 92/206 (44%), Positives = 133/206 (64%), Gaps = 6/206 (2%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++HPNIVRL++V     K+Y+++E+  GG+LFD +  +GRL E++ R Y +Q++ A+
Sbjct: 51  LKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSAL 110

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HSKG+ HRDLKPEN+LLD  G++K++DFGL+     G E L T  GTP Y+APEVL 
Sbjct: 111 EYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTTFVGTPEYMAPEVLL 169

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFW---FSTGAT 176
            +GY   A D+WS GVIL+ L+ G  PF G+  L  L+KKI   +   P      S  A 
Sbjct: 170 GKGYGK-AVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAK 228

Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWF 202
            LI K+L  +P+ R+  E   +HP+F
Sbjct: 229 DLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  225 bits (577), Expect = 2e-72
 Identities = 81/209 (38%), Positives = 117/209 (55%), Gaps = 7/209 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ + HPNIVRL +    +  +Y+++E+  GG+LFD +   G L E++ ++   Q++  +
Sbjct: 52  LRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGL 111

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS G+ HRDLKPEN+LLD  G +K++DFGL+    +    L T  GTP Y+APEVL 
Sbjct: 112 EYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLL 171

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-----EFSCPFWFSTG- 174
                G   DVWS GVIL+ L+ G  PF   ++    + I        EF  P W S   
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSE 231

Query: 175 -ATSLIHKILDPNPKTRIRIEGIRKHPWF 202
            A  LI K L+ +P  R   E I +HPWF
Sbjct: 232 EAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  199 bits (508), Expect = 4e-62
 Identities = 81/202 (40%), Positives = 119/202 (58%), Gaps = 4/202 (1%)

Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           + HP IV+LH    +  K+Y++LE+  GGELF  +  +GR  E   R Y  +++ A+ + 
Sbjct: 50  INHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYL 109

Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HS G+ +RDLKPEN+LLD+ G++K++DFGL+          +T CGTP Y+APEVL  +G
Sbjct: 110 HSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKG 169

Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           Y G A D WS GV+L+ ++ G  PF   D   +Y+KI       P + S  A  LI  +L
Sbjct: 170 Y-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLL 228

Query: 184 DPNPKTRI---RIEGIRKHPWF 202
             +P  R+     E I+ HP+F
Sbjct: 229 QKDPTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  181 bits (461), Expect = 2e-55
 Identities = 74/202 (36%), Positives = 109/202 (53%), Gaps = 33/202 (16%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           +K + HPNIV+L+ V      +Y+++E+  GG L D +  ++G+L E++  R   Q+++ 
Sbjct: 45  LKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEG 104

Query: 60  VAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
           + + HS G+ HRDLKPEN+LLDS  G +K++DFGLS L      LL T  GTP Y+APEV
Sbjct: 105 LEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEV 164

Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
           L  +GY    +D+WS GVIL+             LP L                     L
Sbjct: 165 LLGKGYYSEKSDIWSLGVILYE------------LPELKD-------------------L 193

Query: 179 IHKILDPNPKTRIRIEGIRKHP 200
           I K+L  +P+ R   + I +H 
Sbjct: 194 IRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  180 bits (459), Expect = 1e-54
 Identities = 80/213 (37%), Positives = 120/213 (56%), Gaps = 15/213 (7%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++   HP IV+L+     +  +Y+++E+  GGEL+  +  +G   E   R Y   ++ A 
Sbjct: 47  LEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAF 106

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + H++G+ +RDLKPENLLLDS G +K+ DFG  A   +  +   T CGTP YVAPE++ 
Sbjct: 107 EYLHNRGIIYRDLKPENLLLDSNGYVKLVDFG-FAKKLKSGQKTWTFCGTPEYVAPEIIL 165

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL--YKKINAA----EFSCPFWFSTG 174
           N+GYD  + D WS G++L+ L+ G  PFGE D   +  Y  I       EF  P +    
Sbjct: 166 NKGYD-FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEF--PNYIDKA 222

Query: 175 ATSLIHKILDPNPKTRI-----RIEGIRKHPWF 202
           A  LI ++L  NP+ R+      I+ I+KH WF
Sbjct: 223 AKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  177 bits (452), Expect = 3e-53
 Identities = 76/208 (36%), Positives = 123/208 (59%), Gaps = 9/208 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ +RHP +V L+      + +Y+++E+V GGELF  +   GR  E   R Y  Q++ A+
Sbjct: 55  LQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLAL 114

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLLLDS G +K++DFG +   +      +T CGTP Y+APE++ 
Sbjct: 115 EYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT---YTLCGTPEYLAPEIIL 171

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY G A D W+ G++++ ++AGY PF + +   +Y+KI   +   P +FS  A  LI 
Sbjct: 172 SKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIR 230

Query: 181 KILDPNPKTRI-----RIEGIRKHPWFR 203
            +L  +   R+      +  I+ HPWF 
Sbjct: 231 NLLQVDLTKRLGNLKNGVNDIKNHPWFA 258

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  173 bits (441), Expect = 5e-52
 Identities = 67/201 (33%), Positives = 112/201 (55%), Gaps = 6/201 (2%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI---VHQGRLL-ENDCRRYFQQL 56
           +K + HPNI++ +E    + K+ I++E+  GG+L  KI     +G+   E     +F QL
Sbjct: 53  LKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL 112

Query: 57  IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
             A+ + HS+ + HRD+KP+N+ L S G +K+ DFG+S +    V+L  T  GTP Y++P
Sbjct: 113 CLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSP 172

Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CPFWFSTGA 175
           E+  N+ Y+   +D+WS G +L+ L     PF   +L  L  KI   ++   P  +S+  
Sbjct: 173 ELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSEL 231

Query: 176 TSLIHKILDPNPKTRIRIEGI 196
            +L+  +L  +P+ R  I  I
Sbjct: 232 RNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  166 bits (423), Expect = 4e-49
 Identities = 71/227 (31%), Positives = 116/227 (51%), Gaps = 27/227 (11%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
            ++  HP I++L+        +Y +LE+   GEL   I   G L E   R Y  +++ A+
Sbjct: 56  TRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLAL 115

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFG--------LSALPQQGVELLHTT----- 107
            + HSKG+ HRDLKPEN+LLD   ++K++DFG         S    +G      +     
Sbjct: 116 EYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175

Query: 108 -------CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKK 159
                   GT  YV+PE+L+     G ++D+W+ G I++ ++ G  PF G  +  T ++K
Sbjct: 176 RRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-FQK 233

Query: 160 INAAEFSCPFWFSTGATSLIHKILDPNPKTRIRI----EGIRKHPWF 202
           I   E+S P  F   A  LI K+L  +P+ R+ +    + ++ HP+F
Sbjct: 234 ILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  163 bits (415), Expect = 4e-48
 Identities = 70/215 (32%), Positives = 118/215 (54%), Gaps = 14/215 (6%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +   + P +V+L+     +  +Y+++E++ GG+L   + + G L E+  R Y  +++ A+
Sbjct: 47  LSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLAL 106

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL--------HTTCGTPN 112
            + HS G+ HRDLKP+N+L+DS G+LK++DFGLS +     ++             GTP+
Sbjct: 107 EYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166

Query: 113 YVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP--FW 170
           Y+APEV+  +G+     D WS G IL+  + G  PF       +++ I   +   P    
Sbjct: 167 YIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVE 225

Query: 171 FSTGATSLIHKILDPNPKTRI---RIEGIRKHPWF 202
            S  A  LI K+L P+P+ R+    IE I+ HP+F
Sbjct: 226 VSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|213380 cd12195, CIPK_C, C-terminal regulatory domain of Calcineurin B-Like (CBL)-interacting protein kinases

 Score =  155 bits (394), Expect = 6e-47
 Identities = 56/117 (47%), Positives = 81/117 (69%), Gaps = 2/117 (1%)

Query: 249 NAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRN- 307
           NAF++I+LS GL+L+ LF+  +D VKR+TRF SR+PA+ I+  +E  A+ L  +V  +  
Sbjct: 1   NAFDLISLSSGLDLSGLFEE-EDEVKRETRFTSRKPAEEIIEKLEEAAKKLGFRVRKKKE 59

Query: 308 YKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLEN 364
              +LEG    + G+ AV +EVFEV PSL +V+V+K+AGDTLEYHKF+K+    L  
Sbjct: 60  GGVKLEGQKGGRKGRLAVSVEVFEVTPSLVVVEVKKSAGDTLEYHKFWKDLLRPLLK 116

CIPKs are serine/threonine protein kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They comprise a unique family in higher plants of proteins that interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. The specificity of the response relies on differences in expression and localization of both CBLs and CIPKs, as well as on the interaction specificity of CBL-CIPK combinations. There are 25, 30, and 43 CIPK genes identified in the Arabidopsis thaliana, Oryza sativa, and Zea mays genomes, respectively. The founding member of the CIPK family is Arabidopsis thaliana CIPK24, also called SOS2 (Salt Overlay Sensitive 2). CIPKs contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain that contains the FISL (also called NAF for Asn-Ala-Phe) and PPI-binding motifs, which are involved in the interaction with CBLs and PP2C-type protein phosphatases, respectively. Studies using SOS2, SOS3, and ABI2 phosphatase show that the binding of CBL and PP2C-type protein phosphatase to CIPK is mutually exclusive. The binding of CBL to CIPK is inhibitory to kinase activity. Length = 116

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  159 bits (405), Expect = 4e-46
 Identities = 79/204 (38%), Positives = 120/204 (58%), Gaps = 6/204 (2%)

Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           V HP IV+LH    +  K+Y+IL+F+ GG+LF ++  +    E D + Y  +L  A+ H 
Sbjct: 55  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 114

Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HS G+ +RDLKPEN+LLD  G++K++DFGLS       +  ++ CGT  Y+APEV++ RG
Sbjct: 115 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG 174

Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           +   +AD WS GV++F ++ G LPF   D       I  A+   P + S  A SL+  + 
Sbjct: 175 HT-QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALF 233

Query: 184 DPNPKTRI-----RIEGIRKHPWF 202
             NP  R+      +E I++HP+F
Sbjct: 234 KRNPANRLGAGPDGVEEIKRHPFF 257

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  156 bits (397), Expect = 2e-45
 Identities = 67/209 (32%), Positives = 108/209 (51%), Gaps = 8/209 (3%)

Query: 1   MKIVRHPNIVRL--HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 58
           +  ++HPNIVR    E    +  + I LE+V+GG L   +   G+L E   R+Y +Q+++
Sbjct: 53  LSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE 112

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAP 116
            +A+ HS G+ HRD+K  N+L+DS G +K++DFG +         E   +  GTP ++AP
Sbjct: 113 GLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172

Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPF--WFST 173
           EV+    Y G AAD+WS G  +  +  G  P+ E  +      KI ++          S 
Sbjct: 173 EVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSE 231

Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWF 202
            A   + K L  +PK R   + + +HP+ 
Sbjct: 232 EAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  158 bits (401), Expect = 2e-45
 Identities = 78/226 (34%), Positives = 123/226 (54%), Gaps = 18/226 (7%)

Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           V+HP IV L     +  K+Y+ILE+++GGELF  +  +G  +E+    Y  ++  A+ H 
Sbjct: 57  VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHL 116

Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           H +G+ +RDLKPEN+LLD+ G++K++DFGL         + HT CGT  Y+APE+L   G
Sbjct: 117 HQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSG 176

Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           + G A D WS G +++ ++ G  PF   +      KI   + + P + +  A  L+ K+L
Sbjct: 177 H-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLL 235

Query: 184 DPNPKTRI-----RIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHA 224
             NP +R+         ++ HP+FR             VN DD+ A
Sbjct: 236 KRNPSSRLGAGPGDAAEVQSHPFFR------------HVNWDDLLA 269

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  153 bits (389), Expect = 1e-43
 Identities = 77/203 (37%), Positives = 116/203 (57%), Gaps = 9/203 (4%)

Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           HP IV +        +VY +LEFV GGELF  +   GR   +  + Y  +L+ A  + HS
Sbjct: 77  HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS 136

Query: 66  KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 125
           K + +RDLKPENLLLD+ G++KV+DFG +   ++  +   T CGTP Y+APEV+ ++G+ 
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGFA---KKVPDRTFTLCGTPEYLAPEVIQSKGH- 192

Query: 126 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 185
           G A D W+ GV+L+  +AGY PF +     +Y+KI A     P WF   A  L+  +L  
Sbjct: 193 GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQT 252

Query: 186 NPKTRI-----RIEGIRKHPWFR 203
           +   R+      +  ++ HP+F 
Sbjct: 253 DHTKRLGTLKGGVADVKNHPYFH 275

Length = 329

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  149 bits (377), Expect = 4e-42
 Identities = 75/204 (36%), Positives = 113/204 (55%), Gaps = 4/204 (1%)

Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           V  P IV L     S  K+Y++L F+ GGELF  +  +GR   +  R Y  +L+ A+ + 
Sbjct: 50  VNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENL 109

Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           H   V +RDLKPEN+LLD  G++ + DFGL  L  +  +  +T CGTP Y+APE+L   G
Sbjct: 110 HKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG 169

Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           Y   A D W+ GV+L+ ++ G  PF + ++  +Y+KI       P  F   A  L+  +L
Sbjct: 170 YT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLL 228

Query: 184 DPNPKTRIRIEG---IRKHPWFRK 204
             +P  R+   G   I+ HP+F +
Sbjct: 229 SRDPTRRLGYNGAQEIKNHPFFSQ 252

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  147 bits (373), Expect = 1e-41
 Identities = 73/217 (33%), Positives = 127/217 (58%), Gaps = 14/217 (6%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K V HP I+RL      +  +Y+++E+V GGELF  + + GR   +    Y  +++ A+
Sbjct: 55  LKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCAL 114

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HSK + +RDLKPEN+LLD  G++K++DFG +   ++  +   T CGTP Y+APEV+ 
Sbjct: 115 EYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFA---KKLRDRTWTLCGTPEYLAPEVIQ 171

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++G+   A D W+ G++++ ++ GY PF + +   +Y+KI A +   P      A  LI 
Sbjct: 172 SKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIK 230

Query: 181 KILDPNPKTRIRI-------EGIRKHPWFRK-NYNPV 209
           K+L    +TR R+       + ++ H WF+  +++ V
Sbjct: 231 KLLV-VDRTR-RLGNMKNGADDVKNHRWFKSVDWDDV 265

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  147 bits (373), Expect = 2e-41
 Identities = 74/207 (35%), Positives = 121/207 (58%), Gaps = 12/207 (5%)

Query: 5   RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 64
           +HP + +LH    ++ +++ ++E+V GG+L   I   GR  E   R Y  +++  +   H
Sbjct: 54  KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113

Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSN 121
            +G+ +RDLK +N+LLDS G++K++DFG+    ++G+    TT   CGTP+Y+APE+LS 
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMC---KEGILGGVTTSTFCGTPDYIAPEILSY 170

Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK 181
           + Y G A D W+ GV+L+ ++AG  PF   D   L++ I   E   P W S  A S++  
Sbjct: 171 QPY-GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKS 229

Query: 182 ILDPNPKTRIRI-----EGIRKHPWFR 203
            L  NP+ R+       + I+ HP+FR
Sbjct: 230 FLTKNPEKRLGCLPTGEQDIKGHPFFR 256

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  141 bits (358), Expect = 1e-39
 Identities = 67/208 (32%), Positives = 106/208 (50%), Gaps = 13/208 (6%)

Query: 5   RHPNIVRL--HEVLASRTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLID 58
           +HPNIVR     +  S   +YI++E+  GG+L   I      +  + E    R   QL+ 
Sbjct: 57  KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116

Query: 59  AVAHCHSKG-----VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 113
           A+  CH++      V HRDLKP N+ LD+  N+K+ DFGL+ +         T  GTP Y
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYY 176

Query: 114 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC-PFWFS 172
           ++PE L++  YD   +D+WS G +++ L A   PF   +   L  KI   +F   P+ +S
Sbjct: 177 MSPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYS 235

Query: 173 TGATSLIHKILDPNPKTRIRIEGIRKHP 200
           +    +I  +L+ +P  R   E + + P
Sbjct: 236 SELNEVIKSMLNVDPDKRPSTEELLQLP 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  141 bits (357), Expect = 2e-39
 Identities = 75/213 (35%), Positives = 120/213 (56%), Gaps = 13/213 (6%)

Query: 3   IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 62
           + R P +V LH    + TK+++IL++V GGELF  +  +    E++ R Y  +++ A+ H
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120

Query: 63  CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA--LPQQGVELLHTTCGTPNYVAPEVLS 120
            H  G+ +RD+K EN+LLDS G++ ++DFGLS   L ++  E  ++ CGT  Y+APEV+ 
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE-ERAYSFCGTIEYMAPEVI- 178

Query: 121 NRGYDG--SAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAAEFSCPFWFSTG 174
             G  G   A D WS GV+ F L+ G  PF     +     + ++I  ++   P   S  
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAE 238

Query: 175 ATSLIHKILDPNPKTRIRIEG---IRKHPWFRK 204
           A   I K+L+ +PK R+   G   I+ HP+F+ 
Sbjct: 239 ARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  139 bits (353), Expect = 4e-39
 Identities = 62/204 (30%), Positives = 108/204 (52%), Gaps = 12/204 (5%)

Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P + +L+    S+  +Y+++E++ GG+    I   G L E+  ++Y  +++  V   H +
Sbjct: 57  PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR 116

Query: 67  GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 126
           G+ HRD+KPENLL+D  G+LK++DFGLS    +         GTP+Y+APE +   G D 
Sbjct: 117 GIIHRDIKPENLLIDQTGHLKLTDFGLS----RNGLENKKFVGTPDYLAPETILGVG-DD 171

Query: 127 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATS----LIHKI 182
             +D WS G ++F  + GY PF       ++  I +   + P       +     LI+++
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL 231

Query: 183 LDPNPKTRIR---IEGIRKHPWFR 203
           L  +P  R+     + I+ HP+F+
Sbjct: 232 LCMDPAKRLGANGYQEIKSHPFFK 255

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  138 bits (351), Expect = 8e-39
 Identities = 62/204 (30%), Positives = 109/204 (53%), Gaps = 9/204 (4%)

Query: 5   RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 64
            HP +V L         +Y++++ + GG+L   +  + +  E   + +  +++ A+ + H
Sbjct: 58  NHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLH 117

Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 124
           SKG+ HRD+KP+N+LLD  G++ ++DF ++        L  +T GTP Y+APEVL  +GY
Sbjct: 118 SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD-TLTTSTSGTPGYMAPEVLCRQGY 176

Query: 125 DGSAADVWSCGVILFVLMAGYLPF-GETDLPT---LYKKINAAEFSCPFWFSTGATSLIH 180
              A D WS GV  +  + G  P+ G +         K+  A       W ST A   I+
Sbjct: 177 -SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATW-STEAIDAIN 234

Query: 181 KILDPNPKTRI--RIEGIRKHPWF 202
           K+L+ +P+ R+   ++ ++ HP+F
Sbjct: 235 KLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  139 bits (350), Expect = 1e-37
 Identities = 77/261 (29%), Positives = 118/261 (45%), Gaps = 26/261 (9%)

Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH---QGRLLENDCRRYFQQLIDAVAH 62
            PNIV+L++       +Y+++E+V GG L D +     +G L E++      Q++ A+ +
Sbjct: 57  PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116

Query: 63  CHSKGVYHRDLKPENLLLDSYGN-LKVSDFGLSAL------PQQGVELLHTTCGTPNYVA 115
            HSKG+ HRD+KPEN+LLD  G  +K+ DFGL+ L            L  T+ GTP Y+A
Sbjct: 117 LHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 116 PEVLS--NRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAAEF---- 165
           PEVL   +  Y  S++D+WS G+ L+ L+ G  PF      +      K I         
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236

Query: 166 -----SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLD 220
                S P   S  A+ L+ K+L  +PK R+       H               + +  D
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKES-DLSDLLKPD 295

Query: 221 DVHAVFDDIEDQYVAEQSENK 241
           D   +   +     A  S   
Sbjct: 296 DSAPLRLSLPPSLEALISSLN 316

Length = 384

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  136 bits (343), Expect = 5e-37
 Identities = 72/210 (34%), Positives = 109/210 (51%), Gaps = 11/210 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K V+HP +V LH    +  K+Y +L++V GGELF  +  +    E   R Y  ++  A+
Sbjct: 50  LKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASAL 109

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPE 117
            + HS  + +RDLKPEN+LLDS G++ ++DFGL    ++G+E   TT   CGTP Y+APE
Sbjct: 110 GYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLC---KEGIEHSKTTSTFCGTPEYLAPE 166

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATS 177
           VL  + YD    D W  G +L+ ++ G  PF   D   +Y  I           S  A  
Sbjct: 167 VLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARH 225

Query: 178 LIHKILDPNPKTRI----RIEGIRKHPWFR 203
           L+  +L  +   R+        I+ H +F 
Sbjct: 226 LLEGLLQKDRTKRLGAKDDFLEIKNHVFFS 255

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  135 bits (341), Expect = 8e-37
 Identities = 73/209 (34%), Positives = 113/209 (54%), Gaps = 11/209 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++HP +V LH    +  K+Y +L++V GGELF  +  +   LE   R Y  ++  A+
Sbjct: 50  LKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAI 109

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPE 117
            + HS  + +RDLKPEN+LLDS G++ ++DFGL    ++GVE   TT   CGTP Y+APE
Sbjct: 110 GYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLC---KEGVEPEETTSTFCGTPEYLAPE 166

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATS 177
           VL    YD    D W  G +L+ ++ G  PF   D+  +Y  I       P   +  A  
Sbjct: 167 VLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACD 225

Query: 178 LIHKILDPNPKTRIRIEG----IRKHPWF 202
           L+  +L  + + R+  +     I+ H +F
Sbjct: 226 LLVGLLHKDQRRRLGAKADFLEIKNHVFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  134 bits (338), Expect = 9e-37
 Identities = 60/159 (37%), Positives = 95/159 (59%), Gaps = 8/159 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL-ENDCRRYFQQLIDA 59
           +++++HPN+V+ + V   R KVYI +E+ +GG L + ++  GR+L E+  R Y  QL++ 
Sbjct: 53  LELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRILDEHVIRVYTLQLLEG 111

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFG----LSALPQQGVELLHTTCGTPNYVA 115
           +A+ HS G+ HRD+KP N+ LD  G +K+ DFG    L        E + +  GTP Y+A
Sbjct: 112 LAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMA 171

Query: 116 PEVLSNRGYDG--SAADVWSCGVILFVLMAGYLPFGETD 152
           PEV++     G   AAD+WS G ++  +  G  P+ E D
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD 210

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  134 bits (340), Expect = 1e-36
 Identities = 72/211 (34%), Positives = 113/211 (53%), Gaps = 12/211 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++  RHP +  L     +  ++  ++E+  GGELF  +  +    E+  R Y  +++ A+
Sbjct: 49  LQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSAL 108

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPE 117
            + HS  V +RDLK ENL+LD  G++K++DFGL    ++G+    T    CGTP Y+APE
Sbjct: 109 GYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLC---KEGISDGATMKTFCGTPEYLAPE 165

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATS 177
           VL +  Y G A D W  GV+++ +M G LPF   D   L++ I   E   P   S  A S
Sbjct: 166 VLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKS 224

Query: 178 LIHKILDPNPKTRI-----RIEGIRKHPWFR 203
           L+  +L  +PK R+       + I +H +F 
Sbjct: 225 LLAGLLKKDPKQRLGGGPEDAKEIMEHRFFA 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  133 bits (337), Expect = 9e-36
 Identities = 79/267 (29%), Positives = 123/267 (46%), Gaps = 48/267 (17%)

Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P IV+L+        +Y+++E++ GG+L + ++ +    E   R Y  +L+ A+   H  
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120

Query: 67  GVYHRDLKPENLLLDSYGNLKVSDFGLSA----------LPQQGVELL------------ 104
           G  HRD+KP+N+L+D+ G++K++DFGL                   LL            
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180

Query: 105 -------HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTL 156
                  ++T GTP+Y+APEVL    Y     D WS GVIL+ ++ G+ PF  +T   T 
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQETY 239

Query: 157 YKKINAAE-FSCPF--WFSTGATSLIHKILDPNPKTRI-RIEGIRKHPWFRK-------- 204
            K IN  E    P     S  A  LI ++L   P+ R+   E I+ HP+F+         
Sbjct: 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLCD-PEDRLGSFEEIKSHPFFKGIDWENLRE 298

Query: 205 NYNPVKCSEEEEVNLDDVHAVFDDIED 231
              P       E++     + FDD ED
Sbjct: 299 TKPPFV----PELSSPLDTSNFDDFED 321

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  131 bits (330), Expect = 1e-35
 Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 8/202 (3%)

Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH---QGRLLEND-CRRYFQQLIDA 59
           V HPNI+   E      K+ I++E+   G+L   I     + +L+      R F QL+  
Sbjct: 56  VNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 119
           +   H + + HRDLK  N+LL +   +K+ D G+S + ++   +  T  GTP+Y+APEV 
Sbjct: 116 LQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MAKTQIGTPHYMAPEVW 173

Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CPFWFSTGATSL 178
             R Y    +D+WS G +L+ +     PF    +  L  K+   ++   P  +S    + 
Sbjct: 174 KGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNF 232

Query: 179 IHKILDPNPKTRIRIEGIRKHP 200
           I  +L   PK R   + I   P
Sbjct: 233 IRSMLQVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  130 bits (329), Expect = 1e-35
 Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 2/203 (0%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++HPNIV+    + +   +YIILE+   G L   I   G   E+    Y  Q++  +
Sbjct: 53  LKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGL 112

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           A+ H +GV HRD+K  N+L    G +K++DFG++       +   +  GTP ++APEV+ 
Sbjct: 113 AYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIE 172

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFWFSTGATSLI 179
             G   +A+D+WS G  +  L+ G  P+ +   +  L++ +       P   S      +
Sbjct: 173 MSGAS-TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFL 231

Query: 180 HKILDPNPKTRIRIEGIRKHPWF 202
            +    +P  R   + + KHPW 
Sbjct: 232 MQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  131 bits (332), Expect = 2e-35
 Identities = 79/247 (31%), Positives = 135/247 (54%), Gaps = 20/247 (8%)

Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P +V LH    +  K+++IL++V+GGE+F  +  +    E++ R Y  ++I A+ H H  
Sbjct: 65  PFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL 124

Query: 67  GVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNRGYD 125
           G+ +RD+K EN+LLDS G++ ++DFGLS     +  E  ++ CGT  Y+APE++  +G  
Sbjct: 125 GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGH 184

Query: 126 GSAADVWSCGVILFVLMAGYLPF---GETDLPT-LYKKINAAEFSCPFWFSTGATSLIHK 181
           G A D WS G+++F L+ G  PF   GE +  + + ++I   +   P +    A  L+HK
Sbjct: 185 GKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHK 244

Query: 182 ILDPNPKTRI-----RIEGIRKHPWF----------RKNYNPVKCSEEEEVNLDDVHAVF 226
           +L  +PK R+         I++HP+F          RK   P + S   E+++ +    F
Sbjct: 245 LLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEF 304

Query: 227 DDIEDQY 233
            ++E  Y
Sbjct: 305 TNLEPVY 311

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  131 bits (332), Expect = 3e-35
 Identities = 78/267 (29%), Positives = 131/267 (49%), Gaps = 31/267 (11%)

Query: 5   RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 64
           +   +V+L         +Y+ +E+V GG+    + + G L E+  R Y  ++ +AV   H
Sbjct: 59  KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH 118

Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 124
             G  HRDLKPEN L+D+ G++K++DFGLS      V   ++  G+P+Y+APEVL  +GY
Sbjct: 119 ELGYIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANSVVGSPDYMAPEVLRGKGY 175

Query: 125 DGSAADVWSCGVILFVLMAGYLPFG-----ETDLPTLY--KKINAAEFSCP-FWFSTGAT 176
           D +  D WS G +L+  + G+ PF      ET     Y  + +    +  P F  S  A 
Sbjct: 176 DFT-VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234

Query: 177 SLIHKILDPNPKTRIR-IEGIRKHPWFRK-NYNPVKCSE----------------EEEVN 218
            LI K+++ +P  R   +E I+ HP+F++ ++N ++  +                ++  N
Sbjct: 235 DLITKLIN-DPSRRFGSLEDIKNHPFFKEVDWNELRELKPPFVPELESEIDTGYFDDFEN 293

Query: 219 LDDVHAVFDDIEDQYVAEQSENKVGGP 245
            DD+    D  E +  A +       P
Sbjct: 294 EDDMAKYKDVHEKKKAAGKGGANGRDP 320

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  131 bits (330), Expect = 4e-35
 Identities = 67/187 (35%), Positives = 102/187 (54%), Gaps = 1/187 (0%)

Query: 5   RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 64
           RHP +  L     +  ++  ++E+  GGELF  +  +    E   R Y  +++ A+ + H
Sbjct: 53  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 112

Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 124
           S+ V +RD+K ENL+LD  G++K++DFGL          + T CGTP Y+APEVL +  Y
Sbjct: 113 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172

Query: 125 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 184
            G A D W  GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L 
Sbjct: 173 -GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 231

Query: 185 PNPKTRI 191
            +PK R+
Sbjct: 232 KDPKQRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  131 bits (330), Expect = 5e-35
 Identities = 73/213 (34%), Positives = 120/213 (56%), Gaps = 16/213 (7%)

Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           HP +V LH    + ++++ ++EFV+GG+L   +  Q +L E   R Y  ++  A+   H 
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHE 114

Query: 66  KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 125
           +G+ +RDLK +N+LLD+ G++K++D+G+     +  +   T CGTPNY+APE+L    Y 
Sbjct: 115 RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYG 174

Query: 126 GSAADVWSCGVILFVLMAGYLPF---GETDLPT------LYKKINAAEFSCPFWFSTGAT 176
            S  D W+ GV++F +MAG  PF   G +D P       L++ I   +   P   S  A+
Sbjct: 175 FS-VDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAS 233

Query: 177 SLIHKILDPNPKTRI---RIEG---IRKHPWFR 203
           S++   L+ +PK R+      G   I+ HP+FR
Sbjct: 234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  130 bits (328), Expect = 6e-35
 Identities = 74/216 (34%), Positives = 122/216 (56%), Gaps = 22/216 (10%)

Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           HP +V LH    + ++++ ++E+V GG+L   +  Q +L E   R Y  ++  A+ + H 
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 114

Query: 66  KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSNR 122
           +G+ +RDLK +N+LLDS G++K++D+G+    ++G+    TT   CGTPNY+APE+L   
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMC---KEGLRPGDTTSTFCGTPNYIAPEILRGE 171

Query: 123 GYDGSAADVWSCGVILFVLMAGYLPF---GETDLPT------LYKKINAAEFSCPFWFST 173
            Y G + D W+ GV++F +MAG  PF   G +D P       L++ I   +   P   S 
Sbjct: 172 DY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV 230

Query: 174 GATSLIHKILDPNPKTRI------RIEGIRKHPWFR 203
            A S++   L+ +PK R+          I+ HP+FR
Sbjct: 231 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  128 bits (324), Expect = 8e-35
 Identities = 68/206 (33%), Positives = 108/206 (52%), Gaps = 8/206 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           +K  +HPNIV+ +     + +++I++EF +GG L D +      L E+      ++L+  
Sbjct: 51  LKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKG 110

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 119
           + + HS G+ HRD+K  N+LL S G +K+ DFGLSA         +T  GTP ++APEV+
Sbjct: 111 LEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVI 169

Query: 120 SNRGYDGSAADVWSCGVILFVLMA-GYLPFGE-TDLPTLYK--KINAAEFSCPFWFSTGA 175
           + + YD   AD+WS G I  + +A G  P+ E   +  L+K           P  +S   
Sbjct: 170 NGKPYDY-KADIWSLG-ITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEF 227

Query: 176 TSLIHKILDPNPKTRIRIEGIRKHPW 201
              + K L  NP+ R   E + KHP+
Sbjct: 228 KDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  130 bits (327), Expect = 8e-35
 Identities = 72/209 (34%), Positives = 117/209 (55%), Gaps = 11/209 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K V+HP +V LH    +  K+Y +L+FV GGELF  +  +    E   R Y  ++  A+
Sbjct: 50  LKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASAL 109

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPE 117
            + HS  + +RDLKPEN+LLDS G++ ++DFGL    ++G+    TT   CGTP Y+APE
Sbjct: 110 GYLHSINIVYRDLKPENILLDSQGHVVLTDFGLC---KEGIAQSDTTTTFCGTPEYLAPE 166

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATS 177
           V+  + YD +  D W  G +L+ ++ G  PF   D+  +Y  I           S  A S
Sbjct: 167 VIRKQPYDNT-VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWS 225

Query: 178 LIHKILDPNPKTRIRIEG----IRKHPWF 202
           ++ ++L+ + + R+  +     I++HP+F
Sbjct: 226 ILEELLEKDRQRRLGAKEDFLEIQEHPFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  129 bits (327), Expect = 9e-35
 Identities = 65/207 (31%), Positives = 112/207 (54%), Gaps = 8/207 (3%)

Query: 5   RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 64
           +HP +  LH    ++ +++ ++E+V GG+L  +I    +  E   R Y  ++  A+   H
Sbjct: 54  KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH 113

Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 124
             GV +RDLK +N+LLD+ G+ K++DFG+            T CGTP+Y+APE+L    Y
Sbjct: 114 RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEY 173

Query: 125 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 184
            G + D W+ GV+++ +MAG  PF   +   L++ I   +   P W S  A S++   + 
Sbjct: 174 -GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMT 232

Query: 185 PNPKTRIRI-------EGIRKHPWFRK 204
            NP  R+         + I++HP+F++
Sbjct: 233 KNPNKRLGCVASQGGEDAIKQHPFFKE 259

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  128 bits (324), Expect = 1e-34
 Identities = 68/246 (27%), Positives = 107/246 (43%), Gaps = 67/246 (27%)

Query: 5   RHPNIVRLHEVLASRTKVYIILEFVTGGE-----LFDKIVHQGRLLENDCRRYFQQLIDA 59
           +HPNIV+L +V+ +  K+Y++ E+    +       DK    G L  N  +    QL+  
Sbjct: 56  KHPNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDK--RPGPLSPNLIKSIMYQLLRG 110

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN------- 112
           +A+CHS  + HRDLKP+N+L++  G LK++DFGL+              G P        
Sbjct: 111 LAYCHSHRILHRDLKPQNILINRDGVLKLADFGLA-----------RAFGIPLRTYTHEV 159

Query: 113 ----YVAPEVL-SNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-------- 158
               Y APE+L  ++ Y  +A D+WS G I   ++ G   F G++++  L+K        
Sbjct: 160 VTLWYRAPEILLGSKHY-STAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTP 218

Query: 159 -----------KINAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGI 196
                            F  P +                  L+ K+L  NP  RI  +  
Sbjct: 219 TEESWPGVTKLPDYKPTF--PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEA 276

Query: 197 RKHPWF 202
            KHP+F
Sbjct: 277 LKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  129 bits (325), Expect = 2e-34
 Identities = 69/200 (34%), Positives = 110/200 (55%), Gaps = 2/200 (1%)

Query: 5   RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 64
            HP +  L     ++  ++ ++E++ GG+L   I   GR  E   R Y  ++I  +   H
Sbjct: 54  EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH 113

Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 124
            KG+ +RDLK +N+LLD  G++K++DFG+      G     T CGTP+Y+APE+L  + Y
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKY 173

Query: 125 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 184
           + S  D WS GV+L+ ++ G  PF   D   L+  I       P W S  A   + K+ +
Sbjct: 174 NES-VDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFE 232

Query: 185 PNPKTRIRIEG-IRKHPWFR 203
            +P  R+ ++G IR+HP+FR
Sbjct: 233 RDPTKRLGVDGDIRQHPFFR 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  129 bits (324), Expect = 3e-34
 Identities = 67/191 (35%), Positives = 105/191 (54%), Gaps = 1/191 (0%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K  RHP +  L     ++ ++  ++E+V GGELF  +  +    E+  R Y  +++ A+
Sbjct: 49  LKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSAL 108

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLK ENL+LD  G++K++DFGL          + T CGTP Y+APEVL 
Sbjct: 109 DYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLE 168

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           +  Y G A D W  GV+++ +M G LPF   D   L++ I   +   P   S  A SL+ 
Sbjct: 169 DNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLS 227

Query: 181 KILDPNPKTRI 191
            +L  +P  R+
Sbjct: 228 GLLIKDPNKRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  128 bits (324), Expect = 3e-34
 Identities = 67/203 (33%), Positives = 110/203 (54%), Gaps = 7/203 (3%)

Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P IV L     + + +Y++ ++++GGELF  +  +GR  E+  + Y  +L+ A+ H H  
Sbjct: 56  PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115

Query: 67  GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV-LSNRGYD 125
            + +RDLKPEN+LLD+ G++ + DFGLS       +  +T CGT  Y+APEV L  +GY 
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGY- 174

Query: 126 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF-WFSTGATSLIHKILD 184
               D WS GV++F +  G+ PF   D   +Y+ I   +   P    S      +  +L+
Sbjct: 175 TKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLN 234

Query: 185 PNPKTRI----RIEGIRKHPWFR 203
            NP+ R+        +++HP+F 
Sbjct: 235 RNPQHRLGAHRDAVELKEHPFFA 257

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  127 bits (319), Expect = 5e-34
 Identities = 74/215 (34%), Positives = 124/215 (57%), Gaps = 15/215 (6%)

Query: 3   IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 62
           I + P +V LH    + TK+++IL+++ GGELF  +  + R  E + + Y  +++ A+ H
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120

Query: 63  CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSN 121
            H  G+ +RD+K EN+LLDS G++ ++DFGLS    +  VE  ++ CGT  Y+AP+++  
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV-- 178

Query: 122 RGYDG---SAADVWSCGVILFVLMAGYLPFG----ETDLPTLYKKINAAEFSCPFWFSTG 174
           RG DG    A D WS GV+++ L+ G  PF     +     + ++I  +E   P   S  
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 238

Query: 175 ATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK 204
           A  +I ++L  +PK R+       + I+KHP+F+K
Sbjct: 239 AKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  121 bits (307), Expect = 3e-32
 Identities = 61/215 (28%), Positives = 106/215 (49%), Gaps = 14/215 (6%)

Query: 1   MKIVR---HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 57
           +K +R    P +V+ +       ++ I+LE++ GG L D +   G++ E       +Q++
Sbjct: 50  LKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQIL 109

Query: 58  DAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
             + + H+K  + HRD+KP NLL++S G +K++DFG+S + +  ++  +T  GT  Y++P
Sbjct: 110 KGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSP 169

Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF---GETDLPTLYKKINAAEFSCPFW--- 170
           E +        AAD+WS G+ L     G  PF   G+     L + I   +   P     
Sbjct: 170 ERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC--DGPPPSLPAE 226

Query: 171 -FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
            FS      I   L  +PK R     + +HP+ +K
Sbjct: 227 EFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  122 bits (309), Expect = 3e-32
 Identities = 66/204 (32%), Positives = 112/204 (54%), Gaps = 6/204 (2%)

Query: 5   RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 64
           + P + +LH    +  ++Y ++E+V GG+L   I   G+  E     Y  ++   +   H
Sbjct: 59  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH 118

Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 124
           SKG+ +RDLK +N++LD+ G++K++DFG+      G +   T CGTP+Y+APE+++ + Y
Sbjct: 119 SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY 178

Query: 125 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 184
            G + D W+ GV+L+ ++AG  PF   D   L++ I     S P   S  A S+   +L 
Sbjct: 179 -GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLT 237

Query: 185 PNPKTRIRI-----EGIRKHPWFR 203
            +P  R+         IR+H +FR
Sbjct: 238 KHPAKRLGCGPTGERDIREHAFFR 261

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  123 bits (309), Expect = 4e-32
 Identities = 66/204 (32%), Positives = 108/204 (52%), Gaps = 7/204 (3%)

Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           HP + +L+    +  +++ ++EFV GG+L   I    R  E   R Y  ++  A+   H 
Sbjct: 55  HPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHD 114

Query: 66  KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 125
           KG+ +RDLK +N+LLD  G+ K++DFG+        +   T CGTP+Y+APE+L    Y 
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY- 173

Query: 126 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 185
           G + D W+ GV+L+ ++ G+ PF   +   L++ I   E   P W S  A  ++   +  
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTK 233

Query: 186 NPKTRIRI------EGIRKHPWFR 203
           NP  R+        E I +HP+F+
Sbjct: 234 NPTMRLGSLTLGGEEAILRHPFFK 257

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  122 bits (309), Expect = 5e-32
 Identities = 66/208 (31%), Positives = 106/208 (50%), Gaps = 13/208 (6%)

Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
            RHP +V L     +   V  ++E+  GG+L   I H     E     Y   ++  + + 
Sbjct: 59  ERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYL 117

Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLS 120
           H   + +RDLK +NLLLD+ G +K++DFGL    ++G+     T   CGTP ++APEVL+
Sbjct: 118 HENKIVYRDLKLDNLLLDTEGFVKIADFGLC---KEGMGFGDRTSTFCGTPEFLAPEVLT 174

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
              Y   A D W  GV+++ ++ G  PF   D   ++  I   E   P + S  A S++ 
Sbjct: 175 ETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMR 233

Query: 181 KILDPNPKTRI-----RIEGIRKHPWFR 203
           ++L  NP+ R+       E ++K P+FR
Sbjct: 234 RLLRRNPERRLGSGEKDAEDVKKQPFFR 261

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  121 bits (306), Expect = 9e-32
 Identities = 72/251 (28%), Positives = 136/251 (54%), Gaps = 5/251 (1%)

Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           HP +  L+    ++  ++ ++E++ GG+L   I    +        Y  ++I  +   HS
Sbjct: 55  HPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHS 114

Query: 66  KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 125
           KG+ +RDLK +N+LLD+ G++K++DFG+      G     T CGTP+Y+APE+L  + Y 
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKY- 173

Query: 126 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 185
            ++ D WS GV+L+ ++ G  PF   D   L++ I       P W +  A  ++ K+   
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVR 233

Query: 186 NPKTRIRIEG-IRKHPWFRK-NYNPVKCSEEEEVNLDDVHAVFD--DIEDQYVAEQSENK 241
            P+ R+ ++G IR+HP+FR+ +++ ++  E E      V +  D  + + +++ E+    
Sbjct: 234 EPERRLGVKGDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDKEFLNEKPRLS 293

Query: 242 VGGPLLMNAFE 252
           V   +L+N+ +
Sbjct: 294 VTDRMLINSMD 304

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  120 bits (304), Expect = 9e-32
 Identities = 68/233 (29%), Positives = 102/233 (43%), Gaps = 32/233 (13%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND-CRRYFQQLIDA 59
           +K + HPNI++L +V   +  +Y++ EF+   +L+  I  + R L     + Y  QL+  
Sbjct: 52  LKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQG 110

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 119
           +A CHS G+ HRDLKPENLL+++ G LK++DFGL+      V        T  Y APE+L
Sbjct: 111 LAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELL 170

Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYKKI 160
                  +  D+WS G I   L++    F                        P      
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230

Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 202
              +FS P              S  A  L+ ++L  +P  RI  E    HP+F
Sbjct: 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  122 bits (306), Expect = 1e-31
 Identities = 68/211 (32%), Positives = 117/211 (55%), Gaps = 14/211 (6%)

Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           +P +V LH    + +++++++E+V GG+L   +  Q +L E   R Y  ++  A+   H 
Sbjct: 55  NPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE 114

Query: 66  KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 125
           +G+ +RDLK +N+LLD+ G++K++D+G+        +   T CGTPNY+APE+L    Y 
Sbjct: 115 RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY- 173

Query: 126 GSAADVWSCGVILFVLMAGYLPFG-ETDLPT------LYKKINAAEFSCPFWFSTGATSL 178
           G + D W+ GV++F +MAG  PF   TD P       L++ I       P + S  A+ +
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHV 233

Query: 179 IHKILDPNPKTRIRIE------GIRKHPWFR 203
           +   L+ +PK R+  +       I+ H +FR
Sbjct: 234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFR 264

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  121 bits (304), Expect = 2e-31
 Identities = 69/188 (36%), Positives = 104/188 (55%), Gaps = 2/188 (1%)

Query: 5   RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 64
           RHP +  L     +  ++  ++E+  GGELF  +  +    E+  R Y  +++ A+ + H
Sbjct: 53  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 112

Query: 65  S-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           S K V +RDLK ENL+LD  G++K++DFGL     +    + T CGTP Y+APEVL +  
Sbjct: 113 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 172

Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           Y G A D W  GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L
Sbjct: 173 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLL 231

Query: 184 DPNPKTRI 191
             +PK R+
Sbjct: 232 KKDPKQRL 239

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  121 bits (304), Expect = 2e-31
 Identities = 66/207 (31%), Positives = 106/207 (51%), Gaps = 9/207 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +  + HP  V L+      + +Y++LEFV GGE F  +    R   +    Y  Q++   
Sbjct: 85  LNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIF 144

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            +  S  + +RDLKPENLLLD  G +K++DFG + +        +T CGTP Y+APE+L 
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT---YTLCGTPEYIAPEILL 201

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           N G+ G AAD W+ G+ ++ ++ G  PF   +   +Y+KI       P +       L+ 
Sbjct: 202 NVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMK 260

Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
           K+L  +   R        + +++HPWF
Sbjct: 261 KLLSHDLTKRYGNLKKGAQNVKEHPWF 287

Length = 340

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  121 bits (304), Expect = 5e-31
 Identities = 83/252 (32%), Positives = 125/252 (49%), Gaps = 28/252 (11%)

Query: 3   IVRHPN---IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 59
           I+ H N   IV+LH        +Y+++E++ GG+L + ++    + E   R Y  +++ A
Sbjct: 96  IMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLA 154

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEV 118
           +   HS G  HRD+KP+N+LLD  G+LK++DFG    +   G+    T  GTP+Y++PEV
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEV 214

Query: 119 LSNRGYD---GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI----NAAEFSCPFWF 171
           L ++G D   G   D WS GV L+ ++ G  PF    L   Y KI    N+  F      
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEI 274

Query: 172 STGATSLIHKILDPNPKT--RIRIEGIRKHPWF----------RKNYNPVKCSEEEEVNL 219
           S  A  LI   L        R  ++ I+ HP+F          R+   PV      E++ 
Sbjct: 275 SKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTFDNIRETVAPVV----PELSS 330

Query: 220 DDVHAVFDDIED 231
           D   + FDDIED
Sbjct: 331 DIDTSNFDDIED 342

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  118 bits (298), Expect = 6e-31
 Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 10/207 (4%)

Query: 5   RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHC 63
           +HPNIV L+E      K++I++EF  GG L   ++   R L     RY  +Q+++A+   
Sbjct: 60  KHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL 119

Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL---- 119
           HS  V HRDLK  N+LL   G++K++DFG+SA  +  ++   T  GTP ++APEV+    
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET 179

Query: 120 -SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGA 175
             +  YD   AD+WS G+ L  L     P  E +   +  KI  +E      P  +S+  
Sbjct: 180 FKDNPYD-YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF 238

Query: 176 TSLIHKILDPNPKTRIRIEGIRKHPWF 202
              +   L  +P  R     + KHP+ 
Sbjct: 239 NDFLKSCLVKDPDDRPTAAELLKHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  118 bits (297), Expect = 1e-30
 Identities = 63/199 (31%), Positives = 109/199 (54%), Gaps = 2/199 (1%)

Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           +P +  L+    ++  ++ ++EF+ GG+L   I  +GR        Y  +++  +   HS
Sbjct: 55  NPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHS 114

Query: 66  KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 125
           KG+ +RDLK +N++LD  G++K++DFG+      G     T CGTP+Y+APE+L    Y 
Sbjct: 115 KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYT 174

Query: 126 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 185
            S  D WS GV+L+ ++ G  PF   D   L++ I       P W +  +  ++ K+ + 
Sbjct: 175 FS-VDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFER 233

Query: 186 NPKTRIRIEG-IRKHPWFR 203
           +P  R+ + G IR HP+F+
Sbjct: 234 DPTRRLGVVGNIRGHPFFK 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  119 bits (300), Expect = 1e-30
 Identities = 71/243 (29%), Positives = 110/243 (45%), Gaps = 47/243 (19%)

Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           +P +V+L+        +Y+I+E++ GG++   ++ +    E + R Y  + I A+   H 
Sbjct: 60  NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHK 119

Query: 66  KGVYHRDLKPENLLLDSYGNLKVSDFGL---------------------------SALPQ 98
            G  HRD+KP+NLLLD+ G++K+SDFGL                            + P 
Sbjct: 120 LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPM 179

Query: 99  QGVELLHT-----------TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLP 147
                  T           T GTP+Y+APEV    GY     D WS GVI++ ++ GY P
Sbjct: 180 SSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPP 238

Query: 148 FGETDLPTLYKKI-NAAE---FSCPFWFSTGATSLIHKILDPNPKTRIRIEG---IRKHP 200
           F   +    Y+KI N  E   F      S  A  LI ++     + R+   G   I+ HP
Sbjct: 239 FCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHP 297

Query: 201 WFR 203
           +F+
Sbjct: 298 FFK 300

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  116 bits (293), Expect = 2e-30
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 8/208 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++H  IV+ +  L     + I +E++ GG + D++   G L E   R+Y +Q+++ V
Sbjct: 58  LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGV 117

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFG----LSALPQQGVELLHTTCGTPNYVAP 116
            + HS  + HRD+K  N+L DS GN+K+ DFG    L  +   G  +   T GTP +++P
Sbjct: 118 EYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT-GTPYWMSP 176

Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI--NAAEFSCPFWFSTG 174
           EV+S  GY G  ADVWS G  +  ++    P+ E +      KI         P   S  
Sbjct: 177 EVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPD 235

Query: 175 ATSLIHKILDPNPKTRIRIEGIRKHPWF 202
           A + + +    N K R   E + +H + 
Sbjct: 236 ARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  119 bits (299), Expect = 2e-30
 Identities = 79/247 (31%), Positives = 130/247 (52%), Gaps = 17/247 (6%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M     P +V+L         +Y+++E++ GG+L + ++    + E   + Y  +++ A+
Sbjct: 97  MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLAL 155

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVL 119
              HS G+ HRD+KP+N+LLD +G+LK++DFG    + + G+    T  GTP+Y++PEVL
Sbjct: 156 DAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVL 215

Query: 120 SNR---GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI----NAAEFSCPFWFS 172
            ++   GY G   D WS GV LF ++ G  PF    L   Y KI    N+  F      S
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEIS 275

Query: 173 TGATSLIHKILDPNPKT--RIRIEGIRKHPWFRK---NYNPVKCSEE---EEVNLDDVHA 224
             A +LI   L        R  +E I++HP+F+    N++ ++ +      E++ D   +
Sbjct: 276 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDSS 335

Query: 225 VFDDIED 231
            FDDIED
Sbjct: 336 NFDDIED 342

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  118 bits (296), Expect = 3e-30
 Identities = 65/202 (32%), Positives = 112/202 (55%), Gaps = 6/202 (2%)

Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P + +LH    +  ++Y ++E+V GG+L  +I   GR  E     Y  ++   +   HSK
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 67  GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 126
           G+ +RDLK +N++LDS G++K++DFG+            T CGTP+Y+APE+++ + Y G
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY-G 179

Query: 127 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 186
            + D W+ GV+L+ ++AG  PF   D   L++ I     + P   S  A ++   ++  +
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKH 239

Query: 187 PKTRIRI--EG---IRKHPWFR 203
           P  R+    EG   I++H +FR
Sbjct: 240 PGKRLGCGPEGERDIKEHAFFR 261

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  118 bits (296), Expect = 3e-30
 Identities = 67/206 (32%), Positives = 106/206 (51%), Gaps = 5/206 (2%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K V+HP +V LH    +  K+Y +L+++ GGELF  +  +   LE   R Y  ++  A+
Sbjct: 50  LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASAL 109

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPEN+LLDS G++ ++DFGL     +      T CGTP Y+APEVL 
Sbjct: 110 GYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLH 169

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            + YD    D W  G +L+ ++ G  PF   +   +Y  I           +  A  L+ 
Sbjct: 170 KQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLE 228

Query: 181 KILDPNPKTRIRIEG----IRKHPWF 202
            +L  +   R+  +     I+ H +F
Sbjct: 229 GLLQKDRTKRLGAKDDFMEIKNHIFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  117 bits (293), Expect = 6e-30
 Identities = 65/203 (32%), Positives = 111/203 (54%), Gaps = 6/203 (2%)

Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P + +LH    +  ++Y ++E+V GG+L   I   G+  E     Y  ++   +   H +
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120

Query: 67  GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 126
           G+ +RDLK +N++LDS G++K++DFG+            T CGTP+Y+APE+++ + Y G
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-G 179

Query: 127 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 186
            + D W+ GV+L+ ++AG  PF   D   L++ I     S P   S  A S+   ++  +
Sbjct: 180 KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKH 239

Query: 187 PKTRIRI--EG---IRKHPWFRK 204
           P  R+    EG   IR+H +FR+
Sbjct: 240 PSKRLGCGPEGERDIREHAFFRR 262

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  116 bits (293), Expect = 6e-30
 Identities = 69/257 (26%), Positives = 110/257 (42%), Gaps = 60/257 (23%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTG---GELFDKIVHQGRLLENDCRRYFQQLI 57
           ++ ++HPNI+ L +V   ++ + ++ EF+       + DK +    L   D + Y    +
Sbjct: 56  LQELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI---VLTPADIKSYMLMTL 112

Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN----- 112
             + + HS  + HRDLKP NLL+ S G LK++DFGL+            + G+PN     
Sbjct: 113 RGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLA-----------RSFGSPNRKMTH 161

Query: 113 ------YVAPEVLSNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDLPTLYKKI---- 160
                 Y APE+L    + G   D+WS G I   L+    +LP G++D+  L  KI    
Sbjct: 162 QVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLP-GDSDIDQL-GKIFEAL 219

Query: 161 ------NAAEFSC-------------PFW--FSTG---ATSLIHKILDPNPKTRIRIEGI 196
                 N    +              P    F      A  L+ ++L  NP  RI     
Sbjct: 220 GTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQA 279

Query: 197 RKHPWFRKNYNPVKCSE 213
            +HP+F  +  P   S+
Sbjct: 280 LEHPYFSNDPAPTPPSQ 296

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  114 bits (288), Expect = 9e-30
 Identities = 59/200 (29%), Positives = 106/200 (53%), Gaps = 4/200 (2%)

Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL--ENDCRRYFQQLIDAVA 61
           ++HPNIV+  E       +YI++++  GG+L+ KI  Q  +L  E+    +F Q+  A+ 
Sbjct: 56  MKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115

Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 121
           H H + + HRD+K +N+ L   G +K+ DFG++ +    VEL  T  GTP Y++PE+  N
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICEN 175

Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFSTGATSLIH 180
           R Y+ + +D+W+ G +L+ +      F   ++  L  KI    +      +S    +L+ 
Sbjct: 176 RPYN-NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVS 234

Query: 181 KILDPNPKTRIRIEGIRKHP 200
           ++   NP+ R  +  I +  
Sbjct: 235 QLFKRNPRDRPSVNSILEKN 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  114 bits (289), Expect = 2e-29
 Identities = 77/243 (31%), Positives = 115/243 (47%), Gaps = 50/243 (20%)

Query: 2   KIVRHPNIVRLHEVLASRTK--VYIILEFV----TGGELFDKIVHQGRLLENDCRRYFQQ 55
           + +RHPNIVRL E++ S+ K  +Y++ E++    TG  L D    + +  E+  + Y +Q
Sbjct: 53  QKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG--LLDS--PEVKFTESQIKCYMKQ 108

Query: 56  LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG--TPNY 113
           L++ + + HS G+ HRD+K  N+L+++ G LK++DFGL A P         T    T  Y
Sbjct: 109 LLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGL-ARPYTKRNSADYTNRVITLWY 167

Query: 114 VAPEVL--SNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKI---------- 160
             PE+L  + R Y G   D+WS G IL  L  G   F G T+L  L +KI          
Sbjct: 168 RPPELLLGATR-Y-GPEVDMWSVGCILAELFLGKPIFQGSTELEQL-EKIFELCGSPTDE 224

Query: 161 NAAEFSCPFWF---------------------STGATSLIHKILDPNPKTRIRIEGIRKH 199
           N    S   WF                        A  L+ K+L  +PK RI  +   +H
Sbjct: 225 NWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284

Query: 200 PWF 202
            +F
Sbjct: 285 EYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  114 bits (288), Expect = 2e-29
 Identities = 68/234 (29%), Positives = 105/234 (44%), Gaps = 39/234 (16%)

Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAH 62
            +HP +V+L +V    +   +++E++    L + +  + R L E   + Y + L+  VA+
Sbjct: 56  CQHPYVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAY 114

Query: 63  CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT-TCGTPNYVAPEVL-S 120
            H+ G+ HRDLKP NLL+ + G LK++DFGL+ L  +    L++    T  Y APE+L  
Sbjct: 115 MHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPF--GETD------------------------LP 154
            R YD    D+W+ G I   L+ G  P   GE D                        LP
Sbjct: 175 ARKYD-PGVDLWAVGCIFAELLNG-SPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232

Query: 155 TLYKKINAAEFSCPFW------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 202
             Y KI   E             S  A  L+  +L  +P  R+      +HP+F
Sbjct: 233 -DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  113 bits (284), Expect = 3e-29
 Identities = 66/190 (34%), Positives = 98/190 (51%), Gaps = 4/190 (2%)

Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLL-ENDCRRYFQQLIDAVA 61
           ++HPNIV   E   +   +YI++E+  GG+L  KI  Q G+L  E+   ++F Q+   V 
Sbjct: 55  MKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ 114

Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 121
           H H K V HRD+K +N+ L   G +K+ DFG + L         T  GTP YV PE+  N
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN 174

Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CPFWFSTGATSLIH 180
             Y+ + +D+WS G IL+ L     PF       L  K+    +   P  +S    SLI 
Sbjct: 175 MPYN-NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIK 233

Query: 181 KILDPNPKTR 190
           ++   NP++R
Sbjct: 234 QMFKRNPRSR 243

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  114 bits (288), Expect = 4e-29
 Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 12/215 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           + I   P I +L      +  +Y+++E+  GG+L   +  ++ +  E+  + Y  +L+ A
Sbjct: 55  LSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA 114

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEV 118
           +   H  G  HRD+KPEN+L+D  G++K++DFG +A L    +       GTP+Y+APEV
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEV 174

Query: 119 LSN-RGYDGSAADV----WSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF---- 169
           L+   G       V    WS GVI + ++ G  PF E      Y  I   +    F    
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDP 234

Query: 170 WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
             S+    LI  +L    K R+  EG+  HP+F K
Sbjct: 235 KVSSDFLDLIQSLL-CGQKERLGYEGLCCHPFFSK 268

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  113 bits (284), Expect = 4e-29
 Identities = 64/205 (31%), Positives = 106/205 (51%), Gaps = 11/205 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH---QGRLL-ENDCRRYFQQL 56
           +K + HPN+++         ++ I+LE    G+L   I H   Q RL+ E    +YF QL
Sbjct: 56  LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115

Query: 57  IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
             A+ H HSK + HRD+KP N+ + + G +K+ D GL           H+  GTP Y++P
Sbjct: 116 CSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYKKINAAEFSCPF---WF 171
           E +   GY+   +D+WS G +L+ + A   PF   + +L +L KKI   ++  P     +
Sbjct: 176 ERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP-PLPADHY 233

Query: 172 STGATSLIHKILDPNPKTRIRIEGI 196
           S     L+ + ++P+P+ R  I  +
Sbjct: 234 SEELRDLVSRCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  112 bits (282), Expect = 1e-28
 Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 13/212 (6%)

Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVA 61
           V    IV L     ++  + +++  + GG+L   I + G     E     Y  Q+I  + 
Sbjct: 50  VSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLE 109

Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 121
           H H + + +RDLKPEN+LLD +GN+++SD GL A+  +G + +    GTP Y+APEVL  
Sbjct: 110 HLHQRRIVYRDLKPENVLLDDHGNVRISDLGL-AVELKGGKKIKGRAGTPGYMAPEVLQG 168

Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPFGE----TDLPTLYKKINAAEFSCPFWFSTGATS 177
             YD  + D ++ G  L+ ++AG  PF +     +   L ++        P  FS  A  
Sbjct: 169 EVYD-FSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKD 227

Query: 178 LIHKILDPNPKTRI-----RIEGIRKHPWFRK 204
           L   +L  +P+ R+       + +R+HP F+ 
Sbjct: 228 LCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  111 bits (280), Expect = 1e-28
 Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 7/204 (3%)

Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLEND-CRRYFQQLIDAVA 61
           ++HPNIV          +++I++E+  GG+L  +I  Q G L   D    +F Q+   + 
Sbjct: 56  MKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115

Query: 62  HCHSKGVYHRDLKPENLLLDSYGNL-KVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           H H + + HRD+K +N+ L   G + K+ DFG++      +EL +T  GTP Y++PE+  
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQ 175

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFW--FSTGATSL 178
           NR Y+ +  D+WS G +L+ L     PF   +L  L  KI    F+ P    FS    SL
Sbjct: 176 NRPYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA-PISPNFSRDLRSL 233

Query: 179 IHKILDPNPKTRIRIEGIRKHPWF 202
           I ++   +P+ R  I  I K P+ 
Sbjct: 234 ISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  111 bits (280), Expect = 1e-28
 Identities = 63/205 (30%), Positives = 110/205 (53%), Gaps = 8/205 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL--ENDCRRYFQQLID 58
           +K++ HPNI+  +E       + I++E+  GG L + I  +   L  E+    +F Q++ 
Sbjct: 53  LKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILL 112

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
           A+ H H+K + HRDLK +N+LLD +   +K+ DFG+S +     +  +T  GTP Y++PE
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-AYTVVGTPCYISPE 171

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF--WFSTGA 175
           +   + Y+   +D+W+ G +L+ L +    F   +LP L  KI +  F+ P    +S   
Sbjct: 172 LCEGKPYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA-PISDRYSPDL 229

Query: 176 TSLIHKILDPNPKTRIRIEGIRKHP 200
             LI  +L+ +P  R ++  I   P
Sbjct: 230 RQLILSMLNLDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  112 bits (281), Expect = 2e-28
 Identities = 68/223 (30%), Positives = 117/223 (52%), Gaps = 30/223 (13%)

Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           +P +V +     ++  + +++E+V GG+    + + G L  +  R YF + + A+ + H+
Sbjct: 60  NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHN 119

Query: 66  KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT------------------T 107
            G+ HRDLKP+NLL+ S G++K++DFGLS +   G+  L T                   
Sbjct: 120 YGIVHRDLKPDNLLITSMGHIKLTDFGLSKI---GLMSLTTNLYEGHIEKDTREFLDKQV 176

Query: 108 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFS 166
           CGTP Y+APEV+  +GY G   D W+ G+IL+  + G +PF G+T    L+ ++ + +  
Sbjct: 177 CGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTP-EELFGQVISDDIE 234

Query: 167 CPFW---FSTGATSLIHKILDPNPKTRIRIEG---IRKHPWFR 203
            P         A  LI ++L  NP  R+   G   +++H +F 
Sbjct: 235 WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  110 bits (277), Expect = 3e-28
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 8/200 (4%)

Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL--ENDCRRYFQQLIDAVAHC 63
           HPNI+  +        + I +E+  GG L+DKIV Q   L  E     Y  Q++ AV++ 
Sbjct: 58  HPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYI 117

Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH--TTCGTPNYVAPEVLSN 121
           H  G+ HRD+K  N+ L   G +K+ DFG+S     G E     T  GTP Y++PE+   
Sbjct: 118 HKAGILHRDIKTLNIFLTKAGLIKLGDFGISK--ILGSEYSMAETVVGTPYYMSPELCQG 175

Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CPFWFSTGATSLIH 180
             Y+   +D+W+ G +L+ L+     F  T+   L  KI    ++     +S+   SL+H
Sbjct: 176 VKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVH 234

Query: 181 KILDPNPKTRIRIEGIRKHP 200
            +L  +P+ R   + +   P
Sbjct: 235 SLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  111 bits (279), Expect = 4e-28
 Identities = 60/162 (37%), Positives = 88/162 (54%), Gaps = 6/162 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFV--TGGELFDKIVHQGRLLENDCRRYFQQLID 58
           ++ +RH NIV L E    + ++Y++ E+V  T  EL +     G L  +  R Y  QL+ 
Sbjct: 54  LRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQ 111

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPE 117
           A+A+CHS  + HRD+KPEN+L+   G LK+ DFG + AL  +    L     T  Y APE
Sbjct: 112 AIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE 171

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK 158
           +L      G   DVW+ G I+  L+ G   F G++D+  LY 
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL 213

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  110 bits (277), Expect = 7e-28
 Identities = 71/234 (30%), Positives = 106/234 (45%), Gaps = 33/234 (14%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           MK ++H NIVRLH+V+ +  K+ ++ E++     +  D    +G L  N  + +  QL+ 
Sbjct: 52  MKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLK 111

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CH   V HRDLKP+NLL++  G LK++DFGL+      V        T  Y AP+V
Sbjct: 112 GIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDV 171

Query: 119 L-SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI----------------N 161
           L  +R Y  S  D+WS G I+  ++ G   F  T+      KI                 
Sbjct: 172 LLGSRTYSTS-IDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230

Query: 162 AAEFSCPF-------------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 202
             E+   F                     L+H++L  NP+ RI      +HPWF
Sbjct: 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  109 bits (273), Expect = 1e-27
 Identities = 59/188 (31%), Positives = 96/188 (51%), Gaps = 4/188 (2%)

Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHC 63
              I+R +E    + K+ I++E+   G+L   +  Q    L E+   R+F Q++  +AH 
Sbjct: 58  SSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHL 117

Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HSK + HRD+K  NL LD+Y N+K+ D G++ L        +T  GTP Y++PE+  ++ 
Sbjct: 118 HSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKP 177

Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CPFWFSTGATSLIHKI 182
           Y+   +DVW+ GV+L+    G  PF   +   L  KI    F      +S     LI + 
Sbjct: 178 YN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236

Query: 183 LDPNPKTR 190
           L  + + R
Sbjct: 237 LTKDYRQR 244

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  109 bits (273), Expect = 1e-27
 Identities = 62/201 (30%), Positives = 101/201 (50%), Gaps = 7/201 (3%)

Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           ++HPNIV+          +YI LE V GG L   +   G   E   R Y +Q++  + + 
Sbjct: 59  LQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYL 118

Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC--GTPNYVAPEVLSN 121
           H +   HRD+K  N+L+D+ G +K++DFG++   +Q VE        G+P ++APEV++ 
Sbjct: 119 HDRNTVHRDIKGANILVDTNGVVKLADFGMA---KQVVEFSFAKSFKGSPYWMAPEVIAQ 175

Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEF-SCPFWFSTGATSLI 179
           +G  G AAD+WS G  +  +  G  P+ +   +  ++K   + E    P   S  A   I
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFI 235

Query: 180 HKILDPNPKTRIRIEGIRKHP 200
            K L  +P  R     + +HP
Sbjct: 236 LKCLQRDPSLRPTAAELLEHP 256

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  108 bits (271), Expect = 5e-27
 Identities = 65/212 (30%), Positives = 109/212 (51%), Gaps = 7/212 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M+  +HPNIV ++       ++++++EF+ GG L D IV   R+ E         ++ A+
Sbjct: 70  MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKAL 128

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           +  H++GV HRD+K +++LL S G +K+SDFG  A   + V    +  GTP ++APEV+S
Sbjct: 129 SFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVIS 188

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLP-FGETDLPTLYKKINAAE---FSCPFWFSTGAT 176
              Y G+  D+WS G+++  ++ G  P F E  L  + K+I              S    
Sbjct: 189 RLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM-KRIRDNLPPKLKNLHKVSPRLR 246

Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 208
           S + ++L  +P  R     +  HP+  K   P
Sbjct: 247 SFLDRMLVRDPAQRATAAELLNHPFLAKAGPP 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  108 bits (271), Expect = 5e-27
 Identities = 62/165 (37%), Positives = 90/165 (54%), Gaps = 12/165 (7%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIVRL +V+ S  K+Y++ EF+     +  D     G L     + Y  QL+ 
Sbjct: 52  LKELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQ 110

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTT--CGTPNYVA 115
            +A+CHS  V HRDLKP+NLL+D  G LK++DFGL+ A    GV +   T    T  Y A
Sbjct: 111 GIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF---GVPVRTYTHEVVTLWYRA 167

Query: 116 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYK 158
           PE+L       +  D+WS G I F  M    P   G++++  L++
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCI-FAEMVNRRPLFPGDSEIDQLFR 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  107 bits (267), Expect = 1e-26
 Identities = 63/199 (31%), Positives = 105/199 (52%), Gaps = 11/199 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH---QGRLL-ENDCRRYFQQL 56
           +K + HPN+++ +       ++ I+LE    G+L   I H   Q RL+ E    +YF QL
Sbjct: 56  LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQL 115

Query: 57  IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
             A+ H HS+ V HRD+KP N+ + + G +K+ D GL           H+  GTP Y++P
Sbjct: 116 CSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYKKINAAEFSCPF---WF 171
           E +   GY+   +D+WS G +L+ + A   PF   + +L +L KKI   ++  P     +
Sbjct: 176 ERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP-PLPSDHY 233

Query: 172 STGATSLIHKILDPNPKTR 190
           S     L++  ++P+P+ R
Sbjct: 234 SEELRQLVNMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  106 bits (268), Expect = 1e-26
 Identities = 63/221 (28%), Positives = 113/221 (51%), Gaps = 14/221 (6%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           MK  +HPNIV  ++      ++++++E++ GG L D I  +  R+ E       ++++  
Sbjct: 69  MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQG 128

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 119
           + + HS+ V HRD+K +N+LL   G++K++DFG +A   +     ++  GTP ++APEV+
Sbjct: 129 LEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVI 188

Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLP-FGETDLPTLY----KKINAAEFSCPFWFSTG 174
             + Y     D+WS G++   +  G  P   E  L  L+    K I       P  +S  
Sbjct: 189 KRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI--PPLKNPEKWSPE 245

Query: 175 ATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEE 215
               ++K L  +P+ R   E + +HP+ +K      C +EE
Sbjct: 246 FKDFLNKCLVKDPEKRPSAEELLQHPFLKK-----ACPKEE 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  108 bits (271), Expect = 2e-26
 Identities = 76/254 (29%), Positives = 126/254 (49%), Gaps = 17/254 (6%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M     P +V+L         +Y+++E++ GG+L + ++    + E   R Y  +++ A+
Sbjct: 97  MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLAL 155

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVL 119
              HS G  HRD+KP+N+LLD  G+LK++DFG    + ++G+    T  GTP+Y++PEVL
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 215

Query: 120 SNR---GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI----NAAEFSCPFWFS 172
            ++   GY G   D WS GV L+ ++ G  PF    L   Y KI    N+  F      S
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 275

Query: 173 TGATSLIHKILDPNPKT--RIRIEGIRKHPWFR------KNYNPVKCSEEEEVNLDDVHA 224
             A +LI   L        R  +E I++H +F+      +           +++ D   +
Sbjct: 276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTS 335

Query: 225 VFDDIEDQYVAEQS 238
            FDDIE+    E++
Sbjct: 336 NFDDIEEDKGEEET 349

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  107 bits (269), Expect = 3e-26
 Identities = 68/245 (27%), Positives = 107/245 (43%), Gaps = 52/245 (21%)

Query: 9   IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 68
           +V+L+     +  +Y +++++ GG++   ++  G   E+  R Y  +L  A+   H  G 
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122

Query: 69  YHRDLKPENLLLDSYGNLKVSDFGLS---------------------------------- 94
            HRD+KP+N+L+D  G++K++DFGL                                   
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 95  ---------ALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGY 145
                       Q    L H+  GTPNY+APEVL   GY     D WS GVIL+ ++ G 
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQ 241

Query: 146 LPF-GETDLPTLYKKIN-AAEFSCPFW--FSTGATSLIHKILDPNPKTRI---RIEGIRK 198
            PF  +T   T  K IN       P     S  A+ LI + L    + R+     + I+ 
Sbjct: 242 PPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEIKA 300

Query: 199 HPWFR 203
           HP+F+
Sbjct: 301 HPFFK 305

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 1e-25
 Identities = 50/147 (34%), Positives = 75/147 (51%), Gaps = 16/147 (10%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLL-ENDCRRYFQQLID 58
            K+  HPNIV+L EV     ++Y + E++ G  L+  +   +G+   E+  R    Q++ 
Sbjct: 52  RKLNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQ 110

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL-----SALPQQGVELLHTT-CGTPN 112
            +AH H  G +HRDLKPENLL+     +K++DFGL     S  P       +T    T  
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-------YTDYVSTRW 163

Query: 113 YVAPEVLSNRGYDGSAADVWSCGVILF 139
           Y APE+L       S  D+W+ G I+ 
Sbjct: 164 YRAPEILLRSTSYSSPVDIWALGCIMA 190

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  105 bits (264), Expect = 1e-25
 Identities = 53/153 (34%), Positives = 92/153 (60%), Gaps = 8/153 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V HPN+V+ H++     ++ ++LEF+ GG L    +   + L +  R    Q++  +
Sbjct: 126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGI 181

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           A+ H + + HRD+KP NLL++S  N+K++DFG+S +  Q ++  +++ GT  Y++PE ++
Sbjct: 182 AYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERIN 241

Query: 121 ---NRG-YDGSAADVWSCGVILFVLMAGYLPFG 149
              N G YDG A D+WS GV +     G  PFG
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274

Length = 353

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 2e-25
 Identities = 68/237 (28%), Positives = 113/237 (47%), Gaps = 38/237 (16%)

Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVA 61
           + HP +  L+    + T + +++++  GGELF  +  Q    L E   R Y  +++ A+ 
Sbjct: 58  LDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALE 117

Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-------ALPQQGV----------ELL 104
           + H  G+ +RDLKPEN+LL   G++ +SDF LS           + +           + 
Sbjct: 118 YLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177

Query: 105 HTT------------CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
             T             GT  Y+APEV+S  G+ GSA D W+ G++L+ ++ G  PF  ++
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSN 236

Query: 153 LPTLYKKINAAEFSCP--FWFSTGATSLIHKILDPNPKTRI----RIEGIRKHPWFR 203
               +  I   E + P     S+ A  LI K+L  +P  R+        I++HP+FR
Sbjct: 237 RDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  103 bits (257), Expect = 3e-25
 Identities = 62/199 (31%), Positives = 102/199 (51%), Gaps = 11/199 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH---QGRLL-ENDCRRYFQQL 56
           +K + HPN+++  +      ++ I+LE    G+L   I +   Q RL+ E    +YF QL
Sbjct: 56  LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL 115

Query: 57  IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
             AV H HS+ V HRD+KP N+ + + G +K+ D GL           H+  GTP Y++P
Sbjct: 116 CSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYKKINAAEFSCPF---WF 171
           E +   GY+   +D+WS G +L+ + A   PF   + +L +L +KI   ++  P     +
Sbjct: 176 ERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYP-PLPTEHY 233

Query: 172 STGATSLIHKILDPNPKTR 190
           S     L+   + P+P  R
Sbjct: 234 SEKLRELVSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  102 bits (256), Expect = 3e-25
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 7/201 (3%)

Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKI---VHQGRLL-ENDCRRYFQQLIDAVA 61
           HP IV+ H     R    II E+  G +L  K+    H G+ L EN    +F QL+  V 
Sbjct: 61  HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120

Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 121
           + H + + HRDLK +N+ L +   LK+ DFG+S L     +L  T  GTP Y++PE L +
Sbjct: 121 YMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH 179

Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           +GYD S +D+WS G IL+ +      F G+  L  + + +     S P  +S    S++ 
Sbjct: 180 QGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ 238

Query: 181 KILDPNPKTRIRIEGIRKHPW 201
            +L+ +P  R     I ++P+
Sbjct: 239 SMLNKDPSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  104 bits (260), Expect = 6e-25
 Identities = 69/251 (27%), Positives = 110/251 (43%), Gaps = 56/251 (22%)

Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P +V L+        +Y+I+EF+ GG+L   ++      E+  R Y  + + A+   H  
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120

Query: 67  GVYHRDLKPENLLLDSYGNLKVSDFGLS------------------------ALPQQGVE 102
           G  HRD+KP+N+L+D  G++K+SDFGLS                           +  V 
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180

Query: 103 -----------------------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 139
                                  + ++T GTP+Y+APE+   +GY G   D WS G I+F
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMF 239

Query: 140 VLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFSTGATSLIHKILDPNPKTRIRIEG 195
             + G+ PF   +    Y+KI     +  F      S  A  LI +++  N + R+   G
Sbjct: 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG 298

Query: 196 ---IRKHPWFR 203
              I+ HP+FR
Sbjct: 299 AHEIKSHPFFR 309

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|217748 pfam03822, NAF, NAF domain

 Score = 95.7 bits (239), Expect = 6e-25
 Identities = 26/57 (45%), Positives = 41/57 (71%)

Query: 248 MNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVH 304
           +NAF++I+LS GL+L+ LF+  +   K++TRF SR+PA  I+S +E +A+ L  KV 
Sbjct: 1   LNAFDLISLSSGLDLSGLFEEEKKSKKKETRFTSRKPASEIISKLEEIAKELGFKVK 57

Length = 58

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  103 bits (258), Expect = 7e-25
 Identities = 72/236 (30%), Positives = 113/236 (47%), Gaps = 44/236 (18%)

Query: 9   IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 68
           +V++      +  +Y+I+EF+ GG++   ++ +  L E   + Y  + + A+   H  G 
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122

Query: 69  YHRDLKPENLLLDSYGNLKVSDFGL---------------------SALPQQGV------ 101
            HRD+KP+NLLLD+ G++K+SDFGL                     S    Q +      
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182

Query: 102 --------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETD 152
                   +L ++T GTP+Y+APEV    GY+    D WS GVI++ ++ GY PF  ET 
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241

Query: 153 LPTLYKKINAAE---FSCPFWFSTGATSLIHKILDPNPKTRI---RIEGIRKHPWF 202
             T  K +N  E   F      S  A  LI +    + + RI    +E I+ HP+F
Sbjct: 242 QETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFF 296

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  101 bits (252), Expect = 1e-24
 Identities = 58/156 (37%), Positives = 88/156 (56%), Gaps = 8/156 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRT--KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 58
           +K +RH  IV+ +  L      K+ I +E++ GG + D++   G L EN  RRY +Q++ 
Sbjct: 58  LKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQ 117

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ----QGVELLHTTCGTPNYV 114
            V++ HS  + HRD+K  N+L DS GN+K+ DFG S   Q     G  +   T GTP ++
Sbjct: 118 GVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT-GTPYWM 176

Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE 150
           +PEV+S  GY G  ADVWS    +  ++    P+ E
Sbjct: 177 SPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  101 bits (252), Expect = 1e-24
 Identities = 64/198 (32%), Positives = 101/198 (51%), Gaps = 11/198 (5%)

Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTG---GELFDKIVHQG-RLLENDCRRYFQQLIDA 59
           +RHPNIVR ++      ++YI+++ + G   GE F+ +  +  R  E      F Q++ A
Sbjct: 66  LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125

Query: 60  VAHCH-SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
           + + H  K + HRDL P N++L     + ++DFGL A  +Q    L +  GT  Y  PE+
Sbjct: 126 LRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL-AKQKQPESKLTSVVGTILYSCPEI 184

Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF---WFSTGA 175
           + N  Y G  ADVW+ G IL+ +     PF  T++ +L  KI  A +  P     +S   
Sbjct: 185 VKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE-PLPEGMYSEDV 242

Query: 176 TSLIHKILDPNPKTRIRI 193
           T +I   L P+ + R  I
Sbjct: 243 TDVITSCLTPDAEARPDI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  102 bits (254), Expect = 4e-24
 Identities = 74/249 (29%), Positives = 110/249 (44%), Gaps = 56/249 (22%)

Query: 9   IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 68
           +VRL+     +  +Y +++++ GG++   ++  G   E+  R Y  +L  AV   H  G 
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122

Query: 69  YHRDLKPENLLLDSYGNLKVSDFGL----------------------------------- 93
            HRD+KP+N+L+D  G++K++DFGL                                   
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 94  ------------SALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVL 141
                        A  Q    L H+  GTPNY+APEVL   GY     D WS GVIL+ +
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEM 241

Query: 142 MAGYLPF-GETDLPTLYKKIN-AAEFSCPFW--FSTGATSLIHKILDPNPKTRIRIEG-- 195
           + G  PF  +T L T  K IN       P     S  A+ LI K+    P+ R+   G  
Sbjct: 242 LVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR-GPEDRLGKNGAD 300

Query: 196 -IRKHPWFR 203
            I+ HP+F+
Sbjct: 301 EIKAHPFFK 309

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 99.7 bits (249), Expect = 5e-24
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 27/222 (12%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH---QGRLLENDCRRYFQQLI 57
           M    HPN+V+ +       ++++++ +++GG L D +     +G L E       ++++
Sbjct: 53  MSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL 112

Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL----LHTTCGTPNY 113
             + + HS G  HRD+K  N+LL   G++K++DFG+SA    G +       T  GTP +
Sbjct: 113 KGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCW 172

Query: 114 VAPEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPFG------------ETDLPTLYKKI 160
           +APEV+    GYD   AD+WS G+    L  G  P+             + D P+L    
Sbjct: 173 MAPEVMEQVHGYD-FKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGA 231

Query: 161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 202
           +  ++S  F        +I   L  +P  R   E + KH +F
Sbjct: 232 DYKKYSKSF------RKMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  100 bits (252), Expect = 5e-24
 Identities = 69/268 (25%), Positives = 108/268 (40%), Gaps = 82/268 (30%)

Query: 1   MKIVRHPNIVRLHEVLASRTK-----VYIILEFVTGGELFD----KIVHQGRLLENDCRR 51
           ++ +RH NI+ L ++L   +      VYI    VT  EL +    K++   + L +D  +
Sbjct: 53  LRHLRHENIIGLLDILRPPSPEDFNDVYI----VT--ELMETDLHKVIKSPQPLTDDHIQ 106

Query: 52  YFQ-QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCG 109
           YF  Q++  + + HS  V HRDLKP N+L++S  +LK+ DFGL+  +     E    T  
Sbjct: 107 YFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT-- 164

Query: 110 TPNYV------APEV-LSNRGYDGSAADVWSCGVILFVLMAG------------------ 144
              YV      APE+ LS+  Y   A D+WS G I   L+                    
Sbjct: 165 --EYVVTRWYRAPELLLSSSRYT-KAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVE 221

Query: 145 --------------------YL----PFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
                               YL       +  L  L+   +             A  L+ 
Sbjct: 222 VLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPE-----------AIDLLE 270

Query: 181 KILDPNPKTRIRIEGIRKHPWFRKNYNP 208
           K+L  +PK RI  +    HP+  + ++P
Sbjct: 271 KMLVFDPKKRITADEALAHPYLAQLHDP 298

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  100 bits (250), Expect = 5e-24
 Identities = 61/218 (27%), Positives = 94/218 (43%), Gaps = 55/218 (25%)

Query: 6   HPNIVRLHEVLASRT--KVYIILEFVTGGELFDKIVHQGR---LLENDCRRYFQQLIDAV 60
           HPNI+RL EVL  R   ++ ++ E +    L++ I  +GR   L E   + Y  QL+ ++
Sbjct: 57  HPNILRLIEVLFDRKTGRLALVFELMDM-NLYELI--KGRKRPLPEKRVKSYMYQLLKSL 113

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV------ 114
            H H  G++HRD+KPEN+L+     LK++DFG S                P Y       
Sbjct: 114 DHMHRNGIFHRDIKPENILIKDD-ILKLADFG-SC---------RGIYSKPPYTEYISTR 162

Query: 115 ---APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFW 170
              APE L   GY G   D+W+ G + F +++ +  F G  +L  + K            
Sbjct: 163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAK------------ 210

Query: 171 FSTGATSLIHKIL-DPNPKTRIRIEGIRKHPWFRKNYN 207
                   IH +L  P+ +        +       NYN
Sbjct: 211 --------IHDVLGTPDAEV-----LKKFRKSRHMNYN 235

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  101 bits (252), Expect = 6e-24
 Identities = 58/187 (31%), Positives = 92/187 (49%), Gaps = 36/187 (19%)

Query: 9   IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 68
           +V++      +  +Y+I+EF+ GG++   ++ +  L E + + Y  + + A+   H  G 
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122

Query: 69  YHRDLKPENLLLDSYGNLKVSDFGLS-----------------ALPQQGV---------- 101
            HRD+KP+NLLLDS G++K+SDFGL                  +LP              
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 102 --------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL 153
                   +L  +T GTP+Y+APEV    GY+    D WS GVI++ ++ GY PF     
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241

Query: 154 PTLYKKI 160
              YKK+
Sbjct: 242 QETYKKV 248

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 99.4 bits (248), Expect = 7e-24
 Identities = 66/234 (28%), Positives = 108/234 (46%), Gaps = 33/234 (14%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K ++HPNIV L +VL   +++Y+I EF++    +  D +     +     + Y  Q++ 
Sbjct: 53  LKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQ 112

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +  CHS+ V HRDLKP+NLL+D+ G +K++DFGL+      V +      T  Y APEV
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEV 172

Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYK-----------------K 159
           L       +  D+WS G I F  MA   P   G++++  L++                  
Sbjct: 173 LLGSPRYSTPVDIWSIGTI-FAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231

Query: 160 INAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 202
           +   + + P W                  L+ K+L  +P  RI  +    HP+F
Sbjct: 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 99.5 bits (248), Expect = 7e-24
 Identities = 54/145 (37%), Positives = 81/145 (55%), Gaps = 6/145 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG-ELFDKIVHQGRLLENDCRRYFQQLIDA 59
           +K + HPNIV+L +V+ +  K+Y++ EF+    + F        +     + Y  QL+  
Sbjct: 53  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQG 112

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT--CGTPNYVAPE 117
           +A CHS  V HRDLKP+NLL+++ G +K++DFGL+     GV +   T    T  Y APE
Sbjct: 113 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPE 170

Query: 118 VLSNRGYDGSAADVWSCGVILFVLM 142
           +L    Y  +A D+WS G I F  M
Sbjct: 171 ILLGCKYYSTAVDIWSLGCI-FAEM 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 98.5 bits (245), Expect = 9e-24
 Identities = 63/202 (31%), Positives = 106/202 (52%), Gaps = 5/202 (2%)

Query: 4   VRHPNIVRLHEVLASRT-KVYIILEFVTGGELFDKIVHQ-GRLL-ENDCRRYFQQLIDAV 60
           ++HPNIV   E        +YI++ F  GG+L+ K+  Q G+LL EN    +F Q+  A+
Sbjct: 56  LKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL 115

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + H K + HRDLK +N+ L     +KV D G++ + +   ++  T  GTP Y++PE+ S
Sbjct: 116 QYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFS 175

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL-YKKINAAEFSCPFWFSTGATSLI 179
           N+ Y+   +DVW+ G  ++ +      F   D+ +L Y+ I       P  +S     LI
Sbjct: 176 NKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELI 234

Query: 180 HKILDPNPKTRIRIEGIRKHPW 201
             +L   P+ R  ++ I + P+
Sbjct: 235 ATMLSKRPEKRPSVKSILRQPY 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 98.9 bits (246), Expect = 1e-23
 Identities = 66/206 (32%), Positives = 106/206 (51%), Gaps = 12/206 (5%)

Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P IV +     +  K+  IL+ + GG+L   +   G   E + R Y  ++I  + H H++
Sbjct: 57  PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR 116

Query: 67  GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-RGYD 125
            V +RDLKP N+LLD +G++++SD GL+       +  H + GT  Y+APEVL     YD
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPEVLQKGVAYD 174

Query: 126 GSAADVWSCGVILFVLMAGYLPFGE---TDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 182
            S+AD +S G +LF L+ G+ PF +    D   + +         P  FS    SL+  +
Sbjct: 175 -SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL 233

Query: 183 LDPNPKTRIRIEG-----IRKHPWFR 203
           L  +   R+   G     +++HP+FR
Sbjct: 234 LQRDVNRRLGCLGRGAQEVKEHPFFR 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 98.8 bits (247), Expect = 1e-23
 Identities = 69/236 (29%), Positives = 106/236 (44%), Gaps = 42/236 (17%)

Query: 5   RHPNIVRLHEVLASRT--KVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVA 61
           +HPNIV + EV+      K+Y+++E+V   +L   +   +   L+++ +    QL+  VA
Sbjct: 62  QHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVA 120

Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG--TPNYVAPEVL 119
           H H   + HRDLK  NLLL++ G LK+ DFGL+   + G  L   T    T  Y APE+L
Sbjct: 121 HLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVVTLWYRAPELL 178

Query: 120 SNRGYDGSAADVWSCGVIL--FVLMAGYLPFGETDLPTLYK----------KINAAEFSC 167
                  +A D+WS G I    +      P G++++  L K          KI       
Sbjct: 179 LGAKEYSTAIDMWSVGCIFAELLTKKPLFP-GKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237

Query: 168 PFW----------------FSTGATS-----LIHKILDPNPKTRIRIEGIRKHPWF 202
           P                  F   + S     L++++L  +P  RI  E   KHP+F
Sbjct: 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 97.2 bits (243), Expect = 3e-23
 Identities = 51/164 (31%), Positives = 80/164 (48%), Gaps = 5/164 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           MK + HPNIVRL  V      +YI+ E++ GG+L D +  H  +L   D  +   Q+   
Sbjct: 55  MKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKG 114

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP-NYVAPE 117
           + +  SK   HRDL   N L+     +K+SDFGLS  + +            P  ++APE
Sbjct: 115 MEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPE 174

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI 160
            L +  +  S +DVWS GV+L+ +   G  P+       + + +
Sbjct: 175 SLKDGKFT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL 217

Length = 258

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 97.4 bits (242), Expect = 3e-23
 Identities = 55/156 (35%), Positives = 91/156 (58%), Gaps = 8/156 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 58
           +K ++H  IV+ +  L  R +  + I +E++ GG + D++   G L E+  R+Y +Q+++
Sbjct: 58  LKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE 117

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ----QGVELLHTTCGTPNYV 114
            +++ HS  + HRD+K  N+L DS GN+K+ DFG S   Q     G  +   T GTP ++
Sbjct: 118 GMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT-GTPYWM 176

Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE 150
           +PEV+S  GY G  ADVWS G  +  ++    P+ E
Sbjct: 177 SPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 97.8 bits (243), Expect = 4e-23
 Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 10/208 (4%)

Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCH 64
           HP IV+L        K++I++EF  GG +   ++   R L E   +   +Q+++A+ + H
Sbjct: 68  HPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH 127

Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV-----L 119
           S  + HRDLK  N+LL   G++K++DFG+SA   + ++   +  GTP ++APEV     +
Sbjct: 128 SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETM 187

Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGAT 176
            +  YD   AD+WS G+ L  +     P  E +   +  KI  +E    S P  +S    
Sbjct: 188 KDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR 246

Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWFRK 204
             +   LD +P+TR     + +HP+   
Sbjct: 247 DFLKTALDKHPETRPSAAQLLEHPFVSS 274

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 97.0 bits (242), Expect = 4e-23
 Identities = 52/145 (35%), Positives = 75/145 (51%), Gaps = 15/145 (10%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRL-LEND-----CRRYFQ 54
           +K  RHPNIV        R K++I++E+  GG L D I    R  L        CR   +
Sbjct: 54  LKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLK 112

Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
            L    A+ H  G  HRD+K  N+LL   G++K++DFG+SA     +    +  GTP ++
Sbjct: 113 GL----AYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWM 168

Query: 115 APEVLSNR---GYDGSAADVWSCGV 136
           APEV +     GYDG   D+W+ G+
Sbjct: 169 APEVAAVERKGGYDG-KCDIWALGI 192

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 96.9 bits (241), Expect = 5e-23
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 11/213 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M  + HP+I+R+       +   + +E++ GG +   +   G   E     Y +QL+  +
Sbjct: 57  MARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGL 116

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGN-LKVSDFGLSA-LPQQGV---ELLHTTCGTPNYVA 115
           ++ H   + HRD+K  NLL+DS G  L+++DFG +A L  +G    E      GT  ++A
Sbjct: 117 SYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176

Query: 116 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD----LPTLYKKINAAEF-SCPFW 170
           PEVL    Y G + DVWS G ++  +     P+        L  ++K  +A    S P  
Sbjct: 177 PEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEH 235

Query: 171 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
            S G   +  + L+  P+ R     + KHP FR
Sbjct: 236 LSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 97.4 bits (242), Expect = 5e-23
 Identities = 51/148 (34%), Positives = 89/148 (60%), Gaps = 2/148 (1%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M+  +H N+V +++      ++++++EF+ GG L D IV Q RL E       + ++ A+
Sbjct: 72  MRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQAL 130

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS+GV HRD+K +++LL   G +K+SDFG  A   + V    +  GTP ++APEV+S
Sbjct: 131 CYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS 190

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPF 148
              Y G+  D+WS G+++  ++ G  P+
Sbjct: 191 RTPY-GTEVDIWSLGIMVIEMVDGEPPY 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 96.7 bits (241), Expect = 6e-23
 Identities = 71/236 (30%), Positives = 102/236 (43%), Gaps = 38/236 (16%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K ++H NIVRL++VL S  K+ ++ E+      + FD     G +     + +  QL+ 
Sbjct: 53  LKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSC--NGDIDPEIVKSFMFQLLK 110

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKP+NLL++  G LK++DFGL+      V        T  Y  P+V
Sbjct: 111 GLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDV 170

Query: 119 L-SNRGYDGSAADVWSCGVILFVLMAGYLPF--------------------------GET 151
           L   + Y  S  D+WS G I   L     P                           G +
Sbjct: 171 LFGAKLYSTS-IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVS 229

Query: 152 DLPT-----LYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 202
            LP      +Y    +     P   STG   L+  +L  NP  RI  E   +HP+F
Sbjct: 230 KLPDYKPYPMYPATTSLVNVVPKLNSTG-RDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 96.5 bits (240), Expect = 9e-23
 Identities = 65/208 (31%), Positives = 105/208 (50%), Gaps = 14/208 (6%)

Query: 9   IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLIDAVAHCH 64
           IV L     ++T + +++  + GG+L   I +         E     Y  Q+I  + H H
Sbjct: 55  IVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH 114

Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 124
            + + +RDLKPEN+LLD+ GN+++SD GL+   + G        GTP ++APE+L    Y
Sbjct: 115 QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEY 174

Query: 125 DGSAADVWSCGVILFVLMAGYLPF---GE-TDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           D S  D ++ GV L+ ++A   PF   GE  +   L ++I     + P  FS  + S   
Sbjct: 175 DFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCE 233

Query: 181 KILDPNPKTRI-----RIEGIRKHPWFR 203
            +L  +P+ R+       +G+R HP FR
Sbjct: 234 ALLAKDPEKRLGFRDGNCDGLRTHPLFR 261

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 95.4 bits (237), Expect = 2e-22
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 10/210 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++H NIV+          + I +EFV GG +   +   G L E    +Y +Q++D V
Sbjct: 56  LKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGV 115

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS------ALPQQGVELLHTTCGTPNYV 114
           A+ H+  V HRD+K  N++L   G +K+ DFG +       L      +L +  GTP ++
Sbjct: 116 AYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175

Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF---SCPFWF 171
           APEV++  GY G  +D+WS G  +F +  G  P    D       I A        P  F
Sbjct: 176 APEVINESGY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSF 234

Query: 172 STGATSLIHKILDPNPKTRIRIEGIRKHPW 201
           S  A   +   L  +   R     + +H +
Sbjct: 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDF 264

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 95.1 bits (236), Expect = 2e-22
 Identities = 57/157 (36%), Positives = 89/157 (56%), Gaps = 10/157 (6%)

Query: 1   MKIVRHPNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 57
           +K + H  IV+ +  L     RT + I +E + GG + D++   G L EN  R+Y +Q++
Sbjct: 58  LKNLLHERIVQYYGCLRDPMERT-LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL 116

Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ----QGVELLHTTCGTPNY 113
           + V++ HS  + HRD+K  N+L DS GN+K+ DFG S   Q     G  +   T GTP +
Sbjct: 117 EGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT-GTPYW 175

Query: 114 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE 150
           ++PEV+S  GY G  AD+WS G  +  ++    P+ E
Sbjct: 176 MSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 96.1 bits (240), Expect = 3e-22
 Identities = 82/281 (29%), Positives = 121/281 (43%), Gaps = 57/281 (20%)

Query: 6   HPNIVRLHEVL-ASRTK-VYIILEFVTGGELFDKIVHQGRLLENDCRRY-FQQLIDAVAH 62
           HPNIV+L  V+ A   K +Y++ E++   E     V +  +LE+  +RY   QL+ A+ +
Sbjct: 66  HPNIVKLLNVIKAENDKDIYLVFEYM---ETDLHAVIRANILEDVHKRYIMYQLLKALKY 122

Query: 63  CHSKGVYHRDLKPENLLLDSYGNLKVSDFGL----SALPQ-QGVELLHTTCGTPNYVAPE 117
            HS  V HRDLKP N+LL+S   +K++DFGL    S L +     +L     T  Y APE
Sbjct: 123 IHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPE 182

Query: 118 VL--SNRGYDGSAADVWSCGVILFVLMAG------------------------------- 144
           +L  S R Y     D+WS G IL  ++ G                               
Sbjct: 183 ILLGSTR-YT-KGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240

Query: 145 YLPFGET---DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPW 201
             PF  T    LP+  +K            S  A  L+ K+L  NP  R+  E   +HP+
Sbjct: 241 KSPFAATMLDSLPSRPRKPLDELLPKA---SDDALDLLKKLLVFNPNKRLTAEEALEHPY 297

Query: 202 FRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSENKV 242
             + +NP     +E V    +    DD   +    +  NK+
Sbjct: 298 VAQFHNP----SDEPVLPYPITIPLDD-NVKLSVAEYRNKL 333

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 98.8 bits (246), Expect = 3e-22
 Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 14/200 (7%)

Query: 4   VRHPNIVRL-HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 62
           + HPNIV L     A    ++ + E+V G  L + +   G L   +  R   Q++DA+A 
Sbjct: 35  LYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALAC 94

Query: 63  CHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSAL-------PQQGVELLHTTCGTPN 112
            H++G+ HRDLKP+N+++   G   + KV DFG+  L           +       GTP 
Sbjct: 95  AHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPT 154

Query: 113 YVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWF 171
           Y APE L         +D+++ G+I    + G     G +    LY++++  + S P W 
Sbjct: 155 YCAPEQLRGEPVT-PNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWI 213

Query: 172 -STGATSLIHKILDPNPKTR 190
                  ++ K L+ +P+ R
Sbjct: 214 AGHPLGQVLRKALNKDPRQR 233

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 94.5 bits (235), Expect = 3e-22
 Identities = 51/153 (33%), Positives = 84/153 (54%), Gaps = 5/153 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K + H NIV+      +   + I LE+V GG +   +   GR  E   R + +Q+++ +
Sbjct: 62  LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGL 121

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC--GTPNYVAPEV 118
           A+ HSKG+ HRDLK +NLL+D+ G  K+SDFG+S       +        G+  ++APEV
Sbjct: 122 AYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181

Query: 119 LSN--RGYDGSAADVWSCGVILFVLMAGYLPFG 149
           + +  +GY     D+WS G ++  + AG  P+ 
Sbjct: 182 IHSYSQGYSAK-VDIWSLGCVVLEMFAGRRPWS 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 94.7 bits (235), Expect = 4e-22
 Identities = 60/206 (29%), Positives = 106/206 (51%), Gaps = 13/206 (6%)

Query: 9   IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSK 66
           +V L     ++  + ++L  + GG+L   I + G     E     Y  +++  +   H +
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121

Query: 67  GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 126
              +RDLKPEN+LLD YG++++SD GL+    +G E +    GT  Y+APEVL+N+ Y  
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIRGRVGTVGYMAPEVLNNQRY-T 179

Query: 127 SAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 182
            + D W  G +++ ++ G  PF     +     + +++   E      FS  A S+   +
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKML 239

Query: 183 LDPNPKTRI--RIEG---IRKHPWFR 203
           L  +PK R+  + EG   +++HP+FR
Sbjct: 240 LTKDPKQRLGCQEEGAGEVKRHPFFR 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 94.3 bits (234), Expect = 6e-22
 Identities = 62/205 (30%), Positives = 104/205 (50%), Gaps = 10/205 (4%)

Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P IV +     +  K+  IL+ + GG+L   +   G   E + R Y  ++I  + H H++
Sbjct: 57  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR 116

Query: 67  GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 126
            V +RDLKP N+LLD +G++++SD GL+    +  +  H + GT  Y+APEVL       
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGTAYD 174

Query: 127 SAADVWSCGVILFVLMAGYLPFGE---TDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           S+AD +S G +LF L+ G+ PF +    D   + +         P  FS    SL+  +L
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLL 234

Query: 184 DPNPKTRIRIEG-----IRKHPWFR 203
             +   R+   G     +++H +F+
Sbjct: 235 QRDVSKRLGCLGRGAQEVKEHVFFK 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 95.8 bits (238), Expect = 6e-22
 Identities = 59/201 (29%), Positives = 90/201 (44%), Gaps = 49/201 (24%)

Query: 9   IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 68
           +V+L+     +  +Y +++++ GG++   ++      E   R Y  +L  A+   H  G 
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122

Query: 69  YHRDLKPENLLLDSYGNLKVSDFGL----------------SALPQQGVE---------- 102
            HRD+KP+N+L+D  G++K++DFGL                S + Q  +E          
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 103 ---------------------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVL 141
                                L H+  GTPNY+APEVL  +GY     D WS GVILF +
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEM 241

Query: 142 MAGYLPF-GETDLPTLYKKIN 161
           + G  PF   T   T  K IN
Sbjct: 242 LVGQPPFLAPTPTETQLKVIN 262

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 94.7 bits (235), Expect = 7e-22
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 13/207 (6%)

Query: 9   IVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKG 67
           I  LH        +Y+++++  GG+L   +   + RL E+  R Y  +++ A+   H   
Sbjct: 63  ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122

Query: 68  VYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLS----NR 122
             HRD+KP+N+L+D  G+++++DFG    L + G        GTP+Y++PE+L      +
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182

Query: 123 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI--NAAEFSCPFW---FSTGATS 177
           G  G   D WS GV ++ ++ G  PF    L   Y KI  +   F  P      S  A  
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKD 242

Query: 178 LIHKILDPNPKT--RIRIEGIRKHPWF 202
           LI +++        +  IE  ++HP+F
Sbjct: 243 LIRRLICSREHRLGQNGIEDFKQHPFF 269

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 93.4 bits (233), Expect = 7e-22
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 9/176 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M+ + HPN+V+L  V      +YI++E++ GG+L   +  ++ +L  +D   +  Q+   
Sbjct: 55  MRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARG 114

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 118
           + +  SK   HRDL   N L+     +K+SDFGLS                P  ++APE 
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPES 174

Query: 119 LSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINAAEF-----SCP 168
           L    +  S +DVWS GV+L+ +   G  P+       + + +          +CP
Sbjct: 175 LKEGKF-TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCP 229

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 93.9 bits (233), Expect = 7e-22
 Identities = 48/148 (32%), Positives = 87/148 (58%), Gaps = 2/148 (1%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M+   H N+V ++       ++++++EF+ GG L D + H  R+ E         ++ A+
Sbjct: 73  MRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIATVCLSVLRAL 131

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           ++ H++GV HRD+K +++LL S G +K+SDFG  A   + V    +  GTP ++APEV+S
Sbjct: 132 SYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVIS 191

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPF 148
              Y G+  D+WS G+++  ++ G  P+
Sbjct: 192 RLPY-GTEVDIWSLGIMVIEMIDGEPPY 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 93.1 bits (232), Expect = 1e-21
 Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 16/217 (7%)

Query: 5   RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 64
           R P I + +      +K++II+E+  GG   D ++  G+L E       ++++  + + H
Sbjct: 57  RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLH 115

Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 124
            +G  HRD+K  N+LL   G++K++DFG+S      +   +T  GTP ++APEV+   GY
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGY 175

Query: 125 DGSAADVWSCGVILFVLMAGYLPFGETD-------LPTLY-KKINAAEFSCPFWFSTGAT 176
           D   AD+WS G+    L  G  P  +         +P      +   +FS PF       
Sbjct: 176 D-EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPF------K 228

Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 213
             +   L+ +PK R   + + KH + +K       + 
Sbjct: 229 DFVSLCLNKDPKERPSAKELLKHKFIKKAKKTSYLTL 265

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 93.2 bits (231), Expect = 1e-21
 Identities = 65/215 (30%), Positives = 109/215 (50%), Gaps = 11/215 (5%)

Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCH 64
           HPNIV+L +       ++I++EF  GG +   ++   R L E   R   +Q ++A+ + H
Sbjct: 61  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120

Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL----- 119
              + HRDLK  N+L    G++K++DFG+SA   + ++   +  GTP ++APEV+     
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180

Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGAT 176
            +R YD   ADVWS G+ L  +     P  E +   +  KI  +E    + P  +S+   
Sbjct: 181 KDRPYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFK 239

Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWFRKNYN-PVK 210
             + K L+ N   R     + +HP+   N N P++
Sbjct: 240 DFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPIR 274

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 92.0 bits (229), Expect = 2e-21
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 26/217 (11%)

Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI--VHQGRLLENDCRRYFQQLIDAVA 61
              P IV  +    +   + I +E++ GG L DKI    QGR+ E    +    ++  + 
Sbjct: 56  CNSPYIVGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLT 114

Query: 62  HCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           + H K  + HRD+KP N+L++S G +K+ DFG+S   Q    L  T  GT +Y+APE + 
Sbjct: 115 YLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSG--QLVNSLAKTFVGTSSYMAPERIQ 172

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFG------ETDLPTLYKKIN-------AAEFSC 167
              Y    +D+WS G+ L  L  G  P+       +     L   +N       + +FS 
Sbjct: 173 GNDYSVK-SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSP 231

Query: 168 PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
            F         ++  L  +P+ R   + + +HP+ +K
Sbjct: 232 DF------QDFVNLCLIKDPRERPSYKELLEHPFIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 92.5 bits (230), Expect = 2e-21
 Identities = 58/203 (28%), Positives = 104/203 (51%), Gaps = 11/203 (5%)

Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           PNI + +       +++II+E+  GG +   ++  G + E       ++++ A+ + H  
Sbjct: 62  PNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKV 120

Query: 67  GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-RGYD 125
           GV HRD+K  N+L+ + GN+K+ DFG++AL  Q      T  GTP ++APEV++  + YD
Sbjct: 121 GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYD 180

Query: 126 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP-----FWFSTGATSLIH 180
            + AD+WS G+ ++ +  G  P+ + D    ++ +     S P       +S      + 
Sbjct: 181 -TKADIWSLGITIYEMATGNPPYSDVD---AFRAMMLIPKSKPPRLEDNGYSKLLREFVA 236

Query: 181 KILDPNPKTRIRIEGIRKHPWFR 203
             LD  PK R+  E + K  W +
Sbjct: 237 ACLDEEPKERLSAEELLKSKWIK 259

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 92.5 bits (230), Expect = 4e-21
 Identities = 65/209 (31%), Positives = 106/209 (50%), Gaps = 17/209 (8%)

Query: 9   IVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKG 67
           I  LH        +Y+++++  GG+L   +   + RL E+  R Y  +++ A+   H  G
Sbjct: 63  ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122

Query: 68  VYHRDLKPENLLLDSYGNLKVSDFG--LSALPQQGVELLHTTCGTPNYVAPEVL----SN 121
             HRD+KP+N+LLD  G+++++DFG  L  L    V+      GTP+Y++PE+L      
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSN-VAVGTPDYISPEILQAMEDG 181

Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW---FSTGAT 176
           +G  G   D WS GV ++ ++ G  PF    L   Y KI   +  F  P      S  A 
Sbjct: 182 KGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAK 241

Query: 177 SLIHKILDPNPKTRIRIEGI---RKHPWF 202
            LI +++   P+TR+   G+   + HP+F
Sbjct: 242 DLIRRLICS-PETRLGRNGLQDFKDHPFF 269

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 91.6 bits (227), Expect = 5e-21
 Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 15/216 (6%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M+  +H N+V ++       ++++++EF+ GG L D + H  R+ E         ++ A+
Sbjct: 71  MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLKAL 129

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           +  H++GV HRD+K +++LL   G +K+SDFG  A   + V    +  GTP ++APE++S
Sbjct: 130 SVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELIS 189

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLP-FGETDLP-------TLYKKINAAEFSCPFWFS 172
              Y G   D+WS G+++  ++ G  P F E  L         L  K+       P    
Sbjct: 190 RLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPS--- 245

Query: 173 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 208
                 + ++L  +P  R     + KHP+  K   P
Sbjct: 246 --LKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 92.4 bits (229), Expect = 5e-21
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 13/207 (6%)

Query: 9   IVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKG 67
           I  LH        +Y+++++  GG+L   +   + RL E+  R Y  +++ A+   H   
Sbjct: 63  ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122

Query: 68  VYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLS----NR 122
             HRD+KP+N+LLD  G+++++DFG    + Q G        GTP+Y++PE+L       
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182

Query: 123 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFWF---STGATS 177
           G  G   D WS GV ++ ++ G  PF    L   Y KI   E  F  P      S  A  
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKD 242

Query: 178 LIHKILDPNPKT--RIRIEGIRKHPWF 202
           LI +++    +   +  IE  +KH +F
Sbjct: 243 LIQRLICSRERRLGQNGIEDFKKHAFF 269

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 91.3 bits (227), Expect = 5e-21
 Identities = 53/160 (33%), Positives = 85/160 (53%), Gaps = 3/160 (1%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K +RH N+V L EV   + ++Y++ EFV    L D   +   L E+  R+Y  Q++  +
Sbjct: 54  LKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGI 113

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
             CHS  + HRD+KPEN+L+   G +K+ DFG +       E+      T  Y APE+L 
Sbjct: 114 EFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLV 173

Query: 121 NRGYDGSAADVWSCGVILFVLMAG--YLPFGETDLPTLYK 158
                G A D+W+ G ++  ++ G    P G++D+  LY 
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTGEPLFP-GDSDIDQLYH 212

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 91.4 bits (227), Expect = 6e-21
 Identities = 59/214 (27%), Positives = 104/214 (48%), Gaps = 17/214 (7%)

Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVA 61
           V    +V L     ++  + ++L  + GG+L   I + G     E     Y  ++   + 
Sbjct: 57  VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLE 116

Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 121
             H + + +RDLKPEN+LLD YG++++SD GL+    +G E +    GT  Y+APEV+ N
Sbjct: 117 DLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-ETIRGRVGTVGYMAPEVVKN 175

Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI------NAAEFSCPFWFSTGA 175
             Y   + D W  G +++ ++ G  PF +       +++      +  E+S    FS  A
Sbjct: 176 ERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK--FSEAA 232

Query: 176 TSLIHKILDPNPKTRI-----RIEGIRKHPWFRK 204
            S+  ++L  +P  R+       E ++ HP+FR 
Sbjct: 233 RSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 93.5 bits (232), Expect = 6e-21
 Identities = 66/197 (33%), Positives = 99/197 (50%), Gaps = 16/197 (8%)

Query: 5   RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLIDAV 60
            H  IV+  +   S  K+ +I+E+ +GG+L  +I  + +      E +    F Q++ A+
Sbjct: 123 DHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLAL 182

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL--LHTTCGTPNYVAPEV 118
              HS+ + HRDLK  N+ L   G +K+ DFG S      V L    + CGTP Y+APE+
Sbjct: 183 DEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPEL 242

Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFG-----ETDLPTLYKKINAAEFSCPFWFST 173
              + Y    AD+WS GVIL+ L+  + PF      E     LY K +   F CP   S+
Sbjct: 243 WERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP--FPCP--VSS 297

Query: 174 GATSLIHKILDPNPKTR 190
           G  +L+  +L  NP  R
Sbjct: 298 GMKALLDPLLSKNPALR 314

Length = 478

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 90.3 bits (224), Expect = 7e-21
 Identities = 64/211 (30%), Positives = 104/211 (49%), Gaps = 23/211 (10%)

Query: 3   IVRH--PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           I+ H  PN+V LH+ + S   V+++L+   GG+L+  I     + E   +R+  +++ A+
Sbjct: 39  IIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVAL 98

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPE 117
              H +G+  RDL P N+LLD  G+++++ F       +  E+  +  G      Y APE
Sbjct: 99  DALHREGIVCRDLNPNNILLDDRGHIQLTYFS------RWSEVEDSCDGEAVENMYCAPE 152

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA-AEFSCPFWFSTGAT 176
           V      +  A D WS G ILF L+      G+T +      IN     + P W S  A 
Sbjct: 153 V-GGISEETEACDWWSLGAILFELLT-----GKTLVECHPSGINTHTTLNIPEWVSEEAR 206

Query: 177 SLIHKILDPNPKTRI-----RIEGIRKHPWF 202
           SL+ ++L  NP  R+      +E I+ HP+F
Sbjct: 207 SLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|213376 cd12120, AMPKA_C_like, C-terminal regulatory domain of 5'-AMP-activated protein kinase (AMPK) alpha subunit and similar domains

 Score = 85.7 bits (212), Expect = 8e-21
 Identities = 26/94 (27%), Positives = 34/94 (36%), Gaps = 4/94 (4%)

Query: 273 VKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTR--NYKTRLEGV--SANKTGQFAVVLE 328
            K +    SR     I   I  V E     +  R  N+    + V             +E
Sbjct: 2   KKWELEIHSRIDPSEIYEGIHKVLEGWGKNLVFRITNFIITGKLVNDHILFLRSTLFEIE 61

Query: 329 VFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKL 362
           V+EV P LFMVD +K  G T  + K       KL
Sbjct: 62  VYEVGPGLFMVDFKKKTGSTKTFTKLATKIQIKL 95

This family is composed of AMPKs, microtubule-associated protein/microtubule affinity regulating kinases (MARKs), yeast Kcc4p-like proteins, plant calcineurin B-Like (CBL)-interacting protein kinases (CIPKs), and similar proteins. They are serine/threonine protein kinases (STKs) that catalyze the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. AMPKs act as sensors for the energy status of the cell and are activated by cellular stresses that lead to ATP depletion such as hypoxia, heat shock, and glucose deprivation, among others. MARKs phosphorylate the tau protein and related microtubule-associated proteins (MAPs) on tubulin binding sites to induce detachment from microtubules, and are involved in the regulation of cell shape and polarity, cell cycle control, transport, and the cytoskeleton. Kcc4p and related proteins are septin-associated proteins that are involved in septin organization and in the yeast morphogenesis checkpoint coordinating the cell cycle with bud formation. CIPKs interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. All members of this family contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain which is also called kinase associated domain 1 (KA1) in some cases. The C-terminal regulatory domain serves as a protein interaction domain in AMPKs and CIPKs. In MARKs and Kcc4p-like proteins, this domain binds phospholipids and may be involved in membrane localization. Length = 95

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 90.9 bits (225), Expect = 1e-20
 Identities = 63/210 (30%), Positives = 110/210 (52%), Gaps = 19/210 (9%)

Query: 9   IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF--QQLIDAVAHCHSK 66
           +V L     ++  + ++L  + GG+L   I H G     + R  F   ++   +   H +
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121

Query: 67  GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 126
            + +RDLKPEN+LLD +G++++SD GL+    +G + +    GT  Y+APEV+ N  Y  
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKNERYTF 180

Query: 127 SAADVWSCGVILFVLMAGYLPFGE-------TDLPTLYKKINAAEFSCPFWFSTGATSLI 179
           S  D W+ G +L+ ++AG  PF +        ++  L K++   E+S    FS  A SL 
Sbjct: 181 S-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ-EEYSEK--FSPDARSLC 236

Query: 180 HKILDPNPKTRIRIEG-----IRKHPWFRK 204
             +L  +PK R+  +G     +++HP F++
Sbjct: 237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 89.9 bits (224), Expect = 1e-20
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 10/177 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYF-QQLID 58
           M+ + HPNIV+L  V      + I++E++ GG+L D +  ++ + L       F  Q+  
Sbjct: 55  MRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIAR 114

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
            + +  SK   HRDL   N L+     +K+SDFGLS                P  ++APE
Sbjct: 115 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPE 174

Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINAAEF-----SCP 168
            L    +  S +DVWS GV+L+ +   G  P+       + + +          +CP
Sbjct: 175 SLKEGKF-TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCP 230

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 90.6 bits (225), Expect = 1e-20
 Identities = 70/251 (27%), Positives = 106/251 (42%), Gaps = 56/251 (22%)

Query: 1   MKIVR---HPNIVRLHEVLASRTKV----------YIILEFVTG---GELFDKIVHQGRL 44
           +KI+R   H NIV L E++  +             Y++ E++     G L   +VH    
Sbjct: 57  IKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---F 113

Query: 45  LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 104
            E+  + + +QL++ + +CH K   HRD+K  N+LL++ G +K++DFGL+ L        
Sbjct: 114 SEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173

Query: 105 HTT-CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVL---------------------M 142
           +T    T  Y  PE+L      G A DVWSCG IL  L                     +
Sbjct: 174 YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRL 233

Query: 143 AGY-----------LPFGETDLPT-LYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTR 190
            G            LP+  T  P   Y++    EFS   +  T A  L+  +L  +P  R
Sbjct: 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS---FIPTPALDLLDHMLTLDPSKR 290

Query: 191 IRIEGIRKHPW 201
              E     PW
Sbjct: 291 CTAEEALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 89.2 bits (222), Expect = 2e-20
 Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 2/151 (1%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           +K    P IV+ +      T ++I++E+   G + D + +    L E +      Q +  
Sbjct: 52  LKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKG 111

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 119
           + + HS    HRD+K  N+LL+  G  K++DFG+S      +   +T  GTP ++APEV+
Sbjct: 112 LEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVI 171

Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGE 150
              GY+ + AD+WS G+    +  G  P+ +
Sbjct: 172 QEIGYN-NKADIWSLGITAIEMAEGKPPYSD 201

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 89.5 bits (222), Expect = 3e-20
 Identities = 56/165 (33%), Positives = 88/165 (53%), Gaps = 11/165 (6%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGEL-FDKIVHQGRLLENDCR---RYFQQL 56
           +K ++H NIVRL +V+ S  ++Y++ E++   +L   K +        + R    Y  Q+
Sbjct: 55  LKEMQHGNIVRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQI 111

Query: 57  IDAVAHCHSKGVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYVA 115
           +  +A+CHS  V HRDLKP+NLL+D   N LK++DFGL+      V        T  Y A
Sbjct: 112 LRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRA 171

Query: 116 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYK 158
           PE+L    +  +  D+WS G I F  M    P   G++++  L+K
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCI-FAEMVNQKPLFPGDSEIDELFK 215

Length = 294

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 89.6 bits (222), Expect = 3e-20
 Identities = 59/208 (28%), Positives = 107/208 (51%), Gaps = 9/208 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M+  +HPNIV   +      ++++++E++ GG L D +V +  + E       ++ + A+
Sbjct: 70  MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQAL 128

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA--LPQQGVELLHTTCGTPNYVAPEV 118
              HS  V HRD+K +N+LL   G++K++DFG  A   P+Q      T  GTP ++APEV
Sbjct: 129 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEV 186

Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLY--KKINAAEFSCPFWFSTGA 175
           ++ + Y G   D+WS G++   ++ G  P+  E  L  LY        E   P   S   
Sbjct: 187 VTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 245

Query: 176 TSLIHKILDPNPKTRIRIEGIRKHPWFR 203
              +++ L+ + + R   + + +HP+ +
Sbjct: 246 RDFLNRCLEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 89.4 bits (221), Expect = 4e-20
 Identities = 58/208 (27%), Positives = 108/208 (51%), Gaps = 9/208 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MK +++PNIV   +      ++++++E++ GG L D +V +  + E       ++ + A+
Sbjct: 70  MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQAL 128

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA--LPQQGVELLHTTCGTPNYVAPEV 118
              H+  V HRD+K +N+LL   G++K++DFG  A   P+Q      T  GTP ++APEV
Sbjct: 129 EFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEV 186

Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLY--KKINAAEFSCPFWFSTGA 175
           ++ + Y G   D+WS G++   ++ G  P+  E  L  LY        E   P   S   
Sbjct: 187 VTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIF 245

Query: 176 TSLIHKILDPNPKTRIRIEGIRKHPWFR 203
              +++ L+ + + R   + + +HP+ +
Sbjct: 246 RDFLNRCLEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 87.6 bits (218), Expect = 8e-20
 Identities = 53/218 (24%), Positives = 88/218 (40%), Gaps = 26/218 (11%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF------- 53
           MK + HPN+VRL  V      +Y++LE++ GG+L         L ++             
Sbjct: 50  MKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDL------LDYLRKSRPVFPSPEKSTLS 103

Query: 54  -QQLID-------AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH 105
            + L+         + +  SK   HRDL   N L+     +K+SDFGLS           
Sbjct: 104 LKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRK 163

Query: 106 TTCG-TPN-YVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINA 162
            T G  P  ++APE L +  +  S +DVWS GV+L+ +   G  P+       + + +  
Sbjct: 164 KTGGKLPIRWMAPESLKDGIFT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK 222

Query: 163 AEF-SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH 199
                 P +       L+      +P+ R     + + 
Sbjct: 223 GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 89.9 bits (223), Expect = 1e-19
 Identities = 61/198 (30%), Positives = 100/198 (50%), Gaps = 16/198 (8%)

Query: 8   NIVRLHEVLASRTK--------VYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQ 55
           +IV+ HE  A +          + ++L++   G+L  +I  + +      E++    F Q
Sbjct: 92  SIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ 151

Query: 56  LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNY 113
           ++ AV H HSK + HRD+K  N+LL S G +K+ DFG S +    V  ++  T CGTP Y
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211

Query: 114 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CPFWFS 172
           VAPE+   + Y    AD++S GV+L+ L+    PF   ++  +  K  A  +   P   S
Sbjct: 212 VAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSIS 270

Query: 173 TGATSLIHKILDPNPKTR 190
                ++  +L  +PK R
Sbjct: 271 PEMQEIVTALLSSDPKRR 288

Length = 496

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 87.2 bits (216), Expect = 1e-19
 Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 16/212 (7%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++H NIV+          + I LE+V GG +   + + G   E   R + +Q++  +
Sbjct: 60  LKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGL 119

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGT--PN---- 112
            + H++G+ HRD+K  N+L+D+ G +K+SDFG+S    + +E   L T      P+    
Sbjct: 120 NYLHNRGIIHRDIKGANILVDNKGGIKISDFGIS----KKLEANSLSTKTNGARPSLQGS 175

Query: 113 --YVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPF 169
             ++APEV+    Y    AD+WS G ++  ++ G  PF + T L  ++K    A    P 
Sbjct: 176 VFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPS 234

Query: 170 WFSTGATSLIHKILDPNPKTRIRIEGIRKHPW 201
             S+ A   + K  + +   R     + KHP+
Sbjct: 235 NISSEAIDFLEKTFEIDHNKRPTAAELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 68/262 (25%), Positives = 108/262 (41%), Gaps = 70/262 (26%)

Query: 4   VRHPNIVRLHEVLASR--TKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRY-------- 52
           +RHPNIV L EV+  +    +++++E+                LL+N    +        
Sbjct: 63  LRHPNIVELKEVVVGKHLDSIFLVMEYCE---------QDLASLLDNMPTPFSESQVKCL 113

Query: 53  FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS---ALPQQGVELLHTTCG 109
             QL+  + + H   + HRDLK  NLLL   G LK++DFGL+    LP + +        
Sbjct: 114 MLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM-------- 165

Query: 110 TPN-----YVAPEVLSNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDL--------- 153
           TP      Y APE+L       +A D+W+ G IL  L+A    LP G++++         
Sbjct: 166 TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP-GKSEIEQLDLIIQL 224

Query: 154 ---------PTLYKKINAAEFSCP----------F-WFSTGATSLIHKILDPNPKTRIRI 193
                    P         +F+ P          F W S     L++ +L  +PK R   
Sbjct: 225 LGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATA 284

Query: 194 EGIRKHPWFRKNYNPVKCSEEE 215
           E   +  +F++   P+ C  E 
Sbjct: 285 EEALESSYFKE--KPLPCEPEM 304

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 87.1 bits (215), Expect = 2e-19
 Identities = 58/208 (27%), Positives = 106/208 (50%), Gaps = 9/208 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M+  ++PNIV   +      ++++++E++ GG L D +V +  + E       ++ + A+
Sbjct: 70  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQAL 128

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA--LPQQGVELLHTTCGTPNYVAPEV 118
              HS  V HRD+K +N+LL   G++K++DFG  A   P+Q      T  GTP ++APEV
Sbjct: 129 DFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEV 186

Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLY--KKINAAEFSCPFWFSTGA 175
           ++ + Y G   D+WS G++   ++ G  P+  E  L  LY        E   P   S   
Sbjct: 187 VTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVF 245

Query: 176 TSLIHKILDPNPKTRIRIEGIRKHPWFR 203
              +++ L+ +   R   + + +HP+ +
Sbjct: 246 RDFLNRCLEMDVDRRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 87.0 bits (215), Expect = 2e-19
 Identities = 56/161 (34%), Positives = 82/161 (50%), Gaps = 7/161 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           ++ ++  NIV L E    R K+Y++ E+V     EL ++      +     R Y  QLI 
Sbjct: 54  LRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEE--MPNGVPPEKVRSYIYQLIK 111

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPE 117
           A+  CH   + HRD+KPENLL+     LK+ DFG +    +G    +T    T  Y +PE
Sbjct: 112 AIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLY 157
           +L    Y G A D+WS G IL  L  G   F GE+++  L+
Sbjct: 172 LLLGAPY-GKAVDMWSVGCILGELSDGQPLFPGESEIDQLF 211

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 86.2 bits (214), Expect = 3e-19
 Identities = 57/224 (25%), Positives = 102/224 (45%), Gaps = 39/224 (17%)

Query: 6   HPNIVRLHEV------LASRTKVYIILEFVTGG---ELFDKIVHQGRLLENDCRRYF-QQ 55
           HPNI   +          +  ++++++E   GG   +L   +  +G+ L+ +   Y  ++
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 56  LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVA 115
            +  +A+ H   V HRD+K +N+LL     +K+ DFG+SA     +   +T  GTP ++A
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMA 181

Query: 116 PEVLS-----NRGYDGSAADVWSCGVILFVLMAGYLPFGE------------TDLPTLYK 158
           PEV++     +  YD + +DVWS G+    L  G  P  +               PTL  
Sbjct: 182 PEVIACDEQPDASYD-ARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKS 240

Query: 159 KIN-AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPW 201
             N + +F+            I + L  N + R  +E + +HP+
Sbjct: 241 PENWSKKFN----------DFISECLIKNYEQRPFMEELLEHPF 274

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 87.0 bits (216), Expect = 4e-19
 Identities = 80/256 (31%), Positives = 120/256 (46%), Gaps = 56/256 (21%)

Query: 1   MKIVR---HPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRY 52
           +KI+R   H NI+ + +++   +      VYI+ E +   +L+  I  Q   L ND  +Y
Sbjct: 54  IKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQH--LSNDHIQY 110

Query: 53  F-QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL--SALPQQGVELLHTT-- 107
           F  Q++  + + HS  V HRDLKP NLLL++  +LK+ DFGL   A P+      HT   
Sbjct: 111 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD----HTGFL 166

Query: 108 ---CGTPNYVAPEV-LSNRGYDGSAADVWSCGVILFVLMAG--------Y-----LPFGE 150
                T  Y APE+ L+++GY   A D+WS G IL  +++         Y     L  G 
Sbjct: 167 TEYVATRWYRAPEIMLNSKGYT-KAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGV 225

Query: 151 TDLPT---LYKKIN--AAEF--SCPF-----W------FSTGATSLIHKILDPNPKTRIR 192
              P+   L   I+  A  +  S PF     W          A  L+ K+L  NP  RI 
Sbjct: 226 LGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRIT 285

Query: 193 IEGIRKHPWFRKNYNP 208
           +E    HP+  + ++P
Sbjct: 286 VEEALAHPYLEQYHDP 301

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 85.4 bits (211), Expect = 7e-19
 Identities = 50/150 (33%), Positives = 80/150 (53%), Gaps = 4/150 (2%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLE-NDCRRYFQQLID 58
           ++ V  P IV L     S+T + +++  + GG+L   I + G R LE      Y  Q+  
Sbjct: 47  LEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITC 106

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            + H HS  + +RD+KPEN+LLD  GN ++SD GL A+  +  + +    GT  Y+APE+
Sbjct: 107 GILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGL-AVELKDGKTITQRAGTNGYMAPEI 165

Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF 148
           L    Y     D ++ G  ++ ++AG  PF
Sbjct: 166 LKEEPYSYP-VDWFAMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 84.3 bits (208), Expect = 1e-18
 Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 7/208 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MK  +H NIV        R K++I +EF  GG L D     G L E+      ++ +  +
Sbjct: 60  MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGL 119

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV-- 118
            + HSKG  HRD+K  N+LL   G++K++DFG+SA     +    +  GTP ++APEV  
Sbjct: 120 YYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAA 179

Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP-----FWFST 173
           +  +G      D+W+ G+    L     P  +         +  + F  P       +S 
Sbjct: 180 VERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSN 239

Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPW 201
                +   L  NPK R   E + +HP+
Sbjct: 240 SFHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 84.0 bits (207), Expect = 2e-18
 Identities = 58/208 (27%), Positives = 106/208 (50%), Gaps = 9/208 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M+  ++PNIV   +      ++++++E++ GG L D +V +  + E       ++ + A+
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQAL 129

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA--LPQQGVELLHTTCGTPNYVAPEV 118
              HS  V HRD+K +N+LL   G++K++DFG  A   P+Q      T  GTP ++APEV
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEV 187

Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLY--KKINAAEFSCPFWFSTGA 175
           ++ + Y G   D+WS G++   ++ G  P+  E  L  LY        E   P   S   
Sbjct: 188 VTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246

Query: 176 TSLIHKILDPNPKTRIRIEGIRKHPWFR 203
              +++ LD + + R   + + +H + +
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELLQHQFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 83.6 bits (206), Expect = 3e-18
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 7/202 (3%)

Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P + + +      TK++II+E++ GG   D ++  G   E       ++++  + + HS+
Sbjct: 62  PYVTKYYGSYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSE 120

Query: 67  GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 126
              HRD+K  N+LL   G++K++DFG++          +T  GTP ++APEV+    YD 
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYD- 179

Query: 127 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFW---FSTGATSLIHKIL 183
           S AD+WS G+    L  G  P   +D+  +       + + P     FS      I   L
Sbjct: 180 SKADIWSLGITAIELAKGEPP--NSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACL 237

Query: 184 DPNPKTRIRIEGIRKHPWFRKN 205
           + +P  R   + + KH +  KN
Sbjct: 238 NKDPSFRPTAKELLKHKFIVKN 259

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 50/161 (31%), Positives = 83/161 (51%), Gaps = 1/161 (0%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++H NIV LH+++ ++  +  + E++        I H G L   + R +  QL+  +
Sbjct: 57  LKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGL 116

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           A+ H + + HRDLKP+NLL+   G LK++DFGL+       +   +   T  Y  P+VL 
Sbjct: 117 AYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLL 176

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKI 160
                 SA D+W  G I   ++ G   F G +D+    +KI
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKI 217

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 83.7 bits (207), Expect = 4e-18
 Identities = 70/238 (29%), Positives = 100/238 (42%), Gaps = 46/238 (19%)

Query: 7   PNIVRLHEVLASRTK-----VYIILEFVTGGELFDKIVHQGR-----LLENDCRRYFQQL 56
             IVRL +V     K     +Y++ E++   +L   +   GR     L     + +  QL
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 57  IDAVAHCHSKGVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYVA 115
           +  VAHCH  GV HRDLKP+NLL+D     LK++D GL       V+       T  Y A
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRA 179

Query: 116 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDL------------------PT 155
           PEVL    +  +  D+WS G I F  M+   P   G+++L                  P 
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCI-FAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG 238

Query: 156 LYKKINAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 202
           + K  +  EF  P W            S     L+ K+L  +P  RI  +    HP+F
Sbjct: 239 VSKLRDWHEF--PQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 84.3 bits (209), Expect = 4e-18
 Identities = 67/247 (27%), Positives = 104/247 (42%), Gaps = 47/247 (19%)

Query: 5   RHPNIVRLHEVLASRTK-----VYIILEFVTGGELFDKIVHQ----GRLLEND-CRRYFQ 54
            H N++ + +++    +     VYI+ E      L D  +HQ     + L +D C+ +  
Sbjct: 62  DHENVIAIKDIMPPPHREAFNDVYIVYE------LMDTDLHQIIRSSQTLSDDHCQYFLY 115

Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           QL+  + + HS  V HRDLKP NLLL++  +LK+ DFGL+    +  + +     T  Y 
Sbjct: 116 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYR 175

Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI-------------- 160
           APE+L N     +A DVWS G I   L+     F   D     K I              
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235

Query: 161 ----NAAEF--SCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
                A  +  S P+             +  A  L+ K+L  +P  RI +E    HP+  
Sbjct: 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295

Query: 204 KNYNPVK 210
             ++P  
Sbjct: 296 SLHDPSD 302

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 83.0 bits (206), Expect = 4e-18
 Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 21/208 (10%)

Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           +PN ++L+  + +     +I++++  G+LFD +  +G+L E + ++  +QL++A+   H 
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127

Query: 66  KGVYHRDLKPENLLLDSY-GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 124
             + H D+K EN+L D     + + D+GL  +   G    +   GT +Y +PE +    Y
Sbjct: 128 HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI--IGTPSCYD--GTLDYFSPEKIKGHNY 183

Query: 125 DGSAADVWSCGVILFVLMAGYLPFGETD---------LPTLYKKINAAEFSCPFWFSTGA 175
           D S  D W+ GV+ + L+ G  PF E +         L    KK+   +       S  A
Sbjct: 184 DVS-FDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNV-----SKNA 237

Query: 176 TSLIHKILDPNPKTR-IRIEGIRKHPWF 202
              +  +L  N   R      I KHP+ 
Sbjct: 238 NDFVQSMLKYNINYRLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 83.1 bits (206), Expect = 4e-18
 Identities = 50/144 (34%), Positives = 70/144 (48%), Gaps = 12/144 (8%)

Query: 6   HPNIVRLHEVLA-----SRTKVYIILEFVTG--GELFDKIVHQGRLLENDCRRYFQQLID 58
           HPNIVRL +V          K+ ++ E V         K    G L     +   +QL+ 
Sbjct: 60  HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLMRQLLR 118

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC-GTPNYVAPE 117
            V   HS  + HRDLKP+N+L+ S G +K++DFGL+ +     E+  T+   T  Y APE
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI--YSFEMALTSVVVTLWYRAPE 176

Query: 118 VLSNRGYDGSAADVWSCGVILFVL 141
           VL    Y  +  D+WS G I   L
Sbjct: 177 VLLQSSY-ATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 48/160 (30%), Positives = 80/160 (50%), Gaps = 3/160 (1%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++HPN+V L EV   + K++++ E+     L +   +   + E+  ++   Q + AV
Sbjct: 54  LKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAV 113

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
             CH     HRD+KPEN+L+   G +K+ DFG + +     +       T  Y APE+L 
Sbjct: 114 NFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLV 173

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYK 158
                G   DVW+ G +   L+ G  P   G++D+  LY 
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLTG-QPLWPGKSDVDQLYL 212

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 81.7 bits (201), Expect = 1e-17
 Identities = 46/144 (31%), Positives = 77/144 (53%), Gaps = 2/144 (1%)

Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P + + +      TK++II+E++ GG   D ++  G L E       ++++  + + HS+
Sbjct: 62  PYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSE 120

Query: 67  GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 126
              HRD+K  N+LL  +G +K++DFG++          +T  GTP ++APEV+    YD 
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD- 179

Query: 127 SAADVWSCGVILFVLMAGYLPFGE 150
           S AD+WS G+    L  G  P  E
Sbjct: 180 SKADIWSLGITAIELAKGEPPHSE 203

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 80.9 bits (200), Expect = 2e-17
 Identities = 65/239 (27%), Positives = 110/239 (46%), Gaps = 30/239 (12%)

Query: 1   MKIVRHPNIVRLHE--VLASRTKVYIILEFVTGGEL---FDKIVHQG-RLLENDCRRYFQ 54
            K  + P IV+ +   +  S + + I +E+  GG L   + K+  +G R+ E    +  +
Sbjct: 53  NKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAE 112

Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
            ++  +++ HS+ + HRD+KP N+LL   G +K+ DFG+S   +    L  T  GT  Y+
Sbjct: 113 SVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNSLAGTFTGTSFYM 170

Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF---GETDLP---TLYKKINAAEF--- 165
           APE +  + Y  + +DVWS G+ L  +     PF   GE  L     L   +N       
Sbjct: 171 APERIQGKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELK 229

Query: 166 SCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLD 220
             P     W S      I + L+ +P  R     + +HPW       +K   +++VN+ 
Sbjct: 230 DEPGNGIKW-SEEFKDFIKQCLEKDPTRRPTPWDMLEHPW-------IKAQMKKKVNMA 280

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 80.2 bits (198), Expect = 3e-17
 Identities = 50/144 (34%), Positives = 73/144 (50%), Gaps = 8/144 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K   HPNIV+L  V   +  +YI++E V GG L   +  +   L    ++  Q  +DA 
Sbjct: 46  LKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLT--VKKLLQMSLDAA 103

Query: 61  A---HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVA 115
           A   +  SK   HRDL   N L+     LK+SDFG+S   + G+  +       P  + A
Sbjct: 104 AGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTA 163

Query: 116 PEVLSNRGYDGSAADVWSCGVILF 139
           PE L N G   S +DVWS G++L+
Sbjct: 164 PEAL-NYGRYTSESDVWSYGILLW 186

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 80.4 bits (198), Expect = 4e-17
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 17/208 (8%)

Query: 9   IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF--QQLIDAVAHCHSK 66
           +V L     ++  + ++L  + GG+L   I + G    ++ R  F   +L   +     +
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121

Query: 67  GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 126
            + +RDLKPEN+LLD  G++++SD GL+    +G E +    GT  Y+APEV++N  Y  
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-ETVRGRVGTVGYMAPEVINNEKYTF 180

Query: 127 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI------NAAEFSCPFWFSTGATSLIH 180
           S  D W  G +++ ++ G  PF +       +++      +  E+S    FS  A S+  
Sbjct: 181 S-PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEK--FSEDAKSICR 237

Query: 181 KILDPNPKTRIRIEG-----IRKHPWFR 203
            +L  NPK R+   G     +++HP F+
Sbjct: 238 MLLTKNPKERLGCRGNGAAGVKQHPIFK 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 80.9 bits (199), Expect = 4e-17
 Identities = 60/237 (25%), Positives = 98/237 (41%), Gaps = 37/237 (15%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K ++H NIV LH+++ ++  + ++ E+V     +  DK  H G L   + + +  QL+ 
Sbjct: 57  LKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDK--HPGGLHPENVKLFLFQLLR 114

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +++ H + + HRDLKP+NLL+   G LK++DFGL+               T  Y  P+V
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDV 174

Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF--------------------------GETD 152
           L       +  D+W  G I   ++ G   F                          G   
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234

Query: 153 LP-------TLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 202
           LP       TLY   N  +      +   A  L  K+L   PK R+  +    H +F
Sbjct: 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 80.1 bits (197), Expect = 5e-17
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 15/200 (7%)

Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P I R +      TK++II+E++ GG   D ++  G L E       ++++  + + HS+
Sbjct: 62  PYITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSE 120

Query: 67  GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 126
              HRD+K  N+LL   G++K++DFG++          +T  GTP ++APEV+    YD 
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD- 179

Query: 127 SAADVWSCGVILFVLMAGYLPFGETD-------LPTLYKKINAAEFSCPFWFSTGATSLI 179
             AD+WS G+    L  G  P  +         +P         ++S PF         +
Sbjct: 180 FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPF------KEFV 233

Query: 180 HKILDPNPKTRIRIEGIRKH 199
              L+ +P+ R   + + KH
Sbjct: 234 EACLNKDPRFRPTAKELLKH 253

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 79.9 bits (197), Expect = 5e-17
 Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 22/204 (10%)

Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLL--ENDCRRYFQQLID 58
             ++H NIV+     +      I +E V GG L   +  + G L   E     Y +Q+++
Sbjct: 60  SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE 119

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSY-GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + + H   + HRD+K +N+L+++Y G +K+SDFG S           T  GT  Y+APE
Sbjct: 120 GLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPE 179

Query: 118 VLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFW----- 170
           V+    RGY G+ AD+WS G  +  +  G  PF E   P       AA F    +     
Sbjct: 180 VIDKGPRGY-GAPADIWSLGCTIVEMATGKPPFIELGEP------QAAMFKVGMFKIHPE 232

Query: 171 ----FSTGATSLIHKILDPNPKTR 190
                S  A + I +  +P+P  R
Sbjct: 233 IPESLSAEAKNFILRCFEPDPDKR 256

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 79.3 bits (195), Expect = 7e-17
 Identities = 48/139 (34%), Positives = 76/139 (54%), Gaps = 4/139 (2%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K  +H NIV       SR K++I +E+  GG L D     G L E       ++ +  +
Sbjct: 60  VKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGL 119

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           A+ HSKG  HRD+K  N+LL   G++K++DFG++A     +    +  GTP ++APEV +
Sbjct: 120 AYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAA 179

Query: 121 ---NRGYDGSAADVWSCGV 136
              N GY+    D+W+ G+
Sbjct: 180 VEKNGGYN-QLCDIWAVGI 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 80.2 bits (198), Expect = 9e-17
 Identities = 73/283 (25%), Positives = 112/283 (39%), Gaps = 60/283 (21%)

Query: 1   MKIVR---HPNIVRLHEVLASRTK--------------VYIILEFVTGGELFDKIVHQGR 43
           +KI+R   H NIV+++EVL                   VYI+ E++        ++ QG 
Sbjct: 53  IKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGP 110

Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-NLKVSDFGLSALPQQGVE 102
           L E   R +  QL+  + + HS  V HRDLKP N+ +++    LK+ DFGL+ +      
Sbjct: 111 LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYS 170

Query: 103 ---LLHTTCGTPNYVAPE-VLSNRGYDGSAADVWSCGVILFVLMAGYLPFG--------- 149
               L     T  Y +P  +LS   Y   A D+W+ G I   ++ G   F          
Sbjct: 171 HKGYLSEGLVTKWYRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229

Query: 150 ----------ETDLPTLYKKI------NAAEFSCPFW-----FSTGATSLIHKILDPNPK 188
                     E D   L   I      +  E   P        +  A   + +IL  NP 
Sbjct: 230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPM 289

Query: 189 TRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIED 231
            R+  E    HP+         C  +E V+L   H + D+++D
Sbjct: 290 DRLTAEEALMHPYMS----CYSCPFDEPVSLHPFH-IEDELDD 327

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 54/162 (33%), Positives = 80/162 (49%), Gaps = 19/162 (11%)

Query: 1   MKIVRHPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQ--GRLLENDCRRY 52
           MK+V H NI+ L  V   +        VY+++E      L D  + Q     L+++   Y
Sbjct: 69  MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVME------LMDANLCQVIQMDLDHERMSY 122

Query: 53  F-QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGT 110
              Q++  + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T
Sbjct: 123 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVT 180

Query: 111 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
             Y APEV+   GY     D+WS G I+  ++ G + F  TD
Sbjct: 181 RYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTD 221

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 78.7 bits (194), Expect = 1e-16
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 15/215 (6%)

Query: 7   PNIVRLHEVLASRTKVYIILEFVTGG---ELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           P IV  +        VY+ +E++  G   +L+   V    + E+  RR    ++  +   
Sbjct: 59  PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118

Query: 64  HSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 122
             +  + HRD+KP N+L++  G +K+ DFG+S        L  T  G  +Y+APE + + 
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTNIGCQSYMAPERIKSG 176

Query: 123 GYDGSA-----ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA----AEFSCPFWFST 173
           G + +      +DVWS G+ +  +  G  P+       ++ +++A       + P  +S 
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSD 236

Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 208
            A   + K L+  P  R     + +HPW  K  N 
Sbjct: 237 DAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 78.1 bits (192), Expect = 2e-16
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 15/207 (7%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA- 59
           +K   HPNIV+L  V   R  +YI++E V GG+    +  +   L+   ++  +  +DA 
Sbjct: 46  LKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKT--KQLVKFALDAA 103

Query: 60  --VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN----Y 113
             +A+  SK   HRDL   N L+     LK+SDFG+S     G+   +++ G       +
Sbjct: 104 AGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI---YSSSGLKQIPIKW 160

Query: 114 VAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKINAAEFSCPFWF 171
            APE L N G   S +DVWS G++L+   + G  P+ G T+     +       SCP   
Sbjct: 161 TAPEAL-NYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKC 219

Query: 172 STGATSLIHKILDPNPKTRIRIEGIRK 198
                 ++ +  D  P+ R +   ++K
Sbjct: 220 PDDVYKVMQRCWDYKPENRPKFSELQK 246

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 60/245 (24%), Positives = 105/245 (42%), Gaps = 42/245 (17%)

Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K + H N++ L +V      L     VY++   + G +L + IV   +L ++  +    
Sbjct: 68  LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVY 125

Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS G+ HRDLKP N+ ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 126 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 182

Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKK 159
           APE++ N  +     D+WS G I+  L+ G   F  +D                  L +K
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242

Query: 160 INAAE---------------FSCPF-WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
           I++                 F   F   +  A  L+ K+L  +P  RI       HP+  
Sbjct: 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA 302

Query: 204 KNYNP 208
           + ++P
Sbjct: 303 EYHDP 307

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 44/150 (29%), Positives = 80/150 (53%), Gaps = 12/150 (8%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-----GRLLE-NDCRRYFQ 54
           +K ++H NIV LH+++ +   + ++ E++      DK + Q     G ++  ++ + +  
Sbjct: 58  LKDLKHANIVTLHDIVHTDKSLTLVFEYL------DKDLKQYMDDCGNIMSMHNVKIFLY 111

Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  +A+CH + V HRDLKP+NLL++  G LK++DFGL+       +       T  Y 
Sbjct: 112 QILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYR 171

Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAG 144
            P+VL       +  D+W  G I F + +G
Sbjct: 172 PPDVLLGSSEYSTQIDMWGVGCIFFEMASG 201

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 80.6 bits (198), Expect = 2e-16
 Identities = 59/181 (32%), Positives = 94/181 (51%), Gaps = 36/181 (19%)

Query: 1   MKIVRHPNIVRLHEVLASRT--KVYIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQ 54
           M+ ++H NIVR  +   ++   K+YI++EF   G+L   I       G++ E+      +
Sbjct: 66  MRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR 125

Query: 55  QLIDAVAHCHS-------KGVYHRDLKPENLLLDS-----------YGNL------KVSD 90
           QL+ A+A+CH+       + V HRDLKP+N+ L +             NL      K+ D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185

Query: 91  FGLSALPQQGVE-LLHTTCGTPNYVAPEVL--SNRGYDGSAADVWSCGVILFVLMAGYLP 147
           FGLS     G+E + H+  GTP Y +PE+L    + YD   +D+W+ G I++ L +G  P
Sbjct: 186 FGLSK--NIGIESMAHSCVGTPYYWSPELLLHETKSYD-DKSDMWALGCIIYELCSGKTP 242

Query: 148 F 148
           F
Sbjct: 243 F 243

Length = 1021

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 42/145 (28%), Positives = 80/145 (55%), Gaps = 2/145 (1%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE-NDCRRYFQQLIDA 59
           +K ++H NIV LH+++ +   + ++ E++   +L   + + G L+  ++ + +  QL+  
Sbjct: 57  LKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRG 115

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 119
           +++CH + + HRDLKP+NLL++  G LK++DFGL+       +       T  Y  P+VL
Sbjct: 116 LSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 175

Query: 120 SNRGYDGSAADVWSCGVILFVLMAG 144
                  +  D+W  G IL+ +  G
Sbjct: 176 LGSTEYSTPIDMWGVGCILYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 77.4 bits (191), Expect = 4e-16
 Identities = 65/241 (26%), Positives = 108/241 (44%), Gaps = 45/241 (18%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE-NDCRRYFQQLIDA 59
           +K ++H NIV LH+++ ++  + ++ E++   +L   +   G  L  ++ R +  QL+  
Sbjct: 57  LKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRG 115

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS---ALPQQGV--ELLHTTCGTPNYV 114
           +A+CH + V HRDLKP+NLL+   G LK++DFGL+   ++P +    E++     T  Y 
Sbjct: 116 LAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-----TLWYR 170

Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDL-------------------P 154
            P+VL       ++ D+W  G I + +  G   F G TD+                   P
Sbjct: 171 PPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWP 230

Query: 155 TLYKKINAAEFSCPFW-------------FSTGATSLIHKILDPNPKTRIRIEGIRKHPW 201
            +        +S PF+                    L  K L   PK RI      KHP+
Sbjct: 231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290

Query: 202 F 202
           F
Sbjct: 291 F 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 50/155 (32%), Positives = 78/155 (50%), Gaps = 24/155 (15%)

Query: 1   MKIVR---HPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRR 51
           +KI+R   H NI+ + ++L  R        VY++++ +   +L   I+H  + L  +  R
Sbjct: 55  LKILRHFKHDNIIAIRDIL--RPPGADFKDVYVVMDLM-ESDL-HHIIHSDQPLTEEHIR 110

Query: 52  YF-QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL------SALPQQGVELL 104
           YF  QL+  + + HS  V HRDLKP NLL++    L++ DFG+      S    +     
Sbjct: 111 YFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTE 170

Query: 105 HTTCGTPNYVAPEVL-SNRGYDGSAADVWSCGVIL 138
           +    T  Y APE+L S   Y  +A D+WS G I 
Sbjct: 171 YVA--TRWYRAPELLLSLPEYT-TAIDMWSVGCIF 202

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 76.7 bits (189), Expect = 5e-16
 Identities = 44/141 (31%), Positives = 72/141 (51%), Gaps = 8/141 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQ-QLID 58
           M  +RHPN+V+L  V+     +YI+ E++  G L D +  +GR ++    +  F   + +
Sbjct: 54  MTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCE 113

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
            + +   K   HRDL   N+L+      KVSDFGL+    QG      +   P  + APE
Sbjct: 114 GMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG----QDSGKLPVKWTAPE 169

Query: 118 VLSNRGYDGSAADVWSCGVIL 138
            L  + +  + +DVWS G++L
Sbjct: 170 ALREKKFS-TKSDVWSFGILL 189

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 77.8 bits (192), Expect = 6e-16
 Identities = 48/149 (32%), Positives = 74/149 (49%), Gaps = 13/149 (8%)

Query: 6   HPNIVRLHEV----LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAV 60
           H NI  L+++      +  ++Y+  E +       +I+  G+ L +   + F  Q++  +
Sbjct: 61  HKNITCLYDMDIVFPGNFNELYLYEELMEAD--LHQIIRSGQPLTDAHFQSFIYQILCGL 118

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL----SALPQQGVELLHTTCGTPNYVAP 116
            + HS  V HRDLKP NLL+++   LK+ DFGL    S  P +    +     T  Y AP
Sbjct: 119 KYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178

Query: 117 EV-LSNRGYDGSAADVWSCGVILFVLMAG 144
           E+ LS + Y   A DVWS G IL  L+  
Sbjct: 179 EIMLSFQSYT-KAIDVWSVGCILAELLGR 206

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 77.4 bits (191), Expect = 7e-16
 Identities = 58/256 (22%), Positives = 100/256 (39%), Gaps = 59/256 (23%)

Query: 1   MKIVRHPNIVRLHEVLASRTK--------VYIILEFVT---GGELFDKIVHQGRLLENDC 49
           +K ++HPN+V L ++   R          VY++  ++     G L +  V    L E+  
Sbjct: 61  LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LTESQI 117

Query: 50  RRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--------ALPQQGV 101
           + Y  QL++ + + H   + HRD+K  N+L+D+ G LK++DFGL+             G 
Sbjct: 118 KCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177

Query: 102 ELLHTTCG---TPNYVAPE-VLSNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDLPT 155
                      T  Y  PE +L  R Y  +A D+W  G +   +      L  G++D+  
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRY-TTAVDIWGIGCVFAEMFTRRPILQ-GKSDIDQ 235

Query: 156 LYK---------KINAAEFS----CPFWFST----------------GATSLIHKILDPN 186
           L+          +     +     C    S                     L+ K+L  +
Sbjct: 236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLD 295

Query: 187 PKTRIRIEGIRKHPWF 202
           P  R+      +HP+F
Sbjct: 296 PYKRLTASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 76.2 bits (187), Expect = 7e-16
 Identities = 48/151 (31%), Positives = 82/151 (54%), Gaps = 8/151 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR--RYFQQLID 58
           M  + H N+VRL  V+     +YI++E ++ G L + +  +GR L +  +  ++   + +
Sbjct: 53  MTKLHHKNLVRLLGVIL-HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAE 111

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            + +  SK + HRDL   N+L+   G  KVSDFGL+ +   GV+    +     + APE 
Sbjct: 112 GMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD---NSKLPVKWTAPEA 168

Query: 119 LSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
           L ++ +  S +DVWS GV+L+ V   G  P+
Sbjct: 169 LKHKKFS-SKSDVWSYGVLLWEVFSYGRAPY 198

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 52/146 (35%), Positives = 75/146 (51%), Gaps = 12/146 (8%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K   HPNIVRL  V   +  +YI++E V GG+    +  +G  L+   +   Q + +A 
Sbjct: 47  LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLK--VKELIQMVENAA 104

Query: 61  A---HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN----Y 113
           A   +  SK   HRDL   N L+     LK+SDFG+S   + GV    +T G       +
Sbjct: 105 AGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV--YASTGGMKQIPVKW 162

Query: 114 VAPEVLSNRGYDGSAADVWSCGVILF 139
            APE L N G   S +DVWS G++L+
Sbjct: 163 TAPEAL-NYGRYSSESDVWSFGILLW 187

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 75.7 bits (186), Expect = 1e-15
 Identities = 53/164 (32%), Positives = 78/164 (47%), Gaps = 5/164 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 56  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 115

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 116 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 175

Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 160
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+ +
Sbjct: 176 SLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 218

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 50/140 (35%), Positives = 71/140 (50%), Gaps = 10/140 (7%)

Query: 6   HPNIVRLHEVLAS-----RTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           HPNIVRL +V A+      TKV ++ E V        DK+   G   E   +   +Q + 
Sbjct: 61  HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAET-IKDLMRQFLR 119

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +   H+  + HRDLKPEN+L+ S G +K++DFGL+ +    + L      T  Y APEV
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV-TLWYRAPEV 178

Query: 119 LSNRGYDGSAADVWSCGVIL 138
           L    Y  +  D+WS G I 
Sbjct: 179 LLQSTY-ATPVDMWSVGCIF 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 42/150 (28%), Positives = 77/150 (51%), Gaps = 12/150 (8%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-----GRLLE-NDCRRYFQ 54
           +K ++H NIV LH+++ +   + ++ E++      DK + Q     G  +  ++ + +  
Sbjct: 58  LKDLKHANIVTLHDIIHTEKSLTLVFEYL------DKDLKQYLDDCGNSINMHNVKLFLF 111

Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           QL+  + +CH + V HRDLKP+NLL++  G LK++DFGL+       +       T  Y 
Sbjct: 112 QLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYR 171

Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAG 144
            P++L       +  D+W  G I + +  G
Sbjct: 172 PPDILLGSTDYSTQIDMWGVGCIFYEMSTG 201

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 41/149 (27%), Positives = 73/149 (48%), Gaps = 11/149 (7%)

Query: 1   MKIVRHPNIVRLHEVL--ASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLI 57
           ++ + H NIV+   V        + +I+E++  G L D +  H+ ++       +  Q+ 
Sbjct: 60  LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQIC 119

Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN----- 112
             + +  S+   HRDL   N+L++S   +K+SDFGL+ +  +  +  +     P      
Sbjct: 120 KGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKD--YYYVKEPGESPIF 177

Query: 113 YVAPEVLSNRGYDGSAADVWSCGVILFVL 141
           + APE L    +  SA+DVWS GV L+ L
Sbjct: 178 WYAPECLRTSKFS-SASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 55/152 (36%), Positives = 78/152 (51%), Gaps = 20/152 (13%)

Query: 1   MKIVRHPNIVRLHEVLAS-RTKVYIILEFVTGGELFDKIVH---QGRLLENDCRRYFQ-Q 55
           +K +RH NI+ L ++  S    +Y    FVT  EL    +H     R LE    +YF  Q
Sbjct: 63  LKHLRHENIISLSDIFISPLEDIY----FVT--ELLGTDLHRLLTSRPLEKQFIQYFLYQ 116

Query: 56  LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT--CGTPNY 113
           ++  + + HS GV HRDLKP N+L++   +LK+ DFGL A  Q        T    T  Y
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGL-ARIQDP----QMTGYVSTRYY 171

Query: 114 VAPEV-LSNRGYDGSAADVWSCGVILFVLMAG 144
            APE+ L+ + YD    D+WS G I   ++ G
Sbjct: 172 RAPEIMLTWQKYD-VEVDIWSAGCIFAEMLEG 202

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 75.1 bits (185), Expect = 2e-15
 Identities = 55/155 (35%), Positives = 80/155 (51%), Gaps = 22/155 (14%)

Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID------- 58
           HPNI+RL  V+     V II E++  G L DK      L END +    QL+        
Sbjct: 64  HPNIIRLEGVVTKSRPVMIITEYMENGSL-DKF-----LRENDGKFTVGQLVGMLRGIAS 117

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG--TP-NYVA 115
            + +       HRDL   N+L++S    KVSDFGLS    +  E  +TT G   P  + A
Sbjct: 118 GMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR-LEDSEATYTTKGGKIPIRWTA 176

Query: 116 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE 150
           PE ++ R +  SA+DVWS G++++ +M+    +GE
Sbjct: 177 PEAIAYRKFT-SASDVWSFGIVMWEVMS----YGE 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 68/255 (26%), Positives = 106/255 (41%), Gaps = 47/255 (18%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           +K V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 74  LKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQML 133

Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+        ++     T  Y APE
Sbjct: 134 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF-MMTPYVVTRYYRAPE 192

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI------NAAEFSC---- 167
           V+   GY  +  D+WS G I+  L+ G + F  TD    + K+       +AEF      
Sbjct: 193 VILGMGYKEN-VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251

Query: 168 ---------------------PFWF-----------STGATSLIHKILDPNPKTRIRIEG 195
                                P W            ++ A  L+ K+L  +P  RI ++ 
Sbjct: 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDE 311

Query: 196 IRKHPWFRKNYNPVK 210
             +HP+    Y+P +
Sbjct: 312 ALRHPYITVWYDPAE 326

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 74.8 bits (184), Expect = 2e-15
 Identities = 43/151 (28%), Positives = 76/151 (50%), Gaps = 4/151 (2%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQ-QLID 58
           +K +RH +++ L  V +    VYII E +  G L   +   +G++L          Q+ +
Sbjct: 56  LKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAE 115

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A+   +   HRDL   N+L+      KV+DFGL+ L ++ V L         + APE 
Sbjct: 116 GMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEA 175

Query: 119 LSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
            S+  +  + +DVWS G++L+ +   G +P+
Sbjct: 176 ASHGTFS-TKSDVWSFGILLYEMFTYGQVPY 205

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 74.7 bits (183), Expect = 3e-15
 Identities = 46/160 (28%), Positives = 83/160 (51%), Gaps = 14/160 (8%)

Query: 2   KIVRHPNIVRLHEVLASRT------KVYIILEFVTGGELFDKIVH-QGRLLENDCRRYF- 53
           K   H NI   +     ++      ++++++EF   G + D + + +G  L+ D   Y  
Sbjct: 68  KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYIC 127

Query: 54  QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 113
           ++++  +AH H+  V HRD+K +N+LL     +K+ DFG+SA   + V   +T  GTP +
Sbjct: 128 REILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW 187

Query: 114 VAPEVLS-----NRGYDGSAADVWSCGVILFVLMAGYLPF 148
           +APEV++     +  YD   +D+WS G+    +  G  P 
Sbjct: 188 MAPEVIACDENPDATYD-YRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 74.7 bits (184), Expect = 4e-15
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 19/210 (9%)

Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCH 64
           P IV+ +    + + V+I +E +      DK++   QG + E+   +    ++ A+ +  
Sbjct: 74  PYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK 131

Query: 65  SK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE-LLHT-TCGTPNYVAPEVL-- 119
            K GV HRD+KP N+LLD+ GN+K+ DFG+S    + V+    T + G   Y+APE +  
Sbjct: 132 EKHGVIHRDVKPSNILLDASGNVKLCDFGISG---RLVDSKAKTRSAGCAAYMAPERIDP 188

Query: 120 --SNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYKKINAAEFSCPF--WFST 173
              N  YD   ADVWS G+ L  L  G  P+   +T+   L K +     S P    FS 
Sbjct: 189 PDPNPKYD-IRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSP 247

Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
              S +   L  + + R +   + +HP+ R
Sbjct: 248 DFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 73.8 bits (181), Expect = 6e-15
 Identities = 55/179 (30%), Positives = 85/179 (47%), Gaps = 23/179 (12%)

Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI-------D 58
           HPNI+ L  V+     V I+ E++  G L         L ++D +    QL+        
Sbjct: 64  HPNIIHLEGVVTKSKPVMIVTEYMENGSL------DAFLRKHDGQFTVIQLVGMLRGIAS 117

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVA 115
            + +    G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + A
Sbjct: 118 GMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTA 177

Query: 116 PEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKIN-----AAEFSCP 168
           PE ++ R +  SA+DVWS G++++ +M+ G  P+ E     + K I       A   CP
Sbjct: 178 PEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCP 235

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 74.8 bits (184), Expect = 8e-15
 Identities = 64/250 (25%), Positives = 106/250 (42%), Gaps = 44/250 (17%)

Query: 5   RHPNIVRLHEVLASR-----TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 59
           +H N++   ++L         ++Y++ E +   +L   IV    L  +  + +  Q++  
Sbjct: 57  KHDNVLSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRG 115

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPE 117
           + + HS G+ HRD+KP NLL++S   LK+ DFGL+ +  P +   +      T  Y APE
Sbjct: 116 LKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQYYRAPE 174

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE----------TDL---PTLYKKINAAE 164
           +L    +  SA D+WS G I   L+   + F            TDL   P+L    +A E
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234

Query: 165 ---------------FSCPFWFSTGAT----SLIHKILDPNPKTRIRIEGIRKHPWF--- 202
                              +  S+ AT     L+ ++L  +P  RI       HP+    
Sbjct: 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294

Query: 203 RKNYNPVKCS 212
           R  Y+   C 
Sbjct: 295 RLRYHTCMCK 304

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 53/168 (31%), Positives = 87/168 (51%), Gaps = 16/168 (9%)

Query: 6   HPNIVRLHEVLASRTK-----VYIILEFVTGG---ELFDKIVHQGRLLENDCRRY--FQQ 55
           HPN+V+ + +     K     ++++LE   GG   EL   ++  G+ L+     Y  +  
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137

Query: 56  LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVA 115
           L+  + H H+  + HRD+K  N+LL + G +K+ DFG+SA         +T+ GTP ++A
Sbjct: 138 LL-GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 196

Query: 116 PEVLS-NRGYDGS---AADVWSCGVILFVLMAGYLPFGETD-LPTLYK 158
           PEV++  + YD S     DVWS G+    L  G  P  +   + TL+K
Sbjct: 197 PEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK 244

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 72.3 bits (177), Expect = 2e-14
 Identities = 54/174 (31%), Positives = 83/174 (47%), Gaps = 13/174 (7%)

Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHC 63
           H NI+RL  V+       II E++  G L DK +  H G           + +   + + 
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123

Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLS 120
                 HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + APE ++
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183

Query: 121 NRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKIN-----AAEFSCP 168
            R +  SA+DVWS G++++ +M+ G  P+ +     + K IN      A   CP
Sbjct: 184 YRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCP 236

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 33/166 (19%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY--FQQLID 58
           MK +RH  +V+L+ V +    +YI+ E+++ G L D        L++   +     QL+D
Sbjct: 55  MKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLD-------FLKSGEGKKLRLPQLVD 107

Query: 59  -------AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL-------PQQGVELL 104
                   +A+  S+   HRDL   N+L+      K++DFGL+ L        ++G +  
Sbjct: 108 MAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF- 166

Query: 105 HTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
                 P  + APE  +N G     +DVWS G++L  ++  G +P+
Sbjct: 167 ------PIKWTAPEA-ANYGRFTIKSDVWSFGILLTEIVTYGRVPY 205

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 52/163 (31%), Positives = 78/163 (47%), Gaps = 5/163 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           MK V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQML 136

Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+        ++     T  Y APE
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPE 195

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 160
           V+   GY  +  D+WS G I+  ++ G + F  TD    + K+
Sbjct: 196 VILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 70.9 bits (174), Expect = 7e-14
 Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 5/151 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M+   HP+IV+L  V+ +   V+I++E    GEL   + V++  L       Y  QL  A
Sbjct: 61  MRQFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTA 119

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEV 118
           +A+  SK   HRD+   N+L+ S   +K+ DFGLS  L  +             ++APE 
Sbjct: 120 LAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPES 179

Query: 119 LSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
           ++ R +  SA+DVW  GV ++ +LM G  PF
Sbjct: 180 INFRRFT-SASDVWMFGVCMWEILMLGVKPF 209

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 70.8 bits (173), Expect = 7e-14
 Identities = 44/152 (28%), Positives = 78/152 (51%), Gaps = 5/152 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLID 58
           MK ++H  +VRL+ V+     +YII E++  G L D +     G++L      +  Q+ +
Sbjct: 55  MKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAE 114

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
            +A+   K   HRDL+  N+L+      K++DFGL+ + +            P  + APE
Sbjct: 115 GMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 174

Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            + N G     +DVWS G++L+ ++  G +P+
Sbjct: 175 AI-NFGSFTIKSDVWSFGILLYEIVTYGKIPY 205

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 72.6 bits (178), Expect = 7e-14
 Identities = 32/90 (35%), Positives = 56/90 (62%)

Query: 5   RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 64
           + P IV L+  L S   VY+++E++ GG++   +   G   E    +Y  ++  A+ + H
Sbjct: 62  KSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121

Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLS 94
             G+ HRDLKP+N+L+ + G++K++DFGLS
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 70.9 bits (173), Expect = 7e-14
 Identities = 55/192 (28%), Positives = 93/192 (48%), Gaps = 14/192 (7%)

Query: 21  KVYIILEFVTGGELFDKIVH-QGRLLENDCRRYF-QQLIDAVAHCHSKGVYHRDLKPENL 78
           ++++++EF   G + D I + +G  L+ +   Y  ++++  ++H H   V HRD+K +N+
Sbjct: 83  QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNV 142

Query: 79  LLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS-----NRGYDGSAADVWS 133
           LL     +K+ DFG+SA   + V   +T  GTP ++APEV++     +  YD   +D+WS
Sbjct: 143 LLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYD-FKSDLWS 201

Query: 134 CGVILFVLMAGYLPFGETDLPT----LYKKINAAEFSCPFWFSTGATSLIHKILDPNPKT 189
            G+    +  G  P  +   P     L  +  A       W S    S I   L  N   
Sbjct: 202 LGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAPRLKSKKW-SKKFQSFIESCLVKNHSQ 259

Query: 190 RIRIEGIRKHPW 201
           R   E + KHP+
Sbjct: 260 RPTTEQLMKHPF 271

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 71.3 bits (175), Expect = 8e-14
 Identities = 58/251 (23%), Positives = 102/251 (40%), Gaps = 54/251 (21%)

Query: 1   MKIVRHPNIVRLHEVLAS--------RTKVYIILEFVT---GGELFDKIVHQGRLLENDC 49
           +++++H N+V L E+  +        +   Y++ EF      G L +K V   +   ++ 
Sbjct: 65  LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV---KFTLSEI 121

Query: 50  RRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS---ALPQQGVELLHT 106
           ++  + L++ + + H   + HRD+K  N+L+   G LK++DFGL+   +L +      +T
Sbjct: 122 KKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181

Query: 107 T-CGTPNYVAPEVLSN-RGYDGSAADVWSCGVIL------FVLMAG-------------- 144
               T  Y  PE+L   R Y G   D+W  G I+        +M G              
Sbjct: 182 NRVVTLWYRPPELLLGERDY-GPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC 240

Query: 145 -------------YLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 191
                           F + +LP   K+        P+     A  LI K+L  +P  RI
Sbjct: 241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLK-PYVKDPHALDLIDKLLVLDPAKRI 299

Query: 192 RIEGIRKHPWF 202
             +    H +F
Sbjct: 300 DADTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 71.7 bits (175), Expect = 8e-14
 Identities = 68/256 (26%), Positives = 104/256 (40%), Gaps = 49/256 (19%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           MK V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 70  MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 129

Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAP 116
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y AP
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 187

Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKKIN 161
           EV+   GY  +  D+WS G I+  ++   + F   D                P   KK+ 
Sbjct: 188 EVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246

Query: 162 A------------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIE 194
                        A  + P  F               ++ A  L+ K+L  +P  RI ++
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306

Query: 195 GIRKHPWFRKNYNPVK 210
              +HP+    Y+P +
Sbjct: 307 EALQHPYINVWYDPAE 322

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 15/159 (9%)

Query: 6   HPNIVRLHEVLASRTKV-----YIILEFVTGGELFDKI---VHQGRLLENDCRRY-FQQL 56
           HPN+V+ + +   +        +++LE   GG + D +   + +G  +E     Y   + 
Sbjct: 74  HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133

Query: 57  IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
           +  + H H     HRD+K  N+LL + G +K+ DFG+SA         +T+ GTP ++AP
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 193

Query: 117 EVLS-----NRGYDGSAADVWSCGVILFVLMAGYLPFGE 150
           EV++     +  YD +  DVWS G+    L  G  P  +
Sbjct: 194 EVIACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLAD 231

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 69.7 bits (171), Expect = 1e-13
 Identities = 47/153 (30%), Positives = 68/153 (44%), Gaps = 27/153 (17%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLID 58
           M  + H N++RL+ V+ +   + ++ E    G L D  +    G  L +    Y  Q+ +
Sbjct: 50  MHSLDHENLIRLYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIAN 108

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYV--- 114
            + +  SK   HRDL   N+LL S   +K+ DFGL  ALPQ             +YV   
Sbjct: 109 GMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQ----------NEDHYVMEE 158

Query: 115 ---------APEVLSNRGYDGSAADVWSCGVIL 138
                    APE L  R +   A+DVW  GV L
Sbjct: 159 HLKVPFAWCAPESLRTRTFS-HASDVWMFGVTL 190

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 69.8 bits (171), Expect = 1e-13
 Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 22/161 (13%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD------KIVHQGRLLENDCRRYFQ 54
           M  + HPN+V+L+ V   +  ++I+ E++  G L +        +    LL+  C     
Sbjct: 53  MMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDM-C----S 107

Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTP- 111
            + +A+ +  S G  HRDL   N L+     +KVSDFGL+   L  Q      ++ GT  
Sbjct: 108 DVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT----SSQGTKF 163

Query: 112 --NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFG 149
              +  PEV  +     S +DVWS GV+++ V   G +P+ 
Sbjct: 164 PVKWAPPEVF-DYSRFSSKSDVWSFGVLMWEVFSEGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 70.5 bits (172), Expect = 2e-13
 Identities = 47/166 (28%), Positives = 81/166 (48%), Gaps = 11/166 (6%)

Query: 1   MKIVRHPNIVRLHEVLASRT------KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V    T      +VY++   +  G   + IV   +L +   +    
Sbjct: 68  LKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIY 125

Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           QL+  + + HS G+ HRDLKP N+ ++    L++ DFGL+   +Q  + +     T  Y 
Sbjct: 126 QLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA---RQADDEMTGYVATRWYR 182

Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 160
           APE++ N  +     D+WS G I+  L+ G   F   D     K+I
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 50/169 (29%), Positives = 82/169 (48%), Gaps = 13/169 (7%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M  V HP++VRL  +  S   V +I + +  G L D +  H+  +       +  Q+   
Sbjct: 63  MASVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKG 121

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           +++   K + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E
Sbjct: 122 MSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG    P  Y+ I A E  
Sbjct: 182 SILHRIYT-HKSDVWSYGVTVWELMT----FGA--KP--YEGIPAVEIP 221

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 11/158 (6%)

Query: 1   MKIVRHPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V            VY++   +  G   + IV   +L ++  +    
Sbjct: 70  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 127

Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 128 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 184

Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 68.4 bits (167), Expect = 4e-13
 Identities = 47/161 (29%), Positives = 80/161 (49%), Gaps = 24/161 (14%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID-- 58
           M  + H  +V+L+ V   +  +YI+ E+++ G L + +   G+  +        QL++  
Sbjct: 53  MMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQP------SQLLEMC 106

Query: 59  -----AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTP 111
                 +A+  SK   HRDL   N L+D  G +KVSDFGLS   L  +      ++ G+ 
Sbjct: 107 KDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT----SSVGSK 162

Query: 112 ---NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
               +  PEVL    +  S +DVW+ GV+++ V   G +P+
Sbjct: 163 FPVRWSPPEVLLYSKFS-SKSDVWAFGVLMWEVYSLGKMPY 202

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 69.1 bits (169), Expect = 4e-13
 Identities = 43/141 (30%), Positives = 74/141 (52%), Gaps = 12/141 (8%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTG--GELFDKIVHQGRLLENDCRRYFQQLID 58
           ++ +RHPN +            ++++E+  G   ++ +  VH+  L E +        + 
Sbjct: 69  LQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQ 126

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A+ HS    HRD+K  N+LL   G +K++DFG ++L    V   ++  GTP ++APEV
Sbjct: 127 GLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASL----VSPANSFVGTPYWMAPEV 182

Query: 119 L--SNRG-YDGSAADVWSCGV 136
           +   + G YDG   DVWS G+
Sbjct: 183 ILAMDEGQYDGK-VDVWSLGI 202

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 68.2 bits (167), Expect = 4e-13
 Identities = 50/159 (31%), Positives = 76/159 (47%), Gaps = 19/159 (11%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDA 59
           MK +RHP +++L+ V      +YI+ E +  G L + +    GR L+        QLID 
Sbjct: 55  MKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALK------LPQLIDM 108

Query: 60  VAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP- 111
            A   S   Y       HRDL   N+L+      KV+DFGL+ + ++ +         P 
Sbjct: 109 AAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPI 168

Query: 112 NYVAPE-VLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
            + APE  L NR    S  DVWS G++L  ++  G +P+
Sbjct: 169 KWTAPEAALYNRFSIKS--DVWSFGILLTEIVTYGRMPY 205

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 69.0 bits (169), Expect = 5e-13
 Identities = 59/256 (23%), Positives = 97/256 (37%), Gaps = 49/256 (19%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTG--GELFDKIVHQGRLLENDCRRYFQQLID 58
           M  ++H NI+ L +V      + ++++ +     ++ D+ +   RL E+  +    Q+++
Sbjct: 74  MNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKI---RLTESQVKCILLQILN 130

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS---ALPQQGVEL--LHTTCGTPN- 112
            +   H     HRDL P N+ ++S G  K++DFGL+     P     L    T       
Sbjct: 131 GLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190

Query: 113 --------YVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD------------ 152
                   Y APE+L        A D+WS G I   L+ G   F   +            
Sbjct: 191 TSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELL 250

Query: 153 -------------LP--TLYKKINAAEFSCPFWF-STGATSLIHKILDPNPKTRIRIEGI 196
                        LP  T +      +    F   S  A  L+  +L  NP  RI  +  
Sbjct: 251 GTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEA 310

Query: 197 RKHPWFRKNYNPVKCS 212
            KH +F    +P+ C 
Sbjct: 311 LKHEYF--KSDPLPCD 324

Length = 335

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 69.7 bits (170), Expect = 5e-13
 Identities = 48/151 (31%), Positives = 81/151 (53%), Gaps = 9/151 (5%)

Query: 6   HPNIVRLHEVLASRTKVYII---LEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVA 61
           H NI+++ E+L S    Y+I    +F     ++D+    + R L    R   +QL+ AV 
Sbjct: 222 HENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVE 281

Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP--QQGVELLHTTCGTPNYVAPEVL 119
           + H K + HRD+K EN+ L+  G + + DFG +A+P  ++     +   GT    +PE+L
Sbjct: 282 YIHDKKLIHRDIKLENIFLNCDGKIVLGDFG-TAMPFEKEREAFDYGWVGTVATNSPEIL 340

Query: 120 SNRGYDGSAADVWSCGVILFVLMA-GYLPFG 149
           +  GY     D+WSCG+IL  +++  + P G
Sbjct: 341 AGDGY-CEITDIWSCGLILLDMLSHDFCPIG 370

Length = 501

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 68.1 bits (166), Expect = 6e-13
 Identities = 49/174 (28%), Positives = 86/174 (49%), Gaps = 11/174 (6%)

Query: 1   MKIVRHPNIVRLHEVLAS-RTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQ-QLI 57
           M  +RH N+V+L  V+   +  +YI+ E++  G L D +  +GR +L  DC   F   + 
Sbjct: 53  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 112

Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAP 116
           +A+ +  +    HRDL   N+L+      KVSDFGL+    +       T   P  + AP
Sbjct: 113 EAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLT----KEASSTQDTGKLPVKWTAP 168

Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI-NAAEFSCP 168
           E L  + +  + +DVWS G++L+ + + G +P+    L  +  ++    +   P
Sbjct: 169 EALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP 221

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 67.6 bits (165), Expect = 8e-13
 Identities = 51/157 (32%), Positives = 75/157 (47%), Gaps = 23/157 (14%)

Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           HPNI+ L  V+     V II EF+  G L D  + Q     ND +    QL+  +    +
Sbjct: 64  HPNIIHLEGVVTKSRPVMIITEFMENGAL-DSFLRQ-----NDGQFTVIQLVGMLRGIAA 117

Query: 66  KGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT----CGTP-NY 113
              Y       HRDL   N+L++S    KVSDFGLS   +        T       P  +
Sbjct: 118 GMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW 177

Query: 114 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE 150
            APE ++ R +  SA+DVWS G++++ +M+    +GE
Sbjct: 178 TAPEAIAYRKFT-SASDVWSYGIVMWEVMS----YGE 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 68.4 bits (167), Expect = 9e-13
 Identities = 38/141 (26%), Positives = 74/141 (52%), Gaps = 4/141 (2%)

Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAH 62
           V HP+++R+ + L S     ++L   +  +L+  +  +   L  +      +Q+++ + +
Sbjct: 114 VNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRY 172

Query: 63  CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 122
            H++ + HRD+K EN+ ++    + + D G +  P      L    GT    APEVL+  
Sbjct: 173 LHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL-GLAGTVETNAPEVLARD 231

Query: 123 GYDGSAADVWSCGVILFVLMA 143
            Y+ S AD+WS G++LF ++A
Sbjct: 232 KYN-SKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 67.7 bits (165), Expect = 9e-13
 Identities = 58/162 (35%), Positives = 81/162 (50%), Gaps = 13/162 (8%)

Query: 6   HPNIVRLHEVLA-SRT----KVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           HPN+VRL +V   SRT    K+ ++ E V        DK+   G   E   +    QL+ 
Sbjct: 63  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET-IKDMMFQLLR 121

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +   HS  V HRDLKP+N+L+ S G +K++DFGL+ +    +  L +   T  Y APEV
Sbjct: 122 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-ALTSVVVTLWYRAPEV 180

Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYK 158
           L    Y  +  D+WS G I F  M    P   G +D+  L K
Sbjct: 181 LLQSSY-ATPVDLWSVGCI-FAEMFRRKPLFRGSSDVDQLGK 220

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 67.2 bits (164), Expect = 1e-12
 Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 38/218 (17%)

Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P I+  +       ++ I  EF+ GG L D      ++ E+   R    ++  + +  S 
Sbjct: 59  PYIIGFYGAFFVENRISICTEFMDGGSL-DVY---RKIPEHVLGRIAVAVVKGLTYLWSL 114

Query: 67  GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSNRGYD 125
            + HRD+KP N+L+++ G +K+ DFG+S    Q V  +  T  GT  Y+APE +S   Y 
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVS---TQLVNSIAKTYVGTNAYMAPERISGEQY- 170

Query: 126 GSAADVWSCGVILFVLMAGYLPFGE-------------------TDLPTLYKKINAAEFS 166
           G  +DVWS G+    L  G  P+ +                    D P L       +FS
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL----PVGQFS 226

Query: 167 CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
             F         I + +   PK R   E +  HP+  +
Sbjct: 227 EKF------VHFITQCMRKQPKERPAPENLMDHPFIVQ 258

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 66.8 bits (163), Expect = 1e-12
 Identities = 47/155 (30%), Positives = 78/155 (50%), Gaps = 12/155 (7%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDA 59
           M  + HP +V+L+ V   +  +YI+ EF+  G L + +   QG+L ++      Q + + 
Sbjct: 53  MMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEG 112

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTP---NYV 114
           + +       HRDL   N L+ S G +KVSDFG++   L  +      ++ G      + 
Sbjct: 113 MEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT----SSSGAKFPVKWS 168

Query: 115 APEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            PEV +   Y  S +DVWS GV+++ V   G +PF
Sbjct: 169 PPEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKMPF 202

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 66.5 bits (162), Expect = 4e-12
 Identities = 44/158 (27%), Positives = 78/158 (49%), Gaps = 11/158 (6%)

Query: 1   MKIVRHPNIVRLHEVLASRTKV------YIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      +      Y+++ F+  G    K++   +L E+  +    
Sbjct: 68  LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVY 125

Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + H+ G+ HRDLKP NL ++    LK+ DFGL+   +Q    +     T  Y 
Sbjct: 126 QMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA---RQTDSEMTGYVVTRWYR 182

Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APEV+ N  +     D+WS G I+  ++ G   F   D
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 66.3 bits (162), Expect = 4e-12
 Identities = 44/153 (28%), Positives = 77/153 (50%), Gaps = 10/153 (6%)

Query: 1   MKIVRHPNIVRLHEVLASRTK-----VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQ 55
           ++++RHP+IV +  ++   ++     +Y++ E +   +L   I     L     + +  Q
Sbjct: 53  LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQ 111

Query: 56  LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTT-CGTPN 112
           L+ A+ + H+  V+HRDLKP+N+L ++   LK+ DFGL+  A       +  T    T  
Sbjct: 112 LLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171

Query: 113 YVAPEVL-SNRGYDGSAADVWSCGVILFVLMAG 144
           Y APE+  S       A D+WS G I   ++ G
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 204

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 65.9 bits (160), Expect = 5e-12
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 22/210 (10%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ ++HPN +            ++++E+  G       VH+  L E +        +  +
Sbjct: 79  LQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGL 138

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV-- 118
           A+ HS  + HRD+K  N+LL   G +K++DFG +++        ++  GTP ++APEV  
Sbjct: 139 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASI----ASPANSFVGTPYWMAPEVIL 194

Query: 119 -LSNRGYDGSAADVWSCGVILFVLMAGYLP-FGETDLPTLYK-------KINAAEFSCPF 169
            +    YDG   DVWS G+    L     P F    +  LY         + + E+S   
Sbjct: 195 AMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSD-- 251

Query: 170 WFSTGATSLIHKILDPNPKTRIRIEGIRKH 199
           +F     S + KI    P+ R   E + KH
Sbjct: 252 YFRNFVDSCLQKI----PQDRPTSEELLKH 277

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 65.4 bits (159), Expect = 7e-12
 Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 4/151 (2%)

Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122

Query: 67  -GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 125
             + HRD+KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y 
Sbjct: 123 HKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS 180

Query: 126 GSAADVWSCGVILFVLMAGYLPFGETDLPTL 156
              +D+WS G+ L  +  G  P    D   L
Sbjct: 181 -VQSDIWSMGLSLVEMAIGRYPIPPPDAKEL 210

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 65.5 bits (159), Expect = 7e-12
 Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 4/151 (2%)

Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P IV  +    S  ++ I +E + GG L   +    R+ E    +    ++  +A+   K
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122

Query: 67  -GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 125
             + HRD+KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y 
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS 180

Query: 126 GSAADVWSCGVILFVLMAGYLPFGETDLPTL 156
              +D+WS G+ L  L  G  P    D   L
Sbjct: 181 -VQSDIWSMGLSLVELAIGRYPIPPPDAKEL 210

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 65.1 bits (159), Expect = 7e-12
 Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 17/217 (7%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFV-TGGELFDKIV--HQGRLLENDCRRYFQQLI 57
           M+ V  P  V  +  L     V+I +E + T  + F K V      + E+   +    ++
Sbjct: 54  MRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIV 113

Query: 58  DAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT--CGTPNYV 114
            A+ + HSK  V HRD+KP N+L++  G +K+ DFG+S      V+ +  T   G   Y+
Sbjct: 114 KALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG---YLVDSVAKTIDAGCKPYM 170

Query: 115 APE----VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE--TDLPTLYKKINAAEFSCP 168
           APE     L+ +GYD   +DVWS G+ +  L  G  P+    T    L + +       P
Sbjct: 171 APERINPELNQKGYD-VKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLP 229

Query: 169 F-WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
              FS      ++K L  N K R     + +HP+F  
Sbjct: 230 AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 64.5 bits (157), Expect = 8e-12
 Identities = 47/152 (30%), Positives = 77/152 (50%), Gaps = 6/152 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLID 58
           MK ++HP +VRL+ V+ ++  +YII E++  G L D  K     +L  N       Q+ +
Sbjct: 55  MKQLQHPRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAE 113

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
            +A    K   HRDL+  N+L+      K++DFGL+ L +            P  + APE
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 173

Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            + N G     +DVWS G++L  ++  G +P+
Sbjct: 174 AI-NYGTFTIKSDVWSFGILLTEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 20/155 (12%)

Query: 7   PNIVRLHEVLASRTKVYIILEFV-TGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           P IV+ +  L      +I +E +    + F K V+     E       ++++  +A    
Sbjct: 63  PYIVKFYGALFREGDCWICMELMDISLDKFYKYVY-----EVLKSVIPEEILGKIAVATV 117

Query: 66  KG---------VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
           K          + HRD+KP N+LLD  GN+K+ DFG+S      +         P Y+AP
Sbjct: 118 KALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRP-YMAP 176

Query: 117 E-VLSNR--GYDGSAADVWSCGVILFVLMAGYLPF 148
           E +  +   GYD   +DVWS G+ L+ +  G  P+
Sbjct: 177 ERIDPSARDGYD-VRSDVWSLGITLYEVATGKFPY 210

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 32/173 (18%)

Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGEL--FDKIVHQGRLLENDCR---------RYFQ 54
           HP IV ++ + +    VY  + ++ G  L    K V Q   L  +             F 
Sbjct: 61  HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120

Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL-------------SALPQQGV 101
           ++   + + HSKGV HRDLKP+N+LL  +G + + D+G                + ++ +
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180

Query: 102 ELLHTT-----CGTPNYVAPEVLSNRGYDGS-AADVWSCGVILFVLMAGYLPF 148
                T      GTP+Y+APE L   G   S + D+++ GVIL+ ++    P+
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERL--LGVPASESTDIYALGVILYQMLTLSFPY 231

Length = 932

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 6/152 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLID 58
           MK ++H  +V+LH V+ ++  +YII EF+  G L D  K     +        +  Q+ +
Sbjct: 55  MKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 113

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
            +A    +   HRDL+  N+L+ +    K++DFGL+ + +            P  + APE
Sbjct: 114 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 173

Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            + N G     +DVWS G++L  ++  G +P+
Sbjct: 174 AI-NFGSFTIKSDVWSFGILLMEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 23/153 (15%)

Query: 4   VRHPNIVRLHEVLASRT--KVYIILEFVTGGELFD--KIVHQGR------LLENDCRRYF 53
           ++H N+V L EV        VY++ ++       D  +I+   R      +  +  +   
Sbjct: 59  LKHENVVSLVEVFLEHADKSVYLLFDYAE----HDLWQIIKFHRQAKRVSIPPSMVKSLL 114

Query: 54  QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN----LKVSDFGLSALPQQGVELLHTTCG 109
            Q+++ V + HS  V HRDLKP N+L+   G     +K+ D GL+ L    ++ L     
Sbjct: 115 WQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174

Query: 110 ---TPNYVAPEV-LSNRGYDGSAADVWSCGVIL 138
              T  Y APE+ L  R Y   A D+W+ G I 
Sbjct: 175 VVVTIWYRAPELLLGARHYT-KAIDIWAIGCIF 206

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 32/89 (35%), Positives = 50/89 (56%), Gaps = 11/89 (12%)

Query: 68  VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH----TTCGTPNYVAPEVLSNRG 123
           + HRD+KP N+L++S G +K+ DFG+S       EL++    T  GT  Y++PE +    
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSG------ELINSIADTFVGTSTYMSPERIQGGK 178

Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETD 152
           Y    +DVWS G+ +  L  G  PF  ++
Sbjct: 179 YT-VKSDVWSLGISIIELALGKFPFAFSN 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 40/139 (28%), Positives = 69/139 (49%), Gaps = 8/139 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ +RHPN ++           ++++E+  G       VH+  L E +        +  +
Sbjct: 69  LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV-- 118
           A+ HS  + HRD+K  N+LL   G +K+ DFG +++    +   +   GTP ++APEV  
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI----MAPANXFVGTPYWMAPEVIL 184

Query: 119 -LSNRGYDGSAADVWSCGV 136
            +    YDG   DVWS G+
Sbjct: 185 AMDEGQYDGK-VDVWSLGI 202

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 62.3 bits (151), Expect = 4e-11
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 5/165 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDA 59
           MK+  HP +V+L+ V   R+ + ++ EF+  G L D +  Q G+  +         + + 
Sbjct: 54  MKL-SHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEG 112

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 118
           +A+  S  V HRDL   N L+     +KVSDFG++           T    P  + +PEV
Sbjct: 113 MAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEV 172

Query: 119 LSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINA 162
            S   Y  S +DVWS GV+++ V   G  P+       + + INA
Sbjct: 173 FSFSKYS-SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA 216

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 45/171 (26%), Positives = 76/171 (44%), Gaps = 20/171 (11%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ ++HPN +            ++++E+  G       VH+  L E +        +  +
Sbjct: 75  LQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGL 134

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV-- 118
           A+ HS  + HRD+K  N+LL   G +K++DFG ++         ++  GTP ++APEV  
Sbjct: 135 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA----NSFVGTPYWMAPEVIL 190

Query: 119 -LSNRGYDGSAADVWSCGVILFVL------------MAGYLPFGETDLPTL 156
            +    YDG   DVWS G+    L            M+      + D PTL
Sbjct: 191 AMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL 240

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 42/150 (28%), Positives = 73/150 (48%), Gaps = 13/150 (8%)

Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHC 63
           H NIVRL  V+     + I+ E+++ G L D  +  H+G+L+          L   + + 
Sbjct: 65  HSNIVRLEGVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGMKYL 123

Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---APEVLS 120
              G  H+ L    +L++S    K+S F    L +   E ++TT    + V   APE + 
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAI- 180

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGE 150
              +  SA+DVWS G++++ +M+    +GE
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMS----YGE 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 64/258 (24%), Positives = 107/258 (41%), Gaps = 61/258 (23%)

Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHS 65
           P IV  +    S  ++ I +E + GG L D+++ + GR+ EN   +    ++  + +   
Sbjct: 59  PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLRE 117

Query: 66  K-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 124
           K  + HRD+KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y
Sbjct: 118 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHY 175

Query: 125 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF--------------- 169
               +D+WS G+ L  +  G  P     +P    K   A F  P                
Sbjct: 176 TVQ-SDIWSLGLSLVEMAIGRYP-----IPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229

Query: 170 ----------------------------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPW 201
                                        FS      + K L  NPK R  ++ + KHP+
Sbjct: 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289

Query: 202 FRKNYNPVKCSEEEEVNL 219
            ++       +E EEV+ 
Sbjct: 290 IKR-------AELEEVDF 300

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 60.1 bits (146), Expect = 2e-10
 Identities = 52/173 (30%), Positives = 79/173 (45%), Gaps = 7/173 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M  + HP IVRL  V      + +++E    G L   +  +  +  +D +    Q+   +
Sbjct: 50  MAQLDHPCIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGM 108

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGT-P-NYVAPE 117
           A+  SK   HRDL   N+LL +    K+SDFG+S AL         TT G  P  + APE
Sbjct: 109 AYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPE 168

Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINAAE-FSCP 168
            ++   +  S +DVWS GV L+     G  P+GE     +   + + E    P
Sbjct: 169 CINYGKFS-SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRP 220

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 59.0 bits (143), Expect = 7e-10
 Identities = 47/149 (31%), Positives = 76/149 (51%), Gaps = 11/149 (7%)

Query: 1   MKIVRHPNIVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLI 57
           +K ++H NIV+   V   A R  + +++E++  G L D +  H+ RL       Y  Q+ 
Sbjct: 59  LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQIC 118

Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN----- 112
             + +  SK   HRDL   N+L++S   +K+ DFGL+ +  Q  E  +     P      
Sbjct: 119 KGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE--YYKVREPGESPIF 176

Query: 113 YVAPEVLSNRGYDGSAADVWSCGVILFVL 141
           + APE L+   +   A+DVWS GV+L+ L
Sbjct: 177 WYAPESLTESKFS-VASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 39/154 (25%), Positives = 74/154 (48%), Gaps = 5/154 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIIL-EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 59
           ++ + HP+I++L           +IL  + T  +L+  +  +  +   D     + ++ A
Sbjct: 137 LRAINHPSIIQLKGTFTYNKFTCLILPRYKT--DLYCYLAAKRNIAICDILAIERSVLRA 194

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ-GVELLHTTCGTPNYVAPEV 118
           + + H   + HRD+K EN+ ++  G++ + DFG +  P        +   GT    APE+
Sbjct: 195 IQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPEL 254

Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           L+   Y G A D+WS G++LF +   +    E D
Sbjct: 255 LARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKD 287

Length = 391

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 18/158 (11%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDA 59
           MK +RH  +V+L+ V+ S   +YI+ E+++ G L D +   +GR L+         L+D 
Sbjct: 55  MKKLRHDKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALK------LPNLVDM 107

Query: 60  VAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP- 111
            A   +   Y       HRDL+  N+L+      K++DFGL+ L +            P 
Sbjct: 108 AAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPI 167

Query: 112 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
            + APE  +  G     +DVWS G++L  L+  G +P+
Sbjct: 168 KWTAPEA-ALYGRFTIKSDVWSFGILLTELVTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 51/178 (28%), Positives = 81/178 (45%), Gaps = 23/178 (12%)

Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND------------- 48
           K+  HPNI+ L     +R  +YI +E+   G L D  + + R+LE D             
Sbjct: 58  KLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLD-FLRKSRVLETDPAFAKEHGTASTL 116

Query: 49  -CRRYFQQLIDAVAHCH---SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 104
             ++  Q   D          K   HRDL   N+L+      K++DFGLS    + V + 
Sbjct: 117 TSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVK 174

Query: 105 HTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI 160
            T    P  ++A E L+   Y  + +DVWS GV+L+ +++ G  P+       LY+K+
Sbjct: 175 KTMGRLPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 12/105 (11%)

Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPN 112
           Q+   +++ H +GV H+D+   N ++D    +K++D  LS    P       H      N
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD----YHCLGDNEN 180

Query: 113 ----YVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETD 152
               ++A E L N+ Y  SA+DVWS GV+L+ LM  G  P+ E D
Sbjct: 181 RPVKWMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVEID 224

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 37/165 (22%), Positives = 69/165 (41%), Gaps = 41/165 (24%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR--------RY 52
           MK     ++VRL  V+++     +++E +  G+L    +   R    +          ++
Sbjct: 63  MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKS-YLRSRRPEAENNPGLGPPTLQKF 121

Query: 53  FQ---QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL---------------S 94
            Q   ++ D +A+  +K   HRDL   N ++     +K+ DFG+                
Sbjct: 122 IQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKG 181

Query: 95  ALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 139
            LP +             ++APE L + G   + +DVWS GV+L+
Sbjct: 182 LLPVR-------------WMAPESLKD-GVFTTKSDVWSFGVVLW 212

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 57.4 bits (138), Expect = 2e-09
 Identities = 49/159 (30%), Positives = 77/159 (48%), Gaps = 20/159 (12%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  +Y +  QL+D
Sbjct: 55  MKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKGEMGKYLRLPQLVD 106

Query: 59  AVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP 111
             A   S   Y       HRDL+  N+L+      KV+DFGL+ L +            P
Sbjct: 107 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 166

Query: 112 -NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
             + APE  +  G     +DVWS G++L  L   G +P+
Sbjct: 167 IKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 47/165 (28%), Positives = 75/165 (45%), Gaps = 26/165 (15%)

Query: 1   MKIVRHPNIVRLHEVLASRT------KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF- 53
           +K ++H N++ L +V  S          Y+++ ++       KI+  G  L  D  +Y  
Sbjct: 68  LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIM--GHPLSEDKVQYLV 123

Query: 54  QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 113
            Q++  + + HS G+ HRDLKP NL ++    LK+ DFGL+          H       Y
Sbjct: 124 YQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR---------HADAEMTGY 174

Query: 114 V------APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           V      APEV+ N  +     D+WS G I+  ++ G   F   D
Sbjct: 175 VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 58.0 bits (140), Expect = 3e-09
 Identities = 29/88 (32%), Positives = 51/88 (57%), Gaps = 3/88 (3%)

Query: 54  QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ--QGVELLHTTCGTP 111
           +QL+ A+ + H +G+ HRD+K EN+L++   ++ + DFG +   +        +   GT 
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326

Query: 112 NYVAPEVLSNRGYDGSAADVWSCGVILF 139
           +  APEVL+   Y  S  D+WS G+++F
Sbjct: 327 DTNAPEVLAGDPYTPS-VDIWSAGLVIF 353

Length = 461

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 57.4 bits (138), Expect = 4e-09
 Identities = 41/159 (25%), Positives = 76/159 (47%), Gaps = 17/159 (10%)

Query: 1   MKIVRHPNIVRLHEVLASRT--KVYIILEFVTGGELFDKIVHQG--------RLLENDCR 50
           ++ ++HPN++ L +V  S +  KV+++ ++           H+         +L  +  +
Sbjct: 52  LRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVK 111

Query: 51  RYFQQLIDAVAHCHSKGVYHRDLKPENLLL----DSYGNLKVSDFGLSAL---PQQGVEL 103
               Q++D + + H+  V HRDLKP N+L+       G +K++D G + L   P + +  
Sbjct: 112 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 171

Query: 104 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM 142
           L     T  Y APE+L    +   A D+W+ G I   L+
Sbjct: 172 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 49/178 (27%), Positives = 80/178 (44%), Gaps = 23/178 (12%)

Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND------------- 48
           K+  HPNI+ L      R  +Y+ +E+   G L D  + + R+LE D             
Sbjct: 51  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTL 109

Query: 49  ----CRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 104
                  +   +   + +   K   HRDL   N+L+      K++DFGLS    Q V + 
Sbjct: 110 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVK 167

Query: 105 HTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI 160
            T    P  ++A E L+   Y  + +DVWS GV+L+ +++ G  P+       LY+K+
Sbjct: 168 KTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 224

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 41/159 (25%), Positives = 74/159 (46%), Gaps = 17/159 (10%)

Query: 1   MKIVRHPNIVRLHEVLASRT--KVYIILEFVTGGELFDKIVHQG--------RLLENDCR 50
           ++ ++HPN++ L +V  S    KV+++ ++           H+         +L     +
Sbjct: 52  LRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 111

Query: 51  RYFQQLIDAVAHCHSKGVYHRDLKPENLLL----DSYGNLKVSDFGLSAL---PQQGVEL 103
               Q++D + + H+  V HRDLKP N+L+       G +K++D G + L   P + +  
Sbjct: 112 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 171

Query: 104 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM 142
           L     T  Y APE+L    +   A D+W+ G I   L+
Sbjct: 172 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 56.8 bits (137), Expect = 7e-09
 Identities = 40/152 (26%), Positives = 71/152 (46%), Gaps = 8/152 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K + H  I+ L      ++ V +++      +LF  +   G L         ++L++A+
Sbjct: 140 LKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEAL 198

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC----GTPNYVAP 116
           A+ H +G+ HRD+K EN+ LD   N  + DFG  A  +         C    GT    +P
Sbjct: 199 AYLHGRGIIHRDVKTENIFLDEPENAVLGDFG--AACKLDAHPDTPQCYGWSGTLETNSP 256

Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 148
           E+L+   Y  +  D+WS G++LF +    +  
Sbjct: 257 ELLALDPY-CAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 56.6 bits (136), Expect = 8e-09
 Identities = 40/111 (36%), Positives = 61/111 (54%), Gaps = 3/111 (2%)

Query: 52  YFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGT 110
           Y  QL  A+A+ HSK + HRDLKP+NLL+D +   LK+ DFG +     G   +   C +
Sbjct: 175 YSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC-S 233

Query: 111 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKI 160
             Y APE++       +  D+WS G I+  ++ GY  F G++ +  L + I
Sbjct: 234 RFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII 284

Length = 440

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 56.1 bits (135), Expect = 9e-09
 Identities = 49/182 (26%), Positives = 83/182 (45%), Gaps = 29/182 (15%)

Query: 1   MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGEL---------------FDKI-VHQGR 43
           MK++ +H NI+ L  V      +Y+I+E+   G L               FD   V + +
Sbjct: 71  MKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ 130

Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
           L   D      Q+   + +  S+   HRDL   N+L+     +K++DFGL+    +GV  
Sbjct: 131 LSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLA----RGVHD 186

Query: 104 LHTTCGTPN------YVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTL 156
           +     T N      ++APE L +R Y    +DVWS G++++ +   G  P+    +  L
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245

Query: 157 YK 158
           +K
Sbjct: 246 FK 247

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 15/151 (9%)

Query: 1   MKIVRHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKI----VHQGRLLENDCRRYFQ 54
           +K + H NIV+     + +    + +I+E+V  G L D +    ++  +LL      + Q
Sbjct: 60  LKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL-----LFAQ 114

Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q+ + +A+ HS+   HRDL   N+LLD+   +K+ DFGL+    +G E         + V
Sbjct: 115 QICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 174

Query: 115 ---APEVLSNRGYDGSAADVWSCGVILFVLM 142
              A E L    +   A+DVWS GV L+ L+
Sbjct: 175 FWYAVECLKENKF-SYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 47/182 (25%), Positives = 80/182 (43%), Gaps = 29/182 (15%)

Query: 1   MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFD----------------KIVHQGR 43
           MK++ +H NI+ L  V      +Y+++E+   G L D                    +  
Sbjct: 69  MKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEET 128

Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
           L + D   +  Q+   +    SK   HRDL   N+L+     +K++DFGL+    + +  
Sbjct: 129 LTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA----RDIHH 184

Query: 104 L-----HTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL 156
           +      T    P  ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L
Sbjct: 185 IDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243

Query: 157 YK 158
           +K
Sbjct: 244 FK 245

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 55.1 bits (132), Expect = 1e-08
 Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 7/202 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLE-NDCRRYFQQLID 58
           MK +RH  +V L+ V+ S   +YI+ EF+  G L D +    G+ L+         Q+ D
Sbjct: 55  MKKLRHDKLVPLYAVV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIAD 113

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
            +A+       HRDL+  N+L+      K++DFGL+ L +            P  + APE
Sbjct: 114 GMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKINAAEFSCPFWFSTGA 175
             +  G     +DVWS G++L  L+  G +P+ G  +   L +        CP       
Sbjct: 174 A-ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESL 232

Query: 176 TSLIHKILDPNPKTRIRIEGIR 197
             L+      +P  R   E I+
Sbjct: 233 HELMKLCWKKDPDERPTFEYIQ 254

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 23/178 (12%)

Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND----------CRR 51
           K+  HPNI+ L      R  +Y+ +E+   G L D  + + R+LE D             
Sbjct: 63  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTL 121

Query: 52  YFQQLIDAVA-------HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 104
             QQL+   A       +   K   HRDL   N+L+      K++DFGLS    Q V + 
Sbjct: 122 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVK 179

Query: 105 HTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 160
            T    P  ++A E L+   Y  + +DVWS GV+L+ ++  G  P+       LY+K+
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 46/165 (27%), Positives = 69/165 (41%), Gaps = 22/165 (13%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI--- 57
           M    H NIVRL  V   R   +I+LE + GG+L   +       E       + L+   
Sbjct: 63  MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122

Query: 58  -DAVAHCH---SKGVYHRDLKPENLLLDSYGN---LKVSDFGL------SALPQQGVELL 104
            D    C         HRD+   N LL   G     K++DFG+      ++  ++G   +
Sbjct: 123 RDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAM 182

Query: 105 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
                 P    PE   + G   S  DVWS GV+L+ + + GY+P+
Sbjct: 183 LPIKWMP----PEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPY 222

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 13/169 (7%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +  + T V +I + +  G L D +  H+  +       +  Q+   
Sbjct: 63  MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 121

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E
Sbjct: 122 MNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALE 181

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 182 SILHRIYT-HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 221

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 48/178 (26%), Positives = 80/178 (44%), Gaps = 21/178 (11%)

Query: 1   MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 43
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 77  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQ 136

Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
           L   D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+         
Sbjct: 137 LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 196

Query: 104 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
             TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 21/208 (10%)

Query: 1   MKIVRHPNIVRLHEV-LASRTK-----VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           MK   HPN+++L  V L SR K       +IL F+  G+L   ++   R+ E       Q
Sbjct: 55  MKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQ 113

Query: 55  QLID-------AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT 107
            L+         + +  SK   HRDL   N +L+    + V+DFGLS     G +     
Sbjct: 114 TLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSG-DYYRQG 172

Query: 108 CGTP---NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKK-INA 162
           C +     ++A E L++  Y  + +DVW+ GV ++ +M  G  P+   +   +Y   I  
Sbjct: 173 CASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG 231

Query: 163 AEFSCPFWFSTGATSLIHKILDPNPKTR 190
                P         L+ +   P PK R
Sbjct: 232 NRLKQPPDCLEDVYELMCQCWSPEPKCR 259

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 50.4 bits (120), Expect = 5e-07
 Identities = 60/217 (27%), Positives = 92/217 (42%), Gaps = 23/217 (10%)

Query: 1   MKIVRHPNIVRLHEVLASRTKV------YIILEFVTGGELFDKIVHQGRLLENDCRRYF- 53
           MK   HPN++RL  V     +        +IL F+  G+L   +++  RL   DC +Y  
Sbjct: 54  MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYS-RL--GDCPQYLP 110

Query: 54  -QQLI-------DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH 105
            Q L+         + +  SK   HRDL   N +L+   N+ V+DFGLS     G     
Sbjct: 111 TQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQ 170

Query: 106 TTCGT--PNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINA 162
                    ++A E L++R Y  + +DVWS GV ++ +   G  P+   +   +Y  +  
Sbjct: 171 GRIAKMPVKWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ 229

Query: 163 A-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK 198
                 P     G  SL+      NPK R   E +R 
Sbjct: 230 GNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRC 266

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 50.4 bits (120), Expect = 5e-07
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 9/166 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M  V  P + RL  +  + T V ++ + +  G L D +  ++ R+   D   +  Q+   
Sbjct: 63  MAGVGSPYVCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKG 121

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           +++     + HRDL   N+L+ S  ++K++DFGL+ L        H   G  P  ++A E
Sbjct: 122 MSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMA----GYLPFGETDLPTLYKK 159
            + +R +    +DVWS GV ++ LM      Y      ++P L +K
Sbjct: 182 SILHRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK 226

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 50.0 bits (119), Expect = 8e-07
 Identities = 45/178 (25%), Positives = 79/178 (44%), Gaps = 21/178 (11%)

Query: 1   MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 43
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V   +
Sbjct: 74  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133

Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
           +   D      Q+   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYY 193

Query: 104 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 194 KKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 50.1 bits (119), Expect = 8e-07
 Identities = 51/172 (29%), Positives = 86/172 (50%), Gaps = 21/172 (12%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ------GRLLENDCRRYFQ 54
           M  + HP++VRL  V  S T + ++ + +  G L D  VH+       +LL N C     
Sbjct: 63  MASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLD-YVHEHKDNIGSQLLLNWC----V 116

Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP--- 111
           Q+   + +   + + HRDL   N+L+ S  ++K++DFGL+ L  +G E  +   G     
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL-LEGDEKEYNADGGKMPI 175

Query: 112 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFG---ETDLPTLYKK 159
            ++A E +  R +    +DVWS GV ++ LM  G  P+      ++P L +K
Sbjct: 176 KWMALECIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK 226

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 40/208 (19%)

Query: 6   HPNIVRLHEVLASRTK---VYIILEFVTGGELFDKIVHQGR---LLENDCRRYFQQLIDA 59
           H NIV L   L + T    + +I E+   G+L +  + + R   L   D   +  Q+   
Sbjct: 98  HENIVNL---LGACTIGGPILVITEYCCYGDLLN-FLRRKRESFLTLEDLLSFSYQVAKG 153

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV----- 114
           +A   SK   HRDL   N+LL     +K+ DFGL+       ++++ +    NYV     
Sbjct: 154 MAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR------DIMNDS----NYVVKGNA 203

Query: 115 -------APEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPT---LYKKI-NA 162
                  APE + N  Y    +DVWS G++L+ + + G  P+    +P     YK I   
Sbjct: 204 RLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPY--PGMPVDSKFYKLIKEG 260

Query: 163 AEFSCPFWFSTGATSLIHKILDPNPKTR 190
              + P         ++    D +P  R
Sbjct: 261 YRMAQPEHAPAEIYDIMKTCWDADPLKR 288

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 47/178 (26%), Positives = 80/178 (44%), Gaps = 21/178 (11%)

Query: 1   MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGEL---------------FDKI-VHQGR 43
           MK++ +H NI+ L         +Y+++E+ + G L               FD   + + +
Sbjct: 71  MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ 130

Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
           L   D      Q+   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 131 LTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYY 190

Query: 104 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
             TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 191 KKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 47.3 bits (112), Expect = 6e-06
 Identities = 39/161 (24%), Positives = 74/161 (45%), Gaps = 9/161 (5%)

Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCH 64
           H  IVRL  +      + ++ +    G L D +  H+  L       +  Q+   + +  
Sbjct: 68  HAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE 126

Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP-NYVAPEVLSNR 122
              + HR+L   N+LL S   ++++DFG++  L     +  ++   TP  ++A E +   
Sbjct: 127 EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186

Query: 123 GYDGSAADVWSCGVILFVLMA-GYLPFGET---DLPTLYKK 159
            Y    +DVWS GV ++ +M+ G  P+      ++P L +K
Sbjct: 187 RYT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK 226

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 46.8 bits (111), Expect = 7e-06
 Identities = 38/143 (26%), Positives = 70/143 (48%), Gaps = 7/143 (4%)

Query: 6   HPNIVRLHEVLASR--TKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAH 62
           H NIV+   +        + +I+EF+  G L + +  ++ ++      +Y  Q+   + +
Sbjct: 65  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDY 124

Query: 63  CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ--QGVELLHTTCGTPNY-VAPEVL 119
             S+   HRDL   N+L++S   +K+ DFGL+   +  +    +     +P +  APE L
Sbjct: 125 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184

Query: 120 SNRGYDGSAADVWSCGVILFVLM 142
               +   A+DVWS GV L+ L+
Sbjct: 185 IQSKF-YIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 46.7 bits (111), Expect = 7e-06
 Identities = 50/203 (24%), Positives = 83/203 (40%), Gaps = 20/203 (9%)

Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGEL--FDKIVHQGRLLENDCRRYFQQLIDAVA 61
           + H N+VRL  +       Y+ILE+   G+L  F +   + +  +        +   A+ 
Sbjct: 65  LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRA-TKSKDEKLKPPPLSTKQKVALC 123

Query: 62  HCHSKGV--------YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-N 112
              + G+         HRDL   N L+ S   +KVS   LS                P  
Sbjct: 124 TQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR 183

Query: 113 YVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINAAEFSCPFWF 171
           ++APE +    +  + +DVWS GV+++ V   G LPF       +  ++ A +   P   
Sbjct: 184 WLAPEAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP--V 240

Query: 172 STGATSLIHKIL----DPNPKTR 190
             G  S ++K++      NPK R
Sbjct: 241 PEGCPSRLYKLMTRCWAVNPKDR 263

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 39/168 (23%), Positives = 74/168 (44%), Gaps = 27/168 (16%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGEL----------------FDKIVHQGRL 44
           +K V HP++++L+   +    + +I+E+   G L                 D   +   L
Sbjct: 57  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYL 116

Query: 45  LENDCR--------RYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA- 95
              D R         +  Q+   + +     + HRDL   N+L+     +K+SDFGLS  
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176

Query: 96  LPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLM 142
           + ++   +  +    P  ++A E L +  Y  + +DVWS GV+L+ ++
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 47.5 bits (113), Expect = 8e-06
 Identities = 24/74 (32%), Positives = 39/74 (52%), Gaps = 10/74 (13%)

Query: 50  RRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGV-----EL 103
           +   +Q++ A+   HS G+ HRD+KP+N++     G+ K+ D G +A  + G+     E 
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEF 317

Query: 104 LHTTCGTPNYVAPE 117
           L      P Y APE
Sbjct: 318 LL----DPRYAAPE 327

Length = 566

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 46.8 bits (111), Expect = 8e-06
 Identities = 32/153 (20%), Positives = 61/153 (39%), Gaps = 13/153 (8%)

Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQ-----L 56
           + + HPN+++            ++LEF   G+L + +     ++    ++   Q     +
Sbjct: 50  RELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEV 109

Query: 57  IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL--SALPQQGVELLHTTCGTPNYV 114
              +   H     H DL   N  L +  ++K+ D+GL     P+              ++
Sbjct: 110 ASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWL 169

Query: 115 APEVLSNRGYDGSAAD------VWSCGVILFVL 141
           APE++  RG D    D      +WS GV ++ L
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 4/97 (4%)

Query: 109 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP 168
           GTP+Y+APE+L  + + G A D W+ GV LF  + G  PF +     +++ I   +   P
Sbjct: 542 GTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600

Query: 169 FW---FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 202
                 S  A + I  +L  +P  R  ++ +++HP F
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLF 637

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 29/95 (30%), Positives = 46/95 (48%), Gaps = 3/95 (3%)

Query: 27  EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNL 86
           EF+  G+     + Q +   N  +   +Q++  +   H  G+ HRD+KPENLL+   G +
Sbjct: 289 EFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQV 348

Query: 87  KVSDFGLSALPQQGVEL--LHTTCGTPNYVAPEVL 119
           K+ DFG +     G+    L+     P Y  PE L
Sbjct: 349 KIIDFGAAVDMCTGINFNPLYGML-DPRYSPPEEL 382

Length = 507

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 48/170 (28%), Positives = 70/170 (41%), Gaps = 30/170 (17%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD------KIVHQGRLLENDCRRYFQ 54
           M    HPNIV+L  V       YII+E + GG+L               LL    +    
Sbjct: 53  MSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLT--LKELLD 110

Query: 55  QLIDAVAHCH---SKGVYHRDLKPENLLLDSYGN-----LKVSDFGLSA-------LPQQ 99
             +D    C         HRDL   N L+   G      +K+ DFGL+          ++
Sbjct: 111 ICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKE 170

Query: 100 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
           G  LL        ++APE L + G   + +DVWS GV+++ +L  G  P+
Sbjct: 171 GEGLLPV-----RWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPY 214

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 39/187 (20%), Positives = 78/187 (41%), Gaps = 41/187 (21%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDC---------RR 51
            + ++HPNI+         +++Y++   +  G   D       LL+              
Sbjct: 53  SRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED-------LLKTHFPEGLPELAIAF 105

Query: 52  YFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA--------------LP 97
             + +++A+ + HSKG  HR +K  ++LL   G + +S    S                P
Sbjct: 106 ILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP 165

Query: 98  QQGVELLHTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT 155
           +  V+ L        +++PEVL    +GY+   +D++S G+    L  G++PF +     
Sbjct: 166 KSSVKNL-------PWLSPEVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQ 217

Query: 156 LY-KKIN 161
           +  +K+ 
Sbjct: 218 MLLEKVR 224

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 44/194 (22%), Positives = 79/194 (40%), Gaps = 37/194 (19%)

Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRYFQ---- 54
           HPNIV+L  V A    + ++ E++  G+L +       +         +  R+       
Sbjct: 67  HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126

Query: 55  -----------QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
                      Q+   +A+   +   HRDL   N L+     +K++DFGLS    + +  
Sbjct: 127 LSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS----RNIYS 182

Query: 104 LHTTCGTPN------YVAPE-VLSNRGYDGSAADVWSCGVILFVLMA-GYLP-FGETDLP 154
                 + N      ++ PE +  NR    + +DVW+ GV+L+ + + G  P +G     
Sbjct: 183 ADYYKASENDAIPIRWMPPESIFYNRY--TTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240

Query: 155 TLYKKINAAEFSCP 168
            +Y   +    SCP
Sbjct: 241 VIYYVRDGNVLSCP 254

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 43/170 (25%), Positives = 77/170 (45%), Gaps = 24/170 (14%)

Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDA 59
           K+  HPNIV       +  +++++  F+  G   D I       + E       Q ++ A
Sbjct: 54  KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKA 113

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ-----QGVELLHTTCGTPNY- 113
           + + H  G  HR +K  ++L+   G + +S  GL +        Q + ++H     P Y 
Sbjct: 114 LDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHD---FPKYS 168

Query: 114 ------VAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT 155
                 ++PEVL    +GYD + +D++S G+    L  G++PF   D+P 
Sbjct: 169 VKVLPWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPF--KDMPA 215

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 46/174 (26%), Positives = 79/174 (45%), Gaps = 8/174 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M  + +P IVR+  V  +   + +++E  +GG L   +   +  +  ++      Q+   
Sbjct: 49  MHQLDNPYIVRMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMG 107

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGT-P-NYVAP 116
           + +   K   HRDL   N+LL +    K+SDFGLS AL          + G  P  + AP
Sbjct: 108 MKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAP 167

Query: 117 EVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINAAE-FSCP 168
           E ++ R +  S +DVWS G+ ++     G  P+ +   P +   I   +   CP
Sbjct: 168 ECINFRKFS-SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCP 220

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 44/165 (26%), Positives = 75/165 (45%), Gaps = 20/165 (12%)

Query: 1   MKIVRHPNIVRLHEV---LASRTKV---YIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           MK   HPN+++L  V    +S  K+    +IL F+  G+L   +++  RL     +   Q
Sbjct: 55  MKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYS-RLGGLPEKLPLQ 113

Query: 55  QLIDAVA-------HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT 107
            L+  +        +  ++   HRDL   N +L     + V+DFGLS     G +     
Sbjct: 114 TLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG-DYYRQG 172

Query: 108 CGTP---NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
                   ++A E L++R Y  S +DVW+ GV ++ +   G  P+
Sbjct: 173 RIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 23/87 (26%)

Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---------- 114
           S+   HRDL   N+LL     +K+ DFGL+                P+YV          
Sbjct: 191 SRKCIHRDLAARNILLSENNVVKICDFGLA----------RDIYKDPDYVRKGDARLPLK 240

Query: 115 --APEVLSNRGYDGSAADVWSCGVILF 139
             APE + ++ Y  + +DVWS GV+L+
Sbjct: 241 WMAPESIFDKVYT-TQSDVWSFGVLLW 266

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 41.7 bits (98), Expect = 3e-04
 Identities = 47/164 (28%), Positives = 75/164 (45%), Gaps = 18/164 (10%)

Query: 1   MKIVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLID 58
           MK   HPN++ L  + L S     ++L ++  G+L + I  +       D   +  Q+  
Sbjct: 50  MKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAK 109

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA--------LPQQGVELLHTTCGT 110
            + +  SK   HRDL   N +LD    +KV+DFGL+                  HT    
Sbjct: 110 GMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN-----HTGAKL 164

Query: 111 P-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETD 152
           P  ++A E L  + +  + +DVWS GV+L+ LM  G  P+ + D
Sbjct: 165 PVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVD 207

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 41.2 bits (96), Expect = 6e-04
 Identities = 38/134 (28%), Positives = 60/134 (44%), Gaps = 25/134 (18%)

Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
           L   D   +  Q+   +    SK   HRDL   N+LL     +K+ DFGL+       ++
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLAR------DI 287

Query: 104 LHTTCGTPNYV------------APEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-G 149
           +H +    NYV            APE + +  Y  + +DVWS G++L+ + + G  P+ G
Sbjct: 288 MHDS----NYVSKGSTFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPG 342

Query: 150 ETDLPTLYKKINAA 163
                T Y KI + 
Sbjct: 343 MIVDSTFYNKIKSG 356

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 40.7 bits (95), Expect = 7e-04
 Identities = 40/143 (27%), Positives = 71/143 (49%), Gaps = 7/143 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDA 59
           M+ + +P IVR+  +  + + + +++E    G L +K + + + + E +      Q+   
Sbjct: 50  MQQLDNPYIVRMIGICEAESWM-LVMELAELGPL-NKFLQKNKHVTEKNITELVHQVSMG 107

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGT-P-NYVAP 116
           + +       HRDL   N+LL +    K+SDFGLS AL          T G  P  + AP
Sbjct: 108 MKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAP 167

Query: 117 EVLSNRGYDGSAADVWSCGVILF 139
           E ++   +  S +DVWS GV+++
Sbjct: 168 ECMNYYKFS-SKSDVWSFGVLMW 189

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 40.7 bits (95), Expect = 8e-04
 Identities = 26/106 (24%), Positives = 47/106 (44%), Gaps = 12/106 (11%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG---------ELFDKIVHQGRLLE---ND 48
           M  +++PNI+RL  V  S   + +I E++  G         E+     H   +      +
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130

Query: 49  CRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS 94
                 Q+   + +  S    HRDL   N L+ ++  +K++DFG+S
Sbjct: 131 LLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 40.5 bits (95), Expect = 9e-04
 Identities = 41/158 (25%), Positives = 67/158 (42%), Gaps = 21/158 (13%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV----HQGRLLEN--------- 47
           M  ++HPNIV L  V        ++ E++  G+L + +V    H     E+         
Sbjct: 62  MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL 121

Query: 48  DCRRYFQ---QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VE 102
           DC  +     Q+   + +  S    HRDL   N L+     +K+SDFGLS          
Sbjct: 122 DCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR 181

Query: 103 LLHTTCGTPNYVAPE-VLSNRGYDGSAADVWSCGVILF 139
           +   +     ++ PE +L  +    S  D+WS GV+L+
Sbjct: 182 VQSKSLLPVRWMPPEAILYGKFTTES--DIWSFGVVLW 217

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 38/157 (24%), Positives = 72/157 (45%), Gaps = 25/157 (15%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELF--------DKIVHQGRLLENDCRRY 52
           MK     ++VRL  V++      +++E +  G+L         +   + GR      +  
Sbjct: 63  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT-LQEM 121

Query: 53  FQ---QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-------LPQQGVE 102
            Q   ++ D +A+ ++K   HRDL   N ++     +K+ DFG++          + G  
Sbjct: 122 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKG 181

Query: 103 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 139
           LL        ++APE L + G   +++D+WS GV+L+
Sbjct: 182 LLPV-----RWMAPESLKD-GVFTTSSDMWSFGVVLW 212

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 39/168 (23%), Positives = 72/168 (42%), Gaps = 21/168 (12%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-----------------QGR 43
           M  + HPNIV L  V+     V ++ E++  G+L + ++                  +  
Sbjct: 61  MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120

Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVE 102
           L   D      Q+   + +  S    H+DL   N+L+    ++K+SD GLS  +      
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYY 180

Query: 103 LLHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
            +      P  ++ PE +    +  S +D+WS GV+L+ + + G  P+
Sbjct: 181 RVQPKSLLPIRWMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 39.6 bits (92), Expect = 0.001
 Identities = 39/156 (25%), Positives = 73/156 (46%), Gaps = 23/156 (14%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND-------CRRYF 53
           MK     ++VRL  V++      +I+E +T G+L   +      +EN+        ++  
Sbjct: 63  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122

Query: 54  Q---QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-------ALPQQGVEL 103
           Q   ++ D +A+ ++    HRDL   N ++     +K+ DFG++          + G  L
Sbjct: 123 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 182

Query: 104 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 139
           L        +++PE L + G   + +DVWS GV+L+
Sbjct: 183 LPV-----RWMSPESLKD-GVFTTYSDVWSFGVVLW 212

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 38/153 (24%), Positives = 65/153 (42%), Gaps = 14/153 (9%)

Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQL---ID 58
           +I++HPNI++            ++ E+   G+L   +  +     N      Q++   I 
Sbjct: 50  RILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIA 109

Query: 59  A-VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL--SALPQQGVELLHTTCGTPNYVA 115
           A V H H     H DL   N  L S   +KV D+G+  S   +  +E     C    ++A
Sbjct: 110 AGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLA 169

Query: 116 PEVLSNRGYDG-------SAADVWSCGVILFVL 141
           PE++    + G         ++VW+ GV L+ L
Sbjct: 170 PELVGEF-HGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 28/87 (32%), Positives = 39/87 (44%), Gaps = 23/87 (26%)

Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---------- 114
           S+   HRDL   N+LL     +K+ DFGL+                P+YV          
Sbjct: 197 SRKCIHRDLAARNILLSENNVVKICDFGLA----------RDIYKDPDYVRKGDARLPLK 246

Query: 115 --APEVLSNRGYDGSAADVWSCGVILF 139
             APE + +R Y    +DVWS GV+L+
Sbjct: 247 WMAPETIFDRVYT-IQSDVWSFGVLLW 272

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 23/87 (26%)

Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---------- 114
           S+   HRDL   N+LL     +K+ DFGL+                P+YV          
Sbjct: 192 SRKCIHRDLAARNILLSENNVVKICDFGLA----------RDIYKDPDYVRKGSARLPLK 241

Query: 115 --APEVLSNRGYDGSAADVWSCGVILF 139
             APE + ++ Y  + +DVWS GV+L+
Sbjct: 242 WMAPESIFDKVYT-TQSDVWSFGVLLW 267

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 37.8 bits (88), Expect = 0.002
 Identities = 21/96 (21%), Positives = 39/96 (40%), Gaps = 11/96 (11%)

Query: 5   RHPNIV-RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           R    V ++     S    Y+++E++ G  L         + E +     +QL + +A  
Sbjct: 50  RKGLPVPKVLASGESDGWSYLLMEWIEGETL-------DEVSEEEKEDIAEQLAELLAKL 102

Query: 64  HSKGVY---HRDLKPENLLLDSYGNLKVSDFGLSAL 96
           H   +    H DL P N+L+D    L + D+  +  
Sbjct: 103 HQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 41/155 (26%), Positives = 65/155 (41%), Gaps = 22/155 (14%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M  ++HPNIV+L  +  S    Y+I E++ G  L         +L N      +++   +
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL-------SEVLRNLSWERRRKIAIGI 789

Query: 61  A------HCH-SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN- 112
           A      HC  S  V   +L PE +++D        D     L   G+    T C   + 
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIIID------GKDEPHLRLSLPGLLCTDTKCFISSA 843

Query: 113 YVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLP 147
           YVAPE    +      +D++  G+IL  L+ G  P
Sbjct: 844 YVAPETRETKDIT-EKSDIYGFGLILIELLTGKSP 877

Length = 968

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 38.3 bits (90), Expect = 0.003
 Identities = 23/71 (32%), Positives = 34/71 (47%), Gaps = 5/71 (7%)

Query: 24  IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY 83
           I++E++ G  L D I   G       R   +     V   HS G+ H DL   N++L S 
Sbjct: 76  IVMEYIEGEPLKDLINSNGMEELELSREIGRL----VGKLHSAGIIHGDLTTSNMIL-SG 130

Query: 84  GNLKVSDFGLS 94
           G + + DFGL+
Sbjct: 131 GKIYLIDFGLA 141

Length = 211

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 38.9 bits (90), Expect = 0.003
 Identities = 34/151 (22%), Positives = 65/151 (43%), Gaps = 16/151 (10%)

Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-------------RLLENDCR 50
           ++H +IV+ + V      + ++ E++  G+L   +   G              L ++   
Sbjct: 64  LQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML 123

Query: 51  RYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTC 108
              QQ+   + +  S+   HRDL   N L+     +K+ DFG+S          +   T 
Sbjct: 124 HIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 183

Query: 109 GTPNYVAPEVLSNRGYDGSAADVWSCGVILF 139
               ++ PE +  R +  + +DVWS GV+L+
Sbjct: 184 LPIRWMPPESIMYRKFT-TESDVWSLGVVLW 213

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 38.0 bits (88), Expect = 0.004
 Identities = 45/166 (27%), Positives = 79/166 (47%), Gaps = 21/166 (12%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCR-RYFQQLID 58
           M+ V H +IV L+ V     +  ++ EFV  G L D  +H +  +L    + +  +QL  
Sbjct: 58  MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL-DLFMHRKSDVLTTPWKFKVAKQLAS 116

Query: 59  AVAHCHSKGVYHRDLKPENLLL-----DSYGN--LKVSDFG--LSALP-QQGVELLHTTC 108
           A+++   K + H ++  +N+LL     D      +K+SD G  ++ L  Q+ VE +    
Sbjct: 117 ALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI---- 172

Query: 109 GTPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDL 153
               ++APE + +      AAD WS G  L+ +   G +P  +  L
Sbjct: 173 ---PWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL 215

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	381
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PTZ00284	467	protein kinase; Provisional	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.98
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.98
PLN00181	793	protein SPA1-RELATED; Provisional	99.98
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.98
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.98
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.98
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.96
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.96
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.94
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
KOG3653	534	consensus Transforming growth factor beta/activin	99.94
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.93
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.92
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.9
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.89
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.86
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.84
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.82
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.79
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.79
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.78
PRK09188	365	serine/threonine protein kinase; Provisional	99.76
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.74
PRK12274	218	serine/threonine protein kinase; Provisional	99.72
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.68
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.68
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.68
PRK10345	210	hypothetical protein; Provisional	99.66
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.66
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.65
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.6
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.53
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.52
PF03822	63	NAF: NAF domain; InterPro: IPR004041 The NAF domai	99.51
PRK14879	211	serine/threonine protein kinase; Provisional	99.5
smart00090	237	RIO RIO-like kinase.	99.47
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.44
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.43
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.43
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.42
KOG1243	690	consensus Protein kinase [General function predict	99.36
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.32
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.19
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.18
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.16
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.03
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.02
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.01
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.93
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.82
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.8
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.8
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.77
COG4248	637	Uncharacterized protein with protein kinase and he	98.68
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.66
KOG3087	229	consensus Serine/threonine protein kinase [General	98.56
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.33
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.3
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.29
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.27
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.21
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.19
PF02149	47	KA1: Kinase associated domain 1; InterPro: IPR0017	98.06
PRK09902	216	hypothetical protein; Provisional	97.96
COG0478	304	RIO-like serine/threonine protein kinase fused to	97.78
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.57
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.28
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.25
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.22
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.08
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.06
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	96.69
PF01636	239	APH: Phosphotransferase enzyme family This family	96.61
PLN02876	822	acyl-CoA dehydrogenase	96.36
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.88
KOG1235	538	consensus Predicted unusual protein kinase [Genera	95.65
KOG2268	465	consensus Serine/threonine protein kinase [Signal	95.63
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	94.76
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	94.35
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	94.12
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	94.11
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	93.97
PRK05231	319	homoserine kinase; Provisional	93.44
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	93.3
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	93.3
PRK10271	188	thiK thiamine kinase; Provisional	93.18
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	92.92
PRK10593	297	hypothetical protein; Provisional	92.26
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	92.23
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	91.64
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	91.58
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	91.18
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	90.97
PRK09550	401	mtnK methylthioribose kinase; Reviewed	90.94
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	90.75
PHA03111	444	Ser/Thr kinase; Provisional	90.58
PLN02236	344	choline kinase	90.39
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	90.09
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	90.04
COG2334	331	Putative homoserine kinase type II (protein kinase	89.21
PRK06148	1013	hypothetical protein; Provisional	86.02
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	85.51
PRK11768	325	serine/threonine protein kinase; Provisional	85.26
KOG2270	520	consensus Serine/threonine protein kinase involved	84.42
PRK06149	972	hypothetical protein; Provisional	84.37

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-56  Score=438.16  Aligned_cols=205  Identities=46%  Similarity=0.891  Sum_probs=198.6

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      ||.+.||||+++|++++++.++|+|+||++||+||+++...|+++|.+|.++|+||+.|+.|||..+|+||||||||+|+
T Consensus        66 MkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL  145 (786)
T KOG0588|consen   66 MKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL  145 (786)
T ss_pred             HHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh
Confidence            78999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      |..+++||+|||+|..... +..+.|.||+|+|.|||++.+.+|+|.++||||||||||.||+|++||++.|...++.++
T Consensus       146 d~~~nIKIADFGMAsLe~~-gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV  224 (786)
T KOG0588|consen  146 DVKNNIKIADFGMASLEVP-GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV  224 (786)
T ss_pred             hcccCEeeeccceeecccC-CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence            9999999999999987543 478999999999999999999999999999999999999999999999999999999999


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      +.+.|..|..+|+++++||++||+.||.+|+|.+||++|||+.+..
T Consensus       225 ~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~  270 (786)
T KOG0588|consen  225 QRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT  270 (786)
T ss_pred             HcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence            9999999999999999999999999999999999999999998654

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-55  Score=429.04  Aligned_cols=208  Identities=58%  Similarity=1.046  Sum_probs=198.4

Q ss_pred             CCCCC-ccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVR-HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~-HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |++++ ||||+++++++.+.+.+|+|||||.||+|+++|...+++.|..++.+|+||++||+|||++||+||||||||||
T Consensus        73 ~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENil  152 (370)
T KOG0583|consen   73 LRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENIL  152 (370)
T ss_pred             HHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEE
Confidence            45677 99999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EccC-CCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCC-CCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           80 LDSY-GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG-YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        80 l~~~-~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      ++.+ +++||+|||++.........+++.|||+.|+|||++.+.. |++.++|||||||+||.|++|+.||++.+...++
T Consensus       153 ld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~  232 (370)
T KOG0583|consen  153 LDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLY  232 (370)
T ss_pred             ecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHH
Confidence            9999 9999999999998754456889999999999999999988 9999999999999999999999999999999999


Q ss_pred             HHhhcccCCCCCCC-ChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc-CCCC
Q 016865          158 KKINAAEFSCPFWF-STGATSLIHKILDPNPKTRIRIEGIRKHPWFRK-NYNP  208 (381)
Q Consensus       158 ~~i~~~~~~~p~~~-s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~-~~~~  208 (381)
                      .+|..+.+.+|.|+ |+++++||.+||..||.+|+|+.+|++||||+. ...+
T Consensus       233 ~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~~~~~  285 (370)
T KOG0583|consen  233 RKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKENPLP  285 (370)
T ss_pred             HHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccCCCCC
Confidence            99999999999999 999999999999999999999999999999998 5443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-56  Score=417.13  Aligned_cols=204  Identities=41%  Similarity=0.749  Sum_probs=187.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.|+|||||+++++|+..+..||||||++||+|++++..++.+.|+..+.+++||+.||.|||++||+||||||||||+
T Consensus       230 LkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl  309 (475)
T KOG0615|consen  230 LKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILL  309 (475)
T ss_pred             HHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEe
Confidence            68899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccC---CCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCC--CCCcccHhHHHHHHHHHHhCCCCCCCCChhH
Q 016865           81 DSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY--DGSAADVWSCGVILFVLMAGYLPFGETDLPT  155 (381)
Q Consensus        81 ~~~---~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~--~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  155 (381)
                      ..+   -.+||+|||+|++.+. .....|.||||.|.|||++.+.++  ++.++||||+|||||.+|+|.+||.+...+.
T Consensus       310 ~~~~e~~llKItDFGlAK~~g~-~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~  388 (475)
T KOG0615|consen  310 SNDAEDCLLKITDFGLAKVSGE-GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP  388 (475)
T ss_pred             ccCCcceEEEecccchhhcccc-ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc
Confidence            876   5799999999998764 467899999999999999987663  4468999999999999999999998776554


Q ss_pred             -HHHHhhcccCCCC--CC--CChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          156 -LYKKINAAEFSCP--FW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       156 -~~~~i~~~~~~~p--~~--~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                       ++++|..+.+.+.  .|  +|.++++||.+||..||++|||++|+|+||||+..
T Consensus       389 sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  389 SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence             8999999988764  34  89999999999999999999999999999999854

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.5e-54  Score=417.95  Aligned_cols=206  Identities=36%  Similarity=0.704  Sum_probs=198.0

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      ++|+|||||++|++|+|.+++|||+|+|+.|+|..++++.+.++|.+|+.|++||+.||.|||+++|+|||||..|++++
T Consensus        73 r~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~  152 (592)
T KOG0575|consen   73 RSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLN  152 (592)
T ss_pred             HhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeec
Confidence            67999999999999999999999999999999999999889999999999999999999999999999999999999999


Q ss_pred             cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhh
Q 016865           82 SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN  161 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~  161 (381)
                      ++.++||+|||||+......+...|.||||.|+|||++...+. +..+||||+|||||.||.|++||...+..+.|.+|.
T Consensus       153 ~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gH-sfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik  231 (592)
T KOG0575|consen  153 ENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGH-SFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK  231 (592)
T ss_pred             CcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCC-CCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH
Confidence            9999999999999998876677889999999999999997776 499999999999999999999999999999999999


Q ss_pred             cccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 016865          162 AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  208 (381)
Q Consensus       162 ~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~  208 (381)
                      ..++..|..+|.+|++||.+||++||.+|||++++|.|+||+.++.|
T Consensus       232 ~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p  278 (592)
T KOG0575|consen  232 LNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTP  278 (592)
T ss_pred             hcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcC
Confidence            99999999999999999999999999999999999999999877654

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-51  Score=377.67  Aligned_cols=203  Identities=38%  Similarity=0.766  Sum_probs=190.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |..++||+||+++..|++..++|+|+||+.||+|+.+|.+.+.++|+.|+.|+..|+.||.|||++||+||||||||||+
T Consensus        79 L~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL  158 (357)
T KOG0598|consen   79 LSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL  158 (357)
T ss_pred             HHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee
Confidence            34689999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      |.+|+++|+|||+|+.........++.|||+.|||||++.+.+|+ ..+|.|||||++|+|++|.+||...+...++++|
T Consensus       159 d~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I  237 (357)
T KOG0598|consen  159 DEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKI  237 (357)
T ss_pred             cCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHH
Confidence            999999999999999766655667889999999999999999986 9999999999999999999999999999999999


Q ss_pred             hcccCC-CCCCCChhHHHHHHHhcCCCCCCCC----CHHHHhcCccccc
Q 016865          161 NAAEFS-CPFWFSTGATSLIHKILDPNPKTRI----RIEGIRKHPWFRK  204 (381)
Q Consensus       161 ~~~~~~-~p~~~s~~~~~li~~~L~~dP~~R~----t~~~il~hp~~~~  204 (381)
                      ..+... .|..+|++++++|+++|..||.+|.    ++.+|.+||||..
T Consensus       238 ~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~  286 (357)
T KOG0598|consen  238 LKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKG  286 (357)
T ss_pred             hcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCccccc
Confidence            999854 4555999999999999999999996    6899999999974

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-50  Score=363.86  Aligned_cols=200  Identities=38%  Similarity=0.768  Sum_probs=190.6

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.+.||+++++++.+.+.+.+|+||||.+||+|+.++++.++++|..|+.|+.|++.||+|||+++|++|||||||||+
T Consensus        98 L~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl  177 (355)
T KOG0616|consen   98 LKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL  177 (355)
T ss_pred             HhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee
Confidence            56789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      |.+|.+||+|||+|+....   ...|.||||.|+|||++..++|. .++|.|||||++|||++|.+||...+...+|++|
T Consensus       178 D~~G~iKitDFGFAK~v~~---rT~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI  253 (355)
T KOG0616|consen  178 DQNGHIKITDFGFAKRVSG---RTWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI  253 (355)
T ss_pred             ccCCcEEEEeccceEEecC---cEEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH
Confidence            9999999999999986543   36799999999999999998885 9999999999999999999999999999999999


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  204 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~-----t~~~il~hp~~~~  204 (381)
                      ..+++.+|+.+|+++++||+++|+.|-.+|.     ...+|..||||+.
T Consensus       254 ~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~  302 (355)
T KOG0616|consen  254 LEGKVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG  302 (355)
T ss_pred             HhCcccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence            9999999999999999999999999999994     5689999999974

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-49  Score=382.49  Aligned_cols=201  Identities=35%  Similarity=0.660  Sum_probs=187.7

Q ss_pred             CC-CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            3 IV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         3 ~l-~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      +| +||.|++||..|+|...+|+|+||+++|+|.++|.+.|.|+|..++.|+.||+.||+|||++|||||||||||||+|
T Consensus       129 ~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd  208 (604)
T KOG0592|consen  129 QLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLD  208 (604)
T ss_pred             HhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEc
Confidence            45 89999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCEEEeeccCccCCCCC-------------ccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCC
Q 016865           82 SYGNLKVSDFGLSALPQQG-------------VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF  148 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf  148 (381)
                      ++|++||+|||.|+.+...             .....+.+||-.|++||++.+.. .+..+|||+||||||.|++|.+||
T Consensus       209 ~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~sDiWAlGCilyQmlaG~PPF  287 (604)
T KOG0592|consen  209 KDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGPSSDLWALGCILYQMLAGQPPF  287 (604)
T ss_pred             CCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCC-CCcccchHHHHHHHHHHhcCCCCC
Confidence            9999999999998875431             01125688999999999997654 469999999999999999999999


Q ss_pred             CCCChhHHHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          149 GETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       149 ~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      .+.+....+++|..-.+.+|+.+++.+++||+++|..||.+|+|+++|.+||||..
T Consensus       288 ra~NeyliFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~  343 (604)
T KOG0592|consen  288 RAANEYLIFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG  343 (604)
T ss_pred             ccccHHHHHHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence            99999999999999999999999999999999999999999999999999999974

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=6e-49  Score=365.18  Aligned_cols=202  Identities=29%  Similarity=0.496  Sum_probs=184.8

Q ss_pred             CCCCccccccceEEEEeCCE-EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEE
Q 016865            2 KIVRHPNIVRLHEVLASRTK-VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLL   79 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~-~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NiL   79 (381)
                      +..+|||||.+|++|.++.. ++|+||||+||+|.+.+...++++|.....++.++++||.|||+ .+|+||||||+|||
T Consensus       132 ~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlL  211 (364)
T KOG0581|consen  132 RSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLL  211 (364)
T ss_pred             hhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHee
Confidence            56799999999999999995 99999999999999999988999999999999999999999995 89999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCC-----Chh
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET-----DLP  154 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~-----~~~  154 (381)
                      ++..|.+||||||.|......  ...+.+||..|||||.+.+..|. .++||||||+.++|+.+|+.||...     +..
T Consensus       212 vNskGeVKicDFGVS~~lvnS--~a~tfvGT~~YMsPERi~g~~Ys-~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~  288 (364)
T KOG0581|consen  212 VNSKGEVKICDFGVSGILVNS--IANTFVGTSAYMSPERISGESYS-VKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIF  288 (364)
T ss_pred             eccCCCEEeccccccHHhhhh--hcccccccccccChhhhcCCcCC-cccceecccHHHHHHhhCCCCCCCcCCCCCCHH
Confidence            999999999999999876553  67899999999999999998886 8899999999999999999999774     556


Q ss_pred             HHHHHhhccc-CCCCCC-CChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          155 TLYKKINAAE-FSCPFW-FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       155 ~~~~~i~~~~-~~~p~~-~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      ++...|..+. ...|.. +|+++++||..||++||.+|+|+.|+++|||+++..
T Consensus       289 ~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~  342 (364)
T KOG0581|consen  289 ELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE  342 (364)
T ss_pred             HHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence            7777777654 457775 999999999999999999999999999999998653

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-49  Score=346.32  Aligned_cols=202  Identities=44%  Similarity=0.837  Sum_probs=186.2

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      +.|+||||+++++.+.+....|||+|++.||+|+.-|...-.++|..+..+++||+.||.|||.+||+|||+||+|+|+.
T Consensus        65 ~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLA  144 (355)
T KOG0033|consen   65 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLA  144 (355)
T ss_pred             HhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeee
Confidence            46899999999999999999999999999999998887777789999999999999999999999999999999999997


Q ss_pred             cC---CCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016865           82 SY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK  158 (381)
Q Consensus        82 ~~---~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~  158 (381)
                      ..   .-+|++|||+|.... +........|||.|+|||++...+|. .++|||+||||||-||.|++||.+.+...+|+
T Consensus       145 SK~~~A~vKL~~FGvAi~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~-kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye  222 (355)
T KOG0033|consen  145 SKAKGAAVKLADFGLAIEVN-DGEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYE  222 (355)
T ss_pred             eccCCCceeecccceEEEeC-CccccccccCCCcccCHHHhhcCCCC-CcchhhhhhHHHHHHHhCCCCCCCccHHHHHH
Confidence            44   359999999998776 44567788999999999999888875 99999999999999999999999999999999


Q ss_pred             HhhcccCCCCC--C--CChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          159 KINAAEFSCPF--W--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       159 ~i~~~~~~~p~--~--~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      +|..+.+.+|+  |  +++++++|+++||..||.+|+|+.|+|+|||+...
T Consensus       223 ~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  223 QIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             HHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence            99999887765  4  89999999999999999999999999999999753

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-48  Score=362.09  Aligned_cols=209  Identities=39%  Similarity=0.734  Sum_probs=197.1

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |..|+|||||.+|++|++++++.|||||+.+|+|+|+|...+.++|.+++.+|+||++|+.|||.++++|||||.+|||+
T Consensus       107 MSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL  186 (668)
T KOG0611|consen  107 MSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL  186 (668)
T ss_pred             HhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee
Confidence            67899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      |+|+++||+|||++..+... ..+.|.||+|-|.+||++.+.+|.|+.+|-|||||+||.|+.|..||++.+...+.++|
T Consensus       187 D~N~NiKIADFGLSNly~~~-kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQI  265 (668)
T KOG0611|consen  187 DQNNNIKIADFGLSNLYADK-KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQI  265 (668)
T ss_pred             cCCCCeeeeccchhhhhccc-cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHh
Confidence            99999999999999887654 67899999999999999999999999999999999999999999999999999999999


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCCCC
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC  211 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~~~~  211 (381)
                      ..+.+..|. -+.++.-||+.||..||.+|.|+++|-.|=|++-.|+...+
T Consensus       266 s~GaYrEP~-~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNwgy~~~V~  315 (668)
T KOG0611|consen  266 SRGAYREPE-TPSDASGLIRWMLMVNPERRATIEDIASHWWVNWGYNMPVI  315 (668)
T ss_pred             hcccccCCC-CCchHHHHHHHHHhcCcccchhHHHHhhhheeecccccccc
Confidence            999988776 46788999999999999999999999999888766654433

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5e-48  Score=344.97  Aligned_cols=199  Identities=37%  Similarity=0.739  Sum_probs=184.1

Q ss_pred             CCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccC
Q 016865            4 VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY   83 (381)
Q Consensus         4 l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~   83 (381)
                      ..|||||++.++|+++..+++|+|.|+.|+|||++.....++|...+.+++||+.|++|||.++|+||||||||||++++
T Consensus        80 ~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn  159 (411)
T KOG0599|consen   80 MGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDN  159 (411)
T ss_pred             cCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccc
Confidence            47999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCEEEeeccCccCCCCCccccccccCCCCCCCCceecCC------CCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           84 GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR------GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        84 ~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~------~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      .++||+|||+|.....+ ..+...||||.|.|||.+...      +| +..+|+||||||+|.||+|.+||......-+.
T Consensus       160 ~~i~isDFGFa~~l~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGY-s~EVD~Wa~GVImyTLLaGcpPFwHRkQmlML  237 (411)
T KOG0599|consen  160 MNIKISDFGFACQLEPG-EKLRELCGTPGYLAPETIKCSMYENHPGY-SKEVDEWACGVIMYTLLAGCPPFWHRKQMLML  237 (411)
T ss_pred             cceEEeccceeeccCCc-hhHHHhcCCCcccChhheeeecccCCCCc-cchhhHHHHHHHHHHHHcCCCchhHHHHHHHH
Confidence            99999999999988765 567889999999999998653      34 47899999999999999999999887777788


Q ss_pred             HHhhcccCC--CCCC--CChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          158 KKINAAEFS--CPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       158 ~~i~~~~~~--~p~~--~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      ..|..+++.  .|.|  +|..+++||.+||+.||.+|+|++|+|.||||..
T Consensus       238 R~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  238 RMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             HHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence            888888765  5677  7999999999999999999999999999999953

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-47  Score=356.76  Aligned_cols=204  Identities=38%  Similarity=0.677  Sum_probs=188.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      ||.++|||||++++++++.+.+|+|||||+||||.++|...++++|..++.++.||+.||++||+++|+||||||+|||+
T Consensus        63 Lkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLL  142 (429)
T KOG0595|consen   63 LKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILL  142 (429)
T ss_pred             HHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEe
Confidence            57889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccC------CCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           81 DSY------GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        81 ~~~------~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      +.+      -.+||+|||+|+..... ....+.||||.|||||++....|+ .|+|+||+|+|||+|++|++||+..+..
T Consensus       143 s~~~~~~~~~~LKIADFGfAR~L~~~-~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~  220 (429)
T KOG0595|consen  143 STTARNDTSPVLKIADFGFARFLQPG-SMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPK  220 (429)
T ss_pred             ccCCCCCCCceEEecccchhhhCCch-hHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHH
Confidence            875      35899999999988753 678899999999999999888887 8999999999999999999999999999


Q ss_pred             HHHHHhhcccCC---CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          155 TLYKKINAAEFS---CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       155 ~~~~~i~~~~~~---~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      ++...++.+...   .|.++++...+|+...|..+|..|.+..+-+.|++...+.
T Consensus       221 eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  221 ELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             HHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            998888776543   4456899999999999999999999999999999987654

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-47  Score=342.70  Aligned_cols=192  Identities=34%  Similarity=0.616  Sum_probs=177.4

Q ss_pred             CCCCCccccccceE-EE-EeCCEEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH--CC--Cee
Q 016865            1 MKIVRHPNIVRLHE-VL-ASRTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHS--KG--VYH   70 (381)
Q Consensus         1 lk~l~HpnIv~l~~-~~-~~~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~L~~LH~--~g--i~H   70 (381)
                      ||+|+|||||++++ -| +++..++||||||.+|+|...|++    .+.++|..+|+|+.||+.||.+||+  ..  |+|
T Consensus        72 LkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmH  151 (375)
T KOG0591|consen   72 LKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMH  151 (375)
T ss_pred             HHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceee
Confidence            58999999999998 34 455559999999999999998865    3458999999999999999999999  44  999


Q ss_pred             cCCCCCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCC
Q 016865           71 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE  150 (381)
Q Consensus        71 rDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~  150 (381)
                      |||||.||+++.+|.+||+|||+++++.......++.+|||+||+||++.+.+|+ .++||||+||++|||++-.+||.+
T Consensus       152 RDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g  230 (375)
T KOG0591|consen  152 RDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYG  230 (375)
T ss_pred             ccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCccc
Confidence            9999999999999999999999999998877788999999999999999999997 999999999999999999999999


Q ss_pred             CChhHHHHHhhcccCC-CC-CCCChhHHHHHHHhcCCCCCCCCCH
Q 016865          151 TDLPTLYKKINAAEFS-CP-FWFSTGATSLIHKILDPNPKTRIRI  193 (381)
Q Consensus       151 ~~~~~~~~~i~~~~~~-~p-~~~s~~~~~li~~~L~~dP~~R~t~  193 (381)
                      .+..++.++|..++++ +| ..+|.++..+|..|+.+||..||+.
T Consensus       231 ~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  231 DNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             ccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            9999999999999886 77 5689999999999999999999986

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-46  Score=356.75  Aligned_cols=206  Identities=41%  Similarity=0.738  Sum_probs=194.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      ||.++|||||++|++..+..++|+|+|+-+||+|+|+|.+ ..+++|+.++.||.||+.|+.|||+..++||||||||+.
T Consensus        71 MKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVV  150 (864)
T KOG4717|consen   71 MKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVV  150 (864)
T ss_pred             HHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeE
Confidence            7889999999999999999999999999999999999965 467999999999999999999999999999999999998


Q ss_pred             Ecc-CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016865           80 LDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK  158 (381)
Q Consensus        80 l~~-~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~  158 (381)
                      +.+ -|-+||+|||++..+..+ ..+.+.||++.|-|||++.+..|+.+++||||||||||-|++|++||...+..+...
T Consensus       151 FFEKlGlVKLTDFGFSNkf~PG-~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT  229 (864)
T KOG4717|consen  151 FFEKLGLVKLTDFGFSNKFQPG-KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT  229 (864)
T ss_pred             EeeecCceEeeeccccccCCCc-chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh
Confidence            874 589999999999877654 568999999999999999999999999999999999999999999999999999999


Q ss_pred             HhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 016865          159 KINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  207 (381)
Q Consensus       159 ~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~  207 (381)
                      .|..-.|..|..+|.++++||..||..||++|.|.++|..|+|++..-.
T Consensus       230 mImDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  230 MIMDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             hhhcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence            9999999999999999999999999999999999999999999986543

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-46  Score=349.34  Aligned_cols=206  Identities=33%  Similarity=0.554  Sum_probs=175.7

Q ss_pred             CCCCCccccccceEEEEeCC--EEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            1 MKIVRHPNIVRLHEVLASRT--KVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~--~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      |++++|||||++++......  .++|+|||++||+|.+++.+.+ +++|+.++.|.+|++.||.|||++||+||||||+|
T Consensus        68 L~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~N  147 (313)
T KOG0198|consen   68 LSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPAN  147 (313)
T ss_pred             HHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccce
Confidence            46788999999999855444  7999999999999999999877 79999999999999999999999999999999999


Q ss_pred             EEEcc-CCCEEEeeccCccCCCC---CccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCC-CC
Q 016865           78 LLLDS-YGNLKVSDFGLSALPQQ---GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TD  152 (381)
Q Consensus        78 iLl~~-~~~lkl~DFGls~~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~-~~  152 (381)
                      ||++. ++.+||+|||++.....   .........||+.|||||++........++||||+||++.||+||+.||.. ..
T Consensus       148 iLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~  227 (313)
T KOG0198|consen  148 ILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE  227 (313)
T ss_pred             EEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc
Confidence            99999 79999999999886652   122344678999999999998633333599999999999999999999987 34


Q ss_pred             hhHHHHHhhcc--cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          153 LPTLYKKINAA--EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       153 ~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      .....-.+...  ...+|.++|+++++||.+|+..||.+|||++++|+|||.+...
T Consensus       228 ~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  228 EAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             hHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence            33333333322  2467888999999999999999999999999999999998654

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2e-45  Score=354.63  Aligned_cols=199  Identities=36%  Similarity=0.681  Sum_probs=179.1

Q ss_pred             CCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccC
Q 016865            4 VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY   83 (381)
Q Consensus         4 l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~   83 (381)
                      .++|+||++|..|++..++||||||++|||+...|.+.+.++|+.+++|+.+++.|++.+|+.|++||||||+|+|||..
T Consensus       198 ~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~  277 (550)
T KOG0605|consen  198 VDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAK  277 (550)
T ss_pred             cCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCC
Confidence            57899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCEEEeeccCccCCCC----------------------C--c-----------------------cccccccCCCCCCCC
Q 016865           84 GNLKVSDFGLSALPQQ----------------------G--V-----------------------ELLHTTCGTPNYVAP  116 (381)
Q Consensus        84 ~~lkl~DFGls~~~~~----------------------~--~-----------------------~~~~~~~gt~~y~aP  116 (381)
                      |++||+|||||+-...                      .  .                       ......+|||.|+||
T Consensus       278 GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAP  357 (550)
T KOG0605|consen  278 GHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAP  357 (550)
T ss_pred             CCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccch
Confidence            9999999999853211                      0  0                       001234699999999


Q ss_pred             ceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc--CCCCC--CCChhHHHHHHHhcCCCCCCCCC
Q 016865          117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPF--WFSTGATSLIHKILDPNPKTRIR  192 (381)
Q Consensus       117 E~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~li~~~L~~dP~~R~t  192 (381)
                      |++.+.+|. ..+|+||||||+||||.|.+||.+.+..+.+++|...+  +.+|.  .++++++|||.++|. ||.+|..
T Consensus       358 EVll~kgY~-~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  358 EVLLGKGYG-KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHhcCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence            999999975 99999999999999999999999999999999987654  55554  379999999999999 9999985


Q ss_pred             ---HHHHhcCccccc
Q 016865          193 ---IEGIRKHPWFRK  204 (381)
Q Consensus       193 ---~~~il~hp~~~~  204 (381)
                         ++||.+||||+.
T Consensus       436 ~~G~~EIK~HPfF~~  450 (550)
T KOG0605|consen  436 SKGAEEIKKHPFFKG  450 (550)
T ss_pred             cccHHHHhcCCcccc
Confidence               899999999985

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-45  Score=350.04  Aligned_cols=206  Identities=36%  Similarity=0.644  Sum_probs=184.3

Q ss_pred             CCCCCccccccceEEEEeC--CEEEEEEecCCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            1 MKIVRHPNIVRLHEVLASR--TKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~--~~~~lV~E~~~gg~L~~~i~~~~~-l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      ||+++|||||+|+++..+.  +++|||+|||..|.+... ..... +.+.+|+.|++.++.||+|||.+||+||||||+|
T Consensus       162 lKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~-p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsN  240 (576)
T KOG0585|consen  162 LKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC-PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSN  240 (576)
T ss_pred             HHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccC-CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhh
Confidence            6899999999999999764  689999999999988543 33344 8999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccCccCCCC-----CccccccccCCCCCCCCceecC---CCCCCCcccHhHHHHHHHHHHhCCCCCC
Q 016865           78 LLLDSYGNLKVSDFGLSALPQQ-----GVELLHTTCGTPNYVAPEVLSN---RGYDGSAADVWSCGVILFVLMAGYLPFG  149 (381)
Q Consensus        78 iLl~~~~~lkl~DFGls~~~~~-----~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~~DIwSlGvil~~ll~G~~Pf~  149 (381)
                      +|++++|++||+|||.+..+..     .+..+....|||.|+|||...+   ..|.+.+.||||+||.||.|+.|++||-
T Consensus       241 LLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~  320 (576)
T KOG0585|consen  241 LLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF  320 (576)
T ss_pred             eEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence            9999999999999999886622     2233455789999999999887   5578899999999999999999999999


Q ss_pred             CCChhHHHHHhhcccCCCCCC--CChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 016865          150 ETDLPTLYKKINAAEFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  207 (381)
Q Consensus       150 ~~~~~~~~~~i~~~~~~~p~~--~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~  207 (381)
                      +.....++.+|.+..+.+|..  +.+.+++||.+||.+||.+|+++.+|..|||......
T Consensus       321 ~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~  380 (576)
T KOG0585|consen  321 DDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD  380 (576)
T ss_pred             cchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence            999999999999998888876  7999999999999999999999999999999986643

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-45  Score=322.42  Aligned_cols=199  Identities=38%  Similarity=0.713  Sum_probs=190.0

Q ss_pred             CCCccccccceEEEEeCCEEEEEEecCCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            3 IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~--~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      .|+||||+++|++|-+...+|+++||++.|+|+..+.  ...+++|..+..|++|++.||.|||.++|+||||||+|+|+
T Consensus        78 ~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLl  157 (281)
T KOG0580|consen   78 HLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLL  157 (281)
T ss_pred             ccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhcc
Confidence            5899999999999999999999999999999999998  66789999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.+|.+||+|||.+.....  ....|.|||..|.+||+..+.+++ ..+|+|++|++.||++.|.+||...+..+.|++|
T Consensus       158 g~~~~lkiAdfGwsV~~p~--~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI  234 (281)
T KOG0580|consen  158 GSAGELKIADFGWSVHAPS--NKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRI  234 (281)
T ss_pred             CCCCCeeccCCCceeecCC--CCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHH
Confidence            9999999999999987653  457899999999999999998887 9999999999999999999999999999999999


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      ...++.+|..+|.++.|||.+||..+|.+|.+..|++.|||+..
T Consensus       235 ~k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  235 RKVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             HHccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence            99999999999999999999999999999999999999999864

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-45  Score=356.03  Aligned_cols=203  Identities=26%  Similarity=0.541  Sum_probs=182.9

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+..+|+|||++++.|--++.+|+||||++||+|.|.+.. ..++|.++..+.++++.||+|||.+||+|||||.+|||+
T Consensus       324 m~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL  402 (550)
T KOG0578|consen  324 MRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL  402 (550)
T ss_pred             HHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe
Confidence            6778999999999999989999999999999999998766 459999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh-hHHHHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL-PTLYKK  159 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~  159 (381)
                      +.+|.+||+|||++..+........+.+|||+|||||++....| |.++||||||++..||+-|++||-..+. ..+|..
T Consensus       403 ~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI  481 (550)
T KOG0578|consen  403 TMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI  481 (550)
T ss_pred             ccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHH
Confidence            99999999999999988776567789999999999999988877 5999999999999999999999975444 455544


Q ss_pred             hhcc--cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          160 INAA--EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       160 i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ..++  .++.|..+|+.+++||.+||+.||.+|+|+.++|+||||+..
T Consensus       482 a~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  482 ATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             hhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence            4444  356677899999999999999999999999999999999643

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.1e-45  Score=354.96  Aligned_cols=205  Identities=31%  Similarity=0.598  Sum_probs=195.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++|||||.+++.|++..++|+|+|||.| +|+.++..++.++|+.++.++.|+++||.|||+.+|+|||+||.|||+
T Consensus        55 ~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl  133 (808)
T KOG0597|consen   55 LRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL  133 (808)
T ss_pred             HHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee
Confidence            4679999999999999999999999999987 999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +..|.+|+||||+|+........+....|||.|||||++.+.+|+ ..+|.||+|||+|||++|++||-......+.+.|
T Consensus       134 ~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I  212 (808)
T KOG0597|consen  134 EKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSI  212 (808)
T ss_pred             cCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHH
Confidence            999999999999999887766667778899999999999988887 8999999999999999999999999999999999


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  207 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~  207 (381)
                      .......|...|..+..||..+|.+||.+|+|+.+++.|||+++...
T Consensus       213 ~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~  259 (808)
T KOG0597|consen  213 LKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKIN  259 (808)
T ss_pred             hcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhh
Confidence            99999999999999999999999999999999999999999987654

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.2e-44  Score=346.07  Aligned_cols=203  Identities=34%  Similarity=0.608  Sum_probs=186.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        49 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll  128 (323)
T cd05571          49 LQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML  128 (323)
T ss_pred             HHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE
Confidence            35789999999999999999999999999999999999988889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.+||+|||++.............+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+.......+
T Consensus       129 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~  207 (323)
T cd05571         129 DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI  207 (323)
T ss_pred             CCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCC-ccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH
Confidence            999999999999987543333344567899999999999877664 8999999999999999999999988888888888


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  204 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~-----t~~~il~hp~~~~  204 (381)
                      ......+|..+++++.+||++||..||.+||     ++.++++||||..
T Consensus       208 ~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~  256 (323)
T cd05571         208 LMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS  256 (323)
T ss_pred             HcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            7778888888999999999999999999999     8999999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-45  Score=359.21  Aligned_cols=198  Identities=34%  Similarity=0.681  Sum_probs=186.1

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCC
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG   84 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~   84 (381)
                      +||.+++++..|++++++|+||||+.||++. ++.+.+.++|..|+.|+..++.||.|||++||||||||.+|||+|..|
T Consensus       427 ~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eG  505 (694)
T KOG0694|consen  427 RHPFLVNLFSCFQTKEHLFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEG  505 (694)
T ss_pred             cCCeEeecccccccCCeEEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccC
Confidence            6999999999999999999999999999954 455568899999999999999999999999999999999999999999


Q ss_pred             CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc
Q 016865           85 NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE  164 (381)
Q Consensus        85 ~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~  164 (381)
                      ++||+|||+++..-.......|.||||.|+|||++.+..|. .++|.|||||+|||||.|..||.+.+..+++..|...+
T Consensus       506 h~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~  584 (694)
T KOG0694|consen  506 HVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE  584 (694)
T ss_pred             cEEecccccccccCCCCCccccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC
Confidence            99999999998755444578899999999999999998885 99999999999999999999999999999999999999


Q ss_pred             CCCCCCCChhHHHHHHHhcCCCCCCCCCH-----HHHhcCccccc
Q 016865          165 FSCPFWFSTGATSLIHKILDPNPKTRIRI-----EGIRKHPWFRK  204 (381)
Q Consensus       165 ~~~p~~~s~~~~~li~~~L~~dP~~R~t~-----~~il~hp~~~~  204 (381)
                      ..+|.|+|.++.++++++|..||.+|...     ++|.+||||+.
T Consensus       585 ~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~  629 (694)
T KOG0694|consen  585 VRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRS  629 (694)
T ss_pred             CCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCcccc
Confidence            99999999999999999999999999965     78999999974

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-44  Score=327.45  Aligned_cols=200  Identities=40%  Similarity=0.722  Sum_probs=178.9

Q ss_pred             CccccccceEEEEe----CCEEEEEEecCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            5 RHPNIVRLHEVLAS----RTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         5 ~HpnIv~l~~~~~~----~~~~~lV~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      .|||||+++++|++    ..++.+|||.++||+||.+|...+.  +.|.+|..+++||..|+.|||+.+|.||||||||+
T Consensus       113 ~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENL  192 (400)
T KOG0604|consen  113 GHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENL  192 (400)
T ss_pred             CCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhhe
Confidence            69999999999974    4689999999999999999988765  99999999999999999999999999999999999


Q ss_pred             EEccC---CCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh--
Q 016865           79 LLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL--  153 (381)
Q Consensus        79 Ll~~~---~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~--  153 (381)
                      |...+   ..+||+|||+|+.... ...+.+.|-||+|+|||++....|+ ..+|+||+|||+|.||+|.+||.+...  
T Consensus       193 Lyt~t~~na~lKLtDfGFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~a  270 (400)
T KOG0604|consen  193 LYTTTSPNAPLKLTDFGFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLA  270 (400)
T ss_pred             eeecCCCCcceEecccccccccCC-CccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCcc
Confidence            99864   4699999999987654 3567899999999999999877776 899999999999999999999976543  


Q ss_pred             --hHHHHHhhcccCCCCC--C--CChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          154 --PTLYKKINAAEFSCPF--W--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       154 --~~~~~~i~~~~~~~p~--~--~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                        ..+..+|..+.+.+|.  |  +|..++++|+++|..+|.+|.|+++++.|||+....
T Consensus       271 ispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  271 ISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             CChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence              4577788888887764  5  899999999999999999999999999999998654

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-44  Score=344.84  Aligned_cols=204  Identities=31%  Similarity=0.525  Sum_probs=179.7

Q ss_pred             CCCCC-ccccccceEEEEeCC-EEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            1 MKIVR-HPNIVRLHEVLASRT-KVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         1 lk~l~-HpnIv~l~~~~~~~~-~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      |++|+ |||||++.+++.+.+ .+|+|||||+. +|++.++..+ .|+|..++.|+.||++||+|+|.+|++|||+||||
T Consensus        62 L~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPEN  140 (538)
T KOG0661|consen   62 LRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPEN  140 (538)
T ss_pred             HHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhh
Confidence            56788 999999999999888 99999999976 9999997754 58999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           78 LLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        78 iLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      ||+..+..+||+|||+|+..... .....++.|.+|+|||++...++++.+.|+||+|||++|+.+-++.|.+.+..+..
T Consensus       141 iLi~~~~~iKiaDFGLARev~Sk-pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi  219 (538)
T KOG0661|consen  141 ILISGNDVIKIADFGLAREVRSK-PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQI  219 (538)
T ss_pred             eEecccceeEecccccccccccC-CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHH
Confidence            99999999999999999977654 45678889999999999999999999999999999999999999999988776555


Q ss_pred             HHhhc-------------------ccCCCCC-----------CCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          158 KKINA-------------------AEFSCPF-----------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       158 ~~i~~-------------------~~~~~p~-----------~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      .+|+.                   -.+.+|.           ..++++.++|.+||..||.+|||++++|+||||+...
T Consensus       220 ~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  220 YKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             HHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence            55421                   1233332           2688999999999999999999999999999998653

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-44  Score=340.94  Aligned_cols=204  Identities=36%  Similarity=0.669  Sum_probs=186.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |++++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus        47 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili  126 (312)
T cd05585          47 LAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL  126 (312)
T ss_pred             HHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE
Confidence            35789999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.+||+|||++.............+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+....+..+
T Consensus       127 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~  205 (312)
T cd05585         127 DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI  205 (312)
T ss_pred             CCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCC-CccceechhHHHHHHHhCCCCcCCCCHHHHHHHH
Confidence            999999999999987643333334567899999999999887765 8999999999999999999999988888888888


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCC---CHHHHhcCcccccC
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRI---RIEGIRKHPWFRKN  205 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~---t~~~il~hp~~~~~  205 (381)
                      ......+|..+++++.+||.+||..||.+||   ++.+++.||||...
T Consensus       206 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         206 LQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             HcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence            8888888889999999999999999999997   57999999999753

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6.7e-44  Score=343.60  Aligned_cols=200  Identities=38%  Similarity=0.724  Sum_probs=185.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+++...+.++++.++.++.||+.||+|||++||+||||||+|||+
T Consensus        72 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll  151 (329)
T PTZ00263         72 LMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL  151 (329)
T ss_pred             HHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE
Confidence            45789999999999999999999999999999999999988899999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.+||+|||++......   ..+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+
T Consensus       152 ~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i  227 (329)
T PTZ00263        152 DNKGHVKVTDFGFAKKVPDR---TFTLCGTPEYLAPEVIQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI  227 (329)
T ss_pred             CCCCCEEEeeccCceEcCCC---cceecCChhhcCHHHHcCCCCC-CcceeechHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            99999999999998765432   2456899999999999877764 8999999999999999999999988888888888


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIR-----IEGIRKHPWFRK  204 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t-----~~~il~hp~~~~  204 (381)
                      ..+...+|.++++.+++||.+||+.||.+|++     +++++.||||+.
T Consensus       228 ~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        228 LAGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             hcCCcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence            88888899999999999999999999999997     799999999975

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-44  Score=354.83  Aligned_cols=206  Identities=40%  Similarity=0.781  Sum_probs=198.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.|+|||||+++++.++...+|+||||+.||++++++.+.+++.+..++.+|.|+++|++|||+++|+|||||.+||||
T Consensus       109 mk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL  188 (596)
T KOG0586|consen  109 MKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL  188 (596)
T ss_pred             HHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc
Confidence            68899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.+.++||+|||++.++.. ...+.+.||++.|.|||+..+..|+++.+|+||+|++||.|+.|.+||++.+...+....
T Consensus       189 ~~~mnikIaDfgfS~~~~~-~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv  267 (596)
T KOG0586|consen  189 DENMNIKIADFGFSTFFDY-GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV  267 (596)
T ss_pred             ccccceeeeccccceeecc-cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh
Confidence            9999999999999998875 467899999999999999999999999999999999999999999999999999998899


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  207 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~  207 (381)
                      ..+.+..|..+|.++.++|+++|..+|.+|+++++++.|+|....+.
T Consensus       268 l~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~  314 (596)
T KOG0586|consen  268 LRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLE  314 (596)
T ss_pred             eeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhh
Confidence            99999999999999999999999999999999999999999976553

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=7.4e-45  Score=328.81  Aligned_cols=202  Identities=26%  Similarity=0.470  Sum_probs=173.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      ||+++|||+|+++++|..+..+++|+|||+. ++.+.+++ ..+++++.++.|++|++.|+.|||+++++||||||||||
T Consensus        55 LKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENIL  133 (396)
T KOG0593|consen   55 LKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENIL  133 (396)
T ss_pred             HHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheE
Confidence            5789999999999999999999999999987 44455554 467999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh-HHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYK  158 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~  158 (381)
                      ++.+|.+||||||+|+....+.......+.|.+|+|||.+.+...+|.++||||+||++.||++|.+.|.+.+.. ++|.
T Consensus       134 it~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~  213 (396)
T KOG0593|consen  134 ITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYL  213 (396)
T ss_pred             EecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHH
Confidence            999999999999999987766667788899999999999999777789999999999999999999999876543 3332


Q ss_pred             Hhh-------------c-c----cCCCC--C----------CCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          159 KIN-------------A-A----EFSCP--F----------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       159 ~i~-------------~-~----~~~~p--~----------~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      ...             . .    ...+|  .          .++.-+.+|+++||+.||.+|++.++++.||||.
T Consensus       214 I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd  288 (396)
T KOG0593|consen  214 IRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD  288 (396)
T ss_pred             HHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence            211             0 0    11122  1          2577899999999999999999999999999994

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-43  Score=343.46  Aligned_cols=202  Identities=42%  Similarity=0.759  Sum_probs=185.5

Q ss_pred             CCCCC-ccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVR-HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~-HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+++. |||||.++++|++.+.+|+|||+|.||+|++.|... .++|..+..++.|++.|++|||+.||+||||||||+|
T Consensus        89 l~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L  167 (382)
T KOG0032|consen   89 LQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLL  167 (382)
T ss_pred             HHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHee
Confidence            46677 999999999999999999999999999999999887 5999999999999999999999999999999999999


Q ss_pred             EccC----CCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhH
Q 016865           80 LDSY----GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT  155 (381)
Q Consensus        80 l~~~----~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  155 (381)
                      +...    +.+|++|||+|..... ....++.|||+.|+|||++...+|. ..+||||+||++|.|++|.+||.+.+...
T Consensus       168 ~~~~~~~~~~ik~~DFGla~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~-~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~  245 (382)
T KOG0032|consen  168 LASKDEGSGRIKLIDFGLAKFIKP-GERLHTIVGTPEYVAPEVLGGRPYG-DEVDVWSIGVILYILLSGVPPFWGETEFE  245 (382)
T ss_pred             eccccCCCCcEEEeeCCCceEccC-CceEeeecCCccccCchhhcCCCCC-cccchhHHHHHHHHHhhCCCCCcCCChhH
Confidence            9743    4799999999998776 5678999999999999999877775 99999999999999999999999999888


Q ss_pred             HHHHhhcccCCC--CCC--CChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          156 LYKKINAAEFSC--PFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       156 ~~~~i~~~~~~~--p~~--~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ...++..+++.+  +.|  +|..+++||++||..||.+|+|+.++|+|||++..
T Consensus       246 ~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  246 IFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             HHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            888888887644  445  79999999999999999999999999999999864

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-43  Score=336.09  Aligned_cols=200  Identities=35%  Similarity=0.671  Sum_probs=184.6

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus        55 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli  134 (291)
T cd05612          55 LKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL  134 (291)
T ss_pred             HHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE
Confidence            46789999999999999999999999999999999999988889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.+|.+||+|||++......   ..+.+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+....+..+
T Consensus       135 ~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i  210 (291)
T cd05612         135 DKEGHIKLTDFGFAKKLRDR---TWTLCGTPEYLAPEVIQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI  210 (291)
T ss_pred             CCCCCEEEEecCcchhccCC---cccccCChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999999998765432   2356799999999999877664 8999999999999999999999998888888888


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIR-----IEGIRKHPWFRK  204 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t-----~~~il~hp~~~~  204 (381)
                      ......+|..+++.+++||++||+.||.+|++     ++++++||||+.
T Consensus       211 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  259 (291)
T cd05612         211 LAGKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS  259 (291)
T ss_pred             HhCCcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence            88888888889999999999999999999995     999999999974

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.3e-43  Score=339.84  Aligned_cols=203  Identities=34%  Similarity=0.628  Sum_probs=184.9

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        49 l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll  128 (328)
T cd05593          49 LKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML  128 (328)
T ss_pred             HHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE
Confidence            46789999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.+||+|||++.............+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+.......+
T Consensus       129 ~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~  207 (328)
T cd05593         129 DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI  207 (328)
T ss_pred             CCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh
Confidence            99999999999998754332233456789999999999987666 48999999999999999999999888877777777


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  204 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~-----t~~~il~hp~~~~  204 (381)
                      ......+|..+++++.+||++||..||.+|+     ++.++++||||..
T Consensus       208 ~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~  256 (328)
T cd05593         208 LMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG  256 (328)
T ss_pred             ccCCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            7777888889999999999999999999997     8999999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.5e-43  Score=342.82  Aligned_cols=200  Identities=33%  Similarity=0.620  Sum_probs=184.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus        85 l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl  164 (340)
T PTZ00426         85 LNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL  164 (340)
T ss_pred             HHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE
Confidence            45789999999999999999999999999999999999988899999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.+|.+||+|||++......   ..+.+||+.|+|||++.+..+ +.++||||+||++|+|++|.+||...+....++.+
T Consensus       165 ~~~~~ikL~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i  240 (340)
T PTZ00426        165 DKDGFIKMTDFGFAKVVDTR---TYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKI  240 (340)
T ss_pred             CCCCCEEEecCCCCeecCCC---cceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            99999999999998765432   346789999999999987666 48999999999999999999999988888888888


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  204 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~-----t~~~il~hp~~~~  204 (381)
                      ..+...+|..+++.+.++|++||+.||.+|+     |++++++||||..
T Consensus       241 ~~~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~  289 (340)
T PTZ00426        241 LEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN  289 (340)
T ss_pred             hcCCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            8888888999999999999999999999996     8999999999975

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3e-43  Score=338.11  Aligned_cols=203  Identities=35%  Similarity=0.679  Sum_probs=185.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+++.+|+||||++||+|.+++...+.++++.+..++.|++.||+|||++||+||||||+|||+
T Consensus        54 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~  133 (323)
T cd05584          54 LEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL  133 (323)
T ss_pred             HHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE
Confidence            46789999999999999999999999999999999999988889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.+||+|||++.............+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+.......+
T Consensus       134 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~  212 (323)
T cd05584         134 DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHG-KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI  212 (323)
T ss_pred             CCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCC-CcceecccHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            999999999999987543333344567899999999999876664 8999999999999999999999988887778888


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  204 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~-----t~~~il~hp~~~~  204 (381)
                      ..+....|..+++++.+||.+||+.||.+||     ++++++.||||+.
T Consensus       213 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~  261 (323)
T cd05584         213 LKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRH  261 (323)
T ss_pred             HcCCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence            8888888999999999999999999999999     8999999999975

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.4e-43  Score=337.46  Aligned_cols=200  Identities=33%  Similarity=0.632  Sum_probs=184.0

Q ss_pred             CCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccC
Q 016865            4 VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY   83 (381)
Q Consensus         4 l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~   83 (381)
                      .+||||+++++++.+.+.+|+||||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus        53 ~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~  132 (320)
T cd05590          53 RNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE  132 (320)
T ss_pred             cCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC
Confidence            47999999999999999999999999999999999888899999999999999999999999999999999999999999


Q ss_pred             CCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc
Q 016865           84 GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA  163 (381)
Q Consensus        84 ~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~  163 (381)
                      +.+||+|||++.............+||+.|+|||++.+..+. .++||||+||++|+|++|+.||...+....+..+...
T Consensus       133 ~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~  211 (320)
T cd05590         133 GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYG-PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND  211 (320)
T ss_pred             CcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC
Confidence            999999999987543333344567899999999999876664 8999999999999999999999998888888888888


Q ss_pred             cCCCCCCCChhHHHHHHHhcCCCCCCCCCH------HHHhcCccccc
Q 016865          164 EFSCPFWFSTGATSLIHKILDPNPKTRIRI------EGIRKHPWFRK  204 (381)
Q Consensus       164 ~~~~p~~~s~~~~~li~~~L~~dP~~R~t~------~~il~hp~~~~  204 (381)
                      ....|.++++++.+||++||+.||.+|+++      +++++||||+.
T Consensus       212 ~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~  258 (320)
T cd05590         212 EVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE  258 (320)
T ss_pred             CCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence            888899999999999999999999999998      99999999974

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.4e-43  Score=337.83  Aligned_cols=203  Identities=33%  Similarity=0.611  Sum_probs=184.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        49 l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll  128 (323)
T cd05595          49 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML  128 (323)
T ss_pred             HHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE
Confidence            45789999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.+||+|||++.............+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+.......+
T Consensus       129 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~  207 (323)
T cd05595         129 DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI  207 (323)
T ss_pred             cCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCC-chhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999999987543322334567899999999999877664 8999999999999999999999988888887777


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  204 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~-----t~~~il~hp~~~~  204 (381)
                      .......|..+++++.+||.+||..||.+|+     ++.++++||||..
T Consensus       208 ~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~  256 (323)
T cd05595         208 LMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  256 (323)
T ss_pred             hcCCCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence            7777888888999999999999999999998     8999999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-43  Score=337.98  Aligned_cols=205  Identities=29%  Similarity=0.484  Sum_probs=178.1

Q ss_pred             CCCCCccccccceEEEEeC--CEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            1 MKIVRHPNIVRLHEVLASR--TKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~--~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      ||+|+|||||+|.++..+.  ..+|+|+|||+. ||.-++.. .-.|++.+++.|++||+.||+|||++||+|||||.+|
T Consensus       170 Lr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SN  248 (560)
T KOG0600|consen  170 LRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSN  248 (560)
T ss_pred             HHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccc
Confidence            6889999999999999887  789999999986 88887776 3479999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHH
Q 016865           78 LLLDSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL  156 (381)
Q Consensus        78 iLl~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~  156 (381)
                      ||||++|++||+|||||+++.... ..+...+-|++|.|||.+.+...++.++|+||+||||.||++|+++|.+.+..+.
T Consensus       249 iLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ  328 (560)
T KOG0600|consen  249 ILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ  328 (560)
T ss_pred             eEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH
Confidence            999999999999999999876532 3467788899999999999988888999999999999999999999999887665


Q ss_pred             HHHhhcc----------cCCCC-------------------CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          157 YKKINAA----------EFSCP-------------------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       157 ~~~i~~~----------~~~~p-------------------~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      ..+|...          ...+|                   ..+++.+.+|+..||..||.+|.|+.++|+|+||....
T Consensus       329 l~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p  407 (560)
T KOG0600|consen  329 LHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEP  407 (560)
T ss_pred             HHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCC
Confidence            5554211          01122                   12688999999999999999999999999999995443

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5.9e-43  Score=335.18  Aligned_cols=201  Identities=30%  Similarity=0.630  Sum_probs=183.3

Q ss_pred             CCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEcc
Q 016865            3 IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS   82 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~   82 (381)
                      .++||||+++++++.+++.+|+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus        52 ~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~  131 (316)
T cd05620          52 AWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDR  131 (316)
T ss_pred             ccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC
Confidence            45899999999999999999999999999999999988888999999999999999999999999999999999999999


Q ss_pred             CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhc
Q 016865           83 YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA  162 (381)
Q Consensus        83 ~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~  162 (381)
                      ++.+||+|||++...........+.+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+.......+..
T Consensus       132 ~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~  210 (316)
T cd05620         132 DGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV  210 (316)
T ss_pred             CCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            9999999999987543333344567899999999999877765 899999999999999999999998888888888877


Q ss_pred             ccCCCCCCCChhHHHHHHHhcCCCCCCCCCH-HHHhcCccccc
Q 016865          163 AEFSCPFWFSTGATSLIHKILDPNPKTRIRI-EGIRKHPWFRK  204 (381)
Q Consensus       163 ~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~-~~il~hp~~~~  204 (381)
                      .....|.+++.++++||.+||+.||.+|+++ +++++||||+.
T Consensus       211 ~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~  253 (316)
T cd05620         211 DTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKT  253 (316)
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCC
Confidence            7778889999999999999999999999998 58999999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5.9e-43  Score=335.71  Aligned_cols=200  Identities=32%  Similarity=0.649  Sum_probs=184.7

Q ss_pred             CCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccC
Q 016865            4 VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY   83 (381)
Q Consensus         4 l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~   83 (381)
                      .+||||+++++++.+.+.+|+||||++||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus        53 ~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~  132 (321)
T cd05591          53 AKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE  132 (321)
T ss_pred             cCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC
Confidence            48999999999999999999999999999999999888889999999999999999999999999999999999999999


Q ss_pred             CCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc
Q 016865           84 GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA  163 (381)
Q Consensus        84 ~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~  163 (381)
                      +.+||+|||++.............+||+.|+|||++.+..+. .++||||+||++|+|++|+.||...+....+..+...
T Consensus       133 ~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~  211 (321)
T cd05591         133 GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYG-PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD  211 (321)
T ss_pred             CCEEEeecccceecccCCccccccccCccccCHHHHcCCCCC-CccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence            999999999987543333344567899999999999877664 8999999999999999999999998888888888888


Q ss_pred             cCCCCCCCChhHHHHHHHhcCCCCCCCC-------CHHHHhcCccccc
Q 016865          164 EFSCPFWFSTGATSLIHKILDPNPKTRI-------RIEGIRKHPWFRK  204 (381)
Q Consensus       164 ~~~~p~~~s~~~~~li~~~L~~dP~~R~-------t~~~il~hp~~~~  204 (381)
                      ....|.++++++.++|.+||+.||.+|+       +++++++||||..
T Consensus       212 ~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~  259 (321)
T cd05591         212 DVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE  259 (321)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence            8888999999999999999999999999       9999999999964

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=8.4e-43  Score=334.93  Aligned_cols=202  Identities=34%  Similarity=0.594  Sum_probs=184.2

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      +.++||||+++++.+.+.+.+|+||||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus        51 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~  130 (323)
T cd05575          51 KNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLD  130 (323)
T ss_pred             hhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC
Confidence            56899999999999999999999999999999999998888899999999999999999999999999999999999999


Q ss_pred             cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhh
Q 016865           82 SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN  161 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~  161 (381)
                      .++.+||+|||++.............+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+....+..+.
T Consensus       131 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~  209 (323)
T cd05575         131 SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL  209 (323)
T ss_pred             CCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCC-ccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence            99999999999987543333334566899999999999877765 89999999999999999999999988888888888


Q ss_pred             cccCCCCCCCChhHHHHHHHhcCCCCCCCCCH----HHHhcCccccc
Q 016865          162 AAEFSCPFWFSTGATSLIHKILDPNPKTRIRI----EGIRKHPWFRK  204 (381)
Q Consensus       162 ~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~----~~il~hp~~~~  204 (381)
                      ......++.+++.+.++|.+||+.||.+||++    .++++||||..
T Consensus       210 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~  256 (323)
T cd05575         210 NKPLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS  256 (323)
T ss_pred             cCCCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence            77777788889999999999999999999998    69999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.5e-43  Score=337.13  Aligned_cols=203  Identities=35%  Similarity=0.617  Sum_probs=184.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||+ +||+||||||+|||
T Consensus        49 l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIl  128 (325)
T cd05594          49 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM  128 (325)
T ss_pred             HHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEE
Confidence            35679999999999999999999999999999999999888889999999999999999999997 79999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      ++.++.+||+|||++...........+.+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+.......
T Consensus       129 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~  207 (325)
T cd05594         129 LDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL  207 (325)
T ss_pred             ECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCC-CccccccccceeeeeccCCCCCCCCCHHHHHHH
Confidence            9999999999999987543322334566899999999999877664 899999999999999999999998888777777


Q ss_pred             hhcccCCCCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 016865          160 INAAEFSCPFWFSTGATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  204 (381)
Q Consensus       160 i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~-----t~~~il~hp~~~~  204 (381)
                      +......+|..+++++.+||.+||+.||.+|+     ++.++++||||..
T Consensus       208 i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~  257 (325)
T cd05594         208 ILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG  257 (325)
T ss_pred             HhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence            77777888888999999999999999999997     9999999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-42  Score=327.63  Aligned_cols=204  Identities=32%  Similarity=0.525  Sum_probs=174.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||++++..|..+..+|+||.||.+|++++.+...  .+++|..+..++++++.||.|||.+|.||||||+.||
T Consensus        78 msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnI  157 (516)
T KOG0582|consen   78 MSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNI  157 (516)
T ss_pred             hhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccE
Confidence            67899999999999999999999999999999999999763  4699999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCC-Cc--ccc-ccccCCCCCCCCceecC--CCCCCCcccHhHHHHHHHHHHhCCCCCCCCC
Q 016865           79 LLDSYGNLKVSDFGLSALPQQ-GV--ELL-HTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETD  152 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~-~~--~~~-~~~~gt~~y~aPE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~  152 (381)
                      |++.+|.+||+|||.+...-. +.  ... ++..|||+|||||++..  .+|+ .|+||||+|+...||.+|..||....
T Consensus       158 Li~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYd-fKaDIwSfGITA~ELA~G~aPf~k~p  236 (516)
T KOG0582|consen  158 LIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYD-FKADIWSFGITACELAHGHAPFSKYP  236 (516)
T ss_pred             EEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCcc-chhhhhhhhHHHHHHhcCCCCcccCC
Confidence            999999999999998764332 21  112 67799999999999532  4565 99999999999999999999999877


Q ss_pred             hhHHH-HHhhcccCCCC----------CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          153 LPTLY-KKINAAEFSCP----------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       153 ~~~~~-~~i~~~~~~~p----------~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      ...+. .++++ ..+.+          ..++..++.+|..||+.||.+|||++++|+|+||++..
T Consensus       237 PmkvLl~tLqn-~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k  300 (516)
T KOG0582|consen  237 PMKVLLLTLQN-DPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK  300 (516)
T ss_pred             hHHHHHHHhcC-CCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence            66544 33433 32211          12678899999999999999999999999999998653

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.2e-42  Score=331.24  Aligned_cols=201  Identities=33%  Similarity=0.669  Sum_probs=183.0

Q ss_pred             CCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEcc
Q 016865            3 IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS   82 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~   82 (381)
                      ..+||||+++++++.+.+.+|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus        52 ~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~  131 (316)
T cd05592          52 AWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK  131 (316)
T ss_pred             ccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECC
Confidence            35899999999999999999999999999999999988888999999999999999999999999999999999999999


Q ss_pred             CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhc
Q 016865           83 YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA  162 (381)
Q Consensus        83 ~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~  162 (381)
                      ++.+||+|||++.............+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+....+..+..
T Consensus       132 ~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~  210 (316)
T cd05592         132 DGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYN-ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN  210 (316)
T ss_pred             CCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence            9999999999987544333444567899999999999877664 899999999999999999999998888888888877


Q ss_pred             ccCCCCCCCChhHHHHHHHhcCCCCCCCCCH-HHHhcCccccc
Q 016865          163 AEFSCPFWFSTGATSLIHKILDPNPKTRIRI-EGIRKHPWFRK  204 (381)
Q Consensus       163 ~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~-~~il~hp~~~~  204 (381)
                      .....|.+++.++.+||.+||+.||.+|+++ .++++||||+.
T Consensus       211 ~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~  253 (316)
T cd05592         211 DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRG  253 (316)
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCC
Confidence            7777888999999999999999999999986 48889999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.4e-42  Score=330.99  Aligned_cols=201  Identities=31%  Similarity=0.634  Sum_probs=182.8

Q ss_pred             CCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEcc
Q 016865            3 IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS   82 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~   82 (381)
                      .++||||+++++++.+.+.+|+||||++||+|.+++.....+++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus        52 ~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~  131 (316)
T cd05619          52 AWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDT  131 (316)
T ss_pred             ccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECC
Confidence            35899999999999999999999999999999999988788999999999999999999999999999999999999999


Q ss_pred             CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhc
Q 016865           83 YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA  162 (381)
Q Consensus        83 ~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~  162 (381)
                      ++.+||+|||++.............+||+.|+|||++.+..++ .++||||+||++|+|++|..||...+.....+.+..
T Consensus       132 ~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~  210 (316)
T cd05619         132 DGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYN-TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM  210 (316)
T ss_pred             CCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            9999999999987543332334567899999999999877664 899999999999999999999998888888887777


Q ss_pred             ccCCCCCCCChhHHHHHHHhcCCCCCCCCCHH-HHhcCccccc
Q 016865          163 AEFSCPFWFSTGATSLIHKILDPNPKTRIRIE-GIRKHPWFRK  204 (381)
Q Consensus       163 ~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~-~il~hp~~~~  204 (381)
                      .....|.+++.++.++|.+||+.||.+|+++. ++++||||+.
T Consensus       211 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~  253 (316)
T cd05619         211 DNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFRE  253 (316)
T ss_pred             CCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCC
Confidence            77778889999999999999999999999996 8999999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.7e-42  Score=331.62  Aligned_cols=201  Identities=32%  Similarity=0.576  Sum_probs=182.1

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      +.++||||+++++++.+.+.+|+||||++||+|...+.. +.+++..++.++.||+.||+|||++||+||||||+||+++
T Consensus        57 ~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~  135 (324)
T cd05589          57 NSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD  135 (324)
T ss_pred             cccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC
Confidence            567899999999999999999999999999999887754 6799999999999999999999999999999999999999


Q ss_pred             cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhh
Q 016865           82 SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN  161 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~  161 (381)
                      .++.+||+|||++...........+.+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+.......+.
T Consensus       136 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~  214 (324)
T cd05589         136 TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV  214 (324)
T ss_pred             CCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999999998754333333456789999999999987666 489999999999999999999999888888888888


Q ss_pred             cccCCCCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 016865          162 AAEFSCPFWFSTGATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  204 (381)
Q Consensus       162 ~~~~~~p~~~s~~~~~li~~~L~~dP~~R~-----t~~~il~hp~~~~  204 (381)
                      ......|..+++++.++|.+||+.||.+||     ++.++++||||+.
T Consensus       215 ~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~  262 (324)
T cd05589         215 NDEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD  262 (324)
T ss_pred             hCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence            778888888999999999999999999999     7999999999975

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-42  Score=324.34  Aligned_cols=203  Identities=30%  Similarity=0.526  Sum_probs=180.6

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |++++||.++.||..|++....|+|||||+||+|+...+++  +.++++.|++|+..++.||+|||-.||++||||||||
T Consensus       131 L~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENI  210 (459)
T KOG0610|consen  131 LSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENI  210 (459)
T ss_pred             HHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCccee
Confidence            46799999999999999999999999999999999888664  4699999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCC---------------------------------C-c----------------------c
Q 016865           79 LLDSYGNLKVSDFGLSALPQQ---------------------------------G-V----------------------E  102 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~---------------------------------~-~----------------------~  102 (381)
                      |+-++|++.|+||.|+.....                                 . .                      .
T Consensus       211 LvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~  290 (459)
T KOG0610|consen  211 LVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGA  290 (459)
T ss_pred             EEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCc
Confidence            999999999999988643110                                 0 0                      0


Q ss_pred             ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccCCCCC--CCChhHHHHHH
Q 016865          103 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF--WFSTGATSLIH  180 (381)
Q Consensus       103 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~  180 (381)
                      .....+||-.|+|||++.+.+. +.++|.|+|||+|||||.|..||.+.+..+.+.+|......+|.  .+|..++|||+
T Consensus       291 RSnSFVGThEYlAPEvI~G~GH-gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr  369 (459)
T KOG0610|consen  291 RSNSFVGTHEYLAPEVIRGEGH-GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIR  369 (459)
T ss_pred             cccccccccccccceeeecCCC-CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHH
Confidence            1134569999999999998876 59999999999999999999999999998888888887777775  47899999999


Q ss_pred             HhcCCCCCCCCC----HHHHhcCccccc
Q 016865          181 KILDPNPKTRIR----IEGIRKHPWFRK  204 (381)
Q Consensus       181 ~~L~~dP~~R~t----~~~il~hp~~~~  204 (381)
                      ++|.+||.+|+.    +.||.+||||+.
T Consensus       370 ~LLvKdP~kRlg~~rGA~eIK~HpFF~g  397 (459)
T KOG0610|consen  370 KLLVKDPSKRLGSKRGAAEIKRHPFFEG  397 (459)
T ss_pred             HHhccChhhhhccccchHHhhcCccccC
Confidence            999999999998    999999999985

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.2e-43  Score=334.59  Aligned_cols=203  Identities=39%  Similarity=0.708  Sum_probs=185.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |++++||||+++++++.+.+.+|+||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+||++
T Consensus        52 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~  131 (318)
T cd05582          52 LAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL  131 (318)
T ss_pred             HHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE
Confidence            46789999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.+||+|||++.............+||+.|+|||++.+..+. .++||||+||++|+|++|+.||...+.......+
T Consensus       132 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i  210 (318)
T cd05582         132 DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI  210 (318)
T ss_pred             CCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCC-CccceeccceEeeeeccCCCCCCCCCHHHHHHHH
Confidence            999999999999987654433344567899999999999876664 8999999999999999999999988887777878


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIR-----IEGIRKHPWFRK  204 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t-----~~~il~hp~~~~  204 (381)
                      .......|..+++++.+||++||+.||.+|||     +++++.||||..
T Consensus       211 ~~~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~  259 (318)
T cd05582         211 LKAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST  259 (318)
T ss_pred             HcCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence            77788888889999999999999999999999     788999999975

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.4e-42  Score=332.78  Aligned_cols=199  Identities=34%  Similarity=0.658  Sum_probs=176.7

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCC
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG   84 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~   84 (381)
                      +||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus        54 ~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~  133 (329)
T cd05588          54 NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG  133 (329)
T ss_pred             CCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC
Confidence            79999999999999999999999999999999998888999999999999999999999999999999999999999999


Q ss_pred             CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCC---------hhH
Q 016865           85 NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD---------LPT  155 (381)
Q Consensus        85 ~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~---------~~~  155 (381)
                      .+||+|||++...........+.+||+.|+|||++.+..++ .++||||+||++|+|++|+.||+...         ...
T Consensus       134 ~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~  212 (329)
T cd05588         134 HIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDY  212 (329)
T ss_pred             CEEECcCccccccccCCCccccccCCccccCHHHHcCCCCC-CccceechHHHHHHHHHCCCCcccccccccccccchHH
Confidence            99999999987533222344567899999999999877665 89999999999999999999996321         123


Q ss_pred             HHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCC------HHHHhcCccccc
Q 016865          156 LYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIR------IEGIRKHPWFRK  204 (381)
Q Consensus       156 ~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t------~~~il~hp~~~~  204 (381)
                      ..+.+.......|..++.++.++|++||..||.+|+|      ++++++||||..
T Consensus       213 ~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         213 LFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             HHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            4555666777888899999999999999999999997      789999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-43  Score=323.36  Aligned_cols=208  Identities=30%  Similarity=0.460  Sum_probs=175.2

Q ss_pred             CCCCCccccccceEEEEe-----CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 016865            1 MKIVRHPNIVRLHEVLAS-----RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKP   75 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~-----~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp   75 (381)
                      ||.++|+|||.+++++..     -+.+|+|+|+| +-+|...|+....++++.++.+++||+.||+|+||.||+||||||
T Consensus        75 Lr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKP  153 (359)
T KOG0660|consen   75 LRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKP  153 (359)
T ss_pred             HHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccch
Confidence            467899999999999965     35799999999 459988888877799999999999999999999999999999999


Q ss_pred             CcEEEccCCCEEEeeccCccCCCC--CccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh
Q 016865           76 ENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL  153 (381)
Q Consensus        76 ~NiLl~~~~~lkl~DFGls~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~  153 (381)
                      .|+|++.+..+||+|||+|+....  .....+..+.|.+|.|||++.....++..+||||+||||.||++|++.|.+.+.
T Consensus       154 sNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~  233 (359)
T KOG0660|consen  154 SNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY  233 (359)
T ss_pred             hheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch
Confidence            999999999999999999997643  234567788999999999988766667999999999999999999999988775


Q ss_pred             hHHHHHhhc-----------------------ccCCCC--------CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          154 PTLYKKINA-----------------------AEFSCP--------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       154 ~~~~~~i~~-----------------------~~~~~p--------~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      ....+.|..                       .....|        +..++.+.+|+.+||..||.+|+|++|+|+|||+
T Consensus       234 v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl  313 (359)
T KOG0660|consen  234 VHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYL  313 (359)
T ss_pred             HHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhh
Confidence            443333210                       000111        1378999999999999999999999999999999


Q ss_pred             ccCCCCC
Q 016865          203 RKNYNPV  209 (381)
Q Consensus       203 ~~~~~~~  209 (381)
                      .....|.
T Consensus       314 ~~~hdp~  320 (359)
T KOG0660|consen  314 APYHDPE  320 (359)
T ss_pred             hhhcCCc
Confidence            8765543

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.8e-42  Score=332.86  Aligned_cols=202  Identities=35%  Similarity=0.603  Sum_probs=183.4

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      +.++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus        51 ~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~  130 (325)
T cd05604          51 KNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLD  130 (325)
T ss_pred             HhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC
Confidence            56899999999999999999999999999999999998888999999999999999999999999999999999999999


Q ss_pred             cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhh
Q 016865           82 SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN  161 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~  161 (381)
                      .+|.+||+|||++.............+||+.|+|||++.+..++ .++||||+||++|+|++|..||...+....+..+.
T Consensus       131 ~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~  209 (325)
T cd05604         131 SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL  209 (325)
T ss_pred             CCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHH
Confidence            99999999999987543323334567899999999999877775 89999999999999999999999888888888887


Q ss_pred             cccCCCCCCCChhHHHHHHHhcCCCCCCCCCH----HHHhcCccccc
Q 016865          162 AAEFSCPFWFSTGATSLIHKILDPNPKTRIRI----EGIRKHPWFRK  204 (381)
Q Consensus       162 ~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~----~~il~hp~~~~  204 (381)
                      ......++..+..+.++|++||..||.+||++    .++++||||..
T Consensus       210 ~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~  256 (325)
T cd05604         210 HKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES  256 (325)
T ss_pred             cCCccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence            77777777799999999999999999999977    58999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.2e-42  Score=331.17  Aligned_cols=202  Identities=33%  Similarity=0.598  Sum_probs=183.1

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      +.++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus        51 ~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~  130 (325)
T cd05602          51 KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD  130 (325)
T ss_pred             HhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC
Confidence            56899999999999999999999999999999999998888899999999999999999999999999999999999999


Q ss_pred             cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhh
Q 016865           82 SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN  161 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~  161 (381)
                      .++.+||+|||++.............+||+.|+|||++.+..++ .++||||+||++|+|++|.+||...+....+..+.
T Consensus       131 ~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~  209 (325)
T cd05602         131 SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL  209 (325)
T ss_pred             CCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            99999999999987543333344567899999999999877665 89999999999999999999999888888888877


Q ss_pred             cccCCCCCCCChhHHHHHHHhcCCCCCCCCCHH----HHhcCccccc
Q 016865          162 AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE----GIRKHPWFRK  204 (381)
Q Consensus       162 ~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~----~il~hp~~~~  204 (381)
                      ......++.+++.+.++|.+||+.||.+|+++.    ++++|+||..
T Consensus       210 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~  256 (325)
T cd05602         210 NKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP  256 (325)
T ss_pred             hCCcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence            777777778999999999999999999999876    8999999964

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6.5e-42  Score=328.19  Aligned_cols=199  Identities=36%  Similarity=0.718  Sum_probs=182.9

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCC
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG   84 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~   84 (381)
                      +||||+++++++.+.+.+|+||||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++
T Consensus        54 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~  133 (318)
T cd05570          54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG  133 (318)
T ss_pred             CCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC
Confidence            79999999999999999999999999999999998888999999999999999999999999999999999999999999


Q ss_pred             CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc
Q 016865           85 NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE  164 (381)
Q Consensus        85 ~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~  164 (381)
                      .+||+|||++.............+||+.|+|||++.+..++ .++||||+||++|+|++|+.||...+.......+....
T Consensus       134 ~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~  212 (318)
T cd05570         134 HIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE  212 (318)
T ss_pred             cEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence            99999999987533332334566899999999999887775 89999999999999999999999888888888888778


Q ss_pred             CCCCCCCChhHHHHHHHhcCCCCCCCCCH-----HHHhcCccccc
Q 016865          165 FSCPFWFSTGATSLIHKILDPNPKTRIRI-----EGIRKHPWFRK  204 (381)
Q Consensus       165 ~~~p~~~s~~~~~li~~~L~~dP~~R~t~-----~~il~hp~~~~  204 (381)
                      ...|..+++++.+||++||..||.+|||+     .+++.||||+.
T Consensus       213 ~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~  257 (318)
T cd05570         213 VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE  257 (318)
T ss_pred             CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            88888899999999999999999999999     99999999975

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.5e-42  Score=329.49  Aligned_cols=202  Identities=35%  Similarity=0.607  Sum_probs=183.4

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      +.++||||+++++++.+.+..|+||||++||+|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus        51 ~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~  130 (321)
T cd05603          51 KNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLD  130 (321)
T ss_pred             HhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC
Confidence            56899999999999999999999999999999999998888899999999999999999999999999999999999999


Q ss_pred             cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhh
Q 016865           82 SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN  161 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~  161 (381)
                      .+|.+||+|||++.............+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+....+..+.
T Consensus       131 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~  209 (321)
T cd05603         131 SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL  209 (321)
T ss_pred             CCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh
Confidence            99999999999987543333334567899999999999877765 88999999999999999999999888888888888


Q ss_pred             cccCCCCCCCChhHHHHHHHhcCCCCCCCCCH----HHHhcCccccc
Q 016865          162 AAEFSCPFWFSTGATSLIHKILDPNPKTRIRI----EGIRKHPWFRK  204 (381)
Q Consensus       162 ~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~----~~il~hp~~~~  204 (381)
                      ......|...+..+.++|.+||+.||.+|+++    .++++||||..
T Consensus       210 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~  256 (321)
T cd05603         210 HKPLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP  256 (321)
T ss_pred             cCCCCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence            77778888899999999999999999999976    59999999974

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.2e-42  Score=306.84  Aligned_cols=206  Identities=33%  Similarity=0.489  Sum_probs=179.1

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++|||||.++++|...+.+.||+||++. +|...|+... .+...+++.|+.++++||+|||++.|+||||||.|+|
T Consensus        55 Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLL  133 (318)
T KOG0659|consen   55 LQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLL  133 (318)
T ss_pred             HHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceE
Confidence            4678999999999999999999999999976 9999887654 5789999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      ++.+|.+||+|||+|+.+..........+-|.+|.|||.+.+...++..+|+||.|||+.||+-|.+-|.+.+..+....
T Consensus       134 is~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~  213 (318)
T KOG0659|consen  134 ISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSK  213 (318)
T ss_pred             EcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHH
Confidence            99999999999999999887666666668999999999999988888999999999999999999999988776555444


Q ss_pred             hhcc----------------------cCCCCC------CCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 016865          160 INAA----------------------EFSCPF------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  207 (381)
Q Consensus       160 i~~~----------------------~~~~p~------~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~  207 (381)
                      |...                      .++.|+      -.++++.+|+.+||..||.+|+|+.|+++||||+....
T Consensus       214 If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~  289 (318)
T KOG0659|consen  214 IFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL  289 (318)
T ss_pred             HHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence            4211                      011111      15788999999999999999999999999999987543

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=7.3e-42  Score=329.49  Aligned_cols=201  Identities=34%  Similarity=0.638  Sum_probs=177.0

Q ss_pred             CCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEcc
Q 016865            3 IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS   82 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~   82 (381)
                      ..+||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+||+++.
T Consensus        52 ~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~  131 (329)
T cd05618          52 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS  131 (329)
T ss_pred             cCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECC
Confidence            34899999999999999999999999999999999988888999999999999999999999999999999999999999


Q ss_pred             CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCC---------Ch
Q 016865           83 YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET---------DL  153 (381)
Q Consensus        83 ~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~---------~~  153 (381)
                      ++.+||+|||++.............+||+.|+|||++.+..+. .++||||+||++|+|++|..||...         ..
T Consensus       132 ~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  210 (329)
T cd05618         132 EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE  210 (329)
T ss_pred             CCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCC-CccceecccHHHHHHhhCCCCCccCCCcCCcccccH
Confidence            9999999999987543323334567899999999999877664 8999999999999999999999521         11


Q ss_pred             hHHHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCC------HHHHhcCccccc
Q 016865          154 PTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIR------IEGIRKHPWFRK  204 (381)
Q Consensus       154 ~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t------~~~il~hp~~~~  204 (381)
                      ....+.+.......|..++..+.+||++||..||.+|+|      ++++++||||+.
T Consensus       211 ~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~  267 (329)
T cd05618         211 DYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  267 (329)
T ss_pred             HHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            234455666777888889999999999999999999998      589999999975

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=7.5e-42  Score=333.69  Aligned_cols=202  Identities=32%  Similarity=0.588  Sum_probs=174.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++.+.+...+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus        55 l~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi  134 (363)
T cd05628          55 LVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL  134 (363)
T ss_pred             HHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE
Confidence            35679999999999999999999999999999999999988899999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCc-----------------------------------cccccccCCCCCCCCceecCCCCC
Q 016865           81 DSYGNLKVSDFGLSALPQQGV-----------------------------------ELLHTTCGTPNYVAPEVLSNRGYD  125 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~-----------------------------------~~~~~~~gt~~y~aPE~l~~~~~~  125 (381)
                      +.++.+||+|||++.......                                   ....+.+||+.|+|||++.+..++
T Consensus       135 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~  214 (363)
T cd05628         135 DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN  214 (363)
T ss_pred             CCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC
Confidence            999999999999987542210                                   012346899999999999887775


Q ss_pred             CCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc--cCCCCCC--CChhHHHHHHHhcCCCCC---CCCCHHHHhc
Q 016865          126 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGATSLIHKILDPNPK---TRIRIEGIRK  198 (381)
Q Consensus       126 ~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~--~s~~~~~li~~~L~~dP~---~R~t~~~il~  198 (381)
                       .++||||+||++|+|++|..||.+.+....+.++...  ...+|+.  +++++++||.+|+. +|.   .||+++++++
T Consensus       215 -~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~  292 (363)
T cd05628         215 -KLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKT  292 (363)
T ss_pred             -CchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhC
Confidence             8999999999999999999999988877777776543  3445543  78999999999875 444   4689999999


Q ss_pred             Cccccc
Q 016865          199 HPWFRK  204 (381)
Q Consensus       199 hp~~~~  204 (381)
                      ||||+.
T Consensus       293 hp~f~~  298 (363)
T cd05628         293 NPFFEG  298 (363)
T ss_pred             CCCCCC
Confidence            999975

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=8.3e-42  Score=328.17  Aligned_cols=201  Identities=32%  Similarity=0.632  Sum_probs=181.6

Q ss_pred             CCCc-cccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            3 IVRH-PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         3 ~l~H-pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      .++| ++|+++++++.+.+.+|+||||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus        56 ~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~  135 (324)
T cd05587          56 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD  135 (324)
T ss_pred             hcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEc
Confidence            3444 568899999999999999999999999999998888899999999999999999999999999999999999999


Q ss_pred             cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhh
Q 016865           82 SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN  161 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~  161 (381)
                      .++.+||+|||++.............+||+.|+|||++.+..+. .++||||+||++|+|++|+.||...+....+..+.
T Consensus       136 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~  214 (324)
T cd05587         136 AEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM  214 (324)
T ss_pred             CCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99999999999987533322334567899999999999877764 89999999999999999999999888888888888


Q ss_pred             cccCCCCCCCChhHHHHHHHhcCCCCCCCCCH-----HHHhcCccccc
Q 016865          162 AAEFSCPFWFSTGATSLIHKILDPNPKTRIRI-----EGIRKHPWFRK  204 (381)
Q Consensus       162 ~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~-----~~il~hp~~~~  204 (381)
                      .....+|..+++++.++|++||..||.+|+++     +++++||||+.
T Consensus       215 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~  262 (324)
T cd05587         215 EHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR  262 (324)
T ss_pred             cCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            88888888999999999999999999999987     89999999975

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-42  Score=332.40  Aligned_cols=200  Identities=33%  Similarity=0.626  Sum_probs=181.4

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCC
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG   84 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~   84 (381)
                      +||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus        54 ~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~  133 (330)
T cd05586          54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG  133 (330)
T ss_pred             CCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC
Confidence            79999999999999999999999999999999999888999999999999999999999999999999999999999999


Q ss_pred             CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc
Q 016865           85 NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE  164 (381)
Q Consensus        85 ~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~  164 (381)
                      .+||+|||++...........+.+||+.|+|||++.+....+.++||||+||++|+|++|..||...+....+..+..+.
T Consensus       134 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~  213 (330)
T cd05586         134 HIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK  213 (330)
T ss_pred             CEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC
Confidence            99999999987644333445677899999999998765544689999999999999999999999888888888887777


Q ss_pred             CCCCCC-CChhHHHHHHHhcCCCCCCCC----CHHHHhcCccccc
Q 016865          165 FSCPFW-FSTGATSLIHKILDPNPKTRI----RIEGIRKHPWFRK  204 (381)
Q Consensus       165 ~~~p~~-~s~~~~~li~~~L~~dP~~R~----t~~~il~hp~~~~  204 (381)
                      ...|.. +++++.+||++||..||.+||    +++++++||||..
T Consensus       214 ~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~  258 (330)
T cd05586         214 VRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD  258 (330)
T ss_pred             CCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence            776654 799999999999999999998    7999999999975

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.2e-41  Score=321.45  Aligned_cols=201  Identities=26%  Similarity=0.485  Sum_probs=168.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+..|+||||++| +|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||
T Consensus        57 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil  135 (288)
T cd07871          57 LKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLL  135 (288)
T ss_pred             HHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE
Confidence            4678999999999999999999999999975 8999887654 4789999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      ++.++.+||+|||++..............||+.|+|||++.+....+.++||||+||++|+|++|++||...+.......
T Consensus       136 ~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~  215 (288)
T cd07871         136 INEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL  215 (288)
T ss_pred             ECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999999876544333345667899999999987654445899999999999999999999987665443322


Q ss_pred             hhcc-------------------cCCCC-----------CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          160 INAA-------------------EFSCP-----------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       160 i~~~-------------------~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      +...                   .+.+|           +.+++++++||++||+.||.+|||++|+++||||
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         216 IFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             HHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            2110                   01111           2368899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.2e-41  Score=327.94  Aligned_cols=203  Identities=34%  Similarity=0.640  Sum_probs=176.7

Q ss_pred             CCC-CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            2 KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         2 k~l-~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      +.+ +||||+++++++.+.+.+|+||||++||+|.+++...+.++++.++.++.||+.||.|||++||+||||||+|||+
T Consensus        59 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili  138 (332)
T cd05614          59 EHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL  138 (332)
T ss_pred             HhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE
Confidence            345 5999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCC-ccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCC----hhH
Q 016865           81 DSYGNLKVSDFGLSALPQQG-VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD----LPT  155 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~----~~~  155 (381)
                      +.++.+||+|||++...... .......+||+.|+|||++.+....+.++||||+||++|+|++|..||...+    ...
T Consensus       139 ~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~  218 (332)
T cd05614         139 DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSE  218 (332)
T ss_pred             CCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHH
Confidence            99999999999998764332 2223456899999999999776545689999999999999999999996432    233


Q ss_pred             HHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 016865          156 LYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  204 (381)
Q Consensus       156 ~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~-----t~~~il~hp~~~~  204 (381)
                      ....+.......|..+++.+.++|.+||..||.+||     +++++++||||+.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  272 (332)
T cd05614         219 VSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG  272 (332)
T ss_pred             HHHHHhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            444555556677778999999999999999999999     8899999999975

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-42  Score=333.31  Aligned_cols=203  Identities=30%  Similarity=0.510  Sum_probs=190.4

Q ss_pred             CCCCCccccccceEEEEeCCE-EEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            1 MKIVRHPNIVRLHEVLASRTK-VYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~-~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      +++++|||||.+.+.|..++. +||||+||+||+|.+.|...+  -++|+.+..||.|++.||.|||++.|.|||||+.|
T Consensus        57 is~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~N  136 (426)
T KOG0589|consen   57 LSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCAN  136 (426)
T ss_pred             HHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhh
Confidence            357899999999999998887 999999999999999997754  48999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           78 LLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        78 iLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      |+++.++.+||+|||+|+..........+..|||.|++||++.+.+|. .|+|||||||++|||++-+++|...+...+.
T Consensus       137 ifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li  215 (426)
T KOG0589|consen  137 IFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTLKPAFKASNMSELI  215 (426)
T ss_pred             hhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhcccccCccchHHHH
Confidence            999999999999999999988766688899999999999999999885 9999999999999999999999999999999


Q ss_pred             HHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          158 KKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       158 ~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      .+|..+. .+.|..+|.+++.+|+.||..+|..||++.++|.+|....
T Consensus       216 ~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  216 LKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             HHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence            9998877 5788889999999999999999999999999999998763

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.4e-41  Score=326.36  Aligned_cols=199  Identities=31%  Similarity=0.614  Sum_probs=182.9

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCC
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG   84 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~   84 (381)
                      +||||+++++++.+.+.+|+||||++||+|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus        59 ~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~  138 (323)
T cd05616          59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG  138 (323)
T ss_pred             CCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCC
Confidence            68999999999999999999999999999999998888899999999999999999999999999999999999999999


Q ss_pred             CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc
Q 016865           85 NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE  164 (381)
Q Consensus        85 ~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~  164 (381)
                      .+||+|||++.............+||+.|+|||++.+..++ .++||||+||++|+|++|+.||...+....+..+....
T Consensus       139 ~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~  217 (323)
T cd05616         139 HIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN  217 (323)
T ss_pred             cEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence            99999999987543333344567899999999999887765 89999999999999999999999988888888888888


Q ss_pred             CCCCCCCChhHHHHHHHhcCCCCCCCCCH-----HHHhcCccccc
Q 016865          165 FSCPFWFSTGATSLIHKILDPNPKTRIRI-----EGIRKHPWFRK  204 (381)
Q Consensus       165 ~~~p~~~s~~~~~li~~~L~~dP~~R~t~-----~~il~hp~~~~  204 (381)
                      ..+|..+++++.+++.+||+.||.+|+++     .++++||||+.
T Consensus       218 ~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~  262 (323)
T cd05616         218 VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  262 (323)
T ss_pred             CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence            88888999999999999999999999984     89999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.9e-41  Score=322.37  Aligned_cols=204  Identities=26%  Similarity=0.473  Sum_probs=166.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+....|+||||++ ++|.+++... +.++++.++.++.|++.||+|||++||+||||||+|||
T Consensus        57 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nil  135 (303)
T cd07869          57 LKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLL  135 (303)
T ss_pred             HhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence            467899999999999999999999999996 5888877654 56899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh-hHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL-PTLYK  158 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~~~~  158 (381)
                      ++.++.+||+|||++.............+||+.|+|||++.+....+.++||||+||++|+|++|..||.+... .....
T Consensus       136 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  215 (303)
T cd07869         136 ISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLE  215 (303)
T ss_pred             ECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHH
Confidence            99999999999999875443333345567899999999987655455899999999999999999999976432 22221


Q ss_pred             Hhhc--c-------------------cCC--CCC---------CCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          159 KINA--A-------------------EFS--CPF---------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       159 ~i~~--~-------------------~~~--~p~---------~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      .+..  +                   .+.  .|.         .+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~  294 (303)
T cd07869         216 RIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL  294 (303)
T ss_pred             HHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence            1110  0                   000  000         135789999999999999999999999999999753

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=316.32  Aligned_cols=203  Identities=34%  Similarity=0.631  Sum_probs=191.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+..+||.+..+...|++++.+|+||||+.||+|+-++.+...++|+.++.|...|++||.|||+++|+.||||.+|+|+
T Consensus       222 L~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL  301 (516)
T KOG0690|consen  222 LQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL  301 (516)
T ss_pred             HHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee
Confidence            35678999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      |.+|++||+|||+++..-.......+.||||.|.|||++....| +.++|.|.+||++|||++|++||...+...++..|
T Consensus       302 DkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI  380 (516)
T KOG0690|consen  302 DKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI  380 (516)
T ss_pred             ccCCceEeeecccchhcccccceeccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHH
Confidence            99999999999999865444567889999999999999988877 49999999999999999999999999999999999


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  204 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~-----t~~~il~hp~~~~  204 (381)
                      ...+..+|..+|++++.|+..+|.+||.+|.     .+.+|.+|+||..
T Consensus       381 l~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~  429 (516)
T KOG0690|consen  381 LMEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS  429 (516)
T ss_pred             HhhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence            9999999999999999999999999999998     5789999999974

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.1e-41  Score=318.83  Aligned_cols=201  Identities=31%  Similarity=0.453  Sum_probs=167.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+.+|+||||++++.+.........++++.++.++.|++.||.|||+.||+||||||+||++
T Consensus        54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill  133 (287)
T cd07848          54 LRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI  133 (287)
T ss_pred             HHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence            46789999999999999999999999999988776555555679999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      +.++.+||+|||++....... .......||+.|+|||++.+..++ .++||||+||++|+|++|++||...+.......
T Consensus       134 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~  212 (287)
T cd07848         134 SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYG-KAVDMWSVGCILGELSDGQPLFPGESEIDQLFT  212 (287)
T ss_pred             cCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999999998654321 223456799999999999877764 899999999999999999999987654332211


Q ss_pred             hhcc-------------------cCCCC-------------CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          160 INAA-------------------EFSCP-------------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       160 i~~~-------------------~~~~p-------------~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      +...                   ....|             ..+|+++.+||++||+.||.+|||++++++||||
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         213 IQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             HHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            1110                   00011             1267889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-41  Score=311.83  Aligned_cols=207  Identities=31%  Similarity=0.452  Sum_probs=178.9

Q ss_pred             CCCCCccccccceEEEEeC--CEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            1 MKIVRHPNIVRLHEVLASR--TKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~--~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      |.+.+|||||.+-++....  +.+|||||||+. ||...+...+ ++...+++.++.|+++||+|||++.|+||||||+|
T Consensus       129 Ll~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SN  207 (419)
T KOG0663|consen  129 LLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSN  207 (419)
T ss_pred             HHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhh
Confidence            3467899999999998754  689999999976 9999998765 79999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           78 LLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        78 iLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      +|++..|.+||+|||+|+.++.+.......+-|.+|.|||.+.+..-+++++|+||+|||+.||+++++.|.+....+..
T Consensus       208 LLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl  287 (419)
T KOG0663|consen  208 LLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQL  287 (419)
T ss_pred             eeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHH
Confidence            99999999999999999998887666778889999999999999887779999999999999999999999988766555


Q ss_pred             HHhhc-----------c--------cCCCC------------CC-CChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          158 KKINA-----------A--------EFSCP------------FW-FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       158 ~~i~~-----------~--------~~~~p------------~~-~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      .+|..           +        ...++            .. +|....+|+..+|..||.+|+|+++.|+|+||...
T Consensus       288 ~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  288 DKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET  367 (419)
T ss_pred             HHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence            44421           0        01111            11 45889999999999999999999999999999876


Q ss_pred             CCC
Q 016865          206 YNP  208 (381)
Q Consensus       206 ~~~  208 (381)
                      ..|
T Consensus       368 P~p  370 (419)
T KOG0663|consen  368 PLP  370 (419)
T ss_pred             CCC
Confidence            544

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-41  Score=326.01  Aligned_cols=200  Identities=32%  Similarity=0.620  Sum_probs=177.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+..|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus        55 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~  134 (333)
T cd05600          55 LTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI  134 (333)
T ss_pred             HHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE
Confidence            35678999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.+||+|||++.....   ...+.+||+.|+|||++.+..++ .++||||+||++|+|++|..||...+....+..+
T Consensus       135 ~~~~~~kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i  210 (333)
T cd05600         135 DASGHIKLTDFGLSKGIVT---YANSVVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL  210 (333)
T ss_pred             CCCCCEEEEeCcCCccccc---ccCCcccCccccChhHhcCCCCC-CccceecchHHHhhhhhCCCCCCCCCHHHHHHHH
Confidence            9999999999999876543   34567899999999999887665 8999999999999999999999988777666555


Q ss_pred             hccc--CCCCC------CCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          161 NAAE--FSCPF------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       161 ~~~~--~~~p~------~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      ....  ...|.      .+++++.+||.+||..+|.+|+|++++++||||..
T Consensus       211 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~  262 (333)
T cd05600         211 KYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE  262 (333)
T ss_pred             HhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence            4322  22232      35899999999999999999999999999999985

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.5e-41  Score=318.88  Aligned_cols=202  Identities=28%  Similarity=0.510  Sum_probs=174.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||+++++++.+.+..|+||||++||+|.+.+...  ..+++..+..++.|++.||+|||++||+||||||+||
T Consensus        54 l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Ni  133 (285)
T cd05631          54 LEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENI  133 (285)
T ss_pred             HHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHE
Confidence            45689999999999999999999999999999998888653  3589999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh----
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP----  154 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~----  154 (381)
                      |+++++.+||+|||++...... ......+||+.|+|||++.+..++ .++||||+||++|+|++|+.||...+..    
T Consensus       134 ll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~  211 (285)
T cd05631         134 LLDDRGHIRISDLGLAVQIPEG-ETVRGRVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE  211 (285)
T ss_pred             EECCCCCEEEeeCCCcEEcCCC-CeecCCCCCCCccCHhhhcCCCCC-cccCchhHHHHHHHHHhCCCCCCCCCcchhHH
Confidence            9999999999999998765432 223456799999999999877775 8999999999999999999999875542    


Q ss_pred             HHHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 016865          155 TLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIR-----IEGIRKHPWFRK  204 (381)
Q Consensus       155 ~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t-----~~~il~hp~~~~  204 (381)
                      .....+.......+..+++++.+||++||+.||.+|||     ++++++||||..
T Consensus       212 ~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~  266 (285)
T cd05631         212 EVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN  266 (285)
T ss_pred             HHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence            22333444445666778999999999999999999997     899999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-41  Score=330.69  Aligned_cols=202  Identities=33%  Similarity=0.647  Sum_probs=175.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus        55 l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~  134 (364)
T cd05599          55 LAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL  134 (364)
T ss_pred             HHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE
Confidence            45689999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCcc--------------------------------------ccccccCCCCCCCCceecCC
Q 016865           81 DSYGNLKVSDFGLSALPQQGVE--------------------------------------LLHTTCGTPNYVAPEVLSNR  122 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~--------------------------------------~~~~~~gt~~y~aPE~l~~~  122 (381)
                      +.+|.+||+|||++........                                      ...+.+||+.|+|||++.+.
T Consensus       135 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  214 (364)
T cd05599         135 DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT  214 (364)
T ss_pred             CCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC
Confidence            9999999999999864321100                                      11245799999999999877


Q ss_pred             CCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc--CCCCC--CCChhHHHHHHHhcCCCCCCCCC---HHH
Q 016865          123 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPF--WFSTGATSLIHKILDPNPKTRIR---IEG  195 (381)
Q Consensus       123 ~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~li~~~L~~dP~~R~t---~~~  195 (381)
                      ++. .++||||+||++|+|++|.+||...+....+..+....  +..|.  .+++++++||.+||. +|.+|++   +++
T Consensus       215 ~~~-~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~  292 (364)
T cd05599         215 GYN-KECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNE  292 (364)
T ss_pred             CCC-CeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHH
Confidence            765 89999999999999999999999888776666654432  33343  368999999999997 9999998   999


Q ss_pred             HhcCccccc
Q 016865          196 IRKHPWFRK  204 (381)
Q Consensus       196 il~hp~~~~  204 (381)
                      +++||||+.
T Consensus       293 ll~h~~~~~  301 (364)
T cd05599         293 IKSHPFFKG  301 (364)
T ss_pred             HhcCCCcCC
Confidence            999999975

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.3e-41  Score=324.60  Aligned_cols=200  Identities=32%  Similarity=0.627  Sum_probs=176.6

Q ss_pred             CCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccC
Q 016865            4 VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY   83 (381)
Q Consensus         4 l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~   83 (381)
                      .+||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus        53 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~  132 (327)
T cd05617          53 SSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD  132 (327)
T ss_pred             cCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCC
Confidence            37999999999999999999999999999999999888889999999999999999999999999999999999999999


Q ss_pred             CCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCC-------ChhHH
Q 016865           84 GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET-------DLPTL  156 (381)
Q Consensus        84 ~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~-------~~~~~  156 (381)
                      +.+||+|||++...........+.+||+.|+|||++.+..++ .++||||+||++|+|++|..||...       .....
T Consensus       133 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~  211 (327)
T cd05617         133 GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL  211 (327)
T ss_pred             CCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCC-chheeehhHHHHHHHHhCCCCCCccCCCcccccHHHH
Confidence            999999999987533322344567899999999999877664 8999999999999999999999532       12234


Q ss_pred             HHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCC------HHHHhcCccccc
Q 016865          157 YKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIR------IEGIRKHPWFRK  204 (381)
Q Consensus       157 ~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t------~~~il~hp~~~~  204 (381)
                      .+.+.......|..++..+.++|++||..||.+|++      ++++++||||+.
T Consensus       212 ~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~  265 (327)
T cd05617         212 FQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS  265 (327)
T ss_pred             HHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence            555666667788889999999999999999999998      579999999975

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.2e-41  Score=317.32  Aligned_cols=203  Identities=31%  Similarity=0.544  Sum_probs=175.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE   76 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~   76 (381)
                      |+.++||||+++++++.+++..|+||||++||+|.+.+..    ...+++..+..++.|++.||+|||++||+||||||+
T Consensus        47 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~  126 (280)
T cd05608          47 LAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPE  126 (280)
T ss_pred             HHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence            4678999999999999999999999999999999887743    346899999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh--
Q 016865           77 NLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP--  154 (381)
Q Consensus        77 NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~--  154 (381)
                      ||+++.++.+||+|||++..............||+.|+|||++.+..++ .++||||+||++|+|++|+.||...+..  
T Consensus       127 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~  205 (280)
T cd05608         127 NVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVE  205 (280)
T ss_pred             HEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchh
Confidence            9999999999999999987654433334456799999999999887765 8999999999999999999999765432  


Q ss_pred             --HHHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 016865          155 --TLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  204 (381)
Q Consensus       155 --~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~-----t~~~il~hp~~~~  204 (381)
                        .....+.......|..+++++.+++.+||+.||.+|+     |++++++||||+.
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~  262 (280)
T cd05608         206 NKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD  262 (280)
T ss_pred             HHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence              2333344444566777899999999999999999999     8899999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-41  Score=325.36  Aligned_cols=197  Identities=28%  Similarity=0.443  Sum_probs=172.7

Q ss_pred             CCCCCccccccceEEEEeCC-EEEEEEecCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-CeecCCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRT-KVYIILEFVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKG-VYHRDLKPE   76 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~-~~~lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~~L~~LH~~g-i~HrDlkp~   76 (381)
                      |++++|||||+++|++.+.. .++|||||+++|+|.+++..  .+.++...+..++.||+.|++|||+++ |+||||||+
T Consensus        93 l~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~  172 (362)
T KOG0192|consen   93 LSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSD  172 (362)
T ss_pred             HHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChh
Confidence            45799999999999999887 79999999999999999987  578999999999999999999999999 999999999


Q ss_pred             cEEEccCC-CEEEeeccCccCCCCCccccccccCCCCCCCCceec--CCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh
Q 016865           77 NLLLDSYG-NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS--NRGYDGSAADVWSCGVILFVLMAGYLPFGETDL  153 (381)
Q Consensus        77 NiLl~~~~-~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~  153 (381)
                      |||++.++ ++||+|||+++.............||+.|||||++.  ...|+ .++||||+||+||||+||+.||.....
T Consensus       173 NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~-~K~DvySFgIvlWEl~t~~~Pf~~~~~  251 (362)
T KOG0192|consen  173 NILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYT-EKSDVYSFGIVLWELLTGEIPFEDLAP  251 (362)
T ss_pred             hEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCC-ccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence            99999998 999999999987654322233467999999999998  44675 999999999999999999999998876


Q ss_pred             hHHHHHh--hcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          154 PTLYKKI--NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       154 ~~~~~~i--~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ......+  .......|...++.+..|+.+|+..||..||++.+|+.
T Consensus       252 ~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  252 VQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            4444333  34455667779999999999999999999999999875

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3e-41  Score=331.53  Aligned_cols=202  Identities=33%  Similarity=0.601  Sum_probs=173.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++.+.+++.+|+||||++||+|.+.+.+.+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        55 l~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl  134 (382)
T cd05625          55 LAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI  134 (382)
T ss_pred             HHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence            35789999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCC-----------------------------------------------ccccccccCCCCC
Q 016865           81 DSYGNLKVSDFGLSALPQQG-----------------------------------------------VELLHTTCGTPNY  113 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~-----------------------------------------------~~~~~~~~gt~~y  113 (381)
                      +.+|.+||+|||++......                                               .....+.+||+.|
T Consensus       135 ~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  214 (382)
T cd05625         135 DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNY  214 (382)
T ss_pred             CCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCccc
Confidence            99999999999997532100                                               0011245799999


Q ss_pred             CCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhc--ccCCCCC--CCChhHHHHHHHhcCCCCCC
Q 016865          114 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA--AEFSCPF--WFSTGATSLIHKILDPNPKT  189 (381)
Q Consensus       114 ~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L~~dP~~  189 (381)
                      +|||++.+.+|. .++||||+||++|+|++|++||...+......++..  .....|.  .+++++.++|.+|+ .+|.+
T Consensus       215 ~aPE~~~~~~~~-~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~  292 (382)
T cd05625         215 IAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPED  292 (382)
T ss_pred             CCHHHhcCCCCC-CeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhH
Confidence            999999887775 899999999999999999999988776555555443  2233443  47999999999987 59999


Q ss_pred             CCC---HHHHhcCccccc
Q 016865          190 RIR---IEGIRKHPWFRK  204 (381)
Q Consensus       190 R~t---~~~il~hp~~~~  204 (381)
                      |++   ++++++||||+.
T Consensus       293 R~~~~~~~ei~~hp~f~~  310 (382)
T cd05625         293 RLGKNGADEIKAHPFFKT  310 (382)
T ss_pred             cCCCCCHHHHhcCCCcCC
Confidence            997   999999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=7.9e-41  Score=321.42  Aligned_cols=199  Identities=31%  Similarity=0.621  Sum_probs=181.1

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCC
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG   84 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~   84 (381)
                      +||+|+++++++.+.+.+|+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++
T Consensus        59 ~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~  138 (323)
T cd05615          59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG  138 (323)
T ss_pred             CCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC
Confidence            57889999999999999999999999999999998888899999999999999999999999999999999999999999


Q ss_pred             CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc
Q 016865           85 NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE  164 (381)
Q Consensus        85 ~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~  164 (381)
                      .+||+|||++.............+||+.|+|||++.+..+. .++||||+||++|+|++|.+||...+.....+.+....
T Consensus       139 ~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~  217 (323)
T cd05615         139 HIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYG-KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN  217 (323)
T ss_pred             CEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence            99999999987543332334566799999999999876664 89999999999999999999999888888888888888


Q ss_pred             CCCCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 016865          165 FSCPFWFSTGATSLIHKILDPNPKTRIR-----IEGIRKHPWFRK  204 (381)
Q Consensus       165 ~~~p~~~s~~~~~li~~~L~~dP~~R~t-----~~~il~hp~~~~  204 (381)
                      ...|..+++++.+++.+||+.+|.+|++     .+++++||||+.
T Consensus       218 ~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~  262 (323)
T cd05615         218 VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRR  262 (323)
T ss_pred             CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCC
Confidence            8888899999999999999999999997     478999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5.2e-41  Score=328.75  Aligned_cols=203  Identities=33%  Similarity=0.582  Sum_probs=177.1

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus        97 l~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl  175 (370)
T cd05596          97 MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL  175 (370)
T ss_pred             HHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence            4678999999999999999999999999999999998865 568999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCC---CCCCcccHhHHHHHHHHHHhCCCCCCCCChhHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRG---YDGSAADVWSCGVILFVLMAGYLPFGETDLPTL  156 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~---~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~  156 (381)
                      +.++.+||+|||++....... ....+.+||+.|+|||++.+..   +.+.++||||+||++|+|++|.+||...+....
T Consensus       176 ~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~  255 (370)
T cd05596         176 DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT  255 (370)
T ss_pred             cCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH
Confidence            999999999999987654321 1234668999999999986543   345899999999999999999999998888777


Q ss_pred             HHHhhccc--CCCCC--CCChhHHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 016865          157 YKKINAAE--FSCPF--WFSTGATSLIHKILDPNPKT--RIRIEGIRKHPWFRK  204 (381)
Q Consensus       157 ~~~i~~~~--~~~p~--~~s~~~~~li~~~L~~dP~~--R~t~~~il~hp~~~~  204 (381)
                      +.++....  ..+|.  .+|.++.+||++||..+|.+  |+|++++++||||+.
T Consensus       256 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~  309 (370)
T cd05596         256 YSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN  309 (370)
T ss_pred             HHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence            77775533  44554  47999999999999999998  999999999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-41  Score=327.94  Aligned_cols=202  Identities=34%  Similarity=0.643  Sum_probs=178.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+++.+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus        55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll  134 (350)
T cd05573          55 LADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI  134 (350)
T ss_pred             HHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE
Confidence            35678999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCc-----------------------------cccccccCCCCCCCCceecCCCCCCCcccH
Q 016865           81 DSYGNLKVSDFGLSALPQQGV-----------------------------ELLHTTCGTPNYVAPEVLSNRGYDGSAADV  131 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~-----------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DI  131 (381)
                      +.++.+||+|||++.......                             .......||+.|+|||++.+..+. .++||
T Consensus       135 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di  213 (350)
T cd05573         135 DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG-LECDW  213 (350)
T ss_pred             CCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC-Cceee
Confidence            999999999999987654322                             123456799999999999887664 89999


Q ss_pred             hHHHHHHHHHHhCCCCCCCCChhHHHHHhhc--ccCCCCCC--CChhHHHHHHHhcCCCCCCCCC-HHHHhcCccccc
Q 016865          132 WSCGVILFVLMAGYLPFGETDLPTLYKKINA--AEFSCPFW--FSTGATSLIHKILDPNPKTRIR-IEGIRKHPWFRK  204 (381)
Q Consensus       132 wSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~--~s~~~~~li~~~L~~dP~~R~t-~~~il~hp~~~~  204 (381)
                      |||||++|+|++|..||...+....+.++..  .....|..  +++++.+||.+||. ||.+|++ ++++++||||+.
T Consensus       214 wSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~  290 (350)
T cd05573         214 WSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG  290 (350)
T ss_pred             EecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence            9999999999999999998887766666655  34444444  59999999999997 9999999 999999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.6e-41  Score=311.37  Aligned_cols=205  Identities=31%  Similarity=0.499  Sum_probs=177.5

Q ss_pred             CCCCCccc-cccceEEEEeCC------EEEEEEecCCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCe
Q 016865            1 MKIVRHPN-IVRLHEVLASRT------KVYIILEFVTGGELFDKIVHQG----RLLENDCRRYFQQLIDAVAHCHSKGVY   69 (381)
Q Consensus         1 lk~l~Hpn-Iv~l~~~~~~~~------~~~lV~E~~~gg~L~~~i~~~~----~l~e~~~~~~~~qll~~L~~LH~~gi~   69 (381)
                      |+.|+|+| |+++++++.+.+      .+|+|+||++. +|.+++....    +++...++.+++||+.||+|||++||+
T Consensus        64 lk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~Il  142 (323)
T KOG0594|consen   64 LKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGIL  142 (323)
T ss_pred             HHHhCCCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            46789999 999999999887      89999999976 9999998755    588889999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCC
Q 016865           70 HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFG  149 (381)
Q Consensus        70 HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~  149 (381)
                      ||||||+|||++.+|.+||+|||+|+....+.+.....++|.+|.|||++.+...++...||||+|||++||+++++.|.
T Consensus       143 HRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFp  222 (323)
T KOG0594|consen  143 HRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFP  222 (323)
T ss_pred             cccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999999777666667888899999999999998767799999999999999999999998


Q ss_pred             CCChhHHHHHhhc------------------ccCCCCCC------------CChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          150 ETDLPTLYKKINA------------------AEFSCPFW------------FSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       150 ~~~~~~~~~~i~~------------------~~~~~p~~------------~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      +....+....|..                  ....+|.|            .++++.+++.+||+.+|.+|.|+..++.|
T Consensus       223 G~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  223 GDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            8776554444311                  01122222            23589999999999999999999999999


Q ss_pred             cccccCC
Q 016865          200 PWFRKNY  206 (381)
Q Consensus       200 p~~~~~~  206 (381)
                      |||....
T Consensus       303 ~yf~~~~  309 (323)
T KOG0594|consen  303 PYFSELP  309 (323)
T ss_pred             hhhcccc
Confidence            9998653

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-41  Score=330.32  Aligned_cols=202  Identities=33%  Similarity=0.605  Sum_probs=173.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus        55 l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll  134 (377)
T cd05629          55 LAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI  134 (377)
T ss_pred             HHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE
Confidence            35689999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCc-----------------------------------------------cccccccCCCCC
Q 016865           81 DSYGNLKVSDFGLSALPQQGV-----------------------------------------------ELLHTTCGTPNY  113 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~-----------------------------------------------~~~~~~~gt~~y  113 (381)
                      +.++.+||+|||+++......                                               ......+||+.|
T Consensus       135 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  214 (377)
T cd05629         135 DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDY  214 (377)
T ss_pred             CCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccc
Confidence            999999999999986321100                                               000135799999


Q ss_pred             CCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhc--ccCCCCC--CCChhHHHHHHHhcCCCCCC
Q 016865          114 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA--AEFSCPF--WFSTGATSLIHKILDPNPKT  189 (381)
Q Consensus       114 ~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L~~dP~~  189 (381)
                      +|||++.+..+. .++||||+||++|+|++|.+||...+....+..+..  ....+|.  .+++++.+||.+||. +|.+
T Consensus       215 ~aPE~~~~~~~~-~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~  292 (377)
T cd05629         215 IAPEIFLQQGYG-QECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAEN  292 (377)
T ss_pred             cCHHHHccCCCC-CceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhh
Confidence            999999877764 899999999999999999999988777666666643  2334444  378999999999998 6776


Q ss_pred             C---CCHHHHhcCccccc
Q 016865          190 R---IRIEGIRKHPWFRK  204 (381)
Q Consensus       190 R---~t~~~il~hp~~~~  204 (381)
                      |   +|+.+++.||||+.
T Consensus       293 r~~r~~~~~~l~hp~~~~  310 (377)
T cd05629         293 RLGRGGAHEIKSHPFFRG  310 (377)
T ss_pred             cCCCCCHHHHhcCCCcCC
Confidence            5   59999999999974

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=8.4e-41  Score=328.44  Aligned_cols=203  Identities=31%  Similarity=0.550  Sum_probs=172.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||+
T Consensus        55 l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili  134 (381)
T cd05626          55 LAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI  134 (381)
T ss_pred             HHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE
Confidence            45789999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCC-----------------------------------------------ccccccccCCCCC
Q 016865           81 DSYGNLKVSDFGLSALPQQG-----------------------------------------------VELLHTTCGTPNY  113 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~-----------------------------------------------~~~~~~~~gt~~y  113 (381)
                      +.++.+||+|||++......                                               .....+.+||+.|
T Consensus       135 ~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  214 (381)
T cd05626         135 DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNY  214 (381)
T ss_pred             CCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccc
Confidence            99999999999997532110                                               0011345799999


Q ss_pred             CCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhc--ccCCCCC--CCChhHHHHHHHhc--CCCC
Q 016865          114 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA--AEFSCPF--WFSTGATSLIHKIL--DPNP  187 (381)
Q Consensus       114 ~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L--~~dP  187 (381)
                      +|||++.+..+. .++||||+||++|+|++|.+||...+......++..  .....|.  .+++++.+||.+||  ..+|
T Consensus       215 ~aPE~~~~~~~~-~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~  293 (381)
T cd05626         215 IAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEER  293 (381)
T ss_pred             cCHHHHcCCCCC-CccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccc
Confidence            999999877775 899999999999999999999988776555444432  2344444  47999999999966  4555


Q ss_pred             CCCCCHHHHhcCccccc
Q 016865          188 KTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       188 ~~R~t~~~il~hp~~~~  204 (381)
                      ..|+|+++++.||||..
T Consensus       294 ~~R~~~~~~l~hp~f~~  310 (381)
T cd05626         294 LGRNGADDIKAHPFFSE  310 (381)
T ss_pred             cCCCCHHHHhcCcccCC
Confidence            66999999999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=7.2e-41  Score=327.77  Aligned_cols=203  Identities=33%  Similarity=0.592  Sum_probs=174.9

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus        97 ~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl  175 (370)
T cd05621          97 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL  175 (370)
T ss_pred             HHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE
Confidence            3568999999999999999999999999999999998865 468999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCC---CCCCcccHhHHHHHHHHHHhCCCCCCCCChhHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRG---YDGSAADVWSCGVILFVLMAGYLPFGETDLPTL  156 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~---~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~  156 (381)
                      +.++.+||+|||++....... ....+.+||+.|+|||++.+.+   +.+.++||||+||++|+|++|..||...+....
T Consensus       176 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~  255 (370)
T cd05621         176 DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT  255 (370)
T ss_pred             CCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH
Confidence            999999999999997654321 2234678999999999987543   345899999999999999999999998887777


Q ss_pred             HHHhhcc--cCCCCC--CCChhHHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 016865          157 YKKINAA--EFSCPF--WFSTGATSLIHKILDPNPKT--RIRIEGIRKHPWFRK  204 (381)
Q Consensus       157 ~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~~--R~t~~~il~hp~~~~  204 (381)
                      +.++...  .+..|.  .+++.++++|.+||..+|.+  |+|++++++||||+.
T Consensus       256 ~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~  309 (370)
T cd05621         256 YSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN  309 (370)
T ss_pred             HHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence            7766543  244454  36999999999999866544  899999999999976

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5.1e-41  Score=327.41  Aligned_cols=201  Identities=33%  Similarity=0.625  Sum_probs=175.0

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      +.++||||+++++.+.+.+.+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++
T Consensus        56 ~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~  135 (360)
T cd05627          56 VEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLD  135 (360)
T ss_pred             HhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC
Confidence            56799999999999999999999999999999999998888899999999999999999999999999999999999999


Q ss_pred             cCCCEEEeeccCccCCCCCc-----------------------------------cccccccCCCCCCCCceecCCCCCC
Q 016865           82 SYGNLKVSDFGLSALPQQGV-----------------------------------ELLHTTCGTPNYVAPEVLSNRGYDG  126 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~~~-----------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~  126 (381)
                      .+|.+||+|||++.......                                   ....+.+||+.|+|||++.+..+. 
T Consensus       136 ~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-  214 (360)
T cd05627         136 AKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-  214 (360)
T ss_pred             CCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-
Confidence            99999999999986432110                                   012245799999999999887775 


Q ss_pred             CcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc--cCCCCCC--CChhHHHHHHHhcCCCCCCCC---CHHHHhcC
Q 016865          127 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGATSLIHKILDPNPKTRI---RIEGIRKH  199 (381)
Q Consensus       127 ~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~--~s~~~~~li~~~L~~dP~~R~---t~~~il~h  199 (381)
                      .++||||+||++|+|++|++||...+....+.++...  ...+|..  +++++++||.+|+. ||.+|+   +++++++|
T Consensus       215 ~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         215 KLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            8999999999999999999999988877777666542  3344443  78999999999875 999998   48999999


Q ss_pred             ccccc
Q 016865          200 PWFRK  204 (381)
Q Consensus       200 p~~~~  204 (381)
                      |||+.
T Consensus       294 p~f~~  298 (360)
T cd05627         294 PFFEG  298 (360)
T ss_pred             CCCCC
Confidence            99975

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=8.1e-41  Score=327.76  Aligned_cols=202  Identities=31%  Similarity=0.575  Sum_probs=173.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++.+.+++.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        55 l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill  134 (376)
T cd05598          55 LAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI  134 (376)
T ss_pred             HHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE
Confidence            45789999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCC-------------------------------------------ccccccccCCCCCCCCc
Q 016865           81 DSYGNLKVSDFGLSALPQQG-------------------------------------------VELLHTTCGTPNYVAPE  117 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~-------------------------------------------~~~~~~~~gt~~y~aPE  117 (381)
                      +.++.+||+|||++..+...                                           .....+.+||+.|+|||
T Consensus       135 ~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  214 (376)
T cd05598         135 DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPE  214 (376)
T ss_pred             CCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHH
Confidence            99999999999997532100                                           00112357999999999


Q ss_pred             eecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc--cCCCCC--CCChhHHHHHHHhcCCCCCCCC--
Q 016865          118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPF--WFSTGATSLIHKILDPNPKTRI--  191 (381)
Q Consensus       118 ~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~~R~--  191 (381)
                      ++.+..+. .++||||+||++|+|++|+.||...+.......+...  ....|.  .+++++.++|.+|+ .+|.+|+  
T Consensus       215 ~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~  292 (376)
T cd05598         215 VLLRTGYT-QLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGK  292 (376)
T ss_pred             HHcCCCCC-cceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCC
Confidence            99887775 8999999999999999999999887766555554332  223333  47999999999987 5999999  


Q ss_pred             -CHHHHhcCccccc
Q 016865          192 -RIEGIRKHPWFRK  204 (381)
Q Consensus       192 -t~~~il~hp~~~~  204 (381)
                       |++++++||||+.
T Consensus       293 ~t~~ell~h~~~~~  306 (376)
T cd05598         293 NGADEIKAHPFFKG  306 (376)
T ss_pred             CCHHHHhCCCCcCC
Confidence             9999999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.4e-40  Score=334.41  Aligned_cols=203  Identities=29%  Similarity=0.526  Sum_probs=178.9

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE   76 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~   76 (381)
                      |+.++|||||++++++.+.+.+||||||++||+|.+++..    ...+++..+..++.|++.||+|||++||+||||||+
T Consensus       119 l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~  198 (478)
T PTZ00267        119 LAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSA  198 (478)
T ss_pred             HHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHH
Confidence            4678999999999999999999999999999999987753    346899999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           77 NLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        77 NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      |||++.++.+||+|||++.......  ....+.+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+..
T Consensus       199 NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~Pf~~~~~~  277 (478)
T PTZ00267        199 NIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQR  277 (478)
T ss_pred             hEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999999999999999998654321  234567899999999999876664 8999999999999999999999988877


Q ss_pred             HHHHHhhcccC-CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          155 TLYKKINAAEF-SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       155 ~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      .....+..+.. ..|..+++++.++|.+||..||.+|||+++++.|||++.
T Consensus       278 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        278 EIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             HHHHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence            77766655544 356668999999999999999999999999999999964

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.1e-41  Score=314.28  Aligned_cols=206  Identities=31%  Similarity=0.491  Sum_probs=172.4

Q ss_pred             CCCCCccccccceEEEEeCC-----EEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 016865            1 MKIVRHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHR   71 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~-----~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~L~~LH~~gi~Hr   71 (381)
                      |+.++|||||++.-+|....     ...+||||++. +|.+.+..    +.+++.-.++-|.+||++||.|||+.||+||
T Consensus        71 m~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHR  149 (364)
T KOG0658|consen   71 MRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHR  149 (364)
T ss_pred             HHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccC
Confidence            67899999999999886432     56799999987 99998875    5679999999999999999999999999999


Q ss_pred             CCCCCcEEEcc-CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCC
Q 016865           72 DLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE  150 (381)
Q Consensus        72 Dlkp~NiLl~~-~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~  150 (381)
                      ||||+|+|+|. +|.+||||||.|+....+. ...+...|..|+|||.+.+...++.+.||||+|||+.||+-|++.|.+
T Consensus       150 DIKPqNlLvD~~tg~LKicDFGSAK~L~~~e-pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG  228 (364)
T KOG0658|consen  150 DIKPQNLLVDPDTGVLKICDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG  228 (364)
T ss_pred             CCChheEEEcCCCCeEEeccCCcceeeccCC-CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC
Confidence            99999999995 4999999999999876653 346777899999999999988778999999999999999999999988


Q ss_pred             CChhHHHHHhh---------------cc--cCCCC-----C-------CCChhHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 016865          151 TDLPTLYKKIN---------------AA--EFSCP-----F-------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPW  201 (381)
Q Consensus       151 ~~~~~~~~~i~---------------~~--~~~~p-----~-------~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~  201 (381)
                      .+..+....|.               ..  ...+|     .       ..++++.+|+.++|..+|.+|.|+.|++.|||
T Consensus       229 ~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~f  308 (364)
T KOG0658|consen  229 DSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPF  308 (364)
T ss_pred             CCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchh
Confidence            76543332221               00  11112     1       26899999999999999999999999999999


Q ss_pred             cccCCCC
Q 016865          202 FRKNYNP  208 (381)
Q Consensus       202 ~~~~~~~  208 (381)
                      |..-..+
T Consensus       309 Fdelr~~  315 (364)
T KOG0658|consen  309 FDELRDP  315 (364)
T ss_pred             hHHhhCc
Confidence            9764433

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=5.1e-40  Score=316.77  Aligned_cols=202  Identities=26%  Similarity=0.430  Sum_probs=171.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~-gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||
T Consensus        57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil  136 (331)
T cd06649          57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNIL  136 (331)
T ss_pred             HHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEE
Confidence            467899999999999999999999999999999999998888899999999999999999999986 6999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      ++.++.+||+|||++.....  .......||+.|+|||++.+..+. .++||||+||++|+|++|+.||...+...+...
T Consensus       137 ~~~~~~~kl~Dfg~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~  213 (331)
T cd06649         137 VNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI  213 (331)
T ss_pred             EcCCCcEEEccCcccccccc--cccccCCCCcCcCCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999999876533  223456799999999999877664 899999999999999999999976554333221


Q ss_pred             hhc----------------------------------------------c-cCCCC-CCCChhHHHHHHHhcCCCCCCCC
Q 016865          160 INA----------------------------------------------A-EFSCP-FWFSTGATSLIHKILDPNPKTRI  191 (381)
Q Consensus       160 i~~----------------------------------------------~-~~~~p-~~~s~~~~~li~~~L~~dP~~R~  191 (381)
                      +..                                              . ....+ ..+++++++||.+||..||.+||
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rp  293 (331)
T cd06649         214 FGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERA  293 (331)
T ss_pred             hcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCC
Confidence            110                                              0 00011 13688999999999999999999


Q ss_pred             CHHHHhcCcccccC
Q 016865          192 RIEGIRKHPWFRKN  205 (381)
Q Consensus       192 t~~~il~hp~~~~~  205 (381)
                      |+.++++||||+..
T Consensus       294 t~~ell~h~~~~~~  307 (331)
T cd06649         294 DLKMLMNHTFIKRS  307 (331)
T ss_pred             CHHHHhcChHHhhc
Confidence            99999999999854

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=9.8e-41  Score=321.29  Aligned_cols=203  Identities=33%  Similarity=0.579  Sum_probs=174.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+++... +.+++..++.++.|++.||+|||+.||+||||||+|||
T Consensus        55 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIl  134 (330)
T cd05601          55 LSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVL  134 (330)
T ss_pred             HHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheE
Confidence            35679999999999999999999999999999999999875 67999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCcc-ccccccCCCCCCCCceecC-----CCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVE-LLHTTCGTPNYVAPEVLSN-----RGYDGSAADVWSCGVILFVLMAGYLPFGETDL  153 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~-~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~  153 (381)
                      ++.+|.+||+|||++........ .....+||+.|+|||++..     ....+.++||||+||++|+|++|..||...+.
T Consensus       135 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~  214 (330)
T cd05601         135 IDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS  214 (330)
T ss_pred             ECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH
Confidence            99999999999999976543221 2234579999999999863     22335899999999999999999999988777


Q ss_pred             hHHHHHhhccc--CCCC--CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          154 PTLYKKINAAE--FSCP--FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       154 ~~~~~~i~~~~--~~~p--~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      ...+.++....  ..+|  ..+++++.+||.+||. +|.+|||++++++||||..
T Consensus       215 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~  268 (330)
T cd05601         215 AKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK  268 (330)
T ss_pred             HHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence            66666654322  2233  3579999999999998 9999999999999999975

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=6.6e-40  Score=321.08  Aligned_cols=204  Identities=33%  Similarity=0.585  Sum_probs=174.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus        97 ~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll  175 (371)
T cd05622          97 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL  175 (371)
T ss_pred             HHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE
Confidence            3567999999999999999999999999999999998865 568999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCC-ccccccccCCCCCCCCceecCCC---CCCCcccHhHHHHHHHHHHhCCCCCCCCChhHH
Q 016865           81 DSYGNLKVSDFGLSALPQQG-VELLHTTCGTPNYVAPEVLSNRG---YDGSAADVWSCGVILFVLMAGYLPFGETDLPTL  156 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~---~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~  156 (381)
                      +.++.+||+|||++...... .....+.+||+.|+|||++.+..   +.+.++||||+||++|+|++|.+||...+....
T Consensus       176 ~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~  255 (371)
T cd05622         176 DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT  255 (371)
T ss_pred             CCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH
Confidence            99999999999998765432 12234678999999999987543   345899999999999999999999998888777


Q ss_pred             HHHhhccc--CCCCC--CCChhHHHHHHHhcCCCCCC--CCCHHHHhcCcccccC
Q 016865          157 YKKINAAE--FSCPF--WFSTGATSLIHKILDPNPKT--RIRIEGIRKHPWFRKN  205 (381)
Q Consensus       157 ~~~i~~~~--~~~p~--~~s~~~~~li~~~L~~dP~~--R~t~~~il~hp~~~~~  205 (381)
                      +.++....  ..+|.  .++..++++|.+||..++.+  |++++++++||||+..
T Consensus       256 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         256 YSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             HHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            77775432  33443  48999999999999854443  7899999999999763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.1e-39  Score=307.72  Aligned_cols=198  Identities=30%  Similarity=0.423  Sum_probs=165.3

Q ss_pred             CCCCccccccceEEEE-----eCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 016865            2 KIVRHPNIVRLHEVLA-----SRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK   74 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~-----~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlk   74 (381)
                      +.++||||+++++++.     ....+|+||||++ |+|.+++...  ..+++..+..++.|++.||.|||++||+|||||
T Consensus        59 ~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlk  137 (290)
T cd07862          59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLK  137 (290)
T ss_pred             cccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence            3468999999999985     3457999999996 5899988653  458999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           75 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        75 p~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      |+|||++.++.+||+|||++...... .......||+.|+|||++.+..+. .++||||+||++|+|++|.+||.+.+..
T Consensus       138 p~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~~f~~~~~~  215 (290)
T cd07862         138 PQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDV  215 (290)
T ss_pred             HHHEEEcCCCCEEEccccceEeccCC-cccccccccccccChHHHhCCCCC-CccchHHHHHHHHHHHcCCCCcCCCCHH
Confidence            99999999999999999998765433 234566799999999999776664 8999999999999999999999887665


Q ss_pred             HHHHHhhccc-C--------------------------CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          155 TLYKKINAAE-F--------------------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       155 ~~~~~i~~~~-~--------------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      .....+.... .                          ...+.+++.+.+||.+||+.||++|||+.++++||||
T Consensus       216 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         216 DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             HHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            5444432110 0                          0112367888999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.2e-40  Score=315.96  Aligned_cols=205  Identities=26%  Similarity=0.449  Sum_probs=165.1

Q ss_pred             CCCCCccccccceEEEEeC-----CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASR-----TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKP   75 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp   75 (381)
                      |+.++||||+++++++...     ..+|+||||+. ++|.+.+...+.+++..+..++.||+.||.|||++||+||||||
T Consensus        53 l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp  131 (338)
T cd07859          53 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKP  131 (338)
T ss_pred             HHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence            4678999999999998643     35899999995 69999998888899999999999999999999999999999999


Q ss_pred             CcEEEccCCCEEEeeccCccCCCCC---ccccccccCCCCCCCCceecCC-CCCCCcccHhHHHHHHHHHHhCCCCCCCC
Q 016865           76 ENLLLDSYGNLKVSDFGLSALPQQG---VELLHTTCGTPNYVAPEVLSNR-GYDGSAADVWSCGVILFVLMAGYLPFGET  151 (381)
Q Consensus        76 ~NiLl~~~~~lkl~DFGls~~~~~~---~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DIwSlGvil~~ll~G~~Pf~~~  151 (381)
                      +|||++.++.+||+|||++......   .......+||+.|+|||++.+. ...+.++||||+||++|+|++|++||...
T Consensus       132 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~  211 (338)
T cd07859         132 KNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK  211 (338)
T ss_pred             HHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence            9999999999999999998754321   1122456799999999998652 23358999999999999999999999776


Q ss_pred             ChhHHHHHh---------------hcc-----------cCCCC-----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 016865          152 DLPTLYKKI---------------NAA-----------EFSCP-----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHP  200 (381)
Q Consensus       152 ~~~~~~~~i---------------~~~-----------~~~~p-----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp  200 (381)
                      +.......+               ...           ....+     +.+++.+.++|.+||+.||.+|||++++++||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp  291 (338)
T cd07859         212 NVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADP  291 (338)
T ss_pred             ChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCc
Confidence            543221111               000           00000     13578899999999999999999999999999


Q ss_pred             ccccCC
Q 016865          201 WFRKNY  206 (381)
Q Consensus       201 ~~~~~~  206 (381)
                      ||+...
T Consensus       292 ~f~~~~  297 (338)
T cd07859         292 YFKGLA  297 (338)
T ss_pred             hhhhcC
Confidence            997543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-39  Score=320.46  Aligned_cols=204  Identities=24%  Similarity=0.386  Sum_probs=166.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++..+...|+|||++. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus       137 l~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll  215 (391)
T PHA03212        137 LRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI  215 (391)
T ss_pred             HHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE
Confidence            467899999999999999999999999995 6999999888889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCC-CccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh------
Q 016865           81 DSYGNLKVSDFGLSALPQQ-GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL------  153 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~------  153 (381)
                      +.++.+||+|||++..... ........+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+.      
T Consensus       216 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~  294 (391)
T PHA03212        216 NHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYG-PAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCD  294 (391)
T ss_pred             cCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCcCCcccccccCc
Confidence            9999999999999875332 22233456899999999999877664 899999999999999999987743210      


Q ss_pred             -hHHHHHh--------------------------hccc----CCCCCC-----CChhHHHHHHHhcCCCCCCCCCHHHHh
Q 016865          154 -PTLYKKI--------------------------NAAE----FSCPFW-----FSTGATSLIHKILDPNPKTRIRIEGIR  197 (381)
Q Consensus       154 -~~~~~~i--------------------------~~~~----~~~p~~-----~s~~~~~li~~~L~~dP~~R~t~~~il  197 (381)
                       ......+                          ....    ...|.|     ++.++.+||.+||+.||.+|||++|++
T Consensus       295 ~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL  374 (391)
T PHA03212        295 SDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALL  374 (391)
T ss_pred             hhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHh
Confidence             0000000                          0000    011111     466899999999999999999999999


Q ss_pred             cCcccccCC
Q 016865          198 KHPWFRKNY  206 (381)
Q Consensus       198 ~hp~~~~~~  206 (381)
                      +||||+...
T Consensus       375 ~hp~f~~~~  383 (391)
T PHA03212        375 DFAAFQDIP  383 (391)
T ss_pred             cChhhccCC
Confidence            999998643

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.3e-39  Score=310.56  Aligned_cols=205  Identities=28%  Similarity=0.487  Sum_probs=169.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+++..|+||||+++ +|.+++...+ .+++..++.++.|++.||+|||++||+||||||+||+
T Consensus        58 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nil  136 (309)
T cd07872          58 LKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLL  136 (309)
T ss_pred             HHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence            3578999999999999999999999999975 8888876644 4889999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      ++.++.+||+|||++..............+|+.|+|||++.+....+.++||||+||++|+|++|++||...+..+....
T Consensus       137 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~  216 (309)
T cd07872         137 INERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL  216 (309)
T ss_pred             ECCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            99999999999999876544333334567899999999987655456899999999999999999999987665433222


Q ss_pred             hhc-------------------ccCCCC-----------CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          160 INA-------------------AEFSCP-----------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       160 i~~-------------------~~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      +..                   .....|           +.+++++++||.+||..||.+|||++++++||||+...
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         217 IFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             HHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence            210                   001111           23688999999999999999999999999999998643

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-42  Score=322.63  Aligned_cols=202  Identities=28%  Similarity=0.448  Sum_probs=181.0

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      .+++||||.++|+.+-.+..+|++||||.||++.+.++..+.+.|..+..++++++.||.|||+++.+|||||+.|||+.
T Consensus        66 s~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s  145 (467)
T KOG0201|consen   66 SQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS  145 (467)
T ss_pred             HhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe
Confidence            46789999999999999999999999999999999999877779999999999999999999999999999999999999


Q ss_pred             cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhh
Q 016865           82 SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN  161 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~  161 (381)
                      .+|.+|++|||++.+.........+.+|||.|||||++...+|+ .++||||||++.+||++|.+||.+.+.+.....|-
T Consensus       146 ~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp  224 (467)
T KOG0201|consen  146 ESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP  224 (467)
T ss_pred             ccCcEEEEecceeeeeechhhccccccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc
Confidence            99999999999999877655556899999999999999987887 99999999999999999999998877644333333


Q ss_pred             ccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          162 AAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       162 ~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      +.. ..+...+|+.+++|+..||++||+.|||+.++|+|+|++.
T Consensus       225 k~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  225 KSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             CCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence            222 2233358999999999999999999999999999999987

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-40  Score=301.34  Aligned_cols=202  Identities=32%  Similarity=0.619  Sum_probs=177.9

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCC
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG   84 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~   84 (381)
                      .|+||++++++|++++..|+|||-+.||.|..+|.....++|.+|..+.+.|++||.|||.+||.|||+||||||....+
T Consensus       134 gh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn  213 (463)
T KOG0607|consen  134 GHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPN  213 (463)
T ss_pred             CCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCC
Confidence            69999999999999999999999999999999999999999999999999999999999999999999999999998665


Q ss_pred             ---CEEEeeccCccCCCC-------CccccccccCCCCCCCCceec----CCCCCCCcccHhHHHHHHHHHHhCCCCCCC
Q 016865           85 ---NLKVSDFGLSALPQQ-------GVELLHTTCGTPNYVAPEVLS----NRGYDGSAADVWSCGVILFVLMAGYLPFGE  150 (381)
Q Consensus        85 ---~lkl~DFGls~~~~~-------~~~~~~~~~gt~~y~aPE~l~----~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~  150 (381)
                         -+|||||.+......       ....+.+.||+..|||||++.    ...++..++|.||||||||.||+|++||.+
T Consensus       214 ~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG  293 (463)
T KOG0607|consen  214 KVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG  293 (463)
T ss_pred             CcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence               489999998764332       223467889999999999863    223445899999999999999999999954


Q ss_pred             CC---------------hhHHHHHhhcccCCCCC--C--CChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          151 TD---------------LPTLYKKINAAEFSCPF--W--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       151 ~~---------------~~~~~~~i~~~~~~~p~--~--~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      .-               ...++..|..+.+.+|.  |  +|.++++||+.+|..|+..|.++.++++|||++...
T Consensus       294 ~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~  368 (463)
T KOG0607|consen  294 HCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA  368 (463)
T ss_pred             ccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence            21               23577889999999985  3  899999999999999999999999999999998643

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-40  Score=323.40  Aligned_cols=193  Identities=35%  Similarity=0.647  Sum_probs=174.6

Q ss_pred             CCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE-c
Q 016865            3 IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL-D   81 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl-~   81 (381)
                      .-+||||+++++++.+...+|+|||++.||.+.+.|.....+. ..+..|+.||+.|+.|||++||+||||||+|||+ +
T Consensus       372 ~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~  450 (612)
T KOG0603|consen  372 VRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDG  450 (612)
T ss_pred             hcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecC
Confidence            4589999999999999999999999999999999998866555 7888999999999999999999999999999999 5


Q ss_pred             cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh-HHHHHh
Q 016865           82 SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKI  160 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i  160 (381)
                      +.|+++|+|||.+......   +.+.|-|..|.|||++...+|+ +++||||||++||+||+|+.||...... ++..++
T Consensus       451 ~~g~lrltyFG~a~~~~~~---~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i  526 (612)
T KOG0603|consen  451 SAGHLRLTYFGFWSELERS---CDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI  526 (612)
T ss_pred             CCCcEEEEEechhhhCchh---hcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh
Confidence            8999999999998876543   5677889999999999988886 9999999999999999999999765444 667777


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      ..+.++  .++|.++++||++||+.||.+|+++.+++.||||
T Consensus       527 ~~~~~s--~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  527 QMPKFS--ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             cCCccc--cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            666655  7899999999999999999999999999999999

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-39  Score=306.85  Aligned_cols=202  Identities=28%  Similarity=0.520  Sum_probs=174.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||+++++.+.+.+.+|+||||++||+|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+||
T Consensus        54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni  133 (285)
T cd05605          54 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENI  133 (285)
T ss_pred             HHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHE
Confidence            45789999999999999999999999999999999888654  3589999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHH--
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL--  156 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~--  156 (381)
                      ++++++.++|+|||++...... ......+|++.|+|||++.+..+. .++||||+||++|+|++|..||.+.+....  
T Consensus       134 l~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~  211 (285)
T cd05605         134 LLDDYGHIRISDLGLAVEIPEG-ETIRGRVGTVGYMAPEVVKNERYT-FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE  211 (285)
T ss_pred             EECCCCCEEEeeCCCceecCCC-CccccccCCCCccCcHHhcCCCCC-ccccchhHHHHHHHHHHCCCCCCCCchhhHHH
Confidence            9999999999999998765432 223456899999999999876664 889999999999999999999987654332  


Q ss_pred             --HHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 016865          157 --YKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  204 (381)
Q Consensus       157 --~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~-----t~~~il~hp~~~~  204 (381)
                        ...+.......|..+++.+.+||.+||..||.+||     +++++++||||..
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05605         212 EVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT  266 (285)
T ss_pred             HHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence              22333444456667899999999999999999999     8999999999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-39  Score=299.59  Aligned_cols=201  Identities=31%  Similarity=0.510  Sum_probs=174.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+....|+|+||++|++|.+.+...+.+++..+..++.|++.||.|||+.|++||||+|+||++
T Consensus        58 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv  137 (263)
T cd06625          58 LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR  137 (263)
T ss_pred             HHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence            46789999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCcc---ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      ++++.++|+|||++........   ......|++.|+|||++.+..+ +.++||||+||++|+|++|+.||...+.....
T Consensus       138 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~  216 (263)
T cd06625         138 DSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI  216 (263)
T ss_pred             cCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHH
Confidence            9999999999999875433111   1134568899999999987665 48999999999999999999999876555444


Q ss_pred             HHhhc--ccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          158 KKINA--AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       158 ~~i~~--~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      .++..  .....|..++..+.++|.+||..+|.+|||+.++++||||
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         217 FKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            43332  2345666789999999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-40  Score=308.42  Aligned_cols=199  Identities=34%  Similarity=0.645  Sum_probs=188.7

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCC
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG   84 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~   84 (381)
                      +-|.+++++..|++-+.+|+||||+.||+|-.+|+.-+++.|..|..|+..|+-||-+||++||+.||||.+|||+|.+|
T Consensus       408 kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG  487 (683)
T KOG0696|consen  408 KPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG  487 (683)
T ss_pred             CCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCC
Confidence            56889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc
Q 016865           85 NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE  164 (381)
Q Consensus        85 ~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~  164 (381)
                      ++||+|||+++..-.......|.||||.|+|||++.-.+| +.++|.||+||+|||||+|++||++.+..++++.|....
T Consensus       488 HiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn  566 (683)
T KOG0696|consen  488 HIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN  566 (683)
T ss_pred             ceEeeecccccccccCCcceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc
Confidence            9999999999865555567789999999999999998887 499999999999999999999999999999999999999


Q ss_pred             CCCCCCCChhHHHHHHHhcCCCCCCCCCH-----HHHhcCccccc
Q 016865          165 FSCPFWFSTGATSLIHKILDPNPKTRIRI-----EGIRKHPWFRK  204 (381)
Q Consensus       165 ~~~p~~~s~~~~~li~~~L~~dP~~R~t~-----~~il~hp~~~~  204 (381)
                      .++|..+|.++.++++..|.+.|.+|..+     .+|..||||+.
T Consensus       567 vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~  611 (683)
T KOG0696|consen  567 VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRR  611 (683)
T ss_pred             CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence            99999999999999999999999999865     78999999974

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=8.7e-40  Score=327.05  Aligned_cols=203  Identities=27%  Similarity=0.361  Sum_probs=164.4

Q ss_pred             CCCCCccccccceEEEEeC--------CEEEEEEecCCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 016865            1 MKIVRHPNIVRLHEVLASR--------TKVYIILEFVTGGELFDKIV----HQGRLLENDCRRYFQQLIDAVAHCHSKGV   68 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~--------~~~~lV~E~~~gg~L~~~i~----~~~~l~e~~~~~~~~qll~~L~~LH~~gi   68 (381)
                      |+.++|||||++++++...        ..+++||||+++ +|.+.+.    ....+++..++.++.||+.||+|||++||
T Consensus       113 l~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~I  191 (440)
T PTZ00036        113 MKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFI  191 (440)
T ss_pred             HHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            4678999999999987532        257899999975 6767664    34579999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCC-CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCC
Q 016865           69 YHRDLKPENLLLDSYG-NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLP  147 (381)
Q Consensus        69 ~HrDlkp~NiLl~~~~-~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~P  147 (381)
                      +||||||+|||++.++ .+||+|||+|...... ....+.+||+.|+|||++.+....+.++||||+||++|+|++|.+|
T Consensus       192 iHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~p  270 (440)
T PTZ00036        192 CHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG-QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPI  270 (440)
T ss_pred             ecCCcCHHHEEEcCCCCceeeeccccchhccCC-CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            9999999999999665 6999999999865432 2234567899999999987654446899999999999999999999


Q ss_pred             CCCCChhHHHHHhhc-----------------ccC------------CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          148 FGETDLPTLYKKINA-----------------AEF------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       148 f~~~~~~~~~~~i~~-----------------~~~------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      |.+.+......++..                 ...            .+|...|+++++||.+||+.||.+|||+.++++
T Consensus       271 f~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        271 FSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            987665433322211                 001            123446889999999999999999999999999


Q ss_pred             CcccccC
Q 016865          199 HPWFRKN  205 (381)
Q Consensus       199 hp~~~~~  205 (381)
                      ||||...
T Consensus       351 hp~f~~~  357 (440)
T PTZ00036        351 DPFFDDL  357 (440)
T ss_pred             ChhHHhh
Confidence            9999753

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2e-39  Score=315.32  Aligned_cols=202  Identities=30%  Similarity=0.512  Sum_probs=168.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+.+|+||||+++|+|.+.    ...++..+..++.||+.||.|||++||+||||||+|||+
T Consensus       126 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll  201 (353)
T PLN00034        126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI  201 (353)
T ss_pred             HHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE
Confidence            4678999999999999999999999999999998653    345688889999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecC----CCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh--
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN----RGYDGSAADVWSCGVILFVLMAGYLPFGETDLP--  154 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~--  154 (381)
                      +.++.+||+|||++..............||+.|+|||++..    ..+.+.++|||||||++|+|++|+.||......  
T Consensus       202 ~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~  281 (353)
T PLN00034        202 NSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW  281 (353)
T ss_pred             cCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH
Confidence            99999999999999866543333456689999999999743    245567899999999999999999999743322  


Q ss_pred             -HHHHHhh-cccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          155 -TLYKKIN-AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       155 -~~~~~i~-~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                       .....+. ......+..+++++++||.+||..||.+|||+.|+++||||.+..
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        282 ASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             HHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence             2222222 222344566899999999999999999999999999999998754

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-40  Score=320.66  Aligned_cols=203  Identities=30%  Similarity=0.473  Sum_probs=182.4

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      ...+||+||++++.|.-.+++||..|||.||-....+..- ..+.|++++.+.+|++.||.|||+++|||||||..|||+
T Consensus        84 a~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~  163 (1187)
T KOG0579|consen   84 AECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILL  163 (1187)
T ss_pred             hcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEE
Confidence            4568999999999999999999999999999998877664 468999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecC-----CCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhH
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-----RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT  155 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  155 (381)
                      +-+|.++|+|||.+...........+..|||+|||||++.+     .+|+ +++||||||+.|.+|..+.+|....+...
T Consensus       164 TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMR  242 (1187)
T KOG0579|consen  164 TLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMR  242 (1187)
T ss_pred             EecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHH
Confidence            99999999999999876554455678899999999999753     4676 99999999999999999999999999888


Q ss_pred             HHHHhhcccC---CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          156 LYKKINAAEF---SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       156 ~~~~i~~~~~---~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ..-+|.+...   ..|..+|..+.||+++||.+||..||+++++++||||...
T Consensus       243 VllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~  295 (1187)
T KOG0579|consen  243 VLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA  295 (1187)
T ss_pred             HHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence            8777766543   3577789999999999999999999999999999999853

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.6e-39  Score=303.89  Aligned_cols=202  Identities=29%  Similarity=0.508  Sum_probs=170.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||++++++++++..+|+||||++||+|.+++...+  .+++..+..++.|++.||+|||+.||+||||||+||
T Consensus        47 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Ni  126 (277)
T cd05607          47 LEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENV  126 (277)
T ss_pred             HHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhE
Confidence            467899999999999999999999999999999998886543  488999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh----h
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL----P  154 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~----~  154 (381)
                      +++.++.++|+|||++...... .......|++.|+|||++.+..+ +.++||||+||++|+|++|..||.....    .
T Consensus       127 li~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~  204 (277)
T cd05607         127 LLDDQGNCRLSDLGLAVELKDG-KTITQRAGTNGYMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE  204 (277)
T ss_pred             EEcCCCCEEEeeceeeeecCCC-ceeeccCCCCCccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH
Confidence            9999999999999998765432 22345679999999999987775 4899999999999999999999975432    2


Q ss_pred             HHHHHhhcccCCCC-CCCChhHHHHHHHhcCCCCCCCCCH----HHHhcCccccc
Q 016865          155 TLYKKINAAEFSCP-FWFSTGATSLIHKILDPNPKTRIRI----EGIRKHPWFRK  204 (381)
Q Consensus       155 ~~~~~i~~~~~~~p-~~~s~~~~~li~~~L~~dP~~R~t~----~~il~hp~~~~  204 (381)
                      .............+ ..+++++++||++||+.||.+|||+    ++++.||||+.
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~  259 (277)
T cd05607         205 ELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT  259 (277)
T ss_pred             HHHHHhhccccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence            22333333333222 3479999999999999999999999    77889999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.5e-39  Score=303.34  Aligned_cols=200  Identities=38%  Similarity=0.750  Sum_probs=182.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |++++||||+++++++.+.+.+|+||||+++|+|.+++...+.+++..+..++.|++.||.|||+.|++||||+|.||++
T Consensus        55 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili  134 (290)
T cd05580          55 LQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL  134 (290)
T ss_pred             HHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE
Confidence            46789999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.+||+|||++......   ....+|++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+.....+.+
T Consensus       135 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  210 (290)
T cd05580         135 DSDGYIKITDFGFAKRVKGR---TYTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI  210 (290)
T ss_pred             CCCCCEEEeeCCCccccCCC---CCCCCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999999998765443   345679999999999877655 48899999999999999999999888776777777


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  204 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~-----t~~~il~hp~~~~  204 (381)
                      ..+....|..+++.+.++|.+||..||.+|+     +++++++||||+.
T Consensus       211 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~  259 (290)
T cd05580         211 LEGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG  259 (290)
T ss_pred             hcCCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCccccc
Confidence            7777788888999999999999999999999     9999999999964

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.1e-39  Score=310.90  Aligned_cols=203  Identities=26%  Similarity=0.427  Sum_probs=169.9

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~-gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+++.+|+||||++||+|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||
T Consensus        57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nil  136 (333)
T cd06650          57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL  136 (333)
T ss_pred             HHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEE
Confidence            357899999999999999999999999999999999998888899999999999999999999985 7999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      ++.++.+||+|||++.....  ......+||+.|+|||++.+..++ .++||||+||++|+|++|+.||...+.......
T Consensus       137 i~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~  213 (333)
T cd06650         137 VNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAIGRYPIPPPDAKELELM  213 (333)
T ss_pred             EcCCCCEEEeeCCcchhhhh--hccccCCCCccccCHHHhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHH
Confidence            99999999999999875433  223456799999999999876654 899999999999999999999976543222111


Q ss_pred             h--------------------------------------------hc-ccCCCC-CCCChhHHHHHHHhcCCCCCCCCCH
Q 016865          160 I--------------------------------------------NA-AEFSCP-FWFSTGATSLIHKILDPNPKTRIRI  193 (381)
Q Consensus       160 i--------------------------------------------~~-~~~~~p-~~~s~~~~~li~~~L~~dP~~R~t~  193 (381)
                      +                                            .. .....+ ..+++++++||.+||+.||.+|||+
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~  293 (333)
T cd06650         214 FGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADL  293 (333)
T ss_pred             hcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCH
Confidence            0                                            00 000111 1367889999999999999999999


Q ss_pred             HHHhcCcccccCC
Q 016865          194 EGIRKHPWFRKNY  206 (381)
Q Consensus       194 ~~il~hp~~~~~~  206 (381)
                      .+++.||||+...
T Consensus       294 ~ell~h~~~~~~~  306 (333)
T cd06650         294 KQLMVHAFIKRSE  306 (333)
T ss_pred             HHHhhCHHHhcCc
Confidence            9999999998643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.2e-39  Score=317.20  Aligned_cols=204  Identities=25%  Similarity=0.440  Sum_probs=170.6

Q ss_pred             CCCCCccccccceEEEEeCC-----EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKP   75 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~-----~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp   75 (381)
                      |+.++||||+++++++.+.+     ..|+||||+. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||
T Consensus        53 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp  131 (372)
T cd07853          53 LCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKP  131 (372)
T ss_pred             HHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh
Confidence            45789999999999998876     8999999996 58999888878899999999999999999999999999999999


Q ss_pred             CcEEEccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           76 ENLLLDSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        76 ~NiLl~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      +|||++.++.+||+|||++....... .......+|+.|+|||++.+....+.++||||+||++|+|++|++||...+..
T Consensus       132 ~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  211 (372)
T cd07853         132 GNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI  211 (372)
T ss_pred             HHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH
Confidence            99999999999999999987654321 22334568999999999987654568999999999999999999999877654


Q ss_pred             HHHHHhhc-----------------------ccC---------CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          155 TLYKKINA-----------------------AEF---------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       155 ~~~~~i~~-----------------------~~~---------~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      .....+..                       ...         ......++++.+||.+||+.||.+|||+.++++||||
T Consensus       212 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~  291 (372)
T cd07853         212 QQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYL  291 (372)
T ss_pred             HHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhh
Confidence            43332211                       001         1222357899999999999999999999999999999


Q ss_pred             ccC
Q 016865          203 RKN  205 (381)
Q Consensus       203 ~~~  205 (381)
                      +..
T Consensus       292 ~~~  294 (372)
T cd07853         292 DEG  294 (372)
T ss_pred             CCC
Confidence            864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3e-39  Score=308.79  Aligned_cols=201  Identities=26%  Similarity=0.438  Sum_probs=158.1

Q ss_pred             CCCCCccccccceEEEEe--CCEEEEEEecCCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q 016865            1 MKIVRHPNIVRLHEVLAS--RTKVYIILEFVTGGELFDKIVHQ---------GRLLENDCRRYFQQLIDAVAHCHSKGVY   69 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~i~~~---------~~l~e~~~~~~~~qll~~L~~LH~~gi~   69 (381)
                      |+.++||||+++++++.+  ...+|+||||+. ++|.+.+...         ..+++..++.++.||+.||+|||++||+
T Consensus        52 l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~iv  130 (317)
T cd07868          52 LRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVL  130 (317)
T ss_pred             HHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence            467899999999999864  467999999995 5888877532         2489999999999999999999999999


Q ss_pred             ecCCCCCcEEE----ccCCCEEEeeccCccCCCCCc---cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHH
Q 016865           70 HRDLKPENLLL----DSYGNLKVSDFGLSALPQQGV---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM  142 (381)
Q Consensus        70 HrDlkp~NiLl----~~~~~lkl~DFGls~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll  142 (381)
                      ||||||+|||+    +.++.+||+|||++.......   ......+||+.|+|||++.+....+.++||||+||++|+|+
T Consensus       131 HrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~  210 (317)
T cd07868         131 HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL  210 (317)
T ss_pred             cCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHH
Confidence            99999999999    456789999999997654321   22345678999999999987655568999999999999999


Q ss_pred             hCCCCCCCCChh---------HHHHHhhc----------------------------ccCCC----------CCCCChhH
Q 016865          143 AGYLPFGETDLP---------TLYKKINA----------------------------AEFSC----------PFWFSTGA  175 (381)
Q Consensus       143 ~G~~Pf~~~~~~---------~~~~~i~~----------------------------~~~~~----------p~~~s~~~  175 (381)
                      +|++||......         .....+..                            .....          ....+.++
T Consensus       211 ~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (317)
T cd07868         211 TSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKA  290 (317)
T ss_pred             hCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHH
Confidence            999999643211         11111000                            00000          01135678


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          176 TSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       176 ~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      .+||.+||+.||.+|||++|+++||||
T Consensus       291 ~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         291 FHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-39  Score=309.55  Aligned_cols=203  Identities=29%  Similarity=0.557  Sum_probs=170.8

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      +.++||||+++++++.+.+.+|+||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        56 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill  135 (331)
T cd05597          56 VNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL  135 (331)
T ss_pred             HhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE
Confidence            457999999999999999999999999999999999976 4579999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCcc-ccccccCCCCCCCCceecC----CCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhH
Q 016865           81 DSYGNLKVSDFGLSALPQQGVE-LLHTTCGTPNYVAPEVLSN----RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT  155 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~-~~~~~~gt~~y~aPE~l~~----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  155 (381)
                      +.++.+||+|||++........ .....+||+.|+|||++..    ....+.++||||+||++|+|++|+.||...+...
T Consensus       136 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~  215 (331)
T cd05597         136 DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE  215 (331)
T ss_pred             CCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH
Confidence            9999999999999865443211 2233579999999999863    2344589999999999999999999998877766


Q ss_pred             HHHHhhccc--CCCC---CCCChhHHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 016865          156 LYKKINAAE--FSCP---FWFSTGATSLIHKILDPNPKT--RIRIEGIRKHPWFRK  204 (381)
Q Consensus       156 ~~~~i~~~~--~~~p---~~~s~~~~~li~~~L~~dP~~--R~t~~~il~hp~~~~  204 (381)
                      .+..+....  +..|   ..+|+++++||++||..++.+  |++++++++||||..
T Consensus       216 ~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~  271 (331)
T cd05597         216 TYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG  271 (331)
T ss_pred             HHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence            666664322  3333   247999999999999764443  889999999999965

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.7e-39  Score=310.17  Aligned_cols=203  Identities=29%  Similarity=0.546  Sum_probs=172.3

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      +.++||||+++++++.+.+.+|+||||++||+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus        56 ~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili  135 (332)
T cd05623          56 VNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM  135 (332)
T ss_pred             hhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE
Confidence            467999999999999999999999999999999999977 4678999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecC----CCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhH
Q 016865           81 DSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSN----RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT  155 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  155 (381)
                      +.++.+||+|||++....... ......+||+.|+|||++..    ....+.++||||+||++|+|++|+.||...+...
T Consensus       136 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~  215 (332)
T cd05623         136 DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE  215 (332)
T ss_pred             CCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH
Confidence            999999999999986543221 12234679999999999862    2334589999999999999999999999888777


Q ss_pred             HHHHhhccc--CCCCC---CCChhHHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 016865          156 LYKKINAAE--FSCPF---WFSTGATSLIHKILDPNPKT--RIRIEGIRKHPWFRK  204 (381)
Q Consensus       156 ~~~~i~~~~--~~~p~---~~s~~~~~li~~~L~~dP~~--R~t~~~il~hp~~~~  204 (381)
                      .+.++....  ...|.   .+++++++||++||..+|.+  |++++++++||||..
T Consensus       216 ~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~  271 (332)
T cd05623         216 TYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG  271 (332)
T ss_pred             HHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence            777765443  23333   47999999999999765544  789999999999974

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-40  Score=310.61  Aligned_cols=202  Identities=31%  Similarity=0.551  Sum_probs=181.6

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |.+++.|.||.+-.+|++++.+|+||..|+||+|.-+|.+.+  .++|+.+++|+.+|+.||++||+.+|++|||||+||
T Consensus       239 L~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNI  318 (591)
T KOG0986|consen  239 LEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENI  318 (591)
T ss_pred             HHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhhe
Confidence            346788999999999999999999999999999999998876  799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCC----hh
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD----LP  154 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~----~~  154 (381)
                      |+|+.|+++|+|+|||..+..+ ......+||..|||||++.+..|+ .+.|.||+||+||+|+.|+.||....    ..
T Consensus       319 LLDd~GhvRISDLGLAvei~~g-~~~~~rvGT~GYMAPEvl~ne~Y~-~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e  396 (591)
T KOG0986|consen  319 LLDDHGHVRISDLGLAVEIPEG-KPIRGRVGTVGYMAPEVLQNEVYD-FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE  396 (591)
T ss_pred             eeccCCCeEeeccceEEecCCC-CccccccCcccccCHHHHcCCccc-CCccHHHHHhHHHHHHcccCchhhhhhhhhHH
Confidence            9999999999999999877654 334556999999999999998876 99999999999999999999996543    23


Q ss_pred             HHHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 016865          155 TLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  204 (381)
Q Consensus       155 ~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~-----t~~~il~hp~~~~  204 (381)
                      ++-+.+......+|..+|++++++.+.+|+.||.+|.     +++++.+||||+.
T Consensus       397 Evdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~  451 (591)
T KOG0986|consen  397 EVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD  451 (591)
T ss_pred             HHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence            5556677777788889999999999999999999998     4579999999985

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.1e-38  Score=294.91  Aligned_cols=201  Identities=30%  Similarity=0.559  Sum_probs=174.0

Q ss_pred             CCCCCccccccceEEEEe-CCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            1 MKIVRHPNIVRLHEVLAS-RTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~-~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      ++.++|||++++++.+.. ...+|+||||+++++|.+.+...  ..+++.++..++.|++.||++||++|++||||||+|
T Consensus        53 l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~n  132 (257)
T cd08223          53 LSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQN  132 (257)
T ss_pred             HHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchh
Confidence            357899999999998864 45789999999999999998763  358999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           78 LLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        78 iLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      |+++.++.++|+|||++..............|++.|+|||++.+..++ .++||||+||++++|++|+.||...+.....
T Consensus       133 il~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~  211 (257)
T cd08223         133 VFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLV  211 (257)
T ss_pred             EEEecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence            999999999999999987664433344566789999999999876664 8899999999999999999999887766655


Q ss_pred             HHhhcccC-CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          158 KKINAAEF-SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       158 ~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      ..+..+.. ..+..+++.+.++|.+||+.||.+|||+.++++||||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         212 YRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            55544443 4556689999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=9.9e-39  Score=300.10  Aligned_cols=201  Identities=31%  Similarity=0.490  Sum_probs=174.5

Q ss_pred             CCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEcc
Q 016865            3 IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS   82 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~   82 (381)
                      ..+||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.|++.||+|||+.||+||||||+||+++.
T Consensus        53 ~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~  132 (278)
T cd05606          53 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE  132 (278)
T ss_pred             hCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECC
Confidence            35799999999999999999999999999999999988888999999999999999999999999999999999999999


Q ss_pred             CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCC---hhHHHHH
Q 016865           83 YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD---LPTLYKK  159 (381)
Q Consensus        83 ~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~---~~~~~~~  159 (381)
                      ++.+||+|||++......  ...+.+|++.|+|||++.+....+.++||||+||++|+|++|..||....   .......
T Consensus       133 ~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~  210 (278)
T cd05606         133 HGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM  210 (278)
T ss_pred             CCCEEEccCcCccccCcc--CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Confidence            999999999998755332  23456899999999998754334588999999999999999999997663   2333333


Q ss_pred             hhcccCCCCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcccccC
Q 016865          160 INAAEFSCPFWFSTGATSLIHKILDPNPKTRI-----RIEGIRKHPWFRKN  205 (381)
Q Consensus       160 i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~-----t~~~il~hp~~~~~  205 (381)
                      ........|..+|+++.++|.+||..+|.+|+     ++.++++||||+..
T Consensus       211 ~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~  261 (278)
T cd05606         211 TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL  261 (278)
T ss_pred             hhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence            44445566666899999999999999999999     99999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=7.7e-39  Score=302.01  Aligned_cols=194  Identities=16%  Similarity=0.244  Sum_probs=169.9

Q ss_pred             CCCCCccccccceEEEEe----CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCC
Q 016865            1 MKIVRHPNIVRLHEVLAS----RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKP   75 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~----~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp   75 (381)
                      |++++||||+++++++.+    ...+++||||++||+|.+++...+.+++.....++.|++.||.|||+ .+++||||||
T Consensus        72 l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp  151 (283)
T PHA02988         72 LRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTS  151 (283)
T ss_pred             HHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCCh
Confidence            567899999999999977    45799999999999999999888889999999999999999999998 4999999999


Q ss_pred             CcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecC--CCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh
Q 016865           76 ENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDL  153 (381)
Q Consensus        76 ~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~  153 (381)
                      +|||+++++.+||+|||++......   .....||+.|+|||++.+  ..+ +.++||||+||++|+|++|..||...+.
T Consensus       152 ~nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~  227 (283)
T PHA02988        152 VSFLVTENYKLKIICHGLEKILSSP---PFKNVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTT  227 (283)
T ss_pred             hhEEECCCCcEEEcccchHhhhccc---cccccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCH
Confidence            9999999999999999998764432   234578999999999975  345 5899999999999999999999998887


Q ss_pred             hHHHHHhhc--ccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          154 PTLYKKINA--AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       154 ~~~~~~i~~--~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...+..+..  .....|...++.+.+|+.+||+.||.+|||++++++
T Consensus       228 ~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        228 KEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            777766633  344556568999999999999999999999999985

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=9.8e-39  Score=303.22  Aligned_cols=204  Identities=25%  Similarity=0.478  Sum_probs=169.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+..|+||||++ ++|.+.+... ..+++..++.++.|++.||.|||+.||+||||||+||+
T Consensus        58 l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil  136 (301)
T cd07873          58 LKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLL  136 (301)
T ss_pred             HHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEE
Confidence            357899999999999999999999999997 5898888653 46899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      ++.++.+||+|||++..............+++.|+|||++.+....+.++||||+||++|+|++|++||...+.......
T Consensus       137 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~  216 (301)
T cd07873         137 INERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHF  216 (301)
T ss_pred             ECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999999876543333334556799999999987655556899999999999999999999987765433322


Q ss_pred             hhc-------------------ccCCCC-----------CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          160 INA-------------------AEFSCP-----------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       160 i~~-------------------~~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      +..                   .....|           ..+++.+.+||.+||+.||.+|||++++++||||+.-
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~  292 (301)
T cd07873         217 IFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL  292 (301)
T ss_pred             HHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            111                   001111           2368889999999999999999999999999999753

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.2e-38  Score=296.87  Aligned_cols=200  Identities=31%  Similarity=0.477  Sum_probs=168.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++.+.+.+.+|+||||+++|+|.+++...+.+++..+..++.|++.||+|||+.|++|+||||+||++
T Consensus        60 ~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili  139 (267)
T cd06645          60 MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL  139 (267)
T ss_pred             HHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence            35679999999999999999999999999999999999888899999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceec---CCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS---NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      +.++.+||+|||++..............|++.|+|||++.   ...+ +.++|+||+||++|+|++|..||.........
T Consensus       140 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~  218 (267)
T cd06645         140 TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRAL  218 (267)
T ss_pred             CCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcCCCCcccccchhhH
Confidence            9999999999999875543322334567999999999974   2234 48999999999999999999999665443322


Q ss_pred             HHhhcccCCCC-----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 016865          158 KKINAAEFSCP-----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPW  201 (381)
Q Consensus       158 ~~i~~~~~~~p-----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~  201 (381)
                      ..........+     ..++..+.++|.+||..+|.+|||++++++|||
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         219 FLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            22222222211     236788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.2e-38  Score=299.87  Aligned_cols=200  Identities=30%  Similarity=0.489  Sum_probs=170.9

Q ss_pred             CCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEcc
Q 016865            3 IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS   82 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~   82 (381)
                      ..+||||+.+++.+.+.+..|+||||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus        53 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~  132 (279)
T cd05633          53 TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDE  132 (279)
T ss_pred             hCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECC
Confidence            35799999999999999999999999999999999988888999999999999999999999999999999999999999


Q ss_pred             CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh---HHHHH
Q 016865           83 YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP---TLYKK  159 (381)
Q Consensus        83 ~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~---~~~~~  159 (381)
                      ++.++++|||++......  ......||+.|+|||.+.+....+.++||||+||++|+|++|..||......   .....
T Consensus       133 ~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  210 (279)
T cd05633         133 HGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM  210 (279)
T ss_pred             CCCEEEccCCcceecccc--CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH
Confidence            999999999998754332  2234579999999999864343458999999999999999999999754322   22222


Q ss_pred             hhcccCCCCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 016865          160 INAAEFSCPFWFSTGATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  204 (381)
Q Consensus       160 i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~-----t~~~il~hp~~~~  204 (381)
                      ........|..+++++.++|.+||..||.+|+     |+.++++||||+.
T Consensus       211 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~  260 (279)
T cd05633         211 TLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG  260 (279)
T ss_pred             hhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence            22334456677899999999999999999999     6999999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=334.72  Aligned_cols=199  Identities=34%  Similarity=0.603  Sum_probs=180.9

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCC
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG   84 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~   84 (381)
                      +.+-|++++.+|+++.++|+||||++||+|...+.+.+++||+.|++|+..++.||.-+|+.|+|||||||+|||+|..|
T Consensus       133 ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~G  212 (1317)
T KOG0612|consen  133 NSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSG  212 (1317)
T ss_pred             CcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccC
Confidence            56789999999999999999999999999999999988999999999999999999999999999999999999999999


Q ss_pred             CEEEeeccCccCCCC-CccccccccCCCCCCCCceecC----CCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           85 NLKVSDFGLSALPQQ-GVELLHTTCGTPNYVAPEVLSN----RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        85 ~lkl~DFGls~~~~~-~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      ++||+|||.+-.... +.-...+.+|||.|++||++..    .+.+|..+|.||+||++|||+.|..||...+....|.+
T Consensus       213 HikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~K  292 (1317)
T KOG0612|consen  213 HIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGK  292 (1317)
T ss_pred             cEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHH
Confidence            999999998876653 3334567889999999999863    25668999999999999999999999999999999999


Q ss_pred             hhcc--cCCCC--CCCChhHHHHHHHhcCCCCCCCCC---HHHHhcCccccc
Q 016865          160 INAA--EFSCP--FWFSTGATSLIHKILDPNPKTRIR---IEGIRKHPWFRK  204 (381)
Q Consensus       160 i~~~--~~~~p--~~~s~~~~~li~~~L~~dP~~R~t---~~~il~hp~~~~  204 (381)
                      |...  .+.+|  ..+|+++++||.++|. +|..|..   ++++..||||..
T Consensus       293 Im~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g  343 (1317)
T KOG0612|consen  293 IMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEG  343 (1317)
T ss_pred             HhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccC
Confidence            9776  67788  4589999999999986 5888888   999999999975

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.3e-38  Score=310.27  Aligned_cols=203  Identities=31%  Similarity=0.516  Sum_probs=163.7

Q ss_pred             CCCCCccccccceEEEEeCC------EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRT------KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK   74 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~------~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlk   74 (381)
                      |+.++||||+++++++...+      .+|+||||+++ +|.+.+.  ..+++..+..++.|++.||.|||++||+|||||
T Consensus        74 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlk  150 (359)
T cd07876          74 LKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  150 (359)
T ss_pred             HHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            45789999999999986543      58999999976 6666664  358899999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           75 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        75 p~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      |+|||++.+|.+||+|||++...... .......||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+..
T Consensus       151 p~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~  228 (359)
T cd07876         151 PSNIVVKSDCTLKILDFGLARTACTN-FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHI  228 (359)
T ss_pred             HHHEEECCCCCEEEecCCCccccccC-ccCCCCcccCCCCCchhccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999999998754332 233456789999999999887775 8899999999999999999999876543


Q ss_pred             HHHHHhh----------------------cccCC---------CCC-----------CCChhHHHHHHHhcCCCCCCCCC
Q 016865          155 TLYKKIN----------------------AAEFS---------CPF-----------WFSTGATSLIHKILDPNPKTRIR  192 (381)
Q Consensus       155 ~~~~~i~----------------------~~~~~---------~p~-----------~~s~~~~~li~~~L~~dP~~R~t  192 (381)
                      ..+..+.                      .....         .|.           ..++++++||.+||..||.+|||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t  308 (359)
T cd07876         229 DQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRIS  308 (359)
T ss_pred             HHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCC
Confidence            2211110                      00000         111           13678999999999999999999


Q ss_pred             HHHHhcCcccccCCCC
Q 016865          193 IEGIRKHPWFRKNYNP  208 (381)
Q Consensus       193 ~~~il~hp~~~~~~~~  208 (381)
                      +.|+++||||...+.+
T Consensus       309 ~~e~l~hp~~~~~~~~  324 (359)
T cd07876         309 VDEALRHPYITVWYDP  324 (359)
T ss_pred             HHHHhcCchhhhhcCc
Confidence            9999999999876544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.3e-38  Score=297.65  Aligned_cols=206  Identities=28%  Similarity=0.454  Sum_probs=173.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++...+..|+|+||+++|+|...+.. ...+++..+..++.|++.||.|||+.|++||||||+||+
T Consensus        56 l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nil  135 (282)
T cd06643          56 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNIL  135 (282)
T ss_pred             HHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEE
Confidence            3568999999999999999999999999999999888765 456899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCC----CCCCCcccHhHHHHHHHHHHhCCCCCCCCChhH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR----GYDGSAADVWSCGVILFVLMAGYLPFGETDLPT  155 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  155 (381)
                      ++.++.+||+|||++..............|++.|+|||++...    ...+.++||||+||++|+|++|.+||...+...
T Consensus       136 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~  215 (282)
T cd06643         136 FTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR  215 (282)
T ss_pred             EccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH
Confidence            9999999999999987654322233456789999999998421    222478999999999999999999998776555


Q ss_pred             HHHHhhcc---cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          156 LYKKINAA---EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       156 ~~~~i~~~---~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      ....+...   ....|..++.++.+||.+||..||.+|||++++++||||+...
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  269 (282)
T cd06643         216 VLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS  269 (282)
T ss_pred             HHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence            44444332   2234556889999999999999999999999999999998653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.1e-38  Score=300.30  Aligned_cols=198  Identities=31%  Similarity=0.455  Sum_probs=163.2

Q ss_pred             CCCCccccccceEEEEe-----CCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 016865            2 KIVRHPNIVRLHEVLAS-----RTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK   74 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~-----~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlk   74 (381)
                      +.++||||+++++++.+     ...+++||||+++ +|.+++...  ..++++.++.++.|++.||.|||++||+|||||
T Consensus        57 ~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dik  135 (288)
T cd07863          57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLK  135 (288)
T ss_pred             hhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            34589999999999864     3568999999975 898888663  348999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           75 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        75 p~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      |+||+++.++.+||+|||++...... .......||+.|+|||++.+..+. .++||||+||++|+|++|.+||...+..
T Consensus       136 p~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~~f~~~~~~  213 (288)
T cd07863         136 PENILVTSGGQVKLADFGLARIYSCQ-MALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEA  213 (288)
T ss_pred             HHHEEECCCCCEEECccCccccccCc-ccCCCccccccccCchHhhCCCCC-CcchhhhHHHHHHHHHhCCcCcCCCCHH
Confidence            99999999999999999998765432 223455789999999999876664 8999999999999999999999876654


Q ss_pred             HHHHHhhcc-----------c-------C---------CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          155 TLYKKINAA-----------E-------F---------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       155 ~~~~~i~~~-----------~-------~---------~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      ....++...           .       +         ...+.++..+.++|.+||+.||.+|||+.+++.||||
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         214 DQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             HHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            433332110           0       0         0112367789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-38  Score=298.45  Aligned_cols=205  Identities=32%  Similarity=0.477  Sum_probs=175.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.++...|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+
T Consensus        56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nil  135 (280)
T cd06611          56 LSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNIL  135 (280)
T ss_pred             HHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEE
Confidence            46789999999999999999999999999999999988764 46899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCC----CCCCcccHhHHHHHHHHHHhCCCCCCCCChhH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG----YDGSAADVWSCGVILFVLMAGYLPFGETDLPT  155 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  155 (381)
                      ++.++.++|+|||++..............|++.|+|||++....    ..+.++|+||+||++|+|++|.+||...+...
T Consensus       136 i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~  215 (280)
T cd06611         136 LTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR  215 (280)
T ss_pred             ECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH
Confidence            99999999999999876544333334567899999999975321    22468999999999999999999998877655


Q ss_pred             HHHHhhccc---CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          156 LYKKINAAE---FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       156 ~~~~i~~~~---~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ...++....   +..|..++.++.++|.+||+.+|.+|||++++++||||...
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         216 VLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            555554432   23455688999999999999999999999999999999754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-40  Score=316.30  Aligned_cols=198  Identities=24%  Similarity=0.443  Sum_probs=178.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      ||.|+|||||.|.++|.....+|||||||..|-|...++....+.......|..+|+.|++|||.+.|||||||.-||||
T Consensus       166 LRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLI  245 (904)
T KOG4721|consen  166 LRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILI  245 (904)
T ss_pred             HHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEe
Confidence            67899999999999999999999999999999999999998899999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.+..+||+|||-++..... ...-.++||..|||||++.+.+.. +|+||||+||||||||||..||.+.+...++.-+
T Consensus       246 s~~d~VKIsDFGTS~e~~~~-STkMSFaGTVaWMAPEvIrnePcs-EKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV  323 (904)
T KOG4721|consen  246 SYDDVVKISDFGTSKELSDK-STKMSFAGTVAWMAPEVIRNEPCS-EKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV  323 (904)
T ss_pred             eccceEEeccccchHhhhhh-hhhhhhhhhHhhhCHHHhhcCCcc-cccceehhHHHHHHHHhcCCCccccchheeEEec
Confidence            99999999999988765443 344578999999999999887775 9999999999999999999999887766555444


Q ss_pred             hcc--cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 016865          161 NAA--EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHP  200 (381)
Q Consensus       161 ~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp  200 (381)
                      ...  .+..|..+++.++-||+.||.-.|.+||++.+|+.|=
T Consensus       324 GsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  324 GSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL  365 (904)
T ss_pred             cCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence            333  3466778999999999999999999999999999983

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-38  Score=314.76  Aligned_cols=203  Identities=24%  Similarity=0.382  Sum_probs=167.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.....+|+|||++. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus       140 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill  218 (392)
T PHA03207        140 LKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL  218 (392)
T ss_pred             HHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE
Confidence            467899999999999999999999999995 6899999777889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh---H
Q 016865           81 DSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP---T  155 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~---~  155 (381)
                      +.++.+||+|||++.......  .......||+.|+|||++.+..|. .++||||+||++|+|++|+.||.+....   .
T Consensus       219 ~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~  297 (392)
T PHA03207        219 DEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSS  297 (392)
T ss_pred             cCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHH
Confidence            999999999999987654321  122356799999999999877775 8999999999999999999999654321   1


Q ss_pred             HHHHh----hc-------------------------ccCCCCC-----CCChhHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 016865          156 LYKKI----NA-------------------------AEFSCPF-----WFSTGATSLIHKILDPNPKTRIRIEGIRKHPW  201 (381)
Q Consensus       156 ~~~~i----~~-------------------------~~~~~p~-----~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~  201 (381)
                      ....+    ..                         ..+..|.     .++.++.++|++||..||.+|||+.+++.|||
T Consensus       298 ~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~  377 (392)
T PHA03207        298 QLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL  377 (392)
T ss_pred             HHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCch
Confidence            11111    00                         0011111     24678899999999999999999999999999


Q ss_pred             cccC
Q 016865          202 FRKN  205 (381)
Q Consensus       202 ~~~~  205 (381)
                      |.+.
T Consensus       378 f~~~  381 (392)
T PHA03207        378 FTKE  381 (392)
T ss_pred             hhcc
Confidence            9763

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.5e-38  Score=292.11  Aligned_cols=201  Identities=30%  Similarity=0.542  Sum_probs=176.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||+++++++.+.+..|+||||++|++|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+||
T Consensus        53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~ni  132 (256)
T cd08529          53 LAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNL  132 (256)
T ss_pred             HHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceE
Confidence            46789999999999999999999999999999999998764  5689999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK  158 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~  158 (381)
                      +++.++.++|+|||++.............+|++.|+|||+..+..++ .++|+||+||++++|++|..||...+......
T Consensus       133 li~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~  211 (256)
T cd08529         133 FLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQGALIL  211 (256)
T ss_pred             EEeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999988655433334456789999999999876664 89999999999999999999998887666666


Q ss_pred             HhhcccC-CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          159 KINAAEF-SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       159 ~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      .+..+.. ..+..++.++.++|.+||+.+|++||++.++++|||+
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         212 KIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence            6555443 3344678999999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-40  Score=315.09  Aligned_cols=201  Identities=38%  Similarity=0.652  Sum_probs=189.4

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      ...+.|.||++|..|.+...+|+.||-|-||+|...+...+.|++..+++|...+++|++|||++||++|||||||++++
T Consensus       475 ~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd  554 (732)
T KOG0614|consen  475 MECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLD  554 (732)
T ss_pred             HhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeec
Confidence            34578999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhh
Q 016865           82 SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN  161 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~  161 (381)
                      .+|.+||.|||+|+....+ ....|.||||.|+|||++.+++.+ .++|+||||+++||||+|.+||.+.+....|+.|.
T Consensus       555 ~~Gy~KLVDFGFAKki~~g-~KTwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL  632 (732)
T KOG0614|consen  555 NRGYLKLVDFGFAKKIGSG-RKTWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL  632 (732)
T ss_pred             cCCceEEeehhhHHHhccC-CceeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence            9999999999999988765 567899999999999999999887 99999999999999999999999999999999987


Q ss_pred             cc--cCCCCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 016865          162 AA--EFSCPFWFSTGATSLIHKILDPNPKTRIR-----IEGIRKHPWFRK  204 (381)
Q Consensus       162 ~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t-----~~~il~hp~~~~  204 (381)
                      ++  .+.+|..++..+.+||+++...+|.+|..     +.+|.+|.||..
T Consensus       633 kGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g  682 (732)
T KOG0614|consen  633 KGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG  682 (732)
T ss_pred             hhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence            76  46789999999999999999999999986     899999999964

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.2e-38  Score=311.09  Aligned_cols=204  Identities=31%  Similarity=0.508  Sum_probs=165.4

Q ss_pred             CCCCCccccccceEEEEeC------CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 016865            1 MKIVRHPNIVRLHEVLASR------TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK   74 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~------~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlk   74 (381)
                      |+.++||||+++++++...      ..+|+||||+++ +|.+.+..  .+++..+..++.|++.||.|||++||+|||||
T Consensus        77 l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlk  153 (364)
T cd07875          77 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  153 (364)
T ss_pred             HHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCC
Confidence            4578999999999988643      368999999975 77777743  48899999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           75 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        75 p~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      |+|||++.++.+||+|||++...... .......||+.|+|||++.+..+. .++||||+||++|+|++|+.||...+..
T Consensus       154 p~NIll~~~~~~kL~DfG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~  231 (364)
T cd07875         154 PSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHI  231 (364)
T ss_pred             HHHEEECCCCcEEEEeCCCccccCCC-CcccCCcccCCcCCHHHHhCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999999999765432 233456799999999999887765 8999999999999999999999876654


Q ss_pred             HHHHHhhcc----------------------c-----CC---------C------CCCCChhHHHHHHHhcCCCCCCCCC
Q 016865          155 TLYKKINAA----------------------E-----FS---------C------PFWFSTGATSLIHKILDPNPKTRIR  192 (381)
Q Consensus       155 ~~~~~i~~~----------------------~-----~~---------~------p~~~s~~~~~li~~~L~~dP~~R~t  192 (381)
                      ..+.++...                      .     +.         .      +...+..+++||.+||..||.+|||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t  311 (364)
T cd07875         232 DQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS  311 (364)
T ss_pred             HHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCC
Confidence            433322110                      0     00         0      0113567899999999999999999


Q ss_pred             HHHHhcCcccccCCCCC
Q 016865          193 IEGIRKHPWFRKNYNPV  209 (381)
Q Consensus       193 ~~~il~hp~~~~~~~~~  209 (381)
                      ++++++||||...+.+.
T Consensus       312 ~~e~L~hp~~~~~~~~~  328 (364)
T cd07875         312 VDEALQHPYINVWYDPS  328 (364)
T ss_pred             HHHHhcCcccccccCcc
Confidence            99999999998665543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.6e-38  Score=295.11  Aligned_cols=202  Identities=39%  Similarity=0.737  Sum_probs=178.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      ++.++||||+++++.+.+.+..|+|+||++||+|.+++.+...+++..+..++.|++.||+|||++|++|+||+|+||++
T Consensus        47 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv  126 (262)
T cd05572          47 LEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL  126 (262)
T ss_pred             HHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE
Confidence            35689999999999999999999999999999999999887789999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCC--hhHHHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD--LPTLYK  158 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~--~~~~~~  158 (381)
                      +.++.++|+|||++....... .....+|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||...+  ....+.
T Consensus       127 ~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  204 (262)
T cd05572         127 DSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEYVAPEIILNKGYD-FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYN  204 (262)
T ss_pred             cCCCCEEEeeCCcccccCccc-ccccccCCcCccChhHhcCCCCC-ChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHH
Confidence            999999999999988665432 23345789999999998776664 88999999999999999999998766  455555


Q ss_pred             Hhh--cccCCCCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 016865          159 KIN--AAEFSCPFWFSTGATSLIHKILDPNPKTRIR-----IEGIRKHPWFRK  204 (381)
Q Consensus       159 ~i~--~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t-----~~~il~hp~~~~  204 (381)
                      ++.  ......|...++++.++|.+||..||.+|+|     ++|+++||||+.
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~  257 (262)
T cd05572         205 DILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG  257 (262)
T ss_pred             HHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence            555  3455677777999999999999999999999     999999999974

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.9e-38  Score=298.05  Aligned_cols=201  Identities=30%  Similarity=0.464  Sum_probs=165.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ---GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      |+.++||||+++++++.+++.+|+||||++ |+|.+++...   +.+++..++.++.|++.||.|||++|++||||||+|
T Consensus        53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~n  131 (285)
T cd07861          53 LKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQN  131 (285)
T ss_pred             HHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHH
Confidence            357899999999999999999999999997 5888887642   458999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           78 LLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        78 iLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      |+++.++.+||+|||++..............+++.|+|||++.+....+.++||||+||++|+|++|++||.+.+.....
T Consensus       132 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~  211 (285)
T cd07861         132 LLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL  211 (285)
T ss_pred             EEEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            99999999999999998765433333344567899999999876554458999999999999999999999865542221


Q ss_pred             HHhhc------------------ccC-----------CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          158 KKINA------------------AEF-----------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       158 ~~i~~------------------~~~-----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      ..+..                  ...           .....+++++.++|++||+.||.+|||+.+++.||||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         212 FRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            11100                  000           0112368899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.3e-38  Score=300.47  Aligned_cols=202  Identities=29%  Similarity=0.524  Sum_probs=171.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |++++|+||+++++.+.+.+.+|+||||++||+|.+++...+  .+++..+..++.|++.||.|||+.||+||||||+||
T Consensus        54 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Ni  133 (285)
T cd05630          54 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENI  133 (285)
T ss_pred             HHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHE
Confidence            467899999999999999999999999999999999886533  589999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhH---
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT---  155 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~---  155 (381)
                      +++.++.++|+|||++...... .......||+.|+|||++.+..++ .++||||+||++|+|++|.+||.......   
T Consensus       134 l~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~  211 (285)
T cd05630         134 LLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE  211 (285)
T ss_pred             EECCCCCEEEeeccceeecCCC-ccccCCCCCccccChHHHcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCccchHH
Confidence            9999999999999998765432 223445799999999999877664 89999999999999999999997643221   


Q ss_pred             -HHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 016865          156 -LYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIR-----IEGIRKHPWFRK  204 (381)
Q Consensus       156 -~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t-----~~~il~hp~~~~  204 (381)
                       ............+..+++++.+||.+||+.||.+|||     ++++++||||+.
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~  266 (285)
T cd05630         212 EVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ  266 (285)
T ss_pred             HHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence             1111122223455668999999999999999999999     899999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.8e-38  Score=294.12  Aligned_cols=201  Identities=27%  Similarity=0.481  Sum_probs=173.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+..++||||+++++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||++
T Consensus        60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~  139 (267)
T cd06628          60 LKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV  139 (267)
T ss_pred             HHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE
Confidence            35689999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCc------cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           81 DSYGNLKVSDFGLSALPQQGV------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      +.++.++|+|||++.......      .......|++.|+|||.+.+..+. .++|+||+||++|+|++|+.||...+..
T Consensus       140 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~  218 (267)
T cd06628         140 DNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQL  218 (267)
T ss_pred             cCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCC-chhhhHHHHHHHHHHhhCCCCCCCccHH
Confidence            999999999999987654211      112234689999999999876664 8899999999999999999999876654


Q ss_pred             HHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          155 TLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       155 ~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      .....+... ....|..++..+.++|++||+.||.+|||+.++++||||
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         219 QAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             HHHHHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            444443332 334566689999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.7e-38  Score=294.63  Aligned_cols=194  Identities=27%  Similarity=0.517  Sum_probs=168.1

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCC
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG   84 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~   84 (381)
                      +||||+++++.+...+.+|+||||++||+|.+++...+.++++.+..++.|++.||.|||+.|++||||||+||+++.++
T Consensus        67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~  146 (267)
T PHA03390         67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK  146 (267)
T ss_pred             cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC
Confidence            79999999999999999999999999999999998877899999999999999999999999999999999999999988


Q ss_pred             -CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHH----HHH
Q 016865           85 -NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL----YKK  159 (381)
Q Consensus        85 -~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~----~~~  159 (381)
                       .++|+|||++......    ....|+..|+|||++.+..+. .++|+||+||++|+|++|..||........    ...
T Consensus       147 ~~~~l~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~  221 (267)
T PHA03390        147 DRIYLCDYGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLK  221 (267)
T ss_pred             CeEEEecCccceecCCC----ccCCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHH
Confidence             9999999998765432    234689999999999877765 889999999999999999999975543221    111


Q ss_pred             hhcccCCCCCCCChhHHHHHHHhcCCCCCCCCC-HHHHhcCcccc
Q 016865          160 INAAEFSCPFWFSTGATSLIHKILDPNPKTRIR-IEGIRKHPWFR  203 (381)
Q Consensus       160 i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t-~~~il~hp~~~  203 (381)
                      ........+..+|+.+.+||.+||+.+|.+|++ ++++++||||+
T Consensus       222 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        222 RQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             hhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence            122333455568999999999999999999996 69999999996

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-38  Score=307.66  Aligned_cols=202  Identities=27%  Similarity=0.433  Sum_probs=165.5

Q ss_pred             CCCCCccccccceEEEEeC------CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 016865            1 MKIVRHPNIVRLHEVLASR------TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK   74 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~------~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlk   74 (381)
                      |+.++||||+++++++...      ..+|+++|++ |++|.+.+. .+.+++..++.++.|++.||.|||++||+|||||
T Consensus        68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdik  145 (343)
T cd07878          68 LKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLK  145 (343)
T ss_pred             HHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence            4678999999999988643      4589999998 779987665 4679999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           75 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        75 p~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      |+|||++.++.+||+|||++.....   ...+.+||+.|+|||++.+....+.++||||+||++|+|++|+.||...+..
T Consensus       146 p~Nil~~~~~~~kl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  222 (343)
T cd07878         146 PSNVAVNEDCELRILDFGLARQADD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI  222 (343)
T ss_pred             hhhEEECCCCCEEEcCCccceecCC---CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH
Confidence            9999999999999999999886543   2345679999999999977555568999999999999999999999876544


Q ss_pred             HHHHHhhccc-----------------------CCCC--------CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          155 TLYKKINAAE-----------------------FSCP--------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       155 ~~~~~i~~~~-----------------------~~~p--------~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      .....+....                       ...|        ...++.+.+||.+||..||.+|||+.++++||||.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~  302 (343)
T cd07878         223 DQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFS  302 (343)
T ss_pred             HHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence            3332221100                       0001        12467789999999999999999999999999998


Q ss_pred             cCCC
Q 016865          204 KNYN  207 (381)
Q Consensus       204 ~~~~  207 (381)
                      ....
T Consensus       303 ~~~~  306 (343)
T cd07878         303 QYHD  306 (343)
T ss_pred             ccCC
Confidence            6443

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.7e-38  Score=300.66  Aligned_cols=202  Identities=27%  Similarity=0.472  Sum_probs=170.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NiL   79 (381)
                      |++++||||+++++++.+++.+|+||||++||+|.+++...+.+++..+..++.|++.||.|||+ .|++||||||+||+
T Consensus        53 l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil  132 (308)
T cd06615          53 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNIL  132 (308)
T ss_pred             HHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEE
Confidence            35689999999999999999999999999999999999888889999999999999999999998 59999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      ++.++.+||+|||++.....  ....+.+|++.|+|||++.+..+ +.++|+||+||++|+|++|..||...+.......
T Consensus       133 ~~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~  209 (308)
T cd06615         133 VNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM  209 (308)
T ss_pred             EecCCcEEEccCCCcccccc--cccccCCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHh
Confidence            99999999999999875433  22356689999999999876655 4899999999999999999999976553333222


Q ss_pred             hhcc-------------------------------------cCCCCC-CCChhHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 016865          160 INAA-------------------------------------EFSCPF-WFSTGATSLIHKILDPNPKTRIRIEGIRKHPW  201 (381)
Q Consensus       160 i~~~-------------------------------------~~~~p~-~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~  201 (381)
                      +...                                     ....|. .+++++++|+.+||..||++|||+.++++|||
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~  289 (308)
T cd06615         210 FGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF  289 (308)
T ss_pred             hcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence            2110                                     001111 25788999999999999999999999999999


Q ss_pred             cccC
Q 016865          202 FRKN  205 (381)
Q Consensus       202 ~~~~  205 (381)
                      |...
T Consensus       290 ~~~~  293 (308)
T cd06615         290 IKRA  293 (308)
T ss_pred             hhhc
Confidence            9764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.7e-38  Score=308.81  Aligned_cols=203  Identities=30%  Similarity=0.502  Sum_probs=164.1

Q ss_pred             CCCCCccccccceEEEEeC------CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 016865            1 MKIVRHPNIVRLHEVLASR------TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK   74 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~------~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlk   74 (381)
                      |+.++||||+++++++...      ...|+||||+++ +|.+.+..  .+++..+..++.|++.||.|||++||+|||||
T Consensus        70 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDik  146 (355)
T cd07874          70 MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  146 (355)
T ss_pred             HHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            4568999999999998644      358999999976 67776643  48899999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           75 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        75 p~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      |+|||++.++.+||+|||++...... .......||+.|+|||++.+..+. .++||||+||++|+|++|+.||.+.+..
T Consensus       147 p~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~  224 (355)
T cd07874         147 PSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYI  224 (355)
T ss_pred             hHHEEECCCCCEEEeeCcccccCCCc-cccCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999999999765432 233456799999999999887775 8999999999999999999999876643


Q ss_pred             HHHHHhhc----------------------c-----cCC---------------CCCCCChhHHHHHHHhcCCCCCCCCC
Q 016865          155 TLYKKINA----------------------A-----EFS---------------CPFWFSTGATSLIHKILDPNPKTRIR  192 (381)
Q Consensus       155 ~~~~~i~~----------------------~-----~~~---------------~p~~~s~~~~~li~~~L~~dP~~R~t  192 (381)
                      ..+..+..                      .     ...               .+...+.++++||.+||..||.+|||
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps  304 (355)
T cd07874         225 DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS  304 (355)
T ss_pred             HHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCC
Confidence            32221100                      0     000               01113567899999999999999999


Q ss_pred             HHHHhcCcccccCCCC
Q 016865          193 IEGIRKHPWFRKNYNP  208 (381)
Q Consensus       193 ~~~il~hp~~~~~~~~  208 (381)
                      +.|+++||||...+.+
T Consensus       305 ~~ell~hp~~~~~~~~  320 (355)
T cd07874         305 VDEALQHPYINVWYDP  320 (355)
T ss_pred             HHHHhcCcchhcccCh
Confidence            9999999999866543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.7e-38  Score=306.29  Aligned_cols=203  Identities=30%  Similarity=0.538  Sum_probs=172.1

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      +.++||||+++++++.+.+..|+||||++||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus        56 ~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill  135 (331)
T cd05624          56 VNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL  135 (331)
T ss_pred             HhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE
Confidence            457899999999999999999999999999999999977 4679999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCcc-ccccccCCCCCCCCceecCC----CCCCCcccHhHHHHHHHHHHhCCCCCCCCChhH
Q 016865           81 DSYGNLKVSDFGLSALPQQGVE-LLHTTCGTPNYVAPEVLSNR----GYDGSAADVWSCGVILFVLMAGYLPFGETDLPT  155 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~-~~~~~~gt~~y~aPE~l~~~----~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  155 (381)
                      +.++.+||+|||++........ .....+||+.|+|||++.+.    +..+.++||||+||++|+|++|+.||...+...
T Consensus       136 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~  215 (331)
T cd05624         136 DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE  215 (331)
T ss_pred             cCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH
Confidence            9999999999999876543221 22346799999999998652    223588999999999999999999998887777


Q ss_pred             HHHHhhccc--CCCCCC---CChhHHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 016865          156 LYKKINAAE--FSCPFW---FSTGATSLIHKILDPNPKT--RIRIEGIRKHPWFRK  204 (381)
Q Consensus       156 ~~~~i~~~~--~~~p~~---~s~~~~~li~~~L~~dP~~--R~t~~~il~hp~~~~  204 (381)
                      .+.++....  +..|..   ++++++++|.+||..++.+  |++++++++||||+.
T Consensus       216 ~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~  271 (331)
T cd05624         216 TYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG  271 (331)
T ss_pred             HHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence            666665432  334433   6899999999999876654  579999999999974

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.8e-38  Score=303.93  Aligned_cols=203  Identities=21%  Similarity=0.361  Sum_probs=163.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||+++++++.+++..|+||||+++|+|.+++..  ...+++..++.++.|++.||.|||++||+||||||+||
T Consensus        53 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Ni  132 (327)
T cd08227          53 SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHI  132 (327)
T ss_pred             HHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhE
Confidence            3568999999999999999999999999999999999865  34589999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCC-------ccccccccCCCCCCCCceecCC--CCCCCcccHhHHHHHHHHHHhCCCCCC
Q 016865           79 LLDSYGNLKVSDFGLSALPQQG-------VELLHTTCGTPNYVAPEVLSNR--GYDGSAADVWSCGVILFVLMAGYLPFG  149 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~-------~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DIwSlGvil~~ll~G~~Pf~  149 (381)
                      |++.++.++++|||.+......       ........++..|+|||++.+.  .+ +.++||||+||++|+|++|..||.
T Consensus       133 l~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~  211 (327)
T cd08227         133 LISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFK  211 (327)
T ss_pred             EEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCC-CchhhHHHHHHHHHHHHHCCCCCC
Confidence            9999999999999865432111       0111234578889999998753  34 489999999999999999999997


Q ss_pred             CCChhHHHHHhhcccC----------------------------------------------CCCCCCChhHHHHHHHhc
Q 016865          150 ETDLPTLYKKINAAEF----------------------------------------------SCPFWFSTGATSLIHKIL  183 (381)
Q Consensus       150 ~~~~~~~~~~i~~~~~----------------------------------------------~~p~~~s~~~~~li~~~L  183 (381)
                      .............+..                                              .....+++.+.+||.+||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  291 (327)
T cd08227         212 DMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCL  291 (327)
T ss_pred             CcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHH
Confidence            6543322211111100                                              001124678999999999


Q ss_pred             CCCCCCCCCHHHHhcCccccc
Q 016865          184 DPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       184 ~~dP~~R~t~~~il~hp~~~~  204 (381)
                      +.||.+|||++++++||||+.
T Consensus       292 ~~dP~~Rpt~~ell~~p~f~~  312 (327)
T cd08227         292 QRNPDARPSASTLLNHSFFKQ  312 (327)
T ss_pred             hhCchhcCCHHHHhcChhhhh
Confidence            999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.2e-38  Score=299.30  Aligned_cols=201  Identities=31%  Similarity=0.505  Sum_probs=164.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+.+|+|+||+++ +|.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+||+
T Consensus        53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil  131 (284)
T cd07839          53 LKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLL  131 (284)
T ss_pred             HHhcCCCCeeeHHHHhccCCceEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEE
Confidence            4568999999999999999999999999975 78887765 567999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCC-CCCChhHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK  158 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf-~~~~~~~~~~  158 (381)
                      ++.++.+||+|||++..............+++.|+|||++.+....+.++||||+||++|+|++|..|| ...+......
T Consensus       132 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~  211 (284)
T cd07839         132 INKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK  211 (284)
T ss_pred             EcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHH
Confidence            999999999999998765443333345568899999999877555568999999999999999988885 4333333322


Q ss_pred             Hhhcc----------------c---C----------CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          159 KINAA----------------E---F----------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       159 ~i~~~----------------~---~----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      .+...                .   +          ...+.+++++++||.+||..||.+|||++++++||||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         212 RIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             HHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            22110                0   0          0112368899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.5e-39  Score=298.24  Aligned_cols=201  Identities=38%  Similarity=0.652  Sum_probs=169.8

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      ++++||||+++++++.+....|+||||+++++|.+++...+.+++..+..++.|++.||.+||++|++||||||+||+++
T Consensus        53 ~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~  132 (260)
T PF00069_consen   53 RRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLD  132 (260)
T ss_dssp             HHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEES
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            45689999999999999999999999999999999999778899999999999999999999999999999999999999


Q ss_pred             cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh---HHHH
Q 016865           82 SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP---TLYK  158 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~---~~~~  158 (381)
                      +++.++|+|||.+.............++++.|+|||++......+.++||||||+++|+|++|..||...+..   ....
T Consensus       133 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~  212 (260)
T PF00069_consen  133 ENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE  212 (260)
T ss_dssp             TTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh
Confidence            9999999999998753232344566778999999999873344569999999999999999999999987332   2222


Q ss_pred             HhhcccCCCCC----CCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          159 KINAAEFSCPF----WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       159 ~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      +........+.    ..++++.++|.+||+.||.+|||+.++++||||
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  213 KILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             hcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            22222111111    124899999999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.4e-38  Score=298.54  Aligned_cols=203  Identities=25%  Similarity=0.477  Sum_probs=174.1

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      ++.++||||+++++.+.+...+|+|+||++||+|.+++.. ..+++..+..++.|++.||+|||+.|++||||||+||++
T Consensus        70 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili  148 (296)
T cd06655          70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL  148 (296)
T ss_pred             HHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence            3578999999999999999999999999999999998865 568999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.+||+|||++.............+|++.|+|||.+.+..+. .++||||+||++|+|++|..||...+.......+
T Consensus       149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~  227 (296)
T cd06655         149 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI  227 (296)
T ss_pred             CCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999999987654433333456789999999999876664 8999999999999999999999877654433333


Q ss_pred             hcc---cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          161 NAA---EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       161 ~~~---~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ...   ....|..+++.+.++|.+||..||.+|||+.+++.||||+..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~  275 (296)
T cd06655         228 ATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA  275 (296)
T ss_pred             HhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence            222   223455688999999999999999999999999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=5e-38  Score=292.27  Aligned_cols=201  Identities=29%  Similarity=0.466  Sum_probs=172.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+..|+|+||++||+|.+++.+.+.++++.+..++.|++.||+|||+.||+|+||+|+||++
T Consensus        56 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~  135 (265)
T cd06631          56 LKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML  135 (265)
T ss_pred             HHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE
Confidence            35789999999999999999999999999999999999887889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCC------CccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           81 DSYGNLKVSDFGLSALPQQ------GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      +.++.++|+|||++.....      .........|++.|+|||++.+..+. .++|+||+||++|+|++|..||...+..
T Consensus       136 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~  214 (265)
T cd06631         136 MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYG-RKSDIWSIGCTVFEMATGKPPLASMDRL  214 (265)
T ss_pred             CCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCc-chhhHHHHHHHHHHHHhCCCccccCChH
Confidence            9999999999998875421      11123345689999999999876664 8999999999999999999999876544


Q ss_pred             HHHHHhhcc---cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          155 TLYKKINAA---EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       155 ~~~~~i~~~---~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      .....+...   ....|..++.++.++|++||..+|.+|||+.+++.||||
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         215 AAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             HHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            433333222   123555689999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-38  Score=290.11  Aligned_cols=200  Identities=31%  Similarity=0.468  Sum_probs=171.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+.+|++|||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+
T Consensus        54 l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~  133 (262)
T cd06613          54 LKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANIL  133 (262)
T ss_pred             HHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEE
Confidence            46789999999999999999999999999999999988775 78999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCC---CCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR---GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL  156 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~  156 (381)
                      ++.++.+||+|||++..............|+..|+|||++.+.   .++ .++|+||+||++|+|++|.+||...+....
T Consensus       134 i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~~p~~~~~~~~~  212 (262)
T cd06613         134 LTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRA  212 (262)
T ss_pred             ECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9999999999999987654432233456789999999998765   554 899999999999999999999987765444


Q ss_pred             HHHhhcccCC-----CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 016865          157 YKKINAAEFS-----CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPW  201 (381)
Q Consensus       157 ~~~i~~~~~~-----~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~  201 (381)
                      ...+....+.     .+..++.++.++|.+||..+|..|||+++++.|||
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         213 LFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            4333333222     22335788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5.8e-38  Score=294.63  Aligned_cols=202  Identities=28%  Similarity=0.456  Sum_probs=168.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      ++.++||||+++++++......|+||||++++.|...+.....+++..++.++.|++.||.|||+.|++||||||+||++
T Consensus        54 l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~  133 (286)
T cd07847          54 LKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI  133 (286)
T ss_pred             HHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE
Confidence            35789999999999999999999999999998888877776789999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.+||+|||++..............++..|+|||++.+....+.++||||+||++|+|++|+.||.+.+..+....+
T Consensus       134 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~  213 (286)
T cd07847         134 TKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLI  213 (286)
T ss_pred             cCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            99999999999999866543323344568899999999876554458999999999999999999999876543322211


Q ss_pred             hc---------------cc----CCCC------------CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          161 NA---------------AE----FSCP------------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       161 ~~---------------~~----~~~p------------~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      ..               ..    ...|            ..++..+.+||.+||+.+|.+|||+.+++.||||
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         214 RKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             HHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            10               00    0001            1357889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4.9e-38  Score=316.85  Aligned_cols=199  Identities=22%  Similarity=0.343  Sum_probs=161.5

Q ss_pred             CCccccccceEEEEeC-CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEc
Q 016865            4 VRHPNIVRLHEVLASR-TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLD   81 (381)
Q Consensus         4 l~HpnIv~l~~~~~~~-~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NiLl~   81 (381)
                      .+|++++++++++... ..+|+|||++ |++|.+++...+.+++..++.++.||+.||.|||+ .||+||||||+|||++
T Consensus       188 ~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~  266 (467)
T PTZ00284        188 ADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILME  266 (467)
T ss_pred             ccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEe
Confidence            3567799999999765 5899999998 77999999888889999999999999999999998 5999999999999998


Q ss_pred             cCC----------------CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCC
Q 016865           82 SYG----------------NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGY  145 (381)
Q Consensus        82 ~~~----------------~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~  145 (381)
                      .++                .+||+|||++.....   .....+||+.|+|||++.+..|. .++||||+||++|||++|+
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~  342 (467)
T PTZ00284        267 TSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGK  342 (467)
T ss_pred             cCCcccccccccccCCCCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCC
Confidence            766                499999998764322   23467899999999999887775 8999999999999999999


Q ss_pred             CCCCCCChhHHHHHhhcccCCC----------------------------CC--------------CCChhHHHHHHHhc
Q 016865          146 LPFGETDLPTLYKKINAAEFSC----------------------------PF--------------WFSTGATSLIHKIL  183 (381)
Q Consensus       146 ~Pf~~~~~~~~~~~i~~~~~~~----------------------------p~--------------~~s~~~~~li~~~L  183 (381)
                      +||+..+.......+.......                            |.              ..++.+.+||.+||
T Consensus       343 ~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL  422 (467)
T PTZ00284        343 LLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLL  422 (467)
T ss_pred             CCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhC
Confidence            9998766433222211100000                            00              01456789999999


Q ss_pred             CCCCCCCCCHHHHhcCcccccCCC
Q 016865          184 DPNPKTRIRIEGIRKHPWFRKNYN  207 (381)
Q Consensus       184 ~~dP~~R~t~~~il~hp~~~~~~~  207 (381)
                      ..||.+|||++|+|+||||.+.+.
T Consensus       423 ~~dP~~R~ta~e~L~Hp~~~~~~~  446 (467)
T PTZ00284        423 HYDRQKRLNARQMTTHPYVLKYYP  446 (467)
T ss_pred             CcChhhCCCHHHHhcCccccccCC
Confidence            999999999999999999987543

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.2e-38  Score=319.93  Aligned_cols=202  Identities=30%  Similarity=0.497  Sum_probs=175.3

Q ss_pred             CCCCccccccceEEEEeCC--------EEEEEEecCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q 016865            2 KIVRHPNIVRLHEVLASRT--------KVYIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHCHSKGVY   69 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~--------~~~lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~~L~~LH~~gi~   69 (381)
                      +.++|+||+++++.+....        .+++||||+++|+|.+++...    ..+++..+..++.|++.||+|||++||+
T Consensus        86 ~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~Ii  165 (496)
T PTZ00283         86 LNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMI  165 (496)
T ss_pred             hcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence            4678999999998875432        478999999999999988642    4689999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCCEEEeeccCccCCCCC--ccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCC
Q 016865           70 HRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLP  147 (381)
Q Consensus        70 HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~P  147 (381)
                      ||||||+|||++.++.+||+|||+++.....  .....+.+||+.|+|||++.+..++ .++||||+||++|+|++|+.|
T Consensus       166 HrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~k~DVwSlGvilyeLltG~~P  244 (496)
T PTZ00283        166 HRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRP  244 (496)
T ss_pred             cCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCC
Confidence            9999999999999999999999998765431  2234567899999999999877765 899999999999999999999


Q ss_pred             CCCCChhHHHHHhhcccC-CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          148 FGETDLPTLYKKINAAEF-SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       148 f~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      |...+.......+..+.. ..|..+++++.+++.+||..||.+|||+.++++|||++.
T Consensus       245 f~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        245 FDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL  302 (496)
T ss_pred             CCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence            998887777766655443 467778999999999999999999999999999999874

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=6.3e-38  Score=292.49  Aligned_cols=197  Identities=27%  Similarity=0.406  Sum_probs=164.9

Q ss_pred             CccccccceEEEEeC------CEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 016865            5 RHPNIVRLHEVLASR------TKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE   76 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~------~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~   76 (381)
                      +||||+++++++...      ..+|+||||+++|+|.+++...  ..+++..+..++.|++.||.|||++||+||||||+
T Consensus        61 ~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~  140 (272)
T cd06637          61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQ  140 (272)
T ss_pred             CCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHH
Confidence            799999999999753      5799999999999999998763  35899999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecC-----CCCCCCcccHhHHHHHHHHHHhCCCCCCCC
Q 016865           77 NLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-----RGYDGSAADVWSCGVILFVLMAGYLPFGET  151 (381)
Q Consensus        77 NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~  151 (381)
                      ||++++++.+||+|||++...........+..|++.|+|||++..     ..+ +.++|+||+||++|+|++|..||...
T Consensus       141 nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGv~l~el~~g~~p~~~~  219 (272)
T cd06637         141 NVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDM  219 (272)
T ss_pred             HEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCC-CchhhHHHHHHHHHHHHhCCCCcccc
Confidence            999999999999999998765443333456679999999999863     234 47899999999999999999999766


Q ss_pred             ChhHHHHHhhcccC--CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          152 DLPTLYKKINAAEF--SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       152 ~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      ........+.....  ..+..++.++.+||.+||..||.+|||+.++++||||
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         220 HPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            54443333322211  1223478899999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-38  Score=290.50  Aligned_cols=198  Identities=31%  Similarity=0.603  Sum_probs=173.9

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      +..+||||+++++++.+++.+|+|+||++||+|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++
T Consensus        52 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~  131 (260)
T cd05611          52 IQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID  131 (260)
T ss_pred             hcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC
Confidence            34689999999999999999999999999999999998888899999999999999999999999999999999999999


Q ss_pred             cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhh
Q 016865           82 SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN  161 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~  161 (381)
                      +++.+||+|||++.....    .....|++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+....+..+.
T Consensus       132 ~~~~~~l~dfg~~~~~~~----~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~  206 (260)
T cd05611         132 QTGHLKLTDFGLSRNGLE----NKKFVGTPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL  206 (260)
T ss_pred             CCCcEEEeecccceeccc----cccCCCCcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            999999999998875433    234568899999999987664 589999999999999999999998877776666655


Q ss_pred             cccCCC----CCCCChhHHHHHHHhcCCCCCCCC---CHHHHhcCccccc
Q 016865          162 AAEFSC----PFWFSTGATSLIHKILDPNPKTRI---RIEGIRKHPWFRK  204 (381)
Q Consensus       162 ~~~~~~----p~~~s~~~~~li~~~L~~dP~~R~---t~~~il~hp~~~~  204 (381)
                      ......    +..+++++.++|.+||+.||++||   +++|++.||||++
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~  256 (260)
T cd05611         207 SRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS  256 (260)
T ss_pred             hcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhc
Confidence            444332    234789999999999999999999   5589999999965

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=6e-38  Score=297.53  Aligned_cols=203  Identities=25%  Similarity=0.459  Sum_probs=172.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++.+.+....|+||||++||+|.+++.. ..+++.++..++.|++.||.|||+.||+||||||+||++
T Consensus        71 l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill  149 (296)
T cd06654          71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL  149 (296)
T ss_pred             HHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence            3567999999999999999999999999999999998865 568999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.+||+|||++..............|++.|+|||.+.+..++ .++||||+||++|+|++|+.||...+.......+
T Consensus       150 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~  228 (296)
T cd06654         150 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI  228 (296)
T ss_pred             cCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHH
Confidence            999999999999987654332333456799999999999776654 8999999999999999999999876553322222


Q ss_pred             h-cc--cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          161 N-AA--EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       161 ~-~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      . ..  ....|..+++.+.++|.+||..+|.+|||+.++++||||...
T Consensus       229 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         229 ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             hcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence            2 11  123455688999999999999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.4e-37  Score=293.85  Aligned_cols=204  Identities=29%  Similarity=0.453  Sum_probs=171.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      ++.++||||+++++.+..++..|+||||++||+|..++.. ...+++..+..++.|++.||.|||+.|++||||||+||+
T Consensus        63 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil  142 (292)
T cd06644          63 LATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVL  142 (292)
T ss_pred             HHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEE
Confidence            3578999999999999999999999999999999887754 456899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCC----CCCCcccHhHHHHHHHHHHhCCCCCCCCChhH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG----YDGSAADVWSCGVILFVLMAGYLPFGETDLPT  155 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  155 (381)
                      ++.++.+||+|||++..............|++.|+|||++.+..    ..+.++|+||+||++|+|++|.+||...+...
T Consensus       143 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~  222 (292)
T cd06644         143 LTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR  222 (292)
T ss_pred             EcCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH
Confidence            99999999999998875433222234556899999999985321    12478999999999999999999998766555


Q ss_pred             HHHHhhccc---CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          156 LYKKINAAE---FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       156 ~~~~i~~~~---~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      .+.++....   ...+..++.++.++|.+||..||.+||+++++++||||..
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  274 (292)
T cd06644         223 VLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS  274 (292)
T ss_pred             HHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            444443332   2334557889999999999999999999999999999964

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.4e-38  Score=292.39  Aligned_cols=201  Identities=29%  Similarity=0.417  Sum_probs=167.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++..+..+|+||||+++|+|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||++
T Consensus        60 l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill  139 (267)
T cd06646          60 VKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL  139 (267)
T ss_pred             HHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE
Confidence            35679999999999999999999999999999999999887889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCC--CCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR--GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK  158 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~  158 (381)
                      +.++.+||+|||++..............|++.|+|||.+...  ...+.++|+||+||++|+|++|..||...+......
T Consensus       140 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~  219 (267)
T cd06646         140 TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF  219 (267)
T ss_pred             CCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe
Confidence            999999999999987654322223456789999999998532  222478999999999999999999996554333222


Q ss_pred             HhhcccCCCC-----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 016865          159 KINAAEFSCP-----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPW  201 (381)
Q Consensus       159 ~i~~~~~~~p-----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~  201 (381)
                      .+....+..+     ..++..+.+||++||..+|.+|||++++++|+|
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         220 LMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             eeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            2222222222     236889999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=5e-38  Score=294.69  Aligned_cols=202  Identities=31%  Similarity=0.546  Sum_probs=173.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |++++||||+++++++.+.+..|+||||++||+|.+++...+  .+++..+..++.|++.||.|||+.|++||||+|+||
T Consensus        47 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Ni  126 (277)
T cd05577          47 LEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENV  126 (277)
T ss_pred             HHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence            467899999999999999999999999999999999997765  689999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh----h
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL----P  154 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~----~  154 (381)
                      +++.++.+||+|||++...... .......|+..|+|||++.+..+ +.++||||+||++|+|++|+.||.....    .
T Consensus       127 l~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~  204 (277)
T cd05577         127 LLDDHGNVRISDLGLAVELKGG-KKIKGRAGTPGYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE  204 (277)
T ss_pred             EECCCCCEEEccCcchhhhccC-CccccccCCCCcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHH
Confidence            9999999999999998765432 22344568899999999877665 4899999999999999999999976543    2


Q ss_pred             HHHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 016865          155 TLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  204 (381)
Q Consensus       155 ~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~-----t~~~il~hp~~~~  204 (381)
                      .....+.......|..+++.+.++|.+||+.||.+||     ++.+++.||||..
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~  259 (277)
T cd05577         205 ELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD  259 (277)
T ss_pred             HHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence            2333333344556666899999999999999999999     8899999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.6e-38  Score=300.26  Aligned_cols=201  Identities=26%  Similarity=0.439  Sum_probs=157.1

Q ss_pred             CCCCCccccccceEEEE--eCCEEEEEEecCCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q 016865            1 MKIVRHPNIVRLHEVLA--SRTKVYIILEFVTGGELFDKIVHQ---------GRLLENDCRRYFQQLIDAVAHCHSKGVY   69 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~--~~~~~~lV~E~~~gg~L~~~i~~~---------~~l~e~~~~~~~~qll~~L~~LH~~gi~   69 (381)
                      |+.++||||+++++++.  ++..+|+||||+.+ +|.+.+...         ..+++..++.++.|++.||.|||++||+
T Consensus        52 l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iv  130 (317)
T cd07867          52 LRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVL  130 (317)
T ss_pred             HHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence            45789999999999985  45689999999965 788877521         2478999999999999999999999999


Q ss_pred             ecCCCCCcEEE----ccCCCEEEeeccCccCCCCCc---cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHH
Q 016865           70 HRDLKPENLLL----DSYGNLKVSDFGLSALPQQGV---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM  142 (381)
Q Consensus        70 HrDlkp~NiLl----~~~~~lkl~DFGls~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll  142 (381)
                      ||||||+|||+    +.++.+||+|||++.......   .......||+.|+|||++.+....+.++||||+||++|+|+
T Consensus       131 H~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~  210 (317)
T cd07867         131 HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL  210 (317)
T ss_pred             cCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHH
Confidence            99999999999    456789999999998654321   12345678999999999977555568999999999999999


Q ss_pred             hCCCCCCCCChhH---------HHHHh----------------------------hcccCC----------CCCCCChhH
Q 016865          143 AGYLPFGETDLPT---------LYKKI----------------------------NAAEFS----------CPFWFSTGA  175 (381)
Q Consensus       143 ~G~~Pf~~~~~~~---------~~~~i----------------------------~~~~~~----------~p~~~s~~~  175 (381)
                      +|.+||.......         ....+                            ......          .....+..+
T Consensus       211 tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (317)
T cd07867         211 TSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKV  290 (317)
T ss_pred             hCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHH
Confidence            9999996432110         00000                            000000          011235678


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          176 TSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       176 ~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      .+||.+||+.||.+|||++|+++||||
T Consensus       291 ~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         291 FLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             HHHHHHHhccCcccccCHHHHhcCCCC
Confidence            899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.6e-38  Score=298.55  Aligned_cols=206  Identities=27%  Similarity=0.500  Sum_probs=175.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++.+...+..|+||||+++++|.+++.. +.++++.+..++.||+.||.|||++||+||||||+||++
T Consensus        73 l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill  151 (292)
T cd06658          73 MRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL  151 (292)
T ss_pred             HHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE
Confidence            3568999999999999999999999999999999987754 568999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      ++++.++|+|||++..............|++.|+|||.+.+..++ .++|+||+||++|+|++|+.||...+.......+
T Consensus       152 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~  230 (292)
T cd06658         152 TSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI  230 (292)
T ss_pred             cCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999999987654333333456799999999999776664 8999999999999999999999876655444443


Q ss_pred             hcc---cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 016865          161 NAA---EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  208 (381)
Q Consensus       161 ~~~---~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~  208 (381)
                      ...   ....+..++..+.++|.+||..||.+|||++++++||||+....|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~  281 (292)
T cd06658         231 RDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP  281 (292)
T ss_pred             HhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence            322   112223478899999999999999999999999999999876544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.8e-38  Score=304.80  Aligned_cols=201  Identities=25%  Similarity=0.449  Sum_probs=161.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |++++||||+++++++.+....|+||||+. |+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus       111 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nil  189 (357)
T PHA03209        111 LQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIF  189 (357)
T ss_pred             HHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence            467899999999999999999999999995 588888865 456899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCC-CCCCCCChh----
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGY-LPFGETDLP----  154 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~-~Pf~~~~~~----  154 (381)
                      ++.++.+||+|||++...... .......||+.|+|||++.+..+. .++||||+||++|+|+++. .+|......    
T Consensus       190 l~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~  267 (357)
T PHA03209        190 INDVDQVCIGDLGAAQFPVVA-PAFLGLAGTVETNAPEVLARDKYN-SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEY  267 (357)
T ss_pred             ECCCCCEEEecCccccccccC-cccccccccccccCCeecCCCCCC-chhhHHHHHHHHHHHHHcCCccccCCCCcHHHH
Confidence            999999999999998754332 223456799999999999887765 8999999999999999854 444432211    


Q ss_pred             ------HHHHHhhccc---CCCC------------------------------CCCChhHHHHHHHhcCCCCCCCCCHHH
Q 016865          155 ------TLYKKINAAE---FSCP------------------------------FWFSTGATSLIHKILDPNPKTRIRIEG  195 (381)
Q Consensus       155 ------~~~~~i~~~~---~~~p------------------------------~~~s~~~~~li~~~L~~dP~~R~t~~~  195 (381)
                            .+...+....   ..+|                              ..++.++.+||.+||+.||.+|||+.|
T Consensus       268 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e  347 (357)
T PHA03209        268 VKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEE  347 (357)
T ss_pred             HHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHH
Confidence                  0111110000   0011                              124677888999999999999999999


Q ss_pred             HhcCccccc
Q 016865          196 IRKHPWFRK  204 (381)
Q Consensus       196 il~hp~~~~  204 (381)
                      +++||||++
T Consensus       348 ~l~hp~f~~  356 (357)
T PHA03209        348 ILNYPMFAQ  356 (357)
T ss_pred             HhcCchhcc
Confidence            999999974

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.1e-37  Score=294.11  Aligned_cols=202  Identities=29%  Similarity=0.536  Sum_probs=173.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++|+||+++++.+.+++..|+||||+++|+|.+.+...  ..+++..+..++.|++.||.|||+.||+||||||+||
T Consensus        54 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Ni  133 (285)
T cd05632          54 LEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENI  133 (285)
T ss_pred             HHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHE
Confidence            46789999999999999999999999999999999888653  3699999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH-
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY-  157 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~-  157 (381)
                      ++++++.+||+|||++...... .......|++.|+|||++.+..+. .++|+||+||++|+|++|..||......... 
T Consensus       134 li~~~~~~kl~Dfg~~~~~~~~-~~~~~~~g~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~  211 (285)
T cd05632         134 LLDDYGHIRISDLGLAVKIPEG-ESIRGRVGTVGYMAPEVLNNQRYT-LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE  211 (285)
T ss_pred             EECCCCCEEEecCCcceecCCC-CcccCCCCCcCccChHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999999999998654332 223456799999999999876664 8999999999999999999999876543322 


Q ss_pred             ---HHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 016865          158 ---KKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIR-----IEGIRKHPWFRK  204 (381)
Q Consensus       158 ---~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t-----~~~il~hp~~~~  204 (381)
                         ..+.......+..+++++.+|+.+||+.||.+|||     +.++++||||+.
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05632         212 EVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRN  266 (285)
T ss_pred             HHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhc
Confidence               22333344556668999999999999999999999     889999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=8.2e-38  Score=289.37  Aligned_cols=203  Identities=34%  Similarity=0.643  Sum_probs=179.1

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++.+.+.+..|+||||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||++
T Consensus        47 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~  126 (265)
T cd05579          47 LSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI  126 (265)
T ss_pred             HHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE
Confidence            35678999999999999999999999999999999999887889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCcc--------ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCC
Q 016865           81 DSYGNLKVSDFGLSALPQQGVE--------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD  152 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~  152 (381)
                      +.++.++|+|||++........        ......++..|+|||...+..+ +.++|+||+|+++|++++|..||...+
T Consensus       127 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~  205 (265)
T cd05579         127 DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGET  205 (265)
T ss_pred             cCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999875433211        2234568899999999877664 489999999999999999999999888


Q ss_pred             hhHHHHHhhcccCCCCCCC--ChhHHHHHHHhcCCCCCCCCCH---HHHhcCccccc
Q 016865          153 LPTLYKKINAAEFSCPFWF--STGATSLIHKILDPNPKTRIRI---EGIRKHPWFRK  204 (381)
Q Consensus       153 ~~~~~~~i~~~~~~~p~~~--s~~~~~li~~~L~~dP~~R~t~---~~il~hp~~~~  204 (381)
                      ....+..+..+....|...  ++.+.+++.+||+.+|.+|||+   .++++||||++
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~  262 (265)
T cd05579         206 PEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG  262 (265)
T ss_pred             HHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence            7777777766666666554  8999999999999999999999   99999999974

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.3e-37  Score=287.32  Aligned_cols=201  Identities=27%  Similarity=0.448  Sum_probs=171.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      ++.++||||+++++.+.+....|+++||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+
T Consensus        52 ~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~  131 (256)
T cd06612          52 LKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNIL  131 (256)
T ss_pred             HHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEE
Confidence            3567999999999999999999999999999999999875 456899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      ++.++.+||+|||++..............|+..|+|||++.+..++ .++||||+||++|+|++|+.||...+.......
T Consensus       132 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~  210 (256)
T cd06612         132 LNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM  210 (256)
T ss_pred             ECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCC-chhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh
Confidence            9999999999999988665433233455689999999999877664 899999999999999999999987654433322


Q ss_pred             hhc---ccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          160 INA---AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       160 i~~---~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      +..   .....+..++.++.++|.+||+.||.+|||+.+++.||||
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         211 IPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             hccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            221   1223344578899999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=297.25  Aligned_cols=204  Identities=33%  Similarity=0.560  Sum_probs=175.9

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||+++++.+.+....|+||||+.|++|.+.+...  ..+++..+..++.|++.||.|||+.|++||||||+||
T Consensus        55 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni  134 (316)
T cd05574          55 LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENI  134 (316)
T ss_pred             HHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHe
Confidence            35789999999999999999999999999999999988753  4689999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCcc-----------------------------ccccccCCCCCCCCceecCCCCCCCcc
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVE-----------------------------LLHTTCGTPNYVAPEVLSNRGYDGSAA  129 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~-----------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~  129 (381)
                      +++.++.++|+|||++........                             ......||..|+|||++.+..+ +.++
T Consensus       135 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~  213 (316)
T cd05574         135 LLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAV  213 (316)
T ss_pred             EEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchH
Confidence            999999999999998765432110                             1123468899999999987666 4899


Q ss_pred             cHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccCCCCCC--CChhHHHHHHHhcCCCCCCCCC----HHHHhcCcccc
Q 016865          130 DVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFW--FSTGATSLIHKILDPNPKTRIR----IEGIRKHPWFR  203 (381)
Q Consensus       130 DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~--~s~~~~~li~~~L~~dP~~R~t----~~~il~hp~~~  203 (381)
                      ||||+||++|+|++|..||...+....+..+.......|..  ++..++++|.+||..||.+|||    ++++++||||+
T Consensus       214 Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~  293 (316)
T cd05574         214 DWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR  293 (316)
T ss_pred             HHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhh
Confidence            99999999999999999998887766666665555555544  6899999999999999999999    99999999997


Q ss_pred             cC
Q 016865          204 KN  205 (381)
Q Consensus       204 ~~  205 (381)
                      ..
T Consensus       294 ~~  295 (316)
T cd05574         294 GV  295 (316)
T ss_pred             cC
Confidence            53

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.2e-37  Score=300.75  Aligned_cols=195  Identities=22%  Similarity=0.366  Sum_probs=160.3

Q ss_pred             CC-CccccccceEEEEeC-CEEEEEEecCCCCChHHHHHhc---------------------------------------
Q 016865            3 IV-RHPNIVRLHEVLASR-TKVYIILEFVTGGELFDKIVHQ---------------------------------------   41 (381)
Q Consensus         3 ~l-~HpnIv~l~~~~~~~-~~~~lV~E~~~gg~L~~~i~~~---------------------------------------   41 (381)
                      .+ +||||+++++++... +.+|+||||++||+|.+++...                                       
T Consensus        66 ~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (338)
T cd05102          66 HIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVL  145 (338)
T ss_pred             HhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCcc
Confidence            45 899999999988764 4699999999999999998652                                       


Q ss_pred             -----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCCCEEEeeccCccCCC
Q 016865           42 -----------------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ   98 (381)
Q Consensus        42 -----------------------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~   98 (381)
                                             ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~  225 (338)
T cd05102         146 FSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIY  225 (338)
T ss_pred             ccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccc
Confidence                                   236778889999999999999999999999999999999999999999999997643


Q ss_pred             CCcc--ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhH-HHHHhhcc-cCCCCCCCCh
Q 016865           99 QGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPT-LYKKINAA-EFSCPFWFST  173 (381)
Q Consensus        99 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~  173 (381)
                      ....  ...+..+++.|+|||++.+..++ .++||||+||++|+|++ |..||....... ....+..+ ....|..+++
T Consensus       226 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (338)
T cd05102         226 KDPDYVRKGSARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATP  304 (338)
T ss_pred             cCcchhcccCCCCCccccCcHHhhcCCCC-cccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCH
Confidence            2211  12234467889999999877665 89999999999999997 999998765433 33333332 3345667899


Q ss_pred             hHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          174 GATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       174 ~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ++.+++.+||..||.+|||+.++++
T Consensus       305 ~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         305 EIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHH
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.4e-37  Score=287.62  Aligned_cols=201  Identities=29%  Similarity=0.600  Sum_probs=175.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      ++.++||||+++++++.+.+..|+|+||+++++|.+.+....  .+++..+..++.|++.||.|||++|++|+||+|+||
T Consensus        53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~ni  132 (256)
T cd08218          53 LSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNI  132 (256)
T ss_pred             HHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence            467899999999999999999999999999999999987643  578999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK  158 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~  158 (381)
                      +++.++.++++|||++..............|++.|+|||++.+..+. .++|+||+||++++|++|..||...+......
T Consensus       133 l~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~  211 (256)
T cd08218         133 FLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYN-NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL  211 (256)
T ss_pred             EEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCC-CccchhHHHHHHHHHHcCCCCccCCCHHHHHH
Confidence            99999999999999987654432233345689999999998776654 89999999999999999999998877766666


Q ss_pred             HhhcccC-CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          159 KINAAEF-SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       159 ~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      .+..+.. ..|..++.++.++|.+||+.+|.+||++.++++||||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         212 KIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            6554443 3556689999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.4e-37  Score=286.06  Aligned_cols=201  Identities=29%  Similarity=0.552  Sum_probs=177.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |++++||||+++++++.+.+..++||||++||+|.+++...  ..+++..+..++.|++.||.|||+.|++||||+|+||
T Consensus        53 l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni  132 (256)
T cd08221          53 LSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNI  132 (256)
T ss_pred             HHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhE
Confidence            46789999999999999999999999999999999999764  4589999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK  158 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~  158 (381)
                      ++++++.+||+|||++..............|++.|+|||++.+..+. .++|+||+||++|+|++|..||...+......
T Consensus       133 ~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~  211 (256)
T cd08221         133 FLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVV  211 (256)
T ss_pred             EEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCC-CcchhHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            99999999999999987654433334566799999999999876654 88999999999999999999998877777666


Q ss_pred             HhhcccCC-CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          159 KINAAEFS-CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       159 ~i~~~~~~-~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      .+..+.+. .+..++.++.++|.+||..+|.+|||+.++++|||+
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         212 KIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence            66555443 345578999999999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=290.57  Aligned_cols=202  Identities=28%  Similarity=0.455  Sum_probs=175.4

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      +.++||||+++++++.+....|+|+||+++++|.+++... .+++..+..++.|++.||.|||+.|++||||+|+||+++
T Consensus        54 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~  132 (274)
T cd06609          54 SQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS  132 (274)
T ss_pred             HHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC
Confidence            5678999999999999999999999999999999998764 789999999999999999999999999999999999999


Q ss_pred             cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhh
Q 016865           82 SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN  161 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~  161 (381)
                      +++.++|+|||++..............|++.|+|||++.+..++ .++|+||+||++|+|++|..||...+.......+.
T Consensus       133 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~  211 (274)
T cd06609         133 EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYD-EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP  211 (274)
T ss_pred             CCCCEEEcccccceeecccccccccccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh
Confidence            99999999999998765432334456789999999999876654 89999999999999999999998766555444444


Q ss_pred             ccc-CCCCCC-CChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          162 AAE-FSCPFW-FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       162 ~~~-~~~p~~-~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ... ...+.. +++++.+++.+||..+|.+|||++++++||||...
T Consensus       212 ~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~  257 (274)
T cd06609         212 KNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA  257 (274)
T ss_pred             hcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence            332 233444 78899999999999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.4e-37  Score=294.27  Aligned_cols=208  Identities=29%  Similarity=0.423  Sum_probs=173.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+..|+||||+ +|+|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+
T Consensus        56 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil  134 (298)
T cd07841          56 LQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLL  134 (298)
T ss_pred             HhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEE
Confidence            46789999999999999999999999999 899999997765 7999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      ++.++.++|+|||++..............+++.|+|||.+.+....+.++||||+||++|+|++|.+||...+......+
T Consensus       135 l~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~  214 (298)
T cd07841         135 IASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGK  214 (298)
T ss_pred             EcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHH
Confidence            99999999999999986654333334456788999999986655556899999999999999999988876654443333


Q ss_pred             hhccc----------------C-------C-----CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCC
Q 016865          160 INAAE----------------F-------S-----CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV  209 (381)
Q Consensus       160 i~~~~----------------~-------~-----~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~~  209 (381)
                      +....                +       .     .....+..+.++|.+||..||++|||+.++++||||+....+.
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         215 IFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             HHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence            22110                0       0     0122478899999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.2e-37  Score=289.86  Aligned_cols=202  Identities=28%  Similarity=0.477  Sum_probs=171.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |++++||||+++++++.+.+..++|+||++|++|.+.+...+.+++..+..++.|++.||.|||++|++||||+|+||++
T Consensus        57 l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~  136 (268)
T cd06630          57 MARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLI  136 (268)
T ss_pred             HHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence            35689999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             ccCC-CEEEeeccCccCCCCCc----cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhH
Q 016865           81 DSYG-NLKVSDFGLSALPQQGV----ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT  155 (381)
Q Consensus        81 ~~~~-~lkl~DFGls~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  155 (381)
                      +.++ .+||+|||.+.......    .......|+..|+|||++.+..+. .++|+||+||++|+|++|..||...+...
T Consensus       137 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~  215 (268)
T cd06630         137 DSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYG-RSCDVWSVGCVIIEMATAKPPWNAEKHSN  215 (268)
T ss_pred             cCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcc
Confidence            8776 59999999987654321    112345689999999999776664 89999999999999999999997654432


Q ss_pred             HHHHhh-----cccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          156 LYKKIN-----AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       156 ~~~~i~-----~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      ....+.     ......|..+++++.+++.+||..+|.+|||+.++++||||+
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         216 HLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             hHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            222221     122345566899999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-38  Score=303.49  Aligned_cols=194  Identities=28%  Similarity=0.464  Sum_probs=174.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.|+|+|||++++++..+.-+||||||++.|+|.+++..  .+.+.-.+...++.||++|++||+++++|||||-..||
T Consensus       255 Mk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNi  334 (468)
T KOG0197|consen  255 MKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNI  334 (468)
T ss_pred             HHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhhe
Confidence            7899999999999999998899999999999999999987  45688999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCccccccccC---CCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChh
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVELLHTTCG---TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLP  154 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~~~~~~g---t~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~  154 (381)
                      |++++..+||+|||+|+.....  ......|   ..-|.|||.+....++ .+|||||+||+|+||+| |+.|+...+..
T Consensus       335 LV~~~~~vKIsDFGLAr~~~d~--~Y~~~~~~kfPIkWtAPEa~~~~~FS-~kSDVWSFGVlL~E~fT~G~~py~~msn~  411 (468)
T KOG0197|consen  335 LVDEDLVVKISDFGLARLIGDD--EYTASEGGKFPIKWTAPEALNYGKFS-SKSDVWSFGVLLWELFTYGRVPYPGMSNE  411 (468)
T ss_pred             eeccCceEEEcccccccccCCC--ceeecCCCCCCceecCHHHHhhCCcc-cccceeehhhhHHHHhccCCCCCCCCCHH
Confidence            9999999999999999954432  2222222   4569999999887776 99999999999999999 99999999999


Q ss_pred             HHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 016865          155 TLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIR  197 (381)
Q Consensus       155 ~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il  197 (381)
                      +..+.+..+ +.+.|..+|+++.+++..|+..+|++|||++.+.
T Consensus       412 ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  412 EVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             HHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence            999888776 5788999999999999999999999999999654

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.7e-37  Score=294.03  Aligned_cols=203  Identities=31%  Similarity=0.621  Sum_probs=174.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++.+.+++.+|+||||++||+|.+++...+.+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus        55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll  134 (305)
T cd05609          55 LTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI  134 (305)
T ss_pred             HHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE
Confidence            35789999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCC---------------ccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCC
Q 016865           81 DSYGNLKVSDFGLSALPQQG---------------VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGY  145 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~---------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~  145 (381)
                      +.++.+|++|||++......               ........|+..|+|||.+.+..+ +.++||||+||++|+|++|.
T Consensus       135 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~  213 (305)
T cd05609         135 TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGC  213 (305)
T ss_pred             CCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCC
Confidence            99999999999988632110               001123467889999999877665 58999999999999999999


Q ss_pred             CCCCCCChhHHHHHhhcccCCCCC---CCChhHHHHHHHhcCCCCCCCCC---HHHHhcCccccc
Q 016865          146 LPFGETDLPTLYKKINAAEFSCPF---WFSTGATSLIHKILDPNPKTRIR---IEGIRKHPWFRK  204 (381)
Q Consensus       146 ~Pf~~~~~~~~~~~i~~~~~~~p~---~~s~~~~~li~~~L~~dP~~R~t---~~~il~hp~~~~  204 (381)
                      .||.+.+.......+.......|.   .+++++.++|.+||..||.+|||   +.++++||||..
T Consensus       214 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~  278 (305)
T cd05609         214 VPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG  278 (305)
T ss_pred             CCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence            999887777766666555443332   47899999999999999999998   799999999964

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.7e-37  Score=291.39  Aligned_cols=204  Identities=29%  Similarity=0.511  Sum_probs=175.6

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++...+..|+|+||++|++|.+++.. ++++++.+..++.|++.||+|||++|++||||+|+||++
T Consensus        70 l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~  148 (285)
T cd06648          70 MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL  148 (285)
T ss_pred             HHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE
Confidence            3568999999999999999999999999999999998877 679999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.++|+|||++..............|++.|+|||.+.+..+. .++||||+||++|+|++|..||...+.......+
T Consensus       149 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~  227 (285)
T cd06648         149 TSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI  227 (285)
T ss_pred             cCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCC-CcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH
Confidence            999999999999877544322233456789999999999776664 8999999999999999999999877665555555


Q ss_pred             hcccCC---CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          161 NAAEFS---CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       161 ~~~~~~---~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      ......   .+..++..+.++|.+||..+|.+|||+.++++||||++..
T Consensus       228 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  276 (285)
T cd06648         228 RDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG  276 (285)
T ss_pred             HhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence            444221   2223788999999999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1e-37  Score=296.15  Aligned_cols=204  Identities=25%  Similarity=0.465  Sum_probs=172.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++...+..|+||||++|++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus        70 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili  148 (297)
T cd06656          70 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL  148 (297)
T ss_pred             HHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence            3568999999999999999999999999999999998865 568999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.++|+|||++..............|++.|+|||.+.+..+. .++|+||+||++|+|++|..||...+.......+
T Consensus       149 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~  227 (297)
T cd06656         149 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI  227 (297)
T ss_pred             CCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee
Confidence            999999999999987654433333456789999999999876664 8999999999999999999999765543222112


Q ss_pred             hcc---cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          161 NAA---EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       161 ~~~---~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      ...   ....|..+++.+.+|+.+||..+|.+|||++++++||||+...
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         228 ATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             ccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence            111   1224455788999999999999999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.9e-37  Score=291.29  Aligned_cols=201  Identities=30%  Similarity=0.476  Sum_probs=166.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |++++||||+++++++.+.+..|+||||+. ++|.+++..  .+.+++..+..++.|++.||+|||+.|++||||+|+||
T Consensus        53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~ni  131 (284)
T cd07860          53 LKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL  131 (284)
T ss_pred             HHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence            467899999999999999999999999996 589888865  35689999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK  158 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~  158 (381)
                      +++.++.+||+|||++..............+++.|+|||++.+....+.++||||+||++|+|++|+.||...+......
T Consensus       132 ll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~  211 (284)
T cd07860         132 LINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF  211 (284)
T ss_pred             EECCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            99999999999999987654433333455678999999998776655688999999999999999999997665432222


Q ss_pred             Hhhc-c-----------------cCCC-----------CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          159 KINA-A-----------------EFSC-----------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       159 ~i~~-~-----------------~~~~-----------p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      ++.. .                 ...+           .+.++++++++|.+||+.||.+|||++++++||||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         212 RIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            1110 0                 0011           12367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2e-37  Score=294.13  Aligned_cols=205  Identities=27%  Similarity=0.512  Sum_probs=175.1

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++.+...+..|+||||+++++|.+.+.. ..+++..+..++.|++.||.|||++|++||||||+||++
T Consensus        72 l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill  150 (297)
T cd06659          72 MRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL  150 (297)
T ss_pred             HHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE
Confidence            3568999999999999999999999999999999887654 678999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.+||+|||++.............+|++.|+|||++.+..+ +.++||||+||++|+|++|+.||...+.......+
T Consensus       151 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~  229 (297)
T cd06659         151 TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL  229 (297)
T ss_pred             ccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999999998755443233345679999999999977665 48999999999999999999999876655554444


Q ss_pred             hccc---CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 016865          161 NAAE---FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  207 (381)
Q Consensus       161 ~~~~---~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~  207 (381)
                      ....   ...+..++..+.++|.+||+.+|.+|||++++++||||.+...
T Consensus       230 ~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         230 RDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             hccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence            3322   2223347889999999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-37  Score=310.30  Aligned_cols=202  Identities=22%  Similarity=0.393  Sum_probs=163.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++|||||++++++...+..|+|||++. |+|.+++... +.+++..++.++.|++.||.|||++||+||||||+|||
T Consensus       214 L~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NIL  292 (461)
T PHA03211        214 LRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVL  292 (461)
T ss_pred             HHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEE
Confidence            467899999999999999999999999995 6898888664 46999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCC-----
Q 016865           80 LDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-----  152 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-----  152 (381)
                      ++.++.+||+|||++.......  ......+||+.|+|||++.+..++ .++|||||||+||||++|..|+-...     
T Consensus       293 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~-~~sDvwSlGviL~El~~g~~~lf~~~~~~~~  371 (461)
T PHA03211        293 VNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIFEAAVHTASLFSASRGDER  371 (461)
T ss_pred             ECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCC-chHHHHHHHHHHHHHHHcCCCcccCCccccc
Confidence            9999999999999987654321  122346799999999999887765 89999999999999999876552211     


Q ss_pred             ---hhHHHHHhhcccC-----------------------------CCCCC-----CChhHHHHHHHhcCCCCCCCCCHHH
Q 016865          153 ---LPTLYKKINAAEF-----------------------------SCPFW-----FSTGATSLIHKILDPNPKTRIRIEG  195 (381)
Q Consensus       153 ---~~~~~~~i~~~~~-----------------------------~~p~~-----~s~~~~~li~~~L~~dP~~R~t~~~  195 (381)
                         ...+.+.+.....                             ..+.|     ++.++.+||.+||+.||.+|||+.|
T Consensus       372 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~e  451 (461)
T PHA03211        372 RPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAE  451 (461)
T ss_pred             CCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHH
Confidence               1122222222111                             11112     4678999999999999999999999


Q ss_pred             HhcCccccc
Q 016865          196 IRKHPWFRK  204 (381)
Q Consensus       196 il~hp~~~~  204 (381)
                      +|+||||+.
T Consensus       452 lL~hp~f~~  460 (461)
T PHA03211        452 LLRLPLFQS  460 (461)
T ss_pred             HhhCcccCC
Confidence            999999974

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.5e-37  Score=292.14  Aligned_cols=202  Identities=28%  Similarity=0.435  Sum_probs=168.9

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+..|+||||++++.|...+.....+++..+..++.|++.||.|||+.|++||||+|+||++
T Consensus        54 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~  133 (286)
T cd07846          54 LKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV  133 (286)
T ss_pred             HHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE
Confidence            35689999999999999999999999999999888877666679999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      ++++.++|+|||++..............|+..|+|||++.+....+.++||||+||++|+|++|++||...+.......+
T Consensus       134 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~  213 (286)
T cd07846         134 SQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHI  213 (286)
T ss_pred             CCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Confidence            99999999999998765443333445668999999999876555568899999999999999999999765543222211


Q ss_pred             hcc-------------------cCC------------CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          161 NAA-------------------EFS------------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       161 ~~~-------------------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      ...                   ...            .++.++..+.+|+.+||..+|.+|||+.++++||||
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         214 IKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             HHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            100                   000            122467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.5e-37  Score=285.38  Aligned_cols=191  Identities=30%  Similarity=0.495  Sum_probs=165.5

Q ss_pred             CCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccC
Q 016865            4 VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY   83 (381)
Q Consensus         4 l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~   83 (381)
                      ..||||+++++++.+.+..|+||||++||+|.+++.....+++..+..++.|++.||+|||++||+||||||+||+++.+
T Consensus        42 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~  121 (237)
T cd05576          42 HCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR  121 (237)
T ss_pred             cCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC
Confidence            46999999999999999999999999999999999887789999999999999999999999999999999999999999


Q ss_pred             CCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc
Q 016865           84 GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA  163 (381)
Q Consensus        84 ~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~  163 (381)
                      +.++++|||.+......   .....++..|+|||.+.+..+ +.++|+||+||++|+|++|..||.......    ....
T Consensus       122 ~~~~l~df~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~~----~~~~  193 (237)
T cd05576         122 GHIQLTYFSRWSEVEDS---CDGEAVENMYCAPEVGGISEE-TEACDWWSLGAILFELLTGKTLVECHPSGI----NTHT  193 (237)
T ss_pred             CCEEEecccchhccccc---cccCCcCccccCCcccCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchhc----cccc
Confidence            99999999987654432   234456788999999876666 488999999999999999999886432210    0112


Q ss_pred             cCCCCCCCChhHHHHHHHhcCCCCCCCCCH-----HHHhcCccc
Q 016865          164 EFSCPFWFSTGATSLIHKILDPNPKTRIRI-----EGIRKHPWF  202 (381)
Q Consensus       164 ~~~~p~~~s~~~~~li~~~L~~dP~~R~t~-----~~il~hp~~  202 (381)
                      ....|.++++.++++|.+||+.||.+|+|+     +++++||||
T Consensus       194 ~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         194 TLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             ccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            345778899999999999999999999985     999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.4e-37  Score=288.12  Aligned_cols=200  Identities=31%  Similarity=0.608  Sum_probs=175.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |++++||||+++++.+.+....|+|+||+.|++|.+++.....+++..+..++.|++.||.|||++|++|+||+|+||++
T Consensus        54 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~  133 (258)
T cd05578          54 LQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL  133 (258)
T ss_pred             HHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE
Confidence            46789999999999999999999999999999999999887789999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh---hHHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---PTLY  157 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~---~~~~  157 (381)
                      ++++.++|+|||++...... .......|+..|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.   ....
T Consensus       134 ~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  211 (258)
T cd05578         134 DEQGHVHITDFNIATKVTPD-TLTTSTSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR  211 (258)
T ss_pred             cCCCCEEEeecccccccCCC-ccccccCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH
Confidence            99999999999998765442 13345668999999999977665 4899999999999999999999987663   3333


Q ss_pred             HHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCH--HHHhcCccc
Q 016865          158 KKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRI--EGIRKHPWF  202 (381)
Q Consensus       158 ~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~--~~il~hp~~  202 (381)
                      ..........|..++.++.++|.+||..||.+||++  .++++||||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         212 AKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHhccccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            333334556677789999999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4.5e-37  Score=288.58  Aligned_cols=202  Identities=27%  Similarity=0.459  Sum_probs=168.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      ++.++||||+++++++.+....|+||||+ |++|.+++.. ...+++..++.++.|++.||+|||+.|++|+||||+||+
T Consensus        53 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~  131 (286)
T cd07832          53 LQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLL  131 (286)
T ss_pred             HHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEE
Confidence            35678999999999999999999999999 9999999865 356899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK  158 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~  158 (381)
                      ++.++.++|+|||++....... .......|+..|+|||++.+....+.++||||+||++|+|++|.+||...+......
T Consensus       132 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~  211 (286)
T cd07832         132 ISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLA  211 (286)
T ss_pred             EcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHH
Confidence            9999999999999988654422 223456789999999998766555689999999999999999999997665433332


Q ss_pred             Hhhcc-------------------cCC-----------CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          159 KINAA-------------------EFS-----------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       159 ~i~~~-------------------~~~-----------~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      .+...                   ...           ..+..+.++.+||.+||..+|.+|||++++++||||.
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         212 IVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             HHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            22110                   000           0123578899999999999999999999999999983

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.2e-37  Score=286.73  Aligned_cols=202  Identities=28%  Similarity=0.441  Sum_probs=168.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRL--LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l--~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      ++.++||||+++++++.+.+..|+|+||++|++|.+.+... ..+  ++..+..++.|++.||+|||++||+||||||+|
T Consensus        59 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~n  138 (268)
T cd06624          59 HSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDN  138 (268)
T ss_pred             HHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHH
Confidence            35689999999999999999999999999999999999764 445  888999999999999999999999999999999


Q ss_pred             EEEcc-CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCC-CCCCcccHhHHHHHHHHHHhCCCCCCCCChhH
Q 016865           78 LLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG-YDGSAADVWSCGVILFVLMAGYLPFGETDLPT  155 (381)
Q Consensus        78 iLl~~-~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  155 (381)
                      |+++. ++.++|+|||++..............|++.|+|||++.+.. ..+.++|+||+|+++|+|++|..||.......
T Consensus       139 il~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~  218 (268)
T cd06624         139 VLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ  218 (268)
T ss_pred             EEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh
Confidence            99986 67999999999876543323334456899999999986533 23589999999999999999999997644322


Q ss_pred             --HHHH-hhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          156 --LYKK-INAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       156 --~~~~-i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                        .... ........|..+++++.+++.+||+.+|.+|||+.+++.||||
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         219 AAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             hhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence              1111 1222334566789999999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.3e-37  Score=290.10  Aligned_cols=204  Identities=25%  Similarity=0.443  Sum_probs=171.6

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ---GRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPE   76 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~---~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~   76 (381)
                      |++++||||+++++.+...+.+|+||||++|++|..++...   ..+++..+..++.|++.||.|||+ .||+||||||+
T Consensus        53 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~  132 (286)
T cd06622          53 LHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPT  132 (286)
T ss_pred             HHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHH
Confidence            35689999999999999999999999999999998888663   378999999999999999999997 59999999999


Q ss_pred             cEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCC-----CCCcccHhHHHHHHHHHHhCCCCCCCC
Q 016865           77 NLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY-----DGSAADVWSCGVILFVLMAGYLPFGET  151 (381)
Q Consensus        77 NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-----~~~~~DIwSlGvil~~ll~G~~Pf~~~  151 (381)
                      ||+++.++.+||+|||++.....  ....+..|++.|+|||.+.+...     .+.++||||+||++|+|++|..||...
T Consensus       133 nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  210 (286)
T cd06622         133 NVLVNGNGQVKLCDFGVSGNLVA--SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE  210 (286)
T ss_pred             HEEECCCCCEEEeecCCcccccC--CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence            99999999999999999876533  22345678999999999854332     247899999999999999999999765


Q ss_pred             ChhHHHHH---hhc-ccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          152 DLPTLYKK---INA-AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       152 ~~~~~~~~---i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      +.......   +.. .....|..+++++.+||.+||..+|.+||+++++++||||....
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~  269 (286)
T cd06622         211 TYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK  269 (286)
T ss_pred             chhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence            54443332   222 22345666899999999999999999999999999999997653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-39  Score=336.08  Aligned_cols=204  Identities=32%  Similarity=0.533  Sum_probs=182.0

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      ..++|||+|++|++=.+....||.||||+||+|.+.+...+..+|...+.|..|++.|+.|||+.||+||||||+||+++
T Consensus      1289 E~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld 1368 (1509)
T KOG4645|consen 1289 EGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLD 1368 (1509)
T ss_pred             HhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeee
Confidence            46899999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             cCCCEEEeeccCccCCCCC----ccccccccCCCCCCCCceecCCC--CCCCcccHhHHHHHHHHHHhCCCCCCCC--Ch
Q 016865           82 SYGNLKVSDFGLSALPQQG----VELLHTTCGTPNYVAPEVLSNRG--YDGSAADVWSCGVILFVLMAGYLPFGET--DL  153 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~--~~~~~~DIwSlGvil~~ll~G~~Pf~~~--~~  153 (381)
                      .+|.+|++|||.|......    .+.+....||+.|||||++.+..  -.+-++||||+|||..||.||+.||...  ++
T Consensus      1369 ~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~ 1448 (1509)
T KOG4645|consen 1369 FNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW 1448 (1509)
T ss_pred             cCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh
Confidence            9999999999998755432    23456778999999999998654  2356899999999999999999999754  45


Q ss_pred             hHHHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          154 PTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       154 ~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ..+|..-.....++|..+|++.++||..||+.||++|.++.|+++|.|-+..
T Consensus      1449 aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1449 AIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred             HHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence            6677666666788999999999999999999999999999999999987643

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4e-37  Score=286.73  Aligned_cols=201  Identities=30%  Similarity=0.490  Sum_probs=168.8

Q ss_pred             CCCCCccccccceEEEEe--CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLAS--RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||+++++++.+  ...+++++||+++++|.+.+...+.+++...+.++.|++.||+|||++||+||||||+||
T Consensus        58 l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~ni  137 (266)
T cd06651          58 LKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANI  137 (266)
T ss_pred             HHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHE
Confidence            357899999999999875  368999999999999999998878899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCC---ccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQG---VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT  155 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  155 (381)
                      +++.++.+||+|||++......   ........|+..|+|||.+.+..++ .++||||+||++|+|++|+.||...+...
T Consensus       138 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~el~~g~~pf~~~~~~~  216 (266)
T cd06651         138 LRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYG-RKADVWSLGCTVVEMLTEKPPWAEYEAMA  216 (266)
T ss_pred             EECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCC-chhhhHHHHHHHHHHHHCCCCccccchHH
Confidence            9999999999999998754321   1112335688999999999876654 89999999999999999999998765544


Q ss_pred             HHHHhhc--ccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          156 LYKKINA--AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       156 ~~~~i~~--~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      ....+..  .....|..+++.++++| +||..+|.+|||++++++||||+
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         217 AIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            3333322  23445667889999999 56668999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.4e-37  Score=292.93  Aligned_cols=207  Identities=28%  Similarity=0.423  Sum_probs=170.1

Q ss_pred             CCCCCccccccceEEEEeC--CEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            1 MKIVRHPNIVRLHEVLASR--TKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~--~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      |+.++||||+++++++.+.  +.+|+||||+.+ +|.+.+.. ...+++..+..++.|++.||.|||+.|++||||||+|
T Consensus        60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~n  138 (309)
T cd07845          60 LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSN  138 (309)
T ss_pred             HHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence            3578999999999999765  579999999965 78888765 3568999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           78 LLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        78 iLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      |+++.++.+||+|||++..............+++.|+|||++.+....+.++||||+||++|+|++|.+||...+.....
T Consensus       139 il~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~  218 (309)
T cd07845         139 LLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQL  218 (309)
T ss_pred             EEECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999999998866543223334456889999999876554568999999999999999999999877765554


Q ss_pred             HHhhcc-------------------cCCCC-----------CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 016865          158 KKINAA-------------------EFSCP-----------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  207 (381)
Q Consensus       158 ~~i~~~-------------------~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~  207 (381)
                      ..+...                   .+..+           .++++.+.+||.+||..||.+|||+++++.||||+....
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~  298 (309)
T cd07845         219 DLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL  298 (309)
T ss_pred             HHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence            433221                   11111           235889999999999999999999999999999987654


Q ss_pred             C
Q 016865          208 P  208 (381)
Q Consensus       208 ~  208 (381)
                      +
T Consensus       299 ~  299 (309)
T cd07845         299 P  299 (309)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.7e-37  Score=285.80  Aligned_cols=202  Identities=28%  Similarity=0.467  Sum_probs=171.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ---GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      |+.++||||+++++.+...+..|+||||++|++|.+.+...   ..+++..+..++.|++.||.|||++|++||||+|+|
T Consensus        53 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~n  132 (267)
T cd06610          53 MSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGN  132 (267)
T ss_pred             HHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHh
Confidence            45789999999999999999999999999999999999763   458999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccCccCCCCCcc----ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh
Q 016865           78 LLLDSYGNLKVSDFGLSALPQQGVE----LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL  153 (381)
Q Consensus        78 iLl~~~~~lkl~DFGls~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~  153 (381)
                      |++++++.++|+|||++........    .....+|+..|+|||++......+.++|+||+||++|+|++|+.||...+.
T Consensus       133 i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~  212 (267)
T cd06610         133 ILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP  212 (267)
T ss_pred             EEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh
Confidence            9999999999999999876544221    224457899999999987663445899999999999999999999987665


Q ss_pred             hHHHHHhhcccC-CCC-----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          154 PTLYKKINAAEF-SCP-----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       154 ~~~~~~i~~~~~-~~p-----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      ...+..+..... ..+     ..+++.+.+++.+||..||.+|||++++++||||
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         213 MKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             hhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            544444333221 111     1467899999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=4.9e-37  Score=287.77  Aligned_cols=197  Identities=31%  Similarity=0.553  Sum_probs=163.6

Q ss_pred             CC-CccccccceEEEEeC--CEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            3 IV-RHPNIVRLHEVLASR--TKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         3 ~l-~HpnIv~l~~~~~~~--~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      ++ +||||+++++++.+.  +.+|+||||++ |+|.+.+... ..+++..+..++.|++.||+|||+.|++||||+|+||
T Consensus        53 ~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni  131 (282)
T cd07831          53 RLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENI  131 (282)
T ss_pred             hcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHE
Confidence            44 599999999999988  89999999997 4888888763 5689999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK  158 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~  158 (381)
                      +++. +.+||+|||++...... .......+++.|+|||++....+.+.++||||+||++|+|++|.+||...+......
T Consensus       132 ~l~~-~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~  209 (282)
T cd07831         132 LIKD-DILKLADFGSCRGIYSK-PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIA  209 (282)
T ss_pred             EEcC-CCeEEEecccccccccC-CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHH
Confidence            9999 99999999998765432 122345689999999987665666689999999999999999999998776544333


Q ss_pred             Hhhc------------------ccCCCC-----------CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          159 KINA------------------AEFSCP-----------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       159 ~i~~------------------~~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      .+..                  ..+..|           ..++.++.++|.+||.++|.+|||++++++||||
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         210 KIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             HHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            2211                  111111           2367899999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-37  Score=283.25  Aligned_cols=201  Identities=40%  Similarity=0.743  Sum_probs=181.6

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++.++++...|+||||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||++
T Consensus        47 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~  126 (250)
T cd05123          47 LSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL  126 (250)
T ss_pred             HHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE
Confidence            35789999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.++|+|||++..............|+..|+|||...+... +.++|+||+|+++|++++|..||...+.......+
T Consensus       127 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~  205 (250)
T cd05123         127 DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI  205 (250)
T ss_pred             cCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            99999999999998765443233455678999999999876654 48899999999999999999999888777777777


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCCCH---HHHhcCccc
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRI---EGIRKHPWF  202 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~---~~il~hp~~  202 (381)
                      .......|..++..+.++|++||..||.+|||+   +++++||||
T Consensus       206 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         206 LKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             hcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence            767778888889999999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5e-37  Score=289.80  Aligned_cols=199  Identities=26%  Similarity=0.400  Sum_probs=165.1

Q ss_pred             CccccccceEEEEeC-----CEEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 016865            5 RHPNIVRLHEVLASR-----TKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKP   75 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp   75 (381)
                      +||||+++++++...     +..|+||||++||+|.+++..    ...+++..++.++.|++.||+|||+.|++||||||
T Consensus        77 ~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp  156 (291)
T cd06639          77 NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKG  156 (291)
T ss_pred             CCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH
Confidence            799999999998753     469999999999999998753    35689999999999999999999999999999999


Q ss_pred             CcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCC----CCCCcccHhHHHHHHHHHHhCCCCCCCC
Q 016865           76 ENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG----YDGSAADVWSCGVILFVLMAGYLPFGET  151 (381)
Q Consensus        76 ~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~~DIwSlGvil~~ll~G~~Pf~~~  151 (381)
                      +||+++.++.+||+|||++..............|+..|+|||++....    ..+.++||||+||++|+|++|++||...
T Consensus       157 ~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~  236 (291)
T cd06639         157 NNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM  236 (291)
T ss_pred             HHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence            999999999999999999876543222234557899999999985432    1258999999999999999999999876


Q ss_pred             ChhHHHHHhhccc---CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          152 DLPTLYKKINAAE---FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       152 ~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      +.......+....   ...+..++..+.+||.+||+.+|.+|||+.++++||||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         237 HPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             cHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            6544443333221   223445678899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-37  Score=287.36  Aligned_cols=200  Identities=27%  Similarity=0.414  Sum_probs=165.7

Q ss_pred             CC-CccccccceEEEEeCC------EEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 016865            3 IV-RHPNIVRLHEVLASRT------KVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHR   71 (381)
Q Consensus         3 ~l-~HpnIv~l~~~~~~~~------~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~L~~LH~~gi~Hr   71 (381)
                      .+ +||||+++++++.+..      .+|+||||+++++|.+.+..    ...+++..++.++.|++.||.|||+.|++||
T Consensus        58 ~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~  137 (275)
T cd06608          58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHR  137 (275)
T ss_pred             HhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccC
Confidence            44 7999999999997644      59999999999999998865    3478999999999999999999999999999


Q ss_pred             CCCCCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCC----CCCCcccHhHHHHHHHHHHhCCCC
Q 016865           72 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG----YDGSAADVWSCGVILFVLMAGYLP  147 (381)
Q Consensus        72 Dlkp~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~~DIwSlGvil~~ll~G~~P  147 (381)
                      ||+|+||++++++.+||+|||++..............|++.|+|||++....    ..+.++||||+||++|+|++|..|
T Consensus       138 ~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p  217 (275)
T cd06608         138 DIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP  217 (275)
T ss_pred             CCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCC
Confidence            9999999999999999999999876544333345567999999999975422    224789999999999999999999


Q ss_pred             CCCCChhHHHHHhhccc---CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          148 FGETDLPTLYKKINAAE---FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       148 f~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      |...+.......+....   ...+..++..+.+||.+||..||.+|||+.++++|||+
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         218 LCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             ccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            98665444444443332   22233367899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=5.6e-37  Score=288.06  Aligned_cols=198  Identities=26%  Similarity=0.417  Sum_probs=165.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |++++||||+++++.+...+..++||||+++|+|..+    ..+++..+..++.|++.||.|||+.||+|+||||+||++
T Consensus        53 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill  128 (279)
T cd06619          53 LYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV  128 (279)
T ss_pred             HHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE
Confidence            3568999999999999999999999999999998654    457899999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh-------
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL-------  153 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-------  153 (381)
                      +.++.++|+|||++.....  ......+||+.|+|||++.+..+. .++|+||+||++|+|++|..||.....       
T Consensus       129 ~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~  205 (279)
T cd06619         129 NTRGQVKLCDFGVSTQLVN--SIAKTYVGTNAYMAPERISGEQYG-IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP  205 (279)
T ss_pred             CCCCCEEEeeCCcceeccc--ccccCCCCChhhcCceeecCCCCC-CcchHHHHHHHHHHHHhCCCCchhhcccccccch
Confidence            9999999999999876543  233456899999999999877664 899999999999999999999964321       


Q ss_pred             hHHHHHhhccc-CCC-CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          154 PTLYKKINAAE-FSC-PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       154 ~~~~~~i~~~~-~~~-p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ......+.... ... ...++++++++|.+||+.||.+||+++++++||||+..
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         206 LQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             HHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence            11122222111 111 23478899999999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=6.6e-37  Score=283.31  Aligned_cols=201  Identities=32%  Similarity=0.610  Sum_probs=175.2

Q ss_pred             CCCCCccccccceEEEEe--CCEEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----HCCCe
Q 016865            1 MKIVRHPNIVRLHEVLAS--RTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCH-----SKGVY   69 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~L~~LH-----~~gi~   69 (381)
                      |+.++||||+++++++..  ....|++|||+++++|.+++..    ...+++..++.++.||+.||.|||     +.+++
T Consensus        53 l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~  132 (265)
T cd08217          53 LRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVL  132 (265)
T ss_pred             HHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcce
Confidence            467899999999998754  4678999999999999999865    357899999999999999999999     89999


Q ss_pred             ecCCCCCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCC
Q 016865           70 HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFG  149 (381)
Q Consensus        70 HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~  149 (381)
                      ||||+|+||++++++.+||+|||++...........+..|++.|+|||++.+..+ +.++|+||||+++++|++|..||.
T Consensus       133 h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~  211 (265)
T cd08217         133 HRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFT  211 (265)
T ss_pred             ecCCCHHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCccc
Confidence            9999999999999999999999999876554333445679999999999977665 488999999999999999999999


Q ss_pred             CCChhHHHHHhhcccC-CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          150 ETDLPTLYKKINAAEF-SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       150 ~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      ..+.....+.+..... ..|..++..+.+++.+||..+|.+|||+.++++|||+
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         212 ARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             CcCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            8876666666665544 4566688999999999999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.5e-37  Score=289.40  Aligned_cols=197  Identities=26%  Similarity=0.398  Sum_probs=162.9

Q ss_pred             CccccccceEEEE------eCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 016865            5 RHPNIVRLHEVLA------SRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE   76 (381)
Q Consensus         5 ~HpnIv~l~~~~~------~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~   76 (381)
                      +||||+++++++.      ....+|++|||+++|+|.+++...  ..+++..+..++.||+.||.|||+.||+||||+|+
T Consensus        71 ~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~  150 (282)
T cd06636          71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQ  150 (282)
T ss_pred             CCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence            7999999999985      356899999999999999988753  35889999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecC-----CCCCCCcccHhHHHHHHHHHHhCCCCCCCC
Q 016865           77 NLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-----RGYDGSAADVWSCGVILFVLMAGYLPFGET  151 (381)
Q Consensus        77 NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~  151 (381)
                      ||++++++.++|+|||++..............|++.|+|||++..     ..+ +.++|+|||||++|+|++|..||...
T Consensus       151 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~-~~~~DvwslG~~l~el~~g~~p~~~~  229 (282)
T cd06636         151 NVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATY-DYRSDIWSLGITAIEMAEGAPPLCDM  229 (282)
T ss_pred             HEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCC-CcccchhHHHHHHHHHHhCCCCcccc
Confidence            999999999999999998765433233445679999999999863     234 47899999999999999999999765


Q ss_pred             ChhHHHHHhhccc-CC-CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          152 DLPTLYKKINAAE-FS-CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       152 ~~~~~~~~i~~~~-~~-~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      ........+.... .. .+..++.++.+||.+||..||.+|||+.++++||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         230 HPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             CHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            5433332222221 11 122478999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.8e-37  Score=283.09  Aligned_cols=201  Identities=29%  Similarity=0.482  Sum_probs=173.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+...+|+|+||++|++|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||+|+||++
T Consensus        56 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~  135 (258)
T cd06632          56 LSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV  135 (258)
T ss_pred             HHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence            35689999999999999999999999999999999999887789999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.+||+|||++....... ......|++.|+|||.+......+.++|+||+||++|+|++|..||...........+
T Consensus       136 ~~~~~~kl~d~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~  214 (258)
T cd06632         136 DTNGVVKLADFGMAKQVVEFS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKI  214 (258)
T ss_pred             CCCCCEEEccCccceeccccc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHH
Confidence            999999999999987654322 2345678999999999876552358999999999999999999999876644433333


Q ss_pred             hc--ccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          161 NA--AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       161 ~~--~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      ..  .....|..+++.+.+++.+||..+|.+|||+.+++.|||+
T Consensus       215 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         215 GRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence            32  2234556689999999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.7e-37  Score=288.46  Aligned_cols=198  Identities=24%  Similarity=0.378  Sum_probs=171.1

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHH
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ----------------GRLLENDCRRYFQQLIDAVAHCH   64 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~~L~~LH   64 (381)
                      |+.++||||+++++++.+....|++|||+++|+|.+++...                ..+++..+..++.|++.||+|||
T Consensus        62 l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH  141 (283)
T cd05048          62 MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS  141 (283)
T ss_pred             HHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            35689999999999999999999999999999999999764                45788899999999999999999


Q ss_pred             HCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHH
Q 016865           65 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM  142 (381)
Q Consensus        65 ~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll  142 (381)
                      ++|++||||||+||++++++.+||+|||++.......  .......+++.|+|||.+.+..++ .++||||+||++|+|+
T Consensus       142 ~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDv~slG~il~el~  220 (283)
T cd05048         142 SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFT-TESDIWSFGVVLWEIF  220 (283)
T ss_pred             hCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCc-hhhhHHHHHHHHHHHH
Confidence            9999999999999999999999999999987543321  123345678899999998776664 8999999999999999


Q ss_pred             h-CCCCCCCCChhHHHHHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          143 A-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       143 ~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      + |..||.+.+.......+.... ...|..+++++.+|+.+||+.||.+|||+.+++++
T Consensus       221 ~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         221 SYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             cCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            8 999998887777777665443 34566789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.9e-37  Score=290.12  Aligned_cols=201  Identities=31%  Similarity=0.477  Sum_probs=167.5

Q ss_pred             CCCCCccccccceEEEEeC--CEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            1 MKIVRHPNIVRLHEVLASR--TKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~--~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      |++++||||+++++++.+.  +..|+||||+++ +|.+.+.... .+++..++.++.|++.||+|||++|++||||||+|
T Consensus        58 l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~n  136 (293)
T cd07843          58 LLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSN  136 (293)
T ss_pred             HHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHH
Confidence            3568899999999999877  899999999975 9988887644 58999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           78 LLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        78 iLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      |+++.++.+||+|||++..............+++.|+|||++.+....+.++||||+||++|+|++|.+||...+.....
T Consensus       137 ili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~  216 (293)
T cd07843         137 LLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL  216 (293)
T ss_pred             EEECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            99999999999999998866543333445668899999999876554568999999999999999999999876654433


Q ss_pred             HHhhcc-------------------------------cCCCCCC-CChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          158 KKINAA-------------------------------EFSCPFW-FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       158 ~~i~~~-------------------------------~~~~p~~-~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      .++...                               ...+|.. +++.+.++|++||+.+|++|||+.|++.||||
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         217 NKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             HHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            332110                               0012222 58889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-37  Score=288.51  Aligned_cols=201  Identities=29%  Similarity=0.511  Sum_probs=162.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+++..|+||||+++ +|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+
T Consensus        57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil  135 (291)
T cd07844          57 LKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLL  135 (291)
T ss_pred             HhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEE
Confidence            4678999999999999999999999999975 999988764 46899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCC-hhHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-LPTLYK  158 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-~~~~~~  158 (381)
                      ++.++.+||+|||++..............+++.|+|||++.+....+.++||||+||++|+|++|+.||...+ ..+...
T Consensus       136 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~  215 (291)
T cd07844         136 ISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLH  215 (291)
T ss_pred             EcCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHH
Confidence            9999999999999987543322222334578999999998764444589999999999999999999997654 222211


Q ss_pred             Hhhc-------------------ccCCC-----------CCCCC--hhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          159 KINA-------------------AEFSC-----------PFWFS--TGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       159 ~i~~-------------------~~~~~-----------p~~~s--~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      .+..                   .....           ...++  .++.++|.+||..+|.+|||+.+++.||||
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         216 KIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             HHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            1100                   00000           01234  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-36  Score=284.36  Aligned_cols=202  Identities=29%  Similarity=0.452  Sum_probs=170.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+.+++||||++||+|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||++
T Consensus        62 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~  141 (272)
T cd06629          62 LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV  141 (272)
T ss_pred             HHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE
Confidence            46789999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCC--ccccccccCCCCCCCCceecCCC-CCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           81 DSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLSNRG-YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      +.++.++++|||++......  ........|+..|+|||++.... ..+.++|+||+|+++|++++|..||...+.....
T Consensus       142 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  221 (272)
T cd06629         142 DADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM  221 (272)
T ss_pred             cCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH
Confidence            99999999999998754331  11223456899999999987654 2358899999999999999999999765544333


Q ss_pred             HHhhcc--cCCCCC----CCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          158 KKINAA--EFSCPF----WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       158 ~~i~~~--~~~~p~----~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      ..+...  ....+.    .++.++.++|.+||.++|.+|||++++++||||
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         222 FKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             HHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            322211  222222    358899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=6e-37  Score=287.39  Aligned_cols=203  Identities=27%  Similarity=0.417  Sum_probs=172.9

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+..|+||||++||+|.+++.. +.+++..+..++.|++.||.|||+.|++|+||+|+||++
T Consensus        56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~  134 (277)
T cd06640          56 LSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL  134 (277)
T ss_pred             HHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE
Confidence            3568999999999999999999999999999999998865 678999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.++++|||++..............++..|+|||++.+..+ +.++|+||+||++|+|++|..||...+.......+
T Consensus       135 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~  213 (277)
T cd06640         135 SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI  213 (277)
T ss_pred             cCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh
Confidence            99999999999998765443222334568899999999877665 48999999999999999999999876655444433


Q ss_pred             hcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          161 NAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       161 ~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ... ....+..++..+.++|.+||..+|.+|||+.++++||||...
T Consensus       214 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06640         214 PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN  259 (277)
T ss_pred             hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence            322 223344578899999999999999999999999999999653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-37  Score=286.98  Aligned_cols=202  Identities=31%  Similarity=0.494  Sum_probs=169.1

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+..|+||||++++.+...+.....+++..+..++.|++.||.|||+.|++||||+|+||++
T Consensus        54 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~  133 (288)
T cd07833          54 LRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV  133 (288)
T ss_pred             HHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE
Confidence            46789999999999999999999999999987777666666779999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCcc-ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGVE-LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      ++++.+||+|||++........ ......+++.|+|||++.+....+.++||||+|+++|+|++|.+||...+.......
T Consensus       134 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~  213 (288)
T cd07833         134 SESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL  213 (288)
T ss_pred             CCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999887654322 334567899999999998773445899999999999999999999986654332221


Q ss_pred             hhc----------------c-----c-----------CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          160 INA----------------A-----E-----------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       160 i~~----------------~-----~-----------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      +..                .     .           ...|..+++++.+||++||..+|.+|||++++++||||
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         214 IQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             HHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            110                0     0           01233458899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.9e-37  Score=289.35  Aligned_cols=202  Identities=26%  Similarity=0.425  Sum_probs=171.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++.+.+++..|+||||++||+|.+++.. +.+++..++.++.|++.|+.|||++|++|+||+|+||++
T Consensus        56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i  134 (277)
T cd06642          56 LSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL  134 (277)
T ss_pred             HHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEE
Confidence            4678999999999999999999999999999999998764 678999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      ++++.++++|||++..............|+..|+|||++.+..++ .++|+||+||++|+|++|..||...........+
T Consensus       135 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~  213 (277)
T cd06642         135 SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI  213 (277)
T ss_pred             eCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCc-hhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh
Confidence            999999999999987654432223345689999999999876664 8999999999999999999999765544443333


Q ss_pred             hccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          161 NAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       161 ~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      .... ...+..++.++.++|.+||..+|.+|||+.++++||||..
T Consensus       214 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  258 (277)
T cd06642         214 PKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR  258 (277)
T ss_pred             hcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence            3222 2233447889999999999999999999999999999975

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5.8e-37  Score=283.51  Aligned_cols=198  Identities=33%  Similarity=0.568  Sum_probs=172.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      ++.++||||+++++.+.+++.+|+||||+++|+|.+++...  ..++++.+..++.|++.||.|||++||+|+||||+||
T Consensus        52 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~ni  131 (255)
T cd08219          52 LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNI  131 (255)
T ss_pred             HHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceE
Confidence            35689999999999999999999999999999999988653  3589999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK  158 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~  158 (381)
                      ++++++.++++|||++..............|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+......
T Consensus       132 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~  210 (255)
T cd08219         132 FLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLIL  210 (255)
T ss_pred             EECCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHH
Confidence            9999999999999998765543333445678999999999977665 489999999999999999999999887776666


Q ss_pred             HhhcccC-CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          159 KINAAEF-SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       159 ~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      .+..+.. ..|..++..+.++|.+||+.||.+|||+.+++.-
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         211 KVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            6655544 3566689999999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=9.1e-37  Score=283.99  Aligned_cols=201  Identities=30%  Similarity=0.495  Sum_probs=169.1

Q ss_pred             CCCCCccccccceEEEEeC--CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASR--TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~--~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||+++++++.+.  ..+|+||||++||+|.+++...+.+++..+..++.|++.||+|||++|++|+||||+||
T Consensus        58 l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~ni  137 (265)
T cd06652          58 LKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANI  137 (265)
T ss_pred             HHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence            4578999999999998763  57899999999999999998877899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCC---ccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQG---VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT  155 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  155 (381)
                      +++.++.++|+|||++......   ........|+..|+|||++.+..+ +.++||||+||++|+|++|+.||...+...
T Consensus       138 l~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~  216 (265)
T cd06652         138 LRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMA  216 (265)
T ss_pred             EecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHH
Confidence            9999999999999998754321   112334568999999999987665 489999999999999999999998765444


Q ss_pred             HHHHhhcc--cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          156 LYKKINAA--EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       156 ~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      ....+...  ....|..++..+.++|++|+. +|.+|||++++++|||+.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         217 AIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            33333222  233455678899999999995 899999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.4e-36  Score=280.46  Aligned_cols=200  Identities=31%  Similarity=0.539  Sum_probs=173.1

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |++++||||+++++.+...+..++||||++|++|.+++...  ..+++..+..++.|++.||+|||++|++||||+|+||
T Consensus        53 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni  132 (256)
T cd08220          53 LKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNI  132 (256)
T ss_pred             HhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            46789999999999999999999999999999999999763  3489999999999999999999999999999999999


Q ss_pred             EEccCC-CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           79 LLDSYG-NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        79 Ll~~~~-~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      ++++++ .+||+|||++...... .......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.....
T Consensus       133 l~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~  210 (256)
T cd08220         133 LLDKHKMVVKIGDFGISKILSSK-SKAYTVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALV  210 (256)
T ss_pred             EEcCCCCEEEEccCCCceecCCC-ccccccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHH
Confidence            998654 5899999998765432 22234568999999999977655 48999999999999999999999887776666


Q ss_pred             HHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          158 KKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       158 ~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      ..+.... ...+..+++++.+++.+||..+|.+|||+.++++||||
T Consensus       211 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         211 LKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence            5554443 34566689999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.4e-36  Score=281.77  Aligned_cols=202  Identities=32%  Similarity=0.590  Sum_probs=170.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+.+++|+||+++++|.+++...+.+++..+..++.|++.||.|||+.||+|+||+|+||++
T Consensus        53 ~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~  132 (264)
T cd06626          53 LELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL  132 (264)
T ss_pred             HHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence            46789999999999999999999999999999999999887778999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccc----cccccCCCCCCCCceecCCC--CCCCcccHhHHHHHHHHHHhCCCCCCCCCh-
Q 016865           81 DSYGNLKVSDFGLSALPQQGVEL----LHTTCGTPNYVAPEVLSNRG--YDGSAADVWSCGVILFVLMAGYLPFGETDL-  153 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~----~~~~~gt~~y~aPE~l~~~~--~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-  153 (381)
                      ++++.+||+|||++.........    .....+++.|+|||++.+..  ..+.++||||+|+++|++++|+.||...+. 
T Consensus       133 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~  212 (264)
T cd06626         133 DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE  212 (264)
T ss_pred             CCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch
Confidence            99999999999998765442211    22457889999999987654  135899999999999999999999976532 


Q ss_pred             hHHHHHhh-cccCCCCCCC--ChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          154 PTLYKKIN-AAEFSCPFWF--STGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       154 ~~~~~~i~-~~~~~~p~~~--s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      ......+. ......|.+.  ++.+.++|.+||+.+|.+|||+++++.|||+
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         213 FQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            22222222 2233455554  8999999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-37  Score=286.16  Aligned_cols=201  Identities=28%  Similarity=0.495  Sum_probs=170.9

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCC
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG   84 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~   84 (381)
                      .|||++++++++.++...|+||||++|++|.+++.. +.+++..+..++.|++.||.|||+.|++||||+|+||+++.++
T Consensus        60 ~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~  138 (277)
T cd06917          60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG  138 (277)
T ss_pred             CCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC
Confidence            599999999999999999999999999999998865 5789999999999999999999999999999999999999999


Q ss_pred             CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc
Q 016865           85 NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE  164 (381)
Q Consensus        85 ~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~  164 (381)
                      .++|+|||++..............|+..|+|||.+.+....+.++|+||+||++|+|++|..||...+.......+....
T Consensus       139 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~  218 (277)
T cd06917         139 NVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK  218 (277)
T ss_pred             CEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCC
Confidence            99999999987665433334455799999999998655444689999999999999999999998766544443332222


Q ss_pred             -CCCCCC-CChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          165 -FSCPFW-FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       165 -~~~p~~-~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                       ...+.. ++.++.+++.+||..||.+|||+.+++.||||+...
T Consensus       219 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         219 PPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             CCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence             122222 688999999999999999999999999999997654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=9.5e-37  Score=284.53  Aligned_cols=197  Identities=21%  Similarity=0.323  Sum_probs=167.6

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++..++..|+||||+++|+|.+++... +.+++..++.++.|++.||+|||++|++||||||+||+
T Consensus        60 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nil  139 (266)
T cd05064          60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVL  139 (266)
T ss_pred             HhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEE
Confidence            45789999999999999999999999999999999998764 57899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  157 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~  157 (381)
                      ++.++.+|++|||.+....... .......++..|+|||++.+..+. .++||||+||++|++++ |..||...+.....
T Consensus       140 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~  218 (266)
T cd05064         140 VNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS-SASDVWSFGIVMWEVMSYGERPYWDMSGQDVI  218 (266)
T ss_pred             EcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCcc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH
Confidence            9999999999999876533211 111123356789999999776664 89999999999999875 99999887776666


Q ss_pred             HHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          158 KKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       158 ~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ..+..+ ..+.|..++..+.+++.+||..+|.+|||+++|++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         219 KAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            666544 33556668899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4.6e-37  Score=287.19  Aligned_cols=200  Identities=34%  Similarity=0.634  Sum_probs=178.7

Q ss_pred             CCCC-ccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            2 KIVR-HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         2 k~l~-HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      ++++ ||||+++++++.+.+..|+||||+++++|.+.+...+.+++..+..++.|++.||.|||+.|++|+||+|+||++
T Consensus        56 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i  135 (280)
T cd05581          56 TRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL  135 (280)
T ss_pred             HhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE
Confidence            4566 999999999999999999999999999999999988889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCc--------------------cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGV--------------------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFV  140 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~--------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~  140 (381)
                      +.++.++++|||++.......                    .......|+..|+|||+.....+ +.++|+||+|+++++
T Consensus       136 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~  214 (280)
T cd05581         136 DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQ  214 (280)
T ss_pred             CCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHH
Confidence            999999999999987654321                    12234467899999999876554 589999999999999


Q ss_pred             HHhCCCCCCCCChhHHHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCH----HHHhcCccc
Q 016865          141 LMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRI----EGIRKHPWF  202 (381)
Q Consensus       141 ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~----~~il~hp~~  202 (381)
                      +++|..||...+....++.+.......|..+++.+.++|.+||+.+|.+|||+    +++++||||
T Consensus       215 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         215 MLTGKPPFRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHhCCCCCCCccHHHHHHHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            99999999988776667777777778888899999999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-36  Score=280.47  Aligned_cols=198  Identities=26%  Similarity=0.401  Sum_probs=174.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ---------GRLLENDCRRYFQQLIDAVAHCHSKGVYHR   71 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~---------~~l~e~~~~~~~~qll~~L~~LH~~gi~Hr   71 (381)
                      ++.++||||+++++++.+...+++||||+++|+|.+++...         ..+++..+..++.|++.||+|||++|++||
T Consensus        50 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~  129 (262)
T cd00192          50 MKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHR  129 (262)
T ss_pred             HhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccC
Confidence            35678999999999999999999999999999999999875         679999999999999999999999999999


Q ss_pred             CCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCC
Q 016865           72 DLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF  148 (381)
Q Consensus        72 Dlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf  148 (381)
                      ||||+||+++.++.+||+|||.+.......  .......+++.|+|||.+....+ +.++|||||||++|+|++ |..||
T Consensus       130 di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~  208 (262)
T cd00192         130 DLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPY  208 (262)
T ss_pred             ccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCC
Confidence            999999999999999999999998655422  22345567899999999877655 489999999999999999 69999


Q ss_pred             CCCChhHHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          149 GETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       149 ~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ...+.......+..+ ....|..+|+++.+++.+||..+|.+|||+.+++++
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         209 PGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             CCCCHHHHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            988777777666543 345677789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.7e-36  Score=286.14  Aligned_cols=201  Identities=29%  Similarity=0.480  Sum_probs=161.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+....|+||||+. ++|.+.+.. .+.+++..+..++.|++.||.|||+.||+||||||+||+
T Consensus        57 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil  135 (291)
T cd07870          57 LKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLL  135 (291)
T ss_pred             HHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEE
Confidence            357899999999999999999999999996 577777654 356788999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh-HHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYK  158 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~  158 (381)
                      ++.++.+||+|||++..............+++.|+|||++.+....+.++||||+||++|+|++|..||...+.. ....
T Consensus       136 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~  215 (291)
T cd07870         136 ISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLE  215 (291)
T ss_pred             EcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHH
Confidence            999999999999998764433233345568999999999876544457899999999999999999999765432 1111


Q ss_pred             Hhhc-c---------------c-----C--CCCC---------CCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          159 KINA-A---------------E-----F--SCPF---------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       159 ~i~~-~---------------~-----~--~~p~---------~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      .+.. .               .     .  ..+.         ..++++.+++.+||..||.+|||+.+++.||||
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         216 KIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             HHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            1100 0               0     0  0000         125688999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.1e-36  Score=286.01  Aligned_cols=201  Identities=33%  Similarity=0.537  Sum_probs=167.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ---GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      |++++||||+++++++.+.+..|+||||+++ +|.+++...   ..+++..+..++.|++.||.|||+.|++||||||+|
T Consensus        52 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~n  130 (284)
T cd07836          52 MKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQN  130 (284)
T ss_pred             HHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHH
Confidence            4578999999999999999999999999985 888888654   358999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           78 LLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        78 iLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      |++++++.++++|||++..............+++.|+|||++.+....+.++||||+||++|+|++|..||...+.....
T Consensus       131 i~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~  210 (284)
T cd07836         131 LLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQL  210 (284)
T ss_pred             EEECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            99999999999999998765443233345568899999999876555568999999999999999999999877655443


Q ss_pred             HHhhcc------------------cCC-----------CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          158 KKINAA------------------EFS-----------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       158 ~~i~~~------------------~~~-----------~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      ..+...                  ...           ..+..++.+.++|.+||+.||.+|||+.++++||||
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         211 LKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             HHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            332110                  000           112357889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-36  Score=285.19  Aligned_cols=201  Identities=32%  Similarity=0.467  Sum_probs=166.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      ++.++||||+++++++.+.+..|+||||++ ++|.+++....  .+++..+..++.|++.||+|||++|++||||+|+||
T Consensus        52 l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~ni  130 (283)
T cd07835          52 LKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNL  130 (283)
T ss_pred             HHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHE
Confidence            356799999999999999999999999995 68999887755  689999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK  158 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~  158 (381)
                      +++.++.++|+|||++..............+++.|+|||++.+....+.++||||+||++|+|++|.+||...+......
T Consensus       131 l~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  210 (283)
T cd07835         131 LIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF  210 (283)
T ss_pred             EEcCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999987654332223344678999999998765444588999999999999999999998765433222


Q ss_pred             Hhhcc------------------c-----------CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          159 KINAA------------------E-----------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       159 ~i~~~------------------~-----------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      ++...                  .           ....+.++..+.++|.+||+.||.+|||++++++||||
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         211 RIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             HHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            21110                  0           01123467899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.2e-36  Score=280.96  Aligned_cols=201  Identities=32%  Similarity=0.598  Sum_probs=172.6

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      ++.++||||+++++.+.+.+..|+|+||+++++|.+++....  .+++..+..++.|++.||.|||+.|++|+||||+||
T Consensus        53 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni  132 (257)
T cd08225          53 LAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNI  132 (257)
T ss_pred             HHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHE
Confidence            357899999999999999999999999999999999987643  478999999999999999999999999999999999


Q ss_pred             EEccCC-CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           79 LLDSYG-NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        79 Ll~~~~-~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      ++++++ .+|++|||.+..............|++.|+|||++.+..+. .++|+||+||++++|++|..||...+.....
T Consensus       133 l~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~  211 (257)
T cd08225         133 FLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLV  211 (257)
T ss_pred             EEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence            999886 46999999987665433333455689999999998776654 8999999999999999999999877766555


Q ss_pred             HHhhcccC-CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          158 KKINAAEF-SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       158 ~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      ..+..... ..++.++.++.++|.+||..+|.+|||+.++++||||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         212 LKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHhcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            54443332 2344578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5.6e-37  Score=284.78  Aligned_cols=200  Identities=27%  Similarity=0.480  Sum_probs=170.5

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEE
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLL   79 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NiL   79 (381)
                      +.++||||+++++.+.+.+..|+|+||+++++|.+++... ..+++..+..++.|++.||+|||+ .|++||||||+||+
T Consensus        54 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~  133 (265)
T cd06605          54 HKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNIL  133 (265)
T ss_pred             HHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEE
Confidence            5678999999999999999999999999999999999875 779999999999999999999999 99999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCC-----hh
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-----LP  154 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-----~~  154 (381)
                      +++++.++|+|||.+......  ......|+..|+|||.+.+..++ .++||||+||++|+|++|..||...+     ..
T Consensus       134 ~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  210 (265)
T cd06605         134 VNSRGQIKLCDFGVSGQLVNS--LAKTFVGTSSYMAPERIQGNDYS-VKSDIWSLGLSLIELATGRFPYPPENDPPDGIF  210 (265)
T ss_pred             ECCCCCEEEeecccchhhHHH--HhhcccCChhccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCccccccccHH
Confidence            999999999999998755332  12237789999999999877664 89999999999999999999997542     22


Q ss_pred             HHHHHhhc-ccCCCCCC-CChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          155 TLYKKINA-AEFSCPFW-FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       155 ~~~~~i~~-~~~~~p~~-~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      ...+.+.. .....+.. +++++.++|.+||..||.+|||+.+++.||||+.
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~  262 (265)
T cd06605         211 ELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK  262 (265)
T ss_pred             HHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence            22333322 22234444 7899999999999999999999999999999965

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2e-36  Score=291.76  Aligned_cols=207  Identities=26%  Similarity=0.353  Sum_probs=172.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++...+..|+||||++ |+|.+++.....++++.+..++.|++.||+|||+.|++||||+|+||++
T Consensus        74 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill  152 (335)
T PTZ00024         74 MNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI  152 (335)
T ss_pred             HHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE
Confidence            357899999999999999999999999997 5999999888889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCC--------------CccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCC
Q 016865           81 DSYGNLKVSDFGLSALPQQ--------------GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYL  146 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~--------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~  146 (381)
                      +.++.+||+|||++.....              .........+++.|+|||++.+....+.++|+||+||++|+|++|.+
T Consensus       153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~  232 (335)
T PTZ00024        153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP  232 (335)
T ss_pred             CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            9999999999999875441              11122344578899999998765555689999999999999999999


Q ss_pred             CCCCCChhHHHHHhhccc---------------------C-------CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          147 PFGETDLPTLYKKINAAE---------------------F-------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       147 Pf~~~~~~~~~~~i~~~~---------------------~-------~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ||...+.......+....                     .       ......+.++.++|.+||+.+|.+|||+++++.
T Consensus       233 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        233 LFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            998776544433321100                     0       001235788999999999999999999999999


Q ss_pred             CcccccCCCC
Q 016865          199 HPWFRKNYNP  208 (381)
Q Consensus       199 hp~~~~~~~~  208 (381)
                      ||||+....+
T Consensus       313 ~~~~~~~~~~  322 (335)
T PTZ00024        313 HEYFKSDPLP  322 (335)
T ss_pred             CcccCCCCCC
Confidence            9999876544

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-38  Score=307.76  Aligned_cols=204  Identities=30%  Similarity=0.475  Sum_probs=176.3

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRL--LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l--~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      +.|+|.|||+++|.+..++.+-|.||-.+||+|.+.++.. |++  +|..+-.|.+||++||.|||.+.|+|||||-+|+
T Consensus       627 ~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNV  706 (1226)
T KOG4279|consen  627 STLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNV  706 (1226)
T ss_pred             HHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcE
Confidence            4689999999999999999999999999999999999764 566  7999999999999999999999999999999999


Q ss_pred             EEc-cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCC-CCCCCcccHhHHHHHHHHHHhCCCCCCCCChh--
Q 016865           79 LLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR-GYDGSAADVWSCGVILFVLMAGYLPFGETDLP--  154 (381)
Q Consensus        79 Ll~-~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~--  154 (381)
                      |++ -.|.+||+|||-++....-+....|..||+.|||||++... .-+|.++|||||||.+.||.||++||-+...+  
T Consensus       707 LvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA  786 (1226)
T KOG4279|consen  707 LVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA  786 (1226)
T ss_pred             EEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH
Confidence            997 57999999999887665544556788899999999999643 23479999999999999999999999765432  


Q ss_pred             HHHHH-hhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          155 TLYKK-INAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       155 ~~~~~-i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      .+++. +.+.-.+.|..+|.+++.||.+|+.++|.+||++.++|++||++.+
T Consensus       787 AMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  787 AMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             hhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence            33332 2233456777899999999999999999999999999999999866

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.3e-36  Score=285.92  Aligned_cols=199  Identities=27%  Similarity=0.435  Sum_probs=163.9

Q ss_pred             CC-CccccccceEEEE-----eCCEEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q 016865            3 IV-RHPNIVRLHEVLA-----SRTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD   72 (381)
Q Consensus         3 ~l-~HpnIv~l~~~~~-----~~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrD   72 (381)
                      .+ +||||+++++++.     +.+..|+||||++||+|.+.+..    ...+++..+..++.|++.||.|||+.+++|||
T Consensus        70 ~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d  149 (286)
T cd06638          70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRD  149 (286)
T ss_pred             HHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccC
Confidence            44 7999999999884     44679999999999999988753    34689999999999999999999999999999


Q ss_pred             CCCCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecC-----CCCCCCcccHhHHHHHHHHHHhCCCC
Q 016865           73 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-----RGYDGSAADVWSCGVILFVLMAGYLP  147 (381)
Q Consensus        73 lkp~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DIwSlGvil~~ll~G~~P  147 (381)
                      |||+||+++.++.+||+|||++..............|++.|+|||++..     ..+ +.++||||+||++|+|++|+.|
T Consensus       150 lkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvi~~el~~g~~p  228 (286)
T cd06638         150 VKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTY-DARCDVWSLGITAIELGDGDPP  228 (286)
T ss_pred             CCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccc-cchhhhhhHHHHHHHHhcCCCC
Confidence            9999999999999999999998765433223345579999999999853     223 4789999999999999999999


Q ss_pred             CCCCChhHHHHHhhcc---cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          148 FGETDLPTLYKKINAA---EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       148 f~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      |...+.......+...   ....|..++..+.++|.+||+.||.+|||+.++++||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         229 LADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            9876544333332222   122344568899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-37  Score=281.82  Aligned_cols=200  Identities=33%  Similarity=0.630  Sum_probs=183.8

Q ss_pred             CCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccC
Q 016865            4 VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY   83 (381)
Q Consensus         4 l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~   83 (381)
                      -+||.+|-++.+|++++.+++|.||.+||+|--++.+++++||+.|+.|...|+.||+|||++||+.||||..|+|+|..
T Consensus       308 sn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldae  387 (593)
T KOG0695|consen  308 SNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAE  387 (593)
T ss_pred             cCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccC
Confidence            38999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCC--------CChhH
Q 016865           84 GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE--------TDLPT  155 (381)
Q Consensus        84 ~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~--------~~~~~  155 (381)
                      |++|++|+|.++..-.+.....|.||||.|+|||++.+..| +.++|.|+|||+++||++|+.||+-        .+..-
T Consensus       388 ghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedy  466 (593)
T KOG0695|consen  388 GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDY  466 (593)
T ss_pred             CceeecccchhhcCCCCCcccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHH
Confidence            99999999999865555567889999999999999998877 5999999999999999999999952        22345


Q ss_pred             HHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCC------HHHHhcCccccc
Q 016865          156 LYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIR------IEGIRKHPWFRK  204 (381)
Q Consensus       156 ~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t------~~~il~hp~~~~  204 (381)
                      +++.|...+...|..+|-.+..+++..|.+||.+|..      ..++..||||+.
T Consensus       467 lfqvilekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~  521 (593)
T KOG0695|consen  467 LFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS  521 (593)
T ss_pred             HHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence            6788888899999999999999999999999999974      588999999973

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.3e-36  Score=285.21  Aligned_cols=197  Identities=22%  Similarity=0.339  Sum_probs=168.6

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-------------RLLENDCRRYFQQLIDAVAHCHSKG   67 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-------------~l~e~~~~~~~~qll~~L~~LH~~g   67 (381)
                      |+.++||||+++++++...+.+|+||||+++|+|.+++...+             .+++..+..++.|++.||+|||++|
T Consensus        61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~  140 (288)
T cd05093          61 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH  140 (288)
T ss_pred             HHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            467899999999999999999999999999999999997543             3899999999999999999999999


Q ss_pred             CeecCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-C
Q 016865           68 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-G  144 (381)
Q Consensus        68 i~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G  144 (381)
                      ++||||||+||++++++.+||+|||++.......  .......+++.|+|||++.+..+. .++||||+||++|+|++ |
T Consensus       141 i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~il~~l~t~g  219 (288)
T cd05093         141 FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYG  219 (288)
T ss_pred             eeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999987543321  112234457889999999776554 89999999999999998 9


Q ss_pred             CCCCCCCChhHHHHHhhcccC-CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          145 YLPFGETDLPTLYKKINAAEF-SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       145 ~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      .+||...+.......+..+.. ..+..+++++.+|+.+||+.||.+|||+.+++.
T Consensus       220 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         220 KQPWYQLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            999988777666666665543 345568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.5e-36  Score=295.14  Aligned_cols=207  Identities=30%  Similarity=0.507  Sum_probs=167.2

Q ss_pred             CCCCCccccccceEEEEeC------CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 016865            1 MKIVRHPNIVRLHEVLASR------TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK   74 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~------~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlk   74 (381)
                      |++++||||+++++++...      ...|+||||+.+ +|.+.+...  +++..+..++.|++.||+|||++||+|||||
T Consensus        69 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlk  145 (353)
T cd07850          69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  145 (353)
T ss_pred             HHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCC
Confidence            4678999999999998644      357999999964 888887654  8999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           75 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        75 p~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      |+||+++.++.+||+|||++...... .......|++.|+|||++.+..+. .++||||+||++|+|++|+.||...+..
T Consensus       146 p~Nil~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~  223 (353)
T cd07850         146 PSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHI  223 (353)
T ss_pred             HHHEEECCCCCEEEccCccceeCCCC-CCCCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCCHH
Confidence            99999999999999999998765432 223455789999999999887775 8999999999999999999999766543


Q ss_pred             HHHHHhhcc----------------------cC--------------CC-------CCCCChhHHHHHHHhcCCCCCCCC
Q 016865          155 TLYKKINAA----------------------EF--------------SC-------PFWFSTGATSLIHKILDPNPKTRI  191 (381)
Q Consensus       155 ~~~~~i~~~----------------------~~--------------~~-------p~~~s~~~~~li~~~L~~dP~~R~  191 (381)
                      ..+..+...                      ..              ..       +...++.++++|.+||+.||.+||
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  303 (353)
T cd07850         224 DQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRI  303 (353)
T ss_pred             HHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCc
Confidence            322222100                      00              00       112356789999999999999999


Q ss_pred             CHHHHhcCcccccCCCCCCCc
Q 016865          192 RIEGIRKHPWFRKNYNPVKCS  212 (381)
Q Consensus       192 t~~~il~hp~~~~~~~~~~~~  212 (381)
                      |+.++++||||+.++.+..+.
T Consensus       304 t~~eiL~~~~~~~~~~~~~~~  324 (353)
T cd07850         304 SVDDALQHPYINVWYDPSEVE  324 (353)
T ss_pred             CHHHHhcChhHhhccCCccCC
Confidence            999999999999877654443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.3e-37  Score=301.72  Aligned_cols=200  Identities=25%  Similarity=0.506  Sum_probs=178.3

Q ss_pred             CCCCCccccccceEEEEeCCE--EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG--VYHRDLKPE   76 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~--~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~g--i~HrDlkp~   76 (381)
                      ||.|+|||||++|+.+.+..+  +-+|+|++.+|+|..|+.+.++++...++.|++||+.||.|||++.  |+|||||.+
T Consensus        95 LKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCD  174 (632)
T KOG0584|consen   95 LKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCD  174 (632)
T ss_pred             HccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccc
Confidence            688999999999999987654  9999999999999999999999999999999999999999999995  999999999


Q ss_pred             cEEEcc-CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCC-CChh
Q 016865           77 NLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLP  154 (381)
Q Consensus        77 NiLl~~-~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~-~~~~  154 (381)
                      ||+++. .|.+||+|+|||+.....  ......|||.|||||+.. ..|+ +.+||||||..+.||+|+..||.+ .+..
T Consensus       175 NIFinG~~G~VKIGDLGLAtl~r~s--~aksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~A  250 (632)
T KOG0584|consen  175 NIFVNGNLGEVKIGDLGLATLLRKS--HAKSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPA  250 (632)
T ss_pred             eEEEcCCcCceeecchhHHHHhhcc--ccceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHH
Confidence            999995 589999999999987653  345578999999999986 5776 999999999999999999999976 4667


Q ss_pred             HHHHHhhcccCC--CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          155 TLYKKINAAEFS--CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       155 ~~~~~i~~~~~~--~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ++|+++..+..+  +..--++++++||.+||.. ...|+|+.|+|+||||...
T Consensus       251 QIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  251 QIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            899998777543  2222478999999999999 9999999999999999875

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=8.9e-37  Score=299.26  Aligned_cols=196  Identities=23%  Similarity=0.359  Sum_probs=162.3

Q ss_pred             CCC-CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc---------------------------------------
Q 016865            2 KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ---------------------------------------   41 (381)
Q Consensus         2 k~l-~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~---------------------------------------   41 (381)
                      +.+ +||||+++++++.+.+.+|+||||+++|+|.+++...                                       
T Consensus        96 ~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (374)
T cd05106          96 SHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSS  175 (374)
T ss_pred             HhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccc
Confidence            456 8999999999999999999999999999999998542                                       


Q ss_pred             -------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCCCEEEee
Q 016865           42 -------------------------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSD   90 (381)
Q Consensus        42 -------------------------------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~~lkl~D   90 (381)
                                                     .++++..++.++.|++.||.|||++||+||||||+|||+++++.+||+|
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~D  255 (374)
T cd05106         176 QGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICD  255 (374)
T ss_pred             cccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEee
Confidence                                           1367888999999999999999999999999999999999999999999


Q ss_pred             ccCccCCCCCcc--ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHHH-HHhhcc-cC
Q 016865           91 FGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY-KKINAA-EF  165 (381)
Q Consensus        91 FGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~-~~i~~~-~~  165 (381)
                      ||++........  ...+..+++.|+|||++.+..+. .++||||+||++|+|++ |..||......... ..+..+ ..
T Consensus       256 fGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~  334 (374)
T cd05106         256 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM  334 (374)
T ss_pred             ceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc
Confidence            999875433211  11223356789999999776664 89999999999999997 99999776544333 223222 34


Q ss_pred             CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          166 SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       166 ~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ..|.++++++.++|.+||+.||.+|||+.++++
T Consensus       335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            456678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.2e-36  Score=286.41  Aligned_cols=206  Identities=28%  Similarity=0.515  Sum_probs=173.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++.+...+..|+||||+++++|.+++.. +.+++..+..++.|++.||+|||+.|++||||+|+||++
T Consensus        71 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv  149 (292)
T cd06657          71 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL  149 (292)
T ss_pred             HHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence            3568999999999999999999999999999999887654 578999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.++|+|||++..............|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+
T Consensus       150 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~  228 (292)
T cd06657         150 THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI  228 (292)
T ss_pred             CCCCCEEEcccccceecccccccccccccCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999999988654432222344568999999999876555 48999999999999999999999876655444333


Q ss_pred             hcc---cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 016865          161 NAA---EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  208 (381)
Q Consensus       161 ~~~---~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~  208 (381)
                      ...   .......+++.+.+++.+||+.+|.+||++.+++.||||.+...|
T Consensus       229 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~  279 (292)
T cd06657         229 RDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP  279 (292)
T ss_pred             HhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCC
Confidence            222   122223468899999999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.3e-36  Score=283.37  Aligned_cols=204  Identities=26%  Similarity=0.416  Sum_probs=174.9

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++.+.+++..|+||||+++|+|.+++.. +.+++..+..++.|++.|+.|||+.|++|+||+|+||++
T Consensus        56 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i  134 (277)
T cd06641          56 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL  134 (277)
T ss_pred             HHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE
Confidence            3568999999999999999999999999999999988865 568999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.++|+|||++..............|+..|+|||.+.+...+ .++|+||+||++|+|++|..||...+.......+
T Consensus       135 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~  213 (277)
T cd06641         135 SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPHSELHPMKVLFLI  213 (277)
T ss_pred             CCCCCEEEeecccceecccchhhhccccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH
Confidence            999999999999987554332223445689999999998766554 7899999999999999999999876655554444


Q ss_pred             hccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          161 NAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       161 ~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      .... ...+..++.++.++|.+||..+|.+||++.++++||||....
T Consensus       214 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~  260 (277)
T cd06641         214 PKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFA  260 (277)
T ss_pred             hcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhh
Confidence            3332 234556889999999999999999999999999999998653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3e-36  Score=284.65  Aligned_cols=201  Identities=30%  Similarity=0.449  Sum_probs=162.5

Q ss_pred             CCC-CccccccceEEEEeCCE-----EEEEEecCCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q 016865            2 KIV-RHPNIVRLHEVLASRTK-----VYIILEFVTGGELFDKIVHQ-----GRLLENDCRRYFQQLIDAVAHCHSKGVYH   70 (381)
Q Consensus         2 k~l-~HpnIv~l~~~~~~~~~-----~~lV~E~~~gg~L~~~i~~~-----~~l~e~~~~~~~~qll~~L~~LH~~gi~H   70 (381)
                      +.+ +||||+++++++.....     .|+||||+++ +|.+++...     ..+++..++.++.||+.||.|||++||+|
T Consensus        55 ~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H  133 (295)
T cd07837          55 QMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMH  133 (295)
T ss_pred             HHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence            345 57999999999987665     8999999986 898888653     34799999999999999999999999999


Q ss_pred             cCCCCCcEEEcc-CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCC
Q 016865           71 RDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFG  149 (381)
Q Consensus        71 rDlkp~NiLl~~-~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~  149 (381)
                      |||||+||+++. ++.+||+|||++..............+++.|+|||++.+....+.++||||+||++|+|++|.+||.
T Consensus       134 ~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~  213 (295)
T cd07837         134 RDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFP  213 (295)
T ss_pred             cCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCC
Confidence            999999999998 8899999999987554332233344678999999998664444589999999999999999999998


Q ss_pred             CCChhHHHHHhhccc-----------------CCCC-----------CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 016865          150 ETDLPTLYKKINAAE-----------------FSCP-----------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPW  201 (381)
Q Consensus       150 ~~~~~~~~~~i~~~~-----------------~~~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~  201 (381)
                      ..+.......+....                 ...|           +.+++++.+||.+||.+||.+|||+++++.|||
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~  293 (295)
T cd07837         214 GDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY  293 (295)
T ss_pred             CCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCC
Confidence            765544333221100                 0001           236888999999999999999999999999999


Q ss_pred             cc
Q 016865          202 FR  203 (381)
Q Consensus       202 ~~  203 (381)
                      |+
T Consensus       294 ~~  295 (295)
T cd07837         294 FD  295 (295)
T ss_pred             cC
Confidence            95

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.9e-36  Score=282.45  Aligned_cols=197  Identities=22%  Similarity=0.325  Sum_probs=169.1

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--------------RLLENDCRRYFQQLIDAVAHCHSK   66 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--------------~l~e~~~~~~~~qll~~L~~LH~~   66 (381)
                      |+.++||||+++++++.+....|+||||++||+|.+++...+              .+++..+..++.|++.||.|||++
T Consensus        62 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~  141 (280)
T cd05049          62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ  141 (280)
T ss_pred             HHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC
Confidence            456899999999999999999999999999999999997542              378899999999999999999999


Q ss_pred             CCeecCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-
Q 016865           67 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-  143 (381)
Q Consensus        67 gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-  143 (381)
                      |++||||||+||+++.++.+||+|||++.......  .......+++.|+|||++.+..+. .++|||||||++|+|++ 
T Consensus       142 ~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~e~~~~  220 (280)
T cd05049         142 HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTY  220 (280)
T ss_pred             CeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcc-hhhhHHHHHHHHHHHHhc
Confidence            99999999999999999999999999987543211  112334467889999999876664 88999999999999998 


Q ss_pred             CCCCCCCCChhHHHHHhhcccCC-CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          144 GYLPFGETDLPTLYKKINAAEFS-CPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       144 G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      |..||...+.......+..+... .|..++..+.+++.+||..||.+|||+.++++
T Consensus       221 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         221 GKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            99999887777777766655443 34568999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.4e-36  Score=277.18  Aligned_cols=200  Identities=34%  Similarity=0.594  Sum_probs=176.9

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      +.++|||++++++.+......++|+||++|++|.+++...    ..+++..+..++.|++.||.|||++|++|+||+|+|
T Consensus        54 ~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~n  133 (258)
T cd08215          54 KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQN  133 (258)
T ss_pred             HhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHH
Confidence            5678999999999999999999999999999999999764    678999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           78 LLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        78 iLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      |+++.++.++|+|||++.............+|++.|+|||.+.+..+. .++|+||+|+++++|++|..||...+.....
T Consensus       134 il~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~  212 (258)
T cd08215         134 IFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELA  212 (258)
T ss_pred             eEEcCCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCC-ccccHHHHHHHHHHHHcCCCCCCCCcHHHHH
Confidence            999999999999999988765543344566799999999998776654 8899999999999999999999888766666


Q ss_pred             HHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          158 KKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       158 ~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      ....... ...|..++..+.+++.+||..+|.+|||+.++++||||
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         213 LKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            6554433 34555688999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.5e-36  Score=320.13  Aligned_cols=204  Identities=30%  Similarity=0.461  Sum_probs=166.7

Q ss_pred             CCCCCccccccceEEEEe--CCEEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-------C
Q 016865            1 MKIVRHPNIVRLHEVLAS--RTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSK-------G   67 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~L~~LH~~-------g   67 (381)
                      |+.|+|||||+++++|.+  ...+||||||+++|+|.++|..    .+.+++..++.++.||+.||.|||+.       +
T Consensus        66 L~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~  145 (1021)
T PTZ00266         66 MRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGER  145 (1021)
T ss_pred             HHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCC
Confidence            457899999999999854  4679999999999999999865    35699999999999999999999984       4


Q ss_pred             CeecCCCCCcEEEcc-----------------CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCC-CCCCCcc
Q 016865           68 VYHRDLKPENLLLDS-----------------YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR-GYDGSAA  129 (381)
Q Consensus        68 i~HrDlkp~NiLl~~-----------------~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~  129 (381)
                      |+||||||+|||++.                 .+.+||+|||++...... ......+||+.|+|||++.+. ...+.++
T Consensus       146 IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPEvL~ge~~~~s~KS  224 (1021)
T PTZ00266        146 VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLLHETKSYDDKS  224 (1021)
T ss_pred             ceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccc-ccccccCCCccccCHHHHhccCCCCCchh
Confidence            999999999999964                 235899999999765432 233566799999999998643 2335899


Q ss_pred             cHhHHHHHHHHHHhCCCCCCCCChh-HHHHHhhcccCCCC-CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          130 DVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAEFSCP-FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       130 DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~p-~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      ||||||||||+|++|..||...+.. .+...+... ...| ...++++.+||..||..+|.+|||+.++|.|||++...
T Consensus       225 DVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~-p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~  302 (1021)
T PTZ00266        225 DMWALGCIIYELCSGKTPFHKANNFSQLISELKRG-PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG  302 (1021)
T ss_pred             HHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcC-CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence            9999999999999999999765443 333333332 2222 34789999999999999999999999999999997543

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.2e-36  Score=283.45  Aligned_cols=202  Identities=24%  Similarity=0.408  Sum_probs=169.9

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEE
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLL   80 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NiLl   80 (381)
                      +.++||||+++++.+.+.+.+|+||||+++|+|.+++...+.+++..+..++.|++.||.|||+ .|++||||||+||++
T Consensus        58 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~  137 (284)
T cd06620          58 HECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV  137 (284)
T ss_pred             HHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE
Confidence            5689999999999999999999999999999999999887889999999999999999999997 599999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh------
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP------  154 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~------  154 (381)
                      ++++.++|+|||++......  .....+|+..|+|||++.+..+ +.++||||+||++|+|++|..||...+..      
T Consensus       138 ~~~~~~~l~d~gl~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~  214 (284)
T cd06620         138 NSRGQIKLCDFGVSGELINS--IADTFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDD  214 (284)
T ss_pred             CCCCcEEEccCCcccchhhh--ccCccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhh
Confidence            99999999999998654321  2235679999999999876655 48999999999999999999999764431      


Q ss_pred             -----HHHHHhhcc-cCCCCCC-CChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          155 -----TLYKKINAA-EFSCPFW-FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       155 -----~~~~~i~~~-~~~~p~~-~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                           .....+... ....+.. ++.++.+||.+||.+||.+|||++++++||||....
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         215 PMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             hhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence                 122222221 1222222 778999999999999999999999999999997654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-36  Score=276.32  Aligned_cols=200  Identities=29%  Similarity=0.501  Sum_probs=175.5

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      +.++|||++++++++.+.+..|+||||+++++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++
T Consensus        54 ~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~  133 (254)
T cd06627          54 KNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT  133 (254)
T ss_pred             HhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC
Confidence            56799999999999999999999999999999999998888899999999999999999999999999999999999999


Q ss_pred             cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh-
Q 016865           82 SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI-  160 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i-  160 (381)
                      .++.++|+|||++..............|+..|+|||...+..+ +.++||||+|+++|+|++|..||...+......+. 
T Consensus       134 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~  212 (254)
T cd06627         134 KDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV  212 (254)
T ss_pred             CCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence            9999999999999876554333445678999999999876664 58999999999999999999999876544333333 


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      .......|..++..+.+++.+||..+|++|||+.+++.||||
T Consensus       213 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         213 QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence            233445666789999999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.7e-36  Score=279.60  Aligned_cols=202  Identities=29%  Similarity=0.517  Sum_probs=175.1

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEE
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLL   80 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NiLl   80 (381)
                      +.++||||+++++++...+..|+||||+++++|.+++.....+++..+..++.|++.|+.|||+ .|++||||+|+||++
T Consensus        54 ~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~  133 (264)
T cd06623          54 RSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI  133 (264)
T ss_pred             HhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE
Confidence            4578999999999999999999999999999999999887889999999999999999999999 999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCC---hhHHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD---LPTLY  157 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~---~~~~~  157 (381)
                      +.++.++|+|||++..............++..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+   .....
T Consensus       134 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~  212 (264)
T cd06623         134 NSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM  212 (264)
T ss_pred             CCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH
Confidence            99999999999998866543333345678999999999877654 589999999999999999999997763   34444


Q ss_pred             HHhhcc-cCCCCCC-CChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          158 KKINAA-EFSCPFW-FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       158 ~~i~~~-~~~~p~~-~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      ..+... ....+.. ++..+.++|.+||..+|++|||+.++++|||++.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~  261 (264)
T cd06623         213 QAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK  261 (264)
T ss_pred             HHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence            444432 2334444 7889999999999999999999999999999964

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.8e-36  Score=288.99  Aligned_cols=205  Identities=21%  Similarity=0.387  Sum_probs=165.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||+++++++.+.+..|++|||+++|+|.+++...  ..+++..+..++.|++.||+|||++||+||||||+||
T Consensus        53 l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Ni  132 (314)
T cd08216          53 SRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHI  132 (314)
T ss_pred             HHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceE
Confidence            46789999999999999999999999999999999998753  4589999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCc-------cccccccCCCCCCCCceecCC--CCCCCcccHhHHHHHHHHHHhCCCCCC
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGV-------ELLHTTCGTPNYVAPEVLSNR--GYDGSAADVWSCGVILFVLMAGYLPFG  149 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DIwSlGvil~~ll~G~~Pf~  149 (381)
                      +++.++.+|++|||.+.......       .......++..|+|||++...  .+ +.++|+||+||++|+|++|..||.
T Consensus       133 li~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~Diws~G~il~el~~g~~pf~  211 (314)
T cd08216         133 LLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVPFK  211 (314)
T ss_pred             EEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCC-CcchhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999876432211       112344578899999998653  34 478999999999999999999997


Q ss_pred             CCChhHHH-HHhhcc---------------------------------cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHH
Q 016865          150 ETDLPTLY-KKINAA---------------------------------EFSCPFWFSTGATSLIHKILDPNPKTRIRIEG  195 (381)
Q Consensus       150 ~~~~~~~~-~~i~~~---------------------------------~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~  195 (381)
                      ..+..... .++...                                 ....+..++.++.+|+.+||..||.+|||+++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~  291 (314)
T cd08216         212 DMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ  291 (314)
T ss_pred             CCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHH
Confidence            65433221 221100                                 00011124567899999999999999999999


Q ss_pred             HhcCcccccCC
Q 016865          196 IRKHPWFRKNY  206 (381)
Q Consensus       196 il~hp~~~~~~  206 (381)
                      +++||||+...
T Consensus       292 ll~~p~~~~~~  302 (314)
T cd08216         292 LLNHSFFKQCK  302 (314)
T ss_pred             HhcCchHhhhc
Confidence            99999998543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.7e-36  Score=287.17  Aligned_cols=204  Identities=26%  Similarity=0.480  Sum_probs=171.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++.+...+..|+|+||+++|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||++
T Consensus        70 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili  148 (293)
T cd06647          70 MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL  148 (293)
T ss_pred             HhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE
Confidence            4678999999999999999999999999999999998865 468899999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.+||+|||++..............|++.|+|||.+.+..+ +.++|+||+||++|++++|+.||...+.......+
T Consensus       149 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~  227 (293)
T cd06647         149 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI  227 (293)
T ss_pred             cCCCCEEEccCcceecccccccccccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh
Confidence            99999999999988755443333345578999999999877665 48999999999999999999999876543322222


Q ss_pred             hcc---cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          161 NAA---EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       161 ~~~---~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      ...   ....+..++..++++|.+||..+|.+|||+++++.||||+...
T Consensus       228 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         228 ATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             hcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            211   1223334688899999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.7e-36  Score=283.19  Aligned_cols=203  Identities=28%  Similarity=0.505  Sum_probs=173.9

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++.+...+..|+|+||++|++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+
T Consensus        69 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~  148 (286)
T cd06614          69 MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNIL  148 (286)
T ss_pred             HHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEE
Confidence            457899999999999999999999999999999999998866 7999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      ++.++.++|+|||++..............+++.|+|||++.+..++ .++|+||+||++|+|++|..||...+.......
T Consensus       149 i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~  227 (286)
T cd06614         149 LSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL  227 (286)
T ss_pred             EcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999886544332233455688999999998776664 899999999999999999999987665444333


Q ss_pred             hhcccC-C--CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          160 INAAEF-S--CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       160 i~~~~~-~--~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      +..... .  .+..++..+.++|.+||+.+|.+|||+.++++||||.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         228 ITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             HHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence            332221 1  22237889999999999999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.6e-36  Score=285.33  Aligned_cols=203  Identities=29%  Similarity=0.437  Sum_probs=165.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |++++||||+++++++.+....|+||||++ ++|.+.+.....  +++..++.++.||+.||+|||++|++||||+|+||
T Consensus        55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~ni  133 (294)
T PLN00009         55 LKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNL  133 (294)
T ss_pred             HHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceE
Confidence            467899999999999999999999999996 588888765443  57888999999999999999999999999999999


Q ss_pred             EEcc-CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           79 LLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        79 Ll~~-~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      +++. ++.+||+|||++..............|++.|+|||++.+....+.++||||+||++|+|++|.+||...+.....
T Consensus       134 ll~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~  213 (294)
T PLN00009        134 LIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDEL  213 (294)
T ss_pred             EEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            9985 457999999999765433233344567899999999876544458999999999999999999999876554333


Q ss_pred             HHhhcc------------------cCC-----------CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          158 KKINAA------------------EFS-----------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       158 ~~i~~~------------------~~~-----------~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      .++...                  ...           ..+.+++.+.+++.+||+.+|.+||++.++++||||..
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~  289 (294)
T PLN00009        214 FKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD  289 (294)
T ss_pred             HHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence            322110                  000           11236888999999999999999999999999999975

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.6e-36  Score=285.98  Aligned_cols=197  Identities=21%  Similarity=0.300  Sum_probs=161.6

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHH
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-------------------RLLENDCRRYFQQLIDAVA   61 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-------------------~l~e~~~~~~~~qll~~L~   61 (381)
                      |+.++||||+++++++.+.+..|+||||+++|+|.+++....                   .+++..+..++.||+.||.
T Consensus        73 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~  152 (304)
T cd05096          73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMK  152 (304)
T ss_pred             HhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence            467899999999999999999999999999999999886532                   3567788999999999999


Q ss_pred             HHHHCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHH
Q 016865           62 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF  139 (381)
Q Consensus        62 ~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~  139 (381)
                      |||+.||+||||||+|||++.++.+||+|||++.......  .......++..|+|||++....+ +.++|||||||++|
T Consensus       153 ~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~  231 (304)
T cd05096         153 YLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLW  231 (304)
T ss_pred             HHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHH
Confidence            9999999999999999999999999999999987543321  12234456889999999877665 48999999999999


Q ss_pred             HHHh--CCCCCCCCChhHHHHHhhc--------ccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          140 VLMA--GYLPFGETDLPTLYKKINA--------AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       140 ~ll~--G~~Pf~~~~~~~~~~~i~~--------~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      +|++  |..||...+.......+..        .....|+.+++.+.+|+.+||..||.+|||+++|.+
T Consensus       232 el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         232 EILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             HHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            9986  6788887665544433211        112335567899999999999999999999999853

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.7e-36  Score=282.98  Aligned_cols=204  Identities=34%  Similarity=0.621  Sum_probs=173.3

Q ss_pred             CCC-CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            2 KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         2 k~l-~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      +++ +||||+++++.++.+...|+||||+++|+|.+++.....+++..+..++.|++.||.|||+.|++||||+|+|||+
T Consensus        59 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~  138 (290)
T cd05613          59 EHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL  138 (290)
T ss_pred             HhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE
Confidence            345 6999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCC-ccccccccCCCCCCCCceecCC-CCCCCcccHhHHHHHHHHHHhCCCCCCCCCh----h
Q 016865           81 DSYGNLKVSDFGLSALPQQG-VELLHTTCGTPNYVAPEVLSNR-GYDGSAADVWSCGVILFVLMAGYLPFGETDL----P  154 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~-~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~----~  154 (381)
                      +.++.+||+|||++...... .......+|+..|+|||.+.+. ...+.++||||+||++|+|++|..||...+.    .
T Consensus       139 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~  218 (290)
T cd05613         139 DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQA  218 (290)
T ss_pred             CCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHH
Confidence            99999999999998765432 1223456789999999998653 2335789999999999999999999974332    2


Q ss_pred             HHHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcccccC
Q 016865          155 TLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI-----RIEGIRKHPWFRKN  205 (381)
Q Consensus       155 ~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~-----t~~~il~hp~~~~~  205 (381)
                      .....+.......|..+++.+.+++.+||..||.+|+     ++++++.||||+..
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  274 (290)
T cd05613         219 EISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI  274 (290)
T ss_pred             HHHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence            3334444445556667899999999999999999997     89999999999753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.9e-36  Score=277.96  Aligned_cols=196  Identities=21%  Similarity=0.314  Sum_probs=167.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++. ....++||||+++|+|.+++...+.++++.+..++.|++.||+|||++||+||||||.||++
T Consensus        50 l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill  128 (257)
T cd05116          50 MQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL  128 (257)
T ss_pred             HHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE
Confidence            35689999999999886 45679999999999999999887889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccc---cccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGVEL---LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      +.++.+||+|||++.........   .....+++.|+|||.+....+ +.++||||+||++|+|++ |..||...+....
T Consensus       129 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~  207 (257)
T cd05116         129 VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV  207 (257)
T ss_pred             cCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999998765432211   122334679999999876555 489999999999999998 9999988777666


Q ss_pred             HHHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...+..+. ...|..+++++.++|.+||+.||.+|||+++|.+
T Consensus       208 ~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         208 TQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence            66665543 4567778999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.5e-36  Score=277.31  Aligned_cols=197  Identities=25%  Similarity=0.396  Sum_probs=168.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+..|+||||++||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+||+
T Consensus        53 l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~  132 (256)
T cd05114          53 MMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCL  132 (256)
T ss_pred             HHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEE
Confidence            4678999999999999999999999999999999999875 346899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccc-cccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVEL-LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  157 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~  157 (381)
                      +++++.+||+|||+++........ .....++..|+|||++.+..+. .++||||+|+++|+|++ |+.||...+.....
T Consensus       133 i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~  211 (256)
T cd05114         133 VSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVV  211 (256)
T ss_pred             EcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccc-hhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            999999999999998754332111 1122356689999999776664 89999999999999999 99999888877776


Q ss_pred             HHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          158 KKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       158 ~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ..+..+. ...|...+..+.+++.+||..+|.+|||++++++
T Consensus       212 ~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         212 EMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            6665543 3345567889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-36  Score=306.95  Aligned_cols=203  Identities=28%  Similarity=0.450  Sum_probs=159.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKP   75 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp   75 (381)
                      |+.++||||+++++++.+.+..|+|+|++. ++|.+++...     .......++.++.||+.||+|||++||+||||||
T Consensus       217 l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP  295 (501)
T PHA03210        217 LGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKL  295 (501)
T ss_pred             HHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence            457899999999999999999999999995 5788877542     2234677889999999999999999999999999


Q ss_pred             CcEEEccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCC-CCCCCCh
Q 016865           76 ENLLLDSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYL-PFGETDL  153 (381)
Q Consensus        76 ~NiLl~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~-Pf~~~~~  153 (381)
                      +|||++.++.+||+|||++....... ....+.+||+.|+|||++.+..+. .++||||+||++|+|++|.. ||.....
T Consensus       296 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~~~~~p~~~~~~  374 (501)
T PHA03210        296 ENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDFCPIGDGGG  374 (501)
T ss_pred             HHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCccCCCC
Confidence            99999999999999999998664422 223456899999999999887775 89999999999999999875 4533221


Q ss_pred             ---hHHHHHhh---------------------cccC-----CCC-----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          154 ---PTLYKKIN---------------------AAEF-----SCP-----FWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       154 ---~~~~~~i~---------------------~~~~-----~~p-----~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                         ..+.+.+.                     ...+     ..+     ..++.++.++|.+||..||.+|||+.|++.|
T Consensus       375 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        375 KPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             CHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence               11111111                     0000     001     1246678889999999999999999999999


Q ss_pred             cccccC
Q 016865          200 PWFRKN  205 (381)
Q Consensus       200 p~~~~~  205 (381)
                      |||...
T Consensus       455 p~f~~~  460 (501)
T PHA03210        455 PLFSAE  460 (501)
T ss_pred             hhhhcC
Confidence            999753

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.8e-36  Score=283.42  Aligned_cols=197  Identities=22%  Similarity=0.332  Sum_probs=168.6

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHH
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ----------------GRLLENDCRRYFQQLIDAVAHCH   64 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~~L~~LH   64 (381)
                      |+.++||||+++++++.+.+..++||||+++|+|.+++...                +.+++..++.++.||+.||+|||
T Consensus        61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH  140 (291)
T cd05094          61 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA  140 (291)
T ss_pred             HhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            36789999999999999999999999999999999999653                23789999999999999999999


Q ss_pred             HCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHH
Q 016865           65 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM  142 (381)
Q Consensus        65 ~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll  142 (381)
                      ++||+||||||+||+++.++.++|+|||++.......  .......|++.|+|||++.+..+. .++||||+||++|+|+
T Consensus       141 ~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~  219 (291)
T cd05094         141 SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIF  219 (291)
T ss_pred             hCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCC-chhhHHHHHHHHHHHH
Confidence            9999999999999999999999999999987543321  112344568899999998876664 8899999999999999


Q ss_pred             h-CCCCCCCCChhHHHHHhhcccC-CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          143 A-GYLPFGETDLPTLYKKINAAEF-SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       143 ~-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      + |..||...+.......+..+.. ..+...+..+.+++.+||..+|.+|||+.++++
T Consensus       220 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         220 TYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             hCCCCCCCCCCHHHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            9 9999988777666666655443 334557899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.5e-36  Score=278.62  Aligned_cols=197  Identities=28%  Similarity=0.395  Sum_probs=168.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||+++++++...+.+++||||+++|+|.+++...  ..+++..+..++.|++.||+|||++|++||||||+||
T Consensus        56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~ni  135 (263)
T cd05052          56 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC  135 (263)
T ss_pred             HHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceE
Confidence            45789999999999999999999999999999999998653  3588999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCccc-cccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVEL-LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      ++++++.+||+|||++......... .....++..|+|||++.+..+. .++||||+||++|+|++ |..||...+....
T Consensus       136 l~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~  214 (263)
T cd05052         136 LVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQV  214 (263)
T ss_pred             EEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            9999999999999998765432111 1122346679999998776664 88999999999999998 9999988777777


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...+... ....|..+++++.++|.+||..||++|||+.++++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         215 YELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            6666543 34556678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.9e-36  Score=285.44  Aligned_cols=201  Identities=23%  Similarity=0.411  Sum_probs=160.7

Q ss_pred             CCCCCccccccceEEEEeCC--------EEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 016865            1 MKIVRHPNIVRLHEVLASRT--------KVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHR   71 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~--------~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~Hr   71 (381)
                      |++++||||+++++++.+..        ..|+||||+.+ +|.+.+.... .+++..++.++.|++.||+|||++|++|+
T Consensus        65 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~  143 (310)
T cd07865          65 LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHR  143 (310)
T ss_pred             HHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            36789999999999987543        56999999964 8888776543 68999999999999999999999999999


Q ss_pred             CCCCCcEEEccCCCEEEeeccCccCCCCCc----cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCC
Q 016865           72 DLKPENLLLDSYGNLKVSDFGLSALPQQGV----ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLP  147 (381)
Q Consensus        72 Dlkp~NiLl~~~~~lkl~DFGls~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~P  147 (381)
                      ||||+||+++.++.+||+|||++.......    .......++..|+|||.+.+....+.++||||+|+++|+|++|.+|
T Consensus       144 dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~  223 (310)
T cd07865         144 DMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPI  223 (310)
T ss_pred             CCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCC
Confidence            999999999999999999999987654321    1123456789999999986654345899999999999999999999


Q ss_pred             CCCCChhHHHHHhhcc-------------------cCCCC-------------CCCChhHHHHHHHhcCCCCCCCCCHHH
Q 016865          148 FGETDLPTLYKKINAA-------------------EFSCP-------------FWFSTGATSLIHKILDPNPKTRIRIEG  195 (381)
Q Consensus       148 f~~~~~~~~~~~i~~~-------------------~~~~p-------------~~~s~~~~~li~~~L~~dP~~R~t~~~  195 (381)
                      |...+.......+...                   ....|             ...++.+.+||.+||..||.+|||+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e  303 (310)
T cd07865         224 MQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADT  303 (310)
T ss_pred             CCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHH
Confidence            9876544322221110                   00011             113677889999999999999999999


Q ss_pred             HhcCccc
Q 016865          196 IRKHPWF  202 (381)
Q Consensus       196 il~hp~~  202 (381)
                      +++||||
T Consensus       304 ~l~h~~f  310 (310)
T cd07865         304 ALNHDFF  310 (310)
T ss_pred             HhcCCCC
Confidence            9999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.8e-36  Score=277.36  Aligned_cols=194  Identities=23%  Similarity=0.241  Sum_probs=163.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++......++||||+++|+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+||+
T Consensus        53 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nil  132 (258)
T cd05078          53 MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVL  132 (258)
T ss_pred             HHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEE
Confidence            457899999999999999999999999999999999997644 5899999999999999999999999999999999999


Q ss_pred             EccCCC--------EEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhC-CCCCCC
Q 016865           80 LDSYGN--------LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG-YLPFGE  150 (381)
Q Consensus        80 l~~~~~--------lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G-~~Pf~~  150 (381)
                      ++.++.        ++++|||++.....    .....+++.|+|||++.+....+.++||||+||++|+|++| .+||..
T Consensus       133 i~~~~~~~~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~  208 (258)
T cd05078         133 LIREEDRKTGNPPFIKLSDPGISITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA  208 (258)
T ss_pred             EecccccccCCCceEEecccccccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh
Confidence            987765        69999998865432    23456889999999997655445899999999999999998 577766


Q ss_pred             CChhHHHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          151 TDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       151 ~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      .+...... ........|...+.++.++|.+||+.||.+|||++++++.
T Consensus       209 ~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         209 LDSQKKLQ-FYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             ccHHHHHH-HHHccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            55443322 3334455666678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=7.9e-36  Score=281.52  Aligned_cols=203  Identities=22%  Similarity=0.291  Sum_probs=169.9

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCCee
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG----------RLLENDCRRYFQQLIDAVAHCHSKGVYH   70 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~----------~l~e~~~~~~~~qll~~L~~LH~~gi~H   70 (381)
                      |+.++||||+++++++.+.+..|+||||+++|+|.+++...+          ..+...+..++.|++.||.|||++||+|
T Consensus        63 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H  142 (288)
T cd05061          63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVH  142 (288)
T ss_pred             HHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcC
Confidence            467899999999999999999999999999999999997532          2356778899999999999999999999


Q ss_pred             cCCCCCcEEEccCCCEEEeeccCccCCCCCcc--ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCC
Q 016865           71 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLP  147 (381)
Q Consensus        71 rDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~P  147 (381)
                      |||||+||++++++.+||+|||+++.......  ......++..|+|||.+.+..++ .++||||+||++|+|++ |..|
T Consensus       143 ~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~DvwslG~~l~el~~~~~~p  221 (288)
T cd05061         143 RDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT-TSSDMWSFGVVLWEITSLAEQP  221 (288)
T ss_pred             CCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCC-hHhHHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999875433211  11223457789999998776654 89999999999999998 8999


Q ss_pred             CCCCChhHHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc------Cccccc
Q 016865          148 FGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK------HPWFRK  204 (381)
Q Consensus       148 f~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~------hp~~~~  204 (381)
                      |...+.......+..+ ....+...++.+.+++.+||+.||.+|||+.++++      ||||+.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  285 (288)
T cd05061         222 YQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE  285 (288)
T ss_pred             CCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence            9887776666555443 33455667899999999999999999999999987      888864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.4e-36  Score=281.67  Aligned_cols=201  Identities=27%  Similarity=0.430  Sum_probs=164.9

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCC
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPE   76 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~L~~LH~~-gi~HrDlkp~   76 (381)
                      +.++||||+++++++..++..|+||||++ |+|.+.+..    ...+++..++.++.|++.||+|||++ +++||||||+
T Consensus        55 ~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~  133 (283)
T cd06617          55 RSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPS  133 (283)
T ss_pred             HHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHH
Confidence            56789999999999999999999999997 577776654    34689999999999999999999997 9999999999


Q ss_pred             cEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecC----CCCCCCcccHhHHHHHHHHHHhCCCCCCCCC
Q 016865           77 NLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN----RGYDGSAADVWSCGVILFVLMAGYLPFGETD  152 (381)
Q Consensus        77 NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~  152 (381)
                      ||+++.++.+||+|||++...... .......|+..|+|||++.+    ..+ +.++|+||+||++|+|++|..||....
T Consensus       134 nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~  211 (283)
T cd06617         134 NVLINRNGQVKLCDFGISGYLVDS-VAKTIDAGCKPYMAPERINPELNQKGY-DVKSDVWSLGITMIELATGRFPYDSWK  211 (283)
T ss_pred             HEEECCCCCEEEeecccccccccc-cccccccCCccccChhhcCCccccccc-CccccchhhHHHHHHHHhCCCCCCccc
Confidence            999999999999999998765432 12233568999999998864    223 478999999999999999999997532


Q ss_pred             h--hHHHHHhhcccCCCC-CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          153 L--PTLYKKINAAEFSCP-FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       153 ~--~~~~~~i~~~~~~~p-~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      .  ..............| ..+|.++.++|.+||..+|.+|||++++++||||.+.
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  267 (283)
T cd06617         212 TPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH  267 (283)
T ss_pred             cCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence            2  222222322233333 2478999999999999999999999999999999865

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=6.9e-36  Score=275.81  Aligned_cols=197  Identities=28%  Similarity=0.481  Sum_probs=164.1

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+....|+||||+++++|.+++...+ .+++..++.++.|++.||.|||++|++||||||+||+
T Consensus        47 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil  126 (252)
T cd05084          47 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCL  126 (252)
T ss_pred             HHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEE
Confidence            467899999999999999999999999999999999987644 5899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccc--cccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVEL--LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      ++.++.+||+|||++.........  .....++..|+|||.+.+..+. .++||||+||++|+|++ |.+||...+....
T Consensus       127 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~  205 (252)
T cd05084         127 VTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYS-SESDVWSFGILLWEAFSLGAVPYANLSNQQT  205 (252)
T ss_pred             EcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccCHHHH
Confidence            999999999999998754321110  0111234569999999776654 88999999999999998 9999987665544


Q ss_pred             HHHhhc-ccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINA-AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...+.. .....|..++..+.+++.+||..+|.+|||+.++++
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         206 REAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            444433 234556667899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-36  Score=276.85  Aligned_cols=198  Identities=24%  Similarity=0.401  Sum_probs=167.1

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+..|+||||++|++|.+++... +.++++.+..++.|++.||.|||++|++||||||+||+
T Consensus        53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~  132 (256)
T cd05059          53 MMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCL  132 (256)
T ss_pred             HHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEE
Confidence            36789999999999999999999999999999999999763 46899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccc-cccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVEL-LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  157 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~  157 (381)
                      ++.++.+||+|||++......... .....++..|+|||.+.+..+. .++||||+||++|+|++ |..||...+.....
T Consensus       133 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~  211 (256)
T cd05059         133 VGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS-SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV  211 (256)
T ss_pred             ECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHhccCCCCCCCCCHHHHH
Confidence            999999999999998754332111 1111234579999999876664 89999999999999999 89999877766666


Q ss_pred             HHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          158 KKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       158 ~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ..+... ....|...++.+.+++.+||..+|.+|||+.++++.
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         212 ESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            555543 344566689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-36  Score=291.73  Aligned_cols=199  Identities=28%  Similarity=0.463  Sum_probs=162.9

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccC
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRL-LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY   83 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l-~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~   83 (381)
                      .|.+||++|++-..++.+|+||||=+ -+|...|...... +....+.|.+|++.|++++|..||+|.||||.|+|+-. 
T Consensus       418 g~~~IIqL~DYEv~d~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-  495 (677)
T KOG0596|consen  418 GHDKIIQLYDYEVTDGYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-  495 (677)
T ss_pred             CCceEEEEeeeeccCceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-
Confidence            58999999999999999999999864 5898888776554 44688999999999999999999999999999999865 


Q ss_pred             CCEEEeeccCccCCCCC--ccccccccCCCCCCCCceecCCCCC----------CCcccHhHHHHHHHHHHhCCCCCCCC
Q 016865           84 GNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLSNRGYD----------GSAADVWSCGVILFVLMAGYLPFGET  151 (381)
Q Consensus        84 ~~lkl~DFGls~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~----------~~~~DIwSlGvil~~ll~G~~Pf~~~  151 (381)
                      |.+||+|||+|......  .-...+.+||+.||+||.+....+.          +.++||||||||||+|+.|++||...
T Consensus       496 G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~  575 (677)
T KOG0596|consen  496 GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI  575 (677)
T ss_pred             eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH
Confidence            89999999999876542  2234578999999999998754433          57899999999999999999999753


Q ss_pred             C-hhHHHHHhhcc--cCCCCCCCChh-HHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          152 D-LPTLYKKINAA--EFSCPFWFSTG-ATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       152 ~-~~~~~~~i~~~--~~~~p~~~s~~-~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      - ...-...|...  .+.+|..-+.. +.++++.||..||++|||+.++|+|||++..
T Consensus       576 ~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  576 INQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             HHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence            2 33333334333  23555443333 9999999999999999999999999999753

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.4e-36  Score=291.40  Aligned_cols=207  Identities=27%  Similarity=0.430  Sum_probs=168.1

Q ss_pred             CCCCCccccccceEEEEe----CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 016865            1 MKIVRHPNIVRLHEVLAS----RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE   76 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~----~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~   76 (381)
                      |++++||||+++++++..    ...+|+||||+. |+|.+.+...+.+++..++.++.|++.||.|||++||+||||||+
T Consensus        58 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~  136 (334)
T cd07855          58 LRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPS  136 (334)
T ss_pred             HHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence            467899999999998863    357999999995 589999887778999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccCccCCCCCc----cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCC
Q 016865           77 NLLLDSYGNLKVSDFGLSALPQQGV----ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD  152 (381)
Q Consensus        77 NiLl~~~~~lkl~DFGls~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~  152 (381)
                      ||+++.++.+||+|||++.......    ....+..|+..|+|||++.+....+.++||||+||++|+|++|+.||...+
T Consensus       137 Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~  216 (334)
T cd07855         137 NLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN  216 (334)
T ss_pred             HEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC
Confidence            9999999999999999987543311    122355789999999998664445689999999999999999999997765


Q ss_pred             hhHHHHHhhc--------------------------ccCCC-----CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 016865          153 LPTLYKKINA--------------------------AEFSC-----PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPW  201 (381)
Q Consensus       153 ~~~~~~~i~~--------------------------~~~~~-----p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~  201 (381)
                      .......+..                          .....     .+..++++.++|++||+.+|.+|||+++++.|||
T Consensus       217 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~  296 (334)
T cd07855         217 YVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF  296 (334)
T ss_pred             hHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChh
Confidence            4332211100                          00011     1236889999999999999999999999999999


Q ss_pred             cccCCCC
Q 016865          202 FRKNYNP  208 (381)
Q Consensus       202 ~~~~~~~  208 (381)
                      |.....+
T Consensus       297 ~~~~~~~  303 (334)
T cd07855         297 LAQYHDP  303 (334)
T ss_pred             hhhccCC
Confidence            9865543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=8.8e-36  Score=274.13  Aligned_cols=201  Identities=33%  Similarity=0.539  Sum_probs=173.9

Q ss_pred             CCCCCccccccceEEEEeC--CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASR--TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~--~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      +++++||||+++++.+.+.  +.+++|+||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||
T Consensus        53 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni  132 (260)
T cd06606          53 LSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANI  132 (260)
T ss_pred             HHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence            3578999999999999988  89999999999999999998877899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCcc--ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCC-hhH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-LPT  155 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-~~~  155 (381)
                      +++.++.++|+|||.+........  ......++..|.|||.+.+..+ +.++||||+|+++|+|++|..||...+ ...
T Consensus       133 ~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~  211 (260)
T cd06606         133 LVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMA  211 (260)
T ss_pred             EEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHH
Confidence            999999999999999887655322  1345678999999999877654 489999999999999999999998765 223


Q ss_pred             HHHHhh--cccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          156 LYKKIN--AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       156 ~~~~i~--~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      ....+.  ......|..++..+.++|.+||..||.+|||+.+++.||||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         212 ALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            333333  23334566679999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=8e-36  Score=276.60  Aligned_cols=197  Identities=25%  Similarity=0.426  Sum_probs=169.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||+++++++.+....|+||||+++|+|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||
T Consensus        56 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~ni  135 (261)
T cd05148          56 LKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNI  135 (261)
T ss_pred             HhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceE
Confidence            46789999999999999999999999999999999999753  4588999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  157 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~  157 (381)
                      ++++++.+||+|||++..............++..|+|||++.+..+. .++||||+||++|+|++ |..||...+....+
T Consensus       136 lv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~  214 (261)
T cd05148         136 LVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY  214 (261)
T ss_pred             EEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence            99999999999999987654322222334467789999998776654 88999999999999998 89999887766666


Q ss_pred             HHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          158 KKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       158 ~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ..+... ....|...++.+.+++.+||..||.+|||+.++++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         215 DQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            655543 34556678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-36  Score=285.34  Aligned_cols=201  Identities=27%  Similarity=0.431  Sum_probs=161.1

Q ss_pred             CCCCCccccccceEEEEeC--CEEEEEEecCCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q 016865            1 MKIVRHPNIVRLHEVLASR--TKVYIILEFVTGGELFDKIVHQ-----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL   73 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~--~~~~lV~E~~~gg~L~~~i~~~-----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDl   73 (381)
                      ++.++||||+++++++.+.  ..+|+||||+++ +|.+.+...     ..+++..++.++.|++.||+|||+.||+||||
T Consensus        56 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dl  134 (316)
T cd07842          56 LRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDL  134 (316)
T ss_pred             HHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCC
Confidence            3568999999999999988  899999999975 777766432     26899999999999999999999999999999


Q ss_pred             CCCcEEEcc----CCCEEEeeccCccCCCCCcc---ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCC
Q 016865           74 KPENLLLDS----YGNLKVSDFGLSALPQQGVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYL  146 (381)
Q Consensus        74 kp~NiLl~~----~~~lkl~DFGls~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~  146 (381)
                      ||+||+++.    ++.+||+|||++........   .....++++.|+|||++.+....+.++||||+||++|+|++|++
T Consensus       135 kp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~  214 (316)
T cd07842         135 KPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEP  214 (316)
T ss_pred             CHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCC
Confidence            999999999    89999999999886543221   22345789999999988765544589999999999999999999


Q ss_pred             CCCCCChhH---------HHHHh--------------------------hcccCCCC---------C--CCChhHHHHHH
Q 016865          147 PFGETDLPT---------LYKKI--------------------------NAAEFSCP---------F--WFSTGATSLIH  180 (381)
Q Consensus       147 Pf~~~~~~~---------~~~~i--------------------------~~~~~~~p---------~--~~s~~~~~li~  180 (381)
                      ||...+...         ....+                          .......+         .  ..+.++.++|.
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  294 (316)
T cd07842         215 IFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLR  294 (316)
T ss_pred             CCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHH
Confidence            997544321         00000                          00000111         1  35678999999


Q ss_pred             HhcCCCCCCCCCHHHHhcCccc
Q 016865          181 KILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       181 ~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      +||+.||.+|||+.++++||||
T Consensus       295 ~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         295 KLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHhcCCcccCcCHHHHhcCCCC
Confidence            9999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-38  Score=284.73  Aligned_cols=205  Identities=23%  Similarity=0.412  Sum_probs=180.6

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |++.+.|++|++|+.|-....+|||||||..|++.|.++- ...+.|+++..+++..+.||+|||...-+|||||..|||
T Consensus        82 MQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNIL  161 (502)
T KOG0574|consen   82 MQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNIL  161 (502)
T ss_pred             HHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEE
Confidence            5678999999999999999999999999999999999865 457999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      ++.+|..|++|||.+.+........++..|||.|||||++..-+|+ .++||||||+...||..|++||.+-......--
T Consensus       162 LNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM  240 (502)
T KOG0574|consen  162 LNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM  240 (502)
T ss_pred             EcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEe
Confidence            9999999999999998877655567899999999999999998997 899999999999999999999987655433222


Q ss_pred             hhcc---cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          160 INAA---EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       160 i~~~---~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      |-..   .+.-|...|.++.+|+++||.++|.+|.|+-++++|||++...
T Consensus       241 IPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~  290 (502)
T KOG0574|consen  241 IPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP  290 (502)
T ss_pred             ccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence            2221   2334555799999999999999999999999999999998653

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.4e-36  Score=278.17  Aligned_cols=194  Identities=22%  Similarity=0.262  Sum_probs=160.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.++...++||||+++|+|..++... +.+++..+..++.|++.||+|||++||+||||||+|||
T Consensus        58 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil  137 (262)
T cd05077          58 MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNIL  137 (262)
T ss_pred             HHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEE
Confidence            35689999999999999999999999999999998888653 56899999999999999999999999999999999999


Q ss_pred             EccCCC-------EEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHH-hCCCCCCCC
Q 016865           80 LDSYGN-------LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM-AGYLPFGET  151 (381)
Q Consensus        80 l~~~~~-------lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll-~G~~Pf~~~  151 (381)
                      ++.++.       ++++|||++.....    .....|+..|+|||++.+....+.++||||+||++|+|+ +|..||...
T Consensus       138 l~~~~~~~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  213 (262)
T cd05077         138 LAREGIDGECGPFIKLSDPGIPITVLS----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK  213 (262)
T ss_pred             EecCCccCCCCceeEeCCCCCCccccC----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence            987664       89999998865432    234568899999999875444568999999999999998 599999876


Q ss_pred             ChhHHHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       152 ~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ....... ............++++.+||.+||+.||.+||++.+|+++
T Consensus       214 ~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         214 TLAEKER-FYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             chhHHHH-HHhcCccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            5544332 2233333333356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=4.7e-36  Score=294.27  Aligned_cols=197  Identities=24%  Similarity=0.363  Sum_probs=162.6

Q ss_pred             CCC-CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC--------------------------------------
Q 016865            2 KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--------------------------------------   42 (381)
Q Consensus         2 k~l-~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--------------------------------------   42 (381)
                      +.+ +||||+++++++.+.+..|+||||++||+|.+++....                                      
T Consensus        93 ~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  172 (375)
T cd05104          93 SYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMK  172 (375)
T ss_pred             HHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcC
Confidence            345 89999999999999999999999999999999986422                                      


Q ss_pred             -------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCCC
Q 016865           43 -------------------------------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN   85 (381)
Q Consensus        43 -------------------------------------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~~   85 (381)
                                                           .+++..+..++.|++.||+|||++||+||||||+|||++.++.
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~  252 (375)
T cd05104         173 PGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRI  252 (375)
T ss_pred             CCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCc
Confidence                                                 3678889999999999999999999999999999999999999


Q ss_pred             EEEeeccCccCCCCCcc--ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChh-HHHHHhh
Q 016865           86 LKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLP-TLYKKIN  161 (381)
Q Consensus        86 lkl~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~-~~~~~i~  161 (381)
                      +||+|||++........  ...+..++..|+|||++.+..+. .++||||+||++|+|++ |..||...... ...+.+.
T Consensus       253 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~  331 (375)
T cd05104         253 TKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK  331 (375)
T ss_pred             EEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCC-CCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH
Confidence            99999999876543211  11223456789999999877665 89999999999999998 99999776543 3333333


Q ss_pred             cc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          162 AA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       162 ~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      .+ ....|...+.++.+||.+||+.||++|||+.++++.
T Consensus       332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         332 EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             hCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            33 233455678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=7.9e-36  Score=279.62  Aligned_cols=198  Identities=20%  Similarity=0.249  Sum_probs=166.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCCee
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG----------RLLENDCRRYFQQLIDAVAHCHSKGVYH   70 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~----------~l~e~~~~~~~~qll~~L~~LH~~gi~H   70 (381)
                      |+.++||||+++++++.+.+..++||||+++|+|.+++....          .++...+..++.|++.||.|||+.|++|
T Consensus        63 l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH  142 (277)
T cd05062          63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVH  142 (277)
T ss_pred             HHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            356899999999999999999999999999999999987532          2467788999999999999999999999


Q ss_pred             cCCCCCcEEEccCCCEEEeeccCccCCCCCcc--ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCC
Q 016865           71 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLP  147 (381)
Q Consensus        71 rDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~P  147 (381)
                      |||||+||++++++.++|+|||++........  ......+++.|+|||++.+..+ +.++||||+||++|+|++ |..|
T Consensus       143 ~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p  221 (277)
T cd05062         143 RDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQP  221 (277)
T ss_pred             CCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCC
Confidence            99999999999999999999999875433211  1123356788999999977665 489999999999999999 7999


Q ss_pred             CCCCChhHHHHHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          148 FGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       148 f~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      |...+.......+.... ...|...++.+.+++.+||+.||.+|||+.+++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         222 YQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            98877766665554443 34566688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=7.9e-36  Score=279.78  Aligned_cols=198  Identities=23%  Similarity=0.347  Sum_probs=166.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDL   73 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDl   73 (381)
                      |+.++||||+++++++.+....|+||||++||+|.+++...+       .+++..+..++.|++.||+|||++|++||||
T Consensus        63 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dl  142 (277)
T cd05036          63 MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDI  142 (277)
T ss_pred             HHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccc
Confidence            367899999999999999999999999999999999997643       4889999999999999999999999999999


Q ss_pred             CCCcEEEccCC---CEEEeeccCccCCCCCcc--ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCC
Q 016865           74 KPENLLLDSYG---NLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLP  147 (381)
Q Consensus        74 kp~NiLl~~~~---~lkl~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~P  147 (381)
                      ||+||+++.++   .+||+|||++........  ......++..|+|||++.+..+. .++||||+||++|+|++ |..|
T Consensus       143 kp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~~g~~p  221 (277)
T cd05036         143 AARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFT-SKTDVWSFGVLLWEIFSLGYMP  221 (277)
T ss_pred             chheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcC-chhHHHHHHHHHHHHHcCCCCC
Confidence            99999998765   599999999876532111  11122335689999999776664 89999999999999997 9999


Q ss_pred             CCCCChhHHHHHhhc-ccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          148 FGETDLPTLYKKINA-AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       148 f~~~~~~~~~~~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      |...+.......+.. .....|..++..+.+++.+||..+|++|||+.++++|
T Consensus       222 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         222 YPGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            988776665555433 3345566789999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=9.6e-36  Score=282.29  Aligned_cols=195  Identities=25%  Similarity=0.370  Sum_probs=164.5

Q ss_pred             CC-CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHH
Q 016865            3 IV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHCHS   65 (381)
Q Consensus         3 ~l-~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~~L~~LH~   65 (381)
                      ++ +||||+++++++.+.+.+|+||||+++|+|.+++....                .+++..++.++.|++.||+|||+
T Consensus        58 ~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~  137 (297)
T cd05089          58 KLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE  137 (297)
T ss_pred             hhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            45 79999999999999999999999999999999996532                47889999999999999999999


Q ss_pred             CCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-C
Q 016865           66 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-G  144 (381)
Q Consensus        66 ~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G  144 (381)
                      +||+||||||+|||+++++.+||+|||++........ ......+..|+|||++.+..+. .++|||||||++|+|++ |
T Consensus       138 ~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~el~t~g  215 (297)
T cd05089         138 KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLG  215 (297)
T ss_pred             CCcccCcCCcceEEECCCCeEEECCcCCCccccceec-cCCCCcCccccCchhhccCCCC-chhhHHHHHHHHHHHHcCC
Confidence            9999999999999999999999999999864322111 1112235579999999776664 89999999999999997 9


Q ss_pred             CCCCCCCChhHHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          145 YLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       145 ~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ..||...+......++... ....|..+++.+.+||.+||..+|.+|||++++++.
T Consensus       216 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         216 GTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999888777766666543 234555689999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.1e-35  Score=279.62  Aligned_cols=198  Identities=23%  Similarity=0.373  Sum_probs=167.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHH
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-----------------GRLLENDCRRYFQQLIDAVAHC   63 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~~l~e~~~~~~~~qll~~L~~L   63 (381)
                      |+.++||||+++++++...+..|+||||+++|+|.+++...                 ..+++..+..++.|++.||+||
T Consensus        61 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l  140 (283)
T cd05090          61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL  140 (283)
T ss_pred             HhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence            46789999999999999999999999999999999998532                 2378889999999999999999


Q ss_pred             HHCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHH
Q 016865           64 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVL  141 (381)
Q Consensus        64 H~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~l  141 (381)
                      |++|++||||||+|||+++++.+||+|||+++......  .......++..|+|||++.+..+ +.++||||+||++|+|
T Consensus       141 H~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el  219 (283)
T cd05090         141 SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEI  219 (283)
T ss_pred             HhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHH
Confidence            99999999999999999999999999999997643321  12234456778999999976665 4899999999999999


Q ss_pred             Hh-CCCCCCCCChhHHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          142 MA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       142 l~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ++ |.+||.+.+.......+... ....|..+++.+.+++.+||+.||.+||++.+++++
T Consensus       220 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         220 FSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            98 99999877665555554433 345566789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1e-35  Score=276.06  Aligned_cols=198  Identities=23%  Similarity=0.373  Sum_probs=167.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |++++||||+++++++.+.+..|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+
T Consensus        53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nil  132 (256)
T cd05113          53 MMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCL  132 (256)
T ss_pred             HhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEE
Confidence            46789999999999999999999999999999999998763 46899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCcc-ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVE-LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  157 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~  157 (381)
                      ++.++.+||+|||++........ ......++..|+|||.+.+..+. .++||||+||++|+|++ |..||...+.....
T Consensus       133 i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~  211 (256)
T cd05113         133 VDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFS-SKSDVWAFGVLMWEVYSLGKMPYERFNNSETV  211 (256)
T ss_pred             EcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCccc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH
Confidence            99999999999999875433211 11122355789999999776654 89999999999999998 99999887766666


Q ss_pred             HHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          158 KKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       158 ~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ..+.... ...+...+..+++++.+||..||.+|||+.+++.+
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         212 EKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence            6655443 23455578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.5e-36  Score=285.60  Aligned_cols=196  Identities=24%  Similarity=0.360  Sum_probs=164.7

Q ss_pred             CCC-CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHH
Q 016865            2 KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHCH   64 (381)
Q Consensus         2 k~l-~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~~L~~LH   64 (381)
                      +.+ +||||+++++++.+.+.+|+||||+++|+|.+++...+                .+++..++.++.|++.||+|||
T Consensus        62 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH  141 (303)
T cd05088          62 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS  141 (303)
T ss_pred             HHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH
Confidence            345 89999999999999999999999999999999997542                4789999999999999999999


Q ss_pred             HCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-
Q 016865           65 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-  143 (381)
Q Consensus        65 ~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-  143 (381)
                      ++|++||||||+|||++.++.+||+|||++....... ......++..|+|||++.+..+ +.++||||+||++|+|++ 
T Consensus       142 ~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~  219 (303)
T cd05088         142 QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSL  219 (303)
T ss_pred             hCCccccccchheEEecCCCcEEeCccccCcccchhh-hcccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhc
Confidence            9999999999999999999999999999986432211 1112234667999999876655 489999999999999998 


Q ss_pred             CCCCCCCCChhHHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          144 GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       144 G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      |.+||...+.......+... ....|..+++++.+||.+||+.+|.+|||+++++.+
T Consensus       220 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         220 GGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             CCCCcccCChHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999877776666655443 233455578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.8e-36  Score=278.15  Aligned_cols=200  Identities=32%  Similarity=0.543  Sum_probs=171.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE   76 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~   76 (381)
                      ++.++||||+++++.+.+....|+|+||+++++|.+.+..    ...+++..++.++.|++.||.|||+.|++|+||+|+
T Consensus        56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~  135 (260)
T cd08222          56 LSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAK  135 (260)
T ss_pred             HHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChh
Confidence            3568999999999999999999999999999999988853    346899999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHH
Q 016865           77 NLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL  156 (381)
Q Consensus        77 NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~  156 (381)
                      ||++++ +.++|+|||++..............|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||...+....
T Consensus       136 nili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~  213 (260)
T cd08222         136 NIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSV  213 (260)
T ss_pred             heEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence            999975 679999999987654433334456689999999998776665 789999999999999999999987666555


Q ss_pred             HHHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          157 YKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       157 ~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      ...+.... ...|..++.++.++|.+||..||.+||++.++++||||
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         214 VLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            55544332 34455688999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.3e-36  Score=290.06  Aligned_cols=204  Identities=29%  Similarity=0.458  Sum_probs=167.5

Q ss_pred             CCCCCccccccceEEEEeC-----CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASR-----TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKP   75 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp   75 (381)
                      |+.++||||+++++++...     ..+|+|+||+. ++|.+.+...+.+++..+..++.|++.||.|||++|++||||||
T Consensus        58 l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp  136 (337)
T cd07858          58 LRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKP  136 (337)
T ss_pred             HHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCH
Confidence            3567999999999988654     35899999995 68999998888899999999999999999999999999999999


Q ss_pred             CcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhH
Q 016865           76 ENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT  155 (381)
Q Consensus        76 ~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  155 (381)
                      +||+++.++.+||+|||++..............|+..|+|||.+.+....+.++||||+||++|+|++|.+||.+.+...
T Consensus       137 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  216 (337)
T cd07858         137 SNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH  216 (337)
T ss_pred             HHEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH
Confidence            99999999999999999987654432334456789999999998654445689999999999999999999997665432


Q ss_pred             HHHHhhc------------------------c----cC---CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          156 LYKKINA------------------------A----EF---SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       156 ~~~~i~~------------------------~----~~---~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      ....+..                        .    ..   ...+.+++++.++|++||+.+|.+|||++++++||||..
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~  296 (337)
T cd07858         217 QLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS  296 (337)
T ss_pred             HHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence            2211100                        0    00   012347889999999999999999999999999999975


Q ss_pred             C
Q 016865          205 N  205 (381)
Q Consensus       205 ~  205 (381)
                      .
T Consensus       297 ~  297 (337)
T cd07858         297 L  297 (337)
T ss_pred             h
Confidence            4

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-35  Score=274.66  Aligned_cols=196  Identities=26%  Similarity=0.382  Sum_probs=166.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++. .+..++||||+++|+|.+++.....+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus        50 l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili  128 (257)
T cd05060          50 MAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL  128 (257)
T ss_pred             HHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE
Confidence            46789999999999886 45689999999999999999887789999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccc---cccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLH---TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      +.++.+||+|||++...........   ...++..|+|||.+.+..+. .++||||+||++|+|++ |.+||...+....
T Consensus       129 ~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~  207 (257)
T cd05060         129 VNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS-SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV  207 (257)
T ss_pred             cCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCC-ccchHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence            9999999999999876543222111   11235679999999776654 89999999999999998 9999988777666


Q ss_pred             HHHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...+.... ...|..+++.+.++|.+||.++|.+|||+.++++
T Consensus       208 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         208 IAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            66654443 3566678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.4e-36  Score=288.54  Aligned_cols=206  Identities=29%  Similarity=0.407  Sum_probs=172.2

Q ss_pred             CCCCCccccccceEEEEeCC-----EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKP   75 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~-----~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp   75 (381)
                      |+.++||||+++++++.+..     .+|+||||+. ++|.+.+.....+++..+..++.||+.||+|||+.||+||||||
T Consensus        53 l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp  131 (330)
T cd07834          53 LRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKP  131 (330)
T ss_pred             HHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence            46789999999999998775     8999999997 48999998877899999999999999999999999999999999


Q ss_pred             CcEEEccCCCEEEeeccCccCCCCCc---cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCC
Q 016865           76 ENLLLDSYGNLKVSDFGLSALPQQGV---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD  152 (381)
Q Consensus        76 ~NiLl~~~~~lkl~DFGls~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~  152 (381)
                      +||+++.++.++|+|||++.......   .......+++.|+|||++.+....+.++|+||+||++|+|++|.+||...+
T Consensus       132 ~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~  211 (330)
T cd07834         132 SNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD  211 (330)
T ss_pred             HHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence            99999999999999999988655432   223455689999999999877344589999999999999999999998777


Q ss_pred             hhHHHHHhhcccC-------------------------------CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 016865          153 LPTLYKKINAAEF-------------------------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPW  201 (381)
Q Consensus       153 ~~~~~~~i~~~~~-------------------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~  201 (381)
                      ....+..+.....                               ...+.+++++.++|.+||+.+|.+|||+++++.|||
T Consensus       212 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~  291 (330)
T cd07834         212 YIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY  291 (330)
T ss_pred             HHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCcc
Confidence            6544443321100                               011226788999999999999999999999999999


Q ss_pred             cccCCC
Q 016865          202 FRKNYN  207 (381)
Q Consensus       202 ~~~~~~  207 (381)
                      |+....
T Consensus       292 ~~~~~~  297 (330)
T cd07834         292 LAQLHD  297 (330)
T ss_pred             HHhhcc
Confidence            986543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.4e-36  Score=298.64  Aligned_cols=194  Identities=30%  Similarity=0.426  Sum_probs=164.2

Q ss_pred             cccccceEEEEeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCC
Q 016865            7 PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG   84 (381)
Q Consensus         7 pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~   84 (381)
                      -|+|+++++|...+++|||.|++. -+|+++|+.+  .+++...++.+++||+.||.+||+.||||+|||||||||.+-+
T Consensus       248 ~n~Vrm~d~F~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~  326 (586)
T KOG0667|consen  248 YNIVRMLDYFYFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPK  326 (586)
T ss_pred             eeEEEeeeccccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCC
Confidence            489999999999999999999995 4999999875  4689999999999999999999999999999999999998644


Q ss_pred             --CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhh-
Q 016865           85 --NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN-  161 (381)
Q Consensus        85 --~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~-  161 (381)
                        .+||+|||.|.+....   ..+.+.|..|+|||++.+.+|+ .+.||||||||++||++|.+.|.+.+..+....|. 
T Consensus       327 r~~vKVIDFGSSc~~~q~---vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e  402 (586)
T KOG0667|consen  327 RSRIKVIDFGSSCFESQR---VYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIE  402 (586)
T ss_pred             cCceeEEecccccccCCc---ceeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHH
Confidence              7999999999876543   3488999999999999999997 99999999999999999999998877654443321 


Q ss_pred             ---------------------c------------------------------ccCCCCC----C-------CChhHHHHH
Q 016865          162 ---------------------A------------------------------AEFSCPF----W-------FSTGATSLI  179 (381)
Q Consensus       162 ---------------------~------------------------------~~~~~p~----~-------~s~~~~~li  179 (381)
                                           .                              .....|.    +       -...+.+||
T Consensus       403 ~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dfl  482 (586)
T KOG0667|consen  403 VLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFL  482 (586)
T ss_pred             HhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHH
Confidence                                 0                              0001120    0       124578999


Q ss_pred             HHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          180 HKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       180 ~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ++||+.||.+|+|..++++||||...
T Consensus       483 k~~L~~dP~~R~tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  483 KRCLEWDPAERITPAQALNHPFLTGT  508 (586)
T ss_pred             HHHhccCchhcCCHHHHhcCcccccc
Confidence            99999999999999999999999853

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=6.8e-36  Score=287.52  Aligned_cols=205  Identities=18%  Similarity=0.278  Sum_probs=162.6

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      +.++||||+++++++...+..|+|+||+.+|+|.+.+...  ..+++..+..++.|++.||+|||++||+||||||+||+
T Consensus        54 ~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nil  133 (328)
T cd08226          54 HFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHIL  133 (328)
T ss_pred             HhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            4589999999999999999999999999999999988764  35899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCcc-------ccccccCCCCCCCCceecCCC-CCCCcccHhHHHHHHHHHHhCCCCCCCC
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVE-------LLHTTCGTPNYVAPEVLSNRG-YDGSAADVWSCGVILFVLMAGYLPFGET  151 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~  151 (381)
                      ++.++.++++|||.+........       ......++..|+|||++.+.. ..+.++||||+||++|+|++|.+||...
T Consensus       134 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  213 (328)
T cd08226         134 ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM  213 (328)
T ss_pred             EeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            99999999999985432211100       011223567899999987632 2358999999999999999999999765


Q ss_pred             ChhHHHHHhhccc---------------------------------------------C--CCCCCCChhHHHHHHHhcC
Q 016865          152 DLPTLYKKINAAE---------------------------------------------F--SCPFWFSTGATSLIHKILD  184 (381)
Q Consensus       152 ~~~~~~~~i~~~~---------------------------------------------~--~~p~~~s~~~~~li~~~L~  184 (381)
                      .............                                             .  ..+..+++.+.+||++||.
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  293 (328)
T cd08226         214 LRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQ  293 (328)
T ss_pred             ChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHcc
Confidence            5433322211100                                             0  0111256789999999999


Q ss_pred             CCCCCCCCHHHHhcCcccccCC
Q 016865          185 PNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       185 ~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      .||.+|||++++++||||+...
T Consensus       294 ~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         294 QDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             CCcccCCCHHHHhhCHHHHHHH
Confidence            9999999999999999997543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-35  Score=277.73  Aligned_cols=195  Identities=24%  Similarity=0.362  Sum_probs=164.0

Q ss_pred             CCC-CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHH
Q 016865            2 KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHCH   64 (381)
Q Consensus         2 k~l-~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~~L~~LH   64 (381)
                      +.+ +||||+++++++...+..|+||||+++|+|.+++....                .+++..+..++.|++.||+|||
T Consensus        50 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH  129 (270)
T cd05047          50 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS  129 (270)
T ss_pred             HhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            345 79999999999999999999999999999999997532                4788999999999999999999


Q ss_pred             HCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-
Q 016865           65 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-  143 (381)
Q Consensus        65 ~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-  143 (381)
                      +.|++||||||+||++++++.+|++|||++....... .......+..|+|||++....+ +.++|||||||++|+|++ 
T Consensus       130 ~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~  207 (270)
T cd05047         130 QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSL  207 (270)
T ss_pred             HCCEeecccccceEEEcCCCeEEECCCCCccccchhh-hccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcC
Confidence            9999999999999999999999999999986432211 1112234667999999876665 489999999999999997 


Q ss_pred             CCCCCCCCChhHHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          144 GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       144 G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      |..||...+.......+... ....+..++.++.+++.+||..||.+|||+++++.
T Consensus       208 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         208 GGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCCCccccCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            99999887777766666443 23445557899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-35  Score=278.02  Aligned_cols=197  Identities=21%  Similarity=0.278  Sum_probs=168.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCCee
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG----------RLLENDCRRYFQQLIDAVAHCHSKGVYH   70 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~----------~l~e~~~~~~~~qll~~L~~LH~~gi~H   70 (381)
                      |+.++||||+++++++.+....|+||||+++|+|.+++....          .+++..+..++.|++.||.|||+.|++|
T Consensus        63 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H  142 (277)
T cd05032          63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVH  142 (277)
T ss_pred             HHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            356899999999999999999999999999999999986532          3677899999999999999999999999


Q ss_pred             cCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCC
Q 016865           71 RDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLP  147 (381)
Q Consensus        71 rDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~P  147 (381)
                      |||||+||+++.++.+||+|||+++......  .......++..|+|||.+.+..+ +.++|||||||++|++++ |..|
T Consensus       143 ~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p  221 (277)
T cd05032         143 RDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQP  221 (277)
T ss_pred             cccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCC
Confidence            9999999999999999999999987543321  12234457889999999876665 489999999999999998 9999


Q ss_pred             CCCCChhHHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          148 FGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       148 f~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      |...+.....+.+... ....|..++.++.++|.+||..+|++|||+.++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         222 YQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CccCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            9887776666655543 34566778999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.8e-35  Score=277.48  Aligned_cols=194  Identities=24%  Similarity=0.284  Sum_probs=161.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+..|+||||+++|+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||
T Consensus        70 ~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nil  149 (274)
T cd05076          70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNIL  149 (274)
T ss_pred             HhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEE
Confidence            4678999999999999999999999999999999988865 467899999999999999999999999999999999999


Q ss_pred             EccCC-------CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHH-hCCCCCCCC
Q 016865           80 LDSYG-------NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM-AGYLPFGET  151 (381)
Q Consensus        80 l~~~~-------~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll-~G~~Pf~~~  151 (381)
                      ++..+       .+|++|||++.....    .....++..|+|||.+.+....+.++||||+||++|+|+ +|..||...
T Consensus       150 l~~~~~~~~~~~~~kl~d~g~~~~~~~----~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  225 (274)
T cd05076         150 LARLGLAEGTSPFIKLSDPGVSFTALS----REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER  225 (274)
T ss_pred             EeccCcccCccceeeecCCcccccccc----ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence            98654       389999998754322    123457889999999876444468999999999999985 699999876


Q ss_pred             ChhHHHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       152 ~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ........ .......|...++.+.++|.+||+.+|.+|||+.+++++
T Consensus       226 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         226 TPSEKERF-YEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             ChHHHHHH-HHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            55443322 223334555567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.9e-35  Score=278.74  Aligned_cols=202  Identities=27%  Similarity=0.452  Sum_probs=164.6

Q ss_pred             CCCCCccccccceEEEEe--CCEEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 016865            1 MKIVRHPNIVRLHEVLAS--RTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK   74 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlk   74 (381)
                      |+.++||||+++++++.+  .+.+|+||||++||+|.+++..    ...+++..+..++.|++.||.|||+.|++|+||+
T Consensus        53 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~  132 (287)
T cd06621          53 NKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIK  132 (287)
T ss_pred             HHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            467899999999999865  3579999999999999887653    3458999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh-
Q 016865           75 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL-  153 (381)
Q Consensus        75 p~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-  153 (381)
                      |+||+++.++.++|+|||++......  ......++..|+|||.+.+..++ .++||||+||++|+|++|..||..... 
T Consensus       133 ~~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~  209 (287)
T cd06621         133 PSNILLTRKGQVKLCDFGVSGELVNS--LAGTFTGTSFYMAPERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEP  209 (287)
T ss_pred             HHHEEEecCCeEEEeecccccccccc--ccccccCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCcccCC
Confidence            99999999999999999998754332  12345688999999999776665 899999999999999999999976521 


Q ss_pred             ----hHHHHHhhccc-CCCC------CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          154 ----PTLYKKINAAE-FSCP------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       154 ----~~~~~~i~~~~-~~~p------~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                          ......+.... ...+      ..+++.+.++|.+||..+|.+|||+.|+++||||++.
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         210 PLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             CCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence                22222222211 1111      1246789999999999999999999999999999654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.5e-35  Score=275.14  Aligned_cols=196  Identities=22%  Similarity=0.351  Sum_probs=165.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |++++||||++++++++ ....|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+
T Consensus        49 l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil  127 (257)
T cd05115          49 MHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVL  127 (257)
T ss_pred             HHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEE
Confidence            46789999999999986 4578999999999999999875 456899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccc---cccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVEL---LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPT  155 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~  155 (381)
                      ++.++.+||+|||++.........   .....+++.|+|||++....+ +.++|||||||++|++++ |..||.......
T Consensus       128 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~  206 (257)
T cd05115         128 LVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPE  206 (257)
T ss_pred             EcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHH
Confidence            999999999999998755432211   111223578999999876665 489999999999999997 999998877666


Q ss_pred             HHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          156 LYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       156 ~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ....+..+ ....|...++++.++|.+||..+|++||++.++.+
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         207 VMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             HHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            66555443 34566778999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2e-35  Score=275.12  Aligned_cols=198  Identities=25%  Similarity=0.380  Sum_probs=169.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++.+.+.+..|+||||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+
T Consensus        59 l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nil  138 (266)
T cd05033          59 MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNIL  138 (266)
T ss_pred             HHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEE
Confidence            35789999999999999999999999999999999998763 46899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccc--cccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLH--TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~--~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      +++++.++|+|||++...........  ...+++.|+|||.+.+..++ .++||||||+++|+|++ |..||........
T Consensus       139 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~  217 (266)
T cd05033         139 VNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSYGERPYWDMSNQDV  217 (266)
T ss_pred             EcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCc-cccchHHHHHHHHHHHccCCCCCCCCCHHHH
Confidence            99999999999999987642222222  23346789999999876664 89999999999999998 9999987776666


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ...+... ....+...++.+.+++.+||+.+|.+|||+.+++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         218 IKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            6655543 334556689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.7e-35  Score=278.05  Aligned_cols=197  Identities=21%  Similarity=0.341  Sum_probs=167.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHH
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG---------------RLLENDCRRYFQQLIDAVAHCHS   65 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~---------------~l~e~~~~~~~~qll~~L~~LH~   65 (381)
                      |+.++||||+++++++.+.+..|+||||+++|+|.+++...+               .+++..+..++.|++.||+|||+
T Consensus        61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~  140 (280)
T cd05092          61 LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS  140 (280)
T ss_pred             HhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH
Confidence            367899999999999999999999999999999999987643               47889999999999999999999


Q ss_pred             CCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh
Q 016865           66 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA  143 (381)
Q Consensus        66 ~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~  143 (381)
                      .|++||||||+||++++++.+||+|||++.......  .......+++.|+|||.+.+..++ .++|||||||++|+|++
T Consensus       141 ~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~  219 (280)
T cd05092         141 LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDIWSFGVVLWEIFT  219 (280)
T ss_pred             CCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcC-chhhHHHHHHHHHHHHc
Confidence            999999999999999999999999999986543211  112233457889999999877765 89999999999999998


Q ss_pred             -CCCCCCCCChhHHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          144 -GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       144 -G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                       |.+||...+.......+... ....|..+++.+.++|.+||+.||.+||++++++.
T Consensus       220 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         220 YGKQPWYQLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             CCCCCCccCCHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence             99999877666655555443 34556678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.2e-35  Score=270.39  Aligned_cols=199  Identities=33%  Similarity=0.543  Sum_probs=169.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++......++++||++|++|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||+
T Consensus        51 l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~  130 (253)
T cd05122          51 LKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANIL  130 (253)
T ss_pred             HHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEE
Confidence            35788999999999999999999999999999999998775 57899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      ++.++.++|+|||.+........ .....|+..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......
T Consensus       131 i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  208 (253)
T cd05122         131 LTSDGEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFK  208 (253)
T ss_pred             EccCCeEEEeecccccccccccc-ccceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Confidence            99999999999999877654322 345678999999999976654 4899999999999999999999987754433333


Q ss_pred             hhccc-CCC--CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 016865          160 INAAE-FSC--PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPW  201 (381)
Q Consensus       160 i~~~~-~~~--p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~  201 (381)
                      ..... ...  +..++..+.++|.+||+.||.+|||+.++++|||
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         209 IATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            32221 122  2224889999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-35  Score=274.45  Aligned_cols=200  Identities=33%  Similarity=0.499  Sum_probs=170.0

Q ss_pred             CCCCCccccccceEEEEeC--CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASR--TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~--~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |++++||||+++++.+.+.  ..+++|+||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||
T Consensus        58 l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni  137 (264)
T cd06653          58 LKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANI  137 (264)
T ss_pred             HHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence            3578999999999998764  57999999999999999998878899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCC---ccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQG---VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT  155 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  155 (381)
                      +++.++.++|+|||++......   ........|+..|+|||.+.+..++ .++|+||+||++|+|++|+.||...+...
T Consensus       138 ~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~  216 (264)
T cd06653         138 LRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYG-RKADVWSVACTVVEMLTEKPPWAEYEAMA  216 (264)
T ss_pred             EEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccCHHH
Confidence            9999999999999998765321   1112345689999999999876654 89999999999999999999998765544


Q ss_pred             HHHHhhcc--cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          156 LYKKINAA--EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       156 ~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      ...++...  ....|..+++.+.++|.+||. +|..|||+.+++.|||.
T Consensus       217 ~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         217 AIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            44433322  234577789999999999999 58999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-35  Score=287.05  Aligned_cols=205  Identities=28%  Similarity=0.448  Sum_probs=163.7

Q ss_pred             CCCCCccccccceEEEEeC-----CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASR-----TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKP   75 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp   75 (381)
                      |+.++||||+++++++...     ...|+|+||+.+ +|.+.+.. +.+++..++.++.|++.||.|||+.||+||||||
T Consensus        57 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp  134 (336)
T cd07849          57 LRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKP  134 (336)
T ss_pred             HHhCCCCCcCchhheeecccccccceEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH
Confidence            3578999999999987654     358999999964 88877744 6799999999999999999999999999999999


Q ss_pred             CcEEEccCCCEEEeeccCccCCCCCc---cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCC
Q 016865           76 ENLLLDSYGNLKVSDFGLSALPQQGV---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD  152 (381)
Q Consensus        76 ~NiLl~~~~~lkl~DFGls~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~  152 (381)
                      +||+++.++.+||+|||++.......   ......+||+.|+|||++.+....+.++||||+||++|+|++|++||.+.+
T Consensus       135 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~  214 (336)
T cd07849         135 SNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD  214 (336)
T ss_pred             HHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999987643321   122345789999999987654444689999999999999999999997655


Q ss_pred             hhHHHHHhh---------------cc---------c--CC-----CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 016865          153 LPTLYKKIN---------------AA---------E--FS-----CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPW  201 (381)
Q Consensus       153 ~~~~~~~i~---------------~~---------~--~~-----~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~  201 (381)
                      .......+.               ..         .  ..     ..+.+++++.++|.+||+.+|.+|||+.++++|||
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~  294 (336)
T cd07849         215 YLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY  294 (336)
T ss_pred             HHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence            332211110               00         0  00     01235788999999999999999999999999999


Q ss_pred             cccCCC
Q 016865          202 FRKNYN  207 (381)
Q Consensus       202 ~~~~~~  207 (381)
                      |+....
T Consensus       295 ~~~~~~  300 (336)
T cd07849         295 LEQYHD  300 (336)
T ss_pred             ccccCC
Confidence            986553

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.8e-35  Score=280.36  Aligned_cols=201  Identities=24%  Similarity=0.376  Sum_probs=167.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      ++.++||||+++++++.+.+..|+||||+.| +|.+.+.. .+.+++..+..++.|++.||.|||+.||+||||+|+||+
T Consensus        69 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl  147 (307)
T cd06607          69 LQQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNIL  147 (307)
T ss_pred             HHhCCCCCEEEEEEEEEeCCeEEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEE
Confidence            3568999999999999999999999999974 77776654 456899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecC--CCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      ++.++.+||+|||++......    .+..|++.|+|||++.+  ....+.++||||+|+++|+|++|..||...+.....
T Consensus       148 ~~~~~~~kL~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~  223 (307)
T cd06607         148 LTEPGTVKLADFGSASLVSPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL  223 (307)
T ss_pred             ECCCCCEEEeecCcceecCCC----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH
Confidence            999999999999998754332    34568899999999842  223358999999999999999999999877655443


Q ss_pred             HHhhcc-cCCC-CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          158 KKINAA-EFSC-PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       158 ~~i~~~-~~~~-p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      ..+... .... +..++..+.++|.+||..||.+|||+.+++.||||....
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         224 YHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             HHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence            333322 2222 223678999999999999999999999999999998643

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.1e-35  Score=280.82  Aligned_cols=197  Identities=24%  Similarity=0.388  Sum_probs=167.3

Q ss_pred             CCC-CccccccceEEEEeCCEEEEEEecCCCCChHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHH
Q 016865            2 KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGRLLENDCRRYFQQLIDAVAHCH   64 (381)
Q Consensus         2 k~l-~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~----------------~~~l~e~~~~~~~~qll~~L~~LH   64 (381)
                      +++ +||||+++++++.+++.+|++|||+++|+|.+++..                .+.+++..+..++.|++.||.|||
T Consensus        70 ~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH  149 (293)
T cd05053          70 KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA  149 (293)
T ss_pred             HhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence            455 799999999999999999999999999999999864                245889999999999999999999


Q ss_pred             HCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCcc--ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHH
Q 016865           65 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM  142 (381)
Q Consensus        65 ~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll  142 (381)
                      +.||+||||||+||+++.++.+||+|||++........  ......++..|+|||++.+..++ .++||||+||++|+|+
T Consensus       150 ~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~  228 (293)
T cd05053         150 SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIF  228 (293)
T ss_pred             HCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcC-cccceeehhhHHHHHh
Confidence            99999999999999999999999999999986543211  11222346789999998776664 8999999999999999


Q ss_pred             h-CCCCCCCCChhHHHHHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          143 A-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       143 ~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      + |..||...+.......+.... ...|...+.++.+|+.+||..||.+|||+.+++++
T Consensus       229 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         229 TLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             cCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            8 999998887777666655443 34566688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.7e-35  Score=278.95  Aligned_cols=203  Identities=35%  Similarity=0.603  Sum_probs=171.7

Q ss_pred             CC-CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            3 IV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         3 ~l-~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      .+ +||||+++++.+.+...+|+||||++||+|.+++.....+++..++.++.|++.||.|||+.|++||||+|.||+++
T Consensus        60 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~  139 (288)
T cd05583          60 AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD  139 (288)
T ss_pred             hccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC
Confidence            45 69999999999999999999999999999999998877899999999999999999999999999999999999999


Q ss_pred             cCCCEEEeeccCccCCCCCcc-ccccccCCCCCCCCceecCCC-CCCCcccHhHHHHHHHHHHhCCCCCCCCCh----hH
Q 016865           82 SYGNLKVSDFGLSALPQQGVE-LLHTTCGTPNYVAPEVLSNRG-YDGSAADVWSCGVILFVLMAGYLPFGETDL----PT  155 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~----~~  155 (381)
                      .++.++|+|||++........ .....+|++.|+|||.+.+.. ..+.++||||+|+++|+|++|..||...+.    ..
T Consensus       140 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~  219 (288)
T cd05583         140 SEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSE  219 (288)
T ss_pred             CCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHH
Confidence            999999999999876543211 123456899999999986543 245889999999999999999999964322    23


Q ss_pred             HHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCC---HHHHhcCcccccC
Q 016865          156 LYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIR---IEGIRKHPWFRKN  205 (381)
Q Consensus       156 ~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t---~~~il~hp~~~~~  205 (381)
                      ..+.+.......|..+++++.++|.+||+.||++|||   +.++++||||+..
T Consensus       220 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~  272 (288)
T cd05583         220 ISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI  272 (288)
T ss_pred             HHHHHHccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence            3334444555667778999999999999999999998   5678999999753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-35  Score=288.05  Aligned_cols=203  Identities=27%  Similarity=0.423  Sum_probs=168.0

Q ss_pred             CCCCCccccccceEEEEeCCE------EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK   74 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~------~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlk   74 (381)
                      |+.++||||+++++++...+.      .|+|+||+ |++|.+++.. ..+++..++.++.|++.||.|||+.||+|||||
T Consensus        68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlk  145 (343)
T cd07851          68 LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLK  145 (343)
T ss_pred             HHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            356899999999998876554      99999999 6799988865 579999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           75 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        75 p~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      |+||+++.++.+||+|||++......   .....+++.|+|||++.+....+.++||||+||++|+|++|+.||...+..
T Consensus       146 p~Nill~~~~~~kL~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~  222 (343)
T cd07851         146 PSNIAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI  222 (343)
T ss_pred             HHHeEECCCCCEEEcccccccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH
Confidence            99999999999999999998865432   345578999999999866444568999999999999999999999876654


Q ss_pred             HHHHHhhcccC-------------------------------CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          155 TLYKKINAAEF-------------------------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       155 ~~~~~i~~~~~-------------------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      ..+..+....-                               .....+++.+.++|.+||..||.+|||+.++++||||+
T Consensus       223 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~  302 (343)
T cd07851         223 DQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA  302 (343)
T ss_pred             HHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcc
Confidence            44333221100                               00123588999999999999999999999999999998


Q ss_pred             cCCCC
Q 016865          204 KNYNP  208 (381)
Q Consensus       204 ~~~~~  208 (381)
                      ....+
T Consensus       303 ~~~~~  307 (343)
T cd07851         303 EYHDP  307 (343)
T ss_pred             ccCCC
Confidence            76543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-35  Score=277.32  Aligned_cols=201  Identities=32%  Similarity=0.504  Sum_probs=168.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      ++.++||||+++++++.+....|+|+||++ ++|.+++... ..+++..+..++.|++.||+|||++||+||||+|+||+
T Consensus        52 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~  130 (282)
T cd07829          52 LKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNIL  130 (282)
T ss_pred             HHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEE
Confidence            356789999999999999999999999997 5899999876 57999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      +++++.++|+|||++..............++..|+|||.+.+....+.++|+||+||++|+|++|.+||...+......+
T Consensus       131 ~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~  210 (282)
T cd07829         131 INRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFK  210 (282)
T ss_pred             EcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence            99999999999999887654333344556788999999987664446899999999999999999999987665443332


Q ss_pred             hhc------------------ccCCCCC-----------CCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          160 INA------------------AEFSCPF-----------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       160 i~~------------------~~~~~p~-----------~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      +..                  .....+.           .++..+.++|.+||..||.+|||+++++.||||
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         211 IFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             HHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            211                  0001111           247789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-35  Score=273.27  Aligned_cols=197  Identities=22%  Similarity=0.378  Sum_probs=166.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||+++++++...+..|+||||++|++|.+++....  .+++..+..++.|++.||.|||+.|++||||||+||
T Consensus        55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Ni  134 (261)
T cd05068          55 MKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNV  134 (261)
T ss_pred             HHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceE
Confidence            357899999999999999999999999999999999997644  689999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCccc-cccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVEL-LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      +++.++.+||+|||++......... .....++..|+|||++.+..+ +.++||||+||++|+|++ |+.||.+.+....
T Consensus       135 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~  213 (261)
T cd05068         135 LVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV  213 (261)
T ss_pred             EEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            9999999999999998765432111 111223457999999877665 489999999999999999 9999988776666


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...+... ....+...+..+.+++.+||..+|.+||++.++++
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         214 LQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            6655443 33455567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-36  Score=279.01  Aligned_cols=201  Identities=34%  Similarity=0.528  Sum_probs=167.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+..|+|+||+++ +|.+.+.. .+.+++..+..++.|++.||.|||+.||+|+||||+||+
T Consensus        52 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nil  130 (283)
T cd05118          52 LKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLL  130 (283)
T ss_pred             HHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEE
Confidence            3568999999999999999999999999975 88888866 357899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      ++.++.++|+|||.+..............++..|+|||.+.+....+.++|+||+|+++|+|++|+.||...+..+...+
T Consensus       131 i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~  210 (283)
T cd05118         131 INTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK  210 (283)
T ss_pred             ECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999999876654322333456889999999987763446899999999999999999999987665443333


Q ss_pred             hhcc-------------------cCCC-----------CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          160 INAA-------------------EFSC-----------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       160 i~~~-------------------~~~~-----------p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      +...                   ...+           .+.++.++.++|.+||.+||.+||++.+++.||||
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         211 IFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             HHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            2110                   0001           11267889999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2e-35  Score=272.44  Aligned_cols=199  Identities=30%  Similarity=0.532  Sum_probs=174.6

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE   76 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~   76 (381)
                      |+.++||||+++++++.+....|+|+||+++++|.+++.+    ...+++..+..++.|++.||.|||+.|++||||+|+
T Consensus        53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~  132 (256)
T cd08530          53 LASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSA  132 (256)
T ss_pred             HHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcc
Confidence            3678999999999999999999999999999999998866    356899999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHH
Q 016865           77 NLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL  156 (381)
Q Consensus        77 NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~  156 (381)
                      ||+++.++.+|++|||++......  ......|++.|+|||.+.+..++ .++|+||+|+++|+|++|+.||...+....
T Consensus       133 ni~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~  209 (256)
T cd08530         133 NILLVANDLVKIGDLGISKVLKKN--MAKTQIGTPHYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDL  209 (256)
T ss_pred             eEEEecCCcEEEeeccchhhhccC--CcccccCCccccCHHHHCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999999999999999998765543  33456789999999999876664 789999999999999999999998877666


Q ss_pred             HHHhhcccC-CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          157 YKKINAAEF-SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       157 ~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      ...+....+ ..+..++.+++++|.+||..+|.+|||+.++++||++
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         210 RYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            555554443 3445678999999999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2e-35  Score=274.11  Aligned_cols=197  Identities=21%  Similarity=0.382  Sum_probs=166.1

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||+++++++.+.+..|+||||+++|+|.+++...  ..+++.....++.|++.||+|||+.|++||||||+||
T Consensus        55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~ni  134 (261)
T cd05072          55 MKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANV  134 (261)
T ss_pred             HHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhE
Confidence            36789999999999999999999999999999999998653  4578899999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCcc-ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVE-LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      +++.++.+||+|||++........ ......++..|+|||++....+ +.++||||+||++|+|++ |..||...+....
T Consensus       135 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~  213 (261)
T cd05072         135 LVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV  213 (261)
T ss_pred             EecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH
Confidence            999999999999999986543211 1122345678999999877665 488999999999999998 9999988776665


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...+... ..+.+..++.++.+++.+||..+|.+|||++++.+
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         214 MSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            5555433 23334457899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-36  Score=254.24  Aligned_cols=204  Identities=34%  Similarity=0.548  Sum_probs=175.9

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      ||.++|.|||+++++..++.++.+|+|||.. +|..+... ++.++.+.++.++.|++.||.+||++++.|||+||+|+|
T Consensus        55 lkelkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnll  133 (292)
T KOG0662|consen   55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLL  133 (292)
T ss_pred             HHHhhhcceeehhhhhccCceeEEeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEE
Confidence            4678999999999999999999999999976 78777755 567899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYK  158 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~  158 (381)
                      ++.+|.+|++|||+++.++-+.+-....+-|.+|.+|.++.+...++.+.|+||.|||+.|+.. |++.|.+.+..+...
T Consensus       134 in~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlk  213 (292)
T KOG0662|consen  134 INRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK  213 (292)
T ss_pred             eccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHH
Confidence            9999999999999999887765555667789999999999998877799999999999999987 899999988877666


Q ss_pred             Hhhcc-------cC----------CCCC------------CCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          159 KINAA-------EF----------SCPF------------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       159 ~i~~~-------~~----------~~p~------------~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      +|...       .+          .+|.            .++..-++|++++|.-+|..|++++++++||||...
T Consensus       214 rif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  214 RIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             HHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence            65211       11          1111            134567899999999999999999999999999753

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.4e-35  Score=274.35  Aligned_cols=197  Identities=30%  Similarity=0.567  Sum_probs=165.9

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE   76 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~   76 (381)
                      |+.++||||+++++++.+.+..|+|+||+++|+|.+.+..    ...+++..+..++.|++.||.|||++|++||||||+
T Consensus        56 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~  135 (267)
T cd08228          56 LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPA  135 (267)
T ss_pred             HHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHH
Confidence            4678999999999999999999999999999999988853    234899999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh--h
Q 016865           77 NLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL--P  154 (381)
Q Consensus        77 NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~--~  154 (381)
                      ||+++.++.++|+|||++..............|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||.....  .
T Consensus       136 nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~  214 (267)
T cd08228         136 NVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLF  214 (267)
T ss_pred             HEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCC-chhhHHHHHHHHHHHhcCCCCCccccccHH
Confidence            9999999999999999988665433333456789999999999876664 889999999999999999999965432  3


Q ss_pred             HHHHHhhcccC-CCC-CCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          155 TLYKKINAAEF-SCP-FWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       155 ~~~~~i~~~~~-~~p-~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      .....+..... +.+ ..++..+.++|.+||..+|.+|||+.++++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         215 SLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             HHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence            44444443332 222 247789999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.6e-36  Score=274.20  Aligned_cols=206  Identities=29%  Similarity=0.457  Sum_probs=167.5

Q ss_pred             CCCCccccccceEEEEe-CCEEEEEEecCCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 016865            2 KIVRHPNIVRLHEVLAS-RTKVYIILEFVTGGELFDKIVHQ-----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKP   75 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~-~~~~~lV~E~~~gg~L~~~i~~~-----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp   75 (381)
                      |.++|||||.+..+|-+ +.++|+++||++. +|.+.|...     ..+|....+.++.||+.|++|||++-|+||||||
T Consensus        82 REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKP  160 (438)
T KOG0666|consen   82 RELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKP  160 (438)
T ss_pred             HHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCc
Confidence            66899999999999977 7899999999976 999988642     3588999999999999999999999999999999


Q ss_pred             CcEEEccC----CCEEEeeccCccCCCCCccc---cccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCC
Q 016865           76 ENLLLDSY----GNLKVSDFGLSALPQQGVEL---LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF  148 (381)
Q Consensus        76 ~NiLl~~~----~~lkl~DFGls~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf  148 (381)
                      .|||+..+    |.+||+|||+++.+...-..   ....+-|.+|.|||.+.+...++.+.|+||+|||+.||++-++.|
T Consensus       161 aNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF  240 (438)
T KOG0666|consen  161 ANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLF  240 (438)
T ss_pred             ceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccc
Confidence            99999987    89999999999987663222   234567899999999999887789999999999999999999988


Q ss_pred             CCCCh---------hHHHHHhhc-------cc----CCCCC--------------------C------CChhHHHHHHHh
Q 016865          149 GETDL---------PTLYKKINA-------AE----FSCPF--------------------W------FSTGATSLIHKI  182 (381)
Q Consensus       149 ~~~~~---------~~~~~~i~~-------~~----~~~p~--------------------~------~s~~~~~li~~~  182 (381)
                      .+...         .+...+|..       ..    ...|.                    |      -++.+.+|+.+|
T Consensus       241 ~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~kl  320 (438)
T KOG0666|consen  241 KGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKL  320 (438)
T ss_pred             cchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHH
Confidence            54321         011111110       00    01111                    1      256699999999


Q ss_pred             cCCCCCCCCCHHHHhcCcccccCCCC
Q 016865          183 LDPNPKTRIRIEGIRKHPWFRKNYNP  208 (381)
Q Consensus       183 L~~dP~~R~t~~~il~hp~~~~~~~~  208 (381)
                      |+.||.+|+|++++++|+||.....|
T Consensus       321 L~yDP~kRIta~qAleh~yF~~d~lp  346 (438)
T KOG0666|consen  321 LTYDPIKRITAEQALEHPYFTEDPLP  346 (438)
T ss_pred             hccCchhhccHHHHhcccccccCCCC
Confidence            99999999999999999999987554

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.8e-35  Score=276.60  Aligned_cols=198  Identities=23%  Similarity=0.369  Sum_probs=168.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHH
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ----------------GRLLENDCRRYFQQLIDAVAHCH   64 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~~L~~LH   64 (381)
                      ++.++||||+++++++.+.+..++++||+++++|.+++...                ..+++..+..++.|++.||.|||
T Consensus        62 ~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH  141 (283)
T cd05091          62 RSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS  141 (283)
T ss_pred             HhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence            35689999999999999999999999999999999998532                24788889999999999999999


Q ss_pred             HCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHH
Q 016865           65 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM  142 (381)
Q Consensus        65 ~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll  142 (381)
                      ++||+||||||+||++++++.+||+|||++.......  .......+++.|+|||++.+..+ +.++||||+||++|+|+
T Consensus       142 ~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~  220 (283)
T cd05091         142 SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVF  220 (283)
T ss_pred             HcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHH
Confidence            9999999999999999999999999999987653321  12234456789999999876665 48999999999999999


Q ss_pred             h-CCCCCCCCChhHHHHHhhcccC-CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          143 A-GYLPFGETDLPTLYKKINAAEF-SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       143 ~-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      + |..||.+.+.......+..... ..|..++..+.+|+.+||+.+|.+|||+.+|+..
T Consensus       221 ~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         221 SYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             cCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            8 8999988777777776655543 4566789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.6e-35  Score=274.82  Aligned_cols=198  Identities=27%  Similarity=0.389  Sum_probs=164.5

Q ss_pred             CCCCCccccccceEEEEeC------CEEEEEEecCCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 016865            1 MKIVRHPNIVRLHEVLASR------TKVYIILEFVTGGELFDKIVHQ------GRLLENDCRRYFQQLIDAVAHCHSKGV   68 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~------~~~~lV~E~~~gg~L~~~i~~~------~~l~e~~~~~~~~qll~~L~~LH~~gi   68 (381)
                      |+.++||||+++++++...      ...+++|||+++|+|.+++...      ..+++..+..++.|++.||+|||++||
T Consensus        54 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i  133 (272)
T cd05075          54 MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSF  133 (272)
T ss_pred             HHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            4578999999999987432      3579999999999999887432      247899999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCCEEEeeccCccCCCCCcc--ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CC
Q 016865           69 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GY  145 (381)
Q Consensus        69 ~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~  145 (381)
                      +||||||+|||++.++.+||+|||++........  ......+++.|+|||.+.+..+ +.++||||+||++|+|++ |.
T Consensus       134 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~  212 (272)
T cd05075         134 IHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQ  212 (272)
T ss_pred             eccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCC
Confidence            9999999999999999999999999886543211  1123346778999999977665 489999999999999999 89


Q ss_pred             CCCCCCChhHHHHHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          146 LPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       146 ~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      .||...+....+..+..+. ...+..++..+.++|.+||+.||.+|||+++++++
T Consensus       213 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         213 TPYPGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            9998877666666665543 34556688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.7e-36  Score=290.96  Aligned_cols=198  Identities=32%  Similarity=0.602  Sum_probs=167.4

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCC
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG   84 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~   84 (381)
                      +.+-||+||..|++++++|+||||++||++-.++.+.+-|+|+.|++|+..|..|+++.|..|+|||||||+|||||.+|
T Consensus       687 Dn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdG  766 (1034)
T KOG0608|consen  687 DNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG  766 (1034)
T ss_pred             CCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCC
Confidence            57889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CEEEeeccCccCCCC---------C-----c----------------------------cccccccCCCCCCCCceecCC
Q 016865           85 NLKVSDFGLSALPQQ---------G-----V----------------------------ELLHTTCGTPNYVAPEVLSNR  122 (381)
Q Consensus        85 ~lkl~DFGls~~~~~---------~-----~----------------------------~~~~~~~gt~~y~aPE~l~~~  122 (381)
                      ++||+||||++-+..         +     +                            -..+..+||+.|+|||++...
T Consensus       767 HIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~  846 (1034)
T KOG0608|consen  767 HIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART  846 (1034)
T ss_pred             ceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc
Confidence            999999999874321         0     0                            012344699999999999999


Q ss_pred             CCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhc--ccCCCC--CCCChhHHHHHHHhcCCCCCCCCC---HHH
Q 016865          123 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA--AEFSCP--FWFSTGATSLIHKILDPNPKTRIR---IEG  195 (381)
Q Consensus       123 ~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~~~~~p--~~~s~~~~~li~~~L~~dP~~R~t---~~~  195 (381)
                      +|. ..+|.||.|||||||+.|++||-..+..+...++.+  ..+.+|  ..+|+++.++|.++.. +++.|+.   +++
T Consensus       847 g~~-q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~  924 (1034)
T KOG0608|consen  847 GYT-QLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQ  924 (1034)
T ss_pred             Ccc-ccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhhcccchhh
Confidence            886 899999999999999999999977665443333322  222333  3589999999999764 5778874   678


Q ss_pred             HhcCccccc
Q 016865          196 IRKHPWFRK  204 (381)
Q Consensus       196 il~hp~~~~  204 (381)
                      +..||||+.
T Consensus       925 vKaHpfFkg  933 (1034)
T KOG0608|consen  925 VKAHPFFKG  933 (1034)
T ss_pred             hhcCccccc
Confidence            999999974

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.5e-35  Score=280.81  Aligned_cols=197  Identities=24%  Similarity=0.372  Sum_probs=166.4

Q ss_pred             CCC-CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHH
Q 016865            2 KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHCH   64 (381)
Q Consensus         2 k~l-~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~~L~~LH   64 (381)
                      +.+ +||||+++++++...+..|+||||+++|+|.+++...+                .++...+..++.|++.||+|||
T Consensus        78 ~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH  157 (307)
T cd05098          78 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA  157 (307)
T ss_pred             HHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH
Confidence            345 79999999999999999999999999999999997532                4788899999999999999999


Q ss_pred             HCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCcccccc--ccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHH
Q 016865           65 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT--TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM  142 (381)
Q Consensus        65 ~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~--~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll  142 (381)
                      ++|++||||||+||+++.++.+||+|||++...........+  ..+++.|+|||++.+..+ +.++||||+||++|+|+
T Consensus       158 ~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~  236 (307)
T cd05098         158 SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIF  236 (307)
T ss_pred             HCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999998765432111112  234578999999977665 48999999999999999


Q ss_pred             h-CCCCCCCCChhHHHHHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          143 A-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       143 ~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      + |..||...+.......+.... ...|..++.++.++|.+||..+|.+|||+.+++++
T Consensus       237 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         237 TLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             cCCCCCCCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            8 999998877766666655443 35566689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-35  Score=271.14  Aligned_cols=194  Identities=25%  Similarity=0.455  Sum_probs=167.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||+++++++.+.+..|+||||+++++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||
T Consensus        54 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Ni  133 (256)
T cd05039          54 MTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNV  133 (256)
T ss_pred             HHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceE
Confidence            357899999999999999999999999999999999997755  689999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  157 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~  157 (381)
                      +++.++.+||+|||.+.......   ....++..|+|||.+....+ +.++||||+|+++|+|++ |..||...+.....
T Consensus       134 li~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~  209 (256)
T cd05039         134 LVSEDLVAKVSDFGLAKEASQGQ---DSGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV  209 (256)
T ss_pred             EEeCCCCEEEccccccccccccc---ccCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            99999999999999987653321   13345677999999876555 489999999999999998 99999888776666


Q ss_pred             HHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          158 KKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       158 ~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ..+... ....|..+++.+.++|.+||..+|.+|||++++++
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         210 PHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            555443 33456668999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-35  Score=274.23  Aligned_cols=198  Identities=23%  Similarity=0.347  Sum_probs=165.7

Q ss_pred             CCCCCccccccceEEEEeCCE------EEEEEecCCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQ------GRLLENDCRRYFQQLIDAVAHCHSKGV   68 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~------~~lV~E~~~gg~L~~~i~~~------~~l~e~~~~~~~~qll~~L~~LH~~gi   68 (381)
                      |+.++||||+++++++.....      .++||||+++|+|.+++...      ..+++..+..++.|++.||.|||++|+
T Consensus        55 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i  134 (273)
T cd05035          55 MKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNF  134 (273)
T ss_pred             HHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            356899999999998865543      89999999999999888542      358999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCCEEEeeccCccCCCCCcc--ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CC
Q 016865           69 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GY  145 (381)
Q Consensus        69 ~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~  145 (381)
                      +||||||+||++++++.+||+|||++........  ......++..|+|||++.+..+ +.++||||+||++|+|++ |.
T Consensus       135 ~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~  213 (273)
T cd05035         135 IHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQ  213 (273)
T ss_pred             eccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999876543211  1122345678999999876655 489999999999999999 99


Q ss_pred             CCCCCCChhHHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          146 LPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       146 ~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      +||.+.+....+..+..+ ....|..+++.+.+++.+||+.||.+|||+.+++++
T Consensus       214 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         214 TPYPGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCCCCCCHHHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999887766666655543 445677789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=5.3e-35  Score=270.50  Aligned_cols=196  Identities=26%  Similarity=0.416  Sum_probs=167.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |++++||||+++++++.+ ...++||||+++|+|.+.+....  .+++..++.++.|++.||+|||++|++||||||+||
T Consensus        50 l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~ni  128 (257)
T cd05040          50 MHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNI  128 (257)
T ss_pred             HhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccE
Confidence            467899999999999988 89999999999999999997754  689999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCcc---ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChh
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLP  154 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~  154 (381)
                      +++.++.+||+|||++........   ......++..|+|||.+.+..+. .++||||+||++|+|++ |..||...+..
T Consensus       129 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~  207 (257)
T cd05040         129 LLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS-HASDVWMFGVTLWEMFTYGEEPWAGLSGS  207 (257)
T ss_pred             EEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcC-chhhhHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999876543211   11234577899999998776664 88999999999999999 99999877766


Q ss_pred             HHHHHhhcc--cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          155 TLYKKINAA--EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       155 ~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      .....+...  ....|..++..+.+++.+||..+|++|||+.++++
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         208 QILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence            665555432  23344557899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.3e-35  Score=273.42  Aligned_cols=197  Identities=30%  Similarity=0.571  Sum_probs=165.6

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE   76 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~   76 (381)
                      |+.++||||+++++++.+.+..+++|||++|++|.+++..    ...+++..++.++.|++.||.|||++|++|+||||+
T Consensus        56 l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~  135 (267)
T cd08229          56 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPA  135 (267)
T ss_pred             HHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence            3568999999999999999999999999999999998864    345899999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh--h
Q 016865           77 NLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL--P  154 (381)
Q Consensus        77 NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~--~  154 (381)
                      ||+++.++.++|+|||++.............+|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||.....  .
T Consensus       136 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~  214 (267)
T cd08229         136 NVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLY  214 (267)
T ss_pred             HEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCcc-chhhHHHHHHHHHHHHhCCCCcccccchHH
Confidence            9999999999999999987665433334556799999999999776664 889999999999999999999975443  2


Q ss_pred             HHHHHhhcccCC-C-CCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          155 TLYKKINAAEFS-C-PFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       155 ~~~~~i~~~~~~-~-p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      .....+...... . +..+++.+.++|.+||+.||.+|||+.++++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         215 SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence            333333332222 2 2347889999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.3e-35  Score=282.28  Aligned_cols=197  Identities=20%  Similarity=0.316  Sum_probs=166.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++... ..++|+||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||
T Consensus        63 l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nil  141 (316)
T cd05108          63 MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVL  141 (316)
T ss_pred             HHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheE
Confidence            4678999999999999764 578999999999999999774 45889999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccc--cccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVEL--LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      ++.++.+||+|||++.........  .....++..|+|||++.+..++ .++|||||||++|+|++ |..||.+......
T Consensus       142 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slGv~l~el~t~g~~p~~~~~~~~~  220 (316)
T cd05108         142 VKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEI  220 (316)
T ss_pred             ecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            999999999999999865432211  1223346789999999876665 89999999999999998 9999988766555


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ...+... ....|..++.++.+++.+||..+|.+|||+.+++.+
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         221 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            4444332 345566788999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-35  Score=275.70  Aligned_cols=199  Identities=31%  Similarity=0.474  Sum_probs=165.6

Q ss_pred             CCCC-ccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            2 KIVR-HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         2 k~l~-HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      +.++ ||||+++++++.+++..|+||||+ +|+|.+.+....  .+++..+..++.|++.||.|||++|++|+||+|+||
T Consensus        52 ~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni  130 (283)
T cd07830          52 RKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENL  130 (283)
T ss_pred             HhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhE
Confidence            4567 999999999999999999999999 789999887754  689999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK  158 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~  158 (381)
                      +++.++.++|+|||++...... .......|+..|+|||++.+....+.++|+||+|+++++|++|++||...+....+.
T Consensus       131 ~i~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~  209 (283)
T cd07830         131 LVSGPEVVKIADFGLAREIRSR-PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLY  209 (283)
T ss_pred             EEcCCCCEEEeecccceeccCC-CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHH
Confidence            9999999999999998765432 223445689999999998654444589999999999999999999997766544333


Q ss_pred             Hhhc-------------------ccCCC-----------CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          159 KINA-------------------AEFSC-----------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       159 ~i~~-------------------~~~~~-----------p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      ++..                   .....           .+..++.+.++|++||..+|.+|||++|++.||||
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         210 KICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             HHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            2211                   00000           11236789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=5.6e-35  Score=269.21  Aligned_cols=197  Identities=27%  Similarity=0.480  Sum_probs=166.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+..|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+
T Consensus        46 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nil  125 (250)
T cd05085          46 LKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCL  125 (250)
T ss_pred             HHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEE
Confidence            35689999999999999999999999999999999988753 45789999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCcc-ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVE-LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  157 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~  157 (381)
                      ++.++.+|++|||++........ ......+++.|+|||++.+..+ +.++||||+|+++|++++ |..||...+.....
T Consensus       126 i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~  204 (250)
T cd05085         126 VGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAR  204 (250)
T ss_pred             EcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence            99999999999999875433211 1112234677999999976655 489999999999999998 99999887766655


Q ss_pred             HHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          158 KKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       158 ~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ..+... ....|..++..+.+++.+||..+|.+|||+.++++
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         205 EQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            555443 33556678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.9e-35  Score=279.76  Aligned_cols=196  Identities=23%  Similarity=0.377  Sum_probs=165.4

Q ss_pred             CCC-CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHH
Q 016865            2 KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ----------------GRLLENDCRRYFQQLIDAVAHCH   64 (381)
Q Consensus         2 k~l-~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~~L~~LH   64 (381)
                      +++ +||||+++++++.+.+.+|+||||+++|+|.+++...                ..++...+..++.|++.||.|||
T Consensus        72 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH  151 (314)
T cd05099          72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE  151 (314)
T ss_pred             HhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH
Confidence            345 6999999999999999999999999999999999653                24788899999999999999999


Q ss_pred             HCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCccc--cccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHH
Q 016865           65 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL--LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM  142 (381)
Q Consensus        65 ~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll  142 (381)
                      ++|++||||||+||+++.++.+||+|||++.........  .....+++.|+|||++.+..+. .++||||+||++|+|+
T Consensus       152 ~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~  230 (314)
T cd05099         152 SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIF  230 (314)
T ss_pred             HCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcC-ccchhhHHHHHHHHHH
Confidence            999999999999999999999999999999765432111  1222345689999999776654 8999999999999999


Q ss_pred             h-CCCCCCCCChhHHHHHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          143 A-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       143 ~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      + |..||...+....+..+.... ...|..++.++.++|.+||..+|.+|||+.++++
T Consensus       231 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         231 TLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             hCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            9 999998877766666655443 3455667889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.7e-35  Score=271.74  Aligned_cols=194  Identities=24%  Similarity=0.429  Sum_probs=165.2

Q ss_pred             CCCCCccccccceEEE-EeCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            1 MKIVRHPNIVRLHEVL-ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~-~~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      |++++||||+++++++ .+++..|+||||+++|+|.+++...+  .+++..+..++.|++.||+|||++|++||||||+|
T Consensus        53 l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~n  132 (256)
T cd05082          53 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARN  132 (256)
T ss_pred             HHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchhe
Confidence            4678999999999976 45678999999999999999987644  37899999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           78 LLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        78 iLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      |++++++.+||+|||++......   .....++..|+|||++.+..++ .++||||+||++|+|++ |+.||...+....
T Consensus       133 il~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~  208 (256)
T cd05082         133 VLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDV  208 (256)
T ss_pred             EEEcCCCcEEecCCccceecccc---CCCCccceeecCHHHHccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999998754332   1234456789999998776664 88999999999999998 9999988777766


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...+... ....+..+++.+.++|.+||..+|.+|||+.++++
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         209 VPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            6666543 23445668999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.5e-35  Score=278.67  Aligned_cols=196  Identities=24%  Similarity=0.358  Sum_probs=164.3

Q ss_pred             CCC-CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            2 KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         2 k~l-~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      +++ +||||+++++++...+..|+||||+++|+|.+++....  .+++.++..++.|++.||.|||++||+|+||||+||
T Consensus        93 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Ni  172 (302)
T cd05055          93 SHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNV  172 (302)
T ss_pred             HhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceE
Confidence            456 79999999999999999999999999999999997643  389999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCcc--ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPT  155 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~  155 (381)
                      |++.++.++++|||++........  ......+++.|+|||++.+..+. .++||||+||++|+|++ |..||...+...
T Consensus       173 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~t~g~~p~~~~~~~~  251 (302)
T cd05055         173 LLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDS  251 (302)
T ss_pred             EEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCC-cHhHHHHHHHHHHHHHhCCCCCcCCCCchH
Confidence            999999999999999876543211  11233467889999998776654 89999999999999998 999998766544


Q ss_pred             HHHH-hhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          156 LYKK-INAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       156 ~~~~-i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      .... +..+ ....|...++++.+++.+||..+|.+|||+.++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         252 KFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            3333 3222 22345568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-35  Score=275.25  Aligned_cols=201  Identities=30%  Similarity=0.488  Sum_probs=166.0

Q ss_pred             CCCCCccccccceEEEEeC--CEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            1 MKIVRHPNIVRLHEVLASR--TKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~--~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      ++.++|||++++++++.+.  +..|+||||+++ +|.+.+... ..+++..+..++.|++.||+|||+.|++|+||+|+|
T Consensus        52 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~n  130 (287)
T cd07840          52 LQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSN  130 (287)
T ss_pred             HHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHH
Confidence            3568999999999999988  899999999975 898888765 579999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHH
Q 016865           78 LLLDSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL  156 (381)
Q Consensus        78 iLl~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~  156 (381)
                      |++++++.+||+|||++....... .......++..|+|||.+.+....+.++||||+|+++|+|++|+.||...+....
T Consensus       131 il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~  210 (287)
T cd07840         131 ILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ  210 (287)
T ss_pred             eEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence            999999999999999987654422 1233456788999999876654446899999999999999999999987765444


Q ss_pred             HHHhhccc-----------------------CC--------CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          157 YKKINAAE-----------------------FS--------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       157 ~~~i~~~~-----------------------~~--------~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      ...+....                       ..        ....+++.+.++|++||..+|.+|||++++++||||
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         211 LEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             HHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            33322100                       00        001138899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.8e-35  Score=276.26  Aligned_cols=197  Identities=23%  Similarity=0.332  Sum_probs=166.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc------------------------CCCCHHHHHHHHHHH
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ------------------------GRLLENDCRRYFQQL   56 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~------------------------~~l~e~~~~~~~~ql   56 (381)
                      |+.++||||+++++.+...+..|+|+||+.+|+|.+++...                        ..+++..+..++.|+
T Consensus        57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i  136 (290)
T cd05045          57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQI  136 (290)
T ss_pred             HhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHH
Confidence            46789999999999999999999999999999999988642                        247788999999999


Q ss_pred             HHHHHHHHHCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCcc--ccccccCCCCCCCCceecCCCCCCCcccHhHH
Q 016865           57 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC  134 (381)
Q Consensus        57 l~~L~~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSl  134 (381)
                      +.||.|||+.|++||||||+|||+++++.+||+|||++........  ......++..|+|||++.+..++ .++||||+
T Consensus       137 ~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~sl  215 (290)
T cd05045         137 SRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSF  215 (290)
T ss_pred             HHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcc-hHhHHHHH
Confidence            9999999999999999999999999999999999999875433211  12334567789999998776654 89999999


Q ss_pred             HHHHHHHHh-CCCCCCCCChhHHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          135 GVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       135 Gvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      |+++|+|++ |..||.+.........+... ....|..++.++.+++.+||+.+|.+|||+.++++
T Consensus       216 G~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         216 GVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            999999998 99999887766665555432 33456668999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1e-34  Score=277.58  Aligned_cols=200  Identities=22%  Similarity=0.388  Sum_probs=166.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++|||++++++++.+....|+||||+. |+|.+.+.. ...+++..+..++.|++.||.|||++|++||||+|+||+
T Consensus        75 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nil  153 (313)
T cd06633          75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNIL  153 (313)
T ss_pred             HHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEE
Confidence            357899999999999999999999999996 578787765 456899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecC--CCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      ++.++.+||+|||++.....    .....|+..|+|||++..  ....+.++||||+||++|+|++|..||...+.....
T Consensus       154 i~~~~~~kL~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~  229 (313)
T cd06633         154 LTEPGQVKLADFGSASKSSP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL  229 (313)
T ss_pred             ECCCCCEEEeecCCCcccCC----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            99999999999998864322    235678999999999842  233347899999999999999999999877654444


Q ss_pred             HHhhcccCC-C-CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          158 KKINAAEFS-C-PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       158 ~~i~~~~~~-~-p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ..+...... . ...++..+.+|+.+||+.+|.+|||+.+++.||||+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         230 YHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             HHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence            444332221 1 22367889999999999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.6e-35  Score=277.83  Aligned_cols=197  Identities=22%  Similarity=0.365  Sum_probs=167.6

Q ss_pred             CCC-CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHH
Q 016865            2 KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ----------------GRLLENDCRRYFQQLIDAVAHCH   64 (381)
Q Consensus         2 k~l-~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~~L~~LH   64 (381)
                      +.+ +||||+++++++.+....|+||||+++|+|.+++...                ..++...+..++.|++.||.|||
T Consensus        75 ~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH  154 (304)
T cd05101          75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA  154 (304)
T ss_pred             HhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH
Confidence            456 7999999999999999999999999999999999753                24677889999999999999999


Q ss_pred             HCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCcc--ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHH
Q 016865           65 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM  142 (381)
Q Consensus        65 ~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll  142 (381)
                      ++|++||||||+||+++.++.+||+|||++........  ......+++.|+|||++.+..+. .++|||||||++|+|+
T Consensus       155 ~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~  233 (304)
T cd05101         155 SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIF  233 (304)
T ss_pred             HCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCC-chhhHHHHHHHHHHHH
Confidence            99999999999999999999999999999876543211  12233467789999999776664 8899999999999999


Q ss_pred             h-CCCCCCCCChhHHHHHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          143 A-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       143 ~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      + |..||...+.......+.... ...|..++.++.+||.+||..+|.+|||+.++++.
T Consensus       234 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         234 TLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             cCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            8 899998888777777665443 34455688999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.6e-35  Score=278.23  Aligned_cols=201  Identities=28%  Similarity=0.492  Sum_probs=163.4

Q ss_pred             CCCCCccccccceEEEEeCC----------EEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q 016865            1 MKIVRHPNIVRLHEVLASRT----------KVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVY   69 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~----------~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~   69 (381)
                      ++.++||||+++++++.+..          .+|+|+||+++ ++.+.+... ..++++.+..++.|++.||.|||+.||+
T Consensus        60 ~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~  138 (302)
T cd07864          60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFL  138 (302)
T ss_pred             HHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            35789999999999987654          89999999976 777777653 4689999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCC
Q 016865           70 HRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF  148 (381)
Q Consensus        70 HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf  148 (381)
                      ||||||+||++++++.+||+|||++....... .......++..|+|||.+.+....+.++||||+||++++|++|++||
T Consensus       139 H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~  218 (302)
T cd07864         139 HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIF  218 (302)
T ss_pred             cCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999987654322 12223456889999998865544468999999999999999999999


Q ss_pred             CCCChhHHHHHhhccc-------C-----------------------CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          149 GETDLPTLYKKINAAE-------F-----------------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       149 ~~~~~~~~~~~i~~~~-------~-----------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...+.......+....       +                       .....+++.+.++|.+||..||.+|||+.+++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         219 QANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            8766544433322110       0                       001136889999999999999999999999999


Q ss_pred             Cccc
Q 016865          199 HPWF  202 (381)
Q Consensus       199 hp~~  202 (381)
                      ||||
T Consensus       299 ~~~~  302 (302)
T cd07864         299 SPWL  302 (302)
T ss_pred             CCCC
Confidence            9997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.7e-35  Score=283.65  Aligned_cols=202  Identities=27%  Similarity=0.404  Sum_probs=166.2

Q ss_pred             CCCCCccccccceEEEEeCC------EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRT------KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK   74 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~------~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlk   74 (381)
                      |+.++||||+++++++....      .+|+||||+ |++|.+++.. ..+++..++.++.|++.||.|||+.||+|||||
T Consensus        68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlk  145 (343)
T cd07880          68 LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLK  145 (343)
T ss_pred             HHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            46789999999999997653      469999999 7799887754 679999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           75 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        75 p~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      |+||+++.++.+|++|||++......   .....+++.|+|||++.+....+.++|+||+||++|+|++|..||...+..
T Consensus       146 p~Nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~  222 (343)
T cd07880         146 PGNLAVNEDCELKILDFGLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL  222 (343)
T ss_pred             HHHEEEcCCCCEEEeecccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999999998765432   234567899999999876444568999999999999999999999876654


Q ss_pred             HHHHHhhcccC-------------------------------CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          155 TLYKKINAAEF-------------------------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       155 ~~~~~i~~~~~-------------------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      ..+..+.....                               .....+++.+.++|.+||..||.+|||+.+++.||||+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~  302 (343)
T cd07880         223 DQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE  302 (343)
T ss_pred             HHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHh
Confidence            33332211100                               01134688899999999999999999999999999998


Q ss_pred             cCCC
Q 016865          204 KNYN  207 (381)
Q Consensus       204 ~~~~  207 (381)
                      ....
T Consensus       303 ~~~~  306 (343)
T cd07880         303 EFHD  306 (343)
T ss_pred             hhcC
Confidence            6543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4.5e-35  Score=282.75  Aligned_cols=202  Identities=31%  Similarity=0.423  Sum_probs=164.2

Q ss_pred             CCC-CccccccceEEEEeC--CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            2 KIV-RHPNIVRLHEVLASR--TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         2 k~l-~HpnIv~l~~~~~~~--~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      +++ +||||+++++++...  ...|+||||++ ++|.+.+... .+++..+..++.|++.||.|||+.||+||||||+||
T Consensus        61 ~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~ni  138 (337)
T cd07852          61 QELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNI  138 (337)
T ss_pred             HHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence            456 999999999998653  47899999997 5999888764 788999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCc-----cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGV-----ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL  153 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~  153 (381)
                      +++.++.+||+|||++.......     .......||+.|+|||++.+....+.++||||+||++|+|++|++||.....
T Consensus       139 ll~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~  218 (337)
T cd07852         139 LLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST  218 (337)
T ss_pred             EEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh
Confidence            99999999999999987554321     2233456899999999987655556899999999999999999999976554


Q ss_pred             hHHHHHhhcc---------------------------cC----CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          154 PTLYKKINAA---------------------------EF----SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       154 ~~~~~~i~~~---------------------------~~----~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      ......+...                           ..    ...+.++.++.++|.+||+.||.+|||+.++++||||
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~  298 (337)
T cd07852         219 LNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYV  298 (337)
T ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhh
Confidence            3322221110                           00    0111268899999999999999999999999999999


Q ss_pred             ccC
Q 016865          203 RKN  205 (381)
Q Consensus       203 ~~~  205 (381)
                      +..
T Consensus       299 ~~~  301 (337)
T cd07852         299 AQF  301 (337)
T ss_pred             hhh
Confidence            764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.1e-35  Score=279.41  Aligned_cols=201  Identities=24%  Similarity=0.403  Sum_probs=160.6

Q ss_pred             CCCCCccccccceEEEEeC--------CEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 016865            1 MKIVRHPNIVRLHEVLASR--------TKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHR   71 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~--------~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~Hr   71 (381)
                      |+.++||||+++++++.+.        ..+|+||||+.+ +|...+.. ...+++..+..++.|+++||.|||++||+||
T Consensus        61 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~  139 (311)
T cd07866          61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHR  139 (311)
T ss_pred             HHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            4578999999999987543        357999999965 67776654 3479999999999999999999999999999


Q ss_pred             CCCCCcEEEccCCCEEEeeccCccCCCCCcc-----------ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHH
Q 016865           72 DLKPENLLLDSYGNLKVSDFGLSALPQQGVE-----------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFV  140 (381)
Q Consensus        72 Dlkp~NiLl~~~~~lkl~DFGls~~~~~~~~-----------~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~  140 (381)
                      ||||+||++++++.+||+|||++........           ......|++.|+|||++.+....+.++||||+||++|+
T Consensus       140 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e  219 (311)
T cd07866         140 DIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAE  219 (311)
T ss_pred             CCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHH
Confidence            9999999999999999999999875433111           11234578899999998765444689999999999999


Q ss_pred             HHhCCCCCCCCChhHHHHHhhccc-----------------------CCCC-------CCCChhHHHHHHHhcCCCCCCC
Q 016865          141 LMAGYLPFGETDLPTLYKKINAAE-----------------------FSCP-------FWFSTGATSLIHKILDPNPKTR  190 (381)
Q Consensus       141 ll~G~~Pf~~~~~~~~~~~i~~~~-----------------------~~~p-------~~~s~~~~~li~~~L~~dP~~R  190 (381)
                      |++|++||.+.+.......+....                       ...+       ..+++.+.++|.+||..||.+|
T Consensus       220 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R  299 (311)
T cd07866         220 MFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKR  299 (311)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccC
Confidence            999999998776654433322110                       0001       1245678899999999999999


Q ss_pred             CCHHHHhcCccc
Q 016865          191 IRIEGIRKHPWF  202 (381)
Q Consensus       191 ~t~~~il~hp~~  202 (381)
                      ||+.+++.||||
T Consensus       300 ~t~~ell~~~~f  311 (311)
T cd07866         300 LTASDALEHPYF  311 (311)
T ss_pred             cCHHHHhcCCCC
Confidence            999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=7e-36  Score=303.62  Aligned_cols=194  Identities=33%  Similarity=0.509  Sum_probs=162.2

Q ss_pred             CCCCC-ccccccceEEEE----eC---CEEEEEEecCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--C
Q 016865            1 MKIVR-HPNIVRLHEVLA----SR---TKVYIILEFVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKG--V   68 (381)
Q Consensus         1 lk~l~-HpnIv~l~~~~~----~~---~~~~lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~~L~~LH~~g--i   68 (381)
                      ||+|+ |||||.+++...    .+   -.++|.||||.||.|-|++..  ..+|.|.++++||.|+++||.+||...  |
T Consensus        88 MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPi  167 (738)
T KOG1989|consen   88 MKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPI  167 (738)
T ss_pred             HHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCcc
Confidence            56776 999999999432    11   268999999999999999974  456999999999999999999999998  9


Q ss_pred             eecCCCCCcEEEccCCCEEEeeccCccCCCCCccc---------cccccCCCCCCCCceec---CCCCCCCcccHhHHHH
Q 016865           69 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL---------LHTTCGTPNYVAPEVLS---NRGYDGSAADVWSCGV  136 (381)
Q Consensus        69 ~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~~---------~~~~~gt~~y~aPE~l~---~~~~~~~~~DIwSlGv  136 (381)
                      ||||||-|||||+.+|++||||||.+.-.-.....         --...-|+.|+|||++.   +.+. ++|+|||+|||
T Consensus       168 IHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGc  246 (738)
T KOG1989|consen  168 IHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGC  246 (738)
T ss_pred             chhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHH
Confidence            99999999999999999999999988643221100         11234799999999974   3344 59999999999


Q ss_pred             HHHHHHhCCCCCCCCChhHHHHHhhcccCCCCC--CCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          137 ILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF--WFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       137 il~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      +||-||...+||++...    ..|..+.|.+|+  .+|..+.+||+.||++||.+||++-+++.+
T Consensus       247 lLYkLCy~t~PFe~sg~----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  247 LLYKLCYFTTPFEESGK----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             HHHHHHHhCCCcCcCcc----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence            99999999999987633    346778888887  489999999999999999999999998764

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-35  Score=273.74  Aligned_cols=198  Identities=31%  Similarity=0.445  Sum_probs=164.1

Q ss_pred             CCCCccccccceEEEEeCCE-----EEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 016865            2 KIVRHPNIVRLHEVLASRTK-----VYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK   74 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~-----~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlk   74 (381)
                      +.++||||+++++++.+...     +|++|||+++ +|.+++....  .+++..++.++.|++.||.|||+.|++|+||+
T Consensus        56 ~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~  134 (287)
T cd07838          56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLK  134 (287)
T ss_pred             hccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCC
Confidence            34579999999999988776     9999999975 8988887643  58999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           75 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        75 p~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      |+||+++.++.+||+|||++...... .......+++.|+|||++.+..+ +.++|+||+||++|+|++|.+||...+..
T Consensus       135 ~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~~~~~~~~  212 (287)
T cd07838         135 PQNILVTSDGQVKIADFGLARIYSFE-MALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEA  212 (287)
T ss_pred             hhhEEEccCCCEEEeccCcceeccCC-cccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCcccCCChH
Confidence            99999999999999999998765432 22234458899999999987665 48999999999999999999999877665


Q ss_pred             HHHHHhhccc-C----C-----------C-----------CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          155 TLYKKINAAE-F----S-----------C-----------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       155 ~~~~~i~~~~-~----~-----------~-----------p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      +...++.... .    .           +           .+.+++.+.++|.+||..||.+||++++++.||||
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         213 DQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             HHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            5444332110 0    0           0           01246788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=5.8e-35  Score=276.00  Aligned_cols=197  Identities=19%  Similarity=0.240  Sum_probs=165.6

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCCe
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-----------RLLENDCRRYFQQLIDAVAHCHSKGVY   69 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-----------~l~e~~~~~~~~qll~~L~~LH~~gi~   69 (381)
                      |++++||||+++++++.+++..++||||+++++|.+++....           .+++..++.++.|++.||.|||+.|++
T Consensus        73 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~  152 (296)
T cd05051          73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFV  152 (296)
T ss_pred             HHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Confidence            467899999999999999999999999999999999997755           689999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh--CC
Q 016865           70 HRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA--GY  145 (381)
Q Consensus        70 HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~--G~  145 (381)
                      ||||||+||+++.++.++|+|||++.......  .......+++.|+|||++.+..+ +.++||||+||++|+|++  |.
T Consensus       153 H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~  231 (296)
T cd05051         153 HRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCRE  231 (296)
T ss_pred             ccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCC
Confidence            99999999999999999999999987543321  12234456788999999876555 489999999999999998  78


Q ss_pred             CCCCCCChhHHHHHhhcc--------cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          146 LPFGETDLPTLYKKINAA--------EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       146 ~Pf~~~~~~~~~~~i~~~--------~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      .||...+...........        ....|..++.++.+++.+||+.||.+|||+.++++
T Consensus       232 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         232 QPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             CCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            899876665554443221        12334557899999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3.7e-35  Score=284.15  Aligned_cols=203  Identities=28%  Similarity=0.421  Sum_probs=161.4

Q ss_pred             CCCCCccccccceEEEEeC--------------CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Q 016865            1 MKIVRHPNIVRLHEVLASR--------------TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK   66 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~--------------~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~   66 (381)
                      |+.++||||+++++++...              ...|+||||++ ++|.+.+.. +.+++..++.++.||+.||.|||+.
T Consensus        56 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~  133 (342)
T cd07854          56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSA  133 (342)
T ss_pred             HHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4678999999999877654              36899999997 588887754 5799999999999999999999999


Q ss_pred             CCeecCCCCCcEEEcc-CCCEEEeeccCccCCCCC---ccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHH
Q 016865           67 GVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQG---VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM  142 (381)
Q Consensus        67 gi~HrDlkp~NiLl~~-~~~lkl~DFGls~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll  142 (381)
                      ||+||||||+||+++. ++.+|++|||++......   ........|+..|+|||++.+....+.++||||+||++|+|+
T Consensus       134 givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~  213 (342)
T cd07854         134 NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML  213 (342)
T ss_pred             CcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHH
Confidence            9999999999999984 557899999998754321   112233468899999998765444568999999999999999


Q ss_pred             hCCCCCCCCChhHHHHHhhcc-------------------------cC-----CCCCCCChhHHHHHHHhcCCCCCCCCC
Q 016865          143 AGYLPFGETDLPTLYKKINAA-------------------------EF-----SCPFWFSTGATSLIHKILDPNPKTRIR  192 (381)
Q Consensus       143 ~G~~Pf~~~~~~~~~~~i~~~-------------------------~~-----~~p~~~s~~~~~li~~~L~~dP~~R~t  192 (381)
                      +|+.||...+.......+...                         ..     ...+.++.++.+||.+||..||.+|||
T Consensus       214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  293 (342)
T cd07854         214 TGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT  293 (342)
T ss_pred             hCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccC
Confidence            999999766543333222110                         00     011236788999999999999999999


Q ss_pred             HHHHhcCcccccC
Q 016865          193 IEGIRKHPWFRKN  205 (381)
Q Consensus       193 ~~~il~hp~~~~~  205 (381)
                      +++++.||||+..
T Consensus       294 ~~ell~h~~~~~~  306 (342)
T cd07854         294 AEEALMHPYMSCY  306 (342)
T ss_pred             HHHHhCCCccccc
Confidence            9999999999854

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=7.1e-35  Score=270.50  Aligned_cols=196  Identities=23%  Similarity=0.382  Sum_probs=164.1

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||+++++++. .+..|+||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+||
T Consensus        55 l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Ni  133 (260)
T cd05070          55 MKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANI  133 (260)
T ss_pred             HHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceE
Confidence            46789999999999885 45689999999999999998753  3589999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCcc-ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVE-LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      ++++++.++|+|||++........ ......++..|+|||++.+..+ +.++||||||+++|+|++ |.+||...+....
T Consensus       134 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~  212 (260)
T cd05070         134 LVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREV  212 (260)
T ss_pred             EEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            999999999999999876543211 1122335678999999876655 489999999999999999 9999988776666


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...+... ....|...+..+.+|+.+||.++|.+|||++++.+
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         213 LEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            6555433 34556668899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=7.5e-35  Score=271.55  Aligned_cols=197  Identities=26%  Similarity=0.405  Sum_probs=165.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+++..|+||||++||+|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+
T Consensus        59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nil  138 (267)
T cd05066          59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNIL  138 (267)
T ss_pred             HHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEE
Confidence            35789999999999999999999999999999999999764 46899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccc---cccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLH---TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPT  155 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~  155 (381)
                      ++.++.++++|||++...........   ...++..|+|||.+.+..+ +.++|+||+||++|++++ |..||...+...
T Consensus       139 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~  217 (267)
T cd05066         139 VNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQD  217 (267)
T ss_pred             ECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHH
Confidence            99999999999999886543221111   1223568999999987665 489999999999999887 999998877666


Q ss_pred             HHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          156 LYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       156 ~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ....+... ..+.+..+++.+.+++.+||+.+|.+|||+.++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         218 VIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            65555443 23344457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-36  Score=273.15  Aligned_cols=202  Identities=32%  Similarity=0.530  Sum_probs=167.9

Q ss_pred             CCCCCccccccceEEEEeC------CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 016865            1 MKIVRHPNIVRLHEVLASR------TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK   74 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~------~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlk   74 (381)
                      |+.++|+|||+++.+|.-.      ...|+||||++. +|...+.  -.++-+.+..++.|++.|++|||+.||+|||||
T Consensus        69 ~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLk  145 (369)
T KOG0665|consen   69 MKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLK  145 (369)
T ss_pred             hhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccC
Confidence            5678999999999999643      369999999965 8988887  347788999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           75 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        75 p~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      |+||++..++.+||.|||+|+..... -..+..+.|..|.|||++.+.+|. +.+||||+|||+.||++|...|.+.+..
T Consensus       146 Psnivv~~~~~lKi~dfg~ar~e~~~-~~mtpyVvtRyyrapevil~~~~k-e~vdiwSvGci~gEli~~~Vlf~g~d~i  223 (369)
T KOG0665|consen  146 PSNIVVNSDCTLKILDFGLARTEDTD-FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELILGTVLFPGKDHI  223 (369)
T ss_pred             cccceecchhheeeccchhhcccCcc-cccCchhheeeccCchheeccCCc-ccchhhhhhhHHHHHhhceEEecCchHH
Confidence            99999999999999999999865543 356677899999999999998865 8999999999999999999999877654


Q ss_pred             HHHHHhhc------------------------cc---CC----CCC-----------CCChhHHHHHHHhcCCCCCCCCC
Q 016865          155 TLYKKINA------------------------AE---FS----CPF-----------WFSTGATSLIHKILDPNPKTRIR  192 (381)
Q Consensus       155 ~~~~~i~~------------------------~~---~~----~p~-----------~~s~~~~~li~~~L~~dP~~R~t  192 (381)
                      +.+.++..                        .+   ++    +|.           .-+..+++|+.+||..||++|++
T Consensus       224 dQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Ris  303 (369)
T KOG0665|consen  224 DQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRIS  303 (369)
T ss_pred             HHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhccc
Confidence            43333210                        00   11    111           12456999999999999999999


Q ss_pred             HHHHhcCcccccCCC
Q 016865          193 IEGIRKHPWFRKNYN  207 (381)
Q Consensus       193 ~~~il~hp~~~~~~~  207 (381)
                      ++++|.|||++-++.
T Consensus       304 v~daL~HPY~~vw~~  318 (369)
T KOG0665|consen  304 VDDALRHPYIKVWYD  318 (369)
T ss_pred             HHHHhcCCeeeeecc
Confidence            999999999986554

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.3e-34  Score=272.19  Aligned_cols=196  Identities=19%  Similarity=0.300  Sum_probs=164.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      ++.++||||+++++++. ....++++||+++|+|.+++.. .+.+++..+..++.|++.||.|||++|++||||||+||+
T Consensus        63 l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nil  141 (279)
T cd05111          63 MGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNIL  141 (279)
T ss_pred             HhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEE
Confidence            35789999999999875 4567899999999999999976 356899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      +++++.+||+|||+++......  .......|+..|+|||++.+..++ .++||||+||++|+|++ |..||.+......
T Consensus       142 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~  220 (279)
T cd05111         142 LKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV  220 (279)
T ss_pred             EcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            9999999999999997643321  122344577889999999776664 89999999999999998 9999988776655


Q ss_pred             HHHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...+..+. ...|...+.++.+++.+|+..||.+|||+.++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         221 PDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             HHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            55554443 3344557888999999999999999999999876

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.1e-34  Score=269.47  Aligned_cols=197  Identities=30%  Similarity=0.591  Sum_probs=166.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE   76 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~   76 (381)
                      |+.++|+||+++++.+.+.+..++||||++||+|.+++..    ...++++.+..++.|++.||.|||+.|++||||+|+
T Consensus        56 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~  135 (267)
T cd08224          56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPA  135 (267)
T ss_pred             HHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChh
Confidence            3578999999999999999999999999999999998864    245899999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh--h
Q 016865           77 NLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL--P  154 (381)
Q Consensus        77 NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~--~  154 (381)
                      ||+++.++.++|+|||++..............|++.|+|||++.+..++ .++|+||+||++|+|++|..||.....  .
T Consensus       136 nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~  214 (267)
T cd08224         136 NVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLY  214 (267)
T ss_pred             hEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCC-chhcHHHHHHHHHHHHHCCCCcccCCccHH
Confidence            9999999999999999987654433334456789999999999877665 899999999999999999999965432  2


Q ss_pred             HHHHHhhcccC-CCCC-CCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          155 TLYKKINAAEF-SCPF-WFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       155 ~~~~~i~~~~~-~~p~-~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      .....+..+.. ..|. .++..+.++|.+||..+|.+|||+.++++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         215 SLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            34444433322 2343 57889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.6e-35  Score=272.74  Aligned_cols=198  Identities=24%  Similarity=0.344  Sum_probs=168.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG---------RLLENDCRRYFQQLIDAVAHCHSKGVYHR   71 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~---------~l~e~~~~~~~~qll~~L~~LH~~gi~Hr   71 (381)
                      |++++||||+++++++.+.+..|+||||+++|+|.+++....         .+++..+..++.|++.||+|||++||+||
T Consensus        62 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~  141 (275)
T cd05046          62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHR  141 (275)
T ss_pred             HHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccC
Confidence            457899999999999999999999999999999999998755         68999999999999999999999999999


Q ss_pred             CCCCCcEEEccCCCEEEeeccCccCCCCC-ccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCC
Q 016865           72 DLKPENLLLDSYGNLKVSDFGLSALPQQG-VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFG  149 (381)
Q Consensus        72 Dlkp~NiLl~~~~~lkl~DFGls~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~  149 (381)
                      ||||+||+++.++.++++|||++...... ........++..|+|||.+.+..+. .++||||+||++|+|++ |..||.
T Consensus       142 dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~~~~~p~~  220 (275)
T cd05046         142 DLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFY  220 (275)
T ss_pred             cCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCcc
Confidence            99999999999999999999998643321 1122344567889999998766654 88999999999999999 899998


Q ss_pred             CCChhHHHHHhhcccC--CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          150 ETDLPTLYKKINAAEF--SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       150 ~~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ..........+..+..  ..+..++..+.+++.+||..+|.+|||+.+++.+
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         221 GLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             ccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            7666666666654443  3345578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=291.21  Aligned_cols=199  Identities=34%  Similarity=0.690  Sum_probs=177.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |..++||.||++-..|++.+.++.|||-+.| ++.+.|..  .++++|..-+++..||+.||.|||.+||+|+|||||||
T Consensus       617 Lq~l~HPGiV~le~M~ET~ervFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENV  695 (888)
T KOG4236|consen  617 LQNLHHPGIVNLECMFETPERVFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENV  695 (888)
T ss_pred             HHhcCCCCeeEEEEeecCCceEEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchhe
Confidence            4578999999999999999999999999965 77777743  57899999999999999999999999999999999999


Q ss_pred             EEccCC---CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhH
Q 016865           79 LLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT  155 (381)
Q Consensus        79 Ll~~~~---~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  155 (381)
                      |+....   .+||||||+|++++.. ....+.+|||.|.|||++.+++|. ..-|+||.|||+|.-|+|..||.+..  +
T Consensus       696 LLas~~~FPQvKlCDFGfARiIgEk-sFRrsVVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEdE--d  771 (888)
T KOG4236|consen  696 LLASASPFPQVKLCDFGFARIIGEK-SFRRSVVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNEDE--D  771 (888)
T ss_pred             eeccCCCCCceeeccccceeecchh-hhhhhhcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCcc--c
Confidence            998765   5899999999988764 466788999999999999999997 88999999999999999999997643  4


Q ss_pred             HHHHhhcccCCCCC--C--CChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          156 LYKKINAAEFSCPF--W--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       156 ~~~~i~~~~~~~p~--~--~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      +..+|.++.+-+|+  |  +|+++.+||..+|+..-.+|.|++..+.|||++.
T Consensus       772 IndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~  824 (888)
T KOG4236|consen  772 INDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD  824 (888)
T ss_pred             hhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence            55667777766654  4  8999999999999999999999999999999975

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.9e-35  Score=268.86  Aligned_cols=192  Identities=21%  Similarity=0.256  Sum_probs=159.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.. ...|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+
T Consensus        55 l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nil  133 (259)
T cd05037          55 MSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNIL  133 (259)
T ss_pred             HHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEE
Confidence            467899999999999988 78899999999999999998765 6899999999999999999999999999999999999


Q ss_pred             EccCC-------CEEEeeccCccCCCCCccccccccCCCCCCCCceecCC-CCCCCcccHhHHHHHHHHHHh-CCCCCCC
Q 016865           80 LDSYG-------NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR-GYDGSAADVWSCGVILFVLMA-GYLPFGE  150 (381)
Q Consensus        80 l~~~~-------~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DIwSlGvil~~ll~-G~~Pf~~  150 (381)
                      ++.++       .+||+|||++.....    .....++..|+|||++.+. ...+.++||||+||++|+|++ |..||..
T Consensus       134 l~~~~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~  209 (259)
T cd05037         134 VARYGLNEGYVPFIKLSDPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST  209 (259)
T ss_pred             EecCccccCCceeEEeCCCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCccc
Confidence            99888       799999999876433    2344577889999998765 234589999999999999999 6888977


Q ss_pred             CChhHHHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          151 TDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       151 ~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      .+.......... ....|...+..+.++|.+||..+|.+|||+.++++
T Consensus       210 ~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         210 LSSSEKERFYQD-QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             CCchhHHHHHhc-CCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            654333332221 22222223478999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5e-35  Score=275.52  Aligned_cols=198  Identities=23%  Similarity=0.352  Sum_probs=158.9

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHH---HH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcE
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDK---IV--HQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENL   78 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~---i~--~~~~l~e~~~~~~~~qll~~L~~LH~~-gi~HrDlkp~Ni   78 (381)
                      +||||+++++++...+..+++|||+.+ ++.+.   +.  ..+.+++..+..++.|++.||+|||+. |++||||||+||
T Consensus        61 ~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Ni  139 (288)
T cd06616          61 DCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNI  139 (288)
T ss_pred             CCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHE
Confidence            599999999999999999999999864 55443   22  235699999999999999999999975 999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCC--CCCCCcccHhHHHHHHHHHHhCCCCCCCCCh-hH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR--GYDGSAADVWSCGVILFVLMAGYLPFGETDL-PT  155 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~  155 (381)
                      +++.++.+||+|||++...... .......|++.|+|||++.+.  ...+.++||||+||++|+|++|++||...+. ..
T Consensus       140 l~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~  218 (288)
T cd06616         140 LLDRNGNIKLCDFGISGQLVDS-IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFD  218 (288)
T ss_pred             EEccCCcEEEeecchhHHhccC-CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHH
Confidence            9999999999999998754332 122344689999999998765  2345899999999999999999999976542 11


Q ss_pred             HHHHhhccc-CCC----CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          156 LYKKINAAE-FSC----PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       156 ~~~~i~~~~-~~~----p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      ....+.... ...    +..++.++.+||.+||+.||.+|||++++++||||+.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  272 (288)
T cd06616         219 QLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD  272 (288)
T ss_pred             HHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence            222222211 111    1237889999999999999999999999999999975

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-36  Score=266.57  Aligned_cols=200  Identities=28%  Similarity=0.449  Sum_probs=163.2

Q ss_pred             CCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEE
Q 016865            3 IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLL   80 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~-gi~HrDlkp~NiLl   80 (381)
                      .-+.|+||+.+++|-.+..++|.||.+.. -+...+.+ .+.+||..+-.+...++.||.||..+ ||+|||+||+|||+
T Consensus       147 s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl  225 (391)
T KOG0983|consen  147 SHDCPYIVQCFGYFITNTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL  225 (391)
T ss_pred             ccCCCeeeeeeeEEeeCchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE
Confidence            34579999999999999999999999843 33333332 46799999999999999999999965 89999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCC---CCCCCcccHhHHHHHHHHHHhCCCCCCCCCh-hHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR---GYDGSAADVWSCGVILFVLMAGYLPFGETDL-PTL  156 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~~  156 (381)
                      |+.|++|+||||+|...-.. .......|-+.|||||.+...   .|+ ..+||||||+.|+||.||+.||...+. -+.
T Consensus       226 De~GniKlCDFGIsGrlvdS-kAhtrsAGC~~YMaPERidp~~~~kYD-iRaDVWSlGITlveLaTg~yPy~~c~tdFe~  303 (391)
T KOG0983|consen  226 DERGNIKLCDFGISGRLVDS-KAHTRSAGCAAYMAPERIDPPDKPKYD-IRADVWSLGITLVELATGQYPYKGCKTDFEV  303 (391)
T ss_pred             ccCCCEEeecccccceeecc-cccccccCCccccCccccCCCCCCccc-hhhhhhhhccchhhhhcccCCCCCCCccHHH
Confidence            99999999999999765443 223345689999999998643   455 899999999999999999999988543 344


Q ss_pred             HHHhhcccC-CCCC--CCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          157 YKKINAAEF-SCPF--WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       157 ~~~i~~~~~-~~p~--~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ..++.+... .+|.  .+|+.+.+|+..||++|+.+||...++|+|||+...
T Consensus       304 ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y  355 (391)
T KOG0983|consen  304 LTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY  355 (391)
T ss_pred             HHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence            445544332 2332  389999999999999999999999999999999753

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1e-34  Score=270.31  Aligned_cols=197  Identities=23%  Similarity=0.373  Sum_probs=166.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL   73 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDl   73 (381)
                      |+.++||||+++++++.+....|+||||++||+|.+++...       ..+++..+..++.|++.||.|||+.|++|+||
T Consensus        53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl  132 (269)
T cd05044          53 MSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDL  132 (269)
T ss_pred             HHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence            46789999999999999999999999999999999999642       23788999999999999999999999999999


Q ss_pred             CCCcEEEccCC-----CEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CC
Q 016865           74 KPENLLLDSYG-----NLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GY  145 (381)
Q Consensus        74 kp~NiLl~~~~-----~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~  145 (381)
                      ||+||+++.++     .++++|||++.......  .......++..|+|||++.+..+ +.++|||||||++|+|++ |.
T Consensus       133 ~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~  211 (269)
T cd05044         133 AARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQ  211 (269)
T ss_pred             ChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCC
Confidence            99999999887     89999999987543211  11223346788999999977665 589999999999999998 99


Q ss_pred             CCCCCCChhHHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          146 LPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       146 ~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      .||...+.......+... ....+..+|..+.++|.+||..+|.+|||++++++
T Consensus       212 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         212 QPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             CCCcccCHHHHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            999877766655555433 34556668999999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=9.3e-35  Score=281.03  Aligned_cols=197  Identities=22%  Similarity=0.369  Sum_probs=161.1

Q ss_pred             CCC-CccccccceEEEEe-CCEEEEEEecCCCCChHHHHHhc--------------------------------------
Q 016865            2 KIV-RHPNIVRLHEVLAS-RTKVYIILEFVTGGELFDKIVHQ--------------------------------------   41 (381)
Q Consensus         2 k~l-~HpnIv~l~~~~~~-~~~~~lV~E~~~gg~L~~~i~~~--------------------------------------   41 (381)
                      +++ +||||+++++++.. ...+|++|||+++|+|.+.+...                                      
T Consensus        65 ~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (337)
T cd05054          65 IHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSAS  144 (337)
T ss_pred             HhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccc
Confidence            345 79999999998864 46799999999999999988542                                      


Q ss_pred             -----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCCCEEEeeccCccCCC
Q 016865           42 -----------------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ   98 (381)
Q Consensus        42 -----------------------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~   98 (381)
                                             ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~  224 (337)
T cd05054         145 SGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIY  224 (337)
T ss_pred             cccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcc
Confidence                                   257889999999999999999999999999999999999999999999999998653


Q ss_pred             CCcc--ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhH-HHHHhhcc-cCCCCCCCCh
Q 016865           99 QGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPT-LYKKINAA-EFSCPFWFST  173 (381)
Q Consensus        99 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~  173 (381)
                      ....  ...+..++..|+|||++.+..+. .++||||+||++|+|++ |..||......+ ....+... ....|...++
T Consensus       225 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (337)
T cd05054         225 KDPDYVRKGDARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATP  303 (337)
T ss_pred             cCcchhhccCCCCCccccCcHHhcCCCCC-ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCH
Confidence            3211  12234467789999999887775 89999999999999998 999997654333 22333332 2344556789


Q ss_pred             hHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          174 GATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       174 ~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ++.+++.+||+.+|.+|||++++++|
T Consensus       304 ~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         304 EIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.7e-34  Score=267.84  Aligned_cols=197  Identities=24%  Similarity=0.328  Sum_probs=161.8

Q ss_pred             CCCCCccccccceEEEE-eCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLA-SRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~-~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||+++++++. .++..|+||||+++|+|.+++... ...++..+..++.|++.||+|||+.|++||||||+||
T Consensus        50 l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~ni  129 (262)
T cd05058          50 MKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNC  129 (262)
T ss_pred             HccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceE
Confidence            46789999999999775 456789999999999999998764 3467778889999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCc----cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCCh
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGV----ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDL  153 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~  153 (381)
                      |+++++.+||+|||++.......    .......+++.|+|||.+.+..+. .++||||+||++|+|++ |.+||...+.
T Consensus       130 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~  208 (262)
T cd05058         130 MLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDS  208 (262)
T ss_pred             EEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccc-hHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            99999999999999987543211    111233457789999998776664 89999999999999999 5777877666


Q ss_pred             hHHHHHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          154 PTLYKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       154 ~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ......+..+. ...|..+++.+.+++.+||..+|++|||+.++++
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         209 FDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            55555554432 3445567899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=8.8e-35  Score=271.19  Aligned_cols=197  Identities=18%  Similarity=0.279  Sum_probs=157.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-----RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKP   75 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-----~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp   75 (381)
                      |+.++||||+++++.+.+....|+||||+++|+|.+++....     ..++..+..++.|++.||+|||++||+||||||
T Consensus        49 ~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp  128 (269)
T cd05042          49 YRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLAL  128 (269)
T ss_pred             HHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccH
Confidence            356899999999999999999999999999999999997643     246788899999999999999999999999999


Q ss_pred             CcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCC------CCCCCcccHhHHHHHHHHHHh-CCC
Q 016865           76 ENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNR------GYDGSAADVWSCGVILFVLMA-GYL  146 (381)
Q Consensus        76 ~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~------~~~~~~~DIwSlGvil~~ll~-G~~  146 (381)
                      +|||+++++.+||+|||++.......  .......+++.|+|||++...      ...+.++||||+||++|+|++ |..
T Consensus       129 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~  208 (269)
T cd05042         129 RNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQ  208 (269)
T ss_pred             hheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCC
Confidence            99999999999999999986532211  111233457789999997532      223578999999999999999 889


Q ss_pred             CCCCCChhHHHHH-hhcccCCC-----CCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          147 PFGETDLPTLYKK-INAAEFSC-----PFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       147 Pf~~~~~~~~~~~-i~~~~~~~-----p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ||........... +.......     +..+++...+++..|+ .||.+|||++++++
T Consensus       209 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         209 PYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             CCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            9987655443333 33333222     2347888899999998 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.1e-34  Score=275.83  Aligned_cols=201  Identities=23%  Similarity=0.382  Sum_probs=167.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++|||++++++++.+.+..|+||||+.| +|.+.+.. ...+++..+..++.|++.||.|||++||+||||+|+||+
T Consensus        79 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil  157 (317)
T cd06635          79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNIL  157 (317)
T ss_pred             HHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEE
Confidence            3568999999999999999999999999975 77777754 456899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecC--CCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      ++.++.+||+|||++.....    .....|++.|+|||++..  .+..+.++|+||+||++|+|++|..||...+.....
T Consensus       158 ~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~  233 (317)
T cd06635         158 LTEPGQVKLADFGSASIASP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL  233 (317)
T ss_pred             ECCCCCEEEecCCCccccCC----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence            99999999999998865433    234578999999999742  223358999999999999999999999876655544


Q ss_pred             HHhhcccC-CC-CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          158 KKINAAEF-SC-PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       158 ~~i~~~~~-~~-p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      ..+..... .. +..+++.++++|.+||+.+|.+|||+.++++|||+....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         234 YHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             HHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence            44433322 22 234688999999999999999999999999999997543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.3e-34  Score=268.92  Aligned_cols=196  Identities=25%  Similarity=0.386  Sum_probs=163.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||+++++++. .+..|+||||+++|+|.+++....  .+++..+..++.|++.||.|||+.|++||||||+||
T Consensus        55 l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Ni  133 (260)
T cd05069          55 MKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANI  133 (260)
T ss_pred             HHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceE
Confidence            46789999999999885 456899999999999999997633  478999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      ++++++.++|+|||++....... .......++..|+|||.+.+..+ +.++||||+||++|+|++ |.+||.+.+....
T Consensus       134 ll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~  212 (260)
T cd05069         134 LVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREV  212 (260)
T ss_pred             EEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999987654321 11123346678999999876655 489999999999999999 9999988776666


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...+... ....|..++..+.+++++||..||.+|||++++++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         213 LEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            5555443 23445568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.6e-34  Score=266.51  Aligned_cols=197  Identities=25%  Similarity=0.381  Sum_probs=168.6

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||+++++++.+.+..|++|||+++++|.+.+.....  +++..+..++.|++.||+|||+.|++||||||+||
T Consensus        55 l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~ni  134 (258)
T smart00219       55 MRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNC  134 (258)
T ss_pred             HHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceE
Confidence            3567999999999999999999999999999999999976544  99999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCccccc-cccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVELLH-TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      ++++++.++|+|||++........... ...+++.|+|||.+.+..+ +.++||||+||++|+|++ |.+||...+....
T Consensus       135 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~  213 (258)
T smart00219      135 LVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV  213 (258)
T ss_pred             EEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999999876544211111 1236789999999865555 489999999999999998 8999988777776


Q ss_pred             HHHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      .+.+.... ...+..++.++.+++.+||..||.+|||+.++++
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      214 LEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence            66665443 3456668999999999999999999999999886

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.4e-34  Score=271.49  Aligned_cols=195  Identities=21%  Similarity=0.323  Sum_probs=163.9

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      +.++||||+++++++.+ ...++++||+++|+|.+.+.. .+.+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus        64 ~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~  142 (279)
T cd05109          64 AGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV  142 (279)
T ss_pred             HhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence            56799999999999975 457899999999999999876 4568999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccc--cccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGVEL--LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  157 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~  157 (381)
                      ++++.+||+|||++.........  .....+++.|+|||.+.+..++ .++||||+||++|+|++ |..||.........
T Consensus       143 ~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~  221 (279)
T cd05109         143 KSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPAREIP  221 (279)
T ss_pred             cCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            99999999999998765432111  1122346789999999877665 89999999999999998 99999876665555


Q ss_pred             HHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          158 KKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       158 ~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ..+... ....+..++.++.+++.+||..||.+|||+.+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         222 DLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            545443 23445668999999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2e-34  Score=268.48  Aligned_cols=197  Identities=26%  Similarity=0.391  Sum_probs=165.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+..|+||||+++|+|.+++... +.+++..+..++.|++.||+|||+.|++||||||+||+
T Consensus        60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil  139 (268)
T cd05063          60 MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNIL  139 (268)
T ss_pred             HhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEE
Confidence            46789999999999999999999999999999999998753 56899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCcccc-cc--ccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELL-HT--TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPT  155 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~-~~--~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~  155 (381)
                      +++++.+|++|||++.......... .+  ...++.|+|||++.+..+ +.++||||+||++|+|++ |..||...+...
T Consensus       140 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~  218 (268)
T cd05063         140 VNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHE  218 (268)
T ss_pred             EcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH
Confidence            9999999999999987654321111 11  123457999999977666 489999999999999998 999998777666


Q ss_pred             HHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          156 LYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       156 ~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ....+... ..+.+...+..+.+++.+||..+|.+||++.++++
T Consensus       219 ~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         219 VMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            66666543 22334447899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.9e-35  Score=275.11  Aligned_cols=196  Identities=30%  Similarity=0.497  Sum_probs=162.7

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      ++++||||+++++++...+..++|+||+++|+|.+++...  ..+++.....++.|++.||.|||+++++|+||+|.||+
T Consensus        56 ~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nil  135 (259)
T PF07714_consen   56 RKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNIL  135 (259)
T ss_dssp             HTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            5679999999999999888899999999999999999886  67999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCC--ccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      ++.++.+||+|||++......  ........+...|+|||.+.+..+ +.++||||||+++||+++ |+.||...+....
T Consensus       136 l~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~  214 (259)
T PF07714_consen  136 LDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI  214 (259)
T ss_dssp             EETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccc
Confidence            999999999999998765221  122334557788999999977665 489999999999999999 7899988877776


Q ss_pred             HHHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ..++.... ...|..++..+.++|.+||..||.+|||+.++++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  215 IEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             cccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            66664443 4456668999999999999999999999999875

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.7e-34  Score=267.94  Aligned_cols=196  Identities=26%  Similarity=0.419  Sum_probs=164.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||+++++++. .+..|+||||+++|+|.+++...  ..+++..+..++.|++.||+|||+.|++||||||+||
T Consensus        55 l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni  133 (260)
T cd05067          55 MKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANI  133 (260)
T ss_pred             HHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhE
Confidence            46789999999999874 45799999999999999998653  3588999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      ++++++.++|+|||++....... .......++..|+|||++....+ +.++||||+|+++|+|++ |++||.+.+....
T Consensus       134 ~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  212 (260)
T cd05067         134 LVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV  212 (260)
T ss_pred             EEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHH
Confidence            99999999999999987654221 11123345678999999876655 489999999999999999 9999988777666


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...+... ....+...+.++.++|.+||..+|.+|||+++++.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         213 IQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            6655443 23455567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-34  Score=265.52  Aligned_cols=197  Identities=27%  Similarity=0.427  Sum_probs=166.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      +++++||||+++++++.+....|+||||++|++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+
T Consensus        46 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nil  125 (251)
T cd05041          46 LKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCL  125 (251)
T ss_pred             HHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEE
Confidence            36789999999999999999999999999999999998663 46889999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCcccc--ccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELL--HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      ++.++.+||+|||++..........  ....++..|+|||++.+..+ +.++|+||+||++|+|++ |..||...+....
T Consensus       126 i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~  204 (251)
T cd05041         126 VGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQT  204 (251)
T ss_pred             EcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHH
Confidence            9999999999999987554211111  12234567999999876655 489999999999999999 8999987776555


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...+... ....|..++..+.+++.+||..+|.+|||+.++++
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         205 RERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             HHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            5555443 34456668899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.4e-34  Score=278.87  Aligned_cols=201  Identities=27%  Similarity=0.354  Sum_probs=161.6

Q ss_pred             CccccccceEEEEe----CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            5 RHPNIVRLHEVLAS----RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         5 ~HpnIv~l~~~~~~----~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      +||||+++++....    ...+|+++||+. ++|.+.+.....+++..++.++.||+.||+|||++||+||||||+||++
T Consensus        60 ~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili  138 (332)
T cd07857          60 GHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV  138 (332)
T ss_pred             CCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE
Confidence            69999999987543    256899999985 6999999887889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCc----cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGV----ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL  156 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~  156 (381)
                      +.++.+||+|||++.......    .......||+.|+|||++.+....+.++||||+||++|+|++|.+||...+....
T Consensus       139 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~  218 (332)
T cd07857         139 NADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQ  218 (332)
T ss_pred             cCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHH
Confidence            999999999999987544311    1223457899999999876543335899999999999999999999987553322


Q ss_pred             HHHhhc---------------c----------c---CC---CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          157 YKKINA---------------A----------E---FS---CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       157 ~~~i~~---------------~----------~---~~---~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ...+..               .          .   ..   ..+..+..+.+|+.+||+.||.+|||+.+++.|||+++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~  298 (332)
T cd07857         219 LNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW  298 (332)
T ss_pred             HHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence            211110               0          0   00   011257899999999999999999999999999999765


Q ss_pred             C
Q 016865          206 Y  206 (381)
Q Consensus       206 ~  206 (381)
                      .
T Consensus       299 ~  299 (332)
T cd07857         299 H  299 (332)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.1e-34  Score=268.16  Aligned_cols=195  Identities=24%  Similarity=0.366  Sum_probs=163.4

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      +.++||||+++++.+. ....|+||||+++|+|.+++...  ..++++.+..++.|++.||.|||+.|++||||||+||+
T Consensus        56 ~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nil  134 (262)
T cd05071          56 KKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL  134 (262)
T ss_pred             HhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEE
Confidence            5689999999999875 45689999999999999999753  35789999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCcc-ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVE-LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  157 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~  157 (381)
                      +++++.+||+|||.+........ ......++..|+|||++.+..+ +.++||||+||++|+|++ |.+||...+.....
T Consensus       135 l~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~  213 (262)
T cd05071         135 VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVL  213 (262)
T ss_pred             EcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH
Confidence            99999999999999876543221 1223446778999999877666 489999999999999999 89999877666655


Q ss_pred             HHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          158 KKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       158 ~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ..+... ....+..++..+.++|.+||+.||.+|||+.++++
T Consensus       214 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         214 DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            555433 23445568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.8e-34  Score=266.71  Aligned_cols=198  Identities=26%  Similarity=0.402  Sum_probs=167.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++......|+||||+++|+|.+++... +.++++.++.++.|++.||.|||+.|++||||||+||+
T Consensus        53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~  132 (256)
T cd05112          53 MMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCL  132 (256)
T ss_pred             HHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEE
Confidence            46789999999999999999999999999999999998764 46899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCcc-ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVE-LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  157 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~  157 (381)
                      ++.++.+||+|||++........ ......++..|+|||.+.+..+. .++||||+||++|+|++ |..||...+.....
T Consensus       133 i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  211 (256)
T cd05112         133 VGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS-SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV  211 (256)
T ss_pred             EcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcC-hHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence            99999999999999875433211 11122346789999999776654 89999999999999998 99999887776666


Q ss_pred             HHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          158 KKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       158 ~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ..+..+ ....|...+..+.+|+.+||..+|.+|||+.+++++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         212 ETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence            666544 233455578999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3e-34  Score=267.96  Aligned_cols=197  Identities=19%  Similarity=0.312  Sum_probs=158.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE   76 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~   76 (381)
                      ++.++||||+++++.+.+....|+||||+++|+|.+++...    ...++..+..++.|++.||+|||+.|++||||||+
T Consensus        49 ~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~  128 (268)
T cd05086          49 YRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALR  128 (268)
T ss_pred             HhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccc
Confidence            35689999999999999999999999999999999999753    23567788899999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCC------CCCCcccHhHHHHHHHHHHh-CCCC
Q 016865           77 NLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRG------YDGSAADVWSCGVILFVLMA-GYLP  147 (381)
Q Consensus        77 NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~------~~~~~~DIwSlGvil~~ll~-G~~P  147 (381)
                      |||++.++.+||+|||++.......  ......+|++.|+|||++....      ..+.++||||+||++|+|++ |..|
T Consensus       129 nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p  208 (268)
T cd05086         129 NCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP  208 (268)
T ss_pred             eEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCC
Confidence            9999999999999999976432211  1223567899999999985321      12478999999999999997 6789


Q ss_pred             CCCCChhHHHHHhhcc-cC-----CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          148 FGETDLPTLYKKINAA-EF-----SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       148 f~~~~~~~~~~~i~~~-~~-----~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      |...+....+..+... ..     ..+..+++.+.+++..|+ .+|.+|||++++++
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         209 YSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            9876665555443222 22     223347888999999999 67999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.1e-34  Score=286.51  Aligned_cols=196  Identities=24%  Similarity=0.374  Sum_probs=161.7

Q ss_pred             CCCC-ccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc---------------------------------------
Q 016865            2 KIVR-HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ---------------------------------------   41 (381)
Q Consensus         2 k~l~-HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~---------------------------------------   41 (381)
                      +.++ ||||+++++++.+.+.+|||||||++|+|.+++...                                       
T Consensus        95 ~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (400)
T cd05105          95 THLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENK  174 (400)
T ss_pred             HhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccc
Confidence            4565 999999999999999999999999999999988542                                       


Q ss_pred             ---------------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHH
Q 016865           42 ---------------------------------------------------------GRLLENDCRRYFQQLIDAVAHCH   64 (381)
Q Consensus        42 ---------------------------------------------------------~~l~e~~~~~~~~qll~~L~~LH   64 (381)
                                                                               ..+++..+..++.|++.||+|||
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH  254 (400)
T cd05105         175 GDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA  254 (400)
T ss_pred             ccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                                                     13677888999999999999999


Q ss_pred             HCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCcc--ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHH
Q 016865           65 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM  142 (381)
Q Consensus        65 ~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll  142 (381)
                      +.||+||||||+|||++.++.+||+|||++........  ......+++.|+|||++.+..+ +.++||||+||++|+|+
T Consensus       255 ~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell  333 (400)
T cd05105         255 SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIF  333 (400)
T ss_pred             hCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHH
Confidence            99999999999999999999999999999875433211  1223457788999999977666 48999999999999999


Q ss_pred             h-CCCCCCCCChhH-HHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          143 A-GYLPFGETDLPT-LYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       143 ~-G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      + |..||....... .+..+..+ ....+..++.++.+++.+||..||++|||+.++.+
T Consensus       334 t~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         334 SLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            7 999998754433 33333332 23455568899999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2e-34  Score=274.93  Aligned_cols=200  Identities=24%  Similarity=0.369  Sum_probs=165.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++|||++++++++.+....|+||||+. |+|.+.+.. ...+++..+..++.|++.||.|||++|++||||+|+||+
T Consensus        69 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil  147 (308)
T cd06634          69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL  147 (308)
T ss_pred             HHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEE
Confidence            357899999999999999999999999996 578777654 446899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecC--CCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      ++.++.++|+|||++.....    .....|++.|+|||++.+  ....+.++|||||||++|+|++|..||...+.....
T Consensus       148 ~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~  223 (308)
T cd06634         148 LSEPGLVKLGDFGSASIMAP----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL  223 (308)
T ss_pred             ECCCCcEEECCcccceeecC----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH
Confidence            99999999999999875433    234568999999999752  222347899999999999999999999766544333


Q ss_pred             HHhhcccC-C-CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          158 KKINAAEF-S-CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       158 ~~i~~~~~-~-~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ..+..... . .+..++..+.+||.+||..+|.+|||++++++|||+...
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         224 YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             HHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence            33332222 2 123478899999999999999999999999999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-34  Score=280.82  Aligned_cols=203  Identities=27%  Similarity=0.426  Sum_probs=163.7

Q ss_pred             CCCCCccccccceEEEEeC------CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 016865            1 MKIVRHPNIVRLHEVLASR------TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK   74 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~------~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlk   74 (381)
                      |+.++||||+++++++...      ...|++++++ |++|.+.+.. ..+++..++.++.|++.||+|||++||+|||||
T Consensus        70 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlk  147 (345)
T cd07877          70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK  147 (345)
T ss_pred             HHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence            3578999999999998643      3588999987 7799887654 569999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           75 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        75 p~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      |+||++++++.+||+|||++.....   ......|++.|+|||++.+....+.++||||+||++|+|++|+.||...+..
T Consensus       148 p~NIll~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~  224 (345)
T cd07877         148 PSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI  224 (345)
T ss_pred             hHHEEEcCCCCEEEecccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999999999999999999876432   2345678999999999876444458999999999999999999999765543


Q ss_pred             HHHHHhhccc-----------------------CCCC--------CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          155 TLYKKINAAE-----------------------FSCP--------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       155 ~~~~~i~~~~-----------------------~~~p--------~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      .....+....                       ...|        ...++++.+||.+||+.||.+|+|+.+++.||||+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~  304 (345)
T cd07877         225 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA  304 (345)
T ss_pred             HHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhh
Confidence            3322211100                       0000        12578899999999999999999999999999998


Q ss_pred             cCCCC
Q 016865          204 KNYNP  208 (381)
Q Consensus       204 ~~~~~  208 (381)
                      ....+
T Consensus       305 ~~~~~  309 (345)
T cd07877         305 QYHDP  309 (345)
T ss_pred             hcCCC
Confidence            75543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.4e-34  Score=270.46  Aligned_cols=196  Identities=25%  Similarity=0.359  Sum_probs=158.8

Q ss_pred             CCCCCccccccceEEEEe--CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLAS--RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||+++++++..  ...+|+||||+++|+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||
T Consensus        60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Ni  138 (283)
T cd05080          60 LKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNV  138 (283)
T ss_pred             HHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheE
Confidence            467899999999998865  3479999999999999998876 4699999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCcc---ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh-
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-  154 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-  154 (381)
                      ++++++.+||+|||++........   ......++..|+|||.+.+..+ +.++||||+||++|+|++|..||...... 
T Consensus       139 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~  217 (283)
T cd05080         139 LLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKF  217 (283)
T ss_pred             EEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchh
Confidence            999999999999999886543221   1123345677999999876655 48999999999999999999998653311 


Q ss_pred             -HHH-------------HHhh-cccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          155 -TLY-------------KKIN-AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       155 -~~~-------------~~i~-~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                       ...             ..+. ....+.|..++.++.+++.+||..+|++|||++++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         218 EEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence             000             0011 1112345567899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-36  Score=289.54  Aligned_cols=200  Identities=25%  Similarity=0.395  Sum_probs=171.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |++++|||+|.+-++|--....|+|||||-| +-.|.+. ..+++-|..+..+..+.+.||.|||+.+.||||||..|||
T Consensus        80 L~~l~HPntieYkgCyLre~TaWLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNIL  158 (948)
T KOG0577|consen   80 LRQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNIL  158 (948)
T ss_pred             HHhccCCCcccccceeeccchHHHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceE
Confidence            4678999999999999999999999999965 7777774 3567999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecC---CCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN---RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL  156 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~  156 (381)
                      +++.|.+|++|||.|.....    .++++|||+||||||+.-   ..|+ -++|||||||...||...++|+-..+-...
T Consensus       159 Lse~g~VKLaDFGSAsi~~P----AnsFvGTPywMAPEVILAMDEGqYd-gkvDvWSLGITCIELAERkPPlFnMNAMSA  233 (948)
T KOG0577|consen  159 LSEPGLVKLADFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSA  233 (948)
T ss_pred             ecCCCeeeeccccchhhcCc----hhcccCCccccchhHheeccccccC-CccceeeccchhhhhhhcCCCccCchHHHH
Confidence            99999999999999876543    578999999999999862   3455 799999999999999999999887776554


Q ss_pred             HHHhhcc-cCCCCC-CCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          157 YKKINAA-EFSCPF-WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       157 ~~~i~~~-~~~~p~-~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      .-.|-.. ...++. .+|..++.|+..||++-|.+|||.++++.|+|+...-
T Consensus       234 LYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R  285 (948)
T KOG0577|consen  234 LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER  285 (948)
T ss_pred             HHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence            4444333 333332 3689999999999999999999999999999997643

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-34  Score=266.72  Aligned_cols=197  Identities=23%  Similarity=0.377  Sum_probs=167.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||+++++++.+....|+||||+++++|.+++....  .+++..+..++.|++.||.|||++|++|+||||+||
T Consensus        55 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~ni  134 (261)
T cd05034          55 MKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNI  134 (261)
T ss_pred             HhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheE
Confidence            467899999999999999899999999999999999997643  689999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      +++.++.+|++|||++....... .......++..|+|||.+.+..+ +.++|+||+||++|+|++ |+.||.+.+....
T Consensus       135 li~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~  213 (261)
T cd05034         135 LVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREV  213 (261)
T ss_pred             EEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999987654311 11112234678999999976655 489999999999999998 9999988776666


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...+... ....|...+.++.+++.+||..+|.+|||++++++
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         214 LEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            6666543 33455567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.7e-34  Score=268.01  Aligned_cols=196  Identities=28%  Similarity=0.397  Sum_probs=164.6

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+ ...|+||||+++|+|.+++.... .+++..+..++.|++.||+|||+.|++||||||+||+
T Consensus        61 l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nil  139 (270)
T cd05056          61 MRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVL  139 (270)
T ss_pred             HHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEE
Confidence            357899999999999876 45789999999999999997644 5899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccc-cccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVEL-LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  157 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~  157 (381)
                      ++.++.+||+|||++......... .....+++.|+|||.+....+. .++|||||||++|+|++ |..||...+.....
T Consensus       140 i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~  218 (270)
T cd05056         140 VSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMLGVKPFQGVKNNDVI  218 (270)
T ss_pred             EecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCC-chhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence            999999999999998755432111 1122345689999998766654 89999999999999996 99999887766655


Q ss_pred             HHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          158 KKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       158 ~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ..+..+ ....|..++..+.++|.+|+..+|.+|||+.+++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~  260 (270)
T cd05056         219 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA  260 (270)
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            555443 34566678999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-34  Score=278.70  Aligned_cols=200  Identities=27%  Similarity=0.393  Sum_probs=161.8

Q ss_pred             CCCCCccccccceEEEEeC------CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 016865            1 MKIVRHPNIVRLHEVLASR------TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK   74 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~------~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlk   74 (381)
                      |+.++||||+++++++...      ..+|+|+||+.+ +|.+.+  ...++++.+..++.|++.||.|||+.|++|||||
T Consensus        68 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlk  144 (342)
T cd07879          68 LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLK  144 (342)
T ss_pred             HHhcCCCCccchhheecccccCCCCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            3568999999999998754      357999999964 776654  3468999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           75 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        75 p~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      |+||+++.++.+||+|||++.....   ......|++.|+|||++.+....+.++|+||+||++|+|++|+.||...+..
T Consensus       145 p~NIll~~~~~~kL~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~  221 (342)
T cd07879         145 PGNLAVNEDCELKILDFGLARHADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL  221 (342)
T ss_pred             HHHEEECCCCCEEEeeCCCCcCCCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999999999999999999875433   2234568899999999876444458999999999999999999999877644


Q ss_pred             HHHHHhhcc-----------------------cCCC--------CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          155 TLYKKINAA-----------------------EFSC--------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       155 ~~~~~i~~~-----------------------~~~~--------p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      .....+...                       ....        .+..++.+.+||.+||+.||.+|||+++++.||||+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~  301 (342)
T cd07879         222 DQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFD  301 (342)
T ss_pred             HHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchh
Confidence            333222110                       0000        113577899999999999999999999999999998


Q ss_pred             cCC
Q 016865          204 KNY  206 (381)
Q Consensus       204 ~~~  206 (381)
                      ...
T Consensus       302 ~~~  304 (342)
T cd07879         302 SFR  304 (342)
T ss_pred             hcc
Confidence            653

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.1e-34  Score=271.48  Aligned_cols=197  Identities=23%  Similarity=0.355  Sum_probs=166.1

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC----------------------CCCHHHHHHHHHHHHH
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG----------------------RLLENDCRRYFQQLID   58 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~----------------------~l~e~~~~~~~~qll~   58 (381)
                      |+.++||||+++++++.+....|+||||+++|+|.+++....                      .+++..+..++.|++.
T Consensus        62 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~  141 (288)
T cd05050          62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAA  141 (288)
T ss_pred             HHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHH
Confidence            356899999999999999999999999999999999997421                      3678889999999999


Q ss_pred             HHHHHHHCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHH
Q 016865           59 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGV  136 (381)
Q Consensus        59 ~L~~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGv  136 (381)
                      ||.|||++|++||||||+||++++++.++|+|||++.......  .......+++.|+|||++.+..+. .++||||+||
T Consensus       142 aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~  220 (288)
T cd05050         142 GMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT-TESDVWAYGV  220 (288)
T ss_pred             HHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCC-chhHHHHHHH
Confidence            9999999999999999999999999999999999987543211  112233456789999998776664 8999999999


Q ss_pred             HHHHHHh-CCCCCCCCChhHHHHHhhcccC-CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          137 ILFVLMA-GYLPFGETDLPTLYKKINAAEF-SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       137 il~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ++|+|++ |..||.+.+..+....+..+.. ..|..++.++.+||.+||+.+|.+|||+.|+++
T Consensus       221 il~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         221 VLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            9999998 8899987777666666655443 456668899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.3e-34  Score=271.51  Aligned_cols=197  Identities=20%  Similarity=0.298  Sum_probs=161.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCCe
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-----------RLLENDCRRYFQQLIDAVAHCHSKGVY   69 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-----------~l~e~~~~~~~~qll~~L~~LH~~gi~   69 (381)
                      |+.++||||+++++++.+.+..|+||||+++|+|.+++....           .+++..+..++.|++.||+|||+.|++
T Consensus        73 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~  152 (296)
T cd05095          73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFV  152 (296)
T ss_pred             HHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            457899999999999999999999999999999999987632           366778999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh--CC
Q 016865           70 HRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA--GY  145 (381)
Q Consensus        70 HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~--G~  145 (381)
                      ||||||+|||++.++.++|+|||++.......  .......+++.|+|||+..+..+ +.++||||+||++|+|++  |.
T Consensus       153 H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~  231 (296)
T cd05095         153 HRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKE  231 (296)
T ss_pred             cccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCC
Confidence            99999999999999999999999987543321  11223345678999998876665 489999999999999998  78


Q ss_pred             CCCCCCChhHHHHHhh--------cccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          146 LPFGETDLPTLYKKIN--------AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       146 ~Pf~~~~~~~~~~~i~--------~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      .||...+.........        ......|..+++.+.+|+.+||+.||.+|||+.++++
T Consensus       232 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         232 QPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             CCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            9997765544333221        1122345567899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-34  Score=271.73  Aligned_cols=197  Identities=21%  Similarity=0.281  Sum_probs=161.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG------------RLLENDCRRYFQQLIDAVAHCHSKGV   68 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~------------~l~e~~~~~~~~qll~~L~~LH~~gi   68 (381)
                      |+.++||||+++++++...+..|+||||+++++|.+++....            .+++..+..++.|++.||.|||++|+
T Consensus        71 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i  150 (295)
T cd05097          71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNF  150 (295)
T ss_pred             HHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCe
Confidence            467899999999999999999999999999999999886532            36788899999999999999999999


Q ss_pred             eecCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh--C
Q 016865           69 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA--G  144 (381)
Q Consensus        69 ~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~--G  144 (381)
                      +||||||+||++++++.+||+|||++.......  .......+++.|+|||++.+..+ +.++|||||||++|+|++  |
T Consensus       151 ~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~  229 (295)
T cd05097         151 VHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCK  229 (295)
T ss_pred             eccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCC
Confidence            999999999999999999999999987543321  11223345778999999877665 589999999999999988  6


Q ss_pred             CCCCCCCChhHHHHHhhc--------ccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          145 YLPFGETDLPTLYKKINA--------AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       145 ~~Pf~~~~~~~~~~~i~~--------~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ..||...+.......+..        .....++.+++.+.+|+.+||+.||.+|||++++++
T Consensus       230 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         230 EQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             CCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            789987665544433211        112234557899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.2e-34  Score=267.56  Aligned_cols=197  Identities=19%  Similarity=0.265  Sum_probs=157.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-----RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKP   75 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-----~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp   75 (381)
                      |+.++||||+++++++.+...+|+||||+++|+|.+++....     ..++..+..++.|++.||+|||+.|++||||||
T Consensus        49 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp  128 (269)
T cd05087          49 YRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLAL  128 (269)
T ss_pred             HHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCc
Confidence            367899999999999999999999999999999999986532     356778889999999999999999999999999


Q ss_pred             CcEEEccCCCEEEeeccCccCCCCCcc--ccccccCCCCCCCCceecCCC------CCCCcccHhHHHHHHHHHHh-CCC
Q 016865           76 ENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRG------YDGSAADVWSCGVILFVLMA-GYL  146 (381)
Q Consensus        76 ~NiLl~~~~~lkl~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~------~~~~~~DIwSlGvil~~ll~-G~~  146 (381)
                      +||+++.++.+||+|||++........  ......|++.|+|||++.+..      ..+.++||||+||++|+|++ |..
T Consensus       129 ~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~  208 (269)
T cd05087         129 RNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQ  208 (269)
T ss_pred             ceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCC
Confidence            999999999999999999865432211  122346788999999986422      12578999999999999996 999


Q ss_pred             CCCCCChhHHHHH-hhcccCCC--C---CCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          147 PFGETDLPTLYKK-INAAEFSC--P---FWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       147 Pf~~~~~~~~~~~-i~~~~~~~--p---~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ||...+....... +.......  |   ...++.+.+++.+|+ .+|.+|||+++++.
T Consensus       209 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         209 PYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            9987655443322 22222222  2   235788999999998 68999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.6e-34  Score=277.14  Aligned_cols=197  Identities=22%  Similarity=0.369  Sum_probs=166.6

Q ss_pred             CCC-CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHH
Q 016865            2 KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHCH   64 (381)
Q Consensus         2 k~l-~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~~L~~LH   64 (381)
                      +++ +||||+++++++.+.+.+|++|||+++|+|.+++....                .++...+..++.|++.||.|||
T Consensus        72 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH  151 (334)
T cd05100          72 KMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA  151 (334)
T ss_pred             HhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH
Confidence            456 79999999999999999999999999999999987532                3677888999999999999999


Q ss_pred             HCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCccc--cccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHH
Q 016865           65 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL--LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM  142 (381)
Q Consensus        65 ~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll  142 (381)
                      ++|++||||||+||+++.++.+||+|||+++........  .....++..|+|||++.+..+. .++||||+||++|+|+
T Consensus       152 ~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~  230 (334)
T cd05100         152 SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIF  230 (334)
T ss_pred             HCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC-chhhhHHHHHHHHHHH
Confidence            999999999999999999999999999998765432111  1222345679999999776665 8899999999999999


Q ss_pred             h-CCCCCCCCChhHHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          143 A-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       143 ~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      + |..||...+.......+... ....|..++.++.+++.+||+.+|.+|||+.+++++
T Consensus       231 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         231 TLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             hcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            8 89999888877777666543 234556678999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.2e-34  Score=271.56  Aligned_cols=200  Identities=29%  Similarity=0.439  Sum_probs=162.0

Q ss_pred             CCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEc
Q 016865            4 VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLD   81 (381)
Q Consensus         4 l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NiLl~   81 (381)
                      .+||||+++++++.+....|+||||+. ++|.+.+.. .+.+++..+..++.|++.|++|||+ .||+||||+|+||+++
T Consensus        71 ~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~  149 (296)
T cd06618          71 HDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD  149 (296)
T ss_pred             cCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEc
Confidence            369999999999999999999999985 477776655 4568999999999999999999997 5999999999999999


Q ss_pred             cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCC---CCCCcccHhHHHHHHHHHHhCCCCCCCCCh-hHHH
Q 016865           82 SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG---YDGSAADVWSCGVILFVLMAGYLPFGETDL-PTLY  157 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~~~  157 (381)
                      +++.+||+|||++....... ......|++.|+|||.+.+..   ..+.++||||+|+++|+|++|+.||..... ....
T Consensus       150 ~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~  228 (296)
T cd06618         150 ASGNVKLCDFGISGRLVDSK-AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL  228 (296)
T ss_pred             CCCCEEECccccchhccCCC-cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHH
Confidence            99999999999987654321 123345788999999987543   234789999999999999999999976332 2233


Q ss_pred             HHhhccc-CCCCC--CCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          158 KKINAAE-FSCPF--WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       158 ~~i~~~~-~~~p~--~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ..+.... ...+.  .++.++.+||.+||..||.+|||++++++||||...
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  279 (296)
T cd06618         229 TKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY  279 (296)
T ss_pred             HHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence            3332222 22222  368899999999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-34  Score=267.47  Aligned_cols=196  Identities=23%  Similarity=0.346  Sum_probs=167.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+ ...++||||+++|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+
T Consensus        63 l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil  141 (279)
T cd05057          63 MASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVL  141 (279)
T ss_pred             HHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEE
Confidence            457899999999999987 7899999999999999998764 46899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCcccc--ccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELL--HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      ++.++.+||+|||++..........  ....++..|+|||.+....+. .++|+||+||++|++++ |..||...+....
T Consensus       142 ~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  220 (279)
T cd05057         142 VKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEI  220 (279)
T ss_pred             EcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcC-chhhHHHHHHHHHHHhcCCCCCCCCCCHHHH
Confidence            9999999999999987654321111  122245789999998766654 89999999999999999 9999998877776


Q ss_pred             HHHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      .+.+..+. ...|...+.++.+++.+||..||..|||+.++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         221 PDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            66665543 4556668899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.2e-34  Score=266.64  Aligned_cols=197  Identities=25%  Similarity=0.397  Sum_probs=164.9

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      ++.++||||+++++++.++...++||||+++|+|.+++... +.+++..++.++.|++.||+|||++|++||||||+||+
T Consensus        59 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nil  138 (269)
T cd05065          59 MGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNIL  138 (269)
T ss_pred             HHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEE
Confidence            35789999999999999999999999999999999988763 56899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCcc--cccccc---CCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCCh
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVE--LLHTTC---GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDL  153 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~--~~~~~~---gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~  153 (381)
                      ++.++.+|++|||++........  ......   ++..|+|||.+.+..++ .++||||+||++|+|++ |..||...+.
T Consensus       139 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~e~l~~g~~p~~~~~~  217 (269)
T cd05065         139 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSN  217 (269)
T ss_pred             EcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCccc-chhhhhhhHHHHHHHhcCCCCCCCCCCH
Confidence            99999999999999875433211  111111   24579999999876664 89999999999999987 9999988776


Q ss_pred             hHHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          154 PTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       154 ~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ......+... ..+.+..++..+.+++.+||..+|.+|||+++++.
T Consensus       218 ~~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         218 QDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             HHHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            6666655432 23444557889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=8.3e-34  Score=273.29  Aligned_cols=203  Identities=28%  Similarity=0.476  Sum_probs=163.6

Q ss_pred             CCCCCccccccceEEEEe-CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLAS-RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~-~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.. ....|+|+||+ +++|.+.+.. ..+++..+..++.|++.||.|||+.||+||||+|.||+
T Consensus        63 l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nil  140 (328)
T cd07856          63 LKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNIL  140 (328)
T ss_pred             HHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEe
Confidence            357899999999999875 56899999998 5688877654 56889999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      +++++.+||+|||++.....   ...+..+++.|+|||++.+....+.++||||+||++|+|++|..||...+.......
T Consensus       141 i~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~  217 (328)
T cd07856         141 INENCDLKICDFGLARIQDP---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSI  217 (328)
T ss_pred             ECCCCCEEeCccccccccCC---CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999999875432   223456789999999986634445899999999999999999999977654322111


Q ss_pred             hhc------------------------c--cCCCC-----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 016865          160 INA------------------------A--EFSCP-----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  208 (381)
Q Consensus       160 i~~------------------------~--~~~~p-----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~  208 (381)
                      +..                        .  ....|     +.+++.+.++|.+||+.+|.+|||+++++.||||.....+
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~  297 (328)
T cd07856         218 ITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP  297 (328)
T ss_pred             HHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence            100                        0  00111     2367899999999999999999999999999999765433

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=7.5e-34  Score=266.44  Aligned_cols=197  Identities=22%  Similarity=0.289  Sum_probs=164.9

Q ss_pred             CCCCCccccccceEEEEe-CCEEEEEEecCCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 016865            1 MKIVRHPNIVRLHEVLAS-RTKVYIILEFVTGGELFDKIVHQ--------GRLLENDCRRYFQQLIDAVAHCHSKGVYHR   71 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~-~~~~~lV~E~~~gg~L~~~i~~~--------~~l~e~~~~~~~~qll~~L~~LH~~gi~Hr   71 (381)
                      |+.++||||+++++++.. ....++++||+++|+|.+++...        ..+++..+..++.|++.||+|||++|++||
T Consensus        62 l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~  141 (280)
T cd05043          62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHK  141 (280)
T ss_pred             HHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence            467899999999998765 57899999999999999998653        348899999999999999999999999999


Q ss_pred             CCCCCcEEEccCCCEEEeeccCccCCCCCcc--ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCC
Q 016865           72 DLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF  148 (381)
Q Consensus        72 Dlkp~NiLl~~~~~lkl~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf  148 (381)
                      ||||+||++++++.+||+|||+++.......  ......++..|+|||++.+..+ +.++||||+||++|++++ |++||
T Consensus       142 di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~  220 (280)
T cd05043         142 DIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPY  220 (280)
T ss_pred             ccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCc
Confidence            9999999999999999999999975433211  1122345778999999977666 489999999999999999 99999


Q ss_pred             CCCChhHHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          149 GETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       149 ~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...+.......+..+ ....+..+++++.+++.+||..||++|||+.++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         221 VEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            887766666555443 23345567899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1e-33  Score=261.86  Aligned_cols=193  Identities=26%  Similarity=0.464  Sum_probs=162.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||+++++++..+ ..|+||||+++|+|.+++....  .+++..+..++.|++.||.|||+.|++||||||+||
T Consensus        53 l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~ni  131 (254)
T cd05083          53 MTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNI  131 (254)
T ss_pred             HHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceE
Confidence            3578999999999998764 5799999999999999997643  478999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  157 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~  157 (381)
                      +++.++.+||+|||++......   ......+..|+|||.+.+..+ +.++|+||+||++|+|++ |.+||...+.....
T Consensus       132 li~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  207 (254)
T cd05083         132 LVSEDGVAKVSDFGLARVGSMG---VDNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK  207 (254)
T ss_pred             EEcCCCcEEECCCccceecccc---CCCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH
Confidence            9999999999999998754321   122334678999999876665 489999999999999998 99999888776666


Q ss_pred             HHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          158 KKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       158 ~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ..+..+. ...+..++..+.+++.+||..+|..|||++++++
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         208 ECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            6555442 2334557899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1e-33  Score=262.83  Aligned_cols=196  Identities=23%  Similarity=0.420  Sum_probs=163.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++|+||+++++++.+ ...|++|||+++|+|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+||
T Consensus        55 l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni  133 (260)
T cd05073          55 MKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANI  133 (260)
T ss_pred             HHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceE
Confidence            467899999999999987 7889999999999999999763  3578888999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCcc-ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVE-LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      +++.++.+||+|||++........ ......++..|+|||++....+ +.++|+||+||++|++++ |.+||...+....
T Consensus       134 ~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~  212 (260)
T cd05073         134 LVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV  212 (260)
T ss_pred             EEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            999999999999999876543211 1122345678999999976555 488999999999999999 9999988776666


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...+... ....+...+.++.+++.+||+.+|.+|||+.++++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         213 IRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            6555443 23345568899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.3e-33  Score=263.05  Aligned_cols=195  Identities=31%  Similarity=0.542  Sum_probs=167.2

Q ss_pred             CCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCc
Q 016865            3 IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPEN   77 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~N   77 (381)
                      .++||||+++++++.+++..|+||||++|++|.+.+..    ...+++..++.++.|++.||.|||+ .|++||||+|+|
T Consensus        65 ~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~n  144 (269)
T cd08528          65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNN  144 (269)
T ss_pred             cCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHH
Confidence            57999999999999999999999999999999988743    3468999999999999999999996 789999999999


Q ss_pred             EEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           78 LLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        78 iLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      |+++.++.+||+|||++....... ......|+..|+|||.+.+..+ +.++|+||+|+++|+|++|.+||...+.....
T Consensus       145 il~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~  222 (269)
T cd08528         145 IMLGEDDKVTITDFGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLA  222 (269)
T ss_pred             EEECCCCcEEEecccceeeccccc-ccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHH
Confidence            999999999999999987654432 3456678999999999987655 58999999999999999999999887766665


Q ss_pred             HHhhcccCC-CCC-CCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          158 KKINAAEFS-CPF-WFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       158 ~~i~~~~~~-~p~-~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ..+...... .+. .+++++.++|.+||..||++|||+.++..+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         223 TKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             HHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            555444332 222 578999999999999999999999998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=9.3e-34  Score=269.56  Aligned_cols=197  Identities=21%  Similarity=0.334  Sum_probs=163.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      ++.++||||+++++++.+. ..++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+
T Consensus        63 ~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nil  141 (303)
T cd05110          63 MASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVL  141 (303)
T ss_pred             HHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceee
Confidence            3578999999999998754 4789999999999999987644 5899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCcc--ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      ++.++.+||+|||++........  ......++..|+|||++.+..+. .++||||+||++|+|++ |..||.+......
T Consensus       142 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DiwslG~~l~el~t~g~~p~~~~~~~~~  220 (303)
T cd05110         142 VKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYDGIPTREI  220 (303)
T ss_pred             ecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999986543211  12234457789999998776654 89999999999999998 9999987665554


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ...+..+ ....+...+..+.+++.+|+..+|.+|||++++++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         221 PDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4444333 234455678899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=8.8e-34  Score=296.89  Aligned_cols=94  Identities=34%  Similarity=0.623  Sum_probs=90.1

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      +.++||||+++++++.+.+.+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus        59 ~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~  138 (669)
T cd05610          59 ALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS  138 (669)
T ss_pred             HhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEc
Confidence            56799999999999999999999999999999999998878899999999999999999999999999999999999999


Q ss_pred             cCCCEEEeeccCcc
Q 016865           82 SYGNLKVSDFGLSA   95 (381)
Q Consensus        82 ~~~~lkl~DFGls~   95 (381)
                      .++.+||+|||++.
T Consensus       139 ~~g~vkL~DFGls~  152 (669)
T cd05610         139 NEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCEEEEeCCCCc
Confidence            99999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1e-33  Score=266.45  Aligned_cols=198  Identities=22%  Similarity=0.341  Sum_probs=159.6

Q ss_pred             CCCCCccccccceEEEEeC--CEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            1 MKIVRHPNIVRLHEVLASR--TKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~--~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      |+.++||||+++++++.+.  ...|+||||++||+|.+++.... .+++..+..++.|++.||+|||++|++||||||+|
T Consensus        60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~N  139 (284)
T cd05079          60 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARN  139 (284)
T ss_pred             HHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchhe
Confidence            4678999999999999875  67999999999999999986643 58999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccCccCCCCCcc---ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh-
Q 016865           78 LLLDSYGNLKVSDFGLSALPQQGVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL-  153 (381)
Q Consensus        78 iLl~~~~~lkl~DFGls~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-  153 (381)
                      |+++.++.+||+|||++........   ......|+..|+|||++.+..+. .++||||+||++|+|+++..|+..... 
T Consensus       140 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~ellt~~~~~~~~~~~  218 (284)
T cd05079         140 VLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYELLTYCDSESSPMTL  218 (284)
T ss_pred             EEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCC-ccccchhhhhhhhhhhcCCCCCccccch
Confidence            9999999999999999886543221   12345577889999998776654 899999999999999998776532110 


Q ss_pred             --------------hHHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          154 --------------PTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       154 --------------~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                                    ......+..+ ..+.+..++..+.+||.+||+.||.+|||+.+++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         219 FLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             hhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                          1111111111 223445588999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-34  Score=257.02  Aligned_cols=205  Identities=22%  Similarity=0.383  Sum_probs=169.2

Q ss_pred             CCCCccccccceEEEEeC--------CEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q 016865            2 KIVRHPNIVRLHEVLASR--------TKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRD   72 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~--------~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrD   72 (381)
                      ..|+|+|+++++++|.+.        ..+|+|+++|+. +|+-.+.+. .+++...+..++++++.||.|+|+..|+|||
T Consensus        71 ~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRD  149 (376)
T KOG0669|consen   71 QLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRD  149 (376)
T ss_pred             HHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhc
Confidence            467999999999998543        359999999976 888888765 5799999999999999999999999999999


Q ss_pred             CCCCcEEEccCCCEEEeeccCccCCCCCc----cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCC
Q 016865           73 LKPENLLLDSYGNLKVSDFGLSALPQQGV----ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF  148 (381)
Q Consensus        73 lkp~NiLl~~~~~lkl~DFGls~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf  148 (381)
                      +||+|+|++.+|.+||+|||+++.+....    ......+-|++|.+||.+.+...++.+.|||..|||+.||++|.+.+
T Consensus       150 mKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspim  229 (376)
T KOG0669|consen  150 MKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIM  229 (376)
T ss_pred             ccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccc
Confidence            99999999999999999999997665421    22345567999999999999888889999999999999999999999


Q ss_pred             CCCChhHHHHHhhc--ccC-----------------C---CCC-------------CCChhHHHHHHHhcCCCCCCCCCH
Q 016865          149 GETDLPTLYKKINA--AEF-----------------S---CPF-------------WFSTGATSLIHKILDPNPKTRIRI  193 (381)
Q Consensus       149 ~~~~~~~~~~~i~~--~~~-----------------~---~p~-------------~~s~~~~~li~~~L~~dP~~R~t~  193 (381)
                      .+.+.......|..  +.+                 .   .|.             --++++.+|+.+||..||.+|+++
T Consensus       230 qgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~a  309 (376)
T KOG0669|consen  230 QGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDA  309 (376)
T ss_pred             cCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcch
Confidence            87665443332210  000                 0   111             125689999999999999999999


Q ss_pred             HHHhcCcccccCCC
Q 016865          194 EGIRKHPWFRKNYN  207 (381)
Q Consensus       194 ~~il~hp~~~~~~~  207 (381)
                      +++++|.||.+...
T Consensus       310 d~alnh~~F~kdp~  323 (376)
T KOG0669|consen  310 DQALNHDFFWKDPM  323 (376)
T ss_pred             HhhhchhhhhcCCc
Confidence            99999999987653

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=256.45  Aligned_cols=198  Identities=26%  Similarity=0.418  Sum_probs=160.7

Q ss_pred             CCCCccccccceEEEEe-----CCEEEEEEecCCCCChHHHHHhc---C-CCCHHHHHHHHHHHHHHHHHHHHCC--Cee
Q 016865            2 KIVRHPNIVRLHEVLAS-----RTKVYIILEFVTGGELFDKIVHQ---G-RLLENDCRRYFQQLIDAVAHCHSKG--VYH   70 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~-----~~~~~lV~E~~~gg~L~~~i~~~---~-~l~e~~~~~~~~qll~~L~~LH~~g--i~H   70 (381)
                      |+++||||++++++...     +...||+++|...|+|.+.|...   + -++|.++..|+.++++||++||+..  .+|
T Consensus        73 rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH  152 (302)
T KOG2345|consen   73 RKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAH  152 (302)
T ss_pred             HhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccc
Confidence            57899999999887633     34599999999999999999752   2 5899999999999999999999998  999


Q ss_pred             cCCCCCcEEEccCCCEEEeeccCccCCCCCcc---------ccccccCCCCCCCCceecCCCCC--CCcccHhHHHHHHH
Q 016865           71 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVE---------LLHTTCGTPNYVAPEVLSNRGYD--GSAADVWSCGVILF  139 (381)
Q Consensus        71 rDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~---------~~~~~~gt~~y~aPE~l~~~~~~--~~~~DIwSlGvil~  139 (381)
                      |||||.|||+++.+.+++.|||.++...-.-.         .-.....|.+|+|||.+.-+.+.  ++++|||||||+||
T Consensus       153 ~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLY  232 (302)
T KOG2345|consen  153 RDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLY  232 (302)
T ss_pred             cCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHH
Confidence            99999999999999999999999876442100         01123468999999998755433  58999999999999


Q ss_pred             HHHhCCCCCCCCCh--hHHHHHhhcccCCCCC--CCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          140 VLMAGYLPFGETDL--PTLYKKINAAEFSCPF--WFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       140 ~ll~G~~Pf~~~~~--~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      +|+.|..||+..-.  ..+.-.+.++++++|.  .+|+.+.++|+.||++||.+||++.+++.+
T Consensus       233 a~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  233 AMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             HHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            99999999964211  1222234556666664  389999999999999999999999999864

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.1e-33  Score=279.47  Aligned_cols=197  Identities=25%  Similarity=0.345  Sum_probs=162.9

Q ss_pred             CCCC-ccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC--------------------------------------
Q 016865            2 KIVR-HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--------------------------------------   42 (381)
Q Consensus         2 k~l~-HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--------------------------------------   42 (381)
                      .++. ||||+++++++.+.+.+|+||||+++|+|.+++...+                                      
T Consensus        95 ~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (401)
T cd05107          95 SHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSES  174 (401)
T ss_pred             HhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhcc
Confidence            4566 9999999999999999999999999999999986432                                      


Q ss_pred             ------------------------------------------------------------CCCHHHHHHHHHHHHHHHHH
Q 016865           43 ------------------------------------------------------------RLLENDCRRYFQQLIDAVAH   62 (381)
Q Consensus        43 ------------------------------------------------------------~l~e~~~~~~~~qll~~L~~   62 (381)
                                                                                  .++...++.++.|++.||.|
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~  254 (401)
T cd05107         175 DGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEF  254 (401)
T ss_pred             CccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHH
Confidence                                                                        24666788899999999999


Q ss_pred             HHHCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHH
Q 016865           63 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFV  140 (381)
Q Consensus        63 LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~  140 (381)
                      ||+.|++||||||+|||+++++.+||+|||++.......  ....+..+++.|+|||.+.+..+ +.++||||+||++|+
T Consensus       255 LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e  333 (401)
T cd05107         255 LASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWE  333 (401)
T ss_pred             HhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHH
Confidence            999999999999999999999999999999987543211  11233467889999999977665 489999999999999


Q ss_pred             HHh-CCCCCCCCChhHH-HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          141 LMA-GYLPFGETDLPTL-YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       141 ll~-G~~Pf~~~~~~~~-~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      |++ |..||........ ...+..+ ....|..++.++.+|+.+||..+|.+||++.+|++.
T Consensus       334 ~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         334 IFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            998 8999987554443 3333332 345566789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.4e-33  Score=296.55  Aligned_cols=197  Identities=23%  Similarity=0.350  Sum_probs=157.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-----------GRLLENDCRRYFQQLIDAVAHCHSKGVY   69 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-----------~~l~e~~~~~~~~qll~~L~~LH~~gi~   69 (381)
                      |+.++||||+++++++.+.+..|+||||++||+|.+++...           ..++...+..++.|++.||+|||++||+
T Consensus        56 Ls~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GII  135 (932)
T PRK13184         56 AADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVL  135 (932)
T ss_pred             HHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            35689999999999999999999999999999999988641           2345567889999999999999999999


Q ss_pred             ecCCCCCcEEEccCCCEEEeeccCccCCCCCc------------------cccccccCCCCCCCCceecCCCCCCCcccH
Q 016865           70 HRDLKPENLLLDSYGNLKVSDFGLSALPQQGV------------------ELLHTTCGTPNYVAPEVLSNRGYDGSAADV  131 (381)
Q Consensus        70 HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DI  131 (381)
                      ||||||+|||++.+|.+||+|||++.......                  ......+||+.|+|||++.+..+ +.++||
T Consensus       136 HRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDI  214 (932)
T PRK13184        136 HRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDI  214 (932)
T ss_pred             ccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHH
Confidence            99999999999999999999999997652100                  01123579999999999987766 489999


Q ss_pred             hHHHHHHHHHHhCCCCCCCCChhHHHHHh-hccc--CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          132 WSCGVILFVLMAGYLPFGETDLPTLYKKI-NAAE--FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       132 wSlGvil~~ll~G~~Pf~~~~~~~~~~~i-~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ||+||++|+|++|..||...+........ ....  ......+++.+.+++.+||..||++|++..+.+.
T Consensus       215 WSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl  284 (932)
T PRK13184        215 YALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK  284 (932)
T ss_pred             HHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            99999999999999999775543322211 1111  1111247889999999999999999988665543

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.7e-33  Score=272.74  Aligned_cols=197  Identities=22%  Similarity=0.362  Sum_probs=159.7

Q ss_pred             CCC-CccccccceEEEEe-CCEEEEEEecCCCCChHHHHHhcC-------------------------------------
Q 016865            2 KIV-RHPNIVRLHEVLAS-RTKVYIILEFVTGGELFDKIVHQG-------------------------------------   42 (381)
Q Consensus         2 k~l-~HpnIv~l~~~~~~-~~~~~lV~E~~~gg~L~~~i~~~~-------------------------------------   42 (381)
                      +.+ +||||+++++++.. ...+|+||||+++|+|.+++....                                     
T Consensus        65 ~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (343)
T cd05103          65 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSS  144 (343)
T ss_pred             HhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccc
Confidence            345 68999999998865 457899999999999999986421                                     


Q ss_pred             ------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCCCEEEeecc
Q 016865           43 ------------------------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFG   92 (381)
Q Consensus        43 ------------------------------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFG   92 (381)
                                                    .++...+..++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg  224 (343)
T cd05103         145 QSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFG  224 (343)
T ss_pred             cccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecc
Confidence                                          25677888999999999999999999999999999999999999999999


Q ss_pred             CccCCCCCcc--ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhH-HHHHhhc-ccCCC
Q 016865           93 LSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPT-LYKKINA-AEFSC  167 (381)
Q Consensus        93 ls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~-~~~~i~~-~~~~~  167 (381)
                      ++........  ...+..+++.|+|||++.+..+. .++||||+||++|+|++ |..||....... ....+.. .....
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  303 (343)
T cd05103         225 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA  303 (343)
T ss_pred             cccccccCcchhhcCCCCCCcceECcHHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCC
Confidence            9876432211  11233456789999998776664 89999999999999997 999997654332 2233322 23456


Q ss_pred             CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          168 PFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       168 p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      |.+.++++.+++.+||+.||.+|||+.++++|
T Consensus       304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            67789999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-34  Score=281.48  Aligned_cols=196  Identities=26%  Similarity=0.402  Sum_probs=173.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~-l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |++++|||||++||+...+.-+|||||+|+||+|.+++...+. ++..+...++.+.+.||+|||+++++||||-..|+|
T Consensus       215 Mr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL  294 (474)
T KOG0194|consen  215 MRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCL  294 (474)
T ss_pred             HHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhe
Confidence            6789999999999999999999999999999999999998774 999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccc-cCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  157 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~  157 (381)
                      ++.++.+||+|||+|+..... ...... --...|+|||.+...-| +.++||||+||++||+++ |..||.+....+..
T Consensus       295 ~~~~~~vKISDFGLs~~~~~~-~~~~~~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~  372 (474)
T KOG0194|consen  295 YSKKGVVKISDFGLSRAGSQY-VMKKFLKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK  372 (474)
T ss_pred             ecCCCeEEeCccccccCCcce-eeccccccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHH
Confidence            999999999999998865421 111212 24578999999987756 499999999999999999 89999999999998


Q ss_pred             HHhhcccC--CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          158 KKINAAEF--SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       158 ~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      .++....+  ..|...+++...++.+|+..+|++|||+.++.+
T Consensus       373 ~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  373 AKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            88855444  455667889999999999999999999999876

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=3.4e-33  Score=253.84  Aligned_cols=199  Identities=46%  Similarity=0.800  Sum_probs=173.7

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      ++++|+||+++++.+.+....++++||+++++|.+++.....+++..+..++.|++.++.|||+.|++|+||+|.||+++
T Consensus        42 ~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~  121 (244)
T smart00220       42 KKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLD  121 (244)
T ss_pred             HhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEEC
Confidence            56799999999999999999999999999999999998766689999999999999999999999999999999999999


Q ss_pred             cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCC-CChhHHHHHh
Q 016865           82 SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKI  160 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i  160 (381)
                      +++.++++|||.+....... ......|+..|+|||......++ .++||||+|++++++++|..||.. .+.......+
T Consensus       122 ~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~-~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~  199 (244)
T smart00220      122 EDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEVLLGKGYG-KAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKI  199 (244)
T ss_pred             CCCcEEEccccceeeecccc-ccccccCCcCCCCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence            99999999999988655431 34566789999999999766665 799999999999999999999987 5555555555


Q ss_pred             hcccCCCCCC---CChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          161 NAAEFSCPFW---FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       161 ~~~~~~~p~~---~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      .......+..   ++.++.+++.+||..+|++||++.++++||||
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      200 GKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             hccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence            5444433222   78999999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4.8e-33  Score=263.76  Aligned_cols=194  Identities=14%  Similarity=0.164  Sum_probs=156.1

Q ss_pred             CCCCccccccceEEEEeCC----EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            2 KIVRHPNIVRLHEVLASRT----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~----~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      +.++|+||+++++.+....    ..++++|++.. ++.+.+......++..+..++.|++.||+|||++||+||||||+|
T Consensus        78 ~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~N  156 (294)
T PHA02882         78 HNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPEN  156 (294)
T ss_pred             ccCCCCCCCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence            4578999999999876543    46888998744 677777665567899999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccCccCCCCCc-------cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCC
Q 016865           78 LLLDSYGNLKVSDFGLSALPQQGV-------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE  150 (381)
Q Consensus        78 iLl~~~~~lkl~DFGls~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~  150 (381)
                      ||++.++.++|+|||+|+......       .......||+.|+|||+..+..+ +.++||||+||++|+|++|.+||..
T Consensus       157 ill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~  235 (294)
T PHA02882        157 IMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKG  235 (294)
T ss_pred             EEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCc
Confidence            999999999999999987653211       11234569999999999987776 4999999999999999999999976


Q ss_pred             CCh-hH--------HHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          151 TDL-PT--------LYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       151 ~~~-~~--------~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      .+. ..        ....+..+....+ ..++.+.+++..|+..+|.+||+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        236 FGHNGNLIHAAKCDFIKRLHEGKIKIK-NANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             cccchHHHHHhHHHHHHHhhhhhhccC-CCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            632 21        2233333333333 35789999999999999999999999875

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.6e-33  Score=262.36  Aligned_cols=197  Identities=25%  Similarity=0.367  Sum_probs=156.5

Q ss_pred             CCCCCccccccceEEEEe--CCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            1 MKIVRHPNIVRLHEVLAS--RTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      |+.++||||+++++++..  ...+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|
T Consensus        59 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~n  138 (284)
T cd05081          59 LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRN  138 (284)
T ss_pred             HHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhh
Confidence            357899999999998753  45799999999999999999764 458999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccCccCCCCCccc---cccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           78 LLLDSYGNLKVSDFGLSALPQQGVEL---LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        78 iLl~~~~~lkl~DFGls~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      |+++.++.+||+|||++.........   .....++..|+|||++.+..+ +.++||||+||++|+|++|..|+......
T Consensus       139 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~  217 (284)
T cd05081         139 ILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAE  217 (284)
T ss_pred             EEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchh
Confidence            99999999999999999865432211   111223456999999977665 48999999999999999998776433211


Q ss_pred             H----------------HHHHhhc-ccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          155 T----------------LYKKINA-AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       155 ~----------------~~~~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      .                +...+.. .....+..++.++.+||.+||..+|.+|||+.++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         218 FMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             hhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            0                1111111 122344557899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=5.8e-33  Score=259.10  Aligned_cols=197  Identities=25%  Similarity=0.379  Sum_probs=163.0

Q ss_pred             CCCCCccccccceEEEEeCC------EEEEEEecCCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRT------KVYIILEFVTGGELFDKIVHQ------GRLLENDCRRYFQQLIDAVAHCHSKGV   68 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~------~~~lV~E~~~gg~L~~~i~~~------~~l~e~~~~~~~~qll~~L~~LH~~gi   68 (381)
                      |+.++||||+++++++....      ..++++||+.+|+|.+++...      ..+++..+..++.|++.||+|||++||
T Consensus        55 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i  134 (273)
T cd05074          55 MKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNF  134 (273)
T ss_pred             HhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            46789999999999886532      357899999999998887532      247889999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCCEEEeeccCccCCCCCcc--ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CC
Q 016865           69 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GY  145 (381)
Q Consensus        69 ~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~  145 (381)
                      +||||||+||+++.++.+|++|||++........  ......+++.|++||.+.+..++ .++|||||||++|+|++ |.
T Consensus       135 ~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~sDi~slG~il~el~~~g~  213 (273)
T cd05074         135 IHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQ  213 (273)
T ss_pred             eecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccc-hhhhhHHHHHHHHHHhhCCC
Confidence            9999999999999999999999999876533211  12233456789999998776664 89999999999999999 99


Q ss_pred             CCCCCCChhHHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          146 LPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       146 ~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      +||...+....+..+... ....+...+..+.+++.+||..+|++|||+.+++.
T Consensus       214 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         214 TPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             CCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            999887766666555443 34555678899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7e-34  Score=264.81  Aligned_cols=192  Identities=29%  Similarity=0.460  Sum_probs=157.0

Q ss_pred             cccceEEEEeCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEcc----
Q 016865            9 IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS----   82 (381)
Q Consensus         9 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~----   82 (381)
                      +|.+.++|+-.+++|||+|.+ |-+++|++..++  ++|-+.++.+.+||+.+++|||+.+++|.||||||||+.+    
T Consensus       153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~  231 (415)
T KOG0671|consen  153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYF  231 (415)
T ss_pred             EEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceE
Confidence            677788899999999999998 669999998754  5889999999999999999999999999999999999943    


Q ss_pred             ----------------CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCC
Q 016865           83 ----------------YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYL  146 (381)
Q Consensus        83 ----------------~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~  146 (381)
                                      +-.+|++|||.|+.....   ..+.+.|..|.|||++.+-+++ .++||||+||||+|+.+|..
T Consensus       232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~~  307 (415)
T KOG0671|consen  232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGET  307 (415)
T ss_pred             EEeccCCccceeccCCCcceEEEecCCcceeccC---cceeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccce
Confidence                            224899999999875543   3677899999999999999997 99999999999999999999


Q ss_pred             CCCCCChhH---HHHHhhc------------------ccCCCCCC----------------------C---ChhHHHHHH
Q 016865          147 PFGETDLPT---LYKKINA------------------AEFSCPFW----------------------F---STGATSLIH  180 (381)
Q Consensus       147 Pf~~~~~~~---~~~~i~~------------------~~~~~p~~----------------------~---s~~~~~li~  180 (381)
                      .|...+..+   +.+.|..                  +.+..|..                      .   -.++.+||+
T Consensus       308 LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~  387 (415)
T KOG0671|consen  308 LFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR  387 (415)
T ss_pred             ecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence            997665322   3333211                  01110100                      1   134789999


Q ss_pred             HhcCCCCCCCCCHHHHhcCcccccC
Q 016865          181 KILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       181 ~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      +||..||.+|+|+.|+|.||||+..
T Consensus       388 ~mL~fDP~~RiTl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  388 RMLEFDPARRITLREALSHPFFARL  412 (415)
T ss_pred             HHHccCccccccHHHHhcCHHhhcC
Confidence            9999999999999999999999753

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.1e-33  Score=259.17  Aligned_cols=197  Identities=23%  Similarity=0.341  Sum_probs=160.4

Q ss_pred             CCCCCccccccceEEEEe--CCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            1 MKIVRHPNIVRLHEVLAS--RTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      ++.++||||+++++++..  ....|+||||+++|+|.+++.... .+++..+..++.|++.||+|||+.|++||||||+|
T Consensus        60 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~n  139 (284)
T cd05038          60 LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARN  139 (284)
T ss_pred             HHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHh
Confidence            357899999999999987  568999999999999999997644 58999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccCccCCCCCccc---cccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           78 LLLDSYGNLKVSDFGLSALPQQGVEL---LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        78 iLl~~~~~lkl~DFGls~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      |+++.++.++|+|||++.........   .....++..|+|||.+.+..+ +.++||||+||++|+|++|..||......
T Consensus       140 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~  218 (284)
T cd05038         140 ILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAE  218 (284)
T ss_pred             EEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccch
Confidence            99999999999999999876532111   112345667999999877665 48899999999999999999998653221


Q ss_pred             H---------------HHHHhhc-ccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          155 T---------------LYKKINA-AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       155 ~---------------~~~~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      .               ....+.. .....+..++.++.+++.+||..+|.+|||+.++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         219 FLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             hccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            1               1112221 123344557889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-32  Score=267.66  Aligned_cols=197  Identities=28%  Similarity=0.386  Sum_probs=155.3

Q ss_pred             CCCCCccccccceEEEEeCC-EEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRT-KVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKG---VYHRDLK   74 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~-~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~g---i~HrDlk   74 (381)
                      |.+++|||+|+|+|+|.+.+ ..+||+||+++|+|.+++....  .+++....+|+.+++.||+|||...   |+|||||
T Consensus       125 ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiK  204 (361)
T KOG1187|consen  125 LSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIK  204 (361)
T ss_pred             HhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCC
Confidence            45789999999999999998 5999999999999999997755  7899999999999999999999854   9999999


Q ss_pred             CCcEEEccCCCEEEeeccCccCCCCCccccccc-cCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCC-
Q 016865           75 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-  152 (381)
Q Consensus        75 p~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-  152 (381)
                      |+|||+|++.+.||+|||+|...........+. .||..|+|||+.... ..+.++||||+||+|.|+++|+.|.+... 
T Consensus       205 ssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g-~lt~KsDVySFGVvllElitgr~~~d~~~~  283 (361)
T KOG1187|consen  205 SSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTG-KLTEKSDVYSFGVVLLELITGRKAVDQSRP  283 (361)
T ss_pred             HHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccC-CcCcccccccchHHHHHHHhCCcccCCCCC
Confidence            999999999999999999997654311222233 899999999999763 44589999999999999999998887532 


Q ss_pred             -----hhHHHH-HhhcccC------CCC-CCCC--hh---HHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          153 -----LPTLYK-KINAAEF------SCP-FWFS--TG---ATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       153 -----~~~~~~-~i~~~~~------~~p-~~~s--~~---~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                           ...... .+..+..      .+. ..++  .+   +..+..+|++.+|..||+..++.+
T Consensus       284 ~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  284 RGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             cccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence                 111111 1222111      111 1122  12   456788999999999999999754

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-33  Score=280.04  Aligned_cols=202  Identities=27%  Similarity=0.453  Sum_probs=175.9

Q ss_pred             CCCccccccceEEEEe-----CCEEEEEEecCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 016865            3 IVRHPNIVRLHEVLAS-----RTKVYIILEFVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKP   75 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~-----~~~~~lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp   75 (381)
                      .-+|||++.+|++|.-     .+.+|||||||.||+..|.++.  ..++.|+.+..+++.++.|+.+||.+.++|||||-
T Consensus        72 ~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG  151 (953)
T KOG0587|consen   72 YSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKG  151 (953)
T ss_pred             ccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccC
Confidence            3479999999999963     4689999999999999999876  35689999999999999999999999999999999


Q ss_pred             CcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCC-----CCCCcccHhHHHHHHHHHHhCCCCCCC
Q 016865           76 ENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG-----YDGSAADVWSCGVILFVLMAGYLPFGE  150 (381)
Q Consensus        76 ~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-----~~~~~~DIwSlGvil~~ll~G~~Pf~~  150 (381)
                      .|||++.+|.+|++|||++.+........+|..|||.|||||++....     |+ ..+|+||||++..||-.|.+|+-+
T Consensus       152 ~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd-~R~D~WsLGITaIEladG~PPl~D  230 (953)
T KOG0587|consen  152 QNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYD-YRSDLWSLGITAIEMAEGAPPLCD  230 (953)
T ss_pred             ceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcc-cccchhhccceeehhcCCCCCccC
Confidence            999999999999999999999888777789999999999999997543     43 689999999999999999999988


Q ss_pred             CChhHHHHHhhccc---CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          151 TDLPTLYKKINAAE---FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       151 ~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      .......-+|..+.   ..-|...+.++.+||..||.+|-.+||+..++++|||++..
T Consensus       231 mHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  231 MHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             cchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence            77654444443322   22344578999999999999999999999999999999843

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.98  E-value=1.5e-32  Score=278.35  Aligned_cols=196  Identities=27%  Similarity=0.399  Sum_probs=172.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--------------RLLENDCRRYFQQLIDAVAHCHSK   66 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--------------~l~e~~~~~~~~qll~~L~~LH~~   66 (381)
                      |..++|||||+|+|+|..++-+|+|+|||..|||.+++...+              .++..+...++.||+.|+.||-++
T Consensus       543 la~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~  622 (774)
T KOG1026|consen  543 LAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH  622 (774)
T ss_pred             HHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            356899999999999999999999999999999999996432              267889999999999999999999


Q ss_pred             CCeecCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-
Q 016865           67 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-  143 (381)
Q Consensus        67 gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-  143 (381)
                      .++||||-..|+|+.++-.+||+|||+++..-..+  +......-...|||||.+....|. ++|||||+||+|||+++ 
T Consensus       623 ~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT-teSDVWs~GVvLWEIFsy  701 (774)
T KOG1026|consen  623 HFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT-TESDVWSFGVVLWEIFSY  701 (774)
T ss_pred             cccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc-chhhhhhhhhhhhhhhcc
Confidence            99999999999999999999999999998543221  112122345789999999887775 89999999999999999 


Q ss_pred             CCCCCCCCChhHHHHHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 016865          144 GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIR  197 (381)
Q Consensus       144 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il  197 (381)
                      |+.||.+...++.++.+..++ ++.|...|.++.+|+..|++.+|++||++.||-
T Consensus       702 G~QPy~glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  702 GKQPYYGLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             ccCcccccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            999999999999988887776 578889999999999999999999999999974

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.7e-32  Score=287.02  Aligned_cols=197  Identities=25%  Similarity=0.375  Sum_probs=172.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL   73 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDl   73 (381)
                      |+.++|||||+++|++-+....+|++|||.||||..+|++.       ..+...+...++.|++.|.+||++++++||||
T Consensus       749 m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDL  828 (1025)
T KOG1095|consen  749 MSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDL  828 (1025)
T ss_pred             HhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcch
Confidence            67899999999999999999999999999999999999875       24788999999999999999999999999999


Q ss_pred             CCCcEEEccCCCEEEeeccCccCCCCCccccccccC--CCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCC
Q 016865           74 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGE  150 (381)
Q Consensus        74 kp~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~g--t~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~  150 (381)
                      -..|+|++....+||+|||+|+......-......+  ...|||||.+....+ +.++|||||||+|||+++ |..||.+
T Consensus       829 AaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~  907 (1025)
T KOG1095|consen  829 AARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPS  907 (1025)
T ss_pred             hhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999843322111111112  357999999987555 599999999999999999 9999998


Q ss_pred             CChhHHHH-HhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          151 TDLPTLYK-KINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       151 ~~~~~~~~-~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      .+..+... ....+++..|..++..+.+++..|++.+|.+||++..|++
T Consensus       908 ~~n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  908 RSNFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             cchHHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            87766665 5566788899999999999999999999999999999987

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.98  E-value=8.1e-33  Score=295.51  Aligned_cols=200  Identities=18%  Similarity=0.229  Sum_probs=151.1

Q ss_pred             CCCCc-cccccceEEE-------EeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q 016865            2 KIVRH-PNIVRLHEVL-------ASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD   72 (381)
Q Consensus         2 k~l~H-pnIv~l~~~~-------~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrD   72 (381)
                      |.++| +||+++++.|       .....++.++||+ +++|++++.. ...+++..++.+++||+.||.|||++||+|||
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD  105 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN  105 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence            56788 7999999988       3334688889988 5699999965 34699999999999999999999999999999


Q ss_pred             CCCCcEEEccC-------------------CCEEEeeccCccCCCCCc----------------cccccccCCCCCCCCc
Q 016865           73 LKPENLLLDSY-------------------GNLKVSDFGLSALPQQGV----------------ELLHTTCGTPNYVAPE  117 (381)
Q Consensus        73 lkp~NiLl~~~-------------------~~lkl~DFGls~~~~~~~----------------~~~~~~~gt~~y~aPE  117 (381)
                      |||+|||++..                   +.+|++|||+++......                ......+||+.|+|||
T Consensus       106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE  185 (793)
T PLN00181        106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE  185 (793)
T ss_pred             CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence            99999999654                   445666666664321100                0011246899999999


Q ss_pred             eecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccCC-CCCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q 016865          118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CPFWFSTGATSLIHKILDPNPKTRIRIEGI  196 (381)
Q Consensus       118 ~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~~~L~~dP~~R~t~~~i  196 (381)
                      ++.+..| +.++|||||||+||||++|.+|+.....  ....+.....+ .+....+...+++.+||.++|.+|||+.++
T Consensus       186 ~~~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~ei  262 (793)
T PLN00181        186 EDNGSSS-NCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSEL  262 (793)
T ss_pred             hhccCCC-CchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHH
Confidence            9988777 4899999999999999999998764321  11111111111 011124567899999999999999999999


Q ss_pred             hcCcccccC
Q 016865          197 RKHPWFRKN  205 (381)
Q Consensus       197 l~hp~~~~~  205 (381)
                      ++||||...
T Consensus       263 l~h~~~~~~  271 (793)
T PLN00181        263 LQSEFINEP  271 (793)
T ss_pred             hhchhhhhh
Confidence            999999753

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.98  E-value=6.7e-33  Score=270.93  Aligned_cols=196  Identities=21%  Similarity=0.355  Sum_probs=164.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      +|+-+|.||+-+.|++..... .||+-+|+|.+|+.++.- ..+|.....+.|++|+++|+.|||.++|+|||||..||+
T Consensus       442 lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIF  520 (678)
T KOG0193|consen  442 LKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIF  520 (678)
T ss_pred             HhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceE
Confidence            467799999999999987776 999999999999999854 346888999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCC--CccccccccCCCCCCCCceecC---CCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           80 LDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEVLSN---RGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~--~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      +.+++.+||+|||+++....  ....+.+..|+..|||||++..   .+| +..+||||+|||+|||++|.+||...+..
T Consensus       521 l~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPf-S~qSDVYaFGiV~YELltg~lPysi~~~d  599 (678)
T KOG0193|consen  521 LHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPF-SFQSDVYAFGIVWYELLTGELPYSIQNRD  599 (678)
T ss_pred             EccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCC-CcccchhhhhHHHHHHHhCcCCcCCCChh
Confidence            99999999999999976432  3344567779999999999863   234 48899999999999999999999966655


Q ss_pred             HHHHHhhcccCC-----CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          155 TLYKKINAAEFS-----CPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       155 ~~~~~i~~~~~~-----~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      +.+..+..+...     .-...+.++++|+..|+..++++||++.+||.
T Consensus       600 qIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  600 QIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             heEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            555444444221     11235679999999999999999999999886

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.98  E-value=7.3e-33  Score=278.74  Aligned_cols=196  Identities=32%  Similarity=0.502  Sum_probs=158.7

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCC---C-CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR---L-LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~---l-~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      +|||||++|+.-.+...+||..|+|.. +|.|+++..+.   . .....+....|+++||++||+.+|+||||||.||||
T Consensus       561 ~H~NviRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI  639 (903)
T KOG1027|consen  561 EHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILI  639 (903)
T ss_pred             CCCceEEEEeeccCCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEE
Confidence            699999999999999999999999965 99999987421   1 114568889999999999999999999999999999


Q ss_pred             cc---CC--CEEEeeccCccCCCCCc---cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCC
Q 016865           81 DS---YG--NLKVSDFGLSALPQQGV---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGET  151 (381)
Q Consensus        81 ~~---~~--~lkl~DFGls~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~  151 (381)
                      +.   ++  .++|+|||+++....+.   ....+..||-.|+|||++..... ..++||||+|||+|+.++ |.+||.+.
T Consensus       640 ~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~  718 (903)
T KOG1027|consen  640 SVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDS  718 (903)
T ss_pred             EccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCch
Confidence            86   34  68999999998765532   23566779999999999987655 479999999999999998 59999864


Q ss_pred             ChhHHHHHhhcccCCCC---CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          152 DLPTLYKKINAAEFSCP---FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       152 ~~~~~~~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      -..+  .+|..+.+..-   +.-..++.+||.+||.++|..||++.++|.||+|-.
T Consensus       719 ~~R~--~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~  772 (903)
T KOG1027|consen  719 LERQ--ANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD  772 (903)
T ss_pred             HHhh--hhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence            3322  23444444321   111228999999999999999999999999999964

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=3.6e-32  Score=256.94  Aligned_cols=204  Identities=28%  Similarity=0.483  Sum_probs=171.5

Q ss_pred             CCCCccccccceEEEE-eCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CCeecCCCCCcE
Q 016865            2 KIVRHPNIVRLHEVLA-SRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK--GVYHRDLKPENL   78 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~-~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~--gi~HrDlkp~Ni   78 (381)
                      |.|+||-||++|++|. +.+.+|-|+|||+|.+|.-+++...-++|.+|+.|+.||+.||.||...  .|+|=||||.||
T Consensus       522 KeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNI  601 (775)
T KOG1151|consen  522 KELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNI  601 (775)
T ss_pred             hccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccE
Confidence            5789999999999997 5678999999999999999999888999999999999999999999977  499999999999


Q ss_pred             EEcc---CCCEEEeeccCccCCCCC-------ccccccccCCCCCCCCceecC---CCCCCCcccHhHHHHHHHHHHhCC
Q 016865           79 LLDS---YGNLKVSDFGLSALPQQG-------VELLHTTCGTPNYVAPEVLSN---RGYDGSAADVWSCGVILFVLMAGY  145 (381)
Q Consensus        79 Ll~~---~~~lkl~DFGls~~~~~~-------~~~~~~~~gt~~y~aPE~l~~---~~~~~~~~DIwSlGvil~~ll~G~  145 (381)
                      |+-+   .|.+||+|||+++..+..       ..+.....||.+|.+||.+.-   .+..+.++||||+|||+|.++.|+
T Consensus       602 LLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGr  681 (775)
T KOG1151|consen  602 LLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGR  681 (775)
T ss_pred             EEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccC
Confidence            9953   578999999999987542       234556779999999998642   234468999999999999999999


Q ss_pred             CCCCCCChh-HHHH---HhhcccCCCCC--CCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          146 LPFGETDLP-TLYK---KINAAEFSCPF--WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       146 ~Pf~~~~~~-~~~~---~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      .||...-.. .+.+   .++.....+|+  -+|+++++||++||++.-.+|+.+.++-.||+|...
T Consensus       682 KPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh  747 (775)
T KOG1151|consen  682 KPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH  747 (775)
T ss_pred             CCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence            999764332 2221   23344555654  489999999999999999999999999999999753

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=6.1e-32  Score=277.11  Aligned_cols=188  Identities=19%  Similarity=0.318  Sum_probs=139.2

Q ss_pred             EeCCEEEEEEecCCCCChHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 016865           17 ASRTKVYIILEFVTGGELFDKIVHQGR--------------------LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE   76 (381)
Q Consensus        17 ~~~~~~~lV~E~~~gg~L~~~i~~~~~--------------------l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~   76 (381)
                      .....+++|+||+.+|+|.+++.....                    ..+..+..++.||+.||+|||++||+||||||+
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~  284 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ  284 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence            355689999999999999998865321                    123456789999999999999999999999999


Q ss_pred             cEEEcc-CCCEEEeeccCccCCCCC-ccccccccCCCCCCCCceecCCCCC---------------------CCcccHhH
Q 016865           77 NLLLDS-YGNLKVSDFGLSALPQQG-VELLHTTCGTPNYVAPEVLSNRGYD---------------------GSAADVWS  133 (381)
Q Consensus        77 NiLl~~-~~~lkl~DFGls~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~---------------------~~~~DIwS  133 (381)
                      |||++. ++.+||+|||+|+..... .....+.+||+.|+|||.+....+.                     +.++||||
T Consensus       285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS  364 (566)
T PLN03225        285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS  364 (566)
T ss_pred             HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence            999996 589999999999865432 1233567899999999976432211                     24569999


Q ss_pred             HHHHHHHHHhCCCCCCCCChhHHHHHhhcccCCC---------------------CCCCChhHHHHHHHhcCCCCCCCCC
Q 016865          134 CGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC---------------------PFWFSTGATSLIHKILDPNPKTRIR  192 (381)
Q Consensus       134 lGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~---------------------p~~~s~~~~~li~~~L~~dP~~R~t  192 (381)
                      +||+||+|+++..|++.. .......+.......                     ....+....+||.+||+.||.+|||
T Consensus       365 lGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t  443 (566)
T PLN03225        365 AGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS  443 (566)
T ss_pred             HHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCC
Confidence            999999999988776532 112222221111110                     0112334568999999999999999


Q ss_pred             HHHHhcCcccccC
Q 016865          193 IEGIRKHPWFRKN  205 (381)
Q Consensus       193 ~~~il~hp~~~~~  205 (381)
                      +.++|+||||+..
T Consensus       444 a~e~L~Hpff~~~  456 (566)
T PLN03225        444 AKAALAHPYFDRE  456 (566)
T ss_pred             HHHHhCCcCcCCC
Confidence            9999999999764

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-31  Score=261.74  Aligned_cols=194  Identities=28%  Similarity=0.473  Sum_probs=170.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      ||.++|||||+++|++.+. -.|||||+++-|+|..+++.. ..++-.....|..||..||.|||+...+||||-..|||
T Consensus       445 MrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiL  523 (974)
T KOG4257|consen  445 MRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNIL  523 (974)
T ss_pred             HHhCCCcchhheeeeeecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhhee
Confidence            7899999999999999754 689999999999999999864 46888899999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccC--CCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~g--t~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      +.....+|++|||+|+..+.. ...+...|  ..-|||||.+.-..+. .++|||-|||.+||++. |..||.+....+.
T Consensus       524 VsSp~CVKLaDFGLSR~~ed~-~yYkaS~~kLPIKWmaPESINfRrFT-tASDVWMFgVCmWEIl~lGvkPfqgvkNsDV  601 (974)
T KOG4257|consen  524 VSSPQCVKLADFGLSRYLEDD-AYYKASRGKLPIKWMAPESINFRRFT-TASDVWMFGVCMWEILSLGVKPFQGVKNSDV  601 (974)
T ss_pred             ecCcceeeecccchhhhcccc-chhhccccccceeecCccccchhccc-chhhHHHHHHHHHHHHHhcCCccccccccce
Confidence            999999999999999987653 22333344  4569999999777664 89999999999999998 9999988776677


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIR  197 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il  197 (381)
                      +..+.++ +.++|+.+++.+..|+.+|++++|.+||++.+|.
T Consensus       602 I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  602 IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence            7677665 5789999999999999999999999999987764

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-32  Score=244.48  Aligned_cols=202  Identities=27%  Similarity=0.452  Sum_probs=161.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-----VHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLK   74 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i-----~~~~~l~e~~~~~~~~qll~~L~~LH~~-gi~HrDlk   74 (381)
                      ||.=+.||||++||++-.++..||.||+|+- +|..+.     ..+..++|...-.+.-..+.||.||... +|+|||+|
T Consensus       117 mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvK  195 (361)
T KOG1006|consen  117 MKSSNCPNIVKFYGALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVK  195 (361)
T ss_pred             HhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCC
Confidence            4566889999999999999999999999964 553322     2345799999999999999999999965 89999999


Q ss_pred             CCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCC--CCCCCcccHhHHHHHHHHHHhCCCCCCCCC
Q 016865           75 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR--GYDGSAADVWSCGVILFVLMAGYLPFGETD  152 (381)
Q Consensus        75 p~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~  152 (381)
                      |+|||++..|.+||||||++......- ....-.|-.+|||||.+...  +|+ .++|+||||+.|||+.||..|+.+-+
T Consensus       196 PSNILldr~G~vKLCDFGIcGqLv~Si-AkT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~  273 (361)
T KOG1006|consen  196 PSNILLDRHGDVKLCDFGICGQLVDSI-AKTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWD  273 (361)
T ss_pred             hhheEEecCCCEeeecccchHhHHHHH-HhhhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHH
Confidence            999999999999999999987654321 12334688999999998643  465 89999999999999999999997533


Q ss_pred             h-hHHHHHhhcccCC---CCC---CCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          153 L-PTLYKKINAAEFS---CPF---WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       153 ~-~~~~~~i~~~~~~---~p~---~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      . .+....+..+..+   .+.   .+|..+..+|..||.+|-+.||...+++++||++..
T Consensus       274 svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y  333 (361)
T KOG1006|consen  274 SVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY  333 (361)
T ss_pred             HHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence            2 2223333333332   222   278999999999999999999999999999999753

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=2e-31  Score=233.39  Aligned_cols=196  Identities=27%  Similarity=0.497  Sum_probs=158.8

Q ss_pred             CccccccceEEEEeC--CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEcc
Q 016865            5 RHPNIVRLHEVLASR--TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS   82 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~--~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~   82 (381)
                      .|||||+++++..+.  ....+|+||.++-+.....   ..++...++.|+.||+.||.||||.||+|||+||.|+++|.
T Consensus        91 gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh  167 (338)
T KOG0668|consen   91 GGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDH  167 (338)
T ss_pred             CCCCeeehhhhhcCccccCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeech
Confidence            499999999999865  3578999999887655443   44888899999999999999999999999999999999995


Q ss_pred             C-CCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCC-CC-ChhHHHH-
Q 016865           83 Y-GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFG-ET-DLPTLYK-  158 (381)
Q Consensus        83 ~-~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~-~~-~~~~~~~-  158 (381)
                      . -.++|+|+|+|.+...+ ...+..+.+..|.-||.+.+...+..+-|+||+||+|..|+..+-||- +. +..++.+ 
T Consensus       168 ~~rkLrlIDWGLAEFYHp~-~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkI  246 (338)
T KOG0668|consen  168 ELRKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKI  246 (338)
T ss_pred             hhceeeeeecchHhhcCCC-ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHH
Confidence            4 57999999999987654 446778899999999999887766799999999999999999998883 22 2222211 


Q ss_pred             -----------HhhcccCCC-------------CCC-----------CChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          159 -----------KINAAEFSC-------------PFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       159 -----------~i~~~~~~~-------------p~~-----------~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                                 .+.+-....             .+|           .++++.||+.++|..|-.+|+|+.|++.||||.
T Consensus       247 akVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~  326 (338)
T KOG0668|consen  247 AKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA  326 (338)
T ss_pred             HHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence                       111111111             111           579999999999999999999999999999996


Q ss_pred             c
Q 016865          204 K  204 (381)
Q Consensus       204 ~  204 (381)
                      .
T Consensus       327 ~  327 (338)
T KOG0668|consen  327 P  327 (338)
T ss_pred             H
Confidence            4

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=2.5e-30  Score=259.97  Aligned_cols=197  Identities=20%  Similarity=0.330  Sum_probs=148.2

Q ss_pred             cccccceEEEEe--------CCEEEEEEecCCCCChHHHHHhcC------------------------CCCHHHHHHHHH
Q 016865            7 PNIVRLHEVLAS--------RTKVYIILEFVTGGELFDKIVHQG------------------------RLLENDCRRYFQ   54 (381)
Q Consensus         7 pnIv~l~~~~~~--------~~~~~lV~E~~~gg~L~~~i~~~~------------------------~l~e~~~~~~~~   54 (381)
                      ++++++++++..        ++..|+||||+++|+|.+++....                        .+++..++.++.
T Consensus       237 ~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~  316 (507)
T PLN03224        237 ASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMR  316 (507)
T ss_pred             hhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHH
Confidence            344677777653        357899999999999999886421                        234567889999


Q ss_pred             HHHHHHHHHHHCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCcccccc--ccCCCCCCCCceecCCCC--------
Q 016865           55 QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT--TCGTPNYVAPEVLSNRGY--------  124 (381)
Q Consensus        55 qll~~L~~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~--~~gt~~y~aPE~l~~~~~--------  124 (381)
                      |++.||.|||+.||+||||||+|||++.++.+||+|||++....... ....  ..+|+.|+|||++.....        
T Consensus       317 ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~  395 (507)
T PLN03224        317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPPEELVMPQSCPRAPAPA  395 (507)
T ss_pred             HHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeChhhhcCCCCCCccchhh
Confidence            99999999999999999999999999999999999999987543321 1222  234899999999854321        


Q ss_pred             ------------C-CCcccHhHHHHHHHHHHhCCC-CCCCCChh-----------HHHHHhhcccCCCCC--CCChhHHH
Q 016865          125 ------------D-GSAADVWSCGVILFVLMAGYL-PFGETDLP-----------TLYKKINAAEFSCPF--WFSTGATS  177 (381)
Q Consensus       125 ------------~-~~~~DIwSlGvil~~ll~G~~-Pf~~~~~~-----------~~~~~i~~~~~~~p~--~~s~~~~~  177 (381)
                                  . ..+.||||+|||+|+|++|.+ ||......           ..+..+....+.++.  ..++.+++
T Consensus       396 ~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~d  475 (507)
T PLN03224        396 MAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWD  475 (507)
T ss_pred             hhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHH
Confidence                        1 124799999999999999986 77542211           111222333344443  37899999


Q ss_pred             HHHHhcCCCC---CCCCCHHHHhcCccccc
Q 016865          178 LIHKILDPNP---KTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       178 li~~~L~~dP---~~R~t~~~il~hp~~~~  204 (381)
                      |+.+||..+|   .+|+|++|+|+||||..
T Consensus       476 Li~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        476 LACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             HHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            9999999866   68999999999999964

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-32  Score=244.96  Aligned_cols=202  Identities=27%  Similarity=0.426  Sum_probs=167.8

Q ss_pred             CCCccccccceEEEEeCC-----EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            3 IVRHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~~~-----~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      .++|.|++..+++.+-..     .+|+++|++.. +|...|.....++.+.++-+.+||++||+|||+.||.||||||.|
T Consensus       108 fFkHdNVLSaLDILQPph~dfFqEiYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGN  186 (449)
T KOG0664|consen  108 SFRHDNVLSLLDILQPANPSFFQELYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGN  186 (449)
T ss_pred             hhccccHHHHHHhcCCCCchHHHHHHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCcc
Confidence            468999999999987553     68999999965 999998888889999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHH
Q 016865           78 LLLDSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL  156 (381)
Q Consensus        78 iLl~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~  156 (381)
                      +|++.|..+||||||+++..+... ......+-|-+|.|||++.+...++..+||||.|||+.|++..+..|...+..+.
T Consensus       187 LLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQ  266 (449)
T KOG0664|consen  187 LLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQ  266 (449)
T ss_pred             EEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHH
Confidence            999999999999999999876532 2344556789999999999887777999999999999999999999977665433


Q ss_pred             HHHh-----------------------hcccCCCCC-----------CCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          157 YKKI-----------------------NAAEFSCPF-----------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       157 ~~~i-----------------------~~~~~~~p~-----------~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      .+.|                       ..+....|.           ....++..++.+||..||.+|++.++.+.|++.
T Consensus       267 L~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~  346 (449)
T KOG0664|consen  267 LQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL  346 (449)
T ss_pred             HHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence            3322                       111122221           234578899999999999999999999999998


Q ss_pred             ccC
Q 016865          203 RKN  205 (381)
Q Consensus       203 ~~~  205 (381)
                      ...
T Consensus       347 ~e~  349 (449)
T KOG0664|consen  347 EEG  349 (449)
T ss_pred             ccc
Confidence            643

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=4.5e-31  Score=262.44  Aligned_cols=190  Identities=29%  Similarity=0.523  Sum_probs=152.7

Q ss_pred             CCCCCccccccceEEEEeCC------EEEEEEecCCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 016865            1 MKIVRHPNIVRLHEVLASRT------KVYIILEFVTGGELFDKIVH---QGRLLENDCRRYFQQLIDAVAHCHSKGVYHR   71 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~------~~~lV~E~~~gg~L~~~i~~---~~~l~e~~~~~~~~qll~~L~~LH~~gi~Hr   71 (381)
                      ||+|+|||||+++++=++..      .-.+|||||+||||+..+..   ..+++|.+.+.++..+..|++|||.+||+||
T Consensus        65 lkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHR  144 (732)
T KOG4250|consen   65 LKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHR  144 (732)
T ss_pred             HHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceec
Confidence            68899999999999987654      57899999999999999965   3479999999999999999999999999999


Q ss_pred             CCCCCcEEEcc--CC--CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCC
Q 016865           72 DLKPENLLLDS--YG--NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLP  147 (381)
Q Consensus        72 Dlkp~NiLl~~--~~--~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~P  147 (381)
                      ||||.||++-.  +|  ..||+|||.|+-.+.+ ....+..||+.|.+||+....++++..+|.||+||++|++.||..|
T Consensus       145 DlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lP  223 (732)
T KOG4250|consen  145 DLKPGNIVLQIGEDGQSIYKLTDFGAARELDDN-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELP  223 (732)
T ss_pred             cCCCCcEEEeecCCCceEEeeecccccccCCCC-CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCC
Confidence            99999999853  34  4799999999987765 4778899999999999998656777999999999999999999999


Q ss_pred             CCCCChh-----HHHHHhh--------------c------ccCCCCCCCChh----HHHHHHHhcCCCCCCCC
Q 016865          148 FGETDLP-----TLYKKIN--------------A------AEFSCPFWFSTG----ATSLIHKILDPNPKTRI  191 (381)
Q Consensus       148 f~~~~~~-----~~~~~i~--------------~------~~~~~p~~~s~~----~~~li~~~L~~dP~~R~  191 (381)
                      |......     .++..+.              +      ..++.|...++.    +-.++..||..+|.+|.
T Consensus       224 F~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  224 FIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             CCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence            9432211     2222111              1      112233334443    44578889999999998

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-30  Score=254.93  Aligned_cols=195  Identities=28%  Similarity=0.430  Sum_probs=172.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      ||-++|||+|+++++|..+.-+|||+|||..|+|.|++....  .++.-....++.||.+|++||..+++|||||-..|+
T Consensus       317 MKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNC  396 (1157)
T KOG4278|consen  317 MKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC  396 (1157)
T ss_pred             HHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhc
Confidence            788999999999999999999999999999999999998754  367777888899999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCccccccccC---CCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChh
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVELLHTTCG---TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLP  154 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~~~~~~g---t~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~  154 (381)
                      |+.++..+|++||||++++..+.  .....|   ..-|.|||-+.-..+. .++|||+|||+|||+.| |..||.+-+..
T Consensus       397 LVgEnhiVKvADFGLsRlMtgDT--YTAHAGAKFPIKWTAPEsLAyNtFS-iKSDVWAFGVLLWEIATYGMsPYPGidlS  473 (1157)
T KOG4278|consen  397 LVGENHIVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNTFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLS  473 (1157)
T ss_pred             cccccceEEeeccchhhhhcCCc--eecccCccCcccccCcccccccccc-cchhhHHHHHHHHHHHhcCCCCCCCccHH
Confidence            99999999999999999876532  222233   4579999999877775 89999999999999999 99999999999


Q ss_pred             HHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          155 TLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       155 ~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      +.|..+.++ +..-|..+++.+..|++.|++.+|.+||++.+|-+
T Consensus       474 qVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  474 QVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             HHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence            999887665 45678889999999999999999999999998743

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.97  E-value=3.3e-30  Score=268.07  Aligned_cols=181  Identities=29%  Similarity=0.502  Sum_probs=145.8

Q ss_pred             CEEEEEEecCCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCCCEEEeeccCccCCC
Q 016865           20 TKVYIILEFVTGGELFDKIVHQGRL-LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ   98 (381)
Q Consensus        20 ~~~~lV~E~~~gg~L~~~i~~~~~l-~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~   98 (381)
                      ..+||-||||+.-.|.+.|..+... ..+.++++|+||+.||.|+|++|||||||||.||++++++++||+|||+|+...
T Consensus       669 ~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~  748 (1351)
T KOG1035|consen  669 LILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLK  748 (1351)
T ss_pred             eEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhh
Confidence            4799999999986666666554333 478899999999999999999999999999999999999999999999998611


Q ss_pred             ----C--------------CccccccccCCCCCCCCceecCCC--CCCCcccHhHHHHHHHHHHhCCCCCCCC-ChhHHH
Q 016865           99 ----Q--------------GVELLHTTCGTPNYVAPEVLSNRG--YDGSAADVWSCGVILFVLMAGYLPFGET-DLPTLY  157 (381)
Q Consensus        99 ----~--------------~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~~DIwSlGvil~~ll~G~~Pf~~~-~~~~~~  157 (381)
                          .              .....++.+||--|+|||++.+..  .++.|+|+||||||||||+   .||... ......
T Consensus       749 ~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL  825 (1351)
T KOG1035|consen  749 ENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASIL  825 (1351)
T ss_pred             hhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHH
Confidence                0              112345678999999999998766  2349999999999999997   457543 334455


Q ss_pred             HHhhcccCCCCCCC----ChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          158 KKINAAEFSCPFWF----STGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       158 ~~i~~~~~~~p~~~----s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      ..+..+.++.|..+    -+....+|+.||+.||++|||+.|+|++.||.
T Consensus       826 ~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  826 TNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             HhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence            66666666665321    25577899999999999999999999999995

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=7.3e-31  Score=252.19  Aligned_cols=194  Identities=25%  Similarity=0.406  Sum_probs=159.1

Q ss_pred             cccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccC
Q 016865            7 PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG---RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY   83 (381)
Q Consensus         7 pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~   83 (381)
                      -|+++|+..|...+++|||+|-+. .+|.+.+...|   ++....++.|++||..||..|..+||+|.||||.|||+++.
T Consensus       494 ~Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~  572 (752)
T KOG0670|consen  494 FHCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNES  572 (752)
T ss_pred             hHHHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccC
Confidence            478999999999999999999885 48999998755   47788999999999999999999999999999999999976


Q ss_pred             -CCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhc
Q 016865           84 -GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA  162 (381)
Q Consensus        84 -~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~  162 (381)
                       ..+||||||.|......  ....+.-+..|.|||++.+.+|+ .+.|+||.||.||||.||+..|.+.+...+......
T Consensus       573 k~iLKLCDfGSA~~~~en--eitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me  649 (752)
T KOG0670|consen  573 KNILKLCDFGSASFASEN--EITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME  649 (752)
T ss_pred             cceeeeccCccccccccc--cccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence             46899999998766542  23445567789999999999998 999999999999999999999988765544332211


Q ss_pred             ccCCCCC-----------------------------------------------------CC-------ChhHHHHHHHh
Q 016865          163 AEFSCPF-----------------------------------------------------WF-------STGATSLIHKI  182 (381)
Q Consensus       163 ~~~~~p~-----------------------------------------------------~~-------s~~~~~li~~~  182 (381)
                      ..-++|.                                                     .+       -..+++||.+|
T Consensus       650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm  729 (752)
T KOG0670|consen  650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM  729 (752)
T ss_pred             hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence            1000000                                                     01       13588999999


Q ss_pred             cCCCCCCCCCHHHHhcCccccc
Q 016865          183 LDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       183 L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      |..||.+|+|+.++|+||||..
T Consensus       730 l~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  730 LILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             hccChhhcCCHHHHhcCCcccC
Confidence            9999999999999999999964

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.96  E-value=5.6e-30  Score=279.52  Aligned_cols=190  Identities=22%  Similarity=0.299  Sum_probs=149.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCCCc
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH---SKGVYHRDLKPEN   77 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH---~~gi~HrDlkp~N   77 (381)
                      |++++|||||++++++.+.+..|+||||+++|+|.+++..   +++..+..++.|++.|++|||   +.+|+||||||+|
T Consensus       737 l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~N  813 (968)
T PLN00113        737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEK  813 (968)
T ss_pred             HhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHh
Confidence            4678999999999999999999999999999999999853   889999999999999999999   6699999999999


Q ss_pred             EEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh--hH
Q 016865           78 LLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL--PT  155 (381)
Q Consensus        78 iLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~--~~  155 (381)
                      |+++.++..++. ||.+.....    ..+..||+.|+|||++.+..|. .++||||+||++|||++|+.||+....  ..
T Consensus       814 il~~~~~~~~~~-~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~  887 (968)
T PLN00113        814 IIIDGKDEPHLR-LSLPGLLCT----DTKCFISSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSPADAEFGVHGS  887 (968)
T ss_pred             EEECCCCceEEE-ecccccccc----CCCccccccccCcccccCCCCC-cccchhhHHHHHHHHHhCCCCCCcccCCCCc
Confidence            999998888775 665443221    1234689999999999877765 899999999999999999999954221  11


Q ss_pred             HHH--Hhhccc--------CCC------CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          156 LYK--KINAAE--------FSC------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       156 ~~~--~i~~~~--------~~~------p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ...  ......        ...      +.....++.+++.+|++.||.+|||+.++++.
T Consensus       888 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        888 IVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             HHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            111  100000        000      00112356789999999999999999999873

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=7.7e-30  Score=223.07  Aligned_cols=158  Identities=22%  Similarity=0.238  Sum_probs=128.8

Q ss_pred             CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCccccccccCC
Q 016865           32 GELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT  110 (381)
Q Consensus        32 g~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt  110 (381)
                      |+|.+++... +.++++.++.++.|++.||.|||+++      ||+|||++.++.+|+  ||++......     ...||
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~g~   67 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSRVD   67 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-----cCCCc
Confidence            6899999864 45999999999999999999999999      999999999999999  9998765432     23689


Q ss_pred             CCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh-hHHHHHhhcccCC-------CCCCCCh--hHHHHHH
Q 016865          111 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL-PTLYKKINAAEFS-------CPFWFST--GATSLIH  180 (381)
Q Consensus       111 ~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~~-------~p~~~s~--~~~~li~  180 (381)
                      +.|+|||++.+..|. .++||||+||++|+|++|+.||..... ......+......       .+..++.  ++.++|.
T Consensus        68 ~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  146 (176)
T smart00750       68 PYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR  146 (176)
T ss_pred             ccccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence            999999999887775 899999999999999999999976543 2223332221111       1112333  6999999


Q ss_pred             HhcCCCCCCCCCHHHHhcCcccc
Q 016865          181 KILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       181 ~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      +||..||.+|||+.++++|+|+.
T Consensus       147 ~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      147 VCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHhcccccccCHHHHHHHHHHH
Confidence            99999999999999999999985

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-30  Score=260.73  Aligned_cols=198  Identities=27%  Similarity=0.420  Sum_probs=176.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |-+++|||||+|-++.....-+.||+|||++|+|..+++. ++.|..-+...+++-|++|++||.+.|++||||-..|||
T Consensus       684 MGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNIL  763 (996)
T KOG0196|consen  684 MGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNIL  763 (996)
T ss_pred             cccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhhee
Confidence            6689999999999999999999999999999999999975 577999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCcccccccc-C--CCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTC-G--TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPT  155 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~-g--t~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~  155 (381)
                      ++.+-..|++|||++++.+.+.....+.. |  ...|.|||.+....+. .++||||+||+|||.++ |+-||.+.+.++
T Consensus       764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFT-sASDVWSyGIVmWEVmSyGERPYWdmSNQd  842 (996)
T KOG0196|consen  764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQD  842 (996)
T ss_pred             eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccC-chhhccccceEEEEecccCCCcccccchHH
Confidence            99999999999999998866443333333 3  3679999999887775 89999999999999888 999999998888


Q ss_pred             HHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          156 LYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       156 ~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      .++.|..+ +++.|..++..+.+|+..|+++|-..||+++||..+
T Consensus       843 VIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  843 VIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            88888765 456666789999999999999999999999998763

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.2e-30  Score=267.35  Aligned_cols=204  Identities=29%  Similarity=0.505  Sum_probs=173.1

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      ..++|||++.....+.+....+-+||||++ +|+..+...+.+...++..+++||+.||+|+|+.||.|||+||+|++++
T Consensus       376 ~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~  454 (601)
T KOG0590|consen  376 SSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT  454 (601)
T ss_pred             ccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe
Confidence            357999999998888887777777999999 9999999887899999999999999999999999999999999999999


Q ss_pred             cCCCEEEeeccCccCCCCCc----cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHH-
Q 016865           82 SYGNLKVSDFGLSALPQQGV----ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL-  156 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~-  156 (381)
                      .+|.+||+|||.+..+..+.    ......+|+.+|+|||++.+..|+....||||+|+|+..|.+|+.||........ 
T Consensus       455 ~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~  534 (601)
T KOG0590|consen  455 ENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNS  534 (601)
T ss_pred             cCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccc
Confidence            99999999999998765532    3456788999999999999999999999999999999999999999975543221 


Q ss_pred             -HHHhh-------cccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          157 -YKKIN-------AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       157 -~~~i~-------~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                       +....       .+....-..++...+.+|.+||++||.+|+|+++|++.+||+...
T Consensus       535 ~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  535 FKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             hhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence             11111       111111123688899999999999999999999999999998654

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.6e-29  Score=249.92  Aligned_cols=201  Identities=27%  Similarity=0.425  Sum_probs=175.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |-.|+|||+|+||++.-+ ..+.+|+|+|+.|+|.+.+..  ...|.......|+.||+.|+.||.+++.|||||-..|+
T Consensus       165 M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNl  243 (1039)
T KOG0199|consen  165 MLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNL  243 (1039)
T ss_pred             HHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhh
Confidence            457899999999999988 778999999999999999987  34588889999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCccccc---cccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChh
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVELLH---TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLP  154 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~  154 (381)
                      |+.....+||+||||.+..........   ..--...|.|||.+....+. .++|+|++||.||||++ |+.||.+....
T Consensus       244 llasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFS-haSDvWmyGVTiWEMFtyGEePW~G~~g~  322 (1039)
T KOG0199|consen  244 LLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFS-HASDVWMYGVTIWEMFTYGEEPWVGCRGI  322 (1039)
T ss_pred             eecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcccccc-ccchhhhhhhhHHhhhccCCCCCCCCCHH
Confidence            999999999999999998766443321   12234679999999887775 89999999999999999 99999999998


Q ss_pred             HHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          155 TLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       155 ~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      .+.++|..+ .+.-|..+|.++.++++.||..+|.+|||+..|.+.-+..
T Consensus       323 qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~  372 (1039)
T KOG0199|consen  323 QILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA  372 (1039)
T ss_pred             HHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence            888888754 4677888999999999999999999999999997654443

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.6e-28  Score=254.03  Aligned_cols=194  Identities=25%  Similarity=0.416  Sum_probs=167.3

Q ss_pred             CCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCC
Q 016865            4 VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHCHSKG   67 (381)
Q Consensus         4 l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~~L~~LH~~g   67 (381)
                      .+||||+++.+++..++.+++|+||+..|+|.+++...+                .++..+...++.||+.|++||++.+
T Consensus       359 g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~  438 (609)
T KOG0200|consen  359 GKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP  438 (609)
T ss_pred             cCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC
Confidence            369999999999999999999999999999999998765                3888899999999999999999999


Q ss_pred             CeecCCCCCcEEEccCCCEEEeeccCccCCCCCcccc-ccccCCCC--CCCCceecCCCCCCCcccHhHHHHHHHHHHh-
Q 016865           68 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL-HTTCGTPN--YVAPEVLSNRGYDGSAADVWSCGVILFVLMA-  143 (381)
Q Consensus        68 i~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~~~-~~~~gt~~--y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-  143 (381)
                      ++||||-..|||++.+..+||+|||+|+......... ....|+.+  |||||.+....|. .++||||+||+|||+++ 
T Consensus       439 ~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft-~kSDVWSfGI~L~EifsL  517 (609)
T KOG0200|consen  439 CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFT-SKSDVWSFGILLWEIFTL  517 (609)
T ss_pred             ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccc-ccchhhHHHHHHHHHhhC
Confidence            9999999999999999999999999998644422221 22333344  9999999886664 99999999999999999 


Q ss_pred             CCCCCCCCC-hhHHHHHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          144 GYLPFGETD-LPTLYKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       144 G~~Pf~~~~-~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      |..||.+-. ...+++.+..+. ...|.+++++..++++.|++.+|.+||++.++.+
T Consensus       518 G~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  518 GGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             CCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            999998754 455666666654 4788889999999999999999999999999876

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-29  Score=249.85  Aligned_cols=203  Identities=29%  Similarity=0.453  Sum_probs=175.6

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      ||-.+|||||.+++.+-....+||.||||.||+|.|.-.-.+.++|.++....+..+.||+|||+.|-+|||||-.|||+
T Consensus        66 ~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanill  145 (829)
T KOG0576|consen   66 LRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL  145 (829)
T ss_pred             eecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceee
Confidence            45679999999999999999999999999999999987778899999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceec---CCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS---NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      ++.|.+|++|||.+..+...........|||+|||||+-.   ..+| ...+|||++|+...|+---++|-.+.......
T Consensus       146 td~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggy-nqlcdiwa~gitAiel~eLqpplfdlhpmr~l  224 (829)
T KOG0576|consen  146 TDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWALGITAIELGELQPPLFDLHPMRAL  224 (829)
T ss_pred             cccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccc-cccccccccccchhhhhhcCCcccccchHHHH
Confidence            9999999999999988776555667889999999999853   3345 58999999999999998888887665554444


Q ss_pred             HHhhcccCCCC-----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          158 KKINAAEFSCP-----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       158 ~~i~~~~~~~p-----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      .-..+..+..|     ...++-+-+|++.+|.++|++|||++.+|.|||...
T Consensus       225 ~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  225 FLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             HHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence            44444444433     347889999999999999999999999999999864

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=9.9e-30  Score=247.12  Aligned_cols=143  Identities=33%  Similarity=0.610  Sum_probs=134.8

Q ss_pred             CccccccceEEEEeCCEEEEEEecC-CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccC
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFV-TGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY   83 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~-~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~   83 (381)
                      .|+||++++++|++++++||+||-- +|-+|||+|....+++|.+|..+|+|+..|+++||++||+|||||-||+.++.+
T Consensus       627 sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~  706 (772)
T KOG1152|consen  627 SHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSN  706 (772)
T ss_pred             CccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecC
Confidence            3999999999999999999999964 678999999999999999999999999999999999999999999999999999


Q ss_pred             CCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCC
Q 016865           84 GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFG  149 (381)
Q Consensus        84 ~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~  149 (381)
                      |.+||+|||.|.....  +...+.+||..|.|||++.+..|-|.+-|||++|++||.++..+.||.
T Consensus       707 g~~klidfgsaa~~ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  707 GFVKLIDFGSAAYTKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             CeEEEeeccchhhhcC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999999999887655  456789999999999999999999999999999999999999998884

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.96  E-value=5.6e-29  Score=242.10  Aligned_cols=197  Identities=22%  Similarity=0.301  Sum_probs=164.1

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |.+++|||||+++++|..++-+++|+||++.|+|.+++....  .........++.||++|++||.+.+++||||-+.|+
T Consensus       589 LsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNc  668 (807)
T KOG1094|consen  589 LSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNC  668 (807)
T ss_pred             HhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccce
Confidence            567899999999999999999999999999999999998763  234456677999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh--CCCCCCCCChh
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA--GYLPFGETDLP  154 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~--G~~Pf~~~~~~  154 (381)
                      |++.++++||+|||.++..-.++  +.....+-...|||||.+....+. .++|+|++|+.+||+++  ...||...+..
T Consensus       669 Lv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFt-taSDvWafgvTlwE~~~~C~e~Py~~lt~e  747 (807)
T KOG1094|consen  669 LVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEVFMLCREQPYSQLTDE  747 (807)
T ss_pred             eecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhcccc-chhhhhhhHHHHHHHHHHHhhCchhhhhHH
Confidence            99999999999999998543321  111223446789999999877775 99999999999999775  88999887776


Q ss_pred             HHHHHhhc--------ccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          155 TLYKKINA--------AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       155 ~~~~~i~~--------~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      +...+...        .-.+.|.-++.++.+++.+|+..+-.+|||++++-.
T Consensus       748 ~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  748 QVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             HHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence            66554321        123456678999999999999999999999999754

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.95  E-value=2e-28  Score=211.50  Aligned_cols=146  Identities=29%  Similarity=0.521  Sum_probs=125.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----VHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKP   75 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i----~~~~~l~e~~~~~~~~qll~~L~~LH~~-gi~HrDlkp   75 (381)
                      |+....|.+|.+|+.+.....+||.||.++. +|..+.    ...+.+||..+-+++..++.||.|||++ .++|||+||
T Consensus        99 ~r~~~CPf~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKP  177 (282)
T KOG0984|consen   99 MRTVDCPFTVHFYGALFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKP  177 (282)
T ss_pred             ccCCCCCeEEEeehhhhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCc
Confidence            5667899999999999999999999999965 664432    3456799999999999999999999987 899999999


Q ss_pred             CcEEEccCCCEEEeeccCccCCCCCcccccc-ccCCCCCCCCceecC----CCCCCCcccHhHHHHHHHHHHhCCCCCCC
Q 016865           76 ENLLLDSYGNLKVSDFGLSALPQQGVELLHT-TCGTPNYVAPEVLSN----RGYDGSAADVWSCGVILFVLMAGYLPFGE  150 (381)
Q Consensus        76 ~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~-~~gt~~y~aPE~l~~----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~  150 (381)
                      +|||++..|++|+||||.|......  ...+ ..|...|||||.+..    .+|+ -++||||||+.++||.+++.||+.
T Consensus       178 sNiLIn~~GqVKiCDFGIsG~L~dS--iAkt~daGCkpYmaPEri~~e~n~~gY~-vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  178 SNILINYDGQVKICDFGISGYLVDS--IAKTMDAGCKPYMAPERINPELNQKGYS-VKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             ceEEEccCCcEEEcccccceeehhh--hHHHHhcCCCccCChhhcCcccCcccce-eehhhhhhhhhhhhhhhccccccc
Confidence            9999999999999999998765542  2333 568899999999753    3565 899999999999999999999975

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=9.7e-28  Score=226.44  Aligned_cols=196  Identities=31%  Similarity=0.495  Sum_probs=153.8

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc-cC
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SY   83 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~-~~   83 (381)
                      .|.||+++.+++..++...+||||++.-+..++...   ++-..++.|++.++.||.++|++||+||||||.|+|.+ ..
T Consensus        93 G~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t  169 (418)
T KOG1167|consen   93 GSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRT  169 (418)
T ss_pred             cchhhhcchhhhccCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccccc
Confidence            578999999999999999999999998777776644   67889999999999999999999999999999999998 46


Q ss_pred             CCEEEeeccCccCCCC--------C-------------------------cc-----------ccccccCCCCCCCCcee
Q 016865           84 GNLKVSDFGLSALPQQ--------G-------------------------VE-----------LLHTTCGTPNYVAPEVL  119 (381)
Q Consensus        84 ~~lkl~DFGls~~~~~--------~-------------------------~~-----------~~~~~~gt~~y~aPE~l  119 (381)
                      +.-.|+|||+|.....        .                         ..           ..-...||++|.|||++
T Consensus       170 ~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL  249 (418)
T KOG1167|consen  170 QRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVL  249 (418)
T ss_pred             CCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHH
Confidence            7889999999861100        0                         00           00112499999999999


Q ss_pred             cCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh--h---H---------HHH------H--hhc-cc------------
Q 016865          120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL--P---T---------LYK------K--INA-AE------------  164 (381)
Q Consensus       120 ~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~--~---~---------~~~------~--i~~-~~------------  164 (381)
                      ...+-.++++||||.|||+..++++..||-....  .   +         +.+      +  +.. ..            
T Consensus       250 ~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~  329 (418)
T KOG1167|consen  250 FRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFE  329 (418)
T ss_pred             hhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchh
Confidence            9888778999999999999999999999932210  0   0         000      0  000 00            


Q ss_pred             -------CCCC----------CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          165 -------FSCP----------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       165 -------~~~p----------~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                             .+.+          ..++..+.+|+.+||+.||.+|+|++++|+||||.
T Consensus       330 s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~  385 (418)
T KOG1167|consen  330 TLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD  385 (418)
T ss_pred             ccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence                   0000          11466899999999999999999999999999997

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=1.1e-26  Score=205.53  Aligned_cols=169  Identities=43%  Similarity=0.760  Sum_probs=149.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++|++|+++++++......++++||++|++|.+++... ..++...+..++.+++.++++||+.|++|+||+|.||+
T Consensus        45 ~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~  124 (215)
T cd00180          45 LKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENIL  124 (215)
T ss_pred             HHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEE
Confidence            35688999999999999999999999999999999998775 47899999999999999999999999999999999999


Q ss_pred             Ecc-CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016865           80 LDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK  158 (381)
Q Consensus        80 l~~-~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~  158 (381)
                      ++. ++.++|+|||.+..............++..|++||........+.++|+||+|++++++                 
T Consensus       125 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------  187 (215)
T cd00180         125 LDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------  187 (215)
T ss_pred             EeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------
Confidence            999 89999999999876554322234456889999999987652445889999999999999                 


Q ss_pred             HhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 016865          159 KINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHP  200 (381)
Q Consensus       159 ~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp  200 (381)
                                    ..+.+++.+|+..||.+||+++++++|+
T Consensus       188 --------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 --------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             --------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                          5778999999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.7e-26  Score=221.00  Aligned_cols=75  Identities=27%  Similarity=0.424  Sum_probs=66.8

Q ss_pred             CccccccceEEEEe----CCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCc
Q 016865            5 RHPNIVRLHEVLAS----RTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPEN   77 (381)
Q Consensus         5 ~HpnIv~l~~~~~~----~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~N   77 (381)
                      +-.+||+|++.|..    ..++|+|+|++ |-+|...|...  +++|-..++.|++|++.||.|||. .||||.||||||
T Consensus       140 ~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPEN  218 (590)
T KOG1290|consen  140 GKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPEN  218 (590)
T ss_pred             CCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcce
Confidence            34579999999974    45999999999 77999999764  579999999999999999999996 599999999999


Q ss_pred             EEE
Q 016865           78 LLL   80 (381)
Q Consensus        78 iLl   80 (381)
                      ||+
T Consensus       219 vLl  221 (590)
T KOG1290|consen  219 VLL  221 (590)
T ss_pred             eee
Confidence            998

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.8e-26  Score=218.93  Aligned_cols=195  Identities=24%  Similarity=0.445  Sum_probs=153.8

Q ss_pred             CCCccccccceEEEEeC----CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-----C---CCee
Q 016865            3 IVRHPNIVRLHEVLASR----TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-----K---GVYH   70 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~~----~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~-----~---gi~H   70 (381)
                      +|+|+||+.+++.--.+    +.+|||++|-+.|||+|++.+ ..++-+.+.+++..+++||+|||-     +   .|+|
T Consensus       261 mLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAH  339 (513)
T KOG2052|consen  261 MLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAH  339 (513)
T ss_pred             HhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhc
Confidence            68999999999876432    379999999999999999988 779999999999999999999994     2   3999


Q ss_pred             cCCCCCcEEEccCCCEEEeeccCccCCCCC----ccccccccCCCCCCCCceecCCC----CCC-CcccHhHHHHHHHHH
Q 016865           71 RDLKPENLLLDSYGNLKVSDFGLSALPQQG----VELLHTTCGTPNYVAPEVLSNRG----YDG-SAADVWSCGVILFVL  141 (381)
Q Consensus        71 rDlkp~NiLl~~~~~lkl~DFGls~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~----~~~-~~~DIwSlGvil~~l  141 (381)
                      ||||..|||+..+|...|+|+|||-.....    +-..+..+||..|||||++...-    +++ ..+||||+|.|+||+
T Consensus       340 RDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEi  419 (513)
T KOG2052|consen  340 RDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEI  419 (513)
T ss_pred             cccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHH
Confidence            999999999999999999999999765442    23457889999999999986431    221 469999999999998


Q ss_pred             HhC----------CCCCCC-----CChhHHHHHhhcc--cCCCCC-CCChh----HHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          142 MAG----------YLPFGE-----TDLPTLYKKINAA--EFSCPF-WFSTG----ATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       142 l~G----------~~Pf~~-----~~~~~~~~~i~~~--~~~~p~-~~s~~----~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...          ++||.+     ++..++.+.+...  +...|. |-|.+    ...+++.|+..||.-|.|+--|.+
T Consensus       420 arRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  420 ARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             HHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            743          578843     3444555544433  334443 44433    456889999999999999876654

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=3.2e-27  Score=211.59  Aligned_cols=198  Identities=28%  Similarity=0.439  Sum_probs=154.2

Q ss_pred             CccccccceEE-EEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccC
Q 016865            5 RHPNIVRLHEV-LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY   83 (381)
Q Consensus         5 ~HpnIv~l~~~-~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~   83 (381)
                      .|.||+.-|++ |++.+.+.+++|||+-|+|..-+.. .++-|.....++.|+++|+.|+|+++++|||||.+|||+-..
T Consensus        79 ~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~  157 (378)
T KOG1345|consen   79 PHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDA  157 (378)
T ss_pred             cchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecC
Confidence            58999998875 6788899999999999999888766 568899999999999999999999999999999999999754


Q ss_pred             C--CEEEeeccCccCCCCCccccccccCCCCCCCCceecCC---CC-CCCcccHhHHHHHHHHHHhCCCCCCCCChh-HH
Q 016865           84 G--NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR---GY-DGSAADVWSCGVILFVLMAGYLPFGETDLP-TL  156 (381)
Q Consensus        84 ~--~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~-~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~  156 (381)
                      +  .+|+||||+++..+..   .+...-+..|.|||+....   .+ ..+..|||.+|+|+|.+|+|.+||...... ..
T Consensus       158 df~rvKlcDFG~t~k~g~t---V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~  234 (378)
T KOG1345|consen  158 DFYRVKLCDFGLTRKVGTT---VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKP  234 (378)
T ss_pred             CccEEEeeecccccccCce---ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCch
Confidence            3  7999999998754432   2223346678999986432   12 136789999999999999999999743221 11


Q ss_pred             ---HHHhh-cccCCCCCC---CChhHHHHHHHhcCCCCCCC---CCHHHHhcCcccccCC
Q 016865          157 ---YKKIN-AAEFSCPFW---FSTGATSLIHKILDPNPKTR---IRIEGIRKHPWFRKNY  206 (381)
Q Consensus       157 ---~~~i~-~~~~~~p~~---~s~~~~~li~~~L~~dP~~R---~t~~~il~hp~~~~~~  206 (381)
                         +.++. ......|..   +|+.+..+.++-|.++|++|   -++.......|..+..
T Consensus       235 Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i  294 (378)
T KOG1345|consen  235 YWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLI  294 (378)
T ss_pred             HHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhh
Confidence               22222 223345543   79999999999999999999   6667777777876543

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.94  E-value=1.7e-26  Score=220.44  Aligned_cols=193  Identities=23%  Similarity=0.319  Sum_probs=151.5

Q ss_pred             CCCccccccceEEEEeCC----EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------CCCe
Q 016865            3 IVRHPNIVRLHEVLASRT----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS---------KGVY   69 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~~~----~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~---------~gi~   69 (381)
                      .++|+||++++++-+-.+    .++||+||.+.|+|.+++.. ...+.....+++..+++||+|||+         -.|+
T Consensus       260 ~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~Ia  338 (534)
T KOG3653|consen  260 GMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIA  338 (534)
T ss_pred             CccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccc
Confidence            479999999999887655    89999999999999999987 568999999999999999999996         2599


Q ss_pred             ecCCCCCcEEEccCCCEEEeeccCccCCCC--CccccccccCCCCCCCCceecCCCCC-----CCcccHhHHHHHHHHHH
Q 016865           70 HRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEVLSNRGYD-----GSAADVWSCGVILFVLM  142 (381)
Q Consensus        70 HrDlkp~NiLl~~~~~lkl~DFGls~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~-----~~~~DIwSlGvil~~ll  142 (381)
                      |||||..|||+.+++...|+|||+|..+..  ........+||..|||||++.+.--.     -...||||+|.|||||+
T Consensus       339 HRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~  418 (534)
T KOG3653|consen  339 HRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIA  418 (534)
T ss_pred             cccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999987654  23345668999999999998653221     13589999999999999


Q ss_pred             hCCCC------------CC-----CCChhHHHHH--hhcccCCCCC-C----CChhHHHHHHHhcCCCCCCCCCHHHH
Q 016865          143 AGYLP------------FG-----ETDLPTLYKK--INAAEFSCPF-W----FSTGATSLIHKILDPNPKTRIRIEGI  196 (381)
Q Consensus       143 ~G~~P------------f~-----~~~~~~~~~~--i~~~~~~~p~-~----~s~~~~~li~~~L~~dP~~R~t~~~i  196 (381)
                      +...-            |.     .++..++...  .++.+..+|. |    .-..+++.+..|++.||.-|+|+.=+
T Consensus       419 SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  419 SRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             hhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence            86433            32     1122222222  1333444443 2    24568899999999999999998644

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.93  E-value=1.1e-26  Score=233.39  Aligned_cols=196  Identities=23%  Similarity=0.372  Sum_probs=172.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |.+|+|||++++++++.... +-||++|+++|.|.|+++.. ..+.......|..||++|+.|||.++++||||-..|+|
T Consensus       752 masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVL  830 (1177)
T KOG1025|consen  752 MASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVL  830 (1177)
T ss_pred             HhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhhee
Confidence            56899999999999998766 88999999999999999764 56888999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccC--CCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~g--t~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      +..-+.+||+|||+++.........+...|  .+.|+|-|.+....|. .++||||+||.+||++| |..|+++....++
T Consensus       831 VksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~t-hqSDVWsfGVtiWElmTFGa~Py~gi~~~eI  909 (1177)
T KOG1025|consen  831 VKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYT-HQSDVWSFGVTIWELMTFGAKPYDGIPAEEI  909 (1177)
T ss_pred             ecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCC-chhhhhhhhhhHHHHHhcCCCccCCCCHHHh
Confidence            999999999999999987665444444444  4579999999887775 99999999999999999 9999999888777


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      -..+..+ +++.|+-.+-++..++.+||..|+..||+++++..
T Consensus       910 ~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  910 PDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             hHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence            7666554 57889999999999999999999999999988654

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=2.3e-25  Score=200.64  Aligned_cols=165  Identities=41%  Similarity=0.711  Sum_probs=140.8

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~-l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      +.++|+|++++++.+......++++||+++++|.+.+..... +++.....++.|++.++.+||+.|++|+||+|.||++
T Consensus        52 ~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v  131 (225)
T smart00221       52 KKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL  131 (225)
T ss_pred             HhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence            457899999999999999999999999999999999988666 8999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCcee-cCCCCCCCcccHhHHHHHHHHHHhCCCCCCC--CChhHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVL-SNRGYDGSAADVWSCGVILFVLMAGYLPFGE--TDLPTL  156 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l-~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~--~~~~~~  156 (381)
                      +.++.++|+|||.+....... .......++..|++||.. ....+. .++|+||||+++++|++|+.||..  .+...+
T Consensus       132 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~-~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~  210 (225)
T smart00221      132 GMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYG-EAVDIWSLGVILYELLWGPEPFSGEGEFTSLL  210 (225)
T ss_pred             cCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCC-chhhHHHHHHHHHHHHHCCCCccccchhHHHH
Confidence            999999999999987654431 123456788999999998 444454 699999999999999999999977  344466


Q ss_pred             HHHhhcccCCC
Q 016865          157 YKKINAAEFSC  167 (381)
Q Consensus       157 ~~~i~~~~~~~  167 (381)
                      .+.+..+....
T Consensus       211 ~~~~~~~~~~~  221 (225)
T smart00221      211 SDVWSFGVPLL  221 (225)
T ss_pred             HHHHhcCCccc
Confidence            77776665433

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.92  E-value=3.2e-26  Score=226.12  Aligned_cols=189  Identities=39%  Similarity=0.658  Sum_probs=173.1

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCC
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG   84 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~   84 (381)
                      +||.+|+++..++.++..|+++++..||+|+..+.....+.+...+.+...++-|++++|+.||+|||+|++||+++.+|
T Consensus        55 ~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~G  134 (612)
T KOG0603|consen   55 NTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEG  134 (612)
T ss_pred             CCCceeeeeeeeccccchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccC
Confidence            49999999999999999999999999999999999888899999999999999999999999999999999999999999


Q ss_pred             CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc
Q 016865           85 NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE  164 (381)
Q Consensus        85 ~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~  164 (381)
                      ++++.|||+++..-..    ...|||..|||||++.  +.. ..+|.||+|+++|+|++|..||..    +....|....
T Consensus       135 hi~~tdfglske~v~~----~~~cgt~eymApEI~~--gh~-~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~  203 (612)
T KOG0603|consen  135 HIKLTDFGLSKEAVKE----KIACGTYEYRAPEIIN--GHL-SAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE  203 (612)
T ss_pred             ccccCCchhhhHhHhh----hhcccchhhhhhHhhh--ccC-CcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc
Confidence            9999999999865432    1229999999999997  343 789999999999999999999987    6677788888


Q ss_pred             CCCCCCCChhHHHHHHHhcCCCCCCCCCH-----HHHhcCccccc
Q 016865          165 FSCPFWFSTGATSLIHKILDPNPKTRIRI-----EGIRKHPWFRK  204 (381)
Q Consensus       165 ~~~p~~~s~~~~~li~~~L~~dP~~R~t~-----~~il~hp~~~~  204 (381)
                      +..|..+++.+++++..++..+|.+|.-.     .++++|+||..
T Consensus       204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~  248 (612)
T KOG0603|consen  204 LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQS  248 (612)
T ss_pred             cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchhee
Confidence            99999999999999999999999999854     89999999974

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.91  E-value=5.5e-24  Score=199.13  Aligned_cols=196  Identities=24%  Similarity=0.309  Sum_probs=165.3

Q ss_pred             CCCCccccccceEEEE-eCCEEEEEEecCCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q 016865            2 KIVRHPNIVRLHEVLA-SRTKVYIILEFVTGGELFDKIVHQ--------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRD   72 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~-~~~~~~lV~E~~~gg~L~~~i~~~--------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrD   72 (381)
                      .-+.|||+..+.++.- +...-+.++.+..-|+|..++..-        +.+...+...++.|+..|++|||+.||+|.|
T Consensus       342 y~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkD  421 (563)
T KOG1024|consen  342 YGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKD  421 (563)
T ss_pred             hcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccch
Confidence            3468999999999985 456778888888889999998721        2366778889999999999999999999999


Q ss_pred             CCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCC
Q 016865           73 LKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFG  149 (381)
Q Consensus        73 lkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~  149 (381)
                      |-..|.++|+.-.+||+|=.+++..-..+  -..........||+||.+.+..|+ ..+|+|||||+||||+| |+.|+.
T Consensus       422 iAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsfGVllWELmtlg~~Pya  500 (563)
T KOG1024|consen  422 IAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLWELMTLGKLPYA  500 (563)
T ss_pred             hhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHHHHHhcCCCCcc
Confidence            99999999999999999999988543211  111222345689999999998886 89999999999999999 999999


Q ss_pred             CCChhHHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          150 ETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       150 ~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      +-+..+++..++.+ +...|..+++++..++..|+...|.+||+.+|+..
T Consensus       501 eIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  501 EIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             ccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            99998888887766 45678889999999999999999999999999753

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.90  E-value=5.2e-23  Score=192.63  Aligned_cols=204  Identities=35%  Similarity=0.580  Sum_probs=168.1

Q ss_pred             CCCCcc-ccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            2 KIVRHP-NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG---RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         2 k~l~Hp-nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      +.+.|+ ||+++++.+......+++++|+.++++.+.+....   .+++..+..++.|++.++.|+|+.|++|||+||+|
T Consensus        52 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~n  131 (384)
T COG0515          52 ASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPEN  131 (384)
T ss_pred             HHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHH
Confidence            356777 79999999988888999999999999997777664   79999999999999999999999999999999999


Q ss_pred             EEEccCC-CEEEeeccCccCCCCCcc------ccccccCCCCCCCCceecCC--CCCCCcccHhHHHHHHHHHHhCCCCC
Q 016865           78 LLLDSYG-NLKVSDFGLSALPQQGVE------LLHTTCGTPNYVAPEVLSNR--GYDGSAADVWSCGVILFVLMAGYLPF  148 (381)
Q Consensus        78 iLl~~~~-~lkl~DFGls~~~~~~~~------~~~~~~gt~~y~aPE~l~~~--~~~~~~~DIwSlGvil~~ll~G~~Pf  148 (381)
                      |+++..+ .++++|||.+........      .....+||..|+|||.+.+.  .+.....|+||+|++++++++|..||
T Consensus       132 il~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~  211 (384)
T COG0515         132 ILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPF  211 (384)
T ss_pred             eeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence            9999988 799999999875443221      34678899999999999874  45568999999999999999999998


Q ss_pred             CCCCh----hHHHHHhhcccCC-CCCCCC--------hhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          149 GETDL----PTLYKKINAAEFS-CPFWFS--------TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       149 ~~~~~----~~~~~~i~~~~~~-~p~~~s--------~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      .....    ......+...... ......        ..+.+++.+++..+|..|.+..+...++|....
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         212 EGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             CCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence            77653    3444444443332 222221        478999999999999999999999998776543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=3.1e-24  Score=220.20  Aligned_cols=199  Identities=35%  Similarity=0.590  Sum_probs=173.3

Q ss_pred             ccccccceEEEEeCCEEEEEEecCCCCChHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCcEEEcc
Q 016865            6 HPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQG-RLLENDCRRYFQQLIDAVAHCH-SKGVYHRDLKPENLLLDS   82 (381)
Q Consensus         6 HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i-~~~~-~l~e~~~~~~~~qll~~L~~LH-~~gi~HrDlkp~NiLl~~   82 (381)
                      |+|++++++...+....+++++|+.||++++.+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.+++.
T Consensus        80 h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~  159 (601)
T KOG0590|consen   80 HSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDE  159 (601)
T ss_pred             cccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhcc
Confidence            999999999999999999999999999999999 6665 7889999999999999999999 999999999999999999


Q ss_pred             CC-CEEEeeccCccCCCC---CccccccccC-CCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHH-
Q 016865           83 YG-NLKVSDFGLSALPQQ---GVELLHTTCG-TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL-  156 (381)
Q Consensus        83 ~~-~lkl~DFGls~~~~~---~~~~~~~~~g-t~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~-  156 (381)
                      ++ +++++|||+|+....   ........|| ++.|+|||...+..|.+...|+||+|+++..+++|..||........ 
T Consensus       160 s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~  239 (601)
T KOG0590|consen  160 SGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR  239 (601)
T ss_pred             CCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc
Confidence            99 999999999987655   2345677889 99999999999888999999999999999999999999987654321 


Q ss_pred             HHHhhc--cc--CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          157 YKKINA--AE--FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       157 ~~~i~~--~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      +..+..  ..  ......++..+.+++.++|..+|..|.+.+++..+||+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  240 YSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ceeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence            111111  12  2222338899999999999999999999999999999987

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=2.1e-21  Score=182.47  Aligned_cols=188  Identities=25%  Similarity=0.402  Sum_probs=143.6

Q ss_pred             CccccccceEEEEe---------------------------CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHH
Q 016865            5 RHPNIVRLHEVLAS---------------------------RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI   57 (381)
Q Consensus         5 ~HpnIv~l~~~~~~---------------------------~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll   57 (381)
                      +|||||++..+|.+                           ...+|+||.-.+. +|..++-. ...+....+-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-~~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-RHRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-CCCchHHHHHHHHHHH
Confidence            79999999998844                           2369999998865 88888755 4466778888999999


Q ss_pred             HHHHHHHHCCCeecCCCCCcEEEc--cCC--CEEEeeccCccCCCCC------ccccccccCCCCCCCCceecCCC----
Q 016865           58 DAVAHCHSKGVYHRDLKPENLLLD--SYG--NLKVSDFGLSALPQQG------VELLHTTCGTPNYVAPEVLSNRG----  123 (381)
Q Consensus        58 ~~L~~LH~~gi~HrDlkp~NiLl~--~~~--~lkl~DFGls~~~~~~------~~~~~~~~gt~~y~aPE~l~~~~----  123 (381)
                      +|+.|||.+||.|||+|.+|||+.  +++  .+.|+|||.+-.-+..      .......-|.-..||||+....+    
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            999999999999999999999995  333  5899999987532220      01112344778899999976432    


Q ss_pred             -CCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH-HHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHH
Q 016865          124 -YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY-KKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIE  194 (381)
Q Consensus       124 -~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~-~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~  194 (381)
                       .+-.++|.|++|.+-||+++...||.+.....+- ..+...+ ...|..+++.+++++..+|+.||++|++..
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence             1236899999999999999999999775433221 1122333 356778999999999999999999999853

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.84  E-value=1.9e-21  Score=201.14  Aligned_cols=164  Identities=35%  Similarity=0.628  Sum_probs=134.4

Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCC-----------
Q 016865           32 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG-----------  100 (381)
Q Consensus        32 g~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~-----------  100 (381)
                      ||-.+.++..+.++.+.        +.+++|+|+-||+|||+||+|++++.-|++|++|||++...-..           
T Consensus       136 gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~  207 (1205)
T KOG0606|consen  136 GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIE  207 (1205)
T ss_pred             chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchH
Confidence            34444444445555433        78999999999999999999999999999999999998643210           


Q ss_pred             ---cc-ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccCCCCCC---CCh
Q 016865          101 ---VE-LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFW---FST  173 (381)
Q Consensus       101 ---~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~---~s~  173 (381)
                         .+ .....||||.|+||||+..++| |.++|+|++|+|+|+.+.|..||.+.+..+++.++.......|..   .++
T Consensus       208 k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~  286 (1205)
T KOG0606|consen  208 KDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPP  286 (1205)
T ss_pred             HHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCH
Confidence               01 1245599999999999999888 599999999999999999999999999999988876666555543   689


Q ss_pred             hHHHHHHHhcCCCCCCCC---CHHHHhcCccccc
Q 016865          174 GATSLIHKILDPNPKTRI---RIEGIRKHPWFRK  204 (381)
Q Consensus       174 ~~~~li~~~L~~dP~~R~---t~~~il~hp~~~~  204 (381)
                      +++++|.++|+.+|..|.   .+-++.+|+||+.
T Consensus       287 Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~  320 (1205)
T KOG0606|consen  287 EAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL  320 (1205)
T ss_pred             HHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence            999999999999999997   4677899999974

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.82  E-value=2.5e-21  Score=200.45  Aligned_cols=193  Identities=24%  Similarity=0.405  Sum_probs=147.3

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      +.++|||++++.-+.+.+...|||-+|... +|+|++....-+..-+-+-|+.||+.||..||..||+|||||.||||++
T Consensus        76 ~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT  154 (1431)
T KOG1240|consen   76 ALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT  154 (1431)
T ss_pred             HhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe
Confidence            357899999999999999999999999965 9999998766677778888899999999999999999999999999999


Q ss_pred             cCCCEEEeeccCccC--CCCCc-c----ccccccCCCCCCCCceecCCC----------CCCCcccHhHHHHHHHHHHh-
Q 016865           82 SYGNLKVSDFGLSAL--PQQGV-E----LLHTTCGTPNYVAPEVLSNRG----------YDGSAADVWSCGVILFVLMA-  143 (381)
Q Consensus        82 ~~~~lkl~DFGls~~--~~~~~-~----~~~~~~gt~~y~aPE~l~~~~----------~~~~~~DIwSlGvil~~ll~-  143 (381)
                      .=+.+.|+||..-+-  ...++ .    ...|..--.+|.|||......          .-.++-||||+||+++||++ 
T Consensus       155 SWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~E  234 (1431)
T KOG1240|consen  155 SWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLE  234 (1431)
T ss_pred             eechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhc
Confidence            999999999985431  11111 1    122333456799999875422          12457899999999999999 


Q ss_pred             CCCCCCCCChhHHHHHhhcccCCCC-----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          144 GYLPFGETDLPTLYKKINAAEFSCP-----FWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       144 G~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      |++||.   ..++.. +..+.-..|     .--+...+.+|..|++.||.+|.++++.|+.
T Consensus       235 g~PlF~---LSQL~a-Yr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  235 GRPLFT---LSQLLA-YRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             CCCccc---HHHHHh-HhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            899994   112211 111110000     0124578999999999999999999999985

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.82  E-value=7.4e-20  Score=180.72  Aligned_cols=198  Identities=23%  Similarity=0.338  Sum_probs=159.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCC-eecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGV-YHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi-~HrDlkp~Ni   78 (381)
                      |+.+.|.|+.++++.+-+....++|.+||.-|+|.|.+.. ..+++.-....+.+.++.|+.|+|+..| +|+.+++.|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            7899999999999999999999999999999999999987 4567888888999999999999998765 9999999999


Q ss_pred             EEccCCCEEEeeccCccCCCC--CccccccccCCCCCCCCceecCCCC------CCCcccHhHHHHHHHHHHhCCCCCCC
Q 016865           79 LLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEVLSNRGY------DGSAADVWSCGVILFVLMAGYLPFGE  150 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~------~~~~~DIwSlGvil~~ll~G~~Pf~~  150 (381)
                      +++..-.+|++|||+......  .........-...|.|||.+.....      -+.++||||+|+|++|+++...||+.
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            999999999999999876642  1111222234567999999976422      24579999999999999999999976


Q ss_pred             CCh----hHHHHHhhc-ccCCCCC------CCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          151 TDL----PTLYKKINA-AEFSCPF------WFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       151 ~~~----~~~~~~i~~-~~~~~p~------~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...    .+...++.. +...+-+      ...+++..++..|+..+|..||+++++..
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            332    234444554 2221111      23457899999999999999999999864

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.79  E-value=1.7e-18  Score=166.57  Aligned_cols=191  Identities=22%  Similarity=0.261  Sum_probs=147.4

Q ss_pred             cccccceEEE-EeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccC
Q 016865            7 PNIVRLHEVL-ASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY   83 (381)
Q Consensus         7 pnIv~l~~~~-~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~   83 (381)
                      +++.++++.. ......||||+.+ |.+|.+.....  +.++...+..++.|++.+|+++|+.|++||||||+|+++...
T Consensus        80 ~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~  158 (322)
T KOG1164|consen   80 SHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQS  158 (322)
T ss_pred             CCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCC
Confidence            5888899998 5788999999988 78999977543  579999999999999999999999999999999999999865


Q ss_pred             -----CCEEEeeccCccCCC--C-Cc------cc-cccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCC
Q 016865           84 -----GNLKVSDFGLSALPQ--Q-GV------EL-LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF  148 (381)
Q Consensus        84 -----~~lkl~DFGls~~~~--~-~~------~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf  148 (381)
                           ..+.+.|||+++...  . ..      +. .....||..|+++.+..+... +.+.|+||++-++.+++.|.+||
T Consensus       159 ~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW  237 (322)
T KOG1164|consen  159 SRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPW  237 (322)
T ss_pred             CCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCC
Confidence                 359999999998332  1 11      11 123459999999999877655 58999999999999999999999


Q ss_pred             CCCChhHHHHHh---hcccCC--CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          149 GETDLPTLYKKI---NAAEFS--CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       149 ~~~~~~~~~~~i---~~~~~~--~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ..........++   ......  .....+.++.++...+-..+...+|....+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  238 EALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             ccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            765533222222   211111  223345677777777777888889888877653

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.79  E-value=3.3e-19  Score=160.33  Aligned_cols=190  Identities=22%  Similarity=0.337  Sum_probs=155.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSKG--VYHRDLKPE   76 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~~L~~LH~~g--i~HrDlkp~   76 (381)
                      ||-+.||||+.+++.|.+..++.++..|++-|+|+..+.....  ++..++.+++..+++|++|||+..  |.---|...
T Consensus       241 lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~  320 (448)
T KOG0195|consen  241 LRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSK  320 (448)
T ss_pred             eeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccc
Confidence            4667899999999999999999999999999999999977543  578899999999999999999975  334468899


Q ss_pred             cEEEccCCCEEEe--eccCccCCCCCccccccccCCCCCCCCceecCCCCC--CCcccHhHHHHHHHHHHhCCCCCCCCC
Q 016865           77 NLLLDSYGNLKVS--DFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD--GSAADVWSCGVILFVLMAGYLPFGETD  152 (381)
Q Consensus        77 NiLl~~~~~lkl~--DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~--~~~~DIwSlGvil~~ll~G~~Pf~~~~  152 (381)
                      .+++|++-..+|+  |--++.+.       ....-+|.|++||.+...+.+  -.++|+||+.++|+||-|.+.||.+..
T Consensus       321 hvmidedltarismad~kfsfqe-------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadls  393 (448)
T KOG0195|consen  321 HVMIDEDLTARISMADTKFSFQE-------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLS  393 (448)
T ss_pred             eEEecchhhhheecccceeeeec-------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCC
Confidence            9999998776663  33222211       122347899999999877655  247999999999999999999999877


Q ss_pred             hhHHHHHh--hcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 016865          153 LPTLYKKI--NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIR  197 (381)
Q Consensus       153 ~~~~~~~i--~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il  197 (381)
                      ..+.--++  ...+...|+.+|+....|++-|+..||.+||.++.|.
T Consensus       394 pmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  394 PMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             chhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence            76654444  3445678999999999999999999999999987754

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.78  E-value=8.4e-20  Score=177.68  Aligned_cols=176  Identities=24%  Similarity=0.379  Sum_probs=136.8

Q ss_pred             CEEEEEEecCCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCCCEEEeeccCccC
Q 016865           20 TKVYIILEFVTGGELFDKIVHQGR---LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL   96 (381)
Q Consensus        20 ~~~~lV~E~~~gg~L~~~i~~~~~---l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~   96 (381)
                      .+.||.|++|...+|.+.|.+...   -+...+..++.|+..|++|   +|.+|||+||.||....++.+||.|||+.+.
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            368999999999999999975443   4567889999999999999   9999999999999999999999999999876


Q ss_pred             CCCCc------cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHHHHHhhcccCCCCC
Q 016865           97 PQQGV------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAEFSCPF  169 (381)
Q Consensus        97 ~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~~~p~  169 (381)
                      .....      .......||+.||+||.+.+..|. .++||||||+||+|++. =..+|...   ....-+..+.++...
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~-~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~r~g~ip~~~  481 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS-EKVDIYALGLILAELLIQFSTQFERI---ATLTDIRDGIIPPEF  481 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhhhhhh-hhcchhhHHHHHHHHHHHhccHHHHH---HhhhhhhcCCCChHH
Confidence            54422      134566899999999999998886 99999999999999987 33333221   111122223222111


Q ss_pred             C-CChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          170 W-FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       170 ~-~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      + -.++...|+..||.+.|.+||++.+.-.|+|.
T Consensus       482 ~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  482 LQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             hhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            2 23566799999999999999988887777764

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.76  E-value=1.5e-18  Score=168.04  Aligned_cols=111  Identities=27%  Similarity=0.321  Sum_probs=88.0

Q ss_pred             CCCCCcccccc-ceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC-CCCcE
Q 016865            1 MKIVRHPNIVR-LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL-KPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~-l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDl-kp~Ni   78 (381)
                      |+.++|+||+. +++    .+..|+||||++|++|.. +..   ..   ...++.|++.||.|||++||+|||| ||+||
T Consensus        75 L~~L~h~~iv~~l~~----~~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NI  143 (365)
T PRK09188         75 LKTVRGIGVVPQLLA----TGKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNW  143 (365)
T ss_pred             HHhccCCCCCcEEEE----cCCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceE
Confidence            46789999995 443    246899999999999963 211   11   1468899999999999999999999 99999


Q ss_pred             EEccCCCEEEeeccCccCCCCCc--------cccccccCCCCCCCCceecCC
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGV--------ELLHTTCGTPNYVAPEVLSNR  122 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~--------~~~~~~~gt~~y~aPE~l~~~  122 (381)
                      |++.++.+||+|||+|+......        +...+.++++.|+|||++...
T Consensus       144 Lv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        144 LMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             EEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            99999999999999998654421        112466789999999998643

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.74  E-value=2.6e-18  Score=160.16  Aligned_cols=161  Identities=29%  Similarity=0.405  Sum_probs=105.1

Q ss_pred             EEEEEecCCCCChHHHHHh---cCCC---CHHHHHH-HHHHHHHHHHHHHHCCCeecCCCCCcEEEccCCCEEEeeccCc
Q 016865           22 VYIILEFVTGGELFDKIVH---QGRL---LENDCRR-YFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS   94 (381)
Q Consensus        22 ~~lV~E~~~gg~L~~~i~~---~~~l---~e~~~~~-~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls   94 (381)
                      .+++|+-+. ++|.+.+.-   ....   ....|+. +..|++..+++||+.|++|+||+|+|++++.+|.+.|+||+..
T Consensus       114 ~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~  192 (288)
T PF14531_consen  114 RFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSL  192 (288)
T ss_dssp             EEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGE
T ss_pred             hhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHH
Confidence            477888774 588887642   2222   1233433 3489999999999999999999999999999999999999866


Q ss_pred             cCCCCCccccccccCCCCCCCCceecCCC-------CCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccCCC
Q 016865           95 ALPQQGVELLHTTCGTPNYVAPEVLSNRG-------YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC  167 (381)
Q Consensus        95 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-------~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~  167 (381)
                      ...+..   ......+..|.+||......       ..+.+.|.|+||+++|.|.+|..||+..........   .--.+
T Consensus       193 ~r~g~~---~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~---~f~~C  266 (288)
T PF14531_consen  193 VRAGTR---YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW---DFSRC  266 (288)
T ss_dssp             EETTEE---EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG---GGTTS
T ss_pred             eecCce---eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc---cchhc
Confidence            543321   11134568899999874421       124788999999999999999999986543221111   11134


Q ss_pred             CCCCChhHHHHHHHhcCCCCCCC
Q 016865          168 PFWFSTGATSLIHKILDPNPKTR  190 (381)
Q Consensus       168 p~~~s~~~~~li~~~L~~dP~~R  190 (381)
                      . .++..+++||..+|+.||.+|
T Consensus       267 ~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  267 R-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S----HHHHHHHHHHT-SSGGGS
T ss_pred             C-CcCHHHHHHHHHHccCCcccC
Confidence            4 689999999999999999988

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.72  E-value=1.2e-17  Score=148.51  Aligned_cols=141  Identities=18%  Similarity=0.211  Sum_probs=105.3

Q ss_pred             CCCC-CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC-CCCcE
Q 016865            1 MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL-KPENL   78 (381)
Q Consensus         1 lk~l-~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDl-kp~Ni   78 (381)
                      |++| +|++|++++++    +..|++|||+.|.+|.+.+..      . ...++.|++.+|.+||++||+|||| ||+||
T Consensus        55 L~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NI  123 (218)
T PRK12274         55 LRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANW  123 (218)
T ss_pred             HHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceE
Confidence            3566 45889999886    457999999999998754321      1 2357889999999999999999999 79999


Q ss_pred             EEccCCCEEEeeccCccCCCCCccc-------------cccccCCCCCCCCceecCC-CCCCCcccHhHHHHHHHHHHhC
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVEL-------------LHTTCGTPNYVAPEVLSNR-GYDGSAADVWSCGVILFVLMAG  144 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~-------------~~~~~gt~~y~aPE~l~~~-~~~~~~~DIwSlGvil~~ll~G  144 (381)
                      |++.+|.++|+|||+|.........             ..-...++.|++|+...-- ..+-...+.++-|.-+|.++|+
T Consensus       124 Lv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~  203 (218)
T PRK12274        124 LVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTR  203 (218)
T ss_pred             EEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhc
Confidence            9999999999999999865432210             0112367888888754322 1112456888999999999999


Q ss_pred             CCCCCCCC
Q 016865          145 YLPFGETD  152 (381)
Q Consensus       145 ~~Pf~~~~  152 (381)
                      ..|+-+.+
T Consensus       204 ~~~~~~~~  211 (218)
T PRK12274        204 RVLHWEDN  211 (218)
T ss_pred             cCCccccC
Confidence            98875543

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.68  E-value=1.6e-17  Score=150.40  Aligned_cols=118  Identities=18%  Similarity=0.285  Sum_probs=91.2

Q ss_pred             CCCCccccccceEEEEeC--------CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q 016865            2 KIVRHPNIVRLHEVLASR--------TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL   73 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~--------~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDl   73 (381)
                      .+++||+|..+.+++...        +..+|||||++|.+|.+..    .+++    ....+++.++..||+.|++|||+
T Consensus        90 ~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Di  161 (232)
T PRK10359         90 DRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDP  161 (232)
T ss_pred             HHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCC
Confidence            356899999999987643        3589999999999997763    2333    24569999999999999999999


Q ss_pred             CCCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHH
Q 016865           74 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVL  141 (381)
Q Consensus        74 kp~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~l  141 (381)
                      ||+||+++.+| ++|+|||.+....... ..           ..++....|. .++||||+|+.+..+
T Consensus       162 kp~Nili~~~g-i~liDfg~~~~~~e~~-a~-----------d~~vler~y~-~~~di~~lg~~~~~~  215 (232)
T PRK10359        162 HKGNFIVSKNG-LRIIDLSGKRCTAQRK-AK-----------DRIDLERHYG-IKNEIKDLGYYLLIY  215 (232)
T ss_pred             ChHHEEEeCCC-EEEEECCCcccccchh-hH-----------HHHHHHhHhc-ccccccceeEeehHH
Confidence            99999999988 9999999876543211 00           1134455676 899999999987644

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.68  E-value=3e-16  Score=144.95  Aligned_cols=188  Identities=18%  Similarity=0.259  Sum_probs=149.2

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccC
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY   83 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~   83 (381)
                      .-++|.+.|.+....-+-.||||++ |.+|.|...- .++|+...+..++.|++.-++|+|++..|.|||||+|+||..-
T Consensus        82 g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp  160 (449)
T KOG1165|consen   82 GTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRP  160 (449)
T ss_pred             CCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCC
Confidence            3578888888888888999999998 7899888865 4569999999999999999999999999999999999999754


Q ss_pred             C-----CEEEeeccCccCCCCCc-------cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCC
Q 016865           84 G-----NLKVSDFGLSALPQQGV-------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET  151 (381)
Q Consensus        84 ~-----~lkl~DFGls~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~  151 (381)
                      +     .+-++|||+|+......       +......||..||+-....+...+ ..-|+=|||-+++++|-|.+||.+.
T Consensus       161 ~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQS-RRDDLEaLGHvFmYFLRGsLPWQGL  239 (449)
T KOG1165|consen  161 GTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGL  239 (449)
T ss_pred             CCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhh-hhhhHHHhhhhhhhhccCCCccccc
Confidence            3     58999999998765532       233556799999998888776654 7899999999999999999999764


Q ss_pred             ---ChhHHHHHhhcccCCCCC-----CCChhHHHHHHHhcCCCCCCCCCHH
Q 016865          152 ---DLPTLYKKINAAEFSCPF-----WFSTGATSLIHKILDPNPKTRIRIE  194 (381)
Q Consensus       152 ---~~~~~~~~i~~~~~~~p~-----~~s~~~~~li~~~L~~dP~~R~t~~  194 (381)
                         +..+-|++|.......|.     .++.++...++-.-..+-.+-|..+
T Consensus       240 KA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd  290 (449)
T KOG1165|consen  240 KADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYD  290 (449)
T ss_pred             cCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence               455677777665554442     2566666666665555555555543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.68  E-value=7.5e-17  Score=143.32  Aligned_cols=93  Identities=20%  Similarity=0.253  Sum_probs=74.0

Q ss_pred             CCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCCeecCCCCCcEEEc
Q 016865            3 IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC-HSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~L-H~~gi~HrDlkp~NiLl~   81 (381)
                      .+.|+++.....+...  ..+|||||++|+++...+...+.+++..+..++.|++.+|.|+ |+.||+||||||+|||++
T Consensus        75 ~l~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~  152 (190)
T cd05147          75 RLVTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH  152 (190)
T ss_pred             HHHHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE
Confidence            3455555433332222  2389999999988876655567899999999999999999999 799999999999999998


Q ss_pred             cCCCEEEeeccCccCCC
Q 016865           82 SYGNLKVSDFGLSALPQ   98 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~   98 (381)
                       ++.++|+|||+|....
T Consensus       153 -~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 -DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             -CCcEEEEEccccccCC
Confidence             5889999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10345 hypothetical protein; Provisional

Probab=99.66  E-value=3.7e-16  Score=140.66  Aligned_cols=88  Identities=20%  Similarity=0.202  Sum_probs=72.2

Q ss_pred             CCccccccceEEEEeCC---EEE-EEEec--CCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHCCCeecCCCCC
Q 016865            4 VRHPNIVRLHEVLASRT---KVY-IILEF--VTGGELFDKIVHQGRLLENDCRRYFQQLIDAV-AHCHSKGVYHRDLKPE   76 (381)
Q Consensus         4 l~HpnIv~l~~~~~~~~---~~~-lV~E~--~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L-~~LH~~gi~HrDlkp~   76 (381)
                      .+||||++++++++++.   .++ +|+||  +.+|+|.+++.+ +.++++  ..++.|++.++ +|||+++|+||||||+
T Consensus        58 ~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~  134 (210)
T PRK10345         58 IDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQ  134 (210)
T ss_pred             CCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHH
Confidence            37899999999999874   434 78999  567999999976 457666  35678888777 9999999999999999


Q ss_pred             cEEEccC----CCEEEeeccCc
Q 016865           77 NLLLDSY----GNLKVSDFGLS   94 (381)
Q Consensus        77 NiLl~~~----~~lkl~DFGls   94 (381)
                      |||++..    +.++|+||+.+
T Consensus       135 NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345        135 NILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             HEEEeccCCCCCcEEEEECCCC
Confidence            9999743    37999995544

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.66  E-value=2.2e-16  Score=140.31  Aligned_cols=94  Identities=15%  Similarity=0.243  Sum_probs=75.9

Q ss_pred             CCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEc
Q 016865            3 IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLD   81 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NiLl~   81 (381)
                      ++.|++|.....+....  .|+||||++|+++.........+++..+..++.|++.++.++|+ .||+||||||+|||++
T Consensus        75 ~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~  152 (190)
T cd05145          75 RLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH  152 (190)
T ss_pred             HHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE
Confidence            45667765444443332  48999999988665544445678899999999999999999999 9999999999999999


Q ss_pred             cCCCEEEeeccCccCCCC
Q 016865           82 SYGNLKVSDFGLSALPQQ   99 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~   99 (381)
                       ++.++|+|||++.....
T Consensus       153 -~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 -DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             -CCCEEEEEcccceecCC
Confidence             89999999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.65  E-value=4.1e-16  Score=138.35  Aligned_cols=186  Identities=19%  Similarity=0.257  Sum_probs=146.1

Q ss_pred             ccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEcc---C
Q 016865            8 NIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS---Y   83 (381)
Q Consensus         8 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~---~   83 (381)
                      .|..+..+..++..-.+|||++ |.+|.+...- ...++.....-++-|++.-++|+|.++.+||||||+|+|..-   .
T Consensus        72 GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~  150 (341)
T KOG1163|consen   72 GIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHC  150 (341)
T ss_pred             CCchhhhhccccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeecccccc
Confidence            4555666777888899999998 7799887753 467999999999999999999999999999999999999973   3


Q ss_pred             CCEEEeeccCccCCCCC-------ccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh---
Q 016865           84 GNLKVSDFGLSALPQQG-------VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---  153 (381)
Q Consensus        84 ~~lkl~DFGls~~~~~~-------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~---  153 (381)
                      ..+.++|||+|+.....       .+.-....||..|.+--...+... +..-|+=|+|-+|..+.-|.+||.+...   
T Consensus       151 ~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk  229 (341)
T KOG1163|consen  151 NKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATK  229 (341)
T ss_pred             ceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhH
Confidence            56999999999865432       122345569999998877765444 3778999999999999999999987543   


Q ss_pred             hHHHHHhhcccCCCCC-----CCChhHHHHHHHhcCCCCCCCCCHHH
Q 016865          154 PTLYKKINAAEFSCPF-----WFSTGATSLIHKILDPNPKTRIRIEG  195 (381)
Q Consensus       154 ~~~~~~i~~~~~~~p~-----~~s~~~~~li~~~L~~dP~~R~t~~~  195 (381)
                      .+.+.+|.....+.|.     .+|.++.-.+..|-..--.+-|...-
T Consensus       230 ~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~y  276 (341)
T KOG1163|consen  230 KQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMY  276 (341)
T ss_pred             HHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHH
Confidence            4556677766666553     37888888999888777777666543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.60  E-value=7.4e-16  Score=160.17  Aligned_cols=200  Identities=31%  Similarity=0.537  Sum_probs=168.6

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCC
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG   84 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~   84 (381)
                      +||-+++...-+......++|++|+.||+|...+...+..+++-++.+...+..+++|||+..+.|||++|.|++...+|
T Consensus       862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~g  941 (1205)
T KOG0606|consen  862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDG  941 (1205)
T ss_pred             CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccC
Confidence            34666655555556678999999999999999999988899999999999999999999999999999999999999999


Q ss_pred             CEEEeeccCccCCC---------------------CC--------c--cccccccCCCCCCCCceecCCCCCCCcccHhH
Q 016865           85 NLKVSDFGLSALPQ---------------------QG--------V--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWS  133 (381)
Q Consensus        85 ~lkl~DFGls~~~~---------------------~~--------~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwS  133 (381)
                      +.+++|||......                     ..        .  ...+...||+.|.+||.+.+... +..+|+|+
T Consensus       942 h~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~ 1020 (1205)
T KOG0606|consen  942 HRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWS 1020 (1205)
T ss_pred             CcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhh
Confidence            99999998322100                     00        0  11234569999999999987654 58999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChhHHHHHhhcccCCCCC---CCChhHHHHHHHhcCCCCCCCCCHH---HHhcCcccccC
Q 016865          134 CGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF---WFSTGATSLIHKILDPNPKTRIRIE---GIRKHPWFRKN  205 (381)
Q Consensus       134 lGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~---~~s~~~~~li~~~L~~dP~~R~t~~---~il~hp~~~~~  205 (381)
                      .|+++++.++|.+||........++.+.....+.|.   ..+.++++++.+.|..+|.+|..+.   +...||||+..
T Consensus      1021 ~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1021 SGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred             hhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence            999999999999999999999999888877766543   4799999999999999999999987   89999999853

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.53  E-value=9.5e-15  Score=154.15  Aligned_cols=139  Identities=22%  Similarity=0.306  Sum_probs=120.5

Q ss_pred             cccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEcc----
Q 016865            7 PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS----   82 (381)
Q Consensus         7 pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~----   82 (381)
                      +-|+.++.++.-.+.-++|+||.+.|+|.|++...+.+++.....+..|++.-|++||..||||+||||+|+||..    
T Consensus       754 ~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~  833 (974)
T KOG1166|consen  754 PSIMHISSAHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICA  833 (974)
T ss_pred             cchHHHHHHHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCC
Confidence            4466666666667788999999999999999998889999999999999999999999999999999999999953    


Q ss_pred             ---CCCEEEeeccCccCCCC--CccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCC
Q 016865           83 ---YGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYL  146 (381)
Q Consensus        83 ---~~~lkl~DFGls~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~  146 (381)
                         +--++|+|||.|.-..-  ........++|-.+-.+|+..++++. +.+|.|.++.+++.||.|+.
T Consensus       834 ~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  834 DSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             CCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHHHHHHHHH
Confidence               23599999998864322  22456788899999999999999986 99999999999999999974

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.52  E-value=1.3e-14  Score=134.04  Aligned_cols=197  Identities=17%  Similarity=0.274  Sum_probs=142.1

Q ss_pred             CCCccccccceEEEEeC-----CEEEEEEecCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--Ceec
Q 016865            3 IVRHPNIVRLHEVLASR-----TKVYIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHCHSKG--VYHR   71 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~~L~~LH~~g--i~Hr   71 (381)
                      ++.|.|||+++.++.+.     ....++.||+..|++..++++.    ..+....+.+|..||++||.|||+..  |+|+
T Consensus       123 qlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihg  202 (458)
T KOG1266|consen  123 QLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHG  202 (458)
T ss_pred             HHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccC
Confidence            45799999999999654     4689999999999999999764    35889999999999999999999985  9999


Q ss_pred             CCCCCcEEEccCCCEEEeeccCccCCCC----CccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCC
Q 016865           72 DLKPENLLLDSYGNLKVSDFGLSALPQQ----GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLP  147 (381)
Q Consensus        72 Dlkp~NiLl~~~~~lkl~DFGls~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~P  147 (381)
                      ++....|++..+|-+|+.--.-......    .........|-++|.|||.-....- ..++|||++|....+|..|..-
T Consensus       203 nlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemailEiq  281 (458)
T KOG1266|consen  203 NLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMAILEIQ  281 (458)
T ss_pred             CcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHHHheec
Confidence            9999999999999999853222111111    0011122336688999987644333 3689999999888999888754


Q ss_pred             C-CCCChhHHHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          148 F-GETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       148 f-~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      - .+......-..+...-+...   ..--+++|.+||+..|..||++.+++.||-.-
T Consensus       282 ~tnseS~~~~ee~ia~~i~~le---n~lqr~~i~kcl~~eP~~rp~ar~llfHpllf  335 (458)
T KOG1266|consen  282 STNSESKVEVEENIANVIIGLE---NGLQRGSITKCLEGEPNGRPDARLLLFHPLLF  335 (458)
T ss_pred             cCCCcceeehhhhhhhheeecc---CccccCcCcccccCCCCCCcchhhhhcCceee
Confidence            2 22222222222222211111   12336789999999999999999999999764

>PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs)

Probab=99.51  E-value=3.2e-14  Score=100.82  Aligned_cols=61  Identities=41%  Similarity=0.795  Sum_probs=48.8

Q ss_pred             CcccchhhhhhcCCCCCCcccCccccc-ccccccEEEeCCCHHHHHHHHHHHHHHcCcEEEe
Q 016865          245 PLLMNAFEMITLSQGLNLAALFDRRQD-YVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHT  305 (381)
Q Consensus       245 ~~~~~~~~~~~~s~~~~l~~~~~~~~~-~~~~~trf~s~~~~~~i~~~l~~~~~~~~~~v~~  305 (381)
                      |..+|||++|++|+|+|||+||+..+. .+++.+||+|+.|++.|+++||++++.+|+.|++
T Consensus         2 p~~lNAFdiIS~S~G~DLSgLFe~~~~~~~~~~~RF~S~~~~~~Ii~klEe~a~~~~~~V~K   63 (63)
T PF03822_consen    2 PKSLNAFDIISLSSGFDLSGLFEEKDKSSVKRETRFTSKEPASEIIEKLEEIAKKLGFRVKK   63 (63)
T ss_dssp             -EE--HHHHHCTSTTTSCGGGGGCG-S-SS---EEEEESS-HHHHHHHHHHHHHHTTEEEEE
T ss_pred             CccccHHHHHHhccCCChHHhcCccccccccccceEecCCCHHHHHHHHHHHHHhcCceeeC
Confidence            567999999999999999999976543 3578899999999999999999999999999975

Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D.

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.50  E-value=1e-13  Score=124.64  Aligned_cols=89  Identities=25%  Similarity=0.406  Sum_probs=79.0

Q ss_pred             CCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEcc
Q 016865            3 IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS   82 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~   82 (381)
                      .++|+||.....++.+.+..++||||++|++|.+.+.....    ....++.+++.+|.++|+.|++|||++|.|||++ 
T Consensus        55 ~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-  129 (211)
T PRK14879         55 RARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-  129 (211)
T ss_pred             HHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-
Confidence            45788888888888788889999999999999998865322    7889999999999999999999999999999999 


Q ss_pred             CCCEEEeeccCccC
Q 016865           83 YGNLKVSDFGLSAL   96 (381)
Q Consensus        83 ~~~lkl~DFGls~~   96 (381)
                      ++.++++|||.+..
T Consensus       130 ~~~~~liDf~~a~~  143 (211)
T PRK14879        130 GGKIYLIDFGLAEF  143 (211)
T ss_pred             CCCEEEEECCcccC
Confidence            78999999998865

>smart00090 RIO RIO-like kinase

Probab=99.47  E-value=5.5e-14  Score=129.22  Aligned_cols=77  Identities=18%  Similarity=0.317  Sum_probs=67.0

Q ss_pred             EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-CeecCCCCCcEEEccCCCEEEeeccCccCCC
Q 016865           21 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG-VYHRDLKPENLLLDSYGNLKVSDFGLSALPQ   98 (381)
Q Consensus        21 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~g-i~HrDlkp~NiLl~~~~~lkl~DFGls~~~~   98 (381)
                      ..|+||||++|++|.........+.+..+..++.|++.+|++||+.| |+||||||+||+++ ++.++|+|||.+....
T Consensus       122 ~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      122 RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence            45899999999888776545556677778899999999999999999 99999999999999 8899999999887543

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.44  E-value=1.8e-13  Score=140.45  Aligned_cols=88  Identities=22%  Similarity=0.349  Sum_probs=78.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++|+||+....+..+....++||||++|++|.+.+.        ....++.|++.+|.+||+.|++||||||+|||+
T Consensus       390 l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl  461 (535)
T PRK09605        390 LSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV  461 (535)
T ss_pred             HHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE
Confidence            356789999988888877778899999999999998875        356789999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCC
Q 016865           81 DSYGNLKVSDFGLSALP   97 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~   97 (381)
                       +++.++|+|||+++..
T Consensus       462 -~~~~~~liDFGla~~~  477 (535)
T PRK09605        462 -RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             -ECCcEEEEeCcccccC
Confidence             6789999999998754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.43  E-value=2.1e-13  Score=121.66  Aligned_cols=87  Identities=22%  Similarity=0.344  Sum_probs=72.9

Q ss_pred             CCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEcc
Q 016865            3 IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS   82 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~   82 (381)
                      .++|+++....-++.+.+..++||||++|++|.+.+.....       .++.|++.+|.+||+.|++|||++|.||+++ 
T Consensus        53 ~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-  124 (199)
T TIGR03724        53 RARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-  124 (199)
T ss_pred             HHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-
Confidence            45677666555556667778999999999999988755321       7899999999999999999999999999999 


Q ss_pred             CCCEEEeeccCccCC
Q 016865           83 YGNLKVSDFGLSALP   97 (381)
Q Consensus        83 ~~~lkl~DFGls~~~   97 (381)
                      ++.++++|||++...
T Consensus       125 ~~~~~liDfg~a~~~  139 (199)
T TIGR03724       125 DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCcEEEEECCCCcCC
Confidence            899999999988653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.43  E-value=2.8e-13  Score=124.70  Aligned_cols=90  Identities=28%  Similarity=0.441  Sum_probs=71.3

Q ss_pred             CCCCcccc--ccceEEEEeCC----EEEEEEecCCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 016865            2 KIVRHPNI--VRLHEVLASRT----KVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK   74 (381)
Q Consensus         2 k~l~HpnI--v~l~~~~~~~~----~~~lV~E~~~g-g~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlk   74 (381)
                      +.|+|++|  ++.+++.....    ..++|||+++| .+|.+.+.. ..+++..    +.|++.+|.+||+.||+|||||
T Consensus        95 ~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlk  169 (239)
T PRK01723         95 AQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLN  169 (239)
T ss_pred             HHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCC
Confidence            34667674  66777654332    23599999997 688887754 4566543    5789999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccCccC
Q 016865           75 PENLLLDSYGNLKVSDFGLSAL   96 (381)
Q Consensus        75 p~NiLl~~~~~lkl~DFGls~~   96 (381)
                      |+|||++.++.++|+|||.+..
T Consensus       170 p~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        170 AHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             chhEEEcCCCCEEEEECCCccc
Confidence            9999999989999999998765

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.42  E-value=1.7e-13  Score=136.06  Aligned_cols=195  Identities=22%  Similarity=0.241  Sum_probs=153.7

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHHCCCeecCCCCCcEE
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLID----AVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~-l~e~~~~~~~~qll~----~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      .|+|.++.+..+++.+..|+-+|+|. .+|.++...... +++..++.++.+..+    ||.++|+.+++|-|+||.||+
T Consensus       176 ~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~  254 (524)
T KOG0601|consen  176 SHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIF  254 (524)
T ss_pred             ccccccccCcccccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhhee
Confidence            59999999999999999999999995 688888776555 899999999999999    999999999999999999999


Q ss_pred             EccC-CCEEEeeccCccCCCCCcccc-----ccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCC--
Q 016865           80 LDSY-GNLKVSDFGLSALPQQGVELL-----HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET--  151 (381)
Q Consensus        80 l~~~-~~lkl~DFGls~~~~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~--  151 (381)
                      ...+ ...+++|||+...+....-..     ...-|...|++||...+  ..+...||+|+|.++.+-.+|..+....  
T Consensus       255 ~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~  332 (524)
T KOG0601|consen  255 TTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKN  332 (524)
T ss_pred             cccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCC
Confidence            9999 889999999987665532111     12257889999999864  3458999999999998888877665432  


Q ss_pred             -ChhHHHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          152 -DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       152 -~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                       .+.+.-+.....  .+-...+..+...+..|++.+|..|++++.+++|+++..
T Consensus       333 ~~W~~~r~~~ip~--e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  333 SSWSQLRQGYIPL--EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             CCccccccccCch--hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence             222211111111  111124666777999999999999999999999999874

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.36  E-value=5.3e-12  Score=126.85  Aligned_cols=137  Identities=18%  Similarity=0.297  Sum_probs=105.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH-SKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH-~~gi~HrDlkp~NiL   79 (381)
                      ||.++||||+++++.++..+.+|||+|-+.  -|..++...+   +.....-+.||+.||.||| +.+++|++|.-..|+
T Consensus        63 lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVf  137 (690)
T KOG1243|consen   63 LKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVF  137 (690)
T ss_pred             hhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEE
Confidence            678999999999999999999999999884  4566676643   5566667899999999998 668999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCC
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGY  145 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~  145 (381)
                      ++..|..||++|-++..............---.|..|+.+....   -..|.|-|||++++++.|.
T Consensus       138 Vn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~---~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  138 VNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE---WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             EcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc---cchhhhhHHHHHHHHhCcc
Confidence            99999999999988754433221111222222356666553222   4579999999999999993

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.32  E-value=1.7e-12  Score=115.97  Aligned_cols=74  Identities=19%  Similarity=0.406  Sum_probs=63.4

Q ss_pred             CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCCCEEEeeccCccCCCC
Q 016865           20 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ   99 (381)
Q Consensus        20 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~   99 (381)
                      ...++||||++|++|.+....      ..+..++.+++.++.++|+.||+||||||+||++++++.++|+|||.+.....
T Consensus       104 ~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         104 NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence            456899999999998664321      35677889999999999999999999999999999999999999999865543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.19  E-value=2e-11  Score=102.43  Aligned_cols=84  Identities=23%  Similarity=0.321  Sum_probs=73.5

Q ss_pred             cccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCCCcEEEccC
Q 016865            7 PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK---GVYHRDLKPENLLLDSY   83 (381)
Q Consensus         7 pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~---gi~HrDlkp~NiLl~~~   83 (381)
                      +++++++.+....+..|++|||++|+++...       +......++.+++.++.++|..   +++|+|++|+||+++..
T Consensus        53 ~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~  125 (155)
T cd05120          53 LPVPKVLASGESDGWSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG  125 (155)
T ss_pred             CCCCeEEEEcCCCCccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC
Confidence            5888999988888899999999999877543       5566778899999999999985   79999999999999998


Q ss_pred             CCEEEeeccCccCC
Q 016865           84 GNLKVSDFGLSALP   97 (381)
Q Consensus        84 ~~lkl~DFGls~~~   97 (381)
                      +.++++|||.+...
T Consensus       126 ~~~~l~Df~~~~~~  139 (155)
T cd05120         126 KILGIIDWEYAGYG  139 (155)
T ss_pred             cEEEEEecccccCC
Confidence            99999999988653

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.18  E-value=3.5e-11  Score=106.07  Aligned_cols=76  Identities=21%  Similarity=0.368  Sum_probs=60.3

Q ss_pred             EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEccCCCEEEeeccCccCCC
Q 016865           21 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ   98 (381)
Q Consensus        21 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~   98 (381)
                      ..++||||++|+.+.......... ...++.++.|++.++.++|+ .||+||||||+||+++ ++.++++|||.+....
T Consensus        89 ~~~lv~e~~~g~~~~~~~l~~~~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119          89 RHVLVMEFIGGDGIPAPRLKDVRL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCEEEEEEeCCCCccChhhhhhhh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence            468999999985432211111111 16788999999999999999 9999999999999999 8999999999987544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.16  E-value=1.8e-11  Score=121.78  Aligned_cols=192  Identities=23%  Similarity=0.193  Sum_probs=148.8

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccC-
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY-   83 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~-   83 (381)
                      -|.++++++..+......||=.|||.++++...+.-...+.+...+....|++.++.++|+..++|+|+||+||++..+ 
T Consensus       324 ~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~  403 (524)
T KOG0601|consen  324 SHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG  403 (524)
T ss_pred             cccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch
Confidence            5889999999998888899999999999998877666678899999999999999999999999999999999999987 


Q ss_pred             CCEEEeeccCccCCCCCcccccccc-CCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCC-CCCCCChhHHHHHhh
Q 016865           84 GNLKVSDFGLSALPQQGVELLHTTC-GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYL-PFGETDLPTLYKKIN  161 (381)
Q Consensus        84 ~~lkl~DFGls~~~~~~~~~~~~~~-gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~-Pf~~~~~~~~~~~i~  161 (381)
                      +..++.|||..+......   .... ++..|-.+|++.....+..++|++|+|.-+.+..+|.. ++....    ...+.
T Consensus       404 ~~~~~~~~~~~t~~~~~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----~~~i~  476 (524)
T KOG0601|consen  404 FFSKLGDFGCWTRLAFSS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----SLTIR  476 (524)
T ss_pred             hhhhccccccccccceec---ccccccccccccchhhccccccccccccccccccccccccCcccCccccc----ceeee
Confidence            788999999886422211   1111 23333235555555555689999999999999988863 333222    22344


Q ss_pred             cccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          162 AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       162 ~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      .+.....+..+.++..+.+.++.+++..|+.+.++..|+-|.
T Consensus       477 ~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  477 SGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             cccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence            455555555568889999999999999999999998887664

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.03  E-value=1.3e-10  Score=117.29  Aligned_cols=152  Identities=22%  Similarity=0.370  Sum_probs=114.9

Q ss_pred             HHHHHHHHHHHHHC-CCeecCCCCCcEEEccCCCEEEeeccCccCCCCCcc---------ccccccCCCCCCCCceecCC
Q 016865           53 FQQLIDAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE---------LLHTTCGTPNYVAPEVLSNR  122 (381)
Q Consensus        53 ~~qll~~L~~LH~~-gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~---------~~~~~~gt~~y~aPE~l~~~  122 (381)
                      +.+...|+.|+|.. +++|++|.|++|.++.+|..||+.|+.+.....+..         ......-...|.|||++...
T Consensus       105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            44566899999965 899999999999999999999999998754332111         11111235789999999873


Q ss_pred             CCCCCcccHhHHHHHHHHHH-hCCCCCCCCChhHHHHH----hhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 016865          123 GYDGSAADVWSCGVILFVLM-AGYLPFGETDLPTLYKK----INAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIR  197 (381)
Q Consensus       123 ~~~~~~~DIwSlGvil~~ll-~G~~Pf~~~~~~~~~~~----i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il  197 (381)
                       ..+.++|++|+||.+|.+. +|+..+...+....+..    ...+.+..+..+++++++=+.++|..++..||++..++
T Consensus       185 -~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  185 -TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             -cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence             4468999999999999999 56666655443332221    12223345566899999999999999999999999999


Q ss_pred             cCcccccC
Q 016865          198 KHPWFRKN  205 (381)
Q Consensus       198 ~hp~~~~~  205 (381)
                      ..|||...
T Consensus       264 ~~~ff~D~  271 (700)
T KOG2137|consen  264 SIPFFSDP  271 (700)
T ss_pred             cccccCCc
Confidence            99999864

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.02  E-value=2e-09  Score=105.57  Aligned_cols=172  Identities=19%  Similarity=0.288  Sum_probs=129.8

Q ss_pred             CCCCccccccceEEEEe----CCEEEEEEecCCC-CChHHHHHh---------------cCCCCHHHHHHHHHHHHHHHH
Q 016865            2 KIVRHPNIVRLHEVLAS----RTKVYIILEFVTG-GELFDKIVH---------------QGRLLENDCRRYFQQLIDAVA   61 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~----~~~~~lV~E~~~g-g~L~~~i~~---------------~~~l~e~~~~~~~~qll~~L~   61 (381)
                      |++.|+|||++.++|.+    +..+++|++|.++ ++|.++--.               ..+.+|...|.|+.||..||.
T Consensus       328 kkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~  407 (655)
T KOG3741|consen  328 KKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALY  407 (655)
T ss_pred             HHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHH
Confidence            56899999999999973    3579999999986 677775521               124789999999999999999


Q ss_pred             HHHHCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHH
Q 016865           62 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVL  141 (381)
Q Consensus        62 ~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~l  141 (381)
                      ++|+.|...+-|.|.+||++.+..++|+..|...+.....            .  |-+...    .+-|.=.+|.+++.|
T Consensus       408 sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~------------~--~~le~~----Qq~D~~~lG~ll~aL  469 (655)
T KOG3741|consen  408 SIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP------------T--EPLESQ----QQNDLRDLGLLLLAL  469 (655)
T ss_pred             HHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC------------C--cchhHH----hhhhHHHHHHHHHHH
Confidence            9999999999999999999999999999888776544321            1  112111    345888899999999


Q ss_pred             HhCCCC-CCCCChhHH-HHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          142 MAGYLP-FGETDLPTL-YKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       142 l~G~~P-f~~~~~~~~-~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      .+|..- +........ ...|.       ..+|.+++++|.-+...++.+ -++.+++.+
T Consensus       470 At~~~ns~~~d~~~~s~~~~I~-------~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  470 ATGTENSNRTDSTQSSHLTRIT-------TTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             hhcccccccccchHHHHHHHhh-------hhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            999643 222222222 22222       236889999999999999987 688888765

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.01  E-value=9.4e-10  Score=97.69  Aligned_cols=79  Identities=16%  Similarity=0.312  Sum_probs=62.5

Q ss_pred             CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCCeecCCCCCcEEEccCCCEEEeeccCccCCC
Q 016865           20 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC-HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ   98 (381)
Q Consensus        20 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~L-H~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~   98 (381)
                      ..-+|||||+.++.+..-...+..++++.+..+..|++.++..| |+.|++|+||+|.|||++ ++.+.|+|||.+....
T Consensus        97 ~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146          97 KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            45789999997755533223334566677788899999999999 899999999999999997 4789999999876544


Q ss_pred             C
Q 016865           99 Q   99 (381)
Q Consensus        99 ~   99 (381)
                      .
T Consensus       176 h  176 (197)
T cd05146         176 H  176 (197)
T ss_pred             C
Confidence            3

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.93  E-value=2.6e-09  Score=106.76  Aligned_cols=78  Identities=21%  Similarity=0.346  Sum_probs=60.9

Q ss_pred             CCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHHCCCeecCCCCCcEEEccCCCEEEeeccCccC
Q 016865           19 RTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLID-AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL   96 (381)
Q Consensus        19 ~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~-~L~~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~   96 (381)
                      .+..+|||||++|++|.+..... ...+   ...++.+++. .+..+|..|++|+|++|.||+++.+|.++++|||++..
T Consensus       230 ~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~  306 (437)
T TIGR01982       230 TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGR  306 (437)
T ss_pred             cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence            34578999999999998876432 1222   2345555555 46889999999999999999999999999999999876


Q ss_pred             CCC
Q 016865           97 PQQ   99 (381)
Q Consensus        97 ~~~   99 (381)
                      ...
T Consensus       307 l~~  309 (437)
T TIGR01982       307 LSE  309 (437)
T ss_pred             CCH
Confidence            653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.82  E-value=5e-09  Score=90.57  Aligned_cols=75  Identities=27%  Similarity=0.425  Sum_probs=57.7

Q ss_pred             cceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCC-----eecCCCCCcEEEccCCC
Q 016865           11 RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV-----YHRDLKPENLLLDSYGN   85 (381)
Q Consensus        11 ~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi-----~HrDlkp~NiLl~~~~~   85 (381)
                      +++....  +..++||||++|.++.+.        ......++.+++.+|..||+.++     +|+|++|.||+++ ++.
T Consensus        57 ~~~~~~~--~~~~lv~e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~  125 (170)
T cd05151          57 KLYYFDP--ETGVLITEFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGR  125 (170)
T ss_pred             ceEEEeC--CCCeEEEEecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCe
Confidence            4444432  345799999999887543        11123457899999999999985     9999999999999 678


Q ss_pred             EEEeeccCccC
Q 016865           86 LKVSDFGLSAL   96 (381)
Q Consensus        86 lkl~DFGls~~   96 (381)
                      ++++|||.+..
T Consensus       126 ~~liDf~~a~~  136 (170)
T cd05151         126 LWLIDWEYAGM  136 (170)
T ss_pred             EEEEecccccC
Confidence            99999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.80  E-value=3.2e-09  Score=107.91  Aligned_cols=73  Identities=22%  Similarity=0.423  Sum_probs=58.0

Q ss_pred             CEEEEEEecCCCCChHHH--HHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCC----CEEEe
Q 016865           20 TKVYIILEFVTGGELFDK--IVHQG----RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG----NLKVS   89 (381)
Q Consensus        20 ~~~~lV~E~~~gg~L~~~--i~~~~----~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~----~lkl~   89 (381)
                      +..+|||||++|+.+.+.  +...+    .+.+..+..++.|++       ..|++|+|+||.||+++.+|    .++++
T Consensus       234 t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~ll  306 (537)
T PRK04750        234 SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIAL  306 (537)
T ss_pred             CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEE
Confidence            456799999999999774  33333    255666777777775       48999999999999999888    99999


Q ss_pred             eccCccCCCC
Q 016865           90 DFGLSALPQQ   99 (381)
Q Consensus        90 DFGls~~~~~   99 (381)
                      |||++.....
T Consensus       307 DFGivg~l~~  316 (537)
T PRK04750        307 DFGIVGSLNK  316 (537)
T ss_pred             ecceEEECCH
Confidence            9999876543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.80  E-value=2e-08  Score=87.07  Aligned_cols=74  Identities=23%  Similarity=0.390  Sum_probs=61.0

Q ss_pred             EEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCCCEEEeeccCcc
Q 016865           16 LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA   95 (381)
Q Consensus        16 ~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~   95 (381)
                      ..+.+...|+|||.+|-.|.+.+...       ...++..+=.-+.-||..||+|+||.++||++...+ +.++|||++.
T Consensus        68 dvD~~~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~  139 (204)
T COG3642          68 DVDPDNGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGE  139 (204)
T ss_pred             EEcCCCCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccc
Confidence            34566778999999998888888664       245666777778899999999999999999998755 9999999987


Q ss_pred             CC
Q 016865           96 LP   97 (381)
Q Consensus        96 ~~   97 (381)
                      +.
T Consensus       140 ~s  141 (204)
T COG3642         140 FS  141 (204)
T ss_pred             cc
Confidence            53

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.77  E-value=5.1e-08  Score=91.07  Aligned_cols=77  Identities=22%  Similarity=0.194  Sum_probs=65.1

Q ss_pred             CEEEEEEecCCCC-ChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEcc-------CCCEEEe
Q 016865           20 TKVYIILEFVTGG-ELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-------YGNLKVS   89 (381)
Q Consensus        20 ~~~~lV~E~~~gg-~L~~~i~~--~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~-------~~~lkl~   89 (381)
                      ..-+||||++++- +|.+++..  ....++.....++.++...+.-||..||+|+|+++.|||++.       +..+.++
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI  187 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVI  187 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEE
Confidence            3578999999885 78888754  344567788899999999999999999999999999999985       4579999


Q ss_pred             eccCccC
Q 016865           90 DFGLSAL   96 (381)
Q Consensus        90 DFGls~~   96 (381)
                      ||+.+..
T Consensus       188 Dl~r~~~  194 (268)
T PRK15123        188 DLHRAQI  194 (268)
T ss_pred             ECCcccc
Confidence            9997753

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.68  E-value=2.7e-07  Score=88.99  Aligned_cols=174  Identities=17%  Similarity=0.240  Sum_probs=121.2

Q ss_pred             EEEEEecCCCCCh-HHHHHh---cC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCCCEEEeeccCc
Q 016865           22 VYIILEFVTGGEL-FDKIVH---QG---RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS   94 (381)
Q Consensus        22 ~~lV~E~~~gg~L-~~~i~~---~~---~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls   94 (381)
                      +-+.|...+|-.= .++...   ..   -...+-+.+..+.|+.+..-||..|..-+|++++|+|+++++.+.+.|-..-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence            7788888877432 222211   11   2456788899999999999999999999999999999999999999885532


Q ss_pred             cCCCCCccccccccCCCCCCCCceecCCCC----CCCcccHhHHHHHHHHHHhC-CCCCCCCCh----h-HHHHHhhccc
Q 016865           95 ALPQQGVELLHTTCGTPNYVAPEVLSNRGY----DGSAADVWSCGVILFVLMAG-YLPFGETDL----P-TLYKKINAAE  164 (381)
Q Consensus        95 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~----~~~~~DIwSlGvil~~ll~G-~~Pf~~~~~----~-~~~~~i~~~~  164 (381)
                      ... .........+|.+.|++||...-..+    .+...|.|.|||++|++|.| ++||.+-..    . ..-..|..+.
T Consensus       165 qi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~  243 (637)
T COG4248         165 QIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR  243 (637)
T ss_pred             eec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence            222 23344556789999999998652211    13678999999999999885 999965221    1 1111222111


Q ss_pred             C-----------CCC---CC--CChhHHHHHHHhcCC--CCCCCCCHHHH
Q 016865          165 F-----------SCP---FW--FSTGATSLIHKILDP--NPKTRIRIEGI  196 (381)
Q Consensus       165 ~-----------~~p---~~--~s~~~~~li~~~L~~--dP~~R~t~~~i  196 (381)
                      +           +.|   +|  +++++..|..+|+..  ++.-|||++..
T Consensus       244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW  293 (637)
T COG4248         244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAW  293 (637)
T ss_pred             eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHH
Confidence            1           111   22  688999999999975  46689998653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.66  E-value=9.6e-08  Score=85.93  Aligned_cols=87  Identities=25%  Similarity=0.394  Sum_probs=72.2

Q ss_pred             ccceEEEEeC----CEEEEEEecCCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCC
Q 016865           10 VRLHEVLASR----TKVYIILEFVTGG-ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG   84 (381)
Q Consensus        10 v~l~~~~~~~----~~~~lV~E~~~gg-~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~   84 (381)
                      .+.+.+.+..    ...++|+|+++|. +|.+++......+......++.++...+.-||..||+|+|++|.|||++.++
T Consensus        76 P~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~  155 (206)
T PF06293_consen   76 PEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDD  155 (206)
T ss_pred             CcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCC
Confidence            4445555543    2468999999884 7888887755577788899999999999999999999999999999999887


Q ss_pred             ---CEEEeeccCccC
Q 016865           85 ---NLKVSDFGLSAL   96 (381)
Q Consensus        85 ---~lkl~DFGls~~   96 (381)
                         .+.++||+-+..
T Consensus       156 ~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  156 GQYRFYLIDLDRMRF  170 (206)
T ss_pred             CceeEEEEcchhcee
Confidence               899999997664

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.56  E-value=2.1e-07  Score=80.55  Aligned_cols=83  Identities=27%  Similarity=0.407  Sum_probs=64.3

Q ss_pred             EEEeCCEEEEEEecCCC-CChHHHHHhcC-CCCHHHH-HHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCCC---EEE
Q 016865           15 VLASRTKVYIILEFVTG-GELFDKIVHQG-RLLENDC-RRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN---LKV   88 (381)
Q Consensus        15 ~~~~~~~~~lV~E~~~g-g~L~~~i~~~~-~l~e~~~-~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~~---lkl   88 (381)
                      ++.+...-.|+|||.+| .++.+++.... .-.++.. ..+++++=+.+.-||.++|+|+||..+||++..+|.   +-+
T Consensus        78 ~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~l  157 (229)
T KOG3087|consen   78 IFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPIL  157 (229)
T ss_pred             EEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEE
Confidence            34566677899999987 46777776532 2223333 688899999999999999999999999999986653   589


Q ss_pred             eeccCccCC
Q 016865           89 SDFGLSALP   97 (381)
Q Consensus        89 ~DFGls~~~   97 (381)
                      +|||++...
T Consensus       158 Idfgls~~s  166 (229)
T KOG3087|consen  158 IDFGLSSVS  166 (229)
T ss_pred             Eeecchhcc
Confidence            999998653

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.33  E-value=4.2e-07  Score=80.36  Aligned_cols=74  Identities=22%  Similarity=0.427  Sum_probs=50.7

Q ss_pred             EEEEEecCC--CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHCCCeecCCCCCcEEEccCCCEEEeeccCccCCC
Q 016865           22 VYIILEFVT--GGELFDKIVHQGRLLENDCRRYFQQLIDAVAH-CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ   98 (381)
Q Consensus        22 ~~lV~E~~~--gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~-LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~   98 (381)
                      -+|||||++  |..+.. +... .++.+....++.+++..+.. +|+.||+|+||.+.|||++++ .+.|+|||.+....
T Consensus        81 ~~ivME~I~~~G~~~~~-l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen   81 NVIVMEYIGEDGVPLPR-LKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             TEEEEE--EETTEEGGC-HHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             CEEEEEecCCCccchhh-HHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcceecC
Confidence            369999998  544433 3331 12245667788888886665 579999999999999999987 89999999876443

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.30  E-value=8.6e-07  Score=79.70  Aligned_cols=90  Identities=23%  Similarity=0.346  Sum_probs=67.9

Q ss_pred             cccccceEEEEeC---CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------
Q 016865            7 PNIVRLHEVLASR---TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS------------------   65 (381)
Q Consensus         7 pnIv~l~~~~~~~---~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~------------------   65 (381)
                      .++.+++.+....   +..|+||||++|+++.+.+.. ..++++....++.+++.+|..||+                  
T Consensus        57 ~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~  135 (223)
T cd05154          57 VPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYL  135 (223)
T ss_pred             CCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchH
Confidence            3456677776654   367899999999888765432 346677777777888888888773                  


Q ss_pred             --------------------------------------CCCeecCCCCCcEEEcc--CCCEEEeeccCccCC
Q 016865           66 --------------------------------------KGVYHRDLKPENLLLDS--YGNLKVSDFGLSALP   97 (381)
Q Consensus        66 --------------------------------------~gi~HrDlkp~NiLl~~--~~~lkl~DFGls~~~   97 (381)
                                                            ..++|+|+.|.||+++.  ++.+.|+||+.+...
T Consensus       136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         136 ERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             HHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                                                  23699999999999998  566899999987643

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.29  E-value=2.3e-06  Score=91.56  Aligned_cols=194  Identities=20%  Similarity=0.217  Sum_probs=137.4

Q ss_pred             CCCCccccccceEEEEeCC----EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC-
Q 016865            2 KIVRHPNIVRLHEVLASRT----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE-   76 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~----~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~-   76 (381)
                      ..+.|+|++.++.+--..-    ...+..|+|++-++.+.+..-+..+.+..+.+..+++.||.|+|+...-|.-+... 
T Consensus       237 ~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~  316 (1351)
T KOG1035|consen  237 SKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASS  316 (1351)
T ss_pred             HhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEeccc
Confidence            4568999999998875443    23455688999999999999899999999999999999999999986555544444 


Q ss_pred             --cEEEccCCCEEEe--eccCccCCCCCccccccccCCCCCCCCceecCCCCC-CCcccHhHHHHHHHHHHhCCCCCCCC
Q 016865           77 --NLLLDSYGNLKVS--DFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD-GSAADVWSCGVILFVLMAGYLPFGET  151 (381)
Q Consensus        77 --NiLl~~~~~lkl~--DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~~DIwSlGvil~~ll~G~~Pf~~~  151 (381)
                        +--.+..+...++  ||+.+....... ......-+..+.|||......+. +...|+|.+|..+..+..|..+-...
T Consensus       317 ~~~~~~~~e~~~~~sl~~~~ss~~l~d~~-~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~  395 (1351)
T KOG1035|consen  317 SKESTVDGEGVVAISLSDFDSSKPLPDNE-KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKS  395 (1351)
T ss_pred             ccccccCccceeecchhhhcccccCCCcc-cchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccc
Confidence              3333455566666  888776554422 22333446678888888665543 12369999999999998877543221


Q ss_pred             ChhHHHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       152 ~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ....   .+.      +........+.+.+|+.-++++|+++.+++.|||.+..
T Consensus       396 ~~~~---~~l------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~  440 (1351)
T KOG1035|consen  396 AVPV---SLL------DVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP  440 (1351)
T ss_pred             cchh---hhh------ccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence            1111   010      00111267889999999999999999999999998643

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.27  E-value=1.1e-07  Score=95.83  Aligned_cols=196  Identities=21%  Similarity=0.210  Sum_probs=136.9

Q ss_pred             CCCCccc-cccceEEEEeCCEEEEEEecCCCC-ChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            2 KIVRHPN-IVRLHEVLASRTKVYIILEFVTGG-ELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         2 k~l~Hpn-Iv~l~~~~~~~~~~~lV~E~~~gg-~L~~~i~-~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      .+++||| .+..++-++.++..+++++++.+| +-.+.+. ..-.+.+-+.....+.-..+++++|+.--+|||    ||
T Consensus       288 dK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~  363 (829)
T KOG0576|consen  288 DKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NI  363 (829)
T ss_pred             HHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cc
Confidence            4679999 778788888888999999999887 2222111 111233344455556668899999998878998    77


Q ss_pred             EEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK  158 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~  158 (381)
                      +..+ +..|..||+......... ...+..+++.++|||+.....++ .+.|.||+|+--.+|--|.+|-..+-..  ..
T Consensus       364 l~s~-~~~~~~~~~v~~~L~~~~-~~~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P~~~--~~  438 (829)
T KOG0576|consen  364 LGSE-EEVKLLDFAVPPQLTRTM-KPRTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSPPAV--LP  438 (829)
T ss_pred             cccc-cccccccccCCcccCccc-ccccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCCccc--cC
Confidence            7655 778999999887665432 35677899999999999888887 7899999998777777787776442110  00


Q ss_pred             HhhcccCCC------CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 016865          159 KINAAEFSC------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  207 (381)
Q Consensus       159 ~i~~~~~~~------p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~  207 (381)
                      .+..+ ...      ..|-+..-+++-..|+..-|..|++...++.|.+|.....
T Consensus       439 ~~g~~-p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl  492 (829)
T KOG0576|consen  439 MIGNG-PNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPL  492 (829)
T ss_pred             CCCCC-CCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence            01000 001      1122222335888999999999999999999999976543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.21  E-value=2.8e-06  Score=76.33  Aligned_cols=67  Identities=25%  Similarity=0.515  Sum_probs=53.0

Q ss_pred             CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCCCEEEeeccCcc
Q 016865           20 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA   95 (381)
Q Consensus        20 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~   95 (381)
                      ...+++|||++|.+|.+..    .++++    +...+.+++.-+|+.|++|+|..|.|+++++++ +++.||+..+
T Consensus       116 ~~~~ll~EYIeG~~l~d~~----~i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~  182 (229)
T PF06176_consen  116 SSYVLLMEYIEGVELNDIE----DIDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGKR  182 (229)
T ss_pred             eEEEEEEEEecCeecccch----hcCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECcccc
Confidence            3567899999998886642    13332    445677889999999999999999999999655 9999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.19  E-value=5.3e-08  Score=105.68  Aligned_cols=200  Identities=17%  Similarity=0.055  Sum_probs=150.5

Q ss_pred             CCCccccccceEEEE--eCCEEEEEEecCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----Ceec
Q 016865            3 IVRHPNIVRLHEVLA--SRTKVYIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHCHSKG-----VYHR   71 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~--~~~~~~lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~~L~~LH~~g-----i~Hr   71 (381)
                      ...|+++...+.-..  +....|.+++|+.+|.+++.|.+.    ..+.+.-+....++.+.+..-+|+..     .+|+
T Consensus      1285 ~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~ 1364 (2724)
T KOG1826|consen 1285 EAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSK 1364 (2724)
T ss_pred             hhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhh
Confidence            357888877766554  345689999999999999999763    23455556666667688888888652     7899


Q ss_pred             CCCCCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCC
Q 016865           72 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET  151 (381)
Q Consensus        72 Dlkp~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~  151 (381)
                      ++|+-|.++..+-++|++++|+.+.............+++.|++|++...-.+. .++|+|+.|+-+|+...|..+|-..
T Consensus      1365 ~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s~~ly~rs~~n~~fi~f 1443 (2724)
T KOG1826|consen 1365 SLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFT-KRSDILRRSLSLYLRSDGNAYFIFF 1443 (2724)
T ss_pred             hhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHHHHHHHHhcccHHHHHH
Confidence            999999999999999999999998544444556677889999999998766664 5699999999999999999988543


Q ss_pred             ChhHHHHHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          152 DLPTLYKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       152 ~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      ....+...+.++. .+.+...|.++......+|-..-..||.....+..|.|-
T Consensus      1444 lq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1444 LQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred             HHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence            3333333333332 345555566777777777777788899988888887764

>PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.06  E-value=1.3e-05  Score=53.84  Aligned_cols=43  Identities=21%  Similarity=0.431  Sum_probs=37.8

Q ss_pred             ccEEEEEEEEEEe-CCeEEEEEEccCCCchhHHHHHHHHHHhcc
Q 016865          321 GQFAVVLEVFEVA-PSLFMVDVRKAAGDTLEYHKFYKNFCAKLE  363 (381)
Q Consensus       321 ~~l~~~~ei~~~~-~~~~~V~~~k~~Gd~le~~~~~~~l~~~l~  363 (381)
                      ..+.|.+||+++. ++++.|+|+|.+||.+.|+++|.+|...|+
T Consensus         3 ~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~lc~~il~~l~   46 (47)
T PF02149_consen    3 EVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKDLCSKILNELR   46 (47)
T ss_dssp             C-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHHHHHHHHHHTT
T ss_pred             cceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHHHHHHHHHHcc
Confidence            4588999999997 899999999999999999999999988774

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A.

>PRK09902 hypothetical protein; Provisional

Probab=97.96  E-value=3.4e-05  Score=69.06  Aligned_cols=75  Identities=13%  Similarity=0.121  Sum_probs=62.9

Q ss_pred             EEEEEEecCCC-CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCCC--EEEeeccCcc
Q 016865           21 KVYIILEFVTG-GELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN--LKVSDFGLSA   95 (381)
Q Consensus        21 ~~~lV~E~~~g-g~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~~--lkl~DFGls~   95 (381)
                      .-+||+|-+.| -+|.+.+...  .+.++.....++.++...+.-||+.|+.|+|+.+.||+++.+|.  ++++||--++
T Consensus        99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902         99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            47899997754 5788877552  34577777899999999999999999999999999999997777  9999998654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=97.78  E-value=5.9e-05  Score=69.52  Aligned_cols=74  Identities=22%  Similarity=0.413  Sum_probs=58.8

Q ss_pred             CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCCCEEEeeccCccCC
Q 016865           19 RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP   97 (381)
Q Consensus        19 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~   97 (381)
                      .+.-.+||||++|-.|...     +++.+.+..++..|+.-+.-.-..||+|+|+.+-||+++++|.+.++||--+...
T Consensus       179 ~nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         179 WNRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             cccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCcccccC
Confidence            4567899999999777542     2235566667777777777777999999999999999999999999999866543

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.57  E-value=0.00014  Score=64.43  Aligned_cols=91  Identities=16%  Similarity=0.249  Sum_probs=71.7

Q ss_pred             CCCc-cccccceEEEEeCCEEEEEEecCCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCC
Q 016865            3 IVRH-PNIVRLHEVLASRTKVYIILEFVTGGELFDK---IVHQGRLLENDCRRYFQQLIDAVAHCHS---KGVYHRDLKP   75 (381)
Q Consensus         3 ~l~H-pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~---i~~~~~l~e~~~~~~~~qll~~L~~LH~---~gi~HrDlkp   75 (381)
                      .+.+ +++.+++|+|-    -++|.||...+++...   +..-..-++.....++.|++..++++++   ..+.-.|++|
T Consensus        15 ~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~   90 (188)
T PF12260_consen   15 LLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSP   90 (188)
T ss_pred             HcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecch
Confidence            4444 59999999983    3578999987766431   1122345788999999999999999997   4588899999


Q ss_pred             CcEEEccCCCEEEeeccCccCC
Q 016865           76 ENLLLDSYGNLKVSDFGLSALP   97 (381)
Q Consensus        76 ~NiLl~~~~~lkl~DFGls~~~   97 (381)
                      +|+-++++|++|++|.......
T Consensus        91 ~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   91 DNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             HHeEEeCCCcEEEEechhcchh
Confidence            9999999999999999866543

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.28  E-value=0.00055  Score=68.29  Aligned_cols=153  Identities=22%  Similarity=0.280  Sum_probs=98.1

Q ss_pred             CCCCCccccccceEEEEeC-CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASR-TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~-~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      ++.+.|+|...++++.... ....+|||++ +-+|.|.+.... +-....       +       ..|+.|     .|  
T Consensus        36 lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~-------~-------~~~~~~-----~~--   92 (725)
T KOG1093|consen   36 LKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESL-------L-------AHGVLH-----LN--   92 (725)
T ss_pred             HHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhh-------c-------ccccce-----eh--
Confidence            4667899999999988755 4588999999 459988876643 211111       0       112211     11  


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                           .++++| -+++.                |  |-.      .+.++||||+|.|+.++.-|...|......+....
T Consensus        93 -----~~~~td-~~~t~----------------~--~~~------~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~  142 (725)
T KOG1093|consen   93 -----IIYITD-HFLTK----------------Y--PSP------IGPKSDVWSLGFIILELYLGISLEAELTESEYLEI  142 (725)
T ss_pred             -----hhhccc-ccccc----------------C--CCC------CCcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHH
Confidence                 223333 00000                0  111      12489999999999999999988876655444443


Q ss_pred             hhcccCCCC------------CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          160 INAAEFSCP------------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       160 i~~~~~~~p------------~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      +.+-....-            ..++....++..+|+-..|..||...++.+++-|...+
T Consensus       143 i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~  201 (725)
T KOG1093|consen  143 LLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVY  201 (725)
T ss_pred             HHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHH
Confidence            332221110            11567788999999999999999999999999987654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.25  E-value=0.0021  Score=58.61  Aligned_cols=29  Identities=24%  Similarity=0.261  Sum_probs=25.7

Q ss_pred             CCeecCCCCCcEEEccCCCEEEeeccCccC
Q 016865           67 GVYHRDLKPENLLLDSYGNLKVSDFGLSAL   96 (381)
Q Consensus        67 gi~HrDlkp~NiLl~~~~~lkl~DFGls~~   96 (381)
                      .++|+|+.|.||++++++ +.|+||+.+..
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            478999999999999888 99999997654

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.22  E-value=0.00071  Score=61.81  Aligned_cols=77  Identities=14%  Similarity=0.258  Sum_probs=57.4

Q ss_pred             EEEEEEecCCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEccCCCEEEeeccCccCCC
Q 016865           21 KVYIILEFVTGG-ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ   98 (381)
Q Consensus        21 ~~~lV~E~~~gg-~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~   98 (381)
                      .-.|||||+... .-.-.+. +.++..+++..+..+++..+.-|-. .|++|+||..-|||+. ++.+.|+|||-|....
T Consensus       140 ~nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         140 NNVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             CCeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence            346999999442 1111111 1223344789999999999998887 8999999999999999 8899999999876554


Q ss_pred             C
Q 016865           99 Q   99 (381)
Q Consensus        99 ~   99 (381)
                      +
T Consensus       218 h  218 (268)
T COG1718         218 H  218 (268)
T ss_pred             C
Confidence            3

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.08  E-value=0.001  Score=67.75  Aligned_cols=73  Identities=26%  Similarity=0.461  Sum_probs=55.4

Q ss_pred             CCEEEEEEecCCCCChHHHH--HhcCCCC-----HHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCCCEEEeec
Q 016865           19 RTKVYIILEFVTGGELFDKI--VHQGRLL-----ENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDF   91 (381)
Q Consensus        19 ~~~~~lV~E~~~gg~L~~~i--~~~~~l~-----e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~~lkl~DF   91 (381)
                      .+.-.|+|||++|-.+.+..  .. .+.+     +.-+..++.|++       ..|++|.|..|.||+++.+|.+.+.||
T Consensus       238 t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~~-------~dgffHaDpHpGNi~v~~~g~i~~lDf  309 (517)
T COG0661         238 TTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQLL-------RDGFFHADPHPGNILVRSDGRIVLLDF  309 (517)
T ss_pred             cCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHHH-------hcCccccCCCccceEEecCCcEEEEcC
Confidence            45678999999998887764  33 3444     333444444443       389999999999999999999999999


Q ss_pred             cCccCCCC
Q 016865           92 GLSALPQQ   99 (381)
Q Consensus        92 Gls~~~~~   99 (381)
                      |+......
T Consensus       310 Gi~g~l~~  317 (517)
T COG0661         310 GIVGRLDP  317 (517)
T ss_pred             cceecCCH
Confidence            99876554

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.06  E-value=0.0023  Score=58.67  Aligned_cols=30  Identities=23%  Similarity=0.175  Sum_probs=26.5

Q ss_pred             CCeecCCCCCcEEEccCCCEEEeeccCccC
Q 016865           67 GVYHRDLKPENLLLDSYGNLKVSDFGLSAL   96 (381)
Q Consensus        67 gi~HrDlkp~NiLl~~~~~lkl~DFGls~~   96 (381)
                      .++|+|+.|.|||+++++...|+||+.+..
T Consensus       164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         164 VVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             EEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            489999999999999987788999997654

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=96.69  E-value=0.015  Score=51.94  Aligned_cols=86  Identities=22%  Similarity=0.279  Sum_probs=64.6

Q ss_pred             CCCccccccceEEEEeCCEEEEEEecCCC------CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 016865            3 IVRHPNIVRLHEVLASRTKVYIILEFVTG------GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE   76 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~g------g~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~   76 (381)
                      ...+.+|.++||+.+++...-+|+|....      -+|.+++.. +.+++    .+...+-.-..||-+.+|+.+|++|.
T Consensus        73 ~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~  147 (199)
T PF10707_consen   73 GVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE----ELRQALDEFKRYLLDHHIVIRDLNPH  147 (199)
T ss_pred             CCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH----HHHHHHHHHHHHHHHcCCeecCCCcc
Confidence            34688999999999999999999998642      357777754 45655    33344455567889999999999999


Q ss_pred             cEEEccCC----CEEEee-ccC
Q 016865           77 NLLLDSYG----NLKVSD-FGL   93 (381)
Q Consensus        77 NiLl~~~~----~lkl~D-FGl   93 (381)
                      ||++..++    .+.|+| ||-
T Consensus       148 NIv~~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  148 NIVVQRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             cEEEEecCCCceEEEEEeCCCC
Confidence            99997543    477777 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=96.61  E-value=0.0053  Score=55.10  Aligned_cols=30  Identities=37%  Similarity=0.592  Sum_probs=21.0

Q ss_pred             CCCeecCCCCCcEEEc-cCCCEEEeeccCcc
Q 016865           66 KGVYHRDLKPENLLLD-SYGNLKVSDFGLSA   95 (381)
Q Consensus        66 ~gi~HrDlkp~NiLl~-~~~~lkl~DFGls~   95 (381)
                      ..++|+|+.|.|||++ +++.+.|.||+.+.
T Consensus       166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             EEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             cEEEEeccccccceeeeccceeEEEecccce
Confidence            3599999999999999 66777899998653

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PLN02876 acyl-CoA dehydrogenase

Probab=96.36  E-value=0.0085  Score=65.05  Aligned_cols=33  Identities=30%  Similarity=0.549  Sum_probs=26.5

Q ss_pred             CCeecCCCCCcEEEccC-C-CEEEeeccCccCCCC
Q 016865           67 GVYHRDLKPENLLLDSY-G-NLKVSDFGLSALPQQ   99 (381)
Q Consensus        67 gi~HrDlkp~NiLl~~~-~-~lkl~DFGls~~~~~   99 (381)
                      .++|+|++|.|++++.+ + ..-|.||.++.....
T Consensus       226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~GdP  260 (822)
T PLN02876        226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGNQ  260 (822)
T ss_pred             ceEecCcccccEEEcCCCCeEEEEEeeeccccCCh
Confidence            49999999999999853 3 357999999876543

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.88  E-value=0.026  Score=54.50  Aligned_cols=72  Identities=26%  Similarity=0.348  Sum_probs=56.6

Q ss_pred             CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEEEccCCCEEEeeccCccCC
Q 016865           20 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALP   97 (381)
Q Consensus        20 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~-gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~   97 (381)
                      ...|++|++- |+.+. .+..   -..+++..++++.++-+.-+..+ ..-|||+.-.|||++ +|++.|+||-+++..
T Consensus       299 ~y~yl~~kdh-gt~is-~ik~---~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         299 LYLYLHFKDH-GTPIS-IIKA---DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             eEEEEEEecC-Cceee-eeec---ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence            4678888875 55553 2222   34678889999998888877765 689999999999999 999999999999853

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.65  E-value=0.034  Score=56.75  Aligned_cols=77  Identities=23%  Similarity=0.350  Sum_probs=51.4

Q ss_pred             CEEEEEEecCCCCChHH--HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEcc----CCCEEEeeccC
Q 016865           20 TKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS----YGNLKVSDFGL   93 (381)
Q Consensus        20 ~~~~lV~E~~~gg~L~~--~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~----~~~lkl~DFGl   93 (381)
                      +...|+|||++|..+.|  .|.+. +++...+...+.+...  +-+=..|.+|+|=.|.||++..    ++.+.+.|||+
T Consensus       275 t~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl  351 (538)
T KOG1235|consen  275 TKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAYL--EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGL  351 (538)
T ss_pred             cceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHHH--HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccc
Confidence            46789999999976654  34443 3444433222222111  1122478999999999999994    56899999999


Q ss_pred             ccCCCC
Q 016865           94 SALPQQ   99 (381)
Q Consensus        94 s~~~~~   99 (381)
                      ......
T Consensus       352 ~~~is~  357 (538)
T KOG1235|consen  352 YAVISH  357 (538)
T ss_pred             cccccH
Confidence            876654

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=95.63  E-value=0.011  Score=56.17  Aligned_cols=72  Identities=18%  Similarity=0.318  Sum_probs=56.1

Q ss_pred             eCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCCCEEEeeccCcc
Q 016865           18 SRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA   95 (381)
Q Consensus        18 ~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~   95 (381)
                      +.+.-++|||++.|..|...-.      ...+..+...++.-+--|-.+|+||+|.+--||++++++.++++||--..
T Consensus       179 D~~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  179 DHNRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             cccceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeechHhh
Confidence            3456789999999977754321      12344556667777778889999999999999999999999999997543

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=94.76  E-value=0.07  Score=51.09  Aligned_cols=33  Identities=30%  Similarity=0.450  Sum_probs=29.6

Q ss_pred             CCeecCCCCCcEEEccCCCEEEeeccCccCCCC
Q 016865           67 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ   99 (381)
Q Consensus        67 gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~   99 (381)
                      .++|+|+.+.|++++..+-+-+.||+++...+.
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            489999999999999998899999999887554

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=94.35  E-value=0.11  Score=46.38  Aligned_cols=75  Identities=28%  Similarity=0.348  Sum_probs=53.0

Q ss_pred             CCCCcccc--ccceEEEEeC------------------CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 016865            2 KIVRHPNI--VRLHEVLASR------------------TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA   61 (381)
Q Consensus         2 k~l~HpnI--v~l~~~~~~~------------------~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~   61 (381)
                      +.+++.++  |++|+++.=.                  ....||-||++...         .+    ...-+.++++-+.
T Consensus       112 ke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~----~~~~~~~~~~dl~  178 (207)
T PF13095_consen  112 KEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PL----QIRDIPQMLRDLK  178 (207)
T ss_pred             HhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------cc----chhHHHHHHHHHH
Confidence            34556666  7788877211                  13578888876643         12    2233567888889


Q ss_pred             HHHHCCCeecCCCCCcEEEccCCCEEEeeccCc
Q 016865           62 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS   94 (381)
Q Consensus        62 ~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls   94 (381)
                      .+|..||+-+|+++.|..     .=||+|||.+
T Consensus       179 ~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHKLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHCCeeeccCcccccc-----CCEEEecccC
Confidence            999999999999999986     4489999964

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=94.12  E-value=0.054  Score=49.38  Aligned_cols=31  Identities=35%  Similarity=0.450  Sum_probs=25.9

Q ss_pred             CCCeecCCCCCcEEEccCCCEEEeeccCccC
Q 016865           66 KGVYHRDLKPENLLLDSYGNLKVSDFGLSAL   96 (381)
Q Consensus        66 ~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~   96 (381)
                      .+++|+|+.|.|+++++.+..-|.||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            3589999999999998766567999998754

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=94.11  E-value=0.088  Score=50.11  Aligned_cols=30  Identities=40%  Similarity=0.610  Sum_probs=26.9

Q ss_pred             CCCeecCCCCCcEEEccCCCEEEeeccCcc
Q 016865           66 KGVYHRDLKPENLLLDSYGNLKVSDFGLSA   95 (381)
Q Consensus        66 ~gi~HrDlkp~NiLl~~~~~lkl~DFGls~   95 (381)
                      .+++|+|+.+.|+++++++...|.||+.+.
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            689999999999999998877899999764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=93.97  E-value=0.12  Score=49.10  Aligned_cols=29  Identities=31%  Similarity=0.560  Sum_probs=25.3

Q ss_pred             CCCeecCCCCCcEEEccCCCEEEeeccCcc
Q 016865           66 KGVYHRDLKPENLLLDSYGNLKVSDFGLSA   95 (381)
Q Consensus        66 ~gi~HrDlkp~NiLl~~~~~lkl~DFGls~   95 (381)
                      .+++|+|+.+.||+++. +.+.|.||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            57899999999999998 678999999643

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK05231 homoserine kinase; Provisional

Probab=93.44  E-value=0.15  Score=48.69  Aligned_cols=30  Identities=30%  Similarity=0.433  Sum_probs=25.8

Q ss_pred             CCCeecCCCCCcEEEccCCCEEEeeccCcc
Q 016865           66 KGVYHRDLKPENLLLDSYGNLKVSDFGLSA   95 (381)
Q Consensus        66 ~gi~HrDlkp~NiLl~~~~~lkl~DFGls~   95 (381)
                      .|++|+|+.|.||+++++...-|.||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            489999999999999976656899999764

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=93.30  E-value=0.094  Score=47.58  Aligned_cols=30  Identities=20%  Similarity=0.376  Sum_probs=26.4

Q ss_pred             CCeecCCCCCcEEEcc-CCCEEEeeccCccC
Q 016865           67 GVYHRDLKPENLLLDS-YGNLKVSDFGLSAL   96 (381)
Q Consensus        67 gi~HrDlkp~NiLl~~-~~~lkl~DFGls~~   96 (381)
                      +++|+|+.|.|||+++ ++.+.++||..|..
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            5999999999999998 57899999987653

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=93.30  E-value=0.17  Score=47.94  Aligned_cols=29  Identities=31%  Similarity=0.403  Sum_probs=26.1

Q ss_pred             CCeecCCCCCcEEEccC----CCEEEeeccCcc
Q 016865           67 GVYHRDLKPENLLLDSY----GNLKVSDFGLSA   95 (381)
Q Consensus        67 gi~HrDlkp~NiLl~~~----~~lkl~DFGls~   95 (381)
                      +++|+|+.|.|||++++    +.+.++||..|.
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            58999999999999985    889999999765

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK10271 thiK thiamine kinase; Provisional

Probab=93.18  E-value=0.089  Score=46.40  Aligned_cols=30  Identities=23%  Similarity=0.381  Sum_probs=26.2

Q ss_pred             CeecCCCCCcEEEccCCCEEEeeccCccCCC
Q 016865           68 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQ   98 (381)
Q Consensus        68 i~HrDlkp~NiLl~~~~~lkl~DFGls~~~~   98 (381)
                      .+|+|+.|.|++++++| ++++||+.+....
T Consensus        79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~gD  108 (188)
T PRK10271         79 PLHMDVHAGNLVHSASG-LRLIDWEYAGDGD  108 (188)
T ss_pred             eecCCCCCccEEEECCC-EEEEeCCcccCCC
Confidence            69999999999998877 9999999886543

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=92.92  E-value=0.17  Score=47.72  Aligned_cols=30  Identities=37%  Similarity=0.494  Sum_probs=26.5

Q ss_pred             CCCeecCCCCCcEEEccCCCEEEeeccCcc
Q 016865           66 KGVYHRDLKPENLLLDSYGNLKVSDFGLSA   95 (381)
Q Consensus        66 ~gi~HrDlkp~NiLl~~~~~lkl~DFGls~   95 (381)
                      .+++|+|+.|.|+++++++.+.|.||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            479999999999999997777899998654

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK10593 hypothetical protein; Provisional

Probab=92.26  E-value=0.43  Score=45.34  Aligned_cols=26  Identities=19%  Similarity=0.291  Sum_probs=20.3

Q ss_pred             CCeecCCCCCcEEEccC-CC-EEEeecc
Q 016865           67 GVYHRDLKPENLLLDSY-GN-LKVSDFG   92 (381)
Q Consensus        67 gi~HrDlkp~NiLl~~~-~~-lkl~DFG   92 (381)
                      .++|||+.+.|++++.+ +. +.|.|..
T Consensus       194 sLlHGDlw~gNvl~~~~~~~i~~liDPa  221 (297)
T PRK10593        194 VLVHGNFTLRSMLKDPRSDQLLAMLNPG  221 (297)
T ss_pred             eeEeCCCCcccEEECCCCCceEEEECch
Confidence            47999999999999865 33 5677765

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=92.23  E-value=0.12  Score=46.77  Aligned_cols=37  Identities=32%  Similarity=0.538  Sum_probs=32.1

Q ss_pred             HHHHHHHHH--CCCeecCCCCCcEEEccCCCEEEeeccC
Q 016865           57 IDAVAHCHS--KGVYHRDLKPENLLLDSYGNLKVSDFGL   93 (381)
Q Consensus        57 l~~L~~LH~--~gi~HrDlkp~NiLl~~~~~lkl~DFGl   93 (381)
                      +.+|.-.|+  .+.+|+|..|+||+-|..|.+||.|-+.
T Consensus       151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence            566778884  4799999999999999999999999763

The function of this family is unknown.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=91.64  E-value=0.15  Score=47.07  Aligned_cols=30  Identities=27%  Similarity=0.398  Sum_probs=26.1

Q ss_pred             CCeecCCCCCcEEEccCCCEEEeeccCccCC
Q 016865           67 GVYHRDLKPENLLLDSYGNLKVSDFGLSALP   97 (381)
Q Consensus        67 gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~   97 (381)
                      .++|+|+.|.||++++++ +.++||..+...
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYASDG  176 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccCcC
Confidence            489999999999999877 789999987653

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=91.58  E-value=0.3  Score=45.70  Aligned_cols=31  Identities=39%  Similarity=0.550  Sum_probs=27.9

Q ss_pred             CCeecCCCCCcEEEccCCCEEEeeccCccCC
Q 016865           67 GVYHRDLKPENLLLDSYGNLKVSDFGLSALP   97 (381)
Q Consensus        67 gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~   97 (381)
                      -++|+|+.|+|++.++.|.++|+||-.|...
T Consensus       154 v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~~  184 (269)
T COG0510         154 VPCHNDLNPGNLLLTDKGGLFLIDWEYAGLN  184 (269)
T ss_pred             eeecCCCCccceEEcCCCcEEEEecccCCCc
Confidence            4899999999999999999999999877643

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=91.18  E-value=0.46  Score=42.09  Aligned_cols=31  Identities=26%  Similarity=0.392  Sum_probs=25.6

Q ss_pred             CCCeecCCCCCcEEEccCC-----CEEEeeccCccC
Q 016865           66 KGVYHRDLKPENLLLDSYG-----NLKVSDFGLSAL   96 (381)
Q Consensus        66 ~gi~HrDlkp~NiLl~~~~-----~lkl~DFGls~~   96 (381)
                      ..++|||+.+.|+++..++     .+.+.||..+..
T Consensus       120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~  155 (196)
T smart00587      120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY  155 (196)
T ss_pred             eEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence            4689999999999998543     589999997653

subfamily of choline kinases

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=90.97  E-value=0.19  Score=48.34  Aligned_cols=76  Identities=18%  Similarity=0.233  Sum_probs=43.6

Q ss_pred             EEEEecCCC--CChHHHHHhcCCCC--HHHHHHHHHHHHHHHHHH---H-HCCCeecCCCCCcEEEccCCC---------
Q 016865           23 YIILEFVTG--GELFDKIVHQGRLL--ENDCRRYFQQLIDAVAHC---H-SKGVYHRDLKPENLLLDSYGN---------   85 (381)
Q Consensus        23 ~lV~E~~~g--g~L~~~i~~~~~l~--e~~~~~~~~qll~~L~~L---H-~~gi~HrDlkp~NiLl~~~~~---------   85 (381)
                      .||+.++..  ..+.......-++.  .+-.+.++.|++.-.--+   - -.+.+|-||||.|||+-++..         
T Consensus       247 IIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~  326 (434)
T PF05445_consen  247 IIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNR  326 (434)
T ss_pred             EEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCe
Confidence            477877643  22222222222222  344666777774332112   1 346999999999999965432         


Q ss_pred             ---------EEEeeccCccCCC
Q 016865           86 ---------LKVSDFGLSALPQ   98 (381)
Q Consensus        86 ---------lkl~DFGls~~~~   98 (381)
                               .++.||.+|...+
T Consensus       327 ~~vF~Epi~~~LnDFDfSqv~~  348 (434)
T PF05445_consen  327 NYVFKEPIRCCLNDFDFSQVAN  348 (434)
T ss_pred             EEEecccceeeecccCHHHhcc
Confidence                     5777888776544

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=90.94  E-value=1.2  Score=44.21  Aligned_cols=28  Identities=21%  Similarity=0.355  Sum_probs=23.7

Q ss_pred             CCCeecCCCCCcEEEccCCCEEEeeccCc
Q 016865           66 KGVYHRDLKPENLLLDSYGNLKVSDFGLS   94 (381)
Q Consensus        66 ~gi~HrDlkp~NiLl~~~~~lkl~DFGls   94 (381)
                      ..++|||+.|.|||+..+ .++++||-++
T Consensus       223 ~~l~HgDl~~gni~~~~~-~~~viD~E~a  250 (401)
T PRK09550        223 EALLHGDLHTGSIFVTEE-ETKVIDPEFA  250 (401)
T ss_pred             CceeeccCCcccEEeeCC-CcEEEecccc
Confidence            458999999999999775 5899998754

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=90.75  E-value=0.14  Score=45.74  Aligned_cols=30  Identities=33%  Similarity=0.632  Sum_probs=21.4

Q ss_pred             CCeecCCCCCcEEE-ccCCCEEEeeccCccC
Q 016865           67 GVYHRDLKPENLLL-DSYGNLKVSDFGLSAL   96 (381)
Q Consensus        67 gi~HrDlkp~NiLl-~~~~~lkl~DFGls~~   96 (381)
                      .++|+|+.|.|||+ +.++.++++||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            48999999999999 8889999999998753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PHA03111 Ser/Thr kinase; Provisional

Probab=90.58  E-value=0.3  Score=46.79  Aligned_cols=64  Identities=19%  Similarity=0.190  Sum_probs=37.4

Q ss_pred             EEEEEEecCCC--CChHH-HHHhcCCCC-HHHHHHHHHHHHHHHHHHH----HCCCeecCCCCCcEEEccCC
Q 016865           21 KVYIILEFVTG--GELFD-KIVHQGRLL-ENDCRRYFQQLIDAVAHCH----SKGVYHRDLKPENLLLDSYG   84 (381)
Q Consensus        21 ~~~lV~E~~~g--g~L~~-~i~~~~~l~-e~~~~~~~~qll~~L~~LH----~~gi~HrDlkp~NiLl~~~~   84 (381)
                      .-.||+.++..  ..+.. .+...|-.+ .+-.+.++.|++.-.-.+-    ..+.+|-||||.|||+-++.
T Consensus       249 GnIIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~  320 (444)
T PHA03111        249 GNIIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSD  320 (444)
T ss_pred             CcEEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCC
Confidence            34577777543  22222 222223223 3456777888865442331    24699999999999996554

>PLN02236 choline kinase

Probab=90.39  E-value=0.33  Score=47.12  Aligned_cols=29  Identities=24%  Similarity=0.554  Sum_probs=25.5

Q ss_pred             CCeecCCCCCcEEEcc-CCCEEEeeccCcc
Q 016865           67 GVYHRDLKPENLLLDS-YGNLKVSDFGLSA   95 (381)
Q Consensus        67 gi~HrDlkp~NiLl~~-~~~lkl~DFGls~   95 (381)
                      .++|+|+++.|||+++ ++.+.++||..+.
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            5899999999999986 4689999998765

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=90.09  E-value=0.48  Score=45.16  Aligned_cols=30  Identities=17%  Similarity=0.189  Sum_probs=27.2

Q ss_pred             CCeecCCCCCcEEEccCCCEEEeeccCccC
Q 016865           67 GVYHRDLKPENLLLDSYGNLKVSDFGLSAL   96 (381)
Q Consensus        67 gi~HrDlkp~NiLl~~~~~lkl~DFGls~~   96 (381)
                      +++|+|+.+.|+|+++++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            799999999999999999999999987653

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=90.04  E-value=0.27  Score=46.22  Aligned_cols=31  Identities=23%  Similarity=0.379  Sum_probs=25.8

Q ss_pred             CCeecCCCCCcEEEccCCC-EEEeeccCccCC
Q 016865           67 GVYHRDLKPENLLLDSYGN-LKVSDFGLSALP   97 (381)
Q Consensus        67 gi~HrDlkp~NiLl~~~~~-lkl~DFGls~~~   97 (381)
                      .++|+|+.|.||++++++. .-|.||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            4899999999999997565 469999987653

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=89.21  E-value=0.55  Score=45.30  Aligned_cols=28  Identities=32%  Similarity=0.555  Sum_probs=25.0

Q ss_pred             CeecCCCCCcEEEccCCC-EEEeeccCcc
Q 016865           68 VYHRDLKPENLLLDSYGN-LKVSDFGLSA   95 (381)
Q Consensus        68 i~HrDlkp~NiLl~~~~~-lkl~DFGls~   95 (381)
                      +||+|+.|.||+++.+.. ..+.|||-+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            999999999999998885 8999999653

>PRK06148 hypothetical protein; Provisional

Probab=86.02  E-value=1  Score=50.23  Aligned_cols=31  Identities=29%  Similarity=0.440  Sum_probs=26.1

Q ss_pred             CCCeecCCCCCcEEEccCC--CEE-EeeccCccC
Q 016865           66 KGVYHRDLKPENLLLDSYG--NLK-VSDFGLSAL   96 (381)
Q Consensus        66 ~gi~HrDlkp~NiLl~~~~--~lk-l~DFGls~~   96 (381)
                      .++||+|+.+.|||++.++  .+. |+|||-+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            5799999999999999875  555 999997654

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=85.51  E-value=1.4  Score=42.52  Aligned_cols=28  Identities=36%  Similarity=0.533  Sum_probs=24.7

Q ss_pred             CeecCCCCCcEEEcc-CCCEEEeeccCcc
Q 016865           68 VYHRDLKPENLLLDS-YGNLKVSDFGLSA   95 (381)
Q Consensus        68 i~HrDlkp~NiLl~~-~~~lkl~DFGls~   95 (381)
                      .+|+|+.|.|||+++ ++.++++||..|.
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            799999999999975 4789999999764

>PRK11768 serine/threonine protein kinase; Provisional

Probab=85.26  E-value=1.3  Score=42.55  Aligned_cols=28  Identities=21%  Similarity=0.181  Sum_probs=23.7

Q ss_pred             CCCeecCCCCCcEEEccCCCEEEeeccCcc
Q 016865           66 KGVYHRDLKPENLLLDSYGNLKVSDFGLSA   95 (381)
Q Consensus        66 ~gi~HrDlkp~NiLl~~~~~lkl~DFGls~   95 (381)
                      .+++|+|+.|.|||++ + .+.|.||+-+.
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            4689999999999995 3 57899999764

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=84.42  E-value=2.4  Score=41.49  Aligned_cols=78  Identities=21%  Similarity=0.281  Sum_probs=57.0

Q ss_pred             EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCcEEEccCCCEEEeeccCccCCCC
Q 016865           21 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH-SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ   99 (381)
Q Consensus        21 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH-~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~   99 (381)
                      .-.|||+++.+..-..=...+..++...+..+-.|++.-+.-|- .++.+|.||.--|+|+.+ |.+.|+|.+-|--...
T Consensus       238 ~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G~lyiIDVSQSVE~DH  316 (520)
T KOG2270|consen  238 NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-GKLYIIDVSQSVEHDH  316 (520)
T ss_pred             cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-CEEEEEEccccccCCC
Confidence            35699999953211111122345778889999999988887764 679999999999999875 8899999987765443

>PRK06149 hypothetical protein; Provisional

Probab=84.37  E-value=1.1  Score=49.67  Aligned_cols=31  Identities=26%  Similarity=0.280  Sum_probs=25.3

Q ss_pred             HCCCeecCCCCCcEEEccC--CC---EEEeeccCcc
Q 016865           65 SKGVYHRDLKPENLLLDSY--GN---LKVSDFGLSA   95 (381)
Q Consensus        65 ~~gi~HrDlkp~NiLl~~~--~~---lkl~DFGls~   95 (381)
                      ..|+||+|+.+.||+++.+  +.   .-|+|||-+.
T Consensus       207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~  242 (972)
T PRK06149        207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV  242 (972)
T ss_pred             cccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence            3689999999999999965  23   3799999764

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	381
2ehb_D	143	The Structure Of The C-Terminal Domain Of The Prote		2e-57
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-57
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-56
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		9e-56
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-55
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-53
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-53
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-53
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-53
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-53
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-48
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		9e-48
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-48
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-48
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-47
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-47
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-47
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-46
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-45
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		7e-45
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-44
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-44
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-44
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-44
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-44
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		4e-44
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-44
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-43
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-43
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-43
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-43
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-43
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-43
3soa_A	444	Full-Length Human Camkii Length = 444		8e-43
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-42
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-42
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-42
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		8e-41
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-40
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-40
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-40
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-39
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-39
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-39
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-39
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-38
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-37
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-37
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-37
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-37
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-37
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-37
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-37
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-37
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-37
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-37
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-37
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-37
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-37
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-37
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-37
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-37
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-37
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-37
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-37
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-37
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-37
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-37
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-37
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-37
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-37
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-37
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-37
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-37
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-37
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-37
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-37
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-37
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-37
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-37
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-37
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-37
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-37
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		6e-37
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-37
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-37
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		7e-37
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-37
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-37
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		8e-37
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		9e-37
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-36
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-36
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-36
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-36
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-36
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-36
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-36
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-36
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-36
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-36
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-36
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-36
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-36
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-36
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-36
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-36
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-36
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-36
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-36
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		6e-36
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-36
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-35
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-35
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-35
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-35
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-35
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-35
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		6e-35
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-34
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-34
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		6e-34
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-34
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		8e-34
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-33
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-33
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-33
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-33
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-33
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-33
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-33
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-33
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-33
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-33
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-33
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-32
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-32
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-32
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-32
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-32
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-32
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-32
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-32
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-32
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-32
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-32
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-32
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-32
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-32
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-32
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-32
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		6e-32
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-32
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		7e-32
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		7e-32
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		8e-32
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		9e-32
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-31
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-31
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-31
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-31
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-31
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-31
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		7e-31
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		9e-31
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		9e-31
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-30
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-30
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-30
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-30
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-30
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-30
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-30
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-30
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-30
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-30
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-30
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-30
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-30
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-30
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-30
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-30
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-30
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-30
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-30
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-30
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-30
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-30
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-30
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-30
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-30
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-30
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-30
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-30
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-30
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-30
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-30
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-30
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-30
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-30
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-30
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-30
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-30
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-30
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-30
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-30
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		6e-30
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-30
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		7e-30
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		7e-30
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		7e-30
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		8e-30
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-30
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		9e-30
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-29
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-29
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-29
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-29
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-29
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-29
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-29
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-29
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-29
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-29
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-29
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-29
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-29
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		6e-29
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		7e-29
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		8e-29
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-28
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-28
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-28
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-28
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-28
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-28
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-28
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-28
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-28
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-27
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-27
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-27
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-27
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-27
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-27
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-27
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-27
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-27
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-27
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		7e-27
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		8e-27
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		9e-27
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		9e-27
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-26
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-26
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-26
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-26
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-26
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-26
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-26
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-26
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-26
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-26
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-26
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-26
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-26
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-25
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-25
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-25
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-25
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-25
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-25
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-25
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-25
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-25
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		6e-25
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-25
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-25
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		9e-25
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		9e-25
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-24
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-24
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-24
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-24
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-24
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-24
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-24
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-24
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-24
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-24
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-24
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-24
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-24
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-24
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-24
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-24
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-24
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		7e-24
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		7e-24
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		7e-24
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-23
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-23
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-23
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-23
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-21
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-21
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-21
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-21
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-21
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-21
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-21
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-21
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-21
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-21
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-21
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-21
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-21
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-21
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-21
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-21
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		4e-21
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		4e-21
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		5e-21
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		5e-21
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-21
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-21
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-21
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		6e-21
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		6e-21
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		7e-21
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		7e-21
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		8e-21
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		9e-21
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		9e-21
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-20
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-20
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-20
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-20
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-20
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-20
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-20
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-20
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-20
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-20
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-20
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-20
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-20
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-20
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-20
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-20
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-20
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-20
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		7e-20
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		7e-20
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-20
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-19
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-19
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-19
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-19
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-19
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-19
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-19
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-19
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-19
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-19
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-19
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-19
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-19
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-19
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-19
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-19
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-19
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-19
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-19
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-19
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-19
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-19
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-19
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-19
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-19
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-19
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-19
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-19
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-19
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-19
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-19
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-19
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-19
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-19
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-19
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-19
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-19
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-19
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-19
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		7e-19
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-19
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-19
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		8e-19
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-19
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		9e-19
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-18
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-18
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-18
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-18
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		1e-18
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-18
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-18
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-18
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-18
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-18
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		6e-18
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-17
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-17
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-17
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-17
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-17
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-17
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-17
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-17
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-17
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-17
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-17
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-17
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-17
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-17
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		6e-17
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		7e-17
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		9e-17
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-16
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-16
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-16
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-16
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		7e-16
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		8e-16
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-15
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-15
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-15
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-15
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-15
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-15
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-15
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		8e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		9e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		9e-15
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-14
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-14
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-14
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-14
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-14
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-14
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-14
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-14
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-14
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-14
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-14
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-14
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-14
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-14
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-14
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-14
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-14
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-14
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-14
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-14
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-14
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-14
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-14
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-14
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-14
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-14
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-14
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-14
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-14
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-14
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-14
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-14
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-14
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-14
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-14
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-14
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-14
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-14
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-14
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-14
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-14
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-14
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-14
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-14
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		5e-14
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-14
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		8e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		9e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		9e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-13
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-13
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-13
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-13
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-13
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-13
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-13
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-13
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-13
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-13
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-13
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-13
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-13
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-13
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-13
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-13
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-13
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-13
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-13
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-13
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-13
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-13
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		6e-13
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-13
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		7e-13
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		7e-13
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-13
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		7e-13
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		7e-13
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		7e-13
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-13
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		7e-13
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		7e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		7e-13
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-13
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		8e-13
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-13
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		8e-13
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		9e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		9e-13
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		9e-13
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-13
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-13
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		9e-13
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		9e-13
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-12
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-12
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-12
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-12
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-12
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-12
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-12
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-12
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-12
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-12
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-12
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-12
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-12
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-12
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-12
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-12
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-12
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-12
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-12
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-12
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-12
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-12
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-12
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-12
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-12
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-12
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-12
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-12
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-12
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-12
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-12
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-12
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-12
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-12
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-12
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-12
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-12
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-12
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-12
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-12
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-12
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-12
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-12
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-12
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-12
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-12
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-12
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-12
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-12
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-12
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-12
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-12
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		6e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		6e-12
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-12
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-12
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-12
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-12
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-12
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-12
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-12
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-12
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-12
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		7e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		7e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		7e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-12
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-11
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-11
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-11
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-11
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-11
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-11
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-11
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		3e-11
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		3e-11
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		3e-11
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		3e-11
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		3e-11
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		3e-11
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		3e-11
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		3e-11
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		3e-11
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		3e-11
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-11
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-11
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		3e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-11
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-11
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-11
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-11
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-11
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-11
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		4e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-11
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-11
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-11
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-11
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-11
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		5e-11
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-11
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		5e-11
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-11
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		5e-11
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		6e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		6e-11
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-11
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		6e-11
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		6e-11
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		6e-11
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		6e-11
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		6e-11
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-11
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		6e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-11
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-11
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		6e-11
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		7e-11
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-11
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-11
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		7e-11
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		8e-11
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		8e-11
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-10
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-10
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-10
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-10
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-10
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-10
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-10
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-10
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-10
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-10
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-10
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-10
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-10
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-10
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-10
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-10
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-10
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-10
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-10
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-10
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-10
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-10
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-10
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-10
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		8e-10
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		8e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		9e-10
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-10
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		9e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-09
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-09
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-09
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-09
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-09
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-09
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-09
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-09
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-09
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-09
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-09
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-09
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-09
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-09
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-09
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-09
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-09
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-09
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-09
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-09
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-09
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-09
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-09
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-09
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-09
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-09
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-09
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-09
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-09
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-09
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		3e-09
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-09
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-09
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-09
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-09
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-09
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-09
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-09
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		5e-09
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		5e-09
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		5e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-09
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-09
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		7e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-09
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		8e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		8e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-09
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		9e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		9e-09
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-08
2zfd_B	123	The Crystal Structure Of Plant Specific Calcium Bin		2e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-08
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-08
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-08
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-08
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-08
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-08
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		6e-08
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		6e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		7e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		8e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		8e-08
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		8e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		9e-08
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		9e-08
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-07
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-07
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-07
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-07
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-07
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-07
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-07
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-07
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-07
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-07
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-07
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-07
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-07
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-07
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-07
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-07
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-07
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-07
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-07
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-07
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-07
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-07
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-07
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		6e-07
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		6e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		6e-07
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		6e-07
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		6e-07
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-07
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-07
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		6e-07
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		7e-07
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-07
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		8e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		9e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		9e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		9e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		9e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		9e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-06
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-06
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-06
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		1e-06
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-06
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-06
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-06
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-06
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-06
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-06
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-06
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-06
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-06
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-06
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-06
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-06
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-06
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-06
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-06
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-06
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-06
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-06
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-06
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-06
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-06
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-06
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-06
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		5e-06
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		5e-06
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		6e-06
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		7e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		9e-06
3gni_B	389	Structure Of Strad And Mo25 Length = 389		9e-06
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		9e-06
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-05
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-05
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-05
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		1e-05
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-05
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		1e-05
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-05
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		1e-05
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-05
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		2e-05
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-05
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-05
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-05
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		3e-05
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-05
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		4e-05
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-05
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-05
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-05
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		5e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-05
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-05
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		8e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-04
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-04
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-04
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-04
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-04
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-04
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-04
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-04
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-04

>pdb|2EHB|D Chain D, The Structure Of The C-Terminal Domain Of The Protein Kinase Atsos2 Bound To The Calcium Sensor Atsos3 Length = 143

Iteration: 1
 Score =  219 bits (557), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 103/140 (73%), Positives = 122/140 (87%), Gaps = 3/140 (2%)
Query: 244 GPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKV 303
           GPL+MNAFEMITLSQGLNL+ALFDRRQD+VKRQTRFVSR+    I++NIEAVA S+  K 
Sbjct: 3   GPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKS 62
Query: 304 HTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLE 363
           HTRN+KTRLEG+S+ K GQ AVV+E++EVAPSLFMVDVRKAAG+TLEYHKFYK  C+KLE
Sbjct: 63  HTRNFKTRLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSKLE 122
Query: 364 NIIWKPTEG---SSLLRTMS 380
           NIIW+ TEG   S +LRT++
Sbjct: 123 NIIWRATEGIPKSEILRTIT 142

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  217 bits (553), Expect = 8e-57,   Method: Compositional matrix adjust.
 Identities = 101/243 (41%), Positives = 159/243 (65%), Gaps = 15/243 (6%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K++RHP+I++L++V+ + T + +++E+  GGELFD IV + R+ E++ RR+FQQ+I A+
Sbjct: 63  LKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAI 121
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            +CH   + HRDLKPENLLLD   N+K++DFGLS +   G   L T+CG+PNY APEV++
Sbjct: 122 EYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVIN 180
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            + Y G   DVWSCG++L+V++ G LPF +  +P L+KK+N+  +  P + S GA SLI 
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIR 240
Query: 181 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSEN 240
           +++  +P  RI I+ IR+ PWF              VNL D     ++++  Y   +  +
Sbjct: 241 RMIVADPMQRITIQEIRRDPWF-------------NVNLPDYLRPMEEVQGSYADSRIVS 287
Query: 241 KVG 243
           K+G
Sbjct: 288 KLG 290

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  216 bits (550), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 96/205 (46%), Positives = 143/205 (69%), Gaps = 1/205 (0%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K+ RHP+I++L++V+++ T  ++++E+V+GGELFD I   GR+ E + RR FQQ++ AV
Sbjct: 65  LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAV 124
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            +CH   V HRDLKPEN+LLD++ N K++DFGLS +   G E L T+CG+PNY APEV+S
Sbjct: 125 DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVIS 183
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            R Y G   D+WSCGVIL+ L+ G LPF +  +PTL+KKI    F  P + +    +L+ 
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLM 243
Query: 181 KILDPNPKTRIRIEGIRKHPWFRKN 205
            +L  +P  R  I+ IR+H WF+++
Sbjct: 244 HMLQVDPLKRATIKDIREHEWFKQD 268

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  214 bits (544), Expect = 9e-56,   Method: Compositional matrix adjust.
 Identities = 95/205 (46%), Positives = 142/205 (69%), Gaps = 1/205 (0%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K+ RHP+I++L++V+++ T  ++++E+V+GGELFD I   GR+ E + RR FQQ++ AV
Sbjct: 65  LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAV 124
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            +CH   V HRDLKPEN+LLD++ N K++DFGLS +   G E L  +CG+PNY APEV+S
Sbjct: 125 DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRDSCGSPNYAAPEVIS 183
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            R Y G   D+WSCGVIL+ L+ G LPF +  +PTL+KKI    F  P + +    +L+ 
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLM 243
Query: 181 KILDPNPKTRIRIEGIRKHPWFRKN 205
            +L  +P  R  I+ IR+H WF+++
Sbjct: 244 HMLQVDPLKRATIKDIREHEWFKQD 268

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  211 bits (536), Expect = 7e-55,   Method: Compositional matrix adjust.
 Identities = 94/205 (45%), Positives = 141/205 (68%), Gaps = 1/205 (0%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K+ RHP+I++L++V+++ + +++++E+V+GGELFD I   GRL E + RR FQQ++  V
Sbjct: 70  LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGV 129
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            +CH   V HRDLKPEN+LLD++ N K++DFGLS +   G E L  +CG+PNY APEV+S
Sbjct: 130 DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRXSCGSPNYAAPEVIS 188
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            R Y G   D+WS GVIL+ L+ G LPF +  +PTL+KKI    F  P + +    SL+ 
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLK 248
Query: 181 KILDPNPKTRIRIEGIRKHPWFRKN 205
            +L  +P  R  I+ IR+H WF+++
Sbjct: 249 HMLQVDPMKRATIKDIREHEWFKQD 273

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  205 bits (521), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 92/203 (45%), Positives = 140/203 (68%), Gaps = 2/203 (0%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++++RHP+I++L++V+ S+ ++ +++E+  G ELFD IV + ++ E + RR+FQQ+I AV
Sbjct: 68  LRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAV 126
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            +CH   + HRDLKPENLLLD + N+K++DFGLS +   G   L T+CG+PNY APEV+S
Sbjct: 127 EYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVIS 185
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            + Y G   DVWSCGVIL+V++   LPF +  +P L+K I+   ++ P + S GA  LI 
Sbjct: 186 GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIK 245
Query: 181 KILDPNPKTRIRIEGIRKHPWFR 203
           ++L  NP  RI I  I +  WF+
Sbjct: 246 RMLIVNPLNRISIHEIMQDDWFK 268

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  205 bits (521), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 92/203 (45%), Positives = 140/203 (68%), Gaps = 2/203 (0%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++++RHP+I++L++V+ S+ ++ +++E+  G ELFD IV + ++ E + RR+FQQ+I AV
Sbjct: 67  LRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAV 125
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            +CH   + HRDLKPENLLLD + N+K++DFGLS +   G   L T+CG+PNY APEV+S
Sbjct: 126 EYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVIS 184
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            + Y G   DVWSCGVIL+V++   LPF +  +P L+K I+   ++ P + S GA  LI 
Sbjct: 185 GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIK 244
Query: 181 KILDPNPKTRIRIEGIRKHPWFR 203
           ++L  NP  RI I  I +  WF+
Sbjct: 245 RMLIVNPLNRISIHEIMQDDWFK 267

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  205 bits (521), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 92/203 (45%), Positives = 140/203 (68%), Gaps = 2/203 (0%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++++RHP+I++L++V+ S+ ++ +++E+  G ELFD IV + ++ E + RR+FQQ+I AV
Sbjct: 58  LRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAV 116
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            +CH   + HRDLKPENLLLD + N+K++DFGLS +   G   L T+CG+PNY APEV+S
Sbjct: 117 EYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVIS 175
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            + Y G   DVWSCGVIL+V++   LPF +  +P L+K I+   ++ P + S GA  LI 
Sbjct: 176 GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIK 235
Query: 181 KILDPNPKTRIRIEGIRKHPWFR 203
           ++L  NP  RI I  I +  WF+
Sbjct: 236 RMLIVNPLNRISIHEIMQDDWFK 258

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  204 bits (520), Expect = 5e-53,   Method: Compositional matrix adjust.
 Identities = 92/203 (45%), Positives = 140/203 (68%), Gaps = 2/203 (0%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++++RHP+I++L++V+ S+ ++ +++E+  G ELFD IV + ++ E + RR+FQQ+I AV
Sbjct: 62  LRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAV 120
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            +CH   + HRDLKPENLLLD + N+K++DFGLS +   G   L T+CG+PNY APEV+S
Sbjct: 121 EYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVIS 179
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            + Y G   DVWSCGVIL+V++   LPF +  +P L+K I+   ++ P + S GA  LI 
Sbjct: 180 GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIK 239
Query: 181 KILDPNPKTRIRIEGIRKHPWFR 203
           ++L  NP  RI I  I +  WF+
Sbjct: 240 RMLIVNPLNRISIHEIMQDDWFK 262

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  188 bits (478), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 93/223 (41%), Positives = 139/223 (62%), Gaps = 3/223 (1%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MKI+ HPNIV+L EV+ +   +Y+I+E+ +GGE+FD +V  GR+ E + R  F+Q++ AV
Sbjct: 65  MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAV 124
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            +CH K + HRDLK ENLLLD+  N+K++DFG S     G + L T CG+P Y APE+  
Sbjct: 125 QYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-LDTFCGSPPYAAPELFQ 183
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            + YDG   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ 
Sbjct: 184 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 243
Query: 181 KILDPNPKTRIRIEGIRKHPWFRKNY--NPVKCSEEEEVNLDD 221
           + L  NP  R  +E I K  W    +  + +K   E E+++ D
Sbjct: 244 RFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISD 286

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  187 bits (475), Expect = 9e-48,   Method: Compositional matrix adjust.
 Identities = 88/202 (43%), Positives = 129/202 (63%), Gaps = 1/202 (0%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MK++ HPNIV+L EV+ +   +Y+++E+ +GGE+FD +V  GR+ E + R  F+Q++ AV
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV 126
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            +CH K + HRDLK ENLLLD+  N+K++DFG S     G + L T CG+P Y APE+  
Sbjct: 127 QYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDTFCGSPPYAAPELFQ 185
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            + YDG   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ 
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 245
Query: 181 KILDPNPKTRIRIEGIRKHPWF 202
           K L  NP  R  +E I K  W 
Sbjct: 246 KFLILNPSKRGTLEQIMKDRWM 267

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  187 bits (475), Expect = 9e-48,   Method: Compositional matrix adjust.
 Identities = 88/202 (43%), Positives = 129/202 (63%), Gaps = 1/202 (0%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MK++ HPNIV+L EV+ +   +Y+++E+ +GGE+FD +V  GR+ E + R  F+Q++ AV
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV 126
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            +CH K + HRDLK ENLLLD+  N+K++DFG S     G + L T CG+P Y APE+  
Sbjct: 127 QYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDTFCGSPPYAAPELFQ 185
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            + YDG   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ 
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 245
Query: 181 KILDPNPKTRIRIEGIRKHPWF 202
           K L  NP  R  +E I K  W 
Sbjct: 246 KFLILNPSKRGTLEQIMKDRWM 267

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  187 bits (475), Expect = 9e-48,   Method: Compositional matrix adjust.
 Identities = 88/202 (43%), Positives = 129/202 (63%), Gaps = 1/202 (0%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MK++ HPNIV+L EV+ +   +Y+++E+ +GGE+FD +V  GR+ E + R  F+Q++ AV
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV 126
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            +CH K + HRDLK ENLLLD+  N+K++DFG S     G + L T CG+P Y APE+  
Sbjct: 127 QYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDTFCGSPPYAAPELFQ 185
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            + YDG   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ 
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 245
Query: 181 KILDPNPKTRIRIEGIRKHPWF 202
           K L  NP  R  +E I K  W 
Sbjct: 246 KFLILNPSKRGTLEQIMKDRWM 267

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  186 bits (472), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 92/223 (41%), Positives = 137/223 (61%), Gaps = 3/223 (1%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MKI+ HPNIV+L EV+ +   +Y+I+E+ +GGE+FD +V  GR+ E + R  F+Q++ AV
Sbjct: 68  MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAV 127
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            +CH K + HRDLK ENLLLD+  N+K++DFG S     G + L   CG P Y APE+  
Sbjct: 128 QYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-LDAFCGAPPYAAPELFQ 186
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            + YDG   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ 
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 246
Query: 181 KILDPNPKTRIRIEGIRKHPWFRKNY--NPVKCSEEEEVNLDD 221
           + L  NP  R  +E I K  W    +  + +K   E E+++ D
Sbjct: 247 RFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISD 289

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  185 bits (469), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 87/202 (43%), Positives = 128/202 (63%), Gaps = 1/202 (0%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MK++ HPNIV+L EV+ +   +Y+++E+ +GGE+FD +V  GR+ E + R  F+Q++ AV
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV 126
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            +CH K + HRDLK ENLLLD+  N+K++DFG S     G + L   CG+P Y APE+  
Sbjct: 127 QYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDEFCGSPPYAAPELFQ 185
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            + YDG   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ 
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 245
Query: 181 KILDPNPKTRIRIEGIRKHPWF 202
           K L  NP  R  +E I K  W 
Sbjct: 246 KFLILNPSKRGTLEQIMKDRWM 267

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  185 bits (469), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 87/202 (43%), Positives = 127/202 (62%), Gaps = 1/202 (0%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MK++ HPNIV+L EV+ +   +Y+++E+ +GGE+FD +V  GR+ E + R  F+Q++ AV
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV 126
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            +CH K + HRDLK ENLLLD+  N+K++DFG S     G + L   CG P Y APE+  
Sbjct: 127 QYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDAFCGAPPYAAPELFQ 185
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            + YDG   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ 
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 245
Query: 181 KILDPNPKTRIRIEGIRKHPWF 202
           K L  NP  R  +E I K  W 
Sbjct: 246 KFLILNPSKRGTLEQIMKDRWM 267

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  184 bits (466), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 87/202 (43%), Positives = 128/202 (63%), Gaps = 1/202 (0%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MK++ HPNIV+L EV+ +   +Y+++E+ +GGE+FD +V  G + E + R  F+Q++ AV
Sbjct: 60  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAV 119
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            +CH K + HRDLK ENLLLD+  N+K++DFG S     G + L T CG+P Y APE+  
Sbjct: 120 QYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDTFCGSPPYAAPELFQ 178
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            + YDG   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ 
Sbjct: 179 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 238
Query: 181 KILDPNPKTRIRIEGIRKHPWF 202
           K L  NP  R  +E I K  W 
Sbjct: 239 KFLILNPSKRGTLEQIMKDRWM 260

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 86/200 (43%), Positives = 124/200 (62%), Gaps = 1/200 (0%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           K++ HPNIV+L EV+ +   +Y++ E+ +GGE+FD +V  GR  E + R  F+Q++ AV 
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQ 127
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 121
           +CH K + HRDLK ENLLLD+  N+K++DFG S     G + L   CG P Y APE+   
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNK-LDAFCGAPPYAAPELFQG 186
Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK 181
           + YDG   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ K
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYXSTDCENLLKK 246
Query: 182 ILDPNPKTRIRIEGIRKHPW 201
            L  NP  R  +E I K  W
Sbjct: 247 FLILNPSKRGTLEQIXKDRW 266

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  177 bits (450), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 93/217 (42%), Positives = 135/217 (62%), Gaps = 7/217 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MKI+ HPNIV+L EV+ +   +Y+++E+ +GGE+FD +V  GR+ E + R  F+Q++ AV
Sbjct: 68  MKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV 127
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            +CH K + HRDLK ENLLLD   N+K++DFG S     G + L T CG+P Y APE+  
Sbjct: 128 QYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNK-LDTFCGSPPYAAPELFQ 186
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            + YDG   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ 
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 246
Query: 181 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEV 217
           K+L  NP  R  +E I K  W    +      EEEE+
Sbjct: 247 KLLVLNPIKRGSLEQIMKDRWMNVGH------EEEEL 277

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 95/214 (44%), Positives = 130/214 (60%), Gaps = 17/214 (7%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNIVR  EV+ + T + II+E+ +GGEL+++I + GR  E++ R +FQQL+  V++C
Sbjct: 73  LRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYC 132
Query: 64  HSKGVYHRDLKPENLLLDSY--GNLKVSDFGLSALPQQGVELLH----TTCGTPNYVAPE 117
           HS  + HRDLK EN LLD      LK+ DFG S        +LH    +T GTP Y+APE
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPE 187
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK----INAAEFSCP--FWF 171
           VL  + YDG  ADVWSCGV L+V++ G  PF + + P  Y+K    I + ++S P     
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRI 247
Query: 172 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
           S     LI +I   +P TRI I  I+ H WF KN
Sbjct: 248 SPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  176 bits (445), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 89/206 (43%), Positives = 125/206 (60%), Gaps = 9/206 (4%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           ++HPNIV L ++  S   +Y+I++ V+GGELFD+IV +G   E D  R   Q++DAV + 
Sbjct: 73  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 132
Query: 64  HSKGVYHRDLKPENLL---LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           H  G+ HRDLKPENLL   LD    + +SDFGLS +   G  +L T CGTP YVAPEVL+
Sbjct: 133 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLA 191
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGAT 176
            + Y   A D WS GVI ++L+ GY PF + +   L+++I  A  EF  P+W   S  A 
Sbjct: 192 QKPY-SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 250
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWF 202
             I  +++ +P+ R   E   +HPW 
Sbjct: 251 DFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 89/206 (43%), Positives = 125/206 (60%), Gaps = 9/206 (4%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           ++HPNIV L ++  S   +Y+I++ V+GGELFD+IV +G   E D  R   Q++DAV + 
Sbjct: 73  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 132
Query: 64  HSKGVYHRDLKPENLL---LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           H  G+ HRDLKPENLL   LD    + +SDFGLS +   G  +L T CGTP YVAPEVL+
Sbjct: 133 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLA 191
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGAT 176
            + Y   A D WS GVI ++L+ GY PF + +   L+++I  A  EF  P+W   S  A 
Sbjct: 192 QKPY-SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 250
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWF 202
             I  +++ +P+ R   E   +HPW 
Sbjct: 251 DFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 89/206 (43%), Positives = 125/206 (60%), Gaps = 9/206 (4%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           ++HPNIV L ++  S   +Y+I++ V+GGELFD+IV +G   E D  R   Q++DAV + 
Sbjct: 73  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 132
Query: 64  HSKGVYHRDLKPENLL---LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           H  G+ HRDLKPENLL   LD    + +SDFGLS +   G  +L T CGTP YVAPEVL+
Sbjct: 133 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLA 191
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGAT 176
            + Y   A D WS GVI ++L+ GY PF + +   L+++I  A  EF  P+W   S  A 
Sbjct: 192 QKPY-SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 250
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWF 202
             I  +++ +P+ R   E   +HPW 
Sbjct: 251 DFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 94/214 (43%), Positives = 129/214 (60%), Gaps = 17/214 (7%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNIVR  EV+ + T + I++E+ +GGELF++I + GR  E++ R +FQQLI  V++C
Sbjct: 71  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 130
Query: 64  HSKGVYHRDLKPENLLLDS--YGNLKVSDFGLSALPQQGVELLH----TTCGTPNYVAPE 117
           H+  V HRDLK EN LLD      LK+ DFG S        +LH    +T GTP Y+APE
Sbjct: 131 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPE 185
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK----INAAEFSCPFW--F 171
           VL  + YDG  ADVWSCGV L+V++ G  PF + + P  ++K    I   +++ P +   
Sbjct: 186 VLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHI 245
Query: 172 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
           S     LI +I   +P  RI I  IR H WF KN
Sbjct: 246 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 279

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 94/214 (43%), Positives = 129/214 (60%), Gaps = 17/214 (7%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNIVR  EV+ + T + I++E+ +GGELF++I + GR  E++ R +FQQLI  V++C
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 64  HSKGVYHRDLKPENLLLDS--YGNLKVSDFGLSALPQQGVELLH----TTCGTPNYVAPE 117
           H+  V HRDLK EN LLD      LK+ DFG S        +LH    +T GTP Y+APE
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPE 186
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK----INAAEFSCPFW--F 171
           VL  + YDG  ADVWSCGV L+V++ G  PF + + P  ++K    I   +++ P +   
Sbjct: 187 VLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHI 246
Query: 172 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
           S     LI +I   +P  RI I  IR H WF KN
Sbjct: 247 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 280

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 89/206 (43%), Positives = 125/206 (60%), Gaps = 9/206 (4%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           ++HPNIV L ++  S   +Y+I++ V+GGELFD+IV +G   E D  R   Q++DAV + 
Sbjct: 73  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 132
Query: 64  HSKGVYHRDLKPENLL---LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           H  G+ HRDLKPENLL   LD    + +SDFGLS +   G  +L T CGTP YVAPEVL+
Sbjct: 133 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLA 191
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGAT 176
            + Y   A D WS GVI ++L+ GY PF + +   L+++I  A  EF  P+W   S  A 
Sbjct: 192 QKPY-SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 250
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWF 202
             I  +++ +P+ R   E   +HPW 
Sbjct: 251 DFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 88/212 (41%), Positives = 122/212 (57%), Gaps = 10/212 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++H NIV L ++  S T  Y++++ V+GGELFD+I+ +G   E D     QQ++ AV
Sbjct: 60  LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAV 119
Query: 61  AHCHSKGVYHRDLKPENLLL---DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + H  G+ HRDLKPENLL    +    + ++DFGLS + Q G+  + T CGTP YVAPE
Sbjct: 120 KYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYVAPE 177
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FST 173
           VL+ + Y   A D WS GVI ++L+ GY PF E     L++KI     EF  PFW   S 
Sbjct: 178 VLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISE 236
Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
            A   I  +L+ +P  R   E    HPW   N
Sbjct: 237 SAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 92/223 (41%), Positives = 127/223 (56%), Gaps = 8/223 (3%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           ++++HPNIVRLH+ ++     Y+I + VTGGELF+ IV +    E D     QQ+++AV 
Sbjct: 76  RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVL 135
Query: 62  HCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
           HCH  GV HRDLKPENLLL S      +K++DFGL+   +   +      GTP Y++PEV
Sbjct: 136 HCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV 195
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTG 174
           L    Y G   D+W+CGVIL++L+ GY PF + D   LY++I A   +F  P W   +  
Sbjct: 196 LRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPE 254
Query: 175 ATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEV 217
           A  LI+K+L  NP  RI      KHPW         C   +E 
Sbjct: 255 AKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQET 297

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 92/214 (42%), Positives = 128/214 (59%), Gaps = 17/214 (7%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNIVR  EV+ + T + I++E+ +GGELF++I + GR  E++ R +FQQLI  V++ 
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYA 131
Query: 64  HSKGVYHRDLKPENLLLDS--YGNLKVSDFGLSALPQQGVELLH----TTCGTPNYVAPE 117
           H+  V HRDLK EN LLD      LK++DFG S        +LH    +  GTP Y+APE
Sbjct: 132 HAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSK-----ASVLHSQPKSAVGTPAYIAPE 186
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK----INAAEFSCPFW--F 171
           VL  + YDG  ADVWSCGV L+V++ G  PF + + P  ++K    I   +++ P +   
Sbjct: 187 VLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHI 246
Query: 172 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
           S     LI +I   +P  RI I  IR H WF KN
Sbjct: 247 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 280

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 93/214 (43%), Positives = 128/214 (59%), Gaps = 17/214 (7%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNIVR  EV+ + T + I++E+ +GGELF++I + GR  E++ R +FQQLI  V++C
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 64  HSKGVYHRDLKPENLLLDS--YGNLKVSDFGLSALPQQGVELLH----TTCGTPNYVAPE 117
           H+  V HRDLK EN LLD      LK+  FG S        +LH    +T GTP Y+APE
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK-----SSVLHSQPKSTVGTPAYIAPE 186
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK----INAAEFSCPFW--F 171
           VL  + YDG  ADVWSCGV L+V++ G  PF + + P  ++K    I   +++ P +   
Sbjct: 187 VLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHI 246
Query: 172 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
           S     LI +I   +P  RI I  IR H WF KN
Sbjct: 247 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 280

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 84/209 (40%), Positives = 126/209 (60%), Gaps = 9/209 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ ++H NIV L ++  S   +Y++++ V+GGELFD+IV +G   E D     +Q++DAV
Sbjct: 74  LRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAV 133
Query: 61  AHCHSKGVYHRDLKPENLLL---DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + H  G+ HRDLKPENLL    D    + +SDFGLS +  +G +++ T CGTP YVAPE
Sbjct: 134 YYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKG-DVMSTACGTPGYVAPE 192
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FST 173
           VL+ + Y   A D WS GVI ++L+ GY PF + +   L+++I  A  EF  P+W   S 
Sbjct: 193 VLAQKPY-SKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISD 251
Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWF 202
            A   I  +++ +P  R   E   +HPW 
Sbjct: 252 SAKDFIRNLMEKDPNKRYTCEQAARHPWI 280

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  171 bits (434), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 93/214 (43%), Positives = 128/214 (59%), Gaps = 17/214 (7%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNIVR  EV+ + T + I++E+ +GGELF++I + GR  E++ R +FQQLI  V++C
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 64  HSKGVYHRDLKPENLLLDS--YGNLKVSDFGLSALPQQGVELLHT----TCGTPNYVAPE 117
           H+  V HRDLK EN LLD      LK+  FG S        +LH+    T GTP Y+APE
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK-----SSVLHSQPKDTVGTPAYIAPE 186
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK----INAAEFSCPFW--F 171
           VL  + YDG  ADVWSCGV L+V++ G  PF + + P  ++K    I   +++ P +   
Sbjct: 187 VLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHI 246
Query: 172 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
           S     LI +I   +P  RI I  IR H WF KN
Sbjct: 247 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 280

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  171 bits (432), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 91/223 (40%), Positives = 127/223 (56%), Gaps = 8/223 (3%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           ++++HPNIVRLH+ ++     Y+I + VTGGELF+ IV +    E D     QQ+++AV 
Sbjct: 65  RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVL 124
Query: 62  HCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
           HCH  GV HR+LKPENLLL S      +K++DFGL+   +   +      GTP Y++PEV
Sbjct: 125 HCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV 184
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTG 174
           L    Y G   D+W+CGVIL++L+ GY PF + D   LY++I A   +F  P W   +  
Sbjct: 185 LRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPE 243
Query: 175 ATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEV 217
           A  LI+K+L  NP  RI      KHPW         C   +E 
Sbjct: 244 AKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQET 286

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 88/208 (42%), Positives = 124/208 (59%), Gaps = 8/208 (3%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           ++++HPNIVRLH+ ++     Y++ + VTGGELF+ IV +    E D     QQ++++V 
Sbjct: 58  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN 117
Query: 62  HCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
           HCH  G+ HRDLKPENLLL S      +K++DFGL+   Q   +      GTP Y++PEV
Sbjct: 118 HCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEV 177
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTG 174
           L    Y G   D+W+CGVIL++L+ GY PF + D   LY++I A   +F  P W   +  
Sbjct: 178 LRKDPY-GKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPE 236
Query: 175 ATSLIHKILDPNPKTRIRIEGIRKHPWF 202
           A  LI+K+L  NP  RI      KHPW 
Sbjct: 237 AKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 88/208 (42%), Positives = 124/208 (59%), Gaps = 8/208 (3%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           ++++HPNIVRLH+ ++     Y++ + VTGGELF+ IV +    E D     QQ++++V 
Sbjct: 58  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN 117
Query: 62  HCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
           HCH  G+ HRDLKPENLLL S      +K++DFGL+   Q   +      GTP Y++PEV
Sbjct: 118 HCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEV 177
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTG 174
           L    Y G   D+W+CGVIL++L+ GY PF + D   LY++I A   +F  P W   +  
Sbjct: 178 LRKDPY-GKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPE 236
Query: 175 ATSLIHKILDPNPKTRIRIEGIRKHPWF 202
           A  LI+K+L  NP  RI      KHPW 
Sbjct: 237 AKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 88/207 (42%), Positives = 124/207 (59%), Gaps = 8/207 (3%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           ++++H NIVRLH+ ++     Y++ + VTGGELF+ IV +    E D     QQ+++AV 
Sbjct: 58  RLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVL 117
Query: 62  HCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
           HCH  GV HRDLKPENLLL S      +K++DFGL+   Q   +      GTP Y++PEV
Sbjct: 118 HCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEV 177
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTG 174
           L    Y G   D+W+CGVIL++L+ GY PF + D   LY++I A   +F  P W   +  
Sbjct: 178 LRKEAY-GKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPE 236
Query: 175 ATSLIHKILDPNPKTRIRIEGIRKHPW 201
           A +LI+++L  NP  RI      KHPW
Sbjct: 237 AKNLINQMLTINPAKRITAHEALKHPW 263

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  164 bits (415), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 87/206 (42%), Positives = 123/206 (59%), Gaps = 9/206 (4%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           ++HPNIVRLH+ +   +  Y++ + VTGGELF+ IV +    E D     QQ+++++A+C
Sbjct: 85  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 144
Query: 64  HSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           HS G+ HR+LKPENLLL S      +K++DFGL A+     E  H   GTP Y++PEVL 
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGL-AIEVNDSEAWHGFAGTPGYLSPEVLK 203
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGAT 176
              Y     D+W+CGVIL++L+ GY PF + D   LY +I A   ++  P W   +  A 
Sbjct: 204 KDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 262
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWF 202
           SLI  +L  NPK RI  +   K PW 
Sbjct: 263 SLIDSMLTVNPKKRITADQALKVPWI 288

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 87/206 (42%), Positives = 123/206 (59%), Gaps = 9/206 (4%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           ++HPNIVRLH+ +   +  Y++ + VTGGELF+ IV +    E D     QQ+++++A+C
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 64  HSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           HS G+ HR+LKPENLLL S      +K++DFGL A+     E  H   GTP Y++PEVL 
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGL-AIEVNDSEAWHGFAGTPGYLSPEVLK 180
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGAT 176
              Y     D+W+CGVIL++L+ GY PF + D   LY +I A   ++  P W   +  A 
Sbjct: 181 KDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWF 202
           SLI  +L  NPK RI  +   K PW 
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 87/206 (42%), Positives = 123/206 (59%), Gaps = 9/206 (4%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           ++HPNIVRLH+ +   +  Y++ + VTGGELF+ IV +    E D     QQ+++++A+C
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 120
Query: 64  HSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           HS G+ HR+LKPENLLL S      +K++DFGL A+     E  H   GTP Y++PEVL 
Sbjct: 121 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGL-AIEVNDSEAWHGFAGTPGYLSPEVLK 179
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGAT 176
              Y     D+W+CGVIL++L+ GY PF + D   LY +I A   ++  P W   +  A 
Sbjct: 180 KDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 238
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWF 202
           SLI  +L  NPK RI  +   K PW 
Sbjct: 239 SLIDSMLTVNPKKRITADQALKVPWI 264

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 87/206 (42%), Positives = 123/206 (59%), Gaps = 9/206 (4%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           ++HPNIVRLH+ +   +  Y++ + VTGGELF+ IV +    E D     QQ+++++A+C
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 64  HSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           HS G+ HR+LKPENLLL S      +K++DFGL A+     E  H   GTP Y++PEVL 
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGL-AIEVNDSEAWHGFAGTPGYLSPEVLK 180
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGAT 176
              Y     D+W+CGVIL++L+ GY PF + D   LY +I A   ++  P W   +  A 
Sbjct: 181 KDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWF 202
           SLI  +L  NPK RI  +   K PW 
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 84/207 (40%), Positives = 123/207 (59%), Gaps = 8/207 (3%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           ++++HPNIVRLH+ ++     Y++ + VTGGELF+ IV +    E D      Q++++V 
Sbjct: 85  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVN 144
Query: 62  HCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
           H H   + HRDLKPENLLL S      +K++DFGL+   Q   +      GTP Y++PEV
Sbjct: 145 HIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEV 204
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTG 174
           L    Y G   D+W+CGVIL++L+ GY PF + D   LY++I A   +F  P W   +  
Sbjct: 205 LRKDPY-GKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPE 263
Query: 175 ATSLIHKILDPNPKTRIRIEGIRKHPW 201
           A +LI+++L  NP  RI  +   KHPW
Sbjct: 264 AKNLINQMLTINPAKRITADQALKHPW 290

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 84/206 (40%), Positives = 125/206 (60%), Gaps = 10/206 (4%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           + HPNI++L E+  + T++ ++LE VTGGELFD+IV +G   E D     +Q+++AVA+ 
Sbjct: 105 LSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYL 164
Query: 64  HSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           H  G+ HRDLKPENLL  +      LK++DFGLS + +  V L+ T CGTP Y APE+L 
Sbjct: 165 HENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV-LMKTVCGTPGYCAPEILR 223
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAE--FSCPFW--FSTGA 175
              Y G   D+WS G+I ++L+ G+ PF  E     ++++I   E  F  P+W   S  A
Sbjct: 224 GCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNA 282
Query: 176 TSLIHKILDPNPKTRIRIEGIRKHPW 201
             L+ K++  +PK R+      +HPW
Sbjct: 283 KDLVRKLIVLDPKKRLTTFQALQHPW 308

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 89/212 (41%), Positives = 124/212 (58%), Gaps = 10/212 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MK + HPNI+RL+E     T +Y+++E  TGGELF+++VH+    E+D  R  + ++ AV
Sbjct: 60  MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAV 119
Query: 61  AHCHSKGVYHRDLKPENLLL--DSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
           A+CH   V HRDLKPEN L   DS  + LK+ DFGL+A  + G +++ T  GTP YV+P+
Sbjct: 120 AYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQ 178
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF--WF--ST 173
           VL   G  G   D WS GV+++VL+ GY PF       +  KI    F+ P   W   S 
Sbjct: 179 VLE--GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSP 236
Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
            A SLI ++L  +PK RI      +H WF K 
Sbjct: 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 89/212 (41%), Positives = 124/212 (58%), Gaps = 10/212 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MK + HPNI+RL+E     T +Y+++E  TGGELF+++VH+    E+D  R  + ++ AV
Sbjct: 77  MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAV 136
Query: 61  AHCHSKGVYHRDLKPENLLL--DSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
           A+CH   V HRDLKPEN L   DS  + LK+ DFGL+A  + G +++ T  GTP YV+P+
Sbjct: 137 AYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQ 195
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF--WF--ST 173
           VL   G  G   D WS GV+++VL+ GY PF       +  KI    F+ P   W   S 
Sbjct: 196 VLE--GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSP 253
Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
            A SLI ++L  +PK RI      +H WF K 
Sbjct: 254 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 285

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 80/216 (37%), Positives = 121/216 (56%), Gaps = 4/216 (1%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   GE++ ++    +  E     Y  +L +A+++C
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYC 129
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++  R 
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMIEGRM 187
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L
Sbjct: 188 HD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 246
Query: 184 DPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 218
             NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 247 KHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 282

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 83/211 (39%), Positives = 120/211 (56%), Gaps = 10/211 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K + HPNI++L E+L   +  YI+ E  TGGELFD+I+ + R  E+D  R  +Q+   +
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 61  AHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + H   + HRDLKPEN+LL+S     ++K+ DFGLS   QQ  + +    GT  Y+APE
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAPE 193
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FST 173
           VL  RG      DVWS GVIL++L++G  PF   +   + K++   +  F  P W   S 
Sbjct: 194 VL--RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251
Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
            A  LI K+L  +P  RI      +HPW +K
Sbjct: 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 79/216 (36%), Positives = 120/216 (55%), Gaps = 4/216 (1%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++C
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++  R 
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMIEGRM 185
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L
Sbjct: 186 HD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 244
Query: 184 DPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 218
             NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 245 KHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 280

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 84/222 (37%), Positives = 129/222 (58%), Gaps = 15/222 (6%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K++ HPNI++L++    +   Y+++E   GGELFD+I+H+ +  E D     +Q++  V
Sbjct: 90  LKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGV 149
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + H   + HRDLKPENLLL+S      +K+ DFGLSA+ +   + +    GT  Y+APE
Sbjct: 150 TYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK-MKERLGTAYYIAPE 208
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FST 173
           VL  + YD    DVWS GVILF+L+AGY PFG      + +K+   +  F  P W   S 
Sbjct: 209 VLRKK-YD-EKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE 266
Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEE 215
           GA  LI ++L  + + RI  +   +HPW ++      CS++E
Sbjct: 267 GAKDLIKQMLQFDSQRRISAQQALEHPWIKE-----MCSKKE 303

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 79/216 (36%), Positives = 120/216 (55%), Gaps = 4/216 (1%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++C
Sbjct: 82  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 141
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++  R 
Sbjct: 142 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMIEGRM 199
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L
Sbjct: 200 HD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 258
Query: 184 DPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 218
             NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 259 KHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 294

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 79/216 (36%), Positives = 120/216 (55%), Gaps = 4/216 (1%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++C
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 129
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++  R 
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMIEGRM 187
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L
Sbjct: 188 HD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 246
Query: 184 DPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 218
             NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 247 KHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 282

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 79/216 (36%), Positives = 120/216 (55%), Gaps = 4/216 (1%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++C
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 125
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++  R 
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--DTLCGTLDYLPPEMIEGRM 183
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L
Sbjct: 184 HD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 242
Query: 184 DPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 218
             NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 243 KHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 278

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 79/216 (36%), Positives = 120/216 (55%), Gaps = 4/216 (1%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++C
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++  R 
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMIEGRM 182
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L
Sbjct: 183 HD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 241
Query: 184 DPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 218
             NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 242 KHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 277

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 82/208 (39%), Positives = 118/208 (56%), Gaps = 5/208 (2%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           K++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVL 119
           + H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGAT 176
             R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           +L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 82/208 (39%), Positives = 118/208 (56%), Gaps = 5/208 (2%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           K++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V 
Sbjct: 58  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 117
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVL 119
           + H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L
Sbjct: 118 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGAT 176
             R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           +L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 238 ALLHKILVENPSARITIPDIKKDRWYNK 265

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 82/208 (39%), Positives = 118/208 (56%), Gaps = 5/208 (2%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           K++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVL 119
           + H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGAT 176
             R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           +L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 82/208 (39%), Positives = 118/208 (56%), Gaps = 5/208 (2%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           K++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVL 119
           + H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGAT 176
             R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           +L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 82/208 (39%), Positives = 118/208 (56%), Gaps = 5/208 (2%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           K++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVL 119
           + H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGAT 176
             R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           +L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 82/208 (39%), Positives = 118/208 (56%), Gaps = 5/208 (2%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           K++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V 
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVL 119
           + H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGAT 176
             R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           +L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 82/208 (39%), Positives = 118/208 (56%), Gaps = 5/208 (2%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           K++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVL 119
           + H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGAT 176
             R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           +L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 92/239 (38%), Positives = 130/239 (54%), Gaps = 17/239 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K + HP I+++     +    YI+LE + GGELFDK+V   RL E  C+ YF Q++ AV
Sbjct: 69  LKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + H  G+ HRDLKPEN+LL S      +K++DFG S +  +   L+ T CGTP Y+APE
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLCGTPTYLAPE 186
Query: 118 VLSNRGYDG--SAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAE--FSCPFW-- 170
           VL + G  G   A D WS GVILF+ ++GY PF E     +L  +I + +  F    W  
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 246
Query: 171 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF-----RKNYNPVKCSEEEEVNLDDVHA 224
            S  A  L+ K+L  +PK R   E   +HPW      ++ +  +   E E   L  V A
Sbjct: 247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLA 305

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 82/208 (39%), Positives = 118/208 (56%), Gaps = 5/208 (2%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           K++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVL 119
           + H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGAT 176
             R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           +L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 79/216 (36%), Positives = 120/216 (55%), Gaps = 4/216 (1%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++C
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 150
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++  R 
Sbjct: 151 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMIEGRM 208
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L
Sbjct: 209 HD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 267
Query: 184 DPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 218
             NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 268 KHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 303

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 82/208 (39%), Positives = 118/208 (56%), Gaps = 5/208 (2%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           K++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVL 119
           + H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGAT 176
             R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           +L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 81/218 (37%), Positives = 123/218 (56%), Gaps = 8/218 (3%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++C
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPEVLSN 121
           HSK V HRD+KPENLLL S G LK++DFG S  A   +  EL    CGT +Y+ PE++  
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTEL----CGTLDYLPPEMIEG 180
Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK 181
           R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI +
Sbjct: 181 RMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR 239
Query: 182 ILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 218
           +L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 277

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 82/208 (39%), Positives = 118/208 (56%), Gaps = 5/208 (2%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           K++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVL 119
           + H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGAT 176
             R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           +L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 92/239 (38%), Positives = 130/239 (54%), Gaps = 17/239 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K + HP I+++     +    YI+LE + GGELFDK+V   RL E  C+ YF Q++ AV
Sbjct: 68  LKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 126
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + H  G+ HRDLKPEN+LL S      +K++DFG S +  +   L+ T CGTP Y+APE
Sbjct: 127 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLCGTPTYLAPE 185
Query: 118 VLSNRGYDG--SAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAE--FSCPFW-- 170
           VL + G  G   A D WS GVILF+ ++GY PF E     +L  +I + +  F    W  
Sbjct: 186 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 245
Query: 171 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF-----RKNYNPVKCSEEEEVNLDDVHA 224
            S  A  L+ K+L  +PK R   E   +HPW      ++ +  +   E E   L  V A
Sbjct: 246 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLA 304

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 82/208 (39%), Positives = 118/208 (56%), Gaps = 5/208 (2%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           K++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V 
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVL 119
           + H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGAT 176
             R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           +L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 82/208 (39%), Positives = 118/208 (56%), Gaps = 5/208 (2%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           K++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V 
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVL 119
           + H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGAT 176
             R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           +L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 82/208 (39%), Positives = 118/208 (56%), Gaps = 5/208 (2%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           K++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V 
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVL 119
           + H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGAT 176
             R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           +L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 82/208 (39%), Positives = 118/208 (56%), Gaps = 5/208 (2%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           K++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V 
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVL 119
           + H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGAT 176
             R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           +L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 79/216 (36%), Positives = 119/216 (55%), Gaps = 4/216 (1%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++C
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 129
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE +  R 
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEXIEGRX 187
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L
Sbjct: 188 HD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 246
Query: 184 DPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 218
             NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 247 KHNPSQRPXLREVLEHPWITANSSKPSNCQNKESAS 282

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 92/239 (38%), Positives = 130/239 (54%), Gaps = 17/239 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K + HP I+++     +    YI+LE + GGELFDK+V   RL E  C+ YF Q++ AV
Sbjct: 69  LKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + H  G+ HRDLKPEN+LL S      +K++DFG S +  +   L+ T CGTP Y+APE
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLCGTPTYLAPE 186
Query: 118 VLSNRGYDG--SAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAE--FSCPFW-- 170
           VL + G  G   A D WS GVILF+ ++GY PF E     +L  +I + +  F    W  
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 246
Query: 171 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF-----RKNYNPVKCSEEEEVNLDDVHA 224
            S  A  L+ K+L  +PK R   E   +HPW      ++ +  +   E E   L  V A
Sbjct: 247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLA 305

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 82/208 (39%), Positives = 118/208 (56%), Gaps = 5/208 (2%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           K++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V 
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVL 119
           + H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGAT 176
             R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           +L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 87/213 (40%), Positives = 122/213 (57%), Gaps = 12/213 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K + HP I+++     +    YI+LE + GGELFDK+V   RL E  C+ YF Q++ AV
Sbjct: 69  LKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + H  G+ HRDLKPEN+LL S      +K++DFG S +  +   L+ T CGTP Y+APE
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLCGTPTYLAPE 186
Query: 118 VLSNRGYDG--SAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAE--FSCPFW-- 170
           VL + G  G   A D WS GVILF+ ++GY PF E     +L  +I + +  F    W  
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 246
Query: 171 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
            S  A  L+ K+L  +PK R   E   +HPW +
Sbjct: 247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 92/239 (38%), Positives = 130/239 (54%), Gaps = 17/239 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K + HP I+++     +    YI+LE + GGELFDK+V   RL E  C+ YF Q++ AV
Sbjct: 75  LKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 133
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + H  G+ HRDLKPEN+LL S      +K++DFG S +  +   L+ T CGTP Y+APE
Sbjct: 134 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLCGTPTYLAPE 192
Query: 118 VLSNRGYDG--SAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAE--FSCPFW-- 170
           VL + G  G   A D WS GVILF+ ++GY PF E     +L  +I + +  F    W  
Sbjct: 193 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 252
Query: 171 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF-----RKNYNPVKCSEEEEVNLDDVHA 224
            S  A  L+ K+L  +PK R   E   +HPW      ++ +  +   E E   L  V A
Sbjct: 253 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLA 311

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 80/217 (36%), Positives = 121/217 (55%), Gaps = 6/217 (2%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++C
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 126
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNR 122
           HSK V HRD+KPENLLL S G LK++DFG S   P      L   CGT +Y+ PE++  R
Sbjct: 127 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL---CGTLDYLPPEMIEGR 183
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 182
            +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++
Sbjct: 184 MHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 242
Query: 183 LDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 218
           L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 243 LKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 279

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 80/218 (36%), Positives = 123/218 (56%), Gaps = 8/218 (3%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++C
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 129
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPEVLSN 121
           HSK V HRD+KPENLLL S G LK++DFG S  A   +  +L    CGT +Y+ PE++  
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL----CGTLDYLPPEMIEG 185
Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK 181
           R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI +
Sbjct: 186 RMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR 244
Query: 182 ILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 218
           +L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 245 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 282

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 78/216 (36%), Positives = 120/216 (55%), Gaps = 4/216 (1%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++C
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 126
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HSK V HRD+KPENLLL S G LK+++FG S           T CGT +Y+ PE++  R 
Sbjct: 127 HSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRT--TLCGTLDYLPPEMIEGRM 184
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L
Sbjct: 185 HD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 243
Query: 184 DPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 218
             NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 244 KHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 279

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 80/217 (36%), Positives = 121/217 (55%), Gaps = 6/217 (2%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++C
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNR 122
           HSK V HRD+KPENLLL S G LK++DFG S   P      L   CGT +Y+ PE++  R
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAAL---CGTLDYLPPEMIEGR 184
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 182
            +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++
Sbjct: 185 MHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 243
Query: 183 LDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 218
           L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 244 LKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 280

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 80/218 (36%), Positives = 123/218 (56%), Gaps = 8/218 (3%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++C
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 125
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPEVLSN 121
           HSK V HRD+KPENLLL S G LK++DFG S  A   +  +L    CGT +Y+ PE++  
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL----CGTLDYLPPEMIEG 181
Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK 181
           R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI +
Sbjct: 182 RMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR 240
Query: 182 ILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 218
           +L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 241 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 278

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 80/217 (36%), Positives = 122/217 (56%), Gaps = 6/217 (2%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++C
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 150
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNR 122
           HSK V HRD+KPENLLL S G LK++DFG S   P    + L   CGT +Y+ PE++  R
Sbjct: 151 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDL---CGTLDYLPPEMIEGR 207
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 182
            +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++
Sbjct: 208 MHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 266
Query: 183 LDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 218
           L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 267 LKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 303

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 80/215 (37%), Positives = 122/215 (56%), Gaps = 8/215 (3%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++C
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPEVLSN 121
           HSK V HRD+KPENLLL S G LK++DFG S  A   +  +L    CGT +Y+ PE++  
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL----CGTLDYLPPEMIEG 180
Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK 181
           R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI +
Sbjct: 181 RMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR 239
Query: 182 ILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEE 215
           +L  NP  R  +  + +HPW   N + P  C  +E
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 274

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 81/207 (39%), Positives = 117/207 (56%), Gaps = 5/207 (2%)
Query: 3   IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 62
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 63  CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 120
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 177
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 178 LIHKILDPNPKTRIRIEGIRKHPWFRK 204
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  151 bits (381), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 80/217 (36%), Positives = 121/217 (55%), Gaps = 6/217 (2%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   GE++ ++    +  E     Y  +L +A+++C
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYC 129
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNR 122
           HSK V HRD+KPENLLL S G LK++DFG S   P      L    GT +Y+ PE++  R
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL---XGTLDYLPPEMIEGR 186
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 182
            +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++
Sbjct: 187 MHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 245
Query: 183 LDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 218
           L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 246 LKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 282

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  151 bits (381), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 86/213 (40%), Positives = 123/213 (57%), Gaps = 12/213 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K + HP I+++     +    YI+LE + GGELFDK+V   RL E  C+ YF Q++ AV
Sbjct: 194 LKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 252
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + H  G+ HRDLKPEN+LL S      +K++DFG S +  +   L+ T CGTP Y+APE
Sbjct: 253 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLCGTPTYLAPE 311
Query: 118 VLSNRGYDG--SAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAEFSC--PFW-- 170
           VL + G  G   A D WS GVILF+ ++GY PF E     +L  +I + +++     W  
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 371
Query: 171 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
            S  A  L+ K+L  +PK R   E   +HPW +
Sbjct: 372 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  151 bits (381), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 83/211 (39%), Positives = 120/211 (56%), Gaps = 10/211 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K + HPNI++L E+L   +  YI+ E  TGGELFD+I+ + R  E+D  R  +Q+   +
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 61  AHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + H   + HRDLKPEN+LL+S     ++K+ DFGLS   QQ  + +    GT  Y+APE
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAPE 193
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FST 173
           VL  RG      DVWS GVIL++L++G  PF   +   + K++   +  F  P W   S 
Sbjct: 194 VL--RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251
Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
            A  LI K+L  +P  RI      +HPW +K
Sbjct: 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  151 bits (381), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 86/213 (40%), Positives = 123/213 (57%), Gaps = 12/213 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K + HP I+++     +    YI+LE + GGELFDK+V   RL E  C+ YF Q++ AV
Sbjct: 208 LKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 266
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + H  G+ HRDLKPEN+LL S      +K++DFG S +  +   L+ T CGTP Y+APE
Sbjct: 267 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLCGTPTYLAPE 325
Query: 118 VLSNRGYDG--SAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAEFSC--PFW-- 170
           VL + G  G   A D WS GVILF+ ++GY PF E     +L  +I + +++     W  
Sbjct: 326 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 385
Query: 171 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
            S  A  L+ K+L  +PK R   E   +HPW +
Sbjct: 386 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 418

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  151 bits (381), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 80/215 (37%), Positives = 122/215 (56%), Gaps = 8/215 (3%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++C
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPEVLSN 121
           HSK V HRD+KPENLLL S G LK++DFG S  A   +  +L    CGT +Y+ PE++  
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL----CGTLDYLPPEMIEG 180
Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK 181
           R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI +
Sbjct: 181 RMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR 239
Query: 182 ILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEE 215
           +L  NP  R  +  + +HPW   N + P  C  +E
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 274

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  151 bits (381), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 83/211 (39%), Positives = 120/211 (56%), Gaps = 10/211 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K + HPNI++L E+L   +  YI+ E  TGGELFD+I+ + R  E+D  R  +Q+   +
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 61  AHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + H   + HRDLKPEN+LL+S     ++K+ DFGLS   QQ  + +    GT  Y+APE
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAPE 193
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FST 173
           VL  RG      DVWS GVIL++L++G  PF   +   + K++   +  F  P W   S 
Sbjct: 194 VL--RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251
Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
            A  LI K+L  +P  RI      +HPW +K
Sbjct: 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  150 bits (380), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 79/204 (38%), Positives = 119/204 (58%), Gaps = 6/204 (2%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           V HP IV+LH    +  K+Y+IL+F+ GG+LF ++  +    E D + Y  +L  A+ H 
Sbjct: 84  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 143
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HS G+ +RDLKPEN+LLD  G++K++DFGLS       +  ++ CGT  Y+APEV++ RG
Sbjct: 144 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG 203
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           +  S AD WS GV++F ++ G LPF   D       I  A+   P + S  A SL+  + 
Sbjct: 204 HTQS-ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLF 262
Query: 184 DPNPKTRI-----RIEGIRKHPWF 202
             NP  R+      +E I++H +F
Sbjct: 263 KRNPANRLGAGPDGVEEIKRHSFF 286

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 79/204 (38%), Positives = 119/204 (58%), Gaps = 6/204 (2%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           V HP IV+LH    +  K+Y+IL+F+ GG+LF ++  +    E D + Y  +L  A+ H 
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HS G+ +RDLKPEN+LLD  G++K++DFGLS       +  ++ CGT  Y+APEV++ RG
Sbjct: 143 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG 202
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           +  S AD WS GV++F ++ G LPF   D       I  A+   P + S  A SL+  + 
Sbjct: 203 HTQS-ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLF 261
Query: 184 DPNPKTRI-----RIEGIRKHPWF 202
             NP  R+      +E I++H +F
Sbjct: 262 KRNPANRLGAGPDGVEEIKRHSFF 285

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 76/202 (37%), Positives = 114/202 (56%), Gaps = 3/202 (1%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++C
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++  R 
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMIEGRM 185
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L
Sbjct: 186 HD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 244
Query: 184 DPNPKTRIRIEGIRKHPWFRKN 205
             NP  R  +  + +HPW   N
Sbjct: 245 KHNPSQRPMLREVLEHPWITAN 266

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 79/204 (38%), Positives = 119/204 (58%), Gaps = 6/204 (2%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           V HP IV+LH    +  K+Y+IL+F+ GG+LF ++  +    E D + Y  +L  A+ H 
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HS G+ +RDLKPEN+LLD  G++K++DFGLS       +  ++ CGT  Y+APEV++ RG
Sbjct: 143 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG 202
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           +  S AD WS GV++F ++ G LPF   D       I  A+   P + S  A SL+  + 
Sbjct: 203 HTQS-ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLF 261
Query: 184 DPNPKTRI-----RIEGIRKHPWF 202
             NP  R+      +E I++H +F
Sbjct: 262 KRNPANRLGAGPDGVEEIKRHSFF 285

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 76/202 (37%), Positives = 114/202 (56%), Gaps = 3/202 (1%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++C
Sbjct: 64  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 123
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++  R 
Sbjct: 124 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMIEGRM 181
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L
Sbjct: 182 HD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 240
Query: 184 DPNPKTRIRIEGIRKHPWFRKN 205
             NP  R  +  + +HPW   N
Sbjct: 241 KHNPSQRPMLREVLEHPWITAN 262

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 76/202 (37%), Positives = 114/202 (56%), Gaps = 3/202 (1%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++C
Sbjct: 62  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 121
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++  R 
Sbjct: 122 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMIEGRM 179
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L
Sbjct: 180 HD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 238
Query: 184 DPNPKTRIRIEGIRKHPWFRKN 205
             NP  R  +  + +HPW   N
Sbjct: 239 KHNPSQRPMLREVLEHPWITAN 260

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 76/202 (37%), Positives = 114/202 (56%), Gaps = 3/202 (1%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++C
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 128
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++  R 
Sbjct: 129 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMIEGRM 186
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L
Sbjct: 187 HD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 245
Query: 184 DPNPKTRIRIEGIRKHPWFRKN 205
             NP  R  +  + +HPW   N
Sbjct: 246 KHNPSQRPMLREVLEHPWITAN 267

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 81/208 (38%), Positives = 117/208 (56%), Gaps = 5/208 (2%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           K++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVL 119
           + H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+   GT  YVAPE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGAT 176
             R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           +L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 75/202 (37%), Positives = 115/202 (56%), Gaps = 3/202 (1%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   G ++ ++    R  E     Y  +L +A+++C
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++  R 
Sbjct: 129 HSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMIEGRM 186
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           +D    D+WS GV+ +  + G  PF        Y++I+  EF+ P + + GA  LI ++L
Sbjct: 187 HD-EKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLISRLL 245
Query: 184 DPNPKTRIRIEGIRKHPWFRKN 205
             N   R+ +  + +HPW + N
Sbjct: 246 KHNASQRLTLAEVLEHPWIKAN 267

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 75/202 (37%), Positives = 115/202 (56%), Gaps = 3/202 (1%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   G ++ ++    R  E     Y  +L +A+++C
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++  R 
Sbjct: 129 HSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR--DTLCGTLDYLPPEMIEGRM 186
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           +D    D+WS GV+ +  + G  PF        Y++I+  EF+ P + + GA  LI ++L
Sbjct: 187 HD-EKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLISRLL 245
Query: 184 DPNPKTRIRIEGIRKHPWFRKN 205
             N   R+ +  + +HPW + N
Sbjct: 246 KHNASQRLTLAEVLEHPWIKAN 267

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 77/203 (37%), Positives = 115/203 (56%), Gaps = 5/203 (2%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++C
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNR 122
           HSK V HRD+KPENLLL S G LK++DFG S   P      L   CGT +Y+ PE++  R
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL---CGTLDYLPPEMIEGR 184
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 182
            +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++
Sbjct: 185 MHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 243
Query: 183 LDPNPKTRIRIEGIRKHPWFRKN 205
           L  NP  R  +  + +HPW   N
Sbjct: 244 LKHNPSQRPMLREVLEHPWITAN 266

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 81/208 (38%), Positives = 117/208 (56%), Gaps = 5/208 (2%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           K++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVL 119
           + H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+   GT  YVAPE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGAT 176
             R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           +L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 77/203 (37%), Positives = 115/203 (56%), Gaps = 5/203 (2%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++C
Sbjct: 65  LRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNR 122
           HSK V HRD+KPENLLL S G LK++DFG S   P      L   CGT +Y+ PE++  R
Sbjct: 125 HSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAAL---CGTLDYLPPEMIEGR 181
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 182
            +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++
Sbjct: 182 MHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGARDLISRL 240
Query: 183 LDPNPKTRIRIEGIRKHPWFRKN 205
           L  NP  R  +  + +HPW   N
Sbjct: 241 LKHNPSQRPMLREVLEHPWITAN 263

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 81/208 (38%), Positives = 117/208 (56%), Gaps = 5/208 (2%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           K++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V 
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVL 119
           + H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+   GT  YVAPE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 179
Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGAT 176
             R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           +L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 81/208 (38%), Positives = 117/208 (56%), Gaps = 5/208 (2%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           K++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVL 119
           + H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+   GT  YVAPE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGAT 176
             R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           +L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 81/208 (38%), Positives = 117/208 (56%), Gaps = 5/208 (2%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           K++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVL 119
           + H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+   GT  YVAPE+L
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGAT 176
             R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           +L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 239 ALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 75/202 (37%), Positives = 114/202 (56%), Gaps = 3/202 (1%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++C
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HSK V HRD+KPENLLL S G LK+++FG S           T CGT +Y+ PE++  R 
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRT--TLCGTLDYLPPEMIEGRM 185
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L
Sbjct: 186 HD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 244
Query: 184 DPNPKTRIRIEGIRKHPWFRKN 205
             NP  R  +  + +HPW   N
Sbjct: 245 KHNPSQRPMLREVLEHPWITAN 266

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 77/203 (37%), Positives = 115/203 (56%), Gaps = 5/203 (2%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++C
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNR 122
           HSK V HRD+KPENLLL S G LK++DFG S   P      L   CGT +Y+ PE++  R
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAAL---CGTLDYLPPEMIEGR 181
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 182
            +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++
Sbjct: 182 MHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 240
Query: 183 LDPNPKTRIRIEGIRKHPWFRKN 205
           L  NP  R  +  + +HPW   N
Sbjct: 241 LKHNPSQRPMLREVLEHPWITAN 263

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 77/203 (37%), Positives = 115/203 (56%), Gaps = 5/203 (2%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++C
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNR 122
           HSK V HRD+KPENLLL S G LK++DFG S   P      L   CGT +Y+ PE++  R
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXL---CGTLDYLPPEMIEGR 181
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 182
            +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++
Sbjct: 182 MHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 240
Query: 183 LDPNPKTRIRIEGIRKHPWFRKN 205
           L  NP  R  +  + +HPW   N
Sbjct: 241 LKHNPSQRPMLREVLEHPWITAN 263

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 77/203 (37%), Positives = 115/203 (56%), Gaps = 5/203 (2%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++C
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNR 122
           HSK V HRD+KPENLLL S G LK++DFG S   P      L   CGT +Y+ PE++  R
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL---CGTLDYLPPEMIEGR 181
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 182
            +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++
Sbjct: 182 MHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 240
Query: 183 LDPNPKTRIRIEGIRKHPWFRKN 205
           L  NP  R  +  + +HPW   N
Sbjct: 241 LKHNPSQRPMLREVLEHPWITAN 263

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  148 bits (373), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 77/203 (37%), Positives = 116/203 (57%), Gaps = 5/203 (2%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++C
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNR 122
           HSK V HRD+KPENLLL S G LK++DFG S   P    + L   CGT +Y+ PE++  R
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDL---CGTLDYLPPEMIEGR 184
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 182
            +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++
Sbjct: 185 MHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 243
Query: 183 LDPNPKTRIRIEGIRKHPWFRKN 205
           L  NP  R  +  + +HPW   N
Sbjct: 244 LKHNPSQRPMLREVLEHPWITAN 266

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  148 bits (373), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 77/213 (36%), Positives = 118/213 (55%), Gaps = 3/213 (1%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++C
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 125
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HSK V HRD+KPENLLL S G LK++DFG S           T  GT +Y+ PE++  R 
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRT--TLSGTLDYLPPEMIEGRM 183
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L
Sbjct: 184 HD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 242
Query: 184 DPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEE 216
             NP  R  +  + +HPW   N +    S+ +E
Sbjct: 243 KHNPSQRPMLREVLEHPWITANSSKPSNSQNKE 275

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  146 bits (369), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 94/275 (34%), Positives = 141/275 (51%), Gaps = 21/275 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K + HPNI++L+E    +   Y+++E   GGELFD+I+ + +  E D     +Q++   
Sbjct: 58  LKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGT 117
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + H   + HRDLKPENLLL+S      +K+ DFGLSA  + G + +    GT  Y+APE
Sbjct: 118 TYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK-MKERLGTAYYIAPE 176
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC--PFW--FST 173
           VL  + YD    DVWSCGVIL++L+ GY PFG      + K++   +FS   P W   S 
Sbjct: 177 VLRKK-YD-EKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSD 234
Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDV--HAVFDDIED 231
            A  L+  +L   P  RI  E    HPW  K      CS++      DV  HA+   + +
Sbjct: 235 EAKQLVKLMLTYEPSKRISAEEALNHPWIVKF-----CSQKHT----DVGKHALTGALGN 285
Query: 232 QYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 266
               + S+      +L    ++ TL +   L  +F
Sbjct: 286 MKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIF 320

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 113/202 (55%), Gaps = 3/202 (1%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+R++     R ++Y++LEF   GEL+ ++   GR  E     + ++L DA+ +C
Sbjct: 71  LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYC 130
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           H + V HRD+KPENLL+   G LK++DFG S             CGT +Y+ PE++  + 
Sbjct: 131 HERKVIHRDIKPENLLMGYKGELKIADFGWSV--HAPSLRRRXMCGTLDYLPPEMIEGKT 188
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           +D    D+W  GV+ +  + G  PF        +++I   +   P + S G+  LI K+L
Sbjct: 189 HD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLL 247
Query: 184 DPNPKTRIRIEGIRKHPWFRKN 205
             +P  R+ ++G+ +HPW + N
Sbjct: 248 RYHPPQRLPLKGVMEHPWVKAN 269

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 113/202 (55%), Gaps = 3/202 (1%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +RHPNI+R++     R ++Y++LEF   GEL+ ++   GR  E     + ++L DA+ +C
Sbjct: 72  LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYC 131
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           H + V HRD+KPENLL+   G LK++DFG S             CGT +Y+ PE++  + 
Sbjct: 132 HERKVIHRDIKPENLLMGYKGELKIADFGWSV--HAPSLRRRXMCGTLDYLPPEMIEGKT 189
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           +D    D+W  GV+ +  + G  PF        +++I   +   P + S G+  LI K+L
Sbjct: 190 HD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLL 248
Query: 184 DPNPKTRIRIEGIRKHPWFRKN 205
             +P  R+ ++G+ +HPW + N
Sbjct: 249 RYHPPQRLPLKGVMEHPWVKAN 270

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 82/212 (38%), Positives = 119/212 (56%), Gaps = 15/212 (7%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           HPNIV+LHEV   +   ++++E + GGELF++I  +    E +     ++L+ AV+H H 
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 66  KGVYHRDLKPENLLL-DSYGNL--KVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 122
            GV HRDLKPENLL  D   NL  K+ DFG + L     + L T C T +Y APE+L+  
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPFGETDLP-------TLYKKINAAEFS--CPFW--F 171
           GYD S  D+WS GVIL+ +++G +PF   D          + KKI   +FS     W   
Sbjct: 185 GYDES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243
Query: 172 STGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
           S  A  LI  +L  +P  R+++ G+R + W +
Sbjct: 244 SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ 275

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 82/211 (38%), Positives = 117/211 (55%), Gaps = 10/211 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K + HPNI++L+E    +   Y+++E   GGELFD+I+ + +  E D     +Q++   
Sbjct: 75  LKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGT 134
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + H   + HRDLKPENLLL+S      +K+ DFGLSA  + G + +    GT  Y+APE
Sbjct: 135 TYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK-MKERLGTAYYIAPE 193
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC--PFW--FST 173
           VL  + YD    DVWSCGVIL++L+ GY PFG      + K++   +FS   P W   S 
Sbjct: 194 VLRKK-YD-EKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSD 251
Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
            A  L+  +L   P  RI  E    HPW  K
Sbjct: 252 EAKQLVKLMLTYEPSKRISAEEALNHPWIVK 282

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 76/204 (37%), Positives = 118/204 (57%), Gaps = 6/204 (2%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           V HP +V+LH    +  K+Y+IL+F+ GG+LF ++  +    E D + Y  +L   + H 
Sbjct: 87  VNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHL 146
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HS G+ +RDLKPEN+LLD  G++K++DFGLS       +  ++ CGT  Y+APEV++ +G
Sbjct: 147 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQG 206
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           +  S AD WS GV++F ++ G LPF   D       I  A+   P + ST A SL+  + 
Sbjct: 207 HSHS-ADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFLSTEAQSLLRALF 265
Query: 184 DPNPKTRI-----RIEGIRKHPWF 202
             NP  R+       E I++H ++
Sbjct: 266 KRNPANRLGSGPDGAEEIKRHVFY 289

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 79/209 (37%), Positives = 118/209 (56%), Gaps = 12/209 (5%)
Query: 5   RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 64
           +HPNI+ L +V      VY++ E + GGEL DKI+ Q    E +       +   V + H
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH 133
Query: 65  SKGVYHRDLKPENLL-LDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           ++GV HRDLKP N+L +D  GN   +++ DFG +   +    LL T C T N+VAPEVL 
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLE 193
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLP-TLYKKINAAEFSCP--FWFSTGA 175
            +GYD +A D+WS GV+L+ ++ GY PF  G  D P  +  +I + +FS    +W S   
Sbjct: 194 RQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD 252
Query: 176 TS--LIHKILDPNPKTRIRIEGIRKHPWF 202
           T+  L+ K+L  +P  R+    + +HPW 
Sbjct: 253 TAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 125/210 (59%), Gaps = 11/210 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           + IV HP I+R+        ++++I++++ GGELF  +    R      + Y  ++  A+
Sbjct: 60  LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLAL 119
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVL 119
            + HSK + +RDLKPEN+LLD  G++K++DFG +  +P    ++ +  CGTP+Y+APEV+
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYXLCGTPDYIAPEVV 175
Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 179
           S + Y+ S  D WS G++++ ++AGY PF +++    Y+KI  AE   P +F+     L+
Sbjct: 176 STKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLL 234
Query: 180 HKILDPNPKTRI-----RIEGIRKHPWFRK 204
            +++  +   R+       E ++ HPWF++
Sbjct: 235 SRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  141 bits (355), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 76/213 (35%), Positives = 121/213 (56%), Gaps = 12/213 (5%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           ++  HP+I+ L +   S + ++++ + +  GELFD +  +  L E + R   + L++AV+
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL-- 119
             H+  + HRDLKPEN+LLD    +++SDFG S   + G E L   CGTP Y+APE+L  
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKC 273
Query: 120 ----SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFWFST 173
               ++ GY G   D+W+CGVILF L+AG  PF       + + I     +FS P W   
Sbjct: 274 SMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDR 332
Query: 174 GAT--SLIHKILDPNPKTRIRIEGIRKHPWFRK 204
            +T   LI ++L  +P+ R+  E   +HP+F +
Sbjct: 333 SSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 80/212 (37%), Positives = 119/212 (56%), Gaps = 12/212 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++  +HPNI+ L +V      VY++ E + GGEL DKI+ Q    E +       +   V
Sbjct: 75  LRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTV 134
Query: 61  AHCHSKGVYHRDLKPENLL-LDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + HS+GV HRDLKP N+L +D  GN   L++ DFG +   +    LL T C T N+VAP
Sbjct: 135 EYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAP 194
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLP-TLYKKINAAEF--SCPFW- 170
           EVL  +GYD    D+WS G++L+ ++AGY PF  G +D P  +  +I + +F  S   W 
Sbjct: 195 EVLKRQGYD-EGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWN 253
Query: 171 -FSTGATSLIHKILDPNPKTRIRIEGIRKHPW 201
             S  A  L+ K+L  +P  R+  + + +HPW
Sbjct: 254 TVSETAKDLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  140 bits (354), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 80/208 (38%), Positives = 117/208 (56%), Gaps = 12/208 (5%)
Query: 5   RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 64
           +HPNI+ L +V      VY++ E + GGEL DKI+ Q    E +       +   V + H
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLH 138
Query: 65  SKGVYHRDLKPENLL-LDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           S+GV HRDLKP N+L +D  GN   L++ DFG +   +    LL T C T N+VAPEVL 
Sbjct: 139 SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLK 198
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLP-TLYKKINAAEF--SCPFW--FST 173
            +GYD    D+WS G++L+ ++AGY PF  G +D P  +  +I + +F  S   W   S 
Sbjct: 199 RQGYD-EGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSE 257
Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPW 201
            A  L+ K+L  +P  R+  + + +HPW
Sbjct: 258 TAKDLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 79/210 (37%), Positives = 114/210 (54%), Gaps = 10/210 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K + HPNI++L+E    +   Y++ E  TGGELFD+I+ + R  E D  R  +Q++  +
Sbjct: 80  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGI 139
Query: 61  AHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + H   + HRDLKPENLLL+S     N+++ DFGLS    +  + +    GT  Y+APE
Sbjct: 140 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKMKDKIGTAYYIAPE 198
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FST 173
           VL    YD    DVWS GVIL++L++G  PF   +   + KK+   +  F  P W   S 
Sbjct: 199 VLHGT-YD-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE 256
Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
            A  LI K+L   P  RI       H W +
Sbjct: 257 SAKDLIRKMLTYVPSMRISARDALDHEWIQ 286

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 79/213 (37%), Positives = 117/213 (54%), Gaps = 12/213 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++  +HPNI+ L +V      VY++ E   GGEL DKI+ Q    E +       +   V
Sbjct: 70  LRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTV 129
Query: 61  AHCHSKGVYHRDLKPENLL-LDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + H++GV HRDLKP N+L +D  GN   +++ DFG +   +    LL T C T N+VAP
Sbjct: 130 EYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAP 189
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLP-TLYKKINAAEFSCP--FWF 171
           EVL  +GYD +A D+WS GV+L+  + GY PF  G  D P  +  +I + +FS    +W 
Sbjct: 190 EVLERQGYD-AACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN 248
Query: 172 STGATS--LIHKILDPNPKTRIRIEGIRKHPWF 202
           S   T+  L+ K L  +P  R+    + +HPW 
Sbjct: 249 SVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 79/210 (37%), Positives = 114/210 (54%), Gaps = 10/210 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K + HPNI++L+E    +   Y++ E  TGGELFD+I+ + R  E D  R  +Q++  +
Sbjct: 104 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGI 163
Query: 61  AHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + H   + HRDLKPENLLL+S     N+++ DFGLS    +  + +    GT  Y+APE
Sbjct: 164 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKMKDKIGTAYYIAPE 222
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FST 173
           VL    YD    DVWS GVIL++L++G  PF   +   + KK+   +  F  P W   S 
Sbjct: 223 VLHGT-YD-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE 280
Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
            A  LI K+L   P  RI       H W +
Sbjct: 281 SAKDLIRKMLTYVPSMRISARDALDHEWIQ 310

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 84/210 (40%), Positives = 123/210 (58%), Gaps = 12/210 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V HPNI+ LH+V  +RT V +ILE V+GGELFD +  +  L E +   + +Q++D V
Sbjct: 69  LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 61  AHCHSKGVYHRDLKPEN-LLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + H+K + H DLKPEN +LLD      ++K+ DFGL+   + GVE      GTP +VAP
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAP 187
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFST 173
           E++ N    G  AD+WS GVI ++L++G  PF G+T   TL   I A   +F   F+  T
Sbjct: 188 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-ANITAVSYDFDEEFFSQT 245
Query: 174 G--ATSLIHKILDPNPKTRIRIEGIRKHPW 201
              A   I K+L    + R+ I+   +HPW
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 112/203 (55%), Gaps = 2/203 (0%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAH 62
           ++HP+I+ L+        VY++LE    GE+   + ++ +   EN+ R +  Q+I  + +
Sbjct: 68  LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLY 127
Query: 63  CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 122
            HS G+ HRDL   NLLL    N+K++DFGL+   +   E  +T CGTPNY++PE+ + R
Sbjct: 128 LHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEI-ATR 186
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 182
              G  +DVWS G + + L+ G  PF    +     K+  A++  P + S  A  LIH++
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQL 246
Query: 183 LDPNPKTRIRIEGIRKHPWFRKN 205
           L  NP  R+ +  +  HP+  +N
Sbjct: 247 LRRNPADRLSLSSVLDHPFMSRN 269

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 79/210 (37%), Positives = 114/210 (54%), Gaps = 10/210 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K + HPNI++L+E    +   Y++ E  TGGELFD+I+ + R  E D  R  +Q++  +
Sbjct: 103 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGI 162
Query: 61  AHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + H   + HRDLKPENLLL+S     N+++ DFGLS    +  + +    GT  Y+APE
Sbjct: 163 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKMKDKIGTAYYIAPE 221
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FST 173
           VL    YD    DVWS GVIL++L++G  PF   +   + KK+   +  F  P W   S 
Sbjct: 222 VLHGT-YD-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE 279
Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
            A  LI K+L   P  RI       H W +
Sbjct: 280 SAKDLIRKMLTYVPSMRISARDALDHEWIQ 309

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 78/212 (36%), Positives = 126/212 (59%), Gaps = 12/212 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ +RHPNI+ LH++  ++T V +ILE V+GGELFD +  +  L E++  ++ +Q++D V
Sbjct: 69  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 128
Query: 61  AHCHSKGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + HSK + H DLKPEN++L         +K+ DFG++   + G E      GTP +VAP
Sbjct: 129 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFVAP 187
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFST 173
           E+++     G  AD+WS GVI ++L++G  PF GET   TL   I+A   +F   ++ +T
Sbjct: 188 EIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETL-TNISAVNYDFDEEYFSNT 245
Query: 174 G--ATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
              A   I ++L  +PK R+ I    +H W +
Sbjct: 246 SELAKDFIRRLLVKDPKRRMXIAQSLEHSWIK 277

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 79/214 (36%), Positives = 128/214 (59%), Gaps = 16/214 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ +RHPNI+ LH++  ++T V +ILE V+GGELFD +  +  L E++  ++ +Q++D V
Sbjct: 83  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 142
Query: 61  AHCHSKGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + HSK + H DLKPEN++L         +K+ DFG++   + G E      GTP +VAP
Sbjct: 143 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFVAP 201
Query: 117 EVLSNRGYD--GSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWF 171
           E+++   Y+  G  AD+WS GVI ++L++G  PF GET   TL   I+A   +F   ++ 
Sbjct: 202 EIVN---YEPLGLEADMWSIGVITYILLSGASPFLGETKQETL-TNISAVNYDFDEEYFS 257
Query: 172 STG--ATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
           +T   A   I ++L  +PK R+ I    +H W +
Sbjct: 258 NTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIK 291

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 75/222 (33%), Positives = 121/222 (54%), Gaps = 10/222 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K + HPNI++L +V   +   Y++ EF  GGELF++I+++ +  E D     +Q++  +
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGI 159
Query: 61  AHCHSKGVYHRDLKPENLLLD---SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + H   + HRD+KPEN+LL+   S  N+K+ DFGLS+   +  + L    GT  Y+APE
Sbjct: 160 CYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK-LRDRLGTAYYIAPE 218
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF--W--FST 173
           VL  +       DVWSCGVI+++L+ GY PFG  +   + KK+   ++   F  W   S 
Sbjct: 219 VLKKKY--NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISD 276
Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEE 215
            A  LI  +L  +   R   E      W +K  N +  S+++
Sbjct: 277 EAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQK 318

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 79/214 (36%), Positives = 128/214 (59%), Gaps = 16/214 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ +RHPNI+ LH++  ++T V +ILE V+GGELFD +  +  L E++  ++ +Q++D V
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121
Query: 61  AHCHSKGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + HSK + H DLKPEN++L         +K+ DFG++   + G E      GTP +VAP
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFVAP 180
Query: 117 EVLSNRGYD--GSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWF 171
           E+++   Y+  G  AD+WS GVI ++L++G  PF GET   TL   I+A   +F   ++ 
Sbjct: 181 EIVN---YEPLGLEADMWSIGVITYILLSGASPFLGETKQETL-TNISAVNYDFDEEYFS 236
Query: 172 STG--ATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
           +T   A   I ++L  +PK R+ I    +H W +
Sbjct: 237 NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIK 270

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  137 bits (346), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 79/210 (37%), Positives = 114/210 (54%), Gaps = 10/210 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K + HPNI++L+E    +   Y++ E  TGGELFD+I+ + R  E D  R  +Q++  +
Sbjct: 86  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGI 145
Query: 61  AHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + H   + HRDLKPENLLL+S     N+++ DFGLS    +  + +    GT  Y+APE
Sbjct: 146 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKMKDKIGTAYYIAPE 204
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FST 173
           VL    YD    DVWS GVIL++L++G  PF   +   + KK+   +  F  P W   S 
Sbjct: 205 VLHGT-YD-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE 262
Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
            A  LI K+L   P  RI       H W +
Sbjct: 263 SAKDLIRKMLTYVPSMRISARDALDHEWIQ 292

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 78/212 (36%), Positives = 124/212 (58%), Gaps = 12/212 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 61  AHCHSKGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + HS  + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAP
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAP 186
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFST 173
           E+++     G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T
Sbjct: 187 EIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNT 244
Query: 174 GATS--LIHKILDPNPKTRIRIEGIRKHPWFR 203
            A +   I ++L  +PK R+ I+   +HPW +
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 79/212 (37%), Positives = 124/212 (58%), Gaps = 12/212 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 61  AHCHSKGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + HS  + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAP
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAP 186
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFST 173
           E++ N    G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNT 244
Query: 174 GATS--LIHKILDPNPKTRIRIEGIRKHPWFR 203
            A +   I ++L  +PK R+ I+   +HPW +
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 78/212 (36%), Positives = 124/212 (58%), Gaps = 12/212 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 61  AHCHSKGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + HS  + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAP
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAP 186
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFST 173
           E+++     G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T
Sbjct: 187 EIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNT 244
Query: 174 GATS--LIHKILDPNPKTRIRIEGIRKHPWFR 203
            A +   I ++L  +PK R+ I+   +HPW +
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 78/212 (36%), Positives = 124/212 (58%), Gaps = 12/212 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 61  AHCHSKGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + HS  + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAP
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAP 186
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFST 173
           E+++     G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T
Sbjct: 187 EIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNT 244
Query: 174 GATS--LIHKILDPNPKTRIRIEGIRKHPWFR 203
            A +   I ++L  +PK R+ I+   +HPW +
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 78/212 (36%), Positives = 124/212 (58%), Gaps = 12/212 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 61  AHCHSKGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + HS  + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAP
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAP 186
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFST 173
           E+++     G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T
Sbjct: 187 EIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNT 244
Query: 174 GATS--LIHKILDPNPKTRIRIEGIRKHPWFR 203
            A +   I ++L  +PK R+ I+   +HPW +
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 78/212 (36%), Positives = 124/212 (58%), Gaps = 12/212 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 61  AHCHSKGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + HS  + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAP
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAP 186
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFST 173
           E+++     G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T
Sbjct: 187 EIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNT 244
Query: 174 GATS--LIHKILDPNPKTRIRIEGIRKHPWFR 203
            A +   I ++L  +PK R+ I+   +HPW +
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 79/212 (37%), Positives = 124/212 (58%), Gaps = 12/212 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 61  AHCHSKGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + HS  + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAP
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPAFVAP 186
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFST 173
           E++ N    G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNT 244
Query: 174 GATS--LIHKILDPNPKTRIRIEGIRKHPWFR 203
            A +   I ++L  +PK R+ I+   +HPW +
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 78/212 (36%), Positives = 124/212 (58%), Gaps = 12/212 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 61  AHCHSKGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + HS  + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAP
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAP 186
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFST 173
           E+++     G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T
Sbjct: 187 EIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNT 244
Query: 174 GATS--LIHKILDPNPKTRIRIEGIRKHPWFR 203
            A +   I ++L  +PK R+ I+   +HPW +
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 78/212 (36%), Positives = 124/212 (58%), Gaps = 12/212 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 61  AHCHSKGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + HS  + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAP
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAP 186
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFST 173
           E+++     G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T
Sbjct: 187 EIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNT 244
Query: 174 GATS--LIHKILDPNPKTRIRIEGIRKHPWFR 203
            A +   I ++L  +PK R+ I+   +HPW +
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 78/212 (36%), Positives = 124/212 (58%), Gaps = 12/212 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 61  AHCHSKGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + HS  + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAP
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAP 186
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFST 173
           E+++     G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T
Sbjct: 187 EIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNT 244
Query: 174 GATS--LIHKILDPNPKTRIRIEGIRKHPWFR 203
            A +   I ++L  +PK R+ I+   +HPW +
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 78/212 (36%), Positives = 124/212 (58%), Gaps = 12/212 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V
Sbjct: 67  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 61  AHCHSKGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + HS  + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAP
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAP 185
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFST 173
           E+++     G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T
Sbjct: 186 EIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNT 243
Query: 174 GATS--LIHKILDPNPKTRIRIEGIRKHPWFR 203
            A +   I ++L  +PK R+ I+   +HPW +
Sbjct: 244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 78/212 (36%), Positives = 124/212 (58%), Gaps = 12/212 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V
Sbjct: 67  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 61  AHCHSKGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + HS  + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAP
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAP 185
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFST 173
           E+++     G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T
Sbjct: 186 EIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNT 243
Query: 174 GATS--LIHKILDPNPKTRIRIEGIRKHPWFR 203
            A +   I ++L  +PK R+ I+   +HPW +
Sbjct: 244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 78/212 (36%), Positives = 124/212 (58%), Gaps = 12/212 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 61  AHCHSKGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + HS  + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAP
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAP 186
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFST 173
           E+++     G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T
Sbjct: 187 EIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNT 244
Query: 174 GATS--LIHKILDPNPKTRIRIEGIRKHPWFR 203
            A +   I ++L  +PK R+ I+   +HPW +
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 79/210 (37%), Positives = 111/210 (52%), Gaps = 10/210 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K + HPNI +L+E    +   Y++ E  TGGELFD+I+ + R  E D  R  +Q++  +
Sbjct: 80  LKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGI 139
Query: 61  AHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + H   + HRDLKPENLLL+S     N+++ DFGLS    +  +      GT  Y+APE
Sbjct: 140 TYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKXKDKIGTAYYIAPE 198
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FST 173
           VL    YD    DVWS GVIL++L++G  PF   +   + KK+   +  F  P W   S 
Sbjct: 199 VLHGT-YD-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE 256
Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
            A  LI K L   P  RI       H W +
Sbjct: 257 SAKDLIRKXLTYVPSXRISARDALDHEWIQ 286

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 80/209 (38%), Positives = 122/209 (58%), Gaps = 10/209 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V H N++ LH+V  +RT V +ILE V+GGELFD +  +  L E +   + +Q++D V
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 61  AHCHSKGVYHRDLKPEN-LLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + H+K + H DLKPEN +LLD      ++K+ DFGL+   + GVE      GTP +VAP
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAP 187
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA-EFSCPFWFSTG 174
           E++ N    G  AD+WS GVI ++L++G  PF G+T   TL    + + +F   F+  T 
Sbjct: 188 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246
Query: 175 --ATSLIHKILDPNPKTRIRIEGIRKHPW 201
             A   I K+L    + R+ I+   +HPW
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  134 bits (338), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 72/213 (33%), Positives = 117/213 (54%), Gaps = 12/213 (5%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           K+  HPNI++L +   + T  +++ + +  GELFD +  +  L E + R+  + L++ + 
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 138
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL-- 119
             H   + HRDLKPEN+LLD   N+K++DFG S     G E L + CGTP+Y+APE++  
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLRSVCGTPSYLAPEIIEC 197
Query: 120 ----SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--F 171
               ++ GY G   D+WS GVI++ L+AG  PF       + + I +   +F  P W  +
Sbjct: 198 SMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 256
Query: 172 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           S     L+ + L   P+ R   E    HP+F++
Sbjct: 257 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  134 bits (338), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 79/209 (37%), Positives = 122/209 (58%), Gaps = 10/209 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V H N++ LH+V  +RT V +ILE V+GGELFD +  +  L E +   + +Q++D V
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 61  AHCHSKGVYHRDLKPEN-LLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + H+K + H DLKPEN +LLD      ++K+ DFGL+   + GVE      GTP +VAP
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAP 187
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA-EFSCPFWFSTG 174
           E+++     G  AD+WS GVI ++L++G  PF G+T   TL    + + +F   F+  T 
Sbjct: 188 EIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246
Query: 175 --ATSLIHKILDPNPKTRIRIEGIRKHPW 201
             A   I K+L    + R+ I+   +HPW
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  134 bits (338), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 82/210 (39%), Positives = 122/210 (58%), Gaps = 12/210 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V H N++ LH+V  +RT V +ILE V+GGELFD +  +  L E +   + +Q++D V
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 61  AHCHSKGVYHRDLKPEN-LLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + H+K + H DLKPEN +LLD      ++K+ DFGL+   + GVE      GTP +VAP
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAP 187
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFST 173
           E++ N    G  AD+WS GVI ++L++G  PF G+T   TL   I A   +F   F+  T
Sbjct: 188 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-ANITAVSYDFDEEFFSQT 245
Query: 174 G--ATSLIHKILDPNPKTRIRIEGIRKHPW 201
              A   I K+L    + R+ I+   +HPW
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 80/209 (38%), Positives = 122/209 (58%), Gaps = 10/209 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V H N++ LH+V  +RT V +ILE V+GGELFD +  +  L E +   + +Q++D V
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 61  AHCHSKGVYHRDLKPEN-LLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + H+K + H DLKPEN +LLD      ++K+ DFGL+   + GVE      GTP +VAP
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAP 187
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA-EFSCPFWFSTG 174
           E++ N    G  AD+WS GVI ++L++G  PF G+T   TL    + + +F   F+  T 
Sbjct: 188 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246
Query: 175 --ATSLIHKILDPNPKTRIRIEGIRKHPW 201
             A   I K+L    + R+ I+   +HPW
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 81/210 (38%), Positives = 122/210 (58%), Gaps = 12/210 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V H N++ LH+V  +RT V +ILE V+GGELFD +  +  L E +   + +Q++D V
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 61  AHCHSKGVYHRDLKPEN-LLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + H+K + H DLKPEN +LLD      ++K+ DFGL+   + GVE      GTP +VAP
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAP 187
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFST 173
           E+++     G  AD+WS GVI ++L++G  PF G+T   TL   I A   +F   F+  T
Sbjct: 188 EIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANITAVSYDFDEEFFSQT 245
Query: 174 G--ATSLIHKILDPNPKTRIRIEGIRKHPW 201
              A   I K+L    + R+ I+   +HPW
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  134 bits (337), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 70/205 (34%), Positives = 116/205 (56%), Gaps = 6/205 (2%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           V+HP IV L     +  K+Y+ILE+++GGELF ++  +G  +E+    Y  ++  A+ H 
Sbjct: 78  VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHL 137
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           H KG+ +RDLKPEN++L+  G++K++DFGL         + HT CGT  Y+APE+L   G
Sbjct: 138 HQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSG 197
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           ++  A D WS G +++ ++ G  PF   +      KI   + + P + +  A  L+ K+L
Sbjct: 198 HN-RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLL 256
Query: 184 DPNPKTRI-----RIEGIRKHPWFR 203
             N  +R+         ++ HP+FR
Sbjct: 257 KRNAASRLGAGPGDAGEVQAHPFFR 281

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  134 bits (337), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 72/213 (33%), Positives = 116/213 (54%), Gaps = 12/213 (5%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           K+  HPNI++L +   + T  +++ + +  GELFD +  +  L E + R+  + L++ + 
Sbjct: 66  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 125
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL-- 119
             H   + HRDLKPEN+LLD   N+K++DFG S     G E L   CGTP+Y+APE++  
Sbjct: 126 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIEC 184
Query: 120 ----SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--F 171
               ++ GY G   D+WS GVI++ L+AG  PF       + + I +   +F  P W  +
Sbjct: 185 SMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 243
Query: 172 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           S     L+ + L   P+ R   E    HP+F++
Sbjct: 244 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 72/213 (33%), Positives = 116/213 (54%), Gaps = 12/213 (5%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           K+  HPNI++L +   + T  +++ + +  GELFD +  +  L E + R+  + L++ + 
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 138
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL-- 119
             H   + HRDLKPEN+LLD   N+K++DFG S     G E L   CGTP+Y+APE++  
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIEC 197
Query: 120 ----SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--F 171
               ++ GY G   D+WS GVI++ L+AG  PF       + + I +   +F  P W  +
Sbjct: 198 SMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 256
Query: 172 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           S     L+ + L   P+ R   E    HP+F++
Sbjct: 257 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 77/212 (36%), Positives = 123/212 (58%), Gaps = 12/212 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++HPN++ LHEV  ++T V +I E V GGELFD +  +  L E +   + +Q+++ V
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 61  AHCHSKGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + HS  + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAP
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAP 186
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFST 173
           E+++     G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T
Sbjct: 187 EIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNT 244
Query: 174 GATS--LIHKILDPNPKTRIRIEGIRKHPWFR 203
            A +   I ++L  +PK R+ I+   +HPW +
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 72/213 (33%), Positives = 119/213 (55%), Gaps = 16/213 (7%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           HP +V LH    + ++++ ++E+V GG+L   +  Q +L E   R Y  ++  A+ + H 
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 171
Query: 66  KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 125
           +G+ +RDLK +N+LLDS G++K++D+G+     +  +   T CGTPNY+APE+L    Y 
Sbjct: 172 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY- 230
Query: 126 GSAADVWSCGVILFVLMAGYLPF---GETDLPT------LYKKINAAEFSCPFWFSTGAT 176
           G + D W+ GV++F +MAG  PF   G +D P       L++ I   +   P   S  A 
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 290
Query: 177 SLIHKILDPNPKTRI------RIEGIRKHPWFR 203
           S++   L+ +PK R+          I+ HP+FR
Sbjct: 291 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 76/210 (36%), Positives = 118/210 (56%), Gaps = 7/210 (3%)
Query: 1   MKIVRHPNIVRLHEVL--ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPN+V+L EVL   +   +Y++ E V  G + + +     L E+  R YFQ LI 
Sbjct: 90  LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLKPLSEDQARFYFQDLIK 148
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            + + H + + HRD+KP NLL+   G++K++DFG+S   +    LL  T GTP ++APE 
Sbjct: 149 GIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPES 208
Query: 119 LSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI--NAAEFSCPFWFSTG 174
           LS   + + G A DVW+ GV L+  + G  PF +  +  L+ KI   A EF      +  
Sbjct: 209 LSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAED 268
Query: 175 ATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
              LI ++LD NP++RI +  I+ HPW  +
Sbjct: 269 LKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 115/205 (56%), Gaps = 6/205 (2%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           V+HP IV L     +  K+Y+ILE+++GGELF ++  +G  +E+    Y  ++  A+ H 
Sbjct: 78  VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHL 137
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           H KG+ +RDLKPEN++L+  G++K++DFGL         + H  CGT  Y+APE+L   G
Sbjct: 138 HQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRSG 197
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           ++  A D WS G +++ ++ G  PF   +      KI   + + P + +  A  L+ K+L
Sbjct: 198 HN-RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLL 256
Query: 184 DPNPKTRI-----RIEGIRKHPWFR 203
             N  +R+         ++ HP+FR
Sbjct: 257 KRNAASRLGAGPGDAGEVQAHPFFR 281

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  131 bits (330), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 74/216 (34%), Positives = 122/216 (56%), Gaps = 22/216 (10%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           HP +V LH    + ++++ ++E+V GG+L   +  Q +L E   R Y  ++  A+ + H 
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 139
Query: 66  KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSNR 122
           +G+ +RDLK +N+LLDS G++K++D+G+    ++G+    TT   CGTPNY+APE+L   
Sbjct: 140 RGIIYRDLKLDNVLLDSEGHIKLTDYGMC---KEGLRPGDTTSXFCGTPNYIAPEILRGE 196
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPF---GETDLPT------LYKKINAAEFSCPFWFST 173
            Y G + D W+ GV++F +MAG  PF   G +D P       L++ I   +   P   S 
Sbjct: 197 DY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSMSV 255
Query: 174 GATSLIHKILDPNPKTRI------RIEGIRKHPWFR 203
            A S++   L+ +PK R+          I+ HP+FR
Sbjct: 256 KAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFR 291

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  131 bits (329), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 74/216 (34%), Positives = 122/216 (56%), Gaps = 22/216 (10%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           HP +V LH    + ++++ ++E+V GG+L   +  Q +L E   R Y  ++  A+ + H 
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 124
Query: 66  KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSNR 122
           +G+ +RDLK +N+LLDS G++K++D+G+    ++G+    TT   CGTPNY+APE+L   
Sbjct: 125 RGIIYRDLKLDNVLLDSEGHIKLTDYGMC---KEGLRPGDTTSXFCGTPNYIAPEILRGE 181
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPF---GETDLPT------LYKKINAAEFSCPFWFST 173
            Y G + D W+ GV++F +MAG  PF   G +D P       L++ I   +   P   S 
Sbjct: 182 DY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV 240
Query: 174 GATSLIHKILDPNPKTRI------RIEGIRKHPWFR 203
            A S++   L+ +PK R+          I+ HP+FR
Sbjct: 241 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 276

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 74/216 (34%), Positives = 122/216 (56%), Gaps = 22/216 (10%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           HP +V LH    + ++++ ++E+V GG+L   +  Q +L E   R Y  ++  A+ + H 
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 128
Query: 66  KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSNR 122
           +G+ +RDLK +N+LLDS G++K++D+G+    ++G+    TT   CGTPNY+APE+L   
Sbjct: 129 RGIIYRDLKLDNVLLDSEGHIKLTDYGMC---KEGLRPGDTTSXFCGTPNYIAPEILRGE 185
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPF---GETDLPT------LYKKINAAEFSCPFWFST 173
            Y G + D W+ GV++F +MAG  PF   G +D P       L++ I   +   P   S 
Sbjct: 186 DY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV 244
Query: 174 GATSLIHKILDPNPKTRI------RIEGIRKHPWFR 203
            A S++   L+ +PK R+          I+ HP+FR
Sbjct: 245 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 175
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +       T CGTP Y+APE++ 
Sbjct: 176 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGAT---WTLCGTPEYLAPEIIL 232
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 233 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 291
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 292 NLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 113/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF   +   +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G +KV+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 90  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 149
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 150 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 206
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 207 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 265
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 266 NLLQVDLTKRFGNLKNGVNDIKNHKWF 292

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 67/188 (35%), Positives = 102/188 (54%), Gaps = 1/188 (0%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
            RHP +  L     +  ++  ++E+  GGELF  +  +    E   R Y  +++ A+ + 
Sbjct: 65  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 124
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HS+ V +RD+K ENL+LD  G++K++DFGL          + T CGTP Y+APEVL +  
Sbjct: 125 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 184
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           Y G A D W  GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L
Sbjct: 185 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 243
Query: 184 DPNPKTRI 191
             +PK R+
Sbjct: 244 KKDPKQRL 251

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 175
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 176 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 232
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 233 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 291
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 292 NLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 67/188 (35%), Positives = 102/188 (54%), Gaps = 1/188 (0%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
            RHP +  L     +  ++  ++E+  GGELF  +  +    E   R Y  +++ A+ + 
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HS+ V +RD+K ENL+LD  G++K++DFGL          + T CGTP Y+APEVL +  
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           Y G A D W  GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L
Sbjct: 182 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240
Query: 184 DPNPKTRI 191
             +PK R+
Sbjct: 241 KKDPKQRL 248

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 67/188 (35%), Positives = 102/188 (54%), Gaps = 1/188 (0%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
            RHP +  L     +  ++  ++E+  GGELF  +  +    E   R Y  +++ A+ + 
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HS+ V +RD+K ENL+LD  G++K++DFGL          + T CGTP Y+APEVL +  
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           Y G A D W  GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L
Sbjct: 182 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240
Query: 184 DPNPKTRI 191
             +PK R+
Sbjct: 241 KKDPKQRL 248

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +       T CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEYLAPEIIL 212
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 88  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 147
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 148 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 204
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 205 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 263
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 264 NLLQVDLTKRFGNLKNGVNDIKNHKWF 290

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 155
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 81  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 140
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +       T CGTP Y+APE++ 
Sbjct: 141 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEYLAPEIIL 197
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 198 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 256
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 257 NLLQVDLTKRFGNLKDGVNDIKNHKWF 283

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 82  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 141
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 142 EYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 198
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 199 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 257
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 258 NLLQVDLTKRFGNLKNGVNDIKNHKWF 284

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLPNGVNDIKNHKWF 297

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+  GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENL++D  G +KV+DFGL+   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 107/202 (52%), Gaps = 3/202 (1%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           + HPNI+RL+     R ++Y+ILE+   GEL+ ++       E       ++L DA+ +C
Sbjct: 80  LHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYC 139
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           H K V HRD+KPENLLL   G LK++DFG S           T CGT +Y+ PE++  R 
Sbjct: 140 HGKKVIHRDIKPENLLLGLKGELKIADFGWSV--HAPSLRRKTMCGTLDYLPPEMIEGRM 197
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           ++    D+W  GV+ + L+ G  PF        Y++I   +   P    TGA  LI K+L
Sbjct: 198 HN-EKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLISKLL 256
Query: 184 DPNPKTRIRIEGIRKHPWFRKN 205
             NP  R+ +  +  HPW R N
Sbjct: 257 RHNPSERLPLAQVSAHPWVRAN 278

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 88  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 147
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 148 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 204
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 205 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 263
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 264 NLLQVDLTKRFGNLKNGVNDIKNHKWF 290

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENL++D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIII 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 111/207 (53%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+  GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENL++D  G +KV+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 175
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 176 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 232
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 233 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 291
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 292 NLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 109/204 (53%), Gaps = 9/204 (4%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           V  P +V+L       + +Y++LE+  GGE+F  +   GR  E   R Y  Q++    + 
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HS  + +RDLKPENLL+D  G +KV+DFG +   +     L   CGTP Y+APE++ ++G
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAPEIILSKG 215
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           Y+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+  +L
Sbjct: 216 YN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 274
Query: 184 DPNPKTRI-----RIEGIRKHPWF 202
             +   R       +  I+ H WF
Sbjct: 275 QVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 66/188 (35%), Positives = 101/188 (53%), Gaps = 1/188 (0%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
            RHP +  L     +  ++  ++E+  GGELF  +  +    E   R Y  +++ A+ + 
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HS+ V +RD+K ENL+LD  G++K++DFGL          +   CGTP Y+APEVL +  
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           Y G A D W  GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L
Sbjct: 182 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240
Query: 184 DPNPKTRI 191
             +PK R+
Sbjct: 241 KKDPKQRL 248

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  127 bits (320), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 111/207 (53%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+  GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENL++D  G +KV+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  127 bits (320), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 111/207 (53%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+  GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENL++D  G +KV+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  127 bits (320), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 66/188 (35%), Positives = 101/188 (53%), Gaps = 1/188 (0%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
            RHP +  L     +  ++  ++E+  GGELF  +  +    E   R Y  +++ A+ + 
Sbjct: 67  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 126
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HS+ V +RD+K ENL+LD  G++K++DFGL          +   CGTP Y+APEVL +  
Sbjct: 127 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 186
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           Y G A D W  GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L
Sbjct: 187 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 245
Query: 184 DPNPKTRI 191
             +PK R+
Sbjct: 246 KKDPKQRL 253

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  127 bits (320), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+  GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENL++D  G ++V+DFGL+   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  127 bits (320), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 66/188 (35%), Positives = 101/188 (53%), Gaps = 1/188 (0%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
            RHP +  L     +  ++  ++E+  GGELF  +  +    E   R Y  +++ A+ + 
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HS+ V +RD+K ENL+LD  G++K++DFGL          +   CGTP Y+APEVL +  
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           Y G A D W  GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L
Sbjct: 182 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240
Query: 184 DPNPKTRI 191
             +PK R+
Sbjct: 241 KKDPKQRL 248

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  127 bits (320), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 111/207 (53%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I  H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIXNHKWF 298

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  127 bits (320), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 66/188 (35%), Positives = 101/188 (53%), Gaps = 1/188 (0%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
            RHP +  L     +  ++  ++E+  GGELF  +  +    E   R Y  +++ A+ + 
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HS+ V +RD+K ENL+LD  G++K++DFGL          +   CGTP Y+APEVL +  
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           Y G A D W  GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L
Sbjct: 182 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240
Query: 184 DPNPKTRI 191
             +PK R+
Sbjct: 241 KKDPKQRL 248

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E++ GG++F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G +KV+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E++ GG++F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G +KV+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPN-----PKTRIRIEGIRKHPWF 202
            +L  +        +  +  I+ H WF
Sbjct: 271 NLLQVDLTKAFGNLKNGVNDIKNHKWF 297

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 111/207 (53%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+AP ++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPAIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 110/207 (53%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P + +L       + +Y+++E+  GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 155
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENL++D  G +KV+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 111/207 (53%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+  GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENL++D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 110/207 (53%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P + +L       + +Y+++E+  GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENL++D  G +KV+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 68/188 (36%), Positives = 103/188 (54%), Gaps = 2/188 (1%)
Query: 5   RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 64
           RHP +  L     +  ++  ++E+  GGELF  +  +    E+  R Y  +++ A+ + H
Sbjct: 209 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 268
Query: 65  S-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           S K V +RDLK ENL+LD  G++K++DFGL     +    + T CGTP Y+APEVL +  
Sbjct: 269 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 328
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           Y G A D W  GV+++ +M G LPF   D   L++ I   E   P      A SL+  +L
Sbjct: 329 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLL 387
Query: 184 DPNPKTRI 191
             +PK R+
Sbjct: 388 KKDPKQRL 395

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 110/207 (53%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P + +L       + +Y+++E+  GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENL++D  G +KV+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 68/188 (36%), Positives = 103/188 (54%), Gaps = 2/188 (1%)
Query: 5   RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 64
           RHP +  L     +  ++  ++E+  GGELF  +  +    E+  R Y  +++ A+ + H
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 265
Query: 65  S-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           S K V +RDLK ENL+LD  G++K++DFGL     +    + T CGTP Y+APEVL +  
Sbjct: 266 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 325
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           Y G A D W  GV+++ +M G LPF   D   L++ I   E   P      A SL+  +L
Sbjct: 326 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLL 384
Query: 184 DPNPKTRI 191
             +PK R+
Sbjct: 385 KKDPKQRL 392

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 111/207 (53%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L    GTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---AGTPEYLAPEIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 111/207 (53%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP  +APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEALAPEIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 111/207 (53%), Gaps = 9/207 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L    GTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---XGTPEYLAPEIIL 211
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 181 KILDPNPKTRI-----RIEGIRKHPWF 202
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 75/225 (33%), Positives = 119/225 (52%), Gaps = 19/225 (8%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDA 59
           M ++RHP +V LH+      ++ +I EF++GGELF+K+  +  ++ E++   Y +Q+   
Sbjct: 102 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 161
Query: 60  VAHCHSKGVYHRDLKPENLLLDS--YGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVA 115
           + H H     H DLKPEN++  +     LK+ DFGL+A   P+Q V++   T GT  + A
Sbjct: 162 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAA 218
Query: 116 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK------KINAAEFSCP 168
           PEV   +   G   D+WS GV+ ++L++G  PF GE D  TL         ++ + FS  
Sbjct: 219 PEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG- 276
Query: 169 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 213
              S      I K+L  +P TR+ I    +HPW      P + S+
Sbjct: 277 --ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQ 319

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 75/225 (33%), Positives = 119/225 (52%), Gaps = 19/225 (8%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDA 59
           M ++RHP +V LH+      ++ +I EF++GGELF+K+  +  ++ E++   Y +Q+   
Sbjct: 208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 267
Query: 60  VAHCHSKGVYHRDLKPENLLLDS--YGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVA 115
           + H H     H DLKPEN++  +     LK+ DFGL+A   P+Q V++   T GT  + A
Sbjct: 268 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAA 324
Query: 116 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK------KINAAEFSCP 168
           PEV   +   G   D+WS GV+ ++L++G  PF GE D  TL         ++ + FS  
Sbjct: 325 PEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG- 382
Query: 169 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 213
              S      I K+L  +P TR+ I    +HPW      P + S+
Sbjct: 383 --ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQ 425

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  124 bits (311), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 107/205 (52%), Gaps = 7/205 (3%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           HP + +L     +  +++ ++EFV GG+L   I    R  E   R Y  ++I A+   H 
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD 142
Query: 66  KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 125
           KG+ +RDLK +N+LLD  G+ K++DFG+            T CGTP+Y+APE+L    Y 
Sbjct: 143 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLY- 201
Query: 126 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 185
           G A D W+ GV+L+ ++ G+ PF   +   L++ I   E   P W    AT ++   +  
Sbjct: 202 GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTK 261
Query: 186 NPKTRIRI------EGIRKHPWFRK 204
           NP  R+          I +HP+F++
Sbjct: 262 NPTMRLGSLTQGGEHAILRHPFFKE 286

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 67/188 (35%), Positives = 102/188 (54%), Gaps = 2/188 (1%)
Query: 5   RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 64
           RHP +  L     +  ++  ++E+  GGELF  +  +    E+  R Y  +++ A+ + H
Sbjct: 67  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 126
Query: 65  S-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           S K V +RDLK ENL+LD  G++K++DFGL     +    +   CGTP Y+APEVL +  
Sbjct: 127 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDND 186
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           Y G A D W  GV+++ +M G LPF   D   L++ I   E   P      A SL+  +L
Sbjct: 187 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLL 245
Query: 184 DPNPKTRI 191
             +PK R+
Sbjct: 246 KKDPKQRL 253

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 67/188 (35%), Positives = 102/188 (54%), Gaps = 2/188 (1%)
Query: 5   RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 64
           RHP +  L     +  ++  ++E+  GGELF  +  +    E+  R Y  +++ A+ + H
Sbjct: 66  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 125
Query: 65  S-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           S K V +RDLK ENL+LD  G++K++DFGL     +    +   CGTP Y+APEVL +  
Sbjct: 126 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDND 185
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           Y G A D W  GV+++ +M G LPF   D   L++ I   E   P      A SL+  +L
Sbjct: 186 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLL 244
Query: 184 DPNPKTRI 191
             +PK R+
Sbjct: 245 KKDPKQRL 252

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 67/188 (35%), Positives = 102/188 (54%), Gaps = 2/188 (1%)
Query: 5   RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 64
           RHP +  L     +  ++  ++E+  GGELF  +  +    E+  R Y  +++ A+ + H
Sbjct: 68  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 127
Query: 65  S-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           S K V +RDLK ENL+LD  G++K++DFGL     +    +   CGTP Y+APEVL +  
Sbjct: 128 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDND 187
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           Y G A D W  GV+++ +M G LPF   D   L++ I   E   P      A SL+  +L
Sbjct: 188 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLL 246
Query: 184 DPNPKTRI 191
             +PK R+
Sbjct: 247 KKDPKQRL 254

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 73/216 (33%), Positives = 119/216 (55%), Gaps = 19/216 (8%)
Query: 3   IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLID 58
           +++HP+IV L E  +S   +Y++ EF+ G +L  +IV +        E     Y +Q+++
Sbjct: 82  MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVA 115
           A+ +CH   + HRD+KPEN+LL S  N   +K+ DFG++    +   +     GTP+++A
Sbjct: 142 ALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMA 201
Query: 116 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK-------KINAAEFSCP 168
           PEV+    Y G   DVW CGVILF+L++G LPF  T    L++       K+N  ++S  
Sbjct: 202 PEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWS-- 257
Query: 169 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
              S  A  L+ ++L  +P  RI +     HPW ++
Sbjct: 258 -HISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 70/205 (34%), Positives = 102/205 (49%), Gaps = 1/205 (0%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           H ++V  H        V+++LE      L +    +  L E + R Y +Q++    + H 
Sbjct: 76  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 135
Query: 66  KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 125
             V HRDLK  NL L+    +K+ DFGL+   +   E   T CGTPNY+APEVLS +G+ 
Sbjct: 136 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGH- 194
Query: 126 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 185
               DVWS G I++ L+ G  PF  + L   Y +I   E+S P   +  A SLI K+L  
Sbjct: 195 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQT 254
Query: 186 NPKTRIRIEGIRKHPWFRKNYNPVK 210
           +P  R  I  +    +F   Y P +
Sbjct: 255 DPTARPTINELLNDEFFTSGYIPAR 279

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 116/217 (53%), Gaps = 8/217 (3%)
Query: 1   MKIVRHPNIVRLHEVL--ASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQL 56
           ++ +RH N+++L +VL    + K+Y+++E+   G  E+ D +  + R        YF QL
Sbjct: 60  LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGYFCQL 118
Query: 57  IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYV 114
           ID + + HS+G+ H+D+KP NLLL + G LK+S  G++    P    +   T+ G+P + 
Sbjct: 119 IDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178
Query: 115 APEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFST 173
            PE+ +    + G   D+WS GV L+ +  G  PF   ++  L++ I    ++ P     
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGP 238
Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVK 210
             + L+  +L+  P  R  I  IR+H WFRK + P +
Sbjct: 239 PLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAE 275

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 70/205 (34%), Positives = 102/205 (49%), Gaps = 1/205 (0%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           H ++V  H        V+++LE      L +    +  L E + R Y +Q++    + H 
Sbjct: 80  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 139
Query: 66  KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 125
             V HRDLK  NL L+    +K+ DFGL+   +   E   T CGTPNY+APEVLS +G+ 
Sbjct: 140 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHS 199
Query: 126 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 185
               DVWS G I++ L+ G  PF  + L   Y +I   E+S P   +  A SLI K+L  
Sbjct: 200 FE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQT 258
Query: 186 NPKTRIRIEGIRKHPWFRKNYNPVK 210
           +P  R  I  +    +F   Y P +
Sbjct: 259 DPTARPTINELLNDEFFTSGYIPAR 283

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  121 bits (304), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 70/205 (34%), Positives = 102/205 (49%), Gaps = 1/205 (0%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           H ++V  H        V+++LE      L +    +  L E + R Y +Q++    + H 
Sbjct: 76  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 135
Query: 66  KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 125
             V HRDLK  NL L+    +K+ DFGL+   +   E   T CGTPNY+APEVLS +G+ 
Sbjct: 136 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGH- 194
Query: 126 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 185
               DVWS G I++ L+ G  PF  + L   Y +I   E+S P   +  A SLI K+L  
Sbjct: 195 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQT 254
Query: 186 NPKTRIRIEGIRKHPWFRKNYNPVK 210
           +P  R  I  +    +F   Y P +
Sbjct: 255 DPTARPTINELLNDEFFTSGYIPAR 279

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  121 bits (303), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 129/251 (51%), Gaps = 5/251 (1%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           HP +  +     ++  ++ ++E++ GG+L   I    +   +    Y  ++I  +   HS
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 136
Query: 66  KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 125
           KG+ +RDLK +N+LLD  G++K++DFG+      G    +  CGTP+Y+APE+L  + Y+
Sbjct: 137 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYN 196
Query: 126 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 185
            S  D WS GV+L+ ++ G  PF   D   L+  I       P W    A  L+ K+   
Sbjct: 197 HS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 255
Query: 186 NPKTRIRIEG-IRKHPWFRK-NYNPVKCSEEEEVNLDDVHAVFD--DIEDQYVAEQSENK 241
            P+ R+ + G IR+HP FR+ N+  ++  E +      V + FD  + + +++ E+    
Sbjct: 256 EPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLS 315
Query: 242 VGGPLLMNAFE 252
                L+N+ +
Sbjct: 316 FADRALINSMD 326

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 129/251 (51%), Gaps = 5/251 (1%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           HP +  +     ++  ++ ++E++ GG+L   I    +   +    Y  ++I  +   HS
Sbjct: 78  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 137
Query: 66  KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 125
           KG+ +RDLK +N+LLD  G++K++DFG+      G    +  CGTP+Y+APE+L  + Y+
Sbjct: 138 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKYN 197
Query: 126 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 185
            S  D WS GV+L+ ++ G  PF   D   L+  I       P W    A  L+ K+   
Sbjct: 198 HS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 256
Query: 186 NPKTRIRIEG-IRKHPWFRK-NYNPVKCSEEEEVNLDDVHAVFD--DIEDQYVAEQSENK 241
            P+ R+ + G IR+HP FR+ N+  ++  E +      V + FD  + + +++ E+    
Sbjct: 257 EPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLX 316
Query: 242 VGGPLLMNAFE 252
                L+N+ +
Sbjct: 317 FADRALINSMD 327

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 108/209 (51%), Gaps = 1/209 (0%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           K + +P++V  H        VY++LE      L +    +  + E + R + +Q I  V 
Sbjct: 97  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQ 156
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 121
           + H+  V HRDLK  NL L+   ++K+ DFGL+   +   E   T CGTPNY+APEVL  
Sbjct: 157 YLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCK 216
Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK 181
           +G+     D+WS G IL+ L+ G  PF  + L   Y +I   E+S P   +  A++LI +
Sbjct: 217 KGH-SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRR 275
Query: 182 ILDPNPKTRIRIEGIRKHPWFRKNYNPVK 210
           +L  +P  R  +  +    +F   Y P++
Sbjct: 276 MLHADPTLRPSVAELLTDEFFTSGYAPMR 304

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 72/214 (33%), Positives = 123/214 (57%), Gaps = 13/214 (6%)
Query: 3   IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 62
           I + P +V LH    + TK+++IL+++ GGELF  +  + R  E++ + Y  +++ A+ H
Sbjct: 115 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 174
Query: 63  CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVL-- 119
            H  G+ +RD+K EN+LLDS G++ ++DFGLS        E  +  CGT  Y+AP+++  
Sbjct: 175 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 234
Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPF---GETDLPT-LYKKINAAEFSCPFWFSTGA 175
            + G+D  A D WS GV+++ L+ G  PF   GE +    + ++I  +E   P   S  A
Sbjct: 235 GDSGHD-KAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 293
Query: 176 TSLIHKILDPNPKTRI-----RIEGIRKHPWFRK 204
             LI ++L  +PK R+       + I++H +F+K
Sbjct: 294 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 101/205 (49%), Gaps = 1/205 (0%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           H ++V  H        V+++LE      L +    +  L E + R Y +Q++    + H 
Sbjct: 74  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133
Query: 66  KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 125
             V HRDLK  NL L+    +K+ DFGL+   +   E     CGTPNY+APEVLS +G+ 
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 193
Query: 126 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 185
               DVWS G I++ L+ G  PF  + L   Y +I   E+S P   +  A SLI K+L  
Sbjct: 194 FE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQT 252
Query: 186 NPKTRIRIEGIRKHPWFRKNYNPVK 210
           +P  R  I  +    +F   Y P +
Sbjct: 253 DPTARPTINELLNDEFFTSGYIPAR 277

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 101/205 (49%), Gaps = 1/205 (0%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           H ++V  H        V+++LE      L +    +  L E + R Y +Q++    + H 
Sbjct: 98  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 157
Query: 66  KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 125
             V HRDLK  NL L+    +K+ DFGL+   +   E     CGTPNY+APEVLS +G+ 
Sbjct: 158 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH- 216
Query: 126 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 185
               DVWS G I++ L+ G  PF  + L   Y +I   E+S P   +  A SLI K+L  
Sbjct: 217 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQT 276
Query: 186 NPKTRIRIEGIRKHPWFRKNYNPVK 210
           +P  R  I  +    +F   Y P +
Sbjct: 277 DPTARPTINELLNDEFFTSGYIPAR 301

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 101/205 (49%), Gaps = 1/205 (0%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           H ++V  H        V+++LE      L +    +  L E + R Y +Q++    + H 
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159
Query: 66  KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 125
             V HRDLK  NL L+    +K+ DFGL+   +   E     CGTPNY+APEVLS +G+ 
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH- 218
Query: 126 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 185
               DVWS G I++ L+ G  PF  + L   Y +I   E+S P   +  A SLI K+L  
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQT 278
Query: 186 NPKTRIRIEGIRKHPWFRKNYNPVK 210
           +P  R  I  +    +F   Y P +
Sbjct: 279 DPTARPTINELLNDEFFTSGYIPAR 303

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 107/209 (51%), Gaps = 1/209 (0%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           K + +P++V  H        VY++LE      L +    +  + E + R + +Q I  V 
Sbjct: 97  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQ 156
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 121
           + H+  V HRDLK  NL L+   ++K+ DFGL+   +   E     CGTPNY+APEVL  
Sbjct: 157 YLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCK 216
Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK 181
           +G+     D+WS G IL+ L+ G  PF  + L   Y +I   E+S P   +  A++LI +
Sbjct: 217 KGH-SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRR 275
Query: 182 ILDPNPKTRIRIEGIRKHPWFRKNYNPVK 210
           +L  +P  R  +  +    +F   Y P++
Sbjct: 276 MLHADPTLRPSVAELLTDEFFTSGYAPMR 304

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 107/209 (51%), Gaps = 1/209 (0%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           K + +P++V  H        VY++LE      L +    +  + E + R + +Q I  V 
Sbjct: 97  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQ 156
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 121
           + H+  V HRDLK  NL L+   ++K+ DFGL+   +   E     CGTPNY+APEVL  
Sbjct: 157 YLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCK 216
Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK 181
           +G+     D+WS G IL+ L+ G  PF  + L   Y +I   E+S P   +  A++LI +
Sbjct: 217 KGH-SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRR 275
Query: 182 ILDPNPKTRIRIEGIRKHPWFRKNYNPVK 210
           +L  +P  R  +  +    +F   Y P++
Sbjct: 276 MLHADPTLRPSVAELLTDEFFTSGYAPMR 304

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 107/209 (51%), Gaps = 1/209 (0%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           K + +P++V  H        VY++LE      L +    +  + E + R + +Q I  V 
Sbjct: 81  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQ 140
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 121
           + H+  V HRDLK  NL L+   ++K+ DFGL+   +   E     CGTPNY+APEVL  
Sbjct: 141 YLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCK 200
Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK 181
           +G+     D+WS G IL+ L+ G  PF  + L   Y +I   E+S P   +  A++LI +
Sbjct: 201 KGH-SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRR 259
Query: 182 ILDPNPKTRIRIEGIRKHPWFRKNYNPVK 210
           +L  +P  R  +  +    +F   Y P++
Sbjct: 260 MLHADPTLRPSVAELLTDEFFTSGYAPMR 288

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 111/205 (54%), Gaps = 6/205 (2%)
Query: 5   RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 64
           + P + +LH    +  ++Y ++E+V GG+L   I   G+  E     Y  ++   +   H
Sbjct: 78  KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLH 137
Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 124
            +G+ +RDLK +N++LDS G++K++DFG+              CGTP+Y+APE+++ + Y
Sbjct: 138 KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPY 197
Query: 125 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 184
            G + D W+ GV+L+ ++AG  PF   D   L++ I     S P   S  A S+   ++ 
Sbjct: 198 -GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT 256
Query: 185 PNPKTRIRI--EG---IRKHPWFRK 204
            +P  R+    EG   +R+H +FR+
Sbjct: 257 KHPAKRLGCGPEGERDVREHAFFRR 281

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  117 bits (294), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 60/160 (37%), Positives = 92/160 (57%), Gaps = 1/160 (0%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K V+HP +V LH    +  K+Y +L+++ GGELF  +  +   LE   R Y  ++  A+
Sbjct: 93  LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASAL 152
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPEN+LLDS G++ ++DFGL     +      T CGTP Y+APEVL 
Sbjct: 153 GYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLH 212
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 160
            + YD +  D W  G +L+ ++ G  PF   +   +Y  I
Sbjct: 213 KQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 251

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 79/216 (36%), Positives = 109/216 (50%), Gaps = 19/216 (8%)
Query: 7   PNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAV 60
           P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +     + + +A+
Sbjct: 121 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 180
Query: 61  AHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + HS  + HRD+KPENLL  S      LK++DFG  A        L T C TP YVAPE
Sbjct: 181 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPE 239
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA--EFSCPFW- 170
           VL    YD S  D+WS GVI+++L+ GY PF    G    P +  +I     EF  P W 
Sbjct: 240 VLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 298
Query: 171 -FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
             S     LI  +L   P  R+ I     HPW  ++
Sbjct: 299 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 334

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 79/216 (36%), Positives = 109/216 (50%), Gaps = 19/216 (8%)
Query: 7   PNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAV 60
           P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +     + + +A+
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 61  AHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + HS  + HRD+KPENLL  S      LK++DFG  A        L T C TP YVAPE
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPE 189
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA--EFSCPFW- 170
           VL    YD S  D+WS GVI+++L+ GY PF    G    P +  +I     EF  P W 
Sbjct: 190 VLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 248
Query: 171 -FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
             S     LI  +L   P  R+ I     HPW  ++
Sbjct: 249 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 284

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  117 bits (293), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 79/216 (36%), Positives = 109/216 (50%), Gaps = 19/216 (8%)
Query: 7   PNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAV 60
           P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +     + + +A+
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 174
Query: 61  AHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + HS  + HRD+KPENLL  S      LK++DFG  A        L T C TP YVAPE
Sbjct: 175 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPE 233
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA--EFSCPFW- 170
           VL    YD S  D+WS GVI+++L+ GY PF    G    P +  +I     EF  P W 
Sbjct: 234 VLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 292
Query: 171 -FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
             S     LI  +L   P  R+ I     HPW  ++
Sbjct: 293 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 79/216 (36%), Positives = 109/216 (50%), Gaps = 19/216 (8%)
Query: 7   PNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAV 60
           P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +     + + +A+
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 61  AHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + HS  + HRD+KPENLL  S      LK++DFG  A        L T C TP YVAPE
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPE 189
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA--EFSCPFW- 170
           VL    YD S  D+WS GVI+++L+ GY PF    G    P +  +I     EF  P W 
Sbjct: 190 VLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 248
Query: 171 -FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
             S     LI  +L   P  R+ I     HPW  ++
Sbjct: 249 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 284

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 79/216 (36%), Positives = 109/216 (50%), Gaps = 19/216 (8%)
Query: 7   PNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAV 60
           P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +     + + +A+
Sbjct: 77  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 136
Query: 61  AHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + HS  + HRD+KPENLL  S      LK++DFG  A        L T C TP YVAPE
Sbjct: 137 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPE 195
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA--EFSCPFW- 170
           VL    YD S  D+WS GVI+++L+ GY PF    G    P +  +I     EF  P W 
Sbjct: 196 VLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 254
Query: 171 -FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
             S     LI  +L   P  R+ I     HPW  ++
Sbjct: 255 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 290

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 79/216 (36%), Positives = 109/216 (50%), Gaps = 19/216 (8%)
Query: 7   PNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAV 60
           P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +     + + +A+
Sbjct: 69  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 128
Query: 61  AHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + HS  + HRD+KPENLL  S      LK++DFG  A        L T C TP YVAPE
Sbjct: 129 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPE 187
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA--EFSCPFW- 170
           VL    YD S  D+WS GVI+++L+ GY PF    G    P +  +I     EF  P W 
Sbjct: 188 VLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 246
Query: 171 -FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
             S     LI  +L   P  R+ I     HPW  ++
Sbjct: 247 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 282

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 79/216 (36%), Positives = 109/216 (50%), Gaps = 19/216 (8%)
Query: 7   PNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAV 60
           P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +     + + +A+
Sbjct: 76  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 135
Query: 61  AHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + HS  + HRD+KPENLL  S      LK++DFG  A        L T C TP YVAPE
Sbjct: 136 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPE 194
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA--EFSCPFW- 170
           VL    YD S  D+WS GVI+++L+ GY PF    G    P +  +I     EF  P W 
Sbjct: 195 VLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 253
Query: 171 -FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
             S     LI  +L   P  R+ I     HPW  ++
Sbjct: 254 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 289

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 117/217 (53%), Gaps = 15/217 (6%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDA 59
           M  + HP ++ LH+    + ++ +ILEF++GGELFD+I  +  ++ E +   Y +Q  + 
Sbjct: 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 161
Query: 60  VAHCHSKGVYHRDLKPENLLLDS--YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
           + H H   + H D+KPEN++ ++    ++K+ DFGL A      E++  T  T  + APE
Sbjct: 162 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL-ATKLNPDEIVKVTTATAEFAAPE 220
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK------KINAAEFSCPFW 170
           ++ +R   G   D+W+ GV+ +VL++G  PF GE DL TL        + +   FS    
Sbjct: 221 IV-DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS--- 276
Query: 171 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN 207
            S  A   I  +L   P+ R+ +    +HPW + +++
Sbjct: 277 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 79/216 (36%), Positives = 109/216 (50%), Gaps = 19/216 (8%)
Query: 7   PNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAV 60
           P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +     + + +A+
Sbjct: 85  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 144
Query: 61  AHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + HS  + HRD+KPENLL  S      LK++DFG  A        L T C TP YVAPE
Sbjct: 145 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPE 203
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA--EFSCPFW- 170
           VL    YD S  D+WS GVI+++L+ GY PF    G    P +  +I     EF  P W 
Sbjct: 204 VLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 262
Query: 171 -FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
             S     LI  +L   P  R+ I     HPW  ++
Sbjct: 263 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 298

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 79/216 (36%), Positives = 109/216 (50%), Gaps = 19/216 (8%)
Query: 7   PNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAV 60
           P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +     + + +A+
Sbjct: 75  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 134
Query: 61  AHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + HS  + HRD+KPENLL  S      LK++DFG  A        L T C TP YVAPE
Sbjct: 135 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPE 193
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA--EFSCPFW- 170
           VL    YD S  D+WS GVI+++L+ GY PF    G    P +  +I     EF  P W 
Sbjct: 194 VLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 252
Query: 171 -FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
             S     LI  +L   P  R+ I     HPW  ++
Sbjct: 253 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 288

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 79/216 (36%), Positives = 109/216 (50%), Gaps = 19/216 (8%)
Query: 7   PNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAV 60
           P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +     + + +A+
Sbjct: 70  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 129
Query: 61  AHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + HS  + HRD+KPENLL  S      LK++DFG  A        L T C TP YVAPE
Sbjct: 130 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPE 188
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA--EFSCPFW- 170
           VL    YD S  D+WS GVI+++L+ GY PF    G    P +  +I     EF  P W 
Sbjct: 189 VLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 247
Query: 171 -FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
             S     LI  +L   P  R+ I     HPW  ++
Sbjct: 248 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 283

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 72/195 (36%), Positives = 101/195 (51%), Gaps = 16/195 (8%)
Query: 24  IILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD 81
           II+E + GGELF +I  +G     E +     + +  A+   HS  + HRD+KPENLL  
Sbjct: 84  IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYT 143
Query: 82  SYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVIL 138
           S      LK++DFG +    Q    L T C TP YVAPEVL    YD S  D+WS GVI+
Sbjct: 144 SKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIM 200
Query: 139 FVLMAGYLPF----GETDLPTLYKKINAAE--FSCPFW--FSTGATSLIHKILDPNPKTR 190
           ++L+ G+ PF    G+   P + ++I   +  F  P W   S  A  LI  +L  +P  R
Sbjct: 201 YILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTER 260
Query: 191 IRIEGIRKHPWFRKN 205
           + I     HPW  ++
Sbjct: 261 LTITQFMNHPWINQS 275

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 72/195 (36%), Positives = 101/195 (51%), Gaps = 16/195 (8%)
Query: 24  IILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD 81
           II+E + GGELF +I  +G     E +     + +  A+   HS  + HRD+KPENLL  
Sbjct: 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYT 162
Query: 82  SYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVIL 138
           S      LK++DFG +    Q    L T C TP YVAPEVL    YD S  D+WS GVI+
Sbjct: 163 SKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIM 219
Query: 139 FVLMAGYLPF----GETDLPTLYKKINAAE--FSCPFW--FSTGATSLIHKILDPNPKTR 190
           ++L+ G+ PF    G+   P + ++I   +  F  P W   S  A  LI  +L  +P  R
Sbjct: 220 YILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTER 279
Query: 191 IRIEGIRKHPWFRKN 205
           + I     HPW  ++
Sbjct: 280 LTITQFMNHPWINQS 294

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 79/248 (31%), Positives = 130/248 (52%), Gaps = 17/248 (6%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M     P +V+L         +Y+++E++ GG+L + ++    + E   + Y  +++ A+
Sbjct: 129 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLAL 187
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVL 119
              HS G+ HRD+KP+N+LLD +G+LK++DFG    + + G+    T  GTP+Y++PEVL
Sbjct: 188 DAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVL 247
Query: 120 SNRGYD---GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI----NAAEFSCPFWFS 172
            ++G D   G   D WS GV LF ++ G  PF    L   Y KI    N+  F      S
Sbjct: 248 KSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEIS 307
Query: 173 TGATSLIHKILDPNPK--TRIRIEGIRKHPWFRK---NYNPVKCSEE---EEVNLDDVHA 224
             A +LI   L        R  +E I++HP+F+    N++ ++ +      E++ D   +
Sbjct: 308 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDSS 367
Query: 225 VFDDIEDQ 232
            FDDIED 
Sbjct: 368 NFDDIEDD 375

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 78/216 (36%), Positives = 108/216 (50%), Gaps = 19/216 (8%)
Query: 7   PNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAV 60
           P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +     + + +A+
Sbjct: 69  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 128
Query: 61  AHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + HS  + HRD+KPENLL  S      LK++DFG  A        L   C TP YVAPE
Sbjct: 129 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTEPCYTPYYVAPE 187
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA--EFSCPFW- 170
           VL    YD S  D+WS GVI+++L+ GY PF    G    P +  +I     EF  P W 
Sbjct: 188 VLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 246
Query: 171 -FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
             S     LI  +L   P  R+ I     HPW  ++
Sbjct: 247 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 282

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  114 bits (286), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 110/204 (53%), Gaps = 6/204 (2%)
Query: 5   RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 64
           + P + +LH    +  ++Y ++E+V GG+L   I   GR  E     Y  ++   +    
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 138
Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 124
           SKG+ +RDLK +N++LDS G++K++DFG+              CGTP+Y+APE+++ + Y
Sbjct: 139 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPY 198
Query: 125 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 184
            G + D W+ GV+L+ ++AG  PF   D   L++ I     + P   S  A ++   ++ 
Sbjct: 199 -GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 257
Query: 185 PNPKTRIRI--EG---IRKHPWFR 203
            +P  R+    EG   I++H +FR
Sbjct: 258 KHPGKRLGCGPEGERDIKEHAFFR 281

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 116/216 (53%), Gaps = 19/216 (8%)
Query: 3   IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLID 58
           +++HP+IV L E  +S   +Y++ EF+ G +L  +IV +        E     Y +Q+++
Sbjct: 84  MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 143
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVA 115
           A+ +CH   + HRD+KP  +LL S  N   +K+  FG++    +   +     GTP+++A
Sbjct: 144 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMA 203
Query: 116 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK-------KINAAEFSCP 168
           PEV+    Y G   DVW CGVILF+L++G LPF  T    L++       K+N  ++S  
Sbjct: 204 PEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWS-- 259
Query: 169 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
              S  A  L+ ++L  +P  RI +     HPW ++
Sbjct: 260 -HISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 294

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 116/216 (53%), Gaps = 19/216 (8%)
Query: 3   IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLID 58
           +++HP+IV L E  +S   +Y++ EF+ G +L  +IV +        E     Y +Q+++
Sbjct: 82  MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVA 115
           A+ +CH   + HRD+KP  +LL S  N   +K+  FG++    +   +     GTP+++A
Sbjct: 142 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMA 201
Query: 116 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK-------KINAAEFSCP 168
           PEV+    Y G   DVW CGVILF+L++G LPF  T    L++       K+N  ++S  
Sbjct: 202 PEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWS-- 257
Query: 169 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
              S  A  L+ ++L  +P  RI +     HPW ++
Sbjct: 258 -HISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 74/217 (34%), Positives = 116/217 (53%), Gaps = 19/217 (8%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGR---LLENDCRRYFQQL 56
           +K + HPNI+++ EV      +YI++E   GGEL ++IV  Q R   L E       +Q+
Sbjct: 74  LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM 133
Query: 57  IDAVAHCHSKGVYHRDLKPENLLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNY 113
           ++A+A+ HS+ V H+DLKPEN+L      +  +K+ DFGL+ L +   E      GT  Y
Sbjct: 134 MNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALY 192
Query: 114 VAPEVLSNRGYDGS-AADVWSCGVILFVLMAGYLPFGETDLPTL-----YKKINAAEFSC 167
           +APEV      D +   D+WS GV+++ L+ G LPF  T L  +     YK+ N A    
Sbjct: 193 MAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECR 249
Query: 168 PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           P   +  A  L+ ++L  +P+ R     +  H WF++
Sbjct: 250 P--LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 110/204 (53%), Gaps = 6/204 (2%)
Query: 5   RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 64
           + P + +LH    +  ++Y ++E+V GG+L   I   GR  E     Y  ++   +    
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 124
           SKG+ +RDLK +N++LDS G++K++DFG+              CGTP+Y+APE+++ + Y
Sbjct: 460 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPY 519
Query: 125 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 184
            G + D W+ GV+L+ ++AG  PF   D   L++ I     + P   S  A ++   ++ 
Sbjct: 520 -GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 578
Query: 185 PNPKTRIRI--EG---IRKHPWFR 203
            +P  R+    EG   I++H +FR
Sbjct: 579 KHPGKRLGCGPEGERDIKEHAFFR 602

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 105/200 (52%), Gaps = 10/200 (5%)
Query: 6   HPNIVRLHEVLASRTKVYIILEF-VTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 64
           HP ++RL +   ++    ++LE  +   +LFD I  +G L E   R +F Q++ A+ HCH
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH 156
Query: 65  SKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           S+GV HRD+K EN+L+D   G  K+ DFG  AL     E      GT  Y  PE +S   
Sbjct: 157 SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD--EPYTDFDGTRVYSPPEWISRHQ 214
Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           Y    A VWS G++L+ ++ G +PF E D     ++I  AE   P   S    +LI + L
Sbjct: 215 YHALPATVWSLGILLYDMVCGDIPF-ERD-----QEILEAELHFPAHVSPDCCALIRRCL 268
Query: 184 DPNPKTRIRIEGIRKHPWFR 203
            P P +R  +E I   PW +
Sbjct: 269 APKPSSRPSLEEILLDPWMQ 288

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 108/212 (50%), Gaps = 15/212 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDA 59
           M  + H N+++L++   S+  + +++E+V GGELFD+I+ +   L E D   + +Q+ + 
Sbjct: 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEG 199
Query: 60  VAHCHSKGVYHRDLKPENLLL--DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
           + H H   + H DLKPEN+L        +K+ DFGL A   +  E L    GTP ++APE
Sbjct: 200 IRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGL-ARRYKPREKLKVNFGTPEFLAPE 258
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK------KINAAEFSCPFW 170
           V+ N  +     D+WS GVI ++L++G  PF G+ D  TL         +   EF     
Sbjct: 259 VV-NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQD--- 314
Query: 171 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 202
            S  A   I K+L      RI      KHPW 
Sbjct: 315 ISEEAKEFISKLLIKEKSWRISASEALKHPWL 346

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 104/196 (53%), Gaps = 4/196 (2%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL--ENDCRRYFQQLIDAVA 61
           ++HPNIV+  E       +YI++++  GG+LF +I  Q  +L  E+    +F Q+  A+ 
Sbjct: 80  MKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK 139
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 121
           H H + + HRD+K +N+ L   G +++ DFG++ +    VEL     GTP Y++PE+  N
Sbjct: 140 HVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN 199
Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFSTGATSLIH 180
           + Y+ + +D+W+ G +L+ L      F    +  L  KI +  F      +S    SL+ 
Sbjct: 200 KPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVS 258
Query: 181 KILDPNPKTRIRIEGI 196
           ++   NP+ R  +  I
Sbjct: 259 QLFKRNPRDRPSVNSI 274

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 111/209 (53%), Gaps = 15/209 (7%)
Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCH 64
           P ++ LHEV  + +++ +ILE+  GGE+F   + +    + END  R  +Q+++ V + H
Sbjct: 89  PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 65  SKGVYHRDLKPENLLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 121
              + H DLKP+N+LL S    G++K+ DFG+S       E L    GTP Y+APE+L+ 
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYLAPEILN- 206
Query: 122 RGYD--GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA--AEFSCPFWFSTG--A 175
             YD   +A D+W+ G+I ++L+    PF   D    Y  I+    ++S   + S    A
Sbjct: 207 --YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLA 264
Query: 176 TSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           T  I  +L  NP+ R   E    H W ++
Sbjct: 265 TDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 112/210 (53%), Gaps = 9/210 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M  + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+
Sbjct: 83  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 142
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEV 118
            + H KG+ HRDLKPEN+LL+   +++++DFG + +  P+      ++  GT  YV+PE+
Sbjct: 143 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 202
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
           L+ +     ++D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L
Sbjct: 203 LTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 261
Query: 179 IHKILDPNPKTRI---RIEG---IRKHPWF 202
           + K+L  +   R+    +EG   ++ HP+F
Sbjct: 262 VEKLLVLDATKRLGCEEMEGYGPLKAHPFF 291

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 79/216 (36%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 7   PNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAV 60
           P+IVR+ +V     A R  + I+ E + GGELF +I  +G     E +     + + +A+
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAI 174
Query: 61  AHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + HS  + HRD+KPENLL  S      LK++DFG  A        L T C TP YVAPE
Sbjct: 175 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPE 233
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA--EFSCPFW- 170
           VL    YD S  D WS GVI ++L+ GY PF    G    P    +I     EF  P W 
Sbjct: 234 VLGPEKYDKS-CDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWS 292
Query: 171 -FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
             S     LI  +L   P  R  I     HPW  ++
Sbjct: 293 EVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQS 328

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 110/210 (52%), Gaps = 9/210 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M  + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 145
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEV 118
            + H KG+ HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+
Sbjct: 146 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
           L+ +    S +D+W+ G I++ L+AG  PF   +   ++ KI   E+  P  F   A  L
Sbjct: 206 LTEKSAXKS-SDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDL 264
Query: 179 IHKILDPNPKTRI---RIEG---IRKHPWF 202
           + K+L  +   R+    +EG   ++ HP+F
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 111/210 (52%), Gaps = 9/210 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M  + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+
Sbjct: 83  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 142
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEV 118
            + H KG+ HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+
Sbjct: 143 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 202
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
           L+ +     ++D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L
Sbjct: 203 LTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 261
Query: 179 IHKILDPNPKTRI---RIEG---IRKHPWF 202
           + K+L  +   R+    +EG   ++ HP+F
Sbjct: 262 VEKLLVLDATKRLGCEEMEGYGPLKAHPFF 291

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 112/210 (53%), Gaps = 9/210 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M  + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+
Sbjct: 87  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 146
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEV 118
            + H KG+ HRDLKPEN+LL+   +++++DFG + +  P+      ++  GT  YV+PE+
Sbjct: 147 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 206
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
           L+ +    S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L
Sbjct: 207 LTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 265
Query: 179 IHKILDPNPKTRI---RIEG---IRKHPWF 202
           + K+L  +   R+    +EG   ++ HP+F
Sbjct: 266 VEKLLVLDATKRLGCEEMEGYGPLKAHPFF 295

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 111/210 (52%), Gaps = 9/210 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M  + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 143
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEV 118
            + H KG+ HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+
Sbjct: 144 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPEL 203
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
           L+ +    S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L
Sbjct: 204 LTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 262
Query: 179 IHKILDPNPKTRI---RIEG---IRKHPWF 202
           + K+L  +   R+    +EG   ++ HP+F
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 111/210 (52%), Gaps = 9/210 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M  + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+
Sbjct: 68  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 127
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEV 118
            + H KG+ HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+
Sbjct: 128 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 187
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
           L+ +     ++D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L
Sbjct: 188 LTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 246
Query: 179 IHKILDPNPKTRI---RIEG---IRKHPWF 202
           + K+L  +   R+    +EG   ++ HP+F
Sbjct: 247 VEKLLVLDATKRLGCEEMEGYGPLKAHPFF 276

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 111/210 (52%), Gaps = 9/210 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M  + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+
Sbjct: 62  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 121
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEV 118
            + H KG+ HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 181
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
           L+ +     ++D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L
Sbjct: 182 LTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 240
Query: 179 IHKILDPNPKTRI---RIEG---IRKHPWF 202
           + K+L  +   R+    +EG   ++ HP+F
Sbjct: 241 VEKLLVLDATKRLGCEEMEGYGPLKAHPFF 270

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 111/210 (52%), Gaps = 9/210 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M  + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+
Sbjct: 61  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 120
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEV 118
            + H KG+ HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+
Sbjct: 121 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 180
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
           L+ +     ++D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L
Sbjct: 181 LTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 239
Query: 179 IHKILDPNPKTRI---RIEG---IRKHPWF 202
           + K+L  +   R+    +EG   ++ HP+F
Sbjct: 240 VEKLLVLDATKRLGCEEMEGYGPLKAHPFF 269

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 111/210 (52%), Gaps = 9/210 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M  + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+
Sbjct: 89  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 148
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEV 118
            + H KG+ HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+
Sbjct: 149 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 208
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
           L+ +    S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L
Sbjct: 209 LTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPKARDL 267
Query: 179 IHKILDPNPKTRI---RIEG---IRKHPWF 202
           + K+L  +   R+    +EG   ++ HP+F
Sbjct: 268 VEKLLVLDATKRLGCEEMEGYGPLKAHPFF 297

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 111/210 (52%), Gaps = 9/210 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M  + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 143
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEV 118
            + H KG+ HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+
Sbjct: 144 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
           L+ +    S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L
Sbjct: 204 LTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 262
Query: 179 IHKILDPNPKTRI---RIEG---IRKHPWF 202
           + K+L  +   R+    +EG   ++ HP+F
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 111/210 (52%), Gaps = 9/210 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M  + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 143
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEV 118
            + H KG+ HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+
Sbjct: 144 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
           L+ +    S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L
Sbjct: 204 LTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 262
Query: 179 IHKILDPNPKTRI---RIEG---IRKHPWF 202
           + K+L  +   R+    +EG   ++ HP+F
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 111/210 (52%), Gaps = 9/210 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M  + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+
Sbjct: 63  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 122
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEV 118
            + H KG+ HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+
Sbjct: 123 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 182
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
           L+ +     ++D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L
Sbjct: 183 LTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 241
Query: 179 IHKILDPNPKTRI---RIEG---IRKHPWF 202
           + K+L  +   R+    +EG   ++ HP+F
Sbjct: 242 VEKLLVLDATKRLGCEEMEGYGPLKAHPFF 271

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 111/210 (52%), Gaps = 9/210 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M  + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 145
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEV 118
            + H KG+ HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+
Sbjct: 146 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
           L+ +    S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L
Sbjct: 206 LTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 264
Query: 179 IHKILDPNPKTRI---RIEG---IRKHPWF 202
           + K+L  +   R+    +EG   ++ HP+F
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 111/210 (52%), Gaps = 9/210 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M  + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 145
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEV 118
            + H KG+ HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+
Sbjct: 146 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
           L+ +    S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L
Sbjct: 206 LTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 264
Query: 179 IHKILDPNPKTRI---RIEG---IRKHPWF 202
           + K+L  +   R+    +EG   ++ HP+F
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 111/210 (52%), Gaps = 9/210 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M  + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 143
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEV 118
            + H KG+ HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+
Sbjct: 144 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
           L+ +    S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L
Sbjct: 204 LTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 262
Query: 179 IHKILDPNPKTRI---RIEG---IRKHPWF 202
           + K+L  +   R+    +EG   ++ HP+F
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 111/210 (52%), Gaps = 9/210 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M  + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+
Sbjct: 64  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 123
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEV 118
            + H KG+ HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+
Sbjct: 124 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 183
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
           L+ +     ++D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L
Sbjct: 184 LTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 242
Query: 179 IHKILDPNPKTRI---RIEG---IRKHPWF 202
           + K+L  +   R+    +EG   ++ HP+F
Sbjct: 243 VEKLLVLDATKRLGCEEMEGYGPLKAHPFF 272

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 111/210 (52%), Gaps = 9/210 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M  + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+
Sbjct: 87  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 146
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEV 118
            + H KG+ HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+
Sbjct: 147 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 206
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
           L+ +    S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L
Sbjct: 207 LTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 265
Query: 179 IHKILDPNPKTRI---RIEG---IRKHPWF 202
           + K+L  +   R+    +EG   ++ HP+F
Sbjct: 266 VEKLLVLDATKRLGCEEMEGYGPLKAHPFF 295

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 111/210 (52%), Gaps = 9/210 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M  + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 145
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEV 118
            + H KG+ HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+
Sbjct: 146 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
           L+ +    S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L
Sbjct: 206 LTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 264
Query: 179 IHKILDPNPKTRI---RIEG---IRKHPWF 202
           + K+L  +   R+    +EG   ++ HP+F
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 110/210 (52%), Gaps = 9/210 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M  + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 145
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEV 118
            + H KG+ HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+
Sbjct: 146 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
           L+ +    S +D+W+ G I++ L+AG  PF   +   ++ KI   E+  P  F   A  L
Sbjct: 206 LTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDL 264
Query: 179 IHKILDPNPKTRI---RIEG---IRKHPWF 202
           + K+L  +   R+    +EG   ++ HP+F
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 111/210 (52%), Gaps = 9/210 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M  + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+
Sbjct: 91  MSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 150
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEV 118
            + H KG+ HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+
Sbjct: 151 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 210
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
           L+ +    S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L
Sbjct: 211 LTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 269
Query: 179 IHKILDPNPKTRI---RIEG---IRKHPWF 202
           + K+L  +   R+    +EG   ++ HP+F
Sbjct: 270 VEKLLVLDATKRLGCEEMEGYGPLKAHPFF 299

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 111/210 (52%), Gaps = 9/210 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M  + HP  V+L+       K+Y  L +   G L   I   G   E   R Y  +++ A+
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSAL 145
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEV 118
            + H KG+ HRDLKPEN+LL+   +++++DFG + +  P+      ++  GT  YV+PE+
Sbjct: 146 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 205
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
           L+ +    S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L
Sbjct: 206 LTEKSASKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 264
Query: 179 IHKILDPNPKTRI---RIEG---IRKHPWF 202
           + K+L  +   R+    +EG   ++ HP+F
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 107/212 (50%), Gaps = 13/212 (6%)
Query: 1   MKIVRHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQ 54
           ++ ++HPNIVR ++ +  RT   +YI++E+  GG+L   I    +    L E    R   
Sbjct: 59  LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 55  QLIDAVAHCHSKG-----VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG 109
           QL  A+  CH +      V HRDLKP N+ LD   N+K+ DFGL+ +         T  G
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVG 178
Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCP 168
           TP Y++PE ++   Y+   +D+WS G +L+ L A   PF       L  KI   +F   P
Sbjct: 179 TPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP 237
Query: 169 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHP 200
           + +S     +I ++L+     R  +E I ++P
Sbjct: 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENP 269

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 112/215 (52%), Gaps = 11/215 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M     P +V+L         +Y+++E++ GG+L + ++    + E   R Y  +++ A+
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLAL 186
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVL 119
              HS G  HRD+KP+N+LLD  G+LK++DFG    + ++G+    T  GTP+Y++PEVL
Sbjct: 187 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 246
Query: 120 SNR---GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI----NAAEFSCPFWFS 172
            ++   GY G   D WS GV L+ ++ G  PF    L   Y KI    N+  F      S
Sbjct: 247 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 306
Query: 173 TGATSLIHKILDPNPKT--RIRIEGIRKHPWFRKN 205
             A +LI   L        R  +E I++H +F+ +
Sbjct: 307 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 341

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 112/215 (52%), Gaps = 11/215 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M     P +V+L         +Y+++E++ GG+L + ++    + E   R Y  +++ A+
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLAL 186
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVL 119
              HS G  HRD+KP+N+LLD  G+LK++DFG    + ++G+    T  GTP+Y++PEVL
Sbjct: 187 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 246
Query: 120 SNR---GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI----NAAEFSCPFWFS 172
            ++   GY G   D WS GV L+ ++ G  PF    L   Y KI    N+  F      S
Sbjct: 247 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 306
Query: 173 TGATSLIHKILDPNPKT--RIRIEGIRKHPWFRKN 205
             A +LI   L        R  +E I++H +F+ +
Sbjct: 307 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 341

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 112/215 (52%), Gaps = 11/215 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M     P +V+L         +Y+++E++ GG+L + ++    + E   R Y  +++ A+
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLAL 181
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVL 119
              HS G  HRD+KP+N+LLD  G+LK++DFG    + ++G+    T  GTP+Y++PEVL
Sbjct: 182 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 241
Query: 120 SNR---GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI----NAAEFSCPFWFS 172
            ++   GY G   D WS GV L+ ++ G  PF    L   Y KI    N+  F      S
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 301
Query: 173 TGATSLIHKILDPNPKT--RIRIEGIRKHPWFRKN 205
             A +LI   L        R  +E I++H +F+ +
Sbjct: 302 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 106/212 (50%), Gaps = 13/212 (6%)
Query: 1   MKIVRHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQ 54
           ++ ++HPNIVR ++ +  RT   +YI++E+  GG+L   I    +    L E    R   
Sbjct: 59  LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 55  QLIDAVAHCHSKG-----VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG 109
           QL  A+  CH +      V HRDLKP N+ LD   N+K+ DFGL+ +            G
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG 178
Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCP 168
           TP Y++PE ++   Y+   +D+WS G +L+ L A   PF       L  KI   +F   P
Sbjct: 179 TPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP 237
Query: 169 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHP 200
           + +S     +I ++L+     R  +E I ++P
Sbjct: 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENP 269

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 110/213 (51%), Gaps = 8/213 (3%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILE-FVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 62
           V H NI+++ ++  ++    +++E   +G +LF  I    RL E      F+QL+ AV +
Sbjct: 86  VEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGY 145
Query: 63  CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 122
              K + HRD+K EN+++     +K+ DFG +A  ++G +L +T CGT  Y APEVL   
Sbjct: 146 LRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYTFCGTIEYCAPEVLMGN 204
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 182
            Y G   ++WS GV L+ L+    PF E     L + + AA    P+  S    SL+  +
Sbjct: 205 PYRGPELEMWSLGVTLYTLVFEENPFCE-----LEETVEAA-IHPPYLVSKELMSLVSGL 258
Query: 183 LDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEE 215
           L P P+ R  +E +   PW  +  N    + EE
Sbjct: 259 LQPVPERRTTLEKLVTDPWVTQPVNLADYTWEE 291

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 107/212 (50%), Gaps = 13/212 (6%)
Query: 1   MKIVRHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQ 54
           ++ ++HPNIVR ++ +  RT   +YI++E+  GG+L   I    +    L E    R   
Sbjct: 59  LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 55  QLIDAVAHCHSKG-----VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG 109
           QL  A+  CH +      V HRDLKP N+ LD   N+K+ DFGL+ +     +      G
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVG 178
Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCP 168
           TP Y++PE ++   Y+   +D+WS G +L+ L A   PF       L  KI   +F   P
Sbjct: 179 TPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP 237
Query: 169 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHP 200
           + +S     +I ++L+     R  +E I ++P
Sbjct: 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENP 269

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 105/199 (52%), Gaps = 11/199 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH---QGRLL-ENDCRRYFQQL 56
           +K + HPN+++ +       ++ I+LE    G+L   I H   Q RL+ E    +YF QL
Sbjct: 86  LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 57  IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
             A+ H HS+ V HRD+KP N+ + + G +K+ D GL           H+  GTP Y++P
Sbjct: 146 CSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYKKINAAEFSCPF---WF 171
           E +   GY+   +D+WS G +L+ + A   PF   + +L +L KKI   ++  P     +
Sbjct: 206 ERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP-PLPSDHY 263
Query: 172 STGATSLIHKILDPNPKTR 190
           S     L++  ++P+P+ R
Sbjct: 264 SEELRQLVNMCINPDPEKR 282

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 105/208 (50%), Gaps = 10/208 (4%)
Query: 8   NIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
            ++RL +         +ILE +    +LFD I  +G L E   R +F Q+++AV HCH+ 
Sbjct: 74  GVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 133
Query: 67  GVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 125
           GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +    Y 
Sbjct: 134 GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYH 191
Query: 126 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 185
           G +A VWS G++L+ ++ G +PF E D   +  ++   +       S+    LI   L  
Sbjct: 192 GRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSSECQHLIRWCLAL 245
Query: 186 NPKTRIRIEGIRKHPWFRKNYNPVKCSE 213
            P  R   E I+ HPW +    P + +E
Sbjct: 246 RPSDRPTFEEIQNHPWMQDVLLPQETAE 273

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/182 (35%), Positives = 95/182 (52%), Gaps = 9/182 (4%)
Query: 33  ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDF 91
           +LFD I  +G L E   R +F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DF
Sbjct: 99  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 158
Query: 92  GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET 151
           G  AL +  V       GT  Y  PE +    Y G +A VWS G++L+ ++ G +PF E 
Sbjct: 159 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EH 215
Query: 152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 211
           D   +  ++   +       S+    LI   L   P  R   E I+ HPW +    P + 
Sbjct: 216 DEEIIRGQVFFRQR-----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 270
Query: 212 SE 213
           +E
Sbjct: 271 AE 272

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/182 (35%), Positives = 94/182 (51%), Gaps = 9/182 (4%)
Query: 33  ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDF 91
           +LFD I  +G L E   R +F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DF
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 92  GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET 151
           G  AL +  V       GT  Y  PE +    Y G +A VWS G++L+ ++ G +PF E 
Sbjct: 156 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EH 212
Query: 152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 211
           D   +  ++   +       S     LI   L   P  R   E I+ HPW +    P + 
Sbjct: 213 DEEIIRGQVFFRQR-----VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 267
Query: 212 SE 213
           +E
Sbjct: 268 AE 269

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/182 (36%), Positives = 95/182 (52%), Gaps = 9/182 (4%)
Query: 33  ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDF 91
           +LFD I  +G L E   R +F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DF
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 92  GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET 151
           G  AL +  V       GT  Y  PE +    Y G +A VWS G++L+ ++ G +PF E 
Sbjct: 156 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EH 212
Query: 152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 211
           D     ++I   +       S+    LI   L   P  R   E I+ HPW +    P + 
Sbjct: 213 D-----EEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 267
Query: 212 SE 213
           +E
Sbjct: 268 AE 269

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/182 (35%), Positives = 95/182 (52%), Gaps = 9/182 (4%)
Query: 33  ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDF 91
           +LFD I  +G L E   R +F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DF
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 92  GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET 151
           G  AL +  V       GT  Y  PE +    Y G +A VWS G++L+ ++ G +PF E 
Sbjct: 161 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EH 217
Query: 152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 211
           D   +  ++   +       S+    LI   L   P  R   E I+ HPW +    P + 
Sbjct: 218 DEEIIRGQVFFRQR-----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 272
Query: 212 SE 213
           +E
Sbjct: 273 AE 274

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/182 (35%), Positives = 95/182 (52%), Gaps = 9/182 (4%)
Query: 33  ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDF 91
           +LFD I  +G L E   R +F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DF
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 92  GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET 151
           G  AL +  V       GT  Y  PE +    Y G +A VWS G++L+ ++ G +PF E 
Sbjct: 156 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EH 212
Query: 152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 211
           D   +  ++   +       S+    LI   L   P  R   E I+ HPW +    P + 
Sbjct: 213 DEEIIRGQVFFRQR-----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 267
Query: 212 SE 213
           +E
Sbjct: 268 AE 269

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/182 (35%), Positives = 95/182 (52%), Gaps = 9/182 (4%)
Query: 33  ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDF 91
           +LFD I  +G L E   R +F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DF
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 92  GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET 151
           G  AL +  V       GT  Y  PE +    Y G +A VWS G++L+ ++ G +PF E 
Sbjct: 161 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EH 217
Query: 152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 211
           D   +  ++   +       S+    LI   L   P  R   E I+ HPW +    P + 
Sbjct: 218 DEEIIRGQVFFRQR-----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 272
Query: 212 SE 213
           +E
Sbjct: 273 AE 274

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/182 (35%), Positives = 95/182 (52%), Gaps = 9/182 (4%)
Query: 33  ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDF 91
           +LFD I  +G L E   R +F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 92  GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET 151
           G  AL +  V       GT  Y  PE +    Y G +A VWS G++L+ ++ G +PF E 
Sbjct: 203 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EH 259
Query: 152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 211
           D   +  ++   +       S+    LI   L   P  R   E I+ HPW +    P + 
Sbjct: 260 DEEIIRGQVFFRQR-----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 314
Query: 212 SE 213
           +E
Sbjct: 315 AE 316

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/182 (36%), Positives = 95/182 (52%), Gaps = 9/182 (4%)
Query: 33  ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDF 91
           +LFD I  +G L E   R +F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 92  GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET 151
           G  AL +  V       GT  Y  PE +    Y G +A VWS G++L+ ++ G +PF E 
Sbjct: 188 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EH 244
Query: 152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 211
           D     ++I   +       S+    LI   L   P  R   E I+ HPW +    P + 
Sbjct: 245 D-----EEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 299
Query: 212 SE 213
           +E
Sbjct: 300 AE 301

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/182 (35%), Positives = 95/182 (52%), Gaps = 9/182 (4%)
Query: 33  ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDF 91
           +LFD I  +G L E   R +F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DF
Sbjct: 100 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 159
Query: 92  GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET 151
           G  AL +  V       GT  Y  PE +    Y G +A VWS G++L+ ++ G +PF E 
Sbjct: 160 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EH 216
Query: 152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 211
           D   +  ++   +       S+    LI   L   P  R   E I+ HPW +    P + 
Sbjct: 217 DEEIIRGQVFFRQR-----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 271
Query: 212 SE 213
           +E
Sbjct: 272 AE 273

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/182 (36%), Positives = 95/182 (52%), Gaps = 9/182 (4%)
Query: 33  ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDF 91
           +LFD I  +G L E   R +F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 92  GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET 151
           G  AL +  V       GT  Y  PE +    Y G +A VWS G++L+ ++ G +PF E 
Sbjct: 188 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EH 244
Query: 152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 211
           D     ++I   +       S+    LI   L   P  R   E I+ HPW +    P + 
Sbjct: 245 D-----EEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 299
Query: 212 SE 213
           +E
Sbjct: 300 AE 301

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/182 (36%), Positives = 95/182 (52%), Gaps = 9/182 (4%)
Query: 33  ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDF 91
           +LFD I  +G L E   R +F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 92  GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET 151
           G  AL +  V       GT  Y  PE +    Y G +A VWS G++L+ ++ G +PF E 
Sbjct: 189 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EH 245
Query: 152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 211
           D     ++I   +       S+    LI   L   P  R   E I+ HPW +    P + 
Sbjct: 246 D-----EEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 300
Query: 212 SE 213
           +E
Sbjct: 301 AE 302

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/182 (36%), Positives = 95/182 (52%), Gaps = 9/182 (4%)
Query: 33  ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDF 91
           +LFD I  +G L E   R +F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 92  GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET 151
           G  AL +  V       GT  Y  PE +    Y G +A VWS G++L+ ++ G +PF E 
Sbjct: 189 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EH 245
Query: 152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 211
           D     ++I   +       S+    LI   L   P  R   E I+ HPW +    P + 
Sbjct: 246 D-----EEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 300
Query: 212 SE 213
           +E
Sbjct: 301 AE 302

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/182 (35%), Positives = 95/182 (52%), Gaps = 9/182 (4%)
Query: 33  ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDF 91
           +LFD I  +G L E   R +F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DF
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 92  GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET 151
           G  AL +  V       GT  Y  PE +    Y G +A VWS G++L+ ++ G +PF E 
Sbjct: 161 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EH 217
Query: 152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 211
           D   +  ++   +       S+    LI   L   P  R   E I+ HPW +    P + 
Sbjct: 218 DEEIIRGQVFFRQR-----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 272
Query: 212 SE 213
           +E
Sbjct: 273 AE 274

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/182 (35%), Positives = 95/182 (52%), Gaps = 9/182 (4%)
Query: 33  ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDF 91
           +LFD I  +G L E   R +F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 92  GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET 151
           G  AL +  V       GT  Y  PE +    Y G +A VWS G++L+ ++ G +PF E 
Sbjct: 188 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EH 244
Query: 152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 211
           D   +  ++   +       S+    LI   L   P  R   E I+ HPW +    P + 
Sbjct: 245 DEEIIRGQVFFRQR-----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 299
Query: 212 SE 213
           +E
Sbjct: 300 AE 301

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/182 (35%), Positives = 95/182 (52%), Gaps = 9/182 (4%)
Query: 33  ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDF 91
           +LFD I  +G L E   R +F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 92  GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET 151
           G  AL +  V       GT  Y  PE +    Y G +A VWS G++L+ ++ G +PF E 
Sbjct: 203 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EH 259
Query: 152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 211
           D   +  ++   +       S+    LI   L   P  R   E I+ HPW +    P + 
Sbjct: 260 DEEIIRGQVFFRQR-----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 314
Query: 212 SE 213
           +E
Sbjct: 315 AE 316

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/182 (35%), Positives = 95/182 (52%), Gaps = 9/182 (4%)
Query: 33  ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDF 91
           +LFD I  +G L E   R +F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DF
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 92  GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET 151
           G  AL +  V       GT  Y  PE +    Y G +A VWS G++L+ ++ G +PF E 
Sbjct: 176 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EH 232
Query: 152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 211
           D   +  ++   +       S+    LI   L   P  R   E I+ HPW +    P + 
Sbjct: 233 DEEIIRGQVFFRQR-----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 287
Query: 212 SE 213
           +E
Sbjct: 288 AE 289

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/182 (35%), Positives = 95/182 (52%), Gaps = 9/182 (4%)
Query: 33  ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDF 91
           +LFD I  +G L E   R +F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DF
Sbjct: 115 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 174
Query: 92  GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET 151
           G  AL +  V       GT  Y  PE +    Y G +A VWS G++L+ ++ G +PF E 
Sbjct: 175 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EH 231
Query: 152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 211
           D   +  ++   +       S+    LI   L   P  R   E I+ HPW +    P + 
Sbjct: 232 DEEIIRGQVFFRQR-----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 286
Query: 212 SE 213
           +E
Sbjct: 287 AE 288

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/182 (36%), Positives = 94/182 (51%), Gaps = 9/182 (4%)
Query: 33  ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDF 91
           +LFD I  +G L E   R +F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 92  GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET 151
           G  AL +  V       GT  Y  PE +    Y G +A VWS G++L+ ++ G +PF E 
Sbjct: 188 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EH 244
Query: 152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 211
           D     ++I   +       S     LI   L   P  R   E I+ HPW +    P + 
Sbjct: 245 D-----EEIIGGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 299
Query: 212 SE 213
           +E
Sbjct: 300 AE 301

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 65/182 (35%), Positives = 95/182 (52%), Gaps = 9/182 (4%)
Query: 33  ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDF 91
           +LFD I  +G L E   R +F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DF
Sbjct: 135 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194
Query: 92  GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET 151
           G  AL +  V       GT  Y  PE +    Y G +A VWS G++L+ ++ G +PF E 
Sbjct: 195 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EH 251
Query: 152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 211
           D   +  ++   +       S+    LI   L   P  R   E I+ HPW +    P + 
Sbjct: 252 DEEIIRGQVFFRQR-----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 306
Query: 212 SE 213
           +E
Sbjct: 307 AE 308

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 108/230 (46%), Gaps = 35/230 (15%)
Query: 8   NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 67
           NI+ L E     T+ Y++ E + GG +   I  Q    E +  R  + +  A+   H+KG
Sbjct: 72  NILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKG 131
Query: 68  VYHRDLKPENLLLDS---YGNLKVSDFGL--------SALPQQGVELLHTTCGTPNYVAP 116
           + HRDLKPEN+L +S      +K+ DF L        S  P    EL  T CG+  Y+AP
Sbjct: 132 IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELT-TPCGSAEYMAP 190
Query: 117 EVL----SNRGYDGSAADVWSCGVILFVLMAGYLPF------------GE---TDLPTLY 157
           EV+        +     D+WS GV+L+++++GY PF            GE        L+
Sbjct: 191 EVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 250
Query: 158 KKINAAEFSCP--FW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
           + I   ++  P   W   S+ A  LI K+L  + K R+    + +HPW +
Sbjct: 251 ESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/182 (36%), Positives = 94/182 (51%), Gaps = 9/182 (4%)
Query: 33  ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDF 91
           +LFD I  +G L E   R +F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 92  GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET 151
           G  AL +  V       GT  Y  PE +    Y G +A VWS G++L+ ++ G +PF E 
Sbjct: 189 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EH 245
Query: 152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 211
           D     ++I   +       S     LI   L   P  R   E I+ HPW +    P + 
Sbjct: 246 D-----EEIIGGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 300
Query: 212 SE 213
           +E
Sbjct: 301 AE 302

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 66/182 (36%), Positives = 94/182 (51%), Gaps = 9/182 (4%)
Query: 33  ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDF 91
           +LFD I  +G L E   R +F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 92  GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET 151
           G  AL +  V       GT  Y  PE +    Y G +A VWS G++L+ ++ G +PF E 
Sbjct: 189 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EH 245
Query: 152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 211
           D     ++I   +       S     LI   L   P  R   E I+ HPW +    P + 
Sbjct: 246 D-----EEIIGGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 300
Query: 212 SE 213
           +E
Sbjct: 301 AE 302

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 65/182 (35%), Positives = 94/182 (51%), Gaps = 9/182 (4%)
Query: 33  ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDF 91
           +LFD I  +G L E   R +F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DF
Sbjct: 123 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 182
Query: 92  GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET 151
           G  AL +  V       GT  Y  PE +    Y G +A VWS G++L+ ++ G +PF E 
Sbjct: 183 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EH 239
Query: 152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 211
           D   +  ++   +       S     LI   L   P  R   E I+ HPW +    P + 
Sbjct: 240 DEEIIRGQVFFRQR-----VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 294
Query: 212 SE 213
           +E
Sbjct: 295 AE 296

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 65/182 (35%), Positives = 94/182 (51%), Gaps = 9/182 (4%)
Query: 33  ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDF 91
           +LFD I  +G L E   R +F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 92  GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET 151
           G  AL +  V       GT  Y  PE +    Y G +A VWS G++L+ ++ G +PF E 
Sbjct: 203 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EH 259
Query: 152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 211
           D   +  ++   +       S     LI   L   P  R   E I+ HPW +    P + 
Sbjct: 260 DEEIIRGQVFFRQR-----VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 314
Query: 212 SE 213
           +E
Sbjct: 315 AE 316

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 65/182 (35%), Positives = 94/182 (51%), Gaps = 9/182 (4%)
Query: 33  ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDF 91
           +LFD I  +G L E   R +F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DF
Sbjct: 115 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 174
Query: 92  GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET 151
           G  AL +  V       GT  Y  PE +    Y G +A VWS G++L+ ++ G +PF E 
Sbjct: 175 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EH 231
Query: 152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 211
           D   +  ++   +       S     LI   L   P  R   E I+ HPW +    P + 
Sbjct: 232 DEEIIRGQVFFRQR-----VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 286
Query: 212 SE 213
           +E
Sbjct: 287 AE 288

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 65/182 (35%), Positives = 94/182 (51%), Gaps = 9/182 (4%)
Query: 33  ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDF 91
           +LFD I  +G L E   R +F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DF
Sbjct: 148 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 207
Query: 92  GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET 151
           G  AL +  V       GT  Y  PE +    Y G +A VWS G++L+ ++ G +PF E 
Sbjct: 208 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EH 264
Query: 152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 211
           D   +  ++   +       S     LI   L   P  R   E I+ HPW +    P + 
Sbjct: 265 DEEIIRGQVFFRQR-----VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 319
Query: 212 SE 213
           +E
Sbjct: 320 AE 321

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 65/182 (35%), Positives = 94/182 (51%), Gaps = 9/182 (4%)
Query: 33  ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDF 91
           +LFD I  +G L E   R +F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DF
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 92  GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET 151
           G  AL +  V       GT  Y  PE +    Y G +A VWS G++L+ ++ G +PF E 
Sbjct: 176 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EH 232
Query: 152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 211
           D   +  ++   +       S     LI   L   P  R   E I+ HPW +    P + 
Sbjct: 233 DEEIIRGQVFFRQR-----VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 287
Query: 212 SE 213
           +E
Sbjct: 288 AE 289

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 65/182 (35%), Positives = 94/182 (51%), Gaps = 9/182 (4%)
Query: 33  ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDF 91
           +LFD I  +G L E   R +F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DF
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 92  GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET 151
           G  AL +  V       GT  Y  PE +    Y G +A VWS G++L+ ++ G +PF E 
Sbjct: 176 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EH 232
Query: 152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 211
           D   +  ++   +       S     LI   L   P  R   E I+ HPW +    P + 
Sbjct: 233 DEEIIRGQVFFRQR-----VSXECQHLIRWCLALRPXDRPTFEEIQNHPWMQDVLLPQET 287
Query: 212 SE 213
           +E
Sbjct: 288 AE 289

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 108/208 (51%), Gaps = 9/208 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M+ + HP +V L         ++++++ + GG+L   +       E   + +  +L+ A+
Sbjct: 69  MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMAL 128
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            +  ++ + HRD+KP+N+LLD +G++ ++DF ++A+  +  ++  T  GT  Y+APE+ S
Sbjct: 129 DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT-TMAGTKPYMAPEMFS 187
Query: 121 NR---GYDGSAADVWSCGVILFVLMAGYLPF---GETDLPTLYKKINAAEFSCPFWFSTG 174
           +R   GY   A D WS GV  + L+ G  P+     T    +         + P  +S  
Sbjct: 188 SRKGAGY-SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQE 246
Query: 175 ATSLIHKILDPNPKTRI-RIEGIRKHPW 201
             SL+ K+L+PNP  R  ++  ++  P+
Sbjct: 247 MVSLLKKLLEPNPDQRFSQLSDVQNFPY 274

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 114/260 (43%), Gaps = 61/260 (23%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI---------------------- 38
           MK + HPNI RL+EV      + +++E   GG L DK+                      
Sbjct: 82  MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141
Query: 39  ----------------------VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE 76
                                 V + +L+ N  R    Q+  A+ + H++G+ HRD+KPE
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMR----QIFSALHYLHNQGICHRDIKPE 197
Query: 77  NLLLDSYGN--LKVSDFGLS----ALPQQGVELLHTTCGTPNYVAPEVL--SNRGYDGSA 128
           N L  +  +  +K+ DFGLS     L       + T  GTP +VAPEVL  +N  Y G  
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY-GPK 256
Query: 129 ADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAE-FSCPFW--FSTGATSLIHKILD 184
            D WS GV+L +L+ G +PF G  D  T+ + +N    F  P +   S  A  L+  +L+
Sbjct: 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLN 316
Query: 185 PNPKTRIRIEGIRKHPWFRK 204
            N   R       +HPW  +
Sbjct: 317 RNVDERFDAMRALQHPWISQ 336

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 114/241 (47%), Gaps = 21/241 (8%)
Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P IV +     +  K+  IL+ + GG+L   +   G   E D R Y  ++I  + H H++
Sbjct: 251 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 310
Query: 67  GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 126
            V +RDLKP N+LLD +G++++SD GL+       +  H + GT  Y+APEVL       
Sbjct: 311 FVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPEVLQKGVAYD 368
Query: 127 SAADVWSCGVILFVLMAGYLPFGE---TDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           S+AD +S G +LF L+ G+ PF +    D   + +         P  FS    SL+  +L
Sbjct: 369 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 428
Query: 184 DPNPKTRIRIEG-----IRKHPWFR---------KNYNPVKCSEEEEVNLDDVHAV--FD 227
             +   R+   G     +++ P+FR         + Y P       EVN  D   +  FD
Sbjct: 429 QRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFD 488
Query: 228 D 228
           +
Sbjct: 489 E 489

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 114/241 (47%), Gaps = 21/241 (8%)
Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P IV +     +  K+  IL+ + GG+L   +   G   E D R Y  ++I  + H H++
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311
Query: 67  GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 126
            V +RDLKP N+LLD +G++++SD GL+       +  H + GT  Y+APEVL       
Sbjct: 312 FVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPEVLQKGVAYD 369
Query: 127 SAADVWSCGVILFVLMAGYLPFGE---TDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           S+AD +S G +LF L+ G+ PF +    D   + +         P  FS    SL+  +L
Sbjct: 370 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 429
Query: 184 DPNPKTRIRIEG-----IRKHPWFR---------KNYNPVKCSEEEEVNLDDVHAV--FD 227
             +   R+   G     +++ P+FR         + Y P       EVN  D   +  FD
Sbjct: 430 QRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFD 489
Query: 228 D 228
           +
Sbjct: 490 E 490

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 114/241 (47%), Gaps = 21/241 (8%)
Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P IV +     +  K+  IL+ + GG+L   +   G   E D R Y  ++I  + H H++
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311
Query: 67  GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 126
            V +RDLKP N+LLD +G++++SD GL+       +  H + GT  Y+APEVL       
Sbjct: 312 FVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPEVLQKGVAYD 369
Query: 127 SAADVWSCGVILFVLMAGYLPFGE---TDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           S+AD +S G +LF L+ G+ PF +    D   + +         P  FS    SL+  +L
Sbjct: 370 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 429
Query: 184 DPNPKTRIRIEG-----IRKHPWFR---------KNYNPVKCSEEEEVNLDDVHAV--FD 227
             +   R+   G     +++ P+FR         + Y P       EVN  D   +  FD
Sbjct: 430 QRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFD 489
Query: 228 D 228
           +
Sbjct: 490 E 490

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 114/241 (47%), Gaps = 21/241 (8%)
Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P IV +     +  K+  IL+ + GG+L   +   G   E D R Y  ++I  + H H++
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311
Query: 67  GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 126
            V +RDLKP N+LLD +G++++SD GL+       +  H + GT  Y+APEVL       
Sbjct: 312 FVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPEVLQKGVAYD 369
Query: 127 SAADVWSCGVILFVLMAGYLPFGE---TDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           S+AD +S G +LF L+ G+ PF +    D   + +         P  FS    SL+  +L
Sbjct: 370 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 429
Query: 184 DPNPKTRIRIEG-----IRKHPWFR---------KNYNPVKCSEEEEVNLDDVHAV--FD 227
             +   R+   G     +++ P+FR         + Y P       EVN  D   +  FD
Sbjct: 430 QRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFD 489
Query: 228 D 228
           +
Sbjct: 490 E 490

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 110/248 (44%), Gaps = 43/248 (17%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDK--IVHQGRLLENDCRRYFQ-Q 55
           MK ++H NIVRL++V+ +  K+ ++ EF+     +  D   + +  R LE +  +YFQ Q
Sbjct: 57  MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 56  LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVA 115
           L+  +A CH   + HRDLKP+NLL++  G LK+ DFGL+      V    +   T  Y A
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRA 176
Query: 116 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAAEFSCPFWF 171
           P+VL       ++ D+WSCG IL  ++ G   F     E  L  ++  +     S   W 
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES--LWP 234
Query: 172 ST--------------------------------GATSLIHKILDPNPKTRIRIEGIRKH 199
           S                                      +H +L  NP  R+  +    H
Sbjct: 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294
Query: 200 PWFRKNYN 207
           PWF + Y+
Sbjct: 295 PWFAEYYH 302

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 110/215 (51%), Gaps = 11/215 (5%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCH 64
           HPNIV+L +       ++I++EF  GG +   ++   R L E+  +   +Q +DA+ + H
Sbjct: 93  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 152
Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL----- 119
              + HRDLK  N+L    G++K++DFG+SA   + ++   +  GTP ++APEV+     
Sbjct: 153 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 212
Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGAT 176
            +R YD   ADVWS G+ L  +     P  E +   +  KI  +E    + P  +S+   
Sbjct: 213 KDRPYD-YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 271
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWFRKNYN-PVK 210
             + K L+ N   R     + +HP+   + N P++
Sbjct: 272 DFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIR 306

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 110/215 (51%), Gaps = 11/215 (5%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCH 64
           HPNIV+L +       ++I++EF  GG +   ++   R L E+  +   +Q +DA+ + H
Sbjct: 93  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 152
Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL----- 119
              + HRDLK  N+L    G++K++DFG+SA   + ++   +  GTP ++APEV+     
Sbjct: 153 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETS 212
Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGAT 176
            +R YD   ADVWS G+ L  +     P  E +   +  KI  +E    + P  +S+   
Sbjct: 213 KDRPYD-YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 271
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWFRKNYN-PVK 210
             + K L+ N   R     + +HP+   + N P++
Sbjct: 272 DFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIR 306

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 109/211 (51%), Gaps = 5/211 (2%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M+  +H N+V +++      ++++++EF+ GG L D IV Q RL E       + ++ A+
Sbjct: 96  MRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQAL 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           A+ H++GV HRD+K +++LL   G +K+SDFG  A   + V       GTP ++APEV+S
Sbjct: 155 AYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVIS 214
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---EFSCPFWFSTGATS 177
              Y  +  D+WS G+++  ++ G  P+         K++  +   +       S     
Sbjct: 215 RSLY-ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRD 273
Query: 178 LIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 208
            + ++L  +P+ R   + +  HP+  +   P
Sbjct: 274 FLERMLVRDPQERATAQELLDHPFLLQTGLP 304

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 112/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF++    +  D     G  L    + Y  QL+ 
Sbjct: 57  LKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPL-IKSYLFQLLQ 115
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKPENLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 116 GLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 235
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 236 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 295

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 112/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF++    +  D     G  L    + Y  QL+ 
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPL-IKSYLFQLLQ 117
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKPENLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 118 GLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 238 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 109/215 (50%), Gaps = 11/215 (5%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCH 64
           HPNIV+L +       ++I++EF  GG +   ++   R L E+  +   +Q +DA+ + H
Sbjct: 93  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 152
Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL----- 119
              + HRDLK  N+L    G++K++DFG+SA   + ++      GTP ++APEV+     
Sbjct: 153 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETS 212
Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGAT 176
            +R YD   ADVWS G+ L  +     P  E +   +  KI  +E    + P  +S+   
Sbjct: 213 KDRPYD-YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 271
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWFRKNYN-PVK 210
             + K L+ N   R     + +HP+   + N P++
Sbjct: 272 DFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIR 306

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 13/218 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDA 59
           + I RH NI+ LHE   S  ++ +I EF++G ++F++I      L E +   Y  Q+ +A
Sbjct: 55  LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEA 114
Query: 60  VAHCHSKGVYHRDLKPENLLLDSY--GNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVA 115
           +   HS  + H D++PEN++  +     +K+ +FG +    P     LL T    P Y A
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT---APEYYA 171
Query: 116 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWF 171
           PEV        +A D+WS G +++VL++G  PF       + + I  AE++         
Sbjct: 172 PEV-HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI 230
Query: 172 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
           S  A   + ++L    K+R+      +HPW ++    V
Sbjct: 231 SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERV 268

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+ 
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPL-IKSYLFQLLQ 114
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKPENLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 115 GLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 234
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 13/207 (6%)
Query: 9   IVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKG 67
           I  LH        +Y+++++  GG+L   +   + RL E   R Y  +++ A+   H   
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 68  VYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVL----SNR 122
             HRD+KP+N+L+D  G+++++DFG    L + G        GTP+Y++PE+L      +
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGK 255
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI--NAAEFSCPFW---FSTGATS 177
           G  G   D WS GV ++ ++ G  PF    L   Y KI  +   F  P      S  A  
Sbjct: 256 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKD 315
Query: 178 LIHKILDPNPKT--RIRIEGIRKHPWF 202
           LI +++        +  IE  +KHP+F
Sbjct: 316 LIRRLICSREHRLGQNGIEDFKKHPFF 342

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 112/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF++    +  D     G  L    + Y  QL+ 
Sbjct: 58  LKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPL-IKSYLFQLLQ 116
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 117 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 236
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 237 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 296

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+ 
Sbjct: 57  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQ 115
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKPENLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 116 GLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 235
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 236 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 295

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 112/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF++    +  D     G  L    + Y  QL+ 
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPL-IKSYLFQLLQ 117
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 238 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 110/233 (47%), Gaps = 29/233 (12%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH--------QGRLLENDCRRY 52
           M    HPNIV  +     + +++++++ ++GG + D I H         G L E+     
Sbjct: 67  MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 53  FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH-----TT 107
            +++++ + + H  G  HRD+K  N+LL   G+++++DFG+SA    G ++       T 
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 108 CGTPNYVAPEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPFG------------ETDLP 154
            GTP ++APEV+   RGYD   AD+WS G+    L  G  P+             + D P
Sbjct: 187 VGTPCWMAPEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245
Query: 155 TLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN 207
           +L   +   E    +  S     +I   L  +P+ R     + +H +F+K  N
Sbjct: 246 SLETGVQDKEMLKKYGKSF--RKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+ 
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQ 114
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 174
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 175 LLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 234
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+ 
Sbjct: 58  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQ 116
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKPENLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 117 GLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 236
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 237 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 296

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+ 
Sbjct: 63  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQ 121
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 122 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 181
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 182 LLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 241
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 242 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 301

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 14/208 (6%)
Query: 9   IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLIDAVAHCH 64
           IV L     ++T + +++  + GG++   I +         E     Y  Q++  + H H
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 124
            + + +RDLKPEN+LLD  GN+++SD GL+   + G        GTP ++APE+L    Y
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 125 DGSAADVWSCGVILFVLMAGYLPF---GE-TDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           D S  D ++ GV L+ ++A   PF   GE  +   L +++     + P  FS  +     
Sbjct: 367 DFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCE 425
Query: 181 KILDPNPKTRIRI-----EGIRKHPWFR 203
            +L  +P+ R+       +G+R HP FR
Sbjct: 426 ALLQKDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 14/208 (6%)
Query: 9   IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLIDAVAHCH 64
           IV L     ++T + +++  + GG++   I +         E     Y  Q++  + H H
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 124
            + + +RDLKPEN+LLD  GN+++SD GL+   + G        GTP ++APE+L    Y
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 125 DGSAADVWSCGVILFVLMAGYLPF---GE-TDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           D S  D ++ GV L+ ++A   PF   GE  +   L +++     + P  FS  +     
Sbjct: 367 DFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCE 425
Query: 181 KILDPNPKTRIRI-----EGIRKHPWFR 203
            +L  +P+ R+       +G+R HP FR
Sbjct: 426 ALLQKDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 14/208 (6%)
Query: 9   IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLIDAVAHCH 64
           IV L     ++T + +++  + GG++   I +         E     Y  Q++  + H H
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 124
            + + +RDLKPEN+LLD  GN+++SD GL+   + G        GTP ++APE+L    Y
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 125 DGSAADVWSCGVILFVLMAGYLPF---GE-TDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           D S  D ++ GV L+ ++A   PF   GE  +   L +++     + P  FS  +     
Sbjct: 367 DFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCE 425
Query: 181 KILDPNPKTRIRI-----EGIRKHPWFR 203
            +L  +P+ R+       +G+R HP FR
Sbjct: 426 ALLQKDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+ 
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQ 114
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 234
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+ 
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQ 114
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 234
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+ 
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQ 113
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 173
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 86/148 (58%), Gaps = 2/148 (1%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M+   H N+V ++       ++++++EF+ GG L D + H  R+ E         ++ A+
Sbjct: 96  MRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIATVCLSVLRAL 154
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           ++ H++GV HRD+K +++LL S G +K+SDFG  A   + V       GTP ++APEV+S
Sbjct: 155 SYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVIS 214
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPF 148
              Y G+  D+WS G+++  ++ G  P+
Sbjct: 215 RLPY-GTEVDIWSLGIMVIEMIDGEPPY 241

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+ 
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQ 114
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 234
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+ 
Sbjct: 57  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQ 115
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 116 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 235
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 236 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 295

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+ 
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQ 117
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 238 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+ 
Sbjct: 58  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQ 116
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 117 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 236
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 237 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 296

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+ 
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQ 114
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 174
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 234
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+ 
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQ 113
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 173
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+ 
Sbjct: 57  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQ 115
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 116 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 175
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 235
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 236 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 295

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 14/208 (6%)
Query: 9   IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLIDAVAHCH 64
           IV L     ++T + +++  + GG++   I +         E     Y  Q++  + H H
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 124
            + + +RDLKPEN+LLD  GN+++SD GL+   + G        GTP ++APE+L    Y
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 125 DGSAADVWSCGVILFVLMAGYLPF---GE-TDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           D S  D ++ GV L+ ++A   PF   GE  +   L +++     + P  FS  +     
Sbjct: 367 DFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCE 425
Query: 181 KILDPNPKTRI-----RIEGIRKHPWFR 203
            +L  +P+ R+       +G+R HP FR
Sbjct: 426 ALLQKDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+ 
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQ 113
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 173
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+ 
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQ 114
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 174
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 234
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+ 
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQ 113
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 173
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+ 
Sbjct: 58  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQ 116
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 117 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 236
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 237 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 296

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+ 
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQ 117
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 238 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+ 
Sbjct: 57  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQ 115
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 116 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 235
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 236 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 295

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+ 
Sbjct: 60  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQ 118
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 119 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 178
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 179 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 238
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 239 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 298

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+ 
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQ 114
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 174
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 234
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+ 
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQ 113
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 173
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+ 
Sbjct: 60  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQ 118
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 119 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 178
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 179 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 238
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 239 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 298

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/233 (30%), Positives = 109/233 (46%), Gaps = 37/233 (15%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           H N++ L E      + Y++ E + GG +   I  +    E +     Q +  A+   H+
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129
Query: 66  KGVYHRDLKPENLLLD---SYGNLKVSDFGLSA--------LPQQGVELLHTTCGTPNYV 114
           KG+ HRDLKPEN+L +       +K+ DFGL +         P    ELL T CG+  Y+
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELL-TPCGSAEYM 188
Query: 115 APEVLSNRGYDGSA----ADVWSCGVILFVLMAGYLPF------------GETDLPT--- 155
           APEV+     + S      D+WS GVIL++L++GY PF            GE   P    
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA-CPACQN 247
Query: 156 -LYKKINAAEFSCP--FW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
            L++ I   ++  P   W   S  A  LI K+L  + K R+    + +HPW +
Sbjct: 248 MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+ 
Sbjct: 63  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQ 121
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 122 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 181
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 182 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 241
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 242 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 301

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 109/230 (47%), Gaps = 29/230 (12%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH--------QGRLLENDCRRY 52
           M    HPNIV  +     + +++++++ ++GG + D I H         G L E+     
Sbjct: 62  MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 121
Query: 53  FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH-----TT 107
            +++++ + + H  G  HRD+K  N+LL   G+++++DFG+SA    G ++       T 
Sbjct: 122 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 181
Query: 108 CGTPNYVAPEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPFG------------ETDLP 154
            GTP ++APEV+   RGYD   AD+WS G+    L  G  P+             + D P
Sbjct: 182 VGTPCWMAPEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 240
Query: 155 TLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           +L   +   E    +  S     +I   L  +P+ R     + +H +F+K
Sbjct: 241 SLETGVQDKEMLKKYGKSF--RKMISLCLQKDPEKRPTAAELLRHKFFQK 288

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 110/240 (45%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF+        D     G  L    + Y  QL+ 
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPL-IKSYLFQLLQ 117
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 238 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 83/157 (52%), Gaps = 3/157 (1%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           H NIV + +V       Y+++E++ G  L + I   G L  +    +  Q++D + H H 
Sbjct: 70  HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 66  KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLSNRGY 124
             + HRD+KP+N+L+DS   LK+ DFG++ AL +  +   +   GT  Y +PE       
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 125 DGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKI 160
           D    D++S G++L+ ++ G  PF GET +    K I
Sbjct: 190 D-ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI 225

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 111/240 (46%), Gaps = 35/240 (14%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLID 58
           +K + HPNIV L +V+ S   + ++ EF+       K++ + +  L ++  + Y  QL+ 
Sbjct: 73  LKELHHPNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            VAHCH   + HRDLKP+NLL++S G LK++DFGL+      V        T  Y AP+V
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETD---LPTLYKKI---NAAEF----SC 167
           L       ++ D+WS G I   ++ G   F G TD   LP ++  +   N  E+      
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250
Query: 168 PFW-------------------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 208
           P W                   F      L+  +L  +P  RI       HP+F K+ +P
Sbjct: 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF-KDLDP 309

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 111/240 (46%), Gaps = 35/240 (14%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLID 58
           +K + HPNIV L +V+ S   + ++ EF+       K++ + +  L ++  + Y  QL+ 
Sbjct: 73  LKELHHPNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            VAHCH   + HRDLKP+NLL++S G LK++DFGL+      V        T  Y AP+V
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETD---LPTLYKKI---NAAEF----SC 167
           L       ++ D+WS G I   ++ G   F G TD   LP ++  +   N  E+      
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250
Query: 168 PFW-------------------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 208
           P W                   F      L+  +L  +P  RI       HP+F K+ +P
Sbjct: 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF-KDLDP 309

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+ 
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQ 114
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            ++ CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 115 GLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 174
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 234
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 110/240 (45%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ E V     +  D     G  L    + Y  QL+ 
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPL-IKSYLFQLLQ 117
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 238 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 109/234 (46%), Gaps = 32/234 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+ 
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQ 114
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 234
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
              + S P W                 SL+ ++L  +P  RI  +    HP+F+
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 82/158 (51%), Gaps = 1/158 (0%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K +RH N+V L EV   + + Y++ EFV    L D  +    L     ++Y  Q+I+ +
Sbjct: 78  LKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI 137
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
             CHS  + HRD+KPEN+L+   G +K+ DFG +       E+      T  Y APE+L 
Sbjct: 138 GFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLV 197
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLY 157
                G A DVW+ G ++  +  G   F G++D+  LY
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLY 235

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 106/219 (48%), Gaps = 21/219 (9%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M+  +H N+V ++       ++++++EF+ GG L D + H  R+ E         ++ A+
Sbjct: 71  MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQAL 129
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           +  H++GV HRD+K +++LL   G +K+SDFG  A   + V       GTP ++APE++S
Sbjct: 130 SVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS 189
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLP-FGET----------DLPTLYKKINAAEFSCPF 169
              Y G   D+WS G+++  ++ G  P F E           +LP   K ++        
Sbjct: 190 RLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKV------ 242
Query: 170 WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 208
             S      + ++L  +P  R     + KHP+  K   P
Sbjct: 243 --SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 279

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 106/219 (48%), Gaps = 21/219 (9%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M+  +H N+V ++       ++++++EF+ GG L D + H  R+ E         ++ A+
Sbjct: 75  MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQAL 133
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           +  H++GV HRD+K +++LL   G +K+SDFG  A   + V       GTP ++APE++S
Sbjct: 134 SVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS 193
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLP-FGET----------DLPTLYKKINAAEFSCPF 169
              Y G   D+WS G+++  ++ G  P F E           +LP   K ++        
Sbjct: 194 RLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKV------ 246
Query: 170 WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 208
             S      + ++L  +P  R     + KHP+  K   P
Sbjct: 247 --SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 283

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 106/219 (48%), Gaps = 21/219 (9%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M+  +H N+V ++       ++++++EF+ GG L D + H  R+ E         ++ A+
Sbjct: 82  MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQAL 140
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           +  H++GV HRD+K +++LL   G +K+SDFG  A   + V       GTP ++APE++S
Sbjct: 141 SVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS 200
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLP-FGET----------DLPTLYKKINAAEFSCPF 169
              Y G   D+WS G+++  ++ G  P F E           +LP   K ++        
Sbjct: 201 RLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKV------ 253
Query: 170 WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 208
             S      + ++L  +P  R     + KHP+  K   P
Sbjct: 254 --SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 290

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 106/219 (48%), Gaps = 21/219 (9%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M+  +H N+V ++       ++++++EF+ GG L D + H  R+ E         ++ A+
Sbjct: 80  MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQAL 138
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           +  H++GV HRD+K +++LL   G +K+SDFG  A   + V       GTP ++APE++S
Sbjct: 139 SVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS 198
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLP-FGET----------DLPTLYKKINAAEFSCPF 169
              Y G   D+WS G+++  ++ G  P F E           +LP   K ++        
Sbjct: 199 RLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKV------ 251
Query: 170 WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 208
             S      + ++L  +P  R     + KHP+  K   P
Sbjct: 252 --SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 288

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 110/210 (52%), Gaps = 19/210 (9%)
Query: 9   IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF--QQLIDAVAHCHSK 66
           +V L     ++  + ++L  + GG+L   I H G+    + R  F   ++   +   H +
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 67  GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 126
            + +RDLKPEN+LLD +G++++SD GL+    +G + +    GT  Y+APEV+ N  Y  
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKNERYTF 364
Query: 127 SAADVWSCGVILFVLMAGYLPFGE-------TDLPTLYKKINAAEFSCPFWFSTGATSLI 179
           S  D W+ G +L+ ++AG  PF +        ++  L K++   E+S    FS  A SL 
Sbjct: 365 S-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-PEEYS--ERFSPQARSLC 420
Query: 180 HKILDPNPKTRIRIEG-----IRKHPWFRK 204
            ++L  +P  R+   G     +++HP F+K
Sbjct: 421 SQLLCKDPAERLGCRGGSAREVKEHPLFKK 450

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 110/210 (52%), Gaps = 19/210 (9%)
Query: 9   IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF--QQLIDAVAHCHSK 66
           +V L     ++  + ++L  + GG+L   I H G+    + R  F   ++   +   H +
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 67  GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 126
            + +RDLKPEN+LLD +G++++SD GL+    +G + +    GT  Y+APEV+ N  Y  
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKNERYTF 364
Query: 127 SAADVWSCGVILFVLMAGYLPFGE-------TDLPTLYKKINAAEFSCPFWFSTGATSLI 179
           S  D W+ G +L+ ++AG  PF +        ++  L K++   E+S    FS  A SL 
Sbjct: 365 S-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-PEEYS--ERFSPQARSLC 420
Query: 180 HKILDPNPKTRIRIEG-----IRKHPWFRK 204
            ++L  +P  R+   G     +++HP F+K
Sbjct: 421 SQLLCKDPAERLGCRGGSAREVKEHPLFKK 450

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 109/240 (45%), Gaps = 32/240 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV+L +V+ +  K+Y++ E V        D     G  L    + Y  QL+ 
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPL-IKSYLFQLLQ 113
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 173
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-----------------KI 160
           L    Y  +A D+WS G I   ++     F G++++  L++                  +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 161 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 7/212 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M+  +H N+V ++       ++++++EF+ GG L D + H  R+ E         ++ A+
Sbjct: 125 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQAL 183
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           +  H++GV HRD+K +++LL   G +K+SDFG  A   + V       GTP ++APE++S
Sbjct: 184 SVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS 243
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLP-FGETDLPTLYKKIN---AAEFSCPFWFSTGAT 176
              Y G   D+WS G+++  ++ G  P F E  L  + K I              S    
Sbjct: 244 RLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-KMIRDNLPPRLKNLHKVSPSLK 301
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 208
             + ++L  +P  R     + KHP+  K   P
Sbjct: 302 GFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 333

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 106/219 (48%), Gaps = 21/219 (9%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M+  +H N+V ++       ++++++EF+ GG L D + H  R+ E         ++ A+
Sbjct: 202 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQAL 260
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           +  H++GV HRD+K +++LL   G +K+SDFG  A   + V       GTP ++APE++S
Sbjct: 261 SVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS 320
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLP-FGET----------DLPTLYKKINAAEFSCPF 169
              Y G   D+WS G+++  ++ G  P F E           +LP   K ++        
Sbjct: 321 RLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHK------- 372
Query: 170 WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 208
             S      + ++L  +P  R     + KHP+  K   P
Sbjct: 373 -VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 410

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 108/233 (46%), Gaps = 37/233 (15%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           H N++ L E      + Y++ E + GG +   I  +    E +     Q +  A+   H+
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129
Query: 66  KGVYHRDLKPENLLLD---SYGNLKVSDFGLSA--------LPQQGVELLHTTCGTPNYV 114
           KG+ HRDLKPEN+L +       +K+ DF L +         P    ELL T CG+  Y+
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL-TPCGSAEYM 188
Query: 115 APEVLSNRGYDGSA----ADVWSCGVILFVLMAGYLPF------------GETDLPT--- 155
           APEV+     + S      D+WS GVIL++L++GY PF            GE   P    
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA-CPACQN 247
Query: 156 -LYKKINAAEFSCP--FW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
            L++ I   ++  P   W   S  A  LI K+L  + K R+    + +HPW +
Sbjct: 248 MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 109/228 (47%), Gaps = 30/228 (13%)
Query: 8   NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE--NDCRRYFQQLIDAVAHCHS 65
           N V+    +  ++ ++I +E+   G L+D ++H   L +  ++  R F+Q+++A+++ HS
Sbjct: 76  NFVKPMTAVKKKSTLFIQMEYCENGTLYD-LIHSENLNQQRDEYWRLFRQILEALSYIHS 134
Query: 66  KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH--------------TTCGTP 111
           +G+ HRDLKP N+ +D   N+K+ DFGL+    + +++L               +  GT 
Sbjct: 135 QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTA 194
Query: 112 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW 170
            YVA EVL   G+     D++S G+I F ++    PF    +   + KK+ +     P  
Sbjct: 195 MYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILKKLRSVSIEFPPD 251
Query: 171 FSTGATSLIHKI----LDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEE 214
           F      +  KI    +D +P  R     +    W      PVK  +E
Sbjct: 252 FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL-----PVKHQDE 294

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 99/216 (45%), Gaps = 40/216 (18%)
Query: 7   PNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAV 60
           P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +     + + +A+
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 61  AHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + HS  + HRD+KPENLL  S      LK++DFG +                      +
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----------------------K 168
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA--EFSCPFW- 170
             +   YD S  D+WS GVI+++L+ GY PF    G    P +  +I     EF  P W 
Sbjct: 169 ETTGEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 227
Query: 171 -FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
             S     LI  +L   P  R+ I     HPW  ++
Sbjct: 228 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 106/208 (50%), Gaps = 9/208 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M+  ++PNIV   +      ++++++E++ GG L D +V +  + E       ++ + A+
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQAL 129
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA--LPQQGVELLHTTCGTPNYVAPEV 118
              HS  V HRD+K +N+LL   G++K++DFG  A   P+Q      T  GTP ++APEV
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEV 187
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLY--KKINAAEFSCPFWFSTGA 175
           ++ + Y G   D+WS G++   ++ G  P+  E  L  LY        E   P   S   
Sbjct: 188 VTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 176 TSLIHKILDPNPKTRIRIEGIRKHPWFR 203
              +++ LD + + R   + + +H + +
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELLQHQFLK 274

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 13/207 (6%)
Query: 9   IVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKG 67
           I  LH        +Y+++++  GG+L   +   + +L E+  R Y  +++ A+   H   
Sbjct: 136 ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH 195
Query: 68  VYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVL----SNR 122
             HRD+KP+N+LLD  G+++++DFG    +   G        GTP+Y++PE+L       
Sbjct: 196 YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGM 255
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW---FSTGATS 177
           G  G   D WS GV ++ ++ G  PF    L   Y KI   E  F  P      S  A  
Sbjct: 256 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKD 315
Query: 178 LIHKILDPNPKT--RIRIEGIRKHPWF 202
           LI +++    +   +  IE  +KH +F
Sbjct: 316 LIQRLICSRERRLGQNGIEDFKKHAFF 342

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 100/235 (42%), Gaps = 36/235 (15%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K ++H NIVRLH+VL S  K+ ++ EF      + FD     G L     + +  QL+ 
Sbjct: 55  LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLK 112
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +  CHS+ V HRDLKP+NLL++  G LK++DFGL+      V        T  Y  P+V
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDV 172
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF--------------------------GETD 152
           L       ++ D+WS G I   L     P                             T 
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 153 LP-----TLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 202
           LP      +Y    +     P   +TG   L+  +L  NP  RI  E   +HP+F
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATG-RDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 13/207 (6%)
Query: 9   IVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKG 67
           I  LH        +Y+++++  GG+L   +   + +L E+  R Y  +++ A+   H   
Sbjct: 152 ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH 211
Query: 68  VYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVL----SNR 122
             HRD+KP+N+LLD  G+++++DFG    +   G        GTP+Y++PE+L       
Sbjct: 212 YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGM 271
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW---FSTGATS 177
           G  G   D WS GV ++ ++ G  PF    L   Y KI   E  F  P      S  A  
Sbjct: 272 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKD 331
Query: 178 LIHKILDPNPKT--RIRIEGIRKHPWF 202
           LI +++    +   +  IE  +KH +F
Sbjct: 332 LIQRLICSRERRLGQNGIEDFKKHAFF 358

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 10/205 (4%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCH 64
           HP IV+L        K++I++EF  GG +   ++   R L E   +   +Q+++A+   H
Sbjct: 75  HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH 134
Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV-----L 119
           SK + HRDLK  N+L+   G+++++DFG+SA   + ++   +  GTP ++APEV     +
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGAT 176
            +  YD   AD+WS G+ L  +     P  E +   +  KI  ++      P  +S    
Sbjct: 195 KDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR 253
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPW 201
             +   LD NP+TR     + +HP+
Sbjct: 254 DFLKIALDKNPETRPSAAQLLEHPF 278

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 10/205 (4%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCH 64
           HP IV+L        K++I++EF  GG +   ++   R L E   +   +Q+++A+   H
Sbjct: 67  HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH 126
Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV-----L 119
           SK + HRDLK  N+L+   G+++++DFG+SA   + ++   +  GTP ++APEV     +
Sbjct: 127 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 186
Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGAT 176
            +  YD   AD+WS G+ L  +     P  E +   +  KI  ++      P  +S    
Sbjct: 187 KDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR 245
Query: 177 SLIHKILDPNPKTRIRIEGIRKHPW 201
             +   LD NP+TR     + +HP+
Sbjct: 246 DFLKIALDKNPETRPSAAQLLEHPF 270

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 77/144 (53%), Gaps = 2/144 (1%)
Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P + + +      TK++II+E++ GG   D ++  G L E       ++++  + + HS+
Sbjct: 65  PYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSE 123
Query: 67  GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 126
              HRD+K  N+LL  +G +K++DFG++          +T  GTP ++APEV+    YD 
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD- 182
Query: 127 SAADVWSCGVILFVLMAGYLPFGE 150
           S AD+WS G+    L  G  P  E
Sbjct: 183 SKADIWSLGITAIELARGEPPHSE 206

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 108/228 (47%), Gaps = 30/228 (13%)
Query: 8   NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE--NDCRRYFQQLIDAVAHCHS 65
           N V+    +  ++ ++I +E+     L+D ++H   L +  ++  R F+Q+++A+++ HS
Sbjct: 76  NFVKPMTAVKKKSTLFIQMEYCENRTLYD-LIHSENLNQQRDEYWRLFRQILEALSYIHS 134
Query: 66  KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH--------------TTCGTP 111
           +G+ HRDLKP N+ +D   N+K+ DFGL+    + +++L               +  GT 
Sbjct: 135 QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTA 194
Query: 112 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW 170
            YVA EVL   G+     D++S G+I F ++    PF    +   + KK+ +     P  
Sbjct: 195 MYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILKKLRSVSIEFPPD 251
Query: 171 FSTGATSLIHKI----LDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEE 214
           F      +  KI    +D +P  R     +    W      PVK  +E
Sbjct: 252 FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL-----PVKHQDE 294

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 105/208 (50%), Gaps = 9/208 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M+  ++PNIV   +      ++++++E++ GG L D +V +  + E       ++ + A+
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQAL 129
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA--LPQQGVELLHTTCGTPNYVAPEV 118
              HS  V HRD+K +N+LL   G++K++DFG  A   P+Q         GTP ++APEV
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SEMVGTPYWMAPEV 187
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLY--KKINAAEFSCPFWFSTGA 175
           ++ + Y G   D+WS G++   ++ G  P+  E  L  LY        E   P   S   
Sbjct: 188 VTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 176 TSLIHKILDPNPKTRIRIEGIRKHPWFR 203
              +++ LD + + R   + + +H + +
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELLQHQFLK 274

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 104/235 (44%), Gaps = 36/235 (15%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K ++H NIVRLH+VL S  K+ ++ EF      + FD     G L     + +  QL+ 
Sbjct: 55  LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLK 112
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +  CHS+ V HRDLKP+NLL++  G LK+++FGL+      V        T  Y  P+V
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172
Query: 119 LSNRGYDGSAADVWSCGVILFVLM-AGYLPFGETDLPTLYKKI----------------N 161
           L       ++ D+WS G I   L  AG   F   D+    K+I                 
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 162 AAEFSCPFWFSTGATSLIH--------------KILDPNPKTRIRIEGIRKHPWF 202
             ++  P+      TSL++               +L  NP  RI  E   +HP+F
Sbjct: 233 LPDYK-PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 77/144 (53%), Gaps = 2/144 (1%)
Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P + + +      TK++II+E++ GG   D ++  G L E       ++++  + + HS+
Sbjct: 85  PYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSE 143
Query: 67  GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 126
              HRD+K  N+LL  +G +K++DFG++          +T  GTP ++APEV+    YD 
Sbjct: 144 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD- 202
Query: 127 SAADVWSCGVILFVLMAGYLPFGE 150
           S AD+WS G+    L  G  P  E
Sbjct: 203 SKADIWSLGITAIELARGEPPHSE 226

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 89/160 (55%), Gaps = 7/160 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M+  ++PNIV   +      ++++++E++ GG L D +V +  + E       ++ + A+
Sbjct: 72  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQAL 130
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA--LPQQGVELLHTTCGTPNYVAPEV 118
              HS  V HR++K +N+LL   G++K++DFG  A   P+Q      T  GTP ++APEV
Sbjct: 131 EFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEV 188
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLY 157
           ++ + Y G   D+WS G++   ++ G  P+  E  L  LY
Sbjct: 189 VTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 227

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 99/198 (50%), Gaps = 10/198 (5%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLEND--CRRYFQQLID 58
           K ++H NIV+     +    + I +E V GG L   +  + G L +N+     Y +Q+++
Sbjct: 74  KHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE 133
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSY-GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + + H   + HRD+K +N+L+++Y G LK+SDFG S           T  GT  Y+APE
Sbjct: 134 GLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPE 193
Query: 118 VLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLP--TLYK-KINAAEFSCPFWFS 172
           ++    RGY G AAD+WS G  +  +  G  PF E   P   ++K  +       P   S
Sbjct: 194 IIDKGPRGY-GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMS 252
Query: 173 TGATSLIHKILDPNPKTR 190
             A + I K  +P+P  R
Sbjct: 253 AEAKAFILKCFEPDPDKR 270

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 88/160 (55%), Gaps = 7/160 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M+  ++PNIV   +      ++++++E++ GG L D +V +  + E       ++ + A+
Sbjct: 72  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQAL 130
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA--LPQQGVELLHTTCGTPNYVAPEV 118
              HS  V HRD+K +N+LL   G++K++DFG  A   P+Q         GTP ++APEV
Sbjct: 131 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAPEV 188
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLY 157
           ++ + Y G   D+WS G++   ++ G  P+  E  L  LY
Sbjct: 189 VTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 227

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 88/160 (55%), Gaps = 7/160 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M+  ++PNIV   +      ++++++E++ GG L D +V +  + E       ++ + A+
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQAL 129
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA--LPQQGVELLHTTCGTPNYVAPEV 118
              HS  V HRD+K +N+LL   G++K++DFG  A   P+Q         GTP ++APEV
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAPEV 187
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLY 157
           ++ + Y G   D+WS G++   ++ G  P+  E  L  LY
Sbjct: 188 VTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 82/146 (56%), Gaps = 4/146 (2%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K ++H NIV+L++V+ ++ ++ ++ E +     +L D  V +G L     + +  QL++
Sbjct: 54  LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLN 111
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A+CH + V HRDLKP+NLL++  G LK++DFGL+      V        T  Y AP+V
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDV 171
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAG 144
           L       +  D+WS G I   ++ G
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 82/146 (56%), Gaps = 4/146 (2%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K ++H NIV+L++V+ ++ ++ ++ E +     +L D  V +G L     + +  QL++
Sbjct: 54  LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLN 111
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A+CH + V HRDLKP+NLL++  G LK++DFGL+      V        T  Y AP+V
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDV 171
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAG 144
           L       +  D+WS G I   ++ G
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 99/198 (50%), Gaps = 10/198 (5%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLEND--CRRYFQQLID 58
           K ++H NIV+     +    + I +E V GG L   +  + G L +N+     Y +Q+++
Sbjct: 60  KHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE 119
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSY-GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + + H   + HRD+K +N+L+++Y G LK+SDFG S           T  GT  Y+APE
Sbjct: 120 GLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPE 179
Query: 118 VLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLP--TLYK-KINAAEFSCPFWFS 172
           ++    RGY G AAD+WS G  +  +  G  PF E   P   ++K  +       P   S
Sbjct: 180 IIDKGPRGY-GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMS 238
Query: 173 TGATSLIHKILDPNPKTR 190
             A + I K  +P+P  R
Sbjct: 239 AEAKAFILKCFEPDPDKR 256

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 82/146 (56%), Gaps = 4/146 (2%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 58
           +K ++H NIV+L++V+ ++ ++ ++ E +     +L D  V +G L     + +  QL++
Sbjct: 54  LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLN 111
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            +A+CH + V HRDLKP+NLL++  G LK++DFGL+      V        T  Y AP+V
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAG 144
           L       +  D+WS G I   ++ G
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 76/144 (52%), Gaps = 2/144 (1%)
Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P + + +      TK++II+E++ GG   D ++  G L E       ++++  + + HS+
Sbjct: 65  PYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSE 123
Query: 67  GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 126
              HRD+K  N+LL  +G +K++DFG++          +   GTP ++APEV+    YD 
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYD- 182
Query: 127 SAADVWSCGVILFVLMAGYLPFGE 150
           S AD+WS G+    L  G  P  E
Sbjct: 183 SKADIWSLGITAIELARGEPPHSE 206

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 76/144 (52%), Gaps = 2/144 (1%)
Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P + + +      TK++II+E++ GG   D ++  G L E       ++++  + + HS+
Sbjct: 80  PYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSE 138
Query: 67  GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 126
              HRD+K  N+LL  +G +K++DFG++          +   GTP ++APEV+    YD 
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYD- 197
Query: 127 SAADVWSCGVILFVLMAGYLPFGE 150
           S AD+WS G+    L  G  P  E
Sbjct: 198 SKADIWSLGITAIELARGEPPHSE 221

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MK +RHPNIV     +     + I+ E+++ G L+  +   G   + D RR      D  
Sbjct: 88  MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147
Query: 61  A-----HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVA 115
                 H  +  + HRDLK  NLL+D    +KV DFGLS L            GTP ++A
Sbjct: 148 KGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMA 207
Query: 116 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGA 175
           PEVL +   +   +DV+S GVIL+ L     P+G          +N A+      F    
Sbjct: 208 PEVLRDEPSN-EKSDVYSFGVILWELATLQQPWG---------NLNPAQVVAAVGFKCKR 257
Query: 176 TSLIHKILDPNPKTRIRIEGI-RKHPWFRKNY 206
             +   +   NP+    IEG     PW R ++
Sbjct: 258 LEIPRNL---NPQVAAIIEGCWTNEPWKRPSF 286

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 9   IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKG 67
           I +LH        +Y+++E+  GG+L   +   G R+     R Y  +++ A+   H  G
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG 182
Query: 68  VYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLS------ 120
             HRD+KP+N+LLD  G+++++DFG    L   G        GTP+Y++PE+L       
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGP 242
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI--NAAEFSCPF---WFSTGA 175
             G  G   D W+ GV  + +  G  PF        Y KI       S P         A
Sbjct: 243 GTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEA 302
Query: 176 TSLIHKILDPNPKTRIRIEG---IRKHPWF 202
              I ++L P P+TR+   G    R HP+F
Sbjct: 303 RDFIQRLLCP-PETRLGRGGAGDFRTHPFF 331

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 101/215 (46%), Gaps = 21/215 (9%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M+    P++V+ +      T ++I++E+   G + D I +    L E++     Q  +  
Sbjct: 78  MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKG 137
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 119
           + + H     HRD+K  N+LL++ G+ K++DFG++      +   +   GTP ++APEV+
Sbjct: 138 LEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVI 197
Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGE-----------TDLPTLYKKINAAEFSCP 168
              GY+   AD+WS G+    +  G  P+ +           T+ P  ++K        P
Sbjct: 198 QEIGYN-CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRK--------P 248
Query: 169 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
             +S   T  + + L  +P+ R     + +HP+ R
Sbjct: 249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 19/212 (8%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MK +RHPNIV     +     + I+ E+++ G L+  +   G   + D RR      D  
Sbjct: 88  MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147
Query: 61  A-----HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVA 115
                 H  +  + HR+LK  NLL+D    +KV DFGLS L         +  GTP ++A
Sbjct: 148 KGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMA 207
Query: 116 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGA 175
           PEVL +   +   +DV+S GVIL+ L     P+G          +N A+      F    
Sbjct: 208 PEVLRDEPSN-EKSDVYSFGVILWELATLQQPWG---------NLNPAQVVAAVGFKCKR 257
Query: 176 TSLIHKILDPNPKTRIRIEGI-RKHPWFRKNY 206
             +   +   NP+    IEG     PW R ++
Sbjct: 258 LEIPRNL---NPQVAAIIEGCWTNEPWKRPSF 286

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 105/228 (46%), Gaps = 30/228 (13%)
Query: 8   NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE--NDCRRYFQQLIDAVAHCHS 65
           N V+    +  ++ ++I  E+     L+D ++H   L +  ++  R F+Q+++A+++ HS
Sbjct: 76  NFVKPXTAVKKKSTLFIQXEYCENRTLYD-LIHSENLNQQRDEYWRLFRQILEALSYIHS 134
Query: 66  KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH--------------TTCGTP 111
           +G+ HR+LKP N+ +D   N+K+ DFGL+    + +++L               +  GT 
Sbjct: 135 QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTA 194
Query: 112 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW 170
            YVA EVL   G+     D +S G+I F  +    PF    +   + KK+ +     P  
Sbjct: 195 XYVATEVLDGTGHYNEKIDXYSLGIIFFEXI---YPFSTGXERVNILKKLRSVSIEFPPD 251
Query: 171 FSTGATSLIHKI----LDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEE 214
           F      +  KI    +D +P  R     +    W      PVK  +E
Sbjct: 252 FDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNSGWL-----PVKHQDE 294

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/162 (35%), Positives = 81/162 (50%), Gaps = 19/162 (11%)
Query: 1   MKIVRHPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRY-- 52
           MK+V H NI+ L  V   +        VYI++E      L D  + Q   +E D  R   
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME------LMDANLSQVIQMELDHERMSY 130
Query: 53  -FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGT 110
              Q++  + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T
Sbjct: 131 LLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVT 188
Query: 111 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
             Y APEV+   GY  +  D+WS GVI+  ++ G + F  TD
Sbjct: 189 RYYRAPEVILGMGYKEN-VDIWSVGVIMGEMIKGGVLFPGTD 229

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/162 (35%), Positives = 81/162 (50%), Gaps = 19/162 (11%)
Query: 1   MKIVRHPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRY-- 52
           MK+V H NI+ L  V   +        VYI++E      L D  + Q   +E D  R   
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME------LMDANLSQVIQMELDHERMSY 130
Query: 53  -FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGT 110
              Q++  + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T
Sbjct: 131 LLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVT 188
Query: 111 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
             Y APEV+   GY  +  D+WS GVI+  ++ G + F  TD
Sbjct: 189 RYYRAPEVILGMGYKEN-VDIWSVGVIMGEMIKGGVLFPGTD 229

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 93/189 (49%), Gaps = 7/189 (3%)
Query: 20  TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL 79
           +K++II+E++ GG   D ++  G   E       ++++  + + HS+   HRD+K  N+L
Sbjct: 94  SKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVL 152
Query: 80  LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 139
           L   G++K++DFG++          +T  GTP ++APEV+    YD S AD+WS G+   
Sbjct: 153 LSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYD-SKADIWSLGITAI 211
Query: 140 VLMAGYLPFGETDLPTLYKKINAAEFSCPFW---FSTGATSLIHKILDPNPKTRIRIEGI 196
            L  G  P   +D+  +       + + P     F+      I   L+ +P  R   + +
Sbjct: 212 ELAKGEPP--NSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDACLNKDPSFRPTAKEL 269
Query: 197 RKHPWFRKN 205
            KH +  KN
Sbjct: 270 LKHKFIVKN 278

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 82/159 (51%), Gaps = 3/159 (1%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++HPN+V L EV   + +++++ E+     L +   +Q  + E+  +    Q + AV
Sbjct: 56  LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAV 115
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
             CH     HRD+KPEN+L+  +  +K+ DFG + L     +       T  Y +PE+L 
Sbjct: 116 NFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLV 175
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLY 157
                G   DVW+ G +   L++G +P   G++D+  LY
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLSG-VPLWPGKSDVDQLY 213

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 73/141 (51%), Gaps = 2/141 (1%)
Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P I R        TK++II+E++ GG   D ++  G L E       ++++  + + HS+
Sbjct: 77  PYITRYFGSYLKSTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSE 135
Query: 67  GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 126
              HRD+K  N+LL   G++K++DFG++          +   GTP ++APEV+    YD 
Sbjct: 136 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYD- 194
Query: 127 SAADVWSCGVILFVLMAGYLP 147
             AD+WS G+    L  G  P
Sbjct: 195 FKADIWSLGITAIELAKGEPP 215

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 99/206 (48%), Gaps = 10/206 (4%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAV 60
           K+ +HP  VRL +       +Y+  E + G  L       G  L E     Y +  + A+
Sbjct: 112 KVGQHPCCVRLEQAWEEGGILYLQTE-LCGPSLQQHCEAWGASLPEAQVWGYLRDTLLAL 170
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFG-LSALPQQGVELLHTTCGTPNYVAPEVL 119
           AH HS+G+ H D+KP N+ L   G  K+ DFG L  L   G   +    G P Y+APE+L
Sbjct: 171 AHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE--GDPRYMAPELL 228
Query: 120 SNRGYDGSAADVWSCGV-ILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
             +G  G+AADV+S G+ IL V     LP G      L +     EF+     S+   S+
Sbjct: 229 --QGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTA--GLSSELRSV 284
Query: 179 IHKILDPNPKTRIRIEGIRKHPWFRK 204
           +  +L+P+PK R   E +   P  R+
Sbjct: 285 LVMMLEPDPKLRATAEALLALPVLRQ 310

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 106/256 (41%), Gaps = 47/256 (18%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           +K V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 75  LKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQML 134
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+        ++     T  Y APE
Sbjct: 135 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNF-MMTPYVVTRYYRAPE 193
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI------NAAEFSC---- 167
           V+   GY  +  D+WS G I+  L+ G + F  TD    + K+       +AEF      
Sbjct: 194 VILGMGYKEN-VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQP 252
Query: 168 ---------------------PFWF-----------STGATSLIHKILDPNPKTRIRIEG 195
                                P W            ++ A  L+ K+L  +P  RI ++ 
Sbjct: 253 TVRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDE 312
Query: 196 IRKHPWFRKNYNPVKC 211
             +HP+    Y+P + 
Sbjct: 313 ALRHPYITVWYDPAEA 328

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 80/162 (49%), Gaps = 19/162 (11%)
Query: 1   MKIVRHPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRY-- 52
           MK+V H NI+ L  V   +        VYI++E      L D  + Q   +E D  R   
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME------LMDANLSQVIQMELDHERMSY 130
Query: 53  -FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGT 110
              Q++  + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T
Sbjct: 131 LLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVT 188
Query: 111 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
             Y APEV+   GY  +  D+WS G I+  ++ G + F  TD
Sbjct: 189 RYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 106/255 (41%), Gaps = 47/255 (18%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           +K V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 77  LKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQML 136
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+        ++     T  Y APE
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF-MMTPYVVTRYYRAPE 195
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI------NAAEFSC---- 167
           V+   GY  +  D+WS G I+  L+ G + F  TD    + K+       +AEF      
Sbjct: 196 VILGMGY-AANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQP 254
Query: 168 ---------------------PFWF-----------STGATSLIHKILDPNPKTRIRIEG 195
                                P W            ++ A  L+ K+L  +P  RI ++ 
Sbjct: 255 TVRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDE 314
Query: 196 IRKHPWFRKNYNPVK 210
             +HP+    Y+P +
Sbjct: 315 ALRHPYITVWYDPAE 329

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 77/156 (49%), Gaps = 7/156 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           MK+V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAP 116
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y AP
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 194
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           EV+   GY  +  D+WS G I+  ++ G + F  TD
Sbjct: 195 EVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 106/239 (44%), Gaps = 44/239 (18%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-----GRLLE-NDCRRYFQ 54
           +K ++H NIV LH+++ +   + ++ E++      DK + Q     G ++  ++ + +  
Sbjct: 54  LKDLKHANIVTLHDIIHTEKSLTLVFEYL------DKDLKQYLDDCGNIINMHNVKLFLF 107
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           QL+  +A+CH + V HRDLKP+NLL++  G LK++DFGL+       +       T  Y 
Sbjct: 108 QLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR 167
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPT 155
            P++L       +  D+W  G I + +  G   F                    E   P 
Sbjct: 168 PPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 227
Query: 156 L-----YKKINAAEFS-------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 202
           +     +K  N  ++         P   S GA  L+ K+L    + RI  E   KHP+F
Sbjct: 228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGA-DLLTKLLQFEGRNRISAEDAMKHPFF 285

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 6   HPNIVRLHEVLASRTKV----YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           HP IV +++   + T      YI++E+V G  L D +  +G +              A+ 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTC--GTPNYVAPEV 118
             H  G+ HRD+KP N+L+ +   +KV DFG++ A+   G  +  T    GT  Y++PE 
Sbjct: 131 FSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQ 190
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPF-----WFS 172
                 D   +DV+S G +L+ ++ G  PF G++ +   Y+ +   E   P        S
Sbjct: 191 ARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR--EDPIPPSARHEGLS 247
Query: 173 TGATSLIHKILDPNPKTR------IRIEGIRKH 199
               +++ K L  NP+ R      +R + +R H
Sbjct: 248 ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 110/245 (44%), Gaps = 45/245 (18%)
Query: 5   RHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLID 58
           RH NI+ +++++ + T      VY++   + G +L+  +  Q   L ND   YF  Q++ 
Sbjct: 99  RHENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQH--LSNDHICYFLYQILR 155
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP---QQGVELLHTTCGTPNYVA 115
            + + HS  V HRDLKP NLLL++  +LK+ DFGL+ +          L     T  Y A
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 116 PEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPT 155
           PE++ N +GY  S  D+WS G IL  +++    F                    + DL  
Sbjct: 216 PEIMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 274
Query: 156 LYK-KINAAEFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
           +   K      S P      W        + A  L+ K+L  NP  RI +E    HP+  
Sbjct: 275 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 334
Query: 204 KNYNP 208
           + Y+P
Sbjct: 335 QYYDP 339

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 6   HPNIVRLHEVLASRTKV----YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           HP IV +++   + T      YI++E+V G  L D +  +G +              A+ 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTC--GTPNYVAPEV 118
             H  G+ HRD+KP N+++ +   +KV DFG++ A+   G  +  T    GT  Y++PE 
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPF-----WFS 172
                 D   +DV+S G +L+ ++ G  PF G++ +   Y+ +   E   P        S
Sbjct: 191 ARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR--EDPIPPSARHEGLS 247
Query: 173 TGATSLIHKILDPNPKTR------IRIEGIRKH 199
               +++ K L  NP+ R      +R + +R H
Sbjct: 248 ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 6   HPNIVRLHEVLASRTKV----YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           HP IV +++   + T      YI++E+V G  L D +  +G +              A+ 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTC--GTPNYVAPEV 118
             H  G+ HRD+KP N+++ +   +KV DFG++ A+   G  +  T    GT  Y++PE 
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPF-----WFS 172
                 D   +DV+S G +L+ ++ G  PF G++ +   Y+ +   E   P        S
Sbjct: 191 ARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR--EDPIPPSARHEGLS 247
Query: 173 TGATSLIHKILDPNPKTR------IRIEGIRKH 199
               +++ K L  NP+ R      +R + +R H
Sbjct: 248 ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 76/156 (48%), Gaps = 7/156 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           MK V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAP 116
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y AP
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 194
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           EV+   GY  +  D+WS G I+  ++ G + F  TD
Sbjct: 195 EVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 115/264 (43%), Gaps = 50/264 (18%)
Query: 5   RHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLID 58
           RH N++ + ++L + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++ 
Sbjct: 99  RHENVIGIRDILRASTLEAMRDVYIVQDLMET-DLYKLLKSQQ--LSNDHICYFLYQILR 155
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVA 115
            + + HS  V HRDLKP NLL+++  +LK+ DFGL+  A P+      L     T  Y A
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRA 215
Query: 116 PEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPF-------------------------- 148
           PE++ N +GY  S  D+WS G IL  +++    F                          
Sbjct: 216 PEIMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 274
Query: 149 -----GETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
                    L +L  K   A         + A  L+ ++L  NP  RI +E    HP+  
Sbjct: 275 IINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLE 334
Query: 204 KNYNPVKCSEEEE-----VNLDDV 222
           + Y+P      EE     + LDD+
Sbjct: 335 QYYDPTDEPVAEEPFTFAMELDDL 358

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 6   HPNIVRLHEVLASRTKV----YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           HP IV +++   + T      YI++E+V G  L D +  +G +              A+ 
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 147
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTC--GTPNYVAPEV 118
             H  G+ HRD+KP N+++ +   +KV DFG++ A+   G  +  T    GT  Y++PE 
Sbjct: 148 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 207
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPF-----WFS 172
                 D + +DV+S G +L+ ++ G  PF G++ +   Y+ +   E   P        S
Sbjct: 208 ARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR--EDPIPPSARHEGLS 264
Query: 173 TGATSLIHKILDPNPKTR------IRIEGIRKH 199
               +++ K L  NP+ R      +R + +R H
Sbjct: 265 ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 297

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/245 (29%), Positives = 111/245 (45%), Gaps = 45/245 (18%)
Query: 5   RHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLID 58
           RH NI+ +++++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++ 
Sbjct: 79  RHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILR 135
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE---LLHTTCGTPNYVA 115
            + + HS  V HRDLKP NLLL++  +LK+ DFGL+ +     +    L     T  Y A
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 116 PEVLSN-RGYDGSAADVWSCGVILFVLMAG--------YLP--------FGETDLPTLYK 158
           PE++ N +GY  S  D+WS G IL  +++         YL          G      L  
Sbjct: 196 PEIMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNX 254
Query: 159 KINAAE----FSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
            IN        S P      W        + A  L+ K+L  NP  RI +E    HP+  
Sbjct: 255 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314
Query: 204 KNYNP 208
           + Y+P
Sbjct: 315 QYYDP 319

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 78/162 (48%), Gaps = 5/162 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK ++HPN+V+L  V       YII+EF+T G L D +    R   N     +   Q+  
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 123
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 124 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 183
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 184 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 224

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/245 (29%), Positives = 111/245 (45%), Gaps = 45/245 (18%)
Query: 5   RHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLID 58
           RH NI+ +++++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++ 
Sbjct: 79  RHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILR 135
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE---LLHTTCGTPNYVA 115
            + + HS  V HRDLKP NLLL++  +LK+ DFGL+ +     +    L     T  Y A
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 116 PEVLSN-RGYDGSAADVWSCGVILFVLMAG--------YLP--------FGETDLPTLYK 158
           PE++ N +GY  S  D+WS G IL  +++         YL          G      L  
Sbjct: 196 PEIMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNX 254
Query: 159 KINAAE----FSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
            IN        S P      W        + A  L+ K+L  NP  RI +E    HP+  
Sbjct: 255 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314
Query: 204 KNYNP 208
           + Y+P
Sbjct: 315 QYYDP 319

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 6   HPNIVRLHEVLASRTKV----YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           HP IV ++    + T      YI++E+V G  L D +  +G +              A+ 
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTC--GTPNYVAPEV 118
             H  G+ HRD+KP N+++ +   +KV DFG++ A+   G  +  T    GT  Y++PE 
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPF-----WFS 172
                 D   +DV+S G +L+ ++ G  PF G++ +   Y+ +   E   P        S
Sbjct: 191 ARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR--EDPIPPSARHEGLS 247
Query: 173 TGATSLIHKILDPNPKTR------IRIEGIRKH 199
               +++ K L  NP+ R      +R + +R H
Sbjct: 248 ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 77/170 (45%), Gaps = 24/170 (14%)
Query: 54  QQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN 112
           + ++++ ++ H+ K + HRD+KP N+L+D  G +K+SDFG S       + +  + GT  
Sbjct: 158 KSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD--KKIKGSRGTYE 215
Query: 113 YVAPEVLSNR-GYDGSAADVWSCGVILFVLMAGYLPFG-ETDLPTLYKKINAAEFSCPF- 169
           ++ PE  SN   Y+G+  D+WS G+ L+V+    +PF  +  L  L+  I       P  
Sbjct: 216 FMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLD 275
Query: 170 ------------------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPW 201
                             + S      +   L  NP  RI  E   KH W
Sbjct: 276 RNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW 325

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 111/245 (45%), Gaps = 45/245 (18%)
Query: 5   RHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLID 58
           RH NI+ +++++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++ 
Sbjct: 83  RHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILR 139
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE---LLHTTCGTPNYVA 115
            + + HS  V HRDLKP NLLL++  +LK+ DFGL+ +     +    L     T  Y A
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRA 199
Query: 116 PEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPT 155
           PE++ N +GY  S  D+WS G IL  +++    F                    + DL  
Sbjct: 200 PEIMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 156 LYK-KINAAEFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
           +   K      S P      W        + A  L+ K+L  NP  RI +E    HP+  
Sbjct: 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318
Query: 204 KNYNP 208
           + Y+P
Sbjct: 319 QYYDP 323

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 111/245 (45%), Gaps = 45/245 (18%)
Query: 5   RHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLID 58
           RH NI+ +++++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++ 
Sbjct: 84  RHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILR 140
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE---LLHTTCGTPNYVA 115
            + + HS  V HRDLKP NLLL++  +LK+ DFGL+ +     +    L     T  Y A
Sbjct: 141 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRA 200
Query: 116 PEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPT 155
           PE++ N +GY  S  D+WS G IL  +++    F                    + DL  
Sbjct: 201 PEIMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 259
Query: 156 LYK-KINAAEFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
           +   K      S P      W        + A  L+ K+L  NP  RI +E    HP+  
Sbjct: 260 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 319
Query: 204 KNYNP 208
           + Y+P
Sbjct: 320 QYYDP 324

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 111/245 (45%), Gaps = 45/245 (18%)
Query: 5   RHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLID 58
           RH NI+ +++++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++ 
Sbjct: 79  RHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILR 135
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE---LLHTTCGTPNYVA 115
            + + HS  V HRDLKP NLLL++  +LK+ DFGL+ +     +    L     T  Y A
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 116 PEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPT 155
           PE++ N +GY  S  D+WS G IL  +++    F                    + DL  
Sbjct: 196 PEIMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 254
Query: 156 LYK-KINAAEFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
           +   K      S P      W        + A  L+ K+L  NP  RI +E    HP+  
Sbjct: 255 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314
Query: 204 KNYNP 208
           + Y+P
Sbjct: 315 QYYDP 319

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 104/257 (40%), Gaps = 49/257 (19%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           MK V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 77  MKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQML 136
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAP 116
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y AP
Sbjct: 137 XGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 194
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKKIN 161
           EV+   GY  +  D+WS G I+  ++   + F   D                P   KK+ 
Sbjct: 195 EVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 162 A------------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIE 194
                        A  + P  F               ++ A  L+ K+L  +P  RI ++
Sbjct: 254 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 313
Query: 195 GIRKHPWFRKNYNPVKC 211
              +HP+    Y+P + 
Sbjct: 314 DALQHPYINVWYDPAEV 330

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/245 (29%), Positives = 111/245 (45%), Gaps = 45/245 (18%)
Query: 5   RHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLID 58
           RH NI+ +++++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++ 
Sbjct: 83  RHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILR 139
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVA 115
            + + HS  V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y A
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 116 PEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPT 155
           PE++ N +GY  S  D+WS G IL  +++    F                    + DL  
Sbjct: 200 PEIMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 156 LYK-KINAAEFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
           +   K      S P      W        + A  L+ K+L  NP  RI +E    HP+  
Sbjct: 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318
Query: 204 KNYNP 208
           + Y+P
Sbjct: 319 QYYDP 323

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 78/162 (48%), Gaps = 5/162 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK ++HPN+V+L  V       YII+EF+T G L D +    R   N     +   Q+  
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 188 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 228

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 111/245 (45%), Gaps = 45/245 (18%)
Query: 5   RHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLID 58
           RH NI+ +++++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++ 
Sbjct: 83  RHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILR 139
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE---LLHTTCGTPNYVA 115
            + + HS  V HRDLKP NLLL++  +LK+ DFGL+ +     +    L     T  Y A
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 116 PEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPT 155
           PE++ N +GY  S  D+WS G IL  +++    F                    + DL  
Sbjct: 200 PEIMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 156 LYK-KINAAEFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
           +   K      S P      W        + A  L+ K+L  NP  RI +E    HP+  
Sbjct: 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318
Query: 204 KNYNP 208
           + Y+P
Sbjct: 319 QYYDP 323

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 111/245 (45%), Gaps = 45/245 (18%)
Query: 5   RHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLID 58
           RH NI+ +++++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++ 
Sbjct: 81  RHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILR 137
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVA 115
            + + HS  V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y A
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 116 PEVLSN-RGYDGSAADVWSCGVILFVLMAG--------YLP--------FGETDLPTLYK 158
           PE++ N +GY  S  D+WS G IL  +++         YL          G      L  
Sbjct: 198 PEIMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 256
Query: 159 KINAAE----FSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
            IN        S P      W        + A  L+ K+L  NP  RI +E    HP+  
Sbjct: 257 GINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLA 316
Query: 204 KNYNP 208
           + Y+P
Sbjct: 317 QYYDP 321

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 111/245 (45%), Gaps = 45/245 (18%)
Query: 5   RHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLID 58
           RH NI+ +++++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++ 
Sbjct: 79  RHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILR 135
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE---LLHTTCGTPNYVA 115
            + + HS  V HRDLKP NLLL++  +LK+ DFGL+ +     +    L     T  Y A
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 116 PEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPT 155
           PE++ N +GY  S  D+WS G IL  +++    F                    + DL  
Sbjct: 196 PEIMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 254
Query: 156 LYK-KINAAEFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
           +   K      S P      W        + A  L+ K+L  NP  RI +E    HP+  
Sbjct: 255 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314
Query: 204 KNYNP 208
           + Y+P
Sbjct: 315 QYYDP 319

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/245 (29%), Positives = 112/245 (45%), Gaps = 45/245 (18%)
Query: 5   RHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLID 58
           RH NI+ +++++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++ 
Sbjct: 77  RHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILR 133
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE---LLHTTCGTPNYVA 115
            + + HS  V HRDLKP NLLL++  +LK+ DFGL+ +     +    L     T  Y A
Sbjct: 134 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 116 PEVLSN-RGYDGSAADVWSCGVILFVLMAG--------YLP--------FGETDLPTLYK 158
           PE++ N +GY  S  D+WS G IL  +++         YL          G  +   L  
Sbjct: 194 PEIMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNC 252
Query: 159 KINAAE----FSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
            IN        S P      W        + A  L+ K+L  NP  RI +E    HP+  
Sbjct: 253 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 312
Query: 204 KNYNP 208
           + Y+P
Sbjct: 313 QYYDP 317

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 104/257 (40%), Gaps = 49/257 (19%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           MK V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQML 136
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAP 116
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y AP
Sbjct: 137 XGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 194
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKKIN 161
           EV+   GY  +  D+WS G I+  ++   + F   D                P   KK+ 
Sbjct: 195 EVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 162 A------------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIE 194
                        A  + P  F               ++ A  L+ K+L  +P  RI ++
Sbjct: 254 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 313
Query: 195 GIRKHPWFRKNYNPVKC 211
              +HP+    Y+P + 
Sbjct: 314 DALQHPYINVWYDPAEV 330

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 6   HPNIVRLHEVLASRTKV----YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           HP IV +++   + T      YI++E+V G  L D +  +G +              A+ 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTC--GTPNYVAPEV 118
             H  G+ HRD+KP N+++ +   +KV DFG++ A+   G  +  T    GT  Y++PE 
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPF-----WFS 172
                 D   +DV+S G +L+ ++ G  PF G++     Y+ +   E   P        S
Sbjct: 191 ARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVR--EDPIPPSARHEGLS 247
Query: 173 TGATSLIHKILDPNPKTR------IRIEGIRKH 199
               +++ K L  NP+ R      +R + +R H
Sbjct: 248 ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 76/156 (48%), Gaps = 7/156 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           MK V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAP 116
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y AP
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 194
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           EV+   GY  +  D+WS G I+  ++ G + F  TD
Sbjct: 195 EVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 110/245 (44%), Gaps = 45/245 (18%)
Query: 5   RHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLID 58
           RH NI+ +++++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++ 
Sbjct: 84  RHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILR 140
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP---QQGVELLHTTCGTPNYVA 115
            + + HS  V HRDLKP NLLL++  +LK+ DFGL+ +          L     T  Y A
Sbjct: 141 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 200
Query: 116 PEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPT 155
           PE++ N +GY  S  D+WS G IL  +++    F                    + DL  
Sbjct: 201 PEIMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 259
Query: 156 LYK-KINAAEFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
           +   K      S P      W        + A  L+ K+L  NP  RI +E    HP+  
Sbjct: 260 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 319
Query: 204 KNYNP 208
           + Y+P
Sbjct: 320 QYYDP 324

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 110/245 (44%), Gaps = 45/245 (18%)
Query: 5   RHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLID 58
           RH NI+ +++++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++ 
Sbjct: 85  RHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILR 141
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP---QQGVELLHTTCGTPNYVA 115
            + + HS  V HRDLKP NLLL++  +LK+ DFGL+ +          L     T  Y A
Sbjct: 142 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 201
Query: 116 PEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPT 155
           PE++ N +GY  S  D+WS G IL  +++    F                    + DL  
Sbjct: 202 PEIMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 260
Query: 156 LYK-KINAAEFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
           +   K      S P      W        + A  L+ K+L  NP  RI +E    HP+  
Sbjct: 261 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 320
Query: 204 KNYNP 208
           + Y+P
Sbjct: 321 QYYDP 325

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 110/245 (44%), Gaps = 45/245 (18%)
Query: 5   RHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLID 58
           RH NI+ +++++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++ 
Sbjct: 76  RHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILR 132
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP---QQGVELLHTTCGTPNYVA 115
            + + HS  V HRDLKP NLLL++  +LK+ DFGL+ +          L     T  Y A
Sbjct: 133 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 192
Query: 116 PEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPT 155
           PE++ N +GY  S  D+WS G IL  +++    F                    + DL  
Sbjct: 193 PEIMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 251
Query: 156 LYK-KINAAEFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
           +   K      S P      W        + A  L+ K+L  NP  RI +E    HP+  
Sbjct: 252 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 311
Query: 204 KNYNP 208
           + Y+P
Sbjct: 312 QYYDP 316

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 110/245 (44%), Gaps = 45/245 (18%)
Query: 5   RHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLID 58
           RH NI+ +++++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++ 
Sbjct: 83  RHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILR 139
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP---QQGVELLHTTCGTPNYVA 115
            + + HS  V HRDLKP NLLL++  +LK+ DFGL+ +          L     T  Y A
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 116 PEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPT 155
           PE++ N +GY  S  D+WS G IL  +++    F                    + DL  
Sbjct: 200 PEIMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 156 LYK-KINAAEFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
           +   K      S P      W        + A  L+ K+L  NP  RI +E    HP+  
Sbjct: 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318
Query: 204 KNYNP 208
           + Y+P
Sbjct: 319 QYYDP 323

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 110/245 (44%), Gaps = 45/245 (18%)
Query: 5   RHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLID 58
           RH NI+ +++++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++ 
Sbjct: 81  RHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILR 137
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP---QQGVELLHTTCGTPNYVA 115
            + + HS  V HRDLKP NLLL++  +LK+ DFGL+ +          L     T  Y A
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 116 PEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPT 155
           PE++ N +GY  S  D+WS G IL  +++    F                    + DL  
Sbjct: 198 PEIMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 256
Query: 156 LYK-KINAAEFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
           +   K      S P      W        + A  L+ K+L  NP  RI +E    HP+  
Sbjct: 257 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 316
Query: 204 KNYNP 208
           + Y+P
Sbjct: 317 QYYDP 321

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 110/245 (44%), Gaps = 45/245 (18%)
Query: 5   RHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLID 58
           RH NI+ +++++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++ 
Sbjct: 77  RHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILR 133
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP---QQGVELLHTTCGTPNYVA 115
            + + HS  V HRDLKP NLLL++  +LK+ DFGL+ +          L     T  Y A
Sbjct: 134 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 116 PEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPT 155
           PE++ N +GY  S  D+WS G IL  +++    F                    + DL  
Sbjct: 194 PEIMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 252
Query: 156 LYK-KINAAEFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
           +   K      S P      W        + A  L+ K+L  NP  RI +E    HP+  
Sbjct: 253 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 312
Query: 204 KNYNP 208
           + Y+P
Sbjct: 313 QYYDP 317

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/245 (29%), Positives = 111/245 (45%), Gaps = 45/245 (18%)
Query: 5   RHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLID 58
           RH NI+ +++++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++ 
Sbjct: 87  RHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILR 143
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVA 115
            + + HS  V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y A
Sbjct: 144 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 203
Query: 116 PEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPT 155
           PE++ N +GY  S  D+WS G IL  +++    F                    + DL  
Sbjct: 204 PEIMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 262
Query: 156 LYK-KINAAEFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
           +   K      S P      W        + A  L+ K+L  NP  RI +E    HP+  
Sbjct: 263 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 322
Query: 204 KNYNP 208
           + Y+P
Sbjct: 323 QYYDP 327

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/245 (29%), Positives = 111/245 (45%), Gaps = 45/245 (18%)
Query: 5   RHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLID 58
           RH NI+ +++++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++ 
Sbjct: 79  RHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILR 135
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVA 115
            + + HS  V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y A
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 116 PEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPT 155
           PE++ N +GY  S  D+WS G IL  +++    F                    + DL  
Sbjct: 196 PEIMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 254
Query: 156 LYK-KINAAEFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
           +   K      S P      W        + A  L+ K+L  NP  RI +E    HP+  
Sbjct: 255 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314
Query: 204 KNYNP 208
           + Y+P
Sbjct: 315 QYYDP 319

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 105/262 (40%), Gaps = 49/262 (18%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           MK V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 77  MKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQML 136
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAP 116
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y AP
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 194
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKKIN 161
           EV+   GY  +  D+WS G I+  ++   + F   D                P   KK+ 
Sbjct: 195 EVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 162 A------------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIE 194
                        A  + P  F               ++ A  L+ K+L  +P  RI ++
Sbjct: 254 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 313
Query: 195 GIRKHPWFRKNYNPVKCSEEEE 216
              +HP+    Y+P      +E
Sbjct: 314 DALQHPYINVWYDPAXXXXXDE 335

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 110/245 (44%), Gaps = 45/245 (18%)
Query: 5   RHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLID 58
           RH NI+ +++++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++ 
Sbjct: 83  RHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILR 139
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP---QQGVELLHTTCGTPNYVA 115
            + + HS  V HRDLKP NLLL++  +LK+ DFGL+ +          L     T  Y A
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 116 PEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPT 155
           PE++ N +GY  S  D+WS G IL  +++    F                    + DL  
Sbjct: 200 PEIMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 156 LYK-KINAAEFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
           +   K      S P      W        + A  L+ K+L  NP  RI +E    HP+  
Sbjct: 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318
Query: 204 KNYNP 208
           + Y+P
Sbjct: 319 QYYDP 323

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 104/257 (40%), Gaps = 49/257 (19%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           MK V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQML 129
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAP 116
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y AP
Sbjct: 130 XGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 187
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKKIN 161
           EV+   GY  +  D+WS G I+  ++   + F   D                P   KK+ 
Sbjct: 188 EVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246
Query: 162 A------------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIE 194
                        A  + P  F               ++ A  L+ K+L  +P  RI ++
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306
Query: 195 GIRKHPWFRKNYNPVKC 211
              +HP+    Y+P + 
Sbjct: 307 DALQHPYINVWYDPAEV 323

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 77/162 (47%), Gaps = 5/162 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 187
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 188 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 228

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 110/245 (44%), Gaps = 45/245 (18%)
Query: 5   RHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLID 58
           RH NI+ +++++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++ 
Sbjct: 99  RHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILR 155
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP---QQGVELLHTTCGTPNYVA 115
            + + HS  V HRDLKP NLLL++  +LK+ DFGL+ +          L     T  Y A
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 116 PEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPT 155
           PE++ N +GY  S  D+WS G IL  +++    F                    + DL  
Sbjct: 216 PEIMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 274
Query: 156 LYK-KINAAEFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
           +   K      S P      W        + A  L+ K+L  NP  RI +E    HP+  
Sbjct: 275 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 334
Query: 204 KNYNP 208
           + Y+P
Sbjct: 335 QYYDP 339

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/174 (31%), Positives = 85/174 (48%), Gaps = 13/174 (7%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHC 63
           HPN+V L  V+     V I++EF+  G L D  +  H G+          + +   + + 
Sbjct: 103 HPNVVHLEGVVTRGKPVMIVIEFMENGAL-DAFLRKHDGQFTVIQLVGMLRGIAAGMRYL 161
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLS 120
              G  HRDL   N+L++S    KVSDFGLS + +   E ++TT G      + APE + 
Sbjct: 162 ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQ 221
Query: 121 NRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKIN-----AAEFSCP 168
            R +  SA+DVWS G++++ +M+ G  P+ +     + K I       A   CP
Sbjct: 222 YRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPAPMDCP 274

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 110/245 (44%), Gaps = 45/245 (18%)
Query: 5   RHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLID 58
           RH NI+ +++++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++ 
Sbjct: 81  RHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILR 137
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP---QQGVELLHTTCGTPNYVA 115
            + + HS  V HRDLKP NLLL++  +LK+ DFGL+ +          L     T  Y A
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 116 PEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPT 155
           PE++ N +GY  S  D+WS G IL  +++    F                    + DL  
Sbjct: 198 PEIMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 256
Query: 156 LYK-KINAAEFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
           +   K      S P      W        + A  L+ K+L  NP  RI +E    HP+  
Sbjct: 257 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLA 316
Query: 204 KNYNP 208
           + Y+P
Sbjct: 317 QYYDP 321

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 76/156 (48%), Gaps = 7/156 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           MK V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQML 136
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAP 116
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y AP
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPEVVTRYYRAP 194
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           EV+   GY  +  D+WS G I+  ++ G + F  TD
Sbjct: 195 EVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 107/220 (48%), Gaps = 25/220 (11%)
Query: 1   MKIVRHPNIVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEND----CR 50
           M+IV+HPN+V L     S    + +V++  +LE+V    ++    H  +L +       +
Sbjct: 86  MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIK 144
Query: 51  RYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCG 109
            Y  QL+ ++A+ HS G+ HRD+KP+NLLLD   G LK+ DFG + +   G   +   C 
Sbjct: 145 LYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICS 204
Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCP 168
              Y APE++       +  D+WS G ++  LM G   F GE+ +  L + I        
Sbjct: 205 R-YYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKV------ 257
Query: 169 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 208
               T +   I K ++PN     +   IR HP F K + P
Sbjct: 258 --LGTPSREQI-KTMNPN-YMEHKFPQIRPHP-FSKVFRP 292

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 76/156 (48%), Gaps = 7/156 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           MK V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQML 136
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAP 116
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y AP
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 194
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           EV+   GY  +  D+WS G I+  ++ G + F  TD
Sbjct: 195 EVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 76/156 (48%), Gaps = 7/156 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           MK V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 78  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQML 137
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAP 116
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y AP
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 195
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           EV+   GY  +  D+WS G I+  ++ G + F  TD
Sbjct: 196 EVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTD 230

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 76/156 (48%), Gaps = 7/156 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           MK V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQML 136
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAP 116
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y AP
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 194
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           EV+   GY  +  D+WS G I+  ++ G + F  TD
Sbjct: 195 EVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 77/162 (47%), Gaps = 5/162 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 76  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 135
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 136 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 195
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 196 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 236

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 77/162 (47%), Gaps = 5/162 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 184
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 185 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 225

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 77/162 (47%), Gaps = 5/162 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 188 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 228

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 110/245 (44%), Gaps = 45/245 (18%)
Query: 5   RHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLID 58
           RH NI+ +++++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++ 
Sbjct: 83  RHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKCQH--LSNDHICYFLYQILR 139
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP---QQGVELLHTTCGTPNYVA 115
            + + HS  V HRDLKP NLLL++  +LK+ DFGL+ +          L     T  Y A
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 116 PEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPT 155
           PE++ N +GY  S  D+WS G IL  +++    F                    + DL  
Sbjct: 200 PEIMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 156 LYK-KINAAEFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
           +   K      S P      W        + A  L+ K+L  NP  RI +E    HP+  
Sbjct: 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318
Query: 204 KNYNP 208
           + Y+P
Sbjct: 319 QYYDP 323

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 77/162 (47%), Gaps = 5/162 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 126
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 187 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 227

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 77/162 (47%), Gaps = 5/162 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 122
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 183 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 77/162 (47%), Gaps = 5/162 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 188 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 228

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 21  KVYIILEFVTGGELFDKIVH-QGRLLENDCRRYF-QQLIDAVAHCHSKGVYHRDLKPENL 78
           ++++++EF   G + D I + +G  L+ +   Y  ++++  ++H H   V HRD+K +N+
Sbjct: 101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNV 160
Query: 79  LLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS-----NRGYDGSAADVWS 133
           LL     +K+ DFG+SA   + V   +T  GTP ++APEV++     +  YD   +D+WS
Sbjct: 161 LLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYD-FKSDLWS 219
Query: 134 CGVILFVLMAGYLPFGETDLPT----LYKKINAAEFSCPFWFSTGATSLIHKILDPNPKT 189
            G+    +  G  P  +   P     L  +  A       W S    S I   L  N   
Sbjct: 220 LGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAPRLKSKKW-SKKFQSFIESCLVKNHSQ 277
Query: 190 RIRIEGIRKHPWFRKNYN 207
           R   E + KHP+ R   N
Sbjct: 278 RPATEQLMKHPFIRDQPN 295

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 77/162 (47%), Gaps = 5/162 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 122
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 183 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 77/162 (47%), Gaps = 5/162 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 184
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 185 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 225

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 104/220 (47%), Gaps = 17/220 (7%)
Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K
Sbjct: 83  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 142
Query: 67  -GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 125
             + HRD+KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y 
Sbjct: 143 HKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS 200
Query: 126 GSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFWFSTGATSL-----I 179
              +D+WS G+ L  +  G  P G  +    +++ ++      P    +G  SL     +
Sbjct: 201 -VQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV 259
Query: 180 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNL 219
           +K L  NP  R  ++ +  H + ++       S+ EEV+ 
Sbjct: 260 NKCLIKNPAERADLKQLMVHAFIKR-------SDAEEVDF 292

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 82/162 (50%), Gaps = 8/162 (4%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHC 63
           HPNI+RL  V+     V I+ E++  G L D  +  H  +          + +   + + 
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL 134
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLS 120
              G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++
Sbjct: 135 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 194
Query: 121 NRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKIN 161
            R +  SA+DVWS G++L+ +M+ G  P+ E     + K ++
Sbjct: 195 YRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 235

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 82/162 (50%), Gaps = 8/162 (4%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHC 63
           HPNI+RL  V+     V I+ E++  G L D  +  H  +          + +   + + 
Sbjct: 93  HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL 151
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLS 120
              G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++
Sbjct: 152 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 211
Query: 121 NRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKIN 161
            R +  SA+DVWS G++L+ +M+ G  P+ E     + K ++
Sbjct: 212 YRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 252

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 82/162 (50%), Gaps = 8/162 (4%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHC 63
           HPNI+RL  V+     V I+ E++  G L D  +  H  +          + +   + + 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLS 120
              G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++
Sbjct: 164 SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 121 NRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKIN 161
            R +  SA+DVWS G++L+ +M+ G  P+ E     + K ++
Sbjct: 224 YRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 13/174 (7%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHC 63
           HPNI+RL  V+     V I+ E++  G L D  +  H  +          + +   + + 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLS 120
              G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 121 NRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 168
            R +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 224 YRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 13/174 (7%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHC 63
           HPNI+RL  V+     V I+ E++  G L D  +  H  +          + +   + + 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLS 120
              G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 121 NRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 168
            R +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 224 YRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 13/174 (7%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHC 63
           HPNI+RL  V+     V I+ E++  G L D  +  H  +          + +   + + 
Sbjct: 103 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL 161
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLS 120
              G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++
Sbjct: 162 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 221
Query: 121 NRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 168
            R +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 222 YRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 274

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 13/174 (7%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHC 63
           HPNI+RL  V+     V I+ E++  G L D  +  H  +          + +   + + 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLS 120
              G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 121 NRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 168
            R +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 224 YRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 13/174 (7%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHC 63
           HPNI+RL  V+     V I+ E++  G L D  +  H  +          + +   + + 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLS 120
              G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 121 NRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 168
            R +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 224 YRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 78/162 (48%), Gaps = 5/162 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK ++HPN+V+L  V       YII+EF+T G L D +    R   +     +   Q+  
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 183 SLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 78/162 (48%), Gaps = 5/162 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK ++HPN+V+L  V       YII+EF+T G L D +    R   +     +   Q+  
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 183 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/147 (36%), Positives = 73/147 (49%), Gaps = 14/147 (9%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K   HPNIVRL  V   +  +YI++E V GG+    +  +G  L    +   Q + DA 
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLR--VKTLLQMVGDAA 223
Query: 61  A---HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG----TP-N 112
           A   +  SK   HRDL   N L+     LK+SDFG+S     GV   +   G     P  
Sbjct: 224 AGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV---YAASGGLRQVPVK 280
Query: 113 YVAPEVLSNRGYDGSAADVWSCGVILF 139
           + APE L N G   S +DVWS G++L+
Sbjct: 281 WTAPEAL-NYGRYSSESDVWSFGILLW 306

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/155 (32%), Positives = 75/155 (48%), Gaps = 5/155 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           MK V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 79  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQML 138
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+        ++     T  Y APE
Sbjct: 139 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVV-TRYYRAPE 197
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           V+   GY  +  D+WS G I+  ++ G + F  TD
Sbjct: 198 VILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTD 231

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 104/256 (40%), Gaps = 49/256 (19%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           MK V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 136
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAP 116
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y AP
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 194
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKKIN 161
           EV+   GY  +  D+WS G I+  ++   + F   D                P   KK+ 
Sbjct: 195 EVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 162 A------------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIE 194
                        A  + P  F               ++ A  L+ K+L  +P  RI ++
Sbjct: 254 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 313
Query: 195 GIRKHPWFRKNYNPVK 210
              +HP+    Y+P +
Sbjct: 314 DALQHPYINVWYDPAE 329

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 104/256 (40%), Gaps = 49/256 (19%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           MK V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 136
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAP 116
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y AP
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 194
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKKIN 161
           EV+   GY  +  D+WS G I+  ++   + F   D                P   KK+ 
Sbjct: 195 EVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 162 A------------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIE 194
                        A  + P  F               ++ A  L+ K+L  +P  RI ++
Sbjct: 254 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 313
Query: 195 GIRKHPWFRKNYNPVK 210
              +HP+    Y+P +
Sbjct: 314 DALQHPYINVWYDPAE 329

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 104/256 (40%), Gaps = 49/256 (19%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           MK V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 78  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 137
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAP 116
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y AP
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 195
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKKIN 161
           EV+   GY  +  D+WS G I+  ++   + F   D                P   KK+ 
Sbjct: 196 EVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 254
Query: 162 A------------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIE 194
                        A  + P  F               ++ A  L+ K+L  +P  RI ++
Sbjct: 255 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 314
Query: 195 GIRKHPWFRKNYNPVK 210
              +HP+    Y+P +
Sbjct: 315 DALQHPYINVWYDPAE 330

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 104/256 (40%), Gaps = 49/256 (19%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           MK V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 76  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 135
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAP 116
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y AP
Sbjct: 136 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 193
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKKIN 161
           EV+   GY  +  D+WS G I+  ++   + F   D                P   KK+ 
Sbjct: 194 EVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 252
Query: 162 A------------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIE 194
                        A  + P  F               ++ A  L+ K+L  +P  RI ++
Sbjct: 253 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 312
Query: 195 GIRKHPWFRKNYNPVK 210
              +HP+    Y+P +
Sbjct: 313 DALQHPYINVWYDPAE 328

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 104/256 (40%), Gaps = 49/256 (19%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           MK V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 78  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 137
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAP 116
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y AP
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 195
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKKIN 161
           EV+   GY  +  D+WS G I+  ++   + F   D                P   KK+ 
Sbjct: 196 EVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 254
Query: 162 A------------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIE 194
                        A  + P  F               ++ A  L+ K+L  +P  RI ++
Sbjct: 255 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 314
Query: 195 GIRKHPWFRKNYNPVK 210
              +HP+    Y+P +
Sbjct: 315 DALQHPYINVWYDPAE 330

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/144 (36%), Positives = 71/144 (49%), Gaps = 8/144 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K   HPNIVRL  V   +  +YI++E V GG+    +  +G  L    +   Q + DA 
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLR--VKTLLQMVGDAA 223
Query: 61  A---HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC-GTP-NYVA 115
           A   +  SK   HRDL   N L+     LK+SDFG+S     GV          P  + A
Sbjct: 224 AGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTA 283
Query: 116 PEVLSNRGYDGSAADVWSCGVILF 139
           PE L N G   S +DVWS G++L+
Sbjct: 284 PEAL-NYGRYSSESDVWSFGILLW 306

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 104/256 (40%), Gaps = 49/256 (19%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           MK V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 174
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAP 116
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y AP
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 232
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD---------------LPTLYKKIN 161
           EV+   GY  +  D+WS G I+  ++   + F   D                P   KK+ 
Sbjct: 233 EVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291
Query: 162 A------------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIE 194
                        A  + P  F               ++ A  L+ K+L  +P  RI ++
Sbjct: 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 351
Query: 195 GIRKHPWFRKNYNPVK 210
              +HP+    Y+P +
Sbjct: 352 DALQHPYINVWYDPAE 367

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 104/256 (40%), Gaps = 49/256 (19%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           MK V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 129
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAP 116
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y AP
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 187
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKKIN 161
           EV+   GY  +  D+WS G I+  ++   + F   D                P   KK+ 
Sbjct: 188 EVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246
Query: 162 A------------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIE 194
                        A  + P  F               ++ A  L+ K+L  +P  RI ++
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306
Query: 195 GIRKHPWFRKNYNPVK 210
              +HP+    Y+P +
Sbjct: 307 DALQHPYINVWYDPAE 322

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 104/256 (40%), Gaps = 49/256 (19%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           MK V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 71  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 130
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAP 116
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y AP
Sbjct: 131 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 188
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKKIN 161
           EV+   GY  +  D+WS G I+  ++   + F   D                P   KK+ 
Sbjct: 189 EVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 247
Query: 162 A------------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIE 194
                        A  + P  F               ++ A  L+ K+L  +P  RI ++
Sbjct: 248 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 307
Query: 195 GIRKHPWFRKNYNPVK 210
              +HP+    Y+P +
Sbjct: 308 DALQHPYINVWYDPAE 323

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 104/256 (40%), Gaps = 49/256 (19%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           MK V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 71  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 130
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAP 116
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y AP
Sbjct: 131 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 188
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKKIN 161
           EV+   GY  +  D+WS G I+  ++   + F   D                P   KK+ 
Sbjct: 189 EVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 247
Query: 162 A------------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIE 194
                        A  + P  F               ++ A  L+ K+L  +P  RI ++
Sbjct: 248 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 307
Query: 195 GIRKHPWFRKNYNPVK 210
              +HP+    Y+P +
Sbjct: 308 DALQHPYINVWYDPAE 323

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 11/166 (6%)
Query: 1   MKIVRHPNIVRLHEVLASRT------KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V    T      +VY++   +  G   + IV    L +   +    
Sbjct: 81  LKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKSQALSDEHVQFLVY 138
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           QL+  + + HS G+ HRDLKP N+ ++    L++ DFGL+   +Q  E +     T  Y 
Sbjct: 139 QLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLA---RQADEEMTGYVATRWYR 195
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 160
           APE++ N  +     D+WS G I+  L+ G   F  +D     K+I
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRI 241

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 104/256 (40%), Gaps = 49/256 (19%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           MK V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 174
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAP 116
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y AP
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 232
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD---------------LPTLYKKIN 161
           EV+   GY  +  D+WS G I+  ++   + F   D                P   KK+ 
Sbjct: 233 EVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291
Query: 162 A------------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIE 194
                        A  + P  F               ++ A  L+ K+L  +P  RI ++
Sbjct: 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 351
Query: 195 GIRKHPWFRKNYNPVK 210
              +HP+    Y+P +
Sbjct: 352 DALQHPYINVWYDPAE 367

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 83/174 (47%), Gaps = 13/174 (7%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHC 63
           HPNI+RL  V+     V I+ E +  G L D  +  H  +          + +   + + 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLS 120
              G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++
Sbjct: 164 SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 121 NRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 168
            R +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 224 YRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 82/162 (50%), Gaps = 8/162 (4%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHC 63
           HPNI+RL  V+     V I+ E++  G L D  +  H  +          + +   + + 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLS 120
              G  HRDL   N+L++S    KVSDFGL+ + +   E  +TT G      + +PE ++
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 121 NRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKIN 161
            R +  SA+DVWS G++L+ +M+ G  P+ E     + K ++
Sbjct: 224 YRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 8/162 (4%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHC 63
           HPNI+RL  V+     V I+ E +  G L D  +  H  +          + +   + + 
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL 134
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLS 120
              G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++
Sbjct: 135 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 194
Query: 121 NRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKIN 161
            R +  SA+DVWS G++L+ +M+ G  P+ E     + K ++
Sbjct: 195 YRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 235

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 77/162 (47%), Gaps = 5/162 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK ++HPN+V+L  V       YII EF+T G L D +    R   +     +   Q+  
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 183 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 77/162 (47%), Gaps = 5/162 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK ++HPN+V+L  V       YII EF+T G L D +    R   +     +   Q+  
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 183 SLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 107/267 (40%), Gaps = 49/267 (18%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           MK V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 77  MKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 136
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAP 116
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y AP
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 194
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKKIN 161
           EV+   GY  +  D+WS G I+  ++   + F   D                P   KK+ 
Sbjct: 195 EVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 162 A------------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIE 194
                        A  + P  F               ++ A  L+ K+L  +P  RI ++
Sbjct: 254 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 313
Query: 195 GIRKHPWFRKNYNPVKCSEEEEVNLDD 221
              +HP+    Y      +E E  +++
Sbjct: 314 DALQHPYINVWYXXXXXXDEREHTIEE 340

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 77/162 (47%), Gaps = 5/162 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK ++HPN+V+L  V       YII EF+T G L D +    R   +     +   Q+  
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 127
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 188 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 228

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 25/222 (11%)
Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K
Sbjct: 67  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 126
Query: 67  -GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 125
             + HRD+KP N+L++S G +K+ DFG+S   Q   E+ +   GT +Y++PE L    Y 
Sbjct: 127 HKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDEMANEFVGTRSYMSPERLQGTHYS 184
Query: 126 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYK--------KINAAEFSCPFWFSTGATS 177
              +D+WS G+ L  +  G  P     +  L          K+ +A FS  F        
Sbjct: 185 -VQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSAVFSLEF------QD 237
Query: 178 LIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNL 219
            ++K L  NP  R  ++ +  H + ++       S+ EEV+ 
Sbjct: 238 FVNKCLIKNPAERADLKQLMVHAFIKR-------SDAEEVDF 272

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 111/267 (41%), Gaps = 47/267 (17%)
Query: 1   MKIVRHPNIVRL------HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K +RH N++ L       E L   T  Y+++ F+  G    K++   +L E+  +    
Sbjct: 78  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVY 135
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + H+ G+ HRDLKP NL ++    LK+ DFGL+   +Q    +     T  Y 
Sbjct: 136 QMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA---RQADSEMXGXVVTRWYR 192
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWF--- 171
           APEV+ N        D+WS G I+  ++ G   F  +D     K+I     + P  F   
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252
Query: 172 ----------------------------STGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
                                       S  A +L+ K+L  + + R+       HP+F 
Sbjct: 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 312
Query: 204 KNYNPVKCSEEEEVNLDDVHAVFDDIE 230
             ++      E+E  +      FDD++
Sbjct: 313 SLHD-----TEDEPQVQKYDDSFDDVD 334

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 81/170 (47%), Gaps = 29/170 (17%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL--ENDCRRYFQQLIDAVA 61
           + HPNI+ L +    ++ + ++ +F+      + I+    L+   +  + Y    +  + 
Sbjct: 69  LSHPNIIGLLDAFGHKSNISLVFDFMETD--LEVIIKDNSLVLTPSHIKAYMLMTLQGLE 126
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN--------- 112
           + H   + HRDLKP NLLLD  G LK++DFGL+            + G+PN         
Sbjct: 127 YLHQHWILHRDLKPNNLLLDENGVLKLADFGLA-----------KSFGSPNRAYXHQVVT 175
Query: 113 --YVAPEVLSNRGYDGSAADVWSCGVIL--FVLMAGYLPFGETDLPTLYK 158
             Y APE+L      G   D+W+ G IL   +L   +LP G++DL  L +
Sbjct: 176 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP-GDSDLDQLTR 224

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 13/174 (7%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHC 63
           HPNI+RL  V+     V I+ E++  G L D  +  H  +          + +   + + 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLS 120
              G  HRDL   N+L++S    KVSDFGL  + +   E  +TT G      + +PE ++
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 121 NRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 168
            R +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 224 YRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 78/152 (51%), Gaps = 5/152 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLID 58
           MK ++H  +VRL+ V+     +YII E++  G L D  K    G++L      +  Q+ +
Sbjct: 62  MKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAE 121
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
            +A+   K   HRDL+  N+L+      K++DFGL+ + +            P  + APE
Sbjct: 122 GMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 181
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            + N G     +DVWS G++L+ ++  G +P+
Sbjct: 182 AI-NFGCFTIKSDVWSFGILLYEIVTYGKIPY 212

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 83/174 (47%), Gaps = 13/174 (7%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHC 63
           HPNI+RL  V+     V I+ E +  G L D  +  H  +          + +   + + 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLS 120
              G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 121 NRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 168
            R +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 224 YRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 11/166 (6%)
Query: 1   MKIVRHPNIVRLHEVLASRT------KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V    T      +VY++   +  G   + IV    L +   +    
Sbjct: 81  LKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVY 138
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           QL+  + + HS G+ HRDLKP N+ ++    L++ DFGL+   +Q  E +     T  Y 
Sbjct: 139 QLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLA---RQADEEMTGYVATRWYR 195
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 160
           APE++ N  +     D+WS G I+  L+ G   F  +D     K+I
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRI 241

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 77/162 (47%), Gaps = 5/162 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 309 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 368
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
           A+ +   K   HR+L   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 369 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 428
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 429 SLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 469

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           H NI+RL  V++    + II E++  G L DK      L E D      QL+  +    +
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGAL-DKF-----LREKDGEFSVLQLVGMLRGIAA 158
Query: 66  KGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVA 115
              Y       HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + A
Sbjct: 159 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 218
Query: 116 PEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKIN 161
           PE +S R +  SA+DVWS G++++ +M  G  P+ E     + K IN
Sbjct: 219 PEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 78/152 (51%), Gaps = 5/152 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLID 58
           MK ++H  +VRL+ V+     +YII EF+  G L D  K    G++L      +  Q+ +
Sbjct: 61  MKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAE 120
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
            +A+   K   HRDL+  N+L+      K++DFGL+ + +            P  + APE
Sbjct: 121 GMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 180
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            + N G     ++VWS G++L+ ++  G +P+
Sbjct: 181 AI-NFGCFTIKSNVWSFGILLYEIVTYGKIPY 211

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 77/162 (47%), Gaps = 5/162 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK ++HPN+V+L  V       YII+EF+T G L D +    R   +     +   Q+  
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 120
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 121 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 180
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
            L+   +    +DVW+ GV+L+ +   G  P+   D   +Y+
Sbjct: 181 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYE 221

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 74/160 (46%), Gaps = 14/160 (8%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGEL---FDKIVHQGRLLENDCRR 51
           MK + HPN+V   EV      LA      + +E+  GG+L    ++  +   L E   R 
Sbjct: 67  MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 126
Query: 52  YFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNL---KVSDFGLSALPQQGVELLHTTC 108
               +  A+ + H   + HRDLKPEN++L         K+ D G +    QG EL     
Sbjct: 127 LLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFV 185
Query: 109 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 148
           GT  Y+APE+L  + Y     D WS G + F  + G+ PF
Sbjct: 186 GTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPF 224

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 108/225 (48%), Gaps = 20/225 (8%)
Query: 2   KIVRHPN-IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR-YFQQLIDA 59
           K+ +H + I+RL++   +   +Y+++E   G    +  + + + ++   R+ Y++ +++A
Sbjct: 82  KLQQHSDKIIRLYDYEITDQYIYMVME--CGNIDLNSWLKKKKSIDPWERKSYWKNMLEA 139
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPE 117
           V   H  G+ H DLKP N L+   G LK+ DFG++    P     +  +  GT NY+ PE
Sbjct: 140 VHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPE 198
Query: 118 V---LSNRGYDG-------SAADVWSCGVILFVLMAGYLPFGE--TDLPTLYKKINAA-E 164
               +S+   +G         +DVWS G IL+ +  G  PF +    +  L+  I+   E
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 258
Query: 165 FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              P         ++   L  +PK RI I  +  HP+ +   +PV
Sbjct: 259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 303

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 74/160 (46%), Gaps = 14/160 (8%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGEL---FDKIVHQGRLLENDCRR 51
           MK + HPN+V   EV      LA      + +E+  GG+L    ++  +   L E   R 
Sbjct: 66  MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125
Query: 52  YFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNL---KVSDFGLSALPQQGVELLHTTC 108
               +  A+ + H   + HRDLKPEN++L         K+ D G +    QG EL     
Sbjct: 126 LLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFV 184
Query: 109 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 148
           GT  Y+APE+L  + Y     D WS G + F  + G+ PF
Sbjct: 185 GTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPF 223

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 110/265 (41%), Gaps = 51/265 (19%)
Query: 1   MKIVRHPNIVRLHEV-----LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQ 55
           +K  +H NI+ +  +       +  +VYII E +       +++    L ++  + +  Q
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQ 120
Query: 56  LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL----------PQQGVELLH 105
            + AV   H   V HRDLKP NLL++S  +LKV DFGL+ +          P      + 
Sbjct: 121 TLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMT 180
Query: 106 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVIL------------------FVLMAGYL- 146
               T  Y APEV+        A DVWSCG IL                   +L+ G + 
Sbjct: 181 EXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240
Query: 147 -PFGETDLPTLYKKINAAEF--SCPFW-----------FSTGATSLIHKILDPNPKTRIR 192
            P  + DL  + +   A E+  S P +            +     L+ ++L  +P  RI 
Sbjct: 241 TPHSDNDLRCI-ESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT 299
Query: 193 IEGIRKHPWFRKNYNPVKCSEEEEV 217
            +   +HP+ +  ++P    E E +
Sbjct: 300 AKEALEHPYLQTYHDPNDEPEGEPI 324

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 23/226 (10%)
Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 67  -GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 125
             + HRD+KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y 
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 126 GSAADVWSCGVILFVLMAGYLPFGETDLP-------TLYKKINAAEFSCPFWFSTGATSL 178
              +D+WS G+ L  +  G  P    D          +++ ++      P    +G  SL
Sbjct: 182 -VQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSL 240
Query: 179 -----IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNL 219
                ++K L  NP  R  ++ +  H + ++       S+ EEV+ 
Sbjct: 241 EFQDFVNKCLIKNPAERADLKQLMVHAFIKR-------SDAEEVDF 279

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 11/166 (6%)
Query: 1   MKIVRHPNIVRLHEVLASRT------KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V    T      +VY++   +  G   + IV    L +   +    
Sbjct: 73  LKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVY 130
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           QL+  + + HS G+ HRDLKP N+ ++    L++ DFGL+   +Q  E +     T  Y 
Sbjct: 131 QLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA---RQADEEMTGYVATRWYR 187
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 160
           APE++ N  +     D+WS G I+  L+ G   F  +D     K+I
Sbjct: 188 APEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRI 233

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 111/265 (41%), Gaps = 51/265 (19%)
Query: 1   MKIVRHPNIVRLHEV-----LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQ 55
           +K  +H NI+ +  +       +  +VYII E +       +++    L ++  + +  Q
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQ 120
Query: 56  LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV----ELLHTTCGTP 111
            + AV   H   V HRDLKP NLL++S  +LKV DFGL+ +  +      E      G  
Sbjct: 121 TLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMT 180
Query: 112 NYV------APEVLSNRGYDGSAADVWSCGVIL------------------FVLMAGYL- 146
            YV      APEV+        A DVWSCG IL                   +L+ G + 
Sbjct: 181 EYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240
Query: 147 -PFGETDLPTLYKKINAAEF--SCPFW-----------FSTGATSLIHKILDPNPKTRIR 192
            P  + DL  + +   A E+  S P +            +     L+ ++L  +P  RI 
Sbjct: 241 TPHSDNDLRCI-ESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT 299
Query: 193 IEGIRKHPWFRKNYNPVKCSEEEEV 217
            +   +HP+ +  ++P    E E +
Sbjct: 300 AKEALEHPYLQTYHDPNDEPEGEPI 324

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 124/293 (42%), Gaps = 43/293 (14%)
Query: 1   MKIVRHPNIVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCR 50
           M+ + H NIVRL     S    + +VY+  +L++V    ++    H  R  +       +
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 159
Query: 51  RYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCG 109
            Y  QL  ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C 
Sbjct: 160 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 219
Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCP 168
              Y APE++       S+ DVWS G +L  L+ G   F G++ +  L + I        
Sbjct: 220 R-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL----- 273
Query: 169 FWFSTGATSLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD 221
                  T    +I + NP  T  +   I+ HPW   FR    P     CS   E     
Sbjct: 274 ------GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327
Query: 222 --------VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 266
                    H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 328 RLTPLEACAHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 377

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 124/293 (42%), Gaps = 43/293 (14%)
Query: 1   MKIVRHPNIVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCR 50
           M+ + H NIVRL     S    + +VY+  +L++V    ++    H  R  +       +
Sbjct: 79  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 137
Query: 51  RYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCG 109
            Y  QL  ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C 
Sbjct: 138 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 197
Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCP 168
              Y APE++       S+ DVWS G +L  L+ G   F G++ +  L + I        
Sbjct: 198 R-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL----- 251
Query: 169 FWFSTGATSLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD 221
                  T    +I + NP  T  +   I+ HPW   FR    P     CS   E     
Sbjct: 252 ------GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 305
Query: 222 --------VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 266
                    H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 306 RLTPLEACAHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 355

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 124/293 (42%), Gaps = 43/293 (14%)
Query: 1   MKIVRHPNIVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCR 50
           M+ + H NIVRL     S    + +VY+  +L++V    ++    H  R  +       +
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 125
Query: 51  RYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCG 109
            Y  QL  ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C 
Sbjct: 126 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 185
Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCP 168
              Y APE++       S+ DVWS G +L  L+ G   F G++ +  L + I        
Sbjct: 186 R-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL----- 239
Query: 169 FWFSTGATSLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD 221
                  T    +I + NP  T  +   I+ HPW   FR    P     CS   E     
Sbjct: 240 ------GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 293
Query: 222 --------VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 266
                    H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 294 RLTPLEACAHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 343

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 124/293 (42%), Gaps = 43/293 (14%)
Query: 1   MKIVRHPNIVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCR 50
           M+ + H NIVRL     S    + +VY+  +L++V    ++    H  R  +       +
Sbjct: 68  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 126
Query: 51  RYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCG 109
            Y  QL  ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C 
Sbjct: 127 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 186
Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCP 168
              Y APE++       S+ DVWS G +L  L+ G   F G++ +  L + I        
Sbjct: 187 R-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL----- 240
Query: 169 FWFSTGATSLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD 221
                  T    +I + NP  T  +   I+ HPW   FR    P     CS   E     
Sbjct: 241 ------GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 294
Query: 222 --------VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 266
                    H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 295 RLTPLEACAHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 344

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 124/293 (42%), Gaps = 43/293 (14%)
Query: 1   MKIVRHPNIVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCR 50
           M+ + H NIVRL     S    + +VY+  +L++V    ++    H  R  +       +
Sbjct: 79  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 137
Query: 51  RYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCG 109
            Y  QL  ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C 
Sbjct: 138 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 197
Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCP 168
              Y APE++       S+ DVWS G +L  L+ G   F G++ +  L + I        
Sbjct: 198 R-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL----- 251
Query: 169 FWFSTGATSLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD 221
                  T    +I + NP  T  +   I+ HPW   FR    P     CS   E     
Sbjct: 252 ------GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 305
Query: 222 --------VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 266
                    H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 306 RLTPLEACAHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 355

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRL--LENDCRRYFQQLIDAVAHC 63
           HPN++R       R   YI +E         + V Q     L  +     QQ    +AH 
Sbjct: 77  HPNVIRYFCTEKDRQFQYIAIELCAA--TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134
Query: 64  HSKGVYHRDLKPENLLL---DSYGNLK--VSDFGLS---ALPQQGVELLHTTCGTPNYVA 115
           HS  + HRDLKP N+L+   +++G +K  +SDFGL    A+ +          GT  ++A
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 116 PEVLSNRGYDGS--AADVWSCGVIL-FVLMAGYLPFGETDLPTLYKKINAAEFSCPF--- 169
           PE+LS    +      D++S G +  +V+  G  PFG+    +L ++ N    +C     
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK----SLQRQANILLGACSLDCL 250
Query: 170 ----WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 202
                    A  LI K++  +P+ R   + + KHP+F
Sbjct: 251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 108/225 (48%), Gaps = 20/225 (8%)
Query: 2   KIVRHPN-IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR-YFQQLIDA 59
           K+ +H + I+RL++   +   +Y+++E   G    +  + + + ++   R+ Y++ +++A
Sbjct: 82  KLQQHSDKIIRLYDYEITDQYIYMVME--CGNIDLNSWLKKKKSIDPWERKSYWKNMLEA 139
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPE 117
           V   H  G+ H DLKP N L+   G LK+ DFG++    P     +  +  GT NY+ PE
Sbjct: 140 VHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198
Query: 118 V---LSNRGYDG-------SAADVWSCGVILFVLMAGYLPFGE--TDLPTLYKKINAA-E 164
               +S+   +G         +DVWS G IL+ +  G  PF +    +  L+  I+   E
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 258
Query: 165 FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              P         ++   L  +PK RI I  +  HP+ +   +PV
Sbjct: 259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 303

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 75/148 (50%), Gaps = 6/148 (4%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCH 64
           HPNI+RL  V+       I+ E++  G L   +  H G+          + +   + +  
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSN 121
             G  HRDL   N+L+DS    KVSDFGLS + +   +  +TT G      + APE ++ 
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 122 RGYDGSAADVWSCGVILF-VLMAGYLPF 148
           R +  SA+DVWS GV+++ VL  G  P+
Sbjct: 229 RTFS-SASDVWSFGVVMWEVLAYGERPY 255

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 124/293 (42%), Gaps = 43/293 (14%)
Query: 1   MKIVRHPNIVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCR 50
           M+ + H NIVRL     S    + +VY+  +L++V    ++    H  R  +       +
Sbjct: 75  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 133
Query: 51  RYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCG 109
            Y  QL  ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C 
Sbjct: 134 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 193
Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCP 168
              Y APE++       S+ DVWS G +L  L+ G   F G++ +  L + I        
Sbjct: 194 R-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL----- 247
Query: 169 FWFSTGATSLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD 221
                  T    +I + NP  T  +   I+ HPW   FR    P     CS   E     
Sbjct: 248 ------GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 301
Query: 222 --------VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 266
                    H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 302 RLTPLEACAHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 351

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 124/293 (42%), Gaps = 43/293 (14%)
Query: 1   MKIVRHPNIVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCR 50
           M+ + H NIVRL     S    + +VY+  +L++V    ++    H  R  +       +
Sbjct: 86  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 144
Query: 51  RYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCG 109
            Y  QL  ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C 
Sbjct: 145 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 204
Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCP 168
              Y APE++       S+ DVWS G +L  L+ G   F G++ +  L + I        
Sbjct: 205 R-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL----- 258
Query: 169 FWFSTGATSLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD 221
                  T    +I + NP  T  +   I+ HPW   FR    P     CS   E     
Sbjct: 259 ------GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 312
Query: 222 --------VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 266
                    H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 313 RLTPLEACAHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 362

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 76/162 (46%), Gaps = 5/162 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 123
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
           A+ +   K   HRDL   N L+     +KV+DFGLS L              P  + APE
Sbjct: 124 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPE 183
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 184 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 224

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 115/281 (40%), Gaps = 47/281 (16%)
Query: 1   MKIVRHPNIVRLHEVLASRT------KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF- 53
           +K  +H NI+ + ++L           VY++L+ +       +I+H  + L  +  RYF 
Sbjct: 107 LKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESD--LHQIIHSSQPLTLEHVRYFL 164
Query: 54  QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS----ALPQQGVELLHTTCG 109
            QL+  + + HS  V HRDLKP NLL++    LK+ DFG++      P +    +     
Sbjct: 165 YQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 224
Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFG---------------ETDLP 154
           T  Y APE++ +      A D+WS G I   ++A    F                 T  P
Sbjct: 225 TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284
Query: 155 TLYKKINAAEFSC---------PFWFST-------GATSLIHKILDPNPKTRIRIEGIRK 198
            + + + A              P  + T        A SL+ ++L   P  RI      +
Sbjct: 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344
Query: 199 HPWFRKNYNP---VKCSEEEEVNLDDVHAVFDDIEDQYVAE 236
           HP+  K ++P     C+   +   D      + I++  VAE
Sbjct: 345 HPFLAKYHDPDDEPDCAPPFDFAFDREALTRERIKEAIVAE 385

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 76/163 (46%), Gaps = 5/163 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           MK V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQML 136
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+        ++     T  Y APE
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMEPEVVTRYYRAPE 195
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 160
           V+   GY  +  D+WS G I+  ++   + F   D    + K+
Sbjct: 196 VILGMGYKEN-VDIWSVGCIMGEMVCHKILFPGRDYIDQWNKV 237

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 108/225 (48%), Gaps = 20/225 (8%)
Query: 2   KIVRHPN-IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR-YFQQLIDA 59
           K+ +H + I+RL++   +   +Y+++E   G    +  + + + ++   R+ Y++ +++A
Sbjct: 110 KLQQHSDKIIRLYDYEITDQYIYMVME--CGNIDLNSWLKKKKSIDPWERKSYWKNMLEA 167
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPE 117
           V   H  G+ H DLKP N L+   G LK+ DFG++    P     +  +  GT NY+ PE
Sbjct: 168 VHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 226
Query: 118 V---LSNRGYDG-------SAADVWSCGVILFVLMAGYLPFGE--TDLPTLYKKINAA-E 164
               +S+   +G         +DVWS G IL+ +  G  PF +    +  L+  I+   E
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 286
Query: 165 FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              P         ++   L  +PK RI I  +  HP+ +   +PV
Sbjct: 287 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 331

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 76/162 (46%), Gaps = 5/162 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
           A+ +   K   HRDL   N L+     +KV+DFGLS L              P  + APE
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPE 184
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 185 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 225

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 82/166 (49%), Gaps = 18/166 (10%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           HPNI+ L  V+     V II E++  G L         L +ND R    QL+  +    S
Sbjct: 89  HPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFTVIQLVGMLRGIGS 142
Query: 66  KGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVA 115
              Y       HRDL   N+L++S    KVSDFG+S + +   E  +TT G      + A
Sbjct: 143 GMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTA 202
Query: 116 PEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI 160
           PE ++ R +  SA+DVWS G++++ +M+ G  P+ +     + K I
Sbjct: 203 PEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 247

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 124/293 (42%), Gaps = 43/293 (14%)
Query: 1   MKIVRHPNIVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCR 50
           M+ + H NIVRL     S    + +VY+  +L++V    ++    H  R  +       +
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 125
Query: 51  RYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCG 109
            Y  QL  ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C 
Sbjct: 126 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 185
Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCP 168
              Y APE++       S+ DVWS G +L  L+ G   F G++ +  L + I        
Sbjct: 186 R-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL----- 239
Query: 169 FWFSTGATSLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD 221
                  T    +I + NP  T  +   I+ HPW   FR    P     CS   E     
Sbjct: 240 ------GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 293
Query: 222 --------VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 266
                    H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 294 RLTPLEACAHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 343

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 124/293 (42%), Gaps = 43/293 (14%)
Query: 1   MKIVRHPNIVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCR 50
           M+ + H NIVRL     S    + +VY+  +L++V    ++    H  R  +       +
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 159
Query: 51  RYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCG 109
            Y  QL  ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C 
Sbjct: 160 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 219
Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCP 168
              Y APE++       S+ DVWS G +L  L+ G   F G++ +  L + I        
Sbjct: 220 R-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL----- 273
Query: 169 FWFSTGATSLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD 221
                  T    +I + NP  T  +   I+ HPW   FR    P     CS   E     
Sbjct: 274 ------GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327
Query: 222 --------VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 266
                    H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 328 RLTPLEACAHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 377

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 82/166 (49%), Gaps = 18/166 (10%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           HPNI+ L  V+     V II E++  G L         L +ND R    QL+  +    S
Sbjct: 74  HPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFTVIQLVGMLRGIGS 127
Query: 66  KGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVA 115
              Y       HRDL   N+L++S    KVSDFG+S + +   E  +TT G      + A
Sbjct: 128 GMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTA 187
Query: 116 PEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI 160
           PE ++ R +  SA+DVWS G++++ +M+ G  P+ +     + K I
Sbjct: 188 PEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 232

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 124/293 (42%), Gaps = 43/293 (14%)
Query: 1   MKIVRHPNIVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCR 50
           M+ + H NIVRL     S    + +VY+  +L++V    ++    H  R  +       +
Sbjct: 71  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 129
Query: 51  RYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCG 109
            Y  QL  ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C 
Sbjct: 130 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 189
Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCP 168
              Y APE++       S+ DVWS G +L  L+ G   F G++ +  L + I        
Sbjct: 190 R-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL----- 243
Query: 169 FWFSTGATSLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD 221
                  T    +I + NP  T  +   I+ HPW   FR    P     CS   E     
Sbjct: 244 ------GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 297
Query: 222 --------VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 266
                    H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 298 RLTPLEACAHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 347

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 76/162 (46%), Gaps = 5/162 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK ++HPN+V+L  V       YII EF+T G L D +    R   +     +   Q+  
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 120
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 121 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 180
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
            L+   +    +DVW+ GV+L+ +   G  P+   D   +Y+
Sbjct: 181 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYE 221

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 123/293 (41%), Gaps = 43/293 (14%)
Query: 1   MKIVRHPNIVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCR 50
           M+ + H NIVRL     S    + +VY+  +L++V    ++    H  R  +       +
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPA-TVYRVARHYSRAKQTLPVIYVK 125
Query: 51  RYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCG 109
            Y  QL  ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C 
Sbjct: 126 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 185
Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCP 168
              Y APE++       S+ DVWS G +L  L+ G   F G++ +  L + I        
Sbjct: 186 R-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL----- 239
Query: 169 FWFSTGATSLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD 221
                  T    +I + NP  T      I+ HPW   FR    P     CS   E     
Sbjct: 240 ------GTPTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 293
Query: 222 --------VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 266
                    H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 294 RLTPLEACAHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 343

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 108/225 (48%), Gaps = 20/225 (8%)
Query: 2   KIVRHPN-IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR-YFQQLIDA 59
           K+ +H + I+RL++   +   +Y+++E   G    +  + + + ++   R+ Y++ +++A
Sbjct: 62  KLQQHSDKIIRLYDYEITDQYIYMVME--CGNIDLNSWLKKKKSIDPWERKSYWKNMLEA 119
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPE 117
           V   H  G+ H DLKP N L+   G LK+ DFG++    P     +  +  GT NY+ PE
Sbjct: 120 VHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 178
Query: 118 V---LSNRGYDG-------SAADVWSCGVILFVLMAGYLPFGE--TDLPTLYKKINAA-E 164
               +S+   +G         +DVWS G IL+ +  G  PF +    +  L+  I+   E
Sbjct: 179 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 238
Query: 165 FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              P         ++   L  +PK RI I  +  HP+ +   +PV
Sbjct: 239 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 283

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 82/166 (49%), Gaps = 18/166 (10%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           HPNI+ L  V+     V II E++  G L         L +ND R    QL+  +    S
Sbjct: 68  HPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFTVIQLVGMLRGIGS 121
Query: 66  KGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVA 115
              Y       HRDL   N+L++S    KVSDFG+S + +   E  +TT G      + A
Sbjct: 122 GMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTA 181
Query: 116 PEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI 160
           PE ++ R +  SA+DVWS G++++ +M+ G  P+ +     + K I
Sbjct: 182 PEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 226

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 79/161 (49%), Gaps = 15/161 (9%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE----NDCRRYFQQLIDA 59
           V HPNIV+L+   A    V +++E+  GG L++ ++H    L          +  Q    
Sbjct: 59  VNHPNIVKLYG--ACLNPVCLVMEYAEGGSLYN-VLHGAEPLPYYTAAHAMSWCLQCSQG 115
Query: 60  VAHCHS---KGVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYVA 115
           VA+ HS   K + HRDLKP NLLL + G  LK+ DFG +   Q     +    G+  ++A
Sbjct: 116 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMA 172
Query: 116 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL 156
           PEV     Y     DV+S G+IL+ ++    PF E   P  
Sbjct: 173 PEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAF 212

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 108/225 (48%), Gaps = 20/225 (8%)
Query: 2   KIVRHPN-IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR-YFQQLIDA 59
           K+ +H + I+RL++   +   +Y+++E   G    +  + + + ++   R+ Y++ +++A
Sbjct: 63  KLQQHSDKIIRLYDYEITDQYIYMVME--CGNIDLNSWLKKKKSIDPWERKSYWKNMLEA 120
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPE 117
           V   H  G+ H DLKP N L+   G LK+ DFG++    P     +  +  GT NY+ PE
Sbjct: 121 VHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 118 V---LSNRGYDG-------SAADVWSCGVILFVLMAGYLPFGE--TDLPTLYKKINAA-E 164
               +S+   +G         +DVWS G IL+ +  G  PF +    +  L+  I+   E
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 239
Query: 165 FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              P         ++   L  +PK RI I  +  HP+ +   +PV
Sbjct: 240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 284

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 124/293 (42%), Gaps = 43/293 (14%)
Query: 1   MKIVRHPNIVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCR 50
           M+ + H NIVRL     S    + +VY+  +L++V    ++    H  R  +       +
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 125
Query: 51  RYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCG 109
            Y  QL  ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C 
Sbjct: 126 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCP 168
              Y APE++       S+ DVWS G +L  L+ G   F G++ +  L + I        
Sbjct: 186 R-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL----- 239
Query: 169 FWFSTGATSLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD 221
                  T    +I + NP  T  +   I+ HPW   FR    P     CS   E     
Sbjct: 240 ------GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 293
Query: 222 --------VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 266
                    H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 294 RLTPLEACAHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 343

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 108/225 (48%), Gaps = 20/225 (8%)
Query: 2   KIVRHPN-IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR-YFQQLIDA 59
           K+ +H + I+RL++   +   +Y+++E   G    +  + + + ++   R+ Y++ +++A
Sbjct: 66  KLQQHSDKIIRLYDYEITDQYIYMVME--CGNIDLNSWLKKKKSIDPWERKSYWKNMLEA 123
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPE 117
           V   H  G+ H DLKP N L+   G LK+ DFG++    P     +  +  GT NY+ PE
Sbjct: 124 VHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 182
Query: 118 V---LSNRGYDG-------SAADVWSCGVILFVLMAGYLPFGE--TDLPTLYKKINAA-E 164
               +S+   +G         +DVWS G IL+ +  G  PF +    +  L+  I+   E
Sbjct: 183 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 242
Query: 165 FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              P         ++   L  +PK RI I  +  HP+ +   +PV
Sbjct: 243 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 287

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 3   IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 62
           +++HPNI+ L  V      + +++EF  GG L ++++   R+  +    +  Q+   + +
Sbjct: 62  MLKHPNIIALRGVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPPDILVNWAVQIARGMNY 120
Query: 63  CHSKG---VYHRDLKPENLLL--------DSYGNLKVSDFGLSALPQQGVELLHTTCGTP 111
            H +    + HRDLK  N+L+         S   LK++DFGL+    +  ++  +  G  
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM--SAAGAY 178
Query: 112 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-LPTLYK-KINAAEFSCPF 169
            ++APEV+    +    +DVWS GV+L+ L+ G +PF   D L   Y   +N      P 
Sbjct: 179 AWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS 237
Query: 170 WFSTGATSLIHKILDPNPKTR 190
                   L+    +P+P +R
Sbjct: 238 TCPEPFAKLMEDCWNPDPHSR 258

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 124/293 (42%), Gaps = 43/293 (14%)
Query: 1   MKIVRHPNIVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCR 50
           M+ + H NIVRL     S    + +VY+  +L++V    ++    H  R  +       +
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 125
Query: 51  RYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCG 109
            Y  QL  ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C 
Sbjct: 126 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCP 168
              Y APE++       S+ DVWS G +L  L+ G   F G++ +  L + I        
Sbjct: 186 R-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL----- 239
Query: 169 FWFSTGATSLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD 221
                  T    +I + NP  T  +   I+ HPW   FR    P     CS   E     
Sbjct: 240 ------GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 293
Query: 222 --------VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 266
                    H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 294 RLTPLEACAHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 343

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 79/161 (49%), Gaps = 15/161 (9%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE----NDCRRYFQQLIDA 59
           V HPNIV+L+   A    V +++E+  GG L++ ++H    L          +  Q    
Sbjct: 58  VNHPNIVKLYG--ACLNPVCLVMEYAEGGSLYN-VLHGAEPLPYYTAAHAMSWCLQCSQG 114
Query: 60  VAHCHS---KGVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYVA 115
           VA+ HS   K + HRDLKP NLLL + G  LK+ DFG +   Q     +    G+  ++A
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMA 171
Query: 116 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL 156
           PEV     Y     DV+S G+IL+ ++    PF E   P  
Sbjct: 172 PEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAF 211

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 124/293 (42%), Gaps = 43/293 (14%)
Query: 1   MKIVRHPNIVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCR 50
           M+ + H NIVRL     S    + +VY+  +L++V    ++    H  R  +       +
Sbjct: 103 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 161
Query: 51  RYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCG 109
            Y  QL  ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C 
Sbjct: 162 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 221
Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCP 168
              Y APE++       S+ DVWS G +L  L+ G   F G++ +  L + I        
Sbjct: 222 R-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL----- 275
Query: 169 FWFSTGATSLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD 221
                  T    +I + NP  T  +   I+ HPW   FR    P     CS   E     
Sbjct: 276 ------GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 329
Query: 222 --------VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 266
                    H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 330 RLTPLEACAHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 379

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 124/293 (42%), Gaps = 43/293 (14%)
Query: 1   MKIVRHPNIVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCR 50
           M+ + H NIVRL     S    + +VY+  +L++V    ++    H  R  +       +
Sbjct: 95  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 153
Query: 51  RYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCG 109
            Y  QL  ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C 
Sbjct: 154 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 213
Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCP 168
              Y APE++       S+ DVWS G +L  L+ G   F G++ +  L + I        
Sbjct: 214 R-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL----- 267
Query: 169 FWFSTGATSLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD 221
                  T    +I + NP  T  +   I+ HPW   FR    P     CS   E     
Sbjct: 268 ------GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 321
Query: 222 --------VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 266
                    H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 322 RLTPLEACAHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 371

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 124/293 (42%), Gaps = 43/293 (14%)
Query: 1   MKIVRHPNIVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCR 50
           M+ + H NIVRL     S    + +VY+  +L++V    ++    H  R  +       +
Sbjct: 72  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 130
Query: 51  RYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCG 109
            Y  QL  ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C 
Sbjct: 131 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 190
Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCP 168
              Y APE++       S+ DVWS G +L  L+ G   F G++ +  L + I        
Sbjct: 191 R-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL----- 244
Query: 169 FWFSTGATSLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD 221
                  T    +I + NP  T  +   I+ HPW   FR    P     CS   E     
Sbjct: 245 ------GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 298
Query: 222 --------VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 266
                    H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 299 RLTPLEACAHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 348

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 77/162 (47%), Gaps = 5/162 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK ++HPN+V+L  V       YII EF+T G L D +    R   +     +   Q+  
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 329
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
           A+ +   K   HR+L   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 330 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 389
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 390 SLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 430

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 124/293 (42%), Gaps = 43/293 (14%)
Query: 1   MKIVRHPNIVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCR 50
           M+ + H NIVRL     S    + +VY+  +L++V    ++    H  R  +       +
Sbjct: 105 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 163
Query: 51  RYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCG 109
            Y  QL  ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C 
Sbjct: 164 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 223
Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCP 168
              Y APE++       S+ DVWS G +L  L+ G   F G++ +  L + I        
Sbjct: 224 R-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL----- 277
Query: 169 FWFSTGATSLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD 221
                  T    +I + NP  T  +   I+ HPW   FR    P     CS   E     
Sbjct: 278 ------GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 331
Query: 222 --------VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 266
                    H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 332 RLTPLEACAHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 381

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 124/293 (42%), Gaps = 43/293 (14%)
Query: 1   MKIVRHPNIVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCR 50
           M+ + H NIVRL     S    + +VY+  +L++V    ++    H  R  +       +
Sbjct: 80  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 138
Query: 51  RYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCG 109
            Y  QL  ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C 
Sbjct: 139 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 198
Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCP 168
              Y APE++       S+ DVWS G +L  L+ G   F G++ +  L + I        
Sbjct: 199 R-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL----- 252
Query: 169 FWFSTGATSLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD 221
                  T    +I + NP  T  +   I+ HPW   FR    P     CS   E     
Sbjct: 253 ------GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 306
Query: 222 --------VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 266
                    H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 307 RLTPLEACAHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 356

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 124/293 (42%), Gaps = 43/293 (14%)
Query: 1   MKIVRHPNIVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCR 50
           M+ + H NIVRL     S    + +VY+  +L++V    ++    H  R  +       +
Sbjct: 146 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 204
Query: 51  RYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCG 109
            Y  QL  ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C 
Sbjct: 205 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 264
Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCP 168
              Y APE++       S+ DVWS G +L  L+ G   F G++ +  L + I        
Sbjct: 265 R-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL----- 318
Query: 169 FWFSTGATSLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD 221
                  T    +I + NP  T  +   I+ HPW   FR    P     CS   E     
Sbjct: 319 ------GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 372
Query: 222 --------VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 266
                    H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 373 RLTPLEACAHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 422

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDC-RRYFQQLI 57
           M+ V  P  V  +  L     V+I +E +     + + +++ +G+ +  D   +    ++
Sbjct: 60  MRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 58  DAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            A+ H HSK  V HRD+KP N+L+++ G +K+ DFG+S      V       G   Y+AP
Sbjct: 120 KALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA-KDIDAGCKPYMAP 178
Query: 117 E----VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF--- 169
           E     L+ +GY    +D+WS G+ +  L     P+     P    K    E S      
Sbjct: 179 ERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 237
Query: 170 WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 202
            FS        + L  N K R     + +HP+F
Sbjct: 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 115/281 (40%), Gaps = 47/281 (16%)
Query: 1   MKIVRHPNIVRLHEVLASRT------KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF- 53
           +K  +H NI+ + ++L           VY++L+ +       +I+H  + L  +  RYF 
Sbjct: 108 LKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESD--LHQIIHSSQPLTLEHVRYFL 165
Query: 54  QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS----ALPQQGVELLHTTCG 109
            QL+  + + HS  V HRDLKP NLL++    LK+ DFG++      P +    +     
Sbjct: 166 YQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 225
Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFG---------------ETDLP 154
           T  Y APE++ +      A D+WS G I   ++A    F                 T  P
Sbjct: 226 TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 285
Query: 155 TLYKKINAAEFSC---------PFWFST-------GATSLIHKILDPNPKTRIRIEGIRK 198
            + + + A              P  + T        A SL+ ++L   P  RI      +
Sbjct: 286 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 345
Query: 199 HPWFRKNYNP---VKCSEEEEVNLDDVHAVFDDIEDQYVAE 236
           HP+  K ++P     C+   +   D      + I++  VAE
Sbjct: 346 HPFLAKYHDPDDEPDCAPPFDFAFDREALTRERIKEAIVAE 386

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 108/225 (48%), Gaps = 20/225 (8%)
Query: 2   KIVRHPN-IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR-YFQQLIDA 59
           K+ +H + I+RL++   +   +Y+++E   G    +  + + + ++   R+ Y++ +++A
Sbjct: 110 KLQQHSDKIIRLYDYEITDQYIYMVME--CGNIDLNSWLKKKKSIDPWERKSYWKNMLEA 167
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPE 117
           V   H  G+ H DLKP N L+   G LK+ DFG++    P     +  +  GT NY+ PE
Sbjct: 168 VHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 226
Query: 118 V---LSNRGYDG-------SAADVWSCGVILFVLMAGYLPFGE--TDLPTLYKKINAA-E 164
               +S+   +G         +DVWS G IL+ +  G  PF +    +  L+  I+   E
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 286
Query: 165 FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              P         ++   L  +PK RI I  +  HP+ +   +PV
Sbjct: 287 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 331

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 76/163 (46%), Gaps = 5/163 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           MK V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQML 136
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+        ++     T  Y APE
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMEPEVVTRYYRAPE 195
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 160
           V+   GY  +  D+WS G I+  ++   + F   D    + K+
Sbjct: 196 VILGMGYKEN-VDLWSVGCIMGEMVCHKILFPGRDYIDQWNKV 237

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 13/213 (6%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDC-RRYFQQLI 57
           M+ V  P  V  +  L     V+I +E +     + + +++ +G+ +  D   +    ++
Sbjct: 104 MRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 163
Query: 58  DAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            A+ H HSK  V HRD+KP N+L+++ G +K+ DFG+S      V       G   Y+AP
Sbjct: 164 KALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKT-IDAGCKPYMAP 222
Query: 117 E----VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP--TLYKKINAAEFSCPF- 169
           E     L+ +GY    +D+WS G+ +  L     P+     P   L + +       P  
Sbjct: 223 ERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 281
Query: 170 WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 202
            FS        + L  N K R     + +HP+F
Sbjct: 282 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 110/265 (41%), Gaps = 51/265 (19%)
Query: 1   MKIVRHPNIVRLHEV-----LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQ 55
           +K  +H NI+ +  +       +  +VYII E +       +++    L ++  + +  Q
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQ 120
Query: 56  LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL----------PQQGVELLH 105
            + AV   H   V HRDLKP NLL++S  +LKV DFGL+ +          P      + 
Sbjct: 121 TLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 106 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVIL------------------FVLMAGYL- 146
               T  Y APEV+        A DVWSCG IL                   +L+ G + 
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240
Query: 147 -PFGETDLPTLYKKINAAEF--SCPFW-----------FSTGATSLIHKILDPNPKTRIR 192
            P  + DL  + +   A E+  S P +            +     L+ ++L  +P  RI 
Sbjct: 241 TPHSDNDLRCI-ESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT 299
Query: 193 IEGIRKHPWFRKNYNPVKCSEEEEV 217
            +   +HP+ +  ++P    E E +
Sbjct: 300 AKEALEHPYLQTYHDPNDEPEGEPI 324

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 74/148 (50%), Gaps = 6/148 (4%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCH 64
           HPNI+RL  V+       I+ E++  G L   +  H G+          + +   + +  
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSN 121
             G  HRDL   N+L+DS    KVSDFGLS + +   +   TT G      + APE ++ 
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAF 228
Query: 122 RGYDGSAADVWSCGVILF-VLMAGYLPF 148
           R +  SA+DVWS GV+++ VL  G  P+
Sbjct: 229 RTFS-SASDVWSFGVVMWEVLAYGERPY 255

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 82/170 (48%), Gaps = 13/170 (7%)
Query: 1   MKIVRHPNIVRLHEVLA-----SRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYF 53
           ++   HPN+VRL +V         TK+ ++ E V        DK+   G   E      F
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 54  QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 113
           Q L+  +   HS  V HRDLKP+N+L+ S G +K++DFGL+ +    + L      T  Y
Sbjct: 128 Q-LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWY 185
Query: 114 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYKKIN 161
            APEVL    Y  +  D+WS G I F  M    P   G +D+  L K ++
Sbjct: 186 RAPEVLLQSSY-ATPVDLWSVGCI-FAEMFRRKPLFRGSSDVDQLGKILD 233

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 77/164 (46%), Gaps = 7/164 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           MK V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 71  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQML 130
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAP 116
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y AP
Sbjct: 131 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 188
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 160
           EV+   GY  +  D+WS G I+  ++   + F   D    + K+
Sbjct: 189 EVILGMGYKEN-VDLWSVGCIMGEMVCHKILFPGRDYIDQWNKV 231

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 77/164 (46%), Gaps = 7/164 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           MK V H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++
Sbjct: 82  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQML 141
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAP 116
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y AP
Sbjct: 142 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 199
Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 160
           EV+   GY  +  D+WS G I+  ++   + F   D    + K+
Sbjct: 200 EVILGMGYKEN-VDLWSVGCIMGEMVCHKILFPGRDYIDQWNKV 242

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 80/153 (52%), Gaps = 9/153 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLI 57
           M+   HP+IV+L  V+ +   V+II+E  T GEL  +   Q R    D      Y  QL 
Sbjct: 65  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGEL--RSFLQVRKFSLDLASLILYAYQLS 121
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAP 116
            A+A+  SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++AP
Sbjct: 122 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAP 181
Query: 117 EVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
           E ++ R +  SA+DVW  GV ++ +LM G  PF
Sbjct: 182 ESINFRRFT-SASDVWMFGVCMWEILMHGVKPF 213

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 82/170 (48%), Gaps = 13/170 (7%)
Query: 1   MKIVRHPNIVRLHEVLA-----SRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYF 53
           ++   HPN+VRL +V         TK+ ++ E V        DK+   G   E      F
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 54  QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 113
           Q L+  +   HS  V HRDLKP+N+L+ S G +K++DFGL+ +    + L      T  Y
Sbjct: 128 Q-LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWY 185
Query: 114 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYKKIN 161
            APEVL    Y  +  D+WS G I F  M    P   G +D+  L K ++
Sbjct: 186 RAPEVLLQSSY-ATPVDLWSVGCI-FAEMFRRKPLFRGSSDVDQLGKILD 233

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFLIY 132
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLA---RHTDDEMTGYVATRWYR 189
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 123/293 (41%), Gaps = 43/293 (14%)
Query: 1   MKIVRHPNIVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCR 50
           M+ + H NIVRL     S    +  VY+  +L++V    ++    H  R  +       +
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 125
Query: 51  RYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCG 109
            Y  QL  ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C 
Sbjct: 126 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 185
Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCP 168
              Y APE++       S+ DVWS G +L  L+ G   F G++ +  L + I        
Sbjct: 186 R-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL----- 239
Query: 169 FWFSTGATSLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD 221
                  T    +I + NP  T  +   I+ HPW   FR    P     CS   E     
Sbjct: 240 ------GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 293
Query: 222 --------VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 266
                    H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 294 RLTPLEACAHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 343

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 82/170 (48%), Gaps = 13/170 (7%)
Query: 1   MKIVRHPNIVRLHEVLA-----SRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYF 53
           ++   HPN+VRL +V         TK+ ++ E V        DK+   G   E      F
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 54  QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 113
           Q L+  +   HS  V HRDLKP+N+L+ S G +K++DFGL+ +    + L      T  Y
Sbjct: 128 Q-LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWY 185
Query: 114 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYKKIN 161
            APEVL    Y  +  D+WS G I F  M    P   G +D+  L K ++
Sbjct: 186 RAPEVLLQSSY-ATPVDLWSVGCI-FAEMFRRKPLFRGSSDVDQLGKILD 233

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 78/156 (50%), Gaps = 18/156 (11%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID------- 58
           HPNI+ L  V+     V I+ E++  G L         L +ND +    QL+        
Sbjct: 82  HPNIIHLEGVVTKSKPVMIVTEYMENGSL------DTFLKKNDGQFTVIQLVGMLRGISA 135
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVA 115
            + +    G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + A
Sbjct: 136 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTA 195
Query: 116 PEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGE 150
           PE ++ R +  SA+DVWS G++++ V+  G  P+ E
Sbjct: 196 PEAIAFRKFT-SASDVWSYGIVMWEVVSYGERPYWE 230

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 139
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADEMTGYVATRWYR 196
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 76/162 (46%), Gaps = 5/162 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK ++HPN+V+L  V       YII EF+T G L D +    R   +     +   Q+  
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 120
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 121 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPE 180
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
            L+   +    +DVW+ GV+L+ +   G  P+   D   +Y+
Sbjct: 181 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYE 221

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 80/153 (52%), Gaps = 9/153 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLI 57
           M+   HP+IV+L  V+ +   V+II+E  T GEL  +   Q R    D      Y  QL 
Sbjct: 445 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGEL--RSFLQVRKFSLDLASLILYAYQLS 501
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAP 116
            A+A+  SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++AP
Sbjct: 502 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561
Query: 117 EVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
           E ++ R +  SA+DVW  GV ++ +LM G  PF
Sbjct: 562 ESINFRRFT-SASDVWMFGVCMWEILMHGVKPF 593

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 139
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADEMTGYVATRWYR 196
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 76/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKSQKLTDDHVQFLIY 132
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL    +   + +     T  Y 
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLC---RHTDDEMTGYVATRWYR 189
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFLIY 132
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 189
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 139
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADEMTGYVATRWYR 196
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 73/147 (49%), Gaps = 4/147 (2%)
Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K
Sbjct: 126 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 185
Query: 67  -GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 125
             + HRD+KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y 
Sbjct: 186 HKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS 243
Query: 126 GSAADVWSCGVILFVLMAGYLPFGETD 152
              +D+WS G+ L  +  G  P    D
Sbjct: 244 -VQSDIWSMGLSLVEMAVGRYPIPPPD 269

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 80/151 (52%), Gaps = 5/151 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M+   HP+IV+L  V+ +   V+II+E  T GEL   + V +  L       Y  QL  A
Sbjct: 65  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 123
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 118
           +A+  SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE 
Sbjct: 124 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 183
Query: 119 LSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
           ++ R +  SA+DVW  GV ++ +LM G  PF
Sbjct: 184 INFRRFT-SASDVWMFGVCMWEILMHGVKPF 213

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 134
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 135 QILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLA---RHTDDEMTGYVATRWYR 191
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 123/293 (41%), Gaps = 43/293 (14%)
Query: 1   MKIVRHPNIVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCR 50
           M+ + H NIVRL     S    + +VY+  +L++V    ++    H  R  +       +
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 125
Query: 51  RYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCG 109
            Y  QL  ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C 
Sbjct: 126 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCP 168
              Y APE++       S+ DVWS G +L  L+ G   F G++ +  L + I        
Sbjct: 186 R-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL----- 239
Query: 169 FWFSTGATSLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD 221
                  T    +I + NP  T      I+ HPW   FR    P     CS   E     
Sbjct: 240 ------GTPTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 293
Query: 222 --------VHAVFDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 266
                    H+ FD++ D  V  +  N    P L N F    LS    LA + 
Sbjct: 294 RLTPLEACAHSFFDELRDPNV--KLPNGRDTPALFN-FTTQELSSNPPLATIL 343

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 138
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 139 QILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLA---RHTDDEMTGYVATRWYR 195
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 80/151 (52%), Gaps = 5/151 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M+   HP+IV+L  V+ +   V+II+E  T GEL   + V +  L       Y  QL  A
Sbjct: 93  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 151
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 118
           +A+  SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE 
Sbjct: 152 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 211
Query: 119 LSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
           ++ R +  SA+DVW  GV ++ +LM G  PF
Sbjct: 212 INFRRFT-SASDVWMFGVCMWEILMHGVKPF 241

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 73/145 (50%), Gaps = 10/145 (6%)
Query: 1   MKIVRHPNIVRLHEVLA-SRT----KVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYF 53
           ++   HPN+VRL +V A SRT    KV ++ E V        DK    G L     +   
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLM 118
Query: 54  QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 113
           +Q +  +   H+  + HRDLKPEN+L+ S G +K++DFGL+ +    + L      T  Y
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV-TLWY 177
Query: 114 VAPEVLSNRGYDGSAADVWSCGVIL 138
            APEVL    Y  +  D+WS G I 
Sbjct: 178 RAPEVLLQSTY-ATPVDMWSVGCIF 201

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 80/151 (52%), Gaps = 5/151 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M+   HP+IV+L  V+ +   V+II+E  T GEL   + V +  L       Y  QL  A
Sbjct: 65  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 123
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 118
           +A+  SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE 
Sbjct: 124 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 183
Query: 119 LSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
           ++ R +  SA+DVW  GV ++ +LM G  PF
Sbjct: 184 INFRRFT-SASDVWMFGVCMWEILMHGVKPF 213

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 80/151 (52%), Gaps = 5/151 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M+   HP+IV+L  V+ +   V+II+E  T GEL   + V +  L       Y  QL  A
Sbjct: 62  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 118
           +A+  SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE 
Sbjct: 121 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180
Query: 119 LSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
           ++ R +  SA+DVW  GV ++ +LM G  PF
Sbjct: 181 INFRRFT-SASDVWMFGVCMWEILMHGVKPF 210

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 80/151 (52%), Gaps = 5/151 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M+   HP+IV+L  V+ +   V+II+E  T GEL   + V +  L       Y  QL  A
Sbjct: 67  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 125
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 118
           +A+  SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE 
Sbjct: 126 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 185
Query: 119 LSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
           ++ R +  SA+DVW  GV ++ +LM G  PF
Sbjct: 186 INFRRFT-SASDVWMFGVCMWEILMHGVKPF 215

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V    T       VY++   +  G   + IV   +L ++  +    
Sbjct: 104 LKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 161
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 162 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 218
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 219 APEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTD 256

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 80/151 (52%), Gaps = 5/151 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M+   HP+IV+L  V+ +   V+II+E  T GEL   + V +  L       Y  QL  A
Sbjct: 70  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 128
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 118
           +A+  SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE 
Sbjct: 129 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 188
Query: 119 LSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
           ++ R +  SA+DVW  GV ++ +LM G  PF
Sbjct: 189 INFRRFT-SASDVWMFGVCMWEILMHGVKPF 218

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 4/151 (2%)
Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 67  -GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 125
             + HRD+KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y 
Sbjct: 151 HKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS 208
Query: 126 GSAADVWSCGVILFVLMAGYLPFGETDLPTL 156
              +D+WS G+ L  +  G  P    D   L
Sbjct: 209 -VQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 238

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCAKLTDDHVQFLIY 128
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 185
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 80/151 (52%), Gaps = 5/151 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M+   HP+IV+L  V+ +   V+II+E  T GEL   + V +  L       Y  QL  A
Sbjct: 68  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 126
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 118
           +A+  SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE 
Sbjct: 127 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 186
Query: 119 LSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
           ++ R +  SA+DVW  GV ++ +LM G  PF
Sbjct: 187 INFRRFT-SASDVWMFGVCMWEILMHGVKPF 216

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 137
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 138 QILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLA---RHTDDEMTGYVATRWYR 194
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 132
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGXVATRWYR 189
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 4/151 (2%)
Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 67  -GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 125
             + HRD+KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y 
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 126 GSAADVWSCGVILFVLMAGYLPFGETDLPTL 156
              +D+WS G+ L  +  G  P    D   L
Sbjct: 182 -VQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 211

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 80/153 (52%), Gaps = 9/153 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLI 57
           M+   HP+IV+L  V+ +   V+II+E  T GEL  +   Q R    D      Y  QL 
Sbjct: 445 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGEL--RSFLQVRKFSLDLASLILYAYQLS 501
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAP 116
            A+A+  SK   HRD+   N+L+ +   +K+ DFGLS   +       +    P  ++AP
Sbjct: 502 TALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561
Query: 117 EVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
           E ++ R +  SA+DVW  GV ++ +LM G  PF
Sbjct: 562 ESINFRRFT-SASDVWMFGVCMWEILMHGVKPF 593

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 137
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 138 QILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLA---RHTDDEMTGYVATRWYR 194
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 132
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 189
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 190 APEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 152
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 153 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMXGXVATRWYR 209
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 247

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 86  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 143
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 144 QILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLA---RHTDDEMTGYVATRWYR 200
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 201 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 238

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 4/151 (2%)
Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 67  -GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 125
             + HRD+KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y 
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 126 GSAADVWSCGVILFVLMAGYLPFGETDLPTL 156
              +D+WS G+ L  +  G  P    D   L
Sbjct: 182 -VQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 211

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 107/225 (47%), Gaps = 20/225 (8%)
Query: 2   KIVRHPN-IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR-YFQQLIDA 59
           K+ +H + I+RL++   +   +Y+++E   G    +  + + + ++   R+ Y++ +++A
Sbjct: 110 KLQQHSDKIIRLYDYEITDQYIYMVME--CGNIDLNSWLKKKKSIDPWERKSYWKNMLEA 167
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPE 117
           V   H  G+ H DLKP N L+   G LK+ DFG++    P     +  +  G  NY+ PE
Sbjct: 168 VHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 118 V---LSNRGYDG-------SAADVWSCGVILFVLMAGYLPFGE--TDLPTLYKKINAA-E 164
               +S+   +G         +DVWS G IL+ +  G  PF +    +  L+  I+   E
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 286
Query: 165 FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
              P         ++   L  +PK RI I  +  HP+ +   +PV
Sbjct: 287 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 331

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 73/145 (50%), Gaps = 10/145 (6%)
Query: 1   MKIVRHPNIVRLHEVLA-SRT----KVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYF 53
           ++   HPN+VRL +V A SRT    KV ++ E V        DK    G L     +   
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLM 126
Query: 54  QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 113
           +Q +  +   H+  + HRDLKPEN+L+ S G +K++DFGL+ +    + L      T  Y
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV-TLWY 185
Query: 114 VAPEVLSNRGYDGSAADVWSCGVIL 138
            APEVL    Y  +  D+WS G I 
Sbjct: 186 RAPEVLLQSTY-ATPVDMWSVGCIF 209

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 4/151 (2%)
Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 67  -GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 125
             + HRD+KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y 
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 126 GSAADVWSCGVILFVLMAGYLPFGETDLPTL 156
              +D+WS G+ L  +  G  P    D   L
Sbjct: 182 -VQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 211

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 4/151 (2%)
Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 67  -GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 125
             + HRD+KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y 
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 126 GSAADVWSCGVILFVLMAGYLPFGETDLPTL 156
              +D+WS G+ L  +  G  P    D   L
Sbjct: 182 -VQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 211

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 80/153 (52%), Gaps = 9/153 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLI 57
           M+   HP+IV+L  V+ +   V+II+E  T GEL  +   Q R    D      Y  QL 
Sbjct: 65  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGEL--RSFLQVRKFSLDLASLILYAYQLS 121
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAP 116
            A+A+  SK   HRD+   N+L+ +   +K+ DFGLS   +       +    P  ++AP
Sbjct: 122 TALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 181
Query: 117 EVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
           E ++ R +  SA+DVW  GV ++ +LM G  PF
Sbjct: 182 ESINFRRFT-SASDVWMFGVCMWEILMHGVKPF 213

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 98  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 155
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 156 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMXGYVATRWYR 212
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 250

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 73/145 (50%), Gaps = 10/145 (6%)
Query: 1   MKIVRHPNIVRLHEVLA-SRT----KVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYF 53
           ++   HPN+VRL +V A SRT    KV ++ E V        DK    G L     +   
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLM 118
Query: 54  QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 113
           +Q +  +   H+  + HRDLKPEN+L+ S G +K++DFGL+ +    + L      T  Y
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVV-TLWY 177
Query: 114 VAPEVLSNRGYDGSAADVWSCGVIL 138
            APEVL    Y  +  D+WS G I 
Sbjct: 178 RAPEVLLQSTY-ATPVDMWSVGCIF 201

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 132
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 189
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 132
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 189
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 139
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 196
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 132
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 189
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 132
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 189
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 134
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 135 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 191
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 137
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 138 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 194
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 138
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 139 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 195
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 132
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 189
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 74  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 131
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 132 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 188
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 189 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 226

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 129
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 130 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 186
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 187 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 224

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 85  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 142
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 143 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 199
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 200 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 237

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 144
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 145 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 201
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 239

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 144
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 145 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 201
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 239

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 144
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 145 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 201
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 239

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 129
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 130 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 186
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 187 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 224

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 128
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 185
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 128
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 185
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 137
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 138 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 194
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 86  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 143
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 144 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 200
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 201 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 238

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 132
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 189
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 132
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 189
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 16/153 (10%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDA 59
           M+ + HPN+++   VL    ++  I E++ GG L   I           R  F + +   
Sbjct: 61  MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASG 120
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL------PQQGVELL--------H 105
           +A+ HS  + HRDL   N L+    N+ V+DFGL+ L        +G+  L        +
Sbjct: 121 MAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 106 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVIL 138
           T  G P ++APE+++ R YD    DV+S G++L
Sbjct: 181 TVVGNPYWMAPEMINGRSYD-EKVDVFSFGIVL 212

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 132
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 189
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 134
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 135 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 191
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 94  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 151
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 152 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 208
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 209 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 246

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 134
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 135 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 191
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 73  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 130
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 131 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 187
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 188 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 225

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 98  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 155
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 156 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 212
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 250

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 132
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMAGFVATRWYR 189
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 132
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMAGFVATRWYR 189
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 152
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 153 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 209
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 247

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 138
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 139 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 195
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 128
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMAGFVATRWYR 185
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 152
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 153 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 209
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 247

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 94  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 151
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 152 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 208
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 209 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 246

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 4/151 (2%)
Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P IV  +    S  ++ I +E + GG L   +    R+ E    +    ++  +A+   K
Sbjct: 74  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 133
Query: 67  -GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 125
             + HRD+KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y+APE L    Y 
Sbjct: 134 HQIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMAPERLQGTHYS 191
Query: 126 GSAADVWSCGVILFVLMAGYLPFGETDLPTL 156
              +D+WS G+ L  L  G  P    D   L
Sbjct: 192 -VQSDIWSMGLSLVELAVGRYPIPPPDAKEL 221

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 138
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y 
Sbjct: 139 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 195
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 73/145 (50%), Gaps = 10/145 (6%)
Query: 1   MKIVRHPNIVRLHEVLA-SRT----KVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYF 53
           ++   HPN+VRL +V A SRT    KV ++ E V        DK    G L     +   
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLM 118
Query: 54  QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 113
           +Q +  +   H+  + HRDLKPEN+L+ S G +K++DFGL+ +    +  L     T  Y
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LDPVVVTLWY 177
Query: 114 VAPEVLSNRGYDGSAADVWSCGVIL 138
            APEVL    Y  +  D+WS G I 
Sbjct: 178 RAPEVLLQSTY-ATPVDMWSVGCIF 201

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 14/209 (6%)
Query: 7   PNIVRLHEVLASRTKVYIILEFV-TGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           P IV+      + T V+I +E + T  E   K + QG + E    +    ++ A+ +   
Sbjct: 84  PYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKE 142
Query: 66  K-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL----- 119
           K GV HRD+KP N+LLD  G +K+ DFG+S       +    + G   Y+APE +     
Sbjct: 143 KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD-KAKDRSAGCAAYMAPERIDPPDP 201
Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFG--ETDLPTLYKKINAAEFSCP--FWFSTGA 175
           +   YD   ADVWS G+ L  L  G  P+   +TD   L K +       P    FS   
Sbjct: 202 TKPDYD-IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDF 260
Query: 176 TSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
            S +   L  + + R +   + +H + ++
Sbjct: 261 QSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 111/236 (47%), Gaps = 32/236 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQL---- 56
           +   RHP++V L      R ++ +I +++  G L   +   G  L      + Q+L    
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY--GSDLPTMSMSWEQRLEICI 146
Query: 57  --IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC-----G 109
                + + H++ + HRD+K  N+LLD     K++DFG+S   ++G EL  T       G
Sbjct: 147 GAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS---KKGTELGQTHLXXVVKG 203
Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF 169
           T  Y+ PE    +G     +DV+S GV+LF ++       ++ LP   + +N AE++   
Sbjct: 204 TLGYIDPEYFI-KGRLTEKSDVYSFGVVLFEVLCARSAIVQS-LPR--EMVNLAEWAV-- 257
Query: 170 WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC---SEEEEVNLDDV 222
              +     + +I+DPN   +IR E +RK          VKC   S E+  ++ DV
Sbjct: 258 --ESHNNGQLEQIVDPNLADKIRPESLRKF-----GDTAVKCLALSSEDRPSMGDV 306

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 111/236 (47%), Gaps = 32/236 (13%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQL---- 56
           +   RHP++V L      R ++ +I +++  G L   +   G  L      + Q+L    
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY--GSDLPTMSMSWEQRLEICI 146
Query: 57  --IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC-----G 109
                + + H++ + HRD+K  N+LLD     K++DFG+S   ++G EL  T       G
Sbjct: 147 GAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS---KKGTELDQTHLXXVVKG 203
Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF 169
           T  Y+ PE    +G     +DV+S GV+LF ++       ++ LP   + +N AE++   
Sbjct: 204 TLGYIDPEYFI-KGRLTEKSDVYSFGVVLFEVLCARSAIVQS-LPR--EMVNLAEWAV-- 257
Query: 170 WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC---SEEEEVNLDDV 222
              +     + +I+DPN   +IR E +RK          VKC   S E+  ++ DV
Sbjct: 258 --ESHNNGQLEQIVDPNLADKIRPESLRKF-----GDTAVKCLALSSEDRPSMGDV 306

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 132
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ D+GL+   +   + +     T  Y 
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLA---RHTDDEMTGYVATRWYR 189
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 72/143 (50%), Gaps = 6/143 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M  + H N++RL+ V+ +   + ++ E    G L D++  HQG  L     RY  Q+ + 
Sbjct: 69  MHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 127
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL-SALPQQGVE-LLHTTCGTP-NYVAP 116
           + +  SK   HRDL   NLLL +   +K+ DFGL  ALPQ     ++      P  + AP
Sbjct: 128 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 117 EVLSNRGYDGSAADVWSCGVILF 139
           E L  R +   A+D W  GV L+
Sbjct: 188 ESLKTRTF-SHASDTWMFGVTLW 209

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 74/161 (45%), Gaps = 5/161 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK ++HPN+V+L  V       YI+ E++  G L D +    R         +   Q+  
Sbjct: 82  MKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISS 141
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 142 AMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 201
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLY 157
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y
Sbjct: 202 SLAYNTFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 241

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 72/143 (50%), Gaps = 6/143 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M  + H N++RL+ V+ +   + ++ E    G L D++  HQG  L     RY  Q+ + 
Sbjct: 75  MHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL-SALPQQGVE-LLHTTCGTP-NYVAP 116
           + +  SK   HRDL   NLLL +   +K+ DFGL  ALPQ     ++      P  + AP
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 193
Query: 117 EVLSNRGYDGSAADVWSCGVILF 139
           E L  R +   A+D W  GV L+
Sbjct: 194 ESLKTRTF-SHASDTWMFGVTLW 215

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 97/220 (44%), Gaps = 32/220 (14%)
Query: 2   KIVRHPNIVRL--------HEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRR 51
           K+  HPNIV+          E    + +  ++ E   G   E   K+  +G L  +   +
Sbjct: 81  KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 52  YFQQLIDAVAHCHSKG--VYHRDLKPENLLLDSYGNLKVSDFG------------LSALP 97
            F Q   AV H H +   + HRDLK ENLLL + G +K+ DFG             SA  
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 98  QQGVELLHTTCGTPNYVAPEV--LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT 155
           +  VE   T   TP Y  PE+  L +    G   D+W+ G IL++L     PF   D   
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF--EDGAK 258
Query: 156 LYKKINAAEFSCPFWFS--TGATSLIHKILDPNPKTRIRI 193
           L  +I   ++S P   +  T   SLI  +L  NP+ R+ I
Sbjct: 259 L--RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSI 296

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 72/143 (50%), Gaps = 6/143 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M  + H N++RL+ V+ +   + ++ E    G L D++  HQG  L     RY  Q+ + 
Sbjct: 75  MHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL-SALPQQGVE-LLHTTCGTP-NYVAP 116
           + +  SK   HRDL   NLLL +   +K+ DFGL  ALPQ     ++      P  + AP
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193
Query: 117 EVLSNRGYDGSAADVWSCGVILF 139
           E L  R +   A+D W  GV L+
Sbjct: 194 ESLKTRTF-SHASDTWMFGVTLW 215

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 72/143 (50%), Gaps = 6/143 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M  + H N++RL+ V+ +   + ++ E    G L D++  HQG  L     RY  Q+ + 
Sbjct: 65  MHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL-SALPQQGVE-LLHTTCGTP-NYVAP 116
           + +  SK   HRDL   NLLL +   +K+ DFGL  ALPQ     ++      P  + AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 183
Query: 117 EVLSNRGYDGSAADVWSCGVILF 139
           E L  R +   A+D W  GV L+
Sbjct: 184 ESLKTRTF-SHASDTWMFGVTLW 205

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 72/143 (50%), Gaps = 6/143 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M  + H N++RL+ V+ +   + ++ E    G L D++  HQG  L     RY  Q+ + 
Sbjct: 65  MHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL-SALPQQGVE-LLHTTCGTP-NYVAP 116
           + +  SK   HRDL   NLLL +   +K+ DFGL  ALPQ     ++      P  + AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 117 EVLSNRGYDGSAADVWSCGVILF 139
           E L  R +   A+D W  GV L+
Sbjct: 184 ESLKTRTF-SHASDTWMFGVTLW 205

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 72/143 (50%), Gaps = 6/143 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M  + H N++RL+ V+ +   + ++ E    G L D++  HQG  L     RY  Q+ + 
Sbjct: 69  MHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 127
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL-SALPQQGVE-LLHTTCGTP-NYVAP 116
           + +  SK   HRDL   NLLL +   +K+ DFGL  ALPQ     ++      P  + AP
Sbjct: 128 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 117 EVLSNRGYDGSAADVWSCGVILF 139
           E L  R +   A+D W  GV L+
Sbjct: 188 ESLKTRTF-SHASDTWMFGVTLW 209

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 72/143 (50%), Gaps = 6/143 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M  + H N++RL+ V+ +   + ++ E    G L D++  HQG  L     RY  Q+ + 
Sbjct: 65  MHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL-SALPQQGVE-LLHTTCGTP-NYVAP 116
           + +  SK   HRDL   NLLL +   +K+ DFGL  ALPQ     ++      P  + AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 117 EVLSNRGYDGSAADVWSCGVILF 139
           E L  R +   A+D W  GV L+
Sbjct: 184 ESLKTRTF-SHASDTWMFGVTLW 205

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 7   PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 147
Query: 64  HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 122
           HS G+ HRD+KP N+L+D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 148 HSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 206
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPF 148
                + D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 79/152 (51%), Gaps = 8/152 (5%)
Query: 1   MKIVRHPNIVRLHEVLAS-RTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQ-QLI 57
           M  +RH N+V+L  V+   +  +YI+ E++  G L D +  +GR +L  DC   F   + 
Sbjct: 68  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 127
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
           +A+ +       HRDL   N+L+      KVSDFGL+   ++      T      + APE
Sbjct: 128 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPE 184
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
            L  + +  + +DVWS G++L+ + + G +P+
Sbjct: 185 ALREKKFS-TKSDVWSFGILLWEIYSFGRVPY 215

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 79/152 (51%), Gaps = 8/152 (5%)
Query: 1   MKIVRHPNIVRLHEVLAS-RTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQ-QLI 57
           M  +RH N+V+L  V+   +  +YI+ E++  G L D +  +GR +L  DC   F   + 
Sbjct: 240 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 299
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
           +A+ +       HRDL   N+L+      KVSDFGL+   ++      T      + APE
Sbjct: 300 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPE 356
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
            L  + +  + +DVWS G++L+ + + G +P+
Sbjct: 357 ALREKKFS-TKSDVWSFGILLWEIYSFGRVPY 387

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 86/177 (48%), Gaps = 13/177 (7%)
Query: 1   MKIVRHPNIVRLHEVLAS-RTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQ-QLI 57
           M  +RH N+V+L  V+   +  +YI+ E++  G L D +  +GR +L  DC   F   + 
Sbjct: 53  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 112
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
           +A+ +       HRDL   N+L+      KVSDFGL+   ++      T      + APE
Sbjct: 113 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPE 169
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINA-----AEFSCP 168
            L  + +  + +DVWS G++L+ + + G +P+    L  +  ++       A   CP
Sbjct: 170 ALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 225

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 7   PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 147
Query: 64  HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 122
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 206
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPF 148
                + D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 7/148 (4%)
Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P IV L+  +     V I +E + GG L   +  QG L E+    Y  Q ++ + + HS+
Sbjct: 126 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSR 185
Query: 67  GVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQ---GVELLHT--TCGTPNYVAPEVLS 120
            + H D+K +N+LL S G+   + DFG +   Q    G +LL      GT  ++APEV+ 
Sbjct: 186 RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVL 245
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPF 148
            R  D +  DVWS   ++  ++ G  P+
Sbjct: 246 GRSCD-AKVDVWSSCCMMLHMLNGCHPW 272

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 7   PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 147
Query: 64  HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 122
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 206
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPF 148
                + D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 7   PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 91  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 146
Query: 64  HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 122
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 205
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPF 148
                + D+WS G +L  ++    PF
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 7   PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 91  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 146
Query: 64  HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 122
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 205
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPF 148
                + D+WS G +L  ++    PF
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 7   PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 147
Query: 64  HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 122
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 206
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPF 148
                + D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 7   PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 147
Query: 64  HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 122
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 206
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPF 148
                + D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 7   PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 147
Query: 64  HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 122
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 206
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPF 148
                + D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 7   PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 90  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 145
Query: 64  HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 122
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 204
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPF 148
                + D+WS G +L  ++    PF
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPF 230

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 7   PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 147
Query: 64  HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 122
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 206
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPF 148
                + D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 7   PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 147
Query: 64  HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 122
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 206
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPF 148
                + D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 7   PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 147
Query: 64  HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 122
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 206
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPF 148
                + D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 6/152 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLID 58
           MK ++H  +VRL+ V+ ++  +YII E++  G L D  K     +L  N       Q+ +
Sbjct: 62  MKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
            +A    +   HRDL+  N+L+    + K++DFGL+ L +            P  + APE
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPE 180
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            + N G     +DVWS G++L  ++  G +P+
Sbjct: 181 AI-NYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 81/174 (46%), Gaps = 31/174 (17%)
Query: 1   MKIVR---HPNIVRLHEVLASR--------------TKVYIILEFVTGGELFDKIVHQGR 43
           +KI+R   H NIV++ E+L                   VYI+ E++        ++ QG 
Sbjct: 59  IKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVLEQGP 116
Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-NLKVSDFGLSAL-----P 97
           LLE   R +  QL+  + + HS  V HRDLKP NL +++    LK+ DFGL+ +      
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176
Query: 98  QQGVELLHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFG 149
            +G    H + G  T  Y +P +L +      A D+W+ G I   ++ G   F 
Sbjct: 177 HKG----HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFA 226

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 7   PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 147
Query: 64  HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 122
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 206
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPF 148
                + D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 82/164 (50%), Gaps = 8/164 (4%)
Query: 1   MKIVRHPNIVRLHEVLAS-RTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQ-QLI 57
           M  +RH N+V+L  V+   +  +YI+ E++  G L D +  +GR +L  DC   F   + 
Sbjct: 59  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 118
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
           +A+ +       HRDL   N+L+      KVSDFGL+   ++      T      + APE
Sbjct: 119 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPE 175
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI 160
            L    +  + +DVWS G++L+ + + G +P+    L  +  ++
Sbjct: 176 ALREAAFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 218

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 6/152 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLID 58
           MK ++H  +VRL+ V+ ++  +YII E++  G L D  K     +L  N       Q+ +
Sbjct: 68  MKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 126
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
            +A    +   HRDL+  N+L+    + K++DFGL+ L +            P  + APE
Sbjct: 127 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPE 186
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            + N G     +DVWS G++L  ++  G +P+
Sbjct: 187 AI-NYGTFTIKSDVWSFGILLTEIVTHGRIPY 217

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 74/148 (50%), Gaps = 7/148 (4%)
Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P IV L+  +     V I +E + GG L   +  QG L E+    Y  Q ++ + + HS+
Sbjct: 145 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSR 204
Query: 67  GVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQ---GVELLHT--TCGTPNYVAPEVLS 120
            + H D+K +N+LL S G+   + DFG +   Q    G  LL      GT  ++APEV+ 
Sbjct: 205 RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVL 264
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPF 148
            R  D +  DVWS   ++  ++ G  P+
Sbjct: 265 GRSCD-AKVDVWSSCCMMLHMLNGCHPW 291

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 75/155 (48%), Gaps = 19/155 (12%)
Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKI------VHQGRLLENDCRRYFQQLIDAV 60
           P IV+ +  L      +I +E ++    FDK       V    + E    +     + A+
Sbjct: 81  PYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 61  AHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT--CGTPNYVAPE 117
            H      + HRD+KP N+LLD  GN+K+ DFG+S    Q V+ +  T   G   Y+APE
Sbjct: 139 NHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPE 195
Query: 118 VL----SNRGYDGSAADVWSCGVILFVLMAGYLPF 148
            +    S +GYD   +DVWS G+ L+ L  G  P+
Sbjct: 196 RIDPSASRQGYD-VRSDVWSLGITLYELATGRFPY 229

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 6/152 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLID 58
           MK ++H  +VRL+ V+ ++  +YII E++  G L D  K     +L  N       Q+ +
Sbjct: 63  MKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 121
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
            +A    +   HRDL+  N+L+    + K++DFGL+ L +            P  + APE
Sbjct: 122 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPE 181
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            + N G     +DVWS G++L  ++  G +P+
Sbjct: 182 AI-NYGTFTIKSDVWSFGILLTEIVTHGRIPY 212

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 6/152 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLID 58
           MK ++H  +VRL+ V+ ++  +YII E++  G L D  K     +L  N       Q+ +
Sbjct: 62  MKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
            +A    +   HRDL+  N+L+    + K++DFGL+ L +            P  + APE
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPE 180
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            + N G     +DVWS G++L  ++  G +P+
Sbjct: 181 AI-NYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 6/152 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLID 58
           MK ++H  +VRL+ V+ ++  +YII E++  G L D  K     +L  N       Q+ +
Sbjct: 64  MKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 122
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
            +A    +   HRDL+  N+L+    + K++DFGL+ L +            P  + APE
Sbjct: 123 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPE 182
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            + N G     +DVWS G++L  ++  G +P+
Sbjct: 183 AI-NYGTFTIKSDVWSFGILLTEIVTHGRIPY 213

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 7   PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 97  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 152
Query: 64  HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 122
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 153 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 211
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPF 148
                + D+WS G +L  ++    PF
Sbjct: 212 QMYDYSLDMWSLGCMLASMIFRKEPF 237

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 9/161 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ +RHPN ++           ++++E+  G       VH+  L E +        +  +
Sbjct: 108 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 167
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV-- 118
           A+ HS  + HRD+K  N+LL   G +K+ DFG +++    +   +   GTP ++APEV  
Sbjct: 168 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI----MAPANXFVGTPYWMAPEVIL 223
Query: 119 -LSNRGYDGSAADVWSCGVILFVLMAGYLP-FGETDLPTLY 157
            +    YDG   DVWS G+    L     P F    +  LY
Sbjct: 224 AMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALY 263

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 6/152 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLID 58
           MK ++H  +VRL+ V+ ++  +YII E++  G L D  K     +L  N       Q+ +
Sbjct: 70  MKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 128
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
            +A    +   HRDL+  N+L+    + K++DFGL+ L +            P  + APE
Sbjct: 129 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPE 188
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            + N G     +DVWS G++L  ++  G +P+
Sbjct: 189 AI-NYGTFTIKSDVWSFGILLTEIVTHGRIPY 219

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 132
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+  FGL+   +   + +     T  Y 
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLA---RHTDDEMTGYVATRWYR 189
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 6/152 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLID 58
           MK ++H  +VRL+ V+ ++  +YII E++  G L D  K     +L  N       Q+ +
Sbjct: 62  MKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
            +A    +   HRDL+  N+L+    + K++DFGL+ L +            P  + APE
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPE 180
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            + N G     +DVWS G++L  ++  G +P+
Sbjct: 181 AI-NYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 6/152 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLID 58
           MK ++H  +VRL+ V+ ++  +YII E++  G L D  K     +L  N       Q+ +
Sbjct: 71  MKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 129
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
            +A    +   HRDL+  N+L+    + K++DFGL+ L +            P  + APE
Sbjct: 130 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPE 189
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            + N G     +DVWS G++L  ++  G +P+
Sbjct: 190 AI-NYGTFTIKSDVWSFGILLTEIVTHGRIPY 220

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 9/161 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ +RHPN ++           ++++E+  G       VH+  L E +        +  +
Sbjct: 69  LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV-- 118
           A+ HS  + HRD+K  N+LL   G +K+ DFG +++    +   +   GTP ++APEV  
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI----MAPANXFVGTPYWMAPEVIL 184
Query: 119 -LSNRGYDGSAADVWSCGVILFVLMAGYLP-FGETDLPTLY 157
            +    YDG   DVWS G+    L     P F    +  LY
Sbjct: 185 AMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALY 224

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 132
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ D GL+   +   + +     T  Y 
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLA---RHTDDEMTGYVATRWYR 189
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 82/147 (55%), Gaps = 11/147 (7%)
Query: 7   PNIVRLHEVLA---SRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           PNIV+L +++    S+T   +I E+V   +   K+++   L + D R Y  +L+ A+ +C
Sbjct: 87  PNIVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLYPT-LTDYDIRYYIYELLKALDYC 142
Query: 64  HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN- 121
           HS+G+ HRD+KP N+++D     L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 143 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDL 201
Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPF 148
           + YD S  D+WS G +   ++    PF
Sbjct: 202 QDYDYS-LDMWSLGCMFAGMIFRKEPF 227

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 6/152 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLID 58
           MK ++H  +VRL+ V+ ++  +YII E++  G L D  K     +L  N       Q+ +
Sbjct: 67  MKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 125
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
            +A    +   HRDL+  N+L+    + K++DFGL+ L +            P  + APE
Sbjct: 126 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 185
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            + N G     +DVWS G++L  ++  G +P+
Sbjct: 186 AI-NYGTFTIKSDVWSFGILLTEIVTHGRIPY 216

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 82/147 (55%), Gaps = 11/147 (7%)
Query: 7   PNIVRLHEVLA---SRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           PNIV+L +++    S+T   +I E+V   +   K+++   L + D R Y  +L+ A+ +C
Sbjct: 86  PNIVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLYPT-LTDYDIRYYIYELLKALDYC 141
Query: 64  HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN- 121
           HS+G+ HRD+KP N+++D     L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDL 200
Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPF 148
           + YD S  D+WS G +   ++    PF
Sbjct: 201 QDYDYS-LDMWSLGCMFAGMIFRKEPF 226

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 6/152 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLID 58
           MK ++H  +VRL+ V+ ++  +YII E++  G L D  K     +L  N       Q+ +
Sbjct: 68  MKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 126
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
            +A    +   HRDL+  N+L+    + K++DFGL+ L +            P  + APE
Sbjct: 127 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 186
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            + N G     +DVWS G++L  ++  G +P+
Sbjct: 187 AI-NYGTFTIKSDVWSFGILLTEIVTHGRIPY 217

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 77/146 (52%), Gaps = 9/146 (6%)
Query: 7   PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           PNI+ L +++    SRT   ++ E V   +   K + Q  L + D R Y  +++ A+ +C
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLRQT-LTDYDIRFYMYEILKALDYC 147
Query: 64  HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 122
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 206
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPF 148
                + D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 79/164 (48%), Gaps = 7/164 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++H NI+ L  V+    ++++I E+    +L   +     +     + +  QLI+ V
Sbjct: 87  LKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGV 145
Query: 61  AHCHSKGVYHRDLKPENLLLDSYGN-----LKVSDFGLSALPQQGVELLHTTCGTPNYVA 115
             CHS+   HRDLKP+NLLL          LK+ DFGL+      +        T  Y  
Sbjct: 146 NFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRP 205
Query: 116 PEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
           PE+L    +  ++ D+WS   I   +LM   L  G++++  L+K
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK 249

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 113/288 (39%), Gaps = 79/288 (27%)
Query: 6   HPNIVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAH 62
           H NIV L  VL +     VY++ +++   E     V +  +LE   ++Y   QLI  + +
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYM---ETDLHAVIRANILEPVHKQYVVYQLIKVIKY 124
Query: 63  CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-----------LPQQGVE--------- 102
            HS G+ HRD+KP N+LL++  ++KV+DFGLS            +P    E         
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 103 -LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG----------------- 144
            +L     T  Y APE+L          D+WS G IL  ++ G                 
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244
Query: 145 --------------YLPFGETDLPTLYKKINAAEFSCPFWFST----------------G 174
                           PF +T + +L +K+   + +    F+                  
Sbjct: 245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEE 304
Query: 175 ATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDV 222
           A  L+ K+L  NP  RI      KHP+    +NP      EE N D +
Sbjct: 305 ALDLLDKLLQFNPNKRISANDALKHPFVSIFHNP-----NEEPNCDHI 347

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 6/152 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLID 58
           MK ++H  +VRL+ V+ ++  +YII E++  G L D  K     +L  N       Q+ +
Sbjct: 62  MKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
            +A    +   HRDL+  N+L+    + K++DFGL+ L +            P  + APE
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            + N G     +DVWS G++L  ++  G +P+
Sbjct: 181 AI-NYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 82/147 (55%), Gaps = 11/147 (7%)
Query: 7   PNIVRLHEVLA---SRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           PNIV+L +++    S+T   +I E+V   +   K+++   L + D R Y  +L+ A+ +C
Sbjct: 86  PNIVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLYPT-LTDYDIRYYIYELLKALDYC 141
Query: 64  HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN- 121
           HS+G+ HRD+KP N+++D     L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDL 200
Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPF 148
           + YD S  D+WS G +   ++    PF
Sbjct: 201 QDYDYS-LDMWSLGCMFAGMIFRKEPF 226

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 82/147 (55%), Gaps = 11/147 (7%)
Query: 7   PNIVRLHEVLA---SRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           PNIV+L +++    S+T   +I E+V   +   K+++   L + D R Y  +L+ A+ +C
Sbjct: 86  PNIVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLYPT-LTDYDIRYYIYELLKALDYC 141
Query: 64  HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN- 121
           HS+G+ HRD+KP N+++D     L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDL 200
Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPF 148
           + YD S  D+WS G +   ++    PF
Sbjct: 201 QDYDYS-LDMWSLGCMFAGMIFRKEPF 226

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 82/147 (55%), Gaps = 11/147 (7%)
Query: 7   PNIVRLHEVLA---SRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           PNIV+L +++    S+T   +I E+V   +   K+++   L + D R Y  +L+ A+ +C
Sbjct: 86  PNIVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLYPT-LTDYDIRYYIYELLKALDYC 141
Query: 64  HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN- 121
           HS+G+ HRD+KP N+++D     L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDL 200
Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPF 148
           + YD S  D+WS G +   ++    PF
Sbjct: 201 QDYDYS-LDMWSLGCMFAGMIFRKEPF 226

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 82/147 (55%), Gaps = 11/147 (7%)
Query: 7   PNIVRLHEVLA---SRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           PNIV+L +++    S+T   +I E+V   +   K+++   L + D R Y  +L+ A+ +C
Sbjct: 87  PNIVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLYPT-LTDYDIRYYIYELLKALDYC 142
Query: 64  HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN- 121
           HS+G+ HRD+KP N+++D     L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 143 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDL 201
Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPF 148
           + YD S  D+WS G +   ++    PF
Sbjct: 202 QDYDYS-LDMWSLGCMFAGMIFRKEPF 227

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 22/219 (10%)
Query: 1   MKIVRHPNIVRLHEVLASRTK----VYIILEFVTGGELFDKI----VHQGRLLENDCRRY 52
           +K ++HPNIVR ++   S  K    + ++ E  T G L   +    V + ++L + CR+ 
Sbjct: 79  LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI 138
Query: 53  FQQLIDAVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTP 111
            + L     H  +  + HRDLK +N+ +    G++K+ D GL+ L +          GTP
Sbjct: 139 LKGL--QFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVIGTP 194
Query: 112 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW 170
            + APE    + YD S  DV++ G           P+ E  +   +Y+++ +     P  
Sbjct: 195 EFXAPEXYEEK-YDES-VDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSG--VKPAS 250
Query: 171 FSTGATSLIHKILD----PNPKTRIRIEGIRKHPWFRKN 205
           F   A   + +I++     N   R  I+ +  H +F++ 
Sbjct: 251 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 132
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ D GL+   +   + +     T  Y 
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLA---RHTDDEMTGYVATRWYR 189
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 82/147 (55%), Gaps = 11/147 (7%)
Query: 7   PNIVRLHEVLA---SRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           PNIV+L +++    S+T   +I E+V   +   K+++   L + D R Y  +L+ A+ +C
Sbjct: 88  PNIVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLYPT-LTDYDIRYYIYELLKALDYC 143
Query: 64  HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN- 121
           HS+G+ HRD+KP N+++D     L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 144 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDL 202
Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPF 148
           + YD S  D+WS G +   ++    PF
Sbjct: 203 QDYDYS-LDMWSLGCMFAGMIFRKEPF 228

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 132
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ DF L+   +   + +     T  Y 
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLA---RHTDDEMTGYVATRWYR 189
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 6/152 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLID 58
           MK ++H  +VRL+ V+ ++  +YII E++  G L D  K     +L  N       Q+ +
Sbjct: 57  MKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 115
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
            +A    +   HRDL+  N+L+    + K++DFGL+ L +            P  + APE
Sbjct: 116 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 175
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            + N G     +DVWS G++L  ++  G +P+
Sbjct: 176 AI-NYGTFTIKSDVWSFGILLTEIVTHGRIPY 206

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 82/147 (55%), Gaps = 11/147 (7%)
Query: 7   PNIVRLHEVLA---SRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           PNIV+L +++    S+T   +I E+V   +   K+++   L + D R Y  +L+ A+ +C
Sbjct: 86  PNIVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLYPT-LTDYDIRYYIYELLKALDYC 141
Query: 64  HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN- 121
           HS+G+ HRD+KP N+++D     L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDL 200
Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPF 148
           + YD S  D+WS G +   ++    PF
Sbjct: 201 QDYDYS-LDMWSLGCMFAGMIFRKEPF 226

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 82/147 (55%), Gaps = 11/147 (7%)
Query: 7   PNIVRLHEVLA---SRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           PNIV+L +++    S+T   +I E+V   +   K+++   L + D R Y  +L+ A+ +C
Sbjct: 86  PNIVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLYPT-LTDYDIRYYIYELLKALDYC 141
Query: 64  HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN- 121
           HS+G+ HRD+KP N+++D     L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDL 200
Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPF 148
           + YD S  D+WS G +   ++    PF
Sbjct: 201 QDYDYS-LDMWSLGCMFAGMIFRKEPF 226

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 6/152 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLID 58
           MK ++H  +VRL+ V+ ++  +YII E++  G L D  K     +L  N       Q+ +
Sbjct: 72  MKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 130
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
            +A    +   HRDL+  N+L+    + K++DFGL+ L +            P  + APE
Sbjct: 131 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 190
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            + N G     +DVWS G++L  ++  G +P+
Sbjct: 191 AI-NYGTFTIKSDVWSFGILLTEIVTHGRIPY 221

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 11/158 (6%)
Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V      L     VY++   +  G   + IV   +L ++  +    
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 132
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS  + HRDLKP NL ++    LK+ D GL+   +   + +     T  Y 
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLA---RHTDDEMTGYVATRWYR 189
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APE++ N  +     D+WS G I+  L+ G   F  TD
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 82/147 (55%), Gaps = 11/147 (7%)
Query: 7   PNIVRLHEVLA---SRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           PNIV+L +++    S+T   +I E+V   +   K+++   L + D R Y  +L+ A+ +C
Sbjct: 107 PNIVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLYPT-LTDYDIRYYIYELLKALDYC 162
Query: 64  HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN- 121
           HS+G+ HRD+KP N+++D     L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 163 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDL 221
Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPF 148
           + YD S  D+WS G +   ++    PF
Sbjct: 222 QDYDYS-LDMWSLGCMFAGMIFRKEPF 247

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 84/171 (49%), Gaps = 20/171 (11%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND--CRRYFQQLID 58
           MK ++H  +V+LH V+ ++  +YII EF+  G L D        L++D   ++   +LID
Sbjct: 64  MKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLD-------FLKSDEGSKQPLPKLID 115
Query: 59  -------AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP 111
                   +A    +   HRDL+  N+L+ +    K++DFGL+ + +            P
Sbjct: 116 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 175
Query: 112 -NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 160
             + APE + N G     +DVWS G++L  ++  G +P+     P + + +
Sbjct: 176 IKWTAPEAI-NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 225

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 1   MKIVRHPNIVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLI 57
           +K ++H NIV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+ 
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 124
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN---YV 114
             + +  +K   HRDL   N+L+++   +K+ DFGL+ +  Q  E         +   + 
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY 184
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA 143
           APE L+   +   A+DVWS GV+L+ L  
Sbjct: 185 APESLTESKF-SVASDVWSFGVVLYELFT 212

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 78/155 (50%), Gaps = 12/155 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE-NDCRRYFQQLIDA 59
           M  + HP +V+ + V +    +YI+ E+++ G L + +   G+ LE +        + + 
Sbjct: 57  MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEG 116
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTP---NYV 114
           +A   S    HRDL   N L+D    +KVSDFG++   L  Q V    ++ GT     + 
Sbjct: 117 MAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV----SSVGTKFPVKWS 172
Query: 115 APEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
           APEV     Y  S +DVW+ G++++ V   G +P+
Sbjct: 173 APEVFHYFKY-SSKSDVWAFGILMWEVFSLGKMPY 206

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 80/159 (50%), Gaps = 20/159 (12%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND--CRRYFQQLID 58
           MK ++H  +V+LH V+ ++  +YII EF+  G L D        L++D   ++   +LID
Sbjct: 237 MKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLD-------FLKSDEGSKQPLPKLID 288
Query: 59  -------AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP 111
                   +A    +   HRDL+  N+L+ +    K++DFGL+ + +            P
Sbjct: 289 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 348
Query: 112 -NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
             + APE + N G     +DVWS G++L  ++  G +P+
Sbjct: 349 IKWTAPEAI-NFGSFTIKSDVWSFGILLMEIVTYGRIPY 386

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 1   MKIVRHPNIVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLI 57
           +K ++H NIV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+ 
Sbjct: 96  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 155
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YV 114
             + +  +K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + 
Sbjct: 156 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 215
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA 143
           APE L+   +   A+DVWS GV+L+ L  
Sbjct: 216 APESLTESKF-SVASDVWSFGVVLYELFT 243

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 1   MKIVRHPNIVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLI 57
           +K ++H NIV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+ 
Sbjct: 64  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 123
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YV 114
             + +  +K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + 
Sbjct: 124 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 183
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA 143
           APE L+   +   A+DVWS GV+L+ L  
Sbjct: 184 APESLTESKF-SVASDVWSFGVVLYELFT 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 1   MKIVRHPNIVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLI 57
           +K ++H NIV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+ 
Sbjct: 63  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 122
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YV 114
             + +  +K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + 
Sbjct: 123 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 182
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA 143
           APE L+   +   A+DVWS GV+L+ L  
Sbjct: 183 APESLTESKF-SVASDVWSFGVVLYELFT 210

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 80/179 (44%), Gaps = 37/179 (20%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           HPN++ L  V+   T V II EF+  G L D  + Q     ND +    QL+  +    +
Sbjct: 93  HPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQ-----NDGQFTVIQLVGMLRGIAA 146
Query: 66  KGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY----- 113
              Y       HRDL   N+L++S    KVSDFGLS         L      P Y     
Sbjct: 147 GMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLS-------RFLEDDTSDPTYTSALG 199
Query: 114 -------VAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE 164
                   APE +  R +  SA+DVWS G++++ +M+ G  P+ +    T    INA E
Sbjct: 200 GKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDM---TNQDVINAIE 254

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 1   MKIVRHPNIVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLI 57
           +K ++H NIV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+ 
Sbjct: 69  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 128
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YV 114
             + +  +K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + 
Sbjct: 129 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 188
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA 143
           APE L+   +   A+DVWS GV+L+ L  
Sbjct: 189 APESLTESKF-SVASDVWSFGVVLYELFT 216

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 1   MKIVRHPNIVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLI 57
           +K ++H NIV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+ 
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 124
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YV 114
             + +  +K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + 
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 184
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA 143
           APE L+   +   A+DVWS GV+L+ L  
Sbjct: 185 APESLTESKF-SVASDVWSFGVVLYELFT 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 1   MKIVRHPNIVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLI 57
           +K ++H NIV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+ 
Sbjct: 71  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 130
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YV 114
             + +  +K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + 
Sbjct: 131 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 190
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA 143
           APE L+   +   A+DVWS GV+L+ L  
Sbjct: 191 APESLTESKF-SVASDVWSFGVVLYELFT 218

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 1   MKIVRHPNIVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLI 57
           +K ++H NIV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+ 
Sbjct: 68  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 127
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YV 114
             + +  +K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + 
Sbjct: 128 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 187
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA 143
           APE L+   +   A+DVWS GV+L+ L  
Sbjct: 188 APESLTESKF-SVASDVWSFGVVLYELFT 215

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/130 (33%), Positives = 73/130 (56%), Gaps = 9/130 (6%)
Query: 18  SRTK-VYIILEFVTGGELFDKIVHQGRLLEND---CRRYFQQLIDAVAHCHSKGVYHRDL 73
           S+TK ++I +EF   G L ++ + + R  + D       F+Q+   V + HSK + HRDL
Sbjct: 104 SKTKCLFIQMEFCDKGTL-EQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDL 162
Query: 74  KPENLLLDSYGNLKVSDFGL-SALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 132
           KP N+ L     +K+ DFGL ++L   G      + GT  Y++PE +S++ Y G   D++
Sbjct: 163 KPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT--RSKGTLRYMSPEQISSQDY-GKEVDLY 219
Query: 133 SCGVILFVLM 142
           + G+IL  L+
Sbjct: 220 ALGLILAELL 229

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 1   MKIVRHPNIVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLI 57
           +K ++H NIV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+ 
Sbjct: 70  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 129
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YV 114
             + +  +K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + 
Sbjct: 130 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 189
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA 143
           APE L+   +   A+DVWS GV+L+ L  
Sbjct: 190 APESLTESKF-SVASDVWSFGVVLYELFT 217

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 7/149 (4%)
Query: 1   MKIVRHPNIVRLHEVL--ASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLI 57
           +K ++H NIV+   V   A R  + +I+E++  G L D +  H  R+      +Y  Q+ 
Sbjct: 68  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQIC 127
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YV 114
             + +  +K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + 
Sbjct: 128 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 187
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA 143
           APE L+   +   A+DVWS GV+L+ L  
Sbjct: 188 APESLTESKF-SVASDVWSFGVVLYELFT 215

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 1   MKIVRHPNIVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLI 57
           +K ++H NIV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+ 
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 124
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YV 114
             + +  +K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + 
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 184
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA 143
           APE L+   +   A+DVWS GV+L+ L  
Sbjct: 185 APESLTESKF-SVASDVWSFGVVLYELFT 212

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 13/212 (6%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEF--VTGGELFDKIVHQGRLLENDC-RRYFQQLID 58
           + V  P  V  +  L     V+I  E    +  + + +++ +G+ +  D   +    ++ 
Sbjct: 88  RTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 147
Query: 59  AVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
           A+ H HSK  V HRD+KP N+L+++ G +K  DFG+S      V       G   Y APE
Sbjct: 148 ALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVA-KDIDAGCKPYXAPE 206
Query: 118 ----VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF---W 170
                L+ +GY    +D+WS G+    L     P+     P    K    E S       
Sbjct: 207 RINPELNQKGY-SVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK 265
Query: 171 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 202
           FS        + L  N K R     + +HP+F
Sbjct: 266 FSAEFVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 1   MKIVRHPNIVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLI 57
           +K ++H NIV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+ 
Sbjct: 72  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 131
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YV 114
             + +  +K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + 
Sbjct: 132 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 191
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA 143
           APE L+   +   A+DVWS GV+L+ L  
Sbjct: 192 APESLTESKF-SVASDVWSFGVVLYELFT 219

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 99/230 (43%), Gaps = 35/230 (15%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR--------RYFQQLI 57
           HPN++R +    +   +YI LE          +V    + + + +           +Q+ 
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYG-----------NLK--VSDFGLSALPQQGVEL- 103
             VAH HS  + HRDLKP+N+L+ +             NL+  +SDFGL      G    
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 104 ---LHTTCGTPNYVAPEVL--SNRGYDGSAADVWSCG-VILFVLMAGYLPFGET---DLP 154
              L+   GT  + APE+L  S +     + D++S G V  ++L  G  PFG+    +  
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 263
Query: 155 TLYKKINAAEFSCPFWFS--TGATSLIHKILDPNPKTRIRIEGIRKHPWF 202
            +    +  E  C    S    AT LI +++D +P  R     + +HP F
Sbjct: 264 IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 99/230 (43%), Gaps = 35/230 (15%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR--------RYFQQLI 57
           HPN++R +    +   +YI LE          +V    + + + +           +Q+ 
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYG-----------NLK--VSDFGLSALPQQGVEL- 103
             VAH HS  + HRDLKP+N+L+ +             NL+  +SDFGL      G    
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 104 ---LHTTCGTPNYVAPEVL--SNRGYDGSAADVWSCG-VILFVLMAGYLPFGET---DLP 154
              L+   GT  + APE+L  S +     + D++S G V  ++L  G  PFG+    +  
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 263
Query: 155 TLYKKINAAEFSCPFWFS--TGATSLIHKILDPNPKTRIRIEGIRKHPWF 202
            +    +  E  C    S    AT LI +++D +P  R     + +HP F
Sbjct: 264 IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 1   MKIVRHPNIVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLI 57
           +K ++H NIV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+ 
Sbjct: 83  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 142
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YV 114
             + +  +K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + 
Sbjct: 143 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 202
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA 143
           APE L+   +   A+DVWS GV+L+ L  
Sbjct: 203 APESLTESKF-SVASDVWSFGVVLYELFT 230

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 1   MKIVRHPNIVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLI 57
           +K ++H NIV+   V   A R  + +I+EF+  G L + +  H+ R+      +Y  Q+ 
Sbjct: 68  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQIC 127
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YV 114
             + +  +K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + 
Sbjct: 128 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 187
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA 143
           APE L+   +   A+DVWS GV+L+ L  
Sbjct: 188 APESLTESKF-SVASDVWSFGVVLYELFT 215

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 79/162 (48%), Gaps = 23/162 (14%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M    HPNI+RL  V+ +   V I+ EF+  G L         L  ND +    QL+  +
Sbjct: 69  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL------DSFLRLNDGQFTVIQLVGML 122
Query: 61  AHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTC---G 109
               S   Y       HRDL   N+L++S    KVSDFGLS  L +   +  +T+     
Sbjct: 123 RGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGK 182
Query: 110 TP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE 150
            P  + APE ++ R +  SA+D WS G++++ +M+    FGE
Sbjct: 183 IPIRWTAPEAIAFRKFT-SASDAWSYGIVMWEVMS----FGE 219

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 1   MKIVRHPNIVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLI 57
           +K ++H NIV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+ 
Sbjct: 83  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 142
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YV 114
             + +  +K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + 
Sbjct: 143 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 202
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA 143
           APE L+   +   A+DVWS GV+L+ L  
Sbjct: 203 APESLTESKF-SVASDVWSFGVVLYELFT 230

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 6/152 (3%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLID 58
           MK ++H  +VRL+ V+ ++  +YII E++  G L D  K     +L  N       Q+ +
Sbjct: 58  MKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 116
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
            +A    +   HR+L+  N+L+    + K++DFGL+ L +            P  + APE
Sbjct: 117 GMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 176
Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            + N G     +DVWS G++L  ++  G +P+
Sbjct: 177 AI-NYGTFTIKSDVWSFGILLTEIVTHGRIPY 207

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 76/162 (46%), Gaps = 23/162 (14%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M    HPNI+RL  V+ +   V I+ EF+  G L         L  ND +    QL+  +
Sbjct: 71  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL------DSFLRLNDGQFTVIQLVGML 124
Query: 61  AHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQG----VELLHTTCG 109
               S   Y       HRDL   N+L++S    KVSDFGLS   ++      E       
Sbjct: 125 RGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGK 184
Query: 110 TP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE 150
            P  + APE ++ R +  SA+D WS G++++ +M+    FGE
Sbjct: 185 IPIRWTAPEAIAFRKFT-SASDAWSYGIVMWEVMS----FGE 221

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 111/273 (40%), Gaps = 59/273 (21%)
Query: 6   HPNIVRLHEVLA-----SRTKVYIILEFVTGGELFDKIVHQGRLLENDCR-RYFQQLIDA 59
           HPNI+ L ++       +  K+Y++ E +       +++H  R++ +    +YF   I  
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRTD--LAQVIHDQRIVISPQHIQYFMYHILL 145
Query: 60  VAHC-HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE- 117
             H  H  GV HRDL P N+LL    ++ + DF L+          H       Y APE 
Sbjct: 146 GLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW-YRAPEL 204
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN-------------AAE 164
           V+  +G+     D+WS G ++  +      F  +   T Y ++N                
Sbjct: 205 VMQFKGF-TKLVDMWSAGCVMAEMFNRKALFRGS---TFYNQLNKIVEVVGTPKIEDVVM 260
Query: 165 FSCP----------------FWFSTGATS------LIHKILDPNPKTRIRIEGIRKHPWF 202
           FS P                 W +   T+      LI K+L+ NP+ RI  E   +HP+F
Sbjct: 261 FSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320
Query: 203 RKNYNPVKCSE---------EEEVNLDDVHAVF 226
              ++P+  +E         E   ++ D+H +F
Sbjct: 321 ESLFDPLDLTEGLSERFHFDESVTDVYDMHKIF 353

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 111/273 (40%), Gaps = 59/273 (21%)
Query: 6   HPNIVRLHEVLA-----SRTKVYIILEFVTGGELFDKIVHQGRLLENDCR-RYFQQLIDA 59
           HPNI+ L ++       +  K+Y++ E +       +++H  R++ +    +YF   I  
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRTD--LAQVIHDQRIVISPQHIQYFMYHILL 145
Query: 60  VAHC-HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE- 117
             H  H  GV HRDL P N+LL    ++ + DF L+          H       Y APE 
Sbjct: 146 GLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW-YRAPEL 204
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN-------------AAE 164
           V+  +G+     D+WS G ++  +      F  +   T Y ++N                
Sbjct: 205 VMQFKGF-TKLVDMWSAGCVMAEMFNRKALFRGS---TFYNQLNKIVEVVGTPKIEDVVM 260
Query: 165 FSCP----------------FWFSTGATS------LIHKILDPNPKTRIRIEGIRKHPWF 202
           FS P                 W +   T+      LI K+L+ NP+ RI  E   +HP+F
Sbjct: 261 FSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320
Query: 203 RKNYNPVKCSE---------EEEVNLDDVHAVF 226
              ++P+  +E         E   ++ D+H +F
Sbjct: 321 ESLFDPLDLTEGLSERFHFDESVTDVYDMHKIF 353

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 82/159 (51%), Gaps = 18/159 (11%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID-- 58
           ++  RH NI+ L    +++ ++ I+ ++  G  L+        L  ++ +   ++LID  
Sbjct: 62  LRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYH------HLHASETKFEMKKLIDIA 114
Query: 59  -----AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTP 111
                 + + H+K + HRDLK  N+ L     +K+ DFGL+ +  +  G        G+ 
Sbjct: 115 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSI 174
Query: 112 NYVAPEVLSNRGYDGSA--ADVWSCGVILFVLMAGYLPF 148
            ++APEV+  +  +  +  +DV++ G++L+ LM G LP+
Sbjct: 175 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 213

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 71/157 (45%), Gaps = 20/157 (12%)
Query: 49  CRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL-SALPQQGVELL--- 104
           C   F Q+ +AV   HSKG+ HRDLKP N+       +KV DFGL +A+ Q   E     
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 105 -------HT-TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL 156
                  HT   GT  Y++PE +    Y     D++S G+ILF L+    PF  T +  +
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFELL---YPFS-TQMERV 234
Query: 157 YKKINAAEFSCPFWFSTGATS---LIHKILDPNPKTR 190
               +      P  F+        ++  +L P+P  R
Sbjct: 235 RTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMER 271

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 69/157 (43%), Gaps = 20/157 (12%)
Query: 49  CRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL-SALPQQGVELLHTT 107
           C   F Q+ +AV   HSKG+ HRDLKP N+       +KV DFGL +A+ Q   E    T
Sbjct: 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 108 -----------CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL 156
                       GT  Y++PE +    Y     D++S G+ILF L+  +     T +  +
Sbjct: 226 PMPAYATHXGQVGTKLYMSPEQIHGNNY-SHKVDIFSLGLILFELLYSF----STQMERV 280
Query: 157 YKKINAAEFSCPFWFSTGATS---LIHKILDPNPKTR 190
               +      P  F+        ++  +L P+P  R
Sbjct: 281 RIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER 317

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK +RH  +V+L+ V+ S   +YI++E+++ G L D        L+ +  +Y +  QL+D
Sbjct: 67  MKKLRHEKLVQLYAVV-SEEPIYIVIEYMSKGSLLD-------FLKGEMGKYLRLPQLVD 118
Query: 59  AVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP 111
             A   S   Y       HRDL+  N+L+      KV+DFGL+ L +            P
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFP 178
Query: 112 -NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKINAAEFSCP 168
             + APE  +  G     +DVWS G++L  L   G +P+ G  +   L +        CP
Sbjct: 179 IKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP 237
Query: 169 FWFSTGATSLIHKILDPNPKTRIRIE 194
                    L+ +    +P+ R   E
Sbjct: 238 PECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 80/159 (50%), Gaps = 10/159 (6%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           ++  RH NI+ L     ++  + I+ ++  G  L+  + V + +          +Q    
Sbjct: 86  LRKTRHVNIL-LFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQG 144
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPE 117
           + + H+K + HRD+K  N+ L     +K+ DFGL+ +  +  G + +    G+  ++APE
Sbjct: 145 MDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPE 204
Query: 118 VLSNRGYDGS----AADVWSCGVILFVLMAGYLPFGETD 152
           V+  R  D +     +DV+S G++L+ LM G LP+   +
Sbjct: 205 VI--RMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN 241

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 11/151 (7%)
Query: 1   MKIVRHPNIVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLI 57
           +K ++H NIV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+ 
Sbjct: 66  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 125
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN----- 112
             + +  +K   HR+L   N+L+++   +K+ DFGL+ +  Q  E  +     P      
Sbjct: 126 KGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKE--YYKVKEPGESPIF 183
Query: 113 YVAPEVLSNRGYDGSAADVWSCGVILFVLMA 143
           + APE L+   +   A+DVWS GV+L+ L  
Sbjct: 184 WYAPESLTESKF-SVASDVWSFGVVLYELFT 213

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK +RH  +V+L+ V+ S   +YI++E+++ G L D        L+ +  +Y +  QL+D
Sbjct: 67  MKKLRHEKLVQLYAVV-SEEPIYIVIEYMSKGSLLD-------FLKGEMGKYLRLPQLVD 118
Query: 59  AVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP 111
             A   S   Y       HRDL+  N+L+      KV+DFGL+ L +            P
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 112 -NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKINAAEFSCP 168
             + APE  +  G     +DVWS G++L  L   G +P+ G  +   L +        CP
Sbjct: 179 IKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP 237
Query: 169 FWFSTGATSLIHKILDPNPKTRIRIE 194
                    L+ +    +P+ R   E
Sbjct: 238 PECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 77/145 (53%), Gaps = 9/145 (6%)
Query: 8   NIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 64
           NI++L + +    S+T   ++ E++   +   K ++Q  L + D R Y  +L+ A+ +CH
Sbjct: 94  NIIKLIDTVKDPVSKTPA-LVFEYINNTDF--KQLYQI-LTDFDIRFYMYELLKALDYCH 149
Query: 65  SKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           SKG+ HRD+KP N+++D     L++ D+GL+       E  +    +  +  PE+L +  
Sbjct: 150 SKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQE-YNVRVASRYFKGPELLVDYQ 208
Query: 124 YDGSAADVWSCGVILFVLMAGYLPF 148
               + D+WS G +L  ++    PF
Sbjct: 209 MYDYSLDMWSLGCMLASMIFRREPF 233

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 73/130 (56%), Gaps = 9/130 (6%)
Query: 18  SRTK-VYIILEFVTGGELFDKIVHQGRLLEND---CRRYFQQLIDAVAHCHSKGVYHRDL 73
           S+TK ++I +EF   G L ++ + + R  + D       F+Q+   V + HSK + +RDL
Sbjct: 90  SKTKCLFIQMEFCDKGTL-EQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDL 148
Query: 74  KPENLLLDSYGNLKVSDFGL-SALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 132
           KP N+ L     +K+ DFGL ++L   G      + GT  Y++PE +S++ Y G   D++
Sbjct: 149 KPSNIFLVDTKQVKIGDFGLVTSLKNDGKRX--RSKGTLRYMSPEQISSQDY-GKEVDLY 205
Query: 133 SCGVILFVLM 142
           + G+IL  L+
Sbjct: 206 ALGLILAELL 215

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 81/159 (50%), Gaps = 18/159 (11%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID-- 58
           ++  RH NI+ L    +++ ++ I+ ++  G  L+        L  ++ +   ++LID  
Sbjct: 74  LRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYH------HLHASETKFEMKKLIDIA 126
Query: 59  -----AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTP 111
                 + + H+K + HRDLK  N+ L     +K+ DFGL+    +  G        G+ 
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 112 NYVAPEVLSNRGYDGSA--ADVWSCGVILFVLMAGYLPF 148
            ++APEV+  +  +  +  +DV++ G++L+ LM G LP+
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 77/145 (53%), Gaps = 9/145 (6%)
Query: 8   NIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 64
           NI++L + +    S+T   ++ E++   +   K ++Q  L + D R Y  +L+ A+ +CH
Sbjct: 99  NIIKLIDTVKDPVSKTPA-LVFEYINNTDF--KQLYQ-ILTDFDIRFYMYELLKALDYCH 154
Query: 65  SKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           SKG+ HRD+KP N+++D     L++ D+GL+       E  +    +  +  PE+L +  
Sbjct: 155 SKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQE-YNVRVASRYFKGPELLVDYQ 213
Query: 124 YDGSAADVWSCGVILFVLMAGYLPF 148
               + D+WS G +L  ++    PF
Sbjct: 214 MYDYSLDMWSLGCMLASMIFRREPF 238

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 77/159 (48%), Gaps = 20/159 (12%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  +Y +  QL+D
Sbjct: 67  MKKIRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKGEMGKYLRLPQLVD 118
Query: 59  AVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP 111
             A   S   Y       HRDL+  N+L+      KV+DFGL+ L +            P
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 112 -NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
             + APE  +  G     +DVWS G++L  L   G +P+
Sbjct: 179 IKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P IV L+  +     V I +E + GG L   I   G L E+    Y  Q ++ + + H++
Sbjct: 110 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR 169
Query: 67  GVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQ---GVELLHT--TCGTPNYVAPEVLS 120
            + H D+K +N+LL S G+   + DFG +   Q    G  LL      GT  ++APEV+ 
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPF 148
            +  D +  D+WS   ++  ++ G  P+
Sbjct: 230 GKPCD-AKVDIWSSCCMMLHMLNGCHPW 256

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 28/158 (17%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND--CRRYFQQLID 58
           MK ++H  +V+LH V+ ++  +YII EF+  G L D        L++D   ++   +LID
Sbjct: 231 MKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLD-------FLKSDEGSKQPLPKLID 282
Query: 59  -------AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP 111
                   +A    +   HRDL+  N+L+ +    K++DFGL+ +   G +         
Sbjct: 283 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV---GAKF------PI 333
Query: 112 NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            + APE + N G     +DVWS G++L  ++  G +P+
Sbjct: 334 KWTAPEAI-NFGSFTIKSDVWSFGILLMEIVTYGRIPY 370

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 77/159 (48%), Gaps = 20/159 (12%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  +Y +  QL+D
Sbjct: 233 MKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKGETGKYLRLPQLVD 284
Query: 59  AVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP 111
             A   S   Y       HRDL+  N+L+      KV+DFGL+ L +            P
Sbjct: 285 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 112 -NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
             + APE  +  G     +DVWS G++L  L   G +P+
Sbjct: 345 IKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 382

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 77/159 (48%), Gaps = 20/159 (12%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  +Y +  QL+D
Sbjct: 233 MKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKGETGKYLRLPQLVD 284
Query: 59  AVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP 111
             A   S   Y       HRDL+  N+L+      KV+DFGL+ L +            P
Sbjct: 285 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 112 -NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
             + APE  +  G     +DVWS G++L  L   G +P+
Sbjct: 345 IKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 382

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P IV L+  +     V I +E + GG L   I   G L E+    Y  Q ++ + + H++
Sbjct: 126 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR 185
Query: 67  GVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQ---GVELLHT--TCGTPNYVAPEVLS 120
            + H D+K +N+LL S G+   + DFG +   Q    G  LL      GT  ++APEV+ 
Sbjct: 186 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 245
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPF 148
            +  D +  D+WS   ++  ++ G  P+
Sbjct: 246 GKPCD-AKVDIWSSCCMMLHMLNGCHPW 272

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 7   PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 66
           P IV L+  +     V I +E + GG L   I   G L E+    Y  Q ++ + + H++
Sbjct: 124 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR 183
Query: 67  GVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQ---GVELLHT--TCGTPNYVAPEVLS 120
            + H D+K +N+LL S G+   + DFG +   Q    G  LL      GT  ++APEV+ 
Sbjct: 184 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 243
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPF 148
            +  D +  D+WS   ++  ++ G  P+
Sbjct: 244 GKPCD-AKVDIWSSCCMMLHMLNGCHPW 270

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 12/158 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKV------YIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V    + +      Y+++ F+       KI+   +  E   +    
Sbjct: 77  LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGL-KFSEEKIQYLVY 133
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS GV HRDLKP NL ++    LK+ DFGL+   +     +     T  Y 
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA---RHADAEMTGYVVTRWYR 190
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APEV+ +  +     D+WS G I+  ++ G   F   D
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 74/151 (49%), Gaps = 4/151 (2%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDA 59
           M  + H  +V+L+ V   +  ++II E++  G L + +   + R          + + +A
Sbjct: 73  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 132
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 118
           + +  SK   HRDL   N L++  G +KVSDFGLS       E        P  +  PEV
Sbjct: 133 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEV 192
Query: 119 LSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
           L    +  S +D+W+ GV+++ + + G +P+
Sbjct: 193 LMYSKF-SSKSDIWAFGVLMWEIYSLGKMPY 222

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 79/179 (44%), Gaps = 37/179 (20%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           HPN++ L  V+   T V II EF+  G L D  + Q     ND +    QL+  +    +
Sbjct: 67  HPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQ-----NDGQFTVIQLVGMLRGIAA 120
Query: 66  KGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY----- 113
              Y       HR L   N+L++S    KVSDFGLS         L      P Y     
Sbjct: 121 GMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLS-------RFLEDDTSDPTYTSALG 173
Query: 114 -------VAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE 164
                   APE +  R +  SA+DVWS G++++ +M+ G  P+ +    T    INA E
Sbjct: 174 GKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDM---TNQDVINAIE 228

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 77/159 (48%), Gaps = 20/159 (12%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  +Y +  QL+D
Sbjct: 60  MKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKGETGKYLRLPQLVD 111
Query: 59  AVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP 111
             A   S   Y       HRDL+  N+L+      KV+DFGL+ L +            P
Sbjct: 112 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 171
Query: 112 -NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
             + APE  +  G     +DVWS G++L  L   G +P+
Sbjct: 172 IKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 209

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 80/160 (50%), Gaps = 20/160 (12%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN--------DCRRY 52
           ++  RH NI+ L    +++ ++ I+ ++  G  L+    H   ++E         D  R 
Sbjct: 85  LRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQ 139
Query: 53  FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGT 110
             Q +D   + H+K + HRDLK  N+ L     +K+ DFGL+ +  +  G        G+
Sbjct: 140 TAQGMD---YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 196
Query: 111 PNYVAPEV--LSNRGYDGSAADVWSCGVILFVLMAGYLPF 148
             ++APEV  + ++      +DV++ G++L+ LM G LP+
Sbjct: 197 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 236

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 77/159 (48%), Gaps = 20/159 (12%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  +Y +  QL+D
Sbjct: 316 MKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKGETGKYLRLPQLVD 367
Query: 59  AVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP 111
             A   S   Y       HRDL+  N+L+      KV+DFGL+ L +            P
Sbjct: 368 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 427
Query: 112 -NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
             + APE  +  G     +DVWS G++L  L   G +P+
Sbjct: 428 IKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 465

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 81/164 (49%), Gaps = 20/164 (12%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN--------DCRRY 52
           ++  RH NI+ L    +++ ++ I+ ++  G  L+    H   ++E         D  R 
Sbjct: 60  LRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQ 114
Query: 53  FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGT 110
             Q +D   + H+K + HRDLK  N+ L     +K+ DFGL+ +  +  G        G+
Sbjct: 115 TAQGMD---YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 171
Query: 111 PNYVAPEV--LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
             ++APEV  + ++      +DV++ G++L+ LM G LP+   +
Sbjct: 172 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 215

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 81/164 (49%), Gaps = 20/164 (12%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN--------DCRRY 52
           ++  RH NI+ L    +++ ++ I+ ++  G  L+    H   ++E         D  R 
Sbjct: 58  LRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQ 112
Query: 53  FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGT 110
             Q +D   + H+K + HRDLK  N+ L     +K+ DFGL+ +  +  G        G+
Sbjct: 113 TAQGMD---YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
Query: 111 PNYVAPEV--LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
             ++APEV  + ++      +DV++ G++L+ LM G LP+   +
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 80/160 (50%), Gaps = 20/160 (12%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN--------DCRRY 52
           ++  RH NI+ L    +++ ++ I+ ++  G  L+    H   ++E         D  R 
Sbjct: 86  LRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQ 140
Query: 53  FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGT 110
             Q +D   + H+K + HRDLK  N+ L     +K+ DFGL+ +  +  G        G+
Sbjct: 141 TAQGMD---YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 197
Query: 111 PNYVAPEV--LSNRGYDGSAADVWSCGVILFVLMAGYLPF 148
             ++APEV  + ++      +DV++ G++L+ LM G LP+
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 12/158 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKV------YIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V    + +      Y+++ F+       KI+      E   +    
Sbjct: 95  LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGM-EFSEEKIQYLVY 151
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS GV HRDLKP NL ++    LK+ DFGL+   +     +     T  Y 
Sbjct: 152 QMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA---RHADAEMTGYVVTRWYR 208
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
           APEV+ +  +     D+WS G I+  ++ G   F   D
Sbjct: 209 APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 80/160 (50%), Gaps = 20/160 (12%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN--------DCRRY 52
           ++  RH NI+ L    +++ ++ I+ ++  G  L+    H   ++E         D  R 
Sbjct: 63  LRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQ 117
Query: 53  FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGT 110
             Q +D   + H+K + HRDLK  N+ L     +K+ DFGL+ +  +  G        G+
Sbjct: 118 TAQGMD---YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 174
Query: 111 PNYVAPEV--LSNRGYDGSAADVWSCGVILFVLMAGYLPF 148
             ++APEV  + ++      +DV++ G++L+ LM G LP+
Sbjct: 175 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 214

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 81/164 (49%), Gaps = 20/164 (12%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN--------DCRRY 52
           ++  RH NI+ L    +++ ++ I+ ++  G  L+    H   ++E         D  R 
Sbjct: 63  LRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQ 117
Query: 53  FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGT 110
             Q +D   + H+K + HRDLK  N+ L     +K+ DFGL+ +  +  G        G+
Sbjct: 118 TAQGMD---YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 174
Query: 111 PNYVAPEV--LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
             ++APEV  + ++      +DV++ G++L+ LM G LP+   +
Sbjct: 175 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 97/234 (41%), Gaps = 39/234 (16%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR--------RYFQQLI 57
           HPN++R +    +   +YI LE          +V    + + + +           +Q+ 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYG-----------NLK--VSDFGLSALPQQGVELL 104
             VAH HS  + HRDLKP+N+L+ +             NL+  +SDFGL      G    
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 105 HTT----CGTPNYVAPEV------LSNRGYDGSAADVWSCG-VILFVLMAGYLPFGET-- 151
            T      GT  + APE+      L  +     + D++S G V  ++L  G  PFG+   
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 152 -DLPTLYKKINAAEFSCPFWFS--TGATSLIHKILDPNPKTRIRIEGIRKHPWF 202
            +   +    +  E  C    S    AT LI +++D +P  R     + +HP F
Sbjct: 246 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 4/151 (2%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M  + HP +V+L+ V   +  + ++ EF+  G L D +   +G             + + 
Sbjct: 56  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 115
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 118
           +A+     V HRDL   N L+     +KVSDFG++           T    P  + +PEV
Sbjct: 116 MAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 175
Query: 119 LSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            S   Y  S +DVWS GV+++ V   G +P+
Sbjct: 176 FSFSRYS-SKSDVWSFGVLMWEVFSEGKIPY 205

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 67/142 (47%), Gaps = 9/142 (6%)
Query: 8   NIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           N++ + E    R  + +  E ++    EL  K   QG  L    R++   ++  +   H 
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPL-VRKFAHSILQCLDALHK 218
Query: 66  KGVYHRDLKPENLLLDSYG--NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
             + H DLKPEN+LL   G   +KV DFG S    Q V   +T   +  Y APEV+    
Sbjct: 219 NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV---YTXIQSRFYRAPEVILGAR 275
Query: 124 YDGSAADVWSCGVILFVLMAGY 145
           Y G   D+WS G IL  L+ GY
Sbjct: 276 Y-GMPIDMWSLGCILAELLTGY 296

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 77/159 (48%), Gaps = 20/159 (12%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  +Y +  QL+D
Sbjct: 58  MKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKGEMGKYLRLPQLVD 109
Query: 59  AVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP 111
             A   S   Y       HRDL+  N+L+      KV+DFGL+ L +            P
Sbjct: 110 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 169
Query: 112 -NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
             + APE  +  G     +DVWS G++L  L   G +P+
Sbjct: 170 IKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 207

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 67/142 (47%), Gaps = 9/142 (6%)
Query: 8   NIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           N++ + E    R  + +  E ++    EL  K   QG  L    R++   ++  +   H 
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPL-VRKFAHSILQCLDALHK 218
Query: 66  KGVYHRDLKPENLLLDSYG--NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
             + H DLKPEN+LL   G   +KV DFG S    Q V   +T   +  Y APEV+    
Sbjct: 219 NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV---YTXIQSRFYRAPEVILGAR 275
Query: 124 YDGSAADVWSCGVILFVLMAGY 145
           Y G   D+WS G IL  L+ GY
Sbjct: 276 Y-GMPIDMWSLGCILAELLTGY 296

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 81/160 (50%), Gaps = 16/160 (10%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR-RYFQQLIDA 59
           M  + HPNIV+L+ ++ +  +  +++EFV  G+L+ +++ +   ++   + R    +   
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 60  VAHCHSKG--VYHRDLKPENLLLDSYGN-----LKVSDFGLSALPQQGVELLHTTCGTPN 112
           + +  ++   + HRDL+  N+ L S         KV+DFGLS   QQ V  +    G   
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS---QQSVHSVSGLLGNFQ 191
Query: 113 YVAPEVLS--NRGYDGSAADVWSCGVILFVLMAGYLPFGE 150
           ++APE +      Y    AD +S  +IL+ ++ G  PF E
Sbjct: 192 WMAPETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDE 230

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 77/159 (48%), Gaps = 20/159 (12%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  +Y +  QL+D
Sbjct: 56  MKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKGEMGKYLRLPQLVD 107
Query: 59  AVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP 111
             A   S   Y       HRDL+  N+L+      KV+DFGL+ L +            P
Sbjct: 108 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 167
Query: 112 -NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
             + APE  +  G     +DVWS G++L  L   G +P+
Sbjct: 168 IKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 205

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  +Y +  QL+D
Sbjct: 67  MKKLRHEKLVQLYAVV-SEEPIYIVCEYMSKGSLLD-------FLKGEMGKYLRLPQLVD 118
Query: 59  AVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP 111
             A   S   Y       HRDL+  N+L+      KV+DFGL+ L +            P
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 112 -NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKINAAEFSCP 168
             + APE  +  G     +DVWS G++L  L   G +P+ G  +   L +        CP
Sbjct: 179 IKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP 237
Query: 169 FWFSTGATSLIHKILDPNPKTRIRIE 194
                    L+ +    +P+ R   E
Sbjct: 238 PECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 77/159 (48%), Gaps = 20/159 (12%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  +Y +  QL+D
Sbjct: 67  MKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKGEMGKYLRLPQLVD 118
Query: 59  AVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP 111
             A   S   Y       HRDL+  N+L+      KV+DFGL+ L +            P
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 112 -NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
             + APE  +  G     +DVWS G++L  L   G +P+
Sbjct: 179 IKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK +RH  +V+L+ V+ S   +YI++E+++ G L D        L+ +  +Y +  QL+D
Sbjct: 67  MKKLRHEKLVQLYAVV-SEEPIYIVMEYMSKGCLLD-------FLKGEMGKYLRLPQLVD 118
Query: 59  AVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP 111
             A   S   Y       HRDL+  N+L+      KV+DFGL+ L +            P
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 112 -NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKINAAEFSCP 168
             + APE  +  G     +DVWS G++L  L   G +P+ G  +   L +        CP
Sbjct: 179 IKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP 237
Query: 169 FWFSTGATSLIHKILDPNPKTRIRIE 194
                    L+ +    +P+ R   E
Sbjct: 238 PECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 98/234 (41%), Gaps = 39/234 (16%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR--------RYFQQLI 57
           HPN++R +    +   +YI LE          +V    + + + +           +Q+ 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYG-----------NLK--VSDFGLSALPQQGVEL- 103
             VAH HS  + HRDLKP+N+L+ +             NL+  +SDFGL      G    
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 185
Query: 104 ---LHTTCGTPNYVAPEV------LSNRGYDGSAADVWSCG-VILFVLMAGYLPFGET-- 151
              L+   GT  + APE+      L  +     + D++S G V  ++L  G  PFG+   
Sbjct: 186 RXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 152 -DLPTLYKKINAAEFSCPFWFS--TGATSLIHKILDPNPKTRIRIEGIRKHPWF 202
            +   +    +  E  C    S    AT LI +++D +P  R     + +HP F
Sbjct: 246 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 77/159 (48%), Gaps = 20/159 (12%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  +Y +  QL+D
Sbjct: 233 MKKLRHEKLVQLYAVV-SEEPIYIVGEYMSKGSLLD-------FLKGETGKYLRLPQLVD 284
Query: 59  AVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP 111
             A   S   Y       HRDL+  N+L+      KV+DFGL+ L +            P
Sbjct: 285 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 112 -NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
             + APE  +  G     +DVWS G++L  L   G +P+
Sbjct: 345 IKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 382

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  +Y +  QL+D
Sbjct: 234 MKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKGEMGKYLRLPQLVD 285
Query: 59  AVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP 111
             A   S   Y       HRDL+  N+L+      KV+DFGL  L +            P
Sbjct: 286 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFP 345
Query: 112 -NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
             + APE  +  G     +DVWS G++L  L   G +P+
Sbjct: 346 IKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 383

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 80/159 (50%), Gaps = 18/159 (11%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID-- 58
           ++  RH NI+ L    ++  ++ I+ ++  G  L+        L  ++ +   ++LID  
Sbjct: 74  LRKTRHVNIL-LFMGYSTAPQLAIVTQWCEGSSLYH------HLHASETKFEMKKLIDIA 126
Query: 59  -----AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTP 111
                 + + H+K + HRDLK  N+ L     +K+ DFGL+    +  G        G+ 
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 112 NYVAPEVLSNRGYDGSA--ADVWSCGVILFVLMAGYLPF 148
            ++APEV+  +  +  +  +DV++ G++L+ LM G LP+
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 4/151 (2%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M  + HP +V+L+ V   +  + ++ EF+  G L D +   +G             + + 
Sbjct: 54  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 113
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 118
           +A+     V HRDL   N L+     +KVSDFG++           T    P  + +PEV
Sbjct: 114 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 173
Query: 119 LSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            S   Y  S +DVWS GV+++ V   G +P+
Sbjct: 174 FSFSRYS-SKSDVWSFGVLMWEVFSEGKIPY 203

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 4/151 (2%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M  + HP +V+L+ V   +  + ++ EF+  G L D +   +G             + + 
Sbjct: 56  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 115
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 118
           +A+     V HRDL   N L+     +KVSDFG++           T    P  + +PEV
Sbjct: 116 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 175
Query: 119 LSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            S   Y  S +DVWS GV+++ V   G +P+
Sbjct: 176 FSFSRYS-SKSDVWSFGVLMWEVFSEGKIPY 205

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 4/151 (2%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M  + HP +V+L+ V   +  + ++ EF+  G L D +   +G             + + 
Sbjct: 59  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 118
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 118
           +A+     V HRDL   N L+     +KVSDFG++           T    P  + +PEV
Sbjct: 119 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 178
Query: 119 LSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            S   Y  S +DVWS GV+++ V   G +P+
Sbjct: 179 FSFSRYS-SKSDVWSFGVLMWEVFSEGKIPY 208

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK +RH  +V+L+ V+ S   +YI+ E++  G L D        L+ +  +Y +  QL+D
Sbjct: 64  MKKLRHEKLVQLYAVV-SEEPIYIVTEYMNKGSLLD-------FLKGETGKYLRLPQLVD 115
Query: 59  AVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP 111
             A   S   Y       HRDL+  N+L+      KV+DFGL+ L +            P
Sbjct: 116 MSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFP 175
Query: 112 -NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
             + APE  +  G     +DVWS G++L  L   G +P+
Sbjct: 176 IKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 213

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK +RH  +V+L+ V+ S   +YI+ E++  G L D        L+ +  +Y +  QL+D
Sbjct: 64  MKKLRHEKLVQLYAVV-SEEPIYIVTEYMNKGSLLD-------FLKGETGKYLRLPQLVD 115
Query: 59  AVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP 111
             A   S   Y       HRDL+  N+L+      KV+DFGL+ L +            P
Sbjct: 116 MSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 175
Query: 112 -NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
             + APE  +  G     +DVWS G++L  L   G +P+
Sbjct: 176 IKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 213

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 70/142 (49%), Gaps = 6/142 (4%)
Query: 24  IILEFV--TGGELFDKIVHQGRLLE-NDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL 80
           +I+E+V  T  ++    +  GR +  N    Y  QL  AV   HS G+ HRD+KP+NLL+
Sbjct: 115 VIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV 174
Query: 81  DSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 139
           +S  N LK+ DFG +         +   C    Y APE++        + D+WS G +  
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEPSVAXICSR-FYRAPELMLGATEYTPSIDLWSIGCVFG 233
Query: 140 VLMAGYLPF-GETDLPTLYKKI 160
            L+ G   F GET +  L + I
Sbjct: 234 ELILGKPLFSGETSIDQLVRII 255

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 4/151 (2%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M  + HP +V+L+ V   +  + ++ EF+  G L D +   +G             + + 
Sbjct: 76  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 135
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 118
           +A+     V HRDL   N L+     +KVSDFG++           T    P  + +PEV
Sbjct: 136 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 195
Query: 119 LSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            S   Y  S +DVWS GV+++ V   G +P+
Sbjct: 196 FSFSRYS-SKSDVWSFGVLMWEVFSEGKIPY 225

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 80/164 (48%), Gaps = 20/164 (12%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN--------DCRRY 52
           ++  RH NI+ L    ++  ++ I+ ++  G  L+    H   ++E         D  R 
Sbjct: 58  LRKTRHVNIL-LFMGYSTAPQLAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQ 112
Query: 53  FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGT 110
             Q +D   + H+K + HRDLK  N+ L     +K+ DFGL+ +  +  G        G+
Sbjct: 113 TAQGMD---YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
Query: 111 PNYVAPEV--LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
             ++APEV  + ++      +DV++ G++L+ LM G LP+   +
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 20/160 (12%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN--------DCRRY 52
           ++  RH NI+ L    +++ ++ I+ ++  G  L+    H   ++E         D  R 
Sbjct: 78  LRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQ 132
Query: 53  FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGT 110
             Q +D   + H+K + HRDLK  N+ L     +K+ DFGL+    +  G        G+
Sbjct: 133 TAQGMD---YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 189
Query: 111 PNYVAPEV--LSNRGYDGSAADVWSCGVILFVLMAGYLPF 148
             ++APEV  + ++      +DV++ G++L+ LM G LP+
Sbjct: 190 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 229

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 80/164 (48%), Gaps = 20/164 (12%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN--------DCRRY 52
           ++  RH NI+ L    +++ ++ I+ ++  G  L+    H   ++E         D  R 
Sbjct: 58  LRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQ 112
Query: 53  FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGT 110
             Q +D   + H+K + HRDLK  N+ L     +K+ DFGL+    +  G        G+
Sbjct: 113 TAQGMD---YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 169
Query: 111 PNYVAPEV--LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
             ++APEV  + ++      +DV++ G++L+ LM G LP+   +
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  +Y +  QL+D
Sbjct: 67  MKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKGEMGKYLRLPQLVD 118
Query: 59  AVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP 111
             A   S   Y       HRDL   N+L+      KV+DFGL+ L +            P
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 112 -NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
             + APE  +  G     +DVWS G++L  L   G +P+
Sbjct: 179 IKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 20/160 (12%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN--------DCRRY 52
           ++  RH NI+ L    +++ ++ I+ ++  G  L+    H   ++E         D  R 
Sbjct: 86  LRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQ 140
Query: 53  FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGT 110
             Q +D   + H+K + HRDLK  N+ L     +K+ DFGL+    +  G        G+
Sbjct: 141 TAQGMD---YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 197
Query: 111 PNYVAPEV--LSNRGYDGSAADVWSCGVILFVLMAGYLPF 148
             ++APEV  + ++      +DV++ G++L+ LM G LP+
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 4/151 (2%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M  + HP +V+L+ V   +  + ++ EF+  G L D +   +G             + + 
Sbjct: 57  MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 116
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 118
           +A+     V HRDL   N L+     +KVSDFG++           T    P  + +PEV
Sbjct: 117 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 176
Query: 119 LSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            S   Y  S +DVWS GV+++ V   G +P+
Sbjct: 177 FSFSRYS-SKSDVWSFGVLMWEVFSEGKIPY 206

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  +Y +  QL+D
Sbjct: 67  MKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGCLLD-------FLKGEMGKYLRLPQLVD 118
Query: 59  AVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP 111
             A   S   Y       HRDL+  N+L+      KV+DFGL+ L +            P
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 112 -NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKINAAEFSCP 168
             + APE  +  G     +DVWS G++L  L   G +P+ G  +   L +        CP
Sbjct: 179 IKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP 237
Query: 169 FWFSTGATSLIHKILDPNPKTRIRIE 194
                    L+ +    +P+ R   E
Sbjct: 238 PECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 15/159 (9%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE-NDCRRYFQQLIDAVAH 62
            RH N+V       S   + II     G  L+  +     +L+ N  R+  Q+++  + +
Sbjct: 86  TRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGY 145
Query: 63  CHSKGVYHRDLKPENLLLDSYGNLKVSDFGL---SALPQQGV--ELLHTTCGTPNYVAPE 117
            H+KG+ H+DLK +N+  D+ G + ++DFGL   S + Q G   + L    G   ++APE
Sbjct: 146 LHAKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204
Query: 118 VLSNRGYD--------GSAADVWSCGVILFVLMAGYLPF 148
           ++     D           +DV++ G I + L A   PF
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 55/131 (41%), Gaps = 29/131 (22%)
Query: 47  NDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLS-ALPQQGVELL 104
            + R Y   L  A+   H  G+ HRD+KP N L +       + DFGL+       +ELL
Sbjct: 117 QEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELL 176
Query: 105 H----------------TTC-----------GTPNYVAPEVLSNRGYDGSAADVWSCGVI 137
                            + C           GTP + APEVL+      +A D+WS GVI
Sbjct: 177 KFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVI 236
Query: 138 LFVLMAGYLPF 148
              L++G  PF
Sbjct: 237 FLSLLSGRYPF 247

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 74/161 (45%), Gaps = 17/161 (10%)
Query: 1   MKIVRHPNIVRLHEVLASRT--KVYIILEFVTGGELFDKIVHQG--------RLLENDCR 50
           ++ ++HPN++ L +V  S    KV+++ ++           H+         +L     +
Sbjct: 72  LRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131
Query: 51  RYFQQLIDAVAHCHSKGVYHRDLKPENLLL----DSYGNLKVSDFGLSAL---PQQGVEL 103
               Q++D + + H+  V HRDLKP N+L+       G +K++D G + L   P + +  
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191
Query: 104 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG 144
           L     T  Y APE+L    +   A D+W+ G I   L+  
Sbjct: 192 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 4/151 (2%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDA 59
           M  + H  +V+L+ V   +  ++II E++  G L + +   + R          + + +A
Sbjct: 57  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 116
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 118
           + +  SK   HRDL   N L++  G +KVSDFGLS                P  +  PEV
Sbjct: 117 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 176
Query: 119 LSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
           L    +  S +D+W+ GV+++ + + G +P+
Sbjct: 177 LMYSKF-SSKSDIWAFGVLMWEIYSLGKMPY 206

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 80/160 (50%), Gaps = 16/160 (10%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR-RYFQQLIDA 59
           M  + HPNIV+L+ ++ +  +  +++EFV  G+L+ +++ +   ++   + R    +   
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 60  VAHCHSKG--VYHRDLKPENLLLDSYGN-----LKVSDFGLSALPQQGVELLHTTCGTPN 112
           + +  ++   + HRDL+  N+ L S         KV+DFG S   QQ V  +    G   
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS---QQSVHSVSGLLGNFQ 191
Query: 113 YVAPEVLS--NRGYDGSAADVWSCGVILFVLMAGYLPFGE 150
           ++APE +      Y    AD +S  +IL+ ++ G  PF E
Sbjct: 192 WMAPETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDE 230

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 4/151 (2%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDA 59
           M  + H  +V+L+ V   +  ++II E++  G L + +   + R          + + +A
Sbjct: 53  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 112
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 118
           + +  SK   HRDL   N L++  G +KVSDFGLS                P  +  PEV
Sbjct: 113 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 172
Query: 119 LSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
           L    +  S +D+W+ GV+++ + + G +P+
Sbjct: 173 LMYSKF-SSKSDIWAFGVLMWEIYSLGKMPY 202

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 66/142 (46%), Gaps = 9/142 (6%)
Query: 8   NIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           N++ + E    R  + +  E ++    EL  K   QG  L    R++   ++  +   H 
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPL-VRKFAHSILQCLDALHK 218
Query: 66  KGVYHRDLKPENLLLDSYG--NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
             + H DLKPEN+LL   G   +KV DFG S    Q V   +    +  Y APEV+    
Sbjct: 219 NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV---YXXIQSRFYRAPEVILGAR 275
Query: 124 YDGSAADVWSCGVILFVLMAGY 145
           Y G   D+WS G IL  L+ GY
Sbjct: 276 Y-GMPIDMWSLGCILAELLTGY 296

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 4/151 (2%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDA 59
           M  + H  +V+L+ V   +  ++II E++  G L + +   + R          + + +A
Sbjct: 58  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 117
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 118
           + +  SK   HRDL   N L++  G +KVSDFGLS                P  +  PEV
Sbjct: 118 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 177
Query: 119 LSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
           L    +  S +D+W+ GV+++ + + G +P+
Sbjct: 178 LMYSKF-SSKSDIWAFGVLMWEIYSLGKMPY 207

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 58
           MK +RH  +V+L+ V+ S   + I+ E+++ G L D        L+ +  +Y +  QL+D
Sbjct: 57  MKKLRHEKLVQLYAVV-SEEPIXIVTEYMSKGSLLD-------FLKGETGKYLRLPQLVD 108
Query: 59  AVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP 111
             A   S   Y       HRDL+  N+L+      KV+DFGL+ L +            P
Sbjct: 109 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFP 168
Query: 112 -NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
             + APE  +  G     +DVWS G++L  L   G +P+
Sbjct: 169 IKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 206

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 4/151 (2%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDA 59
           M  + H  +V+L+ V   +  ++II E++  G L + +   + R          + + +A
Sbjct: 64  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 123
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 118
           + +  SK   HRDL   N L++  G +KVSDFGLS                P  +  PEV
Sbjct: 124 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 183
Query: 119 LSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
           L    +  S +D+W+ GV+++ + + G +P+
Sbjct: 184 LMYSKF-SSKSDIWAFGVLMWEIYSLGKMPY 213

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 4/151 (2%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDA 59
           M  + H  +V+L+ V   +  ++II E++  G L + +   + R          + + +A
Sbjct: 73  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 132
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 118
           + +  SK   HRDL   N L++  G +KVSDFGLS                P  +  PEV
Sbjct: 133 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 192
Query: 119 LSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
           L    +  S +D+W+ GV+++ + + G +P+
Sbjct: 193 LMYSKF-SSKSDIWAFGVLMWEIYSLGKMPY 222

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 80/160 (50%), Gaps = 16/160 (10%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR-RYFQQLIDA 59
           M  + HPNIV+L+ ++ +  +  +++EFV  G+L+ +++ +   ++   + R    +   
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 60  VAHCHSKG--VYHRDLKPENLLLDSYGN-----LKVSDFGLSALPQQGVELLHTTCGTPN 112
           + +  ++   + HRDL+  N+ L S         KV+DF LS   QQ V  +    G   
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS---QQSVHSVSGLLGNFQ 191
Query: 113 YVAPEVLS--NRGYDGSAADVWSCGVILFVLMAGYLPFGE 150
           ++APE +      Y    AD +S  +IL+ ++ G  PF E
Sbjct: 192 WMAPETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDE 230

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 4/151 (2%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDA 59
           M  + H  +V+L+ V   +  ++II E++  G L + +   + R          + + +A
Sbjct: 58  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 117
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 118
           + +  SK   HRDL   N L++  G +KVSDFGLS                P  +  PEV
Sbjct: 118 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEV 177
Query: 119 LSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
           L    +  S +D+W+ GV+++ + + G +P+
Sbjct: 178 LMYSKF-SSKSDIWAFGVLMWEIYSLGKMPY 207

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 82/177 (46%), Gaps = 19/177 (10%)
Query: 1   MKIVRHPNIVRL---HEVLASRTKVYIILEFVTGGELFDKIVHQGR---LLENDCRRYFQ 54
           +K + H NIV+L    E   +R KV +I+EF   G L+  +        L E++     +
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKV-LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLL----DSYGNLKVSDFGLSALPQQGVELLHTTCGT 110
            ++  + H    G+ HR++KP N++     D     K++DFG +A   +  E   +  GT
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG-AARELEDDEQFVSLYGT 178
Query: 111 PNYVAPEVLS-------NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 160
             Y+ P++         ++   G+  D+WS GV  +    G LPF   + P   K++
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235

>pdb|2ZFD|B Chain B, The Crystal Structure Of Plant Specific Calcium Binding Protein Atcbl2 In Complex With The Regulatory Domain Of Atcipk14 Length = 123

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 34/101 (33%), Positives = 58/101 (57%), Gaps = 6/101 (5%)
Query: 244 GPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKV 303
           G   MNAF++I+ S G NL+ LF   + Y  R  RFVS   A+ ++  +E +  + +L V
Sbjct: 2   GARRMNAFDIISGSPGFNLSGLFGDARKY-DRVERFVSAWTAERVVERLEEIVSAENLTV 60
Query: 304 HTR-NYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRK 343
             +  +  ++EG    + G FA+V+E+ ++   L M++VRK
Sbjct: 61  AKKETWGMKIEG----QKGNFAMVVEINQLTDELVMIEVRK 97

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 9/161 (5%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCH 64
           H +IVRL   L   + + ++ +++  G L D +  H+G L       +  Q+   + +  
Sbjct: 92  HAHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE 150
Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP-NYVAPEVLSNR 122
             G+ HR+L   N+LL S   ++V+DFG++  LP    +LL++   TP  ++A E +   
Sbjct: 151 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 210
Query: 123 GYDGSAADVWSCGVILFVLMA-GYLPFGE---TDLPTLYKK 159
            Y    +DVWS GV ++ LM  G  P+      ++P L +K
Sbjct: 211 KYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 250

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 9/161 (5%)
Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCH 64
           H +IVRL   L   + + ++ +++  G L D +  H+G L       +  Q+   + +  
Sbjct: 74  HAHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE 132
Query: 65  SKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP-NYVAPEVLSNR 122
             G+ HR+L   N+LL S   ++V+DFG++  LP    +LL++   TP  ++A E +   
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 123 GYDGSAADVWSCGVILFVLMA-GYLPFGE---TDLPTLYKK 159
            Y    +DVWS GV ++ LM  G  P+      ++P L +K
Sbjct: 193 KYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 82/178 (46%), Gaps = 23/178 (12%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND----------CRR 51
           K+  HPNI+ L      R  +Y+ +E+   G L D  + + R+LE D             
Sbjct: 81  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTL 139
Query: 52  YFQQLIDAVA-------HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 104
             QQL+   A       +   K   HRDL   N+L+      K++DFGLS    Q V + 
Sbjct: 140 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVK 197
Query: 105 HTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI 160
            T    P  ++A E L+   Y  + +DVWS GV+L+ +++ G  P+       LY+K+
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 82/178 (46%), Gaps = 23/178 (12%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND----------CRR 51
           K+  HPNI+ L      R  +Y+ +E+   G L D  + + R+LE D             
Sbjct: 71  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTL 129
Query: 52  YFQQLIDAVA-------HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 104
             QQL+   A       +   K   HRDL   N+L+      K++DFGLS    Q V + 
Sbjct: 130 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVK 187
Query: 105 HTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI 160
            T    P  ++A E L+   Y  + +DVWS GV+L+ +++ G  P+       LY+K+
Sbjct: 188 KTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 244

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 7/161 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI--VHQGRLLENDCR-RYFQQLI 57
           M   +H N+V L    +    + ++  ++  G L D++  +     L    R +  Q   
Sbjct: 84  MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAA 143
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT--CGTPNYVA 115
           + +   H     HRD+K  N+LLD     K+SDFGL+   ++  + +  +   GT  Y+A
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMA 203
Query: 116 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL 156
           PE L  RG     +D++S GV+L  ++ G     E   P L
Sbjct: 204 PEAL--RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 71/127 (55%), Gaps = 5/127 (3%)
Query: 19  RTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN 77
           R ++ +++E++  G L D +  H+ RL  +    Y  Q+   + +  S+   HRDL   N
Sbjct: 82  RPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARN 141
Query: 78  LLLDSYGNLKVSDFGLSA-LP-QQGVELLHTTCGTPNY-VAPEVLSNRGYDGSAADVWSC 134
           +L++S  ++K++DFGL+  LP  +   ++     +P +  APE LS+  +    +DVWS 
Sbjct: 142 ILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSF 200
Query: 135 GVILFVL 141
           GV+L+ L
Sbjct: 201 GVVLYEL 207

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 73/165 (44%), Gaps = 30/165 (18%)
Query: 1   MKIVRHPNIVRLHE---VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--- 54
           + ++ HPNIV+L      L  R +  I L  V   E     +H+       CR Y++   
Sbjct: 73  LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVM--EYVPDTLHRC------CRNYYRRQV 124
Query: 55  ------------QLIDAVA--HCHSKGVYHRDLKPENLLL-DSYGNLKVSDFGLSALPQQ 99
                       QLI ++   H  S  V HRD+KP N+L+ ++ G LK+ DFG +     
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184
Query: 100 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG 144
               +   C    Y APE++    +  +A D+WS G I   +M G
Sbjct: 185 SEPNVAYICSR-YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 83/173 (47%), Gaps = 7/173 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLE-NDCRRYFQQLID 58
           MK ++H  +V+L+ V+ S   +YI+ E++  G L D +   +GR L+  +      Q+  
Sbjct: 58  MKKLKHDKLVQLYAVV-SEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAA 116
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
            +A+       HRDL+  N+L+ +    K++DFGL+ L +            P  + APE
Sbjct: 117 GMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPE 176
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKINAAEFSCP 168
             +  G     +DVWS G++L  L+  G +P+ G  +   L +        CP
Sbjct: 177 A-ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCP 228

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 81/177 (45%), Gaps = 19/177 (10%)
Query: 1   MKIVRHPNIVRL---HEVLASRTKVYIILEFVTGGELFDKIVHQGR---LLENDCRRYFQ 54
           +K + H NIV+L    E   +R KV +I+EF   G L+  +        L E++     +
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKV-LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLL----DSYGNLKVSDFGLSALPQQGVELLHTTCGT 110
            ++  + H    G+ HR++KP N++     D     K++DFG +A   +  E      GT
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG-AARELEDDEQFVXLYGT 178
Query: 111 PNYVAPEVL-------SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 160
             Y+ P++         ++   G+  D+WS GV  +    G LPF   + P   K++
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 73/161 (45%), Gaps = 7/161 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI--VHQGRLLENDCR-RYFQQLI 57
           M   +H N+V L    +    + ++  ++  G L D++  +     L    R +  Q   
Sbjct: 84  MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAA 143
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVA 115
           + +   H     HRD+K  N+LLD     K+SDFGL+   ++  +  +     GT  Y+A
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMA 203
Query: 116 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL 156
           PE L  RG     +D++S GV+L  ++ G     E   P L
Sbjct: 204 PEAL--RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 73/161 (45%), Gaps = 7/161 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI--VHQGRLLENDCR-RYFQQLI 57
           M   +H N+V L    +    + ++  ++  G L D++  +     L    R +  Q   
Sbjct: 78  MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAA 137
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVA 115
           + +   H     HRD+K  N+LLD     K+SDFGL+   ++  +  +     GT  Y+A
Sbjct: 138 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMA 197
Query: 116 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL 156
           PE L  RG     +D++S GV+L  ++ G     E   P L
Sbjct: 198 PEAL--RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 236

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 70/128 (54%), Gaps = 5/128 (3%)
Query: 19  RTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN 77
           R  + +++E++  G L D +  H+ RL  +    Y  Q+   + +  S+   HRDL   N
Sbjct: 85  RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARN 144
Query: 78  LLLDSYGNLKVSDFGLSA-LP-QQGVELLHTTCGTPNY-VAPEVLSNRGYDGSAADVWSC 134
           +L++S  ++K++DFGL+  LP  +   ++     +P +  APE LS+  +    +DVWS 
Sbjct: 145 ILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFS-RQSDVWSF 203
Query: 135 GVILFVLM 142
           GV+L+ L 
Sbjct: 204 GVVLYELF 211

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 24/159 (15%)
Query: 3   IVRHPNIVR-LHEVLASR---TKVYIILEFVTGGELFDKIVHQGRLLEN-DCRRYFQQLI 57
           ++RH NI+  +   + SR   T++++I  +   G L+D +  Q   L+   C R    + 
Sbjct: 58  MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIA 115
Query: 58  DAVAHCH--------SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL----H 105
             +AH H           + HRDLK +N+L+   G   ++D GL+ +  Q    L    +
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 106 TTCGTPNYVAPEVLSNR----GYDG-SAADVWSCGVILF 139
              GT  Y+APEVL        +D     D+W+ G++L+
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLW 214

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 2/161 (1%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           ++ P++V +H+      ++Y+    + G +L   +  QG L         +Q+  A+   
Sbjct: 91  LQEPHVVPIHDFGEIDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAA 150
Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGL-SALPQQGVELLHTTCGTPNYVAPEVLSNR 122
           H+ G  HRD+KPEN+L+ +     + DFG+ SA   + +  L  T GT  Y APE  S  
Sbjct: 151 HAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSE- 209
Query: 123 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA 163
            +    AD+++   +L+  + G  P+    L      IN A
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPPYQGDQLSVXGAHINQA 250

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 24/159 (15%)
Query: 3   IVRHPNIVR-LHEVLASR---TKVYIILEFVTGGELFDKIVHQGRLLEN-DCRRYFQQLI 57
           ++RH NI+  +   + SR   T++++I  +   G L+D +  Q   L+   C R    + 
Sbjct: 58  MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIA 115
Query: 58  DAVAHCH--------SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL----H 105
             +AH H           + HRDLK +N+L+   G   ++D GL+ +  Q    L    +
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 106 TTCGTPNYVAPEVLSNR----GYDG-SAADVWSCGVILF 139
              GT  Y+APEVL        +D     D+W+ G++L+
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLW 214

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 70/128 (54%), Gaps = 5/128 (3%)
Query: 19  RTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN 77
           R  + +++E++  G L D +  H+ RL  +    Y  Q+   + +  S+   HRDL   N
Sbjct: 98  RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARN 157
Query: 78  LLLDSYGNLKVSDFGLSA-LP-QQGVELLHTTCGTPNY-VAPEVLSNRGYDGSAADVWSC 134
           +L++S  ++K++DFGL+  LP  +   ++     +P +  APE LS+  +    +DVWS 
Sbjct: 158 ILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFS-RQSDVWSF 216
Query: 135 GVILFVLM 142
           GV+L+ L 
Sbjct: 217 GVVLYELF 224

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 70/128 (54%), Gaps = 5/128 (3%)
Query: 19  RTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN 77
           R  + +++E++  G L D +  H+ RL  +    Y  Q+   + +  S+   HRDL   N
Sbjct: 86  RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARN 145
Query: 78  LLLDSYGNLKVSDFGLSA-LP-QQGVELLHTTCGTPNY-VAPEVLSNRGYDGSAADVWSC 134
           +L++S  ++K++DFGL+  LP  +   ++     +P +  APE LS+  +    +DVWS 
Sbjct: 146 ILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFS-RQSDVWSF 204
Query: 135 GVILFVLM 142
           GV+L+ L 
Sbjct: 205 GVVLYELF 212

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 25/169 (14%)
Query: 2   KIVRHPNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVH---QGRLL-ENDCRRYF 53
           ++  HPNI+RL         ++ + +++L F   G L+++I     +G  L E+      
Sbjct: 81  RLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL 140
Query: 54  QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFG------------LSALPQQGV 101
             +   +   H+KG  HRDLKP N+LL   G   + D G              AL  Q  
Sbjct: 141 LGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ-- 198
Query: 102 ELLHTTCGTPNYVAPEVLSNRGY--DGSAADVWSCGVILFVLMAGYLPF 148
           +     C T +Y APE+ S + +       DVWS G +L+ +M G  P+
Sbjct: 199 DWAAQRC-TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY 246

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 24/159 (15%)
Query: 3   IVRHPNIVR-LHEVLASR---TKVYIILEFVTGGELFDKIVHQGRLLEN-DCRRYFQQLI 57
           ++RH NI+  +   + SR   T++++I  +   G L+D +  Q   L+   C R    + 
Sbjct: 87  MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIA 144
Query: 58  DAVAHCH--------SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL----H 105
             +AH H           + HRDLK +N+L+   G   ++D GL+ +  Q    L    +
Sbjct: 145 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 204
Query: 106 TTCGTPNYVAPEVLSNR----GYDG-SAADVWSCGVILF 139
              GT  Y+APEVL        +D     D+W+ G++L+
Sbjct: 205 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLW 243

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 82/178 (46%), Gaps = 23/178 (12%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND----------CRR 51
           K+  HPNI+ L      R  +Y+ +E+   G L D  + + R+LE D             
Sbjct: 78  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTL 136
Query: 52  YFQQLIDAVA-------HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 104
             QQL+   A       +   K   HR+L   N+L+      K++DFGLS    Q V + 
Sbjct: 137 SSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSR--GQEVYVK 194
Query: 105 HTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI 160
            T    P  ++A E L+   Y  + +DVWS GV+L+ +++ G  P+       LY+K+
Sbjct: 195 KTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 251

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 74/147 (50%), Gaps = 7/147 (4%)
Query: 1   MKIVRHPNIVRLHEVL--ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 58
           ++ + H +I++       A    + +++E+V  G L D +      L      + QQ+ +
Sbjct: 87  LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQ-LLLFAQQICE 145
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL--LHTTCGTPNY-VA 115
            +A+ H++   HRDL   N+LLD+   +K+ DFGL+    +G E   +     +P +  A
Sbjct: 146 GMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYA 205
Query: 116 PEVLSNRGYDGSAADVWSCGVILFVLM 142
           PE L    +   A+DVWS GV L+ L+
Sbjct: 206 PECLKEYKFY-YASDVWSFGVTLYELL 231

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 93/194 (47%), Gaps = 24/194 (12%)
Query: 4   VRHPNIVRLHEVLASRTK-----VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 58
           V HP+IV++   +    +      YI++E+V GG+   +   Q +L   +   Y  +++ 
Sbjct: 136 VVHPSIVQIFNFVEHTDRHGDPVGYIVMEYV-GGQSLKRSKGQ-KLPVAEAIAYLLEILP 193
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
           A+++ HS G+ + DLKPEN++L +   LK+ D G  +     +       GTP + APE+
Sbjct: 194 ALSYLHSIGLVYNDLKPENIML-TEEQLKLIDLGAVSR----INSFGYLYGTPGFQAPEI 248
Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK-INAAEFSCPFWFSTGATS 177
           +  R     A D+++ G  L  L          DLPT   + ++      P   +  +  
Sbjct: 249 V--RTGPTVATDIYTVGRTLAALT--------LDLPTRNGRYVDGLPEDDPVLKTYDSYG 298
Query: 178 -LIHKILDPNPKTR 190
            L+ + +DP+P+ R
Sbjct: 299 RLLRRAIDPDPRQR 312

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 51/105 (48%), Gaps = 4/105 (3%)
Query: 54  QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT--CGTP 111
           Q   + +   H     HRD+K  N+LLD     K+SDFGL+   ++  + +  +   GT 
Sbjct: 131 QGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTT 190
Query: 112 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL 156
            Y APE L  RG     +D++S GV+L  ++ G     E   P L
Sbjct: 191 AYXAPEAL--RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 233

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 74/159 (46%), Gaps = 30/159 (18%)
Query: 1   MKIVRHPNIVRLHEVLASRTK--------VYIILEFVT---GGELFDKIVHQGRLLENDC 49
           +++++H N+V L E+  ++          +Y++ +F      G L + +V   +   ++ 
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEI 127
Query: 50  RRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG 109
           +R  Q L++ + + H   + HRD+K  N+L+   G LK++DFGL+    +   L   +  
Sbjct: 128 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA----RAFSLAKNS-- 181
Query: 110 TPN----------YVAPEVLSNRGYDGSAADVWSCGVIL 138
            PN          Y  PE+L      G   D+W  G I+
Sbjct: 182 QPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 220

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 70/153 (45%), Gaps = 18/153 (11%)
Query: 1   MKIVRHPNIVRLHEVLASRTK--------VYIILEFVT---GGELFDKIVHQGRLLENDC 49
           +++++H N+V L E+  ++          +Y++ +F      G L + +V   +   ++ 
Sbjct: 70  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEI 126
Query: 50  RRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL----SALPQQGVELLH 105
           +R  Q L++ + + H   + HRD+K  N+L+   G LK++DFGL    S           
Sbjct: 127 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 186
Query: 106 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVIL 138
               T  Y  PE+L      G   D+W  G I+
Sbjct: 187 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 219

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 70/153 (45%), Gaps = 18/153 (11%)
Query: 1   MKIVRHPNIVRLHEVLASRTK--------VYIILEFVT---GGELFDKIVHQGRLLENDC 49
           +++++H N+V L E+  ++          +Y++ +F      G L + +V   +   ++ 
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLV---KFTLSEI 127
Query: 50  RRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL----SALPQQGVELLH 105
           +R  Q L++ + + H   + HRD+K  N+L+   G LK++DFGL    S           
Sbjct: 128 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 106 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVIL 138
               T  Y  PE+L      G   D+W  G I+
Sbjct: 188 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 220

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 21/178 (11%)
Query: 1   MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 43
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXX 213
Query: 104 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 70/153 (45%), Gaps = 18/153 (11%)
Query: 1   MKIVRHPNIVRLHEVLASRTK--------VYIILEFVT---GGELFDKIVHQGRLLENDC 49
           +++++H N+V L E+  ++          +Y++ +F      G L + +V   +   ++ 
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEI 127
Query: 50  RRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL----SALPQQGVELLH 105
           +R  Q L++ + + H   + HRD+K  N+L+   G LK++DFGL    S           
Sbjct: 128 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 106 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVIL 138
               T  Y  PE+L      G   D+W  G I+
Sbjct: 188 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 220

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 21/178 (11%)
Query: 1   MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 43
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQ 153
Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXX 213
Query: 104 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 81/178 (45%), Gaps = 21/178 (11%)
Query: 1   MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 43
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 104 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
            +TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 214 KNTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 79/178 (44%), Gaps = 21/178 (11%)
Query: 1   MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGR 43
           MK++ +H NI+ L         +Y+I+E+ + G L + +                  + +
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQ 146
Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
           L   D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+         
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXX 206
Query: 104 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
             TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 263

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 21/178 (11%)
Query: 1   MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 43
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 81  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 140
Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 141 MTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYY 200
Query: 104 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 201 KKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 257

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 21/178 (11%)
Query: 1   MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 43
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 86  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 145
Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 146 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 205
Query: 104 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 206 KKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 262

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 21/178 (11%)
Query: 1   MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 43
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 104 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 21/178 (11%)
Query: 1   MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 43
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 83  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 142
Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 143 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 202
Query: 104 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 203 KKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 259

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 21/178 (11%)
Query: 1   MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 43
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 259
Query: 104 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 260 KKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 81/166 (48%), Gaps = 9/166 (5%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M  V  P + RL  +  + T V ++ + +  G L D +  ++GRL   D   +  Q+   
Sbjct: 73  MAGVGSPYVSRLLGICLTST-VQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKG 131
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           +++     + HRDL   N+L+ S  ++K++DFGL+ L        H   G  P  ++A E
Sbjct: 132 MSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 191
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMA-GYLPFG---ETDLPTLYKK 159
            +  R +    +DVWS GV ++ LM  G  P+      ++P L +K
Sbjct: 192 SILRRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK 236

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 21/178 (11%)
Query: 1   MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 43
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 94  MKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 104 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 8/159 (5%)
Query: 1   MKIVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLID 58
           MK   HPN++ L  + L S     ++L ++  G+L + I ++       D   +  Q+  
Sbjct: 84  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 143
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTP---NYV 114
            + +  SK   HRDL   N +LD    +KV+DFGL+  +  +    +H   G      ++
Sbjct: 144 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWM 203
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETD 152
           A E L  + +  + +DVWS GV+L+ LM  G  P+ + +
Sbjct: 204 ALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 241

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 21/178 (11%)
Query: 1   MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 43
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 94  MKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 104 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 8/159 (5%)
Query: 1   MKIVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLID 58
           MK   HPN++ L  + L S     ++L ++  G+L + I ++       D   +  Q+  
Sbjct: 86  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 145
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTP---NYV 114
            +    SK   HRDL   N +LD    +KV+DFGL+  +  +  + +H   G      ++
Sbjct: 146 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 205
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETD 152
           A E L  + +  + +DVWS GV+L+ LM  G  P+ + +
Sbjct: 206 ALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 243

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 79/178 (44%), Gaps = 21/178 (11%)
Query: 1   MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGR 43
           MK++ +H NI+ L         +Y+I+E+ + G L + +                  + +
Sbjct: 80  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 139
Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
           L   D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+         
Sbjct: 140 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 199
Query: 104 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
             TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 200 KKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 256

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 8/159 (5%)
Query: 1   MKIVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLID 58
           MK   HPN++ L  + L S     ++L ++  G+L + I ++       D   +  Q+  
Sbjct: 83  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 142
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTP---NYV 114
            +    SK   HRDL   N +LD    +KV+DFGL+  +  +  + +H   G      ++
Sbjct: 143 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 202
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETD 152
           A E L  + +  + +DVWS GV+L+ LM  G  P+ + +
Sbjct: 203 ALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 240

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 75/148 (50%), Gaps = 7/148 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 58
           ++ + H +I++       + +  + +++E+V  G L D +      L      + QQ+ +
Sbjct: 70  LRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQ-LLLFAQQICE 128
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL--LHTTCGTPNY-VA 115
            +A+ HS+   HR+L   N+LLD+   +K+ DFGL+    +G E   +     +P +  A
Sbjct: 129 GMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 188
Query: 116 PEVLSNRGYDGSAADVWSCGVILFVLMA 143
           PE L    +   A+DVWS GV L+ L+ 
Sbjct: 189 PECLKEYKF-YYASDVWSFGVTLYELLT 215

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 8/159 (5%)
Query: 1   MKIVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLID 58
           MK   HPN++ L  + L S     ++L ++  G+L + I ++       D   +  Q+  
Sbjct: 90  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 149
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTP---NYV 114
            +    SK   HRDL   N +LD    +KV+DFGL+  +  +  + +H   G      ++
Sbjct: 150 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 209
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETD 152
           A E L  + +  + +DVWS GV+L+ LM  G  P+ + +
Sbjct: 210 ALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 247

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 79/178 (44%), Gaps = 21/178 (11%)
Query: 1   MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGR 43
           MK++ +H NI+ L         +Y+I+E+ + G L + +                  + +
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQ 131
Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
           L   D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+         
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 104 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
             TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 82/169 (48%), Gaps = 13/169 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +  + T V +I++ +  G L D +  H+  +       +  Q+   
Sbjct: 72  MASVDNPHVCRLLGICLTST-VQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKG 130
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E
Sbjct: 131 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 190
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 191 SILHRIYT-HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 230

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 8/159 (5%)
Query: 1   MKIVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLID 58
           MK   HPN++ L  + L S     ++L ++  G+L + I ++       D   +  Q+  
Sbjct: 86  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 145
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTP---NYV 114
            +    SK   HRDL   N +LD    +KV+DFGL+  +  +  + +H   G      ++
Sbjct: 146 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWM 205
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETD 152
           A E L  + +  + +DVWS GV+L+ LM  G  P+ + +
Sbjct: 206 ALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 243

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 79/178 (44%), Gaps = 21/178 (11%)
Query: 1   MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGR 43
           MK++ +H NI+ L         +Y+I+E+ + G L + +                  + +
Sbjct: 76  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 135
Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
           L   D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+         
Sbjct: 136 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 195
Query: 104 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
             TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 196 KKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 252

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 8/159 (5%)
Query: 1   MKIVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLID 58
           MK   HPN++ L  + L S     ++L ++  G+L + I ++       D   +  Q+  
Sbjct: 85  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 144
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTP---NYV 114
            +    SK   HRDL   N +LD    +KV+DFGL+  +  +  + +H   G      ++
Sbjct: 145 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETD 152
           A E L  + +  + +DVWS GV+L+ LM  G  P+ + +
Sbjct: 205 ALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 242

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 79/178 (44%), Gaps = 21/178 (11%)
Query: 1   MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGR 43
           MK++ +H NI+ L         +Y+I+E+ + G L + +                  + +
Sbjct: 79  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 138
Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
           L   D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+         
Sbjct: 139 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 198
Query: 104 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
             TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 199 KKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 255

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 79/174 (45%), Gaps = 8/174 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE-NDCRRYFQQLIDA 59
           M  + +P IVRL  V  +   + +++E   GG L   +V +   +  ++      Q+   
Sbjct: 64  MHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 122
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGT--PNYVAP 116
           + +   K   HRDL   N+LL +    K+SDFGLS AL          + G     + AP
Sbjct: 123 MKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 182
Query: 117 EVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINAAE-FSCP 168
           E ++ R +  S +DVWS GV ++  L  G  P+ +   P +   I   +   CP
Sbjct: 183 ECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP 235

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 79/178 (44%), Gaps = 21/178 (11%)
Query: 1   MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGR 43
           MK++ +H NI+ L         +Y+I+E+ + G L + +                  + +
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 146
Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
           L   D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+         
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 206
Query: 104 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
             TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 263

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 79/178 (44%), Gaps = 21/178 (11%)
Query: 1   MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGR 43
           MK++ +H NI+ L         +Y+I+E+ + G L + +                  + +
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQ 146
Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
           L   D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+         
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 206
Query: 104 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
             TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 263

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 8/159 (5%)
Query: 1   MKIVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLID 58
           MK   HPN++ L  + L S     ++L ++  G+L + I ++       D   +  Q+  
Sbjct: 85  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 144
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTP---NYV 114
            +    SK   HRDL   N +LD    +KV+DFGL+  +  +  + +H   G      ++
Sbjct: 145 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETD 152
           A E L  + +  + +DVWS GV+L+ LM  G  P+ + +
Sbjct: 205 ALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 242

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 79/178 (44%), Gaps = 21/178 (11%)
Query: 1   MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGR 43
           MK++ +H NI+ L         +Y+I+E+ + G L + +                  + +
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
           L   D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+         
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 247
Query: 104 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
             TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 8/159 (5%)
Query: 1   MKIVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLID 58
           MK   HPN++ L  + L S     ++L ++  G+L + I ++       D   +  Q+  
Sbjct: 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 203
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTP---NYV 114
            +    SK   HRDL   N +LD    +KV+DFGL+  +  +  + +H   G      ++
Sbjct: 204 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 263
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETD 152
           A E L  + +  + +DVWS GV+L+ LM  G  P+ + +
Sbjct: 264 ALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 301

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 79/178 (44%), Gaps = 21/178 (11%)
Query: 1   MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGR 43
           MK++ +H NI+ L         +Y+I+E+ + G L + +                  + +
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQ 146
Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
           L   D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+         
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 206
Query: 104 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
             TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 263

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 75/158 (47%), Gaps = 19/158 (12%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR--------Y 52
           MK + HP+IV+L  ++      +II+E    GEL       G  LE +           Y
Sbjct: 63  MKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGEL-------GHYLERNKNSLKVLTLVLY 114
Query: 53  FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP- 111
             Q+  A+A+  S    HRD+   N+L+ S   +K+ DFGLS   +       +    P 
Sbjct: 115 SLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI 174
Query: 112 NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            +++PE ++ R +  +A+DVW   V ++ +L  G  PF
Sbjct: 175 KWMSPESINFRRF-TTASDVWMFAVCMWEILSFGKQPF 211

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 8/159 (5%)
Query: 1   MKIVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLID 58
           MK   HPN++ L  + L S     ++L ++  G+L + I ++       D   +  Q+  
Sbjct: 85  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 144
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTP---NYV 114
            + +  SK   HRDL   N +LD    +KV+DFGL+  +  +    +H   G      ++
Sbjct: 145 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 204
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETD 152
           A E L  + +  + +DVWS GV+L+ LM  G  P+ + +
Sbjct: 205 ALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 242

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 8/159 (5%)
Query: 1   MKIVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLID 58
           MK   HPN++ L  + L S     ++L ++  G+L + I ++       D   +  Q+  
Sbjct: 82  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 141
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTP---NYV 114
            + +  SK   HRDL   N +LD    +KV+DFGL+  +  +    +H   G      ++
Sbjct: 142 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 201
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETD 152
           A E L  + +  + +DVWS GV+L+ LM  G  P+ + +
Sbjct: 202 ALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 239

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 8/159 (5%)
Query: 1   MKIVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLID 58
           MK   HPN++ L  + L S     ++L ++  G+L + I ++       D   +  Q+  
Sbjct: 77  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 136
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTP---NYV 114
            + +  SK   HRDL   N +LD    +KV+DFGL+  +  +    +H   G      ++
Sbjct: 137 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 196
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETD 152
           A E L  + +  + +DVWS GV+L+ LM  G  P+ + +
Sbjct: 197 ALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 234

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 75/158 (47%), Gaps = 19/158 (12%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR--------Y 52
           MK + HP+IV+L  ++      +II+E    GEL       G  LE +           Y
Sbjct: 67  MKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGEL-------GHYLERNKNSLKVLTLVLY 118
Query: 53  FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP- 111
             Q+  A+A+  S    HRD+   N+L+ S   +K+ DFGLS   +       +    P 
Sbjct: 119 SLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI 178
Query: 112 NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            +++PE ++ R +  +A+DVW   V ++ +L  G  PF
Sbjct: 179 KWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPF 215

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 8/159 (5%)
Query: 1   MKIVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLID 58
           MK   HPN++ L  + L S     ++L ++  G+L + I ++       D   +  Q+  
Sbjct: 80  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 139
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTP---NYV 114
            + +  SK   HRDL   N +LD    +KV+DFGL+  +  +    +H   G      ++
Sbjct: 140 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 199
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETD 152
           A E L  + +  + +DVWS GV+L+ LM  G  P+ + +
Sbjct: 200 ALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 237

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 8/159 (5%)
Query: 1   MKIVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLID 58
           MK   HPN++ L  + L S     ++L ++  G+L + I ++       D   +  Q+  
Sbjct: 103 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 162
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTP---NYV 114
            + +  SK   HRDL   N +LD    +KV+DFGL+  +  +    +H   G      ++
Sbjct: 163 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 222
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETD 152
           A E L  + +  + +DVWS GV+L+ LM  G  P+ + +
Sbjct: 223 ALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 260

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 8/159 (5%)
Query: 1   MKIVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLID 58
           MK   HPN++ L  + L S     ++L ++  G+L + I ++       D   +  Q+  
Sbjct: 104 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 163
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTP---NYV 114
            + +  SK   HRDL   N +LD    +KV+DFGL+  +  +    +H   G      ++
Sbjct: 164 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 223
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETD 152
           A E L  + +  + +DVWS GV+L+ LM  G  P+ + +
Sbjct: 224 ALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 261

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 75/158 (47%), Gaps = 19/158 (12%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR--------Y 52
           MK + HP+IV+L  ++      +II+E    GEL       G  LE +           Y
Sbjct: 79  MKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGEL-------GHYLERNKNSLKVLTLVLY 130
Query: 53  FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP- 111
             Q+  A+A+  S    HRD+   N+L+ S   +K+ DFGLS   +       +    P 
Sbjct: 131 SLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI 190
Query: 112 NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            +++PE ++ R +  +A+DVW   V ++ +L  G  PF
Sbjct: 191 KWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPF 227

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 80/178 (44%), Gaps = 21/178 (11%)
Query: 1   MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 43
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
           +   D      QL   + +  S+   HRDL   N+L+     ++++DFGL+         
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYY 213
Query: 104 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 8/159 (5%)
Query: 1   MKIVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLID 58
           MK   HPN++ L  + L S     ++L ++  G+L + I ++       D   +  Q+  
Sbjct: 83  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 142
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTP---NYV 114
            + +  SK   HRDL   N +LD    +KV+DFGL+  +  +    +H   G      ++
Sbjct: 143 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 202
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETD 152
           A E L  + +  + +DVWS GV+L+ LM  G  P+ + +
Sbjct: 203 ALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 240

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 8/159 (5%)
Query: 1   MKIVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLID 58
           MK   HPN++ L  + L S     ++L ++  G+L + I ++       D   +  Q+  
Sbjct: 85  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 144
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTP---NYV 114
            + +  SK   HRDL   N +LD    +KV+DFGL+  +  +    +H   G      ++
Sbjct: 145 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 204
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETD 152
           A E L  + +  + +DVWS GV+L+ LM  G  P+ + +
Sbjct: 205 ALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 242

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 8/159 (5%)
Query: 1   MKIVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLID 58
           MK   HPN++ L  + L S     ++L ++  G+L + I ++       D   +  Q+  
Sbjct: 84  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 143
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTP---NYV 114
            + +  SK   HRDL   N +LD    +KV+DFGL+  +  +    +H   G      ++
Sbjct: 144 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 203
Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETD 152
           A E L  + +  + +DVWS GV+L+ LM  G  P+ + +
Sbjct: 204 ALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 241

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/88 (37%), Positives = 44/88 (50%), Gaps = 3/88 (3%)
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ-QGVELLHTTCGTPNYVAPEVLS 120
           HC  K + HRD+K  N+LLD      V DFGL+ L   +   +     GT  ++APE LS
Sbjct: 158 HCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLS 216
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPF 148
             G      DV+  GV+L  L+ G   F
Sbjct: 217 T-GKSSEKTDVFGYGVMLLELITGQRAF 243

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 75/148 (50%), Gaps = 7/148 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 58
           ++ + H +I++       + +  + +++E+V  G L D +      L      + QQ+ +
Sbjct: 70  LRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQ-LLLFAQQICE 128
Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL--LHTTCGTPNY-VA 115
            +A+ H++   HR+L   N+LLD+   +K+ DFGL+    +G E   +     +P +  A
Sbjct: 129 GMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 188
Query: 116 PEVLSNRGYDGSAADVWSCGVILFVLMA 143
           PE L    +   A+DVWS GV L+ L+ 
Sbjct: 189 PECLKEYKF-YYASDVWSFGVTLYELLT 215

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 82/169 (48%), Gaps = 13/169 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +  + T V +I++ +  G L D +  H+  +       +  Q+   
Sbjct: 75  MASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 133
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E
Sbjct: 134 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 193
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 194 SILHRIYT-HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 233

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 82/169 (48%), Gaps = 13/169 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +  + T V +I++ +  G L D +  H+  +       +  Q+   
Sbjct: 73  MASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 131
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E
Sbjct: 132 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 192 SILHRIYT-HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 231

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 82/169 (48%), Gaps = 13/169 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +  + T V +I++ +  G L D +  H+  +       +  Q+   
Sbjct: 74  MASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 132
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E
Sbjct: 133 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 193 SILHRIYT-HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 232

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 82/169 (48%), Gaps = 13/169 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +  + T V +I++ +  G L D +  H+  +       +  Q+   
Sbjct: 72  MASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 130
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E
Sbjct: 131 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 190
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 191 SILHRIYT-HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 230

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 82/169 (48%), Gaps = 13/169 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +  + T V +I++ +  G L D +  H+  +       +  Q+   
Sbjct: 78  MASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 136
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E
Sbjct: 137 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 197 SILHRIYT-HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 236

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 15/152 (9%)
Query: 1   MKIVRHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKI----VHQGRLLENDCRRYFQ 54
           ++ + H +IV+       + +  V +++E+V  G L D +    V   +LL      + Q
Sbjct: 64  LRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLL-----LFAQ 118
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL--LHTTCGTPN 112
           Q+ + +A+ H++   HR L   N+LLD+   +K+ DFGL+    +G E   +     +P 
Sbjct: 119 QICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 178
Query: 113 Y-VAPEVLSNRGYDGSAADVWSCGVILFVLMA 143
           +  APE L    +   A+DVWS GV L+ L+ 
Sbjct: 179 FWYAPECLKECKFY-YASDVWSFGVTLYELLT 209

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 82/169 (48%), Gaps = 13/169 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +  + T V +I++ +  G L D +  H+  +       +  Q+   
Sbjct: 71  MASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 190 SILHRIYT-HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 229

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 15/152 (9%)
Query: 1   MKIVRHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKI----VHQGRLLENDCRRYFQ 54
           ++ + H +IV+       + +  V +++E+V  G L D +    V   +LL      + Q
Sbjct: 65  LRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLL-----LFAQ 119
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL--LHTTCGTPN 112
           Q+ + +A+ H++   HR L   N+LLD+   +K+ DFGL+    +G E   +     +P 
Sbjct: 120 QICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 179
Query: 113 Y-VAPEVLSNRGYDGSAADVWSCGVILFVLMA 143
           +  APE L    +   A+DVWS GV L+ L+ 
Sbjct: 180 FWYAPECLKECKFY-YASDVWSFGVTLYELLT 210

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +  + T V +I + +  G L D +  H+  +       +  Q+   
Sbjct: 71  MASVDNPHVCRLLGICLTST-VQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 190 SILHRIYT-HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 229

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 82/169 (48%), Gaps = 13/169 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +  + T V +I + +  G L D +  H+  +       +  Q+ + 
Sbjct: 68  MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEG 126
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E
Sbjct: 127 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 186
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 187 SILHRIYT-HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 226

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 85/236 (36%), Gaps = 69/236 (29%)
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYG-------------------NLKVSDFGLSA 95
           QL  AV   H   + H DLKPEN+L  +                      ++V DFG + 
Sbjct: 145 QLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSAT 204
Query: 96  LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT 155
                 E   T   T +Y APEV+   G+     DVWS G I+F    G+  F   D   
Sbjct: 205 FDH---EHHSTIVSTRHYRAPEVILELGW-SQPCDVWSIGCIIFEYYVGFTLFQTHD--- 257
Query: 156 LYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF------------- 202
                           +    +++ +IL P P   IR    RK  +F             
Sbjct: 258 ----------------NREHLAMMERILGPIPSRMIR--KTRKQKYFYRGRLDWDENTSA 299
Query: 203 ----RKNYNPVK---CSEEEEVNLDDVHAVFDDIEDQYVAEQSENKVGGPLLMNAF 251
               R+N  P++    SE EE      H +FD IE     E ++    G  L + F
Sbjct: 300 GRYVRENCKPLRRYLTSEAEE-----HHQLFDLIESMLEYEPAKRLTLGEALQHPF 350

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 17/152 (11%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ------GRLLENDCRRYFQ 54
           M  + HP++VRL  V  S T + ++ + +  G L +  VH+       +LL N C     
Sbjct: 71  MASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLE-YVHEHKDNIGSQLLLNWC----V 124
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP--- 111
           Q+   + +   + + HRDL   N+L+ S  ++K++DFGL+ L  +G E  +   G     
Sbjct: 125 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL-LEGDEKEYNADGGKMPI 183
Query: 112 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA 143
            ++A E +  R +    +DVWS GV ++ LM 
Sbjct: 184 KWMALECIHYRKFT-HQSDVWSYGVTIWELMT 214

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 79/178 (44%), Gaps = 21/178 (11%)
Query: 1   MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 43
           MK++ +H NI+ L         +Y+I+ + + G L + +                V + +
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 104 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 17/152 (11%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ------GRLLENDCRRYFQ 54
           M  + HP++VRL  V  S T + ++ + +  G L +  VH+       +LL N C     
Sbjct: 94  MASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLE-YVHEHKDNIGSQLLLNWC----V 147
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP--- 111
           Q+   + +   + + HRDL   N+L+ S  ++K++DFGL+ L  +G E  +   G     
Sbjct: 148 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL-LEGDEKEYNADGGKMPI 206
Query: 112 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA 143
            ++A E +  R +    +DVWS GV ++ LM 
Sbjct: 207 KWMALECIHYRKFT-HQSDVWSYGVTIWELMT 237

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +  + T V +I + +  G L D +  H+  +       +  Q+   
Sbjct: 71  MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 190 SILHRIYT-HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 229

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 85/217 (39%), Gaps = 47/217 (21%)
Query: 10  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRL--LENDCRRYFQQLIDAVAHCHSKG 67
           V++ E       + I+ E + G   +D I   G L    +  R+   Q+  +V   HS  
Sbjct: 80  VQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK 138
Query: 68  VYHRDLKPENLLL------DSYG-------------NLKVSDFGLSALPQQGVELLHTTC 108
           + H DLKPEN+L       ++Y              ++KV DFG +       E   T  
Sbjct: 139 LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD---EHHSTLV 195
Query: 109 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP 168
            T +Y APEV+   G+     DVWS G IL     G+  F   D                
Sbjct: 196 STRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTHD---------------- 238
Query: 169 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
              S    +++ +IL P PK    I+  RK  +F  +
Sbjct: 239 ---SKEHLAMMERILGPLPKH--MIQKTRKRKYFHHD 270

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +  + T V +I + +  G L D +  H+  +       +  Q+   
Sbjct: 81  MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 139
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E
Sbjct: 140 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 199
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 200 SILHRIYT-HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 239

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 76/173 (43%), Gaps = 37/173 (21%)
Query: 4   VRHPNIVRLHEVLASRT-----KVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQL 56
           + H ++V++ +++  +      ++Y++LE       +LF   V+   L E   +     L
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVY---LTELHIKTLLYNL 165
Query: 57  IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL---PQQG------------- 100
           +  V + HS G+ HRDLKP N L++   ++KV DFGL+     P+ G             
Sbjct: 166 LVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 101 --VELLHTT---------CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM 142
             V   HT            T  Y APE++  +     A DVWS G I   L+
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +  + T V +I + +  G L D +  H+  +       +  Q+   
Sbjct: 71  MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 190 SILHRIYT-HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 229

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 79/178 (44%), Gaps = 21/178 (11%)
Query: 1   MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 43
           MK++ +H NI+ L         +Y+I+ + + G L + +                V + +
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 104 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 158
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +  + T V +I + +  G L D +  H+  +       +  Q+   
Sbjct: 105 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 163
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E
Sbjct: 164 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 223
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 224 SILHRIYT-HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 263

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +  + T V +I + +  G L D +  H+  +       +  Q+   
Sbjct: 71  MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 190 SILHRIYT-HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 229

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +  + T V +I + +  G L D +  H+  +       +  Q+   
Sbjct: 74  MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 132
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E
Sbjct: 133 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 193 SILHRIYT-HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 232

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +  + T V +I + +  G L D +  H+  +       +  Q+   
Sbjct: 74  MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 132
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E
Sbjct: 133 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 193 SILHRIYT-HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 232

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +  + T V +I + +  G L D +  H+  +       +  Q+   
Sbjct: 96  MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 154
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E
Sbjct: 155 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 214
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 215 SILHRIYT-HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 254

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +  + T V +I + +  G L D +  H+  +       +  Q+   
Sbjct: 74  MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 132
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E
Sbjct: 133 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 193 SILHRIYT-HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 232

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +  + T V +I + +  G L D +  H+  +       +  Q+   
Sbjct: 73  MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 131
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E
Sbjct: 132 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 192 SILHRIYT-HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 231

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +  + T V +I + +  G L D +  H+  +       +  Q+   
Sbjct: 78  MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 136
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E
Sbjct: 137 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 197 SILHRIYT-HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 236

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +  + T V +I + +  G L D +  H+  +       +  Q+   
Sbjct: 65  MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 184 SILHRIYT-HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 223

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +  + T V +I + +  G L D +  H+  +       +  Q+   
Sbjct: 77  MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 135
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E
Sbjct: 136 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 195
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 196 SILHRIYT-HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 235

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +  + T V +I + +  G L D +  H+  +       +  Q+   
Sbjct: 78  MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 136
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E
Sbjct: 137 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 197 SILHRIYT-HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 236

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 18/161 (11%)
Query: 5   RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND--------------CR 50
           +H NIV L         V +I E+   G+L + +  + R+LE D                
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 51  RYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCG 109
            +  Q+   +A   SK   HRD+   N+LL +    K+ DFGL+  +      ++     
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 110 TP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
            P  ++APE + +  Y    +DVWS G++L+ + + G  P+
Sbjct: 228 LPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPY 267

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/88 (36%), Positives = 43/88 (48%), Gaps = 3/88 (3%)
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ-QGVELLHTTCGTPNYVAPEVLS 120
           HC  K + HRD+K  N+LLD      V DFGL+ L   +   +     G   ++APE LS
Sbjct: 150 HCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLS 208
Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPF 148
             G      DV+  GV+L  L+ G   F
Sbjct: 209 T-GKSSEKTDVFGYGVMLLELITGQRAF 235

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 18/161 (11%)
Query: 5   RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND--------------CR 50
           +H NIV L         V +I E+   G+L + +  + R+LE D                
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLL 167
Query: 51  RYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCG 109
            +  Q+   +A   SK   HRD+   N+LL +    K+ DFGL+  +      ++     
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 110 TP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
            P  ++APE + +  Y    +DVWS G++L+ + + G  P+
Sbjct: 228 LPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPY 267

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 80/174 (45%), Gaps = 8/174 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE-NDCRRYFQQLIDA 59
           M  + +P IVRL  V  +   + +++E   GG L   +V +   +  ++      Q+   
Sbjct: 390 MHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 448
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGT-P-NYVAP 116
           + +   K   HR+L   N+LL +    K+SDFGLS AL          + G  P  + AP
Sbjct: 449 MKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 508
Query: 117 EVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINAAE-FSCP 168
           E ++ R +  S +DVWS GV ++  L  G  P+ +   P +   I   +   CP
Sbjct: 509 ECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP 561

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +  + T V +I++ +  G L D +  H+  +       +  Q+   
Sbjct: 73  MASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 131
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFG + L     +  H   G  P  ++A E
Sbjct: 132 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 192 SILHRIYT-HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 231

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +  + T V +I++ +  G L D +  H+  +       +  Q+   
Sbjct: 73  MASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 131
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFG + L     +  H   G  P  ++A E
Sbjct: 132 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 192 SILHRIYT-HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 231

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +  + T V +I++ +  G L D +  H+  +       +  Q+   
Sbjct: 75  MASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 133
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFG + L     +  H   G  P  ++A E
Sbjct: 134 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 193
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 194 SILHRIYT-HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 233

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 69/138 (50%), Gaps = 16/138 (11%)
Query: 22  VYIILEFVTGGE----LFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPE 76
           V++++ F   GE    L  K  H+G  L    ++  +QL+  + + H + G+ H D+KPE
Sbjct: 103 VHVVMVFEVLGENLLALIKKYEHRGIPLIY-VKQISKQLLLGLDYMHRRCGIIHTDIKPE 161
Query: 77  NLLL---DSYGNL---KVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAAD 130
           N+L+   DS  NL   K++D G +       E    +  T  Y +PEVL    + G  AD
Sbjct: 162 NVLMEIVDSPENLIQIKIADLGNACWYD---EHYTNSIQTREYRSPEVLLGAPW-GCGAD 217
Query: 131 VWSCGVILFVLMAGYLPF 148
           +WS   ++F L+ G   F
Sbjct: 218 IWSTACLIFELITGDFLF 235

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 69/138 (50%), Gaps = 16/138 (11%)
Query: 22  VYIILEFVTGGE----LFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPE 76
           V++++ F   GE    L  K  H+G  L    ++  +QL+  + + H + G+ H D+KPE
Sbjct: 103 VHVVMVFEVLGENLLALIKKYEHRGIPLIY-VKQISKQLLLGLDYMHRRCGIIHTDIKPE 161
Query: 77  NLLL---DSYGNL---KVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAAD 130
           N+L+   DS  NL   K++D G +       E    +  T  Y +PEVL    + G  AD
Sbjct: 162 NVLMEIVDSPENLIQIKIADLGNACWYD---EHYTNSIQTREYRSPEVLLGAPW-GCGAD 217
Query: 131 VWSCGVILFVLMAGYLPF 148
           +WS   ++F L+ G   F
Sbjct: 218 IWSTACLIFELITGDFLF 235

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 56/123 (45%), Gaps = 23/123 (18%)
Query: 48  DCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-------YGNLKVSD---FGLSALP 97
           D + Y  +++ A+ +     + H DLKPEN+LLD            +V+D     +    
Sbjct: 138 DIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 98  QQGVELLHTTCG------------TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGY 145
             G++L+   C             T  Y APEV+ N G+D S +D+WS G +L  L  G 
Sbjct: 198 STGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGS 256
Query: 146 LPF 148
           L F
Sbjct: 257 LLF 259

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 75/160 (46%), Gaps = 26/160 (16%)
Query: 3   IVRHPNIVR-LHEVLASR---TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 58
           ++RH NI+  +   + SR   T++++I  +   G L+D +  Q  L  +   R       
Sbjct: 58  LLRHDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQT-LEPHLALRLAVSAAC 116
Query: 59  AVAHCHSK--------GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL----HT 106
            +AH H +         + HRD K  N+L+ S     ++D GL+ +  QG + L    + 
Sbjct: 117 GLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNP 176
Query: 107 TCGTPNYVAPEVLSNR-------GYDGSAADVWSCGVILF 139
             GT  Y+APEVL  +        Y  +  D+W+ G++L+
Sbjct: 177 RVGTKRYMAPEVLDEQIRTDCFESYKWT--DIWAFGLVLW 214

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 72/158 (45%), Gaps = 22/158 (13%)
Query: 3   IVRHPNIVRLHEV----LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 58
           ++RH NI+           S T++Y+I ++   G L+D  +    L      +     + 
Sbjct: 87  LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYD-YLKSTTLDAKSMLKLAYSSVS 145
Query: 59  AVAHCHSK--------GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL----HT 106
            + H H++         + HRDLK +N+L+   G   ++D GL+         +    +T
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205
Query: 107 TCGTPNYVAPEVLS---NRGYDGS--AADVWSCGVILF 139
             GT  Y+ PEVL    NR +  S   AD++S G+IL+
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILW 243

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 81/176 (46%), Gaps = 17/176 (9%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDA 59
           K+  HPNIV       +  +++++  F+  G   D I       + E       Q ++ A
Sbjct: 81  KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKA 140
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDF--GLSALPQ-QGVELLHT----TCGTPN 112
           + + H  G  HR +K  ++L+   G + +S     LS +   Q   ++H     +     
Sbjct: 141 LDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 113 YVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT---LYKKINAA 163
           +++PEVL    +GYD + +D++S G+    L  G++PF   D+P    L +K+N  
Sbjct: 201 WLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPF--KDMPATQMLLEKLNGT 253

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 81/183 (44%), Gaps = 31/183 (16%)
Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDA 59
           K+  HPNIV       +  +++++  F+  G   D I       + E       Q ++ A
Sbjct: 65  KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKA 124
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYG---------NLKVSDFG-----LSALPQQGVELLH 105
           + + H  G  HR +K  ++L+   G         NL +   G     +   P+  V++L 
Sbjct: 125 LDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL- 183
Query: 106 TTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT---LYKKI 160
                  +++PEVL    +GYD + +D++S G+    L  G++PF   D+P    L +K+
Sbjct: 184 ------PWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPF--KDMPATQMLLEKL 234
Query: 161 NAA 163
           N  
Sbjct: 235 NGT 237

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 80/169 (47%), Gaps = 13/169 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +  + T V +I + +  G L D +  H+  +       +  Q+   
Sbjct: 73  MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 131
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFG + L     +  H   G  P  ++A E
Sbjct: 132 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 192 SILHRIYT-HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 231

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 80/169 (47%), Gaps = 13/169 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +  + T V +I + +  G L D +  H+  +       +  Q+   
Sbjct: 71  MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFG + L     +  H   G  P  ++A E
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 190 SILHRIYT-HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 229

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 80/169 (47%), Gaps = 13/169 (7%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +  + T V +I + +  G L D +  H+  +       +  Q+   
Sbjct: 78  MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 136
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFG + L     +  H   G  P  ++A E
Sbjct: 137 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
            + +R Y    +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 197 SILHRIYT-HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 236

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/114 (32%), Positives = 49/114 (42%), Gaps = 25/114 (21%)
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLL-----------------DSYGN--LKVSDFGLSA 95
           QL  A+   H   + H DLKPEN+L                   S  N  ++V+DFG + 
Sbjct: 140 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 199
Query: 96  LPQQGVELLHTT-CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 148
              +     HTT   T +Y  PEV+   G+     DVWS G ILF    G+  F
Sbjct: 200 FDHEH----HTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLF 248

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 69/151 (45%), Gaps = 13/151 (8%)
Query: 5   RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ---------GRLLE-NDCRRYFQ 54
           +H NIV L         V +I E+   G+L + +  +         GR LE  D   +  
Sbjct: 100 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 159
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTP-N 112
           Q+   +A   SK   HRD+   N+LL +    K+ DFGL+  +      ++      P  
Sbjct: 160 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 219
Query: 113 YVAPEVLSNRGYDGSAADVWSCGVILFVLMA 143
           ++APE + +  Y    +DVWS G++L+ + +
Sbjct: 220 WMAPESIFDCVYT-VQSDVWSYGILLWEIFS 249

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/114 (32%), Positives = 49/114 (42%), Gaps = 25/114 (21%)
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLL-----------------DSYGN--LKVSDFGLSA 95
           QL  A+   H   + H DLKPEN+L                   S  N  ++V+DFG + 
Sbjct: 163 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 222
Query: 96  LPQQGVELLHTT-CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 148
              +     HTT   T +Y  PEV+   G+     DVWS G ILF    G+  F
Sbjct: 223 FDHEH----HTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLF 271

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 72/157 (45%), Gaps = 14/157 (8%)
Query: 5   RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ---------GRLLE-NDCRRYFQ 54
           +H NIV L         V +I E+   G+L + +  +         GR LE  D   +  
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 167
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTP-N 112
           Q+   +A   SK   HRD+   N+LL +    K+ DFGL+  +      ++      P  
Sbjct: 168 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 227
Query: 113 YVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 148
           ++APE + +  Y    +DVWS G++L+ + + G  P+
Sbjct: 228 WMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPY 263

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/114 (32%), Positives = 49/114 (42%), Gaps = 25/114 (21%)
Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLL-----------------DSYGN--LKVSDFGLSA 95
           QL  A+   H   + H DLKPEN+L                   S  N  ++V+DFG + 
Sbjct: 131 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 96  LPQQGVELLHTT-CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 148
              +     HTT   T +Y  PEV+   G+     DVWS G ILF    G+  F
Sbjct: 191 FDHEH----HTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLF 239

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 67/144 (46%), Gaps = 7/144 (4%)
Query: 6   HPNIVRLHEVLASR--TKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAH 62
           H NIV+   +        + +I+EF+  G L + +  ++ ++      +Y  Q+   + +
Sbjct: 82  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDY 141
Query: 63  CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN---YVAPEVL 119
             S+   HRDL   N+L++S   +K+ DFGL+   +   E         +   + APE L
Sbjct: 142 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 201
Query: 120 SNRGYDGSAADVWSCGVILFVLMA 143
               +   A+DVWS GV L  L+ 
Sbjct: 202 MQSKF-YIASDVWSFGVTLHELLT 224

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 84/217 (38%), Gaps = 47/217 (21%)
Query: 10  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRL--LENDCRRYFQQLIDAVAHCHSKG 67
           V++ E       + I+ E + G   +D I   G L    +  R+   Q+  +V   HS  
Sbjct: 80  VQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK 138
Query: 68  VYHRDLKPENLLL------DSYG-------------NLKVSDFGLSALPQQGVELLHTTC 108
           + H DLKPEN+L       ++Y              ++KV DFG +       E   T  
Sbjct: 139 LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD---EHHSTLV 195
Query: 109 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP 168
              +Y APEV+   G+     DVWS G IL     G+  F   D                
Sbjct: 196 XXRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTHD---------------- 238
Query: 169 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
              S    +++ +IL P PK    I+  RK  +F  +
Sbjct: 239 ---SKEHLAMMERILGPLPKH--MIQKTRKRKYFHHD 270

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 67/144 (46%), Gaps = 7/144 (4%)
Query: 6   HPNIVRLHEVLASR--TKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAH 62
           H NIV+   +        + +I+EF+  G L + +  ++ ++      +Y  Q+   + +
Sbjct: 70  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDY 129
Query: 63  CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN---YVAPEVL 119
             S+   HRDL   N+L++S   +K+ DFGL+   +   E         +   + APE L
Sbjct: 130 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 189
Query: 120 SNRGYDGSAADVWSCGVILFVLMA 143
               +   A+DVWS GV L  L+ 
Sbjct: 190 MQSKF-YIASDVWSFGVTLHELLT 212

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 68/166 (40%), Gaps = 35/166 (21%)
Query: 9   IVRLHEV-----LASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           I+RLH++     L    ++YI+LE       +LF   +    L E   +     L+    
Sbjct: 89  IIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIF---LTEQHVKTILYNLLLGEK 145
Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL------------------ 103
             H  G+ HRDLKP N LL+   ++K+ DFGL+       ++                  
Sbjct: 146 FIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPH 205
Query: 104 -------LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM 142
                  L +   T  Y APE++  +    ++ D+WS G I   L+
Sbjct: 206 NKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELL 251

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 51/102 (50%), Gaps = 8/102 (7%)
Query: 47  NDCRRYFQQLIDAVAHCHSK--GVYHRDLKPENLLL--DSYGNLKVSDFGLSALPQQGVE 102
           N  R++ QQ+  A+    +    + H DLKPEN+LL       +K+ DFG S    Q  +
Sbjct: 157 NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC---QLGQ 213
Query: 103 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG 144
            ++    +  Y +PEVL    YD  A D+WS G IL  +  G
Sbjct: 214 RIYQXIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTG 254

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 88/213 (41%), Gaps = 21/213 (9%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGRLLEN 47
           ++HPN+V L  V+     + +I  + + G+L + +V                 +  L   
Sbjct: 86  LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 145
Query: 48  DCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL--SALPQQGVELLH 105
           D      Q+   + +  S  V H+DL   N+L+    N+K+SD GL          +LL 
Sbjct: 146 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 205
Query: 106 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF-GETDLPTLYKKINAA 163
            +     ++APE +   G     +D+WS GV+L+ V   G  P+ G ++   +    N  
Sbjct: 206 NSLLPIRWMAPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQ 264
Query: 164 EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGI 196
              CP        +L+ +  +  P  R R + I
Sbjct: 265 VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDI 297

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 51/102 (50%), Gaps = 8/102 (7%)
Query: 47  NDCRRYFQQLIDAVAHCHSK--GVYHRDLKPENLLL--DSYGNLKVSDFGLSALPQQGVE 102
           N  R++ QQ+  A+    +    + H DLKPEN+LL       +K+ DFG S    Q  +
Sbjct: 138 NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC---QLGQ 194
Query: 103 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG 144
            ++    +  Y +PEVL    YD  A D+WS G IL  +  G
Sbjct: 195 RIYQXIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTG 235

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 88/213 (41%), Gaps = 21/213 (9%)
Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGRLLEN 47
           ++HPN+V L  V+     + +I  + + G+L + +V                 +  L   
Sbjct: 69  LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 48  DCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL--SALPQQGVELLH 105
           D      Q+   + +  S  V H+DL   N+L+    N+K+SD GL          +LL 
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 106 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF-GETDLPTLYKKINAA 163
            +     ++APE +   G     +D+WS GV+L+ V   G  P+ G ++   +    N  
Sbjct: 189 NSLLPIRWMAPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQ 247
Query: 164 EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGI 196
              CP        +L+ +  +  P  R R + I
Sbjct: 248 VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDI 280

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 51/102 (50%), Gaps = 8/102 (7%)
Query: 47  NDCRRYFQQLIDAVAHCHSK--GVYHRDLKPENLLL--DSYGNLKVSDFGLSALPQQGVE 102
           N  R++ QQ+  A+    +    + H DLKPEN+LL       +K+ DFG S    Q  +
Sbjct: 157 NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSC---QLGQ 213
Query: 103 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG 144
            ++    +  Y +PEVL    YD  A D+WS G IL  +  G
Sbjct: 214 RIYQXIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTG 254

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 73/148 (49%), Gaps = 21/148 (14%)
Query: 8   NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLI------- 57
           ++VRL  V++      +++E +  G+L   +       EN+  R     Q++I       
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL------SALPQQGVELLHTTCGTP 111
           D +A+ ++K   HRDL   N ++     +K+ DFG+      +A  ++G + L       
Sbjct: 141 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPV---- 196
Query: 112 NYVAPEVLSNRGYDGSAADVWSCGVILF 139
            ++APE L + G   +++D+WS GV+L+
Sbjct: 197 RWMAPESLKD-GVFTTSSDMWSFGVVLW 223

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 71/149 (47%), Gaps = 23/149 (15%)
Query: 8   NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLI------- 57
           ++VRL  V++      +++E +  G+L   +       EN+  R     Q++I       
Sbjct: 78  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 137
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-------ALPQQGVELLHTTCGT 110
           D +A+ ++K   HRDL   N ++     +K+ DFG++          + G  LL      
Sbjct: 138 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV---- 193
Query: 111 PNYVAPEVLSNRGYDGSAADVWSCGVILF 139
             ++APE L + G   +++D+WS GV+L+
Sbjct: 194 -RWMAPESLKD-GVFTTSSDMWSFGVVLW 220

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 71/149 (47%), Gaps = 23/149 (15%)
Query: 8   NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLI------- 57
           ++VRL  V++      +++E +  G+L   +       EN+  R     Q++I       
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-------ALPQQGVELLHTTCGT 110
           D +A+ ++K   HRDL   N ++     +K+ DFG++          + G  LL      
Sbjct: 141 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV---- 196
Query: 111 PNYVAPEVLSNRGYDGSAADVWSCGVILF 139
             ++APE L + G   +++D+WS GV+L+
Sbjct: 197 -RWMAPESLKD-GVFTTSSDMWSFGVVLW 223

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 21/215 (9%)
Query: 1   MKIVRHPNIVRLHEV-LASRTK-----VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           MK   HP++ +L  V L SR K       +IL F+  G+L   ++   R+ EN      Q
Sbjct: 79  MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL-ASRIGENPFNLPLQ 137
Query: 55  QLID-------AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT 107
            L+         + +  S+   HRDL   N +L     + V+DFGLS     G +     
Sbjct: 138 TLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG-DYYRQG 196
Query: 108 CGTP---NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKK-INA 162
           C +     ++A E L++  Y    +DVW+ GV ++ +M  G  P+   +   +Y   I  
Sbjct: 197 CASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG 255
Query: 163 AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIR 197
                P         L+++    +PK R     +R
Sbjct: 256 NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLR 290

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 71/149 (47%), Gaps = 23/149 (15%)
Query: 8   NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLI------- 57
           ++VRL  V++      +++E +  G+L   +       EN+  R     Q++I       
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-------ALPQQGVELLHTTCGT 110
           D +A+ ++K   HRDL   N ++     +K+ DFG++          + G  LL      
Sbjct: 141 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV---- 196
Query: 111 PNYVAPEVLSNRGYDGSAADVWSCGVILF 139
             ++APE L + G   +++D+WS GV+L+
Sbjct: 197 -RWMAPESLKD-GVFTTSSDMWSFGVVLW 223

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 71/149 (47%), Gaps = 23/149 (15%)
Query: 8   NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLI------- 57
           ++VRL  V++      +++E +  G+L   +       EN+  R     Q++I       
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-------LPQQGVELLHTTCGT 110
           D +A+ ++K   HRDL   N ++     +K+ DFG++          + G  LL      
Sbjct: 141 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 196
Query: 111 PNYVAPEVLSNRGYDGSAADVWSCGVILF 139
             ++APE L + G   +++D+WS GV+L+
Sbjct: 197 -RWMAPESLKD-GVFTTSSDMWSFGVVLW 223

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 71/149 (47%), Gaps = 23/149 (15%)
Query: 8   NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLI------- 57
           ++VRL  V++      +++E +  G+L   +       EN+  R     Q++I       
Sbjct: 80  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 139
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-------LPQQGVELLHTTCGT 110
           D +A+ ++K   HRDL   N ++     +K+ DFG++          + G  LL      
Sbjct: 140 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 195
Query: 111 PNYVAPEVLSNRGYDGSAADVWSCGVILF 139
             ++APE L + G   +++D+WS GV+L+
Sbjct: 196 -RWMAPESLKD-GVFTTSSDMWSFGVVLW 222

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 71/143 (49%), Gaps = 7/143 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN-DCRRYFQQLIDA 59
           M+ + +P IVR+  +  + + + +++E    G L +K + Q R +++ +      Q+   
Sbjct: 66  MQQLDNPYIVRMIGICEAESWM-LVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMG 123
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGT--PNYVAP 116
           + +       HRDL   N+LL +    K+SDFGLS AL          T G     + AP
Sbjct: 124 MKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAP 183
Query: 117 EVLSNRGYDGSAADVWSCGVILF 139
           E ++   +  S +DVWS GV+++
Sbjct: 184 ECINYYKFS-SKSDVWSFGVLMW 205

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 70/143 (48%), Gaps = 7/143 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN-DCRRYFQQLIDA 59
           M+ + +P IVR+  +  + + + +++E    G L +K + Q R +++ +      Q+   
Sbjct: 82  MQQLDNPYIVRMIGICEAESWM-LVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMG 139
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTP-NYVAP 116
           + +       HRDL   N+LL +    K+SDFGLS      +      T    P  + AP
Sbjct: 140 MKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 199
Query: 117 EVLSNRGYDGSAADVWSCGVILF 139
           E ++   +  S +DVWS GV+++
Sbjct: 200 ECINYYKF-SSKSDVWSFGVLMW 221

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 70/143 (48%), Gaps = 7/143 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN-DCRRYFQQLIDA 59
           M+ + +P IVR+  +  + + + +++E    G L +K + Q R +++ +      Q+   
Sbjct: 82  MQQLDNPYIVRMIGICEAESWM-LVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMG 139
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTP-NYVAP 116
           + +       HRDL   N+LL +    K+SDFGLS      +      T    P  + AP
Sbjct: 140 MKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 199
Query: 117 EVLSNRGYDGSAADVWSCGVILF 139
           E ++   +  S +DVWS GV+++
Sbjct: 200 ECINYYKF-SSKSDVWSFGVLMW 221

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 70/149 (46%), Gaps = 23/149 (15%)
Query: 8   NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND-------CRRYFQ---QLI 57
           ++VRL  V++      +I+E +T G+L   +      +EN+         +  Q   ++ 
Sbjct: 74  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 133
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-------ALPQQGVELLHTTCGT 110
           D +A+ ++    HRDL   N ++     +K+ DFG++          + G  LL      
Sbjct: 134 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV---- 189
Query: 111 PNYVAPEVLSNRGYDGSAADVWSCGVILF 139
             +++PE L + G   + +DVWS GV+L+
Sbjct: 190 -RWMSPESLKD-GVFTTYSDVWSFGVVLW 216

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 70/143 (48%), Gaps = 7/143 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN-DCRRYFQQLIDA 59
           M+ + +P IVR+  +  + + + +++E    G L +K + Q R +++ +      Q+   
Sbjct: 62  MQQLDNPYIVRMIGICEAESWM-LVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMG 119
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTP-NYVAP 116
           + +       HRDL   N+LL +    K+SDFGLS      +      T    P  + AP
Sbjct: 120 MKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179
Query: 117 EVLSNRGYDGSAADVWSCGVILF 139
           E ++   +  S +DVWS GV+++
Sbjct: 180 ECINYYKF-SSKSDVWSFGVLMW 201

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 70/143 (48%), Gaps = 7/143 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN-DCRRYFQQLIDA 59
           M+ + +P IVR+  +  + + + +++E    G L +K + Q R +++ +      Q+   
Sbjct: 66  MQQLDNPYIVRMIGICEAESWM-LVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMG 123
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTP-NYVAP 116
           + +       HRDL   N+LL +    K+SDFGLS      +      T    P  + AP
Sbjct: 124 MKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 183
Query: 117 EVLSNRGYDGSAADVWSCGVILF 139
           E ++   +  S +DVWS GV+++
Sbjct: 184 ECINYYKFS-SKSDVWSFGVLMW 205

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 70/143 (48%), Gaps = 7/143 (4%)
Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN-DCRRYFQQLIDA 59
           M+ + +P IVR+  +  + + + +++E    G L +K + Q R +++ +      Q+   
Sbjct: 72  MQQLDNPYIVRMIGICEAESWM-LVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMG 129
Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTP-NYVAP 116
           + +       HRDL   N+LL +    K+SDFGLS      +      T    P  + AP
Sbjct: 130 MKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 189
Query: 117 EVLSNRGYDGSAADVWSCGVILF 139
           E ++   +  S +DVWS GV+++
Sbjct: 190 ECINYYKF-SSKSDVWSFGVLMW 211

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 70/149 (46%), Gaps = 23/149 (15%)
Query: 8   NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND-------CRRYFQ---QLI 57
           ++VRL  V++      +I+E +T G+L   +      +EN+         +  Q   ++ 
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 142
Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-------ALPQQGVELLHTTCGT 110
           D +A+ ++    HRDL   N ++     +K+ DFG++          + G  LL      
Sbjct: 143 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV---- 198
Query: 111 PNYVAPEVLSNRGYDGSAADVWSCGVILF 139
             +++PE L + G   + +DVWS GV+L+
Sbjct: 199 -RWMSPESLKD-GVFTTYSDVWSFGVVLW 225

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 71/163 (43%), Gaps = 17/163 (10%)
Query: 1   MKIVRHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQ 55
           MK   HPN++RL  V    +     K  +IL F+  G+L   +++  RL         Q 
Sbjct: 90  MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS-RLETGPKHIPLQT 148
Query: 56  LID-------AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC 108
           L+         + +  ++   HRDL   N +L     + V+DFGLS     G        
Sbjct: 149 LLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRI 208
Query: 109 GTP--NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
                 ++A E L++R Y  S +DVW+ GV ++ +   G  P+
Sbjct: 209 AKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPY 250
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	381
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-149
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-136
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-135
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-135
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-134
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-133
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-132
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-131
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-131
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-131
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-128
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-126
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-124
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-124
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-122
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-121
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-116
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-115
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-112
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-90
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-89
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-87
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-87
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-87
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-86
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	8e-86
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-85
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-84
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-84
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-83
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-83
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-82
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-82
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-81
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-81
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-81
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-80
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-80
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-80
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-80
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-79
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-78
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-78
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-78
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-78
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-78
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-77
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-77
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-77
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-77
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	8e-77
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	8e-77
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-76
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-76
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	7e-76
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-74
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-73
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-72
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-68
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-68
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	9e-67
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-66
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	7e-66
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-65
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-64
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-63
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-62
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-62
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-61
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-61
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-61
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-60
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-60
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	9e-60
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	9e-59
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-58
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-58
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-58
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-58
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-58
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-58
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-58
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-56
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-56
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	7e-56
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-56
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	8e-56
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-55
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-55
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-54
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	6e-54
2ehb_D	143	CBL-interacting serine/threonine-protein kinase 2;	9e-54
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-53
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-53
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-52
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-51
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	8e-51
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	9e-45
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-41
2zfd_B	123	Putative uncharacterized protein T20L15_90; calciu	5e-41
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	7e-39
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-38
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-38
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-37
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	7e-37
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-36
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-36
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-36
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-35
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-35
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-35
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-34
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-34
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-34
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-34
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-33
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-33
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-32
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-32
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-32
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	7e-32
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-31
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-31
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-31
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-30
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-30
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-30
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	7e-30
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-29
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-29
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-29
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-29
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-29
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	8e-29
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-28
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-27
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-27
3aln_A	327	Dual specificity mitogen-activated protein kinase;	9e-27
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	9e-27
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-26
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-26
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-26
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	6e-26
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	9e-26
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-25
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-25
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-25
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-25
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-25
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-25
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-24
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-24
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-24
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-24
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-24
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-24
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-24
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-24
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-24
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-23
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-23
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-23
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-23
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	8e-23
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-22
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	7e-22
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-21
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-21
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-21
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	7e-21
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-20
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-19
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-19
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-19
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-19
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	9e-19
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	9e-19
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	9e-19
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-18
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-18
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-18
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-18
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-18
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-18
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-18
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-18
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-18
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	9e-18
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-17
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-17
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-17
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-17
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-17
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-17
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-16
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-16
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-16
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	7e-16
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-16
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-15
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-15
3pls_A	298	Macrophage-stimulating protein receptor; protein k	6e-15
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-14
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-14
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-14
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-14
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-13
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-13
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	7e-13
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-13
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	9e-13
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-12
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-12
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-12
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	7e-12
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-11
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-11
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-11
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-11
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-11
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-11
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-11
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-11
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-11
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	9e-11
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-10
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-10
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	7e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	7e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-07
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	8e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	9e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-04

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  430 bits (1107), Expect = e-149
 Identities = 119/408 (29%), Positives = 198/408 (48%), Gaps = 59/408 (14%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K+ RHP+I++L++V+++ + +++++E+V+GGELFD I   GRL E + RR FQQ++  V
Sbjct: 70  LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGV 129

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            +CH   V HRDLKPEN+LLD++ N K++DFGLS +   G E L T+CG+PNY APEV+S
Sbjct: 130 DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVIS 188

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            R Y G   D+WS GVIL+ L+ G LPF +  +PTL+KKI    F  P + +    SL+ 
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLK 248

Query: 181 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVN--------LDDVHAVFDDIEDQ 232
            +L  +P  R  I+ IR+H WF+++       E+   +        L +V   F+  E++
Sbjct: 249 HMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEE 308

Query: 233 YVAEQSENKVGGPLLMNAFEMI-------------------------------------- 254
            V     N+     L  A+ +I                                      
Sbjct: 309 -VLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVP 367

Query: 255 -------TLSQGLNLAALFDRRQDYVKRQTRFV---SRQPAQVILSNIEAVAESLSLKVH 304
                       L+       +   V++    +   S+     I++ +    + L  +  
Sbjct: 368 FLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWK 427

Query: 305 TRN-YKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEY 351
             N Y  R+   +   +    + L++++V    +++D R    + LE 
Sbjct: 428 VVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  388 bits (1000), Expect = e-136
 Identities = 97/213 (45%), Positives = 144/213 (67%), Gaps = 1/213 (0%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K+ RHP+I++L++V+++ T  ++++E+V+GGELFD I   GR+ E + RR FQQ++ AV
Sbjct: 65  LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAV 124

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            +CH   V HRDLKPEN+LLD++ N K++DFGLS +   G E L T+CG+PNY APEV+S
Sbjct: 125 DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVIS 183

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            R Y G   D+WSCGVIL+ L+ G LPF +  +PTL+KKI    F  P + +    +L+ 
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLM 243

Query: 181 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 213
            +L  +P  R  I+ IR+H WF+++       E
Sbjct: 244 HMLQVDPLKRATIKDIREHEWFKQDLPSYLFPE 276

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  389 bits (1001), Expect = e-135
 Identities = 99/290 (34%), Positives = 144/290 (49%), Gaps = 15/290 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
            + +RHPNIVR  EV+ + T + II+E+ +GGEL+++I + GR  E++ R +FQQL+  V
Sbjct: 70  HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGV 129

Query: 61  AHCHSKGVYHRDLKPENLLLDS--YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
           ++CHS  + HRDLK EN LLD      LK+ DFG S           +T GTP Y+APEV
Sbjct: 130 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEV 188

Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK----INAAEFSCP--FWFS 172
           L  + YDG  ADVWSCGV L+V++ G  PF + + P  Y+K    I + ++S P     S
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRIS 248

Query: 173 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP-VKCSEEEEVNLDDVHAVFDDIED 231
                LI +I   +P TRI I  I+ H WF KN    +           +       ++ 
Sbjct: 249 PECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDT 308

Query: 232 QYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVS 281
                        P + N      ++  L+L    D      + +    S
Sbjct: 309 IMQIISEATI---PAVRNRCLDDFMTDNLDLDDDMDDFDS--ESEIDIDS 353

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  383 bits (987), Expect = e-134
 Identities = 82/211 (38%), Positives = 117/211 (55%), Gaps = 5/211 (2%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
            K++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEV 118
            + H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFW--FSTGA 175
           L  R +     DVWSCG++L  ++AG LP+   +D    Y      +     W    +  
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238

Query: 176 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNY 206
            +L+HKIL  NP  RI I  I+K  W+ K  
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWYNKPL 269

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  382 bits (984), Expect = e-133
 Identities = 84/234 (35%), Positives = 122/234 (52%), Gaps = 6/234 (2%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
            K++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEV 118
            + H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFW--FSTGA 175
           L  R +     DVWSCG++L  ++AG LP+   +D    Y      +     W    +  
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238

Query: 176 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP-VKCSEEEEVNLDDVHAVFDD 228
            +L+HKIL  NP  RI I  I+K  W+ K      K        + +  + F  
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSK 292

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  380 bits (978), Expect = e-132
 Identities = 71/247 (28%), Positives = 122/247 (49%), Gaps = 13/247 (5%)

Query: 1   MKIVRHPNIVRLHEVL--ASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQL 56
           ++ +RH N+++L +VL    + K+Y+++E+   G  E+ D +    R        YF QL
Sbjct: 60  LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQL 118

Query: 57  IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYV 114
           ID + + HS+G+ H+D+KP NLLL + G LK+S  G++         +   T+ G+P + 
Sbjct: 119 IDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178

Query: 115 APEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFST 173
            PE+ +    + G   D+WS GV L+ +  G  PF   ++  L++ I    ++ P     
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGP 238

Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVH-----AVFDD 228
             + L+  +L+  P  R  I  IR+H WFRK + P +       + D         V   
Sbjct: 239 PLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMTVVPY 298

Query: 229 IEDQYVA 235
           +ED + A
Sbjct: 299 LEDLHGA 305

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  378 bits (974), Expect = e-131
 Identities = 100/231 (43%), Positives = 156/231 (67%), Gaps = 3/231 (1%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K++RHP+I++L++V+ + T + +++E+  GGELFD IV + R+ E++ RR+FQQ+I A+
Sbjct: 63  LKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAI 121

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            +CH   + HRDLKPENLLLD   N+K++DFGLS +   G   L T+CG+PNY APEV++
Sbjct: 122 EYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVIN 180

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            + Y G   DVWSCG++L+V++ G LPF +  +P L+KK+N+  +  P + S GA SLI 
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIR 240

Query: 181 KILDPNPKTRIRIEGIRKHPWFRKNY-NPVKCSEEEEVNLDDVHAVFDDIE 230
           +++  +P  RI I+ IR+ PWF  N  + ++  EE + +  D   V    E
Sbjct: 241 RMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGE 291

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  377 bits (970), Expect = e-131
 Identities = 69/210 (32%), Positives = 103/210 (49%), Gaps = 1/210 (0%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
            + + H ++V  H        V+++LE      L +    +  L E + R Y +Q++   
Sbjct: 69  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 128

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + H   V HRDLK  NL L+    +K+ DFGL+   +   E     CGTPNY+APEVLS
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS 188

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            +G+     DVWS G I++ L+ G  PF  + L   Y +I   E+S P   +  A SLI 
Sbjct: 189 KKGHSF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 247

Query: 181 KILDPNPKTRIRIEGIRKHPWFRKNYNPVK 210
           K+L  +P  R  I  +    +F   Y P +
Sbjct: 248 KMLQTDPTARPTINELLNDEFFTSGYIPAR 277

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  377 bits (971), Expect = e-131
 Identities = 69/210 (32%), Positives = 103/210 (49%), Gaps = 1/210 (0%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
            + + H ++V  H        V+++LE      L +    +  L E + R Y +Q++   
Sbjct: 95  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 154

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + H   V HRDLK  NL L+    +K+ DFGL+   +   E     CGTPNY+APEVLS
Sbjct: 155 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS 214

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            +G+     DVWS G I++ L+ G  PF  + L   Y +I   E+S P   +  A SLI 
Sbjct: 215 KKGHSF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 273

Query: 181 KILDPNPKTRIRIEGIRKHPWFRKNYNPVK 210
           K+L  +P  R  I  +    +F   Y P +
Sbjct: 274 KMLQTDPTARPTINELLNDEFFTSGYIPAR 303

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  369 bits (950), Expect = e-128
 Identities = 68/214 (31%), Positives = 114/214 (53%), Gaps = 2/214 (0%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL-ENDCRRYFQQLIDA 59
              ++HP+I+ L+        VY++LE    GE+   + ++ +   EN+ R +  Q+I  
Sbjct: 65  HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITG 124

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 119
           + + HS G+ HRDL   NLLL    N+K++DFGL+   +   E  +T CGTPNY++PE+ 
Sbjct: 125 MLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIA 184

Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 179
           +   + G  +DVWS G + + L+ G  PF    +     K+  A++  P + S  A  LI
Sbjct: 185 TRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLI 243

Query: 180 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 213
           H++L  NP  R+ +  +  HP+  +N +     E
Sbjct: 244 HQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDE 277

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  363 bits (934), Expect = e-126
 Identities = 74/210 (35%), Positives = 117/210 (55%), Gaps = 7/210 (3%)

Query: 1   MKIVRHPNIVRLHEVL--ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPN+V+L EVL   +   +Y++ E V  G + + +     L E+  R YFQ LI 
Sbjct: 90  LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLKPLSEDQARFYFQDLIK 148

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
            + + H + + HRD+KP NLL+   G++K++DFG+S   +    LL  T GTP ++APE 
Sbjct: 149 GIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPES 208

Query: 119 LSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFW--FSTG 174
           LS   + + G A DVW+ GV L+  + G  PF +  +  L+ KI +     P     +  
Sbjct: 209 LSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAED 268

Query: 175 ATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
              LI ++LD NP++RI +  I+ HPW  +
Sbjct: 269 LKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  361 bits (929), Expect = e-124
 Identities = 93/229 (40%), Positives = 133/229 (58%), Gaps = 1/229 (0%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MKI+ HPNIV+L EV+ +   +Y+I+E+ +GGE+FD +V  GR+ E + R  F+Q++ AV
Sbjct: 68  MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAV 127

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            +CH K + HRDLK ENLLLD+  N+K++DFG S     G   L   CG P Y APE+  
Sbjct: 128 QYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFCGAPPYAAPELFQ 186

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            + YDG   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ 
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 246

Query: 181 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDI 229
           + L  NP  R  +E I K  W    +   +     E  LD       DI
Sbjct: 247 RFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDI 295

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  358 bits (920), Expect = e-124
 Identities = 70/210 (33%), Positives = 115/210 (54%), Gaps = 3/210 (1%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
              +RHPNI+R++     R ++Y++LEF   GEL+ ++   GR  E     + ++L DA+
Sbjct: 68  QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADAL 127

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            +CH + V HRD+KPENLL+   G LK++DFG S           T CGT +Y+ PE++ 
Sbjct: 128 HYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--LRRRTMCGTLDYLPPEMIE 185

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            + +D    D+W  GV+ +  + G  PF        +++I   +   P + S G+  LI 
Sbjct: 186 GKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLIS 244

Query: 181 KILDPNPKTRIRIEGIRKHPWFRKNYNPVK 210
           K+L  +P  R+ ++G+ +HPW + N   V 
Sbjct: 245 KLLRYHPPQRLPLKGVMEHPWVKANSRRVL 274

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  352 bits (906), Expect = e-122
 Identities = 78/219 (35%), Positives = 119/219 (54%), Gaps = 4/219 (1%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
              +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+
Sbjct: 63  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 122

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           ++CHSK V HRD+KPENLLL S G LK++DFG S             CGT +Y+ PE++ 
Sbjct: 123 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRTDLCGTLDYLPPEMIE 180

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI 
Sbjct: 181 GRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 239

Query: 181 KILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 218
           ++L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 240 RLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 278

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  352 bits (905), Expect = e-121
 Identities = 69/243 (28%), Positives = 117/243 (48%), Gaps = 8/243 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEF-VTGGELFDKIVHQGRLLENDCRRYFQQLIDA 59
           +  V H NI+++ ++  ++    +++E   +G +LF  I    RL E      F+QL+ A
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSA 142

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 119
           V +   K + HRD+K EN+++     +K+ DFG +A  ++G +L +T CGT  Y APEVL
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYTFCGTIEYCAPEVL 201

Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 179
               Y G   ++WS GV L+ L+    PF E       ++   A    P+  S    SL+
Sbjct: 202 MGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPYLVSKELMSLV 255

Query: 180 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSE 239
             +L P P+ R  +E +   PW  +  N    + EE   ++   +         +  +S 
Sbjct: 256 SGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSL 315

Query: 240 NKV 242
           + V
Sbjct: 316 SDV 318

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  338 bits (869), Expect = e-116
 Identities = 71/222 (31%), Positives = 107/222 (48%), Gaps = 14/222 (6%)

Query: 1   MKIVR----HPNIVRLHEVLASRTKVYIILEF-VTGGELFDKIVHQGRLLENDCRRYFQQ 55
           +  V     HP ++RL +   ++    ++LE  +   +LFD I  +G L E   R +F Q
Sbjct: 88  LWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQ 147

Query: 56  LIDAVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           ++ A+ HCHS+GV HRD+K EN+L+D   G  K+ DFG  AL            GT  Y 
Sbjct: 148 VVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFDGTRVYS 205

Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTG 174
            PE +S   Y    A VWS G++L+ ++ G +PF         ++I  AE   P   S  
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER------DQEILEAELHFPAHVSPD 259

Query: 175 ATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEE 216
             +LI + L P P +R  +E I   PW +     V  +  + 
Sbjct: 260 CCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKG 301

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  337 bits (865), Expect = e-115
 Identities = 71/225 (31%), Positives = 106/225 (47%), Gaps = 12/225 (5%)

Query: 1   MKIVRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLI 57
           +K V      ++RL +         +ILE      +LFD I  +G L E   R +F Q++
Sbjct: 100 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 159

Query: 58  DAVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
           +AV HCH+ GV HRD+K EN+L+D   G LK+ DFG  AL +    +     GT  Y  P
Sbjct: 160 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPP 217

Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGAT 176
           E +    Y G +A VWS G++L+ ++ G +PF         ++I   +       S+   
Sbjct: 218 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQ 271

Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDD 221
            LI   L   P  R   E I+ HPW +    P + +E    +L  
Sbjct: 272 HLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 316

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  331 bits (851), Expect = e-112
 Identities = 54/247 (21%), Positives = 99/247 (40%), Gaps = 32/247 (12%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL--------ENDCRRY 52
           +  +++   +    ++ +  +VYII E++    +     +   L             +  
Sbjct: 97  ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156

Query: 53  FQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP 111
            + ++++ ++ H+ K + HRD+KP N+L+D  G +K+SDFG S         +  + GT 
Sbjct: 157 IKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTY 214

Query: 112 NYVAPEVLSNRG-YDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPF 169
            ++ PE  SN   Y+G+  D+WS G+ L+V+    +PF  +  L  L+  I       P 
Sbjct: 215 EFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPL 274

Query: 170 -------------------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVK 210
                              + S      +   L  NP  RI  E   KH W         
Sbjct: 275 DRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDL 334

Query: 211 CSEEEEV 217
               +E+
Sbjct: 335 REFSKEL 341

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  273 bits (700), Expect = 3e-90
 Identities = 85/215 (39%), Positives = 119/215 (55%), Gaps = 12/215 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K + HP I+++     +    YI+LE + GGELFDK+V   RL E  C+ YF Q++ AV
Sbjct: 69  LKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127

Query: 61  AHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + H  G+ HRDLKPEN+LL S      +K++DFG S +  +   L+ T CGTP Y+APE
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPE 186

Query: 118 VLSNRGYD--GSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWF- 171
           VL + G      A D WS GVILF+ ++GY PF       +L  +I +    F    W  
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 246

Query: 172 -STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
            S  A  L+ K+L  +PK R   E   +HPW +  
Sbjct: 247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  269 bits (691), Expect = 4e-89
 Identities = 55/238 (23%), Positives = 104/238 (43%), Gaps = 34/238 (14%)

Query: 1   MKIVRHPNIVRLHEV-------------LASRTKVYIILEFVTGGELFDKIVHQGRLL-E 46
           +  + H  +VR +               +  ++ ++I +E+   G L+D I  +      
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR 115

Query: 47  NDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV----- 101
           ++  R F+Q+++A+++ HS+G+ HRDLKP N+ +D   N+K+ DFGL+    + +     
Sbjct: 116 DEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175

Query: 102 ---------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 152
                    + L +  GT  YVA EVL   G+     D++S G+I F ++  Y      +
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGME 233

Query: 153 LPTLYKKINAAEFSCPFWF----STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY 206
              + KK+ +     P  F          +I  ++D +P  R     +    W    +
Sbjct: 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  265 bits (680), Expect = 1e-87
 Identities = 86/212 (40%), Positives = 123/212 (58%), Gaps = 9/212 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
            + ++HPNIVRLH+ +   +  Y++ + VTGGELF+ IV +    E D     QQ+++++
Sbjct: 59  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESI 118

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
           A+CHS G+ HR+LKPENLLL S      +K++DFGL+       E  H   GTP Y++PE
Sbjct: 119 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPE 177

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FST 173
           VL    Y     D+W+CGVIL++L+ GY PF + D   LY +I A   ++  P W   + 
Sbjct: 178 VLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 236

Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
            A SLI  +L  NPK RI  +   K PW    
Sbjct: 237 EAKSLIDSMLTVNPKKRITADQALKVPWICNR 268

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  264 bits (676), Expect = 3e-87
 Identities = 88/213 (41%), Positives = 122/213 (57%), Gaps = 12/213 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MK + HPNI+RL+E     T +Y+++E  TGGELF+++VH+    E+D  R  + ++ AV
Sbjct: 60  MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAV 119

Query: 61  AHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
           A+CH   V HRDLKPEN L  +      LK+ DFGL+A  + G +++ T  GTP YV+P+
Sbjct: 120 AYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQ 178

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--FS 172
           VL    Y G   D WS GV+++VL+ GY PF   TD   +  KI      F    W   S
Sbjct: 179 VL-EGLY-GPECDEWSAGVMMYVLLCGYPPFSAPTD-SEVMLKIREGTFTFPEKDWLNVS 235

Query: 173 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
             A SLI ++L  +PK RI      +H WF K 
Sbjct: 236 PQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  264 bits (677), Expect = 5e-87
 Identities = 72/216 (33%), Positives = 116/216 (53%), Gaps = 14/216 (6%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
            K+  HPNI++L +   + T  +++ + +  GELFD +  +  L E + R+  + L++ +
Sbjct: 78  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL- 119
              H   + HRDLKPEN+LLD   N+K++DFG S     G E L   CGTP+Y+APE++ 
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIE 196

Query: 120 -----SNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW- 170
                ++ GY G   D+WS GVI++ L+AG  PF        + + I +   +F  P W 
Sbjct: 197 CSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQ-MLMLRMIMSGNYQFGSPEWD 254

Query: 171 -FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
            +S     L+ + L   P+ R   E    HP+F++ 
Sbjct: 255 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  263 bits (675), Expect = 7e-86
 Identities = 76/215 (35%), Positives = 121/215 (56%), Gaps = 14/215 (6%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
            ++  HP+I+ L +   S + ++++ + +  GELFD +  +  L E + R   + L++AV
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL- 119
           +  H+  + HRDLKPEN+LLD    +++SDFG S   + G E L   CGTP Y+APE+L 
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILK 272

Query: 120 -----SNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW- 170
                ++ GY G   D+W+CGVILF L+AG  PF        + + I     +FS P W 
Sbjct: 273 CSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQ-ILMLRMIMEGQYQFSSPEWD 330

Query: 171 -FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
             S+    LI ++L  +P+ R+  E   +HP+F +
Sbjct: 331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  265 bits (680), Expect = 8e-86
 Identities = 86/216 (39%), Positives = 120/216 (55%), Gaps = 14/216 (6%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K + HP I+++     +    YI+LE + GGELFDK+V   RL E  C+ YF Q++ AV
Sbjct: 194 LKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 252

Query: 61  AHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + H  G+ HRDLKPEN+LL S      +K++DFG S +  +   L+ T CGTP Y+APE
Sbjct: 253 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPE 311

Query: 118 VLSN---RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWF 171
           VL +    GY   A D WS GVILF+ ++GY PF       +L  +I +    F    W 
Sbjct: 312 VLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 370

Query: 172 --STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
             S  A  L+ K+L  +PK R   E   +HPW +  
Sbjct: 371 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  263 bits (673), Expect = 2e-85
 Identities = 86/225 (38%), Positives = 124/225 (55%), Gaps = 11/225 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
            + ++HPNIVRLH+ +   +  Y++ + VTGGELF+ IV +    E D     QQ+++++
Sbjct: 82  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESI 141

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
           A+CHS G+ HR+LKPENLLL S      +K++DFGL+       E  H   GTP Y++PE
Sbjct: 142 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPE 200

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--FS 172
           VL    Y     D+W+CGVIL++L+ GY PF  E     LY +I A   ++  P W   +
Sbjct: 201 VLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKAGAYDYPSPEWDTVT 258

Query: 173 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEV 217
             A SLI  +L  NPK RI  +   K PW             ++ 
Sbjct: 259 PEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDT 303

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  258 bits (662), Expect = 1e-84
 Identities = 88/217 (40%), Positives = 123/217 (56%), Gaps = 10/217 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++H NIV L ++  S T  Y++++ V+GGELFD+I+ +G   E D     QQ++ AV
Sbjct: 60  LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAV 119

Query: 61  AHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + H  G+ HRDLKPENLL  +      + ++DFGLS + Q G+  + T CGTP YVAPE
Sbjct: 120 KYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYVAPE 177

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FST 173
           VL+ + Y   A D WS GVI ++L+ GY PF E     L++KI     EF  PFW   S 
Sbjct: 178 VLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISE 236

Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVK 210
            A   I  +L+ +P  R   E    HPW   N    +
Sbjct: 237 SAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHR 273

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  256 bits (657), Expect = 4e-84
 Identities = 68/215 (31%), Positives = 112/215 (52%), Gaps = 15/215 (6%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQL 56
           +K + HPNI+++ EV      +YI++E   GGEL ++IV        L E       +Q+
Sbjct: 74  LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM 133

Query: 57  IDAVAHCHSKGVYHRDLKPENLLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNY 113
           ++A+A+ HS+ V H+DLKPEN+L      +  +K+ DFGL+ L +   E      GT  Y
Sbjct: 134 MNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALY 192

Query: 114 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAE--FSCPFW 170
           +APEV   R       D+WS GV+++ L+ G LPF G +    + +K    E  ++    
Sbjct: 193 MAPEVF-KRDV-TFKCDIWSAGVVMYFLLTGCLPFTGTSL-EEVQQKATYKEPNYAVECR 249

Query: 171 F-STGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
             +  A  L+ ++L  +P+ R     +  H WF++
Sbjct: 250 PLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  260 bits (666), Expect = 2e-83
 Identities = 91/224 (40%), Positives = 127/224 (56%), Gaps = 8/224 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
            ++++HPNIVRLH+ ++     Y+I + VTGGELF+ IV +    E D     QQ+++AV
Sbjct: 64  CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV 123

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            HCH  GV HR+LKPENLLL S      +K++DFGL+   +   +      GTP Y++PE
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPE 183

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FST 173
           VL    Y G   D+W+CGVIL++L+ GY PF + D   LY++I A   +F  P W   + 
Sbjct: 184 VLRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP 242

Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEV 217
            A  LI+K+L  NP  RI      KHPW         C   +E 
Sbjct: 243 EAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQET 286

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  254 bits (651), Expect = 3e-83
 Identities = 83/213 (38%), Positives = 119/213 (55%), Gaps = 12/213 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K + HPNI++L E+L   +  YI+ E  TGGELFD+I+ + R  E+D  R  +Q+   +
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGI 134

Query: 61  AHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + H   + HRDLKPEN+LL+S     ++K+ DFGLS   QQ    +    GT  Y+APE
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPE 193

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--FS 172
           VL    Y     DVWS GVIL++L++G  PF G+ +   + K++      F  P W   S
Sbjct: 194 VL-RGTY-DEKCDVWSAGVILYILLSGTPPFYGKNE-YDILKRVETGKYAFDLPQWRTIS 250

Query: 173 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
             A  LI K+L  +P  RI      +HPW +K 
Sbjct: 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  254 bits (652), Expect = 1e-82
 Identities = 82/213 (38%), Positives = 124/213 (58%), Gaps = 10/213 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +  + HPNI++L E+  + T++ ++LE VTGGELFD+IV +G   E D     +Q+++AV
Sbjct: 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAV 161

Query: 61  AHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
           A+ H  G+ HRDLKPENLL  +      LK++DFGLS + +    L+ T CGTP Y APE
Sbjct: 162 AYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-VLMKTVCGTPGYCAPE 220

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--FS 172
           +L    Y G   D+WS G+I ++L+ G+ PF  E     ++++I      F  P+W   S
Sbjct: 221 ILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVS 279

Query: 173 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
             A  L+ K++  +PK R+      +HPW    
Sbjct: 280 LNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  253 bits (647), Expect = 2e-82
 Identities = 55/227 (24%), Positives = 102/227 (44%), Gaps = 19/227 (8%)

Query: 1   MKIVRHPN--IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 58
           +  ++  +  I+RL++   +   +Y+++E     +L   +  +  +   + + Y++ +++
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLE 138

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAP 116
           AV   H  G+ H DLKP N L+   G LK+ DFG++   Q      +  +  GT NY+ P
Sbjct: 139 AVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197

Query: 117 EVLSNRGYD----------GSAADVWSCGVILFVLMAGYLPFGETD--LPTLYKKINA-A 163
           E + +                 +DVWS G IL+ +  G  PF +    +  L+  I+   
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 257

Query: 164 EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVK 210
           E   P         ++   L  +PK RI I  +  HP+ +   +PV 
Sbjct: 258 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  250 bits (641), Expect = 1e-81
 Identities = 75/214 (35%), Positives = 122/214 (57%), Gaps = 12/214 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ +RHPNI+ LH++  ++T V +ILE V+GGELFD +  +  L E++  ++ +Q++D V
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121

Query: 61  AHCHSKGVYHRDLKPENLLLDSY----GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + HSK + H DLKPEN++L         +K+ DFG++   + G        GTP +VAP
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKNIFGTPEFVAP 180

Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--F 171
           E+++     G  AD+WS GVI ++L++G  PF GET        I+A   +F   ++   
Sbjct: 181 EIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETK-QETLTNISAVNYDFDEEYFSNT 238

Query: 172 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
           S  A   I ++L  +PK R+ I    +H W +  
Sbjct: 239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  251 bits (642), Expect = 4e-81
 Identities = 73/217 (33%), Positives = 114/217 (52%), Gaps = 14/217 (6%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++  +HPNI+ L +V      VY++ E + GGEL DKI+ Q    E +       +   V
Sbjct: 70  LRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTV 129

Query: 61  AHCHSKGVYHRDLKPENLLL----DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + H++GV HRDLKP N+L      +  ++++ DFG +   +    LL T C T N+VAP
Sbjct: 130 EYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAP 189

Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA--EFSCPFW 170
           EVL  +GYD +A D+WS GV+L+ ++ GY PF     +T    +  +I +     S  +W
Sbjct: 190 EVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTP-EEILARIGSGKFSLSGGYW 247

Query: 171 --FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
              S  A  L+ K+L  +P  R+    + +HPW    
Sbjct: 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  250 bits (641), Expect = 7e-81
 Identities = 69/216 (31%), Positives = 114/216 (52%), Gaps = 13/216 (6%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL----ENDCRRYFQQL 56
             +++HP+IV L E  +S   +Y++ EF+ G +L  +IV +        E     Y +Q+
Sbjct: 80  CHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI 139

Query: 57  IDAVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNY 113
           ++A+ +CH   + HRD+KP  +LL S  N   +K+  FG++    +   +     GTP++
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199

Query: 114 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW- 170
           +APEV+    Y G   DVW CGVILF+L++G LPF  T    L++ I     + +   W 
Sbjct: 200 MAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWS 257

Query: 171 -FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
             S  A  L+ ++L  +P  RI +     HPW ++ 
Sbjct: 258 HISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  248 bits (636), Expect = 2e-80
 Identities = 76/214 (35%), Positives = 120/214 (56%), Gaps = 12/214 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127

Query: 61  AHCHSKGVYHRDLKPENLLLDSY----GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + HS  + H DLKPEN++L         +K+ DFGL+     G        GTP +VAP
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAP 186

Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--F 171
           E+++     G  AD+WS GVI ++L++G  PF G+T   T    ++A   EF   ++   
Sbjct: 187 EIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQET-LANVSAVNYEFEDEYFSNT 244

Query: 172 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
           S  A   I ++L  +PK R+ I+   +HPW +  
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  248 bits (635), Expect = 2e-80
 Identities = 77/226 (34%), Positives = 120/226 (53%), Gaps = 12/226 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V H N++ LH+V  +RT V +ILE V+GGELFD +  +  L E +   + +Q++D V
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128

Query: 61  AHCHSKGVYHRDLKPENLLLDS----YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + H+K + H DLKPEN++L        ++K+ DFGL+   + G        GTP +VAP
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAP 187

Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--F 171
           E+++     G  AD+WS GVI ++L++G  PF G+T        I +   +F   F+   
Sbjct: 188 EIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTK-QETLANITSVSYDFDEEFFSHT 245

Query: 172 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEV 217
           S  A   I K+L    + R+ I+   +HPW     N       E V
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESV 291

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  248 bits (636), Expect = 2e-80
 Identities = 80/253 (31%), Positives = 124/253 (49%), Gaps = 16/253 (6%)

Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           HPNIV+LHEV   +   ++++E + GGELF++I  +    E +     ++L+ AV+H H 
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124

Query: 66  KGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 122
            GV HRDLKPENLL         +K+ DFG + L     + L T C T +Y APE+L+  
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184

Query: 123 GYDGSAADVWSCGVILFVLMAGYLPF-GETD------LPTLYKKINAA--EFSCPFW--F 171
           GYD  + D+WS GVIL+ +++G +PF              + KKI      F    W   
Sbjct: 185 GYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243

Query: 172 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN-YNPVKCSEEEEVNLDDVHAVFDDIE 230
           S  A  LI  +L  +P  R+++ G+R + W +             ++      AV   ++
Sbjct: 244 SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVK 303

Query: 231 DQYVAEQSENKVG 243
             + A     + G
Sbjct: 304 ATFHAFNKYKREG 316

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  249 bits (638), Expect = 2e-80
 Identities = 79/226 (34%), Positives = 120/226 (53%), Gaps = 12/226 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V HPNI+ LH+V  +RT V +ILE V+GGELFD +  +  L E +   + +Q++D V
Sbjct: 69  LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128

Query: 61  AHCHSKGVYHRDLKPENLLLDS----YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + H+K + H DLKPEN++L        ++K+ DFGL+   + G        GTP +VAP
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAP 187

Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--F 171
           E+++     G  AD+WS GVI ++L++G  PF G+T        I A   +F   F+   
Sbjct: 188 EIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTK-QETLANITAVSYDFDEEFFSQT 245

Query: 172 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEV 217
           S  A   I K+L    + R+ I+   +HPW             E V
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESV 291

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  246 bits (629), Expect = 4e-79
 Identities = 59/259 (22%), Positives = 109/259 (42%), Gaps = 25/259 (9%)

Query: 1   MKIVRHPN--IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 58
           +  ++  +  I+RL++   +   +Y+++E     +L   +  +  +   + + Y++ +++
Sbjct: 61  LNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLE 119

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAP 116
           AV   H  G+ H DLKP N L+   G LK+ DFG++   Q      +  +  GT NY+ P
Sbjct: 120 AVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178

Query: 117 EVLSNRGYD----------GSAADVWSCGVILFVLMAGYLPFGETD--LPTLYKKINA-A 163
           E + +                 +DVWS G IL+ +  G  PF +    +  L+  I+   
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 238

Query: 164 EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVH 223
           E   P         ++   L  +PK RI I  +  HP+ +   +PV    +         
Sbjct: 239 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEM--- 295

Query: 224 AVFDDIEDQYVAEQSENKV 242
                +  Q V   S N +
Sbjct: 296 ---KYVLGQLVGLNSPNSI 311

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  245 bits (626), Expect = 3e-78
 Identities = 58/259 (22%), Positives = 107/259 (41%), Gaps = 25/259 (9%)

Query: 1   MKIVRHPN--IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 58
           +  ++  +  I+RL++   +   +Y+++E     +L   +  +  +   + + Y++ +++
Sbjct: 108 LNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLE 166

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAP 116
           AV   H  G+ H DLKP N L+   G LK+ DFG++   Q      +  +  G  NY+ P
Sbjct: 167 AVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225

Query: 117 EVLSNRGYD----------GSAADVWSCGVILFVLMAGYLPFGETD--LPTLYKKINA-A 163
           E + +                 +DVWS G IL+ +  G  PF +    +  L+  I+   
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 285

Query: 164 EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVH 223
           E   P         ++   L  +PK RI I  +  HP+ +   +PV              
Sbjct: 286 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV------NQMAKGTT 339

Query: 224 AVFDDIEDQYVAEQSENKV 242
                +  Q V   S N +
Sbjct: 340 EEMKYVLGQLVGLNSPNSI 358

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  242 bits (619), Expect = 4e-78
 Identities = 48/255 (18%), Positives = 87/255 (34%), Gaps = 46/255 (18%)

Query: 1   MKIVRHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGR---LLENDCRRYFQQ 55
           +K + H NIV+L  +    T     +I+EF   G L+  +        L E++     + 
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120

Query: 56  LIDAVAHCHSKGVYHRDLKPENLLL----DSYGNLKVSDFGLSALPQQGVELLHTTCGTP 111
           ++  + H    G+ HR++KP N++     D     K++DFG +   +   E   +  GT 
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTE 179

Query: 112 NYVAPEVLSNRGYD-------GSAADVWSCGVILFVLMAGYLPF-----GETDLPTLYKK 159
            Y+ P++              G+  D+WS GV  +    G LPF        +   +YK 
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239

Query: 160 INAA------------------EFSCPFW------FSTGATSLIHKILDPNPKTRIRIEG 195
           I                         P             T ++  IL+ + +     + 
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299

Query: 196 IRKHPWFRKNYNPVK 210
                    +     
Sbjct: 300 FFAETSDILHRGNSH 314

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  242 bits (620), Expect = 5e-78
 Identities = 68/231 (29%), Positives = 115/231 (49%), Gaps = 14/231 (6%)

Query: 1   MKIVRH-PNIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLI 57
           +++ +  P ++ LHEV  + +++ +ILE+  GGE+F   +      + END  R  +Q++
Sbjct: 82  LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQIL 141

Query: 58  DAVAHCHSKGVYHRDLKPENLLL---DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           + V + H   + H DLKP+N+LL      G++K+ DFG+S         L    GTP Y+
Sbjct: 142 EGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA-CELREIMGTPEYL 200

Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW- 170
           APE+L+      +A D+W+ G+I ++L+    PF GE +    Y  I+    ++S   + 
Sbjct: 201 APEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDN-QETYLNISQVNVDYSEETFS 258

Query: 171 -FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLD 220
             S  AT  I  +L  NP+ R   E    H W ++         EE  +  
Sbjct: 259 SVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSS 309

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  247 bits (632), Expect = 6e-78
 Identities = 82/225 (36%), Positives = 120/225 (53%), Gaps = 10/225 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K + HPNI++L E+L   +  YI+ E  TGGELFD+I+ + R  E+D  R  +Q+   +
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGI 134

Query: 61  AHCHSKGVYHRDLKPENLLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + H   + HRDLKPEN+LL+S     ++K+ DFGLS   QQ    +    GT  Y+APE
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPE 193

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FST 173
           VL    Y     DVWS GVIL++L++G  PF   +   + K++   +  F  P W   S 
Sbjct: 194 VL-RGTY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251

Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVN 218
            A  LI K+L  +P  RI      +HPW +K  +      +    
Sbjct: 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSL 296

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  242 bits (619), Expect = 6e-78
 Identities = 61/217 (28%), Positives = 109/217 (50%), Gaps = 11/217 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL-ENDCRRYFQQLIDA 59
           + I RH NI+ LHE   S  ++ +I EF++G ++F++I      L E +   Y  Q+ +A
Sbjct: 55  LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEA 114

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGN--LKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
           +   HS  + H D++PEN++  +  +  +K+ +FG +   + G +        P Y APE
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPE 173

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--FS 172
           V  +     +A D+WS G +++VL++G  PF  ET+   + + I  A   F    +   S
Sbjct: 174 VHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETN-QQIIENIMNAEYTFDEEAFKEIS 231

Query: 173 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
             A   + ++L    K+R+      +HPW ++    V
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERV 268

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  250 bits (640), Expect = 3e-77
 Identities = 57/249 (22%), Positives = 93/249 (37%), Gaps = 17/249 (6%)

Query: 1   MKIVRHPNIVRLHEVLASRTKV------YIILEFVTGGELFDKIVHQGR---LLENDCRR 51
           MK + HPN+V   EV     K+       + +E+  GG+L   +        L E   R 
Sbjct: 66  MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125

Query: 52  YFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTC 108
               +  A+ + H   + HRDLKPEN++L         K+ D G +    QG EL     
Sbjct: 126 LLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFV 184

Query: 109 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSC 167
           GT  Y+APE+L  + Y     D WS G + F  + G+ PF         + K+       
Sbjct: 185 GTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243

Query: 168 PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK--NYNPVKCSEEEEVNLDDVHAV 225
              +     ++    + P P     I   +   W +    ++  +   + +         
Sbjct: 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303

Query: 226 FDDIEDQYV 234
            D I    +
Sbjct: 304 LDSILSLKL 312

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  242 bits (619), Expect = 3e-77
 Identities = 68/213 (31%), Positives = 109/213 (51%), Gaps = 11/213 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL-ENDCRRYFQQLIDA 59
           M  + H N+++L++   S+  + +++E+V GGELFD+I+ +   L E D   + +Q+ + 
Sbjct: 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEG 199

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGN--LKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
           + H H   + H DLKPEN+L  +     +K+ DFGL+   +   E L    GTP ++APE
Sbjct: 200 IRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EKLKVNFGTPEFLAPE 258

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--FS 172
           V+ N  +     D+WS GVI ++L++G  PF G+ D       I A   +     +   S
Sbjct: 259 VV-NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-AETLNNILACRWDLEDEEFQDIS 316

Query: 173 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
             A   I K+L      RI      KHPW   +
Sbjct: 317 EEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  241 bits (616), Expect = 3e-77
 Identities = 68/260 (26%), Positives = 106/260 (40%), Gaps = 51/260 (19%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL--------------- 45
           MK + HPNI RL+EV      + +++E   GG L DK+                      
Sbjct: 82  MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141

Query: 46  -------------------------ENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL 80
                                    E       +Q+  A+ + H++G+ HRD+KPEN L 
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF 201

Query: 81  DSYGN--LKVSDFGLS----ALPQQGVELLHTTCGTPNYVAPEVLSNRGYD-GSAADVWS 133
            +  +  +K+ DFGLS     L       + T  GTP +VAPEVL+      G   D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 134 CGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FSTGATSLIHKILDPNPKT 189
            GV+L +L+ G +PF   +      ++   +  F  P +   S  A  L+  +L+ N   
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE 321

Query: 190 RIRIEGIRKHPWFRKNYNPV 209
           R       +HPW  +  + +
Sbjct: 322 RFDAMRALQHPWISQFSDKI 341

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  245 bits (627), Expect = 5e-77
 Identities = 75/222 (33%), Positives = 120/222 (54%), Gaps = 10/222 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K + HPNI++L +V   +   Y++ EF  GGELF++I+++ +  E D     +Q++  +
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGI 159

Query: 61  AHCHSKGVYHRDLKPENLLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + H   + HRD+KPEN+LL++     N+K+ DFGLS+   +    L    GT  Y+APE
Sbjct: 160 CYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPE 218

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FST 173
           VL  + Y     DVWSCGVI+++L+ GY PFG  +   + KK+   +  F    W   S 
Sbjct: 219 VL-KKKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISD 276

Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEE 215
            A  LI  +L  +   R   E      W +K  N +  S+++
Sbjct: 277 EAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQK 318

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  244 bits (624), Expect = 8e-77
 Identities = 78/212 (36%), Positives = 114/212 (53%), Gaps = 10/212 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K + HPNI++L+E    +   Y++ E  TGGELFD+I+ + R  E D  R  +Q++  +
Sbjct: 80  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGI 139

Query: 61  AHCHSKGVYHRDLKPENLLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + H   + HRDLKPENLLL+S     N+++ DFGLS   +   + +    GT  Y+APE
Sbjct: 140 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPE 198

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FST 173
           VL +  Y     DVWS GVIL++L++G  PF   +   + KK+   +  F  P W   S 
Sbjct: 199 VL-HGTY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE 256

Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
            A  LI K+L   P  RI       H W +  
Sbjct: 257 SAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  244 bits (625), Expect = 8e-77
 Identities = 80/212 (37%), Positives = 123/212 (58%), Gaps = 10/212 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K++ HPNI++L++    +   Y+++E   GGELFD+I+H+ +  E D     +Q++  V
Sbjct: 90  LKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGV 149

Query: 61  AHCHSKGVYHRDLKPENLLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + H   + HRDLKPENLLL+S      +K+ DFGLSA+ +   + +    GT  Y+APE
Sbjct: 150 TYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYIAPE 208

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FST 173
           VL  + Y     DVWS GVILF+L+AGY PFG      + +K+   +  F  P W   S 
Sbjct: 209 VL-RKKY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE 266

Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
           GA  LI ++L  + + RI  +   +HPW ++ 
Sbjct: 267 GAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  239 bits (611), Expect = 2e-76
 Identities = 75/222 (33%), Positives = 109/222 (49%), Gaps = 20/222 (9%)

Query: 1   MKIVRHPNIVRLHEV----LASRTKVYIILEFVTGGELFDKIVHQGRLL--ENDCRRYFQ 54
            +    P+IV + +V       +  + II+E + GGELF +I  +G     E +     +
Sbjct: 76  WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR 135

Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTP 111
            +  A+   HS  + HRD+KPENLL  S      LK++DFG +    Q    L T C TP
Sbjct: 136 DIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTP 193

Query: 112 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDL---PTLYKKINAA--EF 165
            YVAPEVL    YD  + D+WS GVI+++L+ G+ PF   T     P + ++I      F
Sbjct: 194 YYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 252

Query: 166 SCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
             P W   S  A  LI  +L  +P  R+ I     HPW  ++
Sbjct: 253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  240 bits (614), Expect = 2e-76
 Identities = 62/213 (29%), Positives = 109/213 (51%), Gaps = 11/213 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL-ENDCRRYFQQLIDA 59
           M  + HP ++ LH+    + ++ +ILEF++GGELFD+I  +   + E +   Y +Q  + 
Sbjct: 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 161

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGN--LKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
           + H H   + H D+KPEN++ ++     +K+ DFGL+       E++  T  T  + APE
Sbjct: 162 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPE 220

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--FS 172
           ++      G   D+W+ GV+ +VL++G  PF GE D     + +     EF    +   S
Sbjct: 221 IVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDD-LETLQNVKRCDWEFDEDAFSSVS 278

Query: 173 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
             A   I  +L   P+ R+ +    +HPW + +
Sbjct: 279 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  239 bits (611), Expect = 7e-76
 Identities = 76/222 (34%), Positives = 110/222 (49%), Gaps = 19/222 (8%)

Query: 1   MKIVRHPNIVRLHEV----LASRTKVYIILEFVTGGELFDKIVHQGRLL--ENDCRRYFQ 54
            +  + P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +     +
Sbjct: 109 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 168

Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTP 111
            + +A+ + HS  + HRD+KPENLL  S      LK++DFG +         L T C TP
Sbjct: 169 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTP 227

Query: 112 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPT---LYKKINAA--EF 165
            YVAPEVL    YD  + D+WS GVI+++L+ GY PF     L     +  +I     EF
Sbjct: 228 YYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 286

Query: 166 SCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
             P W   S     LI  +L   P  R+ I     HPW  ++
Sbjct: 287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  241 bits (616), Expect = 1e-74
 Identities = 69/227 (30%), Positives = 113/227 (49%), Gaps = 11/227 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDA 59
           M ++RHP +V LH+      ++ +I EF++GGELF+K+  +  ++ E++   Y +Q+   
Sbjct: 208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 267

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYG--NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
           + H H     H DLKPEN++  +     LK+ DFGL+A      + +  T GT  + APE
Sbjct: 268 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPE 326

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--FS 172
           V   +   G   D+WS GV+ ++L++G  PF GE D  T  + + +         +   S
Sbjct: 327 VAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDET-LRNVKSCDWNMDDSAFSGIS 384

Query: 173 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNL 219
                 I K+L  +P TR+ I    +HPW      P + S+      
Sbjct: 385 EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRY 431

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  230 bits (588), Expect = 2e-73
 Identities = 68/234 (29%), Positives = 103/234 (44%), Gaps = 35/234 (14%)

Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           H N++ L E      + Y++ E + GG +   I  +    E +     Q +  A+   H+
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129

Query: 66  KGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQG-------VELLHTTCGTPNYVA 115
           KG+ HRDLKPEN+L +       +K+ DF L +  +            L T CG+  Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189

Query: 116 PEVL-----SNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPT-------------- 155
           PEV+         YD    D+WS GVIL++L++GY PF G                    
Sbjct: 190 PEVVEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248

Query: 156 LYKKINAA--EFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
           L++ I     EF    W   S  A  LI K+L  + K R+    + +HPW +  
Sbjct: 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  230 bits (589), Expect = 1e-72
 Identities = 48/255 (18%), Positives = 88/255 (34%), Gaps = 46/255 (18%)

Query: 1   MKIVRHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGR---LLENDCRRYFQQ 55
           +K + H NIV+L  +    T     +I+EF   G L+  +        L E++     + 
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120

Query: 56  LIDAVAHCHSKGVYHRDLKPENLLL----DSYGNLKVSDFGLSALPQQGVELLHTTCGTP 111
           ++  + H    G+ HR++KP N++     D     K++DFG +   +   E   +  GT 
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTE 179

Query: 112 NYVAPEVLSNRGYD-------GSAADVWSCGVILFVLMAGYLPF-----GETDLPTLYKK 159
            Y+ P++              G+  D+WS GV  +    G LPF        +   +YK 
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239

Query: 160 INAA------------------EFSCPFW------FSTGATSLIHKILDPNPKTRIRIEG 195
           I                         P             T ++  IL+ + +     + 
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299

Query: 196 IRKHPWFRKNYNPVK 210
                    +   + 
Sbjct: 300 FFAETSDILHRMVIH 314

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  215 bits (551), Expect = 2e-68
 Identities = 68/219 (31%), Positives = 111/219 (50%), Gaps = 13/219 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRT--KVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQ 54
           ++ ++HPNIVR ++ +  RT   +YI++E+  GG+L   I    +    L E    R   
Sbjct: 59  LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118

Query: 55  QLIDAVAHCHSKG-----VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG 109
           QL  A+  CH +      V HRDLKP N+ LD   N+K+ DFGL+ +         T  G
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVG 178

Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC-P 168
           TP Y++PE ++   Y+   +D+WS G +L+ L A   PF       L  KI   +F   P
Sbjct: 179 TPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP 237

Query: 169 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN 207
           + +S     +I ++L+     R  +E I ++P   ++++
Sbjct: 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH 276

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  219 bits (558), Expect = 3e-68
 Identities = 31/222 (13%), Positives = 72/222 (32%), Gaps = 26/222 (11%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEF--------VTGGELFDKIVHQGRLLENDCRRY 52
           +K  +   ++R+         +     +          G  L         L+ +   + 
Sbjct: 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 211

Query: 53  FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN 112
             Q+I  +A  H  G+ H  L+P +++LD  G + ++ F               +  +  
Sbjct: 212 TLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVSRG 267

Query: 113 YVAPEVLSNRG----------YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA 162
           +  PE+ + R               + D W+ G++++ +    LP  +       + I  
Sbjct: 268 FEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI-- 325

Query: 163 AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
             F           +L+   L    + R+      + P + +
Sbjct: 326 --FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  216 bits (552), Expect = 9e-67
 Identities = 57/241 (23%), Positives = 94/241 (39%), Gaps = 37/241 (15%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-------RLLENDCRRYF 53
            +   HPN++R +    +   +YI LE      L D +  +           E +     
Sbjct: 63  TESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLL 121

Query: 54  QQLIDAVAHCHSKGVYHRDLKPENLLLDS-------------YGNLKVSDFGLSALPQQG 100
           +Q+   VAH HS  + HRDLKP+N+L+ +                + +SDFGL      G
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181

Query: 101 VE----LLHTTCGTPNYVAPEVLSNRGYD------GSAADVWSCGVILFVLM-AGYLPFG 149
                  L+   GT  + APE+L              + D++S G + + ++  G  PFG
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241

Query: 150 ---ETDLPTLYKKINAAEFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
                +   +    +  E  C         AT LI +++D +P  R     + +HP F  
Sbjct: 242 DKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301

Query: 205 N 205
            
Sbjct: 302 K 302

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  213 bits (545), Expect = 1e-66
 Identities = 60/208 (28%), Positives = 108/208 (51%), Gaps = 4/208 (1%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLL-ENDCRRYFQQLID 58
           +  ++HPNIV+  E       +YI++++  GG+LF +I   +G L  E+    +F Q+  
Sbjct: 77  LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICL 136

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 118
           A+ H H + + HRD+K +N+ L   G +++ DFG++ +    VEL     GTP Y++PE+
Sbjct: 137 ALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI 196

Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC-PFWFSTGATS 177
             N+ Y+ + +D+W+ G +L+ L      F    +  L  KI +  F      +S    S
Sbjct: 197 CENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRS 255

Query: 178 LIHKILDPNPKTRIRIEGIRKHPWFRKN 205
           L+ ++   NP+ R  +  I +  +  K 
Sbjct: 256 LVSQLFKRNPRDRPSVNSILEKGFIAKR 283

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  210 bits (537), Expect = 7e-66
 Identities = 63/212 (29%), Positives = 108/212 (50%), Gaps = 9/212 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M  + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 143

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPEV 118
            + H KG+ HRDLKPEN+LL+   +++++DFG +    P+      ++  GT  YV+PE+
Sbjct: 144 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203

Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
           L+ +     ++D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L
Sbjct: 204 LTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 262

Query: 179 IHKILDPNPKTRI------RIEGIRKHPWFRK 204
           + K+L  +   R+          ++ HP+F  
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  212 bits (541), Expect = 5e-65
 Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 18/220 (8%)

Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAV 60
           +   HPN++R       R   YI +E      L + +       L  +     QQ    +
Sbjct: 73  ESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGL 131

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGN-----LKVSDFGLS---ALPQQGVELLHTTCGTPN 112
           AH HS  + HRDLKP N+L+            +SDFGL    A+ +          GT  
Sbjct: 132 AHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191

Query: 113 YVAPEVLS---NRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAEFSCP 168
           ++APE+LS            D++S G + + +++ G  PFG++        + A    C 
Sbjct: 192 WIAPEMLSEDCKENPT-YTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL 250

Query: 169 FWF---STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
                    A  LI K++  +P+ R   + + KHP+F   
Sbjct: 251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  207 bits (528), Expect = 2e-64
 Identities = 51/232 (21%), Positives = 87/232 (37%), Gaps = 22/232 (9%)

Query: 1   MKIVRHPNIVRLHEVLASRT----KVYIILEFVTGGELFDKI----VHQGRLLENDCRRY 52
            ++  HPNI+RL            + +++L F   G L+++I         L E+     
Sbjct: 80  HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWL 139

Query: 53  FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ---------QGVEL 103
              +   +   H+KG  HRDLKP N+LL   G   + D G                 ++ 
Sbjct: 140 LLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199

Query: 104 LHTTCGTPNYVAPEVLSNRGYD--GSAADVWSCGVILFVLMAGYLPFGETDLPT-LYKKI 160
                 T +Y APE+ S + +       DVWS G +L+ +M G  P+             
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259

Query: 161 NAAEFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVK 210
              + S P     S+    L++ ++  +P  R  I  +       +   P +
Sbjct: 260 VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  204 bits (522), Expect = 1e-63
 Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 40/222 (18%)

Query: 1   MKIVRHPNIVRLHEV----LASRTKVYIILEFVTGGELFDKIVHQGRLL--ENDCRRYFQ 54
            +  + P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +     +
Sbjct: 65  WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 124

Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTP 111
            + +A+ + HS  + HRD+KPENLL  S      LK++DFG                   
Sbjct: 125 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF------------------ 166

Query: 112 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPT---LYKKINAA--EF 165
              A E      YD  + D+WS GVI+++L+ GY PF     L     +  +I     EF
Sbjct: 167 ---AKETT-GEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 221

Query: 166 SCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
             P W   S     LI  +L   P  R+ I     HPW  ++
Sbjct: 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  203 bits (518), Expect = 2e-62
 Identities = 67/208 (32%), Positives = 111/208 (53%), Gaps = 9/208 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   ++      T CGTP  +APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWTLCGTPEALAPEIIL 211

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY   A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270

Query: 181 KILDPNPKTRI-----RIEGIRKHPWFR 203
            +L  +   R       +  I+ H WF 
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  201 bits (513), Expect = 4e-62
 Identities = 68/208 (32%), Positives = 123/208 (59%), Gaps = 9/208 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           + IV HP I+R+        ++++I++++ GGELF  +    R      + Y  ++  A+
Sbjct: 60  LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLAL 119

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HSK + +RDLKPEN+LLD  G++K++DFG +   +   ++ +T CGTP+Y+APEV+S
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA---KYVPDVTYTLCGTPDYIAPEVVS 176

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            + Y   + D WS G++++ ++AGY PF +++    Y+KI  AE   P +F+     L+ 
Sbjct: 177 TKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLS 235

Query: 181 KILDPNPKTRI-----RIEGIRKHPWFR 203
           +++  +   R+       E ++ HPWF+
Sbjct: 236 RLITRDLSQRLGNLQNGTEDVKNHPWFK 263

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  199 bits (508), Expect = 3e-61
 Identities = 64/230 (27%), Positives = 97/230 (42%), Gaps = 33/230 (14%)

Query: 1   MKIVR-HPNIVRLH-------EVLASRTKVYIILEFVTGGELFDKIV---HQGRLLENDC 49
           MK +  HPNIV+         E   +    +++L  +  G+L + +     +G L  +  
Sbjct: 79  MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV 138

Query: 50  RRYFQQLIDAVAHCHSKG--VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG------- 100
            + F Q   AV H H +   + HRDLK ENLLL + G +K+ DFG +             
Sbjct: 139 LKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA 198

Query: 101 -----VELLHTTCGTPNYVAPEV--LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL 153
                VE   T   TP Y  PE+  L +    G   D+W+ G IL++L     PF +   
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258

Query: 154 PTLYKKINAAEFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPW 201
                +I   ++S P      T   SLI  +L  NP+ R+ I  +     
Sbjct: 259 ----LRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  198 bits (505), Expect = 4e-61
 Identities = 62/206 (30%), Positives = 91/206 (44%), Gaps = 8/206 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL-ENDCRRYFQQLIDA 59
            K+ +HP  VRL +       +Y+  E   G  L       G  L E     Y +  + A
Sbjct: 111 EKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLA 169

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 119
           +AH HS+G+ H D+KP N+ L   G  K+ DFGL               G P Y+APE+L
Sbjct: 170 LAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GAGEVQEGDPRYMAPELL 228

Query: 120 SNRGYDGSAADVWSCGVILFVLMAGY-LPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
               Y  +AADV+S G+ +  +     LP G      L +     EF      S+   S+
Sbjct: 229 QG-SYG-TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF--TAGLSSELRSV 284

Query: 179 IHKILDPNPKTRIRIEGIRKHPWFRK 204
           +  +L+P+PK R   E +   P  R+
Sbjct: 285 LVMMLEPDPKLRATAEALLALPVLRQ 310

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  197 bits (503), Expect = 4e-61
 Identities = 51/223 (22%), Positives = 88/223 (39%), Gaps = 24/223 (10%)

Query: 1   MKIVRHPNIVRLHE----------------VLASRTKVYIILEFVTGGELFDKIVHQ--G 42
           +  + H NIV  +                   +    ++I +EF   G L   I  +   
Sbjct: 58  LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117

Query: 43  RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE 102
           +L +      F+Q+   V + HSK + +RDLKP N+ L     +K+ DFGL    +    
Sbjct: 118 KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-G 176

Query: 103 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA 162
               + GT  Y++PE +S++ Y     D+++ G+IL  L+       ET     +  +  
Sbjct: 177 KRTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD 233

Query: 163 AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
                   F     +L+ K+L   P+ R     I +     K 
Sbjct: 234 GII--SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  197 bits (503), Expect = 1e-60
 Identities = 70/209 (33%), Positives = 117/209 (55%), Gaps = 6/209 (2%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V+HP IV L     +  K+Y+ILE+++GGELF ++  +G  +E+    Y  ++  A+
Sbjct: 75  LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMAL 134

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            H H KG+ +RDLKPEN++L+  G++K++DFGL         + HT CGT  Y+APE+L 
Sbjct: 135 GHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILM 194

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
             G+   A D WS G +++ ++ G  PF   +      KI   + + P + +  A  L+ 
Sbjct: 195 RSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLK 253

Query: 181 KILDPNPKTRI-----RIEGIRKHPWFRK 204
           K+L  N  +R+         ++ HP+FR 
Sbjct: 254 KLLKRNAASRLGAGPGDAGEVQAHPFFRH 282

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  196 bits (500), Expect = 4e-60
 Identities = 78/209 (37%), Positives = 120/209 (57%), Gaps = 6/209 (2%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +  V HP IV+LH    +  K+Y+IL+F+ GG+LF ++  +    E D + Y  +L  A+
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            H HS G+ +RDLKPEN+LLD  G++K++DFGLS       +  ++ CGT  Y+APEV++
Sbjct: 140 DHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 199

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            RG+   +AD WS GV++F ++ G LPF   D       I  A+   P + S  A SL+ 
Sbjct: 200 RRGH-TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 258

Query: 181 KILDPNPKTRI-----RIEGIRKHPWFRK 204
            +   NP  R+      +E I++H +F  
Sbjct: 259 MLFKRNPANRLGAGPDGVEEIKRHSFFST 287

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  194 bits (496), Expect = 9e-60
 Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 9/223 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQL 56
           +K + HPN+++ +       ++ I+LE    G+L   I H  +    + E    +YF QL
Sbjct: 86  LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145

Query: 57  IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
             A+ H HS+ V HRD+KP N+ + + G +K+ D GL           H+  GTP Y++P
Sbjct: 146 CSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205

Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFG--ETDLPTLYKKINAAEFSC--PFWFS 172
           E +   GY+   +D+WS G +L+ + A   PF   + +L +L KKI   ++       +S
Sbjct: 206 ERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 264

Query: 173 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEE 215
                L++  ++P+P+ R  +  +                   
Sbjct: 265 EELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHH 307

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  191 bits (488), Expect = 9e-59
 Identities = 55/238 (23%), Positives = 88/238 (36%), Gaps = 31/238 (13%)

Query: 1   MKIVRHPNIVRLHEV------------LASRTKVYIILEFVTGGELFDKIVHQGRLL--- 45
           +  + HP IVR                 + +  +YI ++      L D +  +  +    
Sbjct: 57  LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116

Query: 46  ENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--------- 96
            + C   F Q+ +AV   HSKG+ HRDLKP N+       +KV DFGL            
Sbjct: 117 RSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176

Query: 97  ---PQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL 153
              P           GT  Y++PE +    Y     D++S G+ILF L+  Y    + + 
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELL--YPFSTQMER 233

Query: 154 PTLYKKINAAEFS-CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVK 210
                 +   +F             ++  +L P+P  R     I ++  F     P K
Sbjct: 234 VRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGK 291

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  193 bits (493), Expect = 1e-58
 Identities = 66/206 (32%), Positives = 103/206 (50%), Gaps = 5/206 (2%)

Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           K V+HP +V LH    +  K+Y +L+++ GGELF  +  +   LE   R Y  ++  A+ 
Sbjct: 94  KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG 153

Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 121
           + HS  + +RDLKPEN+LLDS G++ ++DFGL     +      T CGTP Y+APEVL  
Sbjct: 154 YLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK 213

Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK 181
           + Y     D W  G +L+ ++ G  PF   +   +Y  I           +  A  L+  
Sbjct: 214 QPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEG 272

Query: 182 ILDPNPKTRI----RIEGIRKHPWFR 203
           +L  +   R+        I+ H +F 
Sbjct: 273 LLQKDRTKRLGAKDDFMEIKSHVFFS 298

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  193 bits (493), Expect = 2e-58
 Identities = 56/210 (26%), Positives = 107/210 (50%), Gaps = 9/210 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M+ + HP +V L         ++++++ + GG+L   +       E   + +  +L+ A+
Sbjct: 69  MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMAL 128

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            +  ++ + HRD+KP+N+LLD +G++ ++DF ++A+  +    + T  GT  Y+APE+ S
Sbjct: 129 DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITTMAGTKPYMAPEMFS 187

Query: 121 NR---GYDGSAADVWSCGVILFVLMAGYLPF---GETDLPTLYKKINAAEFSCPFWFSTG 174
           +R   GY   A D WS GV  + L+ G  P+     T    +         + P  +S  
Sbjct: 188 SRKGAGY-SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQE 246

Query: 175 ATSLIHKILDPNPKTRI-RIEGIRKHPWFR 203
             SL+ K+L+PNP  R  ++  ++  P+  
Sbjct: 247 MVSLLKKLLEPNPDQRFSQLSDVQNFPYMN 276

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  192 bits (489), Expect = 2e-58
 Identities = 69/205 (33%), Positives = 108/205 (52%), Gaps = 6/205 (2%)

Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
            RHP +  L     +  ++  ++E+  GGELF  +  +    E   R Y  +++ A+ + 
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121

Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           HS+ V +RD+K ENL+LD  G++K++DFGL          + T CGTP Y+APEVL +  
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181

Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 183
           Y G A D W  GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L
Sbjct: 182 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240

Query: 184 DPNPKTRI-----RIEGIRKHPWFR 203
             +PK R+       + + +H +F 
Sbjct: 241 KKDPKQRLGGGPSDAKEVMEHRFFL 265

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  192 bits (490), Expect = 3e-58
 Identities = 35/222 (15%), Positives = 68/222 (30%), Gaps = 21/222 (9%)

Query: 1   MKIVRHPNIVRLHEVLASRTK--VYIILEFVTG-----GELFDKIVHQGRLLENDCRRYF 53
           + +   P   +L             +++   +          D +               
Sbjct: 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHIL 199

Query: 54  -QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN 112
             QLI   A+  SKG+ H    P+NL +   G L + D                +     
Sbjct: 200 TAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG---TRGPASSVPVT 256

Query: 113 YVAPEVLSNRGYD-GSAADVWSCGVILFVLMAGYLPFGETD--LPTLYKKINAAE----- 164
           Y   E L+        A + W  G+ ++ +   +LPFG     +   +K+ +        
Sbjct: 257 YAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDS 316

Query: 165 --FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
             F           +LI + L+ + + R+      + P F +
Sbjct: 317 LAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  192 bits (489), Expect = 3e-58
 Identities = 67/208 (32%), Positives = 106/208 (50%), Gaps = 7/208 (3%)

Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
               HP + +L     +  +++ ++EFV GG+L   I    R  E   R Y  ++I A+ 
Sbjct: 79  LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALM 138

Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 121
             H KG+ +RDLK +N+LLD  G+ K++DFG+            T CGTP+Y+APE+L  
Sbjct: 139 FLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQE 198

Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK 181
             Y G A D W+ GV+L+ ++ G+ PF   +   L++ I   E   P W    AT ++  
Sbjct: 199 MLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKS 257

Query: 182 ILDPNPKTRI------RIEGIRKHPWFR 203
            +  NP  R+          I +HP+F+
Sbjct: 258 FMTKNPTMRLGSLTQGGEHAILRHPFFK 285

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  191 bits (488), Expect = 4e-58
 Identities = 64/203 (31%), Positives = 106/203 (52%), Gaps = 2/203 (0%)

Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
               HP +  +     ++  ++ ++E++ GG+L   I    +   +    Y  ++I  + 
Sbjct: 73  LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 132

Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 121
             HSKG+ +RDLK +N+LLD  G++K++DFG+      G    +T CGTP+Y+APE+L  
Sbjct: 133 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG 192

Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK 181
           + Y   + D WS GV+L+ ++ G  PF   D   L+  I       P W    A  L+ K
Sbjct: 193 QKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK 251

Query: 182 ILDPNPKTRIRIEG-IRKHPWFR 203
           +    P+ R+ + G IR+HP FR
Sbjct: 252 LFVREPEKRLGVRGDIRQHPLFR 274

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  191 bits (488), Expect = 5e-58
 Identities = 62/207 (29%), Positives = 109/207 (52%), Gaps = 6/207 (2%)

Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
              + P + +LH    +  ++Y ++E+V GG+L   I   GR  E     Y  ++   + 
Sbjct: 76  LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 135

Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 121
              SKG+ +RDLK +N++LDS G++K++DFG+            T CGTP+Y+APE+++ 
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY 195

Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK 181
           + Y G + D W+ GV+L+ ++AG  PF   D   L++ I     + P   S  A ++   
Sbjct: 196 QPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKG 254

Query: 182 ILDPNPKTRI-----RIEGIRKHPWFR 203
           ++  +P  R+         I++H +FR
Sbjct: 255 LMTKHPGKRLGCGPEGERDIKEHAFFR 281

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  187 bits (478), Expect = 1e-56
 Identities = 69/217 (31%), Positives = 116/217 (53%), Gaps = 16/217 (7%)

Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           +   HP +V LH    + ++++ ++E+V GG+L   +  Q +L E   R Y  ++  A+ 
Sbjct: 65  QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 124

Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 121
           + H +G+ +RDLK +N+LLDS G++K++D+G+     +  +   T CGTPNY+APE+L  
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 184

Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT---------LYKKINAAEFSCPFWFS 172
             Y G + D W+ GV++F +MAG  PF                L++ I   +   P   S
Sbjct: 185 EDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 243

Query: 173 TGATSLIHKILDPNPKTRI------RIEGIRKHPWFR 203
             A S++   L+ +PK R+          I+ HP+FR
Sbjct: 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  187 bits (477), Expect = 5e-56
 Identities = 69/217 (31%), Positives = 116/217 (53%), Gaps = 16/217 (7%)

Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           +   HP +V LH    + ++++ ++E+V GG+L   +  Q +L E   R Y  ++  A+ 
Sbjct: 108 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 167

Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 121
           + H +G+ +RDLK +N+LLDS G++K++D+G+     +  +   T CGTPNY+APE+L  
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 227

Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPFGET---------DLPTLYKKINAAEFSCPFWFS 172
             Y G + D W+ GV++F +MAG  PF                L++ I   +   P   S
Sbjct: 228 EDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 286

Query: 173 TGATSLIHKILDPNPKTRI------RIEGIRKHPWFR 203
             A S++   L+ +PK R+          I+ HP+FR
Sbjct: 287 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  187 bits (477), Expect = 7e-56
 Identities = 35/218 (16%), Positives = 74/218 (33%), Gaps = 20/218 (9%)

Query: 3   IVRHPNIVRLHEVLASRTKVYIILEFVT-----------GGELFDKIVHQGRLLENDCRR 51
           +V+ P   ++  V      ++++  F             G  L         L+ +   +
Sbjct: 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQ 215

Query: 52  YFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ-GVELLHTTCGT 110
              Q+I  +A  H  G+ H  L+P +++LD  G + ++ F          V  +      
Sbjct: 216 LTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAP 275

Query: 111 PNYVAPEVLSNRGYDGS----AADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 166
           P   A  +L    +  +    A D W+ G+ ++ +    LP  +       + I    F 
Sbjct: 276 PETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI----FR 331

Query: 167 CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
                     +L+   L    + R+      + P + +
Sbjct: 332 SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  186 bits (474), Expect = 7e-56
 Identities = 69/216 (31%), Positives = 122/216 (56%), Gaps = 15/216 (6%)

Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
            I + P +V LH    + TK+++IL+++ GGELF  +  + R  E++ + Y  +++ A+ 
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 173

Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPEVL 119
           H H  G+ +RD+K EN+LLDS G++ ++DFGLS   +  +  E  +  CGT  Y+AP+++
Sbjct: 174 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIV 232

Query: 120 --SNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAAEFSCPFWFST 173
              + G+   A D WS GV+++ L+ G  PF     +     + ++I  +E   P   S 
Sbjct: 233 RGGDSGH-DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 291

Query: 174 GATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK 204
            A  LI ++L  +PK R+       + I++H +F+K
Sbjct: 292 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  186 bits (473), Expect = 8e-56
 Identities = 32/229 (13%), Positives = 77/229 (33%), Gaps = 28/229 (12%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-----LLENDCRRYFQQ 55
           +K       ++ +     +    ++ E  + G L + I          + +     +  +
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 56  LIDAVAHCHSKGVYHRDLKPENLLL-----------DSYGNLKVSDFGLSA--LPQQGVE 102
           ++  +   H   + H D+KP+N +L           D    L + D G S          
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 103 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG-YLPFGETDLPTLYKKIN 161
           +    C T  +   E+LSN+ ++    D +     ++ ++ G Y+           + + 
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF 299

Query: 162 AAEFSCPFWFSTGATSLIHKILDPNPKTRI-RIEGIRK--HPWFRKNYN 207
                   W         H +L+      +  ++ +R+     F+++Y 
Sbjct: 300 RRLPHLDMW-----NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  186 bits (474), Expect = 2e-55
 Identities = 69/214 (32%), Positives = 112/214 (52%), Gaps = 13/214 (6%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M     P +V+L         +Y+++E++ GG+L   ++    + E   R Y  +++ A+
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLAL 181

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVL 119
              HS G  HRD+KP+N+LLD  G+LK++DFG    + ++G+    T  GTP+Y++PEVL
Sbjct: 182 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 241

Query: 120 SNRGYD---GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFS 172
            ++G D   G   D WS GV L+ ++ G  PF    L   Y KI   + S  F      S
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 301

Query: 173 TGATSLIHKILDPNPKTRIRIEG---IRKHPWFR 203
             A +LI   L  + + R+   G   I++H +F+
Sbjct: 302 KEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFK 334

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  186 bits (474), Expect = 4e-55
 Identities = 71/206 (34%), Positives = 109/206 (52%), Gaps = 7/206 (3%)

Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
            RHP +  L     +  ++  ++E+  GGELF  +  +    E+  R Y  +++ A+ + 
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 264

Query: 64  HS-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 122
           HS K V +RDLK ENL+LD  G++K++DFGL     +    + T CGTP Y+APEVL + 
Sbjct: 265 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 324

Query: 123 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 182
            Y G A D W  GV+++ +M G LPF   D   L++ I   E   P      A SL+  +
Sbjct: 325 DY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGL 383

Query: 183 LDPNPKTRI-----RIEGIRKHPWFR 203
           L  +PK R+       + I +H +F 
Sbjct: 384 LKKDPKQRLGGGSEDAKEIMQHRFFA 409

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  189 bits (481), Expect = 2e-54
 Identities = 62/207 (29%), Positives = 109/207 (52%), Gaps = 6/207 (2%)

Query: 2   KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
              + P + +LH    +  ++Y ++E+V GG+L   I   GR  E     Y  ++   + 
Sbjct: 397 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 456

Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 121
              SKG+ +RDLK +N++LDS G++K++DFG+            T CGTP+Y+APE+++ 
Sbjct: 457 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY 516

Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK 181
           + Y G + D W+ GV+L+ ++AG  PF   D   L++ I     + P   S  A ++   
Sbjct: 517 QPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKG 575

Query: 182 ILDPNPKTRI-----RIEGIRKHPWFR 203
           ++  +P  R+         I++H +FR
Sbjct: 576 LMTKHPGKRLGCGPEGERDIKEHAFFR 602

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  183 bits (466), Expect = 6e-54
 Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 17/218 (7%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           +       I  LH        +Y+++++  GG+L   +   + RL E   R Y  +++ A
Sbjct: 128 LVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA 187

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEV 118
           +   H     HRD+KP+N+L+D  G+++++DFG    L + G        GTP+Y++PE+
Sbjct: 188 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 247

Query: 119 L-----SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF---- 169
           L         Y G   D WS GV ++ ++ G  PF    L   Y KI   +    F    
Sbjct: 248 LQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV 306

Query: 170 -WFSTGATSLIHKILDPNPKTRIRIEG---IRKHPWFR 203
              S  A  LI +++      R+   G    +KHP+F 
Sbjct: 307 TDVSENAKDLIRRLICSREH-RLGQNGIEDFKKHPFFS 343

>2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} Length = 143

 Score =  173 bits (440), Expect = 9e-54
 Identities = 103/141 (73%), Positives = 122/141 (86%), Gaps = 3/141 (2%)

Query: 243 GGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLK 302
            GPL+MNAFEMITLSQGLNL+ALFDRRQD+VKRQTRFVSR+    I++NIEAVA S+  K
Sbjct: 2   EGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFK 61

Query: 303 VHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKL 362
            HTRN+KTRLEG+S+ K GQ AVV+E++EVAPSLFMVDVRKAAG+TLEYHKFYK  C+KL
Sbjct: 62  SHTRNFKTRLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSKL 121

Query: 363 ENIIWKPTEG---SSLLRTMS 380
           ENIIW+ TEG   S +LRT++
Sbjct: 122 ENIIWRATEGIPKSEILRTIT 142

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  186 bits (473), Expect = 3e-53
 Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 12/213 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +     P IV +     +  K+  IL+ + GG+L   +   G   E D R Y  ++I  +
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            H H++ V +RDLKP N+LLD +G++++SD GL+    +     H + GT  Y+APEVL 
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGTHGYMAPEVLQ 363

Query: 121 -NRGYDGSAADVWSCGVILFVLMAGYLPF---GETDLPTLYKKINAAEFSCPFWFSTGAT 176
               Y  S+AD +S G +LF L+ G+ PF      D   + +         P  FS    
Sbjct: 364 KGVAY-DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 422

Query: 177 SLIHKILDPNPKTRIR-----IEGIRKHPWFRK 204
           SL+  +L  +   R+       + +++ P+FR 
Sbjct: 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  180 bits (459), Expect = 3e-53
 Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 17/219 (7%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDA 59
           +       I +LH        +Y+++E+  GG+L   +   G R+     R Y  +++ A
Sbjct: 115 LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA 174

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEV 118
           +   H  G  HRD+KP+N+LLD  G+++++DFG    L   G        GTP+Y++PE+
Sbjct: 175 IDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEI 234

Query: 119 LSNRGYD------GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF--- 169
           L   G        G   D W+ GV  + +  G  PF        Y KI   +        
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLV 294

Query: 170 --WFSTGATSLIHKILDPNPKTRIRIEG---IRKHPWFR 203
                  A   I ++L   P+TR+   G    R HP+F 
Sbjct: 295 DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFF 332

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  181 bits (461), Expect = 3e-52
 Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 14/213 (6%)

Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDA 59
           V    IV L     ++T + +++  + GG++   I +         E     Y  Q++  
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 119
           + H H + + +RDLKPEN+LLD  GN+++SD GL+   + G        GTP ++APE+L
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361

Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAAEFSCPFWFSTGA 175
               Y   + D ++ GV L+ ++A   PF     + +   L +++     + P  FS  +
Sbjct: 362 LGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS 420

Query: 176 TSLIHKILDPNPKTRI-----RIEGIRKHPWFR 203
                 +L  +P+ R+       +G+R HP FR
Sbjct: 421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  173 bits (440), Expect = 2e-51
 Identities = 53/220 (24%), Positives = 86/220 (39%), Gaps = 19/220 (8%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND---CRRYFQQLI 57
           M      N V   +  + +  +YI ++      L D +  +  L + +   C   F Q+ 
Sbjct: 115 MDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIA 174

Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL------------PQQGVELLH 105
           +AV   HSKG+ HRDLKP N+       +KV DFGL               P        
Sbjct: 175 EAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234

Query: 106 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF 165
              GT  Y++PE +    Y     D++S G+ILF L+  Y    + +   +   +   +F
Sbjct: 235 GQVGTKLYMSPEQIHGNNYS-HKVDIFSLGLILFELL--YSFSTQMERVRIITDVRNLKF 291

Query: 166 SCPFW-FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
              F         ++  +L P+P  R     I ++  F  
Sbjct: 292 PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  178 bits (452), Expect = 8e-51
 Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 13/211 (6%)

Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL--ENDCRRYFQQLIDAVA 61
           V    +V L     ++  + ++L  + GG+L   I H G+    E     Y  ++   + 
Sbjct: 241 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300

Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 121
             H + + +RDLKPEN+LLD +G++++SD GL+    +G + +    GT  Y+APEV+ N
Sbjct: 301 DLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKN 359

Query: 122 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT----LYKKINAAEFSCPFWFSTGATS 177
             Y   + D W+ G +L+ ++AG  PF +         + + +          FS  A S
Sbjct: 360 ERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARS 418

Query: 178 LIHKILDPNPKTRI-----RIEGIRKHPWFR 203
           L  ++L  +P  R+         +++HP F+
Sbjct: 419 LCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  155 bits (393), Expect = 9e-45
 Identities = 43/229 (18%), Positives = 78/229 (34%), Gaps = 33/229 (14%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL----ENDCRRYFQQL 56
             + +H ++VR     A    + I  E+  GG L D I    R++    E + +    Q+
Sbjct: 65  AVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124

Query: 57  IDAVAHCHSKGVYHRDLKPENLLLDSYGNL-------------------KVSDFGLSALP 97
              + + HS  + H D+KP N+ +                         K+ D G     
Sbjct: 125 GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR- 183

Query: 98  QQGVELLHTTCGTPNYVAPEVLS-NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL 156
              +       G   ++A EVL  N  +    AD+++  + +             D    
Sbjct: 184 ---ISSPQVEEGDSRFLANEVLQENYTHL-PKADIFALALTVVCAAGAEPLPRNGD---Q 236

Query: 157 YKKINAAEFS-CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           + +I        P   S   T L+  ++ P+P+ R     + KH     
Sbjct: 237 WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  146 bits (371), Expect = 4e-41
 Identities = 48/210 (22%), Positives = 85/210 (40%), Gaps = 10/210 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
              +  P IV L+  +     V I +E + GG L   I   G L E+    Y  Q ++ +
Sbjct: 104 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGL 163

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNL-KVSDFGLSA-----LPQQGVELLHTTCGTPNYV 114
            + H++ + H D+K +N+LL S G+   + DFG +         + +       GT  ++
Sbjct: 164 EYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHM 223

Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-LPTLYK--KINAAEFSCPFWF 171
           APEV+  +  D +  D+WS   ++  ++ G  P+ +    P   K           P   
Sbjct: 224 APEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSC 282

Query: 172 STGATSLIHKILDPNPKTRIRIEGIRKHPW 201
           +      I + L   P  R     +R+   
Sbjct: 283 APLTAQAIQEGLRKEPVHRASAMELRRKVG 312

>2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} Length = 123

 Score =  140 bits (353), Expect = 5e-41
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 7/127 (5%)

Query: 244 GPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKV 303
           G   MNAF++I+ S G NL+ LF   +    R  RFVS   A+ ++  +E +  + +L V
Sbjct: 2   GARRMNAFDIISGSPGFNLSGLFGDARK-YDRVERFVSAWTAERVVERLEEIVSAENLTV 60

Query: 304 HTR-NYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKN-FCAK 361
             +  +  ++EG      G FA+V+E+ ++   L M++VRK           + +     
Sbjct: 61  AKKETWGMKIEGQK----GNFAMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPF 116

Query: 362 LENIIWK 368
              ++ +
Sbjct: 117 FVELVHE 123

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  139 bits (353), Expect = 7e-39
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 12/215 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG---RLLENDCRRYFQQLI 57
            K ++H NIV+     +    + I +E V GG L   +  +    +  E     Y +Q++
Sbjct: 73  HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL 132

Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSY-GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
           + + + H   + HRD+K +N+L+++Y G LK+SDFG S           T  GT  Y+AP
Sbjct: 133 EGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAP 192

Query: 117 EVL--SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT--LYKKINAAEFSCPF--W 170
           E++    RGY G AAD+WS G  +  +  G  PF E   P   ++ K+   +        
Sbjct: 193 EIIDKGPRGY-GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KVGMFKVHPEIPES 250

Query: 171 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
            S  A + I K  +P+P  R     +    + + +
Sbjct: 251 MSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  138 bits (349), Expect = 4e-38
 Identities = 60/256 (23%), Positives = 104/256 (40%), Gaps = 53/256 (20%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTG--GELFDKIVHQGRLLENDCRRYFQQLID 58
           +K ++HPN+V L EV   + +++++ E+         D+  +Q  + E+  +    Q + 
Sbjct: 56  LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQ 113

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYV--- 114
           AV  CH     HRD+KPEN+L+  +  +K+ DFG +  L        +      + V   
Sbjct: 114 AVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLL---TGPSDYYD----DEVATR 166

Query: 115 ---APEVL-SNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDLPTLYK--KI------ 160
              +PE+L  +  Y G   DVW+ G +   L++G    P G++D+  LY   K       
Sbjct: 167 WYRSPELLVGDTQY-GPPVDVWAIGCVFAELLSGVPLWP-GKSDVDQLYLIRKTLGDLIP 224

Query: 161 ----------NAAEFSCPFW------------FSTGATSLIHKILDPNPKTRIRIEGIRK 198
                       +    P               S  A  L+   L  +P  R+  E +  
Sbjct: 225 RHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284

Query: 199 HPWFRKNYNPVKCSEE 214
           HP+F         ++E
Sbjct: 285 HPYFENIREIEDLAKE 300

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  138 bits (349), Expect = 6e-38
 Identities = 64/256 (25%), Positives = 101/256 (39%), Gaps = 53/256 (20%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTG--GELFDKIVHQGRLLENDCRRYFQQLID 58
           +K +RH N+V L EV   + + Y++ EFV     +  +       L     ++Y  Q+I+
Sbjct: 78  LKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL--FPNGLDYQVVQKYLFQIIN 135

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYV--- 114
            +  CHS  + HRD+KPEN+L+   G +K+ DFG +  L   G             V   
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD-------EVATR 188

Query: 115 ---APEVL-SNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDLPTLYK--KI------ 160
              APE+L  +  Y G A DVW+ G ++  +  G    P G++D+  LY           
Sbjct: 189 WYRAPELLVGDVKY-GKAVDVWAIGCLVTEMFMGEPLFP-GDSDIDQLYHIMMCLGNLIP 246

Query: 161 ----------NAAEFSCPFW------------FSTGATSLIHKILDPNPKTRIRIEGIRK 198
                       A    P               S     L  K L  +P  R     +  
Sbjct: 247 RHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306

Query: 199 HPWFRKNYNPVKCSEE 214
           H +F+ +    + S+E
Sbjct: 307 HDFFQMDGFAERFSQE 322

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  135 bits (343), Expect = 7e-37
 Identities = 61/246 (24%), Positives = 96/246 (39%), Gaps = 58/246 (23%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTG--GELFDKIVHQGRLLENDCRRYFQQLID 58
           ++ + HPNI+ L +    ++ + ++ +F+      +     +   L  +  + Y    + 
Sbjct: 66  LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQ 123

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN------ 112
            + + H   + HRDLKP NLLLD  G LK++DFGL+            + G+PN      
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA-----------KSFGSPNRAYTHQ 172

Query: 113 -----YVAPEVL-SNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDL----------- 153
                Y APE+L   R Y G   D+W+ G IL  L+    +LP G++DL           
Sbjct: 173 VVTRWYRAPELLFGARMY-GVGVDMWAVGCILAELLLRVPFLP-GDSDLDQLTRIFETLG 230

Query: 154 -PT--------------LYKKINAAEFSCPF-WFSTGATSLIHKILDPNPKTRIRIEGIR 197
            PT               +K          F         LI  +   NP  RI      
Sbjct: 231 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290

Query: 198 KHPWFR 203
           K  +F 
Sbjct: 291 KMKYFS 296

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  134 bits (339), Expect = 7e-37
 Identities = 47/214 (21%), Positives = 98/214 (45%), Gaps = 14/214 (6%)

Query: 1   MKIVRHPNIVRLH----EVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQL 56
           +K ++HPNIVR +      +  +  + ++ E +T G L   +     +     R + +Q+
Sbjct: 79  LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI 138

Query: 57  IDAVAHCHSKG--VYHRDLKPENLLLDSY-GNLKVSDFGLSALPQQGVELLHTTCGTPNY 113
           +  +   H++   + HRDLK +N+ +    G++K+ D GL+ L +          GTP +
Sbjct: 139 LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEF 196

Query: 114 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAE--FSCPFW 170
           +APE+     YD  + DV++ G+ +  +     P+ E  +   +Y+++ +     S    
Sbjct: 197 MAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 254

Query: 171 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
                  +I   +  N   R  I+ +  H +F++
Sbjct: 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  133 bits (337), Expect = 2e-36
 Identities = 68/244 (27%), Positives = 102/244 (41%), Gaps = 52/244 (21%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTG--GELFDKIVHQGRLLENDCRRYFQQLID 58
           +K ++H NIVRLH+VL S  K+ ++ EF      + FD     G L     + +  QL+ 
Sbjct: 55  LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLK 112

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS---ALPQQGVELLHTTCGTPN--- 112
            +  CHS+ V HRDLKP+NLL++  G LK+++FGL+    +P +        C +     
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--------CYSAEVVT 164

Query: 113 --YVAPEVL-SNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDL------------PT 155
             Y  P+VL   + Y  ++ D+WS G I   L     P   G                PT
Sbjct: 165 LWYRPPDVLFGAKLY-STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 223

Query: 156 -----------LYKKINAAEFSCPF-----WFSTGATSLIHKILDPNPKTRIRIEGIRKH 199
                       YK       +          +     L+  +L  NP  RI  E   +H
Sbjct: 224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283

Query: 200 PWFR 203
           P+F 
Sbjct: 284 PYFS 287

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  133 bits (338), Expect = 2e-36
 Identities = 68/248 (27%), Positives = 108/248 (43%), Gaps = 60/248 (24%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTG--GELFDKIVHQGRLLENDCRRYFQQLID 58
           +K + HPNIV L +V+ S   + ++ EF+     ++ D+  ++  L ++  + Y  QL+ 
Sbjct: 73  LKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQLLR 130

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN------ 112
            VAHCH   + HRDLKP+NLL++S G LK++DFGL+              G P       
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA-----------RAFGIPVRSYTHE 179

Query: 113 -----YVAPEVL-SNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDLPTLYK--KI-- 160
                Y AP+VL  ++ Y  ++ D+WS G I   ++ G    P G TD   L K   I  
Sbjct: 180 VVTLWYRAPDVLMGSKKY-STSVDIWSIGCIFAEMITGKPLFP-GVTDDDQLPKIFSILG 237

Query: 161 --------------NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEG 195
                            + +   +           F      L+  +L  +P  RI    
Sbjct: 238 TPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARD 297

Query: 196 IRKHPWFR 203
              HP+F+
Sbjct: 298 AMNHPYFK 305

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  131 bits (333), Expect = 6e-36
 Identities = 61/243 (25%), Positives = 109/243 (44%), Gaps = 51/243 (20%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTG--GELFDKIVHQGRLLENDCRRYFQQLID 58
           +K ++H NIV+L++V+ ++ ++ ++ E +     +L D    +G L     + +  QL++
Sbjct: 54  LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLN 111

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS---ALPQQGVELLHTTCGTPN--- 112
            +A+CH + V HRDLKP+NLL++  G LK++DFGL+    +P +          T     
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--------KYTHEIVT 163

Query: 113 --YVAPEVL-SNRGYDGSAADVWSCGVILFVLMAG--YLP-----------F-------- 148
             Y AP+VL  ++ Y  +  D+WS G I   ++ G    P           F        
Sbjct: 164 LWYRAPDVLMGSKKY-STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS 222

Query: 149 ----GETDLP---TLYKKINAAEFSCPF-WFSTGATSLIHKILDPNPKTRIRIEGIRKHP 200
                 T+LP     +       +             L+ K+L  +P  RI  +   +H 
Sbjct: 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282

Query: 201 WFR 203
           +F+
Sbjct: 283 YFK 285

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  130 bits (330), Expect = 2e-35
 Identities = 54/156 (34%), Positives = 78/156 (50%), Gaps = 8/156 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           MK +RHPNIV     +     + I+ E+++ G L+  +   G   + D RR      D V
Sbjct: 88  MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD-V 146

Query: 61  A------HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           A      H  +  + HR+LK  NLL+D    +KV DFGLS L         +  GTP ++
Sbjct: 147 AKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWM 206

Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE 150
           APEVL +   +   +DV+S GVIL+ L     P+G 
Sbjct: 207 APEVLRDEPSN-EKSDVYSFGVILWELATLQQPWGN 241

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  130 bits (329), Expect = 4e-35
 Identities = 57/248 (22%), Positives = 102/248 (41%), Gaps = 60/248 (24%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTG--GELFDKIVHQGRLLENDCRRYFQQLID 58
           +K ++H NIV LH+++ +   + ++ E++     +  D       +  ++ + +  QL+ 
Sbjct: 54  LKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLR 111

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN------ 112
            +A+CH + V HRDLKP+NLL++  G LK++DFGL+                P       
Sbjct: 112 GLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLA-----------RAKSIPTKTYDNE 160

Query: 113 -----YVAPEVL-SNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDLPTLYK--KI-- 160
                Y  P++L  +  Y  +  D+W  G I + +  G    P G T    L+   +I  
Sbjct: 161 VVTLWYRPPDILLGSTDY-STQIDMWGVGCIFYEMATGRPLFP-GSTVEEQLHFIFRILG 218

Query: 161 --------------NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEG 195
                             ++ P +             +    L+ K+L    + RI  E 
Sbjct: 219 TPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAED 278

Query: 196 IRKHPWFR 203
             KHP+F 
Sbjct: 279 AMKHPFFL 286

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  128 bits (325), Expect = 1e-34
 Identities = 59/206 (28%), Positives = 88/206 (42%), Gaps = 28/206 (13%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID-- 58
           +  V HPNIV+L    A    V +++E+  GG L++ +     L            +   
Sbjct: 55  LSRVNHPNIVKL--YGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112

Query: 59  -AVAHCHS---KGVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNY 113
             VA+ HS   K + HRDLKP NLLL + G  LK+ DFG +   Q     +    G+  +
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAW 169

Query: 114 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-------- 165
           +APEV     Y     DV+S G+IL+ ++    PF E   P    +I  A          
Sbjct: 170 MAPEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVHNGTRPPLI 226

Query: 166 -SCPFWFSTGATSLIHKILDPNPKTR 190
            + P        SL+ +    +P  R
Sbjct: 227 KNLPKPIE----SLMTRCWSKDPSQR 248

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  128 bits (324), Expect = 2e-34
 Identities = 66/254 (25%), Positives = 100/254 (39%), Gaps = 63/254 (24%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG-----ELFDKIVHQGRLLENDCRRYFQQ 55
           MK ++H NIVRL++V+ +  K+ ++ EF+        +          L  N  + +  Q
Sbjct: 57  MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116

Query: 56  LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN--- 112
           L+  +A CH   + HRDLKP+NLL++  G LK+ DFGL+              G P    
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA-----------RAFGIPVNTF 165

Query: 113 --------YVAPEVL-SNRGYDGSAADVWSCGVILFVLMAG--YLP-----------F-- 148
                   Y AP+VL  +R Y  ++ D+WSCG IL  ++ G    P           F  
Sbjct: 166 SSEVVTLWYRAPDVLMGSRTY-STSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDI 224

Query: 149 ----------GETDLP------TLYKKINAAEF---SCPFWFSTGATSLIHKILDPNPKT 189
                       T LP            +  +                 +H +L  NP  
Sbjct: 225 MGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDM 284

Query: 190 RIRIEGIRKHPWFR 203
           R+  +    HPWF 
Sbjct: 285 RLSAKQALHHPWFA 298

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  126 bits (320), Expect = 5e-34
 Identities = 59/252 (23%), Positives = 90/252 (35%), Gaps = 63/252 (25%)

Query: 1   MKIVRHPNIVRLHEVLASR-----TKVYIILEFVTG--GELFDKIVHQGRLLENDCRRYF 53
           ++   HPN+VRL +V A+       KV ++ E V        DK    G L     +   
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLM 126

Query: 54  QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN- 112
           +Q +  +   H+  + HRDLKPEN+L+ S G +K++DFGL+                   
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA-----------RIYSYQMA 175

Query: 113 ---------YVAPEVLSNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDLPTLYK--- 158
                    Y APEVL    Y  +  D+WS G I   +         G ++   L K   
Sbjct: 176 LTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFC-GNSEADQLGKIFD 233

Query: 159 --------------KINAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRI 193
                          +    F  P                    L+ ++L  NP  RI  
Sbjct: 234 LIGLPPEDDWPRDVSLPRGAF--PPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISA 291

Query: 194 EGIRKHPWFRKN 205
               +H +  K+
Sbjct: 292 FRALQHSYLHKD 303

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  126 bits (320), Expect = 9e-34
 Identities = 56/251 (22%), Positives = 97/251 (38%), Gaps = 62/251 (24%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++H NI+ L  V+    ++++I E+    +L   +     +     + +  QLI+ V
Sbjct: 87  LKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGV 145

Query: 61  AHCHSKGVYHRDLKPENLLLDSY-----GNLKVSDFGLSALPQQGVELLHTTCGTPN--- 112
             CHS+   HRDLKP+NLLL          LK+ DFGL+              G P    
Sbjct: 146 NFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA-----------RAFGIPIRQF 194

Query: 113 --------YVAPEVL-SNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDLPTLYK--- 158
                   Y  PE+L  +R Y  ++ D+WS   I   ++      P G++++  L+K   
Sbjct: 195 THEIITLWYRPPEILLGSRHY-STSVDIWSIACIWAEMLMKTPLFP-GDSEIDQLFKIFE 252

Query: 159 --------------------------KINAAEFSCPFWFSTGATSLIHKILDPNPKTRIR 192
                                     +    +             L+  +L+ +P  RI 
Sbjct: 253 VLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS 312

Query: 193 IEGIRKHPWFR 203
            +   +HP+F 
Sbjct: 313 AKNALEHPYFS 323

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  126 bits (318), Expect = 1e-33
 Identities = 43/169 (25%), Positives = 71/169 (42%), Gaps = 28/169 (16%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID-- 58
           M+ + HPN+++   VL    ++  I E++ GG L   I              + Q +   
Sbjct: 61  MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYP------WSQRVSFA 114

Query: 59  -----AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH-------- 105
                 +A+ HS  + HRDL   N L+    N+ V+DFGL+ L                 
Sbjct: 115 KDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174

Query: 106 ------TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 148
                 T  G P ++APE+++ R YD    DV+S G++L  ++      
Sbjct: 175 DRKKRYTVVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNAD 222

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  125 bits (316), Expect = 3e-33
 Identities = 62/241 (25%), Positives = 94/241 (39%), Gaps = 45/241 (18%)

Query: 1   MKIVRHPNIVRLHEVLASR-----TKVYIILEFVTG--GELFDKIVHQGRLLENDCRRYF 53
           ++   HPN+VRL +V         TK+ ++ E V        DK+  +  +     +   
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMM 126

Query: 54  QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC-GTPN 112
            QL+  +   HS  V HRDLKP+N+L+ S G +K++DFGL+       ++  T+   T  
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMALTSVVVTLW 184

Query: 113 YVAPEVLSNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDLPTLYK------------ 158
           Y APEVL    Y  +  D+WS G I   +         G +D+  L K            
Sbjct: 185 YRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFR-GSSDVDQLGKILDVIGLPGEED 242

Query: 159 -----KINAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 202
                 +    F                       L+ K L  NP  RI       HP+F
Sbjct: 243 WPRDVALPRQAF--HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

Query: 203 R 203
           +
Sbjct: 301 Q 301

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  122 bits (308), Expect = 1e-32
 Identities = 34/160 (21%), Positives = 69/160 (43%), Gaps = 17/160 (10%)

Query: 1   MKIVRHPNIVRLHEVLAS--RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 58
           ++I  HPN++ +     S       +I  ++  G L++ ++H+G     D  +  +  +D
Sbjct: 61  LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYN-VLHEGTNFVVDQSQAVKFALD 119

Query: 59  AVA------HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN 112
            +A      H     +    L   ++++D     ++S   +    Q            P 
Sbjct: 120 -MARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-----GRMYAPA 173

Query: 113 YVAPEVLSNRGYDGS--AADVWSCGVILFVLMAGYLPFGE 150
           +VAPE L  +  D +  +AD+WS  V+L+ L+   +PF +
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  122 bits (307), Expect = 3e-32
 Identities = 37/153 (24%), Positives = 72/153 (47%), Gaps = 6/153 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDA 59
           ++  RH NI+      ++  ++ I+ ++  G  L+  +       E        +Q    
Sbjct: 74  LRKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 132

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT--CGTPNYVAPE 117
           + + H+K + HRDLK  N+ L     +K+ DFGL+    +           G+  ++APE
Sbjct: 133 MDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192

Query: 118 VLSNRGYD--GSAADVWSCGVILFVLMAGYLPF 148
           V+  +  +     +DV++ G++L+ LM G LP+
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  121 bits (306), Expect = 4e-32
 Identities = 49/158 (31%), Positives = 83/158 (52%), Gaps = 3/158 (1%)

Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
           H NIV + +V       Y+++E++ G  L + I   G L  +    +  Q++D + H H 
Sbjct: 70  HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129

Query: 66  KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLSNRGY 124
             + HRD+KP+N+L+DS   LK+ DFG++ AL +  +   +   GT  Y +PE  +    
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE-QAKGEA 188

Query: 125 DGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKIN 161
                D++S G++L+ ++ G  PF GET +    K I 
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ 226

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  122 bits (308), Expect = 7e-32
 Identities = 56/254 (22%), Positives = 100/254 (39%), Gaps = 58/254 (22%)

Query: 1   MKIVRHPNIVRLHEVLASR--------TKVYIILEFV----TGGELFDKIVHQGRLLEND 48
           +++++H N+V L E+  ++          +Y++ +F      G  L        +   ++
Sbjct: 70  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSN--VLVKFTLSE 125

Query: 49  CRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS---ALPQQGVELLH 105
            +R  Q L++ + + H   + HRD+K  N+L+   G LK++DFGL+   +L +      +
Sbjct: 126 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185

Query: 106 TTC-GTPNYVAPEVL-SNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDL-------- 153
           T    T  Y  PE+L   R Y G   D+W  G I+  +      +  G T+         
Sbjct: 186 TNRVVTLWYRPPELLLGERDY-GPPIDLWGAGCIMAEMWTRSPIMQ-GNTEQHQLALISQ 243

Query: 154 ----PT-----------LYKKIN---------AAEFSCPFWFSTGATSLIHKILDPNPKT 189
                T           LY+K+                 +     A  LI K+L  +P  
Sbjct: 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK-AYVRDPYALDLIDKLLVLDPAQ 302

Query: 190 RIRIEGIRKHPWFR 203
           RI  +    H +F 
Sbjct: 303 RIDSDDALNHDFFW 316

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  121 bits (306), Expect = 7e-32
 Identities = 42/210 (20%), Positives = 82/210 (39%), Gaps = 25/210 (11%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDA 59
            +  RH N+V       S   + II     G  L+  +     +L+ +  R   Q+++  
Sbjct: 83  YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKG 142

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-----ALPQQGVELLHTTCGTPNYV 114
           + + H+KG+ H+DLK +N+  D+ G + ++DFGL          +  + L    G   ++
Sbjct: 143 MGYLHAKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHL 201

Query: 115 APEVLSNRGYDGS--------AADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA---- 162
           APE++     D           +DV++ G I + L A   PF       +  ++      
Sbjct: 202 APEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP 261

Query: 163 --AEFSCPFWFSTGATSLIHKILDPNPKTR 190
             ++       S     ++        + R
Sbjct: 262 NLSQIGMGKEIS----DILLFCWAFEQEER 287

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  120 bits (303), Expect = 1e-31
 Identities = 44/164 (26%), Positives = 81/164 (49%), Gaps = 9/164 (5%)

Query: 6   HPNIVRLHEV----LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 61
           HP IV +++       +    YI++E+V G  L D +  +G +              A+ 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130

Query: 62  HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTC--GTPNYVAPEV 118
             H  G+ HRD+KP N+++ +   +KV DFG++ A+   G  +  T    GT  Y++PE 
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE- 189

Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKIN 161
            +      + +DV+S G +L+ ++ G  PF G++ +   Y+ + 
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 233

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  118 bits (299), Expect = 3e-31
 Identities = 53/211 (25%), Positives = 85/211 (40%), Gaps = 34/211 (16%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M  + HPNIV+L           +++EFV  G+L+ +++ +   +        + ++D  
Sbjct: 77  MSNLNHPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPI--KWSVKLRLMLDIA 132

Query: 61  A-----HCHSKGVYHRDLKPENLLLDSYG-----NLKVSDFGLSALPQQGVELLHTTCGT 110
                    +  + HRDL+  N+ L S         KV+DFGLS   QQ V  +    G 
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS---QQSVHSVSGLLGN 189

Query: 111 PNYVAPEVLSNRG--YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF--- 165
             ++APE +      Y    AD +S  +IL+ ++ G  PF E       K IN       
Sbjct: 190 FQWMAPETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDEYS-YGKIKFINMIREEGL 247

Query: 166 ------SCPFWFSTGATSLIHKILDPNPKTR 190
                  CP        ++I      +PK R
Sbjct: 248 RPTIPEDCPPRLR----NVIELCWSGDPKKR 274

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  117 bits (296), Expect = 1e-30
 Identities = 65/258 (25%), Positives = 105/258 (40%), Gaps = 32/258 (12%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K    P IV+      + T V+I +E +       K   QG + E    +    ++ A+
Sbjct: 78  LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKAL 137

Query: 61  AHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH-----TTCGTPNYV 114
            +   K GV HRD+KP N+LLD  G +K+ DFG+S        L+       + G   Y+
Sbjct: 138 YYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISG------RLVDDKAKDRSAGCAAYM 191

Query: 115 APEVL-----SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKI---NAAEF 165
           APE +     +   YD   ADVWS G+ L  L  G  P+        +  K+        
Sbjct: 192 APERIDPPDPTKPDYD-IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL 250

Query: 166 SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAV 225
                FS    S +   L  + + R +   + +H + ++        E  EV   DV + 
Sbjct: 251 PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR-------YETLEV---DVASW 300

Query: 226 FDDIEDQYVAEQSENKVG 243
           F D+  +  + +S    G
Sbjct: 301 FKDVMAKTESPRSGPSSG 318

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  117 bits (295), Expect = 2e-30
 Identities = 41/148 (27%), Positives = 73/148 (49%), Gaps = 3/148 (2%)

Query: 6   HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 65
            P++V +H+      ++Y+ +  + G +L   +  QG L         +Q+  A+   H+
Sbjct: 93  EPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHA 152

Query: 66  KGVYHRDLKPENLLLDSYGNLKVSDFGL-SALPQQGVELLHTTCGTPNYVAPEVLSNRGY 124
            G  HRD+KPEN+L+ +     + DFG+ SA   + +  L  T GT  Y+APE  S    
Sbjct: 153 AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHA 212

Query: 125 DGSAADVWSCGVILFVLMAGYLPF-GET 151
               AD+++   +L+  + G  P+ G+ 
Sbjct: 213 TY-RADIYALTCVLYECLTGSPPYQGDQ 239

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  116 bits (292), Expect = 5e-30
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 25/223 (11%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +     P + + +      TK++II+E++ GG   D ++  G L E       ++++  +
Sbjct: 74  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGL 132

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS+   HRD+K  N+LL  +G +K++DFG++          +T  GTP ++APEV+ 
Sbjct: 133 DYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK 192

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGET------------DLPTLYKKINAAEFSCP 168
              YD S AD+WS G+    L  G  P  E             + PTL        +S P
Sbjct: 193 QSAYD-SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGN-----YSKP 246

Query: 169 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 211
                     +   L+  P  R   + + KH +  +N      
Sbjct: 247 L------KEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSY 283

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  117 bits (296), Expect = 7e-30
 Identities = 66/248 (26%), Positives = 103/248 (41%), Gaps = 42/248 (16%)

Query: 1   MKIVRHPNIVRLHEVLASRT------KVYIILEFV--TGGELFDKIVHQGRLLEND-CRR 51
           M+ + H NIVRL     S         + ++L++V  T   +        + L     + 
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 160

Query: 52  YFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY-GNLKVSDFGLSALPQQGVELLHTTCGT 110
           Y  QL  ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C +
Sbjct: 161 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-S 219

Query: 111 PNYVAPEV-LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKI-------- 160
             Y APE+      Y  S+ DVWS G +L  L+ G   F G++ +  L + I        
Sbjct: 220 RYYRAPELIFGATDYT-SSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 278

Query: 161 --------NAAEFSCPFW------------FSTGATSLIHKILDPNPKTRIRIEGIRKHP 200
                   N  EF  P                  A +L  ++L+  P  R+       H 
Sbjct: 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338

Query: 201 WFRKNYNP 208
           +F +  +P
Sbjct: 339 FFDELRDP 346

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  119 bits (301), Expect = 1e-29
 Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 16/159 (10%)

Query: 4   VRHPNIVRLHEV-----LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 58
           V HP+IV++               YI++E+V G  L        +L   +   Y  +++ 
Sbjct: 136 VVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILP 193

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL-SALPQQGVELLHTTCGTPNYVAPE 117
           A+++ HS G+ + DLKPEN++L     LK+ D G  S +   G        GTP + APE
Sbjct: 194 ALSYLHSIGLVYNDLKPENIMLTE-EQLKLIDLGAVSRINSFG-----YLYGTPGFQAPE 247

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL 156
           ++  R     A D+++ G  L  L           +  L
Sbjct: 248 IV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL 284

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  114 bits (287), Expect = 1e-29
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 21/164 (12%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA- 59
             +++HPNI+ L  V      + +++EF  GG L   ++   R+            +   
Sbjct: 60  FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNR-VLSGKRI---PPDILVNWAVQIA 115

Query: 60  --VAHCHSKGVY---HRDLKPENLLLDSYG--------NLKVSDFGLSALPQQGVELLHT 106
             + + H + +    HRDLK  N+L+             LK++DFGL+    +  ++  +
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM--S 173

Query: 107 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE 150
             G   ++APEV+    +    +DVWS GV+L+ L+ G +PF  
Sbjct: 174 AAGAYAWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRG 216

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  114 bits (287), Expect = 3e-29
 Identities = 57/207 (27%), Positives = 110/207 (53%), Gaps = 5/207 (2%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M+  +H N+V +++      ++++++EF+ GG L D IV Q RL E       + ++ A+
Sbjct: 96  MRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQAL 154

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           A+ H++GV HRD+K +++LL   G +K+SDFG  A   + V    +  GTP ++APEV+S
Sbjct: 155 AYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS 214

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLP-FGETDLPTLYK--KINAAEFSCPFWFSTGATS 177
              Y  +  D+WS G+++  ++ G  P F ++ +  + +       +       S     
Sbjct: 215 RSLYA-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRD 273

Query: 178 LIHKILDPNPKTRIRIEGIRKHPWFRK 204
            + ++L  +P+ R   + +  HP+  +
Sbjct: 274 FLERMLVRDPQERATAQELLDHPFLLQ 300

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  114 bits (288), Expect = 4e-29
 Identities = 46/191 (24%), Positives = 79/191 (41%), Gaps = 4/191 (2%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +     P IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  +
Sbjct: 85  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 144

Query: 61  AHCHSKG-VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 119
            +   K  + HRD+KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L
Sbjct: 145 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERL 202

Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 179
               Y    +D+WS G+ L  +  G  P    D   L                    +  
Sbjct: 203 QGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261

Query: 180 HKILDPNPKTR 190
             +      +R
Sbjct: 262 RPLNKFGMDSR 272

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  115 bits (290), Expect = 4e-29
 Identities = 67/242 (27%), Positives = 102/242 (42%), Gaps = 42/242 (17%)

Query: 1   MKIVRHPNIVRLHEVLASRT------KVYIILEFV--TGGELFDKIVHQGRLLEND-CRR 51
           M+IV+HPN+V L     S         + ++LE+V  T            + +     + 
Sbjct: 86  MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKL 145

Query: 52  YFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY-GNLKVSDFGLSALPQQGVELLHTTCGT 110
           Y  QL+ ++A+ HS G+ HRD+KP+NLLLD   G LK+ DFG + +   G   +   C +
Sbjct: 146 YMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC-S 204

Query: 111 PNYVAPEV-LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKI-------- 160
             Y APE+      Y  +  D+WS G ++  LM G   F GE+ +  L + I        
Sbjct: 205 RYYRAPELIFGATNYT-TNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR 263

Query: 161 --------NAAEFSCPFW------------FSTGATSLIHKILDPNPKTRIRIEGIRKHP 200
                   N  E   P                  A  LI ++L+  P  R+       HP
Sbjct: 264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP 323

Query: 201 WF 202
           +F
Sbjct: 324 FF 325

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  112 bits (283), Expect = 8e-29
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 5/207 (2%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M+  ++PNIV   +      ++++++E++ GG L D +V +  + E       ++ + A+
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQAL 129

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
              HS  V HRD+K +N+LL   G++K++DFG  A          T  GTP ++APEV++
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLP-FGETDLPTLYK--KINAAEFSCPFWFSTGATS 177
            + Y     D+WS G++   ++ G  P   E  L  LY        E   P   S     
Sbjct: 190 RKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248

Query: 178 LIHKILDPNPKTRIRIEGIRKHPWFRK 204
            +++ L+ + + R   + + +H + + 
Sbjct: 249 FLNRCLEMDVEKRGSAKELLQHQFLKI 275

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  110 bits (278), Expect = 4e-28
 Identities = 42/173 (24%), Positives = 73/173 (42%), Gaps = 22/173 (12%)

Query: 1   MKIVRHPNIVRL----HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQL 56
             ++RH NI+           S T++++I  +   G L+D  +    L    C R    +
Sbjct: 56  TVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYD-YLQLTTLDTVSCLRIVLSI 114

Query: 57  IDAVAHCHSK--------GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL---- 104
              +AH H +         + HRDLK +N+L+   G   ++D GL+ +  Q    L    
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174

Query: 105 HTTCGTPNYVAPEVLSNRGYDGSA-----ADVWSCGVILFVLMAGYLPFGETD 152
           +   GT  Y+APEVL               D+W+ G++L+ +    +  G  +
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  109 bits (275), Expect = 1e-27
 Identities = 54/209 (25%), Positives = 99/209 (47%), Gaps = 7/209 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M+    P++V+ +      T ++I++E+   G + D I +    L E++     Q  +  
Sbjct: 78  MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKG 137

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 119
           + + H     HRD+K  N+LL++ G+ K++DFG++      +   +T  GTP ++APEV+
Sbjct: 138 LEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 197

Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLP--FGETDLPTLYK--KINAAEFSCPFWFSTGA 175
              GY+   AD+WS G I  + MA   P       +  ++         F  P  +S   
Sbjct: 198 QEIGYNCV-ADIWSLG-ITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNF 255

Query: 176 TSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           T  + + L  +P+ R     + +HP+ R 
Sbjct: 256 TDFVKQCLVKSPEQRATATQLLQHPFVRS 284

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  110 bits (276), Expect = 4e-27
 Identities = 53/270 (19%), Positives = 92/270 (34%), Gaps = 70/270 (25%)

Query: 1   MKIVRHPNIVRLHEVLASRT--KVYIILEFV--------TGGELFDKIVHQGRLLENDCR 50
           ++ ++HPN++ L +V  S    KV+++ ++                      +L     +
Sbjct: 72  LRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131

Query: 51  RYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN----LKVSDFGLSALPQQGVELLHT 106
               Q++D + + H+  V HRDLKP N+L+   G     +K++D G + L      L   
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL--FNSPLKPL 189

Query: 107 TCGTPN-----YVAPEVL-SNRGYDGSAADVWSCGVILFVLMAG---------------- 144
               P      Y APE+L   R Y   A D+W+ G I   L+                  
Sbjct: 190 ADLDPVVVTFWYRAPELLLGARHY-TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248

Query: 145 -------------------------YLPFGETDLPTLYKKINAAEFSCPF------WFST 173
                                     +P   T +    +          +         +
Sbjct: 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDS 308

Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
            A  L+ K+L  +P  RI  E   + P+F 
Sbjct: 309 KAFHLLQKLLTMDPIKRITSEQAMQDPYFL 338

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  107 bits (270), Expect = 9e-27
 Identities = 63/250 (25%), Positives = 100/250 (40%), Gaps = 52/250 (20%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV------HQGRLLENDCRRYFQ 54
           M+    P IV+ +  L      +I +E ++    FDK            + E    +   
Sbjct: 75  MRSSDCPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITL 132

Query: 55  QLIDAVAHCHSKG-VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT-----TC 108
             + A+ H      + HRD+KP N+LLD  GN+K+ DFG+S       +L+ +       
Sbjct: 133 ATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG------QLVDSIAKTRDA 186

Query: 109 GTPNYVAPEVL----SNRGYDGSAADVWSCGVILFVLMAGYLPFGET------------- 151
           G   Y+APE +    S +GYD   +DVWS G+ L+ L  G  P+ +              
Sbjct: 187 GCRPYMAPERIDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG 245

Query: 152 DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 211
           D P L       EFS  F       + ++  L  +   R + + + KHP+          
Sbjct: 246 DPPQL-SNSEEREFSPSF------INFVNLCLTKDESKRPKYKELLKHPFILM------- 291

Query: 212 SEEEEVNLDD 221
            EE  V +  
Sbjct: 292 YEERAVEVAC 301

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  107 bits (269), Expect = 9e-27
 Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 10/213 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDA 59
           +    HP IV+L        K++I++EF  GG +   ++   R L     +   +Q+++A
Sbjct: 70  LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEA 129

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV- 118
           +   HSK + HRDLK  N+L+   G+++++DFG+SA   + ++   +  GTP ++APEV 
Sbjct: 130 LNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVV 189

Query: 119 ----LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-LPTLYK--KINAAEFSCPFWF 171
               + +  YD   AD+WS G+ L  +     P  E + +  L K  K +      P  +
Sbjct: 190 MCETMKDTPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKW 248

Query: 172 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           S      +   LD NP+TR     + +HP+   
Sbjct: 249 SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSS 281

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  107 bits (269), Expect = 2e-26
 Identities = 73/285 (25%), Positives = 114/285 (40%), Gaps = 65/285 (22%)

Query: 1   MKIVRHPNIVRLHEVLASRTK-----VYIILEFVTGGELFDKIVHQ---GRLLENDCRRY 52
           +K  +H NI+ +  +    +      VYII E      L    +H+    ++L +D  +Y
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQE------LMQTDLHRVISTQMLSDDHIQY 116

Query: 53  FQ-QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGT 110
           F  Q + AV   H   V HRDLKP NLL++S  +LKV DFGL+  + +   +    T   
Sbjct: 117 FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176

Query: 111 P---NYV------APEV-LSNRGYDGSAADVWSCGVILFVLMAG--------YL------ 146
                +V      APEV L++  Y   A DVWSCG IL  L           Y       
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYS-RAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235

Query: 147 ------PFGETDLPTLYKKINAAEF--SCPFW----FST-------GATSLIHKILDPNP 187
                 P  + DL  +     A E+  S P +                  L+ ++L  +P
Sbjct: 236 FGIIGTPHSDNDLRCIESP-RAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDP 294

Query: 188 KTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQ 232
             RI  +   +HP+ +  ++P     +E        + F+    +
Sbjct: 295 AKRITAKEALEHPYLQTYHDP----NDEPEGEPIPPSFFEFDHYK 335

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  105 bits (264), Expect = 4e-26
 Identities = 57/237 (24%), Positives = 94/237 (39%), Gaps = 34/237 (14%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-----HQGRLLENDCRRYFQQ 55
           M+ V  P  V  +  L     V+I +E +      DK           + E+   +    
Sbjct: 60  MRTVDCPFTVTFYGALFREGDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIAVS 117

Query: 56  LIDAVAHCHSKG-VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL-----HTTCG 109
           ++ A+ H HSK  V HRD+KP N+L+++ G +K+ DFG+S        L+         G
Sbjct: 118 IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG------YLVDDVAKDIDAG 171

Query: 110 TPNYVAPEVLSNR----GYDGSAADVWSCGVILFVLMAGYLPFGETDLP--TLYKKINAA 163
              Y+APE ++      GY    +D+WS G+ +  L     P+     P   L + +   
Sbjct: 172 CKPYMAPERINPELNQKGYS-VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP 230

Query: 164 EFSCP-FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNL 219
               P   FS        + L  N K R     + +HP+F          E +  ++
Sbjct: 231 SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL-------HESKGTDV 280

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  105 bits (264), Expect = 6e-26
 Identities = 56/240 (23%), Positives = 97/240 (40%), Gaps = 49/240 (20%)

Query: 6   HPNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 62
            PNI+ L +++    SRT   +  E V   +   K ++Q  L + D R Y  +++ A+ +
Sbjct: 90  GPNIITLADIVKDPVSRTPALVF-EHVNNTDF--KQLYQ-TLTDYDIRFYMYEILKALDY 145

Query: 63  CHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL-S 120
           CHS G+ HRD+KP N+++D  +  L++ D+GL+     G E       +  +  PE+L  
Sbjct: 146 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV-RVASRYFKGPELLVD 204

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPF--------------------GETDLPTLYKKI 160
            + YD  + D+WS G +L  ++    PF                       D    Y   
Sbjct: 205 YQMYD-YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263

Query: 161 NAAEF--SCPFW----------------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 202
               F                        S  A   + K+L  + ++R+      +HP+F
Sbjct: 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  105 bits (263), Expect = 9e-26
 Identities = 40/173 (23%), Positives = 73/173 (42%), Gaps = 22/173 (12%)

Query: 1   MKIVRHPNIVRL----HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQL 56
             ++RH NI+       +   S T++Y+I ++   G L+D  +    L      +     
Sbjct: 85  TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYD-YLKSTTLDAKSMLKLAYSS 143

Query: 57  IDAVAHCHSK--------GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL---- 104
           +  + H H++         + HRDLK +N+L+   G   ++D GL+         +    
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203

Query: 105 HTTCGTPNYVAPEVLSNRGYDGS-----AADVWSCGVILFVLMAGYLPFGETD 152
           +T  GT  Y+ PEVL              AD++S G+IL+ +    +  G  +
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  106 bits (266), Expect = 1e-25
 Identities = 71/285 (24%), Positives = 113/285 (39%), Gaps = 70/285 (24%)

Query: 1   MKIVRHPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           MK V H NI+ L  V   +        VY+++E +    L  +++     L+++   Y  
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-CQVIQME--LDHERMSYLL 170

Query: 55  -QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 113
            Q++  + H HS G+ HRDLKP N+++ S   LK+ DFGL+        +      TP Y
Sbjct: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TP-Y 223

Query: 114 V------APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-----------LPT- 155
           V      APEV+   GY     D+WS G I+  ++   + F   D           L T 
Sbjct: 224 VVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 282

Query: 156 ---LYKKIN--AAEF--SCPFW----FST-------------------GATSLIHKILDP 185
                KK+      +  + P +    F                      A  L+ K+L  
Sbjct: 283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 342

Query: 186 NPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIE 230
           +P  RI ++   +HP+    Y+P   +E E           D+ E
Sbjct: 343 DPAKRISVDDALQHPYINVWYDP---AEVEAPPPQIYDKQLDERE 384

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  105 bits (263), Expect = 2e-25
 Identities = 72/279 (25%), Positives = 114/279 (40%), Gaps = 58/279 (20%)

Query: 1   MKIVRHPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           MK V H NI+ L  V   +        VYI++E +    L  +++     L+++   Y  
Sbjct: 78  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQME--LDHERMSYLL 133

Query: 55  -QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 113
            Q++  + H HS G+ HRDLKP N+++ S   LK+ DFGL A       ++     T  Y
Sbjct: 134 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYY 192

Query: 114 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-----------LPT----LYK 158
            APEV+   GY     D+WS G I+  ++ G + F  TD           L T      K
Sbjct: 193 RAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251

Query: 159 KIN--AAEF--SCPFW-----------------------FSTGATSLIHKILDPNPKTRI 191
           K+      +  + P +                        ++ A  L+ K+L  +   RI
Sbjct: 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 311

Query: 192 RIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIE 230
            ++   +HP+    Y+P   SE E           D+ E
Sbjct: 312 SVDEALQHPYINVWYDP---SEAEAPPPKIPDKQLDERE 347

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  104 bits (261), Expect = 3e-25
 Identities = 58/276 (21%), Positives = 103/276 (37%), Gaps = 59/276 (21%)

Query: 1   MKIVRHPNIVRLHEVLASRTK-----VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ- 54
           +    HPNI+ L ++     +     +Y++ E +   +L   I  Q  ++     +YF  
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMY 141

Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
            ++  +   H  GV HRDL P N+LL    ++ + DF L+                 +YV
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK-------THYV 194

Query: 115 ------APEV-LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-----------LPT- 155
                 APE+ +  +G+     D+WS G ++  +      F  +            + T 
Sbjct: 195 THRWYRAPELVMQFKGFT-KLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253

Query: 156 ---LYKKI---NAAEF---SCPFW-----------FSTGATSLIHKILDPNPKTRIRIEG 195
                      +A ++   S                   A  LI K+L+ NP+ RI  E 
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQ 313

Query: 196 IRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIED 231
             +HP+F   ++P    +  E   +  H  FD+   
Sbjct: 314 ALRHPYFESLFDP---LDLTEGLSERFH--FDESVT 344

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  103 bits (258), Expect = 4e-25
 Identities = 34/159 (21%), Positives = 71/159 (44%), Gaps = 22/159 (13%)

Query: 1   MKIVRHPNIVRL----HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQL 56
             ++RH NI+      ++   + T+++++ ++   G LFD  +++  +      +     
Sbjct: 90  TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD-YLNRYTVTVEGMIKLALST 148

Query: 57  IDAVAHCHSK--------GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL---- 104
              +AH H +         + HRDLK +N+L+   G   ++D GL+       + +    
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 208

Query: 105 HTTCGTPNYVAPEVLSNRGYDGS-----AADVWSCGVIL 138
           +   GT  Y+APEVL +            AD+++ G++ 
Sbjct: 209 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 247

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  102 bits (256), Expect = 5e-25
 Identities = 59/230 (25%), Positives = 103/230 (44%), Gaps = 29/230 (12%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M    HPNIV  +     + +++++++ ++GG + D I H     E+      +  I  +
Sbjct: 67  MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126

Query: 61  --------AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL-----HTT 107
                    + H  G  HRD+K  N+LL   G+++++DFG+SA    G ++       T 
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186

Query: 108 CGTPNYVAPEVLS-NRGYDGSAADVWSCGVILFVLMAGYLPFGET------------DLP 154
            GTP ++APEV+   RGYD   AD+WS G+    L  G  P+ +             D P
Sbjct: 187 VGTPCWMAPEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245

Query: 155 TLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           +L  +    +      +      +I   L  +P+ R     + +H +F+K
Sbjct: 246 SL--ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  101 bits (253), Expect = 1e-24
 Identities = 24/152 (15%), Positives = 47/152 (30%), Gaps = 30/152 (19%)

Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
           +  P + R+ +V+ +R    ++ E++ GG L +  V           R  Q L  A    
Sbjct: 88  IDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQE--VADTSPSPVGAIRAMQSLAAAADAA 145

Query: 64  HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 123
           H  GV      P  + +   G++ ++                        +         
Sbjct: 146 HRAGVALSIDHPSRVRVSIDGDVVLAYPA--------------------TMPDA------ 179

Query: 124 YDGSAADVWSCGVILFVLMAGYLPFGETDLPT 155
                 D+   G  L+ L+    P  E  + +
Sbjct: 180 --NPQDDIRGIGASLYALLVNRWPLPEAGVRS 209

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  103 bits (257), Expect = 1e-24
 Identities = 31/147 (21%), Positives = 64/147 (43%), Gaps = 12/147 (8%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLID 58
            K+  HPNIV       +  +++++  F+  G   D         + E       Q ++ 
Sbjct: 80  SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLK 139

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQG------VELLHTTCGTP 111
           A+ + H  G  HR +K  ++L+   G + +S    +  +   G       +    +    
Sbjct: 140 ALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199

Query: 112 NYVAPEVL--SNRGYDGSAADVWSCGV 136
            +++PEVL  + +GYD + +D++S G+
Sbjct: 200 PWLSPEVLQQNLQGYD-AKSDIYSVGI 225

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  101 bits (254), Expect = 1e-24
 Identities = 36/171 (21%), Positives = 68/171 (39%), Gaps = 21/171 (12%)

Query: 1   MKIVRHPNIVRL----HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQL 56
           +  ++H NI++         +    +++I  F   G L D  +    +  N+     + +
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSD-FLKANVVSWNELCHIAETM 130

Query: 57  IDAVAHCHSKGVY----------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT 106
              +A+ H               HRD+K +N+LL +     ++DFGL+   + G     T
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT 190

Query: 107 T--CGTPNYVAPEVLSNRGYDGS----AADVWSCGVILFVLMAGYLPFGET 151
               GT  Y+APEVL              D+++ G++L+ L +        
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  103 bits (258), Expect = 2e-24
 Identities = 42/172 (24%), Positives = 72/172 (41%), Gaps = 37/172 (21%)

Query: 1   MKIVRHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ- 54
           +  + H ++V++ +++  +      ++Y++LE     +   K+      L     +    
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDF-KKLFRTPVYLTELHIKTLLY 163

Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS---ALPQQGVELLHTTCGTP 111
            L+  V + HS G+ HRDLKP N L++   ++KV DFGL+     P+ G   L  +    
Sbjct: 164 NLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223

Query: 112 N------------------YV------APEV-LSNRGYDGSAADVWSCGVIL 138
           +                  +V      APE+ L    Y   A DVWS G I 
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYT-EAIDVWSIGCIF 274

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  101 bits (254), Expect = 3e-24
 Identities = 67/280 (23%), Positives = 104/280 (37%), Gaps = 74/280 (26%)

Query: 1   MKIVRHPNIVRLHEVLASRTK--------------------------------------V 22
           MK++ H NI++L +   +                                         +
Sbjct: 54  MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113

Query: 23  YIILEFV--TGGELFDKIVHQGRLLEND-CRRYFQQLIDAVAHCHSKGVYHRDLKPENLL 79
            +I+E+V  T  ++    +  GR +  +    Y  QL  AV   HS G+ HRD+KP+NLL
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL 173

Query: 80  LDSY-GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV-LSNRGYDGSAADVWSCGVI 137
           ++S    LK+ DFG +         +   C +  Y APE+ L    Y   + D+WS G +
Sbjct: 174 VNSKDNTLKLCDFGSAKKLIPSEPSVAYIC-SRFYRAPELMLGATEYT-PSIDLWSIGCV 231

Query: 138 LFVLMAGYLPF-GETDL------------PTL--YKKIN--AAEFSCPFW----FS---- 172
              L+ G   F GET +            PT     ++N    E   P      +     
Sbjct: 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILP 291

Query: 173 ----TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 208
               + A  L+ +IL   P  RI       HP+F    N 
Sbjct: 292 EGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNS 331

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  101 bits (253), Expect = 4e-24
 Identities = 60/253 (23%), Positives = 103/253 (40%), Gaps = 58/253 (22%)

Query: 1   MKIVRHPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K +RH N++ L +V             Y+++ F+ G +L   + H+   L  D  ++  
Sbjct: 78  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLV 134

Query: 55  -QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 113
            Q++  + + H+ G+ HRDLKP NL ++    LK+ DFGL+    +  +   T      Y
Sbjct: 135 YQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA----RQADSEMT-----GY 185

Query: 114 V------APEV-LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI------ 160
           V      APEV L+   Y     D+WS G I+  ++ G   F  +D     K+I      
Sbjct: 186 VVTRWYRAPEVILNWMRYT-QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 244

Query: 161 ------------NAAEF--SCPFW-----------FSTGATSLIHKILDPNPKTRIRIEG 195
                        A  +    P              S  A +L+ K+L  + + R+    
Sbjct: 245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 304

Query: 196 IRKHPWFRKNYNP 208
              HP+F   ++ 
Sbjct: 305 ALAHPYFESLHDT 317

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  100 bits (252), Expect = 4e-24
 Identities = 61/253 (24%), Positives = 101/253 (39%), Gaps = 58/253 (22%)

Query: 1   MKIVRHPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V            VY++   + G +L + +  Q   L +D  ++  
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLI 138

Query: 55  -QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 113
            Q++  + + HS  + HRDLKP NL ++    LK+ DFGL+          HT      Y
Sbjct: 139 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---------HTADEMTGY 189

Query: 114 V------APEV-LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI------ 160
           V      APE+ L+   Y+    D+WS G I+  L+ G   F  TD     K I      
Sbjct: 190 VATRWYRAPEIMLNWMHYN-QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 248

Query: 161 ------------NAAEF--SCPFW-----------FSTGATSLIHKILDPNPKTRIRIEG 195
                       +A  +  S                +  A  L+ K+L  +   RI    
Sbjct: 249 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 308

Query: 196 IRKHPWFRKNYNP 208
              H +F + ++P
Sbjct: 309 ALAHAYFAQYHDP 321

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  100 bits (250), Expect = 5e-24
 Identities = 61/261 (23%), Positives = 98/261 (37%), Gaps = 60/261 (22%)

Query: 1   MKIVRHPNIVRLHEVLASRTK--------------VYIILEFVTGGELFDKIVHQGRLLE 46
           ++ + H NIV++ E+L                   VYI+ E++   +L   ++ QG LLE
Sbjct: 62  IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDL-ANVLEQGPLLE 119

Query: 47  NDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-NLKVSDFGLS-ALPQQGVELL 104
              R +  QL+  + + HS  V HRDLKP NL +++    LK+ DFGL+  +        
Sbjct: 120 EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179

Query: 105 HTTCGTPNYV------APEV-LSNRGYDGSAADVWSCGVILFVLMAGYLPF--------- 148
           H +      +      +P + LS   Y   A D+W+ G I   ++ G   F         
Sbjct: 180 HLS----EGLVTKWYRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234

Query: 149 ----------GETDLPTLYKKINAAEFSCPFW----FST-------GATSLIHKILDPNP 187
                      E D   L   I     +         +         A   + +IL  +P
Sbjct: 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP 294

Query: 188 KTRIRIEGIRKHPWFRKNYNP 208
             R+  E    HP+      P
Sbjct: 295 MDRLTAEEALSHPYMSIYSFP 315

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  100 bits (252), Expect = 6e-24
 Identities = 70/258 (27%), Positives = 113/258 (43%), Gaps = 63/258 (24%)

Query: 1   MKIVRHPNIVRLHEVLASRTK-----VYIILEFVTGGELFDKIVHQ---GRLLENDCRRY 52
           +   RH NI+ +++++ + T      VYI+ +      L +  +++    + L ND   Y
Sbjct: 79  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQD------LMETDLYKLLKTQHLSNDHICY 132

Query: 53  FQ-QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL--SALPQQGVELLHTTCG 109
           F  Q++  + + HS  V HRDLKP NLLL++  +LK+ DFGL   A P        T   
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT--- 189

Query: 110 TPNYV------APEV-LSNRGYDGSAADVWSCGVILFVLMAGYLPF-------------- 148
              YV      APE+ L+++GY   + D+WS G IL  +++    F              
Sbjct: 190 --EYVATRWYRAPEIMLNSKGYT-KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 246

Query: 149 -----GETDLPTLYKKINAAEF--SCPFW----FST-------GATSLIHKILDPNPKTR 190
                 + DL  +     A  +  S P      ++         A  L+ K+L  NP  R
Sbjct: 247 ILGSPSQEDLNCIINL-KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKR 305

Query: 191 IRIEGIRKHPWFRKNYNP 208
           I +E    HP+  + Y+P
Sbjct: 306 IEVEQALAHPYLEQYYDP 323

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  100 bits (250), Expect = 1e-23
 Identities = 65/286 (22%), Positives = 113/286 (39%), Gaps = 55/286 (19%)

Query: 1   MKIVRHPNIVRLHEVLASRTK-------VYIILEFV--TGGELFDKIVHQGRLLENDCRR 51
           + ++ HPNIV+L     +  +       + +++E+V  T          +         +
Sbjct: 73  LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIK 132

Query: 52  YFQ-QLIDAVA--HCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTT 107
            F  QLI ++   H  S  V HRD+KP N+L++ + G LK+ DFG +         +   
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192

Query: 108 CGTPNYVAPEV-LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDL------------ 153
           C +  Y APE+   N+ Y  +A D+WS G I   +M G   F G+               
Sbjct: 193 C-SRYYRAPELIFGNQHYT-TAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250

Query: 154 PTL--YKKINA--AEFSCPFW--------FSTG-------ATSLIHKILDPNPKTRIRIE 194
           P+    +K+N    +              FS         A  L+  +L   P+ R++  
Sbjct: 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPY 310

Query: 195 GIRKHPWFRKNYNPVKCSEEEEVNLDDVHAV---FDDIEDQYVAEQ 237
               HP+F + ++P      +  N  D+      F   E + ++E 
Sbjct: 311 EALCHPYFDELHDP----ATKLPNNKDLPEDLFRFLPNEIEVMSEA 352

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 99.7 bits (249), Expect = 1e-23
 Identities = 62/252 (24%), Positives = 101/252 (40%), Gaps = 57/252 (22%)

Query: 1   MKIVRHPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K ++H N++ L +V    +        Y+++ F+   +L  KI+   +  E   +    
Sbjct: 77  LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDL-QKIMGL-KFSEEKIQYLVY 133

Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + HS GV HRDLKP NL ++    LK+ DFGL+    +  +   T      YV
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA----RHADAEMT-----GYV 184

Query: 115 ------APEV-LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI------- 160
                 APEV LS   Y+    D+WS G I+  ++ G   F   D      +I       
Sbjct: 185 VTRWYRAPEVILSWMHYN-QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 243

Query: 161 -----------NAAEF--SCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGI 196
                       A  +  S P              S  A  L+ K+L+ +   R+     
Sbjct: 244 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA 303

Query: 197 RKHPWFRKNYNP 208
             HP+F    +P
Sbjct: 304 LTHPFFEPFRDP 315

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 99.0 bits (247), Expect = 1e-23
 Identities = 59/236 (25%), Positives = 100/236 (42%), Gaps = 30/236 (12%)

Query: 1   MKIVRHPNIVRLHE------VLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRY 52
            K   H NI   +             ++++++EF   G + D  K      L E      
Sbjct: 75  KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 134

Query: 53  FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN 112
            ++++  ++H H   V HRD+K +N+LL     +K+ DFG+SA   + V   +T  GTP 
Sbjct: 135 CREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 194

Query: 113 YVAPEVL-----SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT--LYK------- 158
           ++APEV+      +  YD   +D+WS G+    +  G  P  +   P   L+        
Sbjct: 195 WMAPEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAP 252

Query: 159 KINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEE 214
           ++ + ++S  F       S I   L  N   R   E + KHP+ R   N  +   +
Sbjct: 253 RLKSKKWSKKF------QSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQ 302

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 99.0 bits (247), Expect = 2e-23
 Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 24/216 (11%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ +RHPN ++           ++++E+  G       VH+  L E +        +  +
Sbjct: 108 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 167

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           A+ HS  + HRD+K  N+LL   G +K+ DFG +++        ++  GTP ++APEV+ 
Sbjct: 168 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVIL 223

Query: 121 NR---GYDGSAADVWSCGVILFVLMAGYLP--FGETDLPTLYK-------KINAAEFSCP 168
                 YDG   DVWS G I  + +A   P  F    +  LY         + +  +S  
Sbjct: 224 AMDEGQYDGK-VDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY 281

Query: 169 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           F       + +   L   P+ R   E + KH +  +
Sbjct: 282 F------RNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 97.8 bits (244), Expect = 8e-23
 Identities = 63/278 (22%), Positives = 98/278 (35%), Gaps = 82/278 (29%)

Query: 6   HPNIVRLHEVLA--SRTKVYIILEFVTGGELFDKIVHQ---GRLLENDCRRYFQ-QLIDA 59
           H NIV L  VL   +   VY++ +        +  +H      +LE   ++Y   QLI  
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFD------YMETDLHAVIRANILEPVHKQYVVYQLIKV 121

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN------- 112
           + + HS G+ HRD+KP N+LL++  ++KV+DFGLS        + +    + N       
Sbjct: 122 IKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181

Query: 113 --------YV------APEV-LSNRGYDGSAADVWSCGVILFVLMAG------------- 144
                   YV      APE+ L +  Y     D+WS G IL  ++ G             
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYT-KGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240

Query: 145 -------------------------YL---------PFGETDLPTLYKKINAAEFSCPFW 170
                                     +                     K    + +    
Sbjct: 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKAD 300

Query: 171 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 208
            +  A  L+ K+L  NP  RI      KHP+    +NP
Sbjct: 301 CNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNP 338

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 97.5 bits (243), Expect = 1e-22
 Identities = 42/173 (24%), Positives = 69/173 (39%), Gaps = 32/173 (18%)

Query: 1   MKIVRHPNIVRLHEVLASRTK-----VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ- 54
           +  ++   I+RL++++          +YI+LE     +L  K+      L  +  +    
Sbjct: 79  LNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDL-KKLFKTPIFLTEEHIKTILY 136

Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-------------ALPQQGV 101
            L+      H  G+ HRDLKP N LL+   ++KV DFGL+              L +   
Sbjct: 137 NLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196

Query: 102 ELLHTTCGTP---NYV------APEV-LSNRGYDGSAADVWSCGVILFVLMAG 144
              H         ++V      APE+ L    Y   + D+WS G I   L+  
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYT-KSIDIWSTGCIFAELLNM 248

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 94.1 bits (234), Expect = 7e-22
 Identities = 36/166 (21%), Positives = 61/166 (36%), Gaps = 29/166 (17%)

Query: 1   MKIVRHPNIVRL-----HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQ 55
           + ++ H NI R            R +  +++E+   G L    +           R    
Sbjct: 61  VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXK-YLSLHTSDWVSSCRLAHS 119

Query: 56  LIDAVAHCHS---------KGVYHRDLKPENLLLDSYGNLKVSDFGLS--------ALPQ 98
           +   +A+ H+           + HRDL   N+L+ + G   +SDFGLS          P 
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179

Query: 99  QGVELLHTTCGTPNYVAPEVLSNR------GYDGSAADVWSCGVIL 138
           +      +  GT  Y+APEVL                D+++ G+I 
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 49/156 (31%), Positives = 68/156 (43%), Gaps = 13/156 (8%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDA 59
           +K   HPNIVRL  V   +  +YI++E V GG+    +  +G  L               
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG------TPNY 113
           + +  SK   HRDL   N L+     LK+SDFG+S     GV              T   
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT--- 282

Query: 114 VAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
            APE L+   Y  S +DVWS G++L+     G  P+
Sbjct: 283 -APEALNYGRYS-SESDVWSFGILLWETFSLGASPY 316

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 92.4 bits (230), Expect = 5e-21
 Identities = 47/153 (30%), Positives = 75/153 (49%), Gaps = 6/153 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M    HPNI+RL  V+     V I+ E++  G L   +  H  +          + +   
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---AP 116
           + +    G  HRDL   N+L++S    KVSDFGL  + +   E  +TT G    +   +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219

Query: 117 EVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
           E ++ R +  SA+DVWS G++L+ V+  G  P+
Sbjct: 220 EAIAYRKFT-SASDVWSYGIVLWEVMSYGERPY 251

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 91.2 bits (227), Expect = 6e-21
 Identities = 50/153 (32%), Positives = 76/153 (49%), Gaps = 6/153 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M    HPNI+RL  V+       I+ E++  G L   +  H G+          + +   
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---AP 116
           + +    G  HRDL   N+L+DS    KVSDFGLS + +   +  +TT G    +   AP
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAP 223

Query: 117 EVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
           E ++ R +  SA+DVWS GV+++ VL  G  P+
Sbjct: 224 EAIAFRTFS-SASDVWSFGVVMWEVLAYGERPY 255

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 91.2 bits (227), Expect = 7e-21
 Identities = 47/153 (30%), Positives = 75/153 (49%), Gaps = 6/153 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M    H NI+RL  V++    + II E++  G L   +    G           + +   
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 159

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---AP 116
           + +  +    HRDL   N+L++S    KVSDFGLS + +   E  +TT G    +   AP
Sbjct: 160 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 219

Query: 117 EVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
           E +S R +  SA+DVWS G++++ V+  G  P+
Sbjct: 220 EAISYRKFT-SASDVWSFGIVMWEVMTYGERPY 251

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 89.8 bits (223), Expect = 7e-20
 Identities = 53/169 (31%), Positives = 78/169 (46%), Gaps = 15/169 (8%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRYF 53
           MK ++HPN+V+L  V       YII EF+T G L D       + V    LL        
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-----MA 324

Query: 54  QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN- 112
            Q+  A+ +   K   HR+L   N L+     +KV+DFGLS L        H     P  
Sbjct: 325 TQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 384

Query: 113 YVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 160
           + APE L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+ +
Sbjct: 385 WTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 432

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 86.5 bits (215), Expect = 3e-19
 Identities = 39/164 (23%), Positives = 77/164 (46%), Gaps = 6/164 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +    + V +I + +  G L D +  H+  +       +  Q+   
Sbjct: 71  MASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189

Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 160
            + +R Y    +DVWS GV ++ ++  G  P+       +   +
Sbjct: 190 SILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 85.4 bits (212), Expect = 5e-19
 Identities = 46/153 (30%), Positives = 68/153 (44%), Gaps = 7/153 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M  + H N++RL+ V      + ++ E    G L D++  HQG  L     RY  Q+ + 
Sbjct: 75  MHSLDHRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---AP 116
           + +  SK   HRDL   NLLL +   +K+ DFGL     Q  +               AP
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193

Query: 117 EVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
           E L  R +   A+D W  GV L+ +   G  P+
Sbjct: 194 ESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPW 225

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 85.4 bits (212), Expect = 5e-19
 Identities = 36/166 (21%), Positives = 66/166 (39%), Gaps = 6/166 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M+ + +P IVR+  +        +++E    G L   +     + + +      Q+   +
Sbjct: 72  MQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT--P-NYVAPE 117
            +       HRDL   N+LL +    K+SDFGLS   +              P  + APE
Sbjct: 131 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 190

Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINA 162
            ++   +  S +DVWS GV+++     G  P+       +   +  
Sbjct: 191 CINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 235

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 85.0 bits (211), Expect = 6e-19
 Identities = 51/164 (31%), Positives = 78/164 (47%), Gaps = 5/164 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLID 58
           MK ++HPN+V+L  V       YII EF+T G L D  +  ++  +          Q+  
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182

Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 160
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+ +
Sbjct: 183 SLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 84.6 bits (210), Expect = 9e-19
 Identities = 44/167 (26%), Positives = 71/167 (42%), Gaps = 7/167 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M  + +P IVRL  V      + +++E   GG L   +   +  +  ++      Q+   
Sbjct: 64  MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 122

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT--P-NYVAP 116
           + +   K   HRDL   N+LL +    K+SDFGLS                  P  + AP
Sbjct: 123 MKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 182

Query: 117 EVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINA 162
           E ++ R +  S +DVWS GV ++  L  G  P+ +   P +   I  
Sbjct: 183 ECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 84.2 bits (209), Expect = 9e-19
 Identities = 42/164 (25%), Positives = 75/164 (45%), Gaps = 4/164 (2%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M  + HP +V+ + V +    +YI+ E+++ G L + +  H   L  +        + + 
Sbjct: 57  MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEG 116

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 118
           +A   S    HRDL   N L+D    +KVSDFG++        +       P  + APEV
Sbjct: 117 MAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEV 176

Query: 119 LSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKIN 161
                Y  S +DVW+ G++++ V   G +P+       +  K++
Sbjct: 177 FHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 84.2 bits (209), Expect = 9e-19
 Identities = 44/164 (26%), Positives = 74/164 (45%), Gaps = 4/164 (2%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M  + HP +V+L+ V   +  + ++ EF+  G L D +   +G             + + 
Sbjct: 57  MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 116

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 118
           +A+     V HRDL   N L+     +KVSDFG++           T    P  + +PEV
Sbjct: 117 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 176

Query: 119 LSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKIN 161
            S   Y  S +DVWS GV+++ V   G +P+       + + I+
Sbjct: 177 FSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 42/164 (25%), Positives = 81/164 (49%), Gaps = 6/164 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           +  + H +IVRL  +    + + ++ +++  G L D +  H+G L       +  Q+   
Sbjct: 69  IGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG 127

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP-NYVAPE 117
           + +    G+ HR+L   N+LL S   ++V+DFG++  LP    +LL++   TP  ++A E
Sbjct: 128 MYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 187

Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 160
            +    Y    +DVWS GV ++ ++  G  P+    L  +   +
Sbjct: 188 SIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 86.0 bits (213), Expect = 1e-18
 Identities = 43/169 (25%), Positives = 76/169 (44%), Gaps = 16/169 (9%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRYF 53
           MK +RH  +V+L+ V  S   +YI+ E+++ G L D       K +   +L++       
Sbjct: 233 MKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD-----MA 286

Query: 54  QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-N 112
            Q+   +A+       HRDL+  N+L+      KV+DFGL+ L +            P  
Sbjct: 287 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 346

Query: 113 YVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 160
           + APE      +    +DVWS G++L  +   G +P+       +  ++
Sbjct: 347 WTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 86.5 bits (214), Expect = 1e-18
 Identities = 43/169 (25%), Positives = 76/169 (44%), Gaps = 16/169 (9%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRYF 53
           MK +RH  +V+L+ V  S   +YI+ E+++ G L D       K +   +L++       
Sbjct: 316 MKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD-----MA 369

Query: 54  QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-N 112
            Q+   +A+       HRDL+  N+L+      KV+DFGL+ L +            P  
Sbjct: 370 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 429

Query: 113 YVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 160
           + APE      +    +DVWS G++L  +   G +P+       +  ++
Sbjct: 430 WTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 84.7 bits (210), Expect = 1e-18
 Identities = 39/164 (23%), Positives = 77/164 (46%), Gaps = 6/164 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M  V +P++ RL  +    + V +I + +  G L D +  H+  +       +  Q+   
Sbjct: 71  MASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPE 117
           + +   + + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189

Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 160
            + +R Y    +DVWS GV ++ ++  G  P+       +   +
Sbjct: 190 SILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 42/167 (25%), Positives = 70/167 (41%), Gaps = 7/167 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M  + +P IVRL  V      + +++E   GG L   +   +  +  ++      Q+   
Sbjct: 390 MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 448

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---AP 116
           + +   K   HR+L   N+LL +    K+SDFGLS                   +   AP
Sbjct: 449 MKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 508

Query: 117 EVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINA 162
           E ++ R +  S +DVWS GV ++  L  G  P+ +   P +   I  
Sbjct: 509 ECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 554

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 83.1 bits (206), Expect = 3e-18
 Identities = 42/144 (29%), Positives = 74/144 (51%), Gaps = 7/144 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLI 57
           +K ++H NIV+   V  S  +  + +I+E++  G L D +  H+ R+      +Y  Q+ 
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 124

Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV--- 114
             + +  +K   HRDL   N+L+++   +K+ DFGL+ +  Q  E         + +   
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY 184

Query: 115 APEVLSNRGYDGSAADVWSCGVIL 138
           APE L+   +   A+DVWS GV+L
Sbjct: 185 APESLTESKFS-VASDVWSFGVVL 207

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 83.1 bits (206), Expect = 4e-18
 Identities = 38/144 (26%), Positives = 68/144 (47%), Gaps = 7/144 (4%)

Query: 1   MKIVRHPNIVRLHEV--LASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLI 57
           ++ + H NIV+   +        + +I+EF+  G L + +  ++ ++      +Y  Q+ 
Sbjct: 77  LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQIC 136

Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV--- 114
             + +  S+   HRDL   N+L++S   +K+ DFGL+   +   E         + V   
Sbjct: 137 KGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY 196

Query: 115 APEVLSNRGYDGSAADVWSCGVIL 138
           APE L    +   A+DVWS GV L
Sbjct: 197 APECLMQSKFY-IASDVWSFGVTL 219

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 82.6 bits (205), Expect = 4e-18
 Identities = 46/174 (26%), Positives = 79/174 (45%), Gaps = 28/174 (16%)

Query: 1   MKIVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRY 52
           M  +RH N+V+L  V +  +  +YI+ E++  G L D        ++    LL+     +
Sbjct: 68  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK-----F 122

Query: 53  FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT-- 110
              + +A+ +       HRDL   N+L+      KVSDFGL+       E   T      
Sbjct: 123 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKL 176

Query: 111 PNYV---APEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 160
           P  V   APE L  + +  + +DVWS G++L+ +   G +P+    L  +  ++
Sbjct: 177 P--VKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 82.4 bits (204), Expect = 7e-18
 Identities = 42/144 (29%), Positives = 74/144 (51%), Gaps = 7/144 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLI 57
           +K ++H NIV+   V  S  +  + +I+E++  G L D +  H+ R+      +Y  Q+ 
Sbjct: 96  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 155

Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV--- 114
             + +  +K   HRDL   N+L+++   +K+ DFGL+ +  Q  E         + +   
Sbjct: 156 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY 215

Query: 115 APEVLSNRGYDGSAADVWSCGVIL 138
           APE L+   +   A+DVWS GV+L
Sbjct: 216 APESLTESKFS-VASDVWSFGVVL 238

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 81.5 bits (202), Expect = 9e-18
 Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 4/164 (2%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M  + H  +V+L+ V   +  ++II E++  G L + +   + R          + + +A
Sbjct: 73  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 132

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 118
           + +  SK   HRDL   N L++  G +KVSDFGLS                P  +  PEV
Sbjct: 133 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 192

Query: 119 LSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKIN 161
           L    +  S +D+W+ GV+++ +   G +P+         + I 
Sbjct: 193 LMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 235

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 45/172 (26%), Positives = 79/172 (45%), Gaps = 24/172 (13%)

Query: 1   MKIVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRY 52
           M  +RH N+V+L  V +  +  +YI+ E++  G L D        ++    LL+     +
Sbjct: 240 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK-----F 294

Query: 53  FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT-- 110
              + +A+ +       HRDL   N+L+      KVSDFGL+       E   T      
Sbjct: 295 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKL 348

Query: 111 P-NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 160
           P  + APE L  + +  + +DVWS G++L+ +   G +P+    L  +  ++
Sbjct: 349 PVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 399

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 81.1 bits (201), Expect = 1e-17
 Identities = 43/164 (26%), Positives = 80/164 (48%), Gaps = 6/164 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYF-QQLID 58
           MK ++H  +VRL+ V  ++  +YII E++  G L D +    G  L  +       Q+ +
Sbjct: 62  MKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 117
            +A    +   HRDL+  N+L+    + K++DFGL+ L +            P  + APE
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180

Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 160
            ++   +    +DVWS G++L  ++  G +P+     P + + +
Sbjct: 181 AINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 81.1 bits (201), Expect = 1e-17
 Identities = 53/151 (35%), Positives = 80/151 (52%), Gaps = 5/151 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M+   HP+IV+L  V+ +   V+II+E  T GEL   + V +  L       Y  QL  A
Sbjct: 70  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 128

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 118
           +A+  SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE 
Sbjct: 129 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 188

Query: 119 LSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
           ++ R +  SA+DVW  GV ++ +LM G  PF
Sbjct: 189 INFRRFT-SASDVWMFGVCMWEILMHGVKPF 218

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 83.4 bits (206), Expect = 1e-17
 Identities = 53/151 (35%), Positives = 80/151 (52%), Gaps = 5/151 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M+   HP+IV+L  V+ +   V+II+E  T GEL   + V +  L       Y  QL  A
Sbjct: 445 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 503

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 118
           +A+  SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE 
Sbjct: 504 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 563

Query: 119 LSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
           ++ R +  SA+DVW  GV ++ +LM G  PF
Sbjct: 564 INFRRFT-SASDVWMFGVCMWEILMHGVKPF 593

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 80.5 bits (199), Expect = 4e-17
 Identities = 39/144 (27%), Positives = 71/144 (49%), Gaps = 7/144 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLI 57
           +K +    IV+   V     +  + +++E++  G L D +  H+ RL  +    Y  Q+ 
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137

Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV--- 114
             + +  S+   HRDL   N+L++S  ++K++DFGL+ L     +         + +   
Sbjct: 138 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197

Query: 115 APEVLSNRGYDGSAADVWSCGVIL 138
           APE LS+  +    +DVWS GV+L
Sbjct: 198 APESLSDNIFS-RQSDVWSFGVVL 220

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 79.5 bits (197), Expect = 4e-17
 Identities = 44/162 (27%), Positives = 73/162 (45%), Gaps = 27/162 (16%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           MK + HP+IV+L  ++      +II+E    GEL   +  ++  L       Y  Q+  A
Sbjct: 67  MKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 125

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV----- 114
           +A+  S    HRD+   N+L+ S   +K+ DFGLS   +             +Y      
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-----------DYYKASVT 174

Query: 115 -------APEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
                  +PE ++ R +  +A+DVW   V ++ +L  G  PF
Sbjct: 175 RLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPF 215

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 39/143 (27%), Positives = 69/143 (48%), Gaps = 7/143 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 58
           ++ + H +I++            + +++E+V  G L D  + +  +       + QQ+ +
Sbjct: 87  LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRD-YLPRHSIGLAQLLLFAQQICE 145

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---A 115
            +A+ H++   HRDL   N+LLD+   +K+ DFGL+    +G E         + V   A
Sbjct: 146 GMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 205

Query: 116 PEVLSNRGYDGSAADVWSCGVIL 138
           PE L    +   A+DVWS GV L
Sbjct: 206 PECLKEYKFY-YASDVWSFGVTL 227

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 42/169 (24%), Positives = 81/169 (47%), Gaps = 16/169 (9%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRYF 53
           MK ++H  +V+LH V  ++  +YII EF+  G L D             +L++     + 
Sbjct: 237 MKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID-----FS 290

Query: 54  QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-N 112
            Q+ + +A    +   HRDL+  N+L+ +    K++DFGL+ + +            P  
Sbjct: 291 AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK 350

Query: 113 YVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 160
           + APE ++   +    +DVWS G++L  ++  G +P+     P + + +
Sbjct: 351 WTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 398

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 77.8 bits (192), Expect = 5e-16
 Identities = 43/170 (25%), Positives = 65/170 (38%), Gaps = 28/170 (16%)

Query: 50  RRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG--NLKVSDFGLSALPQQGVELLHTT 107
           R++   ++  +   H   + H DLKPEN+LL   G   +KV DFG S    Q V   +T 
Sbjct: 203 RKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV---YTY 259

Query: 108 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFS 166
             +  Y APEV+    Y     D+WS G IL  L+ GY    GE +   L          
Sbjct: 260 IQSRFYRAPEVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQL---------- 308

Query: 167 CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEE 216
                     + + ++L    +  +     R   +      P  C+    
Sbjct: 309 ----------ACMIELLGMPSQKLLD-ASKRAKNFVSSKGYPRYCTVTTL 347

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 77.1 bits (190), Expect = 7e-16
 Identities = 40/209 (19%), Positives = 77/209 (36%), Gaps = 59/209 (28%)

Query: 50  RRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLD------SYGNLKVSDFGLSALPQQGVE 102
           ++  +QL+  + + H + G+ H D+KPEN+L++      +   +K++D G +       E
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC---WYDE 190

Query: 103 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK--- 159
               +  T  Y +PEVL    +    AD+WS   ++F L+ G   F   +  +  K    
Sbjct: 191 HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249

Query: 160 ---------------INAAEFSCPFWFSTGAT---------------------------- 176
                          +   +++  F+ S G                              
Sbjct: 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 309

Query: 177 --SLIHKILDPNPKTRIRIEGIRKHPWFR 203
               +  +L  +P+ R    G+  HPW +
Sbjct: 310 ISDFLSPMLQLDPRKRADAGGLVNHPWLK 338

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 76.2 bits (188), Expect = 8e-16
 Identities = 33/165 (20%), Positives = 58/165 (35%), Gaps = 28/165 (16%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           M  + H ++V  + V     +  ++ EFV  G L   +  ++  +         +QL  A
Sbjct: 66  MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA 125

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNL--------KVSDFGLSALPQQGVELLHTTCGTP 111
           +       + H ++  +N+LL    +         K+SD G+S                 
Sbjct: 126 MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK----------- 174

Query: 112 NY-------VAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
           +        V PE + N      A D WS G  L+ +   G  P 
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 12/170 (7%)

Query: 1   MKIVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLID 58
           MK   HPN++ L  + L S     ++L ++  G+L + I          D   +  Q+  
Sbjct: 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 203

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGT--PNYV- 114
            +    SK   HRDL   N +LD    +KV+DFGL+  +  +  + +H   G   P  V 
Sbjct: 204 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP--VK 261

Query: 115 --APEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKIN 161
             A E L  + +  + +DVWS GV+L+ ++  G  P+ + +   +   + 
Sbjct: 262 WMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 310

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 74.2 bits (183), Expect = 4e-15
 Identities = 45/169 (26%), Positives = 78/169 (46%), Gaps = 12/169 (7%)

Query: 1   MKIVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLID 58
           MK   HPN++ L  + L S     ++L ++  G+L + I          D   +  Q+  
Sbjct: 80  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 139

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGT--PNYV- 114
            + +  SK   HRDL   N +LD    +KV+DFGL+  +  +    +H   G   P  V 
Sbjct: 140 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP--VK 197

Query: 115 --APEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 160
             A E L  + +  + +DVWS GV+L+ ++  G  P+ + +   +   +
Sbjct: 198 WMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 245

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 73.8 bits (182), Expect = 6e-15
 Identities = 45/175 (25%), Positives = 75/175 (42%), Gaps = 24/175 (13%)

Query: 1   MKIVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLID 58
           M+ + HPN++ L  + L      +++L ++  G+L   I   Q      D   +  Q+  
Sbjct: 76  MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVAR 135

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS---------ALPQQGVELLHTTCG 109
            + +   +   HRDL   N +LD    +KV+DFGL+         ++ Q     L     
Sbjct: 136 GMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL----- 190

Query: 110 TPNYV---APEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 160
            P  V   A E L    +  + +DVWS GV+L+ +L  G  P+   D   L   +
Sbjct: 191 -P--VKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL 241

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 34/103 (33%), Positives = 52/103 (50%), Gaps = 8/103 (7%)

Query: 50  RRYFQQLIDAVAHCHSK--GVYHRDLKPENLLLDSYGN--LKVSDFGLSALPQQGVELLH 105
           R++ QQ+  A+    +    + H DLKPEN+LL +     +K+ DFG S+      + ++
Sbjct: 160 RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLG--QRIY 216

Query: 106 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 148
               +  Y +PEVL    YD  A D+WS G IL  +  G   F
Sbjct: 217 QYIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLF 258

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 41/187 (21%), Positives = 74/187 (39%), Gaps = 40/187 (21%)

Query: 1   MKIVRHPNIVRL------HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           MK   HP++ +L                 +IL F+  G+L   ++   R+ EN      Q
Sbjct: 79  MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL-ASRIGENPFNLPLQ 137

Query: 55  QLI-------DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT 107
            L+         + +  S+   HRDL   N +L     + V+DFGLS         +++ 
Sbjct: 138 TLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS-------RKIYSG 190

Query: 108 CGTPNY-------------VAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDL 153
               +Y             +A E L++  Y    +DVW+ GV ++ ++  G  P+   + 
Sbjct: 191 ----DYYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIEN 245

Query: 154 PTLYKKI 160
             +Y  +
Sbjct: 246 AEIYNYL 252

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 71.6 bits (176), Expect = 5e-14
 Identities = 48/220 (21%), Positives = 69/220 (31%), Gaps = 67/220 (30%)

Query: 50  RRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN-------------------LKVSD 90
           R    QL  A+   H   + H DLKPEN+L  +                      ++V+D
Sbjct: 126 RHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185

Query: 91  FGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-G 149
           FG SA      E   T   T +Y  PEV+   G+     DVWS G ILF    G+  F  
Sbjct: 186 FG-SATFDH--EHHTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQT 241

Query: 150 ETDLPTL-----------YKKINAAEFSCPFW---------------------------- 170
             +   L              I+       F+                            
Sbjct: 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYML 301

Query: 171 ----FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY 206
                      L+ ++L+ +P  RI +     HP+F    
Sbjct: 302 QDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 70.7 bits (174), Expect = 7e-14
 Identities = 38/162 (23%), Positives = 59/162 (36%), Gaps = 26/162 (16%)

Query: 1   MK-IVRHPNIVRLHEVLASRTKVYIILEFVTGGEL-----------FDKIVHQGRLLEND 48
           +  +  H NIV L           +I E+   G+L                    + +++
Sbjct: 80  LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 49  CRRYFQQLID-------AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV 101
                + L+         +A   SK   HRDL   N+LL      K+ DFGL+   +   
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 102 ELLHTTCGT-PNYV---APEVLSNRGYDGSAADVWSCGVILF 139
             +       P  V   APE + N  Y    +DVWS G+ L+
Sbjct: 200 NYVVKGNARLP--VKWMAPESIFNCVYT-FESDVWSYGIFLW 238

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 38/166 (22%), Positives = 61/166 (36%), Gaps = 38/166 (22%)

Query: 1   MK-IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRY 52
           M  + +H NIV L         V +I E+   G+L +        +         +    
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162

Query: 53  FQQLID-------AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH 105
            + L+         +A   SK   HRD+   N+LL +    K+ DFGL+           
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA----------R 212

Query: 106 TTCGTPNYV------------APEVLSNRGYDGSAADVWSCGVILF 139
                 NY+            APE + +  Y    +DVWS G++L+
Sbjct: 213 DIMNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLW 257

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 69.2 bits (170), Expect = 2e-13
 Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 40/214 (18%)

Query: 4   VRHPNIVRL--------HEVLASRTKVYIILEFVTGGE----LFDKIVHQGRLLENDCRR 51
            RHP++V L          +L     +Y   +++  G     L+   +    +      +
Sbjct: 92  CRHPHLVSLIGFCDERNEMIL-----IY---KYMENGNLKRHLYGSDLPTMSM---SWEQ 140

Query: 52  YFQQLIDA---VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT- 107
             +  I A   + + H++ + HRD+K  N+LLD     K++DFG+S    +  +  H + 
Sbjct: 141 RLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL-DQTHLST 199

Query: 108 --CGTPNYVAPE-VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE 164
              GT  Y+ PE  +  R  + S  DV+S GV+LF ++          LP   + +N AE
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKS--DVYSFGVVLFEVLCARSAI-VQSLPR--EMVNLAE 254

Query: 165 FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK 198
           ++     + G    + +I+DPN   +IR E +RK
Sbjct: 255 WAVE-SHNNGQ---LEQIVDPNLADKIRPESLRK 284

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 68.1 bits (167), Expect = 7e-13
 Identities = 44/224 (19%), Positives = 74/224 (33%), Gaps = 75/224 (33%)

Query: 50  RRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG------------------------- 84
           + Y  +++ A+ +     + H DLKPEN+LLD                            
Sbjct: 140 KLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199

Query: 85  NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG 144
            +K+ DFG  A  +   +   +   T  Y APEV+ N G+D  ++D+WS G +L  L  G
Sbjct: 200 GIKLIDFG-CATFKS--DYHGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTG 255

Query: 145 YLPF-GETDLPTL-----------YKKINAAEFSCPFWF-------------STGATS-- 177
            L F     +  L              +  A  +    +             ++   S  
Sbjct: 256 SLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIK 315

Query: 178 -------------------LIHKILDPNPKTRIRIEGIRKHPWF 202
                               ++ IL  +P  R     + KH + 
Sbjct: 316 HVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 67.7 bits (166), Expect = 7e-13
 Identities = 44/168 (26%), Positives = 63/168 (37%), Gaps = 43/168 (25%)

Query: 1   MK-IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRY 52
           +  +  HPNI+ L      R  +Y+ +E+   G L D               + N     
Sbjct: 79  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138

Query: 53  F--QQLIDA---VA----HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
              QQL+     VA    +   K   HRDL   N+L+      K++DFGLS         
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-------- 190

Query: 104 LHTTCGTPNYV------------APEVLSNRGYDGSAADVWSCGVILF 139
                G   YV            A E L+   Y  + +DVWS GV+L+
Sbjct: 191 -----GQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLW 232

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 67.3 bits (165), Expect = 9e-13
 Identities = 38/177 (21%), Positives = 70/177 (39%), Gaps = 46/177 (25%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI 57
           MK     ++VRL  V++      +I+E +T G+L   +      + N+         ++I
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141

Query: 58  -------DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS---------------A 95
                  D +A+ ++    HRDL   N ++     +K+ DFG++                
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201

Query: 96  LPQQGVELLHTTCGTPNYV---APEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 148
           LP                V   +PE L +  +  + +DVWS GV+L+ +      P+
Sbjct: 202 LP----------------VRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPY 241

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 44/186 (23%), Positives = 76/186 (40%), Gaps = 39/186 (20%)

Query: 1   MKIVRHPNIVRL-----HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQ 55
           MK   HPN++RL             K  +IL F+  G+L   +++  RL         Q 
Sbjct: 90  MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS-RLETGPKHIPLQT 148

Query: 56  LI-------DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC 108
           L+         + +  ++   HRDL   N +L     + V+DFGLS       + +++  
Sbjct: 149 LLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS-------KKIYSG- 200

Query: 109 GTPNY-------------VAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLP 154
              +Y             +A E L++R Y  S +DVW+ GV ++ +   G  P+      
Sbjct: 201 ---DYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNH 256

Query: 155 TLYKKI 160
            +Y  +
Sbjct: 257 EMYDYL 262

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 38/118 (32%), Positives = 48/118 (40%), Gaps = 23/118 (19%)

Query: 50  RRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN-------------------LKVSD 90
           R+   Q+  +V   HS  + H DLKPEN+L                         +KV D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180

Query: 91  FGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 148
           FG SA      E   T   T +Y APEV+   G+     DVWS G IL     G+  F
Sbjct: 181 FG-SATYDD--EHHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTVF 234

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 65.4 bits (160), Expect = 5e-12
 Identities = 36/158 (22%), Positives = 53/158 (33%), Gaps = 29/158 (18%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI--- 57
           +    H NIVR   V       +I++E + GG+L   +                 L+   
Sbjct: 87  ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146

Query: 58  ----DAVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSAL-------PQQGVEL 103
                   +       HRD+   N LL   G     K+ DFG++          + G  +
Sbjct: 147 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206

Query: 104 LHTTCGTPNYV---APEVLSNRGYDGSAADVWSCGVIL 138
           L      P  V    PE      +  S  D WS GV+L
Sbjct: 207 L------P--VKWMPPEAFMEGIFT-SKTDTWSFGVLL 235

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 64.5 bits (158), Expect = 7e-12
 Identities = 32/160 (20%), Positives = 55/160 (34%), Gaps = 27/160 (16%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD---------KIVHQGRLLENDCRR 51
              ++HPN+V L  V+     + +I  + + G+L +          +             
Sbjct: 66  RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125

Query: 52  YFQQLIDAV-------AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 104
                +  V        +  S  V H+DL   N+L+    N+K+SD GL           
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185

Query: 105 HTTCG------TPNYVAPEVLSNRGYDGSAADVWSCGVIL 138
                           APE +    +    +D+WS GV+L
Sbjct: 186 LLGNSLLPIRWM----APEAIMYGKFS-IDSDIWSYGVVL 220

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 64.1 bits (157), Expect = 1e-11
 Identities = 42/163 (25%), Positives = 63/163 (38%), Gaps = 41/163 (25%)

Query: 4   VRHPNIVRL--------HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQ 55
            +H N+V L           L     VY    ++  G L    +         C      
Sbjct: 87  CQHENLVELLGFSSDGDDLCL-----VY---VYMPNGSL-LDRLS--------CLDGTPP 129

Query: 56  L---------IDA---VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
           L           A   +   H     HRD+K  N+LLD     K+SDFGL+   ++  + 
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189

Query: 104 LHTT--CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG 144
           + T+   GT  Y+APE L       S  D++S GV+L  ++ G
Sbjct: 190 VMTSRIVGTTAYMAPEALRGEITPKS--DIYSFGVVLLEIITG 230

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 41/168 (24%), Positives = 66/168 (39%), Gaps = 40/168 (23%)

Query: 1   MK-IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD---------KIVHQGRLLENDCR 50
           MK I +H NI+ L         +Y+I+E+ + G L +                    + +
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187

Query: 51  RYFQQLID-------AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
              + L+         + +  SK   HRDL   N+L+     +K++DFGL+         
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA-------RD 240

Query: 104 LHTTCGTPNYV------------APEVLSNRGYDGSAADVWSCGVILF 139
           +H       Y             APE L +R Y    +DVWS GV+L+
Sbjct: 241 IHH---IDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLW 284

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 63.8 bits (156), Expect = 1e-11
 Identities = 45/156 (28%), Positives = 68/156 (43%), Gaps = 23/156 (14%)

Query: 4   VRHPNIVRLHEVLASRTKVYIILEFVTGG----ELFDKIVHQGRLLENDCRRYFQQLIDA 59
             H N++RL     + T+  ++  ++  G     L ++   Q  L   D  +  +  + +
Sbjct: 84  AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPL---DWPKRQRIALGS 140

Query: 60  VA--------HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---C 108
            A        HC  K + HRD+K  N+LLD      V DFGL+ L        H T    
Sbjct: 141 -ARGLAYLHDHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT--HVTTAVR 196

Query: 109 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG 144
           GT  ++APE LS  G      DV+  GV+L  L+ G
Sbjct: 197 GTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITG 231

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 37/158 (23%), Positives = 53/158 (33%), Gaps = 29/158 (18%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI--- 57
           +    H NIVR   V       +I+LE + GG+L   +                 L+   
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187

Query: 58  ----DAVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSAL-------PQQGVEL 103
                   +       HRD+   N LL   G     K+ DFG++          + G  +
Sbjct: 188 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247

Query: 104 LHTTCGTPNYV---APEVLSNRGYDGSAADVWSCGVIL 138
           L      P  V    PE      +  S  D WS GV+L
Sbjct: 248 L------P--VKWMPPEAFMEGIFT-SKTDTWSFGVLL 276

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 63.4 bits (155), Expect = 2e-11
 Identities = 35/172 (20%), Positives = 65/172 (37%), Gaps = 51/172 (29%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD---------KIVHQGRLLENDCRR 51
           +  ++H +IV+ + V      + ++ E++  G+L            I+  G+  +     
Sbjct: 71  LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130

Query: 52  YFQQLI-------DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS---------- 94
              Q++         + +  S+   HRDL   N L+ +   +K+ DFG+S          
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 190

Query: 95  -----ALPQQGVELLHTTCGTPNYV---APEVLSNRGYDGSAADVWSCGVIL 138
                 LP                +    PE +  R +  + +DVWS GVIL
Sbjct: 191 VGGHTMLP----------------IRWMPPESIMYRKFT-TESDVWSFGVIL 225

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 41/167 (24%), Positives = 63/167 (37%), Gaps = 31/167 (18%)

Query: 1   MK-IVRHPNIVRLHEVLASRTKVYIILEFVTGGEL----------------FDKIVHQGR 43
           M  +  H NIV L         +Y+I E+   G+L                  +   +  
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161

Query: 44  LLENDCRRYFQQLIDA---VA----HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-A 95
             E+     F+ L+     VA        K   HRDL   N+L+     +K+ DFGL+  
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221

Query: 96  LPQQGVELLHTTCGTPNYV---APEVLSNRGYDGSAADVWSCGVILF 139
           +      ++      P  V   APE L    Y    +DVWS G++L+
Sbjct: 222 IMSDSNYVVRGNARLP--VKWMAPESLFEGIYT-IKSDVWSYGILLW 265

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 63.0 bits (154), Expect = 3e-11
 Identities = 37/175 (21%), Positives = 63/175 (36%), Gaps = 47/175 (26%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGEL-----------------FDKIVHQGR 43
           +K V HP++++L+   +    + +I+E+   G L                          
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139

Query: 44  LLENDCRRYFQQLI-------DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL 96
              ++       LI         + +     + HRDL   N+L+     +K+SDFGLS  
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS-- 197

Query: 97  PQQGVELLHTTCGTPNYV------------APEVLSNRGYDGSAADVWSCGVILF 139
                          +YV            A E L +  Y  + +DVWS GV+L+
Sbjct: 198 --------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLW 243

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 62.3 bits (152), Expect = 4e-11
 Identities = 34/157 (21%), Positives = 61/157 (38%), Gaps = 22/157 (14%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGEL--------FDKIVHQGRLLENDCRRY 52
           + +++H +IVR   V      + ++ E++  G+L         D  +  G          
Sbjct: 97  LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156

Query: 53  FQQLI-------DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELL 104
             QL+         + +       HRDL   N L+     +K+ DFG+S  +       +
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 216

Query: 105 HTTCGTPNYV---APEVLSNRGYDGSAADVWSCGVIL 138
                 P  +    PE +  R +  + +DVWS GV+L
Sbjct: 217 GGRTMLP--IRWMPPESILYRKFT-TESDVWSFGVVL 250

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 62.3 bits (152), Expect = 5e-11
 Identities = 39/168 (23%), Positives = 64/168 (38%), Gaps = 40/168 (23%)

Query: 1   MK-IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRY 52
           MK I +H NI+ L         +Y+I+E+ + G L +         +     +       
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153

Query: 53  --FQQLIDAV-------AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
             F+ L+           +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA--------- 204

Query: 104 LHTTCGTPNYV------------APEVLSNRGYDGSAADVWSCGVILF 139
                    Y             APE L +R Y    +DVWS GV+++
Sbjct: 205 -RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMW 250

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 61.5 bits (150), Expect = 9e-11
 Identities = 40/161 (24%), Positives = 65/161 (40%), Gaps = 25/161 (15%)

Query: 1   MK-IVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRR 51
           +  I  H N+V L          + +I+EF   G L         + V      E+  + 
Sbjct: 84  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143

Query: 52  Y--FQQLID-------AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE 102
           +   + LI         +    S+   HRDL   N+LL     +K+ DFGL+    +  +
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203

Query: 103 LLHTTCGT-PNYV---APEVLSNRGYDGSAADVWSCGVILF 139
            +       P  +   APE + +R Y    +DVWS GV+L+
Sbjct: 204 YVRKGDARLP--LKWMAPETIFDRVYT-IQSDVWSFGVLLW 241

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 41/174 (23%), Positives = 67/174 (38%), Gaps = 52/174 (29%)

Query: 1   MK-IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRY 52
           MK I +H NI+ L         +Y+I+E+ + G L +         +     +       
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199

Query: 53  --FQQLID-------AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--------- 94
             F+ L+         + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 259

Query: 95  ------ALPQQGVELLHTTCGTPNYV---APEVLSNRGYDGSAADVWSCGVILF 139
                  LP                V   APE L +R Y    +DVWS GV+++
Sbjct: 260 KKTTNGRLP----------------VKWMAPEALFDRVYT-HQSDVWSFGVLMW 296

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 58.9 bits (143), Expect = 6e-10
 Identities = 36/180 (20%), Positives = 59/180 (32%), Gaps = 59/180 (32%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGEL-----------------FDKIVHQGR 43
           M    +PNIV+L  V A    + ++ E++  G+L                  D       
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163

Query: 44  LLENDCRRYFQQLIDAV-------AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-- 94
                      + +          A+   +   HRDL   N L+     +K++DFGLS  
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223

Query: 95  -------------ALPQQGVELLHTTCGTPNYV---APEVLSNRGYDGSAADVWSCGVIL 138
                        A+P                +    PE +    Y  + +DVW+ GV+L
Sbjct: 224 IYSADYYKADGNDAIP----------------IRWMPPESIFYNRYT-TESDVWAYGVVL 266

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 59.2 bits (143), Expect = 7e-10
 Identities = 43/261 (16%), Positives = 72/261 (27%), Gaps = 104/261 (39%)

Query: 42  GRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLL-------------------- 80
             L     ++  QQ++  + + H+K  + H D+KPEN+LL                    
Sbjct: 141 QGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRS 200

Query: 81  -----------------------------DSYGNLKVSDFGLSALPQQGVELLHTTCGTP 111
                                             +K++D G +    +      T     
Sbjct: 201 GAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQT 256

Query: 112 N-YVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK----------- 159
             Y + EVL   GY+ + AD+WS   + F L  G   F         +            
Sbjct: 257 RQYRSLEVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELL 315

Query: 160 -------INAAEFSCPFWFSTG------------------------------ATSLIHKI 182
                  I A ++S  F+   G                               T  +  +
Sbjct: 316 GKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPM 375

Query: 183 LDPNPKTRIRIEGIRKHPWFR 203
           L+  P+ R       +HPW  
Sbjct: 376 LELIPEKRATAAECLRHPWLN 396

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 53.3 bits (127), Expect = 4e-08
 Identities = 17/78 (21%), Positives = 31/78 (39%), Gaps = 2/78 (2%)

Query: 18  SRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPE 76
              +++I+LEF  GG   +++  +        +    QL  ++A   +     HRDL   
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWG 191

Query: 77  NLLLDSYGNLKVSDFGLS 94
           N+LL      K+      
Sbjct: 192 NVLLKKTSLKKLHYTLNG 209

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 53.4 bits (128), Expect = 4e-08
 Identities = 31/116 (26%), Positives = 54/116 (46%), Gaps = 4/116 (3%)

Query: 35  FDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS 94
             + +++  L       Y  Q+   +    S+   HRDL   N+LL     +K+ DFGL+
Sbjct: 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 240

Query: 95  ALPQQGVELLHTTCGT-P-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLP 147
               +  + +       P  ++APE + +R Y    +DVWS GV+L+ + + G  P
Sbjct: 241 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASP 295

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 53.1 bits (127), Expect = 7e-08
 Identities = 34/123 (27%), Positives = 51/123 (41%), Gaps = 22/123 (17%)

Query: 45  LENDCRRYF---------QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFG 92
           L N C R            Q+I+ V   HSK   HRD+KP+N L+        + + DFG
Sbjct: 92  LFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151

Query: 93  LSAL---PQQGVELLHTT----CGTPNYVAPEVLSNRGYDGS-AADVWSCGVILFVLMAG 144
           L+           + +       GT  Y +  V ++ G + S   D+ S G +L   + G
Sbjct: 152 LAKKYRDTSTHQHIPYRENKNLTGTARYAS--VNTHLGIEQSRRDDLESLGYVLMYFLRG 209

Query: 145 YLP 147
            LP
Sbjct: 210 SLP 212

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 33/129 (25%), Positives = 53/129 (41%), Gaps = 32/129 (24%)

Query: 45  LENDCRRYF---------QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVS-----D 90
           L + C R F          QLI  + + HSK + +RD+KPEN L+   GN         D
Sbjct: 94  LFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIID 153

Query: 91  FGLS-----------ALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS-AADVWSCGVIL 138
           F L+              ++   L     GT  Y++  + ++ G + S   D+ + G + 
Sbjct: 154 FALAKEYIDPETKKHIPYREHKSL----TGTARYMS--INTHLGKEQSRRDDLEALGHMF 207

Query: 139 FVLMAGYLP 147
              + G LP
Sbjct: 208 MYFLRGSLP 216

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 25/128 (19%), Positives = 46/128 (35%), Gaps = 24/128 (18%)

Query: 42  GRLLE---NDCRRYF---------QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKV- 88
           G  L+       + F          +++D + + H     H D+K  NLLL+     +V 
Sbjct: 135 GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVY 194

Query: 89  -SDFGLS---ALPQQGVELLHTT----CGTPNYVAPEVLSNRGYDGS-AADVWSCGVILF 139
             D+GL+                     GT  + +  + ++ G   S   D+   G  + 
Sbjct: 195 LVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTS--IDAHNGVAPSRRGDLEILGYCMI 252

Query: 140 VLMAGYLP 147
             + G+LP
Sbjct: 253 QWLTGHLP 260

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 50.4 bits (121), Expect = 3e-07
 Identities = 34/123 (27%), Positives = 51/123 (41%), Gaps = 22/123 (17%)

Query: 45  LENDCRRYF---------QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFG 92
           L N C R F          Q+I  + + HSK   HRD+KP+N L+        + + DFG
Sbjct: 94  LFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFG 153

Query: 93  LSALPQQGVELLHTT-------CGTPNYVAPEVLSNRGYDGS-AADVWSCGVILFVLMAG 144
           L+   +      H          GT  Y +  + ++ G + S   D+ S G +L     G
Sbjct: 154 LAKKYRDARTHQHIPYRENKNLTGTARYAS--INTHLGIEQSRRDDLESLGYVLMYFNLG 211

Query: 145 YLP 147
            LP
Sbjct: 212 SLP 214

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 50.4 bits (121), Expect = 3e-07
 Identities = 29/125 (23%), Positives = 52/125 (41%), Gaps = 24/125 (19%)

Query: 45  LENDCRRYF---------QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLK-----VSD 90
           L + C R F         +Q++  V   H K + +RD+KP+N L+    +       V D
Sbjct: 95  LLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVD 154

Query: 91  FGLSAL---PQQGVELLHTT----CGTPNYVAPEVLSNRGYDGS-AADVWSCGVILFVLM 142
           FG+      P     + +       GT  Y++  + ++ G + S   D+ + G +    +
Sbjct: 155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMS--INTHLGREQSRRDDLEALGHVFMYFL 212

Query: 143 AGYLP 147
            G LP
Sbjct: 213 RGSLP 217

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 49.3 bits (118), Expect = 8e-07
 Identities = 14/42 (33%), Positives = 23/42 (54%), Gaps = 2/42 (4%)

Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKV--SDFGLS 94
           +++D + + H     H D+K  NLLL      +V  +D+GLS
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLS 200

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 49.4 bits (118), Expect = 9e-07
 Identities = 10/42 (23%), Positives = 21/42 (50%), Gaps = 2/42 (4%)

Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKV--SDFGLS 94
           +L+DA+   H     H ++  EN+ +D     +V  + +G +
Sbjct: 167 RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFA 208

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.9 bits (100), Expect = 2e-04
 Identities = 52/402 (12%), Positives = 103/402 (25%), Gaps = 135/402 (33%)

Query: 8   NIVRLHEVLASRTKV-------YIILEFVTGGELFDKIVHQGRLLENDCRRY-FQQLID- 58
           N+ RL   L  R  +        ++++ V G     K      +  + C  Y  Q  +D 
Sbjct: 130 NVSRLQPYLKLRQALLELRPAKNVLIDGVLG---SGKTW----VALDVCLSYKVQCKMDF 182

Query: 59  -----AVAHCHSKGVYHRDLKP-ENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN 112
                 + +C+S       L+  + LL     N        S +  +   +         
Sbjct: 183 KIFWLNLKNCNSP---ETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSI--------Q 231

Query: 113 YVAPEVLSNRGY-------DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF 165
                +L ++ Y            +V +                           NA   
Sbjct: 232 AELRRLLKSKPYENCLLVLL----NVQNAKA-----------------------WNAFNL 264

Query: 166 SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAV 225
           SC    +T    +    L     T I ++             P    E + + L  +   
Sbjct: 265 SCKILLTTRFKQVT-DFLSAATTTHISLDH------HSMTLTP---DEVKSLLLKYLDCR 314

Query: 226 FDDIEDQYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPA 285
             D+         E     P  ++   +I        A      +D +     +  +   
Sbjct: 315 PQDL-------PREVLTTNPRRLS---II--------AESI---RDGLATWDNW--KHVN 351

Query: 286 QVILSN-IEAVAESLSLKVHTRNYKTRLEGVSANKTGQFAV----------VLEVF---- 330
              L+  IE+    L    + + +             + +V          +L +     
Sbjct: 352 CDKLTTIIESSLNVLEPAEYRKMFD------------RLSVFPPSAHIPTILLSLIWFDV 399

Query: 331 -EVAPSLFMVDVRK---AAGD----TLEYHKFYKNFCAKLEN 364
            +    + +  + K           T+     Y     KLEN
Sbjct: 400 IKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLEN 441

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 41.4 bits (96), Expect = 5e-04
 Identities = 55/427 (12%), Positives = 121/427 (28%), Gaps = 146/427 (34%)

Query: 22  VYIILEF---VTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL 78
              + +    +   E  D I+       +   R F  L+        + +  + +  E +
Sbjct: 35  CKDVQDMPKSILSKEEIDHIIMSKDA-VSGTLRLFWTLLS-----KQEEMVQKFV--EEV 86

Query: 79  LLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW---- 132
           L  +Y  L      +    +Q   +  ++       Y   +V +         +V     
Sbjct: 87  LRINYKFLMSP---IKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKY-------NVSRLQP 136

Query: 133 -------------SCGVILFVLMAGYLPFGETDLPTLYKKINAAE----------FSCP- 168
                        +  V++   + G    G+T +        A +               
Sbjct: 137 YLKLRQALLELRPAKNVLIDG-VLG---SGKTWV--------ALDVCLSYKVQCKMDFKI 184

Query: 169 FWFSTGAT-----------SLIHKI-------LDPNPKTRIRIEGIR---KHPWFRKNYN 207
           FW +                L+++I        D +   ++RI  I+   +     K Y 
Sbjct: 185 FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYE 244

Query: 208 PVKCSEEEEVNLDDV--HAVFD--DIE--------DQYVAEQ-SENKVGGPLLMNAFEMI 254
              C     + L +V     ++  ++          + V +  S        L +    +
Sbjct: 245 --NCL----LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTL 298

Query: 255 TLSQGLNLAALF--DRRQDYVKRQTRFVSRQPAQVILSN---IEAVAESLSLKVHTRNYK 309
           T  +  +L   +   R QD            P +V+ +N   +  +AES+      R+  
Sbjct: 299 TPDEVKSLLLKYLDCRPQDL-----------PREVLTTNPRRLSIIAESI------RDGL 341

Query: 310 TRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFC---------A 360
              +        +   ++E          ++V     +  EY K +              
Sbjct: 342 ATWDNWKHVNCDKLTTIIESS--------LNVL----EPAEYRKMFDRLSVFPPSAHIPT 389

Query: 361 KLENIIW 367
            L ++IW
Sbjct: 390 ILLSLIW 396

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	381
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2ehb_D	143	CBL-interacting serine/threonine-protein kinase 2;	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
2zfd_B	123	Putative uncharacterized protein T20L15_90; calciu	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.89
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.69
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.46
3ose_A	120	Serine/threonine-protein kinase MARK1; kinase asso	99.26
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.22
1v5s_A	126	MAP/microtubule affinity-regulating kinase 3; Ka1	98.82
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.7
4eai_A	106	5'-AMP-activated protein kinase catalytic subunit	98.53
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.47
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.46
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.38
2v8q_A	157	5'-AMP-activated protein kinase catalytic subunit;	98.35
4eag_A	130	EG:132E8.2 protein; AMPK, transferase; HET: ATP TA	98.17
2qrd_A	137	SNF1-like protein kinase SSP2; AMPK, ADP, ATP-bind	98.08
2y8l_A	173	5'-AMP-activated protein kinase catalytic subunit;	98.06
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	97.77
3t4n_A	179	Carbon catabolite-derepressing protein kinase; CBS	97.77
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.72
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.59
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.41
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	96.94
3ats_A	357	Putative uncharacterized protein; hypothetical pro	96.78
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	95.88
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	95.29
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	94.82
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	94.53
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	94.11
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	92.73
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	91.44
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	90.52
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	89.54
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	87.72
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	87.35
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	86.87
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	84.37
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	83.45
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	82.06
3ost_A	128	Serine/threonine-protein kinase KCC4; kinase assoc	80.61
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	80.39

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.5e-58  Score=435.36  Aligned_cols=203  Identities=31%  Similarity=0.557  Sum_probs=190.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |++++|||||+++++|++++.+|||||||+||+|+++|.+.+.++|..++.|+.||+.||+|||++||+||||||+|||+
T Consensus        86 l~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl  165 (311)
T 4aw0_A           86 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL  165 (311)
T ss_dssp             HTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             HHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE
Confidence            57899999999999999999999999999999999999998999999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCC--CccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016865           81 DSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK  158 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~  158 (381)
                      +.+|++||+|||+|+....  ......+.|||+.|+|||++.+.+|+ .++|||||||+||+|++|++||.+.+...++.
T Consensus       166 ~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~  244 (311)
T 4aw0_A          166 NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFA  244 (311)
T ss_dssp             CTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             cCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999999999987643  23346788999999999999988775 89999999999999999999999999999999


Q ss_pred             HhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHH------HhcCccccc
Q 016865          159 KINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEG------IRKHPWFRK  204 (381)
Q Consensus       159 ~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~------il~hp~~~~  204 (381)
                      ++....+.+|..+|+++++||.+||++||.+|||++|      +++||||+.
T Consensus       245 ~i~~~~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~  296 (311)
T 4aw0_A          245 KIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES  296 (311)
T ss_dssp             HHHHTCCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred             HHHcCCCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence            9999999999999999999999999999999999988      589999964

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1e-57  Score=426.70  Aligned_cols=203  Identities=45%  Similarity=0.918  Sum_probs=181.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |++++|||||++++++++++.+||||||| +|+|++++...+++++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        67 l~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl  145 (275)
T 3hyh_A           67 LRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL  145 (275)
T ss_dssp             HHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE
T ss_pred             HHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE
Confidence            46789999999999999999999999999 68999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.+|++||+|||+|+..... ....+.+||+.|+|||++.+..|++.++||||+||++|+|++|++||.+.+...+++.+
T Consensus       146 ~~~~~vkl~DFGla~~~~~~-~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i  224 (275)
T 3hyh_A          146 DEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI  224 (275)
T ss_dssp             CTTCCEEECCSSCC----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCCCCEEEeecCCCeecCCC-CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            99999999999999875543 34567899999999999999888888999999999999999999999999999999999


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ..+.+.+|.++|+++++||.+||+.||.+|||++|+++||||+..
T Consensus       225 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~  269 (275)
T 3hyh_A          225 SNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVD  269 (275)
T ss_dssp             HHTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred             HcCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccC
Confidence            999999999999999999999999999999999999999999864

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2e-57  Score=430.40  Aligned_cols=203  Identities=38%  Similarity=0.693  Sum_probs=189.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |++++|||||++++++++.+.+|||||||+||+|+++|.+.+.+++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus        80 l~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl  159 (304)
T 3ubd_A           80 LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL  159 (304)
T ss_dssp             CCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE
T ss_pred             HHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE
Confidence            67899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.+|++||+|||+|+..........+.|||+.|+|||++.+.+|+ .++||||+||+||+|++|++||.+.+..+.+.++
T Consensus       160 ~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i  238 (304)
T 3ubd_A          160 DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI  238 (304)
T ss_dssp             CTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             cCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH
Confidence            999999999999998765544556788999999999999988886 8999999999999999999999999999999999


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIR-----IEGIRKHPWFRK  204 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t-----~~~il~hp~~~~  204 (381)
                      ....+.+|..+|+++++||.+||+.||.+|||     ++|+++||||+.
T Consensus       239 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~  287 (304)
T 3ubd_A          239 LKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST  287 (304)
T ss_dssp             HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred             HcCCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence            99999999999999999999999999999998     589999999974

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.3e-56  Score=431.36  Aligned_cols=204  Identities=27%  Similarity=0.493  Sum_probs=185.6

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++|||||+++++|++++.+|||||||+||+|.+++.+ +++++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus       125 l~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl  203 (346)
T 4fih_A          125 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL  203 (346)
T ss_dssp             HHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             HHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE
Confidence            4678999999999999999999999999999999998876 679999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.+|++||+|||+|+..........+.|||+.|+|||++.+.+|+ .++|||||||++|||++|++||.+.+....+..+
T Consensus       204 ~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i  282 (346)
T 4fih_A          204 THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI  282 (346)
T ss_dssp             CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             CCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH
Confidence            999999999999998776555566788999999999999888875 9999999999999999999999998888877777


Q ss_pred             hccc---CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          161 NAAE---FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       161 ~~~~---~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      ....   ...+..+|+++++||.+||+.||.+|||++|+++||||++..
T Consensus       283 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          283 RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             HHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence            6543   233345899999999999999999999999999999998754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.1e-56  Score=429.38  Aligned_cols=204  Identities=29%  Similarity=0.599  Sum_probs=186.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |++|+|||||++++++++++.+|||||||+||+|+++|...+  .++|..++.|+.||+.||+|||++||+||||||+||
T Consensus        77 l~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI  156 (350)
T 4b9d_A           77 LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNI  156 (350)
T ss_dssp             HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGE
T ss_pred             HHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHE
Confidence            467899999999999999999999999999999999997543  479999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK  158 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~  158 (381)
                      |++.+|++||+|||+|+..........+.|||+.|+|||++.+..|+ .++|||||||+||+|++|++||.+.+...++.
T Consensus       157 Ll~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~  235 (350)
T 4b9d_A          157 FLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVL  235 (350)
T ss_dssp             EECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             EECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH
Confidence            99999999999999998776544455678999999999999988886 89999999999999999999999999888888


Q ss_pred             HhhcccC-CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          159 KINAAEF-SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       159 ~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ++..+.+ ..+..+|+++++||.+||+.||.+|||++|+++||||++.
T Consensus       236 ~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          236 KIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             HHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence            8877765 4566799999999999999999999999999999999764

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.7e-55  Score=432.16  Aligned_cols=204  Identities=27%  Similarity=0.493  Sum_probs=185.9

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++|||||+++++|.+.+.+|||||||+||+|.+++.. +++++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus       202 l~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl  280 (423)
T 4fie_A          202 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL  280 (423)
T ss_dssp             HHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE
T ss_pred             HHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE
Confidence            4678999999999999999999999999999999998865 679999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.+|.+||+|||+|+..........+.|||+.|||||++.+..|+ .++|||||||++|||++|++||.+.+....+..+
T Consensus       281 ~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i  359 (423)
T 4fie_A          281 THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI  359 (423)
T ss_dssp             CTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             cCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH
Confidence            999999999999998776555566788999999999999888875 9999999999999999999999998888777777


Q ss_pred             hccc---CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          161 NAAE---FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       161 ~~~~---~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      ....   ...+..+|+++++||.+||+.||.+|||++|+|+||||++..
T Consensus       360 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          360 RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             HHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence            6543   334456899999999999999999999999999999998754

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.6e-54  Score=408.18  Aligned_cols=200  Identities=24%  Similarity=0.488  Sum_probs=175.8

Q ss_pred             CCCCCccccccceEEEEe----CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCC
Q 016865            1 MKIVRHPNIVRLHEVLAS----RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG--VYHRDLK   74 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~----~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~g--i~HrDlk   74 (381)
                      |++++|||||++++++++    +..+|||||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++|  |+|||||
T Consensus        79 l~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlK  158 (290)
T 3fpq_A           79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLK  158 (290)
T ss_dssp             HHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCC
T ss_pred             HHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccC
Confidence            468999999999999975    3579999999999999999999899999999999999999999999999  9999999


Q ss_pred             CCcEEEcc-CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCC-
Q 016865           75 PENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-  152 (381)
Q Consensus        75 p~NiLl~~-~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-  152 (381)
                      |+|||++. +|.+||+|||+|+....  ....+.|||+.|||||++.+ +|+ .++|||||||+||+|++|++||.+.+ 
T Consensus       159 p~NILl~~~~g~vKl~DFGla~~~~~--~~~~~~~GTp~YmAPE~~~~-~y~-~~~DiwSlGvilyelltg~~Pf~~~~~  234 (290)
T 3fpq_A          159 CDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQN  234 (290)
T ss_dssp             GGGEEESSTTSCEEECCTTGGGGCCT--TSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred             hhheeEECCCCCEEEEeCcCCEeCCC--CccCCcccCccccCHHHcCC-CCC-cHHHHHHHHHHHHHHHHCCCCCCCCCc
Confidence            99999985 79999999999986543  34567899999999999865 564 99999999999999999999997654 


Q ss_pred             hhHHHHHhhcccC--CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          153 LPTLYKKINAAEF--SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       153 ~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      ...++..+..+..  ..+...++++++||.+||+.||.+|||++|+++||||++
T Consensus       235 ~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          235 AAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            4556666665533  345568999999999999999999999999999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.5e-54  Score=414.09  Aligned_cols=206  Identities=25%  Similarity=0.347  Sum_probs=182.1

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++|||||++++++++.+.+|||||||+||+|+++|...+.+++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus       104 l~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl  183 (336)
T 4g3f_A          104 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL  183 (336)
T ss_dssp             TTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEE
T ss_pred             HHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE
Confidence            67899999999999999999999999999999999999998999999999999999999999999999999999999999


Q ss_pred             ccCC-CEEEeeccCccCCCCCc-----cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           81 DSYG-NLKVSDFGLSALPQQGV-----ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        81 ~~~~-~lkl~DFGls~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      +.+| .+||+|||+|+......     ....+.|||+.|||||++.+.+|+ .++||||+||+||+|++|++||.+.+..
T Consensus       184 ~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~  262 (336)
T 4g3f_A          184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRG  262 (336)
T ss_dssp             CTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSTTTCCS
T ss_pred             eCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHH
Confidence            9988 59999999998654321     122356899999999999988886 8999999999999999999999988777


Q ss_pred             HHHHHhhcccC---CCCCCCChhHHHHHHHhcCCCCCCCCCHHHH-------------hcCcccccCCC
Q 016865          155 TLYKKINAAEF---SCPFWFSTGATSLIHKILDPNPKTRIRIEGI-------------RKHPWFRKNYN  207 (381)
Q Consensus       155 ~~~~~i~~~~~---~~p~~~s~~~~~li~~~L~~dP~~R~t~~~i-------------l~hp~~~~~~~  207 (381)
                      .+..++.....   ..|+.+|+++.+||.+||+.||.+|||+.|+             ++|||+.....
T Consensus       263 ~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~  331 (336)
T 4g3f_A          263 PLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE  331 (336)
T ss_dssp             CCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred             HHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence            77777766543   4677899999999999999999999999997             57999976443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.1e-52  Score=422.25  Aligned_cols=350  Identities=33%  Similarity=0.608  Sum_probs=260.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        70 l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll  149 (476)
T 2y94_A           70 LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL  149 (476)
T ss_dssp             HTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE
T ss_pred             HHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE
Confidence            46889999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++++||+|||++...... ....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+....+.++
T Consensus       150 ~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i  228 (476)
T 2y94_A          150 DAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI  228 (476)
T ss_dssp             CTTCCEEECCCSSCEECCTT-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHH
T ss_pred             ecCCCeEEEeccchhhcccc-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence            99999999999999876543 34567899999999999988877778999999999999999999999999888889999


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCCCCccccccCc-----cchhhhcc--------
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNL-----DDVHAVFD--------  227 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~~~~~~~~~~~~-----~~~~~~~~--------  227 (381)
                      ..+.+..|..+++++.+||++||+.||.+|||++++++||||+................     +.+.....        
T Consensus       229 ~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (476)
T 2y94_A          229 CDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEE  308 (476)
T ss_dssp             HTTCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSSCSSCSHHHHHHHHSCCCC-------
T ss_pred             hcCCcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcCccccCCCCcccccccCCHHHHHHHHHHcCCCHHH
Confidence            88888889999999999999999999999999999999999986543211110000000     00000000        


Q ss_pred             -----------------------------chhhHHHhhhcccc--cCCCcccchhhhhhcCCCCCC------cccC----
Q 016865          228 -----------------------------DIEDQYVAEQSENK--VGGPLLMNAFEMITLSQGLNL------AALF----  266 (381)
Q Consensus       228 -----------------------------~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~s~~~~l------~~~~----  266 (381)
                                                   ...+.+....+...  ...............+.....      ..+.    
T Consensus       309 ~~~~l~~~~~~~~~~~~y~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (476)
T 2y94_A          309 VLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKS  388 (476)
T ss_dssp             ------------------------CCTTCCSSHHHHHHHHHHSCGGGTSCCCCSSCTTTTCSCCCCCCSTTCTTTSSSTT
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHhchhhhhhhhccccccCCccccccccccccCCcccCCcccccCCcccccccccccccc
Confidence                                         00000000000000  000000000000000110000      0000    


Q ss_pred             -cccccccccccEEEeCCCHHHHHHHHHHHHHHcCcEEEe-ecceEEEEeecCCCCccEEEEEEEEEEeCCeEEEEEEcc
Q 016865          267 -DRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHT-RNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKA  344 (381)
Q Consensus       267 -~~~~~~~~~~trf~s~~~~~~i~~~l~~~~~~~~~~v~~-~~~~~~~~~~~~~~~~~l~~~~ei~~~~~~~~~V~~~k~  344 (381)
                       ...+...+++.++.|+.+|.+||..|..|++.+|+.|+. +.+.+++..........+.|.+++|++.++.++|||++.
T Consensus       389 ~~~~~~~~~w~lgi~s~~~p~~im~ev~~al~~lg~~Wk~~~~~~i~~r~~~~~~~~~~k~~lqly~~~~~~~llDf~~~  468 (476)
T 2y94_A          389 KHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSI  468 (476)
T ss_dssp             TCSCCCCCCEEESEEECSCHHHHHHHHHHHHHTTTCBCCEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEE
T ss_pred             cccccccceeeecCccCCCHHHHHHHHHHHHHHcCCeeccCCCEEEEEEECCCCCCceEEEEEEEEEecCCcEEEEeeec
Confidence             001123466778899999999999999999999999987 457787765433334557799999999999999999999


Q ss_pred             CCCchhH
Q 016865          345 AGDTLEY  351 (381)
Q Consensus       345 ~Gd~le~  351 (381)
                      .|+.++|
T Consensus       469 ~~~~~~~  475 (476)
T 2y94_A          469 DDEILEV  475 (476)
T ss_dssp             CCC----
T ss_pred             CCCcccc
Confidence            9999987

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.1e-51  Score=424.72  Aligned_cols=201  Identities=31%  Similarity=0.499  Sum_probs=183.3

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      +.++|||||+++++|++.+.+|||||||+||+|+++|...+.++|..++.|+.||+.||+|||++||+||||||+|||++
T Consensus       247 ~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld  326 (689)
T 3v5w_A          247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD  326 (689)
T ss_dssp             SSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC
T ss_pred             hhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEe
Confidence            56799999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCC---ChhHHHH
Q 016865           82 SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET---DLPTLYK  158 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~---~~~~~~~  158 (381)
                      .+|++||+|||+|.....  ....+.|||+.|+|||++.+...++.++|||||||+||+|++|.+||.+.   +...+..
T Consensus       327 ~~G~vKL~DFGlA~~~~~--~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~  404 (689)
T 3v5w_A          327 EHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR  404 (689)
T ss_dssp             TTSCEEECCCTTCEECSS--CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH
T ss_pred             CCCCEEecccceeeecCC--CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            999999999999986654  34568899999999999975433459999999999999999999999754   3345666


Q ss_pred             HhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 016865          159 KINAAEFSCPFWFSTGATSLIHKILDPNPKTRIR-----IEGIRKHPWFRK  204 (381)
Q Consensus       159 ~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t-----~~~il~hp~~~~  204 (381)
                      .+......+|..+|+++++||.+||+.||.+|++     ++||++||||+.
T Consensus       405 ~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~  455 (689)
T 3v5w_A          405 MTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  455 (689)
T ss_dssp             HHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred             hhcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence            7777888899999999999999999999999998     799999999974

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-51  Score=404.47  Aligned_cols=206  Identities=27%  Similarity=0.400  Sum_probs=178.0

Q ss_pred             CCCCCccccccceEEEEeC------CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 016865            1 MKIVRHPNIVRLHEVLASR------TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK   74 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~------~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlk   74 (381)
                      |+.++|||||++++++.+.      +.+|||||||+ |+|++++...+.+++..++.|++||+.||+|||++||+|||||
T Consensus       107 l~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlK  185 (398)
T 4b99_A          107 LKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLK  185 (398)
T ss_dssp             HHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred             HHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcC
Confidence            4678999999999998643      67999999996 6899999988999999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccCccCCCC----CccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCC
Q 016865           75 PENLLLDSYGNLKVSDFGLSALPQQ----GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE  150 (381)
Q Consensus        75 p~NiLl~~~~~lkl~DFGls~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~  150 (381)
                      |+|||++.+|.+||+|||+|+....    ......+.|||+.|+|||++.+..+++.++||||+|||+|+|++|++||.+
T Consensus       186 P~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g  265 (398)
T 4b99_A          186 PSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG  265 (398)
T ss_dssp             GGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             ccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC
Confidence            9999999999999999999986543    123456789999999999998877777999999999999999999999999


Q ss_pred             CChhHHHHHhhcccCC--------------------CC-----------CCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          151 TDLPTLYKKINAAEFS--------------------CP-----------FWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       151 ~~~~~~~~~i~~~~~~--------------------~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      .+.......|......                    .|           +.+|+++.+||.+||..||.+|||++|+|+|
T Consensus       266 ~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          266 KNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             SSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            8877766665332111                    11           2368999999999999999999999999999


Q ss_pred             cccccCCC
Q 016865          200 PWFRKNYN  207 (381)
Q Consensus       200 p~~~~~~~  207 (381)
                      |||+....
T Consensus       346 p~f~~~~~  353 (398)
T 4b99_A          346 PFLAKYHD  353 (398)
T ss_dssp             GGGTTTCC
T ss_pred             HhhCcCCC
Confidence            99986543

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.1e-50  Score=394.09  Aligned_cols=197  Identities=29%  Similarity=0.479  Sum_probs=162.5

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccC-
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY-   83 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~-   83 (381)
                      +|||||+++++|++.+++|||||||+||+|.+++   +.+++..++.|+.||+.||+|||++||+||||||+|||++.+ 
T Consensus        78 ~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~  154 (361)
T 4f9c_A           78 GQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRL  154 (361)
T ss_dssp             SBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT
T ss_pred             CCCCCceEEEEEEECCEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCC
Confidence            7999999999999999999999999999999988   459999999999999999999999999999999999999876 


Q ss_pred             CCEEEeeccCccCCCCC----------------------------ccccccccCCCCCCCCceecCCCCCCCcccHhHHH
Q 016865           84 GNLKVSDFGLSALPQQG----------------------------VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCG  135 (381)
Q Consensus        84 ~~lkl~DFGls~~~~~~----------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlG  135 (381)
                      +.+||+|||+|+.....                            .....+.|||+.|+|||++.+..+++.++||||+|
T Consensus       155 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG  234 (361)
T 4f9c_A          155 KKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAG  234 (361)
T ss_dssp             TEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHH
T ss_pred             CeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhH
Confidence            89999999999754321                            11234568999999999998876667999999999


Q ss_pred             HHHHHHHhCCCCCCCCC-hhHHHHHhh--------------------------------------cccCC----------
Q 016865          136 VILFVLMAGYLPFGETD-LPTLYKKIN--------------------------------------AAEFS----------  166 (381)
Q Consensus       136 vil~~ll~G~~Pf~~~~-~~~~~~~i~--------------------------------------~~~~~----------  166 (381)
                      ||+|+|++|++||...+ ..+....+.                                      .....          
T Consensus       235 ~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~  314 (361)
T 4f9c_A          235 VIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQG  314 (361)
T ss_dssp             HHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC---------------
T ss_pred             HHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccc
Confidence            99999999999995433 222222111                                      00000          


Q ss_pred             ------CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          167 ------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       167 ------~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                            ....+|+++++||++||+.||.+|+|++|+|+||||+.
T Consensus       315 ~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~  358 (361)
T 4f9c_A          315 HATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD  358 (361)
T ss_dssp             -------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred             ccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence                  11237899999999999999999999999999999974

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=7.7e-50  Score=410.12  Aligned_cols=206  Identities=31%  Similarity=0.651  Sum_probs=187.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++|||||+++++|++.+.+|||||||+||+|+++|.. .+.+++..++.|+.||+.||+|||++||+||||||+|||
T Consensus       208 l~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nil  287 (573)
T 3uto_A          208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIM  287 (573)
T ss_dssp             HHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             HHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhcc
Confidence            4678999999999999999999999999999999999964 467999999999999999999999999999999999999


Q ss_pred             EccC--CCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           80 LDSY--GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        80 l~~~--~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      ++.+  +.+||+|||+|+..... ....+.|||+.|+|||++.+.+|. .++||||+||++|+|++|.+||.+.+....+
T Consensus       288 l~~~~~~~vKl~DFG~a~~~~~~-~~~~~~~GT~~y~APEv~~~~~y~-~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~  365 (573)
T 3uto_A          288 FTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETL  365 (573)
T ss_dssp             ESSSSCCCEEECCCSSCEECCTT-SEEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH
T ss_pred             ccCCCCCCEEEeeccceeEccCC-CceeeeEECccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH
Confidence            9854  89999999999876543 445678999999999999988875 8999999999999999999999999998888


Q ss_pred             HHhhcccCCCC----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 016865          158 KKINAAEFSCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  208 (381)
Q Consensus       158 ~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~  208 (381)
                      .++....+.++    ..+|+++++||.+||+.||.+|||++|+|+||||+....+
T Consensus       366 ~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~  420 (573)
T 3uto_A          366 RNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  420 (573)
T ss_dssp             HHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred             HHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence            88887776554    3489999999999999999999999999999999976554

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=6.8e-50  Score=378.73  Aligned_cols=200  Identities=22%  Similarity=0.333  Sum_probs=178.6

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-------------GRLLENDCRRYFQQLIDAVAHCHSKG   67 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-------------~~l~e~~~~~~~~qll~~L~~LH~~g   67 (381)
                      |++++|||||++++++.+.+.+|||||||+||+|.++|...             ..+++.++..++.|+++||+|||+++
T Consensus        69 l~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~  148 (299)
T 4asz_A           69 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH  148 (299)
T ss_dssp             HTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            57899999999999999999999999999999999999764             36899999999999999999999999


Q ss_pred             CeecCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-C
Q 016865           68 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-G  144 (381)
Q Consensus        68 i~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G  144 (381)
                      |+||||||+|||+++++.+||+|||+|+......  ......+||+.|+|||++.+..|+ .++||||+||+||||+| |
T Consensus       149 iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~k~DVwS~Gvvl~Ellt~G  227 (299)
T 4asz_A          149 FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYG  227 (299)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTT
T ss_pred             cccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHcCC
Confidence            9999999999999999999999999997544322  223345799999999999888875 99999999999999999 9


Q ss_pred             CCCCCCCChhHHHHHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          145 YLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       145 ~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      +.||.+.+..+....+..+. ...|..+|+++.+||.+||+.||.+|||++++.  +|++
T Consensus       228 ~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~  285 (299)
T 4asz_A          228 KQPWYQLSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ  285 (299)
T ss_dssp             CCTTTTSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred             CCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence            99999988888888877654 467888999999999999999999999999984  4664

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.4e-49  Score=376.74  Aligned_cols=198  Identities=27%  Similarity=0.445  Sum_probs=157.6

Q ss_pred             CCCCCccccccceEEEEeCC------------EEEEEEecCCCCChHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHH
Q 016865            1 MKIVRHPNIVRLHEVLASRT------------KVYIILEFVTGGELFDKIVHQGRL---LENDCRRYFQQLIDAVAHCHS   65 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~------------~~~lV~E~~~gg~L~~~i~~~~~l---~e~~~~~~~~qll~~L~~LH~   65 (381)
                      |++++|||||++++++.+.+            .+|||||||+||+|.+++...+.+   ++..++.++.||+.||+|||+
T Consensus        57 l~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~  136 (299)
T 4g31_A           57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS  136 (299)
T ss_dssp             HTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH
Confidence            57899999999999997654            479999999999999999876554   456789999999999999999


Q ss_pred             CCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCc------------cccccccCCCCCCCCceecCCCCCCCcccHhH
Q 016865           66 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV------------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWS  133 (381)
Q Consensus        66 ~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwS  133 (381)
                      +||+||||||+|||++.+|.+||+|||+|+......            ....+.|||+.|||||++.+..|+ .++||||
T Consensus       137 ~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwS  215 (299)
T 4g31_A          137 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFS  215 (299)
T ss_dssp             TTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCC-THHHHHH
T ss_pred             CcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCC-CHHHHHH
Confidence            999999999999999999999999999998754321            123456899999999999988875 8999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCh-hHHHHHhhcccCCCCC---CCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          134 CGVILFVLMAGYLPFGETDL-PTLYKKINAAEFSCPF---WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       134 lGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~~~p~---~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      |||++|||++   ||..... ......+..  ...|+   ..++.+.+||.+||++||.+|||+.|+++||||+.
T Consensus       216 lGvilyell~---Pf~~~~~~~~~~~~~~~--~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~  285 (299)
T 4g31_A          216 LGLILFELLY---PFSTQMERVRTLTDVRN--LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED  285 (299)
T ss_dssp             HHHHHHHHHS---CCSSHHHHHHHHHHHHT--TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred             HHHHHHHHcc---CCCCccHHHHHHHHHhc--CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence            9999999996   8864322 122223332  23332   25678899999999999999999999999999975

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.1e-49  Score=374.06  Aligned_cols=198  Identities=21%  Similarity=0.334  Sum_probs=162.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |++++|||||++++++. ++.+|||||||+||+|.+++... +.+++..+..++.|++.||+|||++||+||||||+|||
T Consensus        86 l~~l~HpNIV~l~g~~~-~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NIL  164 (307)
T 3omv_A           86 LRKTRHVNILLFMGYMT-KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIF  164 (307)
T ss_dssp             HTTCCCTTBCCEEEEEC-SSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEE
T ss_pred             HHhCCCCCEeeEEEEEE-CCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEE
Confidence            57899999999999875 45689999999999999999764 57999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCC--CccccccccCCCCCCCCceecCCC--CCCCcccHhHHHHHHHHHHhCCCCCCCCChhH
Q 016865           80 LDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEVLSNRG--YDGSAADVWSCGVILFVLMAGYLPFGETDLPT  155 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  155 (381)
                      +++++++||+|||+|+....  ......+.+||+.|||||++.+..  .++.++|||||||+||||+||+.||.+.+...
T Consensus       165 l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~  244 (307)
T 3omv_A          165 LHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD  244 (307)
T ss_dssp             EETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH
T ss_pred             ECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH
Confidence            99999999999999987543  223356779999999999996432  23489999999999999999999998766544


Q ss_pred             HH-HHhhcccC-----CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          156 LY-KKINAAEF-----SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       156 ~~-~~i~~~~~-----~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      .. ..+..+..     ..+..+|+++.+||.+||+.||.+|||+.+++++
T Consensus       245 ~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          245 QIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             HHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             HHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            33 33333221     2345689999999999999999999999987543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.7e-49  Score=377.76  Aligned_cols=198  Identities=21%  Similarity=0.317  Sum_probs=170.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHH
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ---------------GRLLENDCRRYFQQLIDAVAHCHS   65 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~---------------~~l~e~~~~~~~~qll~~L~~LH~   65 (381)
                      |++++|||||++++++.+.+.+|||||||+||+|.+++...               +.+++.++..++.|++.||+|||+
T Consensus        97 l~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~  176 (329)
T 4aoj_A           97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG  176 (329)
T ss_dssp             HTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence            57899999999999999999999999999999999999753               358999999999999999999999


Q ss_pred             CCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh
Q 016865           66 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA  143 (381)
Q Consensus        66 ~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~  143 (381)
                      ++|+||||||+|||+++++.+||+|||+|+......  ....+.+||+.|+|||++.+..|+ .++|||||||+||||+|
T Consensus       177 ~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~~sDvwS~Gvvl~Ellt  255 (329)
T 4aoj_A          177 LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFT  255 (329)
T ss_dssp             TTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHT
T ss_pred             CCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCC-ccccccchHHHHHHHHc
Confidence            999999999999999999999999999998654321  223456899999999999888775 99999999999999999


Q ss_pred             -CCCCCCCCChhHHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          144 -GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       144 -G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                       |+.||.+.+..+....+..+ ....|..+|+++.+|+.+||+.||.+|||++|++++
T Consensus       256 ~G~~Pf~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          256 YGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             TSCCTTCSSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence             99999998888877777654 467788899999999999999999999999999863

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=5.6e-48  Score=370.62  Aligned_cols=205  Identities=43%  Similarity=0.807  Sum_probs=192.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus        68 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll  147 (328)
T 3fe3_A           68 MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL  147 (328)
T ss_dssp             HHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             HHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE
Confidence            35689999999999999999999999999999999999988999999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++++||+|||++...... ....+.+||+.|+|||++.+..+++.++||||+||++|+|++|.+||.+.+.......+
T Consensus       148 ~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i  226 (328)
T 3fe3_A          148 DADMNIKIADFGFSNEFTVG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV  226 (328)
T ss_dssp             CTTSCEEECSTTCCGGGSSS-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             cCCCCEEEeeccCceecCCC-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999999999765543 34567899999999999998888878999999999999999999999999999999999


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      ..+.+..|..+|+++.+||++||..||.+|||++++++||||+...
T Consensus       227 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          227 LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             HHCCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             HhCCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            9999999999999999999999999999999999999999998654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=9.3e-49  Score=372.42  Aligned_cols=198  Identities=24%  Similarity=0.383  Sum_probs=177.1

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHH
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ----------------GRLLENDCRRYFQQLIDAVAHCH   64 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~~L~~LH   64 (381)
                      |++++|||||++++++.+.+.+|||||||++|+|.++|...                ..+++..+..++.|++.||+|||
T Consensus        83 l~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH  162 (308)
T 4gt4_A           83 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS  162 (308)
T ss_dssp             HHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence            45789999999999999999999999999999999999642                35899999999999999999999


Q ss_pred             HCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCC--ccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHH
Q 016865           65 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM  142 (381)
Q Consensus        65 ~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll  142 (381)
                      +++|+||||||+|||+++++++||+|||+|+.....  .....+.+||+.|+|||++.+..|+ .++||||+||+||||+
T Consensus       163 ~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s-~ksDVwSfGvvl~El~  241 (308)
T 4gt4_A          163 SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVF  241 (308)
T ss_dssp             HTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHH
T ss_pred             hCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC-ccchhhhHHHHHHHHH
Confidence            999999999999999999999999999999865432  2234567899999999999887775 9999999999999999


Q ss_pred             h-CCCCCCCCChhHHHHHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          143 A-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       143 ~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      | |..||.+.+..+....+..+. .+.|..+|+++.+|+.+||+.||.+|||+.+|+++
T Consensus       242 t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          242 SYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             TTTCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hCCCCCCCCCCHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            8 899999988888888776654 46778899999999999999999999999999874

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.2e-46  Score=362.65  Aligned_cols=203  Identities=33%  Similarity=0.611  Sum_probs=188.9

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        59 l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll  138 (337)
T 1o6l_A           59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML  138 (337)
T ss_dssp             HHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE
T ss_pred             HHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE
Confidence            35689999999999999999999999999999999999988899999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.+|.+||+|||++...........+.+||+.|+|||++.+..|. .++||||+||++|+|++|.+||...+....+..+
T Consensus       139 ~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i  217 (337)
T 1o6l_A          139 DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI  217 (337)
T ss_dssp             CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCC-chhhcccchhHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            999999999999998654433456678999999999999887774 8999999999999999999999998888888888


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  204 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~-----t~~~il~hp~~~~  204 (381)
                      ......+|..+|+++.+||.+||+.||.+||     +++++++||||+.
T Consensus       218 ~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~  266 (337)
T 1o6l_A          218 LMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             HHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             HcCCCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence            8888889999999999999999999999999     9999999999974

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.5e-47  Score=368.74  Aligned_cols=199  Identities=33%  Similarity=0.641  Sum_probs=182.0

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCC
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG   84 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~   84 (381)
                      +||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|
T Consensus        82 ~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g  161 (353)
T 3txo_A           82 NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG  161 (353)
T ss_dssp             TCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS
T ss_pred             CCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCC
Confidence            79999999999999999999999999999999999888999999999999999999999999999999999999999999


Q ss_pred             CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc
Q 016865           85 NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE  164 (381)
Q Consensus        85 ~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~  164 (381)
                      ++||+|||++...........+.|||+.|+|||++.+..|. .++||||+||++|+|++|.+||...+....+..+....
T Consensus       162 ~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~  240 (353)
T 3txo_A          162 HCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYG-PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE  240 (353)
T ss_dssp             CEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCT-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             CEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcC-CccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence            99999999998654444456778999999999999877775 89999999999999999999999999999999999999


Q ss_pred             CCCCCCCChhHHHHHHHhcCCCCCCCCCH------HHHhcCccccc
Q 016865          165 FSCPFWFSTGATSLIHKILDPNPKTRIRI------EGIRKHPWFRK  204 (381)
Q Consensus       165 ~~~p~~~s~~~~~li~~~L~~dP~~R~t~------~~il~hp~~~~  204 (381)
                      ..+|.++++++.+||++||+.||.+||++      +++++||||+.
T Consensus       241 ~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~  286 (353)
T 3txo_A          241 VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE  286 (353)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred             CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence            99999999999999999999999999999      89999999975

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.8e-47  Score=369.84  Aligned_cols=197  Identities=22%  Similarity=0.339  Sum_probs=170.1

Q ss_pred             CCCC-ccccccceEEEEe-CCEEEEEEecCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHH
Q 016865            2 KIVR-HPNIVRLHEVLAS-RTKVYIILEFVTGGELFDKIVHQ----------------GRLLENDCRRYFQQLIDAVAHC   63 (381)
Q Consensus         2 k~l~-HpnIv~l~~~~~~-~~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~~L~~L   63 (381)
                      ++++ |||||+++++|.+ ++.+|||||||+||+|.++|...                ..+++..+..|+.|++.||+||
T Consensus       122 ~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yL  201 (353)
T 4ase_A          122 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL  201 (353)
T ss_dssp             HHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHH
T ss_pred             HHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhH
Confidence            3454 5999999999965 46799999999999999999753                3478999999999999999999


Q ss_pred             HHCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHH
Q 016865           64 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVL  141 (381)
Q Consensus        64 H~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~l  141 (381)
                      |+++|+||||||+|||+++++.+||+|||+|+......  ....+.+||+.|||||++.+..|+ .++|||||||+||||
T Consensus       202 H~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~-~ksDVwS~Gv~l~El  280 (353)
T 4ase_A          202 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEI  280 (353)
T ss_dssp             HHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHH
T ss_pred             hhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC-CcccEeehHHHHHHH
Confidence            99999999999999999999999999999998654422  233467899999999999988775 999999999999999


Q ss_pred             Hh-CCCCCCCCChh-HHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          142 MA-GYLPFGETDLP-TLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       142 l~-G~~Pf~~~~~~-~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      +| |..||.+.+.. .....+..+ ....|..+++++.+||.+||+.||.+|||+++|++|
T Consensus       281 ~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          281 FSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             TTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            98 99999886644 344445443 467788899999999999999999999999999987

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=7.2e-47  Score=364.10  Aligned_cols=204  Identities=47%  Similarity=0.951  Sum_probs=188.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+.+|+||||+ +|+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus        63 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll  141 (336)
T 3h4j_B           63 LKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL  141 (336)
T ss_dssp             HTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE
T ss_pred             HHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE
Confidence            46789999999999999999999999999 78999999988999999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.+||+|||++...... ....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+.......+
T Consensus       142 ~~~~~~kl~DFG~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i  220 (336)
T 3h4j_B          142 DDNLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV  220 (336)
T ss_dssp             CTTCCEEECCSSCTBTTTTS-BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC
T ss_pred             cCCCCEEEEEeccceeccCC-cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence            99999999999999876543 34567899999999999988777678999999999999999999999988777777777


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      ....+..|..+|+++.+||++||..||.+|||++|+++||||+...
T Consensus       221 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  266 (336)
T 3h4j_B          221 NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNL  266 (336)
T ss_dssp             CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred             HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCC
Confidence            7777888999999999999999999999999999999999998654

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.2e-46  Score=360.87  Aligned_cols=200  Identities=32%  Similarity=0.630  Sum_probs=187.3

Q ss_pred             CCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccC
Q 016865            4 VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY   83 (381)
Q Consensus         4 l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~   83 (381)
                      .+||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus        75 ~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~  154 (345)
T 1xjd_A           75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD  154 (345)
T ss_dssp             TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT
T ss_pred             CCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCC
Confidence            48999999999999999999999999999999999988899999999999999999999999999999999999999999


Q ss_pred             CCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc
Q 016865           84 GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA  163 (381)
Q Consensus        84 ~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~  163 (381)
                      |.+||+|||++...........+.+||+.|+|||++.+..|. .++||||+||++|+|++|..||.+.+....+..+...
T Consensus       155 g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~  233 (345)
T 1xjd_A          155 GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD  233 (345)
T ss_dssp             SCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             CCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCC-ChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC
Confidence            999999999998654433456778999999999999887774 8999999999999999999999999988889999888


Q ss_pred             cCCCCCCCChhHHHHHHHhcCCCCCCCCCHH-HHhcCccccc
Q 016865          164 EFSCPFWFSTGATSLIHKILDPNPKTRIRIE-GIRKHPWFRK  204 (381)
Q Consensus       164 ~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~-~il~hp~~~~  204 (381)
                      ...+|.++|+++.+||.+||..||.+|||+. ++++||||+.
T Consensus       234 ~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~  275 (345)
T 1xjd_A          234 NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE  275 (345)
T ss_dssp             CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccC
Confidence            8889999999999999999999999999998 9999999974

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=7.4e-46  Score=354.34  Aligned_cols=200  Identities=34%  Similarity=0.736  Sum_probs=186.9

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        60 l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll  139 (318)
T 1fot_A           60 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL  139 (318)
T ss_dssp             HHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE
T ss_pred             HhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE
Confidence            35689999999999999999999999999999999999988899999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.+|.+||+|||++.....   ...+.+||+.|+|||++.+..|. .++||||+||++|+|++|..||...+....+.++
T Consensus       140 ~~~g~~kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i  215 (318)
T 1fot_A          140 DKNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI  215 (318)
T ss_dssp             CTTSCEEECCCSSCEECSS---CBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             cCCCCEEEeecCcceecCC---ccccccCCccccCHhHhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            9999999999999976543   24567899999999999887775 8999999999999999999999998888888888


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  204 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~-----t~~~il~hp~~~~  204 (381)
                      ......+|..+++++.+||.+||..||.+|+     +++++++||||+.
T Consensus       216 ~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~  264 (318)
T 1fot_A          216 LNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE  264 (318)
T ss_dssp             HHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             HhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence            8888889999999999999999999999999     9999999999974

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1e-45  Score=358.48  Aligned_cols=199  Identities=31%  Similarity=0.600  Sum_probs=186.2

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCC
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG   84 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~   84 (381)
                      +||||+++++++++.+.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|
T Consensus        79 ~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g  158 (353)
T 2i0e_A           79 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG  158 (353)
T ss_dssp             CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS
T ss_pred             CCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC
Confidence            89999999999999999999999999999999999888999999999999999999999999999999999999999999


Q ss_pred             CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhccc
Q 016865           85 NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE  164 (381)
Q Consensus        85 ~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~  164 (381)
                      .+||+|||++...........+.+||+.|+|||++.+..|. .++||||+||++|+|++|.+||...+....++++....
T Consensus       159 ~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~  237 (353)
T 2i0e_A          159 HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN  237 (353)
T ss_dssp             CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             cEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcC-CcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC
Confidence            99999999998654433456678999999999999887774 89999999999999999999999999889999999888


Q ss_pred             CCCCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 016865          165 FSCPFWFSTGATSLIHKILDPNPKTRIR-----IEGIRKHPWFRK  204 (381)
Q Consensus       165 ~~~p~~~s~~~~~li~~~L~~dP~~R~t-----~~~il~hp~~~~  204 (381)
                      ..+|..+|+++.+||.+||..||.+||+     ++++++||||+.
T Consensus       238 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~  282 (353)
T 2i0e_A          238 VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  282 (353)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence            9999999999999999999999999995     699999999974

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.4e-45  Score=360.13  Aligned_cols=203  Identities=33%  Similarity=0.594  Sum_probs=188.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        93 l~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll  172 (373)
T 2r5t_A           93 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL  172 (373)
T ss_dssp             BCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred             HHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE
Confidence            35689999999999999999999999999999999999988899999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.+|++||+|||++...........+.+||+.|+|||++.+..|. .++|||||||++|+|++|.+||...+....+.++
T Consensus       173 ~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i  251 (373)
T 2r5t_A          173 DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI  251 (373)
T ss_dssp             CTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHH
T ss_pred             CCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            999999999999998644333456678999999999999887775 8999999999999999999999999988999999


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCCCH----HHHhcCccccc
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRI----EGIRKHPWFRK  204 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~----~~il~hp~~~~  204 (381)
                      ......+|..+++++++||.+||+.||.+|+++    +++++||||+.
T Consensus       252 ~~~~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~  299 (373)
T 2r5t_A          252 LNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL  299 (373)
T ss_dssp             HHSCCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred             HhcccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence            888888899999999999999999999999987    69999999974

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.4e-45  Score=358.59  Aligned_cols=202  Identities=36%  Similarity=0.626  Sum_probs=184.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|++++...+.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus        69 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll  148 (361)
T 2yab_A           69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIML  148 (361)
T ss_dssp             HTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             HHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence            46789999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             ccCC----CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHH
Q 016865           81 DSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL  156 (381)
Q Consensus        81 ~~~~----~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~  156 (381)
                      +.++    .+||+|||++...... ....+.+||+.|+|||++.+..|. .++||||+||++|+|++|.+||.+.+....
T Consensus       149 ~~~~~~~~~vkl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~~ll~g~~Pf~~~~~~~~  226 (361)
T 2yab_A          149 LDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQET  226 (361)
T ss_dssp             SCTTSSSCCEEECCCSSCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred             eCCCCCccCEEEEecCCceEcCCC-CccccCCCCccEECchHHcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            8877    7999999999866543 334677899999999999877764 899999999999999999999999888888


Q ss_pred             HHHhhcccCCCC----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          157 YKKINAAEFSCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       157 ~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      +..+....+.++    ..+|+++++||.+||..||.+|||++++++||||+.
T Consensus       227 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  278 (361)
T 2yab_A          227 LANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (361)
T ss_dssp             HHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred             HHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence            888887776665    358999999999999999999999999999999974

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.5e-45  Score=362.42  Aligned_cols=200  Identities=34%  Similarity=0.639  Sum_probs=182.5

Q ss_pred             CCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccC
Q 016865            4 VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY   83 (381)
Q Consensus         4 l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~   83 (381)
                      .+||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus       110 ~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~  189 (396)
T 4dc2_A          110 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE  189 (396)
T ss_dssp             TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT
T ss_pred             CCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCC
Confidence            38999999999999999999999999999999999988899999999999999999999999999999999999999999


Q ss_pred             CCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCC---------Chh
Q 016865           84 GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET---------DLP  154 (381)
Q Consensus        84 ~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~---------~~~  154 (381)
                      |.+||+|||+++..........+.|||+.|+|||++.+..|. .++||||+||++|+|++|.+||...         ...
T Consensus       190 g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~-~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~  268 (396)
T 4dc2_A          190 GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED  268 (396)
T ss_dssp             SCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSTTTTC------CCHH
T ss_pred             CCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHH
Confidence            999999999998644444556788999999999999887775 9999999999999999999999632         233


Q ss_pred             HHHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCH------HHHhcCccccc
Q 016865          155 TLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRI------EGIRKHPWFRK  204 (381)
Q Consensus       155 ~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~------~~il~hp~~~~  204 (381)
                      ..++.+......+|..+|+++.+||++||+.||.+||++      +++++||||+.
T Consensus       269 ~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~  324 (396)
T 4dc2_A          269 YLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  324 (396)
T ss_dssp             HHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred             HHHHHHhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence            466777888889999999999999999999999999995      89999999974

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.7e-45  Score=355.72  Aligned_cols=200  Identities=35%  Similarity=0.651  Sum_probs=181.3

Q ss_pred             CCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccC
Q 016865            4 VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY   83 (381)
Q Consensus         4 l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~   83 (381)
                      .+||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus        67 ~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~  146 (345)
T 3a8x_A           67 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE  146 (345)
T ss_dssp             TTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT
T ss_pred             CCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC
Confidence            38999999999999999999999999999999999988899999999999999999999999999999999999999999


Q ss_pred             CCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCC---------CChh
Q 016865           84 GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE---------TDLP  154 (381)
Q Consensus        84 ~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~---------~~~~  154 (381)
                      |.+||+|||++...........+.+||+.|+|||++.+..| +.++||||+||++|+|++|..||..         .+..
T Consensus       147 g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  225 (345)
T 3a8x_A          147 GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED  225 (345)
T ss_dssp             SCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHH
T ss_pred             CCEEEEeccccccccCCCCcccccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHH
Confidence            99999999999864443345667899999999999988777 4899999999999999999999965         2334


Q ss_pred             HHHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCH------HHHhcCccccc
Q 016865          155 TLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRI------EGIRKHPWFRK  204 (381)
Q Consensus       155 ~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~------~~il~hp~~~~  204 (381)
                      ..++.+......+|..+|+++.+||.+||+.||.+|||+      +++++||||+.
T Consensus       226 ~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~  281 (345)
T 3a8x_A          226 YLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  281 (345)
T ss_dssp             HHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred             HHHHHHHcCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence            556677777888899999999999999999999999995      89999999974

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.8e-45  Score=365.74  Aligned_cols=203  Identities=42%  Similarity=0.789  Sum_probs=185.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+..|+||||++||+|++.+...+.+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus        64 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll  143 (444)
T 3soa_A           64 CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLL  143 (444)
T ss_dssp             HHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEE
T ss_pred             HHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE
Confidence            35689999999999999999999999999999999999998899999999999999999999999999999999999999


Q ss_pred             c---cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           81 D---SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        81 ~---~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      +   .++.+||+|||++.............+||+.|+|||++.+..|. .++||||+||++|+|++|.+||.+.+....+
T Consensus       144 ~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyell~G~~Pf~~~~~~~~~  222 (444)
T 3soa_A          144 ASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYG-KPVDLWACGVILYILLVGYPPFWDEDQHRLY  222 (444)
T ss_dssp             SBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             eccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence            8   45789999999998766544455678899999999999877775 8999999999999999999999999888888


Q ss_pred             HHhhcccCCCCC----CCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          158 KKINAAEFSCPF----WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       158 ~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      ..+..+.+..|.    .+|+++.+||.+||+.||.+|||+.++++||||+.
T Consensus       223 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          223 QQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             HHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             HHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence            888877765543    47999999999999999999999999999999975

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.8e-45  Score=354.90  Aligned_cols=200  Identities=34%  Similarity=0.670  Sum_probs=187.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        95 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll  174 (350)
T 1rdq_E           95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI  174 (350)
T ss_dssp             HTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             HHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE
Confidence            46789999999999999999999999999999999999988899999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.+|.+||+|||++......   ..+.+||+.|+|||++.+..|. .++||||+||++|+|++|.+||...+....+.++
T Consensus       175 ~~~g~~kL~DFg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i  250 (350)
T 1rdq_E          175 DQQGYIQVTDFGFAKRVKGR---TWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI  250 (350)
T ss_dssp             CTTSCEEECCCTTCEECSSC---BCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCCCCEEEcccccceeccCC---cccccCCccccCHHHhcCCCCC-CcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHH
Confidence            99999999999999865432   3567899999999999887775 8999999999999999999999999888889999


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIR-----IEGIRKHPWFRK  204 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t-----~~~il~hp~~~~  204 (381)
                      ..+...+|..+++++.+||.+||+.||.+||+     ++++++||||+.
T Consensus       251 ~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~  299 (350)
T 1rdq_E          251 VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             HHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             HcCCCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence            88888999999999999999999999999998     999999999974

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.4e-45  Score=351.75  Aligned_cols=203  Identities=34%  Similarity=0.659  Sum_probs=182.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus        75 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill  154 (327)
T 3a62_A           75 LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML  154 (327)
T ss_dssp             HHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE
T ss_pred             HHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE
Confidence            35679999999999999999999999999999999999988889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.+|.+||+|||++.............+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+.......+
T Consensus       155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i  233 (327)
T 3a62_A          155 NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI  233 (327)
T ss_dssp             CTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             CCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            99999999999998765443344567789999999999987766 48999999999999999999999998888888888


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  204 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~-----t~~~il~hp~~~~  204 (381)
                      .......|..+++++.+||.+||..||.+||     +++++++||||+.
T Consensus       234 ~~~~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~  282 (327)
T 3a62_A          234 LKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH  282 (327)
T ss_dssp             HHTCCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred             HhCCCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence            8888889999999999999999999999999     8999999999974

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=6.1e-45  Score=363.33  Aligned_cols=203  Identities=34%  Similarity=0.614  Sum_probs=187.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||
T Consensus       202 l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIl  281 (446)
T 4ejn_A          202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM  281 (446)
T ss_dssp             CCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEE
T ss_pred             HHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEE
Confidence            56789999999999999999999999999999999999988899999999999999999999998 99999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      ++.++.+||+|||++...........+.+||+.|+|||++.+..|. .++||||+||++|+|++|.+||...+.......
T Consensus       282 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~  360 (446)
T 4ejn_A          282 LDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL  360 (446)
T ss_dssp             ECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             ECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence            9999999999999998654444456678999999999999887774 999999999999999999999999998888888


Q ss_pred             hhcccCCCCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 016865          160 INAAEFSCPFWFSTGATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  204 (381)
Q Consensus       160 i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~-----t~~~il~hp~~~~  204 (381)
                      +......+|..+++++.+||.+||+.||.+||     |++++++||||+.
T Consensus       361 i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~  410 (446)
T 4ejn_A          361 ILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG  410 (446)
T ss_dssp             HHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHhCCCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence            88888889999999999999999999999999     9999999999974

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=7e-45  Score=343.74  Aligned_cols=202  Identities=24%  Similarity=0.451  Sum_probs=179.5

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      +.++||||+++++++.+.+.+|+||||++||+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++
T Consensus        72 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~  150 (297)
T 3fxz_A           72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG  150 (297)
T ss_dssp             HHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred             hcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEC
Confidence            568999999999999999999999999999999999876 4699999999999999999999999999999999999999


Q ss_pred             cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhh
Q 016865           82 SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN  161 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~  161 (381)
                      .++.+||+|||++...........+.+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+.......+.
T Consensus       151 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  229 (297)
T 3fxz_A          151 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA  229 (297)
T ss_dssp             TTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred             CCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99999999999988765544445677899999999999887774 89999999999999999999998877655544443


Q ss_pred             cc---cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          162 AA---EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       162 ~~---~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ..   ....|..+++.+.+||.+||+.||.+|||++++++||||+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          230 TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             HHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             hCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence            22   334566789999999999999999999999999999999854

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.5e-44  Score=351.37  Aligned_cols=201  Identities=42%  Similarity=0.794  Sum_probs=182.0

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      +.++||||+++++++.+.+..|+||||++||+|++.+...+.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus        83 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~  162 (362)
T 2bdw_A           83 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA  162 (362)
T ss_dssp             HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEES
T ss_pred             HhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEe
Confidence            56899999999999999999999999999999999998888899999999999999999999999999999999999998


Q ss_pred             cCC---CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016865           82 SYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK  158 (381)
Q Consensus        82 ~~~---~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~  158 (381)
                      .++   .+||+|||++...... ......+||+.|+|||++.+..|. .++|||||||++|+|++|.+||...+....+.
T Consensus       163 ~~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~  240 (362)
T 2bdw_A          163 SKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYA  240 (362)
T ss_dssp             CSSTTCCEEECCCTTCBCCTTC-CSCCCSCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             cCCCCCCEEEeecCcceEecCC-cccccCCCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            654   5999999999876543 334567899999999999877775 89999999999999999999999988888888


Q ss_pred             HhhcccCCCCC----CCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          159 KINAAEFSCPF----WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       159 ~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      .+..+.+..|.    .+++++.+||.+||+.||.+|||+.++++||||..
T Consensus       241 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          241 QIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             HHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             HHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            88777665553    37999999999999999999999999999999974

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-45  Score=349.14  Aligned_cols=203  Identities=29%  Similarity=0.559  Sum_probs=182.6

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||
T Consensus        55 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl  134 (321)
T 1tki_A           55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENII  134 (321)
T ss_dssp             HHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             HHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEE
Confidence            356899999999999999999999999999999999997654 6999999999999999999999999999999999999


Q ss_pred             Ecc--CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           80 LDS--YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        80 l~~--~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      ++.  ++.+||+|||++...... ......+||+.|+|||++.+..+ +.++||||+||++|+|++|.+||...+.....
T Consensus       135 ~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  212 (321)
T 1tki_A          135 YQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQII  212 (321)
T ss_dssp             ESSSSCCCEEECCCTTCEECCTT-CEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred             EccCCCCCEEEEECCCCeECCCC-CccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHH
Confidence            997  789999999999876543 33456789999999999977655 48999999999999999999999998888888


Q ss_pred             HHhhcccCCCC----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          158 KKINAAEFSCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       158 ~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ..+....+..+    ..+|+++.+||.+||..||.+|||+.|+++||||+..
T Consensus       213 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          213 ENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence            88877776655    3589999999999999999999999999999999864

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.2e-44  Score=343.72  Aligned_cols=202  Identities=35%  Similarity=0.632  Sum_probs=181.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus        68 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll  147 (326)
T 2y0a_A           68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIML  147 (326)
T ss_dssp             HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             HHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEE
Confidence            35679999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             ccCC----CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHH
Q 016865           81 DSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL  156 (381)
Q Consensus        81 ~~~~----~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~  156 (381)
                      +.++    .+||+|||++...... ......+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+....
T Consensus       148 ~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~  225 (326)
T 2y0a_A          148 LDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQET  225 (326)
T ss_dssp             SCSSSSSCCEEECCCTTCEECCTT-SCCCCCCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred             ecCCCCCCCEEEEECCCCeECCCC-CccccccCCcCcCCceeecCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHH
Confidence            9887    7999999999866443 234567899999999999876664 899999999999999999999998887777


Q ss_pred             HHHhhcccCCCC----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          157 YKKINAAEFSCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       157 ~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      ...+....+..+    ..+|+.+.+||.+||..||.+|||++++++||||+.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  277 (326)
T 2y0a_A          226 LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  277 (326)
T ss_dssp             HHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred             HHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence            777766655544    357999999999999999999999999999999975

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.1e-44  Score=351.66  Aligned_cols=203  Identities=26%  Similarity=0.528  Sum_probs=181.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+.+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus        69 l~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll  148 (384)
T 4fr4_A           69 MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL  148 (384)
T ss_dssp             HHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             HHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE
Confidence            35789999999999999999999999999999999999988899999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCC--CCCCcccHhHHHHHHHHHHhCCCCCCCC---ChhH
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG--YDGSAADVWSCGVILFVLMAGYLPFGET---DLPT  155 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~~DIwSlGvil~~ll~G~~Pf~~~---~~~~  155 (381)
                      +.+|.+||+|||++...... ....+.+||+.|+|||++.+..  ..+.++||||+||++|+|++|..||...   ....
T Consensus       149 ~~~g~vkL~DFG~a~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~  227 (384)
T 4fr4_A          149 DEHGHVHITDFNIAAMLPRE-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE  227 (384)
T ss_dssp             CTTSCEEECCCTTCEECCTT-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHH
T ss_pred             CCCCCEEEeccceeeeccCC-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHH
Confidence            99999999999999865443 3456789999999999986422  2358999999999999999999999753   3345


Q ss_pred             HHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCC-HHHHhcCccccc
Q 016865          156 LYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIR-IEGIRKHPWFRK  204 (381)
Q Consensus       156 ~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t-~~~il~hp~~~~  204 (381)
                      ....+......+|..+|+++.+||.+||+.||.+||+ ++++++||||+.
T Consensus       228 ~~~~~~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~  277 (384)
T 4fr4_A          228 IVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND  277 (384)
T ss_dssp             HHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred             HHHHHhhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence            5666677778889999999999999999999999998 899999999974

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.9e-44  Score=350.28  Aligned_cols=205  Identities=44%  Similarity=0.783  Sum_probs=168.9

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      +.++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus        71 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~  150 (361)
T 3uc3_A           71 RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLD  150 (361)
T ss_dssp             HHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEEC
T ss_pred             HhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc
Confidence            56899999999999999999999999999999999998888999999999999999999999999999999999999998


Q ss_pred             cCCC--EEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh----hH
Q 016865           82 SYGN--LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL----PT  155 (381)
Q Consensus        82 ~~~~--lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~----~~  155 (381)
                      .++.  +||+|||++...... ......+||+.|+|||++.+..+++.++||||+||++|+|++|++||...+.    ..
T Consensus       151 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~  229 (361)
T 3uc3_A          151 GSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRK  229 (361)
T ss_dssp             SSSSCCEEECCCCCC----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHH
T ss_pred             CCCCceEEEeecCcccccccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHH
Confidence            7765  999999998754332 2345668999999999998888876669999999999999999999976543    34


Q ss_pred             HHHHhhcccCCCCC--CCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 016865          156 LYKKINAAEFSCPF--WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  207 (381)
Q Consensus       156 ~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~  207 (381)
                      ..+.+....+..|.  .+++++.+||.+||+.||.+|||++++++||||.+...
T Consensus       230 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  283 (361)
T 3uc3_A          230 TIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLP  283 (361)
T ss_dssp             HHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred             HHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence            44455555555555  47999999999999999999999999999999976543

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.4e-44  Score=357.04  Aligned_cols=202  Identities=33%  Similarity=0.572  Sum_probs=180.1

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      +.++||||+++++++.+.+.+|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus       124 ~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~  202 (410)
T 3v8s_A          124 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD  202 (410)
T ss_dssp             HHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred             HhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeEC
Confidence            457999999999999999999999999999999998876 5799999999999999999999999999999999999999


Q ss_pred             cCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCC---CCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           82 SYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRG---YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~---~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      .+|.+||+|||++....... ....+.+||+.|+|||++.+.+   +.+.++||||+||++|+|++|.+||...+....+
T Consensus       203 ~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~  282 (410)
T 3v8s_A          203 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY  282 (410)
T ss_dssp             TTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred             CCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHH
Confidence            99999999999997654422 2345789999999999998655   1358999999999999999999999999988888


Q ss_pred             HHhhccc--CCCCC--CCChhHHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 016865          158 KKINAAE--FSCPF--WFSTGATSLIHKILDPNPKT--RIRIEGIRKHPWFRK  204 (381)
Q Consensus       158 ~~i~~~~--~~~p~--~~s~~~~~li~~~L~~dP~~--R~t~~~il~hp~~~~  204 (381)
                      .++....  +.+|.  .+|+++++||.+||..+|.+  |+++++|++||||+.
T Consensus       283 ~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~  335 (410)
T 3v8s_A          283 SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN  335 (410)
T ss_dssp             HHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred             HHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence            8876542  44554  58999999999999999988  999999999999985

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.7e-44  Score=336.35  Aligned_cols=205  Identities=32%  Similarity=0.500  Sum_probs=171.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+.+|+||||++| +|.+.+.. .+.+++..++.++.|++.||+|||++||+||||||+|||
T Consensus        55 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil  133 (292)
T 3o0g_A           55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLL  133 (292)
T ss_dssp             HTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             HhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            4678999999999999999999999999986 55555544 678999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCC-CCCCChhHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLP-FGETDLPTLYK  158 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~P-f~~~~~~~~~~  158 (381)
                      ++.++.+||+|||++.............+||+.|+|||++.+....+.++||||+||++|+|++|..| |...+......
T Consensus       134 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~  213 (292)
T 3o0g_A          134 INRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK  213 (292)
T ss_dssp             ECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHH
T ss_pred             EcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHH
Confidence            99999999999999987655444556778999999999998776556999999999999999987777 55555554444


Q ss_pred             Hhhccc-----------------------------CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          159 KINAAE-----------------------------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       159 ~i~~~~-----------------------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      .+....                             ...++.+++++++||.+||+.||.+|||++|+++||||+...
T Consensus       214 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          214 RIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             HHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             HHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence            432110                             011224788999999999999999999999999999998643

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.4e-44  Score=343.56  Aligned_cols=203  Identities=38%  Similarity=0.739  Sum_probs=159.2

Q ss_pred             CCC-ccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            3 IVR-HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         3 ~l~-HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      .+. ||||+++++++.+....|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++
T Consensus        61 ~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~  140 (325)
T 3kn6_A           61 LCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFT  140 (325)
T ss_dssp             HTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEE
T ss_pred             HhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEe
Confidence            344 9999999999999999999999999999999999988999999999999999999999999999999999999998


Q ss_pred             cCC---CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh-----
Q 016865           82 SYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL-----  153 (381)
Q Consensus        82 ~~~---~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-----  153 (381)
                      .++   .+||+|||++...........+.+||+.|+|||++.+..|+ .++||||+||++|+|++|..||...+.     
T Consensus       141 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  219 (325)
T 3kn6_A          141 DENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT  219 (325)
T ss_dssp             C----CEEEECCCTTCEECCC----------------------CCCC-HHHHHHHHHHHHHHHHHSSCTTC-------CC
T ss_pred             cCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCccccccc
Confidence            766   79999999998665544556778899999999999887775 899999999999999999999976432     


Q ss_pred             --hHHHHHhhcccCCCCC----CCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          154 --PTLYKKINAAEFSCPF----WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       154 --~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                        ......+..+.+..+.    .+|+++.+||.+||+.||.+|||++++++||||+...
T Consensus       220 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~  278 (325)
T 3kn6_A          220 SAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS  278 (325)
T ss_dssp             CHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred             cHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence              4556667766665553    4799999999999999999999999999999998654

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=8.7e-44  Score=339.15  Aligned_cols=207  Identities=31%  Similarity=0.504  Sum_probs=176.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK   74 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlk   74 (381)
                      |+.++||||+++++++.+.+.+|+||||++ |+|.+++...      ..+++..++.++.||+.||.|||++||+|||||
T Consensus        57 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlk  135 (317)
T 2pmi_A           57 MKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLK  135 (317)
T ss_dssp             HTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             HHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence            467899999999999999999999999998 5999988653      358999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           75 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        75 p~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      |+|||++.+|.+||+|||++.............+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..
T Consensus       136 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  215 (317)
T 2pmi_A          136 PQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE  215 (317)
T ss_dssp             GGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             hHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence            99999999999999999999876544344556789999999999977554569999999999999999999999887766


Q ss_pred             HHHHHhhccc----------------------------------CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 016865          155 TLYKKINAAE----------------------------------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHP  200 (381)
Q Consensus       155 ~~~~~i~~~~----------------------------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp  200 (381)
                      .....+....                                  ...+..+++++.+||.+||+.||.+|||++++++||
T Consensus       216 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp  295 (317)
T 2pmi_A          216 EQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP  295 (317)
T ss_dssp             HHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred             HHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCCh
Confidence            5554442110                                  011224788999999999999999999999999999


Q ss_pred             ccccCCCC
Q 016865          201 WFRKNYNP  208 (381)
Q Consensus       201 ~~~~~~~~  208 (381)
                      ||+..+.+
T Consensus       296 ~f~~~~~~  303 (317)
T 2pmi_A          296 WFAEYYHH  303 (317)
T ss_dssp             GGGGGCC-
T ss_pred             hhhcccch
Confidence            99876543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=5.4e-44  Score=373.58  Aligned_cols=200  Identities=31%  Similarity=0.594  Sum_probs=188.1

Q ss_pred             CCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccC
Q 016865            4 VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY   83 (381)
Q Consensus         4 l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~   83 (381)
                      .+||||+++++++++.+.+||||||++||+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+
T Consensus       399 ~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~  478 (674)
T 3pfq_A          399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE  478 (674)
T ss_dssp             TCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSS
T ss_pred             cCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCC
Confidence            37999999999999999999999999999999999998899999999999999999999999999999999999999999


Q ss_pred             CCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc
Q 016865           84 GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA  163 (381)
Q Consensus        84 ~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~  163 (381)
                      |++||+|||+++..........+.+||+.|+|||++.+..|. .++||||+||+||||++|.+||.+.+...+++.+...
T Consensus       479 g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  557 (674)
T 3pfq_A          479 GHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH  557 (674)
T ss_dssp             SCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS
T ss_pred             CcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCC-ccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC
Confidence            999999999998644433456778999999999999887774 9999999999999999999999999999999999999


Q ss_pred             cCCCCCCCChhHHHHHHHhcCCCCCCCCCH-----HHHhcCccccc
Q 016865          164 EFSCPFWFSTGATSLIHKILDPNPKTRIRI-----EGIRKHPWFRK  204 (381)
Q Consensus       164 ~~~~p~~~s~~~~~li~~~L~~dP~~R~t~-----~~il~hp~~~~  204 (381)
                      ...+|..+|+++.+||++||+.||.+|+++     ++|++||||+.
T Consensus       558 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~  603 (674)
T 3pfq_A          558 NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  603 (674)
T ss_dssp             CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred             CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence            999999999999999999999999999998     99999999974

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=6.8e-44  Score=332.91  Aligned_cols=203  Identities=36%  Similarity=0.686  Sum_probs=183.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+..|+||||+++|+|.+.+...+.+++..++.++.|++.||.|||++||+||||||+||++
T Consensus        63 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili  142 (279)
T 3fdn_A           63 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL  142 (279)
T ss_dssp             HTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE
T ss_pred             HHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE
Confidence            46789999999999999999999999999999999999988899999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.+||+|||++......  .....+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+.......+
T Consensus       143 ~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  219 (279)
T 3fdn_A          143 GSAGELKIADFGWSVHAPSS--RRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI  219 (279)
T ss_dssp             CTTSCEEECSCCEESCC----------CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             cCCCCEEEEeccccccCCcc--cccccCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH
Confidence            99999999999998654432  2345689999999999987665 48999999999999999999999999888888888


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      .......|..+++++.+||.+||+.||.+|||++++++||||+...
T Consensus       220 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          220 SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             HHTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             HhCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence            8888889999999999999999999999999999999999998654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.4e-44  Score=343.26  Aligned_cols=197  Identities=20%  Similarity=0.324  Sum_probs=155.1

Q ss_pred             CCCCCccccccceEEEEeCC----EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CC
Q 016865            1 MKIVRHPNIVRLHEVLASRT----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK--------GV   68 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~----~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~--------gi   68 (381)
                      |.+++|||||++++++.+.+    .+|||||||+||+|.+++.. .+++++.+..++.|++.||+|||++        ||
T Consensus        51 ~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~I  129 (303)
T 3hmm_A           51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI  129 (303)
T ss_dssp             STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCE
T ss_pred             HhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCE
Confidence            45789999999999998654    68999999999999999976 5699999999999999999999987        99


Q ss_pred             eecCCCCCcEEEccCCCEEEeeccCccCCCCCcc----ccccccCCCCCCCCceecCCCC-----CCCcccHhHHHHHHH
Q 016865           69 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE----LLHTTCGTPNYVAPEVLSNRGY-----DGSAADVWSCGVILF  139 (381)
Q Consensus        69 ~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~-----~~~~~DIwSlGvil~  139 (381)
                      +||||||+|||++.++++||+|||+|+.......    ...+.+||+.|+|||++.+...     .+.++|||||||+||
T Consensus       130 iHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~  209 (303)
T 3hmm_A          130 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW  209 (303)
T ss_dssp             ECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHH
T ss_pred             eeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHH
Confidence            9999999999999999999999999986543221    2345689999999999976421     236899999999999


Q ss_pred             HHHhCCCCCCCCC---------------hhHHHHHhhccc--CCCCCC-----CChhHHHHHHHhcCCCCCCCCCHHHHh
Q 016865          140 VLMAGYLPFGETD---------------LPTLYKKINAAE--FSCPFW-----FSTGATSLIHKILDPNPKTRIRIEGIR  197 (381)
Q Consensus       140 ~ll~G~~Pf~~~~---------------~~~~~~~i~~~~--~~~p~~-----~s~~~~~li~~~L~~dP~~R~t~~~il  197 (381)
                      ||+||.+||....               .......+....  ...|..     .++.+.+|+.+||+.||.+|||+.+++
T Consensus       210 El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~  289 (303)
T 3hmm_A          210 EIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK  289 (303)
T ss_dssp             HHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHH
T ss_pred             HHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHH
Confidence            9999987764321               122223332222  233332     224678999999999999999999988


Q ss_pred             c
Q 016865          198 K  198 (381)
Q Consensus       198 ~  198 (381)
                      +
T Consensus       290 ~  290 (303)
T 3hmm_A          290 K  290 (303)
T ss_dssp             H
T ss_pred             H
Confidence            6

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.8e-44  Score=345.18  Aligned_cols=205  Identities=39%  Similarity=0.696  Sum_probs=178.5

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      +.++||||+++++++.+.+..|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus        60 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~  139 (323)
T 3tki_A           60 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD  139 (323)
T ss_dssp             HHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             HhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEe
Confidence            56799999999999999999999999999999999998888899999999999999999999999999999999999999


Q ss_pred             cCCCEEEeeccCccCCCCC--ccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh-HHHH
Q 016865           82 SYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYK  158 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~  158 (381)
                      .++.+||+|||++......  .......+||+.|+|||++.+..+.+.++||||+||++|+|++|..||...+.. ..+.
T Consensus       140 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  219 (323)
T 3tki_A          140 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS  219 (323)
T ss_dssp             TTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH
T ss_pred             CCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Confidence            9999999999999765322  223456789999999999988777668999999999999999999999876543 3333


Q ss_pred             HhhcccCCCC--CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          159 KINAAEFSCP--FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       159 ~i~~~~~~~p--~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      .+.......+  ..+++++.+||.+||..||.+|||++|+++||||+...
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          220 DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             HHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence            3333333333  34899999999999999999999999999999998654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.8e-44  Score=338.93  Aligned_cols=202  Identities=37%  Similarity=0.657  Sum_probs=177.5

Q ss_pred             CCCCCccccccceEEEEe--CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLAS--RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||+++++++.+  ...+|+||||+++|+|.+++ ..+.+++..++.++.|++.||+|||++||+||||||+||
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL  168 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            357899999999999987  67899999999999998754 346799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCC--CCCcccHhHHHHHHHHHHhCCCCCCCCChhHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY--DGSAADVWSCGVILFVLMAGYLPFGETDLPTL  156 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~--~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~  156 (381)
                      |++.++.+||+|||++.............+||+.|+|||++.+...  .+.++||||+||++|+|++|..||...+....
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  248 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL  248 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence            9999999999999999876554444566789999999999976543  35789999999999999999999998887777


Q ss_pred             HHHhhcccCCCC--CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          157 YKKINAAEFSCP--FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       157 ~~~i~~~~~~~p--~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      ...+.......|  ..+++++.+||.+||+.||.+|||+.++++||||+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          249 HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             HHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            777766655544  45899999999999999999999999999999996

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.4e-44  Score=346.33  Aligned_cols=201  Identities=33%  Similarity=0.655  Sum_probs=175.6

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      +.++||||+++++++.+.+.+|+||||++||+|.+.+...    ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus        81 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~N  160 (351)
T 3c0i_A           81 HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHC  160 (351)
T ss_dssp             HHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             HhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHH
Confidence            5679999999999999999999999999999999888643    248999999999999999999999999999999999


Q ss_pred             EEEccCCC---EEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           78 LLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        78 iLl~~~~~---lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      ||++.++.   +||+|||++.............+||+.|+|||++.+..|. .++||||+||++|+|++|..||...+ .
T Consensus       161 Il~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~-~  238 (351)
T 3c0i_A          161 VLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYG-KPVDVWGCGVILFILLSGCLPFYGTK-E  238 (351)
T ss_dssp             EEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCSSH-H
T ss_pred             eEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCC-chHhhHHHHHHHHHHHHCCCCCCCcH-H
Confidence            99987665   9999999998765543445667899999999999877764 89999999999999999999998753 4


Q ss_pred             HHHHHhhcccCCCC----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          155 TLYKKINAAEFSCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       155 ~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      .....+..+.+..+    ..+|+++.+||.+||..||.+|||+.++++||||+.
T Consensus       239 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          239 RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             HHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence            45555655555444    358999999999999999999999999999999974

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.3e-44  Score=339.87  Aligned_cols=204  Identities=32%  Similarity=0.491  Sum_probs=171.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+.+|+||||++| +|.+.+... ..+++..++.++.|++.||.|||++||+||||||+|||
T Consensus        73 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl  151 (311)
T 3niz_A           73 LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLL  151 (311)
T ss_dssp             HHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             HHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEE
Confidence            3567999999999999999999999999985 888887664 45999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      ++.++.+||+|||++.............+||+.|+|||++.+....+.++||||+||++|+|++|..||...+.......
T Consensus       152 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  231 (311)
T 3niz_A          152 INSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK  231 (311)
T ss_dssp             ECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHH
T ss_pred             ECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            99999999999999987655444456678999999999997755556999999999999999999999987665544443


Q ss_pred             hhccc---------------------C---------CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          160 INAAE---------------------F---------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       160 i~~~~---------------------~---------~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      +....                     +         ...+.+++++.+||.+||+.||.+|||++|+++||||+.-
T Consensus       232 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  307 (311)
T 3niz_A          232 IFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL  307 (311)
T ss_dssp             HHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred             HHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence            32100                     0         0112367899999999999999999999999999999853

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.5e-44  Score=356.92  Aligned_cols=203  Identities=29%  Similarity=0.546  Sum_probs=178.9

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      +.++||||+++++++.+.+.+|+||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus       129 ~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl  208 (437)
T 4aw2_A          129 VNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM  208 (437)
T ss_dssp             HHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             HhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE
Confidence            457999999999999999999999999999999999987 5789999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecC----CCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhH
Q 016865           81 DSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSN----RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT  155 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  155 (381)
                      +.+|.+||+|||+|....... ......+||+.|+|||++..    ....+.++||||+||++|+|++|++||.+.+...
T Consensus       209 ~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~  288 (437)
T 4aw2_A          209 DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE  288 (437)
T ss_dssp             CTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             cCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH
Confidence            999999999999997654322 23345789999999999862    2333589999999999999999999999988888


Q ss_pred             HHHHhhcc--cCCCCCC---CChhHHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 016865          156 LYKKINAA--EFSCPFW---FSTGATSLIHKILDPNPKT--RIRIEGIRKHPWFRK  204 (381)
Q Consensus       156 ~~~~i~~~--~~~~p~~---~s~~~~~li~~~L~~dP~~--R~t~~~il~hp~~~~  204 (381)
                      .+.++...  .+.+|..   +|+++++||++||..+|++  |++++++++||||+.
T Consensus       289 ~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~  344 (437)
T 4aw2_A          289 TYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG  344 (437)
T ss_dssp             HHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred             HHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence            88877543  3555554   8999999999999998888  999999999999975

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4.2e-44  Score=345.59  Aligned_cols=201  Identities=36%  Similarity=0.677  Sum_probs=178.2

Q ss_pred             CCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccC
Q 016865            4 VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY   83 (381)
Q Consensus         4 l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~   83 (381)
                      .+||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+.++
T Consensus        73 ~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~  152 (342)
T 2qr7_A           73 GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDE  152 (342)
T ss_dssp             TTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSS
T ss_pred             cCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecC
Confidence            37999999999999999999999999999999999988889999999999999999999999999999999999998543


Q ss_pred             -C---CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCC---ChhHH
Q 016865           84 -G---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET---DLPTL  156 (381)
Q Consensus        84 -~---~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~---~~~~~  156 (381)
                       +   .+||+|||++...........+.+||+.|+|||++.+..|+ .++||||+||++|+|++|..||...   +....
T Consensus       153 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~  231 (342)
T 2qr7_A          153 SGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI  231 (342)
T ss_dssp             SCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHH
T ss_pred             CCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCC-CccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHH
Confidence             3   49999999998765544556678999999999999876665 8999999999999999999999753   44566


Q ss_pred             HHHhhcccCCCC----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          157 YKKINAAEFSCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       157 ~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ...+..+.+..+    ..+|+++.+||++||..||.+|||++++++||||...
T Consensus       232 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          232 LARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             HHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             HHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence            777777766544    3589999999999999999999999999999999653

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=9.3e-44  Score=333.90  Aligned_cols=203  Identities=29%  Similarity=0.480  Sum_probs=169.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+.+|+||||+++ +|.+.+... +.+++..++.++.|++.||+|||++||+||||||+|||
T Consensus        54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil  132 (288)
T 1ob3_A           54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLL  132 (288)
T ss_dssp             GGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             HHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence            4678999999999999999999999999976 999988764 67999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      ++.++.+||+|||++.............+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......
T Consensus       133 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  212 (288)
T 1ob3_A          133 INREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR  212 (288)
T ss_dssp             ECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             EcCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999999876544333445668999999999997655456999999999999999999999988776554444


Q ss_pred             hhcc--c------------------C---------CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          160 INAA--E------------------F---------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       160 i~~~--~------------------~---------~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      +...  .                  +         .....+++++.+||.+||+.||.+|||++++++||||+.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             HHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence            3211  0                  0         011347899999999999999999999999999999975

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.3e-43  Score=329.88  Aligned_cols=205  Identities=47%  Similarity=0.928  Sum_probs=179.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+..|+||||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++
T Consensus        65 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~  144 (276)
T 2h6d_A           65 LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL  144 (276)
T ss_dssp             HHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE
T ss_pred             HhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE
Confidence            35789999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.+||+|||++...... ......+||+.|+|||++.+..+.+.++||||+|+++|+|++|..||...+.......+
T Consensus       145 ~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  223 (276)
T 2h6d_A          145 DAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI  223 (276)
T ss_dssp             CTTSCEEECCCCGGGCCCC--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCCCCEEEeecccccccCCC-cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh
Confidence            99999999999999876543 23456689999999999987776668999999999999999999999998888888888


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      .......|..+++++.++|.+||+.||.+|||++++++||||+...
T Consensus       224 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  269 (276)
T 2h6d_A          224 RGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDL  269 (276)
T ss_dssp             HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             hcCcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence            8888888888999999999999999999999999999999998654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=330.15  Aligned_cols=204  Identities=33%  Similarity=0.631  Sum_probs=158.6

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+..|+||||+++|+|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+
T Consensus        65 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil  144 (278)
T 3cok_A           65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLL  144 (278)
T ss_dssp             HTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEE
T ss_pred             HHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence            36789999999999999999999999999999999999875 56999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      ++.++.+||+|||++.............+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+.......
T Consensus       145 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  223 (278)
T 3cok_A          145 LTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK  223 (278)
T ss_dssp             ECTTCCEEECCCTTCEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----
T ss_pred             EcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH
Confidence            999999999999999866543333456789999999999987665 4899999999999999999999988777666666


Q ss_pred             hhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          160 INAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       160 i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      +....+..|..+++++.+||.+||+.||.+|||++++++||||...
T Consensus       224 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          224 VVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             CCSSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             HhhcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence            6666677888899999999999999999999999999999999754

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.2e-43  Score=330.75  Aligned_cols=207  Identities=33%  Similarity=0.578  Sum_probs=189.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+..|+||||++|++|.+++...+.+++..++.++.|++.||+|||++||+||||||+||++
T Consensus        69 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~  148 (294)
T 2rku_A           69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL  148 (294)
T ss_dssp             HHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             HHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE
Confidence            35789999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.+||+|||++.............+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+....+..+
T Consensus       149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  227 (294)
T 2rku_A          149 NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI  227 (294)
T ss_dssp             CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             cCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999999999866543334456789999999999977665 48999999999999999999999998888888888


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  208 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~  208 (381)
                      .......|..+++.+.++|.+||+.||.+|||++++++||||.....+
T Consensus       228 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~  275 (294)
T 2rku_A          228 KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP  275 (294)
T ss_dssp             HTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             hhccCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence            888888888999999999999999999999999999999999876644

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3e-43  Score=337.96  Aligned_cols=207  Identities=33%  Similarity=0.578  Sum_probs=189.9

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+.+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus        95 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~  174 (335)
T 2owb_A           95 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL  174 (335)
T ss_dssp             HHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred             HHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE
Confidence            35789999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.+||+|||++.............+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+....+..+
T Consensus       175 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  253 (335)
T 2owb_A          175 NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI  253 (335)
T ss_dssp             CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             cCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH
Confidence            99999999999999866543344556789999999999987766 48999999999999999999999988888888888


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  208 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~  208 (381)
                      ....+..|..+++.+.+||.+||+.||.+|||++++++||||...+.+
T Consensus       254 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~  301 (335)
T 2owb_A          254 KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP  301 (335)
T ss_dssp             HHTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             hcCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCcc
Confidence            888888888999999999999999999999999999999999877654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=350.45  Aligned_cols=201  Identities=29%  Similarity=0.535  Sum_probs=176.3

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      +.++||||+++++++.+.+.+|+||||++||+|.+++...+ .+++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus       116 ~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl  195 (412)
T 2vd5_A          116 VNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL  195 (412)
T ss_dssp             HHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             HhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee
Confidence            45789999999999999999999999999999999998754 79999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCcc-ccccccCCCCCCCCceecC-------CCCCCCcccHhHHHHHHHHHHhCCCCCCCCC
Q 016865           81 DSYGNLKVSDFGLSALPQQGVE-LLHTTCGTPNYVAPEVLSN-------RGYDGSAADVWSCGVILFVLMAGYLPFGETD  152 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~-~~~~~~gt~~y~aPE~l~~-------~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~  152 (381)
                      +.+|++||+|||++........ ...+.+||+.|+|||++..       ..| +.++||||+||++|+|++|++||...+
T Consensus       196 d~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~  274 (412)
T 2vd5_A          196 DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSY-GPECDWWALGVFAYEMFYGQTPFYADS  274 (412)
T ss_dssp             CTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEE-CTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             cCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCC-ChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence            9999999999999976544322 2345789999999999973       234 589999999999999999999999988


Q ss_pred             hhHHHHHhhcc--cCCCC---CCCChhHHHHHHHhcCCCCCCC---CCHHHHhcCccccc
Q 016865          153 LPTLYKKINAA--EFSCP---FWFSTGATSLIHKILDPNPKTR---IRIEGIRKHPWFRK  204 (381)
Q Consensus       153 ~~~~~~~i~~~--~~~~p---~~~s~~~~~li~~~L~~dP~~R---~t~~~il~hp~~~~  204 (381)
                      ....+.++...  ....|   ..+|+++++||++||. +|.+|   ++++++++||||+.
T Consensus       275 ~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~  333 (412)
T 2vd5_A          275 TAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG  333 (412)
T ss_dssp             HHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred             HHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence            88887777643  24444   4689999999999999 99998   59999999999975

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.3e-43  Score=330.20  Aligned_cols=203  Identities=34%  Similarity=0.713  Sum_probs=185.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+..|+||||+++|+|.+++...+.+++..++.++.|++.||.|||++||+||||||+||++
T Consensus        68 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~  147 (284)
T 2vgo_A           68 QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM  147 (284)
T ss_dssp             HHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE
T ss_pred             HhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE
Confidence            35789999999999999999999999999999999999988889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.+||+|||++......  .....+||+.|+|||++.+..+. .++||||+|+++|+|++|..||...+.......+
T Consensus       148 ~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  224 (284)
T 2vgo_A          148 GYKGELKIADFGWSVHAPSL--RRRTMCGTLDYLPPEMIEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI  224 (284)
T ss_dssp             CTTCCEEECCCTTCEECSSS--CBCCCCSCGGGCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             cCCCCEEEecccccccCccc--ccccccCCCCcCCHHHhccCCCC-cccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHH
Confidence            99999999999998654432  23466899999999999876664 8999999999999999999999988888877888


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      .......|..+++++.++|.+||..||.+|||++++++||||+...
T Consensus       225 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          225 VNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             HTTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             hccccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence            8788888889999999999999999999999999999999998643

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.6e-43  Score=327.44  Aligned_cols=202  Identities=42%  Similarity=0.754  Sum_probs=182.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+..|+||||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+||++
T Consensus        60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~  139 (277)
T 3f3z_A           60 MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLF  139 (277)
T ss_dssp             HHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             HHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEE
Confidence            35789999999999999999999999999999999999988889999999999999999999999999999999999999


Q ss_pred             ---ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           81 ---DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        81 ---~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                         +.++.+||+|||++...... ......+||+.|+|||++.+.  .+.++||||+||++|+|++|..||...+.....
T Consensus       140 ~~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~  216 (277)
T 3f3z_A          140 LTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM  216 (277)
T ss_dssp             SSSSTTCCEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             ecCCCCCcEEEEecccceeccCc-cchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence               78889999999999765443 334567899999999998653  458999999999999999999999998888888


Q ss_pred             HHhhcccCCCCC----CCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          158 KKINAAEFSCPF----WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       158 ~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ..+..+....|.    .+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          217 LKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             HHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             HHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence            888777776664    589999999999999999999999999999999764

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.8e-43  Score=358.61  Aligned_cols=202  Identities=29%  Similarity=0.528  Sum_probs=181.6

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      +.++||||+++++++.+.+.+|+||||++||+|.+++...    ..+++..++.|+.||+.||.|||++||+||||||+|
T Consensus       240 ~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~N  319 (543)
T 3c4z_A          240 AKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPEN  319 (543)
T ss_dssp             HHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             HhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHH
Confidence            4679999999999999999999999999999999999764    369999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCC----h
Q 016865           78 LLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD----L  153 (381)
Q Consensus        78 iLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~----~  153 (381)
                      ||++.+|.+||+|||++...........+.+||+.|+|||++.+..|. .++||||+||++|+|++|.+||...+    .
T Consensus       320 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DiwSlGvilyelltG~~PF~~~~~~~~~  398 (543)
T 3c4z_A          320 VLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVEN  398 (543)
T ss_dssp             EEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCTTCCCCH
T ss_pred             EEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCC-hHHhcCcchHHHHHHHhCCCCCCCCccchhH
Confidence            999999999999999998765543344566999999999999887775 89999999999999999999997653    3


Q ss_pred             hHHHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 016865          154 PTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIR-----IEGIRKHPWFRK  204 (381)
Q Consensus       154 ~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t-----~~~il~hp~~~~  204 (381)
                      ....+.+......+|..+|+++.+||.+||+.||.+||+     ++++++||||+.
T Consensus       399 ~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~  454 (543)
T 3c4z_A          399 KELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD  454 (543)
T ss_dssp             HHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred             HHHHHHHhhcccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence            556677777778888899999999999999999999996     589999999975

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.9e-43  Score=334.23  Aligned_cols=204  Identities=26%  Similarity=0.482  Sum_probs=179.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++...+..|+||||++||+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus        96 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll  174 (321)
T 2c30_A           96 MRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL  174 (321)
T ss_dssp             HTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             HHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence            4678999999999999999999999999999999998764 579999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.+||+|||++.............+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+.......+
T Consensus       175 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~  253 (321)
T 2c30_A          175 TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYA-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL  253 (321)
T ss_dssp             CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             CCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999999988665443344567899999999999876664 8999999999999999999999888776666655


Q ss_pred             hcccC---CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          161 NAAEF---SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       161 ~~~~~---~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      .....   ..+..+++.+.+||.+||+.||.+|||++++++||||....
T Consensus       254 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          254 RDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             HHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             hcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence            44322   23345789999999999999999999999999999997643

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-43  Score=344.60  Aligned_cols=204  Identities=28%  Similarity=0.621  Sum_probs=180.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+...+|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||
T Consensus       102 l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIl  181 (387)
T 1kob_A          102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIM  181 (387)
T ss_dssp             HTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             HHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeE
Confidence            467899999999999999999999999999999999987644 6999999999999999999999999999999999999


Q ss_pred             Ecc--CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           80 LDS--YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        80 l~~--~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      ++.  .+.+||+|||++...... ......+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+.....
T Consensus       182 l~~~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~  259 (387)
T 1kob_A          182 CETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETL  259 (387)
T ss_dssp             ESSTTCCCEEECCCTTCEECCTT-SCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH
T ss_pred             EecCCCCceEEEecccceecCCC-cceeeeccCCCccCchhccCCCCC-CcccEeeHhHHHHHHHhCCCCCCCCCHHHHH
Confidence            984  467999999999866543 334566899999999999876664 8999999999999999999999988877777


Q ss_pred             HHhhcccCCCC----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          158 KKINAAEFSCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       158 ~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      ..+....+..+    ..+|+++.+||.+||+.||.+|||++++++||||+...
T Consensus       260 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          260 QNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             HHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            77766655433    34799999999999999999999999999999998654

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.8e-43  Score=348.09  Aligned_cols=202  Identities=35%  Similarity=0.645  Sum_probs=167.5

Q ss_pred             CCCccccccceEEEEe----CCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 016865            3 IVRHPNIVRLHEVLAS----RTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE   76 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~----~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~   76 (381)
                      ..+||||+++++++..    ...+|+||||++||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+
T Consensus       111 ~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~  190 (400)
T 1nxk_A          111 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE  190 (400)
T ss_dssp             HTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             hcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcc
Confidence            4589999999999976    678999999999999999998754  5999999999999999999999999999999999


Q ss_pred             cEEEcc---CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh
Q 016865           77 NLLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL  153 (381)
Q Consensus        77 NiLl~~---~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~  153 (381)
                      |||++.   ++.+||+|||++...... ....+.+||+.|+|||++.+..|+ .++||||+||++|+|++|..||...+.
T Consensus       191 Nill~~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~  268 (400)
T 1nxk_A          191 NLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHG  268 (400)
T ss_dssp             GEEESSSSTTCCEEECCCTTCEECC------------CTTCCGGGSCCCCSS-SHHHHHHHHHHHHHHHHSSCSCCCCTT
T ss_pred             eEEEecCCCCccEEEEecccccccCCC-CccccCCCCCCccCHhhcCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCcc
Confidence            999997   788999999999865432 334678899999999999877775 899999999999999999999976543


Q ss_pred             h----HHHHHhhcccCCCC----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          154 P----TLYKKINAAEFSCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       154 ~----~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      .    .....+..+.+..|    ..+|+++.+||++||+.||.+|||++++++||||....
T Consensus       269 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          269 LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             CSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             ccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence            2    24455555555444    34899999999999999999999999999999998643

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.1e-43  Score=337.04  Aligned_cols=204  Identities=26%  Similarity=0.419  Sum_probs=167.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+.+|+||||++| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus        87 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll  165 (329)
T 3gbz_A           87 LKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLL  165 (329)
T ss_dssp             GGGCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             HHHcCCCCcceEEEEEecCCEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEE
Confidence            4678999999999999999999999999975 999999998899999999999999999999999999999999999999


Q ss_pred             c-----cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhH
Q 016865           81 D-----SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT  155 (381)
Q Consensus        81 ~-----~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  155 (381)
                      +     .++.+||+|||++.............+||+.|+|||++.+....+.++||||+||++|+|++|..||...+...
T Consensus       166 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  245 (329)
T 3gbz_A          166 SVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID  245 (329)
T ss_dssp             EC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             ecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH
Confidence            5     44559999999997655433445667899999999999876655699999999999999999999998877665


Q ss_pred             HHHHhhccc-C----------CCC-------------------CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          156 LYKKINAAE-F----------SCP-------------------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       156 ~~~~i~~~~-~----------~~p-------------------~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ....+.... .          ..+                   ..+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          246 QLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             HHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence            544442210 0          001                   1167899999999999999999999999999999864

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.9e-43  Score=343.78  Aligned_cols=204  Identities=21%  Similarity=0.358  Sum_probs=169.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++|||||++++++.+.+.+|+||||++||+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+||
T Consensus        80 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NI  159 (389)
T 3gni_B           80 SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHI  159 (389)
T ss_dssp             HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             HHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            35689999999999999999999999999999999999875  6799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCC-------ccccccccCCCCCCCCceecC--CCCCCCcccHhHHHHHHHHHHhCCCCCC
Q 016865           79 LLDSYGNLKVSDFGLSALPQQG-------VELLHTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFG  149 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~-------~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~  149 (381)
                      |++.++.+||+|||.+......       .......+||+.|+|||++.+  ..| +.++||||+||++|+|++|..||.
T Consensus       160 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~  238 (389)
T 3gni_B          160 LISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFK  238 (389)
T ss_dssp             EECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCB-CTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             EEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCC-CcHhHHHHHHHHHHHHHHCCCCCC
Confidence            9999999999999987543211       122334579999999999977  344 589999999999999999999998


Q ss_pred             CCChhHHHHHhhcccC----------------------------------------------CCCCCCChhHHHHHHHhc
Q 016865          150 ETDLPTLYKKINAAEF----------------------------------------------SCPFWFSTGATSLIHKIL  183 (381)
Q Consensus       150 ~~~~~~~~~~i~~~~~----------------------------------------------~~p~~~s~~~~~li~~~L  183 (381)
                      +.+.......+..+..                                              ..+..+++++.+||.+||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  318 (389)
T 3gni_B          239 DMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCL  318 (389)
T ss_dssp             TCCSTTHHHHC--------------------------------------------------------CCHHHHHHHHHHT
T ss_pred             CCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHh
Confidence            7655444333221111                                              133457899999999999


Q ss_pred             CCCCCCCCCHHHHhcCcccccC
Q 016865          184 DPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       184 ~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      +.||.+|||++++++||||+..
T Consensus       319 ~~dP~~Rpta~ell~hp~f~~~  340 (389)
T 3gni_B          319 QRNPDARPSASTLLNHSFFKQI  340 (389)
T ss_dssp             CSCTTTSCCHHHHTTSGGGGGC
T ss_pred             hcCcccCCCHHHHhcCHHHHHH
Confidence            9999999999999999999864

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.2e-43  Score=360.74  Aligned_cols=202  Identities=29%  Similarity=0.528  Sum_probs=180.9

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+++...+.  +++..++.|+.||+.||+|||++||+||||||+||
T Consensus       238 L~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNI  317 (576)
T 2acx_A          238 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENI  317 (576)
T ss_dssp             HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             HHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheE
Confidence            3567999999999999999999999999999999999987544  99999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCC----hh
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD----LP  154 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~----~~  154 (381)
                      |++.+|.+||+|||++...... ....+.+||+.|+|||++.+..|. .++||||+||++|+|++|.+||...+    ..
T Consensus       318 Lld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APEvl~~~~~~-~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~  395 (576)
T 2acx_A          318 LLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE  395 (576)
T ss_dssp             EECTTSCEEECCCTTCEECCTT-CCEECCCSCGGGCCHHHHTTCEES-SHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH
T ss_pred             EEeCCCCeEEEecccceecccC-ccccccCCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCcccccchhHH
Confidence            9999999999999999865443 234567999999999999887765 89999999999999999999998753    34


Q ss_pred             HHHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 016865          155 TLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  204 (381)
Q Consensus       155 ~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~-----t~~~il~hp~~~~  204 (381)
                      .....+......+|..+|+++.+||.+||+.||.+||     |++++++||||+.
T Consensus       396 ~i~~~i~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~  450 (576)
T 2acx_A          396 EVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK  450 (576)
T ss_dssp             HHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred             HHHHHhhcccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence            5566666667778888999999999999999999999     8999999999975

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5e-43  Score=336.90  Aligned_cols=199  Identities=32%  Similarity=0.551  Sum_probs=177.1

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG-ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg-~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+.+|+||||+.+| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus        83 l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIl  162 (335)
T 3dls_A           83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIV  162 (335)
T ss_dssp             HTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             HHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEE
Confidence            46789999999999999999999999999766 99999998889999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      ++.++.+||+|||++...... ....+.+||+.|+|||++.+..+.+.++||||+||++|+|++|..||....      .
T Consensus       163 l~~~~~~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~  235 (335)
T 3dls_A          163 IAEDFTIKLIDFGSAAYLERG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------E  235 (335)
T ss_dssp             ECTTSCEEECCCTTCEECCTT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------G
T ss_pred             EcCCCcEEEeecccceECCCC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------H
Confidence            999999999999999866543 334567899999999999888876789999999999999999999997532      1


Q ss_pred             hhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          160 INAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       160 i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      ........|..+++++.+||.+||+.||.+|||++++++||||+...
T Consensus       236 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          236 TVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             GTTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             HHhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence            22334456667899999999999999999999999999999998643

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=7e-43  Score=352.88  Aligned_cols=201  Identities=38%  Similarity=0.722  Sum_probs=181.1

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+...+|+|||||+||+|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus        90 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~  169 (494)
T 3lij_A           90 LKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLL  169 (494)
T ss_dssp             HTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             HHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEE
Confidence            46889999999999999999999999999999999999988899999999999999999999999999999999999999


Q ss_pred             ccC---CCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           81 DSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        81 ~~~---~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      +..   +.+||+|||++...... ......+||+.|+|||++.+ .| +.++||||+||++|+|++|.+||.+.+.....
T Consensus       170 ~~~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  246 (494)
T 3lij_A          170 ESKEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEIL  246 (494)
T ss_dssp             SCSSTTCCEEECCCTTCEECBTT-BCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             eCCCCCCcEEEEECCCCeECCCC-ccccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            864   45999999999876543 34566789999999999864 45 48999999999999999999999999888888


Q ss_pred             HHhhcccCCCC--C--CCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          158 KKINAAEFSCP--F--WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       158 ~~i~~~~~~~p--~--~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      ..+..+.+..+  .  .+|+++++||++||+.||.+|||+.++++||||+.
T Consensus       247 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          247 RKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             HHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred             HHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence            88877766543  2  37999999999999999999999999999999975

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=7.3e-43  Score=353.59  Aligned_cols=204  Identities=35%  Similarity=0.679  Sum_probs=184.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+...+|+|||||+||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus       100 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~  179 (504)
T 3q5i_A          100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILL  179 (504)
T ss_dssp             HHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             HHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEE
Confidence            35789999999999999999999999999999999999988899999999999999999999999999999999999999


Q ss_pred             ccCC---CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           81 DSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        81 ~~~~---~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      +.++   .+||+|||++...... ......+||+.|+|||++.+ .| +.++||||+||++|+|++|.+||.+.+.....
T Consensus       180 ~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  256 (504)
T 3q5i_A          180 ENKNSLLNIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDII  256 (504)
T ss_dssp             SSTTCCSSEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             ecCCCCccEEEEECCCCEEcCCC-CccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            9876   6999999999866543 33466789999999999864 45 58999999999999999999999999988888


Q ss_pred             HHhhcccCCCC----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 016865          158 KKINAAEFSCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  207 (381)
Q Consensus       158 ~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~  207 (381)
                      ..+..+.+..+    ..+|+++++||++||+.||.+|||++++++||||+....
T Consensus       257 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          257 KKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             HHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             HHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence            88888776554    458999999999999999999999999999999987543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.5e-43  Score=332.14  Aligned_cols=204  Identities=26%  Similarity=0.423  Sum_probs=168.9

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      +.++||||+++++++.+.+..|+||||+++++|.+++...+.+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        57 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~  136 (311)
T 4agu_A           57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT  136 (311)
T ss_dssp             HHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred             HhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEc
Confidence            56799999999999999999999999999999999888888899999999999999999999999999999999999999


Q ss_pred             cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhh
Q 016865           82 SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN  161 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~  161 (381)
                      .++.+||+|||++.............+||+.|+|||++.+....+.++||||+||++|+|++|.+||.+.+.......+.
T Consensus       137 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  216 (311)
T 4agu_A          137 KHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIR  216 (311)
T ss_dssp             TTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             CCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99999999999998765444445677899999999999875555699999999999999999999998877654433322


Q ss_pred             cc---------------------cCCCC----------CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          162 AA---------------------EFSCP----------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       162 ~~---------------------~~~~p----------~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ..                     ....+          +.+++++.+||.+||+.||.+|||++++++||||+..
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  291 (311)
T 4agu_A          217 KTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI  291 (311)
T ss_dssp             HHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             HHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence            11                     01111          2478889999999999999999999999999999853

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.3e-43  Score=342.36  Aligned_cols=202  Identities=32%  Similarity=0.561  Sum_probs=178.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       140 l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl  219 (373)
T 2x4f_A          140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENIL  219 (373)
T ss_dssp             HTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             HHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEE
Confidence            46789999999999999999999999999999999988764 46999999999999999999999999999999999999


Q ss_pred             E--ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           80 L--DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        80 l--~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      +  +.++.+||+|||++...... ......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+.....
T Consensus       220 l~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~  297 (373)
T 2x4f_A          220 CVNRDAKQIKIIDFGLARRYKPR-EKLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL  297 (373)
T ss_dssp             EEETTTTEEEECCCSSCEECCTT-CBCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred             EecCCCCcEEEEeCCCceecCCc-cccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            9  56678999999999866543 23456689999999999976655 48999999999999999999999988887777


Q ss_pred             HHhhcccCCCC----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          158 KKINAAEFSCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       158 ~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      ..+....+..+    ..+++++.+||.+||+.||.+|||++++++||||+.
T Consensus       298 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~  348 (373)
T 2x4f_A          298 NNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD  348 (373)
T ss_dssp             HHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred             HHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence            77766655443    348999999999999999999999999999999974

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.7e-43  Score=354.81  Aligned_cols=203  Identities=37%  Similarity=0.660  Sum_probs=182.6

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |++++||||+++++++.+.+.+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus        80 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~  159 (484)
T 3nyv_A           80 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL  159 (484)
T ss_dssp             HTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             HHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE
Confidence            46789999999999999999999999999999999999998899999999999999999999999999999999999999


Q ss_pred             ---ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           81 ---DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        81 ---~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                         +.++.+||+|||++...... ......+||+.|+|||++.+ .| +.++||||+||++|+|++|.+||.+.+.....
T Consensus       160 ~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  236 (484)
T 3nyv_A          160 ESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDIL  236 (484)
T ss_dssp             SSSSTTCCEEECCTTHHHHBCCC-CSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             ecCCCCCcEEEEeeeeeEEcccc-cccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence               46789999999999765543 33456789999999999976 45 48999999999999999999999999888888


Q ss_pred             HHhhcccCCC--CC--CCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          158 KKINAAEFSC--PF--WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       158 ~~i~~~~~~~--p~--~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      ..+..+.+..  |.  .+|+++++||.+||+.||.+|||+.++++||||+...
T Consensus       237 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          237 KKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT  289 (484)
T ss_dssp             HHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred             HHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence            8887776543  33  3899999999999999999999999999999998643

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=328.30  Aligned_cols=199  Identities=29%  Similarity=0.412  Sum_probs=169.7

Q ss_pred             CCccccccceEEEEeCC-----EEEEEEecCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 016865            4 VRHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE   76 (381)
Q Consensus         4 l~HpnIv~l~~~~~~~~-----~~~lV~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~   76 (381)
                      ++||||+++++++.+..     .+|+||||+. |+|.+++.....  +++..++.++.|++.||+|||++||+||||||+
T Consensus        71 ~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~  149 (308)
T 3g33_A           71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPE  149 (308)
T ss_dssp             HCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTT
T ss_pred             cCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence            46999999999998765     6999999997 599999987654  999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHH
Q 016865           77 NLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL  156 (381)
Q Consensus        77 NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~  156 (381)
                      |||++.++.+||+|||++...... ......+||+.|+|||++.+..+. .++||||+||++|+|++|.+||...+....
T Consensus       150 Nil~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~  227 (308)
T 3g33_A          150 NILVTSGGTVKLADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQ  227 (308)
T ss_dssp             TEEECTTSCEEECSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCC-STHHHHHHHHHHHHTTTSSCSCCCSSHHHH
T ss_pred             HEEEcCCCCEEEeeCccccccCCC-cccCCccccccccCchHHcCCCCC-chHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999999999999999999876543 334667899999999999887775 899999999999999999999998877666


Q ss_pred             HHHhhcccC-----------C----------------CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          157 YKKINAAEF-----------S----------------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       157 ~~~i~~~~~-----------~----------------~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ..++.....           .                ..+.+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus       228 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          228 LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             HHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             HHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            555432110           0                112478899999999999999999999999999999864

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.2e-43  Score=333.07  Aligned_cols=205  Identities=26%  Similarity=0.464  Sum_probs=168.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+..|+||||++ |+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus        54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl  132 (324)
T 3mtl_A           54 LKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLL  132 (324)
T ss_dssp             HSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEE
T ss_pred             HHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEE
Confidence            467899999999999999999999999997 48999887754 5899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      ++.++.+||+|||++.............+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......
T Consensus       133 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  212 (324)
T 3mtl_A          133 INERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHF  212 (324)
T ss_dssp             ECTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999999986654444456678999999999997755556999999999999999999999998876655444


Q ss_pred             hhccc-------------------CC-----------CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          160 INAAE-------------------FS-----------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       160 i~~~~-------------------~~-----------~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      +....                   +.           .++.+++++.+||.+||+.||.+|||++|+++||||....
T Consensus       213 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  289 (324)
T 3mtl_A          213 IFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG  289 (324)
T ss_dssp             HHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             HHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence            32210                   00           1123688999999999999999999999999999998654

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=6.4e-43  Score=352.42  Aligned_cols=203  Identities=39%  Similarity=0.698  Sum_probs=179.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus        75 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~  154 (486)
T 3mwu_A           75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILL  154 (486)
T ss_dssp             HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             HHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEE
Confidence            35689999999999999999999999999999999999888899999999999999999999999999999999999999


Q ss_pred             c---cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           81 D---SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        81 ~---~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      +   .++.+||+|||++...... ......+||+.|+|||++.+ .| +.++||||+||++|+|++|.+||.+.+.....
T Consensus       155 ~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  231 (486)
T 3mwu_A          155 ESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRG-TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDIL  231 (486)
T ss_dssp             SSSSTTCCEEECSCSCTTTBCCC-----CCTTGGGGCCGGGGGS-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             ecCCCCCCEEEEECCcCeECCCC-CccCCCcCCCCCCCHHHhCC-CC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            5   4567999999999866543 33456789999999999976 45 48999999999999999999999998888888


Q ss_pred             HHhhcccCCC--CC--CCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          158 KKINAAEFSC--PF--WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       158 ~~i~~~~~~~--p~--~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      ..+..+.+..  |.  .+|+++++||.+||+.||.+|||+.++++||||+...
T Consensus       232 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          232 KRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             HHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             HHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence            8887776543  33  3799999999999999999999999999999998654

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=9.8e-43  Score=332.11  Aligned_cols=201  Identities=35%  Similarity=0.621  Sum_probs=181.0

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      +.++||||+++++++.+.+..|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus        70 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~  149 (321)
T 2a2a_A           70 RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL  149 (321)
T ss_dssp             HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES
T ss_pred             HhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEe
Confidence            46799999999999999999999999999999999999888899999999999999999999999999999999999999


Q ss_pred             cCC----CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           82 SYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        82 ~~~----~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      .++    .+||+|||++...... ......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+.....
T Consensus       150 ~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  227 (321)
T 2a2a_A          150 DKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL  227 (321)
T ss_dssp             CTTSSSCCEEECCCTTCEECCTT-CCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH
T ss_pred             cCCCCcCCEEEccCccceecCcc-ccccccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            888    7999999999765543 23456679999999999987666 48999999999999999999999988887777


Q ss_pred             HHhhcccCCCC----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          158 KKINAAEFSCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       158 ~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      ..+.......+    ..+++.+.+||.+||..||.+|||++++++||||+.
T Consensus       228 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~  278 (321)
T 2a2a_A          228 ANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (321)
T ss_dssp             HHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred             HHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence            77776665544    458999999999999999999999999999999974

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1e-42  Score=325.20  Aligned_cols=202  Identities=42%  Similarity=0.792  Sum_probs=181.4

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      +.++||||+++++++.+.+..|+||||++||+|.+.+...+.+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus        60 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~  139 (284)
T 3kk8_A           60 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA  139 (284)
T ss_dssp             HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEES
T ss_pred             HHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEe
Confidence            56799999999999999999999999999999999999888899999999999999999999999999999999999998


Q ss_pred             cCCC---EEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016865           82 SYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK  158 (381)
Q Consensus        82 ~~~~---lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~  158 (381)
                      .++.   +||+|||++...... .......||+.|+|||++.+..+. .++||||+||++|+|++|..||...+......
T Consensus       140 ~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  217 (284)
T 3kk8_A          140 SKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYA  217 (284)
T ss_dssp             SSSTTCCEEECCCTTCEECCSS-CBCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             cCCCCCcEEEeeceeeEEcccC-ccccCCCCCcCCcCchhhcCCCCC-cccchHHHHHHHHHHHHCCCCCCCCchhHHHH
Confidence            7665   999999999765543 234567799999999999877664 89999999999999999999999988888887


Q ss_pred             HhhcccCCCCC----CCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          159 KINAAEFSCPF----WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       159 ~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      .+..+....|.    .+++++.+||.+||+.||.+|||++++++||||+..
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (284)
T 3kk8_A          218 QIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  268 (284)
T ss_dssp             HHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred             HHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence            77776655442    479999999999999999999999999999999764

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=7.7e-43  Score=337.44  Aligned_cols=203  Identities=38%  Similarity=0.715  Sum_probs=168.2

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      +.++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++
T Consensus       103 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~  182 (349)
T 2w4o_A          103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYA  182 (349)
T ss_dssp             HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEES
T ss_pred             HhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEe
Confidence            56799999999999999999999999999999999998888899999999999999999999999999999999999997


Q ss_pred             c---CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhH-HH
Q 016865           82 S---YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT-LY  157 (381)
Q Consensus        82 ~---~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~-~~  157 (381)
                      .   ++.+||+|||++...... ......+||+.|+|||++.+..+. .++||||+||++|+|++|..||....... .+
T Consensus       183 ~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  260 (349)
T 2w4o_A          183 TPAPDAPLKIADFGLSKIVEHQ-VLMKTVCGTPGYCAPEILRGCAYG-PEVDMWSVGIITYILLCGFEPFYDERGDQFMF  260 (349)
T ss_dssp             SSSTTCCEEECCCC-----------------CGGGSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCTTCHHHHH
T ss_pred             cCCCCCCEEEccCccccccCcc-cccccccCCCCccCHHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCcccHHHH
Confidence            5   889999999999865442 234567899999999999877664 89999999999999999999997665443 55


Q ss_pred             HHhhcccCCCC----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          158 KKINAAEFSCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       158 ~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      ..+.......+    ..+++++.+||.+||..||.+|||+.++++||||....
T Consensus       261 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          261 RRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             HHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             HHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            56655544332    34789999999999999999999999999999998643

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.2e-43  Score=342.36  Aligned_cols=202  Identities=30%  Similarity=0.420  Sum_probs=166.9

Q ss_pred             CCC-ccccccceEEEEeCC--EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            3 IVR-HPNIVRLHEVLASRT--KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         3 ~l~-HpnIv~l~~~~~~~~--~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      .+. ||||+++++++...+  .+|+||||++ |+|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus        64 ~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIl  141 (388)
T 3oz6_A           64 ELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNIL  141 (388)
T ss_dssp             HTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             hccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeE
Confidence            454 999999999998654  7999999997 589988876 67999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCC---------------------CccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQ---------------------GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVIL  138 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~---------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil  138 (381)
                      ++.++.+||+|||+|+....                     ........+||+.|+|||++.+....+.++||||+||++
T Consensus       142 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il  221 (388)
T 3oz6_A          142 LNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCIL  221 (388)
T ss_dssp             ECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHH
T ss_pred             EcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHH
Confidence            99999999999999975432                     112245568999999999998755556999999999999


Q ss_pred             HHHHhCCCCCCCCChhHHHHHhhcc-cC----------------------------------------------CCCCCC
Q 016865          139 FVLMAGYLPFGETDLPTLYKKINAA-EF----------------------------------------------SCPFWF  171 (381)
Q Consensus       139 ~~ll~G~~Pf~~~~~~~~~~~i~~~-~~----------------------------------------------~~p~~~  171 (381)
                      |+|++|++||.+.+.......+... ..                                              ..+..+
T Consensus       222 ~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (388)
T 3oz6_A          222 GEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC  301 (388)
T ss_dssp             HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCC
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccC
Confidence            9999999999888766555444211 00                                              011246


Q ss_pred             ChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          172 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       172 s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      ++++.+||.+||+.||.+|||++|+++||||+...
T Consensus       302 ~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~  336 (388)
T 3oz6_A          302 NEEALDLLDKLLQFNPNKRISANDALKHPFVSIFH  336 (388)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTC
T ss_pred             CHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhc
Confidence            88999999999999999999999999999997644

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.7e-42  Score=323.63  Aligned_cols=201  Identities=34%  Similarity=0.622  Sum_probs=170.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE   76 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~   76 (381)
                      |+.++||||+++++++.+.+..|+||||++||+|.+.+..    ...+++..++.++.|++.||+|||++||+||||||+
T Consensus        74 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~  153 (285)
T 3is5_A           74 LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPE  153 (285)
T ss_dssp             HHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG
T ss_pred             HHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHH
Confidence            3578999999999999999999999999999999998854    367999999999999999999999999999999999


Q ss_pred             cEEEc---cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh
Q 016865           77 NLLLD---SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL  153 (381)
Q Consensus        77 NiLl~---~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~  153 (381)
                      ||+++   .++.+||+|||++...... ......+||+.|+|||++.+ .+ +.++||||+||++|+|++|..||...+.
T Consensus       154 NIl~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~  230 (285)
T 3is5_A          154 NILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSL  230 (285)
T ss_dssp             GEEESSSSTTCCEEECCCCCCCC-----------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             HEEEecCCCCCCEEEEeeecceecCCc-ccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCH
Confidence            99994   5578999999999865543 23456779999999999853 44 4899999999999999999999998887


Q ss_pred             hHHHHHhhcccCCCC---CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          154 PTLYKKINAAEFSCP---FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       154 ~~~~~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      ......+.......+   ..+++++.+||.+||+.||.+|||+.|+++||||+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          231 EEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            777666654443332   237899999999999999999999999999999975

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.6e-42  Score=329.03  Aligned_cols=201  Identities=32%  Similarity=0.595  Sum_probs=168.5

Q ss_pred             CCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccC
Q 016865            4 VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY   83 (381)
Q Consensus         4 l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~   83 (381)
                      ++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+
T Consensus        68 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~  147 (316)
T 2ac3_A           68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHP  147 (316)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCS
T ss_pred             cCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccC
Confidence            57999999999999999999999999999999999988889999999999999999999999999999999999999987


Q ss_pred             CC---EEEeeccCccCCCCC-------ccccccccCCCCCCCCceecC-----CCCCCCcccHhHHHHHHHHHHhCCCCC
Q 016865           84 GN---LKVSDFGLSALPQQG-------VELLHTTCGTPNYVAPEVLSN-----RGYDGSAADVWSCGVILFVLMAGYLPF  148 (381)
Q Consensus        84 ~~---lkl~DFGls~~~~~~-------~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DIwSlGvil~~ll~G~~Pf  148 (381)
                      +.   +||+|||++......       .......+||+.|+|||++.+     ..+ +.++||||+||++|+|++|..||
T Consensus       148 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf  226 (316)
T 2ac3_A          148 NQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPF  226 (316)
T ss_dssp             SSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             CCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCC
Confidence            76   999999998754321       112345679999999999864     234 48999999999999999999999


Q ss_pred             CCCCh---------------hHHHHHhhcccCCCC----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          149 GETDL---------------PTLYKKINAAEFSCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       149 ~~~~~---------------~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ...+.               ......+..+.+..|    ..+++++.+||.+||+.||.+|||++++++||||+..
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  302 (316)
T 2ac3_A          227 VGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC  302 (316)
T ss_dssp             CCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred             cccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence            76542               234555666666655    3489999999999999999999999999999999853

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.8e-42  Score=326.06  Aligned_cols=201  Identities=41%  Similarity=0.758  Sum_probs=180.9

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE-
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL-   80 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl-   80 (381)
                      +.++||||+++++++.+.+..|+||||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+||++ 
T Consensus        61 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~  140 (304)
T 2jam_A           61 KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYL  140 (304)
T ss_dssp             HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEES
T ss_pred             HhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEe
Confidence            5679999999999999999999999999999999999888889999999999999999999999999999999999999 


Q ss_pred             --ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016865           81 --DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK  158 (381)
Q Consensus        81 --~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~  158 (381)
                        +.++.+||+|||++.....  ......+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+......
T Consensus       141 ~~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  217 (304)
T 2jam_A          141 TPEENSKIMITDFGLSKMEQN--GIMSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVITYILLCGYPPFYEETESKLFE  217 (304)
T ss_dssp             SSSTTCCEEBCSCSTTCCCCC--BTTHHHHSCCCBCCTTTBSSCSCC-HHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred             cCCCCCCEEEccCCcceecCC--CccccccCCCCccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence              7788999999999876543  234566799999999999877664 89999999999999999999999888877777


Q ss_pred             HhhcccCCCC----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          159 KINAAEFSCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       159 ~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      .+..+.+..+    ..+++++.+||.+||..||.+|||++++++||||+..
T Consensus       218 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          218 KIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             HHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             HHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence            7776654433    3579999999999999999999999999999999864

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.5e-42  Score=322.46  Aligned_cols=205  Identities=39%  Similarity=0.696  Sum_probs=176.9

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      +.++||||+++++++.+.+..|+||||++||+|.+++.....+++..++.++.|++.||.|||++||+||||||+||+++
T Consensus        60 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~  139 (276)
T 2yex_A           60 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD  139 (276)
T ss_dssp             HTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             HhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEc
Confidence            56899999999999999999999999999999999998777899999999999999999999999999999999999999


Q ss_pred             cCCCEEEeeccCccCCCCC--ccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh-HHHH
Q 016865           82 SYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYK  158 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~  158 (381)
                      .++.+||+|||++......  .......+||+.|+|||++.+..+.+.++||||+||++|+|++|..||...+.. ..+.
T Consensus       140 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  219 (276)
T 2yex_A          140 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS  219 (276)
T ss_dssp             TTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHH
T ss_pred             cCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Confidence            9999999999998764322  123456789999999999987776667899999999999999999999876543 3333


Q ss_pred             HhhcccCCCC--CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          159 KINAAEFSCP--FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       159 ~i~~~~~~~p--~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      .+.......+  ..+++.+.+||.+||+.||.+|||++++++||||+...
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          220 DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             HHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence            3333322222  35899999999999999999999999999999998654

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.1e-42  Score=349.09  Aligned_cols=202  Identities=30%  Similarity=0.502  Sum_probs=162.8

Q ss_pred             CCCCCccccccceEEEEeC------CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 016865            1 MKIVRHPNIVRLHEVLASR------TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK   74 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~------~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlk   74 (381)
                      |+.++||||+++++++...      ..+|+||||+++ +|.+.+.  ..+++..++.++.||+.||+|||++||+|||||
T Consensus       115 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlk  191 (464)
T 3ttj_A          115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  191 (464)
T ss_dssp             HHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             HHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            3568999999999999654      468999999976 5767664  359999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           75 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        75 p~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      |+|||++.++.+||+|||++...... ......+||+.|+|||++.+..|+ .++||||+||++|+|++|++||.+.+..
T Consensus       192 p~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~  269 (464)
T 3ttj_A          192 PSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYI  269 (464)
T ss_dssp             GGGEEECTTSCEEECCCCCC-----C-CCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             hHhEEEeCCCCEEEEEEEeeeecCCC-cccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999999999876542 345678899999999999988775 8999999999999999999999988766


Q ss_pred             HHHHHhhccc---------------------------CCCCCC---------------CChhHHHHHHHhcCCCCCCCCC
Q 016865          155 TLYKKINAAE---------------------------FSCPFW---------------FSTGATSLIHKILDPNPKTRIR  192 (381)
Q Consensus       155 ~~~~~i~~~~---------------------------~~~p~~---------------~s~~~~~li~~~L~~dP~~R~t  192 (381)
                      ....++....                           ..+|..               .++++++||.+||+.||.+|||
T Consensus       270 ~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t  349 (464)
T 3ttj_A          270 DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS  349 (464)
T ss_dssp             HHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC
T ss_pred             HHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCC
Confidence            5554442210                           000000               1567999999999999999999


Q ss_pred             HHHHhcCcccccCCC
Q 016865          193 IEGIRKHPWFRKNYN  207 (381)
Q Consensus       193 ~~~il~hp~~~~~~~  207 (381)
                      ++|+++||||+..+.
T Consensus       350 a~e~L~Hp~~~~~~~  364 (464)
T 3ttj_A          350 VDDALQHPYINVWYD  364 (464)
T ss_dssp             HHHHHTSTTTGGGCC
T ss_pred             HHHHhcChhhhhccC
Confidence            999999999987554

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.6e-42  Score=332.03  Aligned_cols=206  Identities=23%  Similarity=0.345  Sum_probs=171.2

Q ss_pred             CCCCccccccceEEEEe--------CCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q 016865            2 KIVRHPNIVRLHEVLAS--------RTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRD   72 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~--------~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrD   72 (381)
                      +.++||||+++++++.+        .+.+|+||||++| +|.+.+... ..+++..++.++.||+.||+|||++||+|||
T Consensus        71 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~D  149 (351)
T 3mi9_A           71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRD  149 (351)
T ss_dssp             HHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             HhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCC
Confidence            56799999999999987        4579999999975 777777653 5799999999999999999999999999999


Q ss_pred             CCCCcEEEccCCCEEEeeccCccCCCC----CccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCC
Q 016865           73 LKPENLLLDSYGNLKVSDFGLSALPQQ----GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF  148 (381)
Q Consensus        73 lkp~NiLl~~~~~lkl~DFGls~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf  148 (381)
                      |||+|||++.++.+||+|||++.....    ........+||+.|+|||++.+....+.++||||+||++|+|++|.+||
T Consensus       150 lkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf  229 (351)
T 3mi9_A          150 MKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM  229 (351)
T ss_dssp             CSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999976542    1223456689999999999977555569999999999999999999999


Q ss_pred             CCCChhHHHHHhhcccCCCCCC--------------------------------CChhHHHHHHHhcCCCCCCCCCHHHH
Q 016865          149 GETDLPTLYKKINAAEFSCPFW--------------------------------FSTGATSLIHKILDPNPKTRIRIEGI  196 (381)
Q Consensus       149 ~~~~~~~~~~~i~~~~~~~p~~--------------------------------~s~~~~~li~~~L~~dP~~R~t~~~i  196 (381)
                      .+.+.......+.......+..                                .++.+.+||.+||+.||.+|||++|+
T Consensus       230 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  309 (351)
T 3mi9_A          230 QGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA  309 (351)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             CCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHH
Confidence            9887766555543322111110                                26789999999999999999999999


Q ss_pred             hcCcccccCCCC
Q 016865          197 RKHPWFRKNYNP  208 (381)
Q Consensus       197 l~hp~~~~~~~~  208 (381)
                      ++||||+....+
T Consensus       310 l~hp~f~~~~~~  321 (351)
T 3mi9_A          310 LNHDFFWSDPMP  321 (351)
T ss_dssp             HTSGGGGSSSCC
T ss_pred             hCCCCcCCCCCc
Confidence            999999875543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.8e-42  Score=331.63  Aligned_cols=203  Identities=29%  Similarity=0.412  Sum_probs=168.5

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      +.++||||+++++++.+.+..|+||||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++
T Consensus        79 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~  158 (331)
T 4aaa_A           79 KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS  158 (331)
T ss_dssp             HHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred             hhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEc
Confidence            56899999999999999999999999999999988887778899999999999999999999999999999999999999


Q ss_pred             cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhh
Q 016865           82 SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN  161 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~  161 (381)
                      .++.+||+|||++.............+||+.|+|||++.+....+.++||||+||++|+|++|.+||...+.......+.
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  238 (331)
T 4aaa_A          159 QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM  238 (331)
T ss_dssp             TTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             CCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence            99999999999998765544445677899999999999876455689999999999999999999998877554433321


Q ss_pred             cc-------------------cCCC------------CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          162 AA-------------------EFSC------------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       162 ~~-------------------~~~~------------p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      ..                   ....            .+.+++.+.+||.+||+.||.+|||++|+++||||+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  312 (331)
T 4aaa_A          239 MCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM  312 (331)
T ss_dssp             HHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred             HHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence            10                   0111            1246899999999999999999999999999999974

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-42  Score=332.50  Aligned_cols=200  Identities=34%  Similarity=0.599  Sum_probs=175.2

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCC
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG   84 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~   84 (381)
                      +||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++
T Consensus       117 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~  196 (355)
T 1vzo_A          117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG  196 (355)
T ss_dssp             TCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS
T ss_pred             CCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC
Confidence            69999999999999999999999999999999999888999999999999999999999999999999999999999999


Q ss_pred             CEEEeeccCccCCCCC-ccccccccCCCCCCCCceecCC-CCCCCcccHhHHHHHHHHHHhCCCCCCCCC----hhHHHH
Q 016865           85 NLKVSDFGLSALPQQG-VELLHTTCGTPNYVAPEVLSNR-GYDGSAADVWSCGVILFVLMAGYLPFGETD----LPTLYK  158 (381)
Q Consensus        85 ~lkl~DFGls~~~~~~-~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~----~~~~~~  158 (381)
                      .+||+|||++...... .......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||...+    ......
T Consensus       197 ~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~  276 (355)
T 1vzo_A          197 HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR  276 (355)
T ss_dssp             CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH
T ss_pred             cEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH
Confidence            9999999999765432 2234456899999999999753 233589999999999999999999997543    234445


Q ss_pred             HhhcccCCCCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 016865          159 KINAAEFSCPFWFSTGATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  204 (381)
Q Consensus       159 ~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~-----t~~~il~hp~~~~  204 (381)
                      .+.......|..+++.+.+||.+||..||.+||     |++++++||||+.
T Consensus       277 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~  327 (355)
T 1vzo_A          277 RILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  327 (355)
T ss_dssp             HHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             HHhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence            555666677888999999999999999999999     9999999999974

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=5.7e-42  Score=333.31  Aligned_cols=199  Identities=35%  Similarity=0.664  Sum_probs=177.1

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCC
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG   84 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~   84 (381)
                      +||||+++++++...+..|+||||++||+|.+++.....+++..++.++.|++.||.|||+.||+||||||+|||++.+|
T Consensus       158 ~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~  237 (365)
T 2y7j_A          158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM  237 (365)
T ss_dssp             TCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred             CCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence            79999999999999999999999999999999998888899999999999999999999999999999999999999999


Q ss_pred             CEEEeeccCccCCCCCccccccccCCCCCCCCceecCC-----CCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           85 NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR-----GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        85 ~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      .+||+|||++...... ......+||+.|+|||++.+.     ...+.++|||||||++|+|++|..||...+.......
T Consensus       238 ~ikl~DfG~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~  316 (365)
T 2y7j_A          238 QIRLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM  316 (365)
T ss_dssp             CEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CEEEEecCcccccCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            9999999998765543 234567899999999998632     2235899999999999999999999998887777777


Q ss_pred             hhcccCCCC----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          160 INAAEFSCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       160 i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      +..+.+..+    ..+++.+.+||.+||..||.+|||++++++||||++
T Consensus       317 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          317 IMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             HHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            766655443    347899999999999999999999999999999963

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6.1e-42  Score=331.32  Aligned_cols=196  Identities=26%  Similarity=0.407  Sum_probs=167.7

Q ss_pred             CCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            3 IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      .++||||+++++++...+..|+||||+ ||+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        92 ~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll  170 (360)
T 3llt_A           92 DINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILL  170 (360)
T ss_dssp             STTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             CCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEE
Confidence            346999999999999999999999999 899999998754  59999999999999999999999999999999999999


Q ss_pred             cc-------------------------CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHH
Q 016865           81 DS-------------------------YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCG  135 (381)
Q Consensus        81 ~~-------------------------~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlG  135 (381)
                      +.                         ++.+||+|||++.....   .....+||+.|+|||++.+..+. .++||||+|
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG  246 (360)
T 3llt_A          171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD---YHGSIINTRQYRAPEVILNLGWD-VSSDMWSFG  246 (360)
T ss_dssp             SCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS---CCCSCCSCGGGCCHHHHTTCCCC-TTHHHHHHH
T ss_pred             ccccccccccchhcccccccccccccCCCCEEEEeccCceecCC---CCcCccCcccccCcHHHcCCCCC-CccchHHHH
Confidence            75                         78999999999976443   23467899999999999887775 899999999


Q ss_pred             HHHHHHHhCCCCCCCCChhHHHHHhhcccCCCC--------------------------C--------------------
Q 016865          136 VILFVLMAGYLPFGETDLPTLYKKINAAEFSCP--------------------------F--------------------  169 (381)
Q Consensus       136 vil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p--------------------------~--------------------  169 (381)
                      |++|+|++|+.||...+.......+.......|                          .                    
T Consensus       247 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  326 (360)
T 3llt_A          247 CVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKI  326 (360)
T ss_dssp             HHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHH
T ss_pred             HHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccccc
Confidence            999999999999988776555444432211111                          1                    


Q ss_pred             CCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          170 WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       170 ~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      ..++.+.+||.+||+.||.+|||++++++||||+
T Consensus       327 ~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          327 IKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             CCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             chHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence            1236788999999999999999999999999995

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.1e-42  Score=344.72  Aligned_cols=205  Identities=26%  Similarity=0.350  Sum_probs=160.3

Q ss_pred             CCCCCccccccceEEEEe-----CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 016865            1 MKIVRHPNIVRLHEVLAS-----RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKP   75 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~-----~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp   75 (381)
                      |+.++|||||++++++..     ...+|+||||+ +|+|.+++...+.+++..++.++.||+.||+|||++||+||||||
T Consensus       106 l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp  184 (458)
T 3rp9_A          106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKP  184 (458)
T ss_dssp             HHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG
T ss_pred             HHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCCh
Confidence            356799999999999943     35799999998 569999998888899999999999999999999999999999999


Q ss_pred             CcEEEccCCCEEEeeccCccCCCCCc---------------------------cccccccCCCCCCCCceecCCCCCCCc
Q 016865           76 ENLLLDSYGNLKVSDFGLSALPQQGV---------------------------ELLHTTCGTPNYVAPEVLSNRGYDGSA  128 (381)
Q Consensus        76 ~NiLl~~~~~lkl~DFGls~~~~~~~---------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~  128 (381)
                      +|||++.++.+||+|||+++......                           ......+||+.|+|||++......+.+
T Consensus       185 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~  264 (458)
T 3rp9_A          185 ANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEA  264 (458)
T ss_dssp             GGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTH
T ss_pred             hhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcH
Confidence            99999999999999999998654211                           124566899999999987554444699


Q ss_pred             ccHhHHHHHHHHHHh-----------CCCCCCCCCh--------------------hHHHHHhhc---------------
Q 016865          129 ADVWSCGVILFVLMA-----------GYLPFGETDL--------------------PTLYKKINA---------------  162 (381)
Q Consensus       129 ~DIwSlGvil~~ll~-----------G~~Pf~~~~~--------------------~~~~~~i~~---------------  162 (381)
                      +||||+|||||||++           |.+||.+.+.                    ......+..               
T Consensus       265 ~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  344 (458)
T 3rp9_A          265 IDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK  344 (458)
T ss_dssp             HHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSC
T ss_pred             hHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCC
Confidence            999999999999998           7777765431                    011111100               


Q ss_pred             --------c-----c---CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          163 --------A-----E---FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       163 --------~-----~---~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                              .     .   ....+..++++.+||++||..||.+|||++|+|+||||+...
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~  404 (458)
T 3rp9_A          345 EDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR  404 (458)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence                    0     0   001123689999999999999999999999999999998653

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-42  Score=331.93  Aligned_cols=205  Identities=25%  Similarity=0.323  Sum_probs=175.7

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      +.++||||+++++++.+.+..|+||||+++ +|.+.+... ..+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus        67 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~  145 (346)
T 1ua2_A           67 QELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL  145 (346)
T ss_dssp             HHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred             hhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE
Confidence            467999999999999999999999999986 888888764 358999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.+||+|||++.............+||+.|+|||++.+....+.++||||+||++|+|++|.+||.+.+.......+
T Consensus       146 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i  225 (346)
T 1ua2_A          146 DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI  225 (346)
T ss_dssp             CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             cCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            99999999999999876554445567789999999999976554568999999999999999999999988776655554


Q ss_pred             hccc--C---------CC-----------------CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 016865          161 NAAE--F---------SC-----------------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  207 (381)
Q Consensus       161 ~~~~--~---------~~-----------------p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~  207 (381)
                      ....  .         ..                 ...+++++.+||.+||..||.+|||++|+++||||+....
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~  300 (346)
T 1ua2_A          226 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG  300 (346)
T ss_dssp             HHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred             HHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence            3210  0         00                 0335789999999999999999999999999999987543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.9e-41  Score=318.05  Aligned_cols=200  Identities=24%  Similarity=0.479  Sum_probs=172.0

Q ss_pred             CCCCCccccccceEEEEe----CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCC
Q 016865            1 MKIVRHPNIVRLHEVLAS----RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG--VYHRDLK   74 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~----~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~g--i~HrDlk   74 (381)
                      |+.++||||+++++++.+    ...+|+||||+++|+|.+++...+.+++..++.++.|++.||.|||++|  |+|||||
T Consensus        79 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dik  158 (290)
T 1t4h_A           79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLK  158 (290)
T ss_dssp             HTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCC
T ss_pred             HHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCC
Confidence            467899999999999976    4679999999999999999998888999999999999999999999999  9999999


Q ss_pred             CCcEEEc-cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh
Q 016865           75 PENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL  153 (381)
Q Consensus        75 p~NiLl~-~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~  153 (381)
                      |+|||++ .++.+||+|||++.....  ......+||+.|+|||++.+ .+ +.++||||+||++|+|++|..||.....
T Consensus       159 p~Nil~~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~  234 (290)
T 1t4h_A          159 CDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQN  234 (290)
T ss_dssp             GGGEEESSTTSCEEECCTTGGGGCCT--TSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred             HHHEEEECCCCCEEEeeCCCcccccc--cccccccCCcCcCCHHHHhc-cC-CCcchHHHHHHHHHHHHhCCCCCCCcCc
Confidence            9999998 789999999999975443  23456679999999999864 34 5899999999999999999999987544


Q ss_pred             -hHHHHHhhccc--CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          154 -PTLYKKINAAE--FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       154 -~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                       ......+..+.  ...+...++++.+||.+||+.||.+|||++++++||||+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          235 AAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence             44444444332  2344557899999999999999999999999999999975

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7e-42  Score=332.98  Aligned_cols=202  Identities=29%  Similarity=0.426  Sum_probs=171.1

Q ss_pred             CCCCCccccccceEEEEeC------CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 016865            1 MKIVRHPNIVRLHEVLASR------TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK   74 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~------~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlk   74 (381)
                      |+.++||||+++++++...      ..+|+||||+ |++|.+++.. +.+++..++.++.||+.||+|||++||+|||||
T Consensus        78 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk  155 (367)
T 1cm8_A           78 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLK  155 (367)
T ss_dssp             HHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             HHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcC
Confidence            3568999999999999865      3579999999 8899998876 679999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           75 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        75 p~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      |+|||++.++.+||+|||+++....   .....+||+.|+|||++.+....+.++||||+||++|+|++|++||.+.+..
T Consensus       156 p~NIll~~~~~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  232 (367)
T 1cm8_A          156 PGNLAVNEDCELKILDFGLARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL  232 (367)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             HHHEEEcCCCCEEEEeeeccccccc---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999999999999999999986543   2356689999999999987444469999999999999999999999987765


Q ss_pred             HHHHHhhccc-------------------------------CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          155 TLYKKINAAE-------------------------------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       155 ~~~~~i~~~~-------------------------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      .....+....                               ......+++++.+||.+||..||.+|||++++++||||+
T Consensus       233 ~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~  312 (367)
T 1cm8_A          233 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE  312 (367)
T ss_dssp             HHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred             HHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHH
Confidence            5444432110                               012234689999999999999999999999999999998


Q ss_pred             cCCC
Q 016865          204 KNYN  207 (381)
Q Consensus       204 ~~~~  207 (381)
                      ....
T Consensus       313 ~~~~  316 (367)
T 1cm8_A          313 SLHD  316 (367)
T ss_dssp             TTC-
T ss_pred             hhcC
Confidence            6543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=7.4e-42  Score=319.26  Aligned_cols=201  Identities=35%  Similarity=0.653  Sum_probs=176.1

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      +.++||||+++++++.+.+..|+||||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++
T Consensus        63 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~  142 (283)
T 3bhy_A           63 REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLL  142 (283)
T ss_dssp             HHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEES
T ss_pred             HhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEe
Confidence            46789999999999999999999999999999999998888899999999999999999999999999999999999999


Q ss_pred             cCC----CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           82 SYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        82 ~~~----~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      .++    .+||+|||++...... .......||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+.....
T Consensus       143 ~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~  220 (283)
T 3bhy_A          143 DKNVPNPRIKLIDFGIAHKIEAG-NEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETL  220 (283)
T ss_dssp             CSSSSSCCEEECCCTTCEECC---------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred             cCCCCCCceEEEecccceeccCC-CcccccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHHCCCCCCCcchHHHH
Confidence            877    8999999998765442 22345679999999999987666 48999999999999999999999988877777


Q ss_pred             HHhhcccCCCC----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          158 KKINAAEFSCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       158 ~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      ..+.......+    ..+++.+.+||.+||..||.+|||+.++++||||+.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  271 (283)
T 3bhy_A          221 TNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA  271 (283)
T ss_dssp             HHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred             HHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence            77666555443    457899999999999999999999999999999974

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.8e-42  Score=337.26  Aligned_cols=203  Identities=30%  Similarity=0.427  Sum_probs=167.6

Q ss_pred             CCCCCccccccceEEEEeCC------EEEEEEecCCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q 016865            1 MKIVRHPNIVRLHEVLASRT------KVYIILEFVTGGELFDKIV----HQGRLLENDCRRYFQQLIDAVAHCHSKGVYH   70 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~------~~~lV~E~~~gg~L~~~i~----~~~~l~e~~~~~~~~qll~~L~~LH~~gi~H   70 (381)
                      |+.++||||+++++++...+      .+|+||||++++ +.+.+.    ....+++..++.++.||+.||+|||++||+|
T Consensus        86 l~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH  164 (394)
T 4e7w_A           86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICH  164 (394)
T ss_dssp             HHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccC
Confidence            46789999999999996543      389999999874 444333    2567999999999999999999999999999


Q ss_pred             cCCCCCcEEEc-cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCC
Q 016865           71 RDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFG  149 (381)
Q Consensus        71 rDlkp~NiLl~-~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~  149 (381)
                      |||||+|||++ .++.+||+|||++...... ......+||+.|+|||++.+....+.++||||+||++|+|++|++||.
T Consensus       165 rDlkp~Nill~~~~~~~kL~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~  243 (394)
T 4e7w_A          165 RDIKPQNLLLDPPSGVLKLIDFGSAKILIAG-EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFP  243 (394)
T ss_dssp             SCCSGGGEEEETTTTEEEECCCTTCEECCTT-CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCCCHHHEEEcCCCCcEEEeeCCCcccccCC-CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            99999999999 7899999999999865443 234566789999999999776555699999999999999999999998


Q ss_pred             CCChhHHHHHhhcc-----------------cCC------------CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 016865          150 ETDLPTLYKKINAA-----------------EFS------------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHP  200 (381)
Q Consensus       150 ~~~~~~~~~~i~~~-----------------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp  200 (381)
                      +.+.......+...                 ...            ++..+++++.+||.+||+.||.+|||+.++++||
T Consensus       244 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  323 (394)
T 4e7w_A          244 GESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP  323 (394)
T ss_dssp             CSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred             CCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcCh
Confidence            87765444333210                 011            2334789999999999999999999999999999


Q ss_pred             ccccC
Q 016865          201 WFRKN  205 (381)
Q Consensus       201 ~~~~~  205 (381)
                      ||+..
T Consensus       324 ~f~~~  328 (394)
T 4e7w_A          324 FFDEL  328 (394)
T ss_dssp             GGSTT
T ss_pred             hhhhh
Confidence            99864

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-41  Score=332.95  Aligned_cols=202  Identities=28%  Similarity=0.385  Sum_probs=169.1

Q ss_pred             CCCCCccccccceEEEEe--------------------------------------CCEEEEEEecCCCCChHHHHH---
Q 016865            1 MKIVRHPNIVRLHEVLAS--------------------------------------RTKVYIILEFVTGGELFDKIV---   39 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~--------------------------------------~~~~~lV~E~~~gg~L~~~i~---   39 (381)
                      |+.++||||+++++++..                                      ...+|+||||++| +|.+.+.   
T Consensus        54 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~  132 (383)
T 3eb0_A           54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFI  132 (383)
T ss_dssp             HTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSE-EHHHHHHHHH
T ss_pred             HHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHH
Confidence            578899999999999944                                      3459999999985 7766664   


Q ss_pred             -hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc-cCCCEEEeeccCccCCCCCccccccccCCCCCCCCc
Q 016865           40 -HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE  117 (381)
Q Consensus        40 -~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~-~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE  117 (381)
                       ..+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++...... ......+||+.|+|||
T Consensus       133 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE  211 (383)
T 3eb0_A          133 RSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPE  211 (383)
T ss_dssp             HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHH
T ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHH
Confidence             356799999999999999999999999999999999999998 6889999999999865443 2345678899999999


Q ss_pred             eecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc-----------------cC------------CCC
Q 016865          118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-----------------EF------------SCP  168 (381)
Q Consensus       118 ~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-----------------~~------------~~p  168 (381)
                      ++.+....+.++||||+||++|+|++|.+||.+.+.......+...                 ..            .+|
T Consensus       212 ~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (383)
T 3eb0_A          212 LMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILP  291 (383)
T ss_dssp             HHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSC
T ss_pred             HhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCC
Confidence            9887664569999999999999999999999987765544443210                 01            134


Q ss_pred             CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          169 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       169 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      ..+++++.+||.+||+.||.+|||+.|+++||||+.
T Consensus       292 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  327 (383)
T 3eb0_A          292 EGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH  327 (383)
T ss_dssp             TTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence            457899999999999999999999999999999974

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=6.8e-42  Score=338.85  Aligned_cols=202  Identities=41%  Similarity=0.742  Sum_probs=164.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |++++||||+++++++.. +..|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus       194 l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll  272 (419)
T 3i6u_A          194 LKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL  272 (419)
T ss_dssp             HHHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             HHhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE
Confidence            356899999999999854 5689999999999999999888899999999999999999999999999999999999999


Q ss_pred             ccCC---CEEEeeccCccCCCCCccccccccCCCCCCCCceecC--CCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh-h
Q 016865           81 DSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDL-P  154 (381)
Q Consensus        81 ~~~~---~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~  154 (381)
                      +.++   .+||+|||++...... ....+.+||+.|+|||++.+  ....+.++||||+||++|+|++|.+||..... .
T Consensus       273 ~~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~  351 (419)
T 3i6u_A          273 SSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV  351 (419)
T ss_dssp             SSSSSSCCEEECCSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC
T ss_pred             ecCCCcceEEEeecccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH
Confidence            7654   5999999999876543 34467789999999999854  22234799999999999999999999976543 3


Q ss_pred             HHHHHhhcccCCCC----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          155 TLYKKINAAEFSCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       155 ~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      .....+..+.+..+    ..+++.+.+||.+||+.||.+|||++++++||||+.
T Consensus       352 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          352 SLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             CHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             HHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence            44455555554433    347999999999999999999999999999999964

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.6e-41  Score=316.63  Aligned_cols=194  Identities=21%  Similarity=0.306  Sum_probs=165.2

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      +||||+++++++.+.+..|+||||++||+|.+++...    +.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus        69 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~  148 (289)
T 1x8b_A           69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFI  148 (289)
T ss_dssp             SCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             CCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEE
Confidence            8999999999999999999999999999999999764    669999999999999999999999999999999999999


Q ss_pred             ccC-------------------CCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHH
Q 016865           81 DSY-------------------GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVL  141 (381)
Q Consensus        81 ~~~-------------------~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~l  141 (381)
                      +.+                   ..+||+|||++......    ....||+.|+|||++.+....+.++||||+||++|+|
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l  224 (289)
T 1x8b_A          149 SRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCA  224 (289)
T ss_dssp             C--------------------CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCcccccccccccccCCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHH
Confidence            844                   47999999998765442    3456999999999998764555799999999999999


Q ss_pred             HhCCCCCCCCChhHHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          142 MAGYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       142 l~G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ++|.+|+...+.   ...+..+ ....|..+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus       225 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          225 AGAEPLPRNGDQ---WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             TTCCCCCSSSHH---HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             hcCCCCCcchhH---HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            999988754432   2333333 335667799999999999999999999999999999999854

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=320.71  Aligned_cols=206  Identities=31%  Similarity=0.624  Sum_probs=179.2

Q ss_pred             CCCCCccccccceEEEE--eCCEEEEEEecCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 016865            1 MKIVRHPNIVRLHEVLA--SRTKVYIILEFVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE   76 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~--~~~~~~lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~   76 (381)
                      |+.++||||+++++++.  +....|+||||+++| |.+.+..  .+.+++..++.++.|++.||.|||++||+||||||+
T Consensus        60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~  138 (305)
T 2wtk_C           60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPG  138 (305)
T ss_dssp             HTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             HHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcc
Confidence            46789999999999994  456899999999876 7777765  456999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccCccCCCC--CccccccccCCCCCCCCceecCCC-CCCCcccHhHHHHHHHHHHhCCCCCCCCCh
Q 016865           77 NLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEVLSNRG-YDGSAADVWSCGVILFVLMAGYLPFGETDL  153 (381)
Q Consensus        77 NiLl~~~~~lkl~DFGls~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~  153 (381)
                      ||+++.++.+||+|||++.....  .........||+.|+|||++.+.. +.+.++||||+||++|+|++|..||...+.
T Consensus       139 NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  218 (305)
T 2wtk_C          139 NLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI  218 (305)
T ss_dssp             GEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Confidence            99999999999999999976542  222344667999999999987543 335789999999999999999999999888


Q ss_pred             hHHHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 016865          154 PTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  207 (381)
Q Consensus       154 ~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~  207 (381)
                      ......+....+..|..+++.+.+||.+||+.||.+|||++++++||||+....
T Consensus       219 ~~~~~~i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          219 YKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             HHHHHHHHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             HHHHHHHhcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence            888888888888888889999999999999999999999999999999987654

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.1e-42  Score=329.58  Aligned_cols=205  Identities=32%  Similarity=0.514  Sum_probs=170.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh----------------------------------------
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------------------------------   40 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~----------------------------------------   40 (381)
                      |+.++||||+++++++.+.+..|+||||++||+|.+++..                                        
T Consensus        82 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (345)
T 3hko_A           82 MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESL  161 (345)
T ss_dssp             HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEEC
T ss_pred             HHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence            3567999999999999999999999999999999998842                                        


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCC--CEEEeeccCccCCCCC----ccccccccCCCCCC
Q 016865           41 QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG--NLKVSDFGLSALPQQG----VELLHTTCGTPNYV  114 (381)
Q Consensus        41 ~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~--~lkl~DFGls~~~~~~----~~~~~~~~gt~~y~  114 (381)
                      ...+++..++.++.|++.||+|||++||+||||||+|||++.++  .+||+|||++......    .......+||+.|+
T Consensus       162 ~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~  241 (345)
T 3hko_A          162 DFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFV  241 (345)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGC
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCcccc
Confidence            11236788999999999999999999999999999999998776  8999999999754321    11235677999999


Q ss_pred             CCceecCC-CCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccCCCC--C--CCChhHHHHHHHhcCCCCCC
Q 016865          115 APEVLSNR-GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP--F--WFSTGATSLIHKILDPNPKT  189 (381)
Q Consensus       115 aPE~l~~~-~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p--~--~~s~~~~~li~~~L~~dP~~  189 (381)
                      |||++.+. ...+.++|||||||++|+|++|..||...+.......+.......+  .  .+++++.+||.+||+.||.+
T Consensus       242 aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  321 (345)
T 3hko_A          242 APEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE  321 (345)
T ss_dssp             CHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred             CchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhH
Confidence            99998652 3335899999999999999999999998888777766665554333  2  27999999999999999999


Q ss_pred             CCCHHHHhcCcccccC
Q 016865          190 RIRIEGIRKHPWFRKN  205 (381)
Q Consensus       190 R~t~~~il~hp~~~~~  205 (381)
                      |||+.++++||||+..
T Consensus       322 Rps~~~~l~hp~~~~~  337 (345)
T 3hko_A          322 RFDAMRALQHPWISQF  337 (345)
T ss_dssp             SCCHHHHHHSHHHHTT
T ss_pred             CCCHHHHhcChhhccC
Confidence            9999999999999764

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.3e-42  Score=329.29  Aligned_cols=202  Identities=25%  Similarity=0.510  Sum_probs=179.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeec
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDK------IVH--QGRLLENDCRRYFQQLIDAVAHCHS-KGVYHR   71 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~------i~~--~~~l~e~~~~~~~~qll~~L~~LH~-~gi~Hr   71 (381)
                      |+.++||||+++++++.+.+..|+||||++||+|.++      +..  ...+++..++.++.|++.||.|||+ +||+||
T Consensus        97 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~  176 (348)
T 2pml_X           97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHR  176 (348)
T ss_dssp             HTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECC
T ss_pred             HHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeec
Confidence            4678999999999999999999999999999999998      655  5679999999999999999999999 999999


Q ss_pred             CCCCCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCC-CCCCCcccHhHHHHHHHHHHhCCCCCCC
Q 016865           72 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR-GYDGSAADVWSCGVILFVLMAGYLPFGE  150 (381)
Q Consensus        72 Dlkp~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DIwSlGvil~~ll~G~~Pf~~  150 (381)
                      ||||+||+++.++.+||+|||++......  ......||+.|+|||++.+. .+.+.++||||+||++|+|++|..||..
T Consensus       177 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  254 (348)
T 2pml_X          177 DVKPSNILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL  254 (348)
T ss_dssp             CCCGGGEEECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCChHhEEEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999999765432  34567799999999999876 4443389999999999999999999988


Q ss_pred             CCh-hHHHHHhhcccCCCC-------------------CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          151 TDL-PTLYKKINAAEFSCP-------------------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       151 ~~~-~~~~~~i~~~~~~~p-------------------~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      .+. ......+.......|                   ..+++++.+||.+||+.||.+|||++++++||||+.
T Consensus       255 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~  328 (348)
T 2pml_X          255 KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD  328 (348)
T ss_dssp             SSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred             CCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence            766 677777777666666                   568999999999999999999999999999999975

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.1e-41  Score=336.61  Aligned_cols=205  Identities=26%  Similarity=0.394  Sum_probs=162.1

Q ss_pred             CCCCCccccccceEEEEeC-----CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASR-----TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKP   75 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp   75 (381)
                      |+.++||||+++++++...     ..+|+||||+. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||
T Consensus        79 l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp  157 (432)
T 3n9x_A           79 LNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKP  157 (432)
T ss_dssp             HHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             HHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence            3568999999999999876     57999999996 59999998888899999999999999999999999999999999


Q ss_pred             CcEEEccCCCEEEeeccCccCCCCCc----------------------cccccccCCCCCCCCceecCCCCCCCcccHhH
Q 016865           76 ENLLLDSYGNLKVSDFGLSALPQQGV----------------------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWS  133 (381)
Q Consensus        76 ~NiLl~~~~~lkl~DFGls~~~~~~~----------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwS  133 (381)
                      +|||++.++.+||+|||++.......                      ....+.+||+.|+|||++......+.++||||
T Consensus       158 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwS  237 (432)
T 3n9x_A          158 ANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWS  237 (432)
T ss_dssp             GGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHH
T ss_pred             HHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccch
Confidence            99999999999999999998654321                      12467789999999999755554569999999


Q ss_pred             HHHHHHHHHhC-----------CCCCCCCCh-----------------hHHH------------------------HHhh
Q 016865          134 CGVILFVLMAG-----------YLPFGETDL-----------------PTLY------------------------KKIN  161 (381)
Q Consensus       134 lGvil~~ll~G-----------~~Pf~~~~~-----------------~~~~------------------------~~i~  161 (381)
                      +||++|+|++|           .++|.+.+.                 ....                        ..+.
T Consensus       238 lG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~  317 (432)
T 3n9x_A          238 TGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIK  317 (432)
T ss_dssp             HHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHH
T ss_pred             HHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHH
Confidence            99999999984           444433321                 0000                        0011


Q ss_pred             cccCCCC-------CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          162 AAEFSCP-------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       162 ~~~~~~p-------~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      ......+       +.+++++.+||.+||+.||.+|||++|+++||||+...
T Consensus       318 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  369 (432)
T 3n9x_A          318 LFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR  369 (432)
T ss_dssp             TSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred             hCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence            1011111       34799999999999999999999999999999998653

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.2e-41  Score=318.41  Aligned_cols=200  Identities=33%  Similarity=0.632  Sum_probs=177.1

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCC
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG   84 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~   84 (381)
                      +||||+++++++.+.+..|+||||+++|+|.+++.....+++..++.++.|++.||.|||++||+||||||+||+++.++
T Consensus        82 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~  161 (298)
T 1phk_A           82 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM  161 (298)
T ss_dssp             TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred             CCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCC
Confidence            59999999999999999999999999999999999888899999999999999999999999999999999999999999


Q ss_pred             CEEEeeccCccCCCCCccccccccCCCCCCCCceecC-----CCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           85 NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-----RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        85 ~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      .+||+|||++...... ......+||+.|+|||++.+     ....+.++||||+||++|+|++|..||...+.......
T Consensus       162 ~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  240 (298)
T 1phk_A          162 NIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM  240 (298)
T ss_dssp             CEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             cEEEecccchhhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHH
Confidence            9999999998765442 23456789999999999851     22335899999999999999999999998887777777


Q ss_pred             hhcccCCCC----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          160 INAAEFSCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       160 i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      +.......+    ..+++.+.+||.+||..||.+|||++++++||||+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (298)
T 1phk_A          241 IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  290 (298)
T ss_dssp             HHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             HhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence            766655433    2478999999999999999999999999999999854

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.3e-41  Score=329.20  Aligned_cols=202  Identities=26%  Similarity=0.435  Sum_probs=170.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~-gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..+..++.|++.||.|||++ ||+||||||+|||
T Consensus        85 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil  164 (360)
T 3eqc_A           85 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL  164 (360)
T ss_dssp             GGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEE
T ss_pred             HHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEE
Confidence            467899999999999999999999999999999999999888999999999999999999999996 9999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      ++.++.+||+|||++.....  ......+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+.......
T Consensus       165 ~~~~~~~kl~Dfg~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  241 (360)
T 3eqc_A          165 VNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM  241 (360)
T ss_dssp             ECTTCCEEECCCCCCHHHHH--HC----CCCCTTCCHHHHTTCCCS-HHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHH
T ss_pred             ECCCCCEEEEECCCCccccc--ccccCCCCCCCeECHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999999864322  223456899999999999877664 899999999999999999999987665433221


Q ss_pred             h------------------------------------------hccc-CCCC-CCCChhHHHHHHHhcCCCCCCCCCHHH
Q 016865          160 I------------------------------------------NAAE-FSCP-FWFSTGATSLIHKILDPNPKTRIRIEG  195 (381)
Q Consensus       160 i------------------------------------------~~~~-~~~p-~~~s~~~~~li~~~L~~dP~~R~t~~~  195 (381)
                      +                                          .... ...+ ..+++++.+||.+||+.||.+|||+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  321 (360)
T 3eqc_A          242 FGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ  321 (360)
T ss_dssp             HC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred             hcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHH
Confidence            1                                          1111 1111 236889999999999999999999999


Q ss_pred             HhcCcccccC
Q 016865          196 IRKHPWFRKN  205 (381)
Q Consensus       196 il~hp~~~~~  205 (381)
                      +++||||+..
T Consensus       322 ll~hp~~~~~  331 (360)
T 3eqc_A          322 LMVHAFIKRS  331 (360)
T ss_dssp             HHTSHHHHHH
T ss_pred             HhhChHhhcc
Confidence            9999999753

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=333.74  Aligned_cols=207  Identities=27%  Similarity=0.430  Sum_probs=158.8

Q ss_pred             CCCCCccccccceEEEEe--CCEEEEEEecCCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q 016865            1 MKIVRHPNIVRLHEVLAS--RTKVYIILEFVTGGELFDKIVHQ---------GRLLENDCRRYFQQLIDAVAHCHSKGVY   69 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~i~~~---------~~l~e~~~~~~~~qll~~L~~LH~~gi~   69 (381)
                      |+.++||||+++++++.+  ...+|+||||+.| +|.+.+...         ..+++..++.++.||+.||.|||++||+
T Consensus        72 l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~iv  150 (405)
T 3rgf_A           72 LRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVL  150 (405)
T ss_dssp             HHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence            356899999999999965  6799999999964 888887532         2499999999999999999999999999


Q ss_pred             ecCCCCCcEEE----ccCCCEEEeeccCccCCCCC---ccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHH
Q 016865           70 HRDLKPENLLL----DSYGNLKVSDFGLSALPQQG---VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM  142 (381)
Q Consensus        70 HrDlkp~NiLl----~~~~~lkl~DFGls~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll  142 (381)
                      ||||||+|||+    +.++.+||+|||++......   .......+||+.|+|||++.+....+.++||||+||++|+|+
T Consensus       151 H~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell  230 (405)
T 3rgf_A          151 HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL  230 (405)
T ss_dssp             CCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHH
T ss_pred             CCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHH
Confidence            99999999999    67789999999999876432   123456789999999999987665569999999999999999


Q ss_pred             hCCCCCCCCChh---------HHHHHhhc-ccCC-------------------------------------CCCCCChhH
Q 016865          143 AGYLPFGETDLP---------TLYKKINA-AEFS-------------------------------------CPFWFSTGA  175 (381)
Q Consensus       143 ~G~~Pf~~~~~~---------~~~~~i~~-~~~~-------------------------------------~p~~~s~~~  175 (381)
                      +|.+||...+..         .....+.. ....                                     .....++.+
T Consensus       231 ~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (405)
T 3rgf_A          231 TSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKA  310 (405)
T ss_dssp             HSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHH
T ss_pred             hCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHH
Confidence            999999754431         11111110 0000                                     001127889


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 016865          176 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  208 (381)
Q Consensus       176 ~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~  208 (381)
                      .+||.+||+.||.+|||++|+|+||||+....+
T Consensus       311 ~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~~  343 (405)
T 3rgf_A          311 FHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLP  343 (405)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSCC
T ss_pred             HHHHHHHccCCcccCCCHHHHhcChhhccCCCC
Confidence            999999999999999999999999999876443

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.1e-41  Score=323.97  Aligned_cols=203  Identities=28%  Similarity=0.447  Sum_probs=167.9

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR---LLENDCRRYFQQLIDAVAHCHSKG--VYHRDLKP   75 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~---l~e~~~~~~~~qll~~L~~LH~~g--i~HrDlkp   75 (381)
                      |++++||||+++++++.+.+.+|+||||++||+|.+++...+.   +++..++.++.|++.||+|||++|  |+||||||
T Consensus        88 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp  167 (309)
T 3p86_A           88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKS  167 (309)
T ss_dssp             HHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCG
T ss_pred             HHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCCh
Confidence            3568999999999999999999999999999999999987553   999999999999999999999999  99999999


Q ss_pred             CcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhH
Q 016865           76 ENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT  155 (381)
Q Consensus        76 ~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  155 (381)
                      +|||++.++.+||+|||++.............+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+...
T Consensus       168 ~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~  246 (309)
T 3p86_A          168 PNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQ  246 (309)
T ss_dssp             GGEEECTTCCEEECCCC-----------------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCCTTTTSCHHH
T ss_pred             hhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999999999999999999865543334456789999999999987766 489999999999999999999999888776


Q ss_pred             HHHHh--hcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc--Cccccc
Q 016865          156 LYKKI--NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK--HPWFRK  204 (381)
Q Consensus       156 ~~~~i--~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~--hp~~~~  204 (381)
                      ....+  .......|..+++++.+||.+||..||.+|||++++++  +++++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          247 VVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             HHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             HHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            66555  33455677889999999999999999999999999987  455544

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.5e-41  Score=319.62  Aligned_cols=204  Identities=26%  Similarity=0.469  Sum_probs=177.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+.+|+||||+++|+|.+++. ....+++..++.++.|++.||.|||+.|++||||||+||+
T Consensus        78 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil  157 (314)
T 3com_A           78 MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNIL  157 (314)
T ss_dssp             HHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             HHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEE
Confidence            357899999999999999999999999999999999987 4567999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      ++.++.+||+|||++..............||+.|+|||++.+..+. .++||||+||++|+|++|..||...+.......
T Consensus       158 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  236 (314)
T 3com_A          158 LNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN-CVADIWSLGITAIEMAEGKPPYADIHPMRAIFM  236 (314)
T ss_dssp             ECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred             ECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            9999999999999997655433344566799999999999877665 899999999999999999999988776554443


Q ss_pred             hhcc---cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          160 INAA---EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       160 i~~~---~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      +...   .+..|..+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~  285 (314)
T 3com_A          237 IPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA  285 (314)
T ss_dssp             HHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred             HhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence            3322   233455689999999999999999999999999999999854

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.4e-41  Score=317.28  Aligned_cols=205  Identities=26%  Similarity=0.470  Sum_probs=167.1

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH--------QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD   72 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~--------~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrD   72 (381)
                      |+.++||||+++++++.+.+..|+||||++||+|.+++..        .+.+++..++.++.|++.||.|||++||+|||
T Consensus        67 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~d  146 (303)
T 2vwi_A           67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRD  146 (303)
T ss_dssp             CCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             HhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCC
Confidence            5678999999999999999999999999999999999874        45689999999999999999999999999999


Q ss_pred             CCCCcEEEccCCCEEEeeccCccCCCCC-----ccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCC
Q 016865           73 LKPENLLLDSYGNLKVSDFGLSALPQQG-----VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLP  147 (381)
Q Consensus        73 lkp~NiLl~~~~~lkl~DFGls~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~P  147 (381)
                      |||+||+++.++.+||+|||++......     .......+||+.|+|||++.+....+.++||||+||++|+|++|..|
T Consensus       147 l~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p  226 (303)
T 2vwi_A          147 VKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP  226 (303)
T ss_dssp             CSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             CChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999998754331     11234567999999999986533335899999999999999999999


Q ss_pred             CCCCChhHHHHHhhcccC----------CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          148 FGETDLPTLYKKINAAEF----------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       148 f~~~~~~~~~~~i~~~~~----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      |...+.............          ..+..+++++.++|.+||+.||.+|||++++++||||+..
T Consensus       227 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  294 (303)
T 2vwi_A          227 YHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA  294 (303)
T ss_dssp             TTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred             CccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence            988766544433222211          1223478899999999999999999999999999999754

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.5e-41  Score=323.49  Aligned_cols=199  Identities=33%  Similarity=0.576  Sum_probs=171.8

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEcc
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS   82 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~   82 (381)
                      +||||+++++++.+.+.+|+||||++||+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus        87 ~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~  166 (327)
T 3lm5_A           87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSS  166 (327)
T ss_dssp             TCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESC
T ss_pred             CCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEec
Confidence            6799999999999999999999999999999988553  67999999999999999999999999999999999999998


Q ss_pred             ---CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           83 ---YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        83 ---~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                         ++.+||+|||++...... ......+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+.......
T Consensus       167 ~~~~~~~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  244 (327)
T 3lm5_A          167 IYPLGDIKIVDFGMSRKIGHA-CELREIMGTPEYLAPEILNYDPIT-TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN  244 (327)
T ss_dssp             BTTBCCEEECCGGGCEEC----------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CCCCCcEEEeeCccccccCCc-cccccccCCcCccCCeeecCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Confidence               789999999999866543 234566899999999999877665 899999999999999999999998888777766


Q ss_pred             hhcccCCCC----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          160 INAAEFSCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       160 i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      +.......+    ..+++.+.+||.+||+.||.+|||++++++||||+..
T Consensus       245 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~  294 (327)
T 3lm5_A          245 ISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW  294 (327)
T ss_dssp             HHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred             HHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence            655444332    3478999999999999999999999999999999754

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.2e-41  Score=320.55  Aligned_cols=194  Identities=28%  Similarity=0.444  Sum_probs=162.4

Q ss_pred             CCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEcc
Q 016865            4 VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS   82 (381)
Q Consensus         4 l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~   82 (381)
                      .+||||+++++++.+.+.+|+||||+ +|+|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.
T Consensus       114 ~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~  192 (311)
T 3p1a_A          114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGP  192 (311)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECG
T ss_pred             cCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECC
Confidence            48999999999999999999999999 67999988764 45999999999999999999999999999999999999999


Q ss_pred             CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhc
Q 016865           83 YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA  162 (381)
Q Consensus        83 ~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~  162 (381)
                      ++.+||+|||++...... ......+||+.|+|||++.+ .+ +.++||||+||++|+|++|..|+...+   ....+..
T Consensus       193 ~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~  266 (311)
T 3p1a_A          193 RGRCKLGDFGLLVELGTA-GAGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQ  266 (311)
T ss_dssp             GGCEEECCCTTCEECC-------CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTT
T ss_pred             CCCEEEccceeeeecccC-CCCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhc
Confidence            999999999998765442 23455679999999999876 45 589999999999999999976654322   2222322


Q ss_pred             ccC--CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          163 AEF--SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       163 ~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      ...  ..+..+++++.+||.+||+.||.+|||++++++||||+.
T Consensus       267 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          267 GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             TCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             cCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            222  234458999999999999999999999999999999975

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=7.2e-42  Score=324.68  Aligned_cols=203  Identities=24%  Similarity=0.383  Sum_probs=168.6

Q ss_pred             CCCCCccccccceEEEEeCC----EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRT----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE   76 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~----~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~   76 (381)
                      |+.++||||+++++++....    ..|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+
T Consensus        66 l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~  145 (311)
T 3ork_A           66 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPA  145 (311)
T ss_dssp             CCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred             HHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHH
Confidence            56789999999999997654    45999999999999999998889999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccCccCCCCCc---cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh
Q 016865           77 NLLLDSYGNLKVSDFGLSALPQQGV---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL  153 (381)
Q Consensus        77 NiLl~~~~~lkl~DFGls~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~  153 (381)
                      |||++.++.+||+|||++.......   ......+||+.|+|||++.+..++ .++||||+||++|+|++|+.||...+.
T Consensus       146 Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~  224 (311)
T 3ork_A          146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSP  224 (311)
T ss_dssp             GEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             HEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence            9999999999999999997654321   223456799999999999887765 899999999999999999999998877


Q ss_pred             hHHHHHhhcccCCC----CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          154 PTLYKKINAAEFSC----PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       154 ~~~~~~i~~~~~~~----p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      ..............    +..+++++.++|.+||+.||.+||+..+++.|+|++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          225 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             HHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            66555444433322    2348999999999999999999999999999999974

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.1e-41  Score=324.96  Aligned_cols=204  Identities=26%  Similarity=0.459  Sum_probs=166.2

Q ss_pred             CCCc--cccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            3 IVRH--PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         3 ~l~H--pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      .++|  |||+++++++.+.+.+|+|||+ .+|+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus        63 ~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll  141 (343)
T 3dbq_A           63 KLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI  141 (343)
T ss_dssp             HHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred             hhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE
Confidence            4555  9999999999999999999995 578999999998899999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCcc--ccccccCCCCCCCCceecC----------CCCCCCcccHhHHHHHHHHHHhCCCCC
Q 016865           81 DSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSN----------RGYDGSAADVWSCGVILFVLMAGYLPF  148 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~----------~~~~~~~~DIwSlGvil~~ll~G~~Pf  148 (381)
                      + ++.+||+|||++........  .....+||+.|+|||++.+          ....+.++||||+||++|+|++|..||
T Consensus       142 ~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf  220 (343)
T 3dbq_A          142 V-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF  220 (343)
T ss_dssp             E-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             E-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcc
Confidence            7 68899999999987644221  2346789999999999864          123358999999999999999999999


Q ss_pred             CCCChh-HHHHHhh--cccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 016865          149 GETDLP-TLYKKIN--AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  208 (381)
Q Consensus       149 ~~~~~~-~~~~~i~--~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~  208 (381)
                      ...... .....+.  ......|...++++.+||.+||+.||.+|||+.++++||||+....+
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  283 (343)
T 3dbq_A          221 QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  283 (343)
T ss_dssp             TTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC-
T ss_pred             hhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCc
Confidence            764332 2222322  23345677788999999999999999999999999999999865543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.5e-41  Score=316.58  Aligned_cols=203  Identities=33%  Similarity=0.593  Sum_probs=176.5

Q ss_pred             CCCCccccccceEEEEe--CCEEEEEEecCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----Cee
Q 016865            2 KIVRHPNIVRLHEVLAS--RTKVYIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHCHSKG-----VYH   70 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~~L~~LH~~g-----i~H   70 (381)
                      +.++||||+++++++.+  ...+|+||||++||+|.+++...    ..+++..++.++.|++.||+|||++|     |+|
T Consensus        60 ~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH  139 (279)
T 2w5a_A           60 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH  139 (279)
T ss_dssp             HHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CC
T ss_pred             HhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEE
Confidence            56799999999998854  67899999999999999999753    24999999999999999999999999     999


Q ss_pred             cCCCCCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCC
Q 016865           71 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE  150 (381)
Q Consensus        71 rDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~  150 (381)
                      |||||+||+++.++.+||+|||++.............+||+.|+|||++.+..++ .++||||+||++|+|++|..||..
T Consensus       140 ~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~  218 (279)
T 2w5a_A          140 RDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTA  218 (279)
T ss_dssp             CCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CC-HHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCcc
Confidence            9999999999999999999999987655433334566899999999999877664 899999999999999999999998


Q ss_pred             CChhHHHHHhhcccC-CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          151 TDLPTLYKKINAAEF-SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       151 ~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      .+.......+..+.. ..|..+++++.++|.+||+.||.+|||++++++|+|+...
T Consensus       219 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          219 FSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             SSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             cCHHHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence            887777777766654 5667789999999999999999999999999999999754

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.4e-41  Score=316.60  Aligned_cols=201  Identities=25%  Similarity=0.390  Sum_probs=158.7

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCC
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPE   76 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~L~~LH~~-gi~HrDlkp~   76 (381)
                      +.++||||+++++++.+.+..|+||||++| +|.+.+..    ...+++..++.++.|++.||+|||++ ||+||||||+
T Consensus        61 ~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~  139 (290)
T 3fme_A           61 RTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPS  139 (290)
T ss_dssp             TTCCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGG
T ss_pred             HhCCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHH
Confidence            578999999999999999999999999975 88776653    46799999999999999999999998 9999999999


Q ss_pred             cEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceec---CCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh
Q 016865           77 NLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS---NRGYDGSAADVWSCGVILFVLMAGYLPFGETDL  153 (381)
Q Consensus        77 NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~  153 (381)
                      ||+++.++.+||+|||++...... ......+||+.|+|||++.   .....+.++||||+||++|+|++|..||.....
T Consensus       140 Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  218 (290)
T 3fme_A          140 NVLINALGQVKMCDFGISGYLVDD-VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT  218 (290)
T ss_dssp             GCEECTTCCEEBCCC----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC
T ss_pred             HEEECCCCCEEEeecCCccccccc-ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc
Confidence            999999999999999999765442 2334557999999999972   223335899999999999999999999986332


Q ss_pred             -h-HHHHHhhcccCCCC-CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          154 -P-TLYKKINAAEFSCP-FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       154 -~-~~~~~i~~~~~~~p-~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                       . .....+.......+ ..+++++.+||.+||+.||.+|||++++++||||+.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          219 PFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             HHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             hHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence             2 23333333333333 358999999999999999999999999999999975

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.4e-41  Score=320.30  Aligned_cols=203  Identities=29%  Similarity=0.468  Sum_probs=170.8

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      +.++||||+++++++.+.+..|+||||++||+|.+++.. .+.+++..++.++.|++.||.|||++|++||||||+||++
T Consensus        71 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~  150 (302)
T 2j7t_A           71 ATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM  150 (302)
T ss_dssp             HHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE
T ss_pred             hcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE
Confidence            467999999999999999999999999999999998875 4679999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceec-----CCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhH
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS-----NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT  155 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  155 (381)
                      +.++.+||+|||++.............+||+.|+|||++.     +..+ +.++||||+||++|+|++|..||...+...
T Consensus       151 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~  229 (302)
T 2j7t_A          151 TLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMR  229 (302)
T ss_dssp             CTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTT-TTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred             CCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCC-chhhhHHHHHHHHHHHhcCCCCCccCCHHH
Confidence            9999999999998754322112234567999999999984     3344 589999999999999999999999888766


Q ss_pred             HHHHhhcccC---CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          156 LYKKINAAEF---SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       156 ~~~~i~~~~~---~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ....+.....   ..+..++.++.++|.+||..||.+|||++++++||||+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  282 (302)
T 2j7t_A          230 VLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI  282 (302)
T ss_dssp             HHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred             HHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence            6655544432   2345689999999999999999999999999999999753

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.6e-41  Score=320.49  Aligned_cols=201  Identities=41%  Similarity=0.750  Sum_probs=170.4

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      +.++||||+++++++.+.+ .|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus        70 ~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~  148 (322)
T 2ycf_A           70 KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS  148 (322)
T ss_dssp             HHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES
T ss_pred             HhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEe
Confidence            4679999999999997765 899999999999999998888899999999999999999999999999999999999998


Q ss_pred             cCCC---EEEeeccCccCCCCCccccccccCCCCCCCCceecC--CCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh-H
Q 016865           82 SYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-T  155 (381)
Q Consensus        82 ~~~~---lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~  155 (381)
                      .++.   +||+|||++...... ......+||+.|+|||++..  ....+.++||||+||++|+|++|..||...... .
T Consensus       149 ~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  227 (322)
T 2ycf_A          149 SQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS  227 (322)
T ss_dssp             SSSSSCCEEECCCTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC
T ss_pred             cCCCCCeEEEccCccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH
Confidence            7665   999999999865442 23456679999999999742  233358999999999999999999999765433 3


Q ss_pred             HHHHhhcccCCCC----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          156 LYKKINAAEFSCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       156 ~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      ....+..+....+    ..+++++.+||.+||..||.+|||++++++||||+.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          228 LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             HHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             HHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence            4444444444332    347999999999999999999999999999999974

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.8e-41  Score=326.21  Aligned_cols=204  Identities=27%  Similarity=0.456  Sum_probs=171.3

Q ss_pred             CCCCccccccceEEEEeC-----CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 016865            2 KIVRHPNIVRLHEVLASR-----TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE   76 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~   76 (381)
                      +.++||||+++++++...     ...|+||||+. |+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+
T Consensus        80 ~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~  157 (364)
T 3qyz_A           80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS  157 (364)
T ss_dssp             HHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             HhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChH
Confidence            567999999999999765     47999999997 599998866 57999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccCccCCCCCc---cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh
Q 016865           77 NLLLDSYGNLKVSDFGLSALPQQGV---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL  153 (381)
Q Consensus        77 NiLl~~~~~lkl~DFGls~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~  153 (381)
                      |||++.++.+||+|||++.......   ......+||+.|+|||++.+....+.++||||+||++|+|++|.+||.+.+.
T Consensus       158 NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  237 (364)
T 3qyz_A          158 NLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY  237 (364)
T ss_dssp             GEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG
T ss_pred             hEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh
Confidence            9999999999999999998654321   1235568999999999976655456999999999999999999999988776


Q ss_pred             hHHHHHhhccc----------------------C---------CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          154 PTLYKKINAAE----------------------F---------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       154 ~~~~~~i~~~~----------------------~---------~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      ......+....                      .         ..++.+++++.+||.+||+.||.+|||++++++||||
T Consensus       238 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~  317 (364)
T 3qyz_A          238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL  317 (364)
T ss_dssp             GGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred             HHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence            55544432110                      0         0113468999999999999999999999999999999


Q ss_pred             ccCCC
Q 016865          203 RKNYN  207 (381)
Q Consensus       203 ~~~~~  207 (381)
                      +..+.
T Consensus       318 ~~~~~  322 (364)
T 3qyz_A          318 EQYYD  322 (364)
T ss_dssp             TTTCC
T ss_pred             hhccC
Confidence            87654

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.7e-42  Score=335.74  Aligned_cols=194  Identities=14%  Similarity=0.197  Sum_probs=161.8

Q ss_pred             CCCCCccccccce-------EEEEeCCE-----------------EEEEEecCCCCChHHHHHhcCCCCH-------HHH
Q 016865            1 MKIVRHPNIVRLH-------EVLASRTK-----------------VYIILEFVTGGELFDKIVHQGRLLE-------NDC   49 (381)
Q Consensus         1 lk~l~HpnIv~l~-------~~~~~~~~-----------------~~lV~E~~~gg~L~~~i~~~~~l~e-------~~~   49 (381)
                      |+.++|||||+++       +++++.+.                 .|+||||+ +|+|.+++...+.+++       ..+
T Consensus       130 l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~  208 (377)
T 3byv_A          130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHAR  208 (377)
T ss_dssp             STTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHH
T ss_pred             ccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHH
Confidence            4667999999999       88776643                 89999999 6799999987665665       778


Q ss_pred             HHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCC-------
Q 016865           50 RRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR-------  122 (381)
Q Consensus        50 ~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~-------  122 (381)
                      ..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....   ...+.+| +.|+|||++.+.       
T Consensus       209 ~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~  284 (377)
T 3byv_A          209 LQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHR  284 (377)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccc
Confidence            88999999999999999999999999999999999999999999985432   3456778 999999999876       


Q ss_pred             ----CCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          123 ----GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       123 ----~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                          .| +.++|||||||++|+|++|+.||...+.......+.    ..+..+++++.+||.+||+.||.+|||+.++++
T Consensus       285 ~~~~~~-~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          285 DRRTLM-TFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             CCEEEC-CHHHHHHHHHHHHHHHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             cccccC-ChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence                55 489999999999999999999997765433332222    233568999999999999999999999999999


Q ss_pred             Cccccc
Q 016865          199 HPWFRK  204 (381)
Q Consensus       199 hp~~~~  204 (381)
                      ||||+.
T Consensus       360 hp~f~~  365 (377)
T 3byv_A          360 TPEYEQ  365 (377)
T ss_dssp             SHHHHH
T ss_pred             ChHHHH
Confidence            999964

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=9.1e-41  Score=314.92  Aligned_cols=202  Identities=23%  Similarity=0.400  Sum_probs=168.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |++++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus        65 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~  144 (294)
T 4eqm_A           65 SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI  144 (294)
T ss_dssp             HTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred             HhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence            46789999999999999999999999999999999999988899999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      +.++.+||+|||++....... ......+||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+......+
T Consensus       145 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  223 (294)
T 4eqm_A          145 DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD-ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK  223 (294)
T ss_dssp             CTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCC-TTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHH
T ss_pred             CCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            999999999999998654421 223456799999999999887764 899999999999999999999998876554443


Q ss_pred             hhcccC-----CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          160 INAAEF-----SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       160 i~~~~~-----~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      ......     ..+..+++.+.++|.+||..||.+||+..+.+.++|..
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          224 HIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             HHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             HhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence            333222     23455899999999999999999999666666666653

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.8e-41  Score=327.92  Aligned_cols=202  Identities=26%  Similarity=0.395  Sum_probs=156.8

Q ss_pred             CCCCCccccccceEEEEeC------CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 016865            1 MKIVRHPNIVRLHEVLASR------TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK   74 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~------~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlk   74 (381)
                      |+.++||||+++++++...      ..+|+||||+ +++|.+++.. +.+++..++.++.||+.||+|||++||+|||||
T Consensus        82 l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlk  159 (367)
T 2fst_X           82 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK  159 (367)
T ss_dssp             HHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             HHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence            3568999999999999754      5689999999 7899988865 679999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           75 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        75 p~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      |+|||++.++.+||+|||++.....   .....+||+.|+|||++.+....+.++||||+||++|+|++|++||.+.+..
T Consensus       160 p~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  236 (367)
T 2fst_X          160 PSNLAVNEDCELKILDFGLARHTAD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI  236 (367)
T ss_dssp             GGGEEECTTCCEEECC------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             HhhEEECCCCCEEEeeccccccccc---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999999999999999999976543   2345689999999999987444568999999999999999999999887765


Q ss_pred             HHHHHhhccc-----------------------CCC--------CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          155 TLYKKINAAE-----------------------FSC--------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       155 ~~~~~i~~~~-----------------------~~~--------p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      .....+....                       ...        ....++++.+||.+||..||.+|||++++++||||+
T Consensus       237 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~  316 (367)
T 2fst_X          237 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA  316 (367)
T ss_dssp             HHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             HHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhh
Confidence            5444332110                       000        123688999999999999999999999999999998


Q ss_pred             cCCC
Q 016865          204 KNYN  207 (381)
Q Consensus       204 ~~~~  207 (381)
                      ....
T Consensus       317 ~~~~  320 (367)
T 2fst_X          317 QYHD  320 (367)
T ss_dssp             TTCC
T ss_pred             hccC
Confidence            6543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=6.2e-41  Score=332.07  Aligned_cols=203  Identities=29%  Similarity=0.386  Sum_probs=165.9

Q ss_pred             CCCCCccccccceEEEEeC------CEEEEEEecCCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q 016865            1 MKIVRHPNIVRLHEVLASR------TKVYIILEFVTGGELFDKIV----HQGRLLENDCRRYFQQLIDAVAHCHSKGVYH   70 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~------~~~~lV~E~~~gg~L~~~i~----~~~~l~e~~~~~~~~qll~~L~~LH~~gi~H   70 (381)
                      |+.++||||+++++++...      ..+++||||+++ +|.+.+.    ....+++..++.++.||+.||+|||++||+|
T Consensus       101 l~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH  179 (420)
T 1j1b_A          101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH  179 (420)
T ss_dssp             HHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred             HHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            4678999999999998542      247899999986 6666554    2467999999999999999999999999999


Q ss_pred             cCCCCCcEEEccC-CCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCC
Q 016865           71 RDLKPENLLLDSY-GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFG  149 (381)
Q Consensus        71 rDlkp~NiLl~~~-~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~  149 (381)
                      |||||+|||++.+ +.+||+|||+++..... ......+||+.|+|||++.+....+.++||||+||++|+|++|++||.
T Consensus       180 rDlkp~NILl~~~~~~~kl~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~  258 (420)
T 1j1b_A          180 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP  258 (420)
T ss_dssp             SCCSGGGEEEETTTTEEEECCCTTCEECCTT-CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cCCChhhEEEeCCCCeEEeccchhhhhcccC-CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence            9999999999965 57899999999865433 233567899999999999776444699999999999999999999998


Q ss_pred             CCChhHHHHHhhc-----------------ccCC------------CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 016865          150 ETDLPTLYKKINA-----------------AEFS------------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHP  200 (381)
Q Consensus       150 ~~~~~~~~~~i~~-----------------~~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp  200 (381)
                      +.+.......+..                 ..+.            ++..+++++.+||.+||+.||.+|||+.|+++||
T Consensus       259 ~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp  338 (420)
T 1j1b_A          259 GDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS  338 (420)
T ss_dssp             CSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             CCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence            8775544333221                 1112            2234689999999999999999999999999999


Q ss_pred             ccccC
Q 016865          201 WFRKN  205 (381)
Q Consensus       201 ~~~~~  205 (381)
                      ||+..
T Consensus       339 ~f~~~  343 (420)
T 1j1b_A          339 FFDEL  343 (420)
T ss_dssp             GGGGG
T ss_pred             hhccc
Confidence            99754

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=5.4e-41  Score=329.39  Aligned_cols=200  Identities=26%  Similarity=0.435  Sum_probs=167.3

Q ss_pred             ccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCCC
Q 016865            6 HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN   85 (381)
Q Consensus         6 HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~~   85 (381)
                      ||||+++++++.+.+.+|+||| +.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.
T Consensus       115 ~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~  192 (390)
T 2zmd_A          115 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGM  192 (390)
T ss_dssp             CTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSC
T ss_pred             CCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCe
Confidence            6999999999999999999999 56889999999988999999999999999999999999999999999999995 589


Q ss_pred             EEEeeccCccCCCCCc--cccccccCCCCCCCCceecCC----------CCCCCcccHhHHHHHHHHHHhCCCCCCCCCh
Q 016865           86 LKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNR----------GYDGSAADVWSCGVILFVLMAGYLPFGETDL  153 (381)
Q Consensus        86 lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~----------~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~  153 (381)
                      +||+|||++.......  ....+.+||+.|+|||++.+.          ...+.++|||||||++|+|++|..||.....
T Consensus       193 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~  272 (390)
T 2zmd_A          193 LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN  272 (390)
T ss_dssp             EEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred             EEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH
Confidence            9999999998764422  123567899999999998652          2345899999999999999999999976533


Q ss_pred             -hHHHHHhhc--ccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 016865          154 -PTLYKKINA--AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  207 (381)
Q Consensus       154 -~~~~~~i~~--~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~  207 (381)
                       ......+..  .....|.+.++++.+||.+||+.||.+|||+.++++||||+....
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~  329 (390)
T 2zmd_A          273 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  329 (390)
T ss_dssp             HHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred             HHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence             233333333  234567778999999999999999999999999999999986543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.1e-41  Score=329.85  Aligned_cols=202  Identities=31%  Similarity=0.489  Sum_probs=159.1

Q ss_pred             CCCCCccccccceEEEEeCC------EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRT------KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK   74 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~------~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlk   74 (381)
                      |+.++||||+++++++...+      .+|+||||++| +|.+.+.  ..+++..+..++.||+.||+|||++||+|||||
T Consensus        78 l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlk  154 (371)
T 2xrw_A           78 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  154 (371)
T ss_dssp             HHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             HHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence            35679999999999997665      89999999975 7888875  459999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           75 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        75 p~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      |+|||++.++.+||+|||++...... ......+||+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+..
T Consensus       155 p~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~  232 (371)
T 2xrw_A          155 PSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHI  232 (371)
T ss_dssp             GGGEEECTTSCEEECCCCC-----------------CTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             HHHEEEcCCCCEEEEEeecccccccc-cccCCceecCCccCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999999999865432 234567899999999999887765 8999999999999999999999887765


Q ss_pred             HHHHHhhcccC----------------------C--------------CCC------CCChhHHHHHHHhcCCCCCCCCC
Q 016865          155 TLYKKINAAEF----------------------S--------------CPF------WFSTGATSLIHKILDPNPKTRIR  192 (381)
Q Consensus       155 ~~~~~i~~~~~----------------------~--------------~p~------~~s~~~~~li~~~L~~dP~~R~t  192 (381)
                      .....+.....                      .              .|.      ..++++++||.+||+.||.+|||
T Consensus       233 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t  312 (371)
T 2xrw_A          233 DQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS  312 (371)
T ss_dssp             HHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred             HHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCC
Confidence            55444422100                      0              000      01567899999999999999999


Q ss_pred             HHHHhcCcccccCCC
Q 016865          193 IEGIRKHPWFRKNYN  207 (381)
Q Consensus       193 ~~~il~hp~~~~~~~  207 (381)
                      ++++++||||+..+.
T Consensus       313 ~~e~l~hp~~~~~~~  327 (371)
T 2xrw_A          313 VDEALQHPYINVWYD  327 (371)
T ss_dssp             HHHHHHSHHHHTTCC
T ss_pred             HHHHhCCcchhhhcC
Confidence            999999999986543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.1e-41  Score=324.42  Aligned_cols=205  Identities=26%  Similarity=0.367  Sum_probs=167.9

Q ss_pred             CCCCccccccceEEEEeCCE-------EEEEEecCCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--HCCC
Q 016865            2 KIVRHPNIVRLHEVLASRTK-------VYIILEFVTGGELFDKIV----HQGRLLENDCRRYFQQLIDAVAHCH--SKGV   68 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~-------~~lV~E~~~gg~L~~~i~----~~~~l~e~~~~~~~~qll~~L~~LH--~~gi   68 (381)
                      +.++||||+++++++.+.+.       +|+||||+++ +|.+.+.    ....+++..++.++.|++.||.|||  ++||
T Consensus        74 ~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~i  152 (360)
T 3e3p_A           74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNV  152 (360)
T ss_dssp             HHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCC
T ss_pred             HhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCe
Confidence            34689999999999976433       8999999987 5544443    4567899999999999999999999  9999


Q ss_pred             eecCCCCCcEEEcc-CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCC
Q 016865           69 YHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLP  147 (381)
Q Consensus        69 ~HrDlkp~NiLl~~-~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~P  147 (381)
                      +||||||+|||++. ++.+||+|||++...... ......+||+.|+|||++.+....+.++||||+||++|+|++|.+|
T Consensus       153 vH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~p  231 (360)
T 3e3p_A          153 CHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPI  231 (360)
T ss_dssp             BCSCCCGGGEEEETTTTEEEECCCTTCBCCCTT-SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ecCcCCHHHEEEeCCCCcEEEeeCCCceecCCC-CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            99999999999996 899999999999876543 2345667999999999997766556999999999999999999999


Q ss_pred             CCCCChhHHHHHhhccc--------------------------------CCCCCCCChhHHHHHHHhcCCCCCCCCCHHH
Q 016865          148 FGETDLPTLYKKINAAE--------------------------------FSCPFWFSTGATSLIHKILDPNPKTRIRIEG  195 (381)
Q Consensus       148 f~~~~~~~~~~~i~~~~--------------------------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~  195 (381)
                      |...+.......+....                                ...+...++++.+||.+||+.||.+|||+.+
T Consensus       232 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  311 (360)
T 3e3p_A          232 FRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYE  311 (360)
T ss_dssp             SCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHH
Confidence            99877665554442210                                0111125678999999999999999999999


Q ss_pred             HhcCcccccCCCC
Q 016865          196 IRKHPWFRKNYNP  208 (381)
Q Consensus       196 il~hp~~~~~~~~  208 (381)
                      +++||||+....+
T Consensus       312 ~l~hp~f~~~~~~  324 (360)
T 3e3p_A          312 ALCHPYFDELHDP  324 (360)
T ss_dssp             HTTSGGGGGGGCT
T ss_pred             HhcCccccccCCc
Confidence            9999999876543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=7.4e-41  Score=323.53  Aligned_cols=199  Identities=24%  Similarity=0.378  Sum_probs=171.8

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      +.++||||+++++++.+.+..|+||||+. |+|.+.+.. .+.+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus       109 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  187 (348)
T 1u5q_A          109 QKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL  187 (348)
T ss_dssp             HHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE
T ss_pred             HhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE
Confidence            56799999999999999999999999997 588887754 5679999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceec---CCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS---NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      +.++.+||+|||++.....    ....+||+.|+|||++.   ...+ +.++||||+||++|+|++|..||...+.....
T Consensus       188 ~~~~~~kL~DfG~a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~  262 (348)
T 1u5q_A          188 SEPGLVKLGDFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSAL  262 (348)
T ss_dssp             ETTTEEEECCCTTCBSSSS----BCCCCSCGGGCCHHHHHTTSSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred             CCCCCEEEeeccCceecCC----CCcccCCcceeCHhhhccccCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            9999999999999976543    24568999999999985   3344 58999999999999999999999887766555


Q ss_pred             HHhhcccCC--CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          158 KKINAAEFS--CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       158 ~~i~~~~~~--~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      ..+......  .+..+++.+.+||.+||+.||.+|||++++++||||....
T Consensus       263 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          263 YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             HHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence            544443322  2345799999999999999999999999999999997643

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=8.3e-41  Score=315.63  Aligned_cols=203  Identities=27%  Similarity=0.425  Sum_probs=179.0

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      +.++||||+++++++.+...+|+||||++||+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus        75 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~  153 (303)
T 3a7i_A           75 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS  153 (303)
T ss_dssp             HHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred             HhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEEC
Confidence            467999999999999999999999999999999998865 6799999999999999999999999999999999999999


Q ss_pred             cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhh
Q 016865           82 SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN  161 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~  161 (381)
                      .++.+||+|||++..............||+.|+|||++.+..+. .++||||+||++|+|++|..||...+.......+.
T Consensus       154 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  232 (303)
T 3a7i_A          154 EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELARGEPPHSELHPMKVLFLIP  232 (303)
T ss_dssp             TTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred             CCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCC-chhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh
Confidence            99999999999997655433334567899999999999877665 89999999999999999999998877766555554


Q ss_pred             ccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          162 AAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       162 ~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      ... ...+..+++.+.+||.+||..||.+|||++++++||||....
T Consensus       233 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  278 (303)
T 3a7i_A          233 KNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA  278 (303)
T ss_dssp             HSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred             cCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence            433 345567899999999999999999999999999999997643

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1e-40  Score=331.41  Aligned_cols=199  Identities=25%  Similarity=0.395  Sum_probs=167.4

Q ss_pred             CCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            3 IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      ..+||||+++++++...+.+|+||||+. |+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus       155 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl  233 (429)
T 3kvw_A          155 KDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL  233 (429)
T ss_dssp             TTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEE
T ss_pred             ccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE
Confidence            3589999999999999999999999996 69999997754  49999999999999999999999999999999999999


Q ss_pred             ccCCC--EEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016865           81 DSYGN--LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK  158 (381)
Q Consensus        81 ~~~~~--lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~  158 (381)
                      +.++.  +||+|||++.....   ...+.+||+.|+|||++.+..|. .++|||||||++|+|++|.+||.+.+......
T Consensus       234 ~~~~~~~vkL~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltG~~pf~~~~~~~~l~  309 (429)
T 3kvw_A          234 KQQGRSGIKVIDFGSSCYEHQ---RVYTYIQSRFYRAPEVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQLA  309 (429)
T ss_dssp             SSTTSCCEEECCCTTCEETTC---CCCSSCSCGGGCCHHHHHTBCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             ccCCCcceEEeecccceecCC---cccccCCCCCccChHHHhCCCCC-chHHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99887  99999999875433   24567899999999999887774 99999999999999999999998877655443


Q ss_pred             Hhhccc----------------------C-------------------------------------CCCCCCChhHHHHH
Q 016865          159 KINAAE----------------------F-------------------------------------SCPFWFSTGATSLI  179 (381)
Q Consensus       159 ~i~~~~----------------------~-------------------------------------~~p~~~s~~~~~li  179 (381)
                      .+....                      +                                     ..+...++++.+||
T Consensus       310 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli  389 (429)
T 3kvw_A          310 CMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFL  389 (429)
T ss_dssp             HHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHH
T ss_pred             HHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHH
Confidence            322100                      0                                     00112378899999


Q ss_pred             HHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          180 HKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       180 ~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      .+||+.||.+|||++|+++||||+...
T Consensus       390 ~~~L~~dP~~Rpta~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          390 KQCLEWDPAVRMTPGQALRHPWLRRRL  416 (429)
T ss_dssp             HHHTCSSTTTSCCHHHHHTSTTTC---
T ss_pred             HHHCCCChhhCCCHHHHhCChhhccCC
Confidence            999999999999999999999998754

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7.9e-41  Score=313.57  Aligned_cols=202  Identities=39%  Similarity=0.698  Sum_probs=177.9

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |++++||||+++++++.+.+..|+||||+++++|.+.+...+.+++..++.++.|++.||.|||++||+||||||+||++
T Consensus        75 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv  154 (287)
T 2wei_A           75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILL  154 (287)
T ss_dssp             HHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             HHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEE
Confidence            35789999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             ccCC---CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           81 DSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        81 ~~~~---~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      +.++   .+||+|||++...... .......||+.|+|||++.+. + +.++||||+|+++|+|++|..||...+.....
T Consensus       155 ~~~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~  231 (287)
T 2wei_A          155 ESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDIL  231 (287)
T ss_dssp             SCSSTTCCEEECSTTGGGTBCCC-SSCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             ecCCCcccEEEeccCcceeecCC-CccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            7644   6999999998865443 233455789999999998653 4 58999999999999999999999988887777


Q ss_pred             HHhhcccCCCC----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          158 KKINAAEFSCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       158 ~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ..+..+.+..+    ..+++++.++|.+||..||.+|||++++++||||+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          232 KRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             HHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             HHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            77766655433    3479999999999999999999999999999999753

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.1e-41  Score=320.58  Aligned_cols=181  Identities=27%  Similarity=0.419  Sum_probs=146.2

Q ss_pred             EEEEEEecCCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCCCEEEeeccCccCC
Q 016865           21 KVYIILEFVTGGELFDKIVHQGR---LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP   97 (381)
Q Consensus        21 ~~~lV~E~~~gg~L~~~i~~~~~---l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~   97 (381)
                      .+|+||||++||+|.+++.....   .++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus       135 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  214 (332)
T 3qd2_B          135 YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM  214 (332)
T ss_dssp             EEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCccccc
Confidence            38999999999999999987544   456678999999999999999999999999999999999999999999999865


Q ss_pred             CCCc------------cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccC
Q 016865           98 QQGV------------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF  165 (381)
Q Consensus        98 ~~~~------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~  165 (381)
                      ....            ......+||+.|+|||++.+..+. .++||||+||++|+|++|..|+...  ......+.....
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~~~~  291 (332)
T 3qd2_B          215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNLKF  291 (332)
T ss_dssp             SCC--------------CCCSCC-CGGGSCHHHHHCCCCC-THHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHTTCC
T ss_pred             ccchhhccccccccccccccccCCCcCccChHHhcCCCCc-chhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhccCC
Confidence            5421            123456799999999999887764 8999999999999999998775321  122222222222


Q ss_pred             C-CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          166 S-CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       166 ~-~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      + .+...++++.+||.+||+.||.+|||++++++||||+.
T Consensus       292 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          292 PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN  331 (332)
T ss_dssp             CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred             CcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence            1 11235788899999999999999999999999999974

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=317.60  Aligned_cols=201  Identities=26%  Similarity=0.385  Sum_probs=164.3

Q ss_pred             CccccccceEEEEe------CCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 016865            5 RHPNIVRLHEVLAS------RTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE   76 (381)
Q Consensus         5 ~HpnIv~l~~~~~~------~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~   76 (381)
                      +||||+++++++..      .+.+|+||||+++|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+
T Consensus        79 ~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~  158 (326)
T 2x7f_A           79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQ  158 (326)
T ss_dssp             CSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG
T ss_pred             CCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHH
Confidence            79999999999987      56899999999999999999764  46999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecC----CCCCCCcccHhHHHHHHHHHHhCCCCCCCCC
Q 016865           77 NLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN----RGYDGSAADVWSCGVILFVLMAGYLPFGETD  152 (381)
Q Consensus        77 NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~  152 (381)
                      ||+++.++.+||+|||++.............+||+.|+|||++..    ....+.++||||+||++|+|++|..||...+
T Consensus       159 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  238 (326)
T 2x7f_A          159 NVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH  238 (326)
T ss_dssp             GEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             HEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence            999999999999999998876543333456689999999999862    2233589999999999999999999998877


Q ss_pred             hhHHHHHhhcccC--CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          153 LPTLYKKINAAEF--SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       153 ~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      .......+.....  ..+..+++.+.+||.+||..||.+|||++++++||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          239 PMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             HHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             HHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence            6555544433322  2234579999999999999999999999999999999854

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.2e-40  Score=318.11  Aligned_cols=199  Identities=24%  Similarity=0.426  Sum_probs=164.4

Q ss_pred             CCC-ccccccceEEEEe--CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            3 IVR-HPNIVRLHEVLAS--RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         3 ~l~-HpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      .++ ||||+++++++.+  ....++||||+++++|.+++.   .+++..++.++.||+.||+|||++||+||||||+|||
T Consensus        86 ~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil  162 (330)
T 3nsz_A           86 NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM  162 (330)
T ss_dssp             HHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             HcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEE
Confidence            454 9999999999998  678999999999999998874   3899999999999999999999999999999999999


Q ss_pred             EccCC-CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh-hHHH
Q 016865           80 LDSYG-NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL-PTLY  157 (381)
Q Consensus        80 l~~~~-~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~~~  157 (381)
                      ++.++ .+||+|||++...... ......+||+.|+|||++.+....+.++||||+||++|+|++|..||..... ....
T Consensus       163 ~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l  241 (330)
T 3nsz_A          163 IDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL  241 (330)
T ss_dssp             EETTTTEEEECCCTTCEECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH
T ss_pred             EcCCCCEEEEEeCCCceEcCCC-CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHH
Confidence            99777 8999999999865443 2345678999999999998755556999999999999999999999954322 1111


Q ss_pred             H-------------HhhcccCC------------------------CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 016865          158 K-------------KINAAEFS------------------------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHP  200 (381)
Q Consensus       158 ~-------------~i~~~~~~------------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp  200 (381)
                      .             .+......                        .+..+++++.+||.+||+.||.+|||++++++||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp  321 (330)
T 3nsz_A          242 VRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP  321 (330)
T ss_dssp             HHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSG
T ss_pred             HHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCc
Confidence            1             11111111                        1122799999999999999999999999999999


Q ss_pred             ccccC
Q 016865          201 WFRKN  205 (381)
Q Consensus       201 ~~~~~  205 (381)
                      ||+..
T Consensus       322 ~f~~~  326 (330)
T 3nsz_A          322 YFYTV  326 (330)
T ss_dssp             GGTTC
T ss_pred             cHhhh
Confidence            99854

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4e-40  Score=313.70  Aligned_cols=199  Identities=30%  Similarity=0.417  Sum_probs=170.5

Q ss_pred             CCccccccceEEEE-----eCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 016865            4 VRHPNIVRLHEVLA-----SRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE   76 (381)
Q Consensus         4 l~HpnIv~l~~~~~-----~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~   76 (381)
                      ++||||+++++++.     .....|+||||++ |+|.+++....  .+++..++.++.|++.||.|||++||+||||||+
T Consensus        71 ~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~  149 (326)
T 1blx_A           71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQ  149 (326)
T ss_dssp             TCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred             cCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHH
Confidence            48999999999997     5678999999997 59999997743  4999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHH
Q 016865           77 NLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL  156 (381)
Q Consensus        77 NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~  156 (381)
                      ||+++.++.+||+|||++...... ......+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+....
T Consensus       150 Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~  227 (326)
T 1blx_A          150 NILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ  227 (326)
T ss_dssp             GEEECTTCCEEECSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             HeEEcCCCCEEEecCcccccccCC-CCccccccccceeCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence            999999999999999999866532 234567899999999999877664 899999999999999999999998776655


Q ss_pred             HHHhhcc-------c--------------------CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          157 YKKINAA-------E--------------------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       157 ~~~i~~~-------~--------------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ...+...       .                    ...+..+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus       228 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  303 (326)
T 1blx_A          228 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  303 (326)
T ss_dssp             HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence            5444211       0                    01224578999999999999999999999999999999754

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=312.76  Aligned_cols=205  Identities=28%  Similarity=0.418  Sum_probs=170.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG---RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      |+.++||||+++++++.+.+..|+||||++||+|.+++....   .+++..++.++.|++.||.|||++||+||||||+|
T Consensus        73 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~N  152 (295)
T 2clq_A           73 HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDN  152 (295)
T ss_dssp             HHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             HHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhh
Confidence            357899999999999999999999999999999999997642   46789999999999999999999999999999999


Q ss_pred             EEEcc-CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCC-CCCCcccHhHHHHHHHHHHhCCCCCCCCChhH
Q 016865           78 LLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG-YDGSAADVWSCGVILFVLMAGYLPFGETDLPT  155 (381)
Q Consensus        78 iLl~~-~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  155 (381)
                      |+++. ++.+||+|||++..............||+.|+|||++.+.. ..+.++||||+||++|+|++|..||...+...
T Consensus       153 il~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  232 (295)
T 2clq_A          153 VLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ  232 (295)
T ss_dssp             EEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH
T ss_pred             EEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh
Confidence            99997 89999999999976554333345668999999999986543 23589999999999999999999997644322


Q ss_pred             H--HH-HhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          156 L--YK-KINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       156 ~--~~-~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      .  .. .........|..+++++.+||.+||+.||.+|||++++++||||+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  285 (295)
T 2clq_A          233 AAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS  285 (295)
T ss_dssp             HHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred             HHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence            1  11 12233345677789999999999999999999999999999999854

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.7e-41  Score=323.79  Aligned_cols=202  Identities=35%  Similarity=0.660  Sum_probs=146.0

Q ss_pred             CCCCccccccceEEEEe----CCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 016865            2 KIVRHPNIVRLHEVLAS----RTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKP   75 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~----~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp   75 (381)
                      +.++||||+++++++..    ...+|+||||++||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||
T Consensus        77 ~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp  156 (336)
T 3fhr_A           77 QASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKP  156 (336)
T ss_dssp             HHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             HhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence            35689999999999986    556999999999999999998754  699999999999999999999999999999999


Q ss_pred             CcEEEccC---CCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCC
Q 016865           76 ENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD  152 (381)
Q Consensus        76 ~NiLl~~~---~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~  152 (381)
                      +|||++.+   +.+||+|||++.....  ......+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+
T Consensus       157 ~NIll~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~  233 (336)
T 3fhr_A          157 ENLLYTSKEKDAVLKLTDFGFAKETTQ--NALQTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNT  233 (336)
T ss_dssp             GGEEESCSSTTCCEEECCCTTCEEC------------------------CHHH-HHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             HHEEEEecCCCceEEEeccccceeccc--cccccCCCCcCccChhhhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCcc
Confidence            99999864   4599999999976543  234567899999999999766664 89999999999999999999997655


Q ss_pred             hhHH----HHHhhcccCCCC----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          153 LPTL----YKKINAAEFSCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       153 ~~~~----~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      ....    ...+.......|    ..+++++.+||.+||+.||.+|||++++++||||+...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  295 (336)
T 3fhr_A          234 GQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM  295 (336)
T ss_dssp             -----------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred             chhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence            4332    222333333222    34899999999999999999999999999999998653

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.3e-40  Score=315.46  Aligned_cols=204  Identities=24%  Similarity=0.341  Sum_probs=163.6

Q ss_pred             CCCCCccccccceEEEEeCCEE------EEEEecCCCCChHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKV------YIILEFVTGGELFDKIVHQG------RLLENDCRRYFQQLIDAVAHCHSKGV   68 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~------~lV~E~~~gg~L~~~i~~~~------~l~e~~~~~~~~qll~~L~~LH~~gi   68 (381)
                      |+.++||||+++++++.+....      |+||||+++|+|.+++....      .+++..++.++.|++.||+|||++||
T Consensus        79 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i  158 (323)
T 3qup_A           79 MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNF  158 (323)
T ss_dssp             HTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCc
Confidence            4678999999999999887655      99999999999999996533      58999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CC
Q 016865           69 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GY  145 (381)
Q Consensus        69 ~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~  145 (381)
                      +||||||+|||++.++.+||+|||++.......  .......+++.|+|||++.+..+. .++||||+||++|+|++ |.
T Consensus       159 vH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~  237 (323)
T 3qup_A          159 IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQ  237 (323)
T ss_dssp             CCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSC
T ss_pred             ccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCC-CccchhhHHHHHHHHHhCCC
Confidence            999999999999999999999999997654321  122344567889999999877665 89999999999999999 99


Q ss_pred             CCCCCCChhHHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCC-------HHHHhcCcccccC
Q 016865          146 LPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIR-------IEGIRKHPWFRKN  205 (381)
Q Consensus       146 ~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t-------~~~il~hp~~~~~  205 (381)
                      +||...+.......+... ....|..+++++.+||.+||+.||.+|||       +++++.|||+...
T Consensus       238 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          238 TPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             CTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             CCccccChHHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence            999988877777766544 45667779999999999999999999999       7888999999754

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=8.2e-41  Score=323.66  Aligned_cols=205  Identities=24%  Similarity=0.384  Sum_probs=162.5

Q ss_pred             CCCCccccccceEEEEe-----CCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 016865            2 KIVRHPNIVRLHEVLAS-----RTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKP   75 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~-----~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp   75 (381)
                      +.++||||+++++++..     ...+|+||||+. |+|.+.+...+ .+++..++.++.||+.||.|||++||+||||||
T Consensus        84 ~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp  162 (362)
T 3pg1_A           84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHP  162 (362)
T ss_dssp             HHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred             HhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCCh
Confidence            56799999999999954     347999999997 58888887543 699999999999999999999999999999999


Q ss_pred             CcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhH
Q 016865           76 ENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT  155 (381)
Q Consensus        76 ~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  155 (381)
                      +|||++.++.+||+|||++...... ......+||+.|+|||++.+....+.++||||+||++|+|++|..||...+...
T Consensus       163 ~NIl~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  241 (362)
T 3pg1_A          163 GNILLADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN  241 (362)
T ss_dssp             GGEEECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             HHEEEcCCCCEEEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999999999999999999754432 234566799999999999874545699999999999999999999999877655


Q ss_pred             HHHHhhcc------------------------cC--------CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          156 LYKKINAA------------------------EF--------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       156 ~~~~i~~~------------------------~~--------~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      ....+...                        ..        ..++..++.+.+||.+||+.||.+|||++++++||||+
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  321 (362)
T 3pg1_A          242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFE  321 (362)
T ss_dssp             HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGT
T ss_pred             HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhh
Confidence            54443210                        00        11234688999999999999999999999999999998


Q ss_pred             cCCCC
Q 016865          204 KNYNP  208 (381)
Q Consensus       204 ~~~~~  208 (381)
                      ..+.+
T Consensus       322 ~~~~~  326 (362)
T 3pg1_A          322 SLFDP  326 (362)
T ss_dssp             TTCCG
T ss_pred             hccCc
Confidence            76543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.6e-40  Score=318.61  Aligned_cols=204  Identities=29%  Similarity=0.433  Sum_probs=167.9

Q ss_pred             CCCCccccccceEEEEeC-----CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 016865            2 KIVRHPNIVRLHEVLASR-----TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE   76 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~   76 (381)
                      +.++||||+++++++...     ...|+||||+. |+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+
T Consensus        64 ~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~  141 (353)
T 2b9h_A           64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPS  141 (353)
T ss_dssp             HHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred             HhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence            567999999999998764     68999999997 589998876 67999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccCccCCCCCcc----------ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCC
Q 016865           77 NLLLDSYGNLKVSDFGLSALPQQGVE----------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYL  146 (381)
Q Consensus        77 NiLl~~~~~lkl~DFGls~~~~~~~~----------~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~  146 (381)
                      |||++.++.+||+|||++........          .....+||+.|+|||++.+....+.++||||+||++|+|++|.+
T Consensus       142 Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~  221 (353)
T 2b9h_A          142 NLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP  221 (353)
T ss_dssp             GEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             HeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCC
Confidence            99999999999999999976543111          12345789999999998765555689999999999999999999


Q ss_pred             CCCCCChhHHHHHhhcc--------------------------cC------CCCCCCChhHHHHHHHhcCCCCCCCCCHH
Q 016865          147 PFGETDLPTLYKKINAA--------------------------EF------SCPFWFSTGATSLIHKILDPNPKTRIRIE  194 (381)
Q Consensus       147 Pf~~~~~~~~~~~i~~~--------------------------~~------~~p~~~s~~~~~li~~~L~~dP~~R~t~~  194 (381)
                      ||.+.+.......+...                          ..      ..++.+++++.+||.+||+.||.+|||++
T Consensus       222 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  301 (353)
T 2b9h_A          222 IFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK  301 (353)
T ss_dssp             SCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             CCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHH
Confidence            99887754433322110                          00      01235789999999999999999999999


Q ss_pred             HHhcCcccccCCC
Q 016865          195 GIRKHPWFRKNYN  207 (381)
Q Consensus       195 ~il~hp~~~~~~~  207 (381)
                      ++++||||+....
T Consensus       302 ell~hp~~~~~~~  314 (353)
T 2b9h_A          302 EALEHPYLQTYHD  314 (353)
T ss_dssp             HHHTSGGGTTTCC
T ss_pred             HHhcCccccccCC
Confidence            9999999986543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.2e-40  Score=322.74  Aligned_cols=197  Identities=22%  Similarity=0.375  Sum_probs=172.5

Q ss_pred             CCC-CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHH
Q 016865            2 KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHCH   64 (381)
Q Consensus         2 k~l-~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~~L~~LH   64 (381)
                      +.+ +||||+++++++.+.+.+|+||||++||+|.+++...+                .+++..+..++.||+.||+|||
T Consensus       141 ~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH  220 (370)
T 2psq_A          141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA  220 (370)
T ss_dssp             HHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence            456 89999999999999999999999999999999998643                4789999999999999999999


Q ss_pred             HCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHH
Q 016865           65 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM  142 (381)
Q Consensus        65 ~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll  142 (381)
                      ++||+||||||+|||++.++.+||+|||++.......  .......||+.|+|||++.+..|. .++|||||||++|+|+
T Consensus       221 ~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ell  299 (370)
T 2psq_A          221 SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIF  299 (370)
T ss_dssp             HTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHH
T ss_pred             hCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCC-cHHHHHHHHHHHHHHH
Confidence            9999999999999999999999999999998554322  122344578899999999887765 8999999999999999


Q ss_pred             h-CCCCCCCCChhHHHHHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          143 A-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       143 ~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      + |..||.+.+.......+..+. ...|..+++++.++|.+||+.||.+|||+.+++++
T Consensus       300 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          300 TLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             TTSCCSSTTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9 999999888877777665543 45677789999999999999999999999999873

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=6.2e-40  Score=312.99  Aligned_cols=195  Identities=28%  Similarity=0.415  Sum_probs=164.9

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEcc
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS   82 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~   82 (381)
                      .|++|+++++++.+.+..|+||||+ +|+|.+++...+  .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus        75 ~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~  153 (339)
T 1z57_A           75 STFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQ  153 (339)
T ss_dssp             CTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESC
T ss_pred             CceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEec
Confidence            4556999999999999999999999 889999998765  5889999999999999999999999999999999999987


Q ss_pred             -------------------CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh
Q 016865           83 -------------------YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA  143 (381)
Q Consensus        83 -------------------~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~  143 (381)
                                         ++.+||+|||++.....   .....+||+.|+|||++.+..++ .++||||+||++|+|++
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~  229 (339)
T 1z57_A          154 SDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYL  229 (339)
T ss_dssp             CCEEEEEC----CEEEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTTSCCC-THHHHHHHHHHHHHHHH
T ss_pred             cccccccCCccccccccccCCCceEeeCcccccCcc---ccccccCCccccChHHhhCCCCC-cchhhHHHHHHHHHHHh
Confidence                               66899999999876443   23466899999999999887765 89999999999999999


Q ss_pred             CCCCCCCCChhHHHHHhhcccCCC--------------------------------------------CCCCChhHHHHH
Q 016865          144 GYLPFGETDLPTLYKKINAAEFSC--------------------------------------------PFWFSTGATSLI  179 (381)
Q Consensus       144 G~~Pf~~~~~~~~~~~i~~~~~~~--------------------------------------------p~~~s~~~~~li  179 (381)
                      |..||...+.......+.......                                            +...++++.+||
T Consensus       230 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  309 (339)
T 1z57_A          230 GFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLI  309 (339)
T ss_dssp             SSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHH
T ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHH
Confidence            999998877654433332111111                                            111246788999


Q ss_pred             HHhcCCCCCCCCCHHHHhcCccccc
Q 016865          180 HKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       180 ~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      .+||+.||.+|||++|+++||||+.
T Consensus       310 ~~~L~~dP~~Rpt~~ell~hp~f~~  334 (339)
T 1z57_A          310 QKMLEYDPAKRITLREALKHPFFDL  334 (339)
T ss_dssp             HHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred             HHHhCcCcccccCHHHHhcCHHHHH
Confidence            9999999999999999999999975

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.9e-40  Score=307.83  Aligned_cols=198  Identities=24%  Similarity=0.390  Sum_probs=173.9

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |++++||||+++++++.+.+..|+||||++||+|.+++... +.+++..++.++.|++.||+|||++||+||||||+||+
T Consensus        59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil  138 (269)
T 4hcu_A           59 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCL  138 (269)
T ss_dssp             HHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             HHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEE
Confidence            35789999999999999999999999999999999999654 45899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  157 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~  157 (381)
                      ++.++.+||+|||++....... .......||+.|+|||++.+..+. .++||||+||++|+|++ |.+||...+.....
T Consensus       139 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~  217 (269)
T 4hcu_A          139 VGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV  217 (269)
T ss_dssp             ECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred             EcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCC-chhhhHHHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence            9999999999999997654321 123345577889999999877765 89999999999999999 99999998887777


Q ss_pred             HHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          158 KKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       158 ~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ..+... ....|..+++.+.++|.+||+.||.+|||+.++++|
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          218 EDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            776655 445566789999999999999999999999999875

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=5.6e-40  Score=308.46  Aligned_cols=202  Identities=27%  Similarity=0.516  Sum_probs=162.0

Q ss_pred             CCCCCccccccceEEEEe-------------CCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC
Q 016865            1 MKIVRHPNIVRLHEVLAS-------------RTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSK   66 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~-------------~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~   66 (381)
                      |+.++||||+++++++.+             .+..|+||||++||+|.+++...+ .+++..++.++.|++.||.|||++
T Consensus        56 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~  135 (303)
T 1zy4_A           56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ  135 (303)
T ss_dssp             HTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC
Confidence            467899999999999865             467999999999999999998644 578899999999999999999999


Q ss_pred             CCeecCCCCCcEEEccCCCEEEeeccCccCCCCC--------------ccccccccCCCCCCCCceecCCCCCCCcccHh
Q 016865           67 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--------------VELLHTTCGTPNYVAPEVLSNRGYDGSAADVW  132 (381)
Q Consensus        67 gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~--------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIw  132 (381)
                      ||+||||||+||+++.++.+||+|||++......              .......+||+.|+|||++.+.+..+.++|||
T Consensus       136 ~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~  215 (303)
T 1zy4_A          136 GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMY  215 (303)
T ss_dssp             TCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHH
T ss_pred             CeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHH
Confidence            9999999999999999999999999998765421              12234567999999999998765556999999


Q ss_pred             HHHHHHHHHHhCCCCCCCC-ChhHHHHHhhcccCCCCC----CCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          133 SCGVILFVLMAGYLPFGET-DLPTLYKKINAAEFSCPF----WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       133 SlGvil~~ll~G~~Pf~~~-~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      |+||++|+|++   ||... +.......+.......|.    ..++.+.++|.+||+.||.+|||++++++||||+..
T Consensus       216 slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          216 SLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             HHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            99999999998   56432 233444555544444443    356779999999999999999999999999999753

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5e-40  Score=311.42  Aligned_cols=203  Identities=28%  Similarity=0.432  Sum_probs=167.5

Q ss_pred             CCCCCccccccceEEEE--------------eCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Q 016865            1 MKIVRHPNIVRLHEVLA--------------SRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK   66 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~--------------~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~   66 (381)
                      |+.++||||+++++++.              +....|+||||++ |+|.+++.. +.+++..++.++.|++.||+|||++
T Consensus        62 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~  139 (320)
T 2i6l_A           62 IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSA  139 (320)
T ss_dssp             HHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhC
Confidence            35789999999999983              4478999999997 599998864 6799999999999999999999999


Q ss_pred             CCeecCCCCCcEEEc-cCCCEEEeeccCccCCCCC---ccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHH
Q 016865           67 GVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQG---VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM  142 (381)
Q Consensus        67 gi~HrDlkp~NiLl~-~~~~lkl~DFGls~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll  142 (381)
                      ||+||||||+||+++ +++.+||+|||++......   ........||+.|+|||++.+....+.++||||+||++|+|+
T Consensus       140 ~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~  219 (320)
T 2i6l_A          140 NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML  219 (320)
T ss_dssp             TCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHH
T ss_pred             CEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHH
Confidence            999999999999997 5679999999999865431   123345678999999999876444568999999999999999


Q ss_pred             hCCCCCCCCChhHHHHHhhccc----------------------C--------CCCCCCChhHHHHHHHhcCCCCCCCCC
Q 016865          143 AGYLPFGETDLPTLYKKINAAE----------------------F--------SCPFWFSTGATSLIHKILDPNPKTRIR  192 (381)
Q Consensus       143 ~G~~Pf~~~~~~~~~~~i~~~~----------------------~--------~~p~~~s~~~~~li~~~L~~dP~~R~t  192 (381)
                      +|+.||...+.......+....                      .        ..+..+++++.+||.+||+.||.+|||
T Consensus       220 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  299 (320)
T 2i6l_A          220 TGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT  299 (320)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCC
T ss_pred             hCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCC
Confidence            9999998877655544432211                      0        012357999999999999999999999


Q ss_pred             HHHHhcCcccccC
Q 016865          193 IEGIRKHPWFRKN  205 (381)
Q Consensus       193 ~~~il~hp~~~~~  205 (381)
                      ++++++||||+..
T Consensus       300 ~~ell~hp~~~~~  312 (320)
T 2i6l_A          300 AEEALSHPYMSIY  312 (320)
T ss_dssp             HHHHHTSHHHHTT
T ss_pred             HHHHhCCcccccc
Confidence            9999999999854

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.3e-40  Score=319.90  Aligned_cols=198  Identities=26%  Similarity=0.396  Sum_probs=163.5

Q ss_pred             CCCCccccccceEEEEeCCEE------EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 016865            2 KIVRHPNIVRLHEVLASRTKV------YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKP   75 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~------~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp   75 (381)
                      +.++||||+++++++...+..      |+||||+. |+|.+.+.  ..+++..++.++.|++.||+|||++||+||||||
T Consensus        96 ~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp  172 (371)
T 4exu_A           96 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKP  172 (371)
T ss_dssp             HHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred             HhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCH
Confidence            567999999999999877654      99999997 58887763  4599999999999999999999999999999999


Q ss_pred             CcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhH
Q 016865           76 ENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT  155 (381)
Q Consensus        76 ~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  155 (381)
                      +|||++.++.+||+|||++.....   .....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+...
T Consensus       173 ~NIll~~~~~~kL~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  249 (371)
T 4exu_A          173 GNLAVNEDCELKILDFGLARHADA---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD  249 (371)
T ss_dssp             GGEEECTTCCEEECSTTCC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             HHeEECCCCCEEEEecCccccccc---CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence            999999999999999999976543   23466899999999999874445689999999999999999999999877655


Q ss_pred             HHHHhhccc-------------------------------CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          156 LYKKINAAE-------------------------------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       156 ~~~~i~~~~-------------------------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      ....+....                               ...++.+++++.+||.+||+.||.+|||++++++||||+.
T Consensus       250 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  329 (371)
T 4exu_A          250 QLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP  329 (371)
T ss_dssp             HHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred             HHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccccc
Confidence            444432100                               0012346899999999999999999999999999999985


Q ss_pred             C
Q 016865          205 N  205 (381)
Q Consensus       205 ~  205 (381)
                      .
T Consensus       330 ~  330 (371)
T 4exu_A          330 F  330 (371)
T ss_dssp             T
T ss_pred             C
Confidence            4

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5.7e-40  Score=311.08  Aligned_cols=197  Identities=24%  Similarity=0.375  Sum_probs=165.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |++++||||+++++++.+.+..|+||||++||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||
T Consensus        61 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil  140 (310)
T 3s95_A           61 MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCL  140 (310)
T ss_dssp             HTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEE
T ss_pred             HHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEE
Confidence            4678999999999999999999999999999999999987 567999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCcc--------------ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCC
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVE--------------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGY  145 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~--------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~  145 (381)
                      ++.++.+||+|||++........              ...+.+||+.|+|||++.+..++ .++||||+||++|+|++|.
T Consensus       141 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~  219 (310)
T 3s95_A          141 VRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRV  219 (310)
T ss_dssp             ECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHTC
T ss_pred             ECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHhcCC
Confidence            99999999999999976543211              11256899999999999887765 8999999999999999999


Q ss_pred             CCCCCCChhHHHHH---hhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          146 LPFGETDLPTLYKK---INAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       146 ~Pf~~~~~~~~~~~---i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      .||...........   ........|..+++.+.++|.+||+.||.+|||+.++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          220 NADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             CSSTTTSCBCTTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCcchhhhHHHHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            99975432111000   001112346678999999999999999999999999987

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.5e-40  Score=314.81  Aligned_cols=197  Identities=25%  Similarity=0.376  Sum_probs=171.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+..|+||||++||+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||
T Consensus       104 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIl  183 (325)
T 3kul_A          104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVL  183 (325)
T ss_dssp             HTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             HHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEE
Confidence            46789999999999999999999999999999999999654 57999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCcc---ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPT  155 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~  155 (381)
                      ++.++.+||+|||++........   ......+|+.|+|||++.+..+. .++||||+||++|+|++ |..||...+...
T Consensus       184 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~  262 (325)
T 3kul_A          184 VDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRD  262 (325)
T ss_dssp             ECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHH
T ss_pred             ECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence            99999999999999986544221   12233467789999999876664 89999999999999999 999999888877


Q ss_pred             HHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          156 LYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       156 ~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ....+... ....|..+++.+.+||.+||..||.+|||+.++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          263 VISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            77766554 45567779999999999999999999999999886

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.8e-40  Score=311.97  Aligned_cols=198  Identities=23%  Similarity=0.336  Sum_probs=173.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCC------------------------CCHHHHHHHHHHH
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR------------------------LLENDCRRYFQQL   56 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~------------------------l~e~~~~~~~~ql   56 (381)
                      |+.++||||+++++++.+.+..|+||||++||+|.+++.....                        +++..++.++.||
T Consensus        80 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi  159 (314)
T 2ivs_A           80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQI  159 (314)
T ss_dssp             HTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHH
T ss_pred             HhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHH
Confidence            4678999999999999999999999999999999999987543                        8899999999999


Q ss_pred             HHHHHHHHHCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCcc--ccccccCCCCCCCCceecCCCCCCCcccHhHH
Q 016865           57 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC  134 (381)
Q Consensus        57 l~~L~~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSl  134 (381)
                      +.||+|||++||+||||||+||+++.++.+||+|||++........  ......||+.|+|||++.+..+. .++||||+
T Consensus       160 ~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~sl  238 (314)
T 2ivs_A          160 SQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSF  238 (314)
T ss_dssp             HHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEEC-HHHHHHHH
T ss_pred             HHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcC-chhhHHHH
Confidence            9999999999999999999999999999999999999976543221  22345678899999999876664 89999999


Q ss_pred             HHHHHHHHh-CCCCCCCCChhHHHHHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          135 GVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       135 Gvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ||++|+|++ |..||...+.......+.... ...|..+++++.++|.+||+.||.+|||+.+++++
T Consensus       239 G~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          239 GVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             HHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999 999999888777776665543 45667799999999999999999999999999874

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.9e-40  Score=313.02  Aligned_cols=194  Identities=34%  Similarity=0.591  Sum_probs=172.3

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc-c
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-S   82 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~g-g~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~-~   82 (381)
                      .||||+++++++.+.+..++||||+.+ ++|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++ +
T Consensus       106 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~  185 (320)
T 3a99_A          106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN  185 (320)
T ss_dssp             SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT
T ss_pred             CCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCC
Confidence            479999999999999999999999976 89999999888999999999999999999999999999999999999999 7


Q ss_pred             CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhc
Q 016865           83 YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA  162 (381)
Q Consensus        83 ~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~  162 (381)
                      ++.+||+|||++......  ......||+.|+|||++.+..+.+.++||||+||++|+|++|..||...+      .+..
T Consensus       186 ~~~~kL~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~  257 (320)
T 3a99_A          186 RGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR  257 (320)
T ss_dssp             TTEEEECCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH
T ss_pred             CCCEEEeeCccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhc
Confidence            899999999998865542  33456799999999999877776688999999999999999999997532      2333


Q ss_pred             ccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          163 AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       163 ~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      .....+..+++++.+||.+||+.||.+|||++++++||||+...
T Consensus       258 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          258 GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             ccccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence            44556777999999999999999999999999999999998643

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=5.2e-40  Score=313.97  Aligned_cols=196  Identities=21%  Similarity=0.336  Sum_probs=169.3

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      +.++||||+++++++. .+..|+||||+++|+|.+++... +.+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus        70 ~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~  148 (325)
T 3kex_A           70 GSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL  148 (325)
T ss_dssp             HTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE
T ss_pred             hcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE
Confidence            4679999999999986 45699999999999999999764 579999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  157 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~  157 (381)
                      +.++.+||+|||++.......  .......||+.|+|||++.+..+. .++||||+||++|+|++ |..||...+.....
T Consensus       149 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~  227 (325)
T 3kex_A          149 KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP  227 (325)
T ss_dssp             SSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH
T ss_pred             CCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCC-hhhHhHHhHHHHHHHHhCCCCCccccCHHHHH
Confidence            999999999999998764421  223456688899999999877764 89999999999999999 99999988777776


Q ss_pred             HHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          158 KKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       158 ~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ..+... ....|..+++++.++|.+||..||.+|||+.+++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          228 DLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             HHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             HHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            666554 456677789999999999999999999999999986

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.3e-40  Score=308.99  Aligned_cols=194  Identities=21%  Similarity=0.231  Sum_probs=166.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~-l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+..|+||||++||+|.+++...+. +++..++.++.|++.||.|||++||+||||||+|||
T Consensus        66 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIl  145 (289)
T 4fvq_A           66 MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNIL  145 (289)
T ss_dssp             HHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred             HHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEE
Confidence            4578999999999999999999999999999999999987654 999999999999999999999999999999999999


Q ss_pred             EccCCC--------EEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhC-CCCCCC
Q 016865           80 LDSYGN--------LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG-YLPFGE  150 (381)
Q Consensus        80 l~~~~~--------lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G-~~Pf~~  150 (381)
                      ++.++.        +||+|||++.....    .....||+.|+|||++.+....+.++||||+||++|+|++| .+||..
T Consensus       146 l~~~~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~  221 (289)
T 4fvq_A          146 LIREEDRKTGNPPFIKLSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA  221 (289)
T ss_dssp             EEECCBGGGTBCCEEEECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             EecCCcccccccceeeeccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc
Confidence            998887        99999999875433    23456899999999998744446899999999999999995 556655


Q ss_pred             CChhHHHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          151 TDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       151 ~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      .+..... .........|...++++.+||.+||+.||.+|||++++++|
T Consensus       222 ~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          222 LDSQRKL-QFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             SCHHHHH-HHHHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             cchHHHH-HHhhccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            5544333 33344556666789999999999999999999999999985

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.2e-40  Score=306.99  Aligned_cols=198  Identities=22%  Similarity=0.360  Sum_probs=173.9

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+..|+||||++||+|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+||+
T Consensus        73 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil  152 (283)
T 3gen_A           73 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCL  152 (283)
T ss_dssp             HHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEE
T ss_pred             HhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEE
Confidence            3578999999999999999999999999999999999976 567999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  157 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~  157 (381)
                      ++.++.+||+|||++....... .......||+.|+|||++.+..+. .++||||+||++|+|++ |..||...+.....
T Consensus       153 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~  231 (283)
T 3gen_A          153 VNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETA  231 (283)
T ss_dssp             ECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred             EcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccChhHHH
Confidence            9999999999999997654321 122344567889999999877764 89999999999999998 99999988887777


Q ss_pred             HHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          158 KKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       158 ~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ..+... ....|...++.+.++|.+||+.||.+|||++++++|
T Consensus       232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          232 EHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            766655 345566789999999999999999999999999875

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5e-40  Score=311.55  Aligned_cols=194  Identities=36%  Similarity=0.644  Sum_probs=168.2

Q ss_pred             CccccccceEEEEeCCEEEEEEec-CCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc-c
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEF-VTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-S   82 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~-~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~-~   82 (381)
                      +||||+++++++.+.+..|+|||| +.+++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++ .
T Consensus        96 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~  175 (312)
T 2iwi_A           96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLR  175 (312)
T ss_dssp             CCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETT
T ss_pred             CCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCC
Confidence            899999999999999999999999 78999999999888899999999999999999999999999999999999999 8


Q ss_pred             CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhc
Q 016865           83 YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA  162 (381)
Q Consensus        83 ~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~  162 (381)
                      ++.+||+|||++......  ......||+.|+|||++.+..+.+.++||||+||++|+|++|+.||....      .+..
T Consensus       176 ~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~  247 (312)
T 2iwi_A          176 RGCAKLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILE  247 (312)
T ss_dssp             TTEEEECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH
T ss_pred             CCeEEEEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhh
Confidence            899999999998865542  34566799999999999877776568999999999999999999997532      2334


Q ss_pred             ccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          163 AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       163 ~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      .....+..+++++.+||.+||+.||.+|||++++++||||+...
T Consensus       248 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          248 AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             TCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             hccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence            55667778999999999999999999999999999999998643

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.2e-40  Score=305.18  Aligned_cols=197  Identities=22%  Similarity=0.363  Sum_probs=172.2

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      +.++||||+++++++.+.+..|+||||++||+|.+++...+ .+++..++.++.|++.||.|||++||+||||||+||++
T Consensus        58 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~  137 (268)
T 3sxs_A           58 MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV  137 (268)
T ss_dssp             HHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE
T ss_pred             HhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE
Confidence            46799999999999999999999999999999999997754 49999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYK  158 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~  158 (381)
                      +.++.+||+|||++....... .......||+.|+|||++.+..+. .++||||+|+++|+|++ |..||...+......
T Consensus       138 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~  216 (268)
T 3sxs_A          138 DRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL  216 (268)
T ss_dssp             CTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEE-TTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred             CCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCc-hhhhhHHHHHHHHHHHcCCCCCccccChHHHHH
Confidence            999999999999997654421 122344567789999999876664 89999999999999999 999999888777766


Q ss_pred             Hhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          159 KINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       159 ~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      .+.... ...|...++.+.++|.+||+.||.+|||+.+++++
T Consensus       217 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          217 KVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            665543 44566789999999999999999999999999985

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=315.48  Aligned_cols=199  Identities=23%  Similarity=0.412  Sum_probs=162.1

Q ss_pred             CCCCCccccccceEEEEeCC--EEEEEEecCCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRT--KVYIILEFVTGGELFDKIVHQGR---LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKP   75 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~--~~~lV~E~~~gg~L~~~i~~~~~---l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp   75 (381)
                      |+.++||||+++++++.+.+  ..|+||||++||+|.+++.....   +++..++.++.|++.||+|||++||+||||||
T Consensus        61 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp  140 (319)
T 4euu_A           61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKP  140 (319)
T ss_dssp             HHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             HHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCH
Confidence            35679999999999998765  88999999999999999976443   99999999999999999999999999999999


Q ss_pred             CcEEE----ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecC-------CCCCCCcccHhHHHHHHHHHHhC
Q 016865           76 ENLLL----DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-------RGYDGSAADVWSCGVILFVLMAG  144 (381)
Q Consensus        76 ~NiLl----~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~~DIwSlGvil~~ll~G  144 (381)
                      +|||+    +.++.+||+|||++...... ....+.+||+.|+|||++..       ....+.++||||+||++|+|++|
T Consensus       141 ~NIll~~~~~~~~~~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g  219 (319)
T 4euu_A          141 GNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG  219 (319)
T ss_dssp             GGEEEEECTTSCEEEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHS
T ss_pred             HHEEEeccCCCCceEEEccCCCceecCCC-CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhC
Confidence            99999    77788999999999866543 23456679999999999862       23335899999999999999999


Q ss_pred             CCCCCCCCh----hHHHHHhhcccC---------------------C----CCCCCChhHHHHHHHhcCCCCCCCCCHHH
Q 016865          145 YLPFGETDL----PTLYKKINAAEF---------------------S----CPFWFSTGATSLIHKILDPNPKTRIRIEG  195 (381)
Q Consensus       145 ~~Pf~~~~~----~~~~~~i~~~~~---------------------~----~p~~~s~~~~~li~~~L~~dP~~R~t~~~  195 (381)
                      ..||...+.    ......+..+..                     .    .+..+++.+.+||.+||+.||.+|||++|
T Consensus       220 ~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~e  299 (319)
T 4euu_A          220 SLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ  299 (319)
T ss_dssp             SCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHH
T ss_pred             CCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHH
Confidence            999964332    223333322211                     1    11124567889999999999999999999


Q ss_pred             HhcCc
Q 016865          196 IRKHP  200 (381)
Q Consensus       196 il~hp  200 (381)
                      +++||
T Consensus       300 ll~h~  304 (319)
T 4euu_A          300 FFAET  304 (319)
T ss_dssp             HHHHH
T ss_pred             hhhcc
Confidence            99997

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=323.97  Aligned_cols=201  Identities=20%  Similarity=0.294  Sum_probs=175.3

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK   74 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlk   74 (381)
                      +.++||||+++++++.+....|+||||++||+|.+++...+       .+++..++.++.|++.||+|||++||+|||||
T Consensus       129 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk  208 (367)
T 3l9p_A          129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA  208 (367)
T ss_dssp             HHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             HhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence            46799999999999999999999999999999999997643       48999999999999999999999999999999


Q ss_pred             CCcEEEccCC---CEEEeeccCccCCCC--CccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCC
Q 016865           75 PENLLLDSYG---NLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF  148 (381)
Q Consensus        75 p~NiLl~~~~---~lkl~DFGls~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf  148 (381)
                      |+|||++.+|   .+||+|||++.....  ........+||+.|+|||++.+..+. .++|||||||++|+|++ |..||
T Consensus       209 p~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~pf  287 (367)
T 3l9p_A          209 ARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPY  287 (367)
T ss_dssp             GGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             hhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCC
Confidence            9999999655   499999999874322  11223456789999999999877765 89999999999999998 99999


Q ss_pred             CCCChhHHHHHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          149 GETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       149 ~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      ...+.......+..+. ...|..+++.+.+||.+||+.||.+|||+++++++.|+-
T Consensus       288 ~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          288 PSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             TTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            9988887777776554 456667899999999999999999999999999998774

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5.6e-40  Score=306.86  Aligned_cols=197  Identities=29%  Similarity=0.405  Sum_probs=160.6

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++. .+..|+||||+++|+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||
T Consensus        70 l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil  148 (281)
T 1mp8_A           70 MRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVL  148 (281)
T ss_dssp             HHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             HHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEE
Confidence            35789999999999984 567899999999999999997654 6999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  157 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~  157 (381)
                      ++.++.+||+|||++....... .......+|+.|+|||++.+..++ .++||||+||++|+|++ |..||...+.....
T Consensus       149 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~  227 (281)
T 1mp8_A          149 VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVI  227 (281)
T ss_dssp             EEETTEEEECC-------------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred             ECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCC-CccCchHHHHHHHHHHhcCCCCCCcCCHHHHH
Confidence            9999999999999998654421 122344577899999999877664 89999999999999997 99999988777776


Q ss_pred             HHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          158 KKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       158 ~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ..+... ....|..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       228 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          228 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            666554 345677899999999999999999999999998863

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=9e-41  Score=325.09  Aligned_cols=195  Identities=18%  Similarity=0.238  Sum_probs=148.2

Q ss_pred             Cccccccce-------EEEEeC-----------------CEEEEEEecCCCCChHHHHHhcC-CCCHHHH------HHHH
Q 016865            5 RHPNIVRLH-------EVLASR-----------------TKVYIILEFVTGGELFDKIVHQG-RLLENDC------RRYF   53 (381)
Q Consensus         5 ~HpnIv~l~-------~~~~~~-----------------~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~------~~~~   53 (381)
                      +||||++++       +++...                 ..+|+||||++ |+|.+++...+ .+++...      ..++
T Consensus       122 ~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~  200 (371)
T 3q60_A          122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILT  200 (371)
T ss_dssp             ----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHH
T ss_pred             cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHH
Confidence            699977755       666543                 34899999998 79999998643 3444444      5667


Q ss_pred             HHHHHHHHHHHHCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecC--CCCCCCcccH
Q 016865           54 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN--RGYDGSAADV  131 (381)
Q Consensus        54 ~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DI  131 (381)
                      .||+.||+|||++||+||||||+|||++.+|.+||+|||++......   .....||+.|+|||++.+  ..| +.++||
T Consensus       201 ~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~-~~~~Di  276 (371)
T 3q60_A          201 AQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATF-THALNA  276 (371)
T ss_dssp             HHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEEC-CHHHHH
T ss_pred             HHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCc-CccccH
Confidence            99999999999999999999999999999999999999999865432   225567799999999976  445 589999


Q ss_pred             hHHHHHHHHHHhCCCCCCCCChhH--HHHH-----hhcccCCCC--CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          132 WSCGVILFVLMAGYLPFGETDLPT--LYKK-----INAAEFSCP--FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       132 wSlGvil~~ll~G~~Pf~~~~~~~--~~~~-----i~~~~~~~p--~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      ||+||++|+|++|+.||.......  .+..     .....+..|  ..+++.+.+||.+||+.||.+|||++++++||||
T Consensus       277 wSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  356 (371)
T 3q60_A          277 WQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF  356 (371)
T ss_dssp             HHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHH
Confidence            999999999999999997764321  1111     111222233  4689999999999999999999999999999999


Q ss_pred             cc
Q 016865          203 RK  204 (381)
Q Consensus       203 ~~  204 (381)
                      +.
T Consensus       357 ~~  358 (371)
T 3q60_A          357 LQ  358 (371)
T ss_dssp             HH
T ss_pred             HH
Confidence            74

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.4e-39  Score=310.81  Aligned_cols=197  Identities=23%  Similarity=0.356  Sum_probs=171.5

Q ss_pred             CCCC-CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHH
Q 016865            1 MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHC   63 (381)
Q Consensus         1 lk~l-~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~~L~~L   63 (381)
                      |+.+ +||||+++++++.+.+..|+||||++||+|.+++...+                .+++..++.++.||+.||.||
T Consensus        79 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L  158 (327)
T 1fvr_A           79 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL  158 (327)
T ss_dssp             HTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred             HHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence            3567 89999999999999999999999999999999997654                689999999999999999999


Q ss_pred             HHCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh
Q 016865           64 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA  143 (381)
Q Consensus        64 H~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~  143 (381)
                      |++||+||||||+|||++.++.+||+|||++...... .......+++.|+|||++.+..+. .++||||+||++|+|++
T Consensus       159 H~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt  236 (327)
T 1fvr_A          159 SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVS  236 (327)
T ss_dssp             HHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHT
T ss_pred             HhCCccCCCCccceEEEcCCCeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCC-chhcchHHHHHHHHHHc
Confidence            9999999999999999999999999999998754321 122345678999999999776664 89999999999999998


Q ss_pred             -CCCCCCCCChhHHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          144 -GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       144 -G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                       |..||...+.......+..+ ....|..+++++.+||.+||..||.+|||+++++++
T Consensus       237 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          237 LGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             TSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCcHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             99999998888777777654 345666789999999999999999999999999985

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=8.9e-40  Score=314.15  Aligned_cols=194  Identities=25%  Similarity=0.389  Sum_probs=161.9

Q ss_pred             ccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE---
Q 016865            6 HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL---   80 (381)
Q Consensus         6 HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl---   80 (381)
                      |++++.+++++...+..|+||||+ +|+|.+.+....  .+++..++.++.||+.||+|||++||+||||||+|||+   
T Consensus        81 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~  159 (355)
T 2eu9_A           81 KFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNS  159 (355)
T ss_dssp             CSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCC
T ss_pred             ceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecc
Confidence            344999999999999999999999 668888887653  69999999999999999999999999999999999999   


Q ss_pred             ----------------ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhC
Q 016865           81 ----------------DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG  144 (381)
Q Consensus        81 ----------------~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G  144 (381)
                                      +.++.+||+|||++.....   .....+||+.|+|||++.+..+. .++||||+||++|+|++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g  235 (355)
T 2eu9_A          160 EFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE---HHTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRG  235 (355)
T ss_dssp             CEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS---CCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccccccCCCcEEEeecCccccccc---cccCCcCCCcccCCeeeecCCCC-CccchHHHHHHHHHHHhC
Confidence                            6678999999999976443   23466899999999999877775 899999999999999999


Q ss_pred             CCCCCCCChhHHHHHhhcccCCCC--------------------------------------------CCCChhHHHHHH
Q 016865          145 YLPFGETDLPTLYKKINAAEFSCP--------------------------------------------FWFSTGATSLIH  180 (381)
Q Consensus       145 ~~Pf~~~~~~~~~~~i~~~~~~~p--------------------------------------------~~~s~~~~~li~  180 (381)
                      ..||...+.......+.......|                                            ...++++.+||.
T Consensus       236 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  315 (355)
T 2eu9_A          236 FTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMR  315 (355)
T ss_dssp             SCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHH
Confidence            999988776544333222111111                                            112457889999


Q ss_pred             HhcCCCCCCCCCHHHHhcCccccc
Q 016865          181 KILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       181 ~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      +||+.||.+|||++++++||||+.
T Consensus       316 ~~L~~dP~~Rpt~~e~l~hp~f~~  339 (355)
T 2eu9_A          316 RMLEFDPAQRITLAEALLHPFFAG  339 (355)
T ss_dssp             HHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred             HHhcCChhhCcCHHHHhcChhhcC
Confidence            999999999999999999999975

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=9.1e-40  Score=319.04  Aligned_cols=194  Identities=24%  Similarity=0.423  Sum_probs=159.0

Q ss_pred             CccccccceEEEE----eCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCc
Q 016865            5 RHPNIVRLHEVLA----SRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPEN   77 (381)
Q Consensus         5 ~HpnIv~l~~~~~----~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~-gi~HrDlkp~N   77 (381)
                      +||||+++++++.    +...+|+||||+ +|+|.+.+...  +.+++..++.++.||+.||+|||++ ||+||||||+|
T Consensus        99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~N  177 (397)
T 1wak_A           99 NREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPEN  177 (397)
T ss_dssp             GGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGG
T ss_pred             CcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence            4899999999998    556899999999 66787777654  4699999999999999999999998 99999999999


Q ss_pred             EEEccCC-------------------------------------------------CEEEeeccCccCCCCCcccccccc
Q 016865           78 LLLDSYG-------------------------------------------------NLKVSDFGLSALPQQGVELLHTTC  108 (381)
Q Consensus        78 iLl~~~~-------------------------------------------------~lkl~DFGls~~~~~~~~~~~~~~  108 (381)
                      ||++.++                                                 .+||+|||++.....   .....+
T Consensus       178 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~---~~~~~~  254 (397)
T 1wak_A          178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK---HFTEDI  254 (397)
T ss_dssp             EEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB---CSCSCC
T ss_pred             eeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc---cCccCC
Confidence            9999775                                                 799999999976543   234568


Q ss_pred             CCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh------HHHHHhhc------------cc------
Q 016865          109 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP------TLYKKINA------------AE------  164 (381)
Q Consensus       109 gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~------~~~~~i~~------------~~------  164 (381)
                      ||+.|+|||++.+..+. .++|||||||++|+|++|..||...+..      .....+..            ..      
T Consensus       255 gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  333 (397)
T 1wak_A          255 QTRQYRSLEVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF  333 (397)
T ss_dssp             SCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTB
T ss_pred             CCCcccCChhhcCCCCC-cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccccccc
Confidence            99999999999887775 8999999999999999999999764421      11111100            00      


Q ss_pred             ------------------------CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          165 ------------------------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       165 ------------------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                                              +..+...++.+.+||.+||+.||.+|||++|+++||||+
T Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          334 TKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             CTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             CCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence                                    011122356788999999999999999999999999996

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-40  Score=314.49  Aligned_cols=197  Identities=22%  Similarity=0.317  Sum_probs=172.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc------------------------CCCCHHHHHHHHHHH
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ------------------------GRLLENDCRRYFQQL   56 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~------------------------~~l~e~~~~~~~~ql   56 (381)
                      |+.++||||+++++++.+.+..|+||||++||+|.+++...                        ..+++..++.++.||
T Consensus       104 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi  183 (343)
T 1luf_A          104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV  183 (343)
T ss_dssp             HHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHH
T ss_pred             HHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHH
Confidence            35789999999999999999999999999999999999763                        568999999999999


Q ss_pred             HHHHHHHHHCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHH
Q 016865           57 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC  134 (381)
Q Consensus        57 l~~L~~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSl  134 (381)
                      +.||.|||++||+||||||+|||++.++.+||+|||++.......  .......||+.|+|||++.+..+. .++||||+
T Consensus       184 ~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~sl  262 (343)
T 1luf_A          184 AAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAY  262 (343)
T ss_dssp             HHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHH
T ss_pred             HHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcC-cccccHHH
Confidence            999999999999999999999999999999999999987543211  223455688999999999877765 89999999


Q ss_pred             HHHHHHHHh-CCCCCCCCChhHHHHHhhcccC-CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          135 GVILFVLMA-GYLPFGETDLPTLYKKINAAEF-SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       135 Gvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ||++|+|++ |..||...+.......+..+.. ..|..+++++.++|.+||+.||.+|||+.++++
T Consensus       263 G~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          263 GVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             HHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            999999999 9999998887777776665543 567789999999999999999999999999986

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=314.90  Aligned_cols=198  Identities=26%  Similarity=0.396  Sum_probs=163.0

Q ss_pred             CCCCccccccceEEEEeCCE------EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 016865            2 KIVRHPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKP   75 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~------~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp   75 (381)
                      +.++||||+++++++.+.+.      +|+||||+. |+|.+.+.  ..+++..++.++.||+.||+|||++||+||||||
T Consensus        78 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp  154 (353)
T 3coi_A           78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKP  154 (353)
T ss_dssp             HHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCG
T ss_pred             HhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence            56799999999999987654      599999997 58887764  3599999999999999999999999999999999


Q ss_pred             CcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhH
Q 016865           76 ENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT  155 (381)
Q Consensus        76 ~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  155 (381)
                      +||+++.++.+||+|||++.....   .....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+...
T Consensus       155 ~NIl~~~~~~~kl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  231 (353)
T 3coi_A          155 GNLAVNEDCELKILDFGLARHADA---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD  231 (353)
T ss_dssp             GGEEECTTCCEEECSTTCTTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH
T ss_pred             HHEeECCCCcEEEeecccccCCCC---CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999999999999999999976543   23456799999999998774445689999999999999999999998877654


Q ss_pred             HHHHhhcc----------------------------c---CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          156 LYKKINAA----------------------------E---FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       156 ~~~~i~~~----------------------------~---~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      ....+...                            .   ...+..+++++.+||.+||+.||.+|||++++++||||+.
T Consensus       232 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  311 (353)
T 3coi_A          232 QLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP  311 (353)
T ss_dssp             HHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred             HHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence            44333210                            0   1122357899999999999999999999999999999975


Q ss_pred             C
Q 016865          205 N  205 (381)
Q Consensus       205 ~  205 (381)
                      .
T Consensus       312 ~  312 (353)
T 3coi_A          312 F  312 (353)
T ss_dssp             T
T ss_pred             c
Confidence            4

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=317.89  Aligned_cols=196  Identities=23%  Similarity=0.378  Sum_probs=173.8

Q ss_pred             CC-CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHH
Q 016865            3 IV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHCHS   65 (381)
Q Consensus         3 ~l-~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~~L~~LH~   65 (381)
                      ++ +||||+++++++.+.+..|+||||++||+|.+++....                .+++..++.++.||+.||.|||+
T Consensus       130 ~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  209 (382)
T 3tt0_A          130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS  209 (382)
T ss_dssp             HHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh
Confidence            44 89999999999999999999999999999999998753                48999999999999999999999


Q ss_pred             CCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh
Q 016865           66 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA  143 (381)
Q Consensus        66 ~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~  143 (381)
                      +||+||||||+|||++.++.+||+|||++.......  .......||+.|+|||++.+..+. .++||||+||++|+|++
T Consensus       210 ~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~ellt  288 (382)
T 3tt0_A          210 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFT  288 (382)
T ss_dssp             TTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHT
T ss_pred             CCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC-chhHHHHHHHHHHHHHh
Confidence            999999999999999999999999999998665422  223445678899999999887665 89999999999999999


Q ss_pred             -CCCCCCCCChhHHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          144 -GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       144 -G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                       |..||...+.......+... ....|..+++++.+||.+||+.||.+|||+.+++++
T Consensus       289 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          289 LGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             TSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             99999998888777776655 445677799999999999999999999999999985

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.2e-40  Score=317.25  Aligned_cols=194  Identities=22%  Similarity=0.346  Sum_probs=165.9

Q ss_pred             CccccccceEEEEeCC-EEEEEEecCCCCChHHHHHhcCC----------------------------------------
Q 016865            5 RHPNIVRLHEVLASRT-KVYIILEFVTGGELFDKIVHQGR----------------------------------------   43 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~-~~~lV~E~~~gg~L~~~i~~~~~----------------------------------------   43 (381)
                      +||||+++++++.+.+ .+|+||||++||+|.+++.....                                        
T Consensus        84 ~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (359)
T 3vhe_A           84 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSA  163 (359)
T ss_dssp             CCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------
T ss_pred             CCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccc
Confidence            7999999999998765 49999999999999999976543                                        


Q ss_pred             --------------------------CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCCCEEEeeccCccCC
Q 016865           44 --------------------------LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP   97 (381)
Q Consensus        44 --------------------------l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~   97 (381)
                                                +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  243 (359)
T 3vhe_A          164 SSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI  243 (359)
T ss_dssp             --------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred             ccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeee
Confidence                                      899999999999999999999999999999999999999999999999999865


Q ss_pred             CCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH-HHHhhc-ccCCCCCCCC
Q 016865           98 QQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL-YKKINA-AEFSCPFWFS  172 (381)
Q Consensus        98 ~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~-~~~i~~-~~~~~p~~~s  172 (381)
                      ....  .......||+.|+|||++.+..+. .++||||+||++|+|++ |..||.+.+.... ...+.. .....|..++
T Consensus       244 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (359)
T 3vhe_A          244 YKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTT  322 (359)
T ss_dssp             TSCTTCEEC--CEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCC
T ss_pred             cccccchhccccCCCceeEChhhhcCCCCC-chhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCC
Confidence            4321  233456789999999999877765 89999999999999998 9999987765433 333333 3456777899


Q ss_pred             hhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          173 TGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       173 ~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      +++.++|.+||+.||.+|||++++++|
T Consensus       323 ~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          323 PEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            999999999999999999999999985

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2e-39  Score=322.47  Aligned_cols=201  Identities=28%  Similarity=0.432  Sum_probs=158.1

Q ss_pred             CC-CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            3 IV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         3 ~l-~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      .+ +|||||++++++.+....|+|||||. |+|.+++.... ..++..+..++.||+.||+|||++||+||||||+|||+
T Consensus        73 ~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll  151 (432)
T 3p23_A           73 ESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILI  151 (432)
T ss_dssp             HSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEE
T ss_pred             hccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEE
Confidence            44 79999999999999999999999996 59999997654 45666788999999999999999999999999999999


Q ss_pred             ccC-----CCEEEeeccCccCCCCCc---cccccccCCCCCCCCceecCC--CCCCCcccHhHHHHHHHHHHh-CCCCCC
Q 016865           81 DSY-----GNLKVSDFGLSALPQQGV---ELLHTTCGTPNYVAPEVLSNR--GYDGSAADVWSCGVILFVLMA-GYLPFG  149 (381)
Q Consensus        81 ~~~-----~~lkl~DFGls~~~~~~~---~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DIwSlGvil~~ll~-G~~Pf~  149 (381)
                      +.+     ..+||+|||++.......   ......+||+.|+|||++.+.  ...+.++||||+||++|+|++ |.+||.
T Consensus       152 ~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~  231 (432)
T 3p23_A          152 SMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG  231 (432)
T ss_dssp             CCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTB
T ss_pred             ecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence            532     258899999998654321   234567899999999999742  223479999999999999999 999997


Q ss_pred             CCChhHHHHHhhcccCCC---CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          150 ETDLPTLYKKINAAEFSC---PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       150 ~~~~~~~~~~i~~~~~~~---p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      ..................   +...+..+.+||.+||+.||.+|||++++++||||..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          232 KSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             STTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             hhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence            665544433332222211   1224567899999999999999999999999999964

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.7e-39  Score=315.02  Aligned_cols=196  Identities=30%  Similarity=0.362  Sum_probs=163.1

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCeecCCCCCcEEE
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCH--SKGVYHRDLKPENLLL   80 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH--~~gi~HrDlkp~NiLl   80 (381)
                      .|+||+++++++...+.+|+||||++ |+|.+++...  +.+++..++.++.|++.||.|||  +.||+||||||+|||+
T Consensus       114 ~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll  192 (382)
T 2vx3_A          114 MKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILL  192 (382)
T ss_dssp             GGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEE
T ss_pred             cceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEE
Confidence            45579999999999999999999996 5999999875  46999999999999999999999  5799999999999999


Q ss_pred             c--cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016865           81 D--SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK  158 (381)
Q Consensus        81 ~--~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~  158 (381)
                      +  .++.+||+|||++.....   .....+||+.|+|||++.+..++ .++||||+||++|+|++|.+||.+.+......
T Consensus       193 ~~~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~  268 (382)
T 2vx3_A          193 CNPKRSAIKIVDFGSSCQLGQ---RIYQYIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMN  268 (382)
T ss_dssp             SSTTSCCEEECCCTTCEETTC---CCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             ecCCCCcEEEEeccCceeccc---ccccccCCccccChHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            5  477899999999976543   23567899999999999887775 89999999999999999999999877665544


Q ss_pred             HhhcccCC-------------------------------------CCCC---------------------------CChh
Q 016865          159 KINAAEFS-------------------------------------CPFW---------------------------FSTG  174 (381)
Q Consensus       159 ~i~~~~~~-------------------------------------~p~~---------------------------~s~~  174 (381)
                      .+......                                     .|..                           .+++
T Consensus       269 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (382)
T 2vx3_A          269 KIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLK  348 (382)
T ss_dssp             HHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHH
T ss_pred             HHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHH
Confidence            43221000                                     0000                           0137


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          175 ATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       175 ~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      +.+||.+||+.||.+|||++|+|+||||+..
T Consensus       349 ~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          349 FKDLILRMLDYDPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred             HHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence            8999999999999999999999999999864

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.4e-39  Score=297.82  Aligned_cols=193  Identities=19%  Similarity=0.318  Sum_probs=168.8

Q ss_pred             CCCCCccccccceEEEEeC--CEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCC
Q 016865            1 MKIVRHPNIVRLHEVLASR--TKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKG--VYHRDLK   74 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~--~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~g--i~HrDlk   74 (381)
                      |++++||||+++++++.+.  +..|+||||++||+|.+++....  .+++..++.++.|++.||.|||++|  |+|||||
T Consensus        61 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dik  140 (271)
T 3kmu_A           61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALN  140 (271)
T ss_dssp             GCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCS
T ss_pred             HHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCc
Confidence            4678999999999999887  78999999999999999998765  4899999999999999999999999  9999999


Q ss_pred             CCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCC--cccHhHHHHHHHHHHhCCCCCCCCC
Q 016865           75 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS--AADVWSCGVILFVLMAGYLPFGETD  152 (381)
Q Consensus        75 p~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~--~~DIwSlGvil~~ll~G~~Pf~~~~  152 (381)
                      |+||+++.++.++|+|||++.....     ....||+.|+|||++.+..+...  ++||||+||++|+|++|..||...+
T Consensus       141 p~Nil~~~~~~~~l~~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~  215 (271)
T 3kmu_A          141 SRSVMIDEDMTARISMADVKFSFQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS  215 (271)
T ss_dssp             GGGEEECTTSCEEEEGGGSCCTTSC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC
T ss_pred             cceEEEcCCcceeEEeccceeeecc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence            9999999999999999998764322     34578999999999987655422  7999999999999999999999887


Q ss_pred             hhHHHHHhhcc--cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          153 LPTLYKKINAA--EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       153 ~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      .......+...  ....|..+++++.++|.+||+.||.+|||++++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          216 NMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             HHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            76665554433  34567779999999999999999999999999986

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.8e-39  Score=310.55  Aligned_cols=196  Identities=20%  Similarity=0.316  Sum_probs=168.9

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      ++++||||+++++++.+.. .++|+||+.+|+|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus        72 ~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll  150 (327)
T 3poz_A           72 ASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV  150 (327)
T ss_dssp             HHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             HhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEE
Confidence            5689999999999998765 7899999999999999987 4569999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCcc--ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  157 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~  157 (381)
                      +.++.+||+|||++........  ......||+.|+|||++.+..+. .++||||+||++|+|++ |..||...+.....
T Consensus       151 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  229 (327)
T 3poz_A          151 KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEIS  229 (327)
T ss_dssp             EETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred             CCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCC-chhhhhhhHHHHHHHHhcCCCCccCCCHHHHH
Confidence            9999999999999976543221  22344568899999999887765 89999999999999999 99999988877776


Q ss_pred             HHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          158 KKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       158 ~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ..+... ....|..++.++.+++.+||+.||.+|||+.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          230 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            666544 355677789999999999999999999999999875

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.2e-39  Score=299.72  Aligned_cols=198  Identities=24%  Similarity=0.385  Sum_probs=172.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+..|+||||++||+|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+
T Consensus        57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil  136 (267)
T 3t9t_A           57 MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCL  136 (267)
T ss_dssp             HHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEE
T ss_pred             HHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEE
Confidence            35789999999999999999999999999999999999765 46899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCC-ccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQG-VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  157 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~  157 (381)
                      ++.++.+||+|||++...... ........||+.|+|||++.+..+. .++||||+|+++|+|++ |..||...+.....
T Consensus       137 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~  215 (267)
T 3t9t_A          137 VGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV  215 (267)
T ss_dssp             ECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred             ECCCCCEEEcccccccccccccccccccccccccccChhhhcCCCcc-chhchhhhHHHHHHHhccCCCCCCCCCHHHHH
Confidence            999999999999998765432 1122345578889999999876664 89999999999999999 99999988877777


Q ss_pred             HHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          158 KKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       158 ~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ..+..+ ....|..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       216 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          216 EDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            766655 344566789999999999999999999999999874

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=6.6e-39  Score=303.96  Aligned_cols=201  Identities=27%  Similarity=0.426  Sum_probs=158.1

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEE
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLL   79 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~-gi~HrDlkp~NiL   79 (381)
                      +.++||||+++++++.+.+.+|+||||+ ++.+...... .+.+++..++.++.|++.||.|||++ ||+||||||+||+
T Consensus        79 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil  157 (318)
T 2dyl_A           79 KSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNIL  157 (318)
T ss_dssp             HTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEE
T ss_pred             HhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEE
Confidence            4679999999999999999999999999 5555555443 46799999999999999999999996 9999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecC----CCCCCCcccHhHHHHHHHHHHhCCCCCCCC-Chh
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN----RGYDGSAADVWSCGVILFVLMAGYLPFGET-DLP  154 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~-~~~  154 (381)
                      ++.++.+||+|||++...... ......+||+.|+|||++..    ....+.++||||+||++|+|++|..||... +..
T Consensus       158 ~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  236 (318)
T 2dyl_A          158 LDERGQIKLCDFGISGRLVDD-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF  236 (318)
T ss_dssp             ECTTSCEEECCCTTC---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH
T ss_pred             ECCCCCEEEEECCCchhccCC-ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH
Confidence            999999999999998765432 23345679999999999852    223358999999999999999999999864 333


Q ss_pred             HHHHHhhccc-CCCC--CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          155 TLYKKINAAE-FSCP--FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       155 ~~~~~i~~~~-~~~p--~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      .....+.... ...|  ..+++++.+||.+||+.||.+|||++++++||||+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (318)
T 2dyl_A          237 EVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR  289 (318)
T ss_dssp             HHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred             HHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence            4444443332 2233  347999999999999999999999999999999974

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.5e-39  Score=317.43  Aligned_cols=197  Identities=28%  Similarity=0.440  Sum_probs=170.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||
T Consensus       166 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil  245 (377)
T 3cbl_A          166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCL  245 (377)
T ss_dssp             HTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             HHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEE
Confidence            568899999999999999999999999999999999997654 5999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccc--cccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVEL--LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      ++.++.+||+|||++.........  .....+++.|+|||++.+..+. .++||||+||++|+|++ |..||...+....
T Consensus       246 ~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~t~g~~p~~~~~~~~~  324 (377)
T 3cbl_A          246 VTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQT  324 (377)
T ss_dssp             ECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH
T ss_pred             EcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999998754332111  1223357789999999876664 89999999999999998 9999998877766


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...+..+ ....|..+++++.+||.+||+.||.+|||++++++
T Consensus       325 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          325 REFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            6655443 45677779999999999999999999999999875

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-39  Score=312.34  Aligned_cols=198  Identities=21%  Similarity=0.345  Sum_probs=169.1

Q ss_pred             CCC-CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHH
Q 016865            2 KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-----------------------RLLENDCRRYFQQLI   57 (381)
Q Consensus         2 k~l-~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-----------------------~l~e~~~~~~~~qll   57 (381)
                      +++ +||||+++++++.+.+..|+||||++||+|.+++....                       .+++..++.++.||+
T Consensus       103 ~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~  182 (344)
T 1rjb_A          103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVA  182 (344)
T ss_dssp             HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHH
T ss_pred             HhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHH
Confidence            345 89999999999999999999999999999999997643                       278999999999999


Q ss_pred             HHHHHHHHCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHH
Q 016865           58 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCG  135 (381)
Q Consensus        58 ~~L~~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlG  135 (381)
                      .||.|||++||+||||||+|||++.++.+||+|||++.......  .......||+.|+|||++.+..+. .++||||+|
T Consensus       183 ~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG  261 (344)
T 1rjb_A          183 KGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYG  261 (344)
T ss_dssp             HHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHH
T ss_pred             HHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCC-hhHhHHHHH
Confidence            99999999999999999999999999999999999998654321  123455678999999999876664 899999999


Q ss_pred             HHHHHHHh-CCCCCCCCChhHHHHHh-hcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 016865          136 VILFVLMA-GYLPFGETDLPTLYKKI-NAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHP  200 (381)
Q Consensus       136 vil~~ll~-G~~Pf~~~~~~~~~~~i-~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp  200 (381)
                      |++|+|++ |..||...+.......+ ... ....|..+++++.+||.+||..||.+|||+.++++|-
T Consensus       262 ~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          262 ILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             HHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            99999998 99999877654443333 322 3456777899999999999999999999999999864

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.7e-39  Score=300.00  Aligned_cols=194  Identities=26%  Similarity=0.459  Sum_probs=160.8

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCCCcE
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG---VYHRDLKPENL   78 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~g---i~HrDlkp~Ni   78 (381)
                      +.++||||+++++++.+.+..|+||||++||+|.+++. .+.+++..++.++.|++.||.|||++|   |+||||||+||
T Consensus        61 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Ni  139 (271)
T 3dtc_A           61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNI  139 (271)
T ss_dssp             HHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGE
T ss_pred             HhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHE
Confidence            46799999999999999999999999999999988875 467999999999999999999999999   99999999999


Q ss_pred             EEcc--------CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCC
Q 016865           79 LLDS--------YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE  150 (381)
Q Consensus        79 Ll~~--------~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~  150 (381)
                      +++.        ++.+||+|||++......  ......||+.|+|||++.+..+. .++||||+|+++|+|++|..||..
T Consensus       140 l~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~  216 (271)
T 3dtc_A          140 LILQKVENGDLSNKILKITDFGLAREWHRT--TKMSAAGAYAWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRG  216 (271)
T ss_dssp             EESSCCSSSCCSSCCEEECCCCC---------------CCGGGSCHHHHHHCCCS-HHHHHHHHHHHHHHHHHCCCTTTT
T ss_pred             EEecccccccccCcceEEccCCcccccccc--cccCCCCccceeCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCC
Confidence            9986        678999999999765442  23356799999999999877664 899999999999999999999998


Q ss_pred             CChhHHHHHhhccc--CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          151 TDLPTLYKKINAAE--FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       151 ~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      .+.......+....  ...|..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          217 IDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             SCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            77766555544333  45567789999999999999999999999999874

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.1e-39  Score=307.46  Aligned_cols=201  Identities=24%  Similarity=0.407  Sum_probs=148.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-----QGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLK   74 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-----~~~l~e~~~~~~~~qll~~L~~LH~~-gi~HrDlk   74 (381)
                      ++.++||||+++++++.+.+..|+||||++| +|.+++..     ...+++..+..++.|++.||.|||++ ||+|||||
T Consensus        75 ~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlk  153 (327)
T 3aln_A           75 MRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIK  153 (327)
T ss_dssp             HSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCC
T ss_pred             HHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCC
Confidence            3578999999999999999999999999986 88777763     56799999999999999999999999 99999999


Q ss_pred             CCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceec----CCCCCCCcccHhHHHHHHHHHHhCCCCCCC
Q 016865           75 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS----NRGYDGSAADVWSCGVILFVLMAGYLPFGE  150 (381)
Q Consensus        75 p~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~  150 (381)
                      |+||+++.++.+||+|||++...... .......||+.|+|||++.    +..+ +.++||||+||++|+|++|..||..
T Consensus       154 p~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~  231 (327)
T 3aln_A          154 PSNILLDRSGNIKLCDFGISGQLVDS-IAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPK  231 (327)
T ss_dssp             GGGEEEETTTEEEECCCSSSCC-------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred             HHHEEEcCCCCEEEccCCCceecccc-cccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCC
Confidence            99999999999999999999765442 2234457999999999983    3344 4899999999999999999999976


Q ss_pred             CChh-HHHHHhhccc-CCC----CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          151 TDLP-TLYKKINAAE-FSC----PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       151 ~~~~-~~~~~i~~~~-~~~----p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      .+.. .....+..+. ...    +..+++++.+||.+||..||.+|||+.++++||||..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~  291 (327)
T 3aln_A          232 WNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM  291 (327)
T ss_dssp             C-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             cchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence            4321 2222222221 112    2347899999999999999999999999999999974

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=7e-39  Score=306.77  Aligned_cols=196  Identities=21%  Similarity=0.320  Sum_probs=165.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.. .++|+||+.+|+|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+|||
T Consensus        71 l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl  149 (327)
T 3lzb_A           71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL  149 (327)
T ss_dssp             HTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             HHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEE
Confidence            46789999999999998765 8899999999999999976 456999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      ++.++.+||+|||++.......  .......||+.|+|||++.+..+. .++||||+||++|+|++ |.+||...+....
T Consensus       150 ~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~  228 (327)
T 3lzb_A          150 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEI  228 (327)
T ss_dssp             EEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred             EcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCC-hHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Confidence            9999999999999998654321  122344568889999999887765 89999999999999999 9999998887777


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...+... ....|..+++++.++|.+||..||.+|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          229 SSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            6666554 35667779999999999999999999999999987

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.5e-39  Score=313.30  Aligned_cols=197  Identities=25%  Similarity=0.400  Sum_probs=161.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |++++||||+++++++.+.+..|+||||++||+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||
T Consensus       100 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl  179 (373)
T 2qol_A          100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNIL  179 (373)
T ss_dssp             HTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             HHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEE
Confidence            467899999999999999999999999999999999997654 6999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccc---cccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVEL---LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPT  155 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~  155 (381)
                      ++.++.+||+|||++.........   .....+|+.|+|||++.+..+. .++||||+||++|+|++ |..||...+...
T Consensus       180 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~SlG~il~ellt~g~~P~~~~~~~~  258 (373)
T 2qol_A          180 INSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQD  258 (373)
T ss_dssp             ECTTCCEEECCC----------------------CTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTC-CTTTTCCHHH
T ss_pred             EcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999876442211   1223457889999999877765 89999999999999998 999999888777


Q ss_pred             HHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          156 LYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       156 ~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ....+..+ ....|..+++.+.++|.+||+.||.+|||+.++++
T Consensus       259 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          259 VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             HHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            77666544 34556678999999999999999999999999886

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.2e-39  Score=302.09  Aligned_cols=196  Identities=28%  Similarity=0.394  Sum_probs=173.1

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      +.++||||+++++++.+.+..|+||||++||+|.+++...  ..+++..++.++.|++.||.|||++||+||||||+||+
T Consensus        64 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil  143 (288)
T 3kfa_A           64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL  143 (288)
T ss_dssp             HHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEE
T ss_pred             HhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEE
Confidence            5689999999999999999999999999999999999864  34899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  157 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~  157 (381)
                      ++.++.+||+|||++....... .......||+.|+|||++.+..+. .++||||+|+++|+|++ |.+||...+.....
T Consensus       144 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~  222 (288)
T 3kfa_A          144 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY  222 (288)
T ss_dssp             ECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred             EcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999998765432 223445678899999999877764 89999999999999999 99999988877776


Q ss_pred             HHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          158 KKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       158 ~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ..+... ....|..+++.+.+||.+||..||.+|||++++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          223 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            666544 45567779999999999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.3e-39  Score=304.32  Aligned_cols=201  Identities=26%  Similarity=0.458  Sum_probs=162.6

Q ss_pred             ccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCCC
Q 016865            6 HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN   85 (381)
Q Consensus         6 HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~~   85 (381)
                      ||||+++++++.+.+..|+||| +.+|+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||+++ +.
T Consensus        87 ~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~  164 (313)
T 3cek_A           87 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GM  164 (313)
T ss_dssp             CTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TE
T ss_pred             CCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-Ce
Confidence            6999999999999999999999 557899999998889999999999999999999999999999999999999964 89


Q ss_pred             EEEeeccCccCCCCCc--cccccccCCCCCCCCceecCC----------CCCCCcccHhHHHHHHHHHHhCCCCCCCCCh
Q 016865           86 LKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNR----------GYDGSAADVWSCGVILFVLMAGYLPFGETDL  153 (381)
Q Consensus        86 lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~----------~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~  153 (381)
                      +||+|||++.......  ......+||+.|+|||++.+.          ...+.++||||+||++|+|++|..||.....
T Consensus       165 ~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (313)
T 3cek_A          165 LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN  244 (313)
T ss_dssp             EEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred             EEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH
Confidence            9999999998654321  123456799999999998652          2335799999999999999999999976543


Q ss_pred             h-HHHHHhhc--ccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 016865          154 P-TLYKKINA--AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  208 (381)
Q Consensus       154 ~-~~~~~i~~--~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~  208 (381)
                      . .....+..  .....|...++++.++|.+||+.||.+|||++++++||||+....+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  302 (313)
T 3cek_A          245 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  302 (313)
T ss_dssp             HHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred             HHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence            2 22233322  2345666789999999999999999999999999999999875543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.8e-39  Score=311.57  Aligned_cols=195  Identities=16%  Similarity=0.163  Sum_probs=162.7

Q ss_pred             CCCCccccccceEEEEe----CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            2 KIVRHPNIVRLHEVLAS----RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~----~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      +.++||||+++++++.+    ....|+||||+ ||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|
T Consensus       103 ~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  181 (345)
T 2v62_A          103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAAN  181 (345)
T ss_dssp             HTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             ccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHH
Confidence            46799999999999988    78999999999 99999999887789999999999999999999999999999999999


Q ss_pred             EEEccCC--CEEEeeccCccCCCCC-------ccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCC
Q 016865           78 LLLDSYG--NLKVSDFGLSALPQQG-------VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF  148 (381)
Q Consensus        78 iLl~~~~--~lkl~DFGls~~~~~~-------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf  148 (381)
                      ||++.++  .+||+|||++......       .......+||+.|+|||++.+..+. .++||||+||++|+|++|..||
T Consensus       182 Ill~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~pf  260 (345)
T 2v62_A          182 LLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALS-RRSDVEILGYCMLRWLCGKLPW  260 (345)
T ss_dssp             EEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCTT
T ss_pred             EEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCc
Confidence            9999887  9999999999765321       1122456899999999999877664 8999999999999999999999


Q ss_pred             CCC--ChhHHHHHhhcccCCCC---------CCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          149 GET--DLPTLYKKINAAEFSCP---------FWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       149 ~~~--~~~~~~~~i~~~~~~~p---------~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...  +...............|         ..+++++.++|.+||..||.+|||++++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          261 EQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             GGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            652  22222211111111122         158899999999999999999999999887

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.4e-38  Score=301.92  Aligned_cols=197  Identities=23%  Similarity=0.376  Sum_probs=161.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++.+.+..|+||||++|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||++
T Consensus        88 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~  167 (309)
T 2h34_A           88 AGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV  167 (309)
T ss_dssp             HTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             HhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE
Confidence            46789999999999999999999999999999999999988889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCC-ccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           81 DSYGNLKVSDFGLSALPQQG-VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      +.++.+||+|||++...... .......+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+.......
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  246 (309)
T 2h34_A          168 SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHAT-YRADIYALTCVLYECLTGSPPYQGDQLSVMGAH  246 (309)
T ss_dssp             CTTSCEEECSCCC----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHH
T ss_pred             cCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCC-chHhHHHHHHHHHHHHHCCCCCCCchHHHHHHH
Confidence            99999999999998765432 1223456799999999999876664 899999999999999999999988766554444


Q ss_pred             hhcccC---CCCCCCChhHHHHHHHhcCCCCCCCC-CHHHHhc
Q 016865          160 INAAEF---SCPFWFSTGATSLIHKILDPNPKTRI-RIEGIRK  198 (381)
Q Consensus       160 i~~~~~---~~p~~~s~~~~~li~~~L~~dP~~R~-t~~~il~  198 (381)
                      +.....   ..+..+|+++.++|.+||+.||.+|| |++++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          247 INQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             hccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            433222   34556899999999999999999999 7888775

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=6.3e-39  Score=305.10  Aligned_cols=198  Identities=20%  Similarity=0.258  Sum_probs=173.1

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ----------GRLLENDCRRYFQQLIDAVAHCHSKGVYH   70 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~----------~~l~e~~~~~~~~qll~~L~~LH~~gi~H   70 (381)
                      |+.++||||+++++++.+.+..|+||||++||+|.+++...          ..+++..+..++.|++.||.|||++||+|
T Consensus        82 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H  161 (322)
T 1p4o_A           82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVH  161 (322)
T ss_dssp             GGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred             HHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence            46789999999999999999999999999999999998753          35689999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCC
Q 016865           71 RDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLP  147 (381)
Q Consensus        71 rDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~P  147 (381)
                      |||||+||+++.++.+||+|||++.......  .......||+.|+|||++.+..+. .++||||+||++|+|++ |..|
T Consensus       162 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p  240 (322)
T 1p4o_A          162 RDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQP  240 (322)
T ss_dssp             SCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCT
T ss_pred             CCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCC-chhhHHHHHHHHHHHHhcCCCc
Confidence            9999999999999999999999987554321  123345678999999999876664 89999999999999999 8999


Q ss_pred             CCCCChhHHHHHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          148 FGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       148 f~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      |...+.......+.... ...|..+++.+.++|.+||+.||.+|||+.++++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          241 YQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             TTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            99888777776665544 35667789999999999999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.4e-39  Score=312.42  Aligned_cols=195  Identities=13%  Similarity=0.156  Sum_probs=160.8

Q ss_pred             CCCCccccccceEEEEeC----CEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 016865            2 KIVRHPNIVRLHEVLASR----TKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE   76 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~----~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~   76 (381)
                      +.++||||+++++++.+.    ...|+||||+ ||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+
T Consensus       103 ~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~  181 (364)
T 3op5_A          103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKAS  181 (364)
T ss_dssp             TTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             hhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHH
Confidence            568999999999999764    5699999999 99999999875 57999999999999999999999999999999999


Q ss_pred             cEEEc--cCCCEEEeeccCccCCCCCc-------cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCC
Q 016865           77 NLLLD--SYGNLKVSDFGLSALPQQGV-------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLP  147 (381)
Q Consensus        77 NiLl~--~~~~lkl~DFGls~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~P  147 (381)
                      |||++  .++.+||+|||++.......       ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..|
T Consensus       182 Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~P  260 (364)
T 3op5_A          182 NLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLP  260 (364)
T ss_dssp             GEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCT
T ss_pred             HEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCC
Confidence            99999  88999999999997654321       11245569999999999988776 4899999999999999999999


Q ss_pred             CCCCChhHHHHH-hhcc---c-------CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          148 FGETDLPTLYKK-INAA---E-------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       148 f~~~~~~~~~~~-i~~~---~-------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      |.+......... ....   .       .-.+..+++++.++|..||..||.+|||++++++
T Consensus       261 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          261 WEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             TGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             ccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            985432221111 1100   0       0012457899999999999999999999999886

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.4e-39  Score=312.15  Aligned_cols=197  Identities=22%  Similarity=0.426  Sum_probs=159.7

Q ss_pred             CccccccceEEEEeCC----EEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCc
Q 016865            5 RHPNIVRLHEVLASRT----KVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPEN   77 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~----~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~-gi~HrDlkp~N   77 (381)
                      .||||+++++++...+    .+++||||+ |++|.+++...  +.+++..++.++.||+.||+|||++ ||+||||||+|
T Consensus        84 ~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~N  162 (373)
T 1q8y_A           84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN  162 (373)
T ss_dssp             HHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGG
T ss_pred             ccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHH
Confidence            4999999999998654    899999999 88999999763  4599999999999999999999998 99999999999


Q ss_pred             EEEcc------CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCC
Q 016865           78 LLLDS------YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET  151 (381)
Q Consensus        78 iLl~~------~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~  151 (381)
                      ||++.      .+.+||+|||++.....   .....+||+.|+|||++.+..+. .++||||+||++|+|++|..||...
T Consensus       163 Ill~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~  238 (373)
T 1q8y_A          163 VLMEIVDSPENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPD  238 (373)
T ss_dssp             EEEEEEETTTTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---
T ss_pred             eEEeccCCCcCcceEEEcccccccccCC---CCCCCCCCccccCcHHHhCCCCC-chHhHHHHHHHHHHHHhCCCCCCCC
Confidence            99953      34799999999976543   23456899999999999887764 8999999999999999999999765


Q ss_pred             Chh------HHHHHhh------------------------------------------cccCCCCCCCChhHHHHHHHhc
Q 016865          152 DLP------TLYKKIN------------------------------------------AAEFSCPFWFSTGATSLIHKIL  183 (381)
Q Consensus       152 ~~~------~~~~~i~------------------------------------------~~~~~~p~~~s~~~~~li~~~L  183 (381)
                      +..      .....+.                                          .....++..+++++.+||.+||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  318 (373)
T 1q8y_A          239 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML  318 (373)
T ss_dssp             ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred             cccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHh
Confidence            421      1111110                                          1112233345678999999999


Q ss_pred             CCCCCCCCCHHHHhcCcccccCC
Q 016865          184 DPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       184 ~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      +.||.+|||++++++||||+...
T Consensus       319 ~~dP~~Rpt~~ell~hp~f~~~~  341 (373)
T 1q8y_A          319 QLDPRKRADAGGLVNHPWLKDTL  341 (373)
T ss_dssp             CSSTTTCBCHHHHHTCGGGTTCT
T ss_pred             ccCccccCCHHHHhhChhhhccc
Confidence            99999999999999999998654

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.1e-39  Score=308.18  Aligned_cols=194  Identities=21%  Similarity=0.257  Sum_probs=164.4

Q ss_pred             CCC-CccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            2 KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         2 k~l-~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      +.+ +||||+++++++.+.+..|+||||+ ||+|.+++.. .+.+++..++.++.|++.||+|||++||+||||||+|||
T Consensus        59 ~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nil  137 (330)
T 2izr_A           59 KQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFL  137 (330)
T ss_dssp             HHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             HHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHee
Confidence            345 8999999999999999999999999 9999999986 467999999999999999999999999999999999999


Q ss_pred             EccCCC-----EEEeeccCccCCCCCcc-------ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCC
Q 016865           80 LDSYGN-----LKVSDFGLSALPQQGVE-------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLP  147 (381)
Q Consensus        80 l~~~~~-----lkl~DFGls~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~P  147 (381)
                      ++.++.     +||+|||++........       .....+||+.|+|||++.+..+. .++|||||||++|+|++|..|
T Consensus       138 l~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~P  216 (330)
T 2izr_A          138 IGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQS-RRDDLEALGHMFMYFLRGSLP  216 (330)
T ss_dssp             ECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCT
T ss_pred             eccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCC-chhHHHHHHHHHHHHhcCCCC
Confidence            998887     99999999986543211       13567899999999999887764 899999999999999999999


Q ss_pred             CCCCCh---hHHHHHhhcccCCCCC-----CCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          148 FGETDL---PTLYKKINAAEFSCPF-----WFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       148 f~~~~~---~~~~~~i~~~~~~~p~-----~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      |...+.   ...+..+.......|.     .++ ++.++|.+||..||.+|||++++++
T Consensus       217 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          217 WQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             TTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            987443   3444555433333321     234 9999999999999999999998876

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.2e-38  Score=318.34  Aligned_cols=194  Identities=25%  Similarity=0.443  Sum_probs=169.2

Q ss_pred             CCCCCccccccceEEEEeCC-EEEEEEecCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            1 MKIVRHPNIVRLHEVLASRT-KVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~-~~~lV~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      |++++||||+++++++.+.. .+|+||||+++|+|.+++...+.  +++..+..++.|++.||+|||++||+||||||+|
T Consensus       240 l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~N  319 (450)
T 1k9a_A          240 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARN  319 (450)
T ss_dssp             HHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             HHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhh
Confidence            46789999999999987665 79999999999999999987554  7999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           78 LLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        78 iLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      ||++.++.+||+|||++......   .....+++.|+|||++.+..++ .++||||+||++|+|++ |..||...+....
T Consensus       320 ill~~~~~~kl~DfG~a~~~~~~---~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~  395 (450)
T 1k9a_A          320 VLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDV  395 (450)
T ss_dssp             EEECTTSCEEECCCTTCEECC---------CCCTTTSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH
T ss_pred             EEECCCCCEEEeeCCCccccccc---ccCCCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999998754322   2344678999999999887775 89999999999999998 9999998877777


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...+..+ ....|..+++++.+||.+||+.||.+|||+.++++
T Consensus       396 ~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          396 VPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            6666554 45677789999999999999999999999999875

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3e-39  Score=305.69  Aligned_cols=197  Identities=24%  Similarity=0.345  Sum_probs=168.3

Q ss_pred             CCC-CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHH
Q 016865            2 KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG------------------RLLENDCRRYFQQLIDAVAH   62 (381)
Q Consensus         2 k~l-~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~------------------~l~e~~~~~~~~qll~~L~~   62 (381)
                      +++ +||||+++++++.+.+..|+||||+++|+|.+++...+                  .+++..++.++.|++.||.|
T Consensus        81 ~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~  160 (313)
T 1t46_A           81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAF  160 (313)
T ss_dssp             HHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHH
T ss_pred             hhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHH
Confidence            345 89999999999999999999999999999999997654                  38999999999999999999


Q ss_pred             HHHCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCcc--ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHH
Q 016865           63 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFV  140 (381)
Q Consensus        63 LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~  140 (381)
                      ||++||+||||||+||+++.++.+||+|||++........  ......||+.|+|||++.+..+. .++||||+||++|+
T Consensus       161 lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~e  239 (313)
T 1t46_A          161 LASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWE  239 (313)
T ss_dssp             HHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHH
T ss_pred             HHHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCC-hHHHHHHHHHHHHH
Confidence            9999999999999999999999999999999987654321  23345678899999999876664 89999999999999


Q ss_pred             HHh-CCCCCCCCChhHHHHHh-hcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          141 LMA-GYLPFGETDLPTLYKKI-NAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       141 ll~-G~~Pf~~~~~~~~~~~i-~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      |++ |..||...+........ ... ....+..+++++.++|.+||+.||.+|||+.+++++
T Consensus       240 llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          240 LFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            999 99999877654433333 222 234456789999999999999999999999999874

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=6.8e-39  Score=301.00  Aligned_cols=196  Identities=20%  Similarity=0.312  Sum_probs=170.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++||||+++++++ ..+..|+||||+++|+|.+++...+.+++..++.++.|++.||+|||++||+||||||+||++
T Consensus        72 l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~  150 (291)
T 1xbb_A           72 MQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL  150 (291)
T ss_dssp             HHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             HHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEE
Confidence            3568999999999999 567789999999999999999988889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCcc---ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      +.++.+||+|||++........   ......||+.|+|||++.+..+. .++||||+||++|+|++ |..||...+....
T Consensus       151 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~  229 (291)
T 1xbb_A          151 VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV  229 (291)
T ss_dssp             EETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred             eCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCC-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            9999999999999976544221   12234567889999999876664 89999999999999999 9999998887777


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...+..+ ....|..+++.+.++|.+||+.||.+|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          230 TAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            6666554 34567789999999999999999999999999886

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.3e-38  Score=316.59  Aligned_cols=198  Identities=29%  Similarity=0.446  Sum_probs=153.6

Q ss_pred             CCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 016865            4 VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL-------ENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE   76 (381)
Q Consensus         4 l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~-------e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~   76 (381)
                      .+||||+++++++.+.+.+|+|||||. |+|.+++...+...       +..+..++.||+.||+|||++||+||||||+
T Consensus        66 ~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~  144 (434)
T 2rio_A           66 DDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQ  144 (434)
T ss_dssp             TTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             cCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChH
Confidence            489999999999999999999999996 59999998754332       2345789999999999999999999999999


Q ss_pred             cEEEccC-------------CCEEEeeccCccCCCCCcc----ccccccCCCCCCCCceecC------CCCCCCcccHhH
Q 016865           77 NLLLDSY-------------GNLKVSDFGLSALPQQGVE----LLHTTCGTPNYVAPEVLSN------RGYDGSAADVWS  133 (381)
Q Consensus        77 NiLl~~~-------------~~lkl~DFGls~~~~~~~~----~~~~~~gt~~y~aPE~l~~------~~~~~~~~DIwS  133 (381)
                      |||++.+             +.+||+|||++........    .....+||+.|+|||++.+      ....+.++||||
T Consensus       145 NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwS  224 (434)
T 2rio_A          145 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFS  224 (434)
T ss_dssp             GEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHH
T ss_pred             hEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHh
Confidence            9999754             4799999999986554221    2345689999999999965      133458999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCChhHHHHHhhcccCCCCC-------CCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          134 CGVILFVLMA-GYLPFGETDLPTLYKKINAAEFSCPF-------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       134 lGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~~~p~-------~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      +||++|+|++ |..||.......  ..+..+....+.       .+++++.+||.+||+.||.+|||+.++++||||..
T Consensus       225 lG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          225 MGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             HHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             HHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            9999999999 999997654433  222222222221       24578999999999999999999999999999964

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-39  Score=302.15  Aligned_cols=197  Identities=23%  Similarity=0.339  Sum_probs=170.8

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      +.++||||+++++++ ..+..|+||||+++|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+||++
T Consensus        65 ~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili  143 (287)
T 1u59_A           65 HQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL  143 (287)
T ss_dssp             HHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             HhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEE
Confidence            467999999999999 456699999999999999998654 469999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCcc---ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      +.++.+||+|||++........   ......||+.|+|||++.+..+. .++||||+||++|+|++ |..||...+....
T Consensus       144 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~  222 (287)
T 1u59_A          144 VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEV  222 (287)
T ss_dssp             EETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH
T ss_pred             cCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence            9999999999999986543211   12344578899999999776664 89999999999999998 9999998877777


Q ss_pred             HHHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 016865          157 YKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHP  200 (381)
Q Consensus       157 ~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp  200 (381)
                      ...+..+. ...|..+++++.++|.+||..||.+|||+.+++++.
T Consensus       223 ~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          223 MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            66665543 456778999999999999999999999999999864

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-38  Score=305.56  Aligned_cols=198  Identities=26%  Similarity=0.376  Sum_probs=167.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+..|+||||++||+|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+
T Consensus       100 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl  179 (333)
T 1mqb_A          100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNIL  179 (333)
T ss_dssp             HHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             HHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEE
Confidence            35789999999999999999999999999999999999764 57999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCcc---ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPT  155 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~  155 (381)
                      ++.++.+||+|||++........   ......+|+.|+|||++.+..+. .++||||+||++|+|++ |..||...+...
T Consensus       180 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~  258 (333)
T 1mqb_A          180 VNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHE  258 (333)
T ss_dssp             ECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             ECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCC-chhhhHHHHHHHHHHHcCCCCCcccCCHHH
Confidence            99999999999999986544211   11233467889999999877665 89999999999999999 999999888777


Q ss_pred             HHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          156 LYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       156 ~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ....+..+ ....|..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          259 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             HHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            77766554 445666789999999999999999999999999874

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.3e-38  Score=302.06  Aligned_cols=198  Identities=23%  Similarity=0.337  Sum_probs=163.5

Q ss_pred             CCCCCccccccceEEEEeCC-----EEEEEEecCCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q 016865            1 MKIVRHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVH------QGRLLENDCRRYFQQLIDAVAHCHSKGVY   69 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~-----~~~lV~E~~~gg~L~~~i~~------~~~l~e~~~~~~~~qll~~L~~LH~~gi~   69 (381)
                      |+.++||||+++++++.+.+     ..|+||||+++|+|.+++..      ...+++..++.++.|++.||.|||++||+
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv  169 (313)
T 3brb_A           90 MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFL  169 (313)
T ss_dssp             HHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred             HhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            35789999999999998765     35999999999999999843      35699999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCC
Q 016865           70 HRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYL  146 (381)
Q Consensus        70 HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~  146 (381)
                      ||||||+||+++.++.+||+|||++.......  .......+++.|+|||++.+..+. .++||||+||++|+|++ |.+
T Consensus       170 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~  248 (313)
T 3brb_A          170 HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMT  248 (313)
T ss_dssp             CCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTSCC
T ss_pred             cCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCcc-chhhhHHHHHHHHHHHhcCCC
Confidence            99999999999999999999999997654321  122344578899999999877665 89999999999999999 999


Q ss_pred             CCCCCChhHHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          147 PFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       147 Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ||...+.......+..+ ....|..+++++.++|.+||..||.+|||+.+++++
T Consensus       249 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          249 PYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             SSTTCCGGGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCccCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99988877776666544 445667789999999999999999999999999874

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.4e-38  Score=297.38  Aligned_cols=192  Identities=18%  Similarity=0.237  Sum_probs=163.1

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccC
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY   83 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~   83 (381)
                      +||||+++++++.+....|+||||+ ||+|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||++.+
T Consensus        64 ~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~  142 (298)
T 1csn_A           64 GCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRP  142 (298)
T ss_dssp             TCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCS
T ss_pred             cCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccC
Confidence            7999999999999999999999999 999999998754 59999999999999999999999999999999999999877


Q ss_pred             CC-----EEEeeccCccCCCCCc-------cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCC
Q 016865           84 GN-----LKVSDFGLSALPQQGV-------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET  151 (381)
Q Consensus        84 ~~-----lkl~DFGls~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~  151 (381)
                      +.     +||+|||++.......       ......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...
T Consensus       143 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~  221 (298)
T 1csn_A          143 NSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGL  221 (298)
T ss_dssp             SSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             CCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchh
Confidence            76     9999999997654321       12356679999999999987776 48999999999999999999999874


Q ss_pred             C---hhHHHHHhhcccCC-----CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          152 D---LPTLYKKINAAEFS-----CPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       152 ~---~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      +   ....+..+......     .+..+++++.++|.+||+.||.+|||++++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          222 KAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             CSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            3   33333333332221     22357999999999999999999999999876

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=8.4e-39  Score=298.69  Aligned_cols=196  Identities=24%  Similarity=0.334  Sum_probs=166.1

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      +.++||||+++++++.+. ..|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++
T Consensus        68 ~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~  146 (281)
T 3cc6_A           68 KNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV  146 (281)
T ss_dssp             HHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE
T ss_pred             HhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE
Confidence            457899999999998754 568999999999999999765 459999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYK  158 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~  158 (381)
                      +.++.+||+|||++....... .......||+.|+|||++.+..+. .++||||+||++|+|++ |..||...+......
T Consensus       147 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~  225 (281)
T 3cc6_A          147 ASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIG  225 (281)
T ss_dssp             EETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH
T ss_pred             CCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCC-chhccHHHHHHHHHHHhCCCCCcccCChHHHHH
Confidence            999999999999998654421 122345578899999999876664 89999999999999998 999998777666666


Q ss_pred             Hhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          159 KINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       159 ~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      .+... ....|..+++.+.++|.+||..||.+|||+.+++++
T Consensus       226 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          226 VLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            55443 345667789999999999999999999999999874

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-38  Score=296.80  Aligned_cols=197  Identities=22%  Similarity=0.347  Sum_probs=168.2

Q ss_pred             CCCCCccccccceEEEEeCCEE-EEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKV-YIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~-~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||+++++++.+.+.. |+||||+.+|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||
T Consensus        76 l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Ni  155 (298)
T 3pls_A           76 MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNC  155 (298)
T ss_dssp             HHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             HHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceE
Confidence            3578999999999999876655 999999999999999976 45689999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCC----ccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCCh
Q 016865           79 LLDSYGNLKVSDFGLSALPQQG----VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDL  153 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~  153 (381)
                      +++.++.+||+|||++......    ........||+.|+|||++.+..+. .++||||+||++|+|++ |.+||...+.
T Consensus       156 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~~~~~~~~~  234 (298)
T 3pls_A          156 MLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDP  234 (298)
T ss_dssp             EECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCG
T ss_pred             EEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCC-hhhchhhHHHHHHHHhhCCCCCCccCCH
Confidence            9999999999999999765432    1223455688999999999877665 89999999999999999 5666776666


Q ss_pred             hHHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          154 PTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       154 ~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ......+... ....|..+++.+.++|.+||+.||.+|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          235 FDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            6666655444 34566778999999999999999999999999886

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=9.2e-39  Score=319.51  Aligned_cols=196  Identities=23%  Similarity=0.431  Sum_probs=170.1

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||+++++++. ...+|+||||+++|+|.+++...  ..+++..+..++.|++.||+|||++||+||||||+||
T Consensus       237 l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Ni  315 (454)
T 1qcf_A          237 MKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANI  315 (454)
T ss_dssp             HTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGE
T ss_pred             HhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence            57899999999999986 66799999999999999999753  3689999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      |++.++.+||+|||+++...... .......+|+.|+|||++....+. .++||||+||++|+|++ |..||.+.+....
T Consensus       316 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~t~g~~P~~~~~~~~~  394 (454)
T 1qcf_A          316 LVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEV  394 (454)
T ss_dssp             EECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             EECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCC-cHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999998654321 112334467889999999876665 89999999999999999 9999998887777


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...+..+ ....|..+++++.+||.+||+.||.+|||++++++
T Consensus       395 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          395 IRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            7666544 44567779999999999999999999999999875

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.8e-38  Score=298.69  Aligned_cols=197  Identities=23%  Similarity=0.318  Sum_probs=166.5

Q ss_pred             CCCCCccccccceEEE-EeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVL-ASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~-~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |++++||||+++++++ .+++..|+||||++||+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||
T Consensus        80 l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Ni  159 (298)
T 3f66_A           80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNC  159 (298)
T ss_dssp             HHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             HHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheE
Confidence            3578999999999986 456789999999999999999976 34589999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCc----cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCCh
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGV----ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDL  153 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~  153 (381)
                      +++.++.+||+|||++.......    .......||+.|+|||++.+..+. .++||||+||++|+|++ |.+||...+.
T Consensus       160 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~~~~  238 (298)
T 3f66_A          160 MLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNT  238 (298)
T ss_dssp             EECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTSCT
T ss_pred             EECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCccCCH
Confidence            99999999999999998654321    123345678899999999877665 89999999999999999 7788887776


Q ss_pred             hHHHHHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          154 PTLYKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       154 ~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ......+.... ...|..+++.+.++|.+||+.||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          239 FDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             TTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            66655554443 3456678999999999999999999999999886

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.8e-38  Score=295.99  Aligned_cols=194  Identities=24%  Similarity=0.435  Sum_probs=163.2

Q ss_pred             CCCCCccccccceEEEEeC-CEEEEEEecCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            1 MKIVRHPNIVRLHEVLASR-TKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~-~~~~lV~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      |+.++||||+++++++.+. +..|+||||+++|+|.+++...+.  +++..+..++.|++.||+|||++||+||||||+|
T Consensus        68 l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~N  147 (278)
T 1byg_A           68 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARN  147 (278)
T ss_dssp             HTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             HHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcce
Confidence            4678999999999997544 579999999999999999976543  8999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           78 LLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        78 iLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      |+++.++.+||+|||++......   .....+++.|+|||++.+..+. .++||||+||++|+|++ |..||...+....
T Consensus       148 il~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~  223 (278)
T 1byg_A          148 VLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDV  223 (278)
T ss_dssp             EEECTTSCEEECCCCC---------------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH
T ss_pred             EEEeCCCcEEEeecccccccccc---ccCCCccccccCHHHhCCCCCC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999998754432   2345688999999999876664 89999999999999998 9999998887777


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...+..+ ....|..+++.+.++|.+||..||.+|||+.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          224 VPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            7666544 44567778999999999999999999999999886

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1e-38  Score=305.95  Aligned_cols=196  Identities=22%  Similarity=0.365  Sum_probs=170.9

Q ss_pred             CC-CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHH
Q 016865            3 IV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHCHS   65 (381)
Q Consensus         3 ~l-~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~~L~~LH~   65 (381)
                      ++ +||||+++++++.+.+.+|+||||++||+|.+++....                .+++..++.++.||+.||.|||+
T Consensus        96 ~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~  175 (334)
T 2pvf_A           96 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS  175 (334)
T ss_dssp             HHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh
Confidence            45 89999999999999999999999999999999997643                38999999999999999999999


Q ss_pred             CCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCcc--ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh
Q 016865           66 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA  143 (381)
Q Consensus        66 ~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~  143 (381)
                      +||+||||||+||+++.++.+||+|||++........  ......+|+.|+|||++.+..+. .++||||+||++|+|++
T Consensus       176 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt  254 (334)
T 2pvf_A          176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFT  254 (334)
T ss_dssp             TTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHT
T ss_pred             CCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcC-hHHHHHHHHHHHHHHHh
Confidence            9999999999999999999999999999976543221  22344578899999999776664 89999999999999999


Q ss_pred             -CCCCCCCCChhHHHHHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          144 -GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       144 -G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                       |..||...+.......+.... ...|..+++++.++|.+||..||.+|||+.+++++
T Consensus       255 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          255 LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             TSCCSSTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCcCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             999999888777776665543 45667789999999999999999999999999874

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=8.3e-39  Score=300.80  Aligned_cols=197  Identities=24%  Similarity=0.355  Sum_probs=160.7

Q ss_pred             CCCCCccccccceEEEEe--CCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            1 MKIVRHPNIVRLHEVLAS--RTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      |+.++||||+++++++.+  ...+|+||||+++|+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|
T Consensus        65 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~N  144 (295)
T 3ugc_A           65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRN  144 (295)
T ss_dssp             HHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             HHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhh
Confidence            357899999999999964  456999999999999999997754 49999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccCccCCCCCc---cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           78 LLLDSYGNLKVSDFGLSALPQQGV---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        78 iLl~~~~~lkl~DFGls~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      ||++.++.+||+|||++.......   .......|++.|+|||++.+..++ .++||||+||++|+|++|..||......
T Consensus       145 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~~~~~~~~~  223 (295)
T 3ugc_A          145 ILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAE  223 (295)
T ss_dssp             EEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTTCTTCSHHHH
T ss_pred             EEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCC-hHHHHHHHHHHHHHHHhcccccCCChHH
Confidence            999999999999999998764422   122344577889999999887765 8999999999999999999998653211


Q ss_pred             ----------------HHHHHh-hcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          155 ----------------TLYKKI-NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       155 ----------------~~~~~i-~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                                      .....+ .......|..+++++.+||.+||+.||.+|||+.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          224 FMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                            111112 22345567779999999999999999999999999886

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=5e-39  Score=307.07  Aligned_cols=201  Identities=19%  Similarity=0.289  Sum_probs=172.7

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK   74 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlk   74 (381)
                      +.++||||+++++++.+....|+||||++||+|.+++....       .+++..++.++.|++.||.|||++||+|||||
T Consensus        88 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlk  167 (327)
T 2yfx_A           88 SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA  167 (327)
T ss_dssp             HHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             hhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCC
Confidence            46799999999999999999999999999999999998753       48899999999999999999999999999999


Q ss_pred             CCcEEEccC---CCEEEeeccCccCCCCC--ccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCC
Q 016865           75 PENLLLDSY---GNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF  148 (381)
Q Consensus        75 p~NiLl~~~---~~lkl~DFGls~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf  148 (381)
                      |+|||++.+   ..+||+|||++......  ........||+.|+|||++.+..+. .++||||+||++|+|++ |..||
T Consensus       168 p~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~  246 (327)
T 2yfx_A          168 ARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPY  246 (327)
T ss_dssp             GGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             HhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCC-chhhHHHHHHHHHHHHcCCCCCC
Confidence            999999954   46999999998643221  1223455689999999999876664 89999999999999998 99999


Q ss_pred             CCCChhHHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          149 GETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       149 ~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      ...+.......+..+ ....+..+++.+.++|.+||..||.+|||+.++++|.|+-
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          247 PSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             TTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCcCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            988877766666554 3456667899999999999999999999999999998874

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.4e-39  Score=307.45  Aligned_cols=199  Identities=20%  Similarity=0.265  Sum_probs=163.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG----RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE   76 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~----~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~   76 (381)
                      |+.++||||+++++++.+.+..|+||||++||+|.+++....    .+++..++.++.|++.||.|||++||+||||||+
T Consensus        89 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~  168 (321)
T 2qkw_B           89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSI  168 (321)
T ss_dssp             GGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCST
T ss_pred             HHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHH
Confidence            467899999999999999999999999999999999886543    5899999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccCccCCCCC--ccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           77 NLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        77 NiLl~~~~~lkl~DFGls~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      ||+++.++.+||+|||++......  .......+||+.|+|||++.+..+. .++||||+||++|+|++|+.||......
T Consensus       169 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~p~~~~~~~  247 (321)
T 2qkw_B          169 NILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLT-EKSDVYSFGVVLFEVLCARSAIVQSLPR  247 (321)
T ss_dssp             TEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCC-THHHHHHHHHHHHHHHHCCTTCSCSSSS
T ss_pred             HEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCC-cccchHhHHHHHHHHHhCCCcccccCcH
Confidence            999999999999999998754331  1223455699999999999876664 8999999999999999999999764332


Q ss_pred             HH---HH----HhhcccC----------CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 016865          155 TL---YK----KINAAEF----------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHP  200 (381)
Q Consensus       155 ~~---~~----~i~~~~~----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp  200 (381)
                      ..   ..    ......+          ..+...+..+.+++.+||+.||.+|||+.+++++-
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          248 EMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             SCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            11   11    1111111          11122456789999999999999999999999864

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.2e-38  Score=322.09  Aligned_cols=197  Identities=27%  Similarity=0.395  Sum_probs=172.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |++++||||+++++++.+...+|+||||+++|+|.+++...  ..+++..+..++.|++.||+|||++||+||||||+||
T Consensus       270 l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NI  349 (495)
T 1opk_A          270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNC  349 (495)
T ss_dssp             HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             HHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhE
Confidence            45689999999999999999999999999999999999864  3589999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      |++.++.+||+|||++....... .......+++.|+|||++.+..+. .++|||||||++|+|++ |..||...+....
T Consensus       350 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~  428 (495)
T 1opk_A          350 LVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQV  428 (495)
T ss_dssp             EECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             EECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCC-cHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999998754321 122334567889999999876664 89999999999999999 9999998887777


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...+... ....|..+++++.+||.+||+.||.+|||+.++++
T Consensus       429 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          429 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            7666544 34567789999999999999999999999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.9e-38  Score=294.58  Aligned_cols=197  Identities=26%  Similarity=0.373  Sum_probs=167.6

Q ss_pred             CCCCccccccceEEEEe----------------CCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH
Q 016865            2 KIVRHPNIVRLHEVLAS----------------RTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHC   63 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~----------------~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~L   63 (381)
                      +.++||||+++++++.+                ...+|+||||+++|+|.+++...  ..+++..++.++.|++.||.||
T Consensus        59 ~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l  138 (284)
T 2a19_B           59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYI  138 (284)
T ss_dssp             HHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH
Confidence            56799999999999865                45699999999999999999754  5799999999999999999999


Q ss_pred             HHCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh
Q 016865           64 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA  143 (381)
Q Consensus        64 H~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~  143 (381)
                      |++||+||||||+||+++.++.+||+|||++...... .......||+.|+|||++.+..+. .++||||+||++|+|++
T Consensus       139 H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~  216 (284)
T 2a19_B          139 HSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-GKRTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLH  216 (284)
T ss_dssp             HHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCC-SCCCCCCSCCTTSCHHHHHCSCCC-THHHHHHHHHHHHHHHS
T ss_pred             HhCCeeeccCCHHHEEEcCCCCEEECcchhheecccc-ccccccCCcccccChhhhccCCCc-chhhhHHHHHHHHHHHh
Confidence            9999999999999999999999999999998765443 233456799999999999877664 89999999999999999


Q ss_pred             CCCCCCCCChhHHHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          144 GYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       144 G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      |..||...  ......+...  ..+..+++.+.++|.+||..||.+|||+.++++|.|.-.
T Consensus       217 ~~~~~~~~--~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          217 VCDTAFET--SKFFTDLRDG--IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             CCSSHHHH--HHHHHHHHTT--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             cCCcchhH--HHHHHHhhcc--cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            99988532  2223333322  345668999999999999999999999999999987654

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-38  Score=309.37  Aligned_cols=198  Identities=23%  Similarity=0.323  Sum_probs=160.3

Q ss_pred             CCCCCccccccceEEEE-eCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLA-SRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~-~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||+++++++. .++..|+||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||
T Consensus       144 l~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI  223 (373)
T 3c1x_A          144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNC  223 (373)
T ss_dssp             STTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             HHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheE
Confidence            57889999999999874 456889999999999999999764 3588999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCc----cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCCh
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGV----ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDL  153 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~  153 (381)
                      |++.++.+||+|||++.......    .......||+.|+|||++.+..+. .++||||+||++|+|++ |.+||...+.
T Consensus       224 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~ellt~~~~p~~~~~~  302 (373)
T 3c1x_A          224 MLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNT  302 (373)
T ss_dssp             EECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCS
T ss_pred             EECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCC-cHHHHHHHHHHHHHHHhCcCCCCCCCCH
Confidence            99999999999999997653321    112334578899999999877665 89999999999999999 7899987766


Q ss_pred             hHHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          154 PTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       154 ~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ......+..+ ....|..+++.+.++|.+||..||.+|||+.+++++
T Consensus       303 ~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          303 FDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             SCHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5555555444 345567789999999999999999999999999874

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.6e-38  Score=303.43  Aligned_cols=197  Identities=20%  Similarity=0.250  Sum_probs=158.0

Q ss_pred             CCCCCccccccceEEEEeCC----EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----------
Q 016865            1 MKIVRHPNIVRLHEVLASRT----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK----------   66 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~----~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~----------   66 (381)
                      |+.++||||+++++++.+..    .+|+||||+++|+|.+++.. +.+++..++.++.|++.||.|||+.          
T Consensus        72 l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~  150 (322)
T 3soc_A           72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKP  150 (322)
T ss_dssp             STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEEC
T ss_pred             HhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCC
Confidence            57889999999999998743    58999999999999999976 5699999999999999999999999          


Q ss_pred             CCeecCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCC----CCCcccHhHHHHHHHH
Q 016865           67 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGY----DGSAADVWSCGVILFV  140 (381)
Q Consensus        67 gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~----~~~~~DIwSlGvil~~  140 (381)
                      ||+||||||+|||++.++.+||+|||++.......  ......+||+.|+|||++.+...    .+.++||||+||++|+
T Consensus       151 ~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~e  230 (322)
T 3soc_A          151 AISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWE  230 (322)
T ss_dssp             EEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             CEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHH
Confidence            99999999999999999999999999997644321  22345689999999999976322    2357899999999999


Q ss_pred             HHhCCCCCCCCCh----------------hHHHHHhhcccC--CCCCC-----CChhHHHHHHHhcCCCCCCCCCHHHHh
Q 016865          141 LMAGYLPFGETDL----------------PTLYKKINAAEF--SCPFW-----FSTGATSLIHKILDPNPKTRIRIEGIR  197 (381)
Q Consensus       141 ll~G~~Pf~~~~~----------------~~~~~~i~~~~~--~~p~~-----~s~~~~~li~~~L~~dP~~R~t~~~il  197 (381)
                      |++|+.||.+...                ......+.....  ..+..     .++++.+||.+||+.||.+|||+.+++
T Consensus       231 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell  310 (322)
T 3soc_A          231 LASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG  310 (322)
T ss_dssp             HHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHH
Confidence            9999999975432                111111111111  11111     234599999999999999999999998


Q ss_pred             c
Q 016865          198 K  198 (381)
Q Consensus       198 ~  198 (381)
                      +
T Consensus       311 ~  311 (322)
T 3soc_A          311 E  311 (322)
T ss_dssp             H
T ss_pred             H
Confidence            6

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=8.3e-38  Score=292.59  Aligned_cols=193  Identities=25%  Similarity=0.400  Sum_probs=162.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCc
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKG--VYHRDLKPEN   77 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~g--i~HrDlkp~N   77 (381)
                      |+.++||||+++++++.+..  ++||||+++|+|.+.+... ..+++..++.++.|++.||+|||++|  |+||||||+|
T Consensus        77 l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~N  154 (287)
T 4f0f_A           77 MSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPN  154 (287)
T ss_dssp             HTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGG
T ss_pred             HHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcce
Confidence            46789999999999997766  6999999999999988654 46999999999999999999999999  9999999999


Q ss_pred             EEEccCCC-----EEEeeccCccCCCCCccccccccCCCCCCCCceecCC-CCCCCcccHhHHHHHHHHHHhCCCCCCCC
Q 016865           78 LLLDSYGN-----LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR-GYDGSAADVWSCGVILFVLMAGYLPFGET  151 (381)
Q Consensus        78 iLl~~~~~-----lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DIwSlGvil~~ll~G~~Pf~~~  151 (381)
                      ||++.++.     +||+|||++.....   .....+||+.|+|||++... ...+.++||||+||++|+|++|..||...
T Consensus       155 il~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  231 (287)
T 4f0f_A          155 IFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY  231 (287)
T ss_dssp             EEESCCCTTCSCCEEECCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             EEEeccCCCCceeEEeCCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccc
Confidence            99998876     99999999975433   24567899999999998432 22357999999999999999999999876


Q ss_pred             ChhHH--HHHhhcc--cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          152 DLPTL--YKKINAA--EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       152 ~~~~~--~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      +....  ...+...  ....|..+++++.++|.+||+.||.+|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          232 SYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            54333  3333222  33566778999999999999999999999999986

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=8.1e-39  Score=303.08  Aligned_cols=194  Identities=22%  Similarity=0.354  Sum_probs=166.4

Q ss_pred             CccccccceEEEEeCC-EEEEEEecCCCCChHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHHCC
Q 016865            5 RHPNIVRLHEVLASRT-KVYIILEFVTGGELFDKIVHQGR----------------LLENDCRRYFQQLIDAVAHCHSKG   67 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~-~~~lV~E~~~gg~L~~~i~~~~~----------------l~e~~~~~~~~qll~~L~~LH~~g   67 (381)
                      +||||+++++++.+.+ .+|+||||++||+|.+++.....                +++..++.++.|++.||.|||++|
T Consensus        89 ~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~  168 (316)
T 2xir_A           89 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK  168 (316)
T ss_dssp             CCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence            7999999999998754 59999999999999999987554                889999999999999999999999


Q ss_pred             CeecCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-C
Q 016865           68 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-G  144 (381)
Q Consensus        68 i~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G  144 (381)
                      |+||||||+||+++.++.+||+|||++.......  .......||+.|+|||++.+..+. .++||||+||++|+|++ |
T Consensus       169 i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g  247 (316)
T 2xir_A          169 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLG  247 (316)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTS
T ss_pred             cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccccc-chhHHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999998654321  223455689999999999877765 89999999999999998 9


Q ss_pred             CCCCCCCChhH-HHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          145 YLPFGETDLPT-LYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       145 ~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ..||...+... ....+..+ ....|..+++++.++|.+||+.||.+|||+.++++|
T Consensus       248 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          248 ASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             CCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99998766433 33333332 355677799999999999999999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=5.1e-39  Score=307.35  Aligned_cols=196  Identities=22%  Similarity=0.348  Sum_probs=167.3

Q ss_pred             CCC-CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHC
Q 016865            2 KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--------------GRLLENDCRRYFQQLIDAVAHCHSK   66 (381)
Q Consensus         2 k~l-~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--------------~~l~e~~~~~~~~qll~~L~~LH~~   66 (381)
                      +.+ +||||+++++++.+.+.+|+||||+++|+|.+++...              ..+++..++.++.|++.||.|||++
T Consensus       104 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~  183 (333)
T 2i1m_A          104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK  183 (333)
T ss_dssp             HHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC
Confidence            345 8999999999999999999999999999999999753              3579999999999999999999999


Q ss_pred             CCeecCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-
Q 016865           67 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-  143 (381)
Q Consensus        67 gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-  143 (381)
                      ||+||||||+|||++.++.+||+|||++.......  .......||+.|+|||++.+..+. .++||||+||++|+|++ 
T Consensus       184 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~  262 (333)
T 2i1m_A          184 NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSL  262 (333)
T ss_dssp             TEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTT
T ss_pred             CcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCC-hHHHHHHHHHHHHHHHcC
Confidence            99999999999999999999999999998654321  123345678899999999877665 89999999999999998 


Q ss_pred             CCCCCCCCChhHHHHHhhcc--cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          144 GYLPFGETDLPTLYKKINAA--EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       144 G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      |..||...........+...  ....|...++.+.++|.+||+.||.+|||+.++++
T Consensus       263 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          263 GLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             SCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            99999877655444333322  33456678999999999999999999999999987

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6.4e-38  Score=296.81  Aligned_cols=197  Identities=30%  Similarity=0.568  Sum_probs=156.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE   76 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~   76 (381)
                      |+.++||||+++++++.+.+..|+||||+++|+|.+++..    ...+++..++.++.|++.||.|||++|++||||||+
T Consensus        86 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~  165 (310)
T 2wqm_A           86 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPA  165 (310)
T ss_dssp             HHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred             HHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHH
Confidence            3578999999999999999999999999999999998864    456899999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCC--hh
Q 016865           77 NLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD--LP  154 (381)
Q Consensus        77 NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~--~~  154 (381)
                      ||+++.++.+||+|||++..............||+.|+|||++.+..+. .++|||||||++|+|++|..||....  ..
T Consensus       166 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~  244 (310)
T 2wqm_A          166 NVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLY  244 (310)
T ss_dssp             GEEECTTSCEEECCC------------------CCSSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTC---CCHH
T ss_pred             HEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccchhHH
Confidence            9999999999999999988665433344566799999999999876664 89999999999999999999997643  23


Q ss_pred             HHHHHhhcccCCC--CCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          155 TLYKKINAAEFSC--PFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       155 ~~~~~i~~~~~~~--p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      .....+....+..  +..+++++.+||.+||..||.+|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          245 SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             HHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            4444444443321  2457999999999999999999999999987

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.1e-38  Score=296.41  Aligned_cols=196  Identities=22%  Similarity=0.400  Sum_probs=152.9

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||++++++. .....++||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+
T Consensus        74 l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil  152 (289)
T 3og7_A           74 LRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIF  152 (289)
T ss_dssp             HTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             HHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence            4678999999999965 56678999999999999999964 356999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCC--CccccccccCCCCCCCCceec---CCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           80 LDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEVLS---NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~--~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      ++.++.+||+|||++.....  ........+||+.|+|||++.   +..+ +.++||||+||++|+|++|..||...+..
T Consensus       153 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~  231 (289)
T 3og7_A          153 LHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNR  231 (289)
T ss_dssp             EETTTEEEECCCC------------------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCH
T ss_pred             ECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchH
Confidence            99999999999999876543  122344567999999999986   3333 47999999999999999999999876544


Q ss_pred             H-HHHHhhcccCC-----CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          155 T-LYKKINAAEFS-----CPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       155 ~-~~~~i~~~~~~-----~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      . ....+......     .+..+++.+.+||.+||+.||.+|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          232 DQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             HHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            3 33333333322     23357899999999999999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=5.1e-38  Score=298.22  Aligned_cols=197  Identities=21%  Similarity=0.303  Sum_probs=165.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++.+.+.+|+||||++||+|.+++...+ .+++..++.++.|++.||+|||++||+||||||+||+
T Consensus        83 l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl  162 (319)
T 2y4i_B           83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVF  162 (319)
T ss_dssp             GTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEE
T ss_pred             HhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEE
Confidence            467899999999999999999999999999999999997654 6899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCC-----CccccccccCCCCCCCCceecCC--------CCCCCcccHhHHHHHHHHHHhCCC
Q 016865           80 LDSYGNLKVSDFGLSALPQQ-----GVELLHTTCGTPNYVAPEVLSNR--------GYDGSAADVWSCGVILFVLMAGYL  146 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~-----~~~~~~~~~gt~~y~aPE~l~~~--------~~~~~~~DIwSlGvil~~ll~G~~  146 (381)
                      ++ ++.+||+|||++.....     .........||+.|+|||++.+.        ...+.++||||+||++|+|++|..
T Consensus       163 ~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~  241 (319)
T 2y4i_B          163 YD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW  241 (319)
T ss_dssp             EC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             Ee-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCC
Confidence            98 68999999999875432     11233455699999999998642        223579999999999999999999


Q ss_pred             CCCCCChhHHHHHhhcccCCC--CCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          147 PFGETDLPTLYKKINAAEFSC--PFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       147 Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ||...+.......+..+....  +..+++++.++|.+||..||.+|||+.++++
T Consensus       242 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          242 PFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             SSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             CCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            999888777766665543322  2347899999999999999999999999987

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.2e-38  Score=295.37  Aligned_cols=196  Identities=24%  Similarity=0.415  Sum_probs=168.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||+++++++.+ +..|+||||++||+|.+++....  .+++..+..++.|++.||+|||++||+||||||+||
T Consensus        62 l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Ni  140 (279)
T 1qpc_A           62 MKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI  140 (279)
T ss_dssp             HHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             HHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhE
Confidence            356799999999999864 56899999999999999986543  699999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      +++.++.+||+|||++....... .......+++.|+|||++.+..+. .++||||+||++|+|++ |..||...+....
T Consensus       141 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~  219 (279)
T 1qpc_A          141 LVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEV  219 (279)
T ss_dssp             EECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred             EEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCC-chhhhHHHHHHHHHHHhCCCCCCcccCHHHH
Confidence            99999999999999998654422 222345578899999999766664 89999999999999999 9999998887777


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...+..+ ....|..+++++.++|.+||..||.+|||++++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          220 IQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            6666544 34556678999999999999999999999999886

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.9e-38  Score=298.83  Aligned_cols=197  Identities=22%  Similarity=0.364  Sum_probs=164.5

Q ss_pred             CCCCCccccccceEEEEeC--CEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            1 MKIVRHPNIVRLHEVLASR--TKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~--~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      |+.++||||+++++++.+.  +.+|+||||++||+|.+++.. .+.+++..++.++.|++.||+|||++||+||||||+|
T Consensus        77 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~N  156 (302)
T 4e5w_A           77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARN  156 (302)
T ss_dssp             HHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             HHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchhe
Confidence            3578999999999999877  679999999999999999954 4579999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccCccCCCCCc---cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCC--
Q 016865           78 LLLDSYGNLKVSDFGLSALPQQGV---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD--  152 (381)
Q Consensus        78 iLl~~~~~lkl~DFGls~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~--  152 (381)
                      |+++.++.+||+|||++.......   .......||+.|+|||++.+..+. .++||||+||++|+|++|..|+....  
T Consensus       157 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~  235 (302)
T 4e5w_A          157 VLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMAL  235 (302)
T ss_dssp             EEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHH
T ss_pred             EEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhH
Confidence            999999999999999998655432   223456688899999999877665 89999999999999999999874321  


Q ss_pred             -------------hhHHHHHhh-cccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          153 -------------LPTLYKKIN-AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       153 -------------~~~~~~~i~-~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                                   .......+. ......|..+++++.+||.+||+.||.+|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          236 FLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence                         111122222 2244567779999999999999999999999999886

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.8e-38  Score=315.90  Aligned_cols=196  Identities=24%  Similarity=0.373  Sum_probs=165.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||+++++++.+ +.+|+||||+++|+|.+++..  ...+++..+..++.|++.||+|||++||+||||||+||
T Consensus       233 l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Ni  311 (452)
T 1fmk_A          233 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI  311 (452)
T ss_dssp             HHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             HHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhE
Confidence            457899999999999876 678999999999999999964  34699999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      |++.++.+||+|||++....... .......+++.|+|||++.+..+. .++||||+||++|+|++ |..||.+.+..+.
T Consensus       312 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~  390 (452)
T 1fmk_A          312 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREV  390 (452)
T ss_dssp             EECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred             EECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCC-ccccHHhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999998654321 122344577889999999877665 89999999999999999 9999998887777


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...+..+ ....|..+++.+.+||.+||+.||.+|||++++++
T Consensus       391 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          391 LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            7666544 45667789999999999999999999999999886

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=322.87  Aligned_cols=196  Identities=23%  Similarity=0.348  Sum_probs=167.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++|||||++++++.+ +.+|+||||++||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||
T Consensus       390 l~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIL  468 (613)
T 2ozo_A          390 MHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVL  468 (613)
T ss_dssp             HTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             HHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEE
Confidence            568899999999999976 5699999999999999999754 45999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCcc---ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPT  155 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~  155 (381)
                      ++.++.+||+|||++........   ......+|+.|+|||++.+..+. .++||||+||++|+|++ |..||...+..+
T Consensus       469 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~  547 (613)
T 2ozo_A          469 LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPE  547 (613)
T ss_dssp             EEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCSHH
T ss_pred             EcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Confidence            99999999999999987643221   12233467899999999877765 89999999999999998 999999888877


Q ss_pred             HHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          156 LYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       156 ~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ....+..+ ....|..+++++.+||.+||+.||.+|||+.++++
T Consensus       548 ~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          548 VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            77777655 35677789999999999999999999999999854

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.7e-38  Score=327.35  Aligned_cols=196  Identities=20%  Similarity=0.315  Sum_probs=169.1

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++|||||++++++.+ +.+|+||||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus       424 l~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl  502 (635)
T 4fl3_A          424 MQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL  502 (635)
T ss_dssp             HHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             HHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEE
Confidence            356899999999999975 4589999999999999999988889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCc---cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGV---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      +.++.+||+|||++.......   .......||+.|+|||++.+..+. .++||||+||++|+|++ |..||.+.+....
T Consensus       503 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~  581 (635)
T 4fl3_A          503 VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV  581 (635)
T ss_dssp             EETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred             eCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999997654322   122334567889999999877775 89999999999999998 9999999888777


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...+..+ ....|..+++++.+||.+||+.||.+|||++++++
T Consensus       582 ~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          582 TAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            7776655 35677789999999999999999999999999875

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.1e-38  Score=300.19  Aligned_cols=200  Identities=22%  Similarity=0.269  Sum_probs=162.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG----RLLENDCRRYFQQLIDAVAHCHSK---GVYHRDL   73 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~----~l~e~~~~~~~~qll~~L~~LH~~---gi~HrDl   73 (381)
                      |+.++||||+++++++.+.+..|+||||++||+|.+++....    .+++..+..++.|++.||+|||++   ||+||||
T Consensus        81 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dl  160 (326)
T 3uim_A           81 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDV  160 (326)
T ss_dssp             GGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCC
T ss_pred             HHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCC
Confidence            467899999999999999999999999999999999997643    389999999999999999999999   9999999


Q ss_pred             CCCcEEEccCCCEEEeeccCccCCCCC-ccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCC-
Q 016865           74 KPENLLLDSYGNLKVSDFGLSALPQQG-VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET-  151 (381)
Q Consensus        74 kp~NiLl~~~~~lkl~DFGls~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~-  151 (381)
                      ||+|||++.++.+||+|||++...... .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||... 
T Consensus       161 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~  239 (326)
T 3uim_A          161 KAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLAR  239 (326)
T ss_dssp             SGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHH
T ss_pred             chhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccc
Confidence            999999999999999999999865432 223445569999999999977666 48999999999999999999999521 


Q ss_pred             ----ChhHHHHHhh----cccC----------CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 016865          152 ----DLPTLYKKIN----AAEF----------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPW  201 (381)
Q Consensus       152 ----~~~~~~~~i~----~~~~----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~  201 (381)
                          ........+.    ....          ..+...++.+.+++.+||+.||.+|||+.++++|-+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          240 LANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             HTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             cccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence                1111111111    0000          111113467999999999999999999999998754

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.5e-38  Score=296.21  Aligned_cols=195  Identities=25%  Similarity=0.403  Sum_probs=167.3

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      +.++||||+++++++.+.. .++||||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||++
T Consensus        76 ~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili  154 (291)
T 1u46_A           76 HSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL  154 (291)
T ss_dssp             HHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred             HhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE
Confidence            4679999999999998765 89999999999999999764 569999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCcc---ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      +.++.+||+|||++........   ......||+.|+|||++.+..++ .++||||+||++|+|++ |..||...+....
T Consensus       155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~  233 (291)
T 1u46_A          155 ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQI  233 (291)
T ss_dssp             EETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred             cCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcccCCHHHH
Confidence            9999999999999876544221   22345678899999999876664 89999999999999999 9999998888777


Q ss_pred             HHHhhccc--CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINAAE--FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...+....  ...+..+++++.++|.+||..||.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          234 LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            77665443  3455678999999999999999999999999987

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-38  Score=298.37  Aligned_cols=196  Identities=24%  Similarity=0.382  Sum_probs=157.7

Q ss_pred             CCCccccccceEEEEeC----CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCee
Q 016865            3 IVRHPNIVRLHEVLASR----TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK--------GVYH   70 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~~----~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~--------gi~H   70 (381)
                      .++||||+++++++.+.    ..+|+||||++||+|.+++.. ..+++..++.++.|++.||.|||++        ||+|
T Consensus        87 ~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH  165 (337)
T 3mdy_A           87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAH  165 (337)
T ss_dssp             TCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEEC
T ss_pred             hhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEe
Confidence            46999999999999887    789999999999999999966 5799999999999999999999999        9999


Q ss_pred             cCCCCCcEEEccCCCEEEeeccCccCCCCCcc----ccccccCCCCCCCCceecCCCCCCC-----cccHhHHHHHHHHH
Q 016865           71 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVE----LLHTTCGTPNYVAPEVLSNRGYDGS-----AADVWSCGVILFVL  141 (381)
Q Consensus        71 rDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~-----~~DIwSlGvil~~l  141 (381)
                      |||||+|||++.++.+||+|||++........    ...+.+||+.|+|||++.+..+...     ++||||+||++|+|
T Consensus       166 ~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el  245 (337)
T 3mdy_A          166 RDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV  245 (337)
T ss_dssp             SCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHH
T ss_pred             cccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHH
Confidence            99999999999999999999999975543211    1235689999999999987665422     38999999999999


Q ss_pred             HhC----------CCCCCCCCh-----hHHHHHhhcc--cCCCCC-----CCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          142 MAG----------YLPFGETDL-----PTLYKKINAA--EFSCPF-----WFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       142 l~G----------~~Pf~~~~~-----~~~~~~i~~~--~~~~p~-----~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ++|          ..||.....     ......+...  ....|.     .+++++.+||.+||+.||.+|||+.++++|
T Consensus       246 ~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          246 ARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             HTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            999          777754321     1222222111  222332     245679999999999999999999999875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.4e-37  Score=291.94  Aligned_cols=195  Identities=19%  Similarity=0.234  Sum_probs=161.1

Q ss_pred             CCCCccccccceEEE-EeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            2 KIVRHPNIVRLHEVL-ASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         2 k~l~HpnIv~l~~~~-~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      +.++|+|++..+..+ .+.+..|+||||+ +|+|.+++.. .+.+++..++.++.|++.||+|||++||+||||||+|||
T Consensus        59 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl  137 (296)
T 3uzp_A           59 KMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFL  137 (296)
T ss_dssp             HHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred             HHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeE
Confidence            456787776666655 6778899999999 8999999974 457999999999999999999999999999999999999


Q ss_pred             E---ccCCCEEEeeccCccCCCCCcc-------ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCC
Q 016865           80 L---DSYGNLKVSDFGLSALPQQGVE-------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFG  149 (381)
Q Consensus        80 l---~~~~~lkl~DFGls~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~  149 (381)
                      +   +.++.+||+|||++........       .....+||+.|+|||++.+..+. .++||||+||++|+|++|+.||.
T Consensus       138 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~  216 (296)
T 3uzp_A          138 MGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQ  216 (296)
T ss_dssp             ECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTS
T ss_pred             EecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCC-cchhhHHHHHHHHHHHhCCCCCC
Confidence            9   4889999999999976544211       23466899999999999877764 89999999999999999999997


Q ss_pred             CCC---hhHHHHHhhcccCCCC-----CCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          150 ETD---LPTLYKKINAAEFSCP-----FWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       150 ~~~---~~~~~~~i~~~~~~~p-----~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ..+   ....+..+.......|     ..+|+++.++|.+||+.||.+|||++++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          217 GLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             SCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             CcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            643   2234444433333333     568999999999999999999999999876

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=9.6e-38  Score=294.62  Aligned_cols=182  Identities=32%  Similarity=0.618  Sum_probs=151.3

Q ss_pred             CCCCccccccceEEEEe----CCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 016865            2 KIVRHPNIVRLHEVLAS----RTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKP   75 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~----~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp   75 (381)
                      +.++||||+++++++.+    ...+|+||||++||+|.+++...+  .+++..++.++.|++.||+|||++||+||||||
T Consensus        66 ~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp  145 (299)
T 3m2w_A           66 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP  145 (299)
T ss_dssp             HHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred             HhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH
Confidence            34689999999999987    778999999999999999998754  699999999999999999999999999999999


Q ss_pred             CcEEEcc---CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCC
Q 016865           76 ENLLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD  152 (381)
Q Consensus        76 ~NiLl~~---~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~  152 (381)
                      +||+++.   ++.+||+|||++.....                      ..+ +.++||||+||++|+|++|..||...+
T Consensus       146 ~Nil~~~~~~~~~~kl~Dfg~a~~~~~----------------------~~~-~~~~DiwslG~il~el~tg~~pf~~~~  202 (299)
T 3m2w_A          146 ENLLYTSKRPNAILKLTDFGFAKETTG----------------------EKY-DKSCDMWSLGVIMYILLCGYPPFYSNH  202 (299)
T ss_dssp             GGEEESSSSTTCCEEECCCTTCEECTT----------------------CGG-GGHHHHHHHHHHHHHHHHSSCSCCC--
T ss_pred             HHEEEecCCCCCcEEEecccccccccc----------------------ccC-CchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence            9999998   78899999998854321                      223 478999999999999999999997655


Q ss_pred             hhHHHH----HhhcccCCCC----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          153 LPTLYK----KINAAEFSCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       153 ~~~~~~----~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      ......    .+.......|    ..+++++.+||.+||+.||.+|||++++++||||+...
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          203 GLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             -----CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             chhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence            433221    2222333333    45899999999999999999999999999999998654

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=8.2e-38  Score=296.75  Aligned_cols=199  Identities=25%  Similarity=0.384  Sum_probs=161.1

Q ss_pred             CCCCCccccccceEEEE----eCCEEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q 016865            1 MKIVRHPNIVRLHEVLA----SRTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD   72 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~----~~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrD   72 (381)
                      |+.++||||+++++++.    .....|+||||+++|+|.+++..    ...+++..++.++.|++.||.|||++||+|||
T Consensus        80 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~d  159 (317)
T 2buj_A           80 HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRD  159 (317)
T ss_dssp             HHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             HhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence            35789999999999997    34589999999999999999876    46799999999999999999999999999999


Q ss_pred             CCCCcEEEccCCCEEEeeccCccCCCCCcc---------ccccccCCCCCCCCceecCCCC--CCCcccHhHHHHHHHHH
Q 016865           73 LKPENLLLDSYGNLKVSDFGLSALPQQGVE---------LLHTTCGTPNYVAPEVLSNRGY--DGSAADVWSCGVILFVL  141 (381)
Q Consensus        73 lkp~NiLl~~~~~lkl~DFGls~~~~~~~~---------~~~~~~gt~~y~aPE~l~~~~~--~~~~~DIwSlGvil~~l  141 (381)
                      |||+||+++.++.+||+|||++........         ......||+.|+|||++.+...  .+.++||||+||++|+|
T Consensus       160 lkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el  239 (317)
T 2buj_A          160 LKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAM  239 (317)
T ss_dssp             CCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHH
T ss_pred             CCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHH
Confidence            999999999999999999999875432110         1134568999999999875442  25899999999999999


Q ss_pred             HhCCCCCCCCCh--hHHHHHhh-cccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          142 MAGYLPFGETDL--PTLYKKIN-AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       142 l~G~~Pf~~~~~--~~~~~~i~-~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ++|..||.....  ......+. ......+..+++++.++|.+||+.||.+|||+++++++
T Consensus       240 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          240 MFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             HHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhCCCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            999999953211  11111121 22233445689999999999999999999999999985

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.7e-37  Score=291.12  Aligned_cols=195  Identities=19%  Similarity=0.237  Sum_probs=161.3

Q ss_pred             CCCCccccccceEEE-EeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            2 KIVRHPNIVRLHEVL-ASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         2 k~l~HpnIv~l~~~~-~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      +.++|+|++..+..+ .+.+..|+||||+ +|+|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+|||
T Consensus        59 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl  137 (296)
T 4hgt_A           59 KMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFL  137 (296)
T ss_dssp             HHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             HHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHee
Confidence            346777777766655 6778999999999 9999999975 457999999999999999999999999999999999999


Q ss_pred             E---ccCCCEEEeeccCccCCCCCc-------cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCC
Q 016865           80 L---DSYGNLKVSDFGLSALPQQGV-------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFG  149 (381)
Q Consensus        80 l---~~~~~lkl~DFGls~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~  149 (381)
                      +   +.++.+||+|||++.......       ......+||+.|+|||++.+..+. .++||||+||++|+|++|..||.
T Consensus       138 ~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~  216 (296)
T 4hgt_A          138 MGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQ  216 (296)
T ss_dssp             ECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTS
T ss_pred             eeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCC-chhHHHHHHHHHHHHhcCCCCCc
Confidence            9   788999999999998654321       123456799999999999887764 89999999999999999999997


Q ss_pred             CCCh---hHHHHHhhcccCCCC-----CCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          150 ETDL---PTLYKKINAAEFSCP-----FWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       150 ~~~~---~~~~~~i~~~~~~~p-----~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ..+.   ...+..+.......|     ..+|+++.+||.+||+.||.+|||++++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          217 GLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             SCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             ccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            6433   233333333333333     557999999999999999999999999886

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.8e-37  Score=291.83  Aligned_cols=195  Identities=26%  Similarity=0.402  Sum_probs=155.9

Q ss_pred             CCCccccccceEEEEe----CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCCee
Q 016865            3 IVRHPNIVRLHEVLAS----RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH--------SKGVYH   70 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~----~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH--------~~gi~H   70 (381)
                      +++||||+++++++.+    ...+|+||||+++|+|.+++.. ..+++..+..++.|++.||+|||        +.||+|
T Consensus        58 ~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH  136 (301)
T 3q4u_A           58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAH  136 (301)
T ss_dssp             CCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEEC
T ss_pred             hccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeec
Confidence            4799999999999754    3569999999999999999854 67999999999999999999999        999999


Q ss_pred             cCCCCCcEEEccCCCEEEeeccCccCCCCCcc----ccccccCCCCCCCCceecCCCCC-----CCcccHhHHHHHHHHH
Q 016865           71 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVE----LLHTTCGTPNYVAPEVLSNRGYD-----GSAADVWSCGVILFVL  141 (381)
Q Consensus        71 rDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~-----~~~~DIwSlGvil~~l  141 (381)
                      |||||+|||++.++.+||+|||++........    .....+||+.|+|||++.+....     +.++||||+||++|+|
T Consensus       137 ~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el  216 (301)
T 3q4u_A          137 RDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV  216 (301)
T ss_dssp             SCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHH
Confidence            99999999999999999999999875433211    12345899999999999765332     2589999999999999


Q ss_pred             HhC----------CCCCCCCCh----hHHHHH-hhcc--cCCCCCC-----CChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          142 MAG----------YLPFGETDL----PTLYKK-INAA--EFSCPFW-----FSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       142 l~G----------~~Pf~~~~~----~~~~~~-i~~~--~~~~p~~-----~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ++|          ..||.....    ...... ....  ....|..     .++++.+||.+||+.||.+|||+.++++
T Consensus       217 ~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          217 ARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             HTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             HhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            999          888854321    122222 2111  1222221     3567999999999999999999999986

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.6e-38  Score=299.79  Aligned_cols=198  Identities=23%  Similarity=0.363  Sum_probs=165.5

Q ss_pred             CCCCCccccccceEEEE--eCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            1 MKIVRHPNIVRLHEVLA--SRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~--~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      |+.++||||+++++++.  +...+|+||||++||+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|
T Consensus        78 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~N  157 (327)
T 3lxl_A           78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARN  157 (327)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             HHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhh
Confidence            35789999999999987  55789999999999999999976 4569999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccCccCCCCCcc---ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           78 LLLDSYGNLKVSDFGLSALPQQGVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        78 iLl~~~~~lkl~DFGls~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      ||++.++.+||+|||++........   ......||+.|+|||++.+..+ +.++||||+||++|+|++|..||......
T Consensus       158 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~  236 (327)
T 3lxl_A          158 ILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAE  236 (327)
T ss_dssp             EEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHH
T ss_pred             EEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccch
Confidence            9999999999999999986543221   2234568888999999987666 48999999999999999999999643321


Q ss_pred             ---------------HHHHHhh-cccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          155 ---------------TLYKKIN-AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       155 ---------------~~~~~i~-~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                                     .....+. ......|..+++++.+||.+||+.||.+|||+++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          237 FLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                           1122222 22345667789999999999999999999999999764

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-37  Score=300.21  Aligned_cols=195  Identities=14%  Similarity=0.171  Sum_probs=160.5

Q ss_pred             CCCCcccccc---------------ceEEEEe-CCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH
Q 016865            2 KIVRHPNIVR---------------LHEVLAS-RTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHC   63 (381)
Q Consensus         2 k~l~HpnIv~---------------l~~~~~~-~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~L   63 (381)
                      +.++||||++               +++++.. ....|+||||+ ||+|.+++...  +.+++..++.++.||+.||+||
T Consensus        97 ~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~L  175 (352)
T 2jii_A           97 QRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFL  175 (352)
T ss_dssp             HHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            4567888887               6778876 78999999999 99999999875  7799999999999999999999


Q ss_pred             HHCCCeecCCCCCcEEEccCC--CEEEeeccCccCCCCCc-------cccccccCCCCCCCCceecCCCCCCCcccHhHH
Q 016865           64 HSKGVYHRDLKPENLLLDSYG--NLKVSDFGLSALPQQGV-------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC  134 (381)
Q Consensus        64 H~~gi~HrDlkp~NiLl~~~~--~lkl~DFGls~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSl  134 (381)
                      |++||+||||||+|||++.++  .+||+|||++.......       ......+||+.|+|||++.+..+. .++|||||
T Consensus       176 H~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~sl  254 (352)
T 2jii_A          176 HENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPS-RRSDLQSL  254 (352)
T ss_dssp             HHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCC-HHHHHHHH
T ss_pred             HhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCC-chhhHHHH
Confidence            999999999999999999998  89999999997654321       122445899999999999876664 89999999


Q ss_pred             HHHHHHHHhCCCCCCCCC--hhHHHHHh---hcccCCCC------CCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          135 GVILFVLMAGYLPFGETD--LPTLYKKI---NAAEFSCP------FWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       135 Gvil~~ll~G~~Pf~~~~--~~~~~~~i---~~~~~~~p------~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ||++|+|++|..||....  ........   .......+      ..+++++.+||.+||..||.+|||++++++
T Consensus       255 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          255 GYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             HHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            999999999999997653  22222222   11111111      136899999999999999999999999886

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=295.36  Aligned_cols=191  Identities=31%  Similarity=0.478  Sum_probs=154.9

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCC
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG---RLLENDCRRYFQQLIDAVAHCHS---KGVYHRDLKP   75 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~~L~~LH~---~gi~HrDlkp   75 (381)
                      +.++||||+++++++.+  ..|+||||++||+|.+++....   .+++..+..++.|++.||.|||+   +||+||||||
T Consensus        56 ~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp  133 (307)
T 2eva_A           56 SRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKP  133 (307)
T ss_dssp             HHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSG
T ss_pred             hcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCCh
Confidence            56799999999998874  4799999999999999998655   37889999999999999999999   8999999999


Q ss_pred             CcEEEccCCC-EEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           76 ENLLLDSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        76 ~NiLl~~~~~-lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      +|||++.++. +||+|||++......   .....||+.|+|||++.+..+. .++||||+||++|+|++|+.||......
T Consensus       134 ~NIll~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~  209 (307)
T 2eva_A          134 PNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGP  209 (307)
T ss_dssp             GGEEEETTTTEEEECCCCC---------------CCTTSSCHHHHTCCCCC-THHHHHHHHHHHHHHHHTCCTTTTTCSS
T ss_pred             hHEEEeCCCCEEEEcccccccccccc---cccCCCCCceEChhhhCCCCCC-cHHHHHHHHHHHHHHHHCCCCchhhCcc
Confidence            9999998887 799999998754432   2345799999999999876664 8999999999999999999999865432


Q ss_pred             --HHHHHh-hcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          155 --TLYKKI-NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       155 --~~~~~i-~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                        .....+ .......+..+++.+.++|.+||+.||.+|||++++++
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          210 AFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             HHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence              222222 22334455668999999999999999999999999987

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=8.1e-38  Score=295.46  Aligned_cols=196  Identities=23%  Similarity=0.347  Sum_probs=161.0

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH---QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~---~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      +.++||||+++++++.+.+..|+||||++||+|.+++..   ...+++..+..++.|++.||.|||++||+||||||+||
T Consensus        85 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Ni  164 (307)
T 2nru_A           85 AKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANI  164 (307)
T ss_dssp             HHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             HhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHE
Confidence            567999999999999999999999999999999999874   34589999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL  156 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~  156 (381)
                      +++.++.+||+|||++.......  ......+||+.|+|||++.+ .+ +.++||||+||++|+|++|.+||...+....
T Consensus       165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~  242 (307)
T 2nru_A          165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EI-TPKSDIYSFGVVLLEIITGLPAVDEHREPQL  242 (307)
T ss_dssp             EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EE-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred             EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CC-CccchhHHHHHHHHHHHHCCCCcccCcchHH
Confidence            99999999999999987654321  12345579999999999865 34 5899999999999999999999976543321


Q ss_pred             ----HHHhhcccC-----------CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          157 ----YKKINAAEF-----------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       157 ----~~~i~~~~~-----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                          ...+.....           ..+...++.+.+++.+||+.||.+|||+.+++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          243 LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             TTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                111111111           1122245678999999999999999999999863

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=302.37  Aligned_cols=192  Identities=13%  Similarity=0.194  Sum_probs=157.8

Q ss_pred             CCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            3 IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-----~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      ...|+||+++++++...+..|+||||++||+|.+++..     .+.+++..++.++.||+.||+|||++||+||||||+|
T Consensus       123 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~N  202 (365)
T 3e7e_A          123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDN  202 (365)
T ss_dssp             GGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGG
T ss_pred             hhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHH
Confidence            34599999999999999999999999999999999974     4569999999999999999999999999999999999


Q ss_pred             EEEcc-----------CCCEEEeeccCccCCCC--CccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhC
Q 016865           78 LLLDS-----------YGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG  144 (381)
Q Consensus        78 iLl~~-----------~~~lkl~DFGls~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G  144 (381)
                      ||++.           ++.+||+|||+|.....  ........+||+.|+|||++.+..|+ .++||||+||++|+|++|
T Consensus       203 Ill~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg  281 (365)
T 3e7e_A          203 FILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFG  281 (365)
T ss_dssp             EEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBS-THHHHHHHHHHHHHHHHS
T ss_pred             EEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCC-ccccHHHHHHHHHHHHhC
Confidence            99998           89999999999964331  22345677899999999999887765 999999999999999999


Q ss_pred             CCCCCCCChhHHHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          145 YLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       145 ~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      +.||...+...    ..........+.++...+++.+||+.+|.+|++..+.+.+
T Consensus       282 ~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          282 TYMKVKNEGGE----CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             SCCCEEEETTE----EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             CCccccCCCCc----eeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence            99995432211    0000111112457789999999999999999765544443

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.1e-37  Score=296.85  Aligned_cols=196  Identities=22%  Similarity=0.326  Sum_probs=163.6

Q ss_pred             CCCCCccccccceEEEEe--CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLAS--RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||+++++++.+  ...+|+||||+++|+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||
T Consensus        87 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Ni  165 (318)
T 3lxp_A           87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNV  165 (318)
T ss_dssp             HHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             HHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheE
Confidence            356899999999999988  4689999999999999998876 4599999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCc---cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh-
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGV---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-  154 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-  154 (381)
                      +++.++.+||+|||++.......   .......||+.|+|||++.+..+. .++||||+||++|+|++|..||...... 
T Consensus       166 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~  244 (318)
T 3lxp_A          166 LLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKF  244 (318)
T ss_dssp             EECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHH
T ss_pred             EEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhh
Confidence            99999999999999998665432   123455688899999999876665 8999999999999999999999754321 


Q ss_pred             --------------HHHHHhh-cccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          155 --------------TLYKKIN-AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       155 --------------~~~~~i~-~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                                    .....+. ......|..+++++.+||.+||+.||.+|||++++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          245 LELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                          1111122 2234566778999999999999999999999999985

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.4e-37  Score=317.18  Aligned_cols=196  Identities=24%  Similarity=0.373  Sum_probs=170.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |+.++||||+++++++.+ ..+||||||+++|+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus       316 l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NI  394 (535)
T 2h8h_A          316 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI  394 (535)
T ss_dssp             HHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             HHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhE
Confidence            457899999999999876 679999999999999999964  34689999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      |++.++.+||+|||++....... .......++..|+|||++....+. .++|||||||+||+|++ |..||.+.+..+.
T Consensus       395 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~  473 (535)
T 2h8h_A          395 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREV  473 (535)
T ss_dssp             EECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH
T ss_pred             EEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999998764321 112334567889999999876665 89999999999999999 9999998887777


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...+..+ ....|..+++.+.+||.+||+.||.+|||++++++
T Consensus       474 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          474 LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            7666554 34567789999999999999999999999999886

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4e-37  Score=320.76  Aligned_cols=196  Identities=29%  Similarity=0.405  Sum_probs=167.6

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+.++||||+++++++. .+..|+||||++||+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||
T Consensus       445 l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NIL  523 (656)
T 2j0j_A          445 MRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVL  523 (656)
T ss_dssp             HHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             HHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEE
Confidence            35679999999999985 466899999999999999997654 6899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  157 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~  157 (381)
                      ++.++.+||+|||++....... .......||+.|+|||++.+..+. .++||||+||++|+|++ |..||.+.+.....
T Consensus       524 l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~  602 (656)
T 2j0j_A          524 VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVI  602 (656)
T ss_dssp             EEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred             EeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCC-chhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence            9999999999999998764421 122344577899999999877664 89999999999999997 99999988877777


Q ss_pred             HHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          158 KKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       158 ~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ..+..+ ....|..+++.+.+||.+||..||.+|||+.++++
T Consensus       603 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          603 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            766554 35677889999999999999999999999999886

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.8e-37  Score=293.82  Aligned_cols=203  Identities=21%  Similarity=0.289  Sum_probs=154.4

Q ss_pred             CCCCccccccceEEEEe-----CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------C
Q 016865            2 KIVRHPNIVRLHEVLAS-----RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK---------G   67 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~-----~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~---------g   67 (381)
                      +.++||||+++++.+..     ...+|+||||++||+|.+++.. ...++..+..++.|++.||.|||+.         |
T Consensus        62 ~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~  140 (336)
T 3g2f_A           62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA  140 (336)
T ss_dssp             TTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC
T ss_pred             HhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhh-cccchhHHHHHHHHHHHHHHHHHhhhccccccccc
Confidence            46899999999986643     2368999999999999999976 4568999999999999999999999         9


Q ss_pred             CeecCCCCCcEEEccCCCEEEeeccCccCCCCC--------ccccccccCCCCCCCCceecCCC------CCCCcccHhH
Q 016865           68 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--------VELLHTTCGTPNYVAPEVLSNRG------YDGSAADVWS  133 (381)
Q Consensus        68 i~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~--------~~~~~~~~gt~~y~aPE~l~~~~------~~~~~~DIwS  133 (381)
                      |+||||||+|||++.++.+||+|||++......        .......+||+.|+|||++.+..      ..+.++||||
T Consensus       141 ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diws  220 (336)
T 3g2f_A          141 ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYA  220 (336)
T ss_dssp             EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHH
T ss_pred             eeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHH
Confidence            999999999999999999999999999755321        12233567999999999997631      2236899999


Q ss_pred             HHHHHHHHHhCCCCCCCC-Chh-----------------HHHHHhh--cccCCCCCC------CChhHHHHHHHhcCCCC
Q 016865          134 CGVILFVLMAGYLPFGET-DLP-----------------TLYKKIN--AAEFSCPFW------FSTGATSLIHKILDPNP  187 (381)
Q Consensus       134 lGvil~~ll~G~~Pf~~~-~~~-----------------~~~~~i~--~~~~~~p~~------~s~~~~~li~~~L~~dP  187 (381)
                      +||++|+|++|..||... ...                 .....+.  .....+|..      +++++.+||.+||+.||
T Consensus       221 lG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP  300 (336)
T 3g2f_A          221 LGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDA  300 (336)
T ss_dssp             HHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSG
T ss_pred             HHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCCh
Confidence            999999999997666322 110                 1111111  112223332      34579999999999999


Q ss_pred             CCCCCHHHHh------cCcccccC
Q 016865          188 KTRIRIEGIR------KHPWFRKN  205 (381)
Q Consensus       188 ~~R~t~~~il------~hp~~~~~  205 (381)
                      .+|||+.+++      .++|-++.
T Consensus       301 ~~Rps~~e~l~~L~~ll~~~~~~~  324 (336)
T 3g2f_A          301 EARLTAQXAEERMAELMMIWERNK  324 (336)
T ss_dssp             GGSCCHHHHHHHHHHHHHCCCC--
T ss_pred             hhCcchHHHHHHHHHHHHHHHhcc
Confidence            9999999994      46666554

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.4e-38  Score=307.46  Aligned_cols=198  Identities=24%  Similarity=0.424  Sum_probs=158.8

Q ss_pred             CCCCCccccccceEEEEeCC--EEEEEEecCCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRT--KVYIILEFVTGGELFDKIVHQG---RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKP   75 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~--~~~lV~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp   75 (381)
                      |+.++||||+++++++.+.+  ..|+||||++||+|.+++....   .+++..++.++.|++.||+|||++||+||||||
T Consensus        61 l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  140 (396)
T 4eut_A           61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKP  140 (396)
T ss_dssp             HHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             HHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCH
Confidence            35689999999999998765  7899999999999999987643   399999999999999999999999999999999


Q ss_pred             CcEEE----ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCC-------CCCCCcccHhHHHHHHHHHHhC
Q 016865           76 ENLLL----DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR-------GYDGSAADVWSCGVILFVLMAG  144 (381)
Q Consensus        76 ~NiLl----~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~~~~~~DIwSlGvil~~ll~G  144 (381)
                      +|||+    +.++.+||+|||++...... ......+||+.|+|||++.+.       ...+.++||||+||++|+|++|
T Consensus       141 ~NIll~~~~~~~~~~kL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg  219 (396)
T 4eut_A          141 GNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG  219 (396)
T ss_dssp             GGEEEEECTTSCEEEEECCGGGCEECCCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred             HHEEEeecCCCceeEEEecCCCceEccCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHC
Confidence            99999    77778999999999866543 334567899999999998641       1224789999999999999999


Q ss_pred             CCCCCCCC----hhHHHHHhhcccC-------------------CCC------CCCChhHHHHHHHhcCCCCCCCCCHHH
Q 016865          145 YLPFGETD----LPTLYKKINAAEF-------------------SCP------FWFSTGATSLIHKILDPNPKTRIRIEG  195 (381)
Q Consensus       145 ~~Pf~~~~----~~~~~~~i~~~~~-------------------~~p------~~~s~~~~~li~~~L~~dP~~R~t~~~  195 (381)
                      ..||...+    ......++..+..                   ..|      ..+++.+.++|.+||+.||.+|||+++
T Consensus       220 ~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e  299 (396)
T 4eut_A          220 SLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ  299 (396)
T ss_dssp             SCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHH
T ss_pred             CCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHH
Confidence            99996422    2233333322211                   011      113567889999999999999999999


Q ss_pred             HhcC
Q 016865          196 IRKH  199 (381)
Q Consensus       196 il~h  199 (381)
                      ++++
T Consensus       300 ~l~~  303 (396)
T 4eut_A          300 FFAE  303 (396)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            8553

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=6e-37  Score=292.30  Aligned_cols=193  Identities=29%  Similarity=0.430  Sum_probs=140.0

Q ss_pred             CccccccceEEEE--------eCCEEEEEEecCCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--Ceec
Q 016865            5 RHPNIVRLHEVLA--------SRTKVYIILEFVTGGELFDKIVH---QGRLLENDCRRYFQQLIDAVAHCHSKG--VYHR   71 (381)
Q Consensus         5 ~HpnIv~l~~~~~--------~~~~~~lV~E~~~gg~L~~~i~~---~~~l~e~~~~~~~~qll~~L~~LH~~g--i~Hr   71 (381)
                      +||||+++++++.        ....+|+||||+. |+|.+++..   .+.+++..++.++.||+.||.|||++|  |+||
T Consensus        84 ~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~  162 (337)
T 3ll6_A           84 GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHR  162 (337)
T ss_dssp             TSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCC
T ss_pred             cCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEc
Confidence            4999999999994        3456999999996 699888865   456999999999999999999999999  9999


Q ss_pred             CCCCCcEEEccCCCEEEeeccCccCCCCCcc------------ccccccCCCCCCCCceec---CCCCCCCcccHhHHHH
Q 016865           72 DLKPENLLLDSYGNLKVSDFGLSALPQQGVE------------LLHTTCGTPNYVAPEVLS---NRGYDGSAADVWSCGV  136 (381)
Q Consensus        72 Dlkp~NiLl~~~~~lkl~DFGls~~~~~~~~------------~~~~~~gt~~y~aPE~l~---~~~~~~~~~DIwSlGv  136 (381)
                      ||||+|||++.++.+||+|||++........            .....+||+.|+|||++.   +..+ +.++|||||||
T Consensus       163 Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~  241 (337)
T 3ll6_A          163 DLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGC  241 (337)
T ss_dssp             CCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHH
T ss_pred             cCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHH
Confidence            9999999999999999999999986543211            112567999999999983   3334 48999999999


Q ss_pred             HHHHHHhCCCCCCCCChhHHHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 016865          137 ILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPW  201 (381)
Q Consensus       137 il~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~  201 (381)
                      ++|+|++|..||...........  ......+...++.+.+||.+||+.||.+|||+.++++|-+
T Consensus       242 il~el~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          242 ILYLLCFRQHPFEDGAKLRIVNG--KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             HHHHHHHSSCCC--------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHhCCCCCcchhHHHhhcC--cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            99999999999976544332221  1122334457889999999999999999999999998743

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3e-37  Score=319.09  Aligned_cols=202  Identities=27%  Similarity=0.405  Sum_probs=163.2

Q ss_pred             CCCCCccccccceEEEEe------CCEEEEEEecCCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 016865            1 MKIVRHPNIVRLHEVLAS------RTKVYIILEFVTGGELFDKIVHQG---RLLENDCRRYFQQLIDAVAHCHSKGVYHR   71 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~------~~~~~lV~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~~L~~LH~~gi~Hr   71 (381)
                      |+.++||||+++++++..      .+..|+||||++||+|.+++....   .+++..++.++.|++.||+|||++||+||
T Consensus        66 L~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHr  145 (676)
T 3qa8_A           66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHR  145 (676)
T ss_dssp             HHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCC
T ss_pred             HHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Confidence            356799999999999765      678899999999999999998744   58999999999999999999999999999


Q ss_pred             CCCCCcEEEccCCC---EEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCC
Q 016865           72 DLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF  148 (381)
Q Consensus        72 Dlkp~NiLl~~~~~---lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf  148 (381)
                      ||||+||+++.++.   +||+|||++...... ......+||+.|+|||++.+..+. .++||||+||++|+|++|..||
T Consensus       146 DLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s-~ksDIwSLGviLyeLltG~~Pf  223 (676)
T 3qa8_A          146 DLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPF  223 (676)
T ss_dssp             CCCSTTEEEECCSSSCEEEECSCCCCCBTTSC-CCCCCCCSCCTTCSSCSSCCSCCS-TTHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCCHHHeEeecCCCceeEEEcccccccccccc-cccccccCCcccCChHHhccCCCC-chhHHHHHHHHHHHHHHCCCCC
Confidence            99999999997765   999999999876543 334567899999999999877765 8999999999999999999999


Q ss_pred             CCCChhHHH---------HH-----hhcccC------CCC----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          149 GETDLPTLY---------KK-----INAAEF------SCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       149 ~~~~~~~~~---------~~-----i~~~~~------~~p----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      .........         ..     ...+..      ..|    ..+++.+.+||.+||..||.+|||++++++||||+.
T Consensus       224 ~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          224 LPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             CSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             CcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence            764322110         00     001111      111    125688999999999999999999999999999963

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=290.50  Aligned_cols=197  Identities=23%  Similarity=0.344  Sum_probs=162.3

Q ss_pred             CCCCCccccccceEEEEeCC--EEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            1 MKIVRHPNIVRLHEVLASRT--KVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~--~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      |+.++||||+++++++.+.+  .+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|
T Consensus        96 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~N  175 (326)
T 2w1i_A           96 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRN  175 (326)
T ss_dssp             HHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             HHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcce
Confidence            35789999999999987544  789999999999999999875 459999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccCccCCCCCcc---ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           78 LLLDSYGNLKVSDFGLSALPQQGVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        78 iLl~~~~~lkl~DFGls~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      |+++.++.+||+|||++........   ......+++.|+|||++.+..+. .++||||+||++|+|++|..||......
T Consensus       176 Ili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~tg~~~~~~~~~~  254 (326)
T 2w1i_A          176 ILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAE  254 (326)
T ss_dssp             EEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHHTTCGGGSHHHH
T ss_pred             EEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCC-chhhHHHHHHHHHHHHhcCCCCCCCHHH
Confidence            9999999999999999986544321   12334577889999999876664 8999999999999999999998643110


Q ss_pred             ----------------HHHHHhh-cccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          155 ----------------TLYKKIN-AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       155 ----------------~~~~~i~-~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                                      .....+. ......|..+++++.++|.+||..||.+|||+.++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          255 FMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                            1111222 2234566778999999999999999999999999885

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.8e-36  Score=287.37  Aligned_cols=196  Identities=21%  Similarity=0.353  Sum_probs=159.9

Q ss_pred             CCCccccccceEEEEeCC----EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCCee
Q 016865            3 IVRHPNIVRLHEVLASRT----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH--------SKGVYH   70 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~~~----~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH--------~~gi~H   70 (381)
                      .++||||+++++++.+..    .+|+||||+++|+|.+++.. ..+++..++.++.|++.||.|||        +.||+|
T Consensus        92 ~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH  170 (342)
T 1b6c_B           92 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH  170 (342)
T ss_dssp             CCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEEC
T ss_pred             hcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeee
Confidence            379999999999998876    89999999999999999976 57999999999999999999999        899999


Q ss_pred             cCCCCCcEEEccCCCEEEeeccCccCCCCCcc----ccccccCCCCCCCCceecCCCCCC-----CcccHhHHHHHHHHH
Q 016865           71 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVE----LLHTTCGTPNYVAPEVLSNRGYDG-----SAADVWSCGVILFVL  141 (381)
Q Consensus        71 rDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~-----~~~DIwSlGvil~~l  141 (381)
                      |||||+|||++.++.+||+|||++........    .....+||+.|+|||++.+.....     .++||||+||++|+|
T Consensus       171 ~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el  250 (342)
T 1b6c_B          171 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI  250 (342)
T ss_dssp             SCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHH
Confidence            99999999999999999999999876543221    234567999999999997653221     579999999999999


Q ss_pred             HhC----------CCCCCCCC-----hhHHHHHhhccc--CCCCCC-----CChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          142 MAG----------YLPFGETD-----LPTLYKKINAAE--FSCPFW-----FSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       142 l~G----------~~Pf~~~~-----~~~~~~~i~~~~--~~~p~~-----~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ++|          ..||....     .......+....  ...|..     .++.+.+||.+||+.||.+|||+.++++|
T Consensus       251 ~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          251 ARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             HTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             HhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            999          78986542     223333333222  222221     23578899999999999999999999875

>2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana}

Probab=100.00  E-value=1.9e-35  Score=246.10  Aligned_cols=136  Identities=76%  Similarity=1.188  Sum_probs=119.1

Q ss_pred             CCcccchhhhhhcCCCCCCcccCcccccccccccEEEeCCCHHHHHHHHHHHHHHcCcEEEeecceEEEEeecCCCCccE
Q 016865          244 GPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRNYKTRLEGVSANKTGQF  323 (381)
Q Consensus       244 ~~~~~~~~~~~~~s~~~~l~~~~~~~~~~~~~~trf~s~~~~~~i~~~l~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l  323 (381)
                      .|..+|||++|++|+++|||+||+..+..++|+|||+|+.|++.|+++|+++|+.+|+.|+++++++++++..+|++|+|
T Consensus         3 ~p~~lNAFdiIs~S~g~dLSgLFe~~~~~~~r~tRF~s~~~a~~ii~klEe~a~~lg~~V~kk~~~vkl~~~~~grkG~l   82 (143)
T 2ehb_D            3 GPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRNFKTRLEGLSSIKAGQL   82 (143)
T ss_dssp             CCEECCHHHHHTTCTTTCGGGGGCSCCCSCCCCCEEEECSCHHHHHHHHHHHHHHTTEEEEESSSEEEEEECCSSGGGCC
T ss_pred             CccccCHHHHHHHCcCCCchhhhccccccccccceEEeCCCHHHHHHHHHHHHHhcCcEEEEcCcEEEEEEecCCCcceE
Confidence            56679999999999999999999765545788999999999999999999999999999999888999999999999999


Q ss_pred             EEEEEEEEEeCCeEEEEEEccCCCchhHHHHHHHHHHhcccceecccCc---ccccccc
Q 016865          324 AVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENIIWKPTEG---SSLLRTM  379 (381)
Q Consensus       324 ~~~~ei~~~~~~~~~V~~~k~~Gd~le~~~~~~~l~~~l~div~~~~~~---~~~~~~~  379 (381)
                      +++||||||+|+++||||+|++||++||+++|++|+++|+||||+|++.   +++++++
T Consensus        83 ~v~~EVfevapsl~vVEvrks~GD~lEy~k~~~~Lr~~L~diV~~~~~~~~~~~~~~~~  141 (143)
T 2ehb_D           83 AVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSKLENIIWRATEGIPKSEILRTI  141 (143)
T ss_dssp             EEEEEEEEEETTEEEEEEEEEESCHHHHHHHHHHHHHHSTTTBCC--------------
T ss_pred             EEEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHhhcceecCCCCCchhhhhhhh
Confidence            9999999999999999999999999999999999999999999999985   5555544

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.6e-35  Score=295.49  Aligned_cols=194  Identities=20%  Similarity=0.266  Sum_probs=159.6

Q ss_pred             CCCc-cccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            3 IVRH-PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         3 ~l~H-pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      .++| ++|..+..++.+.+..||||||+ ||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus        58 ~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl  136 (483)
T 3sv0_A           58 ILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM  136 (483)
T ss_dssp             HTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             HhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEE
Confidence            4555 56666667777889999999999 9999999975 5679999999999999999999999999999999999999


Q ss_pred             ---ccCCCEEEeeccCccCCCCCcc-------ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCC
Q 016865           81 ---DSYGNLKVSDFGLSALPQQGVE-------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE  150 (381)
Q Consensus        81 ---~~~~~lkl~DFGls~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~  150 (381)
                         +.++.+||+|||++........       .....+||+.|+|||++.+..+. .++|||||||+||+|++|..||..
T Consensus       137 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDvwSlGvil~elltG~~Pf~~  215 (483)
T 3sv0_A          137 GLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQG  215 (483)
T ss_dssp             CCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred             ecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCcc
Confidence               6889999999999986544211       12367899999999999887764 899999999999999999999987


Q ss_pred             CCh---hHHHHHhhcccC-----CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          151 TDL---PTLYKKINAAEF-----SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       151 ~~~---~~~~~~i~~~~~-----~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...   ...+.++.....     ..+..+++++.+||.+||..||.+||+++++++
T Consensus       216 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          216 LKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             CCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             ccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            543   233333332222     122457899999999999999999999998765

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.1e-37  Score=295.06  Aligned_cols=172  Identities=18%  Similarity=0.229  Sum_probs=139.9

Q ss_pred             CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCcEEEccCC-------------
Q 016865           19 RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH-SKGVYHRDLKPENLLLDSYG-------------   84 (381)
Q Consensus        19 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH-~~gi~HrDlkp~NiLl~~~~-------------   84 (381)
                      .+.+||||||+++|++.+.+.. +.+++..++.++.||+.||+||| ++||+||||||+|||++.++             
T Consensus       134 ~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~  212 (336)
T 2vuw_A          134 DDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSS  212 (336)
T ss_dssp             TTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEE
T ss_pred             cCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccc
Confidence            7899999999999988777754 67899999999999999999999 99999999999999999987             


Q ss_pred             -------CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHH-HHHHHhCCCCCCCCCh-hH
Q 016865           85 -------NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVI-LFVLMAGYLPFGETDL-PT  155 (381)
Q Consensus        85 -------~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvi-l~~ll~G~~Pf~~~~~-~~  155 (381)
                             .+||+|||+|+....     .+.+||+.|+|||++.+..  +.++||||+|++ .+++++|..||..... ..
T Consensus       213 ~~~~~~~~vkL~DFG~a~~~~~-----~~~~gt~~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~  285 (336)
T 2vuw_A          213 TIPSCGLQVSIIDYTLSRLERD-----GIVVFCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHY  285 (336)
T ss_dssp             EEECTTEEEEECCCTTCBEEET-----TEEECCCCTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHH
T ss_pred             cccCCCceEEEeeccccEecCC-----CcEEEeecccChhhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhH
Confidence                   899999999986543     2558999999999998655  589999998776 7889999999954321 11


Q ss_pred             HHHHhh-cccCCC------CCCCChhHHHHHHHhcCCCCCCCCCHHHHh-cCcccc
Q 016865          156 LYKKIN-AAEFSC------PFWFSTGATSLIHKILDPNPKTRIRIEGIR-KHPWFR  203 (381)
Q Consensus       156 ~~~~i~-~~~~~~------p~~~s~~~~~li~~~L~~dP~~R~t~~~il-~hp~~~  203 (381)
                      ....+. ......      +..+|+++++||++||+.|     |++|++ +||||+
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          286 LTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             HHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            222222 111111      1236889999999999977     999999 999995

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-35  Score=293.17  Aligned_cols=174  Identities=16%  Similarity=0.182  Sum_probs=144.9

Q ss_pred             EEEEEEecCCCCChHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCCCEEEeeccC
Q 016865           21 KVYIILEFVTGGELFDKIVH-------QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL   93 (381)
Q Consensus        21 ~~~lV~E~~~gg~L~~~i~~-------~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGl   93 (381)
                      .++++|+++ +|+|.+++..       .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus       179 ~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~  257 (413)
T 3dzo_A          179 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH  257 (413)
T ss_dssp             SEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGG
T ss_pred             ceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccc
Confidence            578888876 5799998852       23477888999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCccccccccCCCCCCCCcee----------cCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhcc
Q 016865           94 SALPQQGVELLHTTCGTPNYVAPEVL----------SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA  163 (381)
Q Consensus        94 s~~~~~~~~~~~~~~gt~~y~aPE~l----------~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~  163 (381)
                      +.....   ...+.+| +.|+|||++          .+..| +.++|||||||++|+|++|+.||...+.......+.  
T Consensus       258 a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~--  330 (413)
T 3dzo_A          258 LVRDGA---SAVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIF--  330 (413)
T ss_dssp             CEETTE---EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGG--
T ss_pred             eeecCC---ccccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHH--
Confidence            876443   2466788 999999999          33334 479999999999999999999998766544333332  


Q ss_pred             cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          164 EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       164 ~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                        .....+|+++.+||.+||+.||.+|||+.++++||||+.
T Consensus       331 --~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~  369 (413)
T 3dzo_A          331 --RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  369 (413)
T ss_dssp             --SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             --hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence              222357899999999999999999999999999999964

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.4e-35  Score=310.68  Aligned_cols=188  Identities=24%  Similarity=0.352  Sum_probs=154.8

Q ss_pred             CCCCCccccccceEEEEeCCE-----EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRTK-----VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKP   75 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~-----~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp   75 (381)
                      |+.++||||+++++++.+.+.     .||||||++|++|.+.+..  .+++..+..++.||+.||.|||++||+||||||
T Consensus       133 l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp  210 (681)
T 2pzi_A          133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKP  210 (681)
T ss_dssp             GGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred             HHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccCh
Confidence            467899999999999987665     7999999999999987754  799999999999999999999999999999999


Q ss_pred             CcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhH
Q 016865           76 ENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT  155 (381)
Q Consensus        76 ~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  155 (381)
                      +|||++.+ .+||+|||++......    ...+||+.|+|||++.+. + +.++||||+||++|+|++|.+||.......
T Consensus       211 ~NIll~~~-~~kl~DFG~a~~~~~~----~~~~gt~~y~aPE~~~~~-~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~  283 (681)
T 2pzi_A          211 ENIMLTEE-QLKLIDLGAVSRINSF----GYLYGTPGFQAPEIVRTG-P-TVATDIYTVGRTLAALTLDLPTRNGRYVDG  283 (681)
T ss_dssp             GGEEECSS-CEEECCCTTCEETTCC----SCCCCCTTTSCTTHHHHC-S-CHHHHHHHHHHHHHHHHSCCCEETTEECSS
T ss_pred             HHeEEeCC-cEEEEecccchhcccC----CccCCCccccCHHHHcCC-C-CCceehhhhHHHHHHHHhCCCCCccccccc
Confidence            99999974 8999999999765432    456799999999998754 3 589999999999999999999987532111


Q ss_pred             HHHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          156 LYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       156 ~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      ..      ........++.+.++|.+||+.||.+||+..+.+.|+|+.
T Consensus       284 ~~------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          284 LP------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             CC------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             cc------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            00      0000011467899999999999999999999999999874

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.4e-33  Score=263.63  Aligned_cols=166  Identities=15%  Similarity=0.201  Sum_probs=138.5

Q ss_pred             CCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEc
Q 016865            2 KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD   81 (381)
Q Consensus         2 k~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~   81 (381)
                      +.++||||+++++++.+.+..|+||||++|++|.+++.. + .....+..++.|++.||+|||++||+||||||+|||++
T Consensus        86 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~  163 (286)
T 3uqc_A           86 SRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS  163 (286)
T ss_dssp             HTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE
T ss_pred             hcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc
Confidence            568999999999999999999999999999999999854 3 45667889999999999999999999999999999999


Q ss_pred             cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHH---
Q 016865           82 SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK---  158 (381)
Q Consensus        82 ~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~---  158 (381)
                      .+|.+||+++|                    |++|       + +.++|||||||++|+|++|+.||.+.+......   
T Consensus       164 ~~g~~kl~~~~--------------------~~~~-------~-~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~  215 (286)
T 3uqc_A          164 IDGDVVLAYPA--------------------TMPD-------A-NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE  215 (286)
T ss_dssp             TTSCEEECSCC--------------------CCTT-------C-CHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC
T ss_pred             CCCCEEEEecc--------------------ccCC-------C-CchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH
Confidence            99999998443                    3332       3 589999999999999999999998765433211   


Q ss_pred             HhhcccC----CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          159 KINAAEF----SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       159 ~i~~~~~----~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      +......    ..+..+++++.++|.+||+.||.+| |+.++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          216 RDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             BCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             HHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence            1111111    1234589999999999999999999 9999987

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=2.4e-34  Score=295.01  Aligned_cols=184  Identities=13%  Similarity=0.116  Sum_probs=132.8

Q ss_pred             CCC-CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            2 KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         2 k~l-~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      +++ +|+||+++++++++++..||||||++||+|.++|...+.+++.   .++.||+.||+|||++||+||||||+|||+
T Consensus       296 ~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL  372 (569)
T 4azs_A          296 TQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV  372 (569)
T ss_dssp             HSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE
T ss_pred             HhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE
Confidence            455 7999999999999999999999999999999999998888765   478999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.+|++||+|||+|+..........+.+||+.|+|||++.+. + ..++|+||+|++++++.+|..|+.        ..+
T Consensus       373 ~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~-~-~~~~d~~s~g~~~~~l~~~~~~~~--------~~l  442 (569)
T 4azs_A          373 DARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN-K-SWNGFWRSAPVHPFNLPQPWSNWL--------YAV  442 (569)
T ss_dssp             CTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHHHH--------HHH
T ss_pred             CCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCCC-C-CCcccccccccchhhhccccchhH--------HHh
Confidence            999999999999998776655556788999999999999764 3 478999999999988876654431        111


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      .    ..|.. ...+..+...+...+|..|+.......++|..
T Consensus       443 ~----~~~~~-~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~  480 (569)
T 4azs_A          443 W----QEPVE-RWNFVLLLALFEKKAKLPSAEQQRGATEQWII  480 (569)
T ss_dssp             H----TSCGG-GCSHHHHHHHHHTGGGSCCGGGSSCCHHHHHH
T ss_pred             h----cCCCC-CCcHHHHHHHHhCCCCCCCCChhhhccchhHH
Confidence            1    11110 11345667777777888787776666666653

>2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana}

Probab=99.97  E-value=4.5e-32  Score=220.45  Aligned_cols=121  Identities=26%  Similarity=0.410  Sum_probs=106.1

Q ss_pred             CCcccchhhhhhcCCCCCCcccCcccccccccccEEEeCCCHHHHHHHHHHHHHHcCcEEEeecceEEEEeecCCCCccE
Q 016865          244 GPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRNYKTRLEGVSANKTGQF  323 (381)
Q Consensus       244 ~~~~~~~~~~~~~s~~~~l~~~~~~~~~~~~~~trf~s~~~~~~i~~~l~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l  323 (381)
                      +|..+|||++|++|+++|||+||+.. ...+++|||+|+.|++.|+++|+++|+++|+.|++++++   +++.+|++|+|
T Consensus         2 ~~~~lNAFdiIs~S~g~dLSgLFe~~-~~~~r~tRF~S~~~a~~ii~klEe~a~~lg~~v~kk~~~---~~~~~g~kG~l   77 (123)
T 2zfd_B            2 GARRMNAFDIISGSPGFNLSGLFGDA-RKYDRVERFVSAWTAERVVERLEEIVSAENLTVAKKETW---GMKIEGQKGNF   77 (123)
T ss_dssp             --CCCCHHHHHHTSTTSSSGGGGGGG-CSSCCCEEEEESSCHHHHHHHHHHHHHHTTCEEEEEETT---EEEEEEGGGTE
T ss_pred             CcccccHHHHHHHCcCCCchHhcCcc-cccccceEEEeCCCHHHHHHHHHHHHHHCCCEEEEcCCc---cccccCCCccE
Confidence            56679999999999999999999653 224779999999999999999999999999999998876   66778999999


Q ss_pred             EEEEEEEEEeCCeEEEEEEccCCCchhHHHHH-HHHHHhcccceec
Q 016865          324 AVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFY-KNFCAKLENIIWK  368 (381)
Q Consensus       324 ~~~~ei~~~~~~~~~V~~~k~~Gd~le~~~~~-~~l~~~l~div~~  368 (381)
                      +++||||||+|+++||||+|++||++||++|| ++|++.|+||||+
T Consensus        78 ~v~~EVfev~p~l~vVEvrks~GD~lEy~~~~~~~L~~~L~diV~~  123 (123)
T 2zfd_B           78 AMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFFVELVHE  123 (123)
T ss_dssp             EEEEEEEECSSSCEEEEEEEEESCC---CCHHHHTHHHHHHHTBC-
T ss_pred             EEEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHHHhhhhcC
Confidence            99999999999999999999999999999976 5899999999984

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.89  E-value=7.3e-25  Score=223.33  Aligned_cols=138  Identities=20%  Similarity=0.266  Sum_probs=117.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |++++||||+++..++.+.+..||||||++||+|.+++..        +..++.|++.||+|||++||+||||||+|||+
T Consensus       393 l~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl  464 (540)
T 3en9_A          393 LALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIF  464 (540)
T ss_dssp             HHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEE
T ss_pred             HHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEE
Confidence            3567999999766666677788999999999999998865        66899999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCcc-------ccccccCCCCCCCCceecC--CCCCCCcccHhHHHHHHHHHHhCCCCCC
Q 016865           81 DSYGNLKVSDFGLSALPQQGVE-------LLHTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFG  149 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~-------~~~~~~gt~~y~aPE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~  149 (381)
                      +.  .+||+|||+++.......       ...+.+||+.|+|||++..  .+|. ..+|+||.++-..+...++.+|.
T Consensus       465 ~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          465 DK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             SS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHHHHHhccccC
Confidence            99  999999999987655221       1246789999999999976  4564 67899999988888887776663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.69  E-value=1.7e-18  Score=161.97  Aligned_cols=90  Identities=20%  Similarity=0.300  Sum_probs=74.9

Q ss_pred             ccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCCCEE
Q 016865            8 NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLK   87 (381)
Q Consensus         8 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~~lk   87 (381)
                      | +++++++.. +..|+||||++||+|.+ +.      ...+..++.|++.||.|||++||+||||||+|||++ +|.+|
T Consensus       163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vk  232 (282)
T 1zar_A          163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIW  232 (282)
T ss_dssp             T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEE
T ss_pred             C-CCcCeEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEE
Confidence            5 677776654 45699999999999988 42      124567999999999999999999999999999999 99999


Q ss_pred             EeeccCccCCCCCccccccccCCCCCCCCceec
Q 016865           88 VSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS  120 (381)
Q Consensus        88 l~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~  120 (381)
                      |+|||+|..             +..|.|||++.
T Consensus       233 l~DFG~a~~-------------~~~~~a~e~l~  252 (282)
T 1zar_A          233 IIDFPQSVE-------------VGEEGWREILE  252 (282)
T ss_dssp             ECCCTTCEE-------------TTSTTHHHHHH
T ss_pred             EEECCCCeE-------------CCCCCHHHHHH
Confidence            999999853             44578898874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.46  E-value=1.5e-14  Score=133.36  Aligned_cols=72  Identities=21%  Similarity=0.298  Sum_probs=60.5

Q ss_pred             EEEEEEecCCC-C----ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCcEEEccCCCEEEeeccCc
Q 016865           21 KVYIILEFVTG-G----ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH-SKGVYHRDLKPENLLLDSYGNLKVSDFGLS   94 (381)
Q Consensus        21 ~~~lV~E~~~g-g----~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH-~~gi~HrDlkp~NiLl~~~~~lkl~DFGls   94 (381)
                      ..||||||+.+ |    +|.+....   .++..+..++.|++.||.||| +.||+||||||+|||++.  .++|+|||+|
T Consensus       142 ~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~--~~~liDFG~a  216 (258)
T 1zth_A          142 KNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID--KVYFIDMGQA  216 (258)
T ss_dssp             TTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS--SEEECCCTTC
T ss_pred             CCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--cEEEEECccc
Confidence            56899999942 3    67665432   345678899999999999999 999999999999999998  9999999998


Q ss_pred             cCC
Q 016865           95 ALP   97 (381)
Q Consensus        95 ~~~   97 (381)
                      ...
T Consensus       217 ~~~  219 (258)
T 1zth_A          217 VTL  219 (258)
T ss_dssp             EET
T ss_pred             ccC
Confidence            654

>3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} SCOP: d.129.6.1 PDB: 1ul7_A

Probab=99.26  E-value=6.3e-11  Score=95.59  Aligned_cols=84  Identities=13%  Similarity=0.187  Sum_probs=75.6

Q ss_pred             EeCCCHHHHHHHHHHHHHHcCcEEEeec-ceEEEEeecCCCCccEEEEEEEEEEe-CCeEEEEEEccCCCchhHHHHHHH
Q 016865          280 VSRQPAQVILSNIEAVAESLSLKVHTRN-YKTRLEGVSANKTGQFAVVLEVFEVA-PSLFMVDVRKAAGDTLEYHKFYKN  357 (381)
Q Consensus       280 ~s~~~~~~i~~~l~~~~~~~~~~v~~~~-~~~~~~~~~~~~~~~l~~~~ei~~~~-~~~~~V~~~k~~Gd~le~~~~~~~  357 (381)
                      +|..+|.+|+..|+.++.++|+.++.++ |.+++.......++.+.|.+||+++. +++++|+|+|.+||.+.|+++|.+
T Consensus        34 TS~~~P~eIm~eI~rvL~~~gi~~~~~g~y~l~C~~~~~~~~~~v~fElEVckl~~~~l~gV~~kRi~Gd~~~yk~lc~~  113 (120)
T 3ose_A           34 TSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDSLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASK  113 (120)
T ss_dssp             EECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEESCTTTTCCEEEEEEEEEEGGGTEEEEEEEEEESCHHHHHHHHHH
T ss_pred             cccCCHHHHHHHHHHHHHHCCCEEEEcCCEEEEEEecCCCCCccEEEEEEEEEecCCCceeEEEEecCCCHHHHHHHHHH
Confidence            6899999999999999999999998866 78888765445567899999999995 899999999999999999999999


Q ss_pred             HHHhcc
Q 016865          358 FCAKLE  363 (381)
Q Consensus       358 l~~~l~  363 (381)
                      |.+.|+
T Consensus       114 il~~L~  119 (120)
T 3ose_A          114 IANELK  119 (120)
T ss_dssp             HHHHCC
T ss_pred             HHHHhc
Confidence            998875

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.22  E-value=9.6e-13  Score=127.60  Aligned_cols=84  Identities=15%  Similarity=0.150  Sum_probs=63.8

Q ss_pred             ccccccceEEEEeC------CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            6 HPNIVRLHEVLASR------TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         6 HpnIv~l~~~~~~~------~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |+|+.+++.....-      ...+|||||++|++|.+..      ..+.+..++.||+.+|.|||+.||+||||||.|||
T Consensus       164 ~~nL~rL~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NIL  237 (397)
T 4gyi_A          164 FAFMKALYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNIL  237 (397)
T ss_dssp             HHHHHHHHHTTCSCCCEEEEETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEE
T ss_pred             HHHHHHHHhcCCCCCeeeeccCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEE
Confidence            66666665432111      1236999999998885532      12345678899999999999999999999999999


Q ss_pred             EccCCC----------EEEeeccCcc
Q 016865           80 LDSYGN----------LKVSDFGLSA   95 (381)
Q Consensus        80 l~~~~~----------lkl~DFGls~   95 (381)
                      ++++|.          +.|+||+-+-
T Consensus       238 l~~dgd~~d~~~~~~~~~iID~~Q~V  263 (397)
T 4gyi_A          238 IREEKDAEDPSSITLTPIIIXFPQMV  263 (397)
T ss_dssp             EEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred             EeCCCCcccccccccceEEEEeCCcc
Confidence            998773          8999999654

>1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1

Probab=98.82  E-value=8.1e-09  Score=83.20  Aligned_cols=84  Identities=12%  Similarity=0.138  Sum_probs=72.9

Q ss_pred             EeCCCHHHHHHHHHHHHHHcCcEEEe-ecceEEEEeecCCCCccEEEEEEEEEEe-CCeEEEEEEccCCCchhHHHHHHH
Q 016865          280 VSRQPAQVILSNIEAVAESLSLKVHT-RNYKTRLEGVSANKTGQFAVVLEVFEVA-PSLFMVDVRKAAGDTLEYHKFYKN  357 (381)
Q Consensus       280 ~s~~~~~~i~~~l~~~~~~~~~~v~~-~~~~~~~~~~~~~~~~~l~~~~ei~~~~-~~~~~V~~~k~~Gd~le~~~~~~~  357 (381)
                      +|+.+|.+|+..|..+++++|+.++. +.+.+++.......+..+.|.+||+++. .+++.|+|+|.+||.+.|+++|.+
T Consensus        34 TSsk~P~eIm~EI~rvL~~~~i~~k~~~~y~L~C~~~~~~~~~~vkfEiEVcKvp~l~l~GI~fKRisGd~w~YK~lc~~  113 (126)
T 1v5s_A           34 GSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASK  113 (126)
T ss_dssp             CCCSSHHHHHHHHHHHHHHTTEEEEEEETTEEEEEECSSSTTTCEEEEEECCCCTTTCSCCCEEEEEESCHHHHHHHHHH
T ss_pred             ecCCCHHHHHHHHHHHHHHcCCcEEEECCEEEEEEECCCCCCceEEEEEEEEEecCCCceeEEEeeccCchhHHHHHHHH
Confidence            57889999999999999999999987 4577777654333456799999999994 689999999999999999999999


Q ss_pred             HHHhcc
Q 016865          358 FCAKLE  363 (381)
Q Consensus       358 l~~~l~  363 (381)
                      |...|+
T Consensus       114 IL~eLk  119 (126)
T 1v5s_A          114 IANELK  119 (126)
T ss_dssp             HHHHTT
T ss_pred             HHHHHh
Confidence            999887

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.70  E-value=2.2e-08  Score=91.50  Aligned_cols=85  Identities=13%  Similarity=0.091  Sum_probs=70.0

Q ss_pred             ccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------
Q 016865            6 HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS--------------------   65 (381)
Q Consensus         6 HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~--------------------   65 (381)
                      |.++.+++++..+.+..|+||||++|.+|.+.+.     +......++.++..+|..||+                    
T Consensus        69 ~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~  143 (263)
T 3tm0_A           69 KLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELD  143 (263)
T ss_dssp             TSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHH
T ss_pred             CCCCCeEEEEEecCCceEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHH
Confidence            5678899999999999999999999999876531     122345778899999999998                    


Q ss_pred             ---------------------------------------CCCeecCCCCCcEEEccCCCEEEeeccCcc
Q 016865           66 ---------------------------------------KGVYHRDLKPENLLLDSYGNLKVSDFGLSA   95 (381)
Q Consensus        66 ---------------------------------------~gi~HrDlkp~NiLl~~~~~lkl~DFGls~   95 (381)
                                                             .+++|+|++|.|||+++++.+.|+||+.+.
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          144 YLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                                   458999999999999876566799999764

>4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A*

Probab=98.53  E-value=1.1e-06  Score=68.37  Aligned_cols=85  Identities=15%  Similarity=0.274  Sum_probs=71.7

Q ss_pred             EEeCCCHHHHHHHHHHHHHHcCcEEEee-cceEEEEeecCCCCccEEEEEEEEEEeCCeEEEEEEccCCC--------ch
Q 016865          279 FVSRQPAQVILSNIEAVAESLSLKVHTR-NYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGD--------TL  349 (381)
Q Consensus       279 f~s~~~~~~i~~~l~~~~~~~~~~v~~~-~~~~~~~~~~~~~~~~l~~~~ei~~~~~~~~~V~~~k~~Gd--------~l  349 (381)
                      ..|...|.+|+..|..|++.+|+.|+.- .+.+++..........+.|.+++|++.++.+++||++..||        .+
T Consensus        12 IrS~~~P~eiM~eIyraLk~lg~~Wk~~~~Y~lkcR~~~~~~~~~vK~~lQLYkv~~~~YLLDfq~i~g~~~~~~~~~~~   91 (106)
T 4eai_A           12 IRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDGGGGGGGSHTI   91 (106)
T ss_dssp             EEECSCHHHHHHHHHHHHHHHTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEECCSSCCCSSSCHHH
T ss_pred             ceeCCCHHHHHHHHHHHHHHcCCEEeeCCceEEEEEEcCCCCCceeEEEEEEEEecCCcEEEEEEeccCCCCCCCCcCcE
Confidence            4678889999999999999999999875 57888775433334568899999999989999999999994        89


Q ss_pred             hHHHHHHHHHHhcc
Q 016865          350 EYHKFYKNFCAKLE  363 (381)
Q Consensus       350 e~~~~~~~l~~~l~  363 (381)
                      +|-++|.++...|.
T Consensus        92 ~F~d~ca~li~~la  105 (106)
T 4eai_A           92 EFFEMCANLIKILA  105 (106)
T ss_dssp             HHHHHHHHHHHHCC
T ss_pred             eHHHHHHHHHHHHh
Confidence            99999998877764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.47  E-value=8.4e-08  Score=86.86  Aligned_cols=79  Identities=19%  Similarity=0.232  Sum_probs=61.4

Q ss_pred             cccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---------------------
Q 016865            9 IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG---------------------   67 (381)
Q Consensus         9 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~g---------------------   67 (381)
                      +.+++++..+.+..|+||||++|.+|.  .   ....   ...++.++...|..||+..                     
T Consensus        77 vP~~~~~~~~~~~~~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~  148 (264)
T 1nd4_A           77 CAAVLDVVTEAGRDWLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRM  148 (264)
T ss_dssp             BCCEEEEEECSSCEEEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHH
T ss_pred             CCeEEEeccCCCCCEEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHH
Confidence            566888888888899999999998883  1   1122   2356677777788888643                     


Q ss_pred             -------------------------------------CeecCCCCCcEEEccCCCEEEeeccCcc
Q 016865           68 -------------------------------------VYHRDLKPENLLLDSYGNLKVSDFGLSA   95 (381)
Q Consensus        68 -------------------------------------i~HrDlkp~NiLl~~~~~lkl~DFGls~   95 (381)
                                                           ++|+|++|.|||+++++.+.|+|||.+.
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          149 EAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                                 9999999999999877667799999764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.46  E-value=1.9e-07  Score=89.45  Aligned_cols=90  Identities=21%  Similarity=0.407  Sum_probs=72.9

Q ss_pred             ccccccceEEEEeC---CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-----------------
Q 016865            6 HPNIVRLHEVLASR---TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-----------------   65 (381)
Q Consensus         6 HpnIv~l~~~~~~~---~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~-----------------   65 (381)
                      +..+.+++.++.+.   +..|+||||++|..+.+..  ...+++.....++.++...|..||+                 
T Consensus        97 ~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~  174 (359)
T 3dxp_A           97 DVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNY  174 (359)
T ss_dssp             SSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCH
T ss_pred             CCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCc
Confidence            45678888888776   4589999999998775421  2347788888999999999999997                 


Q ss_pred             -----------------------------------------CCCeecCCCCCcEEEccCCC--EEEeeccCccCC
Q 016865           66 -----------------------------------------KGVYHRDLKPENLLLDSYGN--LKVSDFGLSALP   97 (381)
Q Consensus        66 -----------------------------------------~gi~HrDlkp~NiLl~~~~~--lkl~DFGls~~~   97 (381)
                                                               .+++|+|++|.|||++.++.  +.|.||+.+...
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          175 FQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             hHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                                     36899999999999997753  699999988653

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.38  E-value=1.1e-07  Score=89.02  Aligned_cols=126  Identities=17%  Similarity=0.275  Sum_probs=83.9

Q ss_pred             EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 016865           21 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-----------------------------------   65 (381)
Q Consensus        21 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~-----------------------------------   65 (381)
                      .-|+|||+++|..|.+...  ..++.++...++.|+...+..||+                                   
T Consensus        90 ~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (304)
T 3sg8_A           90 MSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG  167 (304)
T ss_dssp             CSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred             cceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence            4589999999988876433  347788888888999999988886                                   


Q ss_pred             -----------------------CCCeecCCCCCcEEEcc--CCCEEEeeccCccCCCCCccccccccCCCCCCCCceec
Q 016865           66 -----------------------KGVYHRDLKPENLLLDS--YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS  120 (381)
Q Consensus        66 -----------------------~gi~HrDlkp~NiLl~~--~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~  120 (381)
                                             ..++|+|++|.||++++  .+.+.|+||+.+................ .-..|+...
T Consensus       168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~-~~~~~~~~~  246 (304)
T 3sg8_A          168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD-EEYGMEFVS  246 (304)
T ss_dssp             HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT-TSCCHHHHH
T ss_pred             ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc-cccCHHHHH
Confidence                                   13699999999999998  4568899999876543211111000000 002222211


Q ss_pred             C--CCCCC-----------CcccHhHHHHHHHHHHhCCCCCC
Q 016865          121 N--RGYDG-----------SAADVWSCGVILFVLMAGYLPFG  149 (381)
Q Consensus       121 ~--~~~~~-----------~~~DIwSlGvil~~ll~G~~Pf~  149 (381)
                      .  ..|..           .-.+.|++|.++|.+.+|..+|-
T Consensus       247 ~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          247 KILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            0  01111           12589999999999999998773

>2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C*

Probab=98.35  E-value=5.8e-06  Score=68.13  Aligned_cols=72  Identities=15%  Similarity=0.263  Sum_probs=57.8

Q ss_pred             EEeCCCHHHHHHHHHHHHHHcCcEEEeec-ceEEEEeecCCCCccEEEEEEEEEEeCCeEEEEEEccCCCchh
Q 016865          279 FVSRQPAQVILSNIEAVAESLSLKVHTRN-YKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLE  350 (381)
Q Consensus       279 f~s~~~~~~i~~~l~~~~~~~~~~v~~~~-~~~~~~~~~~~~~~~l~~~~ei~~~~~~~~~V~~~k~~Gd~le  350 (381)
                      .-|..+|.+||..|..|++.+|+.|++.+ |.+++..........+.|.+++|++.++.+||||++..||+.|
T Consensus         9 IrSrs~P~eIM~EVyRALk~Lg~eWK~~~pY~IkcRw~~~~~~~~vKm~LQLYkv~~~~YLLDFk~l~g~~~e   81 (157)
T 2v8q_A            9 IRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE   81 (157)
T ss_dssp             EEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred             cccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCceEEEEEEEEEecCCCEEEEEEecCCCccc
Confidence            35778899999999999999999999754 7888775433222358899999999999999999999998755

>4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster}

Probab=98.17  E-value=2.4e-05  Score=62.46  Aligned_cols=71  Identities=15%  Similarity=0.274  Sum_probs=55.4

Q ss_pred             EeCCCHHHHHHHHHHHHHHcCcEEEee-cceEEEEeecCCCCccEEEEEEEEEEeCCeEEEEEEccCCCchh
Q 016865          280 VSRQPAQVILSNIEAVAESLSLKVHTR-NYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLE  350 (381)
Q Consensus       280 ~s~~~~~~i~~~l~~~~~~~~~~v~~~-~~~~~~~~~~~~~~~~l~~~~ei~~~~~~~~~V~~~k~~Gd~le  350 (381)
                      -|...|.+|+..|..|++.+|+.|+.. .|.+++..........+.|.+++|++.++.+++||++..||..|
T Consensus        13 rS~~~P~eIM~EVyrALk~Lg~eWK~~~pY~vkcR~~n~~~~~~vKm~LQLYqv~~~~YLLDfk~~~~~~~~   84 (130)
T 4eag_A           13 RSQSKPNDIMLEVYRAMKALSYEWKIINPYHVRVRRQNVKTGKFSKMSLQLYQVDAKSYLLDFKSLTNDEVE   84 (130)
T ss_dssp             CCCSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEESSSSCEEEEEEECC-----
T ss_pred             ecCCCHHHHHHHHHHHHHHCCCEEeeCCCEEEEEEecCCCCCceeEEEEEEEEecCCcEEEEeccCCcchhh
Confidence            466779999999999999999999875 47887775444434457889999999999999999999999644

>2qrd_A SNF1-like protein kinase SSP2; AMPK, ADP, ATP-binding, kinase, nucleotide-binding, serine/T protein kinase, transferase, CBS domain; HET: ADP ATP; 2.41A {Schizosaccharomyces pombe} SCOP: d.129.6.2 PDB: 2ooy_A* 2qr1_A* 2qrc_A* 2oox_A* 2qre_A*

Probab=98.08  E-value=1.1e-05  Score=65.93  Aligned_cols=85  Identities=18%  Similarity=0.228  Sum_probs=68.8

Q ss_pred             EEeCCCHHHHHHHHHHHHHHcCcEEEee---------c-ceEEEEeecCCC-----CccEEEEEEEEEEeCCeEEEEEEc
Q 016865          279 FVSRQPAQVILSNIEAVAESLSLKVHTR---------N-YKTRLEGVSANK-----TGQFAVVLEVFEVAPSLFMVDVRK  343 (381)
Q Consensus       279 f~s~~~~~~i~~~l~~~~~~~~~~v~~~---------~-~~~~~~~~~~~~-----~~~l~~~~ei~~~~~~~~~V~~~k  343 (381)
                      .-|..+|.+||..|..|++.+|+.|++-         + +.+++....+..     ...+.|.+++|++.++.+||||++
T Consensus        17 IRSrs~P~eIM~EVyrALk~Lg~eWk~~~~~~~~~~~~~y~Ik~R~~~~~~~~~~~~~~vkm~iQLYqv~~~~YLlDFk~   96 (137)
T 2qrd_A           17 VRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFMLDVKS   96 (137)
T ss_dssp             EEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEEEEEEE
T ss_pred             cccCCCHHHHHHHHHHHHHHCCCEEEeccccccccCCCceEEEEEEecCCCccccCCceEEEEEEEEEecCCcEEEEEEe
Confidence            4677899999999999999999999875         4 667776433211     235788999999999999999999


Q ss_pred             cCCC---------------c----hhHHHHHHHHHHhcc
Q 016865          344 AAGD---------------T----LEYHKFYKNFCAKLE  363 (381)
Q Consensus       344 ~~Gd---------------~----le~~~~~~~l~~~l~  363 (381)
                      ..|+               .    ++|-.+|.+|...|.
T Consensus        97 ~~~~~~~~~~~~~~~~~~~~~~s~~~Fldlca~Li~eLa  135 (137)
T 2qrd_A           97 NGYKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKLF  135 (137)
T ss_dssp             EEEEESCC-------------CCCTTHHHHHHHHHHHHH
T ss_pred             cCCccccccCccccccCCccccccccHHHHHHHHHHHHh
Confidence            9999               5    899999988877664

>2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A*

Probab=98.06  E-value=2.6e-05  Score=65.12  Aligned_cols=73  Identities=15%  Similarity=0.255  Sum_probs=58.5

Q ss_pred             EEEeCCCHHHHHHHHHHHHHHcCcEEEeec-ceEEEEeecCCCCccEEEEEEEEEEeCCeEEEEEEccCCCchh
Q 016865          278 RFVSRQPAQVILSNIEAVAESLSLKVHTRN-YKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLE  350 (381)
Q Consensus       278 rf~s~~~~~~i~~~l~~~~~~~~~~v~~~~-~~~~~~~~~~~~~~~l~~~~ei~~~~~~~~~V~~~k~~Gd~le  350 (381)
                      ..-|...|.+||..|..|++.+|+.|++.+ |.+++..........+.|.+++|++.++.++|||++..||+.|
T Consensus        22 GIrSrs~P~eIM~EVyRALk~Lg~eWK~i~pY~IkcRw~~~~~~~~vKmeLQLYKv~~~~YLLDFk~l~Gd~~e   95 (173)
T 2y8l_A           22 GIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE   95 (173)
T ss_dssp             SEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred             ecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCeeEEEEEEEEEEcCCCEEEEEEecCCCccc
Confidence            346788999999999999999999999755 7788775433222358899999999999999999999999876

>3t4n_A Carbon catabolite-derepressing protein kinase; CBS domain, nucleotide binding, cytosol, protein binding; HET: ADP; 2.30A {Saccharomyces cerevisiae} SCOP: d.129.6.2 PDB: 3tdh_A* 3te5_A* 2qlv_A

Probab=97.77  E-value=0.0002  Score=60.38  Aligned_cols=84  Identities=13%  Similarity=0.243  Sum_probs=67.4

Q ss_pred             EEeCCCHHHHHHHHHHHHHHcCcEEEee----cceEEEEeecC---------CCCccEEEEEEEEEEeCCeEEEEEEccC
Q 016865          279 FVSRQPAQVILSNIEAVAESLSLKVHTR----NYKTRLEGVSA---------NKTGQFAVVLEVFEVAPSLFMVDVRKAA  345 (381)
Q Consensus       279 f~s~~~~~~i~~~l~~~~~~~~~~v~~~----~~~~~~~~~~~---------~~~~~l~~~~ei~~~~~~~~~V~~~k~~  345 (381)
                      ..|...+.+||..|..|++.+|+.|++.    .|.+++.....         .....+.|.+++|++.++.+||||+ ..
T Consensus        55 IrS~~~P~eIM~EVyrALk~Lg~~WKk~~~~~pY~IkcRw~~~~~~~~~~~~~~p~~vKmeLQLYkv~~~~YLLDfk-~~  133 (179)
T 3t4n_A           55 IRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVDFK-FD  133 (179)
T ss_dssp             EEECSCHHHHHHHHHHHHHHHTCEEECCCGGGTTEEEEEECC-----------CCCEEEEEEEEEEEETTEEEEEEE-EE
T ss_pred             cccCCCHHHHHHHHHHHHHHcCCEEeeCCCCCceEEEEEEeCCCCcccccccCCCceeEEEEEEEEecCCceEEEEE-ec
Confidence            4678889999999999999999999874    46777763211         1123488999999999999999999 77


Q ss_pred             C----------------------CchhHHHHHHHHHHhcc
Q 016865          346 G----------------------DTLEYHKFYKNFCAKLE  363 (381)
Q Consensus       346 G----------------------d~le~~~~~~~l~~~l~  363 (381)
                      |                      .++.|-.+|.+|.-.|.
T Consensus       134 G~e~~~~~~~~~~~~~~~e~~~~s~~pFLdlca~LI~eLa  173 (179)
T 3t4n_A          134 GWESSYGDDTTVSNISEDEMSTFSAYPFLHLTTKLIMELA  173 (179)
T ss_dssp             EEECC----------------CCCCHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccCCccHHHHHHHHHHHHH
Confidence            8                      67889999988877764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.72  E-value=0.00041  Score=61.22  Aligned_cols=121  Identities=14%  Similarity=0.075  Sum_probs=80.5

Q ss_pred             ChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCccccccccCC
Q 016865           33 ELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT  110 (381)
Q Consensus        33 ~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt  110 (381)
                      +|.+.+.. ..+++|++||.++.|.+.+|.-+-. +.-..+=+.|..|++..+|++.+.+ +.+.            ...
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~~  100 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AGE  100 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------ccc
Confidence            68888865 5679999999999999999887632 2222344567999999999998864 1110            123


Q ss_pred             CCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhcccCCCCCCCChhHHHHHHHhcCC
Q 016865          111 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP  185 (381)
Q Consensus       111 ~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~  185 (381)
                      ..+.|||...  ...+.+.=|||||+++|.-+--.+|=                 ..+..+|+++.+||..|..-
T Consensus       101 ~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e-----------------~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A          101 PPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE-----------------NEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             ------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------TEEECCCHHHHHHHHHHTTC
T ss_pred             cCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc-----------------ccchhhCHHHHHHHHHHHhc
Confidence            4567888863  22347788999999999887644332                 12234899999999999866

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.59  E-value=0.00012  Score=66.60  Aligned_cols=84  Identities=15%  Similarity=0.255  Sum_probs=63.3

Q ss_pred             cccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----------------------
Q 016865            9 IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK----------------------   66 (381)
Q Consensus         9 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~----------------------   66 (381)
                      +.+++.++++.+.-|+|||+++|.++.+.....    ......+..++...|.-||+.                      
T Consensus        82 VP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~  157 (272)
T 4gkh_A           82 LPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRM  157 (272)
T ss_dssp             CCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHH
T ss_pred             cCeEEEEEEECCeEEEEEEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHH
Confidence            567788899999999999999998887765432    122334556666666666641                      


Q ss_pred             ------------------------------------CCeecCCCCCcEEEccCCCEEEeeccCccC
Q 016865           67 ------------------------------------GVYHRDLKPENLLLDSYGNLKVSDFGLSAL   96 (381)
Q Consensus        67 ------------------------------------gi~HrDlkp~NiLl~~~~~lkl~DFGls~~   96 (381)
                                                          .++|+|+.|.|||+++.+.+-|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          158 NNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                                                268999999999999877778999997653

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.41  E-value=0.0004  Score=64.78  Aligned_cols=87  Identities=22%  Similarity=0.238  Sum_probs=59.9

Q ss_pred             cccceEEEE-eCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------------------
Q 016865            9 IVRLHEVLA-SRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK---------------------   66 (381)
Q Consensus         9 Iv~l~~~~~-~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~---------------------   66 (381)
                      +.+.+.+.. ..+..|+||||++|..+.+...  ..++......+..|+...|..||+.                     
T Consensus        74 VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~  151 (306)
T 3tdw_A           74 IPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILL  151 (306)
T ss_dssp             CCCEEEEEECTTSCEEEEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHH
T ss_pred             CCCeEeecccCCCceEEEEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHH
Confidence            455566654 3456789999999988766322  2345555555666666666666542                     


Q ss_pred             ---------------------------------------CCeecCCCCCcEEEcc---CCCE-EEeeccCccCC
Q 016865           67 ---------------------------------------GVYHRDLKPENLLLDS---YGNL-KVSDFGLSALP   97 (381)
Q Consensus        67 ---------------------------------------gi~HrDlkp~NiLl~~---~~~l-kl~DFGls~~~   97 (381)
                                                             .++|+|++|.||+++.   ++.+ .|+||+.+...
T Consensus       152 ~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          152 LSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                                                   3599999999999997   4554 89999977643

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=96.78  E-value=0.00063  Score=64.50  Aligned_cols=31  Identities=23%  Similarity=0.336  Sum_probs=25.9

Q ss_pred             CCCeecCCCCCcEEEccCCCEEEeeccCccC
Q 016865           66 KGVYHRDLKPENLLLDSYGNLKVSDFGLSAL   96 (381)
Q Consensus        66 ~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~   96 (381)
                      ..++|+|+.|.|||+++.+.+.|+||+.+..
T Consensus       222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            4699999999999999644578999997653

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=95.88  E-value=0.0091  Score=55.60  Aligned_cols=30  Identities=23%  Similarity=0.305  Sum_probs=27.0

Q ss_pred             CCCeecCCCCCcEEEccCCCEEEeeccCcc
Q 016865           66 KGVYHRDLKPENLLLDSYGNLKVSDFGLSA   95 (381)
Q Consensus        66 ~gi~HrDlkp~NiLl~~~~~lkl~DFGls~   95 (381)
                      .+++|+|++|.|||++.++.+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            579999999999999888899999999653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=95.29  E-value=0.03  Score=52.25  Aligned_cols=31  Identities=32%  Similarity=0.363  Sum_probs=26.9

Q ss_pred             CCCeecCCCCCcEEEccC----CCEEEeeccCccC
Q 016865           66 KGVYHRDLKPENLLLDSY----GNLKVSDFGLSAL   96 (381)
Q Consensus        66 ~gi~HrDlkp~NiLl~~~----~~lkl~DFGls~~   96 (381)
                      ..++|||+.|.|||++.+    +.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            469999999999999874    6799999998754

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=94.82  E-value=0.027  Score=54.01  Aligned_cols=30  Identities=20%  Similarity=0.270  Sum_probs=24.8

Q ss_pred             HCCCeecCCCCCcEEEccCCCEEEeeccCcc
Q 016865           65 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSA   95 (381)
Q Consensus        65 ~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~   95 (381)
                      ...++|+|+.|.|||++.+ .+++.||..+.
T Consensus       226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~  255 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAF  255 (397)
T ss_dssp             CCEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             CCceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence            3579999999999999875 48999997653

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=94.53  E-value=0.049  Score=50.06  Aligned_cols=29  Identities=28%  Similarity=0.353  Sum_probs=24.6

Q ss_pred             CCeecCCCCCcEEEccCCCEEEeeccCccC
Q 016865           67 GVYHRDLKPENLLLDSYGNLKVSDFGLSAL   96 (381)
Q Consensus        67 gi~HrDlkp~NiLl~~~~~lkl~DFGls~~   96 (381)
                      .++|+|+.|.||+ ..++.+.++||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            3799999999999 6667889999987653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=94.11  E-value=0.03  Score=54.27  Aligned_cols=33  Identities=18%  Similarity=0.261  Sum_probs=28.3

Q ss_pred             HHCCCeecCCCCCcEEEccCCCEEEeeccCccCC
Q 016865           64 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP   97 (381)
Q Consensus        64 H~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~   97 (381)
                      +...++|+|++|.|||++.++ ++++||+.+...
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            456799999999999999877 999999987643

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=92.73  E-value=0.21  Score=46.40  Aligned_cols=25  Identities=20%  Similarity=0.153  Sum_probs=22.6

Q ss_pred             CCeecCCCCCcEEEccCCCEEEeecc
Q 016865           67 GVYHRDLKPENLLLDSYGNLKVSDFG   92 (381)
Q Consensus        67 gi~HrDlkp~NiLl~~~~~lkl~DFG   92 (381)
                      .++|+|+.+.|++++.++ +.|.|+.
T Consensus       208 ~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          208 SILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             EEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             eeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            589999999999999887 8899974

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=91.44  E-value=0.07  Score=49.28  Aligned_cols=30  Identities=27%  Similarity=0.331  Sum_probs=25.4

Q ss_pred             CCCeecCCCCCcEEEccCCCEEEeeccCcc
Q 016865           66 KGVYHRDLKPENLLLDSYGNLKVSDFGLSA   95 (381)
Q Consensus        66 ~gi~HrDlkp~NiLl~~~~~lkl~DFGls~   95 (381)
                      .+++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            369999999999999987666899998653

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=90.52  E-value=0.17  Score=46.67  Aligned_cols=29  Identities=17%  Similarity=0.038  Sum_probs=24.7

Q ss_pred             CCCeecCCCCCcEEEccCCCEEEeeccCccC
Q 016865           66 KGVYHRDLKPENLLLDSYGNLKVSDFGLSAL   96 (381)
Q Consensus        66 ~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~   96 (381)
                      ..++|+|++|.|||++ + .+.|+||+.+..
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            4589999999999999 4 899999987643

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=89.54  E-value=1  Score=39.36  Aligned_cols=115  Identities=19%  Similarity=0.269  Sum_probs=81.3

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEccCC
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG   84 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~~~   84 (381)
                      .||+.+.. .+-++.+.+.+.++.-+.+-=+..|   ..++....++++.+|+....++  ..-+|--|.|+||+++.++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~~  116 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI---KSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRDG  116 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG---GGSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTTS
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH---HhcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCCC
Confidence            68888877 6777888888888876544333444   3477888999999998877544  3457778999999999999


Q ss_pred             CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHh-HHHHHHHHHHhCCCCCC
Q 016865           85 NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW-SCGVILFVLMAGYLPFG  149 (381)
Q Consensus        85 ~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIw-SlGvil~~ll~G~~Pf~  149 (381)
                      .+++.-.|+...                 ++|       |.....|.| .+=|++..+++++..|.
T Consensus       117 ~p~i~~RGik~~-----------------l~P-------~~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          117 LPIAKTRGLQNV-----------------VDP-------LPVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             CEEESCCEETTT-----------------BSC-------CCCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             CEEEEEccCccC-----------------CCC-------CCCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999987775322                 122       211333444 36788899999988873

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=87.72  E-value=0.42  Score=45.09  Aligned_cols=28  Identities=29%  Similarity=0.438  Sum_probs=23.6

Q ss_pred             CCeecCCCCCcEEEccCCCEEEeeccCcc
Q 016865           67 GVYHRDLKPENLLLDSYGNLKVSDFGLSA   95 (381)
Q Consensus        67 gi~HrDlkp~NiLl~~~~~lkl~DFGls~   95 (381)
                      +++|+|+.|.|||+++++ +.++||..+.
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            589999999999998655 8999998764

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=87.35  E-value=0.31  Score=45.63  Aligned_cols=31  Identities=19%  Similarity=0.328  Sum_probs=27.3

Q ss_pred             CCCeecCCCCCcEEEccCCCEEEeeccCccC
Q 016865           66 KGVYHRDLKPENLLLDSYGNLKVSDFGLSAL   96 (381)
Q Consensus        66 ~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~   96 (381)
                      .+++|+|+.|.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4699999999999999888899999987654

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=86.87  E-value=1.7  Score=38.02  Aligned_cols=113  Identities=17%  Similarity=0.171  Sum_probs=79.3

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHHCCCeecCCCCCcEEEccC
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA-HCHSKGVYHRDLKPENLLLDSY   83 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~-~LH~~gi~HrDlkp~NiLl~~~   83 (381)
                      .||+.  -..+-.+.+.+.+.++.-+++.=+..+.   .++....++++.+|+.... ++  ..-+|--+.|+||+++.+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~  120 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA  120 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence            56777  4455578888888888776665566664   4778888888888877665 43  445777899999999999


Q ss_pred             CCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHh-HHHHHHHHHHhCCCCC
Q 016865           84 GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW-SCGVILFVLMAGYLPF  148 (381)
Q Consensus        84 ~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIw-SlGvil~~ll~G~~Pf  148 (381)
                      +.+++.-.|+-..                 ++|       |.....|.| .+=|++..++.++..|
T Consensus       121 ~~p~i~hRGi~~~-----------------lpP-------~e~~ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          121 LEPFFLHVGVKES-----------------LPP-------DEWDDERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             CCEEESCCEETTT-----------------BSS-------CSCCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred             CcEEEEEcCCccc-----------------CCC-------CCCCHHHHHHHHHHHHHHHHcCCCCH
Confidence            9999987775322                 222       222334444 3667888888888766

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=84.37  E-value=0.62  Score=45.70  Aligned_cols=15  Identities=27%  Similarity=0.344  Sum_probs=14.1

Q ss_pred             CCeecCCCCCcEEEc
Q 016865           67 GVYHRDLKPENLLLD   81 (381)
Q Consensus        67 gi~HrDlkp~NiLl~   81 (381)
                      .++|+|+.+.|||++
T Consensus       291 v~cHnDl~~gNIL~~  305 (458)
T 2qg7_A          291 VLCHCDLLSSNIINT  305 (458)
T ss_dssp             EEECSCCCGGGEEEC
T ss_pred             eEEecCCCCCcEEee
Confidence            489999999999998

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=83.45  E-value=0.37  Score=46.81  Aligned_cols=17  Identities=35%  Similarity=0.501  Sum_probs=14.9

Q ss_pred             CCeecCCCCCcEEEccC
Q 016865           67 GVYHRDLKPENLLLDSY   83 (381)
Q Consensus        67 gi~HrDlkp~NiLl~~~   83 (381)
                      .++|+|+.+.|||++.+
T Consensus       250 v~~H~Dl~~gNiL~~~~  266 (429)
T 1nw1_A          250 TFCHNDLQEGNILLPKA  266 (429)
T ss_dssp             EEECSCCCGGGEEEEC-
T ss_pred             EEEeCCCCCCeEEeeCC
Confidence            48999999999999875

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=82.06  E-value=0.56  Score=44.83  Aligned_cols=29  Identities=34%  Similarity=0.449  Sum_probs=25.6

Q ss_pred             CCeecCCCCCcEEEccC----CCEEEeeccCcc
Q 016865           67 GVYHRDLKPENLLLDSY----GNLKVSDFGLSA   95 (381)
Q Consensus        67 gi~HrDlkp~NiLl~~~----~~lkl~DFGls~   95 (381)
                      .++|+|+.+.|||++.+    +.+.++||..+.
T Consensus       221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             EEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             EEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            48999999999999876    789999998764

>3ost_A Serine/threonine-protein kinase KCC4; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.69A {Saccharomyces cerevisiae} PDB: 3osm_A

Probab=80.61  E-value=19  Score=28.31  Aligned_cols=85  Identities=13%  Similarity=0.161  Sum_probs=60.6

Q ss_pred             EEEeCCCHHHHHHHHHHHHH---HcCc-EEEeecceEEEEeecCCCC----ccEEEEEEEEEEeCCe-EEEEEEccCCCc
Q 016865          278 RFVSRQPAQVILSNIEAVAE---SLSL-KVHTRNYKTRLEGVSANKT----GQFAVVLEVFEVAPSL-FMVDVRKAAGDT  348 (381)
Q Consensus       278 rf~s~~~~~~i~~~l~~~~~---~~~~-~v~~~~~~~~~~~~~~~~~----~~l~~~~ei~~~~~~~-~~V~~~k~~Gd~  348 (381)
                      -+++..+.......|...++   ..|+ .++.......+.+.....+    -...|.++|++=. +. ++|-|++.+|..
T Consensus        28 ~l~t~v~k~~~~~~L~~LL~~Wk~yGlkdv~~D~~~~~ItGrvs~~N~L~LRsv~F~i~i~~~g-n~~Slv~f~q~rGSs  106 (128)
T 3ost_A           28 EIHAKIPEKRLYEGLHKLLEGWKQYGLKNLVFNITNMIITGKLVNDSILFLRSTLFEIMVLPNG-DGRSLIKFNKKTGST  106 (128)
T ss_dssp             CEEESSCHHHHHHHHHHHHHTCGGGTEEEEEEETTTTEEEEEECCCCSSSCCCEEEEEEEEECS-TTCEEEEEEESSSCH
T ss_pred             EEEEecCHHHHHHHHHHHHHHHHHhCccceEecCCCCEEEEEEccccccccceeEEEEEEeecC-CceEEEEEEEeeccH
Confidence            35788888888888888874   5565 3554443333444333222    3478999999755 66 999999999999


Q ss_pred             hhHHHHHHHHHHhcc
Q 016865          349 LEYHKFYKNFCAKLE  363 (381)
Q Consensus       349 le~~~~~~~l~~~l~  363 (381)
                      -.|++++..|..-|+
T Consensus       107 stf~klv~eiEkVL~  121 (128)
T 3ost_A          107 KTLTKLATEIQIILQ  121 (128)
T ss_dssp             HHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHH
Confidence            999999988776553

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	381
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-68
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	9e-66
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-62
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-61
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-61
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-61
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-60
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-59
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	9e-59
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-58
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-58
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	8e-58
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-57
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-55
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-55
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-54
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-54
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-53
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-53
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-53
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-51
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-50
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-48
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-47
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-46
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-46
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-46
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-46
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-45
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-45
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-45
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-44
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	9e-44
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	9e-44
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-43
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-43
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-43
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	8e-43
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-42
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-42
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-42
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-42
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-42
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-42
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-42
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-42
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-41
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-41
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	9e-40
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-39
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-39
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-36
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-36
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-36
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-36
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	6e-36
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-34
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-34
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	9e-34
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-33
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-32
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-22
d1ul7a_	102	d.129.6.1 (A:) Map/microtubule affinity-regulating	5e-14
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-12

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 5e-68
 Identities = 76/205 (37%), Positives = 114/205 (55%), Gaps = 3/205 (1%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
              +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+
Sbjct: 60  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 119

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           ++CHSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++ 
Sbjct: 120 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRTTLCGTLDYLPPEMIE 177

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI 
Sbjct: 178 GRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 236

Query: 181 KILDPNPKTRIRIEGIRKHPWFRKN 205
           ++L  NP  R  +  + +HPW   N
Sbjct: 237 RLLKHNPSQRPMLREVLEHPWITAN 261

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (529), Expect = 9e-66
 Identities = 82/212 (38%), Positives = 117/212 (55%), Gaps = 5/212 (2%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
            K++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V
Sbjct: 57  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 116

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEV 118
            + H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+
Sbjct: 117 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176

Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFW--FSTGA 175
           L  R +     DVWSCG++L  ++AG LP+   +D    Y      +     W    +  
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 236

Query: 176 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN 207
            +L+HKIL  NP  RI I  I+K  W+ K   
Sbjct: 237 LALLHKILVENPSARITIPDIKKDRWYNKPLK 268

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 3e-62
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 8/215 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL-ENDCRRYFQQLIDA 59
           +    HPNIV+L +       ++I++EF  GG +   ++   R L E+  +   +Q +DA
Sbjct: 63  LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA 122

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 119
           + + H   + HRDLK  N+L    G++K++DFG+SA   + ++   +  GTP ++APEV+
Sbjct: 123 LNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 182

Query: 120 ----SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFS 172
               S        ADVWS G+ L  +     P  E +   +  KI  +E    + P  +S
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 242

Query: 173 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN 207
           +     + K L+ N   R     + +HP+   + N
Sbjct: 243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 277

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 1e-61
 Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 9/211 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M  + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+
Sbjct: 62  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 121

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT--CGTPNYVAPEV 118
            + H KG+ HRDLKPEN+LL+   +++++DFG + +     +        GT  YV+PE+
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 119 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 178
           L+ +     ++D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L
Sbjct: 182 LTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 240

Query: 179 IHKILDPNPKTRIRIE------GIRKHPWFR 203
           + K+L  +   R+  E       ++ HP+F 
Sbjct: 241 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 271

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 3e-61
 Identities = 55/208 (26%), Positives = 102/208 (49%), Gaps = 5/208 (2%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M+  ++PNIV   +      ++++++E++ GG L D +V +  + E       ++ + A+
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQAL 129

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
              HS  V HRD+K +N+LL   G++K++DFG  A          T  GTP ++APEV++
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATS 177
            + Y     D+WS G++   ++ G  P+  E  L  LY        E   P   S     
Sbjct: 190 RKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248

Query: 178 LIHKILDPNPKTRIRIEGIRKHPWFRKN 205
            +++ LD + + R   + + +H + +  
Sbjct: 249 FLNRCLDMDVEKRGSAKELLQHQFLKIA 276

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  196 bits (500), Expect = 7e-61
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 8/227 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ +RHPN ++           ++++E+  G       VH+  L E +        +  +
Sbjct: 69  LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL- 119
           A+ HS  + HRD+K  N+LL   G +K+ DFG +++        ++  GTP ++APEV+ 
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVIL 184

Query: 120 -SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFW--FSTGAT 176
             + G      DVWS G+    L     P    +  +    I   E        +S    
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR 244

Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVH 223
           + +   L   P+ R   E + KH +  +   P    +  +   D V 
Sbjct: 245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVR 291

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  196 bits (498), Expect = 3e-60
 Identities = 67/240 (27%), Positives = 116/240 (48%), Gaps = 9/240 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDA 59
           M ++RHP +V LH+      ++ +I EF++GGELF+K+  +  ++ E++   Y +Q+   
Sbjct: 77  MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136

Query: 60  VAHCHSKGVYHRDLKPENLLLDS--YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
           + H H     H DLKPEN++  +     LK+ DFGL+A      + +  T GT  + APE
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH-LDPKQSVKVTTGTAEFAAPE 195

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFST 173
           V   +   G   D+WS GV+ ++L++G  PFG  +     + + + +++         S 
Sbjct: 196 VAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254

Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQY 233
                I K+L  +P TR+ I    +HPW      P + S+        +        D +
Sbjct: 255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAW 314

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  193 bits (491), Expect = 4e-59
 Identities = 57/216 (26%), Positives = 110/216 (50%), Gaps = 9/216 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDA 59
           M  + HP ++ LH+    + ++ +ILEF++GGELFD+I  +  ++ E +   Y +Q  + 
Sbjct: 80  MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 139

Query: 60  VAHCHSKGVYHRDLKPENLLLDSY--GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
           + H H   + H D+KPEN++ ++    ++K+ DFGL+       E++  T  T  + APE
Sbjct: 140 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPE 198

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFST 173
           ++          D+W+ GV+ +VL++G  PF   D     + +   ++          S 
Sbjct: 199 IVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257

Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
            A   I  +L   P+ R+ +    +HPW + +++ +
Sbjct: 258 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNL 293

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  190 bits (483), Expect = 9e-59
 Identities = 71/213 (33%), Positives = 113/213 (53%), Gaps = 10/213 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
            K+  HPNI++L +   + T  +++ + +  GELFD +  +  L E + R+  + L++ +
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
              H   + HRDLKPEN+LLD   N+K++DFG S     G E L   CGTP+Y+APE++ 
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIE 182

Query: 121 -----NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--F 171
                N    G   D+WS GVI++ L+AG  PF       + + I +   +F  P W  +
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 242

Query: 172 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
           S     L+ + L   P+ R   E    HP+F++
Sbjct: 243 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 1e-58
 Identities = 67/213 (31%), Positives = 106/213 (49%), Gaps = 13/213 (6%)

Query: 1   MKIVRHPNIVRLHEVLASRT--KVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQ 54
           ++ ++HPNIVR ++ +  RT   +YI++E+  GG+L   I    +    L E    R   
Sbjct: 57  LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 116

Query: 55  QLIDAVAHCHSKG-----VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG 109
           QL  A+  CH +      V HRDLKP N+ LD   N+K+ DFGL+ +            G
Sbjct: 117 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG 176

Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCP 168
           TP Y++PE ++   Y+   +D+WS G +L+ L A   PF       L  KI   +F   P
Sbjct: 177 TPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP 235

Query: 169 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPW 201
           + +S     +I ++L+     R  +E I ++P 
Sbjct: 236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 1e-58
 Identities = 64/205 (31%), Positives = 108/205 (52%), Gaps = 2/205 (0%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
                HP +  +     ++  ++ ++E++ GG+L   I    +   +    Y  ++I  +
Sbjct: 57  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL 116

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
              HSKG+ +RDLK +N+LLD  G++K++DFG+      G    +T CGTP+Y+APE+L 
Sbjct: 117 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL 176

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            + Y+  + D WS GV+L+ ++ G  PF   D   L+  I       P W    A  L+ 
Sbjct: 177 GQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLV 235

Query: 181 KILDPNPKTRIRIEG-IRKHPWFRK 204
           K+    P+ R+ + G IR+HP FR+
Sbjct: 236 KLFVREPEKRLGVRGDIRQHPLFRE 260

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  188 bits (479), Expect = 8e-58
 Identities = 89/222 (40%), Positives = 128/222 (57%), Gaps = 9/222 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +  ++HPNIV L ++  S   +Y+I++ V+GGELFD+IV +G   E D  R   Q++DAV
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAV 120

Query: 61  AHCHSKGVYHRDLKPENLLL---DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
            + H  G+ HRDLKPENLL    D    + +SDFGLS +   G  +L T CGTP YVAPE
Sbjct: 121 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPE 179

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FST 173
           VL+ + Y   A D WS GVI ++L+ GY PF + +   L+++I  AE  F  P+W   S 
Sbjct: 180 VLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 238

Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEE 215
            A   I  +++ +P+ R   E   +HPW   +    K   + 
Sbjct: 239 SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQS 280

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 6e-57
 Identities = 59/217 (27%), Positives = 106/217 (48%), Gaps = 9/217 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDA 59
           + I RH NI+ LHE   S  ++ +I EF++G ++F++I      L E +   Y  Q+ +A
Sbjct: 55  LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEA 114

Query: 60  VAHCHSKGVYHRDLKPENLLLDS--YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
           +   HS  + H D++PEN++  +     +K+ +FG +   + G +        P Y APE
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPE 173

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFST 173
           V  +     +A D+WS G +++VL++G  PF       + + I  AE++         S 
Sbjct: 174 VHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232

Query: 174 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVK 210
            A   + ++L    K+R+      +HPW ++    V 
Sbjct: 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVS 269

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 1e-55
 Identities = 56/264 (21%), Positives = 96/264 (36%), Gaps = 55/264 (20%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +     P IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  +
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 117

Query: 61  AHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 119
            +   K  + HRD+KP N+L++S G +K+ DFG+S      +   ++  GT +Y++PE L
Sbjct: 118 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERL 175

Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFW--------- 170
               Y    +D+WS G+ L  +  G  P    D   L                       
Sbjct: 176 QGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234

Query: 171 -----------------------------------FSTGATSLIHKILDPNPKTRIRIEG 195
                                              FS      ++K L  NP  R  ++ 
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294

Query: 196 IRKHPWFRKNYNPVKCSEEEEVNL 219
           +  H + ++       S+ EEV+ 
Sbjct: 295 LMVHAFIKR-------SDAEEVDF 311

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 4e-55
 Identities = 80/259 (30%), Positives = 125/259 (48%), Gaps = 19/259 (7%)

Query: 1   MKIVRHPNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQ 54
            +  + P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +     +
Sbjct: 59  WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 118

Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTP 111
            + +A+ + HS  + HRD+KPENLL  S      LK++DFG +         L T C TP
Sbjct: 119 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTP 177

Query: 112 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA--EF 165
            YVAPEVL    YD  + D+WS GVI+++L+ GY PF    G    P +  +I     EF
Sbjct: 178 YYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236

Query: 166 SCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVH 223
             P W   S     LI  +L   P  R+ I     HPW  ++    +        L +  
Sbjct: 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDK 296

Query: 224 AVFDDIEDQYVAEQSENKV 242
             ++D++++  +  +  +V
Sbjct: 297 ERWEDVKEEMTSALATMRV 315

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 1e-54
 Identities = 48/213 (22%), Positives = 98/213 (46%), Gaps = 14/213 (6%)

Query: 1   MKIVRHPNIVRLHEVLASRTK----VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQL 56
           +K ++HPNIVR ++   S  K    + ++ E +T G L   +     +     R + +Q+
Sbjct: 62  LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI 121

Query: 57  IDAVAHCHSKG--VYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNY 113
           +  +   H++   + HRDLK +N+ +    G++K+ D GL+ L +          GTP +
Sbjct: 122 LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEF 179

Query: 114 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFW-- 170
           +APE+   + YD  + DV++ G+ +  +     P+    +   +Y+++ +      F   
Sbjct: 180 MAPEMYEEK-YD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 237

Query: 171 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
                  +I   +  N   R  I+ +  H +F+
Sbjct: 238 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  180 bits (457), Expect = 5e-54
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 10/211 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +     P IV +     +  K+  IL+ + GG+L   +   G   E D R Y  ++I  +
Sbjct: 61  VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 120

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            H H++ V +RDLKP N+LLD +G++++SD GL+    +     H + GT  Y+APEVL 
Sbjct: 121 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQ 178

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPF---GETDLPTLYKKINAAEFSCPFWFSTGATS 177
                 S+AD +S G +LF L+ G+ PF      D   + +         P  FS    S
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238

Query: 178 LIHKILDPNPKTRIRIEG-----IRKHPWFR 203
           L+  +L  +   R+   G     +++ P+FR
Sbjct: 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 2e-53
 Identities = 70/217 (32%), Positives = 104/217 (47%), Gaps = 13/217 (5%)

Query: 5   RHPNIVRLHEVLASRTKVYIILEFVTGG-ELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 63
               ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV HC
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126

Query: 64  HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 122
           H+ GV HRD+K EN+L+D + G LK+ DFG  AL +    +     GT  Y  PE +   
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVYSPPEWIRYH 184

Query: 123 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 182
            Y G +A VWS G++L+ ++ G +PF   +      +I   +       S+    LI   
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQHLIRWC 238

Query: 183 LDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNL 219
           L   P  R   E I+ HPW +    P    E  E++L
Sbjct: 239 LALRPSDRPTFEEIQNHPWMQDVLLP---QETAEIHL 272

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  177 bits (449), Expect = 3e-53
 Identities = 68/209 (32%), Positives = 125/209 (59%), Gaps = 9/209 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           + IV HP I+R+        ++++I++++ GGELF  +    R      + Y  ++  A+
Sbjct: 58  LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLAL 117

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HSK + +RDLKPEN+LLD  G++K++DFG +   +   ++ +T CGTP+Y+APEV+S
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA---KYVPDVTYTLCGTPDYIAPEVVS 174

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
            + Y+  + D WS G++++ ++AGY PF +++    Y+KI  AE   P +F+     L+ 
Sbjct: 175 TKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLS 233

Query: 181 KILDPNPKTRIR-----IEGIRKHPWFRK 204
           +++  +   R+       E ++ HPWF++
Sbjct: 234 RLITRDLSQRLGNLQNGTEDVKNHPWFKE 262

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 6e-53
 Identities = 68/208 (32%), Positives = 109/208 (52%), Gaps = 6/208 (2%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++  RHP +  L     +  ++  ++E+  GGELF  +  +    E   R Y  +++ A+
Sbjct: 59  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSAL 118

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS+ V +RD+K ENL+LD  G++K++DFGL          + T CGTP Y+APEVL 
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           +  Y   A D W  GV+++ +M G LPF   D   L++ I   E   P   S  A SL+ 
Sbjct: 179 DNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLA 237

Query: 181 KILDPNPKTRIR-----IEGIRKHPWFR 203
            +L  +PK R+       + + +H +F 
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFFL 265

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 2e-51
 Identities = 70/212 (33%), Positives = 113/212 (53%), Gaps = 10/212 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V
Sbjct: 67  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126

Query: 61  AHCHSKGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
            + HS  + H DLKPEN++L         +K+ DFGL+     G        GTP +VAP
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAP 185

Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWF----S 172
           E+++        AD+WS GVI ++L++G  PF           ++A  +     +    S
Sbjct: 186 EIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244

Query: 173 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
             A   I ++L  +PK R+ I+   +HPW + 
Sbjct: 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 2e-50
 Identities = 42/210 (20%), Positives = 85/210 (40%), Gaps = 12/210 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDA 59
           ++  RH NI+      ++  ++ I+ ++  G  L+  + + + +          +Q    
Sbjct: 58  LRKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPE 117
           + + H+K + HRDLK  N+ L     +K+ DFGL+ +     G        G+  ++APE
Sbjct: 117 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176

Query: 118 VL--SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFW----- 170
           V+   ++      +DV++ G++L+ LM G LP+   +       +    +  P       
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236

Query: 171 -FSTGATSLIHKILDPNPKTRIRIEGIRKH 199
                   L+ + L      R     I   
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 2e-48
 Identities = 54/241 (22%), Positives = 87/241 (36%), Gaps = 28/241 (11%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ + HPNI+ L +    ++ + ++ +F+          +   L  +  + Y    +  +
Sbjct: 54  LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGL 113

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + H   + HRDLKP NLLLD  G LK++DFGL+               T  Y APE+L 
Sbjct: 114 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 173

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA-EFSCPFW-------- 170
                G   D+W+ G IL  L+       G++DL  L +        +   W        
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233

Query: 171 ------------------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCS 212
                                    LI  +   NP  RI      K  +F     P    
Sbjct: 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGC 293

Query: 213 E 213
           +
Sbjct: 294 Q 294

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  162 bits (410), Expect = 3e-47
 Identities = 74/254 (29%), Positives = 128/254 (50%), Gaps = 15/254 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
            + HS  + +RDLKPENLL+D  G ++V+DFG +   ++      T CGTP  +APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWTLCGTPEALAPEIIL 211

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 180
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270

Query: 181 KILDPNPKTRIR-----IEGIRKHPWFRK-NYNPVKCSEEE-----EVNLDDVHAVFDDI 229
            +L  +   R       +  I+ H WF   ++  +   + E     +       + FDD 
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDY 330

Query: 230 EDQYVAEQSENKVG 243
           E++ +      K G
Sbjct: 331 EEEEIRVSINEKCG 344

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 2e-46
 Identities = 59/246 (23%), Positives = 100/246 (40%), Gaps = 39/246 (15%)

Query: 1   MKIVRHPNIVRLHEVLASRT----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQL 56
           +   RH NI+ +++++ + T    K   ++  + G +L+  ++    L  +    +  Q+
Sbjct: 60  LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYK-LLKTQHLSNDHICYFLYQI 118

Query: 57  IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL---PQQGVELLHTTCGTPNY 113
           +  + + HS  V HRDLKP NLLL++  +LK+ DFGL+ +          L     T  Y
Sbjct: 119 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178

Query: 114 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI------------- 160
            APE++ N      + D+WS G IL  +++    F           I             
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238

Query: 161 -------NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 202
                       S P               + A  L+ K+L  NP  RI +E    HP+ 
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298

Query: 203 RKNYNP 208
            + Y+P
Sbjct: 299 EQYYDP 304

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 3e-46
 Identities = 47/204 (23%), Positives = 90/204 (44%), Gaps = 9/204 (4%)

Query: 1   MKIVRHPNIVRLHEVLA-SRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLI 57
           M  +RH N+V+L  V+   +  +YI+ E++  G L D +  +GR  L  +   ++   + 
Sbjct: 54  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113

Query: 58  DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
           +A+ +       HRDL   N+L+      KVSDFGL+   ++      T      + APE
Sbjct: 114 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPE 170

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGA 175
            L  + +  + +DVWS G++L+ + + G +P+    L  +  ++        P       
Sbjct: 171 ALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV 229

Query: 176 TSLIHKILDPNPKTRIRIEGIRKH 199
             ++      +   R     +R+ 
Sbjct: 230 YEVMKNCWHLDAAMRPSFLQLREQ 253

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 3e-46
 Identities = 40/210 (19%), Positives = 80/210 (38%), Gaps = 10/210 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M+ + +P IVR+  +        +++E    G L   +     + + +      Q+   +
Sbjct: 62  MQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 120

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPE 117
            +       HRDL   N+LL +    K+SDFGLS   +                 + APE
Sbjct: 121 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGA 175
            ++   +  S +DVWS GV+++   + G  P+       +   +   E   CP       
Sbjct: 181 CINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM 239

Query: 176 TSLIHKILDPNPKTRIRIEGIR---KHPWF 202
             L++     + + R     +    ++ ++
Sbjct: 240 YDLMNLCWTYDVENRPGFAAVELRLRNYYY 269

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  157 bits (397), Expect = 4e-46
 Identities = 57/233 (24%), Positives = 100/233 (42%), Gaps = 29/233 (12%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++H NIV+L++V+ ++ ++ ++ E +         V +G L     + +  QL++ +
Sbjct: 54  LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGI 113

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           A+CH + V HRDLKP+NLL++  G LK++DFGL+      V        T  Y AP+VL 
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW-------- 170
                 +  D+WS G I   ++ G   F          +I       +   W        
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233

Query: 171 -------------------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 204
                                     L+ K+L  +P  RI  +   +H +F++
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 1e-45
 Identities = 67/239 (28%), Positives = 109/239 (45%), Gaps = 30/239 (12%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFV-TGGELFDKIVHQGRLLENDCRRYFQQLIDA 59
           +K + HPNIV+L +V+ +  K+Y++ EF+    + F        +     + Y  QL+  
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 114

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 119
           +A CHS  V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+L
Sbjct: 115 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174

Query: 120 SNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--------------- 163
               Y  +A D+WS G I   ++     F G++++  L++                    
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234

Query: 164 --EFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 209
             + S P W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 4e-45
 Identities = 47/211 (22%), Positives = 84/211 (39%), Gaps = 11/211 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M  + +P IVRL  V      + +++E   GG L   +V  +  +  ++      Q+   
Sbjct: 63  MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 121

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAP 116
           + +   K   HRDL   N+LL +    K+SDFGLS                     + AP
Sbjct: 122 MKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181

Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTG 174
           E ++ R +  S +DVWS GV ++  ++ G  P+ +   P +   I   +   CP      
Sbjct: 182 ECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE 240

Query: 175 ATSLIHKILDPNPKTRIRIEGIR---KHPWF 202
             +L+        + R     +    +  ++
Sbjct: 241 LYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  154 bits (390), Expect = 4e-45
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 12/214 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTK----VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQL 56
              + HP IV +++   + T      YI++E+V G  L D +  +G +            
Sbjct: 61  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 120

Query: 57  IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL---PQQGVELLHTTCGTPNY 113
             A+   H  G+ HRD+KP N+++ +   +KV DFG++         V       GT  Y
Sbjct: 121 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180

Query: 114 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF---- 169
           ++PE       D + +DV+S G +L+ ++ G  PF      ++  +    +   P     
Sbjct: 181 LSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239

Query: 170 WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
             S    +++ K L  NP+ R +     +    R
Sbjct: 240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 1e-44
 Identities = 44/203 (21%), Positives = 86/203 (42%), Gaps = 5/203 (2%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDA 59
           M  + H  +V+L+ V   +  ++II E++  G L + +   + R          + + +A
Sbjct: 53  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 112

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEV 118
           + +  SK   HRDL   N L++  G +KVSDFGLS  +          +     +  PEV
Sbjct: 113 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 172

Query: 119 LSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI-NAAEFSCPFWFSTGAT 176
           L    +  S +D+W+ GV+++ + + G +P+         + I        P   S    
Sbjct: 173 LMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY 231

Query: 177 SLIHKILDPNPKTRIRIEGIRKH 199
           ++++         R   + +  +
Sbjct: 232 TIMYSCWHEKADERPTFKILLSN 254

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 9e-44
 Identities = 43/227 (18%), Positives = 81/227 (35%), Gaps = 29/227 (12%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ------------------- 41
            ++  H NIV L         +Y+I E+   G+L + +  +                   
Sbjct: 95  TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154

Query: 42  ----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL- 96
                 L   D   +  Q+   +     K   HRDL   N+L+     +K+ DFGL+   
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214

Query: 97  -PQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLP 154
                  +         ++APE L    Y    +DVWS G++L+ + + G  P+    + 
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 155 TLYKKI--NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH 199
             + K+  N  +   PF+ +     ++      + + R     +   
Sbjct: 274 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 9e-44
 Identities = 47/252 (18%), Positives = 86/252 (34%), Gaps = 44/252 (17%)

Query: 1   MKIVRHPNIVRLHEVLASRT--------KVYIILEFVTGGELFDKIVHQGRLLENDCRRY 52
           +++++H N+V L E+  ++          +Y++ +F              +   ++ +R 
Sbjct: 63  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV 122

Query: 53  FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL----PQQGVELLHTTC 108
            Q L++ + + H   + HRD+K  N+L+   G LK++DFGL+                  
Sbjct: 123 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182

Query: 109 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP 168
            T  Y  PE+L      G   D+W  G I+  +                  I+    S  
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242

Query: 169 --------------------------------FWFSTGATSLIHKILDPNPKTRIRIEGI 196
                                           +     A  LI K+L  +P  RI  +  
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

Query: 197 RKHPWFRKNYNP 208
             H +F  +  P
Sbjct: 303 LNHDFFWSDPMP 314

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 2e-43
 Identities = 67/284 (23%), Positives = 107/284 (37%), Gaps = 44/284 (15%)

Query: 1   MKIVRHPNIVRLHEVLAS------RTKVYIILEFVTGG---ELFDKIVHQGRLLENDCRR 51
           M+ + H NIVRL     S         + ++L++V              +  L     + 
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126

Query: 52  YFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQGVELLHTTCGT 110
           Y  QL  ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G E   +   +
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICS 185

Query: 111 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI---------- 160
             Y APE++       S+ DVWS G +L  L+ G   F          +I          
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245

Query: 161 -------NAAEFSCPFW------------FSTGATSLIHKILDPNPKTRIRIEGIRKHPW 201
                  N  EF  P                  A +L  ++L+  P  R+       H +
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305

Query: 202 FRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQYVAEQSENKVGGP 245
           F +  +P      +  N  D  A+F+    +  +      +  P
Sbjct: 306 FDELRDP----NVKLPNGRDTPALFNFTTQELSSNPPLATILIP 345

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 3e-43
 Identities = 65/267 (24%), Positives = 112/267 (41%), Gaps = 47/267 (17%)

Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           +K +RH N++ L +V      L   T  Y+++ F+  G    K++   +L E+  +    
Sbjct: 71  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVY 128

Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + + H+ G+ HRDLKP NL ++    LK+ DFGL+   +Q    +     T  Y 
Sbjct: 129 QMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA---RQADSEMTGYVVTRWYR 185

Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWF--- 171
           APEV+ N        D+WS G I+  ++ G   F  +D     K+I     + P  F   
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245

Query: 172 ----------------------------STGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
                                       S  A +L+ K+L  + + R+       HP+F 
Sbjct: 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305

Query: 204 KNYNPVKCSEEEEVNLDDVHAVFDDIE 230
             ++      E+E  +      FDD++
Sbjct: 306 SLHDT-----EDEPQVQKYDDSFDDVD 327

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 8e-43
 Identities = 65/238 (27%), Positives = 96/238 (40%), Gaps = 30/238 (12%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           +K ++H NIVRLH+VL S  K+ ++ EF             G L     + +  QL+  +
Sbjct: 55  LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
             CHS+ V HRDLKP+NLL++  G LK+++FGL+      V        T  Y  P+VL 
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174

Query: 121 NRGYDGSAADVWSCGVILFVLMAGYLP-FGETDLPTLYKKINAAEFSCPF---------- 169
                 ++ D+WS G I   L     P F   D+    K+I     +             
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234

Query: 170 -------------------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 208
                                +     L+  +L  NP  RI  E   +HP+F     P
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 8e-43
 Identities = 52/206 (25%), Positives = 86/206 (41%), Gaps = 9/206 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M  + H N++RL+ V+ +   + ++ E    G L D++  HQG  L     RY  Q+ + 
Sbjct: 65  MHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAP 116
           + +  SK   HRDL   NLLL +   +K+ DFGL     Q  +             + AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAEFSCPFW--FST 173
           E L  R +   A+D W  GV L+ +   G  P+   +   +  KI+      P       
Sbjct: 184 ESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 242

Query: 174 GATSLIHKILDPNPKTRIRIEGIRKH 199
              +++ +     P+ R     +R  
Sbjct: 243 DIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 1e-42
 Identities = 68/215 (31%), Positives = 116/215 (53%), Gaps = 11/215 (5%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
             I + P +V LH    + TK+++IL+++ GGELF  +  + R  E++ + Y  +++ A+
Sbjct: 83  EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 142

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVL 119
            H H  G+ +RD+K EN+LLDS G++ ++DFGLS        E  +  CGT  Y+AP+++
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202

Query: 120 -SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD----LPTLYKKINAAEFSCPFWFSTG 174
                    A D WS GV+++ L+ G  PF           + ++I  +E   P   S  
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 262

Query: 175 ATSLIHKILDPNPKTRIR-----IEGIRKHPWFRK 204
           A  LI ++L  +PK R+       + I++H +F+K
Sbjct: 263 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (373), Expect = 1e-42
 Identities = 49/209 (23%), Positives = 90/209 (43%), Gaps = 9/209 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLID 58
           MK ++H  +VRL+ V+ ++  +YII E++  G L D +      +L  N       Q+ +
Sbjct: 62  MKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPE 117
            +A    +   HRDL+  N+L+    + K++DFGL+  +                + APE
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI-NAAEFSCPFWFSTGA 175
            + N G     +DVWS G++L  ++  G +P+     P + + +        P       
Sbjct: 181 AI-NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL 239

Query: 176 TSLIHKILDPNPKTRIRIEGIRK--HPWF 202
             L+       P+ R   + +R     +F
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 2e-42
 Identities = 48/203 (23%), Positives = 84/203 (41%), Gaps = 5/203 (2%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL-ENDCRRYFQQLIDA 59
           M  + HP +V+L+ V   +  + ++ EF+  G L D +  Q  L            + + 
Sbjct: 54  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 113

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL-SALPQQGVELLHTTCGTPNYVAPEV 118
           +A+     V HRDL   N L+     +KVSDFG+   +          T     + +PEV
Sbjct: 114 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 173

Query: 119 LSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI-NAAEFSCPFWFSTGAT 176
            S   Y  S +DVWS GV+++ + + G +P+       + + I        P   ST   
Sbjct: 174 FSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVY 232

Query: 177 SLIHKILDPNPKTRIRIEGIRKH 199
            +++      P+ R     + + 
Sbjct: 233 QIMNHCWKERPEDRPAFSRLLRQ 255

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  147 bits (373), Expect = 2e-42
 Identities = 49/216 (22%), Positives = 84/216 (38%), Gaps = 16/216 (7%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD-KIVHQGRLLENDCRRYFQQLIDA 59
           M    HPN++ L  V+   T V II EF+  G L      + G+          + +   
Sbjct: 81  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-----CGTPNYV 114
           + +       HRDL   N+L++S    KVSDFGLS   +        T          + 
Sbjct: 141 MKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 200

Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI-NAAEFSCPFWFS 172
           APE +  R +   A+DVWS G++++ +M+ G  P+ +     +   I        P    
Sbjct: 201 APEAIQYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCP 259

Query: 173 TGATSLIHKILDPNPKTRI-------RIEGIRKHPW 201
           +    L+      +   R         ++ + ++P 
Sbjct: 260 SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 295

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 5e-42
 Identities = 61/236 (25%), Positives = 94/236 (39%), Gaps = 35/236 (14%)

Query: 1   MKIVRHPNIVRLHEVLAS-----RTKVYIILEFVTGGEL-FDKIVHQGRLLENDCRRYFQ 54
           ++   HPN+VRL +V         TK+ ++ E V      +   V +  +     +    
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           QL+  +   HS  V HRDLKP+N+L+ S G +K++DFGL+ +    +  L +   T  Y 
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVVTLWYR 182

Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPF---- 169
           APEVL    Y  +  D+WS G I   +      F G +D+  L K ++            
Sbjct: 183 APEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241

Query: 170 ----------------------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 203
                                         L+ K L  NP  RI       HP+F+
Sbjct: 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 5e-42
 Identities = 48/217 (22%), Positives = 78/217 (35%), Gaps = 20/217 (9%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ----------------GRL 44
            K+  HPNI+ L      R  +Y+ +E+   G L D +                     L
Sbjct: 65  CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124

Query: 45  LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 104
                  +   +   + +   K   HRDL   N+L+      K++DFGLS   +  V+  
Sbjct: 125 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-K 183

Query: 105 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI-NA 162
                   ++A E L N     + +DVWS GV+L+ ++  G  P+       LY+K+   
Sbjct: 184 TMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242

Query: 163 AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH 199
                P         L+ +     P  R     I   
Sbjct: 243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 6e-42
 Identities = 60/203 (29%), Positives = 92/203 (45%), Gaps = 6/203 (2%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD-KIVHQGRLLENDCRRYFQQLIDA 59
           M+   HP+IV+L  V+ +   V+II+E  T GEL     V +  L       Y  QL  A
Sbjct: 62  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEV 118
           +A+  SK   HRD+   N+L+ S   +K+ DFGLS   +       +       ++APE 
Sbjct: 121 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180

Query: 119 LSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI-NAAEFSCPFWFSTGAT 176
           ++ R +   A+DVW  GV ++ +LM G  PF       +  +I N      P        
Sbjct: 181 INFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 239

Query: 177 SLIHKILDPNPKTRIRIEGIRKH 199
           SL+ K    +P  R R   ++  
Sbjct: 240 SLMTKCWAYDPSRRPRFTELKAQ 262

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 7e-42
 Identities = 47/212 (22%), Positives = 85/212 (40%), Gaps = 9/212 (4%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLID 58
           MK +RH  +V+L+ V+ S   +YI+ E+++ G L D +  +    L          Q+  
Sbjct: 66  MKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPE 117
            +A+       HRDL+  N+L+      KV+DFGL+  +                + APE
Sbjct: 125 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 184

Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI-NAAEFSCPFWFSTGA 175
                 +    +DVWS G++L  +   G +P+       +  ++       CP       
Sbjct: 185 AALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 243

Query: 176 TSLIHKILDPNPKTRIRIEGIRK--HPWFRKN 205
             L+ +     P+ R   E ++     +F   
Sbjct: 244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  146 bits (368), Expect = 1e-41
 Identities = 62/224 (27%), Positives = 91/224 (40%), Gaps = 8/224 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLID 58
           MK ++HPN+V+L  V       YII EF+T G L D +    R  +          Q+  
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 126

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT-TCGTPNYVAPE 117
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H        + APE
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186

Query: 118 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINA-AEFSCPFWFSTGA 175
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+ +        P       
Sbjct: 187 SLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 245

Query: 176 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNL 219
             L+      NP  R     I +   F   +     S+E E  L
Sbjct: 246 YELMRACWQWNPSDRPSFAEIHQ--AFETMFQESSISDEVEKEL 287

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 3e-41
 Identities = 54/243 (22%), Positives = 92/243 (37%), Gaps = 38/243 (15%)

Query: 1   MKIVRHPNIVRLHEVLASRTKV----YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQL 56
           +K ++H N++ L +V      +     + L     G   + IV   +L ++  +    Q+
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130

Query: 57  IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 116
           +  + + HS  + HRDLKP NL ++    LK+ DFGL+      +        T  Y AP
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAP 187

Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWF----- 171
           E++ N  +     D+WS G I+  L+ G   F  TD     K I     +          
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247

Query: 172 --------------------------STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 205
                                     +  A  L+ K+L  +   RI       H +F + 
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307

Query: 206 YNP 208
           ++P
Sbjct: 308 HDP 310

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 9e-40
 Identities = 45/239 (18%), Positives = 90/239 (37%), Gaps = 9/239 (3%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           M  V +P++ RL  +  + T   I      G  L     H+  +       +  Q+   +
Sbjct: 65  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 124

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC--GTPNYVAPEV 118
            +   + + HRDL   N+L+ +  ++K++DFGL+ L     +  H         ++A E 
Sbjct: 125 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 119 LSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGAT 176
           + +R Y    +DVWS GV ++ LM  G  P+       +   +   E    P   +    
Sbjct: 185 ILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 243

Query: 177 SLIHKILDPNPKTRIRIEGIRKHPWF----RKNYNPVKCSEEEEVNLDDVHAVFDDIED 231
            ++ K    +  +R +   +           + Y  ++  E   +        +  + D
Sbjct: 244 MIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMD 302

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 2e-39
 Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 14/213 (6%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDA 59
           M    H NI+RL  V++    + II E++  G L   +    G           + +   
Sbjct: 63  MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 122

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC---GTPNYVAP 116
           + +  +    HRDL   N+L++S    KVSDFGLS + +   E  +TT        + AP
Sbjct: 123 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

Query: 117 EVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTG 174
           E +S R +  SA+DVWS G++++ +M  G  P+ E     + K IN       P    + 
Sbjct: 183 EAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA 241

Query: 175 ATSLIHKILDPNPKTRI-------RIEGIRKHP 200
              L+ +        R         ++ + + P
Sbjct: 242 IYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  139 bits (352), Expect = 5e-39
 Identities = 49/244 (20%), Positives = 92/244 (37%), Gaps = 45/244 (18%)

Query: 1   MKIVRHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 58
             +   PNI+ L +++         ++ E V   +          L + D R Y  +++ 
Sbjct: 84  ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILK 140

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 117
           A+ +CHS G+ HRD+KP N+++D     L++ D+GL+     G +  +    +  +  PE
Sbjct: 141 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPE 199

Query: 118 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD--------------LPTLYKKINAA 163
           +L +      + D+WS G +L  ++    PF                     LY  I+  
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259

Query: 164 EFSCPFWF------------------------STGATSLIHKILDPNPKTRIRIEGIRKH 199
                  F                        S  A   + K+L  + ++R+      +H
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319

Query: 200 PWFR 203
           P+F 
Sbjct: 320 PYFY 323

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 1e-36
 Identities = 50/226 (22%), Positives = 90/226 (39%), Gaps = 15/226 (6%)

Query: 1   MKIVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFDKIVHQGRLL-ENDCRRYFQQLID 58
           MK   HPN++ L  + L S     ++L ++  G+L + I ++       D   +  Q+  
Sbjct: 82  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 141

Query: 59  AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL----PQQGVELLHTTCGTPNYV 114
            +    SK   HRDL   N +LD    +KV+DFGL+          V           ++
Sbjct: 142 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201

Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI-NAAEFSCPFWFS 172
           A E L  + +  + +DVWS GV+L+ LM  G  P+ + +   +   +        P +  
Sbjct: 202 ALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP 260

Query: 173 TGATSLIHKILDPNPKTRIRIEGIRKH------PWFRKNYNPVKCS 212
                ++ K   P  + R     +          +  ++Y  V  +
Sbjct: 261 DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNAT 306

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  132 bits (333), Expect = 1e-36
 Identities = 37/230 (16%), Positives = 77/230 (33%), Gaps = 23/230 (10%)

Query: 1   MKIVRHPN-IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 59
            K+++    I  +    A      +++E +             +           Q+I  
Sbjct: 56  YKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISR 115

Query: 60  VAHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLH-------TTCG 109
           + + HSK   HRD+KP+N L+        + + DFGL+   +      H          G
Sbjct: 116 IEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 175

Query: 110 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF---GETDLPTLYKKINAAEFS 166
           T  Y +              D+ S G +L     G LP+           Y++I+  + S
Sbjct: 176 TARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234

Query: 167 CPFW-----FSTGATSLIHKILDPNPKTRIRIEGIR---KHPWFRKNYNP 208
            P       + +   + ++         +     +R   ++ + R+ ++ 
Sbjct: 235 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 284

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  131 bits (329), Expect = 5e-36
 Identities = 43/226 (19%), Positives = 81/226 (35%), Gaps = 29/226 (12%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR----------------- 43
           M    +PNIV+L  V A    + ++ E++  G+L + +                      
Sbjct: 70  MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129

Query: 44  -------LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL 96
                  L   +     +Q+   +A+   +   HRDL   N L+     +K++DFGLS  
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 97  --PQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYL-PFGETDL 153
                  +          ++ PE +    Y  + +DVW+ GV+L+ + +  L P+     
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAH 248

Query: 154 PTLYKKINAAEF-SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK 198
             +   +      +CP        +L+       P  R     I +
Sbjct: 249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 6e-36
 Identities = 47/219 (21%), Positives = 84/219 (38%), Gaps = 21/219 (9%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG----------------RL 44
             I +H NI+ L         +Y+I+E+ + G L + +  +                 +L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 45  LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 104
              D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+          
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192

Query: 105 HT--TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKIN 161
            T        ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K + 
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251

Query: 162 AAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH 199
                  P   +     ++       P  R   + + + 
Sbjct: 252 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 6e-36
 Identities = 47/221 (21%), Positives = 74/221 (33%), Gaps = 24/221 (10%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI------------------VHQG 42
             +  H NIV L           +I E+   G+L + +                    + 
Sbjct: 81  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 43  RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE 102
            L   D   +  Q+   +A   SK   HRDL   N+LL      K+ DFGL+   +    
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 103 LLHTT--CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYK 158
            +          ++APE + N       +DVWS G+ L+ L +       G       YK
Sbjct: 201 YVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259

Query: 159 KINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK 198
            I        P         ++    D +P  R   + I +
Sbjct: 260 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 2e-34
 Identities = 45/241 (18%), Positives = 89/241 (36%), Gaps = 44/241 (18%)

Query: 1   MKIVRHPNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQL 56
             ++RH NI+           + T+++++ ++   G LFD + ++  +      +     
Sbjct: 51  TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALST 109

Query: 57  IDAVAHCHS--------KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT- 107
              +AH H           + HRDLK +N+L+   G   ++D GL+       + +    
Sbjct: 110 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 169

Query: 108 ---CGTPNYVAPEVLSNR-----GYDGSAADVWSCGVILFVLMAGYLPFG---------- 149
               GT  Y+APEVL +            AD+++ G++ + +       G          
Sbjct: 170 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229

Query: 150 -----ETDLPTLYKKINAAEFSCPF---WFSTGATSLIHKI----LDPNPKTRIRIEGIR 197
                +  +  + K +   +        W S  A  ++ KI       N   R+    I+
Sbjct: 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289

Query: 198 K 198
           K
Sbjct: 290 K 290

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 3e-34
 Identities = 44/224 (19%), Positives = 83/224 (37%), Gaps = 21/224 (9%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN----------DCR 50
           MK     ++VRL  V++      +I+E +T G+L   +      + N             
Sbjct: 77  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 51  RYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT--C 108
           +   ++ D +A+ ++    HRDL   N ++     +K+ DFG++    +           
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 109 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG-YLPFGETDLPTLYKKINAAE-FS 166
               +++PE L +  +    +DVWS GV+L+ +      P+       + + +       
Sbjct: 197 LPVRWMSPESLKDGVFTT-YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 255

Query: 167 CPFWFSTGATSLIHKILDPNPKTRIRIEGIRK------HPWFRK 204
            P         L+      NPK R     I         P FR+
Sbjct: 256 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 9e-34
 Identities = 63/281 (22%), Positives = 103/281 (36%), Gaps = 53/281 (18%)

Query: 1   MKIVRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 54
           MK V H NI+ L  V      L     VY+++E +         V Q  L          
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLY 126

Query: 55  QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 114
           Q++  + H HS G+ HRDLKP N+++ S   LK+ DFGL+        ++     T  Y 
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYR 185

Query: 115 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWF--- 171
           APEV+   GY     D+WS G I+  ++   + F   D    + K+     +    F   
Sbjct: 186 APEVILGMGYKE-NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244

Query: 172 ---------------------------------------STGATSLIHKILDPNPKTRIR 192
                                                  ++ A  L+ K+L  +P  RI 
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304

Query: 193 IEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEDQY 233
           ++   +HP+    Y+P +         D      +   +++
Sbjct: 305 VDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEW 345

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 3e-33
 Identities = 43/221 (19%), Positives = 80/221 (36%), Gaps = 23/221 (10%)

Query: 1   MKIVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFDKI----------------VHQGR 43
           + I  H N+V L          + +I+EF   G L   +                +++  
Sbjct: 71  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 44  LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 103
           L       Y  Q+   +    S+   HRDL   N+LL     +K+ DFGL+    +  + 
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190

Query: 104 LHTT--CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGY-LPFGETDLPTLYKKI 160
           +          ++APE + +R Y    +DVWS GV+L+ + +    P+    +   + + 
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249

Query: 161 --NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH 199
                    P + +      +       P  R     + +H
Sbjct: 250 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  121 bits (304), Expect = 2e-32
 Identities = 33/219 (15%), Positives = 70/219 (31%), Gaps = 22/219 (10%)

Query: 1   MKIVRH-PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 59
            K++     I  ++          ++++ +         +   +          +Q++  
Sbjct: 54  YKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLAR 113

Query: 60  VAHCHSKGVYHRDLKPENLLLDSY-----GNLKVSDFGLSALPQQGVE-------LLHTT 107
           V   H K + +RD+KP+N L+          + V DFG+    +  V             
Sbjct: 114 VQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 173

Query: 108 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL---YKKINAAE 164
            GT  Y++      R       D+ + G +    + G LP+      T    Y++I   +
Sbjct: 174 SGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 232

Query: 165 FSCPFW-----FSTGATSLIHKILDPNPKTRIRIEGIRK 198
            S P       F       +H   +         + ++ 
Sbjct: 233 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 95.1 bits (235), Expect = 2e-22
 Identities = 40/268 (14%), Positives = 86/268 (32%), Gaps = 64/268 (23%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVT-----GGELFDKIVHQGRLLENDCRRYFQQ 55
              +   +I++L +    +    + +  V            K      +     ++  +Q
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 56  LIDAVAHCHSK-GVYHRDLKPENLLLDSYG------NLKVSDFGLSALPQQGVELLHTTC 108
           L+  + + H + G+ H D+KPEN+L++          +K++D G +    +       + 
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY---TNSI 190

Query: 109 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK---------- 158
            T  Y +PEVL    +    AD+WS   ++F L+ G   F   +  +  K          
Sbjct: 191 QTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

Query: 159 --------------------------------------KINAAEFSCPFWFSTGATSLIH 180
                                                  +   ++      +   +  + 
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309

Query: 181 KILDPNPKTRIRIEGIRKHPWFRKNYNP 208
            +L  +P+ R    G+  HPW +     
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGM 337

>d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} Length = 102

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Kinase associated domain 1, KA1
domain: Map/microtubule affinity-regulating kinase 3
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 65.2 bits (159), Expect = 5e-14
 Identities = 11/85 (12%), Positives = 28/85 (32%), Gaps = 2/85 (2%)

Query: 281 SRQPAQVILSNIEAVAESLSLKVHTR-NYKTRLEGVSANKTGQFAVVLEVFEVA-PSLFM 338
           S      ++  I  V  + +     R  +         +        +EV ++   SL  
Sbjct: 17  SSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNG 76

Query: 339 VDVRKAAGDTLEYHKFYKNFCAKLE 363
           V  ++ +G ++ +         +L+
Sbjct: 77  VRFKRISGTSIAFKNIASKIANELK 101

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 63.6 bits (154), Expect = 1e-12
 Identities = 23/146 (15%), Positives = 55/146 (37%), Gaps = 28/146 (19%)

Query: 1   MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 60
           ++ ++   + +++          +++E +             R+   +       +++ V
Sbjct: 68  LQKLQGLAVPKVYAW----EGNAVLMELIDAK-------ELYRVRVENPDEVLDMILEEV 116

Query: 61  AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 120
           A  + +G+ H DL   N+L+   G + + DF  S      VE+          +  +V +
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQS------VEVGEEGW--REILERDVRN 167

Query: 121 -----NRGYDGSAADVWSCGVILFVL 141
                +R Y  +  D+ S   I  +L
Sbjct: 168 IITYFSRTY-RTEKDINS--AIDRIL 190

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	381
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.66
d1ul7a_	102	Map/microtubule affinity-regulating kinase 3 {Mous	99.45
d2v8qa1	153	5'-AMP-activated protein kinase catalytic subunit	98.06
d2qrda1	127	Snf1-like protein kinase ssp2 {Schizosaccharomyces	97.7
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.34
d2qlva1	171	Carbon catabolite-derepressing protein kinase SNF1	97.33
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	96.51
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	95.23
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	93.18
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	88.29

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-55  Score=407.21  Aligned_cols=202  Identities=38%  Similarity=0.704  Sum_probs=189.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |++++|||||++++++.+++.+|+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        60 l~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill  139 (263)
T d2j4za1          60 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL  139 (263)
T ss_dssp             HHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred             HHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee
Confidence            46789999999999999999999999999999999999988899999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.+|.+||+|||+|.....  ......+||+.|+|||++.+..|+ .++|||||||++|+|++|++||.+.+....+.++
T Consensus       140 ~~~~~~kl~DFG~a~~~~~--~~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i  216 (263)
T d2j4za1         140 GSAGELKIADFGWSVHAPS--SRRTTLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI  216 (263)
T ss_dssp             CTTSCEEECCCCSCSCCCC--CCCEETTEEGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             cCCCCEeecccceeeecCC--CcccccCCCCcccCHHHHcCCCCC-chhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            9999999999999986654  234577899999999999987775 8999999999999999999999999988999999


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ....+..|..+|+++++||.+||++||.+|||++|+++||||+.+
T Consensus       217 ~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~~  261 (263)
T d2j4za1         217 SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN  261 (263)
T ss_dssp             HTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             HcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence            999999999999999999999999999999999999999999753

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-55  Score=404.39  Aligned_cols=206  Identities=39%  Similarity=0.689  Sum_probs=180.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |++++|||||++++++.+++.+|||||||+||+|++++...+.+++..++.++.||++||+|||++||+||||||+|||+
T Consensus        57 l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl  136 (271)
T d1nvra_          57 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL  136 (271)
T ss_dssp             HHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred             HHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE
Confidence            46789999999999999999999999999999999999888889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCC--ccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh-HHH
Q 016865           81 DSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLY  157 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~  157 (381)
                      ++++++||+|||+|+.....  .....+.+||+.|+|||++.+..+++.++||||+||++|+|++|++||...+.. ..+
T Consensus       137 ~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~  216 (271)
T d1nvra_         137 DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY  216 (271)
T ss_dssp             CTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH
T ss_pred             CCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH
Confidence            99999999999999865432  233567789999999999998888778899999999999999999999765543 333


Q ss_pred             HHhhcccCCCC--CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          158 KKINAAEFSCP--FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       158 ~~i~~~~~~~p--~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      ..+.......+  ..+|+++.+||.+||+.||.+|||++|+++||||++..
T Consensus       217 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l  267 (271)
T d1nvra_         217 SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  267 (271)
T ss_dssp             HHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence            33333333322  34899999999999999999999999999999998654

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-53  Score=407.48  Aligned_cols=203  Identities=33%  Similarity=0.609  Sum_probs=192.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++|||||++++++++.+.+|+|||||+||+|++++...+.++|+.++.|+.||+.||+|||++||+||||||+|||+
T Consensus        59 l~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl  138 (337)
T d1o6la_          59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML  138 (337)
T ss_dssp             HHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE
T ss_pred             HHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe
Confidence            46789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.+|.+||+|||+|+..........+.|||+.|+|||++.+.+|+ .++|||||||++|+|++|++||.+.+...+++++
T Consensus       139 ~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~-~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i  217 (337)
T d1o6la_         139 DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI  217 (337)
T ss_dssp             CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             cCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCC-hhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHH
Confidence            999999999999998765544566788999999999999988885 8999999999999999999999999999999999


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIR-----IEGIRKHPWFRK  204 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t-----~~~il~hp~~~~  204 (381)
                      ....+.+|..+|+++++||++||++||.+|++     ++++++||||+.
T Consensus       218 ~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~  266 (337)
T d1o6la_         218 LMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             HHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             hcCCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence            99999999999999999999999999999994     999999999974

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=400.88  Aligned_cols=202  Identities=25%  Similarity=0.462  Sum_probs=180.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++|||||++++++.+.+.+|||||||+||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        71 l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl  149 (293)
T d1yhwa1          71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL  149 (293)
T ss_dssp             HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             HHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE
Confidence            4678999999999999999999999999999999987765 679999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.+|++||+|||+|+............+||+.|+|||++.+..|+ .++||||+||++|+|++|++||.+.+.......+
T Consensus       150 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~  228 (293)
T d1yhwa1         150 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI  228 (293)
T ss_dssp             CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             CCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCC-chhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence            999999999999998765544556778899999999999887775 8999999999999999999999887766554444


Q ss_pred             hcc---cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          161 NAA---EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       161 ~~~---~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      ...   .+..|..+|+++++||.+||++||.+|||++|+++||||+.
T Consensus       229 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         229 ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             HHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            332   34456679999999999999999999999999999999975

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-54  Score=401.75  Aligned_cols=203  Identities=31%  Similarity=0.558  Sum_probs=184.6

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |++++|||||++++++.+++.+|+|||||+||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus        62 l~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll  141 (288)
T d1uu3a_          62 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL  141 (288)
T ss_dssp             HHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             HHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc
Confidence            45789999999999999999999999999999999999998999999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCC--ccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016865           81 DSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK  158 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~  158 (381)
                      +++|.+||+|||+|+.....  .....+.+||+.|+|||++.+..|+ .++||||+||++|+|++|++||.+.+....+.
T Consensus       142 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~  220 (288)
T d1uu3a_         142 NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ  220 (288)
T ss_dssp             CTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCC-cccceehhhHHHHHHhhCCCCCCCcCHHHHHH
Confidence            99999999999999876432  2334567899999999999888775 89999999999999999999999999889999


Q ss_pred             HhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHH------HhcCccccc
Q 016865          159 KINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEG------IRKHPWFRK  204 (381)
Q Consensus       159 ~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~------il~hp~~~~  204 (381)
                      ++....+.+|..+|+++++||.+||+.||.+|||++|      +++||||+.
T Consensus       221 ~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~  272 (288)
T d1uu3a_         221 KIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES  272 (288)
T ss_dssp             HHHTTCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred             HHHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence            9998889999999999999999999999999999988      578999964

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-53  Score=396.31  Aligned_cols=204  Identities=29%  Similarity=0.498  Sum_probs=180.5

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |++++|||||++++++.+.+.+|+|||||+||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus        63 l~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIl  142 (288)
T d2jfla1          63 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNIL  142 (288)
T ss_dssp             HHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             HHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhhee
Confidence            4578999999999999999999999999999999998765 456999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecC-----CCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-----RGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      ++.+|++||+|||+|...........+.+||+.|+|||++..     ..| +.++||||+||++|+|++|++||.+.+..
T Consensus       143 l~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyemltg~~Pf~~~~~~  221 (288)
T d2jfla1         143 FTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAEIEPPHHELNPM  221 (288)
T ss_dssp             ECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHHHHSSCTTTTSCGG
T ss_pred             ECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHHhhCCCCCCCCCHH
Confidence            999999999999999765443334567889999999999842     334 48999999999999999999999988887


Q ss_pred             HHHHHhhccc---CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          155 TLYKKINAAE---FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       155 ~~~~~i~~~~---~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      +...++....   ...|..+|+++++||.+||+.||.+|||++|+++||||+..
T Consensus       222 ~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         222 RVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             GHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             HHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            7777766554   34456689999999999999999999999999999999753

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-52  Score=395.93  Aligned_cols=203  Identities=41%  Similarity=0.776  Sum_probs=172.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++|||||++++++.+++.+|||||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        61 l~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~  140 (307)
T d1a06a_          61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLY  140 (307)
T ss_dssp             HHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             HHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceee
Confidence            46789999999999999999999999999999999999998899999999999999999999999999999999999999


Q ss_pred             c---cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           81 D---SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        81 ~---~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      .   +++.+||+|||+|...... ....+.+||+.|+|||++.+..|+ .++||||+||++|+|++|.+||.+.+.....
T Consensus       141 ~~~~~~~~vkl~DFG~a~~~~~~-~~~~~~~GT~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~  218 (307)
T d1a06a_         141 YSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLF  218 (307)
T ss_dssp             SSSSTTCCEEECCC-------------------CTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             cccCCCceEEEeccceeEEccCC-CeeeeeeeCccccCcHHHcCCCCC-cHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH
Confidence            5   4789999999999866543 345678899999999999888775 8999999999999999999999998888888


Q ss_pred             HHhhcccCCCC----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          158 KKINAAEFSCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       158 ~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      ..+.......+    ..+|+++.+||.+||++||.+|||++|+++||||+..
T Consensus       219 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         219 EQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             HHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             HHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            88877665443    4589999999999999999999999999999999754

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.1e-52  Score=392.98  Aligned_cols=200  Identities=34%  Similarity=0.736  Sum_probs=188.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |++++|||||++++++.+.+.+|+|||||+||+|.+.+.....++++.++.++.||+.||+|||++||+||||||+|||+
T Consensus        58 l~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl  137 (316)
T d1fota_          58 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL  137 (316)
T ss_dssp             HHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE
T ss_pred             HHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE
Confidence            46789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.+|.+||+|||+|.....   ...+.+||+.|+|||++.+..|+ .++||||+||++|+|++|+.||.+.+......++
T Consensus       138 ~~~g~vkL~DFG~a~~~~~---~~~~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i  213 (316)
T d1fota_         138 DKNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI  213 (316)
T ss_dssp             CTTSCEEECCCSSCEECSS---CBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             cCCCCEEEecCccceEecc---ccccccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHHH
Confidence            9999999999999987654   24578999999999999887776 8999999999999999999999999999999999


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  204 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~-----t~~~il~hp~~~~  204 (381)
                      ..+....|+.+|+++.++|.+||..||.+|+     |++++++||||+.
T Consensus       214 ~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~  262 (316)
T d1fota_         214 LNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE  262 (316)
T ss_dssp             HHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             HcCCCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence            8888999999999999999999999999996     9999999999975

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-52  Score=388.25  Aligned_cols=201  Identities=33%  Similarity=0.604  Sum_probs=169.0

Q ss_pred             CCCCCccccccceEEEEe--CCEEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----Ce
Q 016865            1 MKIVRHPNIVRLHEVLAS--RTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKG-----VY   69 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~L~~LH~~g-----i~   69 (381)
                      |++++|||||++++++.+  .+.+|||||||+||+|.+++..    .+.+++..++.++.||+.||+|||++|     |+
T Consensus        57 l~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~Ii  136 (269)
T d2java1          57 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVL  136 (269)
T ss_dssp             TTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC------
T ss_pred             HHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEE
Confidence            678999999999999965  4579999999999999998864    457999999999999999999999976     99


Q ss_pred             ecCCCCCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCC
Q 016865           70 HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFG  149 (381)
Q Consensus        70 HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~  149 (381)
                      ||||||+|||++.+|.+||+|||+|+..........+.+||+.|+|||++.+..|+ .++|||||||++|+|++|++||.
T Consensus       137 HrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyel~tg~~Pf~  215 (269)
T d2java1         137 HRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFT  215 (269)
T ss_dssp             ---CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             eCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCC-hHHHHHhhCHHHHHHhhCCCCCC
Confidence            99999999999999999999999998766544556678999999999999887775 89999999999999999999999


Q ss_pred             CCChhHHHHHhhcccC-CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 016865          150 ETDLPTLYKKINAAEF-SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  202 (381)
Q Consensus       150 ~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  202 (381)
                      +.+..+...++..+.+ ..|..+|+++.+||.+||+.||.+|||++|+++|||+
T Consensus       216 ~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         216 AFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             CSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            9888888888877665 4667799999999999999999999999999999995

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=382.81  Aligned_cols=199  Identities=24%  Similarity=0.481  Sum_probs=174.6

Q ss_pred             CCCCCccccccceEEEEe----CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCC
Q 016865            1 MKIVRHPNIVRLHEVLAS----RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG--VYHRDLK   74 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~----~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~g--i~HrDlk   74 (381)
                      |++++|||||++++++++    +..+|+|||||+||+|.+++.+.+.++++.++.++.||+.||+|||++|  |+|||||
T Consensus        62 l~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiK  141 (270)
T d1t4ha_          62 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLK  141 (270)
T ss_dssp             HTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCC
T ss_pred             HHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcC
Confidence            578999999999999975    4579999999999999999998889999999999999999999999999  9999999


Q ss_pred             CCcEEEc-cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCC-
Q 016865           75 PENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-  152 (381)
Q Consensus        75 p~NiLl~-~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-  152 (381)
                      |+|||++ .++.+||+|||+|+....  ....+.+||+.|+|||++.+ +| +.++||||+||++|+|++|++||.+.+ 
T Consensus       142 p~NILl~~~~~~~Kl~DFGla~~~~~--~~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~~  217 (270)
T d1t4ha_         142 CDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQN  217 (270)
T ss_dssp             GGGEEESSTTSCEEECCTTGGGGCCT--TSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred             hhhceeeCCCCCEEEeecCcceeccC--CccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCccc
Confidence            9999997 478999999999986543  23467899999999999865 46 499999999999999999999997654 


Q ss_pred             hhHHHHHhhcccC--CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          153 LPTLYKKINAAEF--SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       153 ~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      ....++.+..+..  ..+...++++.+||.+||++||++|||++|+++||||+
T Consensus       218 ~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         218 AAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            4556666655433  23455899999999999999999999999999999996

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-52  Score=393.72  Aligned_cols=201  Identities=31%  Similarity=0.626  Sum_probs=189.6

Q ss_pred             CCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEcc
Q 016865            3 IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS   82 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~   82 (381)
                      .++|||||++++++.+++.+|||||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus        59 ~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~  138 (320)
T d1xjda_          59 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK  138 (320)
T ss_dssp             HTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT
T ss_pred             hCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecC
Confidence            57999999999999999999999999999999999999899999999999999999999999999999999999999999


Q ss_pred             CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhc
Q 016865           83 YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA  162 (381)
Q Consensus        83 ~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~  162 (381)
                      +|++||+|||++.............+||+.|+|||++.+..|+ .++||||+||++|+|++|+.||.+.+...++.++..
T Consensus       139 ~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~  217 (320)
T d1xjda_         139 DGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM  217 (320)
T ss_dssp             TSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence            9999999999998766544556678999999999999988876 899999999999999999999999999999999998


Q ss_pred             ccCCCCCCCChhHHHHHHHhcCCCCCCCCCHH-HHhcCccccc
Q 016865          163 AEFSCPFWFSTGATSLIHKILDPNPKTRIRIE-GIRKHPWFRK  204 (381)
Q Consensus       163 ~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~-~il~hp~~~~  204 (381)
                      +.+.+|..+|+++.+||++||+.||.+|||+. ++++||||+.
T Consensus       218 ~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         218 DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             CCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence            89999999999999999999999999999995 8999999974

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-52  Score=395.21  Aligned_cols=201  Identities=27%  Similarity=0.444  Sum_probs=170.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~-gi~HrDlkp~NiL   79 (381)
                      |+.++|||||+++++|.+.+.+||||||++||+|.+++.+.+.+++..++.++.|++.||.|||++ ||+||||||+|||
T Consensus        58 l~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NIL  137 (322)
T d1s9ja_          58 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL  137 (322)
T ss_dssp             GGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEE
T ss_pred             HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHee
Confidence            578999999999999999999999999999999999999888999999999999999999999974 9999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  159 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~  159 (381)
                      ++.+|++||+|||+|.....  ....+.+||+.|+|||++.+..|+ .++||||+||++|||++|+.||...+.......
T Consensus       138 l~~~~~vkl~DFGla~~~~~--~~~~~~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~  214 (322)
T d1s9ja_         138 VNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM  214 (322)
T ss_dssp             ECTTCCEEECCCCCCHHHHH--HTC---CCSSCCCCHHHHHCSCCC-TTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHH
T ss_pred             ECCCCCEEEeeCCCccccCC--CccccccCCccccCchHHcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            99999999999999985432  334577999999999999988775 899999999999999999999976543221100


Q ss_pred             ------------------------------------------hhcc-cCCCCC-CCChhHHHHHHHhcCCCCCCCCCHHH
Q 016865          160 ------------------------------------------INAA-EFSCPF-WFSTGATSLIHKILDPNPKTRIRIEG  195 (381)
Q Consensus       160 ------------------------------------------i~~~-~~~~p~-~~s~~~~~li~~~L~~dP~~R~t~~~  195 (381)
                                                                +... ....|. .+|+++.+||.+||+.||.+|||++|
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e  294 (322)
T d1s9ja_         215 FGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ  294 (322)
T ss_dssp             C------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             HHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence                                                      0000 001111 25889999999999999999999999


Q ss_pred             HhcCccccc
Q 016865          196 IRKHPWFRK  204 (381)
Q Consensus       196 il~hp~~~~  204 (381)
                      +|+||||+.
T Consensus       295 ~L~Hpf~~~  303 (322)
T d1s9ja_         295 LMVHAFIKR  303 (322)
T ss_dssp             HHTSHHHHH
T ss_pred             HhhCHhhCc
Confidence            999999975

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.2e-51  Score=387.63  Aligned_cols=202  Identities=24%  Similarity=0.361  Sum_probs=178.9

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |++++|||||++++++.+++.+|+|||||.||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus        69 l~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl  148 (309)
T d1u5ra_          69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL  148 (309)
T ss_dssp             HTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE
T ss_pred             HHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE
Confidence            57899999999999999999999999999999998888888899999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCC--CCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR--GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK  158 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~  158 (381)
                      +.++.+||+|||+|.....    ..+.+||+.|+|||++.+.  +.++.++|||||||++|+|++|..||.+.+......
T Consensus       149 ~~~~~~Kl~DFG~a~~~~~----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~  224 (309)
T d1u5ra_         149 SEPGLVKLGDFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY  224 (309)
T ss_dssp             ETTTEEEECCCTTCBSSSS----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred             CCCCCEEEeecccccccCC----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            9999999999999986543    3467899999999998642  223489999999999999999999999888776666


Q ss_pred             HhhcccCC--CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          159 KINAAEFS--CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       159 ~i~~~~~~--~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      ++......  .+..+|+++++||.+||+.||.+|||++|+++||||....
T Consensus       225 ~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~  274 (309)
T d1u5ra_         225 HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (309)
T ss_dssp             HHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence            66554432  2345899999999999999999999999999999998643

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.6e-51  Score=393.94  Aligned_cols=204  Identities=28%  Similarity=0.619  Sum_probs=185.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |++++|||||++++++++++.+|||||||+||+|++.+...+ ++++..++.++.||+.||+|||++||+||||||+|||
T Consensus        80 l~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NIL  159 (352)
T d1koba_          80 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIM  159 (352)
T ss_dssp             HTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccc
Confidence            578999999999999999999999999999999999886644 6999999999999999999999999999999999999


Q ss_pred             Ec--cCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           80 LD--SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        80 l~--~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      ++  .++.+||+|||+|...... ....+.+||+.|+|||++.+..|+ .++||||+||++|+|++|.+||.+.+.....
T Consensus       160 l~~~~~~~vkL~DFGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~  237 (352)
T d1koba_         160 CETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETL  237 (352)
T ss_dssp             ESSTTCCCEEECCCTTCEECCTT-SCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH
T ss_pred             ccccCCCeEEEeecccceecCCC-CceeeccCcccccCHHHHcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            98  5789999999999876543 445678899999999999887775 8999999999999999999999998888888


Q ss_pred             HHhhcccCCCC----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          158 KKINAAEFSCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       158 ~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      ..+....+..|    ..+|+++.+||.+||++||.+|||++|+++||||+...
T Consensus       238 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         238 QNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             HHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence            88877766554    35899999999999999999999999999999998654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.6e-51  Score=393.64  Aligned_cols=205  Identities=31%  Similarity=0.642  Sum_probs=184.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |++++|||||++++++.+.+.+|||||||+||+|++++.. .+.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus        77 l~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIl  156 (350)
T d1koaa2          77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIM  156 (350)
T ss_dssp             HHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHee
Confidence            4578999999999999999999999999999999999954 467999999999999999999999999999999999999


Q ss_pred             Ecc--CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           80 LDS--YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        80 l~~--~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      ++.  ++.+||+|||+|+..... ....+.+||+.|+|||++.+..|+ .++||||+||++|+|++|.+||.+.+..+..
T Consensus       157 l~~~~~~~vkL~DFG~a~~~~~~-~~~~~~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~  234 (350)
T d1koaa2         157 FTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETL  234 (350)
T ss_dssp             ESSTTSCCEEECCCTTCEECCTT-SCEEEECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             eccCCCCeEEEeecchheecccc-cccceecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHHHHH
Confidence            964  578999999999876543 345678899999999999988775 8999999999999999999999998888888


Q ss_pred             HHhhcccCCCC----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 016865          158 KKINAAEFSCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  207 (381)
Q Consensus       158 ~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~  207 (381)
                      ..+....+..+    ..+|+++++||.+||..||.+|||++|+++||||+....
T Consensus       235 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~  288 (350)
T d1koaa2         235 RNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  288 (350)
T ss_dssp             HHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred             HHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            88877766554    348999999999999999999999999999999987544

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-51  Score=384.36  Aligned_cols=202  Identities=35%  Similarity=0.642  Sum_probs=184.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |++++|||||++++++++.+.+|||||||+||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus        67 l~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill  146 (293)
T d1jksa_          67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIML  146 (293)
T ss_dssp             HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEE
Confidence            45789999999999999999999999999999999999988899999999999999999999999999999999999999


Q ss_pred             ccCC----CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHH
Q 016865           81 DSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL  156 (381)
Q Consensus        81 ~~~~----~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~  156 (381)
                      +.+|    .+|++|||+|...... ....+.+||+.|+|||++.+..| +.++||||+||++|+|++|+.||.+.+..+.
T Consensus       147 ~~~~~~~~~vkl~DfG~a~~~~~~-~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~  224 (293)
T d1jksa_         147 LDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQET  224 (293)
T ss_dssp             SCSSSSSCCEEECCCTTCEECTTS-CBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             ecCCCcccceEecchhhhhhcCCC-ccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHH
Confidence            9776    5999999999876543 34567789999999999987666 5999999999999999999999999888888


Q ss_pred             HHHhhcccCCCC----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          157 YKKINAAEFSCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       157 ~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      ...+.......+    ..+|+++++||++||+.||.+|||++|+++||||+.
T Consensus       225 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  276 (293)
T d1jksa_         225 LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  276 (293)
T ss_dssp             HHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred             HHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            888877766554    458999999999999999999999999999999975

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=6.8e-51  Score=393.79  Aligned_cols=202  Identities=31%  Similarity=0.490  Sum_probs=180.8

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++|||||++++++.+.+.+|+|||||+||+|.++|...+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        61 l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl  140 (364)
T d1omwa3          61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL  140 (364)
T ss_dssp             HSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             HhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE
Confidence            35678999999999999999999999999999999999998999999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh---HHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP---TLY  157 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~---~~~  157 (381)
                      +.+|.+||+|||+|+.....  ...+.+||+.|+|||++.+...++.++|||||||+||+|++|+.||...+..   ...
T Consensus       141 ~~~g~iKl~DFGla~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~  218 (364)
T d1omwa3         141 DEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID  218 (364)
T ss_dssp             CSSSCEEECCCTTCEECSSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH
T ss_pred             cCCCcEEEeeeceeeecCCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999999999866542  3467789999999999975554469999999999999999999999875543   334


Q ss_pred             HHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 016865          158 KKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIR-----IEGIRKHPWFRK  204 (381)
Q Consensus       158 ~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t-----~~~il~hp~~~~  204 (381)
                      ..+.......|..+|+++++||.+||+.||.+|||     ++++++||||+.
T Consensus       219 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~  270 (364)
T d1omwa3         219 RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  270 (364)
T ss_dssp             HHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred             HhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence            44555566778889999999999999999999999     799999999975

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.5e-51  Score=391.92  Aligned_cols=200  Identities=34%  Similarity=0.668  Sum_probs=188.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++|||||++++++.+...+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus        95 l~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl  174 (350)
T d1rdqe_          95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI  174 (350)
T ss_dssp             HTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             HHHcCCCcEeecccccccccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc
Confidence            57899999999999999999999999999999999999998999999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.+|++||+|||+|+....   ...+.+||+.|+|||++.+.+|+ .++|||||||++|+|++|++||.+.+....+.++
T Consensus       175 ~~~g~ikL~DFG~a~~~~~---~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i  250 (350)
T d1rdqe_         175 DQQGYIQVTDFGFAKRVKG---RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI  250 (350)
T ss_dssp             CTTSCEEECCCTTCEECSS---CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCCCCEEeeeceeeeeccc---ccccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHHHHHH
Confidence            9999999999999987653   23567899999999999988775 8999999999999999999999999988899999


Q ss_pred             hcccCCCCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 016865          161 NAAEFSCPFWFSTGATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  204 (381)
Q Consensus       161 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~-----t~~~il~hp~~~~  204 (381)
                      ..+....|..+|+++.+||++||+.||.+|+     |++++++||||+.
T Consensus       251 ~~~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~  299 (350)
T d1rdqe_         251 VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             HHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             hcCCCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence            9998899999999999999999999999995     9999999999974

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-51  Score=384.13  Aligned_cols=208  Identities=25%  Similarity=0.308  Sum_probs=180.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++|||||++++++.+++.+||||||+.||++...+...+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        54 l~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli  133 (299)
T d1ua2a_          54 LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL  133 (299)
T ss_dssp             HHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred             HHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe
Confidence            35689999999999999999999999999998887776667789999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.+||+|||+|...........+.+||+.|+|||++.+..+++.++||||+||++|+|++|.+||.+.+..+...++
T Consensus       134 ~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i  213 (299)
T d1ua2a_         134 DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI  213 (299)
T ss_dssp             CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             cCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHH
Confidence            99999999999999877665555677899999999999976666679999999999999999999999988776665554


Q ss_pred             hcccC--------------------CC--------CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 016865          161 NAAEF--------------------SC--------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  208 (381)
Q Consensus       161 ~~~~~--------------------~~--------p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~  208 (381)
                      .....                    ..        ...+|+++.+||.+||+.||++|||++|+|+||||+....|
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p  289 (299)
T d1ua2a_         214 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  289 (299)
T ss_dssp             HHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             HHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence            32100                    00        12368899999999999999999999999999999865433

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.3e-50  Score=377.66  Aligned_cols=202  Identities=33%  Similarity=0.638  Sum_probs=181.1

Q ss_pred             CCCC-ccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            2 KIVR-HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         2 k~l~-HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      +.++ |||||++++++.+++.+|||||||+||+|.++|...+.++++.++.|+.||+.||+|||++||+||||||+|||+
T Consensus        64 ~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill  143 (277)
T d1phka_          64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL  143 (277)
T ss_dssp             HHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             HHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE
Confidence            3455 999999999999999999999999999999999998999999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecC-----CCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhH
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-----RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT  155 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  155 (381)
                      +.++.+||+|||++...... ......+||+.|+|||++.+     ....+.++||||+||++|+|++|++||.+.+...
T Consensus       144 ~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~  222 (277)
T d1phka_         144 DDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML  222 (277)
T ss_dssp             CTTCCEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             cCCCCeEEccchheeEccCC-CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH
Confidence            99999999999999876543 23456789999999999863     2233689999999999999999999999998888


Q ss_pred             HHHHhhcccCCCCC----CCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          156 LYKKINAAEFSCPF----WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       156 ~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      ..+.+..+....+.    .+|+++++||.+||++||.+|||++|+++||||+.
T Consensus       223 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         223 MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             HHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             HHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            88877776654332    58999999999999999999999999999999974

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-50  Score=383.49  Aligned_cols=203  Identities=29%  Similarity=0.558  Sum_probs=184.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |++++|||||++++++++.+.+|||||||+||+|+++|...+ .+++++++.++.||+.||+|||++||+||||||+|||
T Consensus        55 l~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIl  134 (321)
T d1tkia_          55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENII  134 (321)
T ss_dssp             HHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             HHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCccccccccee
Confidence            467899999999999999999999999999999999998755 6999999999999999999999999999999999999


Q ss_pred             EccC--CCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHH
Q 016865           80 LDSY--GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  157 (381)
Q Consensus        80 l~~~--~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~  157 (381)
                      ++.+  +.+||+|||++...... ....+.+||+.|+|||++.+..|. .++||||+||++|+|++|.+||...+....+
T Consensus       135 l~~~~~~~ikl~DFG~~~~~~~~-~~~~~~~~t~~y~ape~~~~~~~~-~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~  212 (321)
T d1tkia_         135 YQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQII  212 (321)
T ss_dssp             ESSSSCCCEEECCCTTCEECCTT-CEEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred             ecCCCceEEEEcccchhhccccC-CcccccccccccccchhccCCCCC-chhhcccHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            9854  48999999999876543 345678899999999999877765 8999999999999999999999999988888


Q ss_pred             HHhhcccCCCCC----CCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 016865          158 KKINAAEFSCPF----WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       158 ~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      .++....+.+|.    .+|+++++||.+||+.||.+|||++|+++||||+..
T Consensus       213 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         213 ENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            888887776654    589999999999999999999999999999999754

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-50  Score=383.67  Aligned_cols=202  Identities=35%  Similarity=0.635  Sum_probs=173.3

Q ss_pred             CCCccccccceEEEEe----CCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 016865            3 IVRHPNIVRLHEVLAS----RTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE   76 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~----~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~   76 (381)
                      ..+|||||+++++|++    ++.+|||||||+||+|+++|...  ..+++.+++.++.||+.||+|||++||+||||||+
T Consensus        61 ~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~  140 (335)
T d2ozaa1          61 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE  140 (335)
T ss_dssp             HTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             hcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccc
Confidence            4589999999999986    46799999999999999999874  36999999999999999999999999999999999


Q ss_pred             cEEEcc---CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh
Q 016865           77 NLLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL  153 (381)
Q Consensus        77 NiLl~~---~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~  153 (381)
                      |||++.   .+.+||+|||+|+..... ....+.+||+.|+|||++.+..|+ .++|||||||+||+|++|++||.+.+.
T Consensus       141 NIll~~~~~~~~~Kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~  218 (335)
T d2ozaa1         141 NLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHG  218 (335)
T ss_dssp             GEEESCSSTTCCEEECCCTTCEECCCC-CCCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTC
T ss_pred             ccccccccccccccccccceeeeccCC-CccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCH
Confidence            999985   457999999999866543 345678899999999999887775 899999999999999999999976654


Q ss_pred             hH----HHHHhhcccCCCCC----CCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          154 PT----LYKKINAAEFSCPF----WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       154 ~~----~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      ..    +...+....+.+|.    .+|+++.+||++||+.||.+|||++|+++||||+...
T Consensus       219 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  279 (335)
T d2ozaa1         219 LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  279 (335)
T ss_dssp             C--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred             HHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence            33    33445555555553    3799999999999999999999999999999997643

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-50  Score=371.45  Aligned_cols=194  Identities=34%  Similarity=0.585  Sum_probs=174.7

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEcc-
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-   82 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~g-g~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~-   82 (381)
                      .|||||++++++.+.+..|+||||+.+ +++.+++...+.++++.++.++.||+.||+|||++||+||||||+|||++. 
T Consensus        67 ~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~  146 (273)
T d1xwsa_          67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN  146 (273)
T ss_dssp             SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETT
T ss_pred             CCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecC
Confidence            399999999999999999999999976 688899988889999999999999999999999999999999999999985 


Q ss_pred             CCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHhhc
Q 016865           83 YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA  162 (381)
Q Consensus        83 ~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~  162 (381)
                      ++.+||+|||+|.....  ....+.+||+.|+|||++.+..+++.++||||+||++|+|++|+.||...      ..+..
T Consensus       147 ~~~vkl~DFG~a~~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~  218 (273)
T d1xwsa_         147 RGELKLIDFGSGALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIR  218 (273)
T ss_dssp             TTEEEECCCTTCEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHH
T ss_pred             CCeEEECccccceeccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhh
Confidence            47999999999986543  33567889999999999988787778899999999999999999999753      23455


Q ss_pred             ccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 016865          163 AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  206 (381)
Q Consensus       163 ~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  206 (381)
                      +...++..+|+++++||++||+.||.+|||++|+++||||+...
T Consensus       219 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         219 GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             cccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            66778888999999999999999999999999999999998643

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-48  Score=365.54  Aligned_cols=207  Identities=31%  Similarity=0.488  Sum_probs=175.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHH-h-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-H-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~-~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |++++|||||++++++.+.+.+|+||||+.++ +.+.+. . .+.+++..++.++.|++.||+|||++||+||||||+||
T Consensus        55 l~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNI  133 (298)
T d1gz8a_          55 LKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL  133 (298)
T ss_dssp             HTTCCCTTBCCEEEEEEETTEEEEEEECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             HHhCCCCcEEEeccccccccceeEEEeecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchhe
Confidence            57899999999999999999999999999765 444443 3 45699999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK  158 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~  158 (381)
                      |++.++++||+|||+|.............+||+.|+|||++....+.+.++||||+||++|+|++|+.||.+.+......
T Consensus       134 l~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~  213 (298)
T d1gz8a_         134 LINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF  213 (298)
T ss_dssp             EECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             eecccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHH
Confidence            99999999999999998765555566777899999999999888888899999999999999999999998877655443


Q ss_pred             Hhhcc------------------cCCCC-----------CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 016865          159 KINAA------------------EFSCP-----------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  208 (381)
Q Consensus       159 ~i~~~------------------~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~  208 (381)
                      ++...                  ....+           ..+|+++.+||++||++||.+|||++|+++||||+.-..|
T Consensus       214 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         214 RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             HHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             HHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            32110                  00111           1367899999999999999999999999999999865544

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=9e-48  Score=359.77  Aligned_cols=204  Identities=28%  Similarity=0.437  Sum_probs=172.6

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++|||||++++++.+.+..|++|||+.++.+.......+.+++..++.++.||+.||+|||+.||+||||||+|||+
T Consensus        54 l~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll  133 (286)
T d1ob3a_          54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI  133 (286)
T ss_dssp             GGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             HHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE
Confidence            57899999999999999999999999999988887777777889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHHHHHh
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  160 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i  160 (381)
                      +.++.+|++|||+|..............|++.|+|||++.+..+.+.++||||+||++|+|++|++||.+.+..+...++
T Consensus       134 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i  213 (286)
T d1ob3a_         134 NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI  213 (286)
T ss_dssp             CTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            99999999999999765544344556679999999999988777789999999999999999999999887765554443


Q ss_pred             hccc-----------------------------CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          161 NAAE-----------------------------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       161 ~~~~-----------------------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      ....                             ...+..+|+++.+||++||++||++|||++|+++||||++
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         214 FRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             HHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             HHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            2100                             0112346889999999999999999999999999999973

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-48  Score=360.96  Aligned_cols=200  Identities=20%  Similarity=0.325  Sum_probs=174.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |++++|||||++++++.++ ..|||||||+||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus        62 l~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill  140 (277)
T d1xbba_          62 MQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL  140 (277)
T ss_dssp             HHTCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             HHhCCCCCCceEEEEeccC-CEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc
Confidence            4678999999999999754 578999999999999999998899999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCc---cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGV---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      +.++.+||+|||+|+......   .......||+.|+|||++.+..|+ .++||||+||++|||++ |++||.+.+..+.
T Consensus       141 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~  219 (277)
T d1xbba_         141 VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV  219 (277)
T ss_dssp             EETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred             cccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCC-chhhhccchhhhhHHhhCCCCCCCCCCHHHH
Confidence            999999999999998654321   122345789999999999877765 89999999999999998 9999999888777


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHH---hcCccc
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGI---RKHPWF  202 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~i---l~hp~~  202 (381)
                      ...+..+ ....|..+|+++.+||.+||+.||.+|||++++   |+|+|+
T Consensus       220 ~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         220 TAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            7777664 456788899999999999999999999999998   456655

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-47  Score=358.10  Aligned_cols=200  Identities=29%  Similarity=0.389  Sum_probs=169.6

Q ss_pred             CCCccccccceEEEEe-----CCEEEEEEecCCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 016865            3 IVRHPNIVRLHEVLAS-----RTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE   76 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~-----~~~~~lV~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~   76 (381)
                      .++||||+++++++..     ...+|++|||+.+|.+..... ....++++.++.++.|++.||+|||++||+||||||+
T Consensus        66 ~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~  145 (305)
T d1blxa_          66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQ  145 (305)
T ss_dssp             HTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred             hcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCcc
Confidence            3589999999999963     357999999999877654443 3456999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhHH
Q 016865           77 NLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL  156 (381)
Q Consensus        77 NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~  156 (381)
                      |||++.++.+||+|||++...... ....+.+||+.|+|||++.+..|+ .++||||+||++|+|++|++||.+.+....
T Consensus       146 NILi~~~~~~kl~dfg~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~  223 (305)
T d1blxa_         146 NILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ  223 (305)
T ss_dssp             GEEECTTCCEEECSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             EEEEcCCCCeeecchhhhhhhccc-ccCCCcccChhhcCcchhcCCCCC-hhehhhchHHHHHHHHHCCCCCCCCCHHHH
Confidence            999999999999999998865443 345678899999999999888875 899999999999999999999998876655


Q ss_pred             HHHhhcc-------c--------------------CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          157 YKKINAA-------E--------------------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       157 ~~~i~~~-------~--------------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      ..++...       .                    ...+..+|+.+.+||++||+.||.+|||++|+|+||||+.
T Consensus       224 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~  298 (305)
T d1blxa_         224 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD  298 (305)
T ss_dssp             HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred             HHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence            5443211       0                    0123347899999999999999999999999999999975

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-48  Score=366.94  Aligned_cols=194  Identities=22%  Similarity=0.349  Sum_probs=169.6

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHH
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-----------------------RLLENDCRRYFQQLIDAVA   61 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-----------------------~l~e~~~~~~~~qll~~L~   61 (381)
                      +|||||++++++.+.+.+|+|||||+||+|.++|....                       .+++..++.++.|++.||+
T Consensus        99 ~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~  178 (325)
T d1rjba_          99 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGME  178 (325)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHH
T ss_pred             CCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHH
Confidence            89999999999999999999999999999999997542                       4789999999999999999


Q ss_pred             HHHHCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHH
Q 016865           62 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF  139 (381)
Q Consensus        62 ~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~  139 (381)
                      |||++||+||||||+|||++.++.+||+|||+|+......  ....+.+||+.|+|||++.+..|+ .++||||+||++|
T Consensus       179 yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwS~Gvil~  257 (325)
T d1rjba_         179 FLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLW  257 (325)
T ss_dssp             HHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHH
T ss_pred             HHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC-cceeccchhHHHH
Confidence            9999999999999999999999999999999998654422  233466789999999999887775 8999999999999


Q ss_pred             HHHh-CCCCCCCCChhHHHHHhhcc--cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          140 VLMA-GYLPFGETDLPTLYKKINAA--EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       140 ~ll~-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ||++ |.+||.+.+......++...  ....|..+|+++.+||.+||+.||++|||++||++|
T Consensus       258 emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         258 EIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             HHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            9998 89999887665544444333  456677899999999999999999999999999875

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-47  Score=355.10  Aligned_cols=198  Identities=20%  Similarity=0.317  Sum_probs=162.9

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |++++|||||++++++. .+.+|||||||+||+|.+++... +.+++..+..++.|++.||+|||++||+||||||+|||
T Consensus        58 l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiL  136 (276)
T d1uwha_          58 LRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIF  136 (276)
T ss_dssp             HTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             HHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEE
Confidence            57889999999999874 46789999999999999999754 56999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCC--ccccccccCCCCCCCCceecCCC--CCCCcccHhHHHHHHHHHHhCCCCCCCCChhH
Q 016865           80 LDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLSNRG--YDGSAADVWSCGVILFVLMAGYLPFGETDLPT  155 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~--~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  155 (381)
                      ++.++.+||+|||+|+.....  .....+.+||+.|+|||++.+..  ..+.++||||+||+||||++|+.||.+.+...
T Consensus       137 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~  216 (276)
T d1uwha_         137 LHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD  216 (276)
T ss_dssp             EETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH
T ss_pred             EcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH
Confidence            999999999999999876432  22345678999999999986432  23589999999999999999999998766543


Q ss_pred             H-HHHhhcccC-----CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          156 L-YKKINAAEF-----SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       156 ~-~~~i~~~~~-----~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      . ...+..+..     ..+..+|+++.+||.+||+.||.+|||+++++++
T Consensus       217 ~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         217 QIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             HHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            3 333333321     2345689999999999999999999999999986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.7e-47  Score=355.93  Aligned_cols=198  Identities=25%  Similarity=0.376  Sum_probs=165.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |++++|||||++++++.+.+.+|+|||||+||+|.+++... +.+++..+..++.|++.||+|||++||+||||||+|||
T Consensus        81 l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NIL  160 (299)
T d1jpaa_          81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNIL  160 (299)
T ss_dssp             HTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             HHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEE
Confidence            57899999999999999999999999999999999988774 46999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCcc-----ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCCh
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVE-----LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDL  153 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~  153 (381)
                      ++.++.+||+|||+|+.......     ......||+.|+|||++.+..|+ .++|||||||++|||+| |.+||.+.+.
T Consensus       161 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~el~t~g~~Pf~~~~~  239 (299)
T d1jpaa_         161 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTN  239 (299)
T ss_dssp             ECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             ECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCC-cccccccchHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999987543211     11234578999999999887775 89999999999999998 8999999888


Q ss_pred             hHHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          154 PTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       154 ~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      .+....+..+ ..+.|..+++++.+||.+||+.||.+|||+.+++++
T Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         240 QDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            8777777654 356677799999999999999999999999998864

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-47  Score=357.25  Aligned_cols=201  Identities=23%  Similarity=0.350  Sum_probs=175.9

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |++++|||||++++++.++ .+|||||||+||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||
T Consensus        63 l~~l~HpnIv~l~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nil  141 (285)
T d1u59a_          63 MHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVL  141 (285)
T ss_dssp             HHHCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             HHhCCCCCEeeEeeeeccC-eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhhee
Confidence            4578999999999999754 58999999999999998865 357999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCc---cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGV---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPT  155 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~  155 (381)
                      ++.++.+||+|||+|+......   ......+||+.|+|||++.+..|+ .++||||+||++|||+| |..||.+.+..+
T Consensus       142 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~  220 (285)
T d1u59a_         142 LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPE  220 (285)
T ss_dssp             EEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHH
T ss_pred             eccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCC-ccchhhcchHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999998654421   223456789999999999877765 89999999999999998 999999888777


Q ss_pred             HHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHH---hcCcccc
Q 016865          156 LYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGI---RKHPWFR  203 (381)
Q Consensus       156 ~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~i---l~hp~~~  203 (381)
                      ....+..+ ....|..+|+++.+||.+||+.||.+|||+.++   |+|+|+.
T Consensus       221 ~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         221 VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            77777665 456788899999999999999999999999888   5677764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-47  Score=350.03  Aligned_cols=198  Identities=24%  Similarity=0.391  Sum_probs=165.1

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |++++|||||++++++.+++.+|+||||+++|+|.+++... ..++++.+..++.|++.||+|||++||+||||||+|||
T Consensus        54 l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nil  133 (263)
T d1sm2a_          54 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCL  133 (263)
T ss_dssp             HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEE
T ss_pred             HHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhhee
Confidence            35789999999999999999999999999999999998764 46889999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  157 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~  157 (381)
                      +++++++||+|||+|+...... .......||+.|+|||++.+..|+ .++||||+||++|||+| |.+||...+.....
T Consensus       134 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~  212 (263)
T d1sm2a_         134 VGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV  212 (263)
T ss_dssp             ECGGGCEEECSCC------------------CTTSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHH
T ss_pred             ecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCC-chhhhcchHHHHHHHHHCCCCCCCCCCHHHHH
Confidence            9999999999999998664422 223456799999999999888775 89999999999999999 67888877777777


Q ss_pred             HHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          158 KKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       158 ~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ..+..+ ....|..+++++.+||.+||+.||.+|||++++++|
T Consensus       213 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         213 EDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            777654 345677789999999999999999999999999985

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-46  Score=350.93  Aligned_cols=197  Identities=27%  Similarity=0.383  Sum_probs=171.4

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |++++|||||++++++.+.+.+|||||||++|+|.+++...  ..+++..+..++.|++.||+|||++||+||||||+||
T Consensus        67 l~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NI  146 (287)
T d1opja_          67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC  146 (287)
T ss_dssp             HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             HHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeE
Confidence            45789999999999999999999999999999999999764  4689999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCC-CCCCCChhHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYL-PFGETDLPTL  156 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~-Pf~~~~~~~~  156 (381)
                      |+++++.+||+|||+|+...... .......||+.|+|||++.+..|+ .++||||+||++|||++|.. ||...+....
T Consensus       147 Ll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~  225 (287)
T d1opja_         147 LVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQV  225 (287)
T ss_dssp             EECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             EECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCcchHHHH
Confidence            99999999999999998765432 223345689999999999887775 89999999999999999654 5566666666


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      .+.+..+ ....|..+|+++.+||.+||+.||.+|||++++++
T Consensus       226 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         226 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            6666544 45677789999999999999999999999999976

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-46  Score=354.90  Aligned_cols=203  Identities=33%  Similarity=0.589  Sum_probs=177.0

Q ss_pred             CCCCc-cccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            2 KIVRH-PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         2 k~l~H-pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      ++++| |||+++++++.+...+|+||||+.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        83 ~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill  162 (322)
T d1vzoa_          83 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL  162 (322)
T ss_dssp             HHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred             HhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee
Confidence            45666 89999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCC-CccccccccCCCCCCCCceecCCC-CCCCcccHhHHHHHHHHHHhCCCCCCCCChhHH--
Q 016865           81 DSYGNLKVSDFGLSALPQQ-GVELLHTTCGTPNYVAPEVLSNRG-YDGSAADVWSCGVILFVLMAGYLPFGETDLPTL--  156 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~--  156 (381)
                      +.+|.+||+|||+|+.... ......+.+|++.|+|||.+.+.. +.+.++||||+||+||+|++|..||...+....  
T Consensus       163 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~  242 (322)
T d1vzoa_         163 DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA  242 (322)
T ss_dssp             CTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH
T ss_pred             cCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999999999976543 233456788999999999997654 346899999999999999999999977654433  


Q ss_pred             --HHHhhcccCCCCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 016865          157 --YKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  204 (381)
Q Consensus       157 --~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~-----t~~~il~hp~~~~  204 (381)
                        ...........|..+|+++.+||++||++||.+||     |++|+++||||+.
T Consensus       243 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         243 EISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             HHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             HHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence              33333445667778999999999999999999999     5899999999974

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-46  Score=352.34  Aligned_cols=206  Identities=22%  Similarity=0.301  Sum_probs=169.9

Q ss_pred             CCCCCccccccceEEEEe--------CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecC
Q 016865            1 MKIVRHPNIVRLHEVLAS--------RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD   72 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~--------~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrD   72 (381)
                      |+.++||||+++++++.+        ++.+|+||||+.++.+.........+++..++.++.|++.||+|||++||+|||
T Consensus        63 l~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrD  142 (318)
T d3blha1          63 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRD  142 (318)
T ss_dssp             HHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             HHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecC
Confidence            467899999999999855        356899999998877766656667899999999999999999999999999999


Q ss_pred             CCCCcEEEccCCCEEEeeccCccCCCC----CccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCC
Q 016865           73 LKPENLLLDSYGNLKVSDFGLSALPQQ----GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF  148 (381)
Q Consensus        73 lkp~NiLl~~~~~lkl~DFGls~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf  148 (381)
                      |||+|||++.++.+||+|||++.....    ......+.+||+.|+|||++.+...++.++||||+||++|+|++|++||
T Consensus       143 lKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf  222 (318)
T d3blha1         143 MKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM  222 (318)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             cCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCC
Confidence            999999999999999999999975543    1223456789999999999987655569999999999999999999999


Q ss_pred             CCCChhHHHHHhhcccCCCCC--------------------------------CCChhHHHHHHHhcCCCCCCCCCHHHH
Q 016865          149 GETDLPTLYKKINAAEFSCPF--------------------------------WFSTGATSLIHKILDPNPKTRIRIEGI  196 (381)
Q Consensus       149 ~~~~~~~~~~~i~~~~~~~p~--------------------------------~~s~~~~~li~~~L~~dP~~R~t~~~i  196 (381)
                      .+.+.......+.......+.                                ..++++++||.+||+.||++|||++|+
T Consensus       223 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~el  302 (318)
T d3blha1         223 QGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA  302 (318)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             CCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence            887765554443222111110                                036788999999999999999999999


Q ss_pred             hcCcccccCC
Q 016865          197 RKHPWFRKNY  206 (381)
Q Consensus       197 l~hp~~~~~~  206 (381)
                      ++||||+..+
T Consensus       303 L~Hpff~~~p  312 (318)
T d3blha1         303 LNHDFFWSDP  312 (318)
T ss_dssp             HHSGGGSSSS
T ss_pred             HcChhhccCC
Confidence            9999998654

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=350.19  Aligned_cols=201  Identities=24%  Similarity=0.413  Sum_probs=173.6

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |++++|||||++++++.+ +.+|+||||+++|+|.+++...  .++++..+..++.||+.||+|||++||+||||||+||
T Consensus        62 l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NI  140 (272)
T d1qpca_          62 MKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI  140 (272)
T ss_dssp             HHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             HHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhhe
Confidence            457899999999998754 5679999999999999977543  3599999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      |+++++.+||+|||+|+...... .......||+.|+|||++.+..|+ .++||||+||++|||+| |.+||...+....
T Consensus       141 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~-~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~  219 (272)
T d1qpca_         141 LVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEV  219 (272)
T ss_dssp             EECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred             eeecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCC-chhhhhhhHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999998765432 234456799999999999877775 89999999999999999 5666777777777


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc--Ccccc
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK--HPWFR  203 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~--hp~~~  203 (381)
                      .+.+..+ ....|..+++++.+||.+||+.||.+|||++++++  |+||.
T Consensus       220 ~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         220 IQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            7777654 45677889999999999999999999999999988  78885

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-46  Score=356.73  Aligned_cols=205  Identities=29%  Similarity=0.349  Sum_probs=168.0

Q ss_pred             CCCCCccccccceEEEEe------CCEEEEEEecCCCCChHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 016865            1 MKIVRHPNIVRLHEVLAS------RTKVYIILEFVTGGELFD---KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR   71 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~------~~~~~lV~E~~~gg~L~~---~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~Hr   71 (381)
                      |+.++||||++++++|..      ..++|||||||++|.+..   +......+++..++.++.||+.||+|||++||+||
T Consensus        67 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHr  146 (350)
T d1q5ka_          67 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHR  146 (350)
T ss_dssp             HHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECC
T ss_pred             HHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Confidence            467899999999999954      346899999998764322   22345679999999999999999999999999999


Q ss_pred             CCCCCcEEEccCC-CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCC
Q 016865           72 DLKPENLLLDSYG-NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE  150 (381)
Q Consensus        72 Dlkp~NiLl~~~~-~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~  150 (381)
                      ||||+|||++.++ .+||+|||++...... ....+.+||+.|+|||++.+..+++.++||||+||++|+|++|++||..
T Consensus       147 DiKp~NILl~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~  225 (350)
T d1q5ka_         147 DIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG  225 (350)
T ss_dssp             CCCGGGEEECTTTCCEEECCCTTCEECCTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             CCCcceEEEecCCCceeEecccchhhccCC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCC
Confidence            9999999999775 8999999999866543 3456778999999999987766567999999999999999999999988


Q ss_pred             CChhHHHHHhhcc-----------------cCC------------CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 016865          151 TDLPTLYKKINAA-----------------EFS------------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPW  201 (381)
Q Consensus       151 ~~~~~~~~~i~~~-----------------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~  201 (381)
                      .+.......+...                 ...            .....|+++.+||.+||+.||.+|||+.|+|+|||
T Consensus       226 ~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~  305 (350)
T d1q5ka_         226 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF  305 (350)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             CCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence            7765544333210                 011            12347899999999999999999999999999999


Q ss_pred             cccCC
Q 016865          202 FRKNY  206 (381)
Q Consensus       202 ~~~~~  206 (381)
                      |+.-.
T Consensus       306 f~~~~  310 (350)
T d1q5ka_         306 FDELR  310 (350)
T ss_dssp             GGGGG
T ss_pred             hcccc
Confidence            97643

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-46  Score=347.06  Aligned_cols=197  Identities=29%  Similarity=0.406  Sum_probs=164.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |++++|||||++++++. ++.+|+||||+++|+|.+++.. .+.+++..++.++.||++||+|||++||+||||||+||+
T Consensus        62 l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIl  140 (273)
T d1mp8a_          62 MRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVL  140 (273)
T ss_dssp             HHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             HHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhhee
Confidence            46789999999999995 5679999999999999998765 456999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  157 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~  157 (381)
                      ++.++.+||+|||+|+...... ......+||+.|+|||++.+..|+ .++||||+||++|||++ |.+||...+..+.+
T Consensus       141 l~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~  219 (273)
T d1mp8a_         141 VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVI  219 (273)
T ss_dssp             EEETTEEEECC-------------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred             ecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCC-CccccccchHHHHHHHhcCCCCCCCCCHHHHH
Confidence            9999999999999998755422 233456789999999999887775 89999999999999998 99999998888888


Q ss_pred             HHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          158 KKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       158 ~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      .++..+. .+.|+.+|+++.+||.+||..||.+|||++++++|
T Consensus       220 ~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         220 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            8776654 56788899999999999999999999999999875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.7e-46  Score=348.34  Aligned_cols=202  Identities=24%  Similarity=0.400  Sum_probs=165.3

Q ss_pred             CCCCCccccccceEEEEeCC----EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRT----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE   76 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~----~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~   76 (381)
                      |+.++|||||++++++.+.+    .+||||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+
T Consensus        61 l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~  140 (277)
T d1o6ya_          61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPA  140 (277)
T ss_dssp             HHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             HHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCc
Confidence            46789999999999998654    48999999999999999999899999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccCccCCCCC---ccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCCh
Q 016865           77 NLLLDSYGNLKVSDFGLSALPQQG---VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL  153 (381)
Q Consensus        77 NiLl~~~~~lkl~DFGls~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~  153 (381)
                      |||++.++..+++|||.+......   .....+.+||+.|+|||++.+..|+ .++||||+||++|+|++|++||.+.+.
T Consensus       141 NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~  219 (277)
T d1o6ya_         141 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSP  219 (277)
T ss_dssp             GEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCH
Confidence            999999999999999988654332   2234567899999999999887775 899999999999999999999998887


Q ss_pred             hHHHHHhhcccCC----CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          154 PTLYKKINAAEFS----CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       154 ~~~~~~i~~~~~~----~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      .....++......    .+..+|+++.+||.+||++||.+||+..+.+.|+|.+
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         220 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             HHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            7666655444432    2345899999999999999999999544445567764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-46  Score=341.86  Aligned_cols=198  Identities=22%  Similarity=0.360  Sum_probs=176.9

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |++++||||+++++++.+++.+|+||||+++|+|.+++.. ...+++..+..++.|+++||+|||++||+||||||+|||
T Consensus        53 ~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nil  132 (258)
T d1k2pa_          53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCL  132 (258)
T ss_dssp             HHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEE
T ss_pred             HHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEE
Confidence            4678999999999999999999999999999999998755 456899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  157 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~  157 (381)
                      +++++.+||+|||++....... ......+||+.|+|||++.+..|+ .++||||+||++|||+| |+.||...+..+..
T Consensus       133 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~  211 (258)
T d1k2pa_         133 VNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETA  211 (258)
T ss_dssp             ECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH
T ss_pred             EcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHHH
Confidence            9999999999999997654422 223356789999999999888775 89999999999999998 89999999888888


Q ss_pred             HHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          158 KKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       158 ~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      .++..+ ....|...++++.+||.+||+.||.+|||++++++|
T Consensus       212 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         212 EHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            877765 446677789999999999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-45  Score=352.21  Aligned_cols=200  Identities=28%  Similarity=0.418  Sum_probs=169.8

Q ss_pred             CCCCCccccccceEEEEeCC------EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRT------KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK   74 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~------~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlk   74 (381)
                      |+.++|||||+++++|.+.+      .+|+||||+ |++|...+. .+++++..++.++.||+.||+|||++||+|||||
T Consensus        71 l~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiK  148 (346)
T d1cm8a_          71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLK  148 (346)
T ss_dssp             HHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             HHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccC
Confidence            46789999999999997654      589999999 567766554 4789999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           75 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        75 p~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      |+|||++.++.+|++|||+|.....   .....+||+.|+|||++.+..+.+.++||||+||++|+|++|++||.+.+..
T Consensus       149 p~NIL~~~~~~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~  225 (346)
T d1cm8a_         149 PGNLAVNEDCELKILDFGLARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL  225 (346)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             cchhhcccccccccccccceeccCC---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH
Confidence            9999999999999999999986544   2456789999999999988777779999999999999999999999887654


Q ss_pred             HHHHHhhccc-------------------------------CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 016865          155 TLYKKINAAE-------------------------------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  203 (381)
Q Consensus       155 ~~~~~i~~~~-------------------------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  203 (381)
                      .....+....                               ......+|+++.+||.+||..||.+|||++|+|+||||+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~  305 (346)
T d1cm8a_         226 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE  305 (346)
T ss_dssp             HHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred             HHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhC
Confidence            4433221100                               012234789999999999999999999999999999998


Q ss_pred             cC
Q 016865          204 KN  205 (381)
Q Consensus       204 ~~  205 (381)
                      .-
T Consensus       306 ~~  307 (346)
T d1cm8a_         306 SL  307 (346)
T ss_dssp             TT
T ss_pred             cC
Confidence            64

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-45  Score=340.69  Aligned_cols=204  Identities=31%  Similarity=0.467  Sum_probs=176.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      |+.++|||||++++++.+....++|+|++.|++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus        55 l~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli  134 (292)
T d1unla_          55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI  134 (292)
T ss_dssp             HTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             HHhcCcCCEEeeccccccccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc
Confidence            47899999999999999999999999999999999988888899999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCC-CCCChhHHHHH
Q 016865           81 DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKK  159 (381)
Q Consensus        81 ~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf-~~~~~~~~~~~  159 (381)
                      +.++.+||+|||.|..............+++.|+|||++.+..+.+.++||||+||++|+|++|+.|| ...+......+
T Consensus       135 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~  214 (292)
T d1unla_         135 NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR  214 (292)
T ss_dssp             CTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHH
T ss_pred             ccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHH
Confidence            99999999999999876654444556678899999999988777779999999999999999999886 44454444444


Q ss_pred             hhcc-----------------------------cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          160 INAA-----------------------------EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       160 i~~~-----------------------------~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      +...                             ....+..+|+.+.+||++||++||.+|||++|+|+||||+.
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~  288 (292)
T d1unla_         215 IFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD  288 (292)
T ss_dssp             HHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred             HHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence            3211                             00122346889999999999999999999999999999975

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-45  Score=349.04  Aligned_cols=206  Identities=28%  Similarity=0.477  Sum_probs=169.1

Q ss_pred             CCCCCccccccceEEEEeCC-----EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKP   75 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~-----~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp   75 (381)
                      |++++||||+++++++....     .+|++ +|+.||+|++++.. +++++..++.++.|++.||+|||++||+||||||
T Consensus        60 l~~l~hp~iv~~~~~~~~~~~~~~~~~~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp  137 (345)
T d1pmea_          60 LLRFRHENIIGINDIIRAPTIEQMKDVYLV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKP  137 (345)
T ss_dssp             HHHCCCTTBCCCCEEECCSSTTTCCCEEEE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             HHHcCCCCCCcEEEEEeeccccccceEEEE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCc
Confidence            46789999999999997653     35555 55668999999876 5799999999999999999999999999999999


Q ss_pred             CcEEEccCCCEEEeeccCccCCCCC---ccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCC
Q 016865           76 ENLLLDSYGNLKVSDFGLSALPQQG---VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD  152 (381)
Q Consensus        76 ~NiLl~~~~~lkl~DFGls~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~  152 (381)
                      +|||++.++.+||+|||+|......   .......+||+.|+|||++....+++.++||||+||++|+|++|..||...+
T Consensus       138 ~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~  217 (345)
T d1pmea_         138 SNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH  217 (345)
T ss_dssp             GGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence            9999999999999999999765432   2234667899999999998766666799999999999999999999998776


Q ss_pred             hhHHHHHhhcc-------------------------cC------CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 016865          153 LPTLYKKINAA-------------------------EF------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPW  201 (381)
Q Consensus       153 ~~~~~~~i~~~-------------------------~~------~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~  201 (381)
                      ...........                         ..      ...+.+|+++++||.+||+.||.+|||++|+|+|||
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf  297 (345)
T d1pmea_         218 YLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY  297 (345)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             HHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence            54333222100                         00      012246889999999999999999999999999999


Q ss_pred             cccCCCC
Q 016865          202 FRKNYNP  208 (381)
Q Consensus       202 ~~~~~~~  208 (381)
                      |+....+
T Consensus       298 ~~~~~~~  304 (345)
T d1pmea_         298 LEQYYDP  304 (345)
T ss_dssp             GTTTCCG
T ss_pred             hccCCCC
Confidence            9866543

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-45  Score=340.03  Aligned_cols=203  Identities=23%  Similarity=0.366  Sum_probs=168.9

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |++++|||||++++++.+ +.+|+||||+++|+|.+++..  .+.+++..+..++.||+.||+|||++||+||||||+||
T Consensus        66 l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NI  144 (285)
T d1fmka3          66 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI  144 (285)
T ss_dssp             HHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             HHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEE
Confidence            457899999999999854 568999999999999988854  45799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCc-cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhC-CCCCCCCChhHH
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG-YLPFGETDLPTL  156 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G-~~Pf~~~~~~~~  156 (381)
                      |++.++.+||+|||+|+...... ......+||+.|+|||++.+..++ .++||||+||++|||++| .+|+...+..+.
T Consensus       145 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~S~Giil~el~t~~~p~~~~~~~~~~  223 (285)
T d1fmka3         145 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREV  223 (285)
T ss_dssp             EECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred             EECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCC-cHHhhhcchHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999998654322 233456799999999999887775 899999999999999995 566666676667


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc--CcccccC
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK--HPWFRKN  205 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~--hp~~~~~  205 (381)
                      ...+..+ ....|..+|+++.+||.+||+.||++|||++++++  ++||...
T Consensus       224 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         224 LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            7666544 45678889999999999999999999999999987  8888754

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-44  Score=337.56  Aligned_cols=197  Identities=26%  Similarity=0.364  Sum_probs=165.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |++++|||||++++++.+.+..|+||||+.+|++.+.+... +.+++..+..++.|++.||+|||++||+||||||+|||
T Consensus        63 l~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NIL  142 (283)
T d1mqba_          63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNIL  142 (283)
T ss_dssp             HHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             HHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEE
Confidence            46789999999999999999999999999999999988764 56999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCcc---ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhC-CCCCCCCChhH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG-YLPFGETDLPT  155 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G-~~Pf~~~~~~~  155 (381)
                      ++.++.+||+|||+|+.......   ......||+.|+|||++.+..|+ .++||||+||++|||++| .+||...+..+
T Consensus       143 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~sDI~S~Gvil~el~t~~~~~~~~~~~~~  221 (283)
T d1mqba_         143 VNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHE  221 (283)
T ss_dssp             ECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             ECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCC-CcccccccHHHHHHHHhCCCCccccCCHHH
Confidence            99999999999999987544211   22345689999999999887775 899999999999999995 56666667777


Q ss_pred             HHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          156 LYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       156 ~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ....+..+ ..+.|..+++++.+||.+||+.||.+|||+.++++
T Consensus       222 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         222 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            77766554 44667778999999999999999999999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-44  Score=339.36  Aligned_cols=197  Identities=23%  Similarity=0.340  Sum_probs=173.3

Q ss_pred             CCCC-CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHH
Q 016865            1 MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ----------------GRLLENDCRRYFQQLIDAVAHC   63 (381)
Q Consensus         1 lk~l-~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~~L~~L   63 (381)
                      |+++ +|||||++++++.+++.+|+||||++||+|.++|...                ..+++..+..++.|++.||.||
T Consensus        64 l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~l  143 (309)
T d1fvra_          64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL  143 (309)
T ss_dssp             HTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred             HHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhh
Confidence            3556 7999999999999999999999999999999999653                5689999999999999999999


Q ss_pred             HHCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh
Q 016865           64 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA  143 (381)
Q Consensus        64 H~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~  143 (381)
                      |++||+||||||+|||++.++.+||+|||+|+..... ......+||+.|+|||.+.+..|+ .++|||||||++|||++
T Consensus       144 H~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~-~~sDvwSfGvil~ell~  221 (309)
T d1fvra_         144 SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVS  221 (309)
T ss_dssp             HHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHT
T ss_pred             hcCCccccccccceEEEcCCCceEEcccccccccccc-ccccceecCCcccchHHhccCCCC-ccceeehhHHHHHHHHh
Confidence            9999999999999999999999999999999865442 223456799999999999887775 89999999999999999


Q ss_pred             C-CCCCCCCChhHHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          144 G-YLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       144 G-~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      | .+||.+.+...++..+..+ ....|..+++++.+||.+||+.||++|||++++++|
T Consensus       222 ~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         222 LGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             TSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            6 5789888888888887654 456677899999999999999999999999999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-44  Score=340.85  Aligned_cols=195  Identities=22%  Similarity=0.325  Sum_probs=160.8

Q ss_pred             CCccccccceEEEEeC-CEEEEEEecCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHC
Q 016865            4 VRHPNIVRLHEVLASR-TKVYIILEFVTGGELFDKIVHQ----------------GRLLENDCRRYFQQLIDAVAHCHSK   66 (381)
Q Consensus         4 l~HpnIv~l~~~~~~~-~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~~L~~LH~~   66 (381)
                      .+||||+++++++.+. ..+|+|||||+||+|.+++...                ..+++..+..++.|+++||+|||++
T Consensus        74 ~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~  153 (299)
T d1ywna1          74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR  153 (299)
T ss_dssp             CCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             cCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4799999999998654 5799999999999999999753                2488999999999999999999999


Q ss_pred             CCeecCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhC
Q 016865           67 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG  144 (381)
Q Consensus        67 gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G  144 (381)
                      ||+||||||+|||+++++++||+|||+|+......  ....+.+||+.|+|||++.+..|+ .++||||+||++|||++|
T Consensus       154 ~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDiwS~Gvil~ellt~  232 (299)
T d1ywna1         154 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSL  232 (299)
T ss_dssp             TCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTT
T ss_pred             CCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC-cccceeehHHHHHHHHhC
Confidence            99999999999999999999999999998654322  233456899999999999887774 999999999999999986


Q ss_pred             -CCCCCCCChhHHH-HHhhc-ccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          145 -YLPFGETDLPTLY-KKINA-AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       145 -~~Pf~~~~~~~~~-~~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                       .+||...+....+ ..+.. .....|..+++++.+||.+||+.||.+|||++|+++|
T Consensus       233 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         233 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             SCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence             6788776654433 33333 3456777899999999999999999999999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-44  Score=342.07  Aligned_cols=198  Identities=21%  Similarity=0.314  Sum_probs=171.0

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |++++|||||++++++.++ ..++++||+.+|+|.+.+... ..+++..++.++.|++.||+|||++||+||||||+|||
T Consensus        65 l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIl  143 (317)
T d1xkka_          65 MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL  143 (317)
T ss_dssp             HHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             HHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcce
Confidence            4578999999999999875 567888999999999988764 57999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCcc--ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      ++.++.+||+|||+|+.......  ......||+.|+|||++.+..|+ .++||||+||++|||+| |.+||.+.+..+.
T Consensus       144 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~  222 (317)
T d1xkka_         144 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEI  222 (317)
T ss_dssp             EEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH
T ss_pred             eCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCC-hhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH
Confidence            99999999999999986544222  23345689999999999887775 89999999999999998 8999998888877


Q ss_pred             HHHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 016865          157 YKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHP  200 (381)
Q Consensus       157 ~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp  200 (381)
                      ...+..+. ...|..+++++.+||.+||..||.+|||+.++++|.
T Consensus       223 ~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         223 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             HHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence            77776654 567778999999999999999999999999999873

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-44  Score=344.48  Aligned_cols=203  Identities=25%  Similarity=0.357  Sum_probs=167.6

Q ss_pred             CCCCCccccccceEEEEeC-----CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC
Q 016865            1 MKIVRHPNIVRLHEVLASR-----TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKP   75 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp   75 (381)
                      |+.++|||||++++++...     ...+++|+|+.||+|.+++.. +++++..++.++.||+.||+|||++||+||||||
T Consensus        71 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp  149 (348)
T d2gfsa1          71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKP  149 (348)
T ss_dssp             HHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred             HHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCC
Confidence            4578999999999999643     344666777789999998754 6799999999999999999999999999999999


Q ss_pred             CcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChhH
Q 016865           76 ENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT  155 (381)
Q Consensus        76 ~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~  155 (381)
                      +|||++.+|.+|++|||++.....   ...+.+||+.|+|||++.+..+.+.++||||+||++|+|++|.+||.+.+...
T Consensus       150 ~NILi~~~~~~kl~dfg~a~~~~~---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~  226 (348)
T d2gfsa1         150 SNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID  226 (348)
T ss_dssp             GGEEECTTCCEEECCC----CCTG---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccchhcccCc---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH
Confidence            999999999999999999876543   34677899999999998887777799999999999999999999998877655


Q ss_pred             HHHHhhcccCC-----------------------C--------CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 016865          156 LYKKINAAEFS-----------------------C--------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  204 (381)
Q Consensus       156 ~~~~i~~~~~~-----------------------~--------p~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  204 (381)
                      ....+......                       .        ...+|+++++||++||+.||.+|||++|+|+||||+.
T Consensus       227 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~  306 (348)
T d2gfsa1         227 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  306 (348)
T ss_dssp             HHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             HHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence            54444221111                       0        1237899999999999999999999999999999986


Q ss_pred             CCC
Q 016865          205 NYN  207 (381)
Q Consensus       205 ~~~  207 (381)
                      ...
T Consensus       307 ~~~  309 (348)
T d2gfsa1         307 YHD  309 (348)
T ss_dssp             TCC
T ss_pred             CCC
Confidence            543

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5.8e-44  Score=340.14  Aligned_cols=199  Identities=23%  Similarity=0.430  Sum_probs=163.3

Q ss_pred             CCC-CccccccceEEEEeC--CEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            2 KIV-RHPNIVRLHEVLASR--TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         2 k~l-~HpnIv~l~~~~~~~--~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      +.+ +||||+++++++...  ..+|+|||||++|+|.+..   +.+++..++.++.||+.||+|||++||+||||||+||
T Consensus        84 ~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NI  160 (328)
T d3bqca1          84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNV  160 (328)
T ss_dssp             HHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             HhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccce
Confidence            345 499999999999854  5799999999999997653   5699999999999999999999999999999999999


Q ss_pred             EEccCC-CEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh-HH
Q 016865           79 LLDSYG-NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TL  156 (381)
Q Consensus        79 Ll~~~~-~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~  156 (381)
                      |++.++ .+||+|||+|...... ......+||+.|+|||++.+....+.++||||+||++|+|++|..||...+.. ..
T Consensus       161 Li~~~~~~vkl~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~  239 (328)
T d3bqca1         161 MIDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ  239 (328)
T ss_dssp             EEETTTTEEEECCGGGCEECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH
T ss_pred             EEcCCCCeeeecccccceeccCC-CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHH
Confidence            999765 5999999999866543 34567789999999999887766569999999999999999999999765422 11


Q ss_pred             HHHhh-------------cccC------------------------CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          157 YKKIN-------------AAEF------------------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       157 ~~~i~-------------~~~~------------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ...+.             ....                        .....+|+++.+||++||..||.+|||++|+|+|
T Consensus       240 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         240 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             HHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11110             0000                        0112268999999999999999999999999999


Q ss_pred             ccccc
Q 016865          200 PWFRK  204 (381)
Q Consensus       200 p~~~~  204 (381)
                      |||+.
T Consensus       320 p~F~~  324 (328)
T d3bqca1         320 PYFYT  324 (328)
T ss_dssp             GGGTT
T ss_pred             cccCC
Confidence            99975

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-44  Score=331.11  Aligned_cols=195  Identities=24%  Similarity=0.427  Sum_probs=165.6

Q ss_pred             CCCCCccccccceEEEE-eCCEEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCc
Q 016865            1 MKIVRHPNIVRLHEVLA-SRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN   77 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~-~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N   77 (381)
                      |++++||||+++++++. +++.+|+||||+++|+|.+++...+  .++++.++.++.||+.||.|||+++|+||||||+|
T Consensus        54 l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~N  133 (262)
T d1byga_          54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARN  133 (262)
T ss_dssp             HTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             HHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHh
Confidence            47889999999999985 4567899999999999999996543  48999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhHH
Q 016865           78 LLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  156 (381)
Q Consensus        78 iLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~  156 (381)
                      ||++.++.+|++|||+++....   ...+..+|+.|+|||++.+..++ .++||||+||++|||++ |.+||...+..+.
T Consensus       134 il~~~~~~~kl~dfg~s~~~~~---~~~~~~~~~~y~aPE~l~~~~~t-~~sDIwSfG~il~el~t~~~~p~~~~~~~~~  209 (262)
T d1byga_         134 VLVSEDNVAKVSDFGLTKEASS---TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDV  209 (262)
T ss_dssp             EEECTTSCEEECCCCC---------------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH
T ss_pred             heecCCCCEeecccccceecCC---CCccccccccCCChHHHhCCCCC-hHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH
Confidence            9999999999999999986543   23456789999999999887774 89999999999999998 8999998888888


Q ss_pred             HHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          157 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       157 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      ...+..+ ....|..+++++.+||.+||+.||.+|||+.+++++
T Consensus       210 ~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         210 VPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            8877653 567788899999999999999999999999999873

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-43  Score=333.70  Aligned_cols=193  Identities=23%  Similarity=0.377  Sum_probs=173.8

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ----------------GRLLENDCRRYFQQLIDAVAHCHSKGV   68 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~~L~~LH~~gi   68 (381)
                      +|||||++++++.+++.+|+||||+++|+|.++|...                ..+++..+..++.||+.||+|||++||
T Consensus        77 ~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~i  156 (299)
T d1fgka_          77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC  156 (299)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             CCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCE
Confidence            8999999999999999999999999999999999754                348999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCCEEEeeccCccCCCCC--ccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CC
Q 016865           69 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GY  145 (381)
Q Consensus        69 ~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~  145 (381)
                      +||||||+|||++.++.+||+|||++......  .......+||+.|+|||++.+..|+ .++||||+||++|||++ |.
T Consensus       157 vHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~-~k~DiwS~Gvvl~ell~~g~  235 (299)
T d1fgka_         157 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGG  235 (299)
T ss_dssp             CCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSC
T ss_pred             EeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC-chhhhHHhHHHHHHhccCCC
Confidence            99999999999999999999999999866442  1233456799999999999887775 99999999999999998 79


Q ss_pred             CCCCCCChhHHHHHhhcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          146 LPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       146 ~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      +||.+.+....+..+..+ ....|.++|+++.+||.+||+.||.+|||+.|+++
T Consensus       236 ~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         236 SPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             CSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            999998888888777654 45678889999999999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-44  Score=332.23  Aligned_cols=196  Identities=26%  Similarity=0.402  Sum_probs=168.3

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      |++++|||||++++++.+ ..+|+||||+++|++.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||
T Consensus        65 l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIl  143 (273)
T d1u46a_          65 MHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL  143 (273)
T ss_dssp             HHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred             HHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhc
Confidence            457899999999999965 467899999999999988765 456999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccCccCCCCCcc---ccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-CCCCCCCCChhH
Q 016865           80 LDSYGNLKVSDFGLSALPQQGVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPT  155 (381)
Q Consensus        80 l~~~~~lkl~DFGls~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~  155 (381)
                      ++.++.+||+|||+++.......   .....+|++.|+|||++.+..++ .++||||+||++|||+| |.+||.+.+..+
T Consensus       144 l~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~  222 (273)
T d1u46a_         144 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQ  222 (273)
T ss_dssp             EEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             cccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCC-cchhhhhhHHHHHHHHhCCCCCCCCcCHHH
Confidence            99999999999999987644211   23345678899999999886664 89999999999999998 899999999888


Q ss_pred             HHHHhhcccC--CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          156 LYKKINAAEF--SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       156 ~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...++.....  ..|..+|+++.+||.+||+.||++|||+++|++
T Consensus       223 ~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         223 ILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             HHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            8887765543  455678999999999999999999999999864

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-43  Score=341.38  Aligned_cols=201  Identities=30%  Similarity=0.492  Sum_probs=157.2

Q ss_pred             CCCCCccccccceEEEEe------CCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Q 016865            1 MKIVRHPNIVRLHEVLAS------RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK   74 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~------~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlk   74 (381)
                      |++++|||||+++++|..      .+.+|+|||||.|+ +.+.+  ...+++..++.++.||+.||+|||++||+|||||
T Consensus        70 l~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlK  146 (355)
T d2b1pa1          70 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  146 (355)
T ss_dssp             HHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             HHhcCCCCeeEEEEEEecccccccCceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCC
Confidence            356899999999999963      47899999999765 54544  3569999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCCChh
Q 016865           75 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  154 (381)
Q Consensus        75 p~NiLl~~~~~lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~  154 (381)
                      |+|||++.++.+|++|||++...... ......+||+.|+|||++.+..++ .++||||+||++|+|++|++||.+.+..
T Consensus       147 P~Nil~~~~~~~kl~df~~~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~-~~~DiwSlG~~l~ell~g~~pF~~~~~~  224 (355)
T d2b1pa1         147 PSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYI  224 (355)
T ss_dssp             GGGEEECTTCCEEECCCCC----------------CCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             ccccccccccceeeechhhhhccccc-cccccccccccccChhhhcCCCCC-CCcccccccchHHHHhhCCCCCCCCCHH
Confidence            99999999999999999998866543 344567899999999999887765 8999999999999999999999877655


Q ss_pred             HHHHHhhc----------------------ccCC--------------CC------CCCChhHHHHHHHhcCCCCCCCCC
Q 016865          155 TLYKKINA----------------------AEFS--------------CP------FWFSTGATSLIHKILDPNPKTRIR  192 (381)
Q Consensus       155 ~~~~~i~~----------------------~~~~--------------~p------~~~s~~~~~li~~~L~~dP~~R~t  192 (381)
                      ....++..                      ....              .+      ...|+++++||++||..||.+|||
T Consensus       225 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t  304 (355)
T d2b1pa1         225 DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS  304 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC
T ss_pred             HHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcC
Confidence            44333211                      0000              00      014678999999999999999999


Q ss_pred             HHHHhcCcccccCC
Q 016865          193 IEGIRKHPWFRKNY  206 (381)
Q Consensus       193 ~~~il~hp~~~~~~  206 (381)
                      ++|+|+||||+...
T Consensus       305 a~elL~Hpw~~~~~  318 (355)
T d2b1pa1         305 VDDALQHPYINVWY  318 (355)
T ss_dssp             HHHHHTSTTTGGGC
T ss_pred             HHHHhcCcccCCCC
Confidence            99999999998754

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-43  Score=333.23  Aligned_cols=197  Identities=21%  Similarity=0.299  Sum_probs=172.2

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC------------------------CCCHHHHHHHHHHH
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG------------------------RLLENDCRRYFQQL   56 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~------------------------~l~e~~~~~~~~ql   56 (381)
                      |++++||||+++++++.+.+..++||||+++|+|.+++....                        .+++..+..++.|+
T Consensus        70 l~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi  149 (301)
T d1lufa_          70 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV  149 (301)
T ss_dssp             HHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHH
T ss_pred             HHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHH
Confidence            467899999999999999999999999999999999996532                        37889999999999


Q ss_pred             HHHHHHHHHCCCeecCCCCCcEEEccCCCEEEeeccCccCCCCC--ccccccccCCCCCCCCceecCCCCCCCcccHhHH
Q 016865           57 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC  134 (381)
Q Consensus        57 l~~L~~LH~~gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSl  134 (381)
                      +.||+|||++||+||||||+|||++.++++||+|||+|+.....  .....+.+||+.|+|||++.+..|+ .++|||||
T Consensus       150 ~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~  228 (301)
T d1lufa_         150 AAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAY  228 (301)
T ss_dssp             HHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHH
T ss_pred             HHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccc
Confidence            99999999999999999999999999999999999999754332  2233467899999999999988776 89999999


Q ss_pred             HHHHHHHHhCC-CCCCCCChhHHHHHhhcccC-CCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          135 GVILFVLMAGY-LPFGETDLPTLYKKINAAEF-SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       135 Gvil~~ll~G~-~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ||++|||++|. +||.+.+..+....+..+.. ..|..+++++.+||.+||+.||.+|||+.||++
T Consensus       229 Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         229 GVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            99999999984 78998888888887776654 467789999999999999999999999999865

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-42  Score=329.30  Aligned_cols=193  Identities=24%  Similarity=0.346  Sum_probs=167.0

Q ss_pred             CccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHC
Q 016865            5 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG------------------RLLENDCRRYFQQLIDAVAHCHSK   66 (381)
Q Consensus         5 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~------------------~l~e~~~~~~~~qll~~L~~LH~~   66 (381)
                      +|||||++++++.+...+|+|||||+||+|.+++....                  .+++..+..++.||+.||+|||++
T Consensus        85 ~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~  164 (311)
T d1t46a_          85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK  164 (311)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            79999999999999999999999999999999997543                  589999999999999999999999


Q ss_pred             CCeecCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHh-
Q 016865           67 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-  143 (381)
Q Consensus        67 gi~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~-  143 (381)
                      |++||||||+||+++.++++|++|||+++......  ......+||+.|+|||++.+..+ +.++|||||||++|||++ 
T Consensus       165 ~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~  243 (311)
T d1t46a_         165 NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSL  243 (311)
T ss_dssp             TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTT
T ss_pred             CeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhC
Confidence            99999999999999999999999999998765422  22345689999999999987666 489999999999999998 


Q ss_pred             CCCCCCCCChhHHHHHh-hcc-cCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          144 GYLPFGETDLPTLYKKI-NAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       144 G~~Pf~~~~~~~~~~~i-~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      |.+||...+....+.++ ..+ ....|..+|+++.+||.+||+.||.+|||+++|++
T Consensus       244 g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         244 GSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             TCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            67777776665554443 332 34556678999999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-42  Score=326.15  Aligned_cols=197  Identities=20%  Similarity=0.251  Sum_probs=173.7

Q ss_pred             CCCCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q 016865            1 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ----------GRLLENDCRRYFQQLIDAVAHCHSKGVYH   70 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~----------~~l~e~~~~~~~~qll~~L~~LH~~gi~H   70 (381)
                      |++++|||||++++++...+..++||||+++|+|.+++...          ..+++..+..++.|++.||.|||+++|+|
T Consensus        77 l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivH  156 (308)
T d1p4oa_          77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVH  156 (308)
T ss_dssp             GGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred             HHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeee
Confidence            57889999999999999999999999999999999988643          23688999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCCEEEeeccCccCCCCCc--cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhC-CCC
Q 016865           71 RDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG-YLP  147 (381)
Q Consensus        71 rDlkp~NiLl~~~~~lkl~DFGls~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G-~~P  147 (381)
                      |||||+|||+++++++||+|||+|+......  ......+||+.|+|||.+.+..+. .++||||+||++|||++| .+|
T Consensus       157 rDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p  235 (308)
T d1p4oa_         157 RDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQP  235 (308)
T ss_dssp             SCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCT
T ss_pred             ceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCC
Confidence            9999999999999999999999998654421  223445789999999999887775 899999999999999997 689


Q ss_pred             CCCCChhHHHHHhhccc-CCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          148 FGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       148 f~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      |.+.+..+.+..+..+. ...|..+|+.+.++|.+||+.||.+|||++++++
T Consensus       236 ~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         236 YQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             TTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            99888888887776544 4567789999999999999999999999999987

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-42  Score=322.57  Aligned_cols=198  Identities=22%  Similarity=0.279  Sum_probs=165.0

Q ss_pred             CCCCCccccccceEEEEe-CCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcE
Q 016865            1 MKIVRHPNIVRLHEVLAS-RTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL   78 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~-~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~Ni   78 (381)
                      |++++|||||++++++.+ ++.+|+|||||++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||
T Consensus        82 l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NI  161 (311)
T d1r0pa_          82 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNC  161 (311)
T ss_dssp             HHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             HHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhE
Confidence            467899999999999865 568999999999999999887543 577889999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccCccCCCCCc----cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCC-CCh
Q 016865           79 LLDSYGNLKVSDFGLSALPQQGV----ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDL  153 (381)
Q Consensus        79 Ll~~~~~lkl~DFGls~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~-~~~  153 (381)
                      |+++++.+||+|||+++......    .......||+.|+|||++.+..+. .++|||||||++|||++|..||.. .+.
T Consensus       162 Ll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~SfGivl~El~t~~~p~~~~~~~  240 (311)
T d1r0pa_         162 MLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNT  240 (311)
T ss_dssp             EECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCC----
T ss_pred             eECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCC-ChhHhhhhHHHHHHHHHCCCCCCCCCCH
Confidence            99999999999999998654321    122335689999999999877764 899999999999999997666643 344


Q ss_pred             hHHHHHhhc-ccCCCCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 016865          154 PTLYKKINA-AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  199 (381)
Q Consensus       154 ~~~~~~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  199 (381)
                      .+....+.. .....|..+++++.+||.+||+.||++|||+.|+++|
T Consensus       241 ~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         241 FDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             --CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            444444443 3456778899999999999999999999999999987

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-40  Score=313.75  Aligned_cols=197  Identities=20%  Similarity=0.322  Sum_probs=154.8

Q ss_pred             CCCCCccccccceEEEEeCC----EEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------CCC
Q 016865            1 MKIVRHPNIVRLHEVLASRT----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS--------KGV   68 (381)
Q Consensus         1 lk~l~HpnIv~l~~~~~~~~----~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~--------~gi   68 (381)
                      +++++|||||++++++.+.+    .+|+||||+++|+|.+++.. .+++++....++.|++.||+|||+        +||
T Consensus        51 ~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~I  129 (303)
T d1vjya_          51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI  129 (303)
T ss_dssp             STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEE
T ss_pred             HhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCe
Confidence            46789999999999998654    68999999999999999976 469999999999999999999996        599


Q ss_pred             eecCCCCCcEEEccCCCEEEeeccCccCCCCCc----cccccccCCCCCCCCceecCCCC-----CCCcccHhHHHHHHH
Q 016865           69 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV----ELLHTTCGTPNYVAPEVLSNRGY-----DGSAADVWSCGVILF  139 (381)
Q Consensus        69 ~HrDlkp~NiLl~~~~~lkl~DFGls~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~-----~~~~~DIwSlGvil~  139 (381)
                      +||||||+|||++.++.+||+|||+++......    ......+||+.|+|||++.+...     .+.++|||||||+||
T Consensus       130 vHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~  209 (303)
T d1vjya_         130 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW  209 (303)
T ss_dssp             ECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHH
T ss_pred             eccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHH
Confidence            999999999999999999999999998654321    12345789999999999876432     236899999999999


Q ss_pred             HHHhCCCCCCCCC---------------hhHHHHHhhcccC--CCCCC-----CChhHHHHHHHhcCCCCCCCCCHHHHh
Q 016865          140 VLMAGYLPFGETD---------------LPTLYKKINAAEF--SCPFW-----FSTGATSLIHKILDPNPKTRIRIEGIR  197 (381)
Q Consensus       140 ~ll~G~~Pf~~~~---------------~~~~~~~i~~~~~--~~p~~-----~s~~~~~li~~~L~~dP~~R~t~~~il  197 (381)
                      ||++|.+||....               .............  ..|..     ....+.+|+.+||+.||.+|||+.|++
T Consensus       210 el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~  289 (303)
T d1vjya_         210 EIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK  289 (303)
T ss_dssp             HHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHH
T ss_pred             HHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHH
Confidence            9999998874321               1112222222222  22221     123588999999999999999999987


Q ss_pred             c
Q 016865          198 K  198 (381)
Q Consensus       198 ~  198 (381)
                      +
T Consensus       290 ~  290 (303)
T d1vjya_         290 K  290 (303)
T ss_dssp             H
T ss_pred             H
Confidence            6

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-39  Score=306.76  Aligned_cols=203  Identities=17%  Similarity=0.185  Sum_probs=157.8

Q ss_pred             CCCCcccc-ccceEEEEeCCEEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEE
Q 016865            2 KIVRHPNI-VRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL   79 (381)
Q Consensus         2 k~l~HpnI-v~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiL   79 (381)
                      ++++|+|+ +.+.+++.+.+..++||||+. |+|.+.+.. .+.+++..+..++.|++.||+|||++||+||||||+|||
T Consensus        57 ~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl  135 (299)
T d1ckia_          57 KMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFL  135 (299)
T ss_dssp             HHSTTSTTCCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred             HHccCCCcccEEEEEEecCCEEEEEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhcc
Confidence            45666665 455666688899999999994 566666544 567999999999999999999999999999999999999


Q ss_pred             Ecc---CCCEEEeeccCccCCCCCc-------cccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCC
Q 016865           80 LDS---YGNLKVSDFGLSALPQQGV-------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFG  149 (381)
Q Consensus        80 l~~---~~~lkl~DFGls~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~  149 (381)
                      ++.   +..+||+|||+|+......       ....+.+||+.|+|||++.+..|+ .++||||+||++|+|++|..||.
T Consensus       136 ~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~el~tg~~P~~  214 (299)
T d1ckia_         136 MGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQ  214 (299)
T ss_dssp             ECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC-HHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             ccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCC-ChhhEEecCHHHHHHHhCCCccc
Confidence            864   4579999999998654321       223466899999999999887775 89999999999999999999997


Q ss_pred             CCChhHHHH---HhhcccC-----CCCCCCChhHHHHHHHhcCCCCCCCCCHHH---HhcCcccccCC
Q 016865          150 ETDLPTLYK---KINAAEF-----SCPFWFSTGATSLIHKILDPNPKTRIRIEG---IRKHPWFRKNY  206 (381)
Q Consensus       150 ~~~~~~~~~---~i~~~~~-----~~p~~~s~~~~~li~~~L~~dP~~R~t~~~---il~hp~~~~~~  206 (381)
                      .........   +......     ..+..+|+++.+||.+||..||.+||++++   +|+|+|.+..+
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~  282 (299)
T d1ckia_         215 GLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  282 (299)
T ss_dssp             CCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred             ccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCC
Confidence            755433222   2222111     123458999999999999999999999874   57788776554

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.4e-38  Score=296.71  Aligned_cols=194  Identities=17%  Similarity=0.235  Sum_probs=160.4

Q ss_pred             CCC-ccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEE
Q 016865            3 IVR-HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL   80 (381)
Q Consensus         3 ~l~-HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl   80 (381)
                      .++ |+||+++++++.+....|+||||+ ||+|.+.+...+ .+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus        56 ~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili  134 (293)
T d1csna_          56 LLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLI  134 (293)
T ss_dssp             HTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE
T ss_pred             HhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceee
Confidence            444 599999999999999999999999 789999887654 69999999999999999999999999999999999999


Q ss_pred             cc-----CCCEEEeeccCccCCCCC-------ccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCC
Q 016865           81 DS-----YGNLKVSDFGLSALPQQG-------VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF  148 (381)
Q Consensus        81 ~~-----~~~lkl~DFGls~~~~~~-------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf  148 (381)
                      +.     ++.+||+|||+|+.....       .....+.+||+.|+|||++.+..++ .++||||+||++|+|++|.+||
T Consensus       135 ~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~Pf  213 (293)
T d1csna_         135 GRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPW  213 (293)
T ss_dssp             CCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCC-hHHHHHHhhHHHHHHHhCCCcC
Confidence            74     578999999999865431       1224466899999999999887775 8999999999999999999999


Q ss_pred             CCCCh---hHHHHHhhcccCC-----CCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 016865          149 GETDL---PTLYKKINAAEFS-----CPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  198 (381)
Q Consensus       149 ~~~~~---~~~~~~i~~~~~~-----~p~~~s~~~~~li~~~L~~dP~~R~t~~~il~  198 (381)
                      ...+.   ...+.++......     .+..+|+++.+++..|+..+|.+||+.+.+.+
T Consensus       214 ~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         214 QGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             SSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            75443   2333333322211     23457899999999999999999999877654

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.4e-37  Score=295.63  Aligned_cols=198  Identities=21%  Similarity=0.407  Sum_probs=152.1

Q ss_pred             CCccccccceEEEEe--CCEEEEEEecCCCCChHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCc
Q 016865            4 VRHPNIVRLHEVLAS--RTKVYIILEFVTGGELFDKI---VHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPEN   77 (381)
Q Consensus         4 l~HpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~i---~~~~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~N   77 (381)
                      +.||||+++++++..  ....+++|+++..+......   .....+++..++.++.|++.||+|||+ .||+||||||+|
T Consensus        77 ~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~N  156 (362)
T d1q8ya_          77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN  156 (362)
T ss_dssp             HHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGG
T ss_pred             cCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhH
Confidence            358999999999864  46777888777655433322   234578999999999999999999998 899999999999


Q ss_pred             EEEccCCC------EEEeeccCccCCCCCccccccccCCCCCCCCceecCCCCCCCcccHhHHHHHHHHHHhCCCCCCCC
Q 016865           78 LLLDSYGN------LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET  151 (381)
Q Consensus        78 iLl~~~~~------lkl~DFGls~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~  151 (381)
                      ||++.++.      +|++|||.|.....   .....+||+.|+|||++.+..|+ .++||||+||++++|++|+.||...
T Consensus       157 Ill~~~~~~~~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~  232 (362)
T d1q8ya_         157 VLMEIVDSPENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPD  232 (362)
T ss_dssp             EEEEEEETTTTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---
T ss_pred             eeeeccCcccccceeeEeeccccccccc---ccccccccccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCC
Confidence            99987654      99999999876543   23567899999999999988885 8999999999999999999999643


Q ss_pred             Chh-------HHHHHhh-----------c------------------------------ccCCCCCCCChhHHHHHHHhc
Q 016865          152 DLP-------TLYKKIN-----------A------------------------------AEFSCPFWFSTGATSLIHKIL  183 (381)
Q Consensus       152 ~~~-------~~~~~i~-----------~------------------------------~~~~~p~~~s~~~~~li~~~L  183 (381)
                      +..       .....+.           .                              .....+...++++.+||.+||
T Consensus       233 ~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL  312 (362)
T d1q8ya_         233 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML  312 (362)
T ss_dssp             ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred             ccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHC
Confidence            321       0000000           0                              000111124678999999999


Q ss_pred             CCCCCCCCCHHHHhcCcccccC
Q 016865          184 DPNPKTRIRIEGIRKHPWFRKN  205 (381)
Q Consensus       184 ~~dP~~R~t~~~il~hp~~~~~  205 (381)
                      +.||.+|||++|+|+||||+..
T Consensus       313 ~~dP~~Rpta~e~L~Hp~f~~~  334 (362)
T d1q8ya_         313 QLDPRKRADAGGLVNHPWLKDT  334 (362)
T ss_dssp             CSSTTTCBCHHHHHTCGGGTTC
T ss_pred             CCChhHCcCHHHHhcCcccCCC
Confidence            9999999999999999999854

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.66  E-value=4.9e-18  Score=147.45  Aligned_cols=85  Identities=19%  Similarity=0.321  Sum_probs=69.8

Q ss_pred             CCCccccccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCcEEEcc
Q 016865            3 IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS   82 (381)
Q Consensus         3 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NiLl~~   82 (381)
                      ++.|+|++..+++..    .+++|||++++.+.       .+++..+..++.|++.||.|||++||+||||||+|||+++
T Consensus        70 ~l~~~~v~~~~~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~  138 (191)
T d1zara2          70 KLQGLAVPKVYAWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE  138 (191)
T ss_dssp             HTTTSSSCCEEEEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET
T ss_pred             HccCCCcceEEEecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC
Confidence            467888888776532    27999999886553       2556677889999999999999999999999999999996


Q ss_pred             CCCEEEeeccCccCCCC
Q 016865           83 YGNLKVSDFGLSALPQQ   99 (381)
Q Consensus        83 ~~~lkl~DFGls~~~~~   99 (381)
                      ++ ++|+|||+|.....
T Consensus       139 ~~-~~liDFG~a~~~~~  154 (191)
T d1zara2         139 EG-IWIIDFPQSVEVGE  154 (191)
T ss_dssp             TE-EEECCCTTCEETTS
T ss_pred             CC-EEEEECCCcccCCC
Confidence            54 89999999876543

>d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Kinase associated domain 1, KA1
domain: Map/microtubule affinity-regulating kinase 3
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.45  E-value=2.1e-13  Score=104.69  Aligned_cols=84  Identities=13%  Similarity=0.165  Sum_probs=78.0

Q ss_pred             EeCCCHHHHHHHHHHHHHHcCcEEEee-cceEEEEeecCCCCccEEEEEEEEEEe-CCeEEEEEEccCCCchhHHHHHHH
Q 016865          280 VSRQPAQVILSNIEAVAESLSLKVHTR-NYKTRLEGVSANKTGQFAVVLEVFEVA-PSLFMVDVRKAAGDTLEYHKFYKN  357 (381)
Q Consensus       280 ~s~~~~~~i~~~l~~~~~~~~~~v~~~-~~~~~~~~~~~~~~~~l~~~~ei~~~~-~~~~~V~~~k~~Gd~le~~~~~~~  357 (381)
                      +|..+|++|+..|+++++.+|+.++.+ .+.++.....++.++.|.|.+||+++. +++++|+|+|.+||+++|+++|.+
T Consensus        16 TS~~~P~eIm~eI~rvL~~lgv~~~~~g~y~l~c~~~~~~~~~~v~fEieV~kv~~~~l~gv~~kR~~Gd~~~yk~l~~~   95 (102)
T d1ul7a_          16 TSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASK   95 (102)
T ss_dssp             CBCSCHHHHHHHHHHHHHHTTCEEEECSTTCEEEEECSSCGGGCEEEEEEEEECSSSSSEEEEEEEEESCHHHHHHHHHH
T ss_pred             CcCCCHHHHHHHHHHHHHHcCcEEEEcCCEEEEEEecCCCCCceEEEEEEEEEcCCCceEEEEEEEccCCHHHHHHHHHH
Confidence            689999999999999999999999875 488999988888899999999999995 799999999999999999999999


Q ss_pred             HHHhcc
Q 016865          358 FCAKLE  363 (381)
Q Consensus       358 l~~~l~  363 (381)
                      |...|+
T Consensus        96 il~~l~  101 (102)
T d1ul7a_          96 IANELK  101 (102)
T ss_dssp             HHHHCC
T ss_pred             HHHhcc
Confidence            988775

>d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Ssp2 C-terminal domain-like
domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.06  E-value=1.5e-05  Score=63.12  Aligned_cols=72  Identities=15%  Similarity=0.263  Sum_probs=59.8

Q ss_pred             EEeCCCHHHHHHHHHHHHHHcCcEEEeec-ceEEEEeecCCCCccEEEEEEEEEEeCCeEEEEEEccCCCchh
Q 016865          279 FVSRQPAQVILSNIEAVAESLSLKVHTRN-YKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLE  350 (381)
Q Consensus       279 f~s~~~~~~i~~~l~~~~~~~~~~v~~~~-~~~~~~~~~~~~~~~l~~~~ei~~~~~~~~~V~~~k~~Gd~le  350 (381)
                      .-|...|.+||..|..|++.+|+.|++-+ |.+++..........+.|.+++|++.++.+||||+...|+-.|
T Consensus         5 IrS~s~P~dIM~eVyrALk~L~~eWk~~~~y~ir~R~~~~~~~~~~Km~lQLYqv~~~~YLLDfk~i~~~~~e   77 (153)
T d2v8qa1           5 IRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE   77 (153)
T ss_dssp             EEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred             cccCCCHHHHHHHHHHHHHHcCCeEEecCceEEEEEEECCCCCceeEEEEEEEEEcCCceEEEeeecCcchhc
Confidence            35788999999999999999999998754 7888876655545668899999999999999999999998655

>d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Ssp2 C-terminal domain-like
domain: Snf1-like protein kinase ssp2
species: Schizosaccharomyces pombe [TaxId: 4896]

Probab=97.70  E-value=0.00011  Score=56.82  Aligned_cols=85  Identities=19%  Similarity=0.244  Sum_probs=63.5

Q ss_pred             EEeCCCHHHHHHHHHHHHHHcCcEEEeec----------ceEEEEeec-----CCCCccEEEEEEEEEEeCCeEEEEEE-
Q 016865          279 FVSRQPAQVILSNIEAVAESLSLKVHTRN----------YKTRLEGVS-----ANKTGQFAVVLEVFEVAPSLFMVDVR-  342 (381)
Q Consensus       279 f~s~~~~~~i~~~l~~~~~~~~~~v~~~~----------~~~~~~~~~-----~~~~~~l~~~~ei~~~~~~~~~V~~~-  342 (381)
                      .-|...|.+||..|..|++++|+.|++-+          +.+++....     .....-+.|.+++|++.++.+||||+ 
T Consensus         7 IRSrs~P~eiM~eVYrALk~Lg~eWk~~~~~~~~~~~d~y~Ir~R~~~~~~~~~~~~~~vkm~iQLYqve~~~YLlDFK~   86 (127)
T d2qrda1           7 VRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFMLDVKS   86 (127)
T ss_dssp             EEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEEEEEEE
T ss_pred             cccCCChHHHHHHHHHHHHHcCCEEeecCcccccccCCceEEEEEeecCCccccCCCceEEEEEEEEEEcCCcEEEEEcc
Confidence            35788999999999999999999998643          557666321     22233478889999999999999998 


Q ss_pred             -----ccCC-------------CchhHHHHHHHHHHhcc
Q 016865          343 -----KAAG-------------DTLEYHKFYKNFCAKLE  363 (381)
Q Consensus       343 -----k~~G-------------d~le~~~~~~~l~~~l~  363 (381)
                           ...|             .+.+|-.+|.+|.-.|.
T Consensus        87 dg~e~~~~~~~~~~~~~~~~~~s~~pFldl~a~LI~qL~  125 (127)
T d2qrda1          87 NGYKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKLF  125 (127)
T ss_dssp             EEEEESCC-------------CCCTTHHHHHHHHHHHHH
T ss_pred             CCcccccCCccccccCccccccCCccHHHHHHHHHHHHh
Confidence                 2222             24778888888776664

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.34  E-value=0.00011  Score=64.37  Aligned_cols=82  Identities=12%  Similarity=0.115  Sum_probs=56.6

Q ss_pred             cccceEEEEeCCEEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------
Q 016865            9 IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-----------------------   65 (381)
Q Consensus         9 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~L~~LH~-----------------------   65 (381)
                      +.+++.+.++.+..|+||++++|..+.+.....     .....+..++...+..||+                       
T Consensus        72 vP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~  146 (263)
T d1j7la_          72 VPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLL  146 (263)
T ss_dssp             CCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHH
T ss_pred             CCcEEEEEecCCceEEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHH
Confidence            567788888899999999999998775543221     1122233344444444442                       


Q ss_pred             ------------------------------------CCCeecCCCCCcEEEccCCCEEEeeccCcc
Q 016865           66 ------------------------------------KGVYHRDLKPENLLLDSYGNLKVSDFGLSA   95 (381)
Q Consensus        66 ------------------------------------~gi~HrDlkp~NiLl~~~~~lkl~DFGls~   95 (381)
                                                          ..++|+|+.|.|||+++++..-|.||+.+.
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         147 NNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                                126899999999999976666799999764

>d2qlva1 d.129.6.2 (A:460-630) Carbon catabolite-derepressing protein kinase SNF1 {Saccharomyces cerevisiae [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Ssp2 C-terminal domain-like
domain: Carbon catabolite-derepressing protein kinase SNF1
species: Saccharomyces cerevisiae [TaxId: 4932]

Probab=97.33  E-value=0.0004  Score=56.41  Aligned_cols=86  Identities=13%  Similarity=0.234  Sum_probs=58.7

Q ss_pred             cEEEeCCCHHHHHHHHHHHHHHcCcEEEeec----ceEEEEeec---------CCCCccEEEEEEEEEEeCCeEEEEEEc
Q 016865          277 TRFVSRQPAQVILSNIEAVAESLSLKVHTRN----YKTRLEGVS---------ANKTGQFAVVLEVFEVAPSLFMVDVRK  343 (381)
Q Consensus       277 trf~s~~~~~~i~~~l~~~~~~~~~~v~~~~----~~~~~~~~~---------~~~~~~l~~~~ei~~~~~~~~~V~~~k  343 (381)
                      =..-|..+|.+||..|..|++++|+.|++-+    +.+++....         ......+.|.+++|++.++.+||||+-
T Consensus        48 fGIRSrs~P~eiM~evykALk~Lg~eWk~~~~~~~~~ir~Rwk~~~~~~~~~~~~~~~~vk~~iQLYqv~~~~YLlDFK~  127 (171)
T d2qlva1          48 FGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVDFKF  127 (171)
T ss_dssp             ESEEECSCHHHHHHHHHHHHHHHTCEECCCC---CCEEEEEEC--------------CEEEEEEEEEC---CCEEEEEEE
T ss_pred             eecccCCCHHHHHHHHHHHHHHcCCEEeecCCCCceEEEEEeecCCCcccccCCCCCceEEEEEEEEEEcCCceEEEEec
Confidence            3457899999999999999999999997643    567665321         111234788999999999999999973


Q ss_pred             -----cCC----------------CchhHHHHHHHHHHhc
Q 016865          344 -----AAG----------------DTLEYHKFYKNFCAKL  362 (381)
Q Consensus       344 -----~~G----------------d~le~~~~~~~l~~~l  362 (381)
                           +.|                .+.+|-++|.+|.-.|
T Consensus       128 ~g~e~~~~~~~~~~~~~~~e~~~~Sp~pFldlca~LI~qL  167 (171)
T d2qlva1         128 DGWESSYGDDTTVSNISEDEMSTFSAYPFLHLTTKLIMEL  167 (171)
T ss_dssp             EEEEC--------------CHHHHTSHHHHHHHHHHHHHH
T ss_pred             CCccccccccccccccCCCcccCcCCccHHHHHHHHHHHH
Confidence                 222                2366888887766554

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=96.51  E-value=0.00057  Score=59.14  Aligned_cols=28  Identities=21%  Similarity=0.156  Sum_probs=24.5

Q ss_pred             CeecCCCCCcEEEccCCCEEEeeccCcc
Q 016865           68 VYHRDLKPENLLLDSYGNLKVSDFGLSA   95 (381)
Q Consensus        68 i~HrDlkp~NiLl~~~~~lkl~DFGls~   95 (381)
                      ++|+|+.|.|||+++++.+-|+||+.+.
T Consensus       177 liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         177 VTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             EEeCCCCCcceEEeCCceEEEEEchhcc
Confidence            7999999999999987667899999654

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=95.23  E-value=0.0078  Score=55.75  Aligned_cols=28  Identities=21%  Similarity=0.242  Sum_probs=24.1

Q ss_pred             CCeecCCCCCcEEEccCCCEEEeeccCcc
Q 016865           67 GVYHRDLKPENLLLDSYGNLKVSDFGLSA   95 (381)
Q Consensus        67 gi~HrDlkp~NiLl~~~~~lkl~DFGls~   95 (381)
                      .++|+|+.|.|||+++++ ++|.||..+.
T Consensus       224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~  251 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE-TKVIDPEFAF  251 (392)
T ss_dssp             EEECSCCCGGGEEECSSC-EEECCCTTCE
T ss_pred             ceeccCCcCCceeEcCCc-eEEechhhcc
Confidence            589999999999998765 8999998654

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=93.18  E-value=0.011  Score=52.60  Aligned_cols=29  Identities=28%  Similarity=0.337  Sum_probs=26.2

Q ss_pred             CCCeecCCCCCcEEEccCCCEEEeeccCc
Q 016865           66 KGVYHRDLKPENLLLDSYGNLKVSDFGLS   94 (381)
Q Consensus        66 ~gi~HrDlkp~NiLl~~~~~lkl~DFGls   94 (381)
                      .|++|+|+.+.|+++++++..-|.||+.+
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~  211 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFA  211 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred             cccccCCcchhhhhcccccceeEeccccc
Confidence            47999999999999998887789999965

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=88.29  E-value=0.17  Score=44.92  Aligned_cols=28  Identities=21%  Similarity=0.188  Sum_probs=22.7

Q ss_pred             CCCeecCCCCCcEEEccCCCEEEeeccCcc
Q 016865           66 KGVYHRDLKPENLLLDSYGNLKVSDFGLSA   95 (381)
Q Consensus        66 ~gi~HrDlkp~NiLl~~~~~lkl~DFGls~   95 (381)
                      .+++|+|+.|.|||+++ + ..+.||+-+.
T Consensus       192 ~~liHgDlh~~NvL~~~-~-~~~IDFdd~~  219 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRD-G-PMFVDLDDAR  219 (325)
T ss_dssp             CEECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred             ceeecCCCCcccEEEeC-C-ceEEechhcc
Confidence            36899999999999974 3 4589999764